PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	McNamara, CW; Lee, MCS; Lim, CS; Lim, SH; Roland, J; Nagle, A; Simon, O; Yeung, BKS; Chatterjee, AK; McCormack, SL; Manary, MJ; Zeeman, AM; Dechering, KJ; Kumar, TRS; Henrich, PP; Gagaring, K; Ibanez, M; Kato, N; Kuhen, KL; Fischli, C; Rottmann, M; Plouffe, DM; Bursulaya, B; Meister, S; Rameh, L; Trappe, J; Haasen, D; Timmerman, M; Sauerwein, RW; Suwanarusk, R; Russell, B; Renia, L; Nosten, F; Tully, DC; Kocken, CHM; Glynne, RJ; Bodenreider, C; Fidock, DA; Diagana, TT; Winzeler, EA				McNamara, Case W.; Lee, Marcus C. S.; Lim, Chek Shik; Lim, Siau Hoi; Roland, Jason; Nagle, Advait; Simon, Oliver; Yeung, Bryan K. S.; Chatterjee, Arnab K.; McCormack, Susan L.; Manary, Micah J.; Zeeman, Anne-Marie; Dechering, Koen J.; Kumar, T. R. Santha; Henrich, Philipp P.; Gagaring, Kerstin; Ibanez, Maureen; Kato, Nobutaka; Kuhen, Kelli L.; Fischli, Christoph; Rottmann, Matthias; Plouffe, David M.; Bursulaya, Badry; Meister, Stephan; Rameh, Lucia; Trappe, Joerg; Haasen, Dorothea; Timmerman, Martijn; Sauerwein, Robert W.; Suwanarusk, Rossarin; Russell, Bruce; Renia, Laurent; Nosten, Francois; Tully, David C.; Kocken, Clemens H. M.; Glynne, Richard J.; Bodenreider, Christophe; Fidock, David A.; Diagana, Thierry T.; Winzeler, Elizabeth A.			Targeting Plasmodium PI(4)K to eliminate malaria	NATURE			English	Article							ZINC-FINGER NUCLEASES; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; SACCHAROMYCES-CEREVISIAE; DRUG DISCOVERY; FALCIPARUM; KINASE; VIVAX; YEAST; TRANSMISSION; POTENT	Achieving the goal of malaria elimination will depend on targeting Plasmodium pathways essential across all life stages. Here we identify a lipid kinase, phosphatidylinositol-4-OH kinase (PI(4)K), as the target of imidazopyrazines, a new antimalarial compound class that inhibits the intracellular development of multiple Plasmodium species at each stage of infection in the vertebrate host. Imidazopyrazines demonstrate potent preventive, therapeutic, and transmission-blocking activity in rodent malaria models, are active against blood-stage field isolates of the major human pathogens P. falciparum and P. vivax, and inhibit liver-stage hypnozoites in the simian parasite P. cynomolgi. We show that imidazopyrazines exert their effect through inhibitory interaction with the ATP-binding pocket of PI(4)K, altering the intracellular distribution of phosphatidylinositol-4-phosphate. Collectively, our data define PI(4)K as a key Plasmodium vulnerability, opening up new avenues of target-based discovery to identify drugs with an ideal activity profile for the prevention, treatment and elimination of malaria.	[McNamara, Case W.; Roland, Jason; Nagle, Advait; Chatterjee, Arnab K.; McCormack, Susan L.; Gagaring, Kerstin; Ibanez, Maureen; Kato, Nobutaka; Kuhen, Kelli L.; Plouffe, David M.; Bursulaya, Badry; Tully, David C.; Glynne, Richard J.; Winzeler, Elizabeth A.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Lee, Marcus C. S.; Kumar, T. R. Santha; Henrich, Philipp P.; Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Lim, Chek Shik; Lim, Siau Hoi; Simon, Oliver; Yeung, Bryan K. S.; Diagana, Thierry T.] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Manary, Micah J.; Meister, Stephan; Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Zeeman, Anne-Marie; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands; [Dechering, Koen J.; Timmerman, Martijn; Sauerwein, Robert W.] TropIQ Hlth Sci, NL-6525 GA Nijmegen, Netherlands; [Fischli, Christoph; Rottmann, Matthias] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Rottmann, Matthias] Univ Basel, CH-4003 Basel, Switzerland; [Rameh, Lucia] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Trappe, Joerg; Haasen, Dorothea] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [Suwanarusk, Rossarin; Russell, Bruce; Renia, Laurent] ASTAR, Singapore Immunol Network, Lab Malaria Immunobiol, Biopolis, Singapore 138648, Singapore; [Russell, Bruce] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117545, Singapore; [Nosten, Francois] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford OX3 7BN, England; [Nosten, Francois] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot 63110, Thailand; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA	Novartis; Columbia University; Novartis; University of California System; University of California San Diego; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Boston University; Novartis; Radboud University Nijmegen; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Columbia University	Winzeler, EA (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	thierry.diagana@novartis.com; ewinzeler@ucsd.edu	Sauerwein, Robert/C-8519-2013; Meister, Stephan/M-6608-2014; Russell, Bruce/A-9240-2011; Nosten, Francois/AAC-5509-2019; Renia, Laurent/E-2117-2011; Suwanarusk, Rossarin/E-2115-2013; Winzeler, Elizabeth/AAP-6752-2020	Meister, Stephan/0000-0003-2436-7037; Russell, Bruce/0000-0003-2333-4348; Nosten, Francois/0000-0002-7951-0745; Renia, Laurent/0000-0003-0349-1557; Suwanarusk, Rossarin/0000-0002-7310-245X; Winzeler, Elizabeth/0000-0002-4049-2113; Lee, Marcus/0000-0002-4973-0915; Fidock, David/0000-0001-6753-8938; Zeeman, Anne-Marie/0000-0002-0157-4669; Yeung, Bryan KS/0000-0002-8866-1764; Kocken, Clemens/0000-0002-4784-1734; Rottmann, Matthias/0000-0002-2207-7899	Wellcome Trust [WT078285, WT096157]; Medicines for Malaria Venture (MMV); Swiss Tropical and Public Health Institute; Columbia University; Novartis Institute for Tropical Diseases; Singapore Immunology Network and Horizontal Programme on Infectious Diseases under the Agency Science Technology and Research (A*STAR, Singapore); Wellcome Trust (UK); Wellcome Trust (UK), as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Bill and Melinda Gates Foundation; National Institutes of Health [R01AI090141, R01085584, R01079709]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079709, R01AI085584, R01AI103058, R01AI090141] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Medicines for Malaria Venture (MMV); Swiss Tropical and Public Health Institute; Columbia University; Novartis Institute for Tropical Diseases; Singapore Immunology Network and Horizontal Programme on Infectious Diseases under the Agency Science Technology and Research (A*STAR, Singapore); Wellcome Trust (UK)(Wellcome Trust); Wellcome Trust (UK), as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Miller for critical review of the manuscript and figure design. We also thank A. Rodriguez and the insectary core facility team at New York University for reliable supplies of malaria-infected mosquitoes. We gratefully acknowledge translational research grants (WT078285 and WT096157) from the Wellcome Trust and funding from the Medicines for Malaria Venture (MMV) to the Genomics Institute of the Novartis Research Foundation, the Swiss Tropical and Public Health Institute, Columbia University, the Novartis Institute for Tropical Diseases, the Singapore Immunology Network and Horizontal Programme on Infectious Diseases under the Agency Science Technology and Research (A*STAR, Singapore), and the Wellcome Trust (UK). Shoklo Malaria Research Unit is sponsored by The Wellcome Trust (UK), as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University. E. A. W. and D. A. F. are supported by grants from the Bill and Melinda Gates Foundation, MMV, and the National Institutes of Health (R01AI090141 to E. A. W. and R01085584 and R01079709 to D.A.F.).	Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; D'Alessandro S, 2013, J ANTIMICROB CHEMOTH, V68, P2048, DOI 10.1093/jac/dkt165; de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.E03-12-0862; Dechering KJ, 1997, MOL BIOCHEM PARASIT, V89, P235, DOI 10.1016/S0166-6851(97)00123-0; Dembele L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018162; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Fidock DA, 1998, MOL PHARMACOL, V54, P1140, DOI 10.1124/mol.54.6.1140; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Furet P, 2013, BIOORG MED CHEM LETT, V23, P3741, DOI 10.1016/j.bmcl.2013.05.007; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; GUGUENGUILLOUZO C, 1982, CELL BIOL INT REP, V6, P625, DOI 10.1016/0309-1651(82)90187-4; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kruger T, 2010, MOL BIOCHEM PARASIT, V172, P149, DOI 10.1016/j.molbiopara.2010.03.020; LaMarche MJ, 2012, ANTIMICROB AGENTS CH, V56, P5149, DOI 10.1128/AAC.00946-12; Li C, 2013, DRUG DISCOV TODAY, V18, P71, DOI 10.1016/j.drudis.2012.09.004; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Mandl A, 2007, MOL CELL BIOL, V27, P8098, DOI 10.1128/MCB.00756-07; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Mayinger P, 2012, BBA-MOL CELL BIOL L, V1821, P1104, DOI 10.1016/j.bbalip.2012.01.002; MAZIER D, 1985, SCIENCE, V227, P440, DOI 10.1126/science.3880923; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Onishi M, 2010, MOL CELL BIOL, V30, P2057, DOI 10.1128/MCB.01529-09; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Polevoy G, 2009, J CELL BIOL, V187, P847, DOI 10.1083/jcb.200908107; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Russell B, 2008, ANTIMICROB AGENTS CH, V52, P1040, DOI 10.1128/AAC.01334-07; Russell BM, 2003, ANTIMICROB AGENTS CH, V47, P170, DOI 10.1128/AAC.47.1.170-173.2003; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Vale N, 2009, EUR J MED CHEM, V44, P937, DOI 10.1016/j.ejmech.2008.08.011; Van Der Kolk M, 2005, PARASITOLOGY, V130, P13, DOI 10.1017/S0031182004006067; van Pelt-Koops JC, 2012, ANTIMICROB AGENTS CH, V56, P3544, DOI 10.1128/AAC.06377-11; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005	46	285	292	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					248	+		10.1038/nature12782	http://dx.doi.org/10.1038/nature12782			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24284631	Green Accepted, Green Submitted			2022-12-24	WOS:000328121500030
J	Tan, CL; Plotkin, JL; Veno, MT; von Schimmelmann, M; Feinberg, P; Mann, S; Handler, A; Kjems, J; Surmeier, DJ; O'Carroll, D; Greengard, P; Schaefer, A				Tan, Chan Lek; Plotkin, Joshua L.; Veno, Morten T.; von Schimmelmann, Melanie; Feinberg, Philip; Mann, Silas; Handler, Annie; Kjems, Jorgen; Surmeier, D. James; O'Carroll, Donal; Greengard, Paul; Schaefer, Anne			MicroRNA-128 Governs Neuronal Excitability and Motor Behavior in Mice	SCIENCE			English	Article							SYNAPTIC PLASTICITY; RECEPTOR; BRAIN; SPECIFICITY; ACTIVATION; EXPRESSION; STRIATUM; EPILEPSY; KINASE	The control of motor behavior in animals and humans requires constant adaptation of neuronal networks to signals of various types and strengths. We found that microRNA-128 (miR-128), which is expressed in adult neurons, regulates motor behavior by modulating neuronal signaling networks and excitability. miR-128 governs motor activity by suppressing the expression of various ion channels and signaling components of the extracellular signal-regulated kinase ERK2 network that regulate neuronal excitability. In mice, a reduction of miR-128 expression in postnatal neurons causes increased motor activity and fatal epilepsy. Overexpression of miR-128 attenuates neuronal responsiveness, suppresses motor activity, and alleviates motor abnormalities associated with Parkinson's-like disease and seizures in mice. These data suggest a therapeutic potential for miR-128 in the treatment of epilepsy and movement disorders.	[Tan, Chan Lek; von Schimmelmann, Melanie; Feinberg, Philip; Mann, Silas; Handler, Annie; Greengard, Paul; Schaefer, Anne] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Plotkin, Joshua L.; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Veno, Morten T.; Kjems, Jorgen] Aarhus Univ, Fac Sci, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Veno, Morten T.; Kjems, Jorgen] Aarhus Univ, Fac Sci, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [von Schimmelmann, Melanie; Feinberg, Philip; Mann, Silas; Schaefer, Anne] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Psychiat, Fishberg Dept Neurosci, New York, NY 10029 USA; [O'Carroll, Donal] European Mol Biol Lab, Mouse Biol Unit, I-00015 Monterotondo, Italy; [O'Carroll, Donal] Rockefeller Univ, Lab Immune Cell Epigenet & Signaling, New York, NY 10065 USA	Rockefeller University; Northwestern University; Feinberg School of Medicine; Aarhus University; Aarhus University; Icahn School of Medicine at Mount Sinai; European Molecular Biology Laboratory (EMBL); Rockefeller University	Schaefer, A (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA.	anne.schaefer@mssm.edu	Plotkin, Joshua/AAJ-5043-2021; Kjems, Jorgen/I-3490-2016	Kjems, Jorgen/0000-0003-4128-9317; Veno, Morten/0000-0002-4754-5193; Greengard, Paul/0000-0002-4437-0893; Handler, Annie/0000-0001-6414-8627; Tan, Chan Lek/0000-0001-5032-5119; Plotkin, Joshua/0000-0001-6232-7613; O'Carroll, Donal/0000-0002-8626-2217	NIH [1DP2MH100012-01, DA025962, P50MH090963, DA10044, NS34696]; Seaver Autism Foundation; USAMRAA [W81XWH-090100402]; JPB Foundation; Lundbeck Foundation; Center for Integrative Sequencing at Aarhus University; CHDI Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [DP2MH100012, P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044, R03DA025962] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Autism Foundation; USAMRAA; JPB Foundation; Lundbeck Foundation(Lundbeckfonden); Center for Integrative Sequencing at Aarhus University; CHDI Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Rajewsky, G. Schuetz, and N. Heintz for mice and reagents. We thank C. Bargman and A. Tarakhovsky for valuable comments and P. Zamore for advice and critical reading of the manuscript. This work was supported by the NIH 1DP2MH100012-01 and DA025962 (A. S.), P50MH090963 (P. G., A. S., and D.J.S.), DA10044 (P. G.), NS34696 (D.J.S.), the Seaver Autism Foundation (A. S.), the USAMRAA W81XWH-090100402 and JPB Foundation (P. G.), the Lundbeck Foundation and Center for Integrative Sequencing at Aarhus University (M. T. V. and J.K), and the CHDI Foundation (D.J.S.). The authors declare no competing financial interests. The microarray data reported in this paper are archived at the Gene Expression Omnibus (GEO) Repository (www.ncbi.nlm.nih.gov/geo, accession no. GSE48813). Correspondence and requests for materials should be addressed to A. S. via anne.schaefer@mssm.edu. Mount Sinai and The Rockefeller University filed a United State provisional patent application (61/896,463 and 61/898,952) that covers the treatment of epilepsy using miR-128.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blair MA, 2011, EPILEPSIA, V52, P993, DOI 10.1111/j.1528-1167.2011.03059.x; Brodie MJ, 2010, SEIZURE-EUR J EPILEP, V19, P650, DOI 10.1016/j.seizure.2010.10.027; Cenci MA, 2010, PROG BRAIN RES, V183, P209, DOI 10.1016/S0079-6123(10)83011-0; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chioza BA, 2009, EPILEPSY RES, V87, P247, DOI 10.1016/j.eplepsyres.2009.09.010; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Feyder M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00071; Gerfen CR, 2002, J NEUROSCI, V22, P5042, DOI 10.1523/JNEUROSCI.22-12-05042.2002; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Kim DS, 2000, J NEUROSCI, V20, P4405, DOI 10.1523/JNEUROSCI.20-12-04405.2000; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Megraw M, 2010, THEOR CHEM ACC, V125, P593, DOI 10.1007/s00214-009-0647-4; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nateri AS, 2007, EMBO J, V26, P4891, DOI 10.1038/sj.emboj.7601911; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Ramos JW, 2000, MOL BIOL CELL, V11, P2863, DOI 10.1091/mbc.11.9.2863; Schaefer A, 2010, J EXP MED, V207, P1843, DOI 10.1084/jem.20100451; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Valjent E, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-20; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267	30	195	200	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1254	1258		10.1126/science.1244193	http://dx.doi.org/10.1126/science.1244193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311694	Green Accepted			2022-12-24	WOS:000327857900053
J	Zhai, SY; Ark, ED; Parra-Bueno, P; Yasuda, R				Zhai, Shenyu; Ark, Eugene D.; Parra-Bueno, Paula; Yasuda, Ryohei			Long-Distance Integration of Nuclear ERK Signaling Triggered by Activation of a Few Dendritic Spines	SCIENCE			English	Article							LATE-PHASE; TRANSCRIPTION FACTORS; SYNAPTIC ACTIVATION; TERM POTENTIATION; PLASTICITY; CA2+; RAS; RECEPTORS; CELL	The late phase of long-term potentiation (LTP) at glutamatergic synapses, which is thought to underlie long-lasting memory, requires gene transcription in the nucleus. However, the mechanism by which signaling initiated at synapses is transmitted into the nucleus to induce transcription has remained elusive. Here, we found that induction of LTP in only three to seven dendritic spines in rat CA1 pyramidal neurons was sufficient to activate extracellular signal-regulated kinase (ERK) in the nucleus and regulate downstream transcription factors. Signaling from individual spines was integrated over a wide range of time (>30 minutes) and space (>80 micrometers). Spatially dispersed inputs over multiple branches activated nuclear ERK much more efficiently than clustered inputs over one branch. Thus, biochemical signals from individual dendritic spines exert profound effects on nuclear signaling.	[Zhai, Shenyu; Ark, Eugene D.; Yasuda, Ryohei] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Parra-Bueno, Paula; Yasuda, Ryohei] Max Planck Florida Inst Neurosci, Jupiter, FL 33458 USA; [Yasuda, Ryohei] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Max Planck Society; Duke University; Howard Hughes Medical Institute	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ryohei.yasuda@mpfi.org		Yasuda, Ryohei/0000-0001-6263-9297; Zhai, Shenyu/0000-0002-7097-9387	Howard Hughes Medical Institute; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068410] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. West, S. Dudek, S. Soderling, K. Tanaka, and G. Augustine for discussion; N. Hedrick and L. Colgan for comments on the manuscript; A. Wan for preparing cultured slices; and D. Kloetzer for laboratory management. This study was funded by Howard Hughes Medical Institute, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke. The authors made the following contributions: S.Z. and R.Y. designed experiments, S.Z. collected the majority of the data, E.D.A. performed the GCaMP imaging with pharmacological inhibitors, P.P.-B. performed the patch clamp experiments, S.Z. and R.Y. analyzed the data and wrote the paper, and all authors discussed the results and commented on the manuscript.	Adams JP, 2005, NAT REV NEUROSCI, V6, P737, DOI 10.1038/nrn1749; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dudek SM, 2002, P NATL ACAD SCI USA, V99, P3962, DOI 10.1073/pnas.062510599; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Goldberg J, 2002, TRENDS NEUROSCI, V25, P433, DOI 10.1016/S0166-2236(02)02200-2; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Hagenston AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004564; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Karpova A, 2013, CELL, V152, P1119, DOI 10.1016/j.cell.2013.02.002; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Patterson MA, 2010, P NATL ACAD SCI USA, V107, P15951, DOI 10.1073/pnas.0913875107; Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	35	76	79	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1107	1111		10.1126/science.1245622	http://dx.doi.org/10.1126/science.1245622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288335	Green Accepted			2022-12-24	WOS:000327518600061
J	Willyard, C				Willyard, Cassandra			STEM CELLS A time to heal	NATURE			English	Editorial Material							SPINAL-CORD-INJURY											Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Park JH, 2012, NEUROSURGERY, V70, P1238, DOI 10.1227/NEU.0b013e31824387f9; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Zhang YW, 2006, STEM CELLS DEV, V15, P943, DOI 10.1089/scd.2006.15.943	6	10	10	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S4	S6		10.1038/503S4a	http://dx.doi.org/10.1038/503S4a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24227005				2022-12-24	WOS:000326894200003
J	Das, S; Marsden, PA				Das, Sunit; Marsden, Philip A.			Angiogenesis in Glioblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELLS; GROWTH		[Das, Sunit] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Das, Sunit] St Michaels Hosp, Dept Neurosurg, Toronto, ON M5B 1W8, Canada; [Das, Sunit] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Marsden, Philip A.] Univ Toronto, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Das, S (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Das, Sunit/J-3903-2015	Das, Sunit/0000-0002-2146-4168	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076540] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL076540] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Ricci-Vitiani L, 2011, NATURE, V469, P432, DOI 10.1038/nature09734; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624	5	158	159	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1561	1563		10.1056/NEJMcibr1309402	http://dx.doi.org/10.1056/NEJMcibr1309402			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	24131182	Green Accepted			2022-12-24	WOS:000328101700017
J	Zhou, LJ; Hang, J; Zhou, YL; Wan, RX; Lu, GF; Yin, P; Yan, CY; Shi, YG				Zhou, Lijun; Hang, Jing; Zhou, Yulin; Wan, Ruixue; Lu, Guifeng; Yin, Ping; Yan, Chuangye; Shi, Yigong			Crystal structures of the Lsm complex bound to the 3 ' end sequence of U6 small nuclear RNA	NATURE			English	Article							SM-LIKE PROTEINS; SNRNA; U1; YEAST; CORE; U2; U4; RIBONUCLEOPROTEINS; CHAPERONE; DOMAIN	Splicing of precursor messenger RNA (pre-mRNA) in eukaryotic cells is carried out by the spliceosome(1), which consists of five small nuclear ribonucleoproteins (snRNPs) and a number of accessory factors and enzymes(2). Each snRNP contains a ring-shaped subcomplex of seven proteins and a specific RNA molecule(2-4). The U6 snRNP contains a unique heptameric Lsm protein complex, which specifically recognizes the U6 small nuclear RNA at its 3' end. Here we report the crystal structures of the heptameric Lsm complex, both by itself and in complex with a 3' fragment of U6 snRNA, at 2.8 angstrom resolution. Each of the seven Lsm proteins interacts with two neighbouring Lsm components to form a doughnut-shaped assembly, with the order Lsm3-2-8-4-7-5-6. The four uridine nucleotides at the 3' end of U6 snRNA are modularly recognized by Lsm3, Lsm2, Lsm8 and Lsm4, with the uracil base specificity conferred by a highly conserved asparagine residue. The uracil base at the extreme 3' end is sandwiched by His 36 and Arg 69 from Lsm3, through pi-pi and cation-pi interactions, respectively. The distinctive end-recognition of U6 snRNA by the Lsm complex contrasts with RNA binding by the Sm complex in the other snRNPs. The structural features and associated biochemical analyses deepen mechanistic understanding of the U6 snRNP function in pre-mRNA splicing.	[Zhou, Lijun; Zhou, Yulin; Shi, Yigong] Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China; [Zhou, Lijun; Hang, Jing; Yin, Ping; Yan, Chuangye; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Zhou, Lijun; Hang, Jing; Yin, Ping; Yan, Chuangye; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Hang, Jing; Wan, Ruixue; Lu, Guifeng; Yan, Chuangye] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X; Zhou, Lijun/0000-0002-0393-4787	National Natural Science Foundation of China [31130002, 31021002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank S. Huang and J. He at SSRF beamline BL17U and N. Shimizu, T. Kumasaka, and S. Baba at the Spring-8 beamline BL41XU for on-site assistance. This work was supported by funds from National Natural Science Foundation of China projects 31130002 and 31021002.	Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERGET SM, 1986, CELL, V46, P691, DOI 10.1016/0092-8674(86)90344-2; BLACK DL, 1986, CELL, V46, P697, DOI 10.1016/0092-8674(86)90345-4; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; DATTA B, 1991, NATURE, V352, P821, DOI 10.1038/352821a0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FABRIZIO P, 1994, SCIENCE, V264, P261, DOI 10.1126/science.8146658; He WH, 2000, CURR OPIN CELL BIOL, V12, P346, DOI 10.1016/S0955-0674(00)00098-3; HINTERBERGER M, 1983, J BIOL CHEM, V258, P2604; JANDROSITZ A, 1995, EMBO J, V14, P820, DOI 10.1002/j.1460-2075.1995.tb07060.x; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Karaduman R, 2006, J MOL BIOL, V356, P1248, DOI 10.1016/j.jmb.2005.12.013; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Leung AKW, 2011, NATURE, V473, P536, DOI 10.1038/nature09956; Licht K, 2008, RNA, V14, P1532, DOI 10.1261/rna.1129608; LUND E, 1992, SCIENCE, V255, P327, DOI 10.1126/science.1549778; Martin-Tumasz S, 2011, NUCLEIC ACIDS RES, V39, P7837, DOI 10.1093/nar/gkr455; Martin-Tumasz S, 2010, RNA, V16, P792, DOI 10.1261/rna.1913310; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore M., 1993, RNA WORLD, P303; Nilsen Timothy W, 2013, Cold Spring Harb Protoc, V2013, P180, DOI 10.1101/pdb.prot072942; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannone BK, 1998, EMBO J, V17, P7442, DOI 10.1093/emboj/17.24.7442; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Will C. L., 2006, RNA WORLD, P181; WU J, 1991, NATURE, V352, P818, DOI 10.1038/352818a0; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zaric B, 2005, J BIOL CHEM, V280, P16066, DOI 10.1074/jbc.M414481200	37	67	77	2	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					116	+		10.1038/nature12803	http://dx.doi.org/10.1038/nature12803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24240276				2022-12-24	WOS:000330648100043
J	Ioannidis, JPA				Ioannidis, John P. A.			More Than a Billion People Taking Statins? Potential Implications of the New Cardiovascular Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Prevent Res Ctr, 1265 Welch Rd,Med Sch Off Bldg,Room X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					Ajay VS, 2010, INDIAN J MED RES, V132, P561; Brawley O, 2011, JAMA-J AM MED ASSOC, V306, P2495, DOI 10.1001/jama.2011.1800; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6989; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5535; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2	9	157	160	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2014	311	5					463	464		10.1001/jama.2013.284657	http://dx.doi.org/10.1001/jama.2013.284657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302GF	24296612				2022-12-24	WOS:000330589800013
J	Coin, I; Katritch, V; Sun, TT; Xiang, Z; Siu, FY; Beyermann, M; Stevens, RC; Wang, L				Coin, Irene; Katritch, Vsevolod; Sun, Tingting; Xiang, Zheng; Siu, Fai Yiu; Beyermann, Michael; Stevens, Raymond C.; Wang, Lei			Genetically Encoded Chemical Probes in Cells Reveal the Binding Path of Urocortin-I to CRF Class B GPCR	CELL			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PROTEIN-COUPLED RECEPTOR; FACTOR TYPE-1 RECEPTOR; SAUVAGINE CROSS-LINKS; COMPETITIVE ANTAGONISTS; PHOTOLABILE PROBES; MAMMALIAN-CELLS; AMINO-ACID; MID-REGION; HORMONE	Molecular determinants regulating the activation of class B G-protein-coupled receptors (GPCRs) by native peptide agonists are largely unknown. We have investigated here the interaction between the corticotropin releasing factor receptor type 1 (CRF1R) and its native 40-mer peptide ligand Urocortin-I directly in mammalian cells. By incorporating unnatural amino acid photochemical and new click-chemical probes into the intact receptor expressed in the native membrane of live cells, 44 intermolecular spatial constraints have been derived for the ligand-receptor interaction. The data were analyzed in the context of the recently resolved crystal structure of CRF1R transmembrane domain and existing extracellular domain structures, yielding a complete conformational model for the peptide-receptor complex. Structural features of the receptor-ligand complex yield molecular insights on the mechanism of receptor activation and the basis for discrimination between agonist and antagonist function.	[Coin, Irene; Sun, Tingting; Xiang, Zheng; Wang, Lei] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Katritch, Vsevolod; Siu, Fai Yiu; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Beyermann, Michael] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	Salk Institute; Scripps Research Institute; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Wang, L (corresponding author), Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA.	lwang@salk.edu	Xiang, Zheng/D-9625-2011; Katritch, Vsevolod/Y-2721-2019; Katritch, Vsevolod/Q-8357-2016; Wang, Lei/E-7912-2011; Stevens, Raymond/K-7272-2015	Katritch, Vsevolod/0000-0003-3883-4505; Wang, Lei/0000-0002-5859-2526; Stevens, Raymond/0000-0002-4522-8725; Xiang, Zheng/0000-0003-2925-842X	European Commission; NIH [U54 GM094618, F32 DK088392, 1DP2OD004744-01, P30CA014195]; CIRM [RN1-00577-1]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004744] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Peptide Biology Laboratory at Salk for sharing the alpha Ucn1 antibody prepared by Joan Vaughan. I.C. was supported by a Marie Curie fellowship from the European Commission (FP7). V.K. and R.C.S. acknowledge support from NIH (U54 GM094618). F.Y.S. was supported by an NIH fellowship (F32 DK088392). L.W. acknowledges support from CIRM (RN1-00577-1) and NIH (1DP2OD004744-01 and P30CA014195). R.C.S. is a founder of Receptors, a GPCR SBDD company, which does not work on CRF1R.	Abagyan RA, 2012, ICM MANUAL; Assil-Kishawi I, 2002, J BIOL CHEM, V277, P32558, DOI 10.1074/jbc.M204964200; Assil-Kishawi I, 2008, J BIOL CHEM, V283, P35644, DOI 10.1074/jbc.M806351200; Beyermann M, 2007, BRIT J PHARMACOL, V151, P851, DOI 10.1038/sj.bjp.0707293; Coin I, 2011, ANGEW CHEM INT EDIT, V50, P8077, DOI 10.1002/anie.201102646; Dong MQ, 2012, FASEB J, V26, P5092, DOI 10.1096/fj.12-212399; Dong M, 2011, J BIOL CHEM, V286, P23888, DOI 10.1074/jbc.M111.245969; Grace CRR, 2007, J AM CHEM SOC, V129, P16102, DOI 10.1021/ja0760933; Grace CRR, 2010, J BIOL CHEM, V285, P38580, DOI 10.1074/jbc.M110.121897; Grunbeck A, 2012, ACS CHEM BIOL, V7, P967, DOI 10.1021/cb300059z; GULYAS J, 1995, P NATL ACAD SCI USA, V92, P10575, DOI 10.1073/pnas.92.23.10575; Hemley CF, 2007, CURR DRUG TARGETS, V8, P105, DOI 10.2174/138945007779315542; Hoare SRJ, 2006, BIOCHEM PHARMACOL, V72, P244, DOI 10.1016/j.bcp.2006.04.007; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; KORNREICH WD, 1992, J MED CHEM, V35, P1870, DOI 10.1021/jm00088a024; Kraetke O, 2005, BIOCHEMISTRY-US, V44, P15569, DOI 10.1021/bi0507027; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; Monaghan P, 2008, BIOCHEMISTRY-US, V47, P5889, DOI 10.1021/bi800122f; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pham VI, 2004, J PEPT SCI, V10, P179, DOI 10.1002/psc.541; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; RIVIER J, 1983, P NATL ACAD SCI-BIOL, V80, P4851, DOI 10.1073/pnas.80.15.4851; Rivier J, 1998, J MED CHEM, V41, P2614, DOI 10.1021/jm980164e; RIVIER J, 1984, SCIENCE, V224, P889, DOI 10.1126/science.6326264; ROMIER C, 1993, PROTEIN ENG, V6, P149, DOI 10.1093/protein/6.2.149; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Takimoto JK, 2009, MOL BIOSYST, V5, P931, DOI 10.1039/b904228h; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xiang Z, 2013, NAT METHODS, V10, P885, DOI [10.1038/NMETH.2595, 10.1038/nmeth.2595]	39	125	125	1	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1258	1269		10.1016/j.cell.2013.11.008	http://dx.doi.org/10.1016/j.cell.2013.11.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24290358	Green Accepted, Bronze			2022-12-24	WOS:000328271100011
J	Sia, GM; Clem, RL; Huganir, RL				Sia, G. M.; Clem, R. L.; Huganir, R. L.			The Human Language-Associated Gene SRPX2 Regulates Synapse Formation and Vocalization in Mice	SCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; ULTRASONIC VOCALIZATION; HIKARU-GENKI; SPEECH; FOXP2; DISORDERS; PROTEIN; AUTISM; DIFFERENTIATION; DROSOPHILA	Synapse formation in the developing brain depends on the coordinated activity of synaptogenic proteins, some of which have been implicated in a number of neurodevelopmental disorders. Here, we show that the sushi repeat-containing protein X-linked 2 (SRPX2) gene encodes a protein that promotes synaptogenesis in the cerebral cortex. In humans, SRPX2 is an epilepsy- and language-associated gene that is a target of the foxhead box protein P2 (FoxP2) transcription factor. We also show that FoxP2 modulates synapse formation through regulating SRPX2 levels and that SRPX2 reduction impairs development of ultrasonic vocalization in mice. Our results suggest FoxP2 modulates the development of neural circuits through regulating synaptogenesis and that SRPX2 is a synaptogenic factor that plays a role in the pathogenesis of language disorders.	[Sia, G. M.; Huganir, R. L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Sia, G. M.; Huganir, R. L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Clem, R. L.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Icahn School of Medicine at Mount Sinai	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, 725 North Wolfe St, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Sia, Gek Ming/0000-0001-9333-0065	National Institutes of Health [P50MH084020, NS050274]; Millipore; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH084020, R01MH095058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millipore; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Pletnikov and J. Yocum of the Behavioral Core Facility and M. Pucak of the Multiphoton/Electrophysiology Core Facility. We also thank H. Vega, S. Yang, N. O'Sullivan, and X. Wang for technical assistance. This study was supported by National Institutes of Health grant P50MH084020 to R.L.H. and grant NS050274 to the Multiphoton Core Facility. Under a licensing agreement between Millipore and the Johns Hopkins University, R.L.H. is entitled to a share of royalties received by the University on sales of products described in this article. R.L.H. is a paid consultant to Millipore. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict-of-interest policies.	Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; French CA, 2007, GENESIS, V45, P440, DOI 10.1002/dvg.20305; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Gaub S, 2010, GENES BRAIN BEHAV, V9, P390, DOI 10.1111/j.1601-183X.2010.00570.x; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; HOSHINO M, 1993, NEURON, V10, P395, DOI 10.1016/0896-6273(93)90329-P; Hoshino M, 1996, DEVELOPMENT, V122, P589; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Reimers-Kipping S, 2011, NEUROSCIENCE, V175, P75, DOI 10.1016/j.neuroscience.2010.11.042; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174	32	93	102	0	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					987	991		10.1126/science.1245079	http://dx.doi.org/10.1126/science.1245079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24179158	Green Accepted			2022-12-24	WOS:000327223500045
J	Nijman, SMB; Friend, SH				Nijman, Sebastian M. B.; Friend, Stephen H.			Potential of the Synthetic Lethality Principle	SCIENCE			English	Editorial Material							GENETIC INTERACTIONS; INHIBITION; THERAPY; CANCER; PHENOTYPE; YEAST; EGFR		[Nijman, Sebastian M. B.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Friend, Stephen H.] Sage Bionetworks, Seattle, WA 98109 USA	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Nijman, SMB (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	snijman@cemm.oeaw.ac.at; friend@sagebase.org		Nijman, Sebastian/0000-0003-0464-6661				Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609	14	51	57	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					809	811		10.1126/science.1244669	http://dx.doi.org/10.1126/science.1244669			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233712				2022-12-24	WOS:000326923000021
J	Engel, C; Sainsbury, S; Cheung, AC; Kostrewa, D; Cramer, P				Engel, Christoph; Sainsbury, Sarah; Cheung, Alan C.; Kostrewa, Dirk; Cramer, Patrick			RNA polymerase I structure and transcription regulation	NATURE			English	Article							CROSS-LINKING; DNA-BINDING; ARCHITECTURE; SUBUNITS; SUBCOMPLEX; COMPLEX; TFIIF; PHOSPHORYLATION; CRYSTALLIZATION; RECRUITMENT	Transcription of ribosomal RNA by RNA polymerase (Pol) I initiates ribosome biogenesis and regulates eukaryotic cell growth. The crystal structure of Pol I from the yeast Saccharomyces cerevisiae at 2.8 angstrom resolution reveals all 14 subunits of the 590-kilodalton enzyme, and shows differences to Pol II. An 'expander' element occupies the DNA template site and stabilizes an expanded active centre cleft with an unwound bridge helix. A 'connector' element invades the cleft of an adjacent polymerase and stabilizes an inactive polymerase dimer. The connector and expander must detach during Pol I activation to enable transcription initiation and cleft contraction by convergent movement of the polymerase 'core' and 'shelf' modules. Conversion between an inactive expanded and an active contracted polymerase state may generally underlie transcription. Regulatory factors can modulate the core-shelf interface that includes a 'composite' active site for RNA chain initiation, elongation, proofreading and termination.	[Engel, Christoph; Sainsbury, Sarah; Cheung, Alan C.; Kostrewa, Dirk; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Engel, Christoph; Sainsbury, Sarah; Cheung, Alan C.; Kostrewa, Dirk; Cramer, Patrick] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci Munich CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de		Engel, Christoph/0000-0001-8451-3599; Cheung, Alan/0000-0001-6430-5127	Boehringer Ingelheim Fonds; Elite Network Bavaria program 'Protein Dynamics in Health and Disease'; Graduate Research Academy 'RNA Biology' of SFB960; Alexander-von-Humboldt Foundation; Deutsche Forschungsgemeinschaft [SFB646, TR5, GraKo1721, SFB960, CIPSM, NIM]; European Research Council; Jung-Stiftung; Vallee Foundation	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Elite Network Bavaria program 'Protein Dynamics in Health and Disease'; Graduate Research Academy 'RNA Biology' of SFB960; Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Jung-Stiftung; Vallee Foundation	We thank C. Kuhn, who obtained the first Pol I crystals. We thank C. Bajen, S. Benkert, S. Geiger, S. Jennebach, T. Gubbey and K. Maier. We thank the crystallization facility (Conti Department) and the Jentsch Department of the Max-Planck-Institut for Biochemistry. Part of this work was performed at the European Synchrotron Radiation Facility at Grenoble, France, and at the Swiss Light Source at the Paul-Scherrer-Institut, Villigen, Switzerland. C. E. was supported by a PhD student fellowship of the Boehringer Ingelheim Fonds, the Elite Network Bavaria program 'Protein Dynamics in Health and Disease', and the Graduate Research Academy 'RNA Biology' of SFB960. S. S. was supported by a postdoctoral fellowship of the Alexander-von-Humboldt Foundation. P. C. was supported by the Deutsche Forschungsgemeinschaft (SFB646, TR5, GraKo1721, SFB960, CIPSM, NIM), an Advanced Grant of the European Research Council, the Jung-Stiftung, and the Vallee Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alic N, 2007, P NATL ACAD SCI USA, V104, P10400, DOI 10.1073/pnas.0704116104; Arimbasseri AG, 2013, BBA-GENE REGUL MECH, V1829, P318, DOI 10.1016/j.bbagrm.2012.10.006; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Beckouet F, 2011, FEBS LETT, V585, P3355, DOI 10.1016/j.febslet.2011.09.011; Bischler N, 1998, BIOPHYS J, V74, P1522, DOI 10.1016/S0006-3495(98)77864-6; Bischler N, 2002, EMBO J, V21, P4136, DOI 10.1093/emboj/cdf392; Blattner C, 2011, GENE DEV, V25, P2093, DOI 10.1101/gad.17363311; BUHLER JM, 1974, J BIOL CHEM, V249, P5963; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Clemente-Blanco A, 2009, NATURE, V458, P219, DOI 10.1038/nature07652; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398; Fernandez-Tornero C, 2010, EMBO J, V29, P3762, DOI 10.1038/emboj.2010.266; Geiger SR, 2008, ACTA CRYSTALLOGR F, V64, P413, DOI 10.1107/S174430910800972X; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Gerber J, 2008, NUCLEIC ACIDS RES, V36, P793, DOI 10.1093/nar/gkm1093; Hirata A, 2008, MOL MICROBIOL, V70, P623, DOI 10.1111/j.1365-2958.2008.06430.x; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Knutson BA, 2011, SCIENCE, V333, P1637, DOI 10.1126/science.1207699; Korkhin Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000102; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Milkereit P, 1998, EMBO J, V17, P3692, DOI 10.1093/emboj/17.13.3692; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; Naidu S, 2011, SCIENCE, V333, P1640, DOI 10.1126/science.1207656; Nielsen S, 2013, SCIENCE, V340, P1577, DOI 10.1126/science.1237934; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; SCHULTZ P, 1993, EMBO J, V12, P2601, DOI 10.1002/j.1460-2075.1993.tb05920.x; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SMID A, 1995, J BIOL CHEM, V270, P13534, DOI 10.1074/jbc.270.22.13534; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Tschochner H, 1996, P NATL ACAD SCI USA, V93, P12914, DOI 10.1073/pnas.93.23.12914; Van Mullem V, 2002, MOL MICROBIOL, V43, P1105; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212; Zuo YH, 2013, MOL CELL, V50, P430, DOI 10.1016/j.molcel.2013.03.020	63	138	156	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					650	+		10.1038/nature12712	http://dx.doi.org/10.1038/nature12712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24153182	Green Published, Green Submitted			2022-12-24	WOS:000326293200040
J	Kuchenreuther, JM; Myers, WK; Stich, TA; George, SJ; NejatyJahromy, Y; Swartz, JR; Britt, RD				Kuchenreuther, Jon M.; Myers, William K.; Stich, Troy A.; George, Simon J.; NejatyJahromy, Yaser; Swartz, James R.; Britt, R. David			A Radical Intermediate in Tyrosine Scission to the CO and CN- Ligands of FeFe Hydrogenase	SCIENCE			English	Article							ESCHERICHIA-COLI; ACONITASE; CLUSTER; HYDG; IDENTIFICATION; CYANIDE; OXYGEN	The radical S-adenosylmethionine (SAM) enzyme HydG lyses free L-tyrosine to produce CO and CN- for the assembly of the catalytic H cluster of FeFe hydrogenase. We used electron paramagnetic resonance spectroscopy to detect and characterize HydG reaction intermediates generated with a set of H-2, C-13, and N-15 nuclear spin-labeled tyrosine substrates. We propose a detailed reaction mechanism in which the radical SAM reaction, initiated at an N-terminal 4Fe-4S cluster, generates a tyrosine radical bound to a C-terminal 4Fe-4S cluster. Heterolytic cleavage of this tyrosine radical at the C-alpha-C-beta bond forms a transient 4-oxidobenzyl (4OB(center dot)) radical and a dehydroglycine bound to the C-terminal 4Fe-4S cluster. Electron and proton transfer to this 4OB(center dot) radical forms p-cresol, with the conversion of this dehydroglycine ligand to Fe-bound CO and CN-, a key intermediate in the assembly of the 2Fe subunit of the H cluster.	[Kuchenreuther, Jon M.; Myers, William K.; Stich, Troy A.; George, Simon J.; NejatyJahromy, Yaser; Britt, R. David] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of California System; University of California Davis; Stanford University; Stanford University	Britt, RD (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	rdbritt@ucdavis.edu	NejatyJahromy, Yaser/T-9182-2017	NejatyJahromy, Yaser/0000-0002-3367-7208; Myers, William/0000-0001-5935-9112; George, Simon/0000-0002-4864-5479	Division of Chemical Sciences, Geosciences, and Biosciences [DE-FG02-11ER16282]; Division of Material Sciences and Engineering of the Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-09ER46632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104543] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/D048559/1] Funding Source: researchfish; EPSRC [EP/D048559/1] Funding Source: UKRI	Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); Division of Material Sciences and Engineering of the Office of Basic Energy Sciences of the U.S. Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Division of Chemical Sciences, Geosciences, and Biosciences (R.D.B. award no. DE-FG02-11ER16282) and the Division of Material Sciences and Engineering (J.R.S. award no. DE-FG02-09ER46632) of the Office of Basic Energy Sciences of the U.S. Department of Energy. We thank D. Suess for useful discussions on the proposed HydG mechanism.	BARRY BA, 1987, P NATL ACAD SCI USA, V84, P7099, DOI 10.1073/pnas.84.20.7099; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Berggren G, 2013, NATURE, V499, P66, DOI 10.1038/nature12239; Dole F, 1997, J AM CHEM SOC, V119, P11540, DOI 10.1021/ja9717727; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Esselborn J, 2013, NAT CHEM BIOL, V9, P607, DOI [10.1038/NCHEMBIO.1311, 10.1038/nchembio.1311]; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Fugate CJ, 2012, J AM CHEM SOC, V134, P9042, DOI 10.1021/ja3012963; GEORGE SJ, 1989, BIOCHEM J, V264, P275, DOI 10.1042/bj2640275; GILCHRIST ML, 1995, P NATL ACAD SCI USA, V92, P9545, DOI 10.1073/pnas.92.21.9545; Hulsebosch RJ, 1997, J AM CHEM SOC, V119, P8685, DOI 10.1021/ja9707872; KENNEDY MC, 1984, J BIOL CHEM, V259, P4463; KENT TA, 1982, P NATL ACAD SCI-BIOL, V79, P1096, DOI 10.1073/pnas.79.4.1096; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Kuchenreuther JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045850; Kuchenreuther JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020346; MICHAELS R, 1965, ARCH BIOCHEM BIOPHYS, V111, P121, DOI 10.1016/0003-9861(65)90329-2; Mulder DW, 2011, STRUCTURE, V19, P1038, DOI 10.1016/j.str.2011.06.008; Nicolet Y, 2012, J BIOL CHEM, V287, P13532, DOI 10.1074/jbc.R111.310797; Nicolet Y, 2010, FEBS LETT, V584, P4197, DOI 10.1016/j.febslet.2010.09.008; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; RICHARDS AJM, 1990, SPECTROCHIM ACTA A, V46, P987, DOI 10.1016/0584-8539(90)80015-Q; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Tron C, 2011, EUR J INORG CHEM, P1121, DOI 10.1002/ejic.201001101; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u	31	79	79	1	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					472	475		10.1126/science.1241859	http://dx.doi.org/10.1126/science.1241859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159045	Green Submitted			2022-12-24	WOS:000326042600041
J	Basil, N				Basil, Neil			Stoma care: the market in products lets patients down	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Basil, Neil] Patient Choice, Benfleet SS7 3TN, Essex, England			neil.basil@patientchoicefoundation.org						[Anonymous], 2013, YOU YOURS; Burch J., 2008, STOMA CARE; NHS Business Services Authority, PRESCR COST AN PCA D; Thomas L, 2013, BBC	4	2	2	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2013	347								f6129	10.1136/bmj.f6129	http://dx.doi.org/10.1136/bmj.f6129			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WP	24136685				2022-12-24	WOS:000325982700005
J	Benoit, RM; Frey, D; Hilbert, M; Kevenaar, JT; Wieser, MM; Stirnimann, CU; McMillan, D; Ceska, T; Lebon, F; Jaussi, R; Steinmetz, MO; Schertler, GFX; Hoogenraad, CC; Capitani, G; Kammerer, RA				Benoit, Roger M.; Frey, Daniel; Hilbert, Manuel; Kevenaar, Josta T.; Wieser, Mara M.; Stirnimann, Christian U.; McMillan, David; Ceska, Tom; Lebon, Florence; Jaussi, Rolf; Steinmetz, Michel O.; Schertler, Gebhard F. X.; Hoogenraad, Casper C.; Capitani, Guido; Kammerer, Richard A.			Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A	NATURE			English	Article							LOW PH; DESIGN; PRION; DNA; AGGREGATION; PREDICTION; DYNAMICS; RECEPTOR; BINDING; MOTIFS	Botulinum neurotoxin A (BoNT/A) belongs to the most dangerous class of bioweapons(1). Despite this, BoNT/A is used to treat a wide range of common medical conditions such as migraines and a variety of ocular motility and movement disorders(2). BoNT/A is probably best known for its use as an antiwrinkle agent in cosmetic applications (including Botox and Dysport)(3). BoNT/A application causes long-lasting flaccid paralysis of muscles through inhibiting the release of the neurotransmitter acetylcholine by cleaving synaptosomal-associated protein 25 (SNAP-25) within presynaptic nerve terminals(4). Two types of BoNT/A receptor have been identified, both of which are required for BoNT/A toxicity and are therefore likely to cooperate with each other(5): gangliosides and members of the synaptic vesicle glycoprotein 2 (SV2) family, which are putative transporter proteins that are predicted to have 12 transmembrane domains, associate with the receptor-binding domain of the toxin(5). Recently, fibroblast growth factor receptor 3 (FGFR3) has also been reported to be a potential BoNT/A receptor(6). In SV2 proteins, the BoNT/A-binding site has been mapped to the luminal domain(7), but the molecular details of the interaction between BoNT/A and SV2 are unknown. Here we determined the high-resolution crystal structure of the BoNT/A receptor-binding domain (BoNT/A-RBD) in complex with the SV2C luminal domain (SV2C-LD). SV2C-LD consists of a right-handed, quadrilateral beta-helix that associates with BoNT/A-RBD mainly through backbone-to-backbone interactions at open beta-strand edges, in a manner that resembles the inter-strand interactions in amyloid structures. Competition experiments identified a peptide that inhibits the formation of the complex. Our findings provide a strong platform for the development of novel antitoxin agents and for the rational design of BoNT/A variants with improved therapeutic properties.	[Benoit, Roger M.; Frey, Daniel; Hilbert, Manuel; Wieser, Mara M.; Jaussi, Rolf; Steinmetz, Michel O.; Schertler, Gebhard F. X.; Capitani, Guido; Kammerer, Richard A.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Kevenaar, Josta T.; Hoogenraad, Casper C.] Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands; [Stirnimann, Christian U.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [McMillan, David; Ceska, Tom] UCB NewMed, UCB Pharma, UCB Celltech, Slough SL1 4EN, Berks, England; [Lebon, Florence] UCB NewMed, UCB Pharma, B-1420 Braine Lalleud, Belgium; [Schertler, Gebhard F. X.] ETH, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Utrecht University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Celltech Group Ltd; UCB Pharma SA; UCB Pharma SA; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kammerer, RA (corresponding author), Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland.	richard.kammerer@psi.ch	Hoogenraad, Casper/B-8866-2011; Schertler, Gebhard/M-9512-2014; Steinmetz, Michel O/AAA-3349-2022	Hoogenraad, Casper/0000-0002-2666-0758; Steinmetz, Michel O/0000-0001-6157-3687; Schertler, Gebhard F.X./0000-0002-5846-6810; Benoit, Roger/0000-0001-9420-7739; Stirnimann, Christian/0000-0002-1030-8864; Kammerer, Richard/0000-0003-4570-5197	UCB Pharma, UCB NewMedicines; Swiss National Science Foundation [310030B_138659]; Netherlands Organization for Scientific Research (NWO-ALW-VICI); Netherlands Organization for Health Research and Development (ZonMW-TOP)	UCB Pharma, UCB NewMedicines; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Netherlands Organization for Scientific Research (NWO-ALW-VICI)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMW-TOP)(Netherlands Organization for Health Research and Development)	We thank A. Blanc for performing the mass spectrometry analysis of the recombinant proteins and L. Knecht for help with protein production. This work was supported by UCB Pharma, UCB NewMedicines. This work was also supported by the Swiss National Science Foundation (grant 310030B_138659), The Netherlands Organization for Scientific Research (NWO-ALW-VICI) and The Netherlands Organization for Health Research and Development (ZonMW-TOP).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anderson ER, 2004, AM J HEALTH-SYST PH, V61, pS24, DOI 10.1093/ajhp/61.suppl_6.S24; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benoit RM, 2006, PROTEIN EXPRES PURIF, V45, P66, DOI 10.1016/j.pep.2005.09.022; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bryan AW, 2011, P NATL ACAD SCI USA, V108, P11099, DOI 10.1073/pnas.1017504108; Cai S., 2007, Infectious Disorders - Drug Targets, V7, P47, DOI 10.2174/187152607780090667; Carruthers J, 2004, CLIN DERMATOL, V22, P89, DOI 10.1016/j.clindermatol.2003.11.013; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000245; Fu ZJ, 2009, BIOCHEMISTRY-US, V48, P5631, DOI 10.1021/bi9002138; Hegde SS, 2005, SCIENCE, V308, P1480, DOI 10.1126/science.1110699; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jacky BPS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003369; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kapitein LC, 2010, METHOD CELL BIOL, V97, P111, DOI 10.1016/S0091-679X(10)97007-6; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Markey AC, 2000, CLIN EXP DERMATOL, V25, P173, DOI 10.1046/j.1365-2230.2000.00606.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Olieric N, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-56; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Spangler SA, 2013, J CELL BIOL, V201, P915, DOI 10.1083/jcb.201301011; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun SH, 2012, BIOCHEMISTRY-US, V51, P5655, DOI 10.1021/bi3004928; Sun SH, 2011, CELL HOST MICROBE, V10, P237, DOI 10.1016/j.chom.2011.06.012; Vetting MW, 2011, ACTA CRYSTALLOGR F, V67, P296, DOI 10.1107/S1744309110053315; Vetting MW, 2006, BIOCHEMISTRY-US, V45, P1, DOI 10.1021/bi052130w; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Zhang YL, 1998, ANAL BIOCHEM, V261, P139, DOI 10.1006/abio.1998.2738	45	77	83	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					108	+		10.1038/nature12732	http://dx.doi.org/10.1038/nature12732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24240280				2022-12-24	WOS:000329163300033
J	Ferner, R				Ferner, Robin			A fat chance of slimming	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION		Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				[Anonymous], 1946, BMJ-BRIT MED J, V2, P949; [Anonymous], 1937, BMJ-BRIT MED J, V1937, P1076; [Anonymous], 1973, BMJ-BRIT MED J, V4, P692; [Anonymous], 2008, ANN ICRP, V38, P1; Bao Y, 2013, NEW ENGL J MED, V369, P2001, DOI 10.1056/NEJMoa1307352; BHASIN S, 1981, AM J MED, V71, P887, DOI 10.1016/0002-9343(81)90392-2; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Fishman AP, 1999, CIRCULATION, V99, P156, DOI 10.1161/01.CIR.99.1.156; Gokmen MR, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4000; Grundlingh J, 2011, J MED TOXICOL, V7, P205, DOI 10.1007/s13181-011-0162-6; HEDBERG CW, 1987, NEW ENGL J MED, V316, P993, DOI 10.1056/NEJM198704163161605; Horner W D, 1941, Trans Am Ophthalmol Soc, V39, P405; NHS Choices, 2013, WARN ISS DEADL DNP D; Patterson S W, 1935, Br Med J, V2, P442; REES SG, 1985, BMJ-BRIT MED J, V291, P1764, DOI 10.1136/bmj.291.6511.1764	15	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2013	347								f7389	10.1136/bmj.f7389	http://dx.doi.org/10.1136/bmj.f7389			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZL	24326891				2022-12-24	WOS:000328574700011
J	Assie, G; Libe, R; Espiard, S; Rizk-Rabin, M; Guimier, A; Luscap, W; Barreau, O; Lefevre, L; Sibony, M; Guignat, L; Rodriguez, S; Perlemoine, K; Rene-Corail, F; Letourneur, F; Trabulsi, B; Poussier, A; Chabbert-Buffet, N; Borson-Chazot, F; Groussin, L; Bertagna, X; Stratakis, CA; Ragazzon, B; Bertherat, J				Assie, Guillaume; Libe, Rossella; Espiard, Stephanie; Rizk-Rabin, Marthe; Guimier, Anne; Luscap, Windy; Barreau, Olivia; Lefevre, Lucile; Sibony, Mathilde; Guignat, Laurence; Rodriguez, Stephanie; Perlemoine, Karine; Rene-Corail, Fernande; Letourneur, Franck; Trabulsi, Bilal; Poussier, Alix; Chabbert-Buffet, Nathalie; Borson-Chazot, Francoise; Groussin, Lionel; Bertagna, Xavier; Stratakis, Constantine A.; Ragazzon, Bruno; Bertherat, Jerome			ARMC5 Mutations in Macronodular Adrenal Hyperplasia with Cushing's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; ADRENOCORTICAL TUMORS; GENE-EXPRESSION; FREQUENT; PROTEIN; RECEPTORS; HYPERCORTISOLISM; PATHWAY; DISEASE; CANCERS	BackgroundCorticotropin-independent macronodular adrenal hyperplasia may be an incidental finding or it may be identified during evaluation for Cushing's syndrome. Reports of familial cases and the involvement of both adrenal glands suggest a genetic origin of this condition. MethodsWe genotyped blood and tumor DNA obtained from 33 patients with corticotropin-independent macronodular adrenal hyperplasia (12 men and 21 women who were 30 to 73 years of age), using single-nucleotide polymorphism arrays, microsatellite markers, and whole-genome and Sanger sequencing. The effects of armadillo repeat containing 5 (ARMC5) inactivation and overexpression were tested in cell-culture models. ResultsThe most frequent somatic chromosome alteration was loss of heterozygosity at 16p (in 8 of 33 patients for whom data were available [24%]). The most frequent mutation identified by means of whole-genome sequencing was in ARMC5, located at 16p11.2. ARMC5 mutations were detected in tumors obtained from 18 of 33 patients (55%). In all cases, both alleles of ARMC5 carried mutations: one germline and the other somatic. In 4 patients with a germline ARMC5 mutation, different nodules from the affected adrenals harbored different secondary ARMC5 alterations. Transcriptome-based classification of corticotropin-independent macronodular adrenal hyperplasia indicated that ARMC5 mutations influenced gene expression, since all cases with mutations clustered together. ARMC5 inactivation decreased steroidogenesis in vitro, and its overexpression altered cell survival. ConclusionsSome cases of corticotropin-independent macronodular adrenal hyperplasia appear to be genetic, most often with inactivating mutations of ARMC5, a putative tumor-suppressor gene. Genetic testing for this condition, which often has a long and insidious prediagnostic course, might result in earlier identification and better management. (Funded by Agence Nationale de la Recherche and others.)	[Assie, Guillaume; Libe, Rossella; Espiard, Stephanie; Rizk-Rabin, Marthe; Guimier, Anne; Luscap, Windy; Barreau, Olivia; Lefevre, Lucile; Rodriguez, Stephanie; Perlemoine, Karine; Rene-Corail, Fernande; Letourneur, Franck; Groussin, Lionel; Bertagna, Xavier; Ragazzon, Bruno; Bertherat, Jerome] Inst Cochin, INSERM Unite 1016, CNRS, UMR 8104, Paris, France; [Assie, Guillaume; Espiard, Stephanie; Guimier, Anne; Barreau, Olivia; Lefevre, Lucile; Sibony, Mathilde; Perlemoine, Karine; Rene-Corail, Fernande; Groussin, Lionel; Bertagna, Xavier; Bertherat, Jerome] Univ Paris 05, Fac Med Paris Descartes, Sorbonne Paris Cite, Paris, France; [Assie, Guillaume; Libe, Rossella; Barreau, Olivia; Guignat, Laurence; Groussin, Lionel; Bertagna, Xavier; Bertherat, Jerome] Referral Ctr Rare Adrenal Dis, Dept Endocrinol, Paris, France; [Sibony, Mathilde] Hop Cochin, AP HP, Dept Pathol, F-75674 Paris, France; [Chabbert-Buffet, Nathalie] Hop Tenon, Dept Obstet & Gynecol, Unit Endocrinol, F-75970 Paris, France; [Trabulsi, Bilal] Ctr Hosp, Ctr Bretagne, Unit Endocrinol, Noyal Pontivy, France; [Poussier, Alix] Hotel Dieu Creusot, Unit Endocrinol, Le Creusot, France; [Borson-Chazot, Francoise] Grp Hosp Est, Dept Endocrinol Lyon Est, Bron, France; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Endocrinol Inter Inst, Training Program, NIH, Bethesda, MD USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); CHU Lyon; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bertherat, J (corresponding author), Hop Cochin, Serv Malad Endocriniennes & Metab, Ctr Reference Malad Rares Surrenale, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	jerome.bertherat@cch.aphp.fr	Stratakis, Constantine/AAP-4745-2020; Ragazzon, Bruno/E-6541-2017; Rizk-Rabin, Marthe/A-1698-2018	Ragazzon, Bruno/0000-0001-9476-4973; Assie, Guillaume/0000-0001-9590-0906; Sibony, Mathilde/0000-0002-1282-8732; Groussin, Lionel/0000-0003-1476-475X; Rizk-Rabin, Marthe/0000-0003-1558-737X; Rodriguez, Stephanie/0000-0003-4520-144X; libe, rossella/0000-0003-2881-6362; RONDOF, Windy/0000-0002-8160-4900; BERTHERAT, Jerome/0000-0003-2551-3008; Borson-Chazot, Francoise/0000-0003-2515-7840; Guimier, Anne/0000-0002-4759-0621	Agence Nationale de la Recherche [ANR-10-Blan-1136]; Corticomedullosurrenale Tumeur Endocrine Network (Programme Hospitalier de Recherche Clinique grant) [AOM95201]; Assistance Publique-Hopitaux de Paris (Clinical Research Center) [Genhyper P061006]; Institut National du Cancer [Recherche Translationelle 2009-RT-02]; Seventh Framework Program of the European Commission [F2-2010-259735]; INSERM (Contrat d'Interface); Conny-Maeva Charitable Foundation; intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); Corticomedullosurrenale Tumeur Endocrine Network (Programme Hospitalier de Recherche Clinique grant); Assistance Publique-Hopitaux de Paris (Clinical Research Center); Institut National du Cancer(Institut National du Cancer (INCA) France); Seventh Framework Program of the European Commission; INSERM (Contrat d'Interface)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Conny-Maeva Charitable Foundation; intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported in part by grants from Agence Nationale de la Recherche (ANR-10-Blan-1136), Corticomedullosurrenale Tumeur Endocrine Network (Programme Hospitalier de Recherche Clinique grant AOM95201), Assistance Publique-Hopitaux de Paris (Clinical Research Center Grant Genhyper P061006), Institut National du Cancer (Recherche Translationelle 2009-RT-02), the Seventh Framework Program of the European Commission (F2-2010-259735), INSERM (Contrat d'Interface, to Dr. Assie), the Conny-Maeva Charitable Foundation, and the intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Antonini SR, 2006, CLIN ENDOCRINOL, V64, P29, DOI 10.1111/j.1365-2265.2005.02411.x; Assie G, 2008, AM J HUM GENET, V82, P903, DOI 10.1016/j.ajhg.2008.01.012; Assie G, 2010, J CLIN ENDOCR METAB, V95, pE253, DOI 10.1210/jc.2009-2281; Bertherat J, 2005, J CLIN ENDOCR METAB, V90, P1302, DOI 10.1210/jc.2004-1256; Bourdeau I, 2001, J CLIN ENDOCR METAB, V86, P5534, DOI 10.1210/jc.86.11.5534; Carney JA, 2011, AM J SURG PATHOL, V35, P1311, DOI 10.1097/PAS.0b013e31821ec4ce; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; FINDLAY JC, 1993, J CLIN ENDOCR METAB, V76, P189, DOI 10.1210/jc.76.1.189; Gagliardi L, 2009, CLIN ENDOCRINOL, V70, P883, DOI 10.1111/j.1365-2265.2008.03471.x; Gaujoux S, 2010, CLIN CANCER RES, V16, P5133, DOI 10.1158/1078-0432.CCR-10-1497; Gicquel C, 2001, CANCER RES, V61, P6762; Groussin L, 2000, J CLIN ENDOCR METAB, V85, P345, DOI 10.1210/jc.85.1.345; Hsiao HP, 2009, J CLIN ENDOCR METAB, V94, P2930, DOI 10.1210/jc.2009-0516; LACROIX A, 1992, NEW ENGL J MED, V327, P974, DOI 10.1056/NEJM199210013271402; Lacroix A, 2010, CLIN ENDOCRINOL, V73, P1, DOI 10.1111/j.1365-2265.2009.03689.x; Lacroix A, 2009, BEST PRACT RES CL EN, V23, P245, DOI 10.1016/j.beem.2008.10.011; Libe R, 2008, CLIN CANCER RES, V14, P4016, DOI 10.1158/1078-0432.CCR-08-0106; Libe R, 2007, CLIN CANCER RES, V13, P844, DOI 10.1158/1078-0432.CCR-06-2085; Libe R, 2011, J CLIN ENDOCR METAB, V96, pE208, DOI 10.1210/jc.2010-1704; Libe R, 2010, EUR J ENDOCRINOL, V163, P129, DOI 10.1530/EJE-10-0195; Matyakhina L, 2005, J CLIN ENDOCR METAB, V90, P3773, DOI 10.1210/jc.2004-2377; Ragazzon B, 2009, CANCER RES, V69, P7278, DOI 10.1158/0008-5472.CAN-09-1601; REZNIK Y, 1992, NEW ENGL J MED, V327, P981, DOI 10.1056/NEJM199210013271403; Rizk-Rabin M, 2008, CANCER EPIDEM BIOMAR, V17, P2275, DOI 10.1158/1055-9965.EPI-07-2924; Swain JM, 1998, ARCH SURG-CHICAGO, V133, P541, DOI 10.1001/archsurg.133.5.541; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Vezzosi D, 2007, EUR J ENDOCRINOL, V156, P21, DOI 10.1530/eje.1.02324; Yoshida M, 2011, ENDOCR J, V58, P269, DOI 10.1507/endocrj.K10E-218	29	220	231	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2105	2114		10.1056/NEJMoa1304603	http://dx.doi.org/10.1056/NEJMoa1304603			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258OB	24283224	Green Accepted			2022-12-24	WOS:000327467500008
J	Spence, D				Spence, Des			Labelled for life	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Callard F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4312; Centers for Disease Control and Prevention, 2011, MENT HLTH BAS	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2013	347								f7037	10.1136/bmj.f7037	http://dx.doi.org/10.1136/bmj.f7037			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263GF	24284339				2022-12-24	WOS:000327794500008
J	Kent, A				Kent, Alastair			Commentary: Patients will need knowledgeable guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Genet Alliance UK, London N1 3QP, England		Kent, A (corresponding author), Genet Alliance UK, London N1 3QP, England.	alastair@geneticalliance.org.uk							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2013	347								f6991	10.1136/bmj.f6991	http://dx.doi.org/10.1136/bmj.f6991			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FN	24285799				2022-12-24	WOS:000327792500004
J	Mitchell, L; Brook, E; Lee, JE; Buizert, C; Sowers, T				Mitchell, Logan; Brook, Ed; Lee, James E.; Buizert, Christo; Sowers, Todd			Constraints on the Late Holocene Anthropogenic Contribution to the Atmospheric Methane Budget	SCIENCE			English	Article							PREINDUSTRIAL; ANTARCTICA; EMISSIONS	The origin of the late preindustrial Holocene (LPIH) increase in atmospheric methane concentrations has been much debated. Hypotheses invoking changes in solely anthropogenic sources or solely natural sources have been proposed to explain the increase in concentrations. Here two high-resolution, high-precision ice core methane concentration records from Greenland and Antarctica are presented and are used to construct a high-resolution record of the methane inter-polar difference (IPD). The IPD record constrains the latitudinal distribution of emissions and shows that LPIH emissions increased primarily in the tropics, with secondary increases in the subtropical Northern Hemisphere. Anthropogenic and natural sources have different latitudinal characteristics, which are exploited to demonstrate that both anthropogenic and natural sources are needed to explain LPIH changes in methane concentration.	[Mitchell, Logan; Brook, Ed; Lee, James E.; Buizert, Christo] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Sowers, Todd] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Sowers, Todd] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA	Oregon State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Mitchell, L (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	logan.e.mitchell@gmail.com	Mitchell, Logan E/A-5481-2011	Mitchell, Logan E/0000-0002-8749-954X; Buizert, Christo/0000-0002-2227-1747; Lee, James/0000-0002-9137-1530	NSF Office of Polar Programs (OPP) [0538578, 0520523, 0944584, 0538538]; NASA/Oregon Space Grant Consortium [NNG05GJ85H]; NOAA Climate and Global Change Fellowship Program; NSF [0230396, 0440817, 0944348, 0944266]; NSF OPP; Directorate For Geosciences [1043518, 0538578] Funding Source: National Science Foundation	NSF Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NASA/Oregon Space Grant Consortium(National Aeronautics & Space Administration (NASA)); NOAA Climate and Global Change Fellowship Program; NSF(National Science Foundation (NSF)); NSF OPP(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF Office of Polar Programs (OPP) grants 0538578, 0520523, 0944584, and 0538538; and by NASA/Oregon Space Grant Consortium grant NNG05GJ85H and the NOAA Climate and Global Change Fellowship Program, administered by the University Corporation for Atmospheric Research (C.B.). We thank two anonymous reviewers whose comments greatly improved the manuscript; B. Markle, A. Morin, B. Williams, and J. Edwards for assisting in sample preparation and analysis; T. Marik, who provided the original eight-box model code (BOSCAGE); J. Severinghaus and G. Etiope, who contributed preliminary results from their work; T. Konijnendijk, J. Van Etten, and J. Singarayer, who provided model data from their published works; the WAIS Divide Science Coordination Office at the Desert Research Institute, Reno, NV for the collection and distribution of the WAIS Divide ice core (K. Taylor, NSF grants 0230396, 0440817, 0944348, and 0944266-University of New Hampshire); NSF OPP, which funds the Ice Drilling Program Office and Ice Drilling Design and Operations group for coring activities; NSF, which funds the National Ice Core Laboratory, which curated and processed the core; Raytheon Polar Services, which provided logistics support in Antarctica; and the 109th New York Air National Guard for airlift in Antarctica. Data and description can be downloaded from the NOAA National Climate Data Center (www.ncdc.noaa.gov/paleo/paleo.html). EBAMM model code is archived with L.E.M.'s thesis (31), available online at http://ir.library.oregonstate.edu/xmlui/handle/1957/37906.	Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Chappellaz J, 1997, J GEOPHYS RES-ATMOS, V102, P15987, DOI 10.1029/97JD01017; Dlugokencky EJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039780; Etheridge DM, 1998, J GEOPHYS RES-ATMOS, V103, P15979, DOI 10.1029/98JD00923; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Fudge TJ, 2013, NATURE, V500, P440, DOI 10.1038/nature12376; Fuller DQ, 2011, HOLOCENE, V21, P743, DOI 10.1177/0959683611398052; FUNG I, 1991, J GEOPHYS RES-ATMOS, V96, P13033, DOI 10.1029/91JD01247; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Houweling S, 2000, J GEOPHYS RES-ATMOS, V105, P17243, DOI 10.1029/2000JD900193; Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983; KHALIL MAK, 1983, J GEOPHYS RES-OCEANS, V88, P5131, DOI 10.1029/JC088iC09p05131; Konijnendijk TYM, 2011, CLIM PAST, V7, P635, DOI 10.5194/cp-7-635-2011; Lassey KR, 2007, ATMOS CHEM PHYS, V7, P2119, DOI 10.5194/acp-7-2119-2007; Macfarlane DG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025005; Marik T., 1998, THESIS U HEIDELBERG; Mitchell L. E., 2013, THESIS OREGON STATE; Mitchell LE, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001441; Montzka SA, 2011, SCIENCE, V331, P67, DOI 10.1126/science.1197640; Naik V, 2013, ATMOS CHEM PHYS, V13, P5277, DOI 10.5194/acp-13-5277-2013; NAKAZAWA T, 1993, GEOPHYS RES LETT, V20, P943, DOI 10.1029/93GL00776; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Ruddiman WF, 2011, HOLOCENE, V21, P865, DOI 10.1177/0959683610387172; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Ruddiman WF, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000207; Ruddiman WF, 2008, QUATERNARY SCI REV, V27, P1291, DOI 10.1016/j.quascirev.2008.03.007; Ruddiman WF, 2009, QUATERNARY SCI REV, V28, P3011, DOI 10.1016/j.quascirev.2009.05.022; Sapart CJ, 2012, NATURE, V490, P85, DOI 10.1038/nature11461; Singarayer JS, 2011, NATURE, V470, P82, DOI 10.1038/nature09739; Wang XF, 2006, QUATERNARY SCI REV, V25, P3391, DOI 10.1016/j.quascirev.2006.02.009	30	60	60	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					964	966		10.1126/science.1238920	http://dx.doi.org/10.1126/science.1238920			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264988				2022-12-24	WOS:000327223500039
J	Hooton, TM; Roberts, PL; Cox, ME; Stapleton, AE				Hooton, Thomas M.; Roberts, Pacita L.; Cox, Marsha E.; Stapleton, Ann E.			Voided Midstream Urine Culture and Acute Cystitis in Premenopausal Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE UNCOMPLICATED CYSTITIS; TRACT-INFECTIONS; URETHRAL SYNDROME; BACTERIURIA; PYELONEPHRITIS; CIPROFLOXACIN; EPIDEMIOLOGY; DIAGNOSIS	Background The cause of acute uncomplicated cystitis is determined on the basis of cultures of voided midstream urine, but few data guide the interpretation of such results, especially when gram-positive bacteria grow. Methods Women from 18 to 49 years of age with symptoms of cystitis provided specimens of midstream urine, after which we collected urine by means of a urethral catheter for culture (catheter urine). We compared microbial species and colony counts in the paired specimens. The primary outcome was a comparison of positive predictive values and negative predictive values of organisms grown in midstream urine, with the presence or absence of the organism in catheter urine used as the reference. Results The analysis of 236 episodes of cystitis in 226 women yielded 202 paired specimens of midstream urine and catheter urine that could be evaluated. Cultures were positive for uropathogens in 142 catheter specimens (70%), 4 of which had more than one uropathogen, and in 157 midstream specimens (78%). The presence of Escherichia coli in midstream urine was highly predictive of bladder bacteriuria even at very low counts, with a positive predictive value of 102 colony-forming units (CFU) per milliliter of 93% (Spearman's r = 0.944). In contrast, in midstream urine, enterococci (in 10% of cultures) and group B streptococci (in 12% of cultures) were not predictive of bladder bacteriuria at any colony count (Spearman's r = 0.322 for enterococci and 0.272 for group B streptococci). Among 41 episodes in which enterococcus, group B streptococci, or both were found in midstream urine, E. coli grew from catheter urine cultures in 61%. Conclusions Cultures of voided midstream urine in healthy premenopausal women with acute uncomplicated cystitis accurately showed evidence of bladder E. coli but not of enterococci or group B streptococci, which are often isolated with E. coli but appear to rarely cause cystitis by themselves.	[Hooton, Thomas M.] Univ Miami, Sch Med, Dept Med, Miami, FL USA; [Roberts, Pacita L.; Cox, Marsha E.; Stapleton, Ann E.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	University of Miami; University of Washington; University of Washington Seattle	Hooton, TM (corresponding author), Dept Med, Clin Res Bldg,1120 NW 14th St,Suite 853, Miami, FL 33136 USA.	thooton@med.miami.edu	Stapleton, Ann E/N-2428-2015	Stapleton, Ann E/0000-0003-0130-8659	National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK088830, P01 DK053369, ORWH SCOR P50 DK064540]; Merck; Pinnacle Pharmaceuticals; National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088830, P50DK064540, P01DK053369] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Merck(Merck & Company); Pinnacle Pharmaceuticals; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases.	Baron E.J., 1999, MANUAL CLIN MICROBIO, V7th; Barr Richard H., 1948, CALIFORNIA MED, V68, P437; Bent S, 2002, JAMA-J AM MED ASSOC, V287, P2701, DOI 10.1001/jama.287.20.2701; Cai T, 2009, J CHEMOTHERAPY, V21, P535, DOI 10.1179/joc.2009.21.5.535; CURRAN JW, 1977, SEX TRANSM DIS, V4, P119, DOI 10.1097/00007435-197707000-00012; FIHN SD, 1988, J INFECT DIS, V157, P196, DOI 10.1093/infdis/157.1.196; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; GALLAGHER DJ, 1965, BMJ-BRIT MED J, V1, P622, DOI 10.1136/bmj.1.5435.622; Gupta K, 2001, ANN INTERN MED, V135, P9, DOI 10.7326/0003-4819-135-1-200107030-00004; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Hooton TM, 2012, JAMA-J AM MED ASSOC, V307, P583, DOI 10.1001/jama.2012.80; Hooton TM, 2005, JAMA-J AM MED ASSOC, V293, P949, DOI 10.1001/jama.293.8.949; Kahlmeter G, 2003, INT J ANTIMICROB AG, V22, pS49, DOI 10.1016/S0924-8579(03)00229-2; Kallen AJ, 2006, ARCH INTERN MED, V166, P635, DOI 10.1001/archinte.166.6.635; Kass, 1960, BIOLOGY PYELONEPHRIT, P399; KASS EH, 1956, T ASSOC AM PHYSICIAN, V69, P56; KASS EH, 1960, ARCH INTERN MED, V105, P194, DOI 10.1001/archinte.1960.00270140016003; KASS EH, 1962, ANN INTERN MED, V56, P46, DOI 10.7326/0003-4819-56-1-46; Little P, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c199; MABECK CE, 1969, ACTA MED SCAND, V186, P35; Marple CD, 1941, ANN INTERN MED, V14, P2220, DOI 10.7326/0003-4819-14-12-2220; Matsumoto T, 2012, J INFECT CHEMOTHER, V18, P597, DOI 10.1007/s10156-012-0419-2; McIsaac Warren J, 2008, Can J Infect Dis Med Microbiol, V19, P287; MONZON OT, 1958, NEW ENGL J MED, V259, P764, DOI 10.1056/NEJM195810162591603; Naber KG, 2008, EUR UROL, V54, P1164, DOI 10.1016/j.eururo.2008.05.010; NORDEN CW, 1968, ANNU REV MED, V19, P431, DOI 10.1146/annurev.me.19.020168.002243; Ronald A, 2002, AM J MED, V113, p14S; SANFORD JP, 1956, AM J MED, V20, P88, DOI 10.1016/0002-9343(56)90175-9; Schappert Susan M, 2011, Vital Health Stat 13, P1; STAMEY TA, 1971, CALIF MED, V115, P1; STAMM WE, 1980, NEW ENGL J MED, V303, P409, DOI 10.1056/NEJM198008213030801; STAMM WE, 1982, NEW ENGL J MED, V307, P463, DOI 10.1056/NEJM198208193070802; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11	34	157	167	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1883	1891		10.1056/NEJMoa1302186	http://dx.doi.org/10.1056/NEJMoa1302186			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300MP	24224622	Green Accepted			2022-12-24	WOS:000330468300007
J	Guest, JA; Quincy, L				Guest, James A.; Quincy, Lynn			Consumers Gaining Ground in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Guest, James A.] Consumer Reports, Yonkers, NY 10703 USA; [Quincy, Lynn] Consurmer Reports, Washington, DC USA		Guest, JA (corresponding author), Consumer Reports, 101 Truman Ave, Yonkers, NY 10703 USA.	jguest@consumer.org						James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Millman J., 2013, POLITICO PAVIA  0319; Quincy L., 2012, WHATS DOOR CONSUMERS; Quincy L., 2013, EARLY EXPERIENCE NEW; The American College of Obstetricians and Gynecologists Committee on Obstetric Practice the Society for Maternal-Fetal Medicine, 2013, NONM IND EARL TERM D, P561	5	6	6	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1939	1940		10.1001/jama.2013.282000	http://dx.doi.org/10.1001/jama.2013.282000			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219947				2022-12-24	WOS:000326832900016
J	Jones, K; Saxon, L; Cunningham, W; Adams, P				Jones, Katie; Saxon, Leanne; Cunningham, William; Adams, Phil		Guideline Dev Grp	Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jones, Katie; Saxon, Leanne] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Cunningham, William] Hadrian Primary Care Alliance, Corbridge, England; [Adams, Phil] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England	Royal College of Physicians; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust	Jones, K (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	katie.jones@rcplondon.ac.uk						[Anonymous], 2007, SEC PREV PRIM SEC CA; British Medical Association Royal Pharmaceutical Society of Great Britain, 2013, 66 BMA RPS; National Institute for Health and Care Excellence, 2013, MYOC INF ST SEGM EL; National Institute for Health and Care Excellence, 2010, CLOP MOD REL DIP PRE; National Institute for Health and Care Excellence, 2009, PRAS TREATM AC COR S; National Institute for Health and Care Excellence, QUAL OUTC FRAM NICE; National Institute for Health and Care Excellence, 2011, TIC TREATM AC COR SY; National Institute for Health and Care Excellence, 2004, DYSP MAN DYSP AD PRI; National Institute for Health and Care Excellence, 2006, OB PREV ID ASS MAN O; National Institute for Health and Care Excellence, 2013, SEC PREV PRIM SEC CA; National Institute for Health and Care Excellence, 2004, CLOP TREATM NON ST S, V80; National Institute for Health and Care Excellence, 2010, UNST ANG NSTEMI EARL; National Institute for Health and Care Excellence, 2008, CARD RISK ASS MOD BL; National Institute for Health and Care Excellence, 2006, BRIEF INT REF SMOK C BRIEF INT REF SMOK C	14	27	28	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 13	2013	347								f6544	10.1136/bmj.f6544	http://dx.doi.org/10.1136/bmj.f6544			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254GO	24227827				2022-12-24	WOS:000327153200001
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: gabapentin and pregabalin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MISUSE											Centers for Disease Control and Prevention (CDC), 2013, POL IMP PRESCR PAINK; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Health and Social Care Information Centre, 2013, PRESCR COST AN ENGL; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Maskell PD, 2013, BMJ; Millar J, 2013, EMERG MED J, V30, P874, DOI DOI 10.1136/EMERMED-2013-203113.20; Moore RA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007938.pub2; Moore RA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007076.pub2; Moore RA, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD008242.PUB2; NICE CfCPa, 2010, NEUR PAIN PHARM MAN; Schifano F, 2011, PSYCHOTHER PSYCHOSOM, V80, P118, DOI 10.1159/000321079; Smith BH, 2012, BRIT J GEN PRACT, V62, P406, DOI 10.3399/bjgp12X653516; US Drug Enforcement Agency (DEA), DRUG SCHED; Wiffen PJ, 2013, COCHRANE DB SYST REV, V6	14	25	27	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 8	2013	347								f6747	10.1136/bmj.f6747	http://dx.doi.org/10.1136/bmj.f6747			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XT	24212252				2022-12-24	WOS:000326890800014
J	Yu, XF; Rollins, D; Ruhn, KA; Stubblefield, JJ; Green, CB; Kashiwada, M; Rothman, PB; Takahashi, JS; Hooper, LV				Yu, Xiaofei; Rollins, Darcy; Ruhn, Kelly A.; Stubblefield, Jeremy J.; Green, Carla B.; Kashiwada, Masaki; Rothman, Paul B.; Takahashi, Joseph S.; Hooper, Lora V.			T(H)17 Cell Differentiation Is Regulated by the Circadian Clock	SCIENCE			English	Article							REV-ERB-ALPHA; T-HELPER-CELLS; TRANSCRIPTION; ARCHITECTURE; HOMEOSTASIS; MICROBIOTA; MAMMALS; E4BP4; GENE	Circadian clocks regulate numerous physiological processes that vary across the day-night (diurnal) cycle, but if and how the circadian clock regulates the adaptive immune system is mostly unclear. Interleukin-17-producing CD4(+) T helper (T(H)17) cells are proinflammatory immune cells that protect against bacterial and fungal infections at mucosal surfaces. Their lineage specification is regulated by the orphan nuclear receptor ROR gamma t. We show that the transcription factor NFIL3 suppresses T(H)17 cell development by directly binding and repressing the Ror gamma t promoter. NFIL3 links T(H)17 cell development to the circadian clock network through the transcription factor REV-ERB alpha. Accordingly, T(H)17 lineage specification varies diurnally and is altered in Rev-erba(-/-) mice. Light-cycle disruption elevated intestinal T(H)17 cell frequencies and increased susceptibility to inflammatory disease. Thus, lineage specification of a key immune cell is under direct circadian control.	[Yu, Xiaofei; Rollins, Darcy; Ruhn, Kelly A.; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Stubblefield, Jeremy J.; Green, Carla B.; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Kashiwada, Masaki; Rothman, Paul B.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Takahashi, Joseph S.; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu	Yu, Xiaofei/J-9245-2017; yu, Xiaofei/E-7100-2011; Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Yu, Xiaofei/0000-0002-1712-331X; Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878	NIH [R01 DK070855]; Burroughs Wellcome Foundation; Howard Hughes Medical Institute; Grants-in-Aid for Scientific Research [24590088] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Behrendt, C. Clements, and S. Murray for assistance with mouse experiments. M. Izumo provided advice and assistance with the circadian cycle experiments, and B. Li for help with the EMSA. We also thank F. Yarovinsky for critical reading of the manuscript. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. The MODE-K cells were supplied to the authors under a materials transfer agreement from Inserm. J.S.T. is cofounder, scientific advisory board member and paid consultant of Reset Therapeutics, Inc., a biotech company working on circadian rhythms and metabolism. This work was supported by NIH R01 DK070855 (L.V.H.), a Burroughs Wellcome Foundation New Investigators in the Pathogenesis of Infectious Diseases Award (L.V.H.), and the Howard Hughes Medical Institute (J.S.T. and L.V.H.).	Arjona A, 2012, TRENDS IMMUNOL, V33, P607, DOI 10.1016/j.it.2012.08.007; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Bollinger T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029801; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Male V, 2012, TRENDS IMMUNOL, V33, P98, DOI 10.1016/j.it.2011.10.002; Maloy KJ, 2008, MUCOSAL IMMUNOL, V1, P339, DOI 10.1038/mi.2008.28; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Motomura Y, 2011, NAT IMMUNOL, V12, P450, DOI 10.1038/ni.2020; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504	27	253	266	4	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					727	730		10.1126/science.1243884	http://dx.doi.org/10.1126/science.1243884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202171	Green Accepted			2022-12-24	WOS:000326647600040
J	Naesens, M; Heylen, L; Lerut, E; Claes, K; De Wever, L; Claus, F; Oyen, R; Kuypers, D; Evenepoel, P; Bammens, B; Sprangers, B; Meijers, B; Pirenne, J; Monbaliu, D; de Jonge, H; Metalidis, C; De Vusser, K; Vanrenterghem, Y				Naesens, Maarten; Heylen, Line; Lerut, Evelyne; Claes, Kathleen; De Wever, Liesbeth; Claus, Filip; Oyen, Raymond; Kuypers, Dirk; Evenepoel, Pieter; Bammens, Bert; Sprangers, Ben; Meijers, Bjorn; Pirenne, Jacques; Monbaliu, Diethard; de Jonge, Hylke; Metalidis, Christoph; De Vusser, Katrien; Vanrenterghem, Yves			Intrarenal Resistive Index after Renal Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESISTANCE INDEX; DOPPLER INDEXES; VASCULAR-RESISTANCE; ALLOGRAFT SURVIVAL; DUPLEX SONOGRAPHY; PULSE PRESSURE; RECIPIENTS; REJECTION; DIAGNOSIS; KIDNEYS	BackgroundThe intrarenal resistive index is routinely measured in many renal-transplantation centers for assessment of renal-allograft status, although the value of the resistive index remains unclear. MethodsIn a single-center, prospective study involving 321 renal-allograft recipients, we measured the resistive index at baseline, at the time of protocol-specified renal-allograft biopsies (3, 12, and 24 months after transplantation), and at the time of biopsies performed because of graft dysfunction. A total of 1124 renal-allograft resistive-index measurements were included in the analysis. All patients were followed for at least 4.5 years after transplantation. ResultsAllograft recipients with a resistive index of at least 0.80 had higher mortality than those with a resistive index of less than 0.80 at 3, 12, and 24 months after transplantation (hazard ratio, 5.20 [95% confidence interval {CI}, 2.14 to 12.64; P<0.001]; 3.46 [95% CI, 1.39 to 8.56; P=0.007]; and 4.12 [95% CI, 1.26 to 13.45; P=0.02], respectively). The need for dialysis did not differ significantly between patients with a resistive index of at least 0.80 and those with a resistive index of less than 0.80 at 3, 12, and 24 months after transplantation (hazard ratio, 1.95 [95% CI, 0.39 to 9.82; P=0.42]; 0.44 [95% CI, 0.05 to 3.72; P=0.45]; and 1.34 [95% CI, 0.20 to 8.82; P=0.76], respectively). At protocol-specified biopsy time points, the resistive index was not associated with renal-allograft histologic features. Older recipient age was the strongest determinant of a higher resistive index (P<0.001). At the time of biopsies performed because of graft dysfunction, antibody-mediated rejection or acute tubular necrosis, as compared with normal biopsy results, was associated with a higher resistive index (0.870.12 vs. 0.780.14 [P=0.05], and 0.860.09 vs. 0.780.14 [P=0.007], respectively). Conclusions<p id="p005">The resistive index, routinely measured at predefined time points after transplantation, reflects characteristics of the recipient but not those of the graft. (ClinicalTrials.gov number, NCT01879124.)	[Naesens, Maarten; Heylen, Line; Claes, Kathleen; Kuypers, Dirk; Evenepoel, Pieter; Bammens, Bert; Sprangers, Ben; Meijers, Bjorn; de Jonge, Hylke; Metalidis, Christoph; De Vusser, Katrien; Vanrenterghem, Yves] Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Louvain, Belgium; [Lerut, Evelyne] Univ Hosp Leuven, Dept Pathol, Louvain, Belgium; [De Wever, Liesbeth; Claus, Filip; Oyen, Raymond] Univ Hosp Leuven, Dept Radiol, Louvain, Belgium; [Pirenne, Jacques; Monbaliu, Diethard] Univ Hosp Leuven, Dept Abdominal Transplant Surg, Louvain, Belgium; [Naesens, Maarten; Claes, Kathleen; Kuypers, Dirk; Evenepoel, Pieter; Bammens, Bert; Sprangers, Ben; Meijers, Bjorn; Pirenne, Jacques; Monbaliu, Diethard; De Vusser, Katrien; Vanrenterghem, Yves] Katholieke Univ Leuven, Dept Microbiol & Immunol, Louvain, Belgium; [Lerut, Evelyne; De Wever, Liesbeth; Claus, Filip; Oyen, Raymond] Katholieke Univ Leuven, Dept Imaging & Pathol, Louvain, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven	Naesens, M (corresponding author), Katholieke Univ Leuven, Dept Nephrol & Renal Transplantat, Univ Hosp Leuven, Dept Microbiol & Immunol, Herestr 49, B-3000 Louvain, Belgium.	maarten.naesens@uzleuven.be	Monbaliu, Diethard/AAK-8499-2020; De Vusser, Katrien/AAE-2856-2019; Bammens, Bert/D-4659-2018; Mark, Patrick/N-5536-2014; Sprangers, Ben/T-6559-2017; Naesens, Maarten/J-4766-2015; Kuypers, Dirk RJ/D-4393-2018; Meijers, Bjorn/D-6169-2018; PIRENNE, Jacques/I-3728-2018	Monbaliu, Diethard/0000-0002-0506-1609; Bammens, Bert/0000-0002-2477-2633; Mark, Patrick/0000-0003-3387-2123; Sprangers, Ben/0000-0003-1314-9675; Naesens, Maarten/0000-0002-5625-0792; Kuypers, Dirk RJ/0000-0001-5546-9680; De Vusser, Katrien/0000-0002-3096-6207; Meijers, Bjorn/0000-0002-2846-2026; PIRENNE, Jacques/0000-0002-8147-8801; Heylen, Line/0000-0002-4595-0195	Clinical Research Foundation, University Hospitals Leuven, Leuven, Belgium	Clinical Research Foundation, University Hospitals Leuven, Leuven, Belgium	Supported by funding from the Clinical Research Foundation, University Hospitals Leuven, Leuven, Belgium (to Drs. Naesens and Lerut).	BUCKLEY AR, 1987, AM J ROENTGENOL, V149, P521, DOI 10.2214/ajr.149.3.521; Danovitch, 2010, HDB KIDNEY TRANSPLAN; Doxiadis ILN, 2004, TRANSPLANTATION, V77, P615, DOI 10.1097/01.TP.0000103725.72023.D7; Frei U, 2008, AM J TRANSPLANT, V8, P50, DOI 10.1111/j.1600-6143.2007.02014.x; GOTTLIEB RH, 1995, AM J ROENTGENOL, V165, P1441, DOI 10.2214/ajr.165.6.7484582; Hamano K, 2008, DIABETES CARE, V31, P1853, DOI 10.2337/dc08-0168; Hashimoto J, 2011, HYPERTENSION, V58, P839, DOI 10.1161/HYPERTENSIONAHA.111.177469; Hausberg M, 2005, J HYPERTENS, V23, P1795, DOI 10.1097/01.hjh.0000183525.50875.d1; Heine GH, 2005, KIDNEY INT, V68, P878, DOI 10.1111/j.1523-1755.2005.00470.x; Ikee R, 2005, AM J KIDNEY DIS, V46, P603, DOI 10.1053/j.ajkd.2005.06.006; Keogan MT, 1996, RADIOLOGY, V199, P165, DOI 10.1148/radiology.199.1.8633141; Krumme B, 1997, J AM SOC NEPHROL, V8, P813; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Nankivell BJ, 2011, LANCET, V378, P1428, DOI 10.1016/S0140-6736(11)60699-5; Nosadini R, 2006, DIABETES, V55, P234, DOI 10.2337/diabetes.55.1.234; Ohta Y, 2005, J HYPERTENS, V23, P1905, DOI 10.1097/01.hjh.0000181323.44162.01; Okura T, 2010, J NEPHROL, V23, P175; Parolini C, 2009, RADIOLOGY, V252, P888, DOI 10.1148/radiol.2523080351; Petersen LJ, 1997, NEPHROL DIAL TRANSPL, V12, P1376, DOI 10.1093/ndt/12.7.1376; Poggio ED, 2006, AM J TRANSPLANT, V6, P100, DOI 10.1111/j.1600-6143.2005.01140.x; Radermacher J, 2002, HYPERTENSION, V39, P699, DOI 10.1161/hy0202.103782; Radermacher J, 2003, NEW ENGL J MED, V349, P115, DOI 10.1056/NEJMoa022602; RIFKIN MD, 1987, AM J ROENTGENOL, V148, P759, DOI 10.2214/ajr.148.4.759; RIGSBY CM, 1986, RADIOLOGY, V158, P375, DOI 10.1148/radiology.158.2.3510443; Schwenger V, 2006, AM J TRANSPLANT, V6, P2721, DOI 10.1111/j.1600-6143.2006.01524.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259; Sugiura T, 2009, NEPHROL DIAL TRANSPL, V24, P2780, DOI 10.1093/ndt/gfp121; Tublin ME, 1999, RADIOLOGY, V213, P258, DOI 10.1148/radiology.213.1.r99oc19258; Vallejos A, 2005, NEPHROL DIAL TRANSPL, V20, P2511, DOI 10.1093/ndt/gfi041; Yilmaz S, 2003, J AM SOC NEPHROL, V14, P773, DOI 10.1097/01.ASN.0000054496.68498.13	32	130	139	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1797	1806		10.1056/NEJMoa1301064	http://dx.doi.org/10.1056/NEJMoa1301064			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24195547				2022-12-24	WOS:000326607800008
J	Rosenthal, Y; Linsley, BK; Oppo, DW				Rosenthal, Yair; Linsley, Braddock K.; Oppo, Delia W.			Pacific Ocean Heat Content During the Past 10,000 Years	SCIENCE			English	Article							WESTERN EQUATORIAL PACIFIC; TEMPERATURE; WATER; VARIABILITY; THROUGHFLOW	Observed increases in ocean heat content (OHC) and temperature are robust indicators of global warming during the past several decades. We used high-resolution proxy records from sediment cores to extend these observations in the Pacific 10,000 years beyond the instrumental record. We show that water masses linked to North Pacific and Antarctic intermediate waters were warmer by 2.1 +/- 0.4 degrees C and 1.5 +/- 0.4 degrees C, respectively, during the middle Holocene Thermal Maximum than over the past century. Both water masses were similar to 0.9 degrees C warmer during the Medieval Warm period than during the Little Ice Age and similar to 0.65 degrees warmer than in recent decades. Although documented changes in global surface temperatures during the Holocene and Common era are relatively small, the concomitant changes in OHC are large.	[Rosenthal, Yair] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Rosenthal, Yair] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08901 USA; [Linsley, Braddock K.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Oppo, Delia W.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Columbia University; Woods Hole Oceanographic Institution	Rosenthal, Y (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	rosentha@imcs.rutgers.edu		Linsley, Braddock/0000-0003-2085-0662	Center of Research and Development for Oceanography (LIPI) of Indonesia; NSF	Center of Research and Development for Oceanography (LIPI) of Indonesia; NSF(National Science Foundation (NSF))	We are indebted to Y. S. Djajadihardja, F. Syamsudin, the captain and crew of our 2003 R/V Baruna Jaya VIII cruise, the Indonesian Agency for Assessment and Application of Technology (BPPT), and the Center of Research and Development for Oceanography (LIPI) of Indonesia for their support of this project. This work was also supported by the NSF. We thank M. Chong, K. Esswein, A. Morely, S. Woodard, and S. Howe for technical assistance; A. L. Gordon for helpful discussions; and the National Ocean Sciences Accelerator Mass Spectrometry and Radio analytical facilities at Woods Hole Oceanographic Institution. Helpful comments from reviewers are highly appreciated.	Bostock HC, 2013, QUATERNARY SCI REV, V74, P35, DOI 10.1016/j.quascirev.2012.07.018; Dang H., 2011, GEOPHYS RES LETT, V39, P1; Easterling DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037810; FINE RA, 1994, J GEOPHYS RES-OCEANS, V99, P25063, DOI 10.1029/94JC02277; Gordon A.L, 2005, OCEANOGRAPHY, V18, P15, DOI [10.5670/oceanog.2005.01, DOI 10.5670/OCEANOG.2005.01]; Hansen J, 2005, SCIENCE, V308, P1431, DOI 10.1126/science.1110252; Leduc G, 2010, QUATERNARY SCI REV, V29, P989, DOI 10.1016/j.quascirev.2010.01.004; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Linsley BK, 2010, NAT GEOSCI, V3, P578, DOI [10.1038/NGEO920, 10.1038/ngeo920]; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Masson V, 2000, QUATERNARY RES, V54, P348, DOI 10.1006/qres.2000.2172; Mauritzen C, 2012, NAT GEOSCI, V5, P905, DOI [10.1038/NGEO1639, 10.1038/ngeo1639]; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Mohtadi M, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002132; Morley A, 2011, EARTH PLANET SC LETT, V308, P161, DOI 10.1016/j.epsl.2011.05.043; Oppo DW, 2009, NATURE, V460, P1113, DOI 10.1038/nature08233; Orsi AJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051260; Rosenthal Y, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003333; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Sprintall J, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005257; Steinke S, 2011, GLOBAL PLANET CHANGE, V78, P170, DOI 10.1016/j.gloplacha.2011.06.006; Talley LD, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002826; Wanner H, 2008, QUATERNARY SCI REV, V27, P1791, DOI 10.1016/j.quascirev.2008.06.013; Wijffels S, 2002, DEEP-SEA RES PT II, V49, P1341, DOI 10.1016/S0967-0645(01)00155-2; Xu J, 2008, EARTH PLANET SC LETT, V273, P152, DOI 10.1016/j.epsl.2008.06.029; Zenk W, 2005, PROG OCEANOGR, V67, P245, DOI 10.1016/j.pocean.2005.05.003	29	59	59	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					617	621		10.1126/science.1240837	http://dx.doi.org/10.1126/science.1240837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179224				2022-12-24	WOS:000326334300048
J	Paerl, HW; Otten, TG				Paerl, Hans W.; Otten, Timothy G.			Blooms Bite the Hand That Feeds Them	SCIENCE			English	Editorial Material							DISSOLVED ORGANIC-CARBON; PATTERNS; SURFACE		[Paerl, Hans W.; Otten, Timothy G.] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA; [Otten, Timothy G.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	University of North Carolina; University of North Carolina Chapel Hill; Oregon State University	Paerl, HW (corresponding author), Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA.	hans_paerl@unc.edu						Bade DL, 2007, BIOGEOCHEMISTRY, V84, P115, DOI 10.1007/s10533-006-9013-y; Bozarth CS, 2010, APPL ENVIRON MICROB, V76, P5207, DOI 10.1128/AEM.00001-10; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; COOPER WJ, 1983, SCIENCE, V220, P711, DOI 10.1126/science.220.4598.711; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Evans CD, 2005, ENVIRON POLLUT, V137, P55, DOI 10.1016/j.envpol.2004.12.031; Hanson PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021884; Horner-Devine MC, 2003, ECOL LETT, V6, P613; Kardinaal WEA, 2007, APPL ENVIRON MICROB, V73, P2939, DOI 10.1128/AEM.02892-06; Lee DY, 1997, J PHYCOL, V33, P991, DOI 10.1111/j.0022-3646.1997.00991.x; Otten TG, 2012, ENVIRON SCI TECHNOL, V46, P3480, DOI 10.1021/es2041288; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2011, SCI TOTAL ENVIRON, V409, P1739, DOI 10.1016/j.scitotenv.2011.02.001; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	15	141	155	7	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					433	434		10.1126/science.1245276	http://dx.doi.org/10.1126/science.1245276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159037				2022-12-24	WOS:000326042600030
J	Saharia, KK; Koup, RA				Saharia, Kapil K.; Koup, Richard A.			T Cell Susceptibility to HIV Influences Outcome of Opportunistic Infections	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; MYCOBACTERIUM-TUBERCULOSIS INFECTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; ACTIVE ANTIRETROVIRAL THERAPY; CYTOMEGALOVIRUS-SPECIFIC CD4(+); INTERFERON-GAMMA-RECEPTOR; MEDIATED IMMUNE-RESPONSES; END-ORGAN DISEASE; LANGERHANS CELLS	During HIV infection, the timing of opportunistic infections is not always associated with severity of CD4 T cell depletion, and different opportunistic pathogens reactivate at different CD4 T cell thresholds. Here, we examine how differences in the phenotype and function of pathogen-specific CD4 T cells influence susceptibility to HIV infection. By focusing on three common opportunistic infections (Mycobacterium tuberculosis, human papillomavirus, and cytomegalovirus), we investigate how differential depletion of pathogen-specific CD4 T cells impacts the natural history of these pathogens in HIV infection. A broader understanding of this relationship can better inform treatment strategies against copathogens.	[Saharia, Kapil K.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Saharia, Kapil K.] Univ Maryland, Sch Med, Div Infect Dis, Baltimore, MD 21201 USA; [Koup, Richard A.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Koup, RA (corresponding author), NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	rkoup@mail.nih.gov			Intramural NIH HHS [ZIA AI005014-12] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005073] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Adler DH, 2010, CURR HIV RES, V8, P493, DOI 10.2174/157016210793499240; Barry AP, 2007, J IMMUNOL, V178, P8002, DOI 10.4049/jimmunol.178.12.8002; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Bates M, 2013, CURR OPIN PULM MED, V19, P229, DOI 10.1097/MCP.0b013e32835f4fe4; Blitz S, 2013, J INFECT DIS, V208, P454, DOI 10.1093/infdis/jit181; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Bronke C, 2005, J INFECT DIS, V191, P873, DOI 10.1086/427828; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Caruso AM, 1999, J IMMUNOL, V162, P5407; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Casazza JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000646; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; COLEMAN N, 1994, AM J CLIN PATHOL, V102, P768, DOI 10.1093/ajcp/102.6.768; Connor JP, 1999, GYNECOL ONCOL, V75, P130, DOI 10.1006/gyno.1999.5559; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Dal Maso L, 2009, BRIT J CANCER, V100, P840, DOI 10.1038/sj.bjc.6604923; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; de Jong A, 2004, CANCER RES, V64, P5449, DOI 10.1158/0008-5472.CAN-04-0831; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Diedrich CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009611; EVANDER M, 1995, J INFECT DIS, V171, P1026, DOI 10.1093/infdis/171.4.1026; Farhat S, 2009, INT J GYNECOL CANCER, V19, P508, DOI 10.1111/IGC.0b013e3181a388c4; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Franceschi S, 2010, BRIT J CANCER, V103, P416, DOI 10.1038/sj.bjc.6605756; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Geldmacher C, 2012, TRENDS IMMUNOL, V33, P207, DOI 10.1016/j.it.2012.01.011; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, HUM IMMUNOL, V65, P500, DOI 10.1016/j.humimm.2004.02.012; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Heuts F, 2013, P NATL ACAD SCI USA, V110, P6482, DOI 10.1073/pnas.1219985110; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; Hu HT, 2013, BLOOD, V121, P1136, DOI 10.1182/blood-2012-07-446278; Insinga RP, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-119; Jacobson MA, 2001, J INFECT DIS, V183, P1399, DOI 10.1086/319854; Jaspan HB, 2011, J INFECT DIS, V204, P1550, DOI 10.1093/infdis/jir591; Kadish AS, 2002, CANCER EPIDEM BIOMAR, V11, P483; Kalsdorf B, 2009, AM J RESP CRIT CARE, V180, P1262, DOI 10.1164/rccm.200907-1011OC; KAMIJO R, 1993, J EXP MED, V178, P1435, DOI 10.1084/jem.178.4.1435; Khan N, 2004, J IMMUNOL, V173, P7481, DOI 10.4049/jimmunol.173.12.7481; Komanduri KV, 2001, VIROLOGY, V279, P459, DOI 10.1006/viro.2000.0697; Komanduri KV, 1998, NAT MED, V4, P953, DOI 10.1038/nm0898-953; LANG DJ, 1989, J ACQ IMMUN DEF SYND, V2, P540; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Lin PL, 2012, AIDS RES HUM RETROV, V28, P1693, DOI [10.1089/aid.2012.0028, 10.1089/AID.2012.0028]; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lodi S, 2013, THORAX, V68, P207, DOI 10.1136/thoraxjnl-2012-201740; Lopez-Maderuelo D, 2003, AM J RESP CRIT CARE, V167, P970, DOI 10.1164/rccm.200205-438BC; Luchters SMF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-18; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Matthews K, 2003, J VIROL, V77, P8378, DOI 10.1128/JVI.77.15.8378-8385.2003; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; Minga AK, 2008, JAIDS-J ACQ IMM DEF, V48, P350, DOI 10.1097/QAI.0b013e3181775e55; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; MUNOZ A, 1993, AM J EPIDEMIOL, V137, P423, DOI 10.1093/oxfordjournals.aje.a116691; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Nakagawa M, 2000, J INFECT DIS, V182, P595, DOI 10.1086/315706; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Nowak RG, 2011, J INFECT DIS, V203, P1182, DOI 10.1093/infdis/jiq172; Palefsky JM, 1999, JNCI-J NATL CANCER I, V91, P226, DOI 10.1093/jnci/91.3.226; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Patel NR, 2009, J LEUKOCYTE BIOL, V86, P53, DOI [10.1189/JLB.0908574, 10.1189/jlb.0908574]; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; PERTEL P, 1992, J ACQ IMMUN DEF SYND, V5, P1069; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Powles T, 2009, J CLIN ONCOL, V27, P884, DOI 10.1200/JCO.2008.19.6626; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; REDDEHASE MJ, 1985, J VIROL, V55, P264, DOI 10.1128/JVI.55.2.264-273.1985; RIDDELL SR, 1992, SCIENCE, V257, P238; Sarkar AK, 2005, GYNECOL ONCOL, V99, pS251, DOI 10.1016/j.ygyno.2005.07.099; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Schluger NW, 2002, CHEST, V122, P597, DOI 10.1378/chest.122.2.597; Scriba TJ, 2012, AM J RESP CRIT CARE, V185, P769, DOI 10.1164/rccm.201108-1548OC; Sester M, 2002, J VIROL, V76, P3748, DOI 10.1128/JVI.76.8.3748-3755.2002; Singh DK, 2009, J INFECT DIS, V199, P1851, DOI 10.1086/599123; Slight SR, 2013, J CLIN INVEST, V123, P712, DOI 10.1172/JCI65728; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Sutherland JS, 2010, J IMMUNOL, V184, P6537, DOI 10.4049/jimmunol.1000399; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Sutherland R, 2006, AIDS, V20, P821, DOI 10.1097/01.aids.0000218545.31716.a4; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; TAY SK, 1987, BRIT J OBSTET GYNAEC, V94, P10, DOI 10.1111/j.1471-0528.1987.tb02244.x; Theiler RN, 2010, OBSTET GYNECOL, V115, P1150, DOI 10.1097/AOG.0b013e3181e00927; Tu WW, 2004, J IMMUNOL, V172, P3260, DOI 10.4049/jimmunol.172.5.3260; Van Crevel R, 2003, ADV EXP MED BIOL, V531, P241; VESSEY CJ, 1995, J PATHOL, V176, P151, DOI 10.1002/path.1711760208; Viard JP, 2011, AIDS, V25, P1305, DOI 10.1097/QAD.0b013e328347f6f7; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wang CH, 2011, J INFECT DIS, V203, P479, DOI 10.1093/infdis/jiq083; Welters MJP, 2010, P NATL ACAD SCI USA, V107, P11895, DOI 10.1073/pnas.1006500107; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wilkinson KA, 2009, AM J RESP CRIT CARE, V180, P674, DOI 10.1164/rccm.200904-0568OC; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Yanik EL, 2013, CLIN INFECT DIS, V57, P756, DOI 10.1093/cid/cit369; Yazdanpanah Y, 2001, INT J EPIDEMIOL, V30, P864, DOI 10.1093/ije/30.4.864; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836	113	29	29	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					505	514		10.1016/j.cell.2013.09.045	http://dx.doi.org/10.1016/j.cell.2013.09.045			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243010	Bronze, Green Accepted			2022-12-24	WOS:000326571800006
J	Savulescu, J; Creaney, L; Vondy, A				Savulescu, Julian; Creaney, Leon; Vondy, Anna			Should athletes be allowed to use performance enhancing drugs?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE; EXERCISE; ABUSE		[Savulescu, Julian] Univ Oxford, Oxford, England; [Creaney, Leon] Univ Hosp Birmingham, Birmingham, W Midlands, England; [Vondy, Anna] Royal Liverpool Univ Hosp, Emergency Dept, Salisbury, Merseyside, England	University of Oxford; University of Birmingham; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital	Savulescu, J (corresponding author), Univ Oxford, Oxford, England.	julian.savulescu@philosophy.ox.ac.uk; leon.creaney@uhb.nhs.uk						Bonetti A, 2008, INT J SPORTS MED, V29, P679, DOI 10.1055/s-2007-965808; Bowers LD., WITNESS STATEMENT US; Bronstein AC, 2012, CLIN TOXICOL, V50, P911, DOI 10.3109/15563650.2012.746424; Di Luigi L, 2010, J SEX MED, V7, P2591, DOI 10.1111/j.1743-6109.2009.01694.x; Drepper D, 2013, SPIEGEL INT     0903; Eriksson A, 2005, HISTOCHEM CELL BIOL, V124, P167, DOI 10.1007/s00418-005-0029-5; ERIKSSON A, 2006, STRENGTH TRAINING AN; Garevik N, 2011, J STEROID BIOCHEM, V127, P295, DOI 10.1016/j.jsbmb.2011.08.005; Goodbody J., 1998, TIMES; Hamilton T., 2012, SECRET RACE INSIDE H; Hermann A, 2013, CONVERSATION; Kirk J, 2012, ARCH DIS CHILD, V97, P63, DOI 10.1136/adc.2010.186205; Laure P, 2007, BRIT J SPORT MED, V41, P660, DOI 10.1136/bjsm.2007.035733; Lopez B, 2011, SPORT HIST, V31, P84, DOI 10.1080/17460263.2011.555208; Lucia A, 2001, BRIT J SPORT MED, V35, P424, DOI 10.1136/bjsm.35.6.424; Marijon E, 2013, EUR HEART J; Robson D., 2010, CBC SPORTS      0604; SCOTT WC, 1990, JAMA-J AM MED ASSOC, V264, P1660, DOI 10.1001/jama.1990.03450130030017; Shermer M, 2008, SCI AM, V298, P82, DOI 10.1038/scientificamerican0408-82; SMITH JA, 1995, SPORTS MED, V19, P9, DOI 10.2165/00007256-199519010-00002; Staunton P., 2013, GOAL            0502; World Anti Doping Agency, 2011, QUEST ANSW EPO DET	22	9	9	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2013	347								f6150	10.1136/bmj.f6150	http://dx.doi.org/10.1136/bmj.f6150			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CI	24149520				2022-12-24	WOS:000326293800006
J	Zenner, D; Zumla, A; Gill, P; Cosford, P; Abubakar, I				Zenner, Dominik; Zumla, Alimuddin; Gill, Paramjit; Cosford, Paul; Abubakar, Ibrahim			Reversing the tide of the UK tuberculosis epidemic	LANCET			English	Editorial Material							LATENT TUBERCULOSIS; IMMIGRANTS		[Zenner, Dominik; Abubakar, Ibrahim] Publ Hlth England, TB Sect, Ctr Infect Dis Surveillance & Control, London NW9 5EQ, England; [Zenner, Dominik; Abubakar, Ibrahim] UCL, Res Dept Infect & Populat Hlth, London, England; [Cosford, Paul] Publ Hlth England, Hlth Protect & Med Directorate, London NW9 5EQ, England; [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England; [Gill, Paramjit] Univ Birmingham, Birmingham, W Midlands, England	Public Health England; University of London; University College London; Public Health England; University of London; University College London; University of Birmingham	Zenner, D (corresponding author), Publ Hlth England, TB Sect, Ctr Infect Dis Surveillance & Control, London NW9 5EQ, England.	dominik.zenner@phe.gov.uk	ZUMLA, Alimuddin/ABA-8208-2020; Zenner, Dominik/AAF-5134-2019	ZUMLA, Alimuddin/0000-0002-5111-5735; Abubakar, Ibrahim/0000-0002-0370-1430; Zenner, Dominik/0000-0002-9200-6180	Department of Health [08/68/01] Funding Source: Medline; National Institute for Health Research [08/68/01] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Abubakar I, 2012, LANCET, V379, pE21, DOI 10.1016/S0140-6736(11)61428-1; [Anonymous], 2013, TUB UK 2013 REP; Brewin P, 2006, J PUBLIC HEALTH-UK, V28, P253, DOI 10.1093/pubmed/fdl031; European Centre for Disease Prevention and Control WHO Regional Office for Europe, 2013, TUB SURV MON EUR 201; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; National Institute for Health and Clinical Excellence, 2011, TUB CLIN DIAGN MAN T; Pareek M, 2011, EUR RESPIR J, V37, P1175, DOI 10.1183/09031936.00105810; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Smieja M, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001363; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Zumla A, 2011, LANCET, V377, P10, DOI 10.1016/S0140-6736(10)62176-9	12	16	16	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1311	1312		10.1016/S0140-6736(13)62113-3	http://dx.doi.org/10.1016/S0140-6736(13)62113-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	24139110				2022-12-24	WOS:000325975700004
J	Rivara, FP; Graham, R				Rivara, Frederick P.; Graham, Robert			Sports-Related Concussions in Youth Report From the Institute of Medicine and National Research Council	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rivara, Frederick P.] Univ Washington, Seattle, WA 98104 USA; [Rivara, Frederick P.] Seattle Childrens Hosp, Seattle, WA USA; [Graham, Robert] George Washington Univ, Washington, DC USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; George Washington University	Rivara, FP (corresponding author), Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, 325 9th Ave,POB 359960, Seattle, WA 98104 USA.	fpr@uw.edu						Committee on Sports-Related Concussions in Youth Institute of Medicine National Research Council, 2013, SPORTS RELATED CONCU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001	2	39	40	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2014	311	3					239	240		10.1001/jama.2013.282985	http://dx.doi.org/10.1001/jama.2013.282985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	287TZ	24185195				2022-12-24	WOS:000329566400011
J	Neculai, D; Schwake, M; Ravichandran, M; Zunke, F; Collins, RF; Peters, J; Neculai, M; Plumb, J; Loppnau, P; Pizarro, JC; Seitova, A; Trimble, WS; Saftig, P; Grinstein, S; Dhe-Paganon, S				Neculai, Dante; Schwake, Michael; Ravichandran, Mani; Zunke, Friederike; Collins, Richard F.; Peters, Judith; Neculai, Mirela; Plumb, Jonathan; Loppnau, Peter; Pizarro, Juan Carlos; Seitova, Alma; Trimble, William S.; Saftig, Paul; Grinstein, Sergio; Dhe-Paganon, Sirano			Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36	NATURE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR CLASS-B; SCAVENGER RECEPTOR; BINDING; IDENTIFICATION; PHOSPHOLIPIDS; INHIBITORS; LIPIDS	Members of the CD36 superfamily of scavenger receptor proteins are important regulators of lipid metabolism and innate immunity. They recognize normal and modified lipoproteins, as well as pathogen-associated molecular patterns. The family consists of three members: SR-BI (which delivers cholesterol to the liver and steroidogenic organs and is a co-receptor for hepatitis C virus), LIMP-2/LGP85 (which mediates lysosomal delivery of beta-glucocerebrosidase and serves as a receptor for enterovirus 71 and coxsackieviruses) and CD36 (a fatty-acid transporter and receptor for phagocytosis of effete cells and Plasmodium-infected erythrocytes). Notably, CD36 is also a receptor for modified lipoproteins and beta-amyloid, and has been implicated in the pathogenesis of atherosclerosis and of Alzheimer's disease(1). Despite their prominent roles in health and disease, understanding the function and abnormalities of the CD36 family members has been hampered by the paucity of information about their structure. Here we determine the crystal structure of LIMP-2 and infer, by homology modelling, the structure of SR-BI and CD36. LIMP-2 shows a helical bundle where beta-glucocerebrosidase binds, and where ligands are most likely to bind to SR-BI and CD36. Remarkably, the crystal structure also shows the existence of a large cavity that traverses the entire length of the molecule. Mutagenesis of SR-BI indicates that the cavity serves as a tunnel through which cholesterol(esters) are delivered from the bound lipoprotein to the outer leaflet of the plasma membrane. We provide evidence supporting a model(2) whereby lipidic constituents of the ligands attached to the receptor surface are handed off to the membrane through the tunnel, accounting for the selective lipid transfer characteristic of SR-BI and CD36.	[Neculai, Dante; Collins, Richard F.; Plumb, Jonathan; Trimble, William S.; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Schwake, Michael; Zunke, Friederike; Peters, Judith; Saftig, Paul] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany; [Schwake, Michael] Univ Bielefeld, Fak Chem, D-33615 Bielefeld, Germany; [Ravichandran, Mani; Neculai, Mirela; Loppnau, Peter; Pizarro, Juan Carlos; Seitova, Alma; Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Pizarro, Juan Carlos] Tulane Univ, Dept Trop Med, New Orleans, LA 70118 USA; [Trimble, William S.; Grinstein, Sergio] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Grinstein, Sergio] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5C 1N8, Canada; [Dhe-Paganon, Sirano] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Kiel; University of Bielefeld; University of Toronto; Structural Genomics Consortium; Tulane University; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Harvard University; Dana-Farber Cancer Institute	Grinstein, S (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sergio.grinstein@sickkids.ca	Schwake, Michael/F-5381-2010; Neculai, Dante/A-9923-2011; Saftig, Paul/A-7966-2010	Neculai, Dante/0000-0001-8887-9168; Schwake, Michael/0000-0002-4173-2166; Zunke, Friederike/0000-0002-0408-6388	Canadian Institutes for Health Research [MOP-102474, MOP-126069]; Deutsche Forschungsgemeinschaft [GRK1459, SFB877]; Bohringer Ingelheim Fonds; Canada Research Chair in Molecular Cell Biology; Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bohringer Ingelheim Fonds; Canada Research Chair in Molecular Cell Biology(Canada Research Chairs); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank W. Temple, D. Cossar, S. Graslund, C. Arrowsmith, R. Stahelin, L. Andresen, J. Groth, M. Langer and J. Scott for assistance and discussions. This study was supported by the Canadian Institutes for Health Research (grants MOP-102474 and MOP-126069) and the Deutsche Forschungsgemeinschaft (grants GRK1459 to M. S. and SFB877). F.Z. is supported through the Bohringer Ingelheim Fonds. W. S. T. is the recipient of a Canada Research Chair in Molecular Cell Biology. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanz J, 2010, HUM MOL GENET, V19, P563, DOI 10.1093/hmg/ddp523; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Chadwick AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045660; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jimenez-Dalmaroni MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007411; Kar NS, 2008, J BIOL CHEM, V283, P8765, DOI 10.1074/jbc.M709195200; Liu B, 2002, J BIOL CHEM, V277, P34125, DOI 10.1074/jbc.M204265200; Navazo MDP, 1996, ARTERIOSCL THROM VAS, V16, P1033, DOI 10.1161/01.ATV.16.8.1033; Nieland TJF, 2008, BIOCHEMISTRY-US, V47, P460, DOI 10.1021/bi701277x; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Rasmussen JT, 1998, EUR J BIOCHEM, V257, P488, DOI 10.1046/j.1432-1327.1998.2570488.x; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Ryeom SW, 1996, J BIOL CHEM, V271, P20536, DOI 10.1074/jbc.271.34.20536; Stylianou IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006521; Yu M, 2012, BIOCHEMISTRY-US, V51, P10044, DOI 10.1021/bi301203x; Yu M, 2011, P NATL ACAD SCI USA, V108, P12243, DOI 10.1073/pnas.1109078108; Zachos C, 2012, TRAFFIC, V13, P1113, DOI 10.1111/j.1600-0854.2012.01372.x	21	176	195	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					172	176		10.1038/nature12684	http://dx.doi.org/10.1038/nature12684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24162852				2022-12-24	WOS:000327851700054
J	Barouch, DH				Barouch, Dan H.			The Quest for an HIV-1 Vaccine - Moving Forward	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EFFICACY TRIAL; DOUBLE-BLIND; INFECTION; THAILAND	The challenges in the development of a prophylactic HIV-1 vaccine are unprecedented in the history of vaccinology. But there are reasons for optimism, and indeed, several promising vaccine concepts are currently moving toward clinical efficacy trials. Vaccines have historically been the most effective biomedical interventions for controlling global infectious diseases. The development of a safe and effective vaccine against human immunodeficiency virus type 1 (HIV-1) is therefore a critical research priority. Although other HIV-1 prevention efforts based on behavioral risk reduction, male circumcision, topical microbicides, preexposure prophylaxis, and treatment as prevention have had substantial effects on HIV-1 transmission rates, it is likely that a vaccine will be required to end the global HIV-1 epidemic. The challenges in the development of a prophylactic HIV-1 vaccine, however, are unprecedented in the history of vaccinology. First, HIV-1 exhibits tremendous ...	[Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.] Harvard Univ, Sch Med, Boston, MA USA; [Barouch, Dan H.] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA; [Barouch, Dan H.] Harvard Univ, Cambridge, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.		Barouch, Dan/Y-3918-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084794, U19AI078526, U19AI096040, U19AI095985] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI096040, R01 AI084794, U19 AI095985, U19 AI078526] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492	5	16	18	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2073	2076		10.1056/NEJMp1312711	http://dx.doi.org/10.1056/NEJMp1312711			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	258OB	24283223	Green Accepted			2022-12-24	WOS:000327467500003
J	Roehr, B				Roehr, Bob			What will climate change mean for infectious disease? As global climate change becomes more apparent with each passing day, predicting how that will play out in shifting patterns of disease remains very much conjecture	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Chowdhary A, 2013, J ANTIMICROB CHEMOTH	3	1	2	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2013	347								f6713	10.1136/bmj.f6713	http://dx.doi.org/10.1136/bmj.f6713			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FA	24277338				2022-12-24	WOS:000327791000002
J	Gerhart-Hines, Z; Feng, D; Emmett, MJ; Everett, LJ; Loro, E; Briggs, ER; Bugge, A; Hou, C; Ferrara, C; Seale, P; Pryma, DA; Khurana, TS; Lazar, MA				Gerhart-Hines, Zachary; Feng, Dan; Emmett, Matthew J.; Everett, Logan J.; Loro, Emanuele; Briggs, Erika R.; Bugge, Anne; Hou, Catherine; Ferrara, Christine; Seale, Patrick; Pryma, Daniel A.; Khurana, Tejvir S.; Lazar, Mitchell A.			The nuclear receptor Rev-erb alpha controls circadian thermogenic plasticity	NATURE			English	Article							BROWN ADIPOSE-TISSUE; NONSHIVERING THERMOGENESIS; METABOLISM; COLD; BEHAVIOR; RHYTHM; UCP1	Circadian oscillation of body temperature is a basic, evolutionarily conserved feature of mammalian biology(1). In addition, homeostatic pathways allow organisms to protect their core temperatures in response to cold exposure(2). However, the mechanism responsible for coordinating daily body temperature rhythm and adaptability to environmental challenges is unknown. Here we show that the nuclear receptor Rev-erb alpha (also known as Nr1d1), a powerful transcriptional repressor, links circadian and thermogenic networks through the regulation of brown adipose tissue (BAT) function. Mice exposed to cold fare considerably better at 05:00 (Zeitgeber time 22) when Rev-erb alpha is barely expressed than at 17:00 (Zeitgeber time 10) when Rev-erb alpha is abundant. Deletion of Rev-erb alpha markedly improves cold tolerance at 17: 00, indicating that overcoming Rev-erb alpha-dependent repression is a fundamental feature of the thermogenic response to cold. Physiological induction of uncoupling protein 1 (Ucp1) by cold temperatures is preceded by rapid downregulation of Rev-erb alpha in BAT. Rev-erb alpha represses Ucp1 in a brown-adipose-cell-autonomous manner and BAT Ucp1 levels are high in Rev-erb alpha-null mice, even at thermoneutrality. Genetic loss of Rev-erb alpha also abolishes normal rhythms of body temperature and BAT activity. Thus, Rev-erb alpha acts as a thermogenic focal point required for establishing and maintaining body temperature rhythm in a manner that is adaptable to environmental demands.	[Gerhart-Hines, Zachary; Feng, Dan; Emmett, Matthew J.; Everett, Logan J.; Briggs, Erika R.; Bugge, Anne; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA; [Gerhart-Hines, Zachary; Feng, Dan; Emmett, Matthew J.; Everett, Logan J.; Briggs, Erika R.; Bugge, Anne; Seale, Patrick; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Loro, Emanuele; Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Loro, Emanuele; Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Hou, Catherine; Pryma, Daniel A.] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Ferrara, Christine] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Seale, Patrick] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Everett, Logan/AAK-1523-2021; Loro, Emanuele/J-5212-2019; Lazar, Mitchell A/AAF-3738-2019	Loro, Emanuele/0000-0002-0822-4514; Feng, Dan/0000-0001-5926-8894; Emmett, Matthew/0000-0002-8855-423X; Bugge, Anne/0000-0001-5885-4541; Gerhart-Hines, Zachary/0000-0003-2981-4991	NIH [R01 DK45586, F-32 DK095563]; JPB Foundation; Novo Nordisk STAR postdoctoral program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, U19DK062434, F32DK095526, F32DK095563, R01DK045586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Novo Nordisk STAR postdoctoral program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Functional Genomics Core (J. Schug) and the Mouse Phenotyping, Physiology, and Metabolism Core (R. Ahima and R. Dhir) of the Penn Diabetes Research Center (NIH P30 DK19525). We also thank the Small Animal Imaging Facility of the Perelman School of Medicine at the University of Pennsylvania (E. Blankemeyer). This work was supported by NIH grants R01 DK45586 (M.A.L.) and F-32 DK095563 (Z.G.-H.) and the JPB Foundation. A.B. was funded by the Novo Nordisk STAR postdoctoral program.	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Pearen MA, 2006, ENDOCRINOLOGY, V147, P5217, DOI 10.1210/en.2006-0447; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Saito S, 2008, GENE, V408, P37, DOI 10.1016/j.gene.2007.10.018; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; TALAN MI, 1991, PHYSIOL BEHAV, V50, P613, DOI 10.1016/0031-9384(91)90554-2; van der Veen DR, 2012, OBESITY, V20, P1527, DOI 10.1038/oby.2012.78; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vosselman MJ, 2012, DIABETES, V61, P3106, DOI 10.2337/db12-0288; Woldt E., 2013, NATURE MED	30	179	186	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					410	+		10.1038/nature12642	http://dx.doi.org/10.1038/nature12642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24162845	Green Accepted			2022-12-24	WOS:000327163200044
J	Vinden, C; Nash, DM; Rangrej, J; Shariff, SZ; Dixon, SN; Jain, AK; Garg, AX				Vinden, Christopher; Nash, Danielle M.; Rangrej, Jagadish; Shariff, Salimah Z.; Dixon, Stephanie N.; Jain, Arsh K.; Garg, Amit X.			Complications of Daytime Elective Laparoscopic Cholecystectomies Performed by Surgeons Who Operated the Night Before	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SLEEP-DEPRIVATION; OUTCOMES	IMPORTANCE The effect of surgeons' disrupted sleep on patient outcomes is not clearly defined. OBJECTIVE To assess if surgeons operating the night before have more complications of elective surgery performed the next day. DESIGN, SETTING, AND PARTICIPANTS Population-based, matched, retrospective cohort study using administrative health care databases in Ontario, Canada (2012 population, 13 505 900). Participants were 2078 patients who underwent elective laparoscopic cholecystectomies performed by surgeons who operated the night before, matched with 4 other elective laparoscopic cholecystectomy recipients (n = 8312). EXPOSURE In total, 94 183 eligible elective laparoscopic cholecystectomies were performed between 2004 and 2011. Of these surgeries, there were 2078 procedures in which 331 different surgeons across 102 community hospitals had operated between midnight and 7 AM the night before. Each "at-risk" surgery was randomly matched with 4 other elective laparoscopic cholecystectomies (n = 8312) performed by the same surgeon, who had no evidence of having operated the night before. MAIN OUTCOMES AND MEASURES The primary outcome was conversion from a laparoscopic cholecystectomy to open cholecystectomy. Secondary outcomes included evidence of iatrogenic injuries or death. Risks were quantified using generalized estimating equations. RESULTS No significant association was found in conversion rates to open operations between surgeons when they operated the night before compared with when they did not operate the previous night (46/2031 [2.2%] vs 157/8124 [1.9%]; adjusted odds ratio [OR], 1.18; 95% CI, 0.85-1.64). There was no association between operating the night before vs not operating the night before, and risk of iatrogenic injuries (14/2031 [0.7%] vs 72/8124 [0.9%]; adjusted OR, 0.77; 95% CI, 0.43-1.37) or death (<= 5/2031 [<= 0.2%] vs 7/8124 [0.1%]). CONCLUSIONS AND RELEVANCE No significant association was found between operating the night before and not operating the previous night for conversion to open cholecystectomy, risk of iatrogenic complications, or death for elective daytime cholecystectomy. These findings do not support safety concerns related to surgeons operating the night before performing elective surgery.	[Vinden, Christopher] Univ Western Ontario, Dept Surg, Div Gen Surg, London, ON N6A 3K7, Canada; [Vinden, Christopher; Nash, Danielle M.; Shariff, Salimah Z.; Dixon, Stephanie N.; Jain, Arsh K.; Garg, Amit X.] Inst Clin Evaluat Sci, London, ON, Canada; [Dixon, Stephanie N.; Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Rangrej, Jagadish] Inst Clin Evaluat Sci, Toronto, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto	Vinden, C (corresponding author), Victoria Hosp, London Hlth Sci Ctr, 800 Commissioners Rd E,Room E2-218, London, ON N6A 5W9, Canada.	chris.vinden@lhsc.on.ca	Jain, Arsh/G-3308-2011; Garg, Amit X/G-3295-2011	Shariff, Salimah/0000-0002-1219-6763	Ontario Ministry of Health and Long-Term Care; Academic Medical Organization of Southwestern Ontario; Lawson Health Research Institute; Schulich School of Medicine and Dentistry; Western University; Division of General Surgery at the London Health Sciences Centre; ICES Western facility	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario; Lawson Health Research Institute; Schulich School of Medicine and Dentistry; Western University; Division of General Surgery at the London Health Sciences Centre; ICES Western facility	The Institute for Clinical Evaluative Sciences (ICES) is a nonprofit research corporation funded by the Ontario Ministry of Health and Long-Term Care. This work was supported by personnel at the ICES Western facility, which receives support from the Academic Medical Organization of Southwestern Ontario, the Lawson Health Research Institute, the Schulich School of Medicine and Dentistry, and multiple departments at Western University. This project was funded by the Division of General Surgery at the London Health Sciences Centre.	ASCH DA, 1988, NEW ENGL J MED, V318, P771, DOI 10.1056/NEJM198803243181209; Chu MWA, 2011, ARCH SURG-CHICAGO, V146, P1080, DOI 10.1001/archsurg.2011.121; Ellman PI, 2004, ANN THORAC SURG, V78, P906, DOI 10.1016/j.athoracsur.2004.04.006; Goel V, 1996, PATTERNS HLTH CARE O; Hallock GG, 2011, ANN PLAS SURG, V66, P323, DOI 10.1097/SAP.0b013e3182118fc0; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Harvey EJ, 2011, CAN J SURG, V54, P4, DOI 10.1503/cjs.001611; KOSLOWSKY M, 1992, CHRONOBIOL INT, V9, P132, DOI 10.3109/07420529209064524; MacDonald NE, 2011, CAN MED ASSOC J, V183, P1689, DOI 10.1503/cmaj.110402; Molnar AO, 2011, J AM SOC NEPHROL, V22, P939, DOI 10.1681/ASN.2010050442; Nurok M, 2010, NEW ENGL J MED, V363, P2577, DOI 10.1056/NEJMp1007901; Payette M, 2009, AM J SURG, V197, P820, DOI 10.1016/j.amjsurg.2008.05.013; Pellegrini CA, 2010, NEW ENGL J MED, V363, P2672, DOI 10.1056/NEJMc1012517; Rothschild JM, 2009, JAMA-J AM MED ASSOC, V302, P1565, DOI 10.1001/jama.2009.1423; Sharpe JP, 2013, J AM COLL SURGEONS, V216, P791, DOI 10.1016/j.jamcollsurg.2012.12.005; Siddiqui NF, 2012, CAN MED ASSOC J, V184, P1237, DOI 10.1503/cmaj.110895; Stavert RR, 2013, NEW ENGL J MED, V368, P8, DOI 10.1056/NEJMp1210501; Sturm L, 2011, ANZ J SURG, V81, P502, DOI 10.1111/j.1445-2197.2010.05642.x; Temple J, TIME TRAINING REV IM; TILLEY AJ, 1982, HUM FACTORS, V24, P629, DOI 10.1177/001872088202400601; Urbach DR, 2005, CAN MED ASSOC J, V172, P1015, DOI 10.1503/cmaj.1041363; WILKINSON RT, 1992, SLEEP, AROUSAL, AND PERFORMANCE, P254	22	33	33	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1837	1841		10.1001/jama.2013.280372	http://dx.doi.org/10.1001/jama.2013.280372			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24193081	Bronze			2022-12-24	WOS:000326550900017
J	Sun, LO; Jiang, Z; Rivlin-Etzion, M; Hand, R; Brady, CM; Matsuoka, RL; Yau, KW; Feller, MB; Kolodkin, AL				Sun, Lu O.; Jiang, Zheng; Rivlin-Etzion, Michal; Hand, Randal; Brady, Colleen M.; Matsuoka, Ryota L.; Yau, King-Wai; Feller, Marla B.; Kolodkin, Alex L.			On and Off Retinal Circuit Assembly by Divergent Molecular Mechanisms	SCIENCE			English	Article							DIRECTION-SELECTIVITY; AMACRINE CELLS; ORGANIZATION; LAMINATION; PLEXIN-A2; DENDRITES	Direction-selective responses to motion can be to the onset (On) or cessation (Off) of illumination. Here, we show that the transmembrane protein semaphorin 6A and its receptor plexin A2 are critical for achieving radially symmetric arborization of On starburst amacrine cell (SAC) dendrites and normal SAC stratification in the mouse retina. Plexin A2 is expressed in both On and Off SACs; however, semaphorin 6A is expressed in On SACs. Specific On-Off bistratified direction- selective ganglion cells in semaphorin 6A(-/-) mutants exhibit decreased tuning of On directional motion responses. These results correlate the elaboration of symmetric SAC dendritic morphology and asymmetric responses to motion, shedding light on the development of visual pathways that use the same cell types for divergent outputs.	[Sun, Lu O.; Jiang, Zheng; Hand, Randal; Brady, Colleen M.; Matsuoka, Ryota L.; Yau, King-Wai; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Sun, Lu O.; Hand, Randal; Brady, Colleen M.; Matsuoka, Ryota L.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Rivlin-Etzion, Michal; Feller, Marla B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Rivlin-Etzion, Michal; Feller, Marla B.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu	Matsuoka, Ryota L./K-5439-2019; Jiang, Zheng/A-7674-2015; Sun, Lu O/P-9339-2015	Matsuoka, Ryota L./0000-0001-6214-2889; Sun, Lu O/0000-0002-9293-7241; Rivlin, Michal/0000-0002-1310-3370; Longley, Colleen/0000-0001-8326-6143	Human Frontier Science Program Organization; National Postdoctoral Award Program for Advancing Women in Science; Edmond and Lily Safra (ELSC) Fellowship for postdoctoral training in Brain Science;  [NS35165];  [EY06837];  [EY019498];  [EY013528]; NATIONAL EYE INSTITUTE [F32EY006837, R01EY006837, R37EY006837, R01EY019498, R01EY013528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035165, R37NS035165, P30NS050274, R56NS035165] Funding Source: NIH RePORTER	Human Frontier Science Program Organization(Human Frontier Science Program); National Postdoctoral Award Program for Advancing Women in Science; Edmond and Lily Safra (ELSC) Fellowship for postdoctoral training in Brain Science; ; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Ginty for the ROSA<SUP>LSL-Tdtomato</SUP> mice, J. Nathans for Six3-cre, ChAT::cre, ChAT::cre<SUP>ER</SUP>, and ROSA<SUP>iAP</SUP> mice, and Y. Yoshida for the Sema6B<SUP>-/-</SUP> and Sema6C<SUP>-/-</SUP>;6D<SUP>-/-</SUP> eyes. We also thank S. Hattar, M. Riccomagno, and Q. Wang for comments on the manuscript and all Kolodkin laboratory members for assistance and discussions throughout the course of this project. This work was supported by NS35165 (A. L. K.); EY06837 (K.-W.Y.); EY019498 and EY013528 (M. B. F.); and the Human Frontier Science Program Organization, the National Postdoctoral Award Program for Advancing Women in Science, and the Edmond and Lily Safra (ELSC) Fellowship for postdoctoral training in Brain Science (M. R.-E.). A. L. K. is an investigator of the Howard Hughes Medical Institute.	Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Chalupa LM, 2004, PROG RETIN EYE RES, V23, P31, DOI 10.1016/j.preteyeres.2003.10.001; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Ford KJ, 2012, VISUAL NEUROSCI, V29, P61, DOI 10.1017/S0952523811000216; Haklai-Topper L, 2010, EMBO J, V29, P2635, DOI 10.1038/emboj.2010.147; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Matsuoka RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063207; Matsuoka RL, 2012, J NEUROSCI, V32, P6859, DOI 10.1523/JNEUROSCI.0267-12.2012; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Rivlin-Etzion M, 2011, J NEUROSCI, V31, P8760, DOI 10.1523/JNEUROSCI.0564-11.2011; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Wei W, 2011, TRENDS NEUROSCI, V34, P638, DOI 10.1016/j.tins.2011.08.002; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; WONG ROL, 1989, J COMP NEUROL, V287, P164, DOI 10.1002/cne.902870203; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	25	89	89	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					590	+		10.1126/science.1241974	http://dx.doi.org/10.1126/science.1241974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179230	Green Accepted			2022-12-24	WOS:000326334300039
J	Murdock, DJE; Dong, XP; Repetski, JE; Marone, F; Stampanoni, M; Donoghue, PCJ				Murdock, Duncan J. E.; Dong, Xi-Ping; Repetski, John E.; Marone, Federica; Stampanoni, Marco; Donoghue, Philip C. J.			The origin of conodonts and of vertebrate mineralized skeletons	NATURE			English	Article							TEETH; PHYLOGENY; ANATOMY; JAWS	Conodonts are an extinct group of jawless vertebrates whose toothlike elements are the earliest instance of a mineralized skeleton in the vertebrate lineage(1,2), inspiring the 'inside-out' hypothesis that teeth evolved independently of the vertebrate dermal skeleton and before the origin of jaws(3-6). However, these propositions have been based on evidence from derived euconodonts. Here we test hypotheses of a paraconodont ancestry of euconodonts(7-11) using synchrotron radiation X-ray tomographic microscopy to characterize and compare the microstructure of morphologically similar euconodont and paraconodont elements. Paraconodonts exhibit a range of grades of structural differentiation, including tissues and a pattern of growth common to euconodont basal bodies. The different grades of structural differentiation exhibited by paraconodonts demonstrate the stepwise acquisition of euconodont characters, resolving debate over the relationship between these two groups. By implication, the putative homology of euconodont crown tissue and vertebrate enamel must be rejected as these tissues have evolved independently and convergently. Thus, the precise ontogenetic, structural and topological similarities between conodont elements and vertebrate odontodes appear to be a remarkable instance of convergence. The last common ancestor of conodonts and jawed vertebrates probably lacked mineralized skeletal tissues. The hypothesis that teeth evolved before jaws and the inside-out hypothesis of dental evolution must be rejected; teeth seem to have evolved through the extension of odontogenic competence from the external dermis to internal epithelium soon after the origin of jaws.	[Murdock, Duncan J. E.; Donoghue, Philip C. J.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Dong, Xi-Ping] Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China; [Dong, Xi-Ping] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China; [Repetski, John E.] US Geol Survey, Natl Ctr, Reston, VA 20192 USA; [Marone, Federica; Stampanoni, Marco] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Stampanoni, Marco] Univ Zurich, Inst Biomed Engn, CH-8006 Zurich, Switzerland; [Stampanoni, Marco] ETH, CH-8006 Zurich, Switzerland	University of Bristol; Peking University; Chinese Academy of Sciences; United States Department of the Interior; United States Geological Survey; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Donoghue, PCJ (corresponding author), Univ Bristol, Sch Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	phil.donoghue@bristol.ac.uk	Stampanoni, Marco/J-4099-2013; Dong, Xi-ping/N-5741-2014; Murdock, Duncan/H-3503-2019; Donoghue, Philip/A-3873-2008; Marone, Federica/J-4420-2013; Stampanoni, Marco/AAZ-3033-2021; Stampanoni, Marco/GRR-9695-2022	Stampanoni, Marco/0000-0001-7486-6681; Dong, Xi-ping/0000-0001-5917-7159; Murdock, Duncan/0000-0001-6838-5566; Donoghue, Philip/0000-0003-3116-7463; Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681	Swiss Light Source, Paul Scherrer Institut (Villigen, Switzerland); NERC [NE/G016623/1]; Paul Scherrer Institut; NSFC [41372015]; Natural Environment Research Council [NE/G016623/1] Funding Source: researchfish	Swiss Light Source, Paul Scherrer Institut (Villigen, Switzerland); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Paul Scherrer Institut; NSFC(National Natural Science Foundation of China (NSFC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The SRXTM experiments were performed on the TOMCAT beamline at the Swiss Light Source, Paul Scherrer Institut (Villigen, Switzerland), funded through a project awarded to P.C.J.D. and S. Bengtson (Stockholm). NERC grant NE/G016623/1 to P.C.J.D., a studentship to DJEM funded by NERC and the Paul Scherrer Institut, and NSFC Project 41372015 to X.-P.D. Thanks to R. Stamm (USGS) for reviewing a draft of this manuscript; and thanks to J. E. Cunningham, D. O. Jones and M. Rucklin for assistance at the beamline. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	ALDRIDGE RJ, 1993, PHILOS T R SOC B, V340, P405, DOI 10.1098/rstb.1993.0082; BENGTSON S, 1976, LETHAIA, V9, P184; Blieck A, 2010, EPISODES, V33, P234, DOI 10.18814/epiiugs/2010/v33i4/002; Donoghue PCJ, 1998, PHILOS T R SOC B, V353, P633, DOI 10.1098/rstb.1998.0231; Donoghue PCJ, 2002, MICROSC RES TECHNIQ, V59, P352, DOI 10.1002/jemt.10217; Donoghue PCJ, 2001, SYST ASSOC SPEC VOL, V61, P85; Donoghue PCJ, 2001, P ROY SOC B-BIOL SCI, V268, P1691, DOI 10.1098/rspb.2001.1728; Donoghue PCJ, 1998, LETHAIA, V31, P211; Donoghue PCJ, 2006, NATURE, V442, P680, DOI 10.1038/nature04890; DZIK J, 1976, Acta Palaeontologica Polonica, V21, P395; Dzik J., 1986, PROBLEMATIC FOSSIL T, P240; Fraser GJ, 2010, BIOESSAYS, V32, P808, DOI 10.1002/bies.200900151; Gross W., 1957, Palaeontologische Zeitschrift, V31, P78; Muller K. J, 1971, Mem Fac Sci Kyoto Univ (Geol Mineral), V38, P1; Muller K.J., 1972, International Geol Congr, V24, P20; Patterson C., 1982, PROBLEMS PHYLOGENETI, V29, P21; Pridmore PA, 1996, LETHAIA, V29, P317, DOI 10.1111/j.1502-3931.1996.tb01667.x; Rucklin M, 2012, NATURE, V491, P748, DOI 10.1038/nature11555; Rucklin M, 2011, EVOL DEV, V13, P523, DOI 10.1111/j.1525-142X.2011.00508.x; SANSOM IJ, 1992, SCIENCE, V256, P1308, DOI 10.1126/science.1598573; SANSOM IJ, 1994, NATURE, V368, P591, DOI 10.1038/368591a0; Smith M.M., 2000, P133, DOI 10.1017/CBO9780511542626.010; Smith MA, 1998, INT REV NEUROBIOL, V42, P1, DOI 10.1016/S0074-7742(08)60607-8; Smith MM, 2001, SYST ASSOC SPEC VOL, V61, P223; Stampanoni M, 2006, PROC SPIE, V6318, DOI 10.1117/12.679497; Szaniawski H., 1987, P35; SZANIAWSKI H, 1993, J PALEONTOL, V67, P640, DOI 10.1017/S0022336000024963; SZANIAWSKI H, 1982, J PALEONTOL, V56, P806; Turner S, 2010, GEODIVERSITAS, V32, P545, DOI 10.5252/g2010n4a1	29	57	61	1	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					546	+		10.1038/nature12645	http://dx.doi.org/10.1038/nature12645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24132236				2022-12-24	WOS:000325988400053
J	Gill, ON; Spencer, Y; Richard-Loendt, A; Kelly, C; Dabaghian, R; Boyes, L; Linehan, J; Simmons, M; Webb, P; Bellerby, P; Andrews, N; Hilton, DA; Ironside, JW; Beck, J; Poulter, M; Mead, S; Brandner, S				Gill, O. Noel; Spencer, Yvonne; Richard-Loendt, Angela; Kelly, Carole; Dabaghian, Reza; Boyes, Lynnette; Linehan, Jacqueline; Simmons, Marion; Webb, Paul; Bellerby, Peter; Andrews, Nick; Hilton, David A.; Ironside, James W.; Beck, Jon; Poulter, Mark; Mead, Simon; Brandner, Sebastian			Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CREUTZFELDT-JAKOB-DISEASE; VARIANT CJD; TISSUE SAMPLES; BLOOD-TRANSFUSION; TONSIL SPECIMENS; ACCUMULATION; SCRAPIE; SHEEP; BSE; TRANSMISSION	Objectives To carry out a further survey of archived appendix samples to understand better the differences between existing estimates of the prevalence of subclinical infection with prions after the bovine spongiform encephalopathy epizootic and to see whether a broader birth cohort was affected, and to understand better the implications for the management of blood and blood products and for the handling of surgical instruments. Design Irreversibly unlinked and anonymised large scale survey of archived appendix samples. Setting Archived appendix samples from the pathology departments of 41 UK hospitals participating in the earlier survey, and additional hospitals in regions with lower levels of participation in that survey. Sample 32 441 archived appendix samples fixed in formalin and embedded in paraffin and tested for the presence of abnormal prion protein (PrP). Results Of the 32 441 appendix samples 16 were positive for abnormal PrP, indicating an overall prevalence of 493 per million population (95% confidence interval 282 to 801 per million). The prevalence in those born in 1941-60 (733 per million, 269 to 1596 per million) did not differ significantly from those born between 1961 and 1985 (412 per million, 198 to 758 per million) and was similar in both sexes and across the three broad geographical areas sampled. Genetic testing of the positive specimens for the genotype at PRNP codon 129 revealed a high proportion that were valine homozygous compared with the frequency in the normal population, and in stark contrast with confirmed clinical cases of vCJD, all of which were methionine homozygous at PRNP codon 129. Conclusions This study corroborates previous studies and suggests a high prevalence of infection with abnormal PrP, indicating vCJD carrier status in the population compared with the 177 vCJD cases to date. These findings have important implications for the management of blood and blood products and for the handling of surgical instruments.	[Gill, O. Noel; Kelly, Carole; Andrews, Nick] Publ Hlth England, Natl Ctr Infect Dis Surveillance & Control, HIV & STI Dept, London, England; [Gill, O. Noel; Kelly, Carole; Andrews, Nick] Publ Hlth England, Natl Ctr Infect Dis Surveillance & Control, CJD Sect, London, England; [Gill, O. Noel; Kelly, Carole; Andrews, Nick] Publ Hlth England, Natl Ctr Infect Dis Surveillance & Control, CJD Sect, London, England; [Spencer, Yvonne; Webb, Paul; Bellerby, Peter] Anim Hlth & Vet Labs Agcy, Sci Directorate, Pathol Unit, Addlestone, Surrey, England; [Simmons, Marion] Anim Hlth & Vet Labs Agcy, Sci Directorate, Pathol Unit, EU Reference Lab, Addlestone, Surrey, England; [Richard-Loendt, Angela; Brandner, Sebastian] UCL Inst Neurol, Div Neuropathol, Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Richard-Loendt, Angela; Boyes, Lynnette; Beck, Jon; Poulter, Mark; Mead, Simon; Brandner, Sebastian] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Dabaghian, Reza; Mead, Simon] Publ Hlth England, Virus Reference Dept, London, England; [Beck, Jon; Poulter, Mark] UCL Inst Neurol, MRC Prion Unit, London, England; [Hilton, David A.] Derriford Hosp, Dept Cellular & Anat Pathol, Plymouth PL6 8DH, Devon, England; [Ironside, James W.] Univ Edinburgh, Sch Mol & Clin Med, Natl Creutzfeldt Jakob Dis Res & Surveillance Uni, Edinburgh, Midlothian, Scotland	Public Health England; Public Health England; Public Health England; Veterinary Laboratories Agency; Veterinary Laboratories Agency; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Public Health England; University of London; University College London; Derriford Hospital; University of Edinburgh	Brandner, S (corresponding author), UCL Inst Neurol, Div Neuropathol, Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	s.brandner@ucl.ac.uk	Bellerby, Peter/F-1182-2011; Brandner, Sebastian/J-4562-2014; Simmons, Marion/C-2586-2011; Webb, Paul/C-3285-2011; Spencer, Yvonne I/C-6549-2011; Beck, Jon/GRX-8457-2022	Brandner, Sebastian/0000-0002-9821-0342; Mead, Simon/0000-0002-4326-1468; Ironside, James/0000-0001-5869-2108	Policy Research Programme of the UK Department of Health; MRC [G0600953, MC_U123160651, G0900580] Funding Source: UKRI; Medical Research Council [G0900580, G0600953, MC_U123160651] Funding Source: researchfish	Policy Research Programme of the UK Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This was an independent scientific survey commissioned and funded by the Policy Research Programme of the UK Department of Health. The views expressed are those of the authors and not necessarily those of the UK Department of Health.	Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Bell JE, 1997, NEUROPATH APPL NEURO, V23, P26, DOI 10.1111/j.1365-2990.1997.tb01182.x; Bennett P, 2011, BLOOD BORNE TRANSMIS; Beringue V, 2012, SCIENCE, V335, P472, DOI 10.1126/science.1215659; Clewley JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1442; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; Collinge J, 1996, LANCET, V348, P56, DOI 10.1016/S0140-6736(05)64378-4; de Marco MF, 2010, J PATHOL, V222, P380, DOI 10.1002/path.2767; Frosh A, 2004, LANCET, V364, P1260, DOI 10.1016/S0140-6736(04)17143-2; Garske T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015626; Georgsson G, 2008, ARCH VIROL, V153, P637, DOI 10.1007/s00705-008-0035-8; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hilton DA, 2002, BRIT MED J, V325, P633, DOI 10.1136/bmj.325.7365.633; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Ironside JW, 2006, BRIT MED J, V332, P1186, DOI 10.1136/bmj.38804.511644.55; Joiner S, 2002, J NEUROL NEUROSUR PS, V73, P597, DOI 10.1136/jnnp.73.5.597; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Mead S, 2012, HUM MOL GENET, V21, P1897, DOI 10.1093/hmg/ddr607; Parchi P, 1997, NATURE, V386, P232, DOI 10.1038/386232a0; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Ryder SJ, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-9; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002; TSUNODA R, 1990, VIRCHOWS ARCH B, V59, P95, DOI 10.1007/BF02899393; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wadsworth JDF, 2011, J PATHOL, V223, P511, DOI 10.1002/path.2821; Zeidler M, 1997, LANCET, V350, P668, DOI 10.1016/S0140-6736(05)63366-1; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831	35	184	188	1	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2013	347								f5675	10.1136/bmj.f5675	http://dx.doi.org/10.1136/bmj.f5675			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WK	24129059	Green Submitted, hybrid, Green Published			2022-12-24	WOS:000325982200004
J	Yamauchi, Y; Riel, JM; Stoytcheva, Z; Ward, MA				Yamauchi, Yasuhiro; Riel, Jonathan M.; Stoytcheva, Zoia; Ward, Monika A.			Two Y Genes Can Replace the Entire Y Chromosome for Assisted Reproduction in the Mouse	SCIENCE			English	Article							SEX-DETERMINING REGION; MICE; EXPRESSION; INITIATION; SPERMIOGENESIS; DEFICIENCY; FERTILITY; SRY	The Y chromosome is thought to be important for male reproduction. We have previously shown that, with the use of assisted reproduction, live offspring can be obtained from mice lacking the entire Y chromosome long arm. Here, we demonstrate that live mouse progeny can also be generated by using germ cells from males with the Y chromosome contribution limited to only two genes, the testis determinant factor Sry and the spermatogonial proliferation factor Eif2s3y. Sry is believed to function primarily in sex determination during fetal life. Eif2s3y may be the only Y chromosome gene required to drive mouse spermatogenesis, allowing formation of haploid germ cells that are functional in assisted reproduction. Our findings are relevant, but not directly translatable, to human male infertility cases.	[Yamauchi, Yasuhiro; Riel, Jonathan M.; Stoytcheva, Zoia; Ward, Monika A.] Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, Honolulu, HI 96822 USA	University of Hawaii System	Ward, MA (corresponding author), Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, 1960 East West Rd, Honolulu, HI 96822 USA.	mward@hawaii.edu			NIH [HD072380, HD058059, GM103457]; Hawaii Community Foundation [13ADVC-60314]; NIH grants National Institute on Minority Health and Health Disparities [NIH. G12 MD007601]; National Institute of General Medical Sciences, NIH [P30 GM103341]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072380] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD058059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457, P30GM103341] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hawaii Community Foundation; NIH grants National Institute on Minority Health and Health Disparities; National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The work was supported by NIH HD072380, HD058059, and GM103457 (Project 2) and Hawaii Community Foundation 13ADVC-60314 grants to M. A. W. The authors thank P. Burgoyne for providing paternal stock mice for breeding, overall support, and insightful discussions and N. Vernet from P. Burgoyne's group for sharing protocols and expertise on histological and DNA content analyses. We are grateful to numerous students who have helped with mouse genotyping. Histological sections were prepared by John A. Burns School of Medicine Histopathology Core supported by NIH grants National Institute on Minority Health and Health Disparities, NIH. G12 MD007601 and the National Institute of General Medical Sciences, NIH, P30 GM103341.	Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS199, DOI 10.1016/j.fertnstert.2008.08.033; BURGOYNE PS, 1992, CELL, V71, P391, DOI 10.1016/0092-8674(92)90509-B; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Ehrmann IE, 1998, HUM MOL GENET, V7, P1725, DOI 10.1093/hmg/7.11.1725; Foresta C, 2000, HUM MOL GENET, V9, P1161, DOI 10.1093/hmg/9.8.1161; Gianaroli L, 1999, FERTIL STERIL, V72, P539, DOI 10.1016/S0015-0282(99)00285-X; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; JESKE YWA, 1995, NAT GENET, V10, P480, DOI 10.1038/ng0895-480; Kleiman SE, 2007, HUM REPROD, V22, P151, DOI 10.1093/humrep/del341; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; Mitchell M J, 2000, Results Probl Cell Differ, V28, P233; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Riel JM, 2013, J CELL SCI, V126, P803, DOI 10.1242/jcs.114488; Saremi A, 2002, ARCH ANDROLOGY, V48, P315, DOI 10.1080/01485010290031637; Sargent CA, 1999, J MED GENET, V36, P670; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; STERN C, 1957, AM J HUM GENET, V9, P147; Sun C, 1999, NAT GENET, V23, P429, DOI 10.1038/70539; Tamashiro KLK, 1999, J ASSIST REPROD GEN, V16, P315, DOI 10.1023/A:1020406016312; Vernet N, 2012, REPRODUCTION, V144, P433, DOI 10.1530/REP-12-0158; Vernet N, 2011, CURR BIOL, V21, P787, DOI 10.1016/j.cub.2011.03.057; Yamauchi Y, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r66; Yamauchi Y, 2009, BIOL REPROD, V81, P353, DOI 10.1095/biolreprod.109.076307	29	55	59	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					69	72		10.1126/science.1242544	http://dx.doi.org/10.1126/science.1242544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24263135	Green Accepted			2022-12-24	WOS:000329162000049
J	Courtin, J; Chaudun, F; Rozeske, RR; Karalis, N; Gonzalez-Campo, C; Wurtz, H; Abdi, A; Baufreton, J; Bienvenu, TCM; Herry, C				Courtin, Julien; Chaudun, Fabrice; Rozeske, Robert R.; Karalis, Nikolaos; Gonzalez-Campo, Cecilia; Wurtz, Helene; Abdi, Azzedine; Baufreton, Jerome; Bienvenu, Thomas C. M.; Herry, Cyril			Prefrontal parvalbumin interneurons shape neuronal activity to drive fear expression	NATURE			English	Article							HIPPOCAMPAL THETA; PRELIMBIC CORTEX; OSCILLATIONS; SYNCHRONIZATION; EXTINCTION; AMYGDALA; NETWORK; MODULATION; CIRCUITS; RESET	Synchronization of spiking activity in neuronal networks is a fundamental process that enables the precise transmission of information to drive behavioural responses(1-3). Incortical areas, synchronization of principal-neuron spiking activity is an effective mechanism for information coding that is regulated by GABA (gamma-aminobutyric acid)-ergic interneurons through the generation of neuronal oscillations(4,5). Although neuronal synchrony has been demonstrated to be crucial for sensory, motor and cognitive processing(6-8), it has not been investigated at the level of defined circuits involved in the control of emotional behaviour. Converging evidence indicates that fear behaviour is regulated by the dorsomedial prefrontal cortex(9-12) (dmPFC). This control over fear behaviour relies on the activation of specific prefrontal projections to the basolateral complex of the amygdala (BLA), a structure that encodes associative fear memories(13-15). However, it remains to be established how the precise temporal control of fear behaviour is achieved at the level of prefrontal circuits. Here we use single-unit recordings and optogenetic manipulations in behaving mice to show that fear expression is causally related to the phasic inhibition of prefrontal parvalbumin interneurons (PVINs). Inhibition of PVIN activity disinhibits prefrontal projection neurons and synchronizes their firing by resetting local theta oscillations, leading to fear expression. Our results identify two complementary neuronal mechanisms mediated by PVINs that precisely coordinate and enhance the neuronal activity of prefrontal projection neurons to drive fear expression.	[Courtin, Julien; Chaudun, Fabrice; Rozeske, Robert R.; Karalis, Nikolaos; Gonzalez-Campo, Cecilia; Wurtz, Helene; Bienvenu, Thomas C. M.; Herry, Cyril] INSERM, Neuroctr Magendie, U862, F-33077 Bordeaux, France; [Courtin, Julien; Chaudun, Fabrice; Rozeske, Robert R.; Karalis, Nikolaos; Gonzalez-Campo, Cecilia; Wurtz, Helene; Bienvenu, Thomas C. M.; Herry, Cyril] Univ Bordeaux, Neuroctr Magendie, U862, F-33077 Bordeaux, France; [Abdi, Azzedine; Baufreton, Jerome] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France; [Abdi, Azzedine; Baufreton, Jerome] CNRS, Inst Malad Neurodegenerat, UMR 5293, F-33000 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Herry, C (corresponding author), INSERM, Neuroctr Magendie, U862, 146 Rue Leo Saignat, F-33077 Bordeaux, France.	cyril.herry@inserm.fr	Herry, Cyril/AAP-9902-2020; courtin, julien/AAH-2380-2022; courtin, julien/AEN-1402-2022; Karalis, Nikolaos/U-4987-2017	Herry, Cyril/0000-0003-2973-0843; courtin, julien/0000-0002-6454-3245; courtin, julien/0000-0002-6454-3245; Karalis, Nikolaos/0000-0002-1804-9756; Bienvenu, Thomas/0000-0002-7416-0504; Baufreton, Jerome/0000-0002-2623-6375	French National Research Agency [ANR-2010-BLAN-1442-01, ANR-10-EQPX-08 OPTOPATH]; European Research Council (ERC) under the European Union [281168]; Fonds AXA pour la recherche doctoral fellowship; Conseil Regional d'Aquitaine	French National Research Agency(French National Research Agency (ANR)); European Research Council (ERC) under the European Union(European Research Council (ERC)); Fonds AXA pour la recherche doctoral fellowship(AXA Research Fund); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	We thank members of the Herry laboratory, K. Benchenane and D. Dupret for comments on the manuscript, K. Deisseroth and E. Boyden for generously sharing material, J. Bacelo, S. Wolff and P. Tovote for technical and computational assistance, the Bordeaux Imaging center of the University of Bordeaux, and C. Poujol and S. Marais for technical assistance with microscopy. This work was supported by grants from the French National Research Agency (ANR-2010-BLAN-1442-01; ANR-10-EQPX-08 OPTOPATH), the European Research Council (ERC) under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no. 281168, a Fonds AXA pour la recherche doctoral fellowship (J. C.) and the Conseil Regional d'Aquitaine. T. C. M. B is a fellow of Ecole de l'Inserm Liliane Bettencourt-MD-PhD program, France.	Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Burgos-Robles A, 2009, J NEUROSCI, V29, P8474, DOI 10.1523/JNEUROSCI.0378-09.2009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1979, ELECTROEN CLIN NEURO, V47, P64, DOI 10.1016/0013-4694(79)90033-6; Chang CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011971; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; DISCALA G, 1987, PHYSIOL BEHAV, V40, P55, DOI 10.1016/0031-9384(87)90185-5; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Hartwich K, 2009, J NEUROSCI, V29, P9563, DOI 10.1523/JNEUROSCI.1397-09.2009; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Knapska E, 2012, P NATL ACAD SCI USA, V109, P17093, DOI 10.1073/pnas.1202087109; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Livneh U, 2012, NEURON, V75, P133, DOI 10.1016/j.neuron.2012.05.016; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; McCartney H, 2004, HIPPOCAMPUS, V14, P684, DOI 10.1002/hipo.20019; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rizzuto DS, 2003, P NATL ACAD SCI USA, V100, P7931, DOI 10.1073/pnas.0732061100; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Tang JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-6; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Yoder RM, 2005, HIPPOCAMPUS, V15, P381, DOI 10.1002/hipo.20062	30	298	302	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					92	+		10.1038/nature12755	http://dx.doi.org/10.1038/nature12755			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24256726				2022-12-24	WOS:000329163300030
J	Hu, LL; Li, Z; Cheng, JD; Rao, QH; Gong, W; Liu, MJ; Shi, YJG; Zhu, JY; Wang, P; Xu, YH				Hu, Lulu; Li, Ze; Cheng, Jingdong; Rao, Qinhui; Gong, Wei; Liu, Mengjie; Shi, Yujiang Geno; Zhu, Jiayu; Wang, Ping; Xu, Yanhui			Crystal Structure of TET2-DNA Complex: Insight into TET-Mediated 5mC Oxidation	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; 5-METHYLCYTOSINE OXIDATION; DNA DEMETHYLATION; CXXC DOMAIN; FAMILY PROTEINS; NUCLEIC-ACIDS; MAMMALIAN DNA; GENOMIC DNA; 5-HYDROXYMETHYLCYTOSINE; ENZYMES	TET proteins oxidize 5-methylcytosine (5mC) on DNA and play important roles in various biological processes. Mutations of TET2 are frequently observed in myeloid malignance. Here, we present the crystal structure of human TET2 bound to methylated DNA at 2.02 angstrom resolution. The structure shows that two zinc fingers bring the Cys-rich and DSBH domains together to form a compact catalytic domain. The Cys-rich domain stabilizes the DNA above the DSBH core. TET2 specifically recognizes CpG dinucleotide and shows substrate preference for 5mC in a CpG context. 5mC is inserted into the catalytic cavity with the methyl group orientated to catalytic Fe(II) for reaction. The methyl group is not involved in TET2-DNA contacts so that the catalytic cavity allows TET2 to accommodate 5mC derivatives for further oxidation. Mutations of Fe(II)/NOG-chelating, DNA-interacting, and zinc-chelating residues are frequently observed in human cancers. Our studies provide a structural basis for understanding the mechanisms of TET-mediated 5mC oxidation.	[Hu, Lulu; Li, Ze; Cheng, Jingdong; Rao, Qinhui; Gong, Wei; Liu, Mengjie; Shi, Yujiang Geno; Zhu, Jiayu; Wang, Ping; Xu, Yanhui] Fudan Univ, Shanghai Canc Ctr, Dept Oncol, Shanghai 200032, Peoples R China; [Hu, Lulu; Li, Ze; Cheng, Jingdong; Rao, Qinhui; Gong, Wei; Liu, Mengjie; Shi, Yujiang Geno; Zhu, Jiayu; Wang, Ping; Xu, Yanhui] Fudan Univ, Inst Biomed Sci, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Hu, Lulu; Xu, Yanhui] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Shi, Yujiang Geno] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Shi, Yujiang Geno] Brigham & Womens Hosp, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Fudan University; Fudan University; Fudan University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Xu, YH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Oncol, Shanghai 200032, Peoples R China.	xuyh@fudan.edu.cn	Liu, Mengjie/AAD-7684-2020; Xu, Yanhui/D-5119-2019; Liu, Mengjie/AAZ-6249-2020; Wang, Ping/GZB-2001-2022	Liu, Mengjie/0000-0002-2889-2210; Liu, Mengjie/0000-0002-2889-2210; Wang, Ping/0000-0002-2710-7188	National Basic Research Program of China [2011CB965300, 2009CB918600]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China [2014ZX09507-002, 2011ZX09506-001]; National Natural Science Foundation of China [31270779, 31030019, 11079016, 30870493]; Basic Research Project of Shanghai Science and Technology Commission [12JC1402700]; Fok Ying Tung Education Foundation [20090071220012]	National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of Shanghai Science and Technology Commission; Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation)	We thank Drs. Zhiyong Lou and Haifeng Hou for their help in structure determination. We thank staff members of beamline BL17U at SSRF for assistance in data collection and Mr. Lei Zhang and staff members of Biomedical Core Facility, Fudan University for their help on mass spectrometry analyses. We thank Drs. Yang Shi and Guoliang Xu for critical reading of the manuscript. This work was supported by grants from the National Basic Research Program of China (2011CB965300, 2009CB918600), the National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" of China (2014ZX09507-002, 2011ZX09506-001), the National Natural Science Foundation of China (31270779, 31030019, 11079016, 30870493), Basic Research Project of Shanghai Science and Technology Commission (12JC1402700), and Fok Ying Tung Education Foundation (20090071220012).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Cliffe LJ, 2009, NUCLEIC ACIDS RES, V37, P1452, DOI 10.1093/nar/gkn1067; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Ko M, 2013, NATURE, V497, P122, DOI 10.1038/nature12052; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Ono R, 2002, CANCER RES, V62, P4075; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; WYATT GR, 1953, BIOCHEM J, V55, P774, DOI 10.1042/bj0550774; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yang CG, 2009, CHEMBIOCHEM, V10, P417, DOI 10.1002/cbic.200800580; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Yu Z, 2007, NUCLEIC ACIDS RES, V35, P2107, DOI 10.1093/nar/gkm049	48	261	275	2	127	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1545	1555		10.1016/j.cell.2013.11.020	http://dx.doi.org/10.1016/j.cell.2013.11.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24315485	Bronze			2022-12-24	WOS:000328693300011
J	Larson, EB; Yaffe, K; Langa, KM				Larson, Eric B.; Yaffe, Kristine; Langa, Kenneth M.			New Insights into the Dementia Epidemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVALENCE; TRENDS		[Larson, Eric B.] Univ Washington, Grp Hlth Res Inst, Seattle, WA 98195 USA; [Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Larson, Eric B.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Yaffe, Kristine] San Francisco Vet Affairs VA Med Ctr, San Francisco, CA USA; [Langa, Kenneth M.] Univ Michigan, Div Gen Med, VA Ann Arbor Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Langa, Kenneth M.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Larson, EB (corresponding author), Univ Washington, Grp Hlth Res Inst, Seattle, WA 98195 USA.			Langa, Kenneth/0000-0002-2798-1836	NATIONAL INSTITUTE ON AGING [U01AG006781, U01AG009740, K24AG031155, P01AG031098] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG031098, U01 AG009740, K24 AG031155, U01 AG006781] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Manton K C, 2005, Adv Gerontol, V16, P30; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6	5	218	223	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 12	2013	369	24					2275	2277		10.1056/NEJMp1311405	http://dx.doi.org/10.1056/NEJMp1311405			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	268FV	24283198	Green Accepted			2022-12-24	WOS:000328156300003
J	Friedfeld, MR; Shevlin, M; Hoyt, JM; Krska, SW; Tudge, MT; Chirik, PJ				Friedfeld, Max R.; Shevlin, Michael; Hoyt, Jordan M.; Krska, Shane W.; Tudge, Matthew T.; Chirik, Paul J.			Cobalt Precursors for High-Throughput Discovery of Base Metal Asymmetric Alkene Hydrogenation Catalysts	SCIENCE			English	Article							AMINO-ACID DERIVATIVES; COMPLEXES; REDUCTION; LIGANDS; MECHANISM; C=O	Asymmetric hydrogenation of alkenes is one of the most widely used methods for the preparation of single enantiomer compounds, especially in the pharmaceutical and agrochemical industries. For more than four decades, precious metal complexes containing rhodium, iridium, and ruthenium have been predominantly used as catalysts. Here, we report rapid evaluation of libraries of chiral phosphine ligands with a set of simple cobalt precursors. From these studies, base metal precatalysts have been discovered for the hydrogenation of functionalized and unfunctionalized olefins with high enantiomeric excesses, demonstrating the potential utility of more earth-abundant metals in asymmetric hydrogenation.	[Friedfeld, Max R.; Hoyt, Jordan M.; Chirik, Paul J.] Princeton Univ, Dept Chem, Princeton, NJ 08540 USA; [Shevlin, Michael; Krska, Shane W.; Tudge, Matthew T.] Merck Res Labs, Dept Proc Chem, Rahway, NJ 07065 USA	Princeton University; Merck & Company	Friedfeld, MR (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08540 USA.			Shevlin, Michael/0000-0003-2566-5095	Federal Ministry of Education and Research (BMBF); State of Mecklenburg-Vorpommern	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Mecklenburg-Vorpommern	We gratefully acknowledge the support from the Federal Ministry of Education and Research (BMBF) and the State of Mecklenburg-Vorpommern. We thank the analytical department of the Leibniz-Institute for Catalysis, Rostock for the nuclear magnetic resonance measurements. The Leibniz Institute for Catalysis has filed a patent on the catalysts reported herein. Author contributions: M.B. and R.V.J. planned the project; R.V.J. developed and prepared the catalysts; R.V.J designed and performed all catalytic hydrogenation experiments; R.V.J., M.B., and A.B. wrote the paper; A.-E.S., H.J., and M.B were involved in the development of this class of catalysts; M.-M.P. performed TEM measurements and analysis; J. Radnik did the XPS measurements; J. Rabeah and A.B. conducted EPR measurements; and H.H. and V.S. performed Mossbauer measurements.	ASHBY MT, 1991, J AM CHEM SOC, V113, P589, DOI 10.1021/ja00002a029; Bell S, 2006, SCIENCE, V311, P642, DOI 10.1126/science.1121977; Blaser H.-U., 2010, ASYMMETRIC CATALYSIS, Vsecond; Blaser HU, 2007, ACCOUNTS CHEM RES, V40, P1240, DOI 10.1021/ar7001057; BURK MJ, 1993, J AM CHEM SOC, V115, P10125, DOI 10.1021/ja00075a031; Busacca CA, 2011, ADV SYNTH CATAL, V353, P1825, DOI 10.1002/adsc.201100488; Church TL, 2008, COORDIN CHEM REV, V252, P513, DOI 10.1016/j.ccr.2007.09.015; CORMA A, 1992, J ORGANOMET CHEM, V431, P233, DOI 10.1016/0022-328X(92)80121-D; Cozzi PG, 2001, ADV SYNTH CATAL, V343, P450, DOI 10.1002/1615-4169(200107)343:5<450::AID-ADSC450>3.0.CO;2-7; Cui XH, 2005, CHEM REV, V105, P3272, DOI 10.1021/cr0500131; DiMasi JA, 2004, PHARMACOECONOMICS, V22, P1, DOI 10.2165/00019053-200422002-00002; HALPERN J, 1982, SCIENCE, V217, P401, DOI 10.1126/science.217.4558.401; Hoge G, 2003, J AM CHEM SOC, V125, P10219, DOI 10.1021/ja034715o; HORNER L, 1968, ANGEW CHEM INT EDIT, V7, P942, DOI 10.1002/anie.196809422; Hsiao Y, 2004, J AM CHEM SOC, V126, P9918, DOI 10.1021/ja047901i; Johnson NB, 2007, ACCOUNTS CHEM RES, V40, P1291, DOI 10.1021/ar700114k; Knijnenburg Q, 2005, J MOL CATAL A-CHEM, V232, P151, DOI 10.1016/j.molcata.2004.12.039; Knowles WS, 2002, ANGEW CHEM INT EDIT, V41, P1999; KNOWLES WS, 1968, CHEM COMMUN, P1445, DOI 10.1039/c19680001445; LEUTENEGGER U, 1989, ANGEW CHEM INT EDIT, V28, P60, DOI 10.1002/anie.198900601; Mazuela J, 2011, J AM CHEM SOC, V133, P13634, DOI 10.1021/ja204948k; Monfette S, 2012, J AM CHEM SOC, V134, P4561, DOI 10.1021/ja300503k; Nindakova LO, 2007, RUSS J ORG CHEM+, V43, P1322, DOI 10.1134/S1070428007090102; Nindakova LO, 2005, RUSS CHEM B+, V54, P348, DOI 10.1007/s11172-005-0258-8; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; Plietker B., 2008, IRON CATALYSIS ORGAN; Roseblade SJ, 2007, ACCOUNTS CHEM RES, V40, P1402, DOI 10.1021/ar700113g; Rouhi AM, 2004, CHEM ENG NEWS, V82, P47, DOI 10.1021/cen-v082n024.p047; SCHROCK RR, 1971, J AM CHEM SOC, V93, P2397; Shultz CS, 2007, ACCOUNTS CHEM RES, V40, P1320, DOI 10.1021/ar700141v; Takeuchi S., 1981, B CHEM SOC JPN, V54, P2124; Thayer AM, 2007, CHEM ENG NEWS, V85, P11, DOI 10.1021/cen-v085n032.p011; Vineyard B. D., 1972, CHEM COMMUN, V1972, P10; Zhang GQ, 2013, J AM CHEM SOC, V135, P8668, DOI 10.1021/ja402679a; Zhang GQ, 2012, ANGEW CHEM INT EDIT, V51, P12102, DOI 10.1002/anie.201206051; Zhu D, 2010, ORGANOMETALLICS, V29, P1897, DOI 10.1021/om901045s	36	255	259	7	259	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1076	1080		10.1126/science.1243550	http://dx.doi.org/10.1126/science.1243550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288328				2022-12-24	WOS:000327518600052
J	Heinz, S; Romanoski, CE; Benner, C; Allison, KA; Kaikkonen, MU; Orozco, LD; Glass, CK				Heinz, S.; Romanoski, C. E.; Benner, C.; Allison, K. A.; Kaikkonen, M. U.; Orozco, L. D.; Glass, C. K.			Effect of natural genetic variation on enhancer selection and function	NATURE			English	Article							REGULATORY ELEMENTS; OPEN CHROMATIN; TRANSCRIPTION; BINDING; MACROPHAGE; RESPONSES; ALIGNMENT; SNPS; MAP	The mechanisms by which genetic variation affects transcription regulation and phenotypes at the nucleotide level are incompletely understood. Here we use natural genetic variation as an in vivo mutagenesis screen to assess the genome-wide effects of sequence variation on lineage-determining and signal-specific transcription factor binding, epigenomics and transcriptional outcomes in primary macrophages from different mouse strains. We find substantial genetic evidence to support the concept that lineage-determining transcription factors define epigenetic and transcriptomic states by selecting enhancer-like regions in the genome in a collaborative fashion and facilitating binding of signal-dependent factors. This hierarchical model of transcription factor function suggests that limited sets of genomic data for lineage-determining transcription factors and informative histone modifications can be used for the prioritization of disease-associated regulatory variants.	[Heinz, S.; Romanoski, C. E.; Benner, C.; Allison, K. A.; Kaikkonen, M. U.; Glass, C. K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Benner, C.] Salk Inst Biol Studies, Integrat Genom & Bioinformat Core, La Jolla, CA 92037 USA; [Benner, C.; Glass, C. K.] Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA; [Kaikkonen, M. U.] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, Kuopio 70211, Finland; [Orozco, L. D.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Glass, C. K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; University of Eastern Finland; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr,Mail Code 0651, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Kaikkonen, Minna U/AAK-3612-2020; Glass, Christopher/AAI-3933-2021	Kaikkonen, Minna U/0000-0001-6294-0979; Glass, Christopher/0000-0003-4344-3592; Romanoski, Casey/0000-0002-0149-225X; Benner, Christopher/0000-0002-4618-0719; Heinz, Sven/0000-0002-4665-1007	National Institutes of Health (NIH) [DK091183, CA17390, DK063491]; Foundation Leducq; Academy of Finland; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation; American Heart Association Western States Affiliates [12POST11760017]; NIH [5T32DK007494]; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA173903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR059033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091183, P01DK074868, T32DK007494, P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq(Leducq Foundation); Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); American Heart Association Western States Affiliates(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. J. Lusis for providing access to eQTL data (http://systems.genetics.ucla.edu/) and for productive conversations. We thank D. Pollard for discussions and suggestions, and L. Bautista for assistance with figure preparation. These studies were supported by National Institutes of Health (NIH) grants DK091183, CA17390 and DK063491 (C.K.G.). M.U.K. was supported by the Foundation Leducq Career Development award and grants from Academy of Finland, Finnish Foundation for Cardiovascular Research and Finnish Cultural Foundation, North Savo Regional fund. C.E.R. was supported by the American Heart Association Western States Affiliates (12POST11760017) and the NIH (5T32DK007494).	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kirby A, 2010, GENETICS, V185, P1081, DOI 10.1534/genetics.110.115014; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Smale ST, 2012, CURR OPIN IMMUNOL, V24, P51, DOI 10.1016/j.coi.2011.12.008; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Pham TH, 2013, NUCLEIC ACIDS RES, V41, P6391, DOI 10.1093/nar/gkt355; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70	39	228	229	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					487	+		10.1038/nature12615	http://dx.doi.org/10.1038/nature12615			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24121437	Green Accepted, Green Submitted			2022-12-24	WOS:000327464200035
J	Avraham, KB				Avraham, Karen B.			Rescue from Hearing Loss in Usher's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEAFNESS	A mouse model of a particular genetic form of Usher's syndrome, which involves hearing loss and difficulties with balance, showed that hearing at the low and middle frequencies and balance can be rescued. Attempts to restore or prevent genetically based hearing loss by means of biologic intervention have been largely unsuccessful because of the limitations inherent in both regenerating lost mechanosensory cells and salvaging the remaining function of partially damaged cells. Although the current treatment for hearing loss relies primarily on the use of cochlear implants (the Lasker-DeBakey Clinical Medical Research Award of 2013 was bestowed on the pioneers of this technology), the implants are still far from ideal. Elucidation of the genetic basis of many forms of hearing loss and advances in gene delivery may change this picture. Earlier this year, Lentz ...	[Avraham, Karen B.] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Avraham, Karen B.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Avraham, KB (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.			Avraham, Karen B/0000-0002-4913-251X				Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; Gregory FD, 2013, J PHYSIOL-LONDON, V591, P3253, DOI 10.1113/jphysiol.2013.254367; Lentz J, 2007, MUTAT RES-FUND MOL M, V616, P139, DOI 10.1016/j.mrfmmm.2006.11.006; Lentz JJ, 2013, NAT MED, V19, P345, DOI 10.1038/nm.3106; Southwell AL, 2012, TRENDS MOL MED, V18, P634, DOI 10.1016/j.molmed.2012.09.001	5	6	6	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1758	1760		10.1056/NEJMcibr1311048	http://dx.doi.org/10.1056/NEJMcibr1311048			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243IY	24171523				2022-12-24	WOS:000326311300015
J	Rowe, AH; Xiao, YC; Rowe, MP; Cummins, TR; Zakon, HH				Rowe, Ashlee H.; Xiao, Yucheng; Rowe, Matthew P.; Cummins, Theodore R.; Zakon, Harold H.			Voltage-Gated Sodium Channel in Grasshopper Mice Defends Against Bark Scorpion Toxin	SCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; FORMALIN TEST; NA+ CHANNEL; SENSORY NEURONS; ONYCHOMYS SPP.; ALPHA-SUBUNIT; PAIN; NA(V)1.8; BINDING; RESISTANCE	Painful venoms are used to deter predators. Pain itself, however, can signal damage and thus serves an important adaptive function. Evolution to reduce general pain responses, although valuable for preying on venomous species, is rare, likely because it comes with the risk of reduced response to tissue damage. Bark scorpions capitalize on the protective pain pathway of predators by inflicting intensely painful stings. However, grasshopper mice regularly attack and consume bark scorpions, grooming only briefly when stung. Bark scorpion venom induces pain in many mammals (house mice, rats, humans) by activating the voltage-gated Na+ channel Nav1.7, but has no effect on Nav1.8. Grasshopper mice Nav1.8 has amino acid variants that bind bark scorpion toxins and inhibit Na+ currents, blocking action potential propagation and inducing analgesia. Thus, grasshopper mice have solved the predator-pain problem by using a toxin bound to a nontarget channel to block transmission of the pain signals the venom itself is initiating.	[Rowe, Ashlee H.; Zakon, Harold H.] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; [Xiao, Yucheng; Cummins, Theodore R.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Rowe, Matthew P.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77341 USA; [Zakon, Harold H.] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA	University of Texas System; University of Texas Austin; Indiana University System; Indiana University Bloomington; Texas State University System; Sam Houston State University; Marine Biological Laboratory - Woods Hole	Rowe, AH (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.	roweashl@msu.edu			NSF IOS Award [1122115]; Department of the Army from Army Research Office Life Sciences Division [W911NF-06-1-0213, W911NF-09-1-0355]; NIH from National Institute of Neurological Disorders and Stroke [NS 053422]; Office of Research and Sponsored Projects, Sam Houston State University; Division Of Integrative Organismal Systems [1448393] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053422, R56NS053422] Funding Source: NIH RePORTER	NSF IOS Award; Department of the Army from Army Research Office Life Sciences Division; NIH from National Institute of Neurological Disorders and Stroke; Office of Research and Sponsored Projects, Sam Houston State University; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Heitlinger, the Santa Rita Experimental Range (Univ. of Arizona), and the Arizona Game and Fish Department for assistance with animal collections. We also thank Y. Lu and M. Wu for technical assistance with Nav1.8 sequencing and construct assembly. This work was supported, in part or in whole, by NSF IOS Award 1122115 (to A. H. R., M. P. R., and H.H.Z.), Department of the Army grants W911NF-06-1-0213 and W911NF-09-1-0355 from the Army Research Office Life Sciences Division (to A. H. R. and H.H.Z.), NIH grant NS 053422 from the National Institute of Neurological Disorders and Stroke (to T. R. C. and Y. X.), and a Faculty Research Grant from the Office of Research and Sponsored Projects, Sam Houston State University (to M. P. R.). The Department of Biological Sciences at Sam Houston State University provided logistical support for fieldwork. We declare no conflict of interest. The data are included in the main article and in the supplementary materials. The gene (Scn10a) encoding O. torridus Nav1.8 has been deposited in NCBI's GenBank gene database. Information about the GenBank accession numbers can be found in the supplementary materials.	Blair NT, 2002, J NEUROSCI, V22, P10277; Boyer LV, 2009, NEW ENGL J MED, V360, P2090, DOI 10.1056/NEJMoa0808455; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Choi JS, 2011, J NEUROPHYSIOL, V106, P3173, DOI 10.1152/jn.00100.2011; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; CURRY SC, 1984, J TOXICOL-CLIN TOXIC, V21, P417; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Fet V., 2000, CATALOG SCORPIONS WO, V1, P54; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Gilchrist J, 2012, TOXINS, V4, P620, DOI 10.3390/toxins4080620; Gurevitz M, 2012, TOXICON, V60, P502, DOI 10.1016/j.toxicon.2012.03.022; Kaneko Y, 1997, BIOCHEM BIOPH RES CO, V240, P651, DOI 10.1006/bbrc.1997.7696; KREIENKAMP HJ, 1994, J BIOL CHEM, V269, P8108; Leo S, 2010, BEHAV BRAIN RES, V208, P149, DOI 10.1016/j.bbr.2009.11.023; Lolignier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023083; LoVecchio F, 2003, J TOXICOL-CLIN TOXIC, V41, P937, DOI 10.1081/CLT-120026514; Maertens C, 2006, MOL PHARMACOL, V70, P405, DOI 10.1124/mol.106.022970; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Moraes ER, 2011, NEUROTOX RES, V19, P102, DOI 10.1007/s12640-009-9144-8; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Rowe AH, 2006, ANIM BEHAV, V71, P725, DOI 10.1016/j.anbehav.2005.08.003; Rowe AH, 2008, TOXICON, V52, P597, DOI 10.1016/j.toxicon.2008.07.004; Rowe AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023520; Saab CY, 2002, NEUROSCI LETT, V331, P79, DOI 10.1016/S0304-3940(02)00860-1; Schmidt J.O., 1990, INSECT DEFENSES ADAP, P383; Shields SD, 2010, PAIN, V151, P422, DOI 10.1016/j.pain.2010.08.001; Simard J.M., 1992, NAT TOXINS, V1, P236; Skolnik AB, 2013, PEDIATR EMERG CARE, V29, P98, DOI 10.1097/PEC.0b013e31827b5733; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; Sufka KJ, 1998, EUR J PAIN-LONDON, V2, P351, DOI 10.1016/S1090-3801(98)90033-7; Takacs Z, 2001, MOL BIOL EVOL, V18, P1800, DOI 10.1093/oxfordjournals.molbev.a003967; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Venkatesh B, 2005, CURR BIOL, V15, P2069, DOI 10.1016/j.cub.2005.10.068; Yotsu-Yamashita M, 2000, BIOCHEM BIOPH RES CO, V267, P403, DOI 10.1006/bbrc.1999.1974; Zhang JZ, 2012, J BIOL CHEM, V287, P30719, DOI 10.1074/jbc.M112.370742	43	90	96	17	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					441	446		10.1126/science.1236451	http://dx.doi.org/10.1126/science.1236451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159039	Green Submitted, Green Accepted			2022-12-24	WOS:000326042600033
J	Jager, N; Schlesner, M; Jones, DTW; Raffel, S; Mallm, JP; Junge, KM; Weichenhan, D; Bauer, T; Ishaque, N; Kool, M; Northcott, PA; Korshunov, A; Drews, RM; Koster, J; Versteeg, R; Richter, J; Hummel, M; Mack, SC; Taylor, MD; Witt, H; Swartman, B; Schulte-Bockholt, D; Sultan, M; Yaspo, ML; Lehrach, H; Hutter, B; Brors, B; Wolf, S; Plass, C; Siebert, R; Trumpp, A; Rippe, K; Lehmann, I; Lichter, P; Pfister, SM; Eils, R				Jaeger, Natalie; Schlesner, Matthias; Jones, David T. W.; Raffel, Simon; Mallm, Jan-Philipp; Junge, Kristin M.; Weichenhan, Dieter; Bauer, Tobias; Ishaque, Naveed; Kool, Marcel; Northcott, Paul A.; Korshunov, Andrey; Drews, Ruben M.; Koster, Jan; Versteeg, Rogier; Richter, Julia; Hummel, Michael; Mack, Stephen C.; Taylor, Michael D.; Witt, Hendrik; Swartman, Benedict; Schulte-Bockholt, Dietrich; Sultan, Marc; Yaspo, Marie-Laure; Lehrach, Hans; Hutter, Barbara; Brors, Benedikt; Wolf, Stephan; Plass, Christoph; Siebert, Reiner; Trumpp, Andreas; Rippe, Karsten; Lehmann, Irina; Lichter, Peter; Pfister, Stefan M.; Eils, Roland			Hypermutation of the Inactive X Chromosome Is a Frequent Event in Cancer	CELL			English	Article							MUTATION-RATE; GENOME; GENE; ORGANIZATION; INSTABILITY; CHROMATIN; PATTERNS; LEUKEMIA; DEFECTS; ORIGIN	Mutation is a fundamental process in tumorigenesis. However, the degree to which the rate of somatic mutation varies across the human genome and the mechanistic basis underlying this variation remain to be fully elucidated. Here, we performed a cross-cancer comparison of 402 whole genomes comprising a diverse set of childhood and adult tumors, including both solid and hematopoietic malignancies. Surprisingly, we found that the inactive X chromosome of many female cancer genomes accumulates on average twice and up to four times as many somatic mutations per megabase, as compared to the individual autosomes. Whole-genome sequencing of clonally expanded hematopoietic stem/progenitor cells (HSPCs) from healthy individuals and a premalignant myelodysplastic syndrome (MDS) sample revealed no X chromosome hypermutation. Our data suggest that hypermutation of the inactive X chromosome is an early and frequent feature of tumorigenesis resulting from DNA replication stress in aberrantly proliferating cells.	[Jaeger, Natalie; Schlesner, Matthias; Bauer, Tobias; Ishaque, Naveed; Drews, Ruben M.; Hutter, Barbara; Brors, Benedikt; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Jones, David T. W.; Kool, Marcel; Northcott, Paul A.; Witt, Hendrik; Pfister, Stefan M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Raffel, Simon; Trumpp, Andreas] German Canc Res Ctr, Div Stem Cells & Canc, D-69120 Heidelberg, Germany; [Raffel, Simon; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, D-69120 Heidelberg, Germany; [Mallm, Jan-Philipp; Rippe, Karsten] DKFZ, Res Grp Genome Org & Funct, D-69120 Heidelberg, Germany; [Mallm, Jan-Philipp; Rippe, Karsten] BioQuant, D-69120 Heidelberg, Germany; [Junge, Kristin M.; Lehmann, Irina] Helmholtz Ctr Environm Res Leipzig, UFZ, Dept Environm Immunol, D-04318 Leipzig, Germany; [Weichenhan, Dieter; Plass, Christoph] DKFZ, Div Epigen & Canc Risk Factors, D-69120 Heidelberg, Germany; [Korshunov, Andrey] Heidelberg Univ, Dept Neuropathol, D-69120 Heidelberg, Germany; [Korshunov, Andrey] DKFZ, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Koster, Jan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Richter, Julia; Siebert, Reiner] Univ Kiel, Inst Human Genet, D-24105 Kiel, Germany; [Hummel, Michael] Charite, Inst Pathol, D-10117 Berlin, Germany; [Mack, Stephen C.; Taylor, Michael D.] Hosp Sick Children, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Mack, Stephen C.; Taylor, Michael D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1X8, Canada; [Witt, Hendrik; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Swartman, Benedict; Schulte-Bockholt, Dietrich] BG Trauma Ctr, Dept Trauma & Orthopaed Surg, D-67071 Ludwigshafen, Germany; [Sultan, Marc; Yaspo, Marie-Laure; Lehrach, Hans] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Wolf, Stephan] DKFZ, Genom & Prote Core Facil, D-69120 Heidelberg, Germany; [Trumpp, Andreas; Lichter, Peter; Pfister, Stefan M.] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Lichter, Peter] DKFZ, Div Mol Genet, D-69120 Heidelberg, Germany; [Eils, Roland] Heidelberg Univ, Bioquant Ctr, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany; [Ishaque, Naveed; Lichter, Peter; Eils, Roland] DKFZ, DKFZ HIPO, Heidelberg Ctr Personalized Oncol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Kiel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ruprecht Karls University Heidelberg; Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Eils, R (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	r.eils@dkfz-heidelberg.de	Jones, David T. W./Z-1963-2019; Pfister, Stefan M/F-6860-2013; Plass, Christoph/H-7192-2014; Schlesner, Matthias/I-4030-2013; Junge, Kristin M/L-2630-2019; Versteeg, Rogier/AAQ-1765-2020; Ishaque, Naveed/AAF-3454-2020; Witt, Hendrik/L-7810-2015; Siebert, Reiner/A-8049-2010; Kool, Marcel/H-2541-2013; Brors, Benedikt/E-5620-2013; Rippe, Karsten/A-3562-2012; Koster, Jan/C-5934-2008; Northcott, Paul A/N-4022-2018; Trumpp, Andreas/Z-2141-2019; Jones, David TW/G-9588-2013; Eils, Roland/B-6121-2009	Pfister, Stefan M/0000-0002-5447-5322; Schlesner, Matthias/0000-0002-5896-4086; Ishaque, Naveed/0000-0002-8426-901X; Brors, Benedikt/0000-0001-5940-3101; Rippe, Karsten/0000-0001-9951-9395; Koster, Jan/0000-0002-0890-7585; Northcott, Paul A/0000-0002-1220-5252; Trumpp, Andreas/0000-0002-6212-3466; Jones, David TW/0000-0002-2036-5141; Eils, Roland/0000-0002-0034-4036; Hutter, Barbara/0000-0002-9034-0329; Junge, Kristin/0000-0001-5016-110X; Taylor, Michael/0000-0001-7009-3466; Mallm, Jan-Philipp/0000-0002-7059-4030; Mack, Stephen C./0000-0001-9620-4742; Hummel, Michael/0000-0001-6717-605X; Raffel, Simon/0000-0003-4671-1097; Bauer, Tobias/0000-0002-4961-3639; Jaeger, Natalie/0000-0002-9589-7580; Versteeg, Rogier/0000-0001-7172-0388; Drews, Ruben/0000-0001-7360-4970; Lehmann, Irina/0000-0001-8875-5587	PedBrain Tumor Project; MMMLSeq Project; German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A, MedSys 0315416C, 01KU1002A, 01KU1002B, 01KU1002C, 01KU1002D, 01KU1002E, 01KU1002F, 01KU1002G, 01KU1002H, 01KU1002I, 01KU1002J]; German Cancer Research Center Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Max Planck Society; Genome Canada; Canadian Institute for Health Research (CIHR); Genome BC; Genome Quebec; CIHR-ICR (Institute for Cancer Research); Dietmar Hopp Foundation	PedBrain Tumor Project; MMMLSeq Project; German Cancer Aid(Deutsche Krebshilfe); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Cancer Research Center Heidelberg Center for Personalized Oncology (DKFZ-HIPO); Max Planck Society(Max Planck Society); Genome Canada(Genome Canada); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome BC; Genome Quebec; CIHR-ICR (Institute for Cancer Research)(Canadian Institutes of Health Research (CIHR)); Dietmar Hopp Foundation	We would like to acknowledge the members of the PedBrain Tumor and MMML-Seq Project contributing to the ICGC. For technical support and expertise, we thank the DKFZ Genomics and Proteomics Core Facility, specifically Sabine Schmidt and Sasithorn Chotewutmontri. We acknowledge assistance provided by Hans-Jorg Warnatz for RNA sequencing and analysis at the Max Planck Institute for Molecular Genetics. We especially express our gratitude to Edith Heard for very helpful comments on our manuscript. This work was principally supported by the PedBrain Tumor Project and the MMMLSeq Project contributing to the ICGC, funded by German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants 01KU1201A, MedSys 0315416C and 01KU1002A to 01KU1002J). Additional support came from the German Cancer Research Center Heidelberg Center for Personalized Oncology (DKFZ-HIPO), the Max Planck Society, Genome Canada, and the Canadian Institute for Health Research (CIHR) with cofunding from Genome BC, Genome Quebec, CIHR-ICR (Institute for Cancer Research), and the Dietmar Hopp Foundation.	Barakat TS, 2012, DEVELOPMENT, V139, P2085, DOI 10.1242/dev.069328; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Ellegren H, 2003, CURR OPIN GENET DEV, V13, P562, DOI 10.1016/j.gde.2003.10.008; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hansen RS, 1996, HUM MOL GENET, V5, P1345, DOI 10.1093/hmg/5.9.1345; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Jones DTW, 2013, NAT GENET, V45, P927, DOI 10.1038/ng.2682; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2502; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Malcom CM, 2003, MOL BIOL EVOL, V20, P1633, DOI 10.1093/molbev/msg178; Mietton F, 2009, MOL CELL BIOL, V29, P150, DOI 10.1128/MCB.00997-08; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; MORISHIMA A, 1962, P NATL ACAD SCI USA, V48, P756, DOI 10.1073/pnas.48.5.756; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tort F, 2006, CANCER RES, V66, P10258, DOI 10.1158/0008-5472.CAN-06-2178; Weischenfeldt J, 2013, CANCER CELL, V23, P159, DOI 10.1016/j.ccr.2013.01.002; Weisse K, 2012, CLIN EXP ALLERGY, V42, P1337, DOI 10.1111/j.1365-2222.2012.04024.x; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733	34	48	48	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					567	581		10.1016/j.cell.2013.09.042	http://dx.doi.org/10.1016/j.cell.2013.09.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24139898	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000326571800012
J	McColl, K				McColl, Karen			PUBLIC HEALTH POLICY IN NEWYORK CITY What's next for public health in a post-Bloomberg NYC?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												karenmccoll@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2013	347								f6272	10.1136/bmj.f6272	http://dx.doi.org/10.1136/bmj.f6272			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WQ	24141605				2022-12-24	WOS:000325982800003
J	Thomas, KH; Martin, RM; Davies, NM; Metcalfe, C; Windmeijer, F; Gunnell, D				Thomas, Kyla H.; Martin, Richard M.; Davies, Neil M.; Metcalfe, Chris; Windmeijer, Frank; Gunnell, David			Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; GENERAL-PRACTICE; VARENICLINE; INSTRUMENTS; VALIDATION; NICOTINE; EVENTS; SAFETY	Objective To compare the risk of suicide, self harm, and depression in patients prescribed varenicline or bupropion with those prescribed nicotine replacement therapy. Design Prospective cohort study within the Clinical Practice Research Datalink. Setting 349 general practices in England. Participants 119 546 men and women aged 18 years and over who used a smoking cessation product between 1 September 2006 and 31 October 2011. There were 81 545 users of nicotine replacement products (68.2% of all users of smoking cessation medicines), 6741 bupropion (5.6%), and 31 260 varenicline (26.2%) users. Main outcome measures Outcomes were treated depression and fatal and non-fatal self harm within three months of the first smoking cessation prescription, determined from linkage with mortality data from the Office for National Statistics (for suicide) and Hospital Episode Statistics data (for hospital admissions relating to non-fatal self harm). Hazard ratios or risk differences were estimated using Cox multivariable regression models, propensity score matching, and instrumental variable analysis using physicians' prescribing preferences as an instrument. Sensitivity analyses were performed for outcomes at six and nine months. Results We detected 92 cases of fatal and non-fatal self harm (326.5 events per 100 000 person years) and 1094 primary care records of treated depression (6963.3 per 100 000 person years). Cox regression analyses showed no evidence that patients prescribed varenicline had higher risks of fatal or non-fatal self harm (hazard ratio 0.88, 95% confidence interval 0.52 to 1.49) or treated depression (0.75, 0.65 to 0.87) compared with those prescribed nicotine replacement therapy. There was no evidence that patients prescribed bupropion had a higher risk of fatal or non-fatal self harm (0.83, 0.30 to 2.31) or of treated depression (0.63, 0.46 to 0.87) compared with patients prescribed nicotine replacement therapy. Similar findings were obtained using propensity score methods and instrumental variable analyses. Conclusions There is no evidence of an increased risk of suicidal behaviour in patients prescribed varenicline or bupropion compared with those prescribed nicotine replacement therapy. These findings should be reassuring for users and prescribers of smoking cessation medicines.	[Thomas, Kyla H.; Martin, Richard M.; Metcalfe, Chris; Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Martin, Richard M.; Davies, Neil M.] Univ Bristol, MRC Integrat Epidemiol Unit IEU, Bristol BS8 2PS, Avon, England; [Windmeijer, Frank] Univ Bristol, Dept Econ, CMPO, Bristol BS8 2PS, Avon, England	University of Bristol; University of Bristol; University of Bristol	Thomas, KH (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England.	kyla.thomas@bristol.ac.uk	Gunnell, David/ABE-6653-2020; Windmeijer, Frank/AAL-5695-2020	Gunnell, David/0000-0002-0829-6470; Metcalfe, Chris/0000-0001-8318-8907; Davies, Neil/0000-0002-2460-0508; Thomas, Kyla/0000-0001-5418-4034; Martin, Richard/0000-0002-7992-7719; Windmeijer, Frank/0000-0002-4232-2783	ESRC [ES/H005331/1] Funding Source: UKRI; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: Medline; Department of Health [DRF-2010-03-138] Funding Source: Medline; Economic and Social Research Council [ES/H005331/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10068, DRF-2010-03-138] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Baum C.F., 2002, IVREG2 STATA MODULE; Brookhart MA, 2006, EPIDEMIOLOGY, V17, P268, DOI 10.1097/01.ede.0000193606.58671.c5; Cahill K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub6; Cahill K, 2009, DRUG SAFETY, V32, P119, DOI 10.2165/00002018-200932020-00005; Campbell AR, 2010, AM J HEALTH-SYST PH, V67, P1832, DOI 10.2146/ajhp100196; Clarke PS, 2012, J AM STAT ASSOC, V107, P1638, DOI 10.1080/01621459.2012.734171; Davies NM, 2013, EPIDEMIOLOGY, V24, P352, DOI 10.1097/EDE.0b013e318289e024; Davies NM, 2013, EPIDEMIOLOGY, V24, P363, DOI 10.1097/EDE.0b013e31828abafb; Dhillon S, 2008, DRUGS, V68, P653, DOI 10.2165/00003495-200868050-00011; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; Faulk K., 2013, BIRMINGHAM NEWS 0301; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Gunnell D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3805; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Harrison-Woolrych M, 2011, DRUG SAFETY, V34, P763, DOI 10.2165/11594450-000000000-00000; Hernan MA, 2006, EPIDEMIOLOGY, V17, P360, DOI 10.1097/01.ede.0000222409.00878.37; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; Kasliwal R, 2009, DRUG SAFETY, V32, P499, DOI 10.2165/00002018-200932060-00006; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Leuven Edwin., 2003, PSMATCH2 STATA MODUL; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Martens EP, 2006, EPIDEMIOLOGY, V17, P260, DOI 10.1097/01.ede.0000215160.88317.cb; Martin RM, 2006, BRIT J CLIN PHARMACO, V61, P224, DOI 10.1111/j.1365-2125.2005.02527.x; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Medicines and Healthcare Products Regulatory Agency, 2008, DRUG SAFETY UPDATE, V2, P2; Meyer TE, 2013, ADDICTION, V108, P203, DOI 10.1111/j.1360-0443.2012.04024.x; Miller M, 2000, AM J PUBLIC HEALTH, V90, P768, DOI 10.2105/AJPH.90.5.768; Miller M, 2000, AM J EPIDEMIOL, V151, P1060, DOI 10.1093/oxfordjournals.aje.a010148; Mills EJ, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-25; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Moore TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027016; National Institute for Health and Clinical Excellence, 2010, NICE IMPL UPT REP SM; National Institute for Health and Clinical Excellence, 2008, NICE PUBL HLTH GUID; Office for National Statistics, 2011, STAT B, P1; Rassen JA, 2009, J CLIN EPIDEMIOL, V62, P1233, DOI 10.1016/j.jclinepi.2008.12.006; Rassen JA, 2009, J CLIN EPIDEMIOL, V62, P1226, DOI 10.1016/j.jclinepi.2008.12.005; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Setakis E, 2010, PHARMACOEPIDEM DR S, V19, pS310; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Thomas KH, 2013, BRIT J CLIN PHARMACO, V76, P145, DOI 10.1111/bcp.12059; Twigg L, 2004, SMOKING EPIDEMIC ENG; US Food and Drug Administration, 2009, FDA DRUG SAFETY NEWS; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; World Health Organization, 2019, WHO REPORT GLOBAL TO	46	77	78	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2013	347								f5704	10.1136/bmj.f5704	http://dx.doi.org/10.1136/bmj.f5704			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	235OP	24124105	hybrid, Green Published			2022-12-24	WOS:000325729300001
J	Koslow, JA; Couture, J				Koslow, J. Anthony; Couture, Jennifer			Follow the fish	NATURE			English	Editorial Material							OXYGEN; CLIMATE		[Koslow, J. Anthony; Couture, Jennifer] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Koslow, JA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	jkoslow@ucsd.edu						Alverson K, 2008, J OCEAN TECHNOL, P19; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Deutsch C, 2011, SCIENCE, V333, P336, DOI 10.1126/science.1202422; Kaartvedt S, 2012, MAR ECOL PROG SER, V456, P1, DOI 10.3354/meps09785; Koslow JA, 2011, MAR ECOL PROG SER, V436, P207, DOI 10.3354/meps09270; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Ohman M. D., 2003, OCEANOGRAPHY, V16, P76, DOI DOI 10.5670/OCEANOG.2003.34; Roberts C, 2012, OCEAN LIFE FATE MAN; Shaffer G, 2009, NAT GEOSCI, V2, P105, DOI 10.1038/NGEO420; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847	10	25	25	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					163	164		10.1038/502163a	http://dx.doi.org/10.1038/502163a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24137750	Bronze			2022-12-24	WOS:000325436100021
J	Cash, RA; Halder, SR; Husain, M; Islam, MS; Mallick, FH; May, MA; Rahman, M; Rahman, MA				Cash, Richard A.; Halder, Shantana R.; Husain, Mushtuq; Islam, Md Sirajul; Mallick, Fuad H.; May, Maria A.; Rahman, Mahmudur; Rahman, M. Aminur			Reducing the health effect of natural hazards in Bangladesh	LANCET			English	Article							DHAKA CITY; CYCLONE; DISASTER; DISEASE; FLOODS	Bangladesh, with a population of 151 million people, is a country that is particularly prone to natural disasters: 26% of the population are affected by cyclones and 70% live in flood-prone regions. Mortality and morbidity from these events have fallen substantially in the past 50 years, partly because of improvements in disaster management. Thousands of cyclone shelters have been built and government and civil society have mobilised strategies to provide early warning and respond quickly. Increasingly, flood and cyclone interventions have leveraged community resilience, and general activities for poverty reduction have integrated disaster management. Furthermore, overall population health has improved greatly on the basis of successful public health activities, which has helped to mitigate the effect of natural disasters. Challenges to the maintenance and reduction of the effect of cyclones and floods include rapid urbanisation and the growing effect of global warming. Although the effects of earthquakes are unknown, some efforts to prepare for this type of event are underway.	[Cash, Richard A.] Publ Hlth Fdn India, New Delhi, India; [Cash, Richard A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Halder, Shantana R.] Govt Bangladesh, Comprehens Disaster Management Programme, Disaster Management & Relief Bhaban, Dhaka, Bangladesh; [Husain, Mushtuq; Rahman, Mahmudur] Inst Epidemiol & Dis Control Res, Dhaka, Bangladesh; [Islam, Md Sirajul] Int Ctr Diarrhoeal Dis Res, Environm Microbiol Lab, Dhaka 1000, Bangladesh; [Mallick, Fuad H.; Rahman, M. Aminur] BRAC Univ, Dept Architecture, Postgrad Programs Disaster Management, Dhaka, Bangladesh; [May, Maria A.] BRAC, BRAC Ctr, Social Innovat Lab, Dhaka 1212, Bangladesh	Public Health Foundation of India; Harvard University; Harvard T.H. Chan School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; Bangladesh Rural Advancement Committee BRAC	May, MA (corresponding author), BRAC, BRAC Ctr, Social Innovat Lab, Dhaka 1212, Bangladesh.	maria.a@brac.net		Rahman, Mohammad Aminur/0000-0003-4775-6748				Adams AM, 2013, LANCET; Ahmed F., 2007, BANGLADESH CYCLONE S; Ahmed S, 1992, CRISIS DEV, P819; Ahmed SM, 1999, EXPERIENCES DELUGE F, P1; Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Akhter SH, 2010, EARTHQUAKES DHAKA; [Anonymous], 2004, MONS FLOODS 2004 POS; [Anonymous], 2010, NAT PLAN DIS MAN; BERN C, 1993, B WORLD HEALTH ORGAN, V71, P73; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; CHOWDHURY AMR, 1993, DISASTERS, V17, P291, DOI 10.1111/j.1467-7717.1993.tb00503.x; Chowdhury M, 1992, CRISIS DEV COPING DI, P101; CUSTERS P, 1992, ECON POLIT WEEKLY, V27, P327; DOW K, 1992, GEOFORUM, V23, P417, DOI 10.1016/0016-7185(92)90052-6; Fernandes A, 2012, B WORLD HEALTH ORGAN, V90, P631, DOI 10.2471/BLT.12.104901; Government of Bangladesh, 2008, CYCL SIDR BANGL DAM; Haque MM, 1992, CRISIS DEV COPING DI, P27; Haque U, 2012, B WORLD HEALTH ORGAN, V90, P150, DOI 10.2471/BLT.11.088302; Hossain H, 1992, CRISIS DEV, P13; International Flood Network, 2009, FLOOD INF IMP CYCL A; IRIN News, 2012, IRIN NEWS       0222; Islam MS, 2011, T ROY SOC TROP MED H, V105, P341, DOI 10.1016/j.trstmh.2011.03.003; Islam MS, 2007, J APPL MICROBIOL, V103, P80, DOI 10.1111/j.1365-2672.2006.03234.x; Kouadio IK, 2012, EXPERT REV ANTI-INFE, V10, P95, DOI [10.1586/ERI.11.155, 10.1586/eri.11.155]; Mallick FH, 2008, J S ASIA DISASTER ST, V1, P59; Mollica R, 2006, HEALING INVISIBLE WO; Paul BK, 2011, NAT HAZARDS, V56, P841, DOI 10.1007/s11069-010-9595-5; Paul BK, 1997, GEOFORUM, V28, P121, DOI 10.1016/S0016-7185(97)00004-3; Pelling Mark, 2003, VULNERABILITY CITIES; Potsdam Institute for Climate Impact Research and Climate Analytics, 2013, TURN HEAT CLIM EXTR; Rahman MA, HAZARDS DISASTERS SO; Rashid SF, 2000, DISASTERS, V24, P240, DOI 10.1111/1467-7717.00145; Robinson S., 2007, BANGLADESH SURVIVED; Roy P, 2011, DISTANCE SAVED FRAGI; Schwartz BS, 2006, AM J TROP MED HYG, V74, P1067, DOI 10.4269/ajtmh.2006.74.1067; Shafie H, 2009, ENDOWED WISDOM KNOWL; Shultz JM, 2005, EPIDEMIOL REV, V27, P21, DOI 10.1093/epirev/mxi011; SOMMER A, 1972, LANCET, V1, P1029; Tod I, 2008, ASSESSMENT EFFECTIVE; Zimmermann M, 2010, DIS RISK RED PROGR B	40	35	36	2	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2013	382	9910					2094	2103		10.1016/S0140-6736(13)61948-0	http://dx.doi.org/10.1016/S0140-6736(13)61948-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	275OX	24268610	Green Submitted			2022-12-24	WOS:000328687800031
J	Belgrano, A; Fowler, CW				Belgrano, Andrea; Fowler, Charles W.			How Fisheries Affect Evolution	SCIENCE			English	Editorial Material							BODY-SIZE; CONSEQUENCES		[Belgrano, Andrea] Swedish Univ Agr Sci, Dept Aquat Resources, Inst Marine Res, SE-45330 Lysekil, Sweden; [Belgrano, Andrea] Swedish Inst Marine Environm SIME, SE-40530 Gothenburg, Sweden; [Fowler, Charles W.] Seattle Univ, Dept Biol, Seattle, WA 98122 USA	Swedish University of Agricultural Sciences; Seattle University	Belgrano, A (corresponding author), Swedish Univ Agr Sci, Dept Aquat Resources, Inst Marine Res, Turistgatan 5, SE-45330 Lysekil, Sweden.	andrea.belgrano@slu.se; fowlerc@seattleu.edu						Andersen KH, 2009, P NATL ACAD SCI USA, V106, P11657, DOI 10.1073/pnas.0901690106; Branch TA, 2013, TRENDS ECOL EVOL, V28, P409, DOI 10.1016/j.tree.2013.03.003; Eikeset AM, 2013, P NATL ACAD SCI USA, V110, P12259, DOI 10.1073/pnas.1212593110; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; Garcia SM, 2012, SCIENCE, V335, P1045, DOI 10.1126/science.1214594; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Palkovacs EP, 2012, EVOL APPL, V5, P183, DOI 10.1111/j.1752-4571.2011.00212.x; Shackell NL, 2010, P ROY SOC B-BIOL SCI, V277, P1353, DOI 10.1098/rspb.2009.1020; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; van Wijk SJ, 2013, FRONT ECOL ENVIRON, V11, P181, DOI 10.1890/120229; Yamamichi M, 2011, AM NAT, V178, P287, DOI 10.1086/661241; Zhou SJ, 2010, P NATL ACAD SCI USA, V107, P9485, DOI 10.1073/pnas.0912771107	12	21	21	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1176	1177		10.1126/science.1245490	http://dx.doi.org/10.1126/science.1245490			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	264DT	24311669				2022-12-24	WOS:000327857900024
J	Field, AE; Camargo, CA; Ogino, S				Field, Alison E.; Camargo, Carlos A., Jr.; Ogino, Shuji			The Merits of Subtyping Obesity One Size Does Not Fit All	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BODY-MASS INDEX; ASSOCIATION; PREVALENCE; TRENDS		[Field, Alison E.; Camargo, Carlos A., Jr.] Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Dept Epidemiol,Dept Med, Boston, MA 02115 USA; [Field, Alison E.; Camargo, Carlos A., Jr.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Field, Alison E.] Boston Childrens Hosp, Dept Med, Div Adolescent Med, Boston, MA USA; [Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Dept Epidemiol,Dept Pathol, Boston, MA 02115 USA; [Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Field, AE (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Adolescent Med, 300 Longwood Ave,AU 506, Boston, MA 02115 USA.	alison.field@childrens.harvard.edu	Field, Alison/AAA-4508-2021; Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654; Ogino, Shuji/0000-0002-3909-2323				Chaput JP, 2008, AM J CLIN NUTR, V87, P303, DOI 10.1093/ajcn/87.2.303; Epstein LH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-13; Ferriday D, 2011, INT J OBESITY, V35, P142, DOI 10.1038/ijo.2010.117; Field AE, 2012, PEDIATRICS, V130, pE289, DOI 10.1542/peds.2011-3663; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ogino S, 2014, ONCOGENE, V33, P2949, DOI 10.1038/onc.2013.244; Roemmich JN, 2008, PHYSIOL BEHAV, V93, P1011, DOI 10.1016/j.physbeh.2008.01.010; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174	10	73	76	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2147	2148		10.1001/jama.2013.281501	http://dx.doi.org/10.1001/jama.2013.281501			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24189835				2022-12-24	WOS:000327404400020
J	Richards, T				Richards, Tessa			Journey of a patient editor	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						Treasure T, 2007, BMJ-BRIT MED J, V334, P831, DOI 10.1136/bmj.39161.403218.AD	1	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2013	347								f6913	10.1136/bmj.f6913	http://dx.doi.org/10.1136/bmj.f6913			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KF	24259330	Bronze			2022-12-24	WOS:000327457400011
J	Madhani, HD				Madhani, Hiten D.			The Frustrated Gene: Origins of Eukaryotic Gene Expression	CELL			English	Article							MESSENGER-RNA DECAY; COMPARATIVE GENOMICS; EVOLUTION; DNA; METHYLATION; PROTEIN; INTERFERENCE; INTRONS; YEAST; SPLICEOSOME	Eukarytotic gene expression is frustrated by a series of steps that are generally not observed in prokaryotes and are therefore not essential for the basic chemistry of transcription and translation. Their evolution may have been driven by the need to defend against parasitic nucleic acids.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	hitenmadhani@gmail.com		Madhani, Hiten/0000-0001-7400-6657	NIGMS NIH HHS [R01 GM071801, GM071801] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071801] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ammar R, 2012, ELIFE, V1, DOI 10.7554/eLife.00078; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Belew AT, 2011, NUCLEIC ACIDS RES, V39, P2799, DOI 10.1093/nar/gkq1220; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Craig N., 2002, MOBILE GENETIC ELEME; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Dawkins R, 1976, SELFISH GENE; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; EHRENFELD E, 1982, CELL, V28, P435, DOI 10.1016/0092-8674(82)90195-7; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Gornik SG, 2012, CURR BIOL, V22, P2303, DOI 10.1016/j.cub.2012.10.036; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; HICKEY DA, 1982, GENETICS, V101, P519; Hollien J, 2013, BBA-MOL CELL RES, V1833, P2458, DOI 10.1016/j.bbamcr.2013.01.016; James ER, 2002, CELL DEATH DIFFER, V9, P355, DOI 10.1038/sj.cdd.4400986; Joshua-Tor L, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003772; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-22; Law JA, 2013, NATURE, V498, P385, DOI 10.1038/nature12178; Le Hir H, 2008, CELL, V133, P213, DOI 10.1016/j.cell.2008.04.002; Li VC, 2009, MOL BIOL EVOL, V26, P1103, DOI 10.1093/molbev/msp030; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Nakano K, 2013, MICROBES INFECT, V15, P491, DOI 10.1016/j.micinf.2013.03.006; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Peng JC, 2013, CURR OPIN CELL BIOL, V25, P190, DOI 10.1016/j.ceb.2013.01.010; Pikaard C. S., 2013, COLD SPRING HARB SYM, V77, P205; Rogozin IB, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-11; Roth SL, 2011, J VIROL, V85, P7393, DOI 10.1128/JVI.00635-11; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880; Smolle M, 2013, EPIGENETICS-US, V8, P10, DOI 10.4161/epi.23333; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; Walsh D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012351; Werner M, 2011, NUCLEIC ACIDS RES, V39, P4756, DOI 10.1093/nar/gkr038; YU YT, 1995, RNA, V1, P46; Zhang F, 2012, CELL, V151, P871, DOI 10.1016/j.cell.2012.09.040; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	42	30	30	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					744	749		10.1016/j.cell.2013.10.003	http://dx.doi.org/10.1016/j.cell.2013.10.003			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209615	Bronze, Green Accepted			2022-12-24	WOS:000326934300006
J	Roehr, B				Roehr, Bob			ENERGY DRINKS Energy drinks: cause for concern or scaremongering?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Bronstein AC, CAFFEINE ENERGY DRIN; Higgins JP, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.12.023; Liu J., 2013, THESIS TEXAS MED CTR; Martin-lof A, 2013, AM J TRANSPLANT; Schneider MB, 2011, PEDIATRICS, V127, P1182, DOI 10.1542/peds.2011-0965; Sullum J., 2011, REASON 2011	6	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2013	347								f6343	10.1136/bmj.f6343	http://dx.doi.org/10.1136/bmj.f6343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CK	24157499				2022-12-24	WOS:000326294000003
J	Lajoie, MJ; Kosuri, S; Mosberg, JA; Gregg, CJ; Zhang, D; Church, GM				Lajoie, M. J.; Kosuri, S.; Mosberg, J. A.; Gregg, C. J.; Zhang, D.; Church, G. M.			Probing the Limits of Genetic Recoding in Essential Genes	SCIENCE			English	Article							SYNONYMOUS CODON USAGE; ESCHERICHIA-COLI; IN-VIVO; TRANSLATION; GENOME; REVEALS; CELL; EXPRESSION; EFFICIENCY; SELECTION	Engineering radically altered genetic codes will allow for genomically recoded organisms that have expanded chemical capabilities and are isolated from nature. We have previously reassigned the translation function of the UAG stop codon; however, reassigning sense codons poses a greater challenge because such codons are more prevalent, and their usage regulates gene expression in ways that are difficult to predict. To assess the feasibility of radically altering the genetic code, we selected a panel of 42 highly expressed essential genes for modification. Across 80 Escherichia coli strains, we removed all instances of 13 rare codons from these genes and attempted to shuffle all remaining codons. Our results suggest that the genome-wide removal of 13 codons is feasible; however, several genome design constraints were apparent, underscoring the importance of a strategy that rapidly prototypes and tests many designs in small pieces.	[Lajoie, M. J.; Mosberg, J. A.; Gregg, C. J.; Church, G. M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lajoie, M. J.; Mosberg, J. A.] Harvard Univ, Program Chem Biol, Cambridge, MA 02138 USA; [Kosuri, S.; Zhang, D.; Church, G. M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu	Zhang, Di/AAN-3312-2021	Zhang, Di/0000-0002-9007-4665; church, george/0000-0001-6232-9969; Kosuri, Sriram/0000-0002-4661-0600	U.S. Department of Energy [DE-FG02-02ER63445]; NSF [SA5283-11210]; Defense Advanced Research Projects Agency [N66001-12-C-4040]; U.S. Office of Naval Research [N000141010144]; Agilent Technologies; Wyss Institute; Department of Defense National Defense Science and Engineering Graduate Fellowship	U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); U.S. Office of Naval Research(Office of Naval Research); Agilent Technologies; Wyss Institute; Department of Defense National Defense Science and Engineering Graduate Fellowship(United States Department of Defense)	We thank S. Vassallo and J. Ho for technical assistance and U. Laserson, D. Goodman, N. Eroshenko, D. Mandell, D. Soll, L. Ling, and F. Isaacs for helpful comments. Funding was from the U.S. Department of Energy (DE-FG02-02ER63445), NSF (SA5283-11210), the Defense Advanced Research Projects Agency (N66001-12-C-4040), the U.S. Office of Naval Research (N000141010144), Agilent Technologies, Wyss Institute, and Department of Defense National Defense Science and Engineering Graduate Fellowship (M.J.L.).	AKASHI H, 1994, GENETICS, V136, P927; Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Angov E, 2011, BIOTECHNOL J, V6, P650, DOI 10.1002/biot.201000332; BULMER M, 1991, GENETICS, V129, P897; Carr PA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks455; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; Frenkel-Morgenstern M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.3; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Schafer MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025736; Shinhara A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-428; Sorensen MA, 2005, J MOL BIOL, V354, P16, DOI 10.1016/j.jmb.2005.08.076; Sykes MT, 2010, ANAL CHEM, V82, P5038, DOI 10.1021/ac9028664; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Yamazaki Yukiko, 2008, V416, P385, DOI 10.1007/978-1-59745-321-9_26; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; ZELL R, 1987, EMBO J, V6, P1809, DOI 10.1002/j.1460-2075.1987.tb02435.x	30	92	103	3	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					361	363		10.1126/science.1241460	http://dx.doi.org/10.1126/science.1241460			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136967				2022-12-24	WOS:000325755100045
J	de la Roche, M; Ritter, AT; Angus, KL; Dinsmore, C; Earnshaw, CH; Reiter, JF; Griffiths, GM				de la Roche, Maike; Ritter, Alex T.; Angus, Karen L.; Dinsmore, Colin; Earnshaw, Charles H.; Reiter, Jeremy F.; Griffiths, Gillian M.			Hedgehog Signaling Controls T Cell Killing at the Immunological Synapse	SCIENCE			English	Article							PRIMARY CILIUM; ACTIVATION; POLARIZATION; INHIBITION	The centrosome is essential for cytotoxic T lymphocyte (CTL) function, contacting the plasma membrane and directing cytotoxic granules for secretion at the immunological synapse. Centrosome docking at the plasma membrane also occurs during cilia formation. The primary cilium, formed in nonhematopoietic cells, is essential for vertebrate Hedgehog (Hh) signaling. Lymphocytes do not form primary cilia, but we found and describe here that Hh signaling played an important role in CTL killing. T cell receptor activation, which "prearms" CTLs with cytotoxic granules, also initiated Hh signaling. Hh pathway activation occurred intracellularly and triggered Rac1 synthesis. These events "prearmed" CTLs for action by promoting the actin remodeling required for centrosome polarization and granule release. Thus, Hh signaling plays a role in CTL function, and the immunological synapse may represent a modified cilium.	[de la Roche, Maike; Ritter, Alex T.; Angus, Karen L.; Earnshaw, Charles H.; Griffiths, Gillian M.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Dinsmore, Colin; Reiter, Jeremy F.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Ritter, Alex T.] NICHD, NIH, Bethesda, MD 20892 USA	University of Cambridge; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Griffiths, GM (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	gg305@cam.ac.uk	Earnshaw, Charles/AAN-6210-2021	Griffiths, Gillian/0000-0003-0434-5842; Earnshaw, Charles/0000-0002-7926-8506; de la Roche, Maike/0000-0002-0558-4119; Dinsmore, Colin/0000-0002-6404-1202; Angus-Cole, Karen/0000-0002-6262-4041	Wellcome Trust [075880]; Wellcome Trust Strategic Award for core facilities at the CIMR [100140]; NIH [R01AR05439, R01GM095941]; Burroughs Wellcome Fund; David and Lucile F. Packard Foundation; Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095941] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Strategic Award for core facilities at the CIMR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); David and Lucile F. Packard Foundation; Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Rohatgi for the MSCV-Ptch1-EYFP construct and the Smo antibodies; S. Munro (Cambridge) for PACT (pericentrin)-RFP; M. Davidson (University of Florida) for Farnesyl-5-TagBFP2; R. Zamoyska for Lck-depleted spleens; D. Fearon, T. Crompton, J. Kaufman, M. A. de la Roche, and A. Schuldt for helpful discussions and critical reading of the manuscript; and R. Rohatgi and J. Stinchcombe for helpful discussions. We also thank the flow cytometry core facility at the Cambridge Institute for Medical Research (CIMR) for cell sorting and assistance with the calcium assay. This work was supported by a Wellcome Trust Principal Research Fellowship to G. M. G. (075880), a Wellcome Trust Strategic Award for core facilities at the CIMR (100140), NIH (R01AR05439 and R01GM095941), the Burroughs Wellcome Fund, the David and Lucile F. Packard Foundation, and the Sandler Family Supporting Foundation to J. R. The data presented in this paper are provided in the main paper and supplementary materials.	Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; El Abdaloussi E, 2006, NAT IMMUNOL, V7, P418, DOI 10.1038/ni1313; Filbert EL, 2012, J IMMUNOL, V188, P5421, DOI 10.4049/jimmunol.1200242; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Gao J, 2009, CELL STEM CELL, V4, P548, DOI 10.1016/j.stem.2009.03.015; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Griffiths GM, 2010, J CELL BIOL, V189, P397, DOI 10.1083/jcb.201002027; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Kornberg TB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002447; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nishimura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041413; Outram SV, 2009, BLOOD, V113, P2217, DOI 10.1182/blood-2008-03-144840; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Sasaki N, 2010, MOL CELL NEUROSCI, V45, P335, DOI 10.1016/j.mcn.2010.07.006; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Valentini RP, 1997, J BIOL CHEM, V272, P8466, DOI 10.1074/jbc.272.13.8466; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Yi JS, 2013, J CELL BIOL, V202, P779, DOI 10.1083/jcb.201301004	30	91	91	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1247	1250		10.1126/science.1244689	http://dx.doi.org/10.1126/science.1244689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311692	Green Accepted			2022-12-24	WOS:000327857900051
J	George, J; Majeed, W; Mackenzie, IS; MacDonald, TM; Wei, L				George, Jacob; Majeed, Waseem; Mackenzie, Isla S.; MacDonald, Thomas M.; Wei, Li			Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; MORTALITY; SALT; POTASSIUM; REDUCTION	Objective To determine whether patients taking formulations of drugs that contain sodium have a higher incidence of cardiovascular events compared with patients on non-sodium formulations of the same drugs. Design Nested case-control study. Setting UK Primary Care Patients registered on the Clinical Practice Research Datalink (CPRD). Participants All patients aged 18 or over who were prescribed at least two prescriptions of sodium-containing formulations or matched standard formulations of the same drug between January 1987 and December 2010. Main outcome measures Composite primary outcome of incident non-fatal myocardial infarction, incident non-fatal stroke, or vascular death. We performed 1: 1 incidence density sampling matched controls using the UK Clinical Practice Research Datalink (CPRD). For the secondary analyses, cases were patients with the individual components of the primary study composite endpoint of hypertension, incident heart failure, and all cause mortality. Results 1 292 337 patients were included in the study cohort. Mean follow-up time was 7.23 years. A total of 61 072 patients with an incident cardiovascular event were matched with controls. For the primary endpoint of incident non-fatal myocardial infarction, incident non-fatal stroke, or vascular death the adjusted odds ratio for exposure to sodium-containing drugs was 1.16 (95% confidence interval 1.12 to 1.21). The adjusted odds ratios for the secondary endpoints were 1.22 (1.16 to 1.29) for incident non-fatal stroke, 1.28 (1.23 to 1.33) for all cause mortality, 7.18 (6.74 to 7.65) for hypertension, 0.98 (0.93 to 1.04) for heart failure, 0.94 (0.88 to 1.00) for incident non-fatal myocardial infarction, and 0.70 (0.31 to 1.59) for vascular death. The median time from date of first prescription (that is, date of entry into cohort) to first event was 3.92 years. Conclusions Exposure to sodium-containing formulations of effervescent, dispersible, and soluble medicines was associated with significantly increased odds of adverse cardiovascular events compared with standard formulations of those same drugs. Sodium-containing formulations should be prescribed with caution only if the perceived benefits outweigh these risks.	[George, Jacob] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland; [Majeed, Waseem] Ninewells Hosp, NHS Tayside, Dundee DD1 9SY, Scotland; [Mackenzie, Isla S.; MacDonald, Thomas M.; Wei, Li] Univ Dundee, Ninewells Hosp & Med Sch, Med Monitoring Unit, Dundee DD1 9SY, Scotland; [Mackenzie, Isla S.; MacDonald, Thomas M.; Wei, Li] Univ Dundee, Ninewells Hosp & Med Sch, Hypertens Res Ctr, Dundee DD1 9SY, Scotland; [Wei, Li] UCL Sch Pharm, Dept Practice & Policy, London WC1H 9JP, England	University of Dundee; University of Dundee; University of Dundee; University of London; University College London	MacDonald, TM (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Med Monitoring Unit, Dundee DD1 9SY, Scotland.	tom@memo.dundee.ac.uk		Majeed, Waseem/0000-0001-7836-0610; MacDonald, Thomas/0000-0001-5189-6669; George, Jacob/0000-0001-8154-8278; Mackenzie, Isla/0000-0002-3680-7127	TENOVUS Scotland [T10/12]	TENOVUS Scotland	This study was funded by TENOVUS Scotland (ref T10/12). The funder had no role in the design, conduct or data interpretation of the study.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Alderman MH, 1998, LANCET, V351, P781, DOI 10.1016/S0140-6736(97)09092-2; Alderman MH, 2012, CURR HYPERTENS REP, V14, P193, DOI 10.1007/s11906-012-0275-6; Azoulay L, 2013, THROMB HAEMOSTASIS, V109, P431, DOI 10.1160/TH12-08-0542; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; DAHL LK, 1954, ARCH INTERN MED, V94, P525, DOI 10.1001/archinte.1954.00250040017003; Denny SD, 2006, AM J MED, V119, P327, DOI [10.1016/j.amjmed.2005.08.027, 10.1016/j.amjmed.2005.10.042]; ELLIOTT P, 1988, BRIT MED J, V297, P319; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Food Standards Agency, 2002, HLTH IN WORTH ITS SA; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Gupta D, 2012, CIRCULATION, V126, P479, DOI 10.1161/CIRCULATIONAHA.111.062430; Haddy FJ, 2006, AM J PHYSIOL-REG I, V290, pR546, DOI 10.1152/ajpregu.00491.2005; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Institute of Medicine, 2010, STRAT RED SOD INT US; Li XY, 2012, CNS NEUROSCI THER, V18, P691, DOI 10.1111/j.1755-5949.2012.00355.x; Lim PO, 2001, HYPERTENSION, V37, P856, DOI 10.1161/01.HYP.37.3.856; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; Pimenta E, 2009, HYPERTENSION, V54, P475, DOI 10.1161/HYPERTENSIONAHA.109.131235; Tzemos N, 2008, HYPERTENSION, V51, P1525, DOI 10.1161/HYPERTENSIONAHA.108.109868; Ubeda A, 2009, PHARMACOEPIDEM DR S, V18, P417, DOI 10.1002/pds.1701; Yang QH, 2011, ARCH INTERN MED, V171, P1183, DOI 10.1001/archinternmed.2011.257	23	41	43	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2013	347								f6954	10.1136/bmj.f6954	http://dx.doi.org/10.1136/bmj.f6954			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FN	24284017	hybrid, Green Published			2022-12-24	WOS:000327792500003
J	Fier, PS; Hartwig, JF				Fier, Patrick S.; Hartwig, John F.			Selective C-H Fluorination of Pyridines and Diazines Inspired by a Classic Amination Reaction	SCIENCE			English	Article							BASE-INITIATED REACTIONS; FUNCTIONALIZATION; HALOPYRIDINES; HETEROARENES; METALATION	Fluorinated heterocycles are prevalent in pharmaceuticals, agrochemicals, and materials. However, reactions that incorporate fluorine into heteroarenes are limited in scope and can be hazardous. We present a broadly applicable and safe method for the site-selective fluorination of a single carbon-hydrogen bond in pyridines and diazines using commercially available silver(II) fluoride. The reactions occur at ambient temperature within 1 hour with exclusive selectivity for fluorination adjacent to nitrogen. The mild conditions allow access to fluorinated derivatives of medicinally important compounds, as well as a range of 2-substituted pyridines prepared by subsequent nucleophilic displacement of fluoride. Mechanistic studies demonstrate that the pathway of a classic pyridine amination can be adapted for selective fluorination of a broad range of nitrogen heterocycles.	[Fier, Patrick S.; Hartwig, John F.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hartwig, JF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jhartwig@berkeley.edu			NIH [R37GM-55382]; Chevron; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM055382] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chevron; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NIH (R37GM-55382) for support of this work and Chevron for a fellowship to P.S.F. A provisional patent application has been filed on this reaction.	Adams DJ, 1999, CHEM SOC REV, V28, P225, DOI 10.1039/a808707e; ANDRAE D, 1990, THEOR CHIM ACTA, V77, P123, DOI 10.1007/BF01114537; Begue J.-P., 2008, BIOORGANIC MED CHEM; BELL TW, 1987, J ORG CHEM, V52, P3847, DOI 10.1021/jo00226a023; Bobbio C, 2005, J ORG CHEM, V70, P3039, DOI 10.1021/jo047979h; BRADLOW HI, 1949, J ORG CHEM, V14, P509, DOI 10.1021/jo01156a002; Chambers RD, 1999, J CHEM SOC PERK T 1, P803, DOI 10.1039/a809838g; Cherng YH, 2002, TETRAHEDRON, V58, P4931, DOI 10.1016/S0040-4020(02)00424-6; Erian AW, 2001, J HETEROCYCLIC CHEM, V38, P793, DOI 10.1002/jhet.5570380401; ESTEL L, 1988, J ORG CHEM, V53, P2740, DOI 10.1021/jo00247a016; Fujiwara Y, 2012, NATURE, V492, P95, DOI 10.1038/nature11680; FUKUHARA T, 1988, J FLUORINE CHEM, V38, P435, DOI 10.1016/S0022-1139(00)81078-7; GUNGOR T, 1981, J ORGANOMET CHEM, V215, P139, DOI 10.1016/S0022-328X(00)80124-2; Honda T, 2003, HETEROCYCLES, V59, P169, DOI 10.3987/COM-02-S11; KAUFFMANN T, 1983, CHEM BER-RECL, V116, P992, DOI 10.1002/cber.19831160316; Kirsch P., 2004, MODERN FLUOROORGANIC; KISELYOV AS, 1994, SYNTHETIC COMMUN, V24, P2387, DOI 10.1080/00397919408019063; Kling A, 2003, BIOORGAN MED CHEM, V11, P1319, DOI 10.1016/S0968-0896(02)00616-8; Kraikivskii PB, 2012, J ORGANOMET CHEM, V715, P43, DOI 10.1016/j.jorganchem.2012.05.035; Kraikivskii PB, 2011, J ORGANOMET CHEM, V696, P3376, DOI 10.1016/j.jorganchem.2011.07.022; Kraikivskii PB, 2009, J ORGANOMET CHEM, V694, P3912, DOI 10.1016/j.jorganchem.2009.08.010; Kuduk SD, 2005, ORG LETT, V7, P577, DOI 10.1021/ol047688v; Leahy DK, 2012, ORG PROCESS RES DEV, V16, P244, DOI 10.1021/op2003634; LOUPY A, 1991, HETEROCYCLES, V32, P1947, DOI 10.3987/COM-91-5819; MCGILL CK, 1988, ADV HETEROCYCL CHEM, V44, P1, DOI 10.1016/S0065-2725(08)60261-5; MEINERT H, 1965, Z CHEM, V5, P64; MINISCI F, 1989, HETEROCYCLES, V28, P489, DOI 10.3987/REV-88-SR1; Nagib DA, 2011, NATURE, V480, P224, DOI 10.1038/nature10647; O'Hara F, 2013, J AM CHEM SOC, V135, P12122, DOI 10.1021/ja406223k; PIERS E, 1974, CAN J CHEM, V52, P3563, DOI 10.1139/v74-532; SCHROEDER H, 1962, J ORG CHEM, V27, P2580, DOI 10.1021/jo01054a066; Simons J. H., 1948, U.S. Patent, Patent No. [2,447,717, 2447717]; Sun H, 2006, ANGEW CHEM INT EDIT, V45, P2720, DOI 10.1002/anie.200504555; Thomas S, 2003, ORG LETT, V5, P3867, DOI 10.1021/ol035430j; Umemoto T, 1996, J FLUORINE CHEM, V77, P161, DOI 10.1016/0022-1139(96)03402-1; UMEMOTO T, 1989, J ORG CHEM, V54, P1726, DOI 10.1021/jo00268a041; UMEMOTO T, 1987, TETRAHEDRON LETT, V28, P2705, DOI 10.1016/S0040-4039(00)96186-0; VANDERPUY M, 1987, TETRAHEDRON LETT, V28, P255, DOI 10.1016/S0040-4039(00)95700-9; Wittman MD, 2009, J MED CHEM, V52, P7360, DOI 10.1021/jm900786r; ZWEIG A, 1980, J ORG CHEM, V45, P3597, DOI 10.1021/jo01306a011	40	170	175	3	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					956	960		10.1126/science.1243759	http://dx.doi.org/10.1126/science.1243759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264986				2022-12-24	WOS:000327223500037
J	Mack, MJ; Brennan, JM; Brindis, R; Carroll, J; Edwards, F; Grover, F; Shahian, D; Tuzcu, EM; Peterson, ED; Rumsfeld, JS; Hewitt, K; Shewan, C; Michaels, J; Christensen, B; Christian, A; O'Brien, S; Holmes, D				Mack, Michael J.; Brennan, J. Matthew; Brindis, Ralph; Carroll, John; Edwards, Fred; Grover, Fred; Shahian, David; Tuzcu, E. Murat; Peterson, Eric D.; Rumsfeld, John S.; Hewitt, Kathleen; Shewan, Cynthia; Michaels, Joan; Christensen, Barb; Christian, Alexander; O'Brien, Sean; Holmes, David		STS ACC TVT Registry	Outcomes Following Transcatheter Aortic Valve Replacement in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							END-POINT DEFINITIONS; MEDICAL DEVICES; IMPLANTATION; SURVEILLANCE; REGISTRY; STENOSIS	IMPORTANCE Transcatheter aortic valve replacement (TAVR) was approved by the US Food and Drug Administration for the treatment of severe, symptomatic aortic stenosis and inoperable status (in 2011) and high-risk but operable status (starting in 2012). A national registry (the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy [STS/ACC TVT] Registry) was initiated to meet a condition for Medicare coverage and also facilitates outcome assessment and comparison with other trials and international registries. OBJECTIVE To report the initial US commercial experience with TAVR. DESIGN, SETTING, AND PARTICIPANTS We obtained results from all eligible US TAVR cases (n=7710) from 224 participating registry hospitals following the Edwards Sapien XT device commercialization (November 2011-May 2013). MAIN OUTCOMES AND MEASURES Primary outcomes included all-cause in-hospital mortality and stroke following TAVR. Secondary analyses included procedural complications and outcomes by clinical indication and access site. Device implantation success was defined as successful vascular access, deployment of a single device in the proper anatomic position, appropriate valve function without either moderate or severe AR, and successful retrieval of the delivery system. Thirty-day outcomes are presented for a representative 3133 cases (40.6%) at 114 centers with at least 80% complete follow-up reporting. RESULTS The 7710 patients who underwent TAVR included 1559 (20%) cases that were inoperable and 6151 (80%) cases that were high-risk but operable. The median age was 84 years (interquartile range [IQR], 78-88 years); 3783 patients (49%) were women and the median STS predicted risk of mortality was 7% (IQR, 5%-11%). At baseline, 2176 patients (75%) were either not at all satisfied (1297 patients [45%]) or mostly dissatisfied (879 patients [30%]) with their symptom status; 2198 (72%) had a 5-m walk time longer than 6 seconds (slow gait speed). The most common vascular access approach was transfemoral (4972 patients [64%]), followed by transapical (2197 patients [29%]) and other alternative approaches (536 patients [7%]); successful device implantation occurred in 7069 patients (92%; 95% CI, 91%-92%). The observed incidence of in-hospital mortality was 5.5% (95% CI, 5.0%-6.1%). Other major complications included stroke (2.0%; 95% CI, 1.7%-2.4%), dialysis-dependent renal failure (1.9%; 95% CI, 1.6%-2.2%), and major vascular injury (6.4%; 95% CI, 5.8%-6.9%). Median hospital stay was 6 days (IQR, 4-10 days), with 4613 (63%) discharged home. Among patients with available follow-up at 30 days (n=3133), the incidence of mortality was 7.6% (95% CI, 6.7%-8.6%) (noncardiovascular cause, 52%); a stroke had occurred in 2.8% (95% CI, 2.3%-3.5%), new dialysis in 2.5% (95% CI, 2.0%-3.1%), and reintervention in 0.5% (95% CI, 0.3%-0.8%). CONCLUSIONS AND RELEVANCE Among patients undergoing TAVR at US centers in the STS/ACC TVT Registry, device implantation success was achieved in 92% of cases, the overall in-hospital mortality rate was 5.5%, and the stroke rate was 2.0%. Although these postmarket US approval findings are comparable with prior published trial data and international experience, long-term follow-up is essential to assess continued efficacy and safety.	[Mack, Michael J.] Heart Hosp Baylor Plano, Baylor Healthcare Syst, Plano, TX USA; [Brennan, J. Matthew; Peterson, Eric D.; Christensen, Barb; O'Brien, Sean] Duke Clin Res Inst, Durham, NC USA; [Brindis, Ralph] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Carroll, John; Grover, Fred; Rumsfeld, John S.] Univ Colorado, Denver, CO 80202 USA; [Edwards, Fred] Univ Florida, Jacksonville, FL USA; [Shahian, David] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Tuzcu, E. Murat] Cleveland Clin, Cleveland, OH 44106 USA; [Hewitt, Kathleen; Michaels, Joan; Christensen, Barb] Amer Coll Cardiol, Washington, DC USA; [Shewan, Cynthia] Soc Thorac Surg, Chicago, IL USA; [Holmes, David] Mayo Clin, Rochester, MN USA	Baylor Health Care System; Duke University; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Denver; State University System of Florida; University of Florida; Harvard University; Massachusetts General Hospital; Cleveland Clinic Foundation; American College of Cardiology; Society of Thoracic Surgeons; Mayo Clinic	Mack, MJ (corresponding author), Baylor Hlth Care Syst, 1100 Allied Dr, Plano, TX 75093 USA.	michael.mack@baylorhealth.edu	Peterson, Eric David/ABF-5033-2021; Doğan, Ali/AAN-5331-2020		American College of Cardiology Foundation; Society of Thoracic Surgeons	American College of Cardiology Foundation(General Electric); Society of Thoracic Surgeons	This study was funded by the American College of Cardiology Foundation and the Society of Thoracic Surgeons.	American College of Cardiology; Society of Thoracic Surgeons, ACC STS TVT REG DAT; American College of Cardiology; Society of Thoracic Surgeons, ACC STS TVT REG NCDR; Cardiac Interventions Today, 2013, CARDIAC INTERVE 0923; Carroll JD, 2013, J AM COLL CARDIOL, V62, P1026, DOI 10.1016/j.jacc.2013.03.060; Centers for Medicare and Medicaid Services, NAT COV DET NCD TRAN; Department of Health and Human Services, 2011, CORR REG PREM APPR A; Garin O, 2014, HEART FAIL REV, V19, P359, DOI 10.1007/s10741-013-9394-7; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Hamm CW, 2013, EUR HEART J, DOI 10.1093/eurheart/eht381; Hauser RG, 2012, NEW ENGL J MED, V366, P873, DOI 10.1056/NEJMp1114695; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1016/j.jacc.2012.09.001, 10.1093/ejcts/ezs533]; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Resnic FS, 2012, NEW ENGL J MED, V366, P875, DOI 10.1056/NEJMp1114865; Rumsfeld JS, 2010, JAMA-J AM MED ASSOC, V304, P2065, DOI 10.1001/jama.2010.1648; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Society of Thoracic Surgeons, ONL STS RISK CALC; Thomas M, 2010, CIRCULATION, V122, P62, DOI 10.1161/CIRCULATIONAHA.109.907402; U.S. Food and Drug Administration, 2012, FDA EXP APPR US SAP; US Food and Drug Administration, 2012, STRENGTH NAT SYST ME; Wilson Christopher M, 2013, Cardiopulm Phys Ther J, V24, P36	22	364	373	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2069	2077		10.1001/jama.2013.282043	http://dx.doi.org/10.1001/jama.2013.282043			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240934	Bronze			2022-12-24	WOS:000327098900023
J	Cannon, B				Cannon, Bill			SENSATION AND LOSS	NATURE			English	Editorial Material																			0	7	7	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S2	S3		10.1038/503S2a	http://dx.doi.org/10.1038/503S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24227004	Bronze			2022-12-24	WOS:000326894200002
J	Williams, CL; Bunch, KJ; Stiller, CA; Murphy, MFG; Botting, BJ; Wallace, WH; Davies, M; Sutcliffe, AG				Williams, Carrie L.; Bunch, Kathryn J.; Stiller, Charles A.; Murphy, Michael F. G.; Botting, Beverley J.; Wallace, W. Hamish; Davies, Melanie; Sutcliffe, Alastair G.			Cancer Risk among Children Born after Assisted Conception	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; IN-VITRO FERTILIZATION; CHILDHOOD-CANCER; DNA METHYLATION; REPRODUCTIVE TECHNOLOGIES; EPIGENETIC ALTERATIONS; TWINS; IVF; SINGLETONS; DISORDERS	BackgroundAccurate population-based data are needed on the incidence of cancer in children born after assisted conception. MethodsWe linked data on all children born in Britain between 1992 and 2008 after assisted conception without donor involvement with data from the United Kingdom National Registry of Childhood Tumours to determine the number of children in whom cancer developed before 15 years of age. Cohort cancer rates were compared with population-based rates in Britain over the same period, with stratification for potential mediating and moderating factors, including sex, age at diagnosis, birth weight, singleton versus multiple birth, parity, parental age, type of assisted conception, and cause of parental infertility. ResultsThe cohort consisted of 106,013 children born after assisted conception (700,705 person-years of observation). The average duration of follow-up was 6.6 years. Overall, 108 cancers were identified, as compared with 109.7 expected cancers (standardized incidence ratio, 0.98; 95% confidence interval [CI], 0.81 to 1.19; P=0.87). Assisted conception was not associated with an increased risk of leukemia, neuroblastoma, retinoblastoma, central nervous system tumors, or renal or germ-cell tumors. It was associated with an increased risk of hepatoblastoma (standardized incidence ratio, 3.64; 95% CI, 1.34 to 7.93; P=0.02; absolute excess risk, 6.21 cases per 1 million person-years) and rhabdomyosarcoma (standardized incidence ratio, 2.62; 95% CI, 1.26 to 4.82; P=0.02; absolute excess risk, 8.82 cases per 1 million person-years), with hepatoblastoma developing in 6 children and rhabdomyosarcoma in 10 children. The excess risk of hepatoblastoma was associated with low birth weight. ConclusionsThere was no increase in the overall risk of cancer among British children born after assisted conception during the 17-year study period. Increased risks of hepatoblastoma and rhabdomyosarcoma were detected, but the absolute risks were small. (Funded by Cancer Research UK and others.)	[Williams, Carrie L.; Botting, Beverley J.; Sutcliffe, Alastair G.] UCL, Inst Child Hlth, London WC1N 1EH, England; [Davies, Melanie] Univ Coll London Hosp, Reprod Med Unit, London, England; [Bunch, Kathryn J.; Stiller, Charles A.; Murphy, Michael F. G.] Univ Oxford, Childhood Canc Res Grp, Dept Paediat, Oxford, England; [Wallace, W. Hamish] Univ Edinburgh, Royal Hosp Sick Children, Dept Paediat Oncol, Edinburgh, Midlothian, Scotland	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Oxford; University of Edinburgh	Sutcliffe, AG (corresponding author), UCL, Inst Child Hlth, Gen & Adolescent Paediat Unit, 30 Guilford St, London WC1N 1EH, England.	a.sutcliffe@ucl.ac.uk		Davies, Melanie/0000-0001-6907-5527; wallace, william, hamish/0000-0001-8080-5674; Sutcliffe, Alastair/0000-0001-8542-6155; Stiller, Charles/0000-0002-3006-7869	Cancer Research UK; Cancer Research UK [16874, 11704] Funding Source: researchfish; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [DRF-2011-04-148] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Cancer Research UK and others	Adamson GD, 2012, HUM REPROD S2, V27, pii38; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Bruinsma F, 2000, HUM REPROD, V15, P604, DOI 10.1093/humrep/15.3.604; Chen SL, 2010, FERTIL STERIL, V94, P2356, DOI 10.1016/j.fertnstert.2010.01.120; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; Gicquel C, 2003, AM J HUM GENET, V72, P1338, DOI 10.1086/374824; Halliday J, 2004, AM J HUM GENET, V75, P526, DOI 10.1086/423902; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Hiura H, 2012, HUM REPROD, V27, P2541, DOI 10.1093/humrep/des197; Kallen B, 2010, PEDIATRICS, V126, pE270, DOI 10.1542/peds.2009-3225; Katagiri Y, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/437528; Katari S, 2009, HUM MOL GENET, V18, P3769, DOI 10.1093/hmg/ddp319; Klip H, 2003, HUM REPROD, V18, P1951, DOI 10.1093/humrep/deg358; Kroll ME, 2011, BRIT J CANCER, V104, P1227, DOI 10.1038/bjc.2011.70; Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62; Maher ER, 2003, HUM REPROD, V18, P2508, DOI 10.1093/humrep/deg486; McDonald SD, 2010, EUR J OBSTET GYN R B, V148, P105, DOI 10.1016/j.ejogrb.2009.09.019; McLaughlin CC, 2006, AM J EPIDEMIOL, V163, P818, DOI 10.1093/aje/kwj104; Murphy MFG, 2008, PEDIATR BLOOD CANCER, V51, P62, DOI 10.1002/pbc.21479; Office for National Statistics, 2011, INT LIF TABL UK 1980; Pinborg A, 2004, HUM REPROD, V19, P435, DOI 10.1093/humrep/deh063; Puumala SE, 2012, HUM REPROD, V27, P1649, DOI 10.1093/humrep/des109; Puumala SE, 2009, CANCER EPIDEM BIOMAR, V18, P162, DOI 10.1158/1055-9965.EPI-08-0660; Raimondi S, 2005, BRIT J CANCER, V93, P1053, DOI 10.1038/sj.bjc.6602838; Santos F, 2010, HUM REPROD, V25, P2387, DOI 10.1093/humrep/deq151; Schieve LA, 2004, OBSTET GYNECOL, V103, P1154, DOI 10.1097/01.AOG.0000124571.04890.67; Spector LG, 2008, BRIT J CANCER, V98, P1570, DOI 10.1038/sj.bjc.6604335; Spector LG, 2009, PEDIATRICS, V124, P96, DOI 10.1542/peds.2008-3069; StataCorp, 2019, STATA STAT SOFTWARE; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Sutcliffe AG, 1995, HUM REPROD, V10, P3332, DOI 10.1093/oxfordjournals.humrep.a135915; Sutcliffe AG, 2007, LANCET, V370, P351, DOI 10.1016/S0140-6736(07)60456-5; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; Williams C, 2011, ARCH DIS CHILD S, V96, pA6; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343	38	71	74	4	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1819	1827		10.1056/NEJMoa1301675	http://dx.doi.org/10.1056/NEJMoa1301675			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24195549				2022-12-24	WOS:000326607800010
J	Chung, HS; Eaton, WA				Chung, Hoi Sung; Eaton, William A.			Single-molecule fluorescence probes dynamics of barrier crossing	NATURE			English	Article							SOLVENT VISCOSITY; INTERNAL-FRICTION; FOLDING RATES; PROTEIN; DEPENDENCE; KINETICS; STATES; FORCE; MODEL	Kramers developed the theory on how chemical reaction rates are influenced by the viscosity of the medium(1,2). At the viscosity of water, the kinetics of unimolecular reactions are described by diffusion of a Brownian particle over a free-energy barrier separating reactants and products. For reactions in solution this famous theory extended Eyring's transition state theory, and is widely applied in physics, chemistry and biology, including to reactions as complex as protein folding(3,4). Because the diffusion coefficient of Kramers' theory is determined by the dynamics in the sparsely populated region of the barrier top, its properties have not been directly measured for any molecular system. Here we show that the Kramers diffusion coefficient and free-energy barrier can be characterized by measuring the temperature- and viscosity-dependence of the transition path time for protein folding. The transition path is the small fraction of an equilibrium trajectory for a single molecule when the free-energy barrier separating two states is actually crossed. Its duration, the transition path time, can now be determined from photon trajectories for single protein molecules undergoing folding/unfolding transitions(5). Our finding of a long transition path time with an unusually small solvent viscosity dependence suggests that internal friction as well as solvent friction determine the Kramers diffusion coefficient for alpha-helical proteins, as opposed to a breakdown of his theory, which occurs for many small-molecule reactions(2). It is noteworthy that the new and fundamental information concerning Kramers' theory and the dynamics of barrier crossings obtained here come from experiments on a protein rather than a much simpler chemical or physical system.	[Chung, Hoi Sung; Eaton, William A.] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chung, HS (corresponding author), NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.	chunghoi@niddk.nih.gov; eaton@helix.nih.gov	Chung, Hoi Sung/C-2624-2009	Chung, Hoi Sung/0000-0001-6897-4969	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029055] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are particularly indebted to J. M. Louis for the preparation, dye labelling and purification of the protein used in this work, with technical assistance from A. Aniana. We also thank R. Best, G. Hummer and A. Szabo for discussions and comments on the manuscript, and D. E. Shaw Research for providing access to their molecular dynamics trajectories for the calculations by R. Best. This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Benninger RKP, 2006, ANAL CHEM, V78, P2272, DOI 10.1021/ac051990f; Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; BRYNGELSON JD, 1989, J PHYS CHEM-US, V93, P6902, DOI 10.1021/j100356a007; Cellmer T, 2008, P NATL ACAD SCI USA, V105, P18320, DOI 10.1073/pnas.0806154105; Chung HS, 2013, CHEM PHYS, V422, P229, DOI 10.1016/j.chemphys.2012.08.005; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Chung HS, 2011, J PHYS CHEM A, V115, P3642, DOI 10.1021/jp1009669; Chung HS, 2009, P NATL ACAD SCI USA, V106, P11837, DOI 10.1073/pnas.0901178106; Eaton W. A., P NATL ACAD IN PRESS; Godoy-Ruiz R, 2008, J PHYS CHEM B, V112, P5938, DOI 10.1021/jp0757715; Gopich IV, 2009, J PHYS CHEM B, V113, P10965, DOI 10.1021/jp903671p; Hagen SJ, 2010, CURR PROTEIN PEPT SC, V11, P385; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hummer G, 2005, ACCOUNTS CHEM RES, V38, P504, DOI 10.1021/ar040148d; Hummer G, 2004, J CHEM PHYS, V120, P516, DOI 10.1063/1.1630572; Jas GS, 2001, J PHYS CHEM B, V105, P261, DOI 10.1021/jp0022048; Klimov DK, 1997, PHYS REV LETT, V79, P317, DOI 10.1103/PhysRevLett.79.317; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kubelka J, 2008, P NATL ACAD SCI USA, V105, P18655, DOI 10.1073/pnas.0808600105; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Liu F, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3077008; Makarov DE, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4773283; Merchant KA, 2007, P NATL ACAD SCI USA, V104, P1528, DOI 10.1073/pnas.0607097104; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Portman JJ, 2001, J CHEM PHYS, V114, P5082, DOI 10.1063/1.1334663; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Schulz JCF, 2012, J AM CHEM SOC, V134, P6273, DOI 10.1021/ja211494h; Socci ND, 1996, J CHEM PHYS, V104, P5860, DOI 10.1063/1.471317; Soranno A, 2012, P NATL ACAD SCI USA, V109, P17800, DOI 10.1073/pnas.1117368109; Sutto L, 2007, P NATL ACAD SCI USA, V104, P19825, DOI 10.1073/pnas.0709922104; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wensley BG, 2010, NATURE, V463, P685, DOI 10.1038/nature08743; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609; Zagrovic B, 2003, J COMPUT CHEM, V24, P1432, DOI 10.1002/jcc.10297; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P15486, DOI 10.1073/pnas.2136623100	38	169	169	2	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					685	+		10.1038/nature12649	http://dx.doi.org/10.1038/nature12649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24153185	Green Accepted			2022-12-24	WOS:000326293200048
J	Auyeung, E; Li, TING; Senesi, AJ; Schmucker, AL; Pals, BC; de la Cruz, MO; Mirkin, CA				Auyeung, Evelyn; Li, Ting I. N. G.; Senesi, Andrew J.; Schmucker, Abrin L.; Pals, Bridget C.; de la Cruz, Monica Olvera; Mirkin, Chad A.			DNA-mediated nanoparticle crystallization into Wulff polyhedra	NATURE			English	Article							SUPERLATTICES; EVOLUTION; GROWTH; SHAPE; SIZE	Crystallization is a fundamental and ubiquitous process much studied over the centuries. But although the crystallization of atoms is fairly well understood(1,2), it remains challenging to predict reliably the outcome of molecular crystallization processes that are complicated by various molecular interactions and solvent involvement. This difficulty also applies to nanoparticles: high-quality three-dimensional crystals(3-6) are mostly produced using drying and sedimentation techniques that are often impossible to rationalize and control to give a desired crystal symmetry, lattice spacing and habit (crystal shape). In principle, DNA-mediated assembly of nanoparticles offers an ideal opportunity for studying nanoparticle crystallization(7-17): a well-defined set of rules have been developed to target desired lattice symmetries and lattice constants(8,9,18), and the occurrence of features such as grain boundaries and twinning in DNA superlattices and traditional crystals comprised of molecular or atomic building blocks suggests that similar principles govern their crystallization. But the presence of charged biomolecules, interparticle spacings of tens of nanometres, and the realization so far of only polycrystalline DNA-interconnected nanoparticle superlattices, all suggest that DNA-guided crystallization may differ from traditional crystal growth. Here we show that very slow cooling, over several days, of solutions of complementary-DNA-modified nanoparticles through the melting temperature of the system gives the thermodynamic product with a specific and uniform crystal habit. We find that our nanoparticle assemblies have the Wulff equilibrium crystal structure that is predicted from theoretical considerations and molecular dynamics simulations, thus establishing that DNA hybridization can direct nanoparticle assembly along a pathway that mimics atomic crystallization.	[Auyeung, Evelyn; Li, Ting I. N. G.; de la Cruz, Monica Olvera; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Auyeung, Evelyn; Li, Ting I. N. G.; Senesi, Andrew J.; Schmucker, Abrin L.; Pals, Bridget C.; de la Cruz, Monica Olvera; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Senesi, Andrew J.; Schmucker, Abrin L.; de la Cruz, Monica Olvera; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.	chadnano@northwestern.edu	de la Cruz, Monica Olvera/X-2039-2019; Schmucker, Abrin L/A-7426-2010; de la Cruz, Monica Olvera/N-6359-2018; Mirkin, Chad A/E-3911-2010	de la Cruz, Monica Olvera/0000-0002-9802-3627; Li, Ting/0000-0002-0778-6371; Mirkin, Chad/0000-0002-6634-7627; Schmucker, Abrin/0000-0002-3534-2145	Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiative (MURI) [FA9550-11-1-0275]; National Science Foundation Materials Research Science and Engineering Center at the Materials Research Center of Northwestern University [DMR-1121262]; Non-equilibrium Energy Research Center (NERC), an Energy Frontier Research Center; Department of Energy (DoE), Office of Science, Office of Basic Energy Sciences [DE-SC0000989]; National Defense Science and Engineering Graduate (NDSEG) Fellowship [32 CFR 168a]; Ryan Fellowship from Northwestern University; DoE [DE-AC02-06CH11357]; US Department of Defense National Security Science and Engineering Faculty Fellowship [FA9550-10-1-0167]; Direct For Mathematical & Physical Scien [1121262] Funding Source: National Science Foundation	Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiative (MURI)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); National Science Foundation Materials Research Science and Engineering Center at the Materials Research Center of Northwestern University; Non-equilibrium Energy Research Center (NERC), an Energy Frontier Research Center(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Department of Energy (DoE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Defense Science and Engineering Graduate (NDSEG) Fellowship; Ryan Fellowship from Northwestern University; DoE(United States Department of Energy (DOE)); US Department of Defense National Security Science and Engineering Faculty Fellowship; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	C. A. M. and M.O.d.l.C. acknowledge support from the following awards: the Air Force Office of Scientific Research (AFOSR) Multidisciplinary University Research Initiative (MURI) FA9550-11-1-0275, the National Science Foundation Materials Research Science and Engineering Center programme DMR-1121262 at the Materials Research Center of Northwestern University, and the Non-equilibrium Energy Research Center (NERC), an Energy Frontier Research Center funded by the Department of Energy (DoE), Office of Science, Office of Basic Energy Sciences under Award DE-SC0000989. E. A. acknowledges a National Defense Science and Engineering Graduate (NDSEG) Fellowship (number 32 CFR 168a). T. L. acknowledges a Ryan Fellowship from Northwestern University. T. L. thanks S. Dhakal and K. Kohlstedt for sharing scripts on the colloid model and S. Patala and J. Zwanikken for discussions. SAXS experiments were carried out at the Dupont-Northwestern-Dow Collaborative Access Team beam line at the Advanced Photon Source (APS) at Argonne National Laboratory, and use of the APS was supported by the DoE (DE-AC02-06CH11357). The electron microscopy work was performed at the Electron Probe Instrumentation Center of the NU Atomic and Nanoscale Characterization Experimental Center at Northwestern University. The computational work was performed using the TARDIS computer cluster supported by the US Department of Defense National Security Science and Engineering Faculty Fellowship (number FA9550-10-1-0167).	Abrosimov NV, 1997, J CRYST GROWTH, V174, P182, DOI 10.1016/S0022-0248(96)01102-5; Auyeung E, 2012, ADV MATER, V24, P5181, DOI 10.1002/adma.201202069; Auyeung E, 2012, NAT NANOTECHNOL, V7, P24, DOI [10.1038/nnano.2011.222, 10.1038/NNANO.2011.222]; Che JG, 1998, PHYS REV B, V57, P1875, DOI 10.1103/PhysRevB.57.1875; Compton OC, 2007, J AM CHEM SOC, V129, P7793, DOI 10.1021/ja069033q; Cutler JI, 2012, J AM CHEM SOC, V134, P1376, DOI 10.1021/ja209351u; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Knorowski C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215501; Li TING, 2013, J AM CHEM SOC, V135, P8535, DOI 10.1021/ja312644h; Li TING, 2012, NANO LETT, V12, P2509, DOI 10.1021/nl300679e; Macfarlane RJ, 2013, SCIENCE, V341, P1222, DOI 10.1126/science.1241402; Macfarlane RJ, 2013, ANGEW CHEM INT EDIT, V52, P5688, DOI 10.1002/anie.201209336; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Macfarlane RJ, 2010, ANGEW CHEM INT EDIT, V49, P4589, DOI 10.1002/anie.201000633; MACKENZIE JK, 1962, J PHYS CHEM SOLIDS, V23, P185, DOI 10.1016/0022-3697(62)90001-X; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nagaoka Y, 2012, J AM CHEM SOC, V134, P2868, DOI 10.1021/ja209062d; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Rupich SM, 2010, J AM CHEM SOC, V132, P289, DOI 10.1021/ja9074425; Senesi AJ, 2013, ANGEW CHEM INT EDIT, V52, P6624, DOI 10.1002/anie.201301936; SUNDQUIST BE, 1964, ACTA METALL MATER, V12, P67, DOI 10.1016/0001-6160(64)90055-0; Wang T, 2013, CHEM SOC REV, V42, P2804, DOI 10.1039/c2cs35318k; Wulff G, 1901, Z KRYSTALLOGR MINERA, V34, P449, DOI 10.1524/zkri.1901.34.1.449; Xia YN, 2009, ANGEW CHEM INT EDIT, V48, P60, DOI 10.1002/anie.200802248; Zhang C, 2013, NAT MATER, V12, P741, DOI [10.1038/NMAT3647, 10.1038/nmat3647]; Zwanikken JW, 2011, J PHYS CHEM C, V115, P16368, DOI 10.1021/jp205583j	28	311	314	22	538	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					73	77		10.1038/nature12739	http://dx.doi.org/10.1038/nature12739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24284632				2022-12-24	WOS:000329163300026
J	Boskovski, MT; Yuan, SAL; Pedersen, NB; Goth, CK; Makova, S; Clausen, H; Brueckner, M; Khokha, MK				Boskovski, Marko T.; Yuan, Shiaulou; Pedersen, Nis Borbye; Goth, Christoffer Knak; Makova, Svetlana; Clausen, Henrik; Brueckner, Martina; Khokha, Mustafa K.			The heterotaxy gene GALNT11 glycosylates Notch to orchestrate cilia type and laterality	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; CONGENITAL HEART-DISEASE; LEFT-RIGHT AXIS; LEFTWARD FLOW; O-GLYCOSYLATION; FLUID-FLOW; XENOPUS EMBRYOS; NODE; PROTEIN; MOUSE	Heterotaxy is a disorder of left-right body patterning, or laterality, that is associated with major congenital heart disease(1). The aetiology and mechanisms underlying most cases of human heterotaxy are poorly understood. In vertebrates, laterality is initiated at the embryonic left-right organizer, where motile cilia generate leftward flow that is detected by immotile sensory cilia, which transduce flow into downstream asymmetric signals(2-6). The mechanism that specifies these two cilia types remains unknown. Here we show that the N-acetylgalactosamine-type O-glycosylation enzyme GALNT11 is crucial to such determination. We previously identified GALNT11 as a candidate disease gene in a patient with heterotaxy(7), and now demonstrate, in Xenopus tropicalis, that galnt11 activates Notch signalling. GALNT11 O-glycosylates human NOTCH1 peptides in vitro, thereby supporting a mechanism of Notch activation either by increasing ADAM17-mediated ectodomain shedding of the Notch receptor or by modification of specific EGF repeats. We further developed a quantitative live imaging technique for Xenopus left-right organizer cilia and show that Galnt11-mediated Notch1 signalling modulates the spatial distribution and ratio of motile and immotile cilia at the left-right organizer. galnt11 or notch1 depletion increases the ratio of motile cilia at the expense of immotile cilia and produces a laterality defect reminiscent of loss of the ciliary sensor Pkd2. By contrast, Notch overexpression decreases this ratio, mimicking the ciliopathy primary ciliary dyskinesia. Together our data demonstrate that Galnt11 modifies Notch, establishing an essential balance between motile and immotile cilia at the left-right organizer to determine laterality, and reveal a novel mechanism for human heterotaxy.	[Boskovski, Marko T.; Yuan, Shiaulou; Makova, Svetlana; Brueckner, Martina; Khokha, Mustafa K.] Yale Univ, Sch Med, Dept Pediat & Genet, Program Vertebrate Dev Biol, New Haven, CT 06520 USA; [Pedersen, Nis Borbye; Goth, Christoffer Knak; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, DK-2200 Copenhagen N, Denmark	Yale University; University of Copenhagen	Khokha, MK (corresponding author), Yale Univ, Sch Med, Dept Pediat & Genet, Program Vertebrate Dev Biol, 333 Cedar St, New Haven, CT 06520 USA.	mustafa.khokha@yale.edu	Borbye-Lorenzen, Nis/J-6369-2014; clausen, henrik/AAD-8016-2021	Borbye-Lorenzen, Nis/0000-0003-3725-4533; Goth, Christoffer/0000-0002-5766-1411; Yuan, Shiaulou/0000-0002-5061-6132; Clausen, Henrik/0000-0002-0915-5055	National Center for Research Resources/National Institutes of Health (NIH) [TL 1 RR024137]; NIH Roadmap for Medical Research; NIH [5T32HD00709436, R01HL093280, DE018825, DE018824]; Danish National Research Foundation [DNRF107]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024137] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018825, R01DE018824] Funding Source: NIH RePORTER	National Center for Research Resources/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Foundation(Danmarks Grundforskningsfond); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the patients and their families, who are the inspiration for this study. We thank S. Kubek and M. Slocum for animal husbandry. We thank U. Mandel, M. Vester-Christensen, T. D. Madsen and S. B. Levery for help with generation of polyclonal antibodies, recombinant GALNT enzymes, in vitro glycosylation experiments and mass spectrometry. Thanks to the Center for Cellular and Molecular Imaging at Yale for assistance with SEM/TEM (C. Rahner and M. Graham) and confocal imaging. Thanks to C. Kintner and Z. Sun for reagents. Thanks to R. Harland, K. Liem, R. Lifton, J. McGrath, A. Horwich and Z. Sun for critical reading of the manuscript. M. T. B. was supported by grant number TL 1 RR024137 from the National Center for Research Resources/National Institutes of Health (NIH) and NIH Roadmap for Medical Research. S.Y. was supported by NIH training grant 5T32HD00709436. This work was supported by NIH R01HL093280 to M. B. and NIH DE018825, DE018824 to M. K. K., and the Danish National Research Foundation (DNRF107) to H.C.	Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bisgrove BW, 2012, DEV BIOL, V363, P166, DOI 10.1016/j.ydbio.2011.12.030; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chung MI, 2012, DEV BIOL, V363, P155, DOI 10.1016/j.ydbio.2011.12.029; Deblandre GA, 1999, DEVELOPMENT, V126, P4715; del Viso Florencia, 2012, Methods Mol Biol, V917, P33, DOI 10.1007/978-1-61779-992-1_3; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Kamura K, 2011, DEVELOPMENT, V138, P1121, DOI 10.1242/dev.058271; Kato Y, 2011, CELL MOL LIFE SCI, V68, P2555, DOI 10.1007/s00018-011-0695-5; Khokha MK, 2002, DEV DYNAM, V225, P499, DOI 10.1002/dvdy.10184; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Krebs LT, 2003, GENE DEV, V17, P1207, DOI 10.1101/gad.1084703; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pedersen JW, 2011, J BIOL CHEM, V286, P32684, DOI 10.1074/jbc.M111.273722; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Rana NA, 2011, CURR OPIN STRUC BIOL, V21, P583, DOI 10.1016/j.sbi.2011.08.008; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Schweickert A, 2010, CURR BIOL, V20, P738, DOI 10.1016/j.cub.2010.02.061; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Shinohara K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1624; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/NMETH.1731, 10.1038/nmeth.1731]; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Sutherland MJ, 2009, AM J MED GENET C, V151C, P307, DOI 10.1002/ajmg.c.30228; Vick P, 2009, DEV BIOL, V331, P281, DOI 10.1016/j.ydbio.2009.05.547; Vonica A, 2007, DEV BIOL, V303, P281, DOI 10.1016/j.ydbio.2006.09.039; Walentek P, 2012, CELL REP, V1, P516, DOI 10.1016/j.celrep.2012.03.005; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Yoshiba S, 2012, SCIENCE, V338, P226, DOI 10.1126/science.1222538; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	40	116	125	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					456	+		10.1038/nature12723	http://dx.doi.org/10.1038/nature12723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24226769	Green Accepted			2022-12-24	WOS:000328575300056
J	Alfandre, D; Schumann, JH				Alfandre, David; Schumann, John Henning			What Is Wrong With Discharges Against Medical Advice (and How to Fix Them)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Alfandre, David] NYU, Sch Med, VA Natl Ctr Eth Hlth Care, New York, NY 10010 USA; [Schumann, John Henning] Univ Oklahoma, Sch Community Med, Dept Internal Med, Tulsa, OK USA	New York University; University of Oklahoma System; University of Oklahoma - Tulsa	Alfandre, D (corresponding author), NYU, Sch Med, VA Natl Ctr Eth Hlth Care, 423 E 23rd St,10P6, New York, NY 10010 USA.	david.alfandre@va.gov		Alfandre, David/0000-0001-9778-7580				Alfandre D, 2013, J GEN INTERN MED, V28, P1657, DOI 10.1007/s11606-013-2540-z; BECKMAN HB, 1994, ARCH INTERN MED, V154, P1365, DOI 10.1001/archinte.154.12.1365; Devitt PJ, 2000, J FAM PRACTICE, V49, P224; Fiscella K, 2007, AM J MED, V120, P1047, DOI 10.1016/j.amjmed.2007.08.024; Glasgow JM, 2010, J GEN INTERN MED, V25, P926, DOI 10.1007/s11606-010-1371-4; Schaefer GR, 2012, J GEN INTERN MED, V27, P825, DOI 10.1007/s11606-012-1984-x; Schumann J., 2012, CAN IGNORING MED ADV	7	19	19	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2393	2394		10.1001/jama.2013.280887	http://dx.doi.org/10.1001/jama.2013.280887			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24216713				2022-12-24	WOS:000328030900014
J	Nelson, ER; Wardell, SE; Jasper, JS; Park, S; Suchindran, S; Howe, MK; Carver, NJ; Pillai, RV; Sullivan, PM; Sondhi, V; Umetani, M; Geradts, J; McDonnell, DP				Nelson, Erik R.; Wardell, Suzanne E.; Jasper, Jeff S.; Park, Sunghee; Suchindran, Sunil; Howe, Matthew K.; Carver, Nicole J.; Pillai, Ruchita V.; Sullivan, Patrick M.; Sondhi, Varun; Umetani, Michihisa; Geradts, Joseph; McDonnell, Donald P.			27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology	SCIENCE			English	Article							STEROL 27-HYDROXYLASE; CHOLESTEROL; ESTROGEN; RISK; PROGRESSION; METABOLISM; INDUCTION; OXYSTEROL; OBESITY; MODEL	Hypercholesterolemia is a risk factor for estrogen receptor (ER)-positive breast cancers and is associated with a decreased response of tumors to endocrine therapies. Here, we show that 27-hydroxycholesterol (27HC), a primary metabolite of cholesterol and an ER and liver X receptor (LXR) ligand, increases ER-dependent growth and LXR-dependent metastasis in mouse models of breast cancer. The effects of cholesterol on tumor pathology required its conversion to 27HC by the cytochrome P450 oxidase CYP27A1 and were attenuated by treatment with CYP27A1 inhibitors. In human breast cancer specimens, CYP27A1 expression levels correlated with tumor grade. In high-grade tumors, both tumor cells and tumor-associated macrophages exhibited high expression levels of the enzyme. Thus, lowering circulating cholesterol levels or interfering with its conversion to 27HC may be a useful strategy to prevent and/or treat breast cancer.	[Nelson, Erik R.; Wardell, Suzanne E.; Jasper, Jeff S.; Park, Sunghee; Howe, Matthew K.; Carver, Nicole J.; Pillai, Ruchita V.; McDonnell, Donald P.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Suchindran, Sunil] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27708 USA; [Sullivan, Patrick M.] Duke Univ, Sch Med, Dept Med, Div Geriatr, Durham, NC 27710 USA; [Sondhi, Varun; Umetani, Michihisa] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Sondhi, Varun; Umetani, Michihisa] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Geradts, Joseph] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University	McDonnell, DP (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	donald.mcdonnell@duke.edu	Umetani, Michi/AAP-3964-2020; Nelson, Erik/U-2697-2019; Nelson, Erik/B-5158-2013	Umetani, Michi/0000-0001-8474-7088; Nelson, Erik/0000-0002-8887-1905; Nelson, Erik/0000-0002-8887-1905; Jasper, Jeff/0000-0003-3941-0018	NIH [K99CA172357, R37DK048807]; U.S. Department of Defense (DOD) [BC085585, DOD BC094960]; NATIONAL CANCER INSTITUTE [K99CA172357, T32CA059365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048807] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense (DOD)(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the NIH [grants K99CA172357 (E.R.N.) and R37DK048807 (D.P.M.)] and the U.S. Department of Defense (DOD) [grants BC085585 (E.R.N.) and DOD BC094960 (D.P.M.)]. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or DOD. Expression profiling data on 27HC in MCF7 cells were uploaded to Gene Expression Omnibus (GEO) (accession no. GSE46924) and were part of a larger study (GEO accession no. GSE35428).	Ahern TP, 2011, JNCI-J NATL CANCER I, V103, P1461, DOI 10.1093/jnci/djr291; Alikhani N, 2013, ONCOGENE, V32, P961, DOI 10.1038/onc.2012.113; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; BOYD NF, 1990, JNCI-J NATL CANCER I, V82, P460, DOI 10.1093/jnci/82.6.460; Capasso I, 2010, CANCER BIOL THER, V10, P1240, DOI 10.4161/cbt.10.12.13473; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Connor CE, 2001, CANCER RES, V61, P2917; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; DuSell CD, 2010, ENDOCRINOLOGY, V151, P3675, DOI 10.1210/en.2010-0080; FERRARONI M, 1993, INT J EPIDEMIOL, V22, P772, DOI 10.1093/ije/22.5.772; Gerber JG, 2005, JAIDS-J ACQ IMM DEF, V39, P307, DOI 10.1097/01.qai.0000167156.44980.33; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hansson M, 2003, BBA-MOL CELL RES, V1593, P283, DOI 10.1016/S0167-4889(02)00398-1; Karuna R, 2011, ATHEROSCLEROSIS, V214, P448, DOI 10.1016/j.atherosclerosis.2010.10.042; Kitahara CM, 2011, J CLIN ONCOL, V29, P1592, DOI 10.1200/JCO.2010.31.5200; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Llaverias G, 2011, AM J PATHOL, V178, P402, DOI 10.1016/j.ajpath.2010.11.005; Lyons MA, 2001, LIPIDS, V36, P701, DOI 10.1007/s11745-001-0775-8; Nelson ER, 2011, ENDOCRINOLOGY, V152, P4691, DOI 10.1210/en.2011-1298; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Renehan Andrew G., 2008, Archives of Physiology and Biochemistry, V114, P71, DOI [10.1080/13813450801954303, 10.1080/13813450801954303 ]; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; Undela K, 2012, BREAST CANCER RES TR, V135, P261, DOI 10.1007/s10549-012-2154-x; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476	26	503	517	11	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1094	1098		10.1126/science.1241908	http://dx.doi.org/10.1126/science.1241908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288332	Green Accepted			2022-12-24	WOS:000327518600057
J	Teufel, R; Miyanaga, A; Michaudel, Q; Stull, F; Louie, G; Noel, JP; Baran, PS; Palfey, B; Moore, BS				Teufel, Robin; Miyanaga, Akimasa; Michaudel, Quentin; Stull, Frederick; Louie, Gordon; Noel, Joseph P.; Baran, Phil S.; Palfey, Bruce; Moore, Bradley S.			Flavin-mediated dual oxidation controls an enzymatic Favorskii-type rearrangement	NATURE			English	Article							DEPENDENT MONOOXYGENASE; CRYSTAL-STRUCTURE; SWISS-MODEL; ENTEROCIN; PROTEIN; OXYGEN; HYDROXYLATION; ENVIRONMENT; MECHANISM; SYNTHASE	Flavoproteins catalyse a diversity of fundamental redox reactions and are one of the most studied enzyme families(1,2). As monooxygenases, they are universally thought to control oxygenation by means of a peroxyflavin species that transfers a single atom of molecular oxygen to an organic substrate(1,3,4). Here we report that the bacterial flavoenzyme EncM(5,6) catalyses the peroxyflavin-independent oxygenation-dehydrogenation dual oxidation of a highly reactive poly(beta-carbonyl). The crystal structure of EncM with bound substrate mimics and isotope labelling studies reveal previously unknown flavin redox biochemistry. We show that EncM maintains an unexpected stable flavin-oxygenating species, proposed to be a flavin-N5-oxide, to promote substrate oxidation and trigger a rare Favorskii-type rearrangement that is central to the biosynthesis of the antibiotic enterocin. This work provides new insight into the fine-tuning of the flavin cofactor in offsetting the innate reactivity of a polyketide substrate to direct its efficient electrocyclization.	[Teufel, Robin; Miyanaga, Akimasa; Moore, Bradley S.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Michaudel, Quentin; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Stull, Frederick; Palfey, Bruce] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA; [Louie, Gordon; Noel, Joseph P.] Salk Inst Biol Studies, Howard Hughes Med Inst, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Palfey, Bruce] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Moore, Bradley S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Scripps Research Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; Salk Institute; University of Michigan System; University of Michigan; University of California System; University of California San Diego	Moore, BS (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.	bsmoore@ucsd.edu	Michaudel, Quentin/F-1678-2018; Michaudel, Quentin/AAE-8261-2020; Miyanaga, Akimasa/C-1472-2015; Noel, Joseph P/A-9459-2009	Michaudel, Quentin/0000-0002-1791-9174; Michaudel, Quentin/0000-0002-1791-9174; Miyanaga, Akimasa/0000-0003-2219-6051; Palfey, Bruce/0000-0001-5098-259X; Teufel, Robin/0000-0001-5863-7248; Moore, Bradley/0000-0002-4652-1253; Stull, Frederick/0000-0002-2969-4224	US National Institutes of Health [R01AI47818]; National Science Foundation (NSF) [EEC-0813570, MCB-0645794, CHE-1213620]; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft [TE 931/1-1]; Japan Society for the Promotion of Science [21-644]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047818] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Bowman for technical assistance; Y. Su for mass spectrometric measurements; D.-H. Huang and L. Pasternack for NMR spectroscopic assistance; A. Rheingold for X-ray crystallographic analysis; and C. Hertweck for establishing the synthesis of 26. This research was supported by US National Institutes of Health grant R01AI47818 to B.S.M., National Science Foundation (NSF) awards EEC-0813570 and MCB-0645794 and the Howard Hughes Medical Institute for grants to J.P.N., NSF grant CHE-1213620 to B.P., and fellowships to R.T. from the Deutsche Forschungsgemeinschaft (TE 931/1-1) and to A.M. from the Japan Society for the Promotion of Science (21-644).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baumann K, 2004, TETRAHEDRON LETT, V45, P549, DOI 10.1016/j.tetlet.2003.10.199; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Cheng Q, 2007, NAT CHEM BIOL, V3, P557, DOI 10.1038/nchembio.2007.22; Crosby J, 2012, NAT PROD REP, V29, P1111, DOI 10.1039/c2np20062g; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENTSCH B, 1989, BIOCHIM BIOPHYS ACTA, V999, P313, DOI 10.1016/0167-4838(89)90014-9; ENTSCH B, 1976, J BIOL CHEM, V251, P2550; Garman EF, 2006, ACTA CRYSTALLOGR D, V62, P32, DOI 10.1107/S0907444905034207; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han L, 1998, J BACTERIOL, V180, P4481, DOI 10.1128/JB.180.17.4481-4486.1998; Hertweck C, 2004, CHEM BIOL, V11, P461, DOI 10.1016/j.chembiol.2004.03.018; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; Izumikawa W, 2006, J AM CHEM SOC, V128, P1428, DOI 10.1021/ja0559707; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kalaitzis JA, 2003, J AM CHEM SOC, V125, P9290, DOI 10.1021/ja035973o; Koetter JWA, 2005, J MOL BIOL, V352, P418, DOI 10.1016/j.jmb.2005.07.041; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ORF HW, 1974, P NATL ACAD SCI USA, V71, P2646, DOI 10.1073/pnas.71.7.2646; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Piel J, 2000, CHEM BIOL, V7, P943, DOI 10.1016/S1074-5521(00)00044-2; RASTETTER WH, 1979, J AM CHEM SOC, V101, P2228, DOI 10.1021/ja00502a063; SETO H, 1976, TETRAHEDRON LETT, P4367; Takikawa H, 2008, ANGEW CHEM INT EDIT, V47, P7446, DOI 10.1002/anie.200801586; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; WALSH C, 1978, BIOCHEMISTRY-US, V17, P1942, DOI 10.1021/bi00603a022; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; Xiang L, 2004, P NATL ACAD SCI USA, V101, P15609, DOI 10.1073/pnas.0405508101	40	102	102	6	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					552	+		10.1038/nature12643	http://dx.doi.org/10.1038/nature12643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24162851	Green Accepted			2022-12-24	WOS:000327464200049
J	Mordwinkin, NM; Lee, AS; Wu, JC				Mordwinkin, Nicholas M.; Lee, Andrew S.; Wu, Joseph C.			Patient-Specific Stem Cells and Cardiovascular Drug Discovery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mordwinkin, Nicholas M.; Lee, Andrew S.; Wu, Joseph C.] Stanford Univ, Stanford Cardiovasc Inst, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Mordwinkin, Nicholas M.; Lee, Andrew S.; Wu, Joseph C.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Wu, JC (corresponding author), Stanford Univ, 265 Campus Dr,Room G1120B, Stanford, CA 94305 USA.	joewu@stanford.edu	Lee, Andrew/GVU-2817-2022; Wu, Joseph/H-1067-2013	Wu, Joseph/0000-0002-6068-8041; Mordwinkin, Nicholas/0000-0002-3019-0170	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393, R01HL113006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009035] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL113006, U01 HL107393] Funding Source: Medline; NIBIB NIH HHS [T32 EB009035] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Abassi YA, 2012, BRIT J PHARMACOL, V165, P1424, DOI 10.1111/j.1476-5381.2011.01623.x; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Ferri N, 2013, PHARMACOL THERAPEUT, V138, P470, DOI 10.1016/j.pharmthera.2013.03.005; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Paul SM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004452; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934	9	30	30	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2039	2040		10.1001/jama.2013.282409	http://dx.doi.org/10.1001/jama.2013.282409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240927	Green Accepted			2022-12-24	WOS:000327098900016
J	Clawson, GA				Clawson, Gary A.			Fusion for Moving	SCIENCE			English	Editorial Material							CIRCULATING TUMOR-CELLS; MESENCHYMAL TRANSITION		[Clawson, Gary A.] Penn State Univ, Gittlen Canc Res Fdn, Dept Pathol, Hershey, PA 17033 USA; [Clawson, Gary A.] Penn State Univ, Milton S Hershey Med Ctr, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Clawson, GA (corresponding author), Penn State Univ, Gittlen Canc Res Fdn, Dept Pathol, Hershey, PA 17033 USA.	gac4@psu.edu			NATIONAL CANCER INSTITUTE [R21CA170121] Funding Source: NIH RePORTER; NCI NIH HHS [CA170121] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bitarte N, 2011, STEM CELLS, V29, P1661, DOI 10.1002/stem.741; Clawson GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041052; Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148; Denz A, 2010, J SURG RES, V160, P29, DOI 10.1016/j.jss.2009.03.048; Funamizu N, 2013, INT J CANCER, V132, P785, DOI 10.1002/ijc.27736; Itakura E, 2011, AM J SURG PATHOL, V35, P1657, DOI 10.1097/PAS.0b013e3182322cf7; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Lazova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066731; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Pavelic SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-22; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Sergeant G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-527; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yuan T, 2013, GENET MOL RES, V12, P6629, DOI [10.4238/2013.January.4.3, 10.4238/2013.Janruary.4.3]	15	31	33	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					699	700		10.1126/science.1244270	http://dx.doi.org/10.1126/science.1244270			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202164				2022-12-24	WOS:000326647600027
J	Xu, C; Tabebordbar, M; Iovino, S; Ciarlo, C; Liu, JX; Castiglioni, A; Price, E; Liu, M; Barton, ER; Kahn, CR; Wagers, AJ; Zon, LI				Xu, Cong; Tabebordbar, Mohammadsharif; Iovino, Salvatore; Ciarlo, Christie; Liu, Jingxia; Castiglioni, Alessandra; Price, Emily; Liu, Min; Barton, Elisabeth R.; Kahn, C. Ronald; Wagers, Amy J.; Zon, Leonard I.			A Zebrafish Embryo Culture System Defines Factors that Promote Vertebrate Myogenesis across Species	CELL			English	Article							MUSCLE STEM-CELLS; SKELETAL-MUSCLE; SATELLITE CELLS; ADENYLATE-CYCLASE; SELF-RENEWAL; CYCLIC-AMP; EXPRESSION; PATHWAY; PROGENITORS; FORSKOLIN	Ex vivo expansion of satellite cells and directed differentiation of pluripotent cells to mature skeletal muscle have proved difficult challenges for regenerative biology. Using a zebrafish embryo culture system with reporters of early and late skeletal muscle differentiation, we examined the influence of 2,400 chemicals on myogenesis and identified six that expanded muscle progenitors, including three GSK3 beta inhibitors, two calpain inhibitors, and one adenylyl cyclase activator, forskolin. Forskolin also enhanced proliferation of mouse satellite cells in culture and maintained their ability to engraft muscle in vivo. A combination of bFGF, forskolin, and the GSK3 beta inhibitor BIO induced skeletal muscle differentiation in human induced pluripotent stem cells (iPSCs) and produced engraftable myogenic progenitors that contributed to muscle repair in vivo. In summary, these studies reveal functionally conserved pathways regulating myogenesis across species and identify chemical compounds that expand mouse satellite cells and differentiate human iPSCs into engraftable muscle.	[Xu, Cong; Ciarlo, Christie; Liu, Jingxia; Price, Emily; Zon, Leonard I.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Xu, Cong; Ciarlo, Christie; Liu, Jingxia; Price, Emily; Zon, Leonard I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Xu, Cong; Tabebordbar, Mohammadsharif; Ciarlo, Christie; Liu, Jingxia; Castiglioni, Alessandra; Price, Emily; Wagers, Amy J.; Zon, Leonard I.] Harvard Stem Cell Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; [Xu, Cong; Tabebordbar, Mohammadsharif; Iovino, Salvatore; Ciarlo, Christie; Liu, Jingxia; Price, Emily; Kahn, C. Ronald; Zon, Leonard I.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Tabebordbar, Mohammadsharif; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Iovino, Salvatore; Castiglioni, Alessandra; Kahn, C. Ronald; Wagers, Amy J.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Castiglioni, Alessandra] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Liu, Min] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Iovino, Salvatore; Wagers, Amy J.] Harvard Univ, Sch Med, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Vita-Salute San Raffaele University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Harvard University; Harvard Medical School	Wagers, AJ (corresponding author), Harvard Stem Cell Inst, Howard Hughes Med Inst, Boston, MA 02115 USA.	amy_wagers@harvard.edu; zon@enders.tch.harvard.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Castiglioni, Alessandra/0000-0002-1761-9761; Xu, Cong/0000-0003-3689-5945	NIH [P30DK036836, DP2OD004345, UO1HL100402, DK31036]; HHMI; NIH NIDDK [R24DK092760-03, 5P30 DK49216-19]; NIH NCI [5R01CA103846-10]; NIH NHLBI [5U01HL10001-05]; Novo Nordisk Diabetes Center in Copenhagen; Paul D. Wellstone Muscular Dystrophy Research Center [U54 AR052646]; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE [R01CA103846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402, R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, R01DK033201, R37DK031036, R24DK092760, P30DK036836, P30DK049216, R01DK055545] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Novo Nordisk Diabetes Center in Copenhagen; Paul D. Wellstone Muscular Dystrophy Research Center; Harvard Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Schlaeger for helpful discussions; W. Yee of hESC Core Facility at Children's Hospital Boston for screening support; K. Zhu for mouse satellite cell differentiation data analysis; E. Durand for cAMP assay assistance; J. LaVecchio, S. Ionescu, A. Wakabayashi, and G. Buruzula of Joslin's HSCI/DERC Flow Cytometry Core (NIH award P30DK036836); and the HSCRB/HSCI Flow Cytometry Core at Harvard for excellent flow cytometry support. We thank C. Cahill of Joslin's electron microscopy core for help with EM and immune-gold assays, and we thank C. Cowan and L. Daheron of the HSCI iPSC Core Facility for assistance with human iPSC generation. This work was supported by HHMI, NIH NIDDK R24DK092760-03, NIH NIDDK 5P30 DK49216-19, NIH NCI 5R01CA103846-10, and NIH NHLBI 5U01HL10001-05 to L.I.Z.; NIH DP2OD004345 and UO1HL100402 to A. J. W.; NIH DK31036 to C. R. K.; the Novo Nordisk Diabetes Center in Copenhagen to C. R. K.; the Paul D. Wellstone Muscular Dystrophy Research Center (U54 AR052646 to E. R. B.); and the Harvard Stem Cell Institute to A. J. W. A. J. W is an Early Career Scientist of the Howard Hughes Medical Institute. L.I.Z. is an Investigator of the Howard Hughes Medical Institute, a founder and stockholder of Fate, Inc., and a scientific advisor for Stemgent.	Awaya T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051638; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; CARLSEN RC, 1975, J PHYSIOL-LONDON, V247, P343, DOI 10.1113/jphysiol.1975.sp010935; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Fan LC, 2006, METHOD ENZYMOL, V418, P64, DOI 10.1016/S0076-6879(06)18004-0; Fisher ME, 2002, DEVELOPMENT, V129, P1307; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Hinits Y, 2009, DEVELOPMENT, V136, P403, DOI 10.1242/dev.028019; Huang HG, 2012, CELL REP, V2, P695, DOI 10.1016/j.celrep.2012.08.015; Ju BS, 2003, DEV DYNAM, V227, P14, DOI 10.1002/dvdy.10273; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; LEPEUCH CJ, 1979, BIOCHEMISTRY-US, V18, P5267, DOI 10.1021/bi00591a001; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; METZGER H, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1248; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Rodriguez G, 2013, J BIOL CHEM, V288, P7137, DOI 10.1074/jbc.M112.408765; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schnapp E, 2009, J CELL SCI, V122, P481, DOI 10.1242/jcs.038356; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Stewart R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024714; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016; Tedesco FS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003541; Thisse B, 2001, ZFIN DIRECT DATA SUB; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yano Y, 2007, ONCOL REP, V18, P441; ZALIN RJ, 1975, EXP CELL RES, V93, P55, DOI 10.1016/0014-4827(75)90422-X; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zheng JK, 2006, CELL RES, V16, P713, DOI 10.1038/sj.cr.7310080	50	112	120	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					909	921		10.1016/j.cell.2013.10.023	http://dx.doi.org/10.1016/j.cell.2013.10.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209627	Green Accepted, Bronze			2022-12-24	WOS:000326934300019
J	Bird, ST; Delaney, JAC; Brophy, JM; Etminan, M; Skeldon, SC; Hartzema, AG				Bird, Steven T.; Delaney, Joseph A. C.; Brophy, James M.; Etminan, Mahyar; Skeldon, Sean C.; Hartzema, Abraham G.			Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONTROLLED CASE SERIES; URINARY-TRACT SYMPTOMS; BLOCKERS; SAFETY	Objective To characterize risk of hypotension requiring admission to hospital in middle aged and older men treated with tamsulosin for benign prostatic hyperplasia. Design Population based retrospective cohort study (between patient methodology) and self controlled case series (within patient methodology). Setting Healthcare claims data from the IMS Lifelink database in the United States. Participants Men aged 40-85 years with private US healthcare insurance entering the cohort at their first dispensing for tamsulosin or for a 5a reductase inhibitor (5ARI) between January 2001 and June 2011 after a minimum of six months' enrolment. Main outcomes measures Hypotension requiring admission to hospital. Cox proportional hazards models estimated rate ratios at time varying intervals during follow-up: weeks 1-4, 5-8, and 9-12 after tamsulosin initiation; weeks 1-4, 5-8, and 9-12 after restarting tamsulosin (after a four week gap); and maintenance tamsulosin treatment (remaining exposed person time). Covariates included age, calendar year, demographics, antihypertensive use, healthcare use, and a Charlson comorbidity score. A self controlled case series, having implicit control for time invariant covariates, was additionally conducted. Results Among 383 567 new users of study drugs (tamsulosin 297 596; 5ARI 85 971), 2562 admissions to hospital for severe hypotension were identified. The incidence for hypotension was higher for tamsulosin (42.4 events per 10 000 person years) than for 5ARIs (31.3 events per 10 000 person years) or all accrued person time (29.1 events per 10 000 person years). After tamsulosin initiation, the cohort analysis identified an increased rate of hypotension during weeks 1-4 (rate ratio 2.12 (95% confidence interval 1.29 to 3.04)) and 5-8 (1.51 (1.04 to 2.18)), and no significant increase at weeks 9-12. The rate ratio for hypotension also increased at weeks 1-4 (1.84 (1.46 to 2.33)) and 5-8 (1.85 (1.45 to 2.36)) after restarting tamsulosin, as did maintenance tamsulosin treatment (1.19 (1.07 to 1.32)). The self controlled case series gave similar results as the cohort analysis. Conclusions We observed a temporal association between tamsulosin use for benign prostatic hyperplasia and severe hypotension during the first eight weeks after initiating treatment and the first eight weeks after restarting treatment. This association suggests that physicians should focus on improving counseling strategies to warn patients regarding the "first dose phenomenon" with tamsulosin.	[Bird, Steven T.] US FDA, Ctr Drug Evaluat & Res, Off Surveillance & Epidemiol, Dept Epidemiol, Silver Spring, MD USA; [Bird, Steven T.; Hartzema, Abraham G.] Univ Florida, Coll Pharm & Epidemiol Pharmaceut Outcomes & Poli, Gainesville, FL USA; [Delaney, Joseph A. C.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Brophy, James M.] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; [Etminan, Mahyar] Univ British Columbia, Fac Med, Therapeut Evaluat Unit, Prov Hlth Serv Author, Vancouver, BC V5Z 1M9, Canada; [Skeldon, Sean C.] Univ Toronto, Dept Surg, Div Urol, Toronto, ON, Canada; [Skeldon, Sean C.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada	US Food & Drug Administration (FDA); State University System of Florida; University of Florida; University of Washington; University of Washington Seattle; McGill University; Royal Victoria Hospital; University of British Columbia; University of Toronto; University of British Columbia	Etminan, M (corresponding author), Univ British Columbia, Fac Med, Therapeut Evaluat Unit, Prov Hlth Serv Author, Vancouver, BC V5Z 1M9, Canada.	metminan@popi.ubc.ca	Delaney, Joseph A/J-8204-2019; brophy, james/H-6673-2019	Delaney, Joseph A/0000-0003-1771-1776; brophy, james/0000-0001-8049-6875	McGill University Health Center; Fonds de la Recherche en Sante du Quebec; Ministere de la Sante et des Services Sociaux	McGill University Health Center; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Ministere de la Sante et des Services Sociaux	This work was funded in part by the McGill University Health Center, Fonds de la Recherche en Sante du Quebec, and the Ministere de la Sante et des Services Sociaux. The authors had full autonomy in the study design; the collection, analysis, and interpretation of data; the writing of the article; and the decision to submit it for publication. The authors have no other conflicts or competing interests to declare. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure. pdf and declare: support from the McGill University Health Center, Fonds de la Recherche en Sante du Quebec, and the Ministere de la Sante et des Services Sociaux for the submitted work; JMB has received peer review financial support from le Fonds de la Recherche en Sante du Quebec, JACD has a research grant from the Agency for Healthcare Research and Quality, AGH is a principal investigator for the Observational Medical Outcomes Partnership, a private-public partnership designed to help improve drug safety monitoring, and STB is employed by the US Food and Drug Administration; no other relationships or activities that could appear to have influenced the submitted work.	American Urological Association, 2010, MAN BEN PROST HYP BP; [Anonymous], 1997, 20579 NDA FOOD DRUG; BENDALL MJ, 1975, BRIT MED J, V2, P727, DOI 10.1136/bmj.2.5973.727-a; Bird ST, 2013, CAN MED ASSOC J, V185, pE475, DOI 10.1503/cmaj.121730; Black L, 2006, AM J MANAG CARE, V12, pS99; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Douglas IJ, 2013, BMJ-BRIT MED J, V346, P1936; Farrington CP, 2006, J R STAT SOC C-APPL, V55, P553, DOI 10.1111/j.1467-9876.2006.00554.x; Farrington CP, 2011, J AM STAT ASSOC, V106, P417, DOI 10.1198/jasa.2011.ap10108; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; FORRAY C, 1994, MOL PHARMACOL, V45, P703; IMS Health, 2010, LIFELINK HLTH PLAN C; Jacobsen SJ, 2008, JAMA-J AM MED ASSOC, V300, P1660, DOI 10.1001/jama.300.14.1660; Jick SS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2151; Maclure M, 2012, PHARMACOEPIDEM DR S, V21, P50, DOI 10.1002/pds.2330; NASH DT, 1990, CLIN CARDIOL, V13, P764, DOI 10.1002/clc.4960131104; Parsons JK, 2009, BJU INT, V104, P63, DOI 10.1111/j.1464-410X.2008.08317.x; Pfizer Pharmaceuticals, 2010, CARD PACK INS; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Provider Synergies, 2010, BEN PROST HYP BPH TR; Stafford RS, 2004, JAMA-J AM MED ASSOC, V291, P54, DOI 10.1001/jama.291.1.54; Whitaker HJ, 2007, ENVIRONMETRICS, V18, P157, DOI 10.1002/env.809; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342; Wilt T, 2002, COCHRANE DB SYST REV, V4; Winterstein AG, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4627; Wright AJ, 2011, CAN MED ASSOC J, V183, P303, DOI 10.1503/cmaj.100702; Yoshimura K, 2013, INT J MED SCI, V10, P864, DOI 10.7150/ijms.5892	29	48	50	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 5	2013	347								f6320	10.1136/bmj.f6320	http://dx.doi.org/10.1136/bmj.f6320			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250XL	24192967	hybrid, Green Published			2022-12-24	WOS:000326890000002
J	Kruglov, AA; Grivennikov, SI; Kuprash, DV; Winsauer, C; Prepens, S; Seleznik, GM; Eberl, G; Littman, DR; Heikenwalder, M; Tumanov, AV; Nedospasov, SA				Kruglov, Andrey A.; Grivennikov, Sergei I.; Kuprash, Dmitry V.; Winsauer, Caroline; Prepens, Sandra; Seleznik, Gitta Maria; Eberl, Gerard; Littman, Dan R.; Heikenwalder, Mathias; Tumanov, Alexei V.; Nedospasov, Sergei A.			Nonredundant Function of Soluble LT alpha(3) Produced by Innate Lymphoid Cells in Intestinal Homeostasis	SCIENCE			English	Article							B-CELLS; GUT; GENERATION; RESPONSES; MICE	Immunoglobulin A (IgA) production at mucosal surfaces contributes to protection against pathogens and controls intestinal microbiota composition. However, mechanisms regulating IgA induction are not completely defined. We show that soluble lymphotoxin alpha (sLT alpha(3)) produced by ROR gamma t(+) innate lymphoid cells (ILCs) controls T cell-dependent IgA induction in the lamina propria via regulation of T cell homing to the gut. By contrast, membrane-bound lymphotoxin beta (LT alpha(1)beta(2)) produced by ROR gamma t(+) ILCs is critical for T cell-independent IgA induction in the lamina propria via control of dendritic cell functions. Ablation of LT alpha in ROR gamma t(+) cells abrogated IgA production in the gut and altered microbiota composition. Thus, soluble and membrane-bound lymphotoxins produced by ILCs distinctly organize adaptive immune responses in the gut and control commensal microbiota composition.	[Kruglov, Andrey A.; Winsauer, Caroline; Prepens, Sandra; Nedospasov, Sergei A.] German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany; [Kruglov, Andrey A.; Kuprash, Dmitry V.; Nedospasov, Sergei A.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Kruglov, Andrey A.; Kuprash, Dmitry V.; Nedospasov, Sergei A.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119991, Russia; [Grivennikov, Sergei I.] Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19111 USA; [Kuprash, Dmitry V.; Nedospasov, Sergei A.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Seleznik, Gitta Maria; Heikenwalder, Mathias] Univ Zurich Hosp, Inst Clin Pathol, Dept Pathol, CH-8091 Zurich, Switzerland; [Eberl, Gerard] Inst Pasteur, F-75724 Paris, France; [Eberl, Gerard] Inst Pasteur, Dept Biotechnol, CNRS, Unite Rech Associee 1961, F-75724 Paris, France; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Mol Pathogenesis Program,Skirball Inst, New York, NY 10016 USA; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-81675 Munich, Germany; [Tumanov, Alexei V.] Trudeau Inst, Saranac Lake, NY 12983 USA	Deutsches Rheuma-Forschungszentrum (DRFZ); Lomonosov Moscow State University; Lomonosov Moscow State University; Fox Chase Cancer Center; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of Zurich; University Zurich Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Howard Hughes Medical Institute; New York University; New York University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Trudeau Institute	Kruglov, AA (corresponding author), German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany.	andrey_krugloff@mail.ru; sergei@nedos.net	Nedospasov, Sergei/Q-7319-2016; Kuprash, Dmitry/O-4899-2015; Kruglov, Andrey/AAP-2023-2021; Heikenwalder, Mathias/AAA-2269-2020; Tumanov, Alexei/AAR-1607-2021; Kruglov, Andrey A/F-7543-2017; Grivennikov, Sergei/AAE-7365-2019; Eberl, Gerard/A-1160-2013; Nedospasov, Sergei/L-1990-2015; Nedospasov, Sergei/C-3043-2018	Kuprash, Dmitry/0000-0002-1488-4148; Tumanov, Alexei/0000-0001-6042-0152; Kruglov, Andrey A/0000-0002-4597-2087; Grivennikov, Sergei/0000-0003-2987-0555; Eberl, Gerard/0000-0002-1119-5638	Deutsche Forschungsgemeinschaft [SFB633 A13, NE1466/2-1]; MCB Program of the Russian Academy of Sciences; Crohn's and Colitis Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MCB Program of the Russian Academy of Sciences; Crohn's and Colitis Foundation	We thank S. Fillatreau, J. Gommerman, A. Rudensky, and F. Melchers for useful discussions and critiques; K. Holden-Dye for editing of the manuscript; L. Drutskaya, K. Horn, M. Drutskaya, and D. Schlienz for expert technical support throughout the project; H. Schafer, S. Gruczek, and M. Ohde for excellent animal husbandry; the members of the German Rheumatism Research Center Flow Cytometry Core Facility (T. Kaiser, J. Kirsch) for help with FACS analysis and cell sorting; H. Hecker-Kia, H. Schliemann, and T. Geske for antibody preparation; and J. Hirscher for help with figure preparation. Supported by Deutsche Forschungsgemeinschaft grants (SFB633 A13 and NE1466/2-1) and the MCB Program of the Russian Academy of Sciences (S.A.N. and D. V. K.), and the Crohn's and Colitis Foundation (A. V. T.). Bacterial 16S rRNA pyrosequencing reads have been deposited in the NCBI Short Read Archive database with accession numbers SRX362155, SRX362156, SRX362157, and SRX362158. Author contributions: A. A. K. and S.A.N. designed research; A. A. K., D. V. K., S. I. G., S. P., C. W., G. M. S., M. H., and A. V. T. performed experiments; D. R. L. and G. E. provided ROR gamma t-Cre animals and discussed the data; and A. A. K. and S.A.N. wrote the manuscript.	Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Kang HS, 2002, NAT IMMUNOL, V3, P576, DOI 10.1038/ni795; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Liepinsh DJ, 2006, MOL CELL BIOL, V26, P4214, DOI 10.1128/MCB.01751-05; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Newberry RD, 2002, J IMMUNOL, V168, P4988, DOI 10.4049/jimmunol.168.10.4988; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Tumanov AV, 2002, IMMUNITY, V17, P239, DOI 10.1016/S1074-7613(02)00397-7; Wang YG, 2010, IMMUNITY, V32, P403, DOI 10.1016/j.immuni.2010.02.011; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003	29	180	193	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1243	1246		10.1126/science.1243364	http://dx.doi.org/10.1126/science.1243364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311691				2022-12-24	WOS:000327857900050
J	Fauci, AS; Marston, HD				Fauci, Anthony S.; Marston, Hilary D.			Achieving an AIDS-free World: Science and Implementation	CELL			English	Editorial Material							HIV-1 INFECTION; PREVENTION; ANTIBODIES; VACCINE		[Fauci, Anthony S.; Marston, Hilary D.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						[Anonymous], 2013, WHO GLOB UPD HIV TRE; Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Folkers GK, 2010, JAMA-J AM MED ASSOC, V304, P350, DOI 10.1001/jama.2010.957; Granich R, 2013, CURR OPIN HIV AIDS, V8, P41, DOI 10.1097/COH.0b013e32835b80dd; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Okwundu CI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007189.pub3; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; US Department of State, 2013, REC 10 ANN US PRES P	12	1	1	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					733	734		10.1016/j.cell.2013.10.016	http://dx.doi.org/10.1016/j.cell.2013.10.016			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24157218	Bronze			2022-12-24	WOS:000326934300001
J	Ji, N; Middelkoop, TC; Mentink, RA; Betist, MC; Tonegawa, S; Mooijman, D; Korswagen, HC; van Oudenaarden, A				Ji, Ni; Middelkoop, Teije C.; Mentink, Remco A.; Betist, Marco C.; Tonegawa, Satto; Mooijman, Dylan; Korswagen, Hendrik C.; van Oudenaarden, Alexander			Feedback Control of Gene Expression Variability in the Caenorhabditis elegans Wnt Pathway	CELL			English	Article							SINGLE-MOLECULE LEVEL; POSITIVE-FEEDBACK; C-ELEGANS; FLUCTUATING ENVIRONMENTS; NOISE-PROPAGATION; PHENOTYPIC DIVERSITY; REGULATORY NETWORKS; STOCHASTIC NATURE; ESCHERICHIA-COLI; CELL-MIGRATION	Variability in gene expression contributes to phenotypic heterogeneity even in isogenic populations. Here, we used the stereotyped, Wnt signaling-dependent development of the Caenorhabditis elegans Q neuroblast to probe endogenous mechanisms that control gene expression variability. We found that the key Hox gene that orients Q neuroblast migration exhibits increased gene expression variability in mutants in which Wnt pathway activity has been perturbed. Distinct features of the gene expression distributions prompted us on a systematic search for regulatory interactions, revealing a network of interlocked positive and negative feedback loops. Interestingly, positive feedback appeared to cooperate with negative feedback to reduce variability while keeping the Hox gene expression at elevated levels. A minimal model correctly predicts the increased gene expression variability across mutants. Our results highlight the influence of gene network architecture on expression variability and implicate feedback regulation as an effective mechanism to ensure developmental robustness.	[Ji, Ni] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Middelkoop, Teije C.; Mentink, Remco A.; Betist, Marco C.; Mooijman, Dylan; Korswagen, Hendrik C.; van Oudenaarden, Alexander] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Middelkoop, Teije C.; Mentink, Remco A.; Betist, Marco C.; Mooijman, Dylan; Korswagen, Hendrik C.; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Tonegawa, Satto] Milton Acad, Milton, MA 02186 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Korswagen, HC (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	r.korswagen@hubrecht.eu; a.vanoudenaarden@hubrecht.eu	van Oudenaarden, Alexander/AAA-1705-2019; Middelkoop, Teije/AGH-5328-2022; Korswagen, Hendrik/I-8782-2012	Middelkoop, Teije/0000-0002-0346-6143; Mentink, Remco/0000-0003-1005-7767	NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; NIH Pioneer award [DP1CA174420]; ERC Advanced grant [2011-294325_GeneNoiseControl]; Dutch Cancer Society [HUBR 2008-4114]; NATIONAL CANCER INSTITUTE [U54CA143874, DP1CA174420] Funding Source: NIH RePORTER	NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC Advanced grant; Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the NIH/NCI Physical Sciences Oncology Center at MIT (U54CA143874), a NIH Pioneer award (DP1CA174420), an ERC Advanced grant (2011-294325_GeneNoiseControl) (A.v.O.), and a grant from the Dutch Cancer Society (HUBR 2008-4114) (H. C. K.). We thank N. Paquin for MosSCI cloning vector, N. Bhatla and Y. Zheng for help with strain construction, D. Grun for identifying enriched MAB-5 binding motifs, K. Cadigan for information on putative TCF binding sites, J. Goncalves and Y. Yuan for discussion on network inference, C. Kenyon, K. Shen, H. Sawa, H. R. Horvitz, and the Caenorhabditis Genetics Center (University of Minnesota, Minneapolis) for strains and transgenes, and we also thank H. R. Horvitz, J. Slotine, E. Nedivi, E. Sontag, D. Del Vecchio, G. Neuert, S. Itzkovitz, M. Bienko, and T. Okubo for critical discussion on the project.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Aranda-Anzaldo A, 2003, MECH AGEING DEV, V124, P711, DOI 10.1016/S0047-6374(03)00089-7; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Boettiger AN, 2013, CELL REP, V3, P8, DOI 10.1016/j.celrep.2012.12.015; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Bruggeman FJ, 2002, J THEOR BIOL, V218, P507, DOI 10.1006/jtbi.2002.3096; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chung HJ, 2005, MOL CELLS, V20, P157; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Eldar A, 2009, NATURE, V460, P510, DOI 10.1038/nature08150; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; Harris J, 1996, DEVELOPMENT, V122, P3117; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lagha M, 2012, TRENDS GENET, V28, P409, DOI 10.1016/j.tig.2012.03.006; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Nijhout HF, 2002, BIOESSAYS, V24, P553, DOI 10.1002/bies.10093; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; Sato A, 1999, DEVELOPMENT, V126, P4421; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; Weinberger L, 2012, MOL CELL, V47, P193, DOI 10.1016/j.molcel.2012.05.008; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zinovyeva AY, 2008, GENETICS, V179, P1357, DOI 10.1534/genetics.108.090290	71	59	60	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					869	880		10.1016/j.cell.2013.09.060	http://dx.doi.org/10.1016/j.cell.2013.09.060			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209624	Bronze			2022-12-24	WOS:000326934300016
J	Naruse, G; Shimada, K				Naruse, Genki; Shimada, Kota			Cutaneous and Gastrointestinal Purpura	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 38-year-old previously healthy man presented with progressive rash, abdominal pain, arthralgia, and low-grade fever of 2-weeks' duration despite treatment with oral prednisolone. Physical examination showed diffuse abdominal tenderness and palpable purpura distal to the knees. A 38-year-old previously healthy man presented with progressive rash, abdominal pain, arthralgia, and low-grade fever that had lasted for 2 weeks despite treatment with oral prednisolone at a dose of 30 mg per day. Physical examination showed diffuse abdominal tenderness and palpable purpura distal to the knees (Panel A). The white-cell count and C-reactive protein level were elevated (13,600 cells per cubic millimeter [normal range, 3900 to 9000] and 6.5 mg per liter [normal value, <3.0], respectively), but other laboratory tests, including platelet count and urinalysis, were normal. Computed tomography revealed thickening of the duodenal and jejunal walls. Upper gastrointestinal ...	[Naruse, Genki; Shimada, Kota] Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan		Naruse, G (corresponding author), Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan.	kouta_shimada@tmhp.jp							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1843	1843		10.1056/NEJMicm1302936	http://dx.doi.org/10.1056/NEJMicm1302936			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24195551				2022-12-24	WOS:000326607800013
J	Jencks, SF; Brock, JE				Jencks, Stephen F.; Brock, Jane E.			Hospital Accountability and Population Health: Lessons From Measuring Readmission Rates	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							REHOSPITALIZATIONS; PROGRAM		CFMC, Englewood, CO USA		Jencks, SF (corresponding author), 8 Midvale Rd, Baltimore, MD 21210 USA.	steve.jencks@comcast.net			Integrating Care for Populations & Communities National Coordinating Center at CFMC; Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services	Integrating Care for Populations & Communities National Coordinating Center at CFMC; Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services	Dr. Brock was partially supported by the Integrating Care for Populations & Communities National Coordinating Center at CFMC with the Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services.	Berenson RA, 2012, NEW ENGL J MED, V366, P1364, DOI 10.1056/NEJMp1201268; Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Department of Health and Human Services Centers for Medicare & Medicaid Services, 2012, FED REGISTER, V77, P27870; Epstein AM, 2011, NEW ENGL J MED, V365, P2287, DOI 10.1056/NEJMsa1101942; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; Medicare.gov, 2013, FREQ ASK QUEST CMS P; U. S. Department of Health and Human Services, 2011, C NAT STRAT QUAL IMP	9	17	17	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					629	630		10.7326/0003-4819-159-9-201311050-00010	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-00010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249HX	24189596				2022-12-24	WOS:000326769400008
J	Fernandez-Tornero, C; Moreno-Morcillo, M; Rashid, UJ; Taylor, NMI; Ruiz, FM; Gruene, T; Legrand, P; Steuerwald, U; Muller, CW				Fernandez-Tornero, Carlos; Moreno-Morcillo, Maria; Rashid, Umar J.; Taylor, Nicholas M. I.; Ruiz, Federico M.; Gruene, Tim; Legrand, Pierre; Steuerwald, Ulrich; Mueller, Christoph W.			Crystal structure of the 14-subunit RNA polymerase I	NATURE			English	Article							CONFORMATIONAL FLEXIBILITY; TRANSCRIPTION INITIATION; ELECTRON-MICROSCOPY; ELONGATION COMPLEX; PHASE INFORMATION; CROSS-LINKING; ARCHITECTURE; SUBUNITS; MODEL; TFIIF	Protein biosynthesis depends on the availability of ribosomes, which in turn relies on ribosomal RNA production. In eukaryotes, this process is carried out by RNA polymerase I (Pol I), a 14-subunit enzyme, the activity of which is a major determinant of cell growth. Here we present the crystal structure of Pol I from Saccharomyces cerevisiae at 3.0 angstrom resolution. The Pol I structure shows a compact core with a wide DNA-binding cleft and a tightly anchored stalk. An extended loop mimics the DNA backbone in the cleft and may be involved in regulating Pol I transcription. Subunit A12.2 extends from the A190 jaw to the active site and inserts a transcription elongation factor TFIIS-like zinc ribbon into the nucleotide triphosphate entry pore, providing insight into the role of A12.2 in RNA cleavage and Pol I insensitivity to alpha-amanitin. The A49-A34.5 heterodimer embraces subunit A135 through extended arms, thereby contacting and potentially regulating subunit A12.2.	[Fernandez-Tornero, Carlos; Taylor, Nicholas M. I.; Ruiz, Federico M.] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Moreno-Morcillo, Maria; Rashid, Umar J.; Steuerwald, Ulrich; Mueller, Christoph W.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Gruene, Tim] Univ Gottingen, Dept Struct Chem, D-37077 Gottingen, Germany; [Legrand, Pierre] SOLEIL Synchrotron, F-91192 Gif Sur Yvette, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); European Molecular Biology Laboratory (EMBL); University of Gottingen; SOLEIL Synchrotron	Fernandez-Tornero, C (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maeztu 9, Madrid 28040, Spain.	cftornero@cib.csic.es; cmueller@embl.de	Fernandez-Tornero, Carlos/AAV-8028-2021; Ruiz, Federico M./AAO-9600-2021; Taylor, Nicholas/O-6477-2016; Müller, Christoph W/I-7420-2012; LEGRAND, Pierre/G-7709-2011; Fernandez-Tornero, Carlos/I-6888-2015	Fernandez-Tornero, Carlos/0000-0001-5097-731X; Ruiz, Federico M./0000-0002-0385-7777; Taylor, Nicholas/0000-0003-0761-4921; Müller, Christoph W/0000-0003-2176-8337; LEGRAND, Pierre/0000-0003-2431-2255; Fernandez-Tornero, Carlos/0000-0001-5097-731X; Moreno Morcillo, Maria/0000-0001-7928-3338; Moreno Morcillo, Maria/0000-0003-4603-2529	EMBL Heidelberg Protein Expression and Purification, Proteomics Core Facilities and Crystallization Platform; 'Fermentation et culture de microorganisms' (CNRS) [IFR88]; EMBO Long-Term fellowships; Marie-Curie fellowship [FP7-PEOPLE-2011-IEF 301002]; Fundacion Futuro fellowship; ESF/CSIC; Volkswagen Stiftung; Spanish Ministry of Science [BFU2010-16336]	EMBL Heidelberg Protein Expression and Purification, Proteomics Core Facilities and Crystallization Platform; 'Fermentation et culture de microorganisms' (CNRS); EMBO Long-Term fellowships; Marie-Curie fellowship(European Commission); Fundacion Futuro fellowship; ESF/CSIC; Volkswagen Stiftung(Volkswagen); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank H. Grotsch for preparing the loop deletion yeast strain, and G. von Scheven and A. Scholz for technical assistance. We are also grateful to C. Vonrhein, G. Bricogne, S. Glatt and A. Romero for advice and discussions. We thank staff from the European synchrotrons SOLEIL, DESY, ESRF and SLS, where data were collected during different stages of the project. In particular, we thank A. Thompson for access and support at beamline Proxima 1 (Soleil) and T. Schneider and G. Bourenkov at beamline P14 (PETRA III). We also acknowledge support by the EMBL Heidelberg Protein Expression and Purification, Proteomics Core Facilities and Crystallization Platform, and the 'Fermentation et culture de microorganisms' (IFR88, CNRS). We are grateful to M. Bauzan, E. Poilpre and J. Scheurich for yeast fermentation. M.M.-M. and U. J. R. were supported by EMBO Long-Term fellowships, M.M.-M. by the Marie-Curie fellowship (FP7-PEOPLE-2011-IEF 301002), N.M.I.T. by a Fundacion Futuro fellowship, F. M. R. by an ESF/CSIC funded JAE-DOC contract and T. G. by the Volkswagen Stiftung via the Niedersachsenprofessur of Prof. G. M. Sheldrick. This work was also partly funded by grant BFU2010-16336 of the Spanish Ministry of Science.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Bischler N, 2002, EMBO J, V21, P4136, DOI 10.1093/emboj/cdf392; Blattner C, 2011, GENE DEV, V25, P2093, DOI 10.1101/gad.17363311; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Carter R, 2010, MOL BIOL EVOL, V27, P1035, DOI 10.1093/molbev/msp316; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; De Carlo S, 2003, J MOL BIOL, V329, P891, DOI 10.1016/S0022-2836(03)00510-2; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Fernandez-Tornero C, 2010, EMBO J, V29, P3762, DOI 10.1038/emboj.2010.266; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; HUET J, 1975, P NATL ACAD SCI USA, V72, P3034, DOI 10.1073/pnas.72.8.3034; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; Jovanovic M, 2011, J BIOL CHEM, V286, P14469, DOI 10.1074/jbc.M110.212902; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KEDINGER C, 1970, BIOCHEM BIOPH RES CO, V38, P165, DOI 10.1016/0006-291X(70)91099-5; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Mosley AL, 2013, MOL CELL PROTEOMICS, V12, P1530, DOI 10.1074/mcp.M112.024034; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; SCHULTZ P, 1993, EMBO J, V12, P2601, DOI 10.1002/j.1460-2075.1993.tb05920.x; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Tan Lin, 2008, J Biol, V7, P40, DOI 10.1186/jbiol98; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P1790, DOI 10.1073/pnas.71.5.1790; Weinzierl ROJ, 2011, ARCHAEA, V2011, DOI 10.1155/2011/608385; WITTEKIND M, 1988, MOL CELL BIOL, V8, P3997, DOI 10.1128/MCB.8.10.3997; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	55	124	128	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					644	+		10.1038/nature12636	http://dx.doi.org/10.1038/nature12636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24153184				2022-12-24	WOS:000326293200039
J	Joseph, CG; Darrah, E; Shah, AA; Skora, AD; Casciola-Rosen, LA; Wigley, FM; Boin, F; Fava, A; Thoburn, C; Kinde, I; Jiao, YC; Papadopoulos, N; Kinzler, KW; Vogelstein, B; Rosen, A				Joseph, Christine G.; Darrah, Erika; Shah, Ami A.; Skora, Andrew D.; Casciola-Rosen, Livia A.; Wigley, Fredrick M.; Boin, Francesco; Fava, Andrea; Thoburn, Chris; Kinde, Isaac; Jiao, Yuchen; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Rosen, Antony			Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer	SCIENCE			English	Article							CD4(+) T-CELLS; ANTIGENS; EXPRESSION; MUTATIONS	Autoimmune diseases are thought to be initiated by exposures to foreign antigens that cross-react with endogenous molecules. Scleroderma is an autoimmune connective tissue disease in which patients make antibodies to a limited group of autoantigens, including RPC1, encoded by the POLR3A gene. As patients with scleroderma and antibodies against RPC1 are at increased risk for cancer, we hypothesized that the "foreign" antigens in this autoimmune disease are encoded by somatically mutated genes in the patients' incipient cancers. Studying cancers from scleroderma patients, we found genetic alterations of the POLR3A locus in six of eight patients with antibodies to RPC1 but not in eight patients without antibodies to RPC1. Analyses of peripheral blood lymphocytes and serum suggested that POLR3A mutations triggered cellular immunity and cross-reactive humoral immune responses. These results offer insight into the pathogenesis of scleroderma and provide support for the idea that acquired immunity helps to control naturally occurring cancers.	[Joseph, Christine G.; Skora, Andrew D.; Kinde, Isaac; Jiao, Yuchen; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Ludwig Ctr, Baltimore, MD 21287 USA; [Joseph, Christine G.; Skora, Andrew D.; Kinde, Isaac; Jiao, Yuchen; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Darrah, Erika; Shah, Ami A.; Casciola-Rosen, Livia A.; Wigley, Fredrick M.; Boin, Francesco; Fava, Andrea; Rosen, Antony] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21224 USA; [Thoburn, Chris] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Div Immunol, Baltimore, MD 21287 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Kinzler, KW (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Ludwig Ctr, Baltimore, MD 21287 USA.	kinzlke@jhmi.edu; vogelbe@jhmi.edu; arosen@jhmi.edu	Thoburn, Christopher J/U-9170-2017; Boin, Francesco/T-3186-2017; Fava, Andrea/AAF-8515-2019; Boin, Francesco/AAI-1471-2021	Thoburn, Christopher J/0000-0001-7743-9183; Fava, Andrea/0000-0001-6738-4836; Jiao, Yuchen/0000-0001-7917-8810; Boin, Francesco/0000-0003-4840-3063; Darrah, Erika/0000-0003-1119-0279	Virginia; D. K. Ludwig Fund for Cancer Research; Donald B. and Dorothy L. Stabler Foundation; Scleroderma Research Foundation; Rheumatology Research Foundation Career Development Bridge Funding Award; NIH [K23 AR061439, P30-AR053503, CA43460, CA 57345, CA 62924]; NATIONAL CANCER INSTITUTE [P50CA062924, R01CA043460, R01CA057345, R37CA043460, R37CA057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053503, K23AR061439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	Virginia; D. K. Ludwig Fund for Cancer Research; Donald B. and Dorothy L. Stabler Foundation; Scleroderma Research Foundation; Rheumatology Research Foundation Career Development Bridge Funding Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Ptak, N. Silliman. L. Dobbyn, J. Schaeffer, and M. Sampedro for expert technical assistance and J. Wu for advice on capturing. These studies were supported by The Virginia and D. K. Ludwig Fund for Cancer Research, The Donald B. and Dorothy L. Stabler Foundation, the Scleroderma Research Foundation, the Rheumatology Research Foundation Career Development Bridge Funding Award, and NIH grants K23 AR061439, P30-AR053503, CA43460, CA 57345, and CA 62924.	Albert ML, 2004, NAT REV CANCER, V4, P36, DOI 10.1038/nrc1255; Bernatsky S, 2005, ARTHRITIS RHEUM-US, V52, P1481, DOI 10.1002/art.21029; Buchbinder R, 2001, ANN INTERN MED, V134, P1087, DOI 10.7326/0003-4819-134-12-200106190-00008; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; BURNET M, 1957, BMJ-BRIT MED J, V1, P841, DOI 10.1136/bmj.1.5023.841; Casciola-Rosen L, 2005, J EXP MED, V201, P591, DOI 10.1084/jem.20041367; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Ding ZC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890178; Doyle HA, 2005, ANN NY ACAD SCI, V1050, P1, DOI 10.1196/annals.1313.001; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Engelhorn ME, 2006, NAT MED, V12, P198, DOI 10.1038/nm1363; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gaudin C, 1999, J IMMUNOL, V162, P1730; Harris ML, 2003, CURR OPIN RHEUMATOL, V15, P778, DOI 10.1097/00002281-200311000-00016; Jackson KJL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00263; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; LIN RH, 1991, J EXP MED, V173, P1433, DOI 10.1084/jem.173.6.1433; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; MAMULA MJ, 1994, J IMMUNOL, V152, P1453; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Nepom GT, 2002, ARTHRITIS RHEUM, V46, P5, DOI 10.1002/1529-0131(200201)46:1<5::AID-ART10063>3.0.CO;2-S; Quezada SA, 2013, BRIT J CANCER, V108, P1560, DOI 10.1038/bjc.2013.117; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shah AA, 2011, CURR OPIN RHEUMATOL, V23, P530, DOI 10.1097/BOR.0b013e32834a5081; Shah AA, 2010, ARTHRITIS RHEUM-US, V62, P2787, DOI 10.1002/art.27549; Tatsis E, 1999, ARTHRITIS RHEUM-US, V42, P751, DOI 10.1002/1529-0131(199904)42:4<751::AID-ANR19>3.0.CO;2-D; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	36	273	282	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2014	343	6167					152	157		10.1126/science.1246886	http://dx.doi.org/10.1126/science.1246886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BZ	24310608	Green Accepted			2022-12-24	WOS:000329440800034
J	Curtis, JR; Back, AL; Ford, DW; Downey, L; Shannon, SE; Doorenbos, AZ; Kross, EK; Reinke, LF; Feemster, LC; Edlund, B; Arnold, RW; O'Connor, K; Engelberg, RA				Curtis, J. Randall; Back, Anthony L.; Ford, Dee W.; Downey, Lois; Shannon, Sarah E.; Doorenbos, Ardith Z.; Kross, Erin K.; Reinke, Lynn F.; Feemster, Laura C.; Edlund, Barbara; Arnold, Richard W.; O'Connor, Kim; Engelberg, Ruth A.			Effect of Communication Skills Training for Residents and Nurse Practitioners on Quality of Communication With Patients With Serious Illness A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; EARLY PALLIATIVE CARE; CELL LUNG-CANCER; DYING PATIENTS; PHYSICIAN COMMUNICATION; CHRONIC DISEASE; MENTAL-HEALTH; MEDICAL-CARE; END; PERSPECTIVES	IMPORTANCE Communication about end-of-life care is a core clinical skill. Simulation-based training improves skill acquisition, but effects on patient-reported outcomes are unknown. OBJECTIVE To assess the effects of a communication skills intervention for internal medicine and nurse practitioner trainees on patient- and family-reported outcomes. DESIGN, SETTING, AND PARTICIPANTS Randomized trial conducted with 391 internal medicine and 81 nurse practitioner trainees between 2007 and 2013 at the University of Washington and Medical University of South Carolina. INTERVENTION Participants were randomized to an 8-session, simulation-based, communication skills intervention (N = 232) or usual education (N = 240). MAIN OUTCOMES AND MEASURES Primary outcome was patient- reported quality of communication (QOC; mean rating of 17 items rated from 0-10, with 0 = poor and 10 = perfect). Secondary outcomes were patient- reported quality of end-of-life care (QEOLC; mean rating of 26 items rated from 0-10) and depressive symptoms (assessed using the 8-item Personal Health Questionnaire [PHQ-8]; range, 0-24, higher scores worse) and family-reported QOC and QEOLC. Analyses were clustered by trainee. RESULTS There were 1866 patient ratings (44% response) and 936 family ratings (68% response). The intervention was not associated with significant changes in QOC or QEOLC. Mean values for postintervention patient QOC and QEOLC were 6.5 (95% CI, 6.2 to 6.8) and 8.3 (95% CI, 8.1 to 8.5) respectively, compared with 6.3 (95% CI, 6.2 to 6.5) and 8.3 (95% CI, 8.1 to 8.4) for control conditions. After adjustment, comparing intervention with control, there was no significant difference in the QOC score for patients (difference, 0.4 points [95% CI, -0.1 to 0.9]; P = .15) or families (difference, 0.1 [95% CI, -0.8 to 1.0]; P = .81). There was no significant difference in QEOLC score for patients (difference, 0.3 points [95% CI, -0.3 to 0.8]; P = .34) or families (difference, 0.1 [95% CI, -0.7 to 0.8]; P = .88). The intervention was associated with significantly increased depression scores among patients of postintervention trainees (mean score, 10.0 [95% CI, 9.1 to 10.8], compared with 8.8 [95% CI, 8.4 to 9.2]) for control conditions; adjusted model showed an intervention effect of 2.2 (95% CI, 0.6 to 3.8; P = .006). CONCLUSIONS AND RELEVANCE Among internal medicine and nurse practitioner trainees, simulation-based communication training compared with usual education did not improve quality of communication about end-of-life care or quality of end-of-life care but was associated with a small increase in patients' depressive symptoms. These findings raise questions about skills transfer from simulation training to actual patient care and the adequacy of communication skills assessment.	[Curtis, J. Randall; Downey, Lois; Kross, Erin K.; Feemster, Laura C.; Engelberg, Ruth A.] Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care, Dept Med, Seattle, WA 98104 USA; [Curtis, J. Randall; Shannon, Sarah E.; Doorenbos, Ardith Z.; Reinke, Lynn F.] Univ Washington, Sch Nursing, Dept Biobehav Nursing & Hlth Syst, Seattle, WA 98104 USA; [Back, Anthony L.] Univ Washington, Dept Med, Div Med Oncol, Seattle Canc Care Alliance, Seattle, WA 98104 USA; [Back, Anthony L.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Ford, Dee W.] Med Univ S Carolina, Dept Med, Div Pulm & Crit Care, Charleston, SC USA; [Reinke, Lynn F.; Feemster, Laura C.] VA Puget Sound Hlth Care Syst, Hlth Serv Res & Dev, Seattle, WA USA; [Edlund, Barbara] Med Univ S Carolina, Coll Nursing, Charleston, SC USA; [Arnold, Richard W.; O'Connor, Kim] Univ Washington, Dept Med, Seattle, WA 98104 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Medical University of South Carolina; University of Washington; University of Washington Seattle	Curtis, JR (corresponding author), Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care, Box 359762, Seattle, WA 98104 USA.	jrc@u.washington.edu		Curtis, J. Randall/0000-0001-9529-845X; Shannon, Sarah E/0000-0001-8492-8743	National Institute of Nursing Research of the National Institutes of Health [R01NR009987]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL111116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR009987] Funding Source: NIH RePORTER	National Institute of Nursing Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by the National Institute of Nursing Research of the National Institutes of Health (R01NR009987).	Alexander SC, 2006, ACAD MED, V81, P1008, DOI 10.1097/01.ACM.0000242580.83851.ad; Au DH, 2012, CHEST, V141, P726, DOI 10.1378/chest.11-0362; Back AL, 2007, ARCH INTERN MED, V167, P453, DOI 10.1001/archinte.167.5.453; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Bays AM, 2014, J PALLIAT MED, V17, P159, DOI 10.1089/jpm.2013.0318; Carline JD, 2003, J PAIN SYMPTOM MANAG, V25, P19, DOI 10.1016/S0885-3924(02)00537-7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clayton JM, 2012, J PALLIAT MED, V15, P585, DOI 10.1089/jpm.2011.0292; Curtis JR, 2004, EUR RESPIR J, V24, P200, DOI 10.1183/09031936.04.00010104; Curtis JR, 2002, CHEST, V122, P356, DOI 10.1378/chest.122.1.356; Curtis JR, 2001, J GEN INTERN MED, V16, P41; Ell K, 2008, J CLIN ONCOL, V26, P4488, DOI 10.1200/JCO.2008.16.6371; Engelberg R, 2006, J PALLIAT MED, V9, P1086, DOI 10.1089/jpm.2006.9.1086; Engelberg RA, 2010, J PAIN SYMPTOM MANAG, V39, P951, DOI 10.1016/j.jpainsymman.2009.11.313; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Fiscella K, 2007, ANN FAM MED, V5, P151, DOI 10.1370/afm.643; Frosch DL, 2010, J AM GERIATR SOC, V58, P1496, DOI 10.1111/j.1532-5415.2010.02980.x; Fryer-Edwards K, 2006, ACAD MED, V81, P638, DOI 10.1097/01.ACM.0000232414.43142.45; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Gysels M, 2005, SUPPORT CARE CANCER, V13, P356, DOI 10.1007/s00520-004-0732-0; Haywood KL, 2005, QUAL LIFE RES, V14, P1651, DOI 10.1007/s11136-005-1743-0; Hopman WM, 2009, CHRONIC DIS CAN, V29, P108; Jackson VA, 2011, J PALLIAT MED, V14, P775, DOI 10.1089/jpm.2010.0493; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Lowe B, 2003, PSYCHOSOM MED, V65, P764, DOI 10.1097/01.PSY.0000079379.39918.17; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; McBurney CR, 2002, PHARMACOTHERAPY, V22, P1616, DOI 10.1592/phco.22.17.1616.34121; Reeder BA, 2008, J PHYS ACT HEALTH, V5, P74, DOI 10.1123/jpah.5.1.74; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; Shilling V, 2003, PSYCHO-ONCOL, V12, P599, DOI 10.1002/pon.731; Szmuilowicz E, 2012, J PALLIAT MED, V15, P768, DOI 10.1089/jpm.2011.0446; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Wenrich MD, 2003, J PAIN SYMPTOM MANAG, V25, P236, DOI 10.1016/S0885-3924(02)00694-2; Wenrich MD, 2001, ARCH INTERN MED, V161, P868, DOI 10.1001/archinte.161.6.868; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	41	274	278	7	102	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2271	2281		10.1001/jama.2013.282081	http://dx.doi.org/10.1001/jama.2013.282081			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	262OV	24302090	Green Accepted, Bronze			2022-12-24	WOS:000327746300012
J	Yelenik, SG; D'Antonio, CM				Yelenik, Stephanie G.; D'Antonio, Carla M.			Self-reinforcing impacts of plant invasions change over time	NATURE			English	Article							DRY HAWAIIAN WOODLANDS; BIOLOGICAL INVASIONS; RESTORATION ECOLOGY; NITROGEN DYNAMICS; EXOTIC GRASSES; SOIL FEEDBACKS; C-4 GRASSES; FIRE; STATES; SUCCESSION	Returning native species to habitats degraded by biological invasions is a critical conservation goal(1). A leading hypothesis poses that exotic plant dominance is self-reinforced by impacts on ecosystem processes, leading to persistent stable states(2-6). Invaders have been documented to modify fire regimes, alter soil nutrients or shift microbial communities in ways that feed back to benefit themselves over competitors(2,5-7). However, few studies have followed invasions through time to ask whether ecosystem impacts and feedbacks persist(8,9). Here we return to woodland sites in Hawai'i Volcanoes National Park that were invaded by exotic C-4 grasses in the 1960s, the ecosystem impacts of which were studied intensively in the 1990s(10-12). We show that positive feedbacks between exotic grasses and soil nitrogen cycling have broken down, but rather than facilitating native vegetation, the weakening feedbacks facilitate new exotic species. Data from the 1990s showed that exotic grasses increased nitrogen-mineralization rates by two-to fourfold, but were nitrogen-limited(10,12,13). Thus, the impacts of the invader created a positive feedback early in the invasion. We now show that annual net soil nitrogen mineralization has since dropped to pre-invasion levels. In addition, a seedling outplanting experiment that varied soil nitrogen and grass competition demonstrates that the changing impacts of grasses do not favour native species re-establishment. Instead, decreased nitrogen availability most benefits another aggressive invader, the nitrogen-fixing tree Morella faya. Long-term studies of invasions may reveal that ecosystem impacts and feedbacks shift over time, but that this may not benefit native species recovery.	[Yelenik, Stephanie G.; D'Antonio, Carla M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Yelenik, SG (corresponding author), US Geol Survey, Pacific Isl Ecosyst Res Ctr, Hawaii Natl Pk, HI 96718 USA.	syelenik@usgs.gov	Yelenik, Stephanie/ABC-8265-2020	Yelenik, Stephanie/0000-0002-9011-0769	National Science Foundation [DEB 1029168]	National Science Foundation(National Science Foundation (NSF))	We thank M. Mack for previous data. We thank S. McDaniel and S. Doyle for native seed and the National Park Service for field site access and laboratory and greenhouse facilities. N. DiManno, V. Vincent, T. Kalei, T. D'Antonio-Dudley, K. Roehr, W. Buckley, M. Wasser and C. French helped with field work and N. DiManno, V. Vincent and S. Ma helped with laboratory work. We are appreciative of early manuscript comments from E. Mordecai and statistical advice from K. Brinck. This research was funded by National Science Foundation grant DEB 1029168.	Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; BEATTY SW, 1992, MADRONO, V39, P54; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.1890/1540-9295(2003)001[0376:ASSIE]2.0.CO;2; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; D'Antonio CM, 2006, BIOTROPICA, V38, P458, DOI 10.1111/j.1744-7429.2006.00170.x; D'Antonio CM, 2011, ECOL APPL, V21, P1617, DOI 10.1890/10-0638.1; D'Antonio CM, 2001, ECOLOGY, V82, P89, DOI 10.1890/0012-9658(2001)082[0089:FIDOTI]2.0.CO;2; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Dobson AP, 1997, SCIENCE, V277, P515, DOI 10.1126/science.277.5325.515; Funk JL, 2008, TRENDS ECOL EVOL, V23, P695, DOI 10.1016/j.tree.2008.07.013; HUGHES F, 1991, ECOLOGY, V72, P743, DOI 10.2307/2937215; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Levine JM, 2006, ECOL LETT, V9, P1005, DOI 10.1111/j.1461-0248.2006.00949.x; Mack MC, 2003, ECOL APPL, V13, P154, DOI 10.1890/1051-0761(2003)013[0154:EGACOS]2.0.CO;2; Mack MC, 2001, ECOL APPL, V11, P1323, DOI 10.1890/1051-0761(2001)011[1323:AOENDB]2.0.CO;2; MACK MC, 1998, THESIS U CALIFORNIA; Nadelhoffer K. J., 1994, STABLE ISOTOPES ECOL, V316, P22; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scowcroft PG, 2013, NEW FOREST, V44, P409, DOI 10.1007/s11056-012-9352-6; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Sullivan JJ, 2007, NEW ZEAL J ECOL, V31, P22; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; van der Putten WH, 2007, ISME J, V1, P28, DOI 10.1038/ismej.2007.9; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Yelenik SG, 2011, ECOLOGY, V92, P66, DOI 10.1890/10-0465.1	30	98	104	7	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					517	+		10.1038/nature12798	http://dx.doi.org/10.1038/nature12798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24256723				2022-12-24	WOS:000327464200041
J	Chiu, YT				Chiu, Yu-Tzu			Typhoon Haiyan: Philippines faces long road to recovery	LANCET			English	Editorial Material																			0	12	12	1	30	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1691	1692		10.1016/S0140-6736(13)62380-6	http://dx.doi.org/10.1016/S0140-6736(13)62380-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259PX	24278979				2022-12-24	WOS:000327539900012
J	Dougan, SK; Ashour, J; Karssemeijer, RA; Popp, MW; Avalos, AM; Barisa, M; Altenburg, AF; Ingram, JR; Cragnolini, JJ; Guo, CG; Alt, FW; Jaenisch, R; Ploegh, HL				Dougan, Stephanie K.; Ashour, Joseph; Karssemeijer, Roos A.; Popp, Maximilian W.; Avalos, Ana M.; Barisa, Marta; Altenburg, Arwen F.; Ingram, Jessica R.; Cragnolini, Juan Jose; Guo, Chunguang; Alt, Frederick W.; Jaenisch, Rudolf; Ploegh, Hidde L.			Antigen-specific B-cell receptor sensitizes B cells to infection by influenza virus	NATURE			English	Article							TRANSNUCLEAR MICE; T-CELLS; IN-VIVO; MEMORY; LUNG; STRAINS; ENTRY	Influenza A virus-specific B lymphocytes and the antibodies they produce protect against infection(1). However, the outcome of interactions between an influenza haemagglutinin-specific B cell via its receptor (BCR) and virus is unclear. Through somatic cell nuclear transfer we generated mice that harbour B cells with a BCR specific for the haemagglutinin of influenza A/WSN/33 virus (FluBI mice). Their B cells secrete an immunoglobulin gamma 2b that neutralizes infectious virus. Whereas B cells from FluBI and control mice bind equivalent amounts of virus through interaction of haemagglutinin with surface-disposed sialic acids, the A/WSN/33 virus infects only the haemagglutinin-specific B cells. Mere binding of virus is not sufficient for infection of B cells: this requires interactions of the BCR with haemagglutinin, causing both disruption of antibody secretion and FluBI B-cell death within 18 h. In mice infected with A/WSN/33, lung-resident FluBI B cells are infected by the virus, thus delaying the onset of protective antibody release into the lungs, whereas FluBI cells in the draining lymph node are not infected and proliferate. We propose that influenza targets and kills influenza-specific B cells in the lung, thus allowing the virus to gain purchase before the initiation of an effective adaptive response.	[Dougan, Stephanie K.; Ashour, Joseph; Karssemeijer, Roos A.; Popp, Maximilian W.; Avalos, Ana M.; Barisa, Marta; Altenburg, Arwen F.; Ingram, Jessica R.; Cragnolini, Juan Jose; Jaenisch, Rudolf; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Popp, Maximilian W.; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Guo, Chunguang; Alt, Frederick W.] Boston Childrens Hosp, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Altenburg, Arwen/N-4302-2018	Altenburg, Arwen/0000-0002-5361-4909; Ashour, Joseph/0000-0003-3809-2783; Barisa, Marta/0000-0001-7846-6810	Cancer Research Institute; Human Frontiers Science Program; National Institutes of Health; American Association for Cancer Research-Pancreatic Cancer Action Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033456, R01AI087879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP1GM106409, R01GM100518] Funding Source: NIH RePORTER	Cancer Research Institute; Human Frontiers Science Program(Human Frontier Science Program); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research-Pancreatic Cancer Action Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.K.D. and C.G. were funded by the Cancer Research Institute. J.J.C. was funded by the Human Frontiers Science Program. F.W.A., R.J. and H.L.P. are funded by grants from the National Institutes of Health. F.W.A. is a Howard Hughes Medical Institute investigator. S.K.D. and H.L.P. are funded by the American Association for Cancer Research-Pancreatic Cancer Action Network. We are grateful to P. Wisniewski for cell sorting, to J. Jackson for mouse husbandry, to G. Bell for statistical analysis, to N. Watson for electron microscopy and to M. Witte for sortase nucleophiles.	Antos JM, 2008, J AM CHEM SOC, V130, P16338, DOI 10.1021/ja806779e; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; DELIMA MCP, 1995, BBA-BIOMEMBRANES, V1236, P323; Dougan SK, 2013, CANCER IMMUNOL RES, V1, P99, DOI 10.1158/2326-6066.CIR-13-0047; Dougan SK, 2012, P NATL ACAD SCI USA, V109, P13739, DOI 10.1073/pnas.1210273109; Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Huang RTC, 1996, FEBS LETT, V392, P59, DOI 10.1016/0014-5793(96)00783-1; JONES PD, 1987, VACCINE, V5, P244, DOI 10.1016/0264-410X(87)90109-5; Joo HM, 2008, P NATL ACAD SCI USA, V105, P3485, DOI 10.1073/pnas.0800003105; Kirak Oktay, 2010, J Vis Exp, DOI 10.3791/2168; Kirak O, 2010, SCIENCE, V328, P243, DOI 10.1126/science.1178590; Kishigami S, 2006, NAT PROTOC, V1, P125, DOI 10.1038/nprot.2006.21; Londrigan SL, 2011, J VIROL, V85, P2990, DOI 10.1128/JVI.01705-10; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; MORGAN DJ, 1993, VIRUS RES, V29, P179, DOI 10.1016/0168-1702(93)90058-U; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Popp M.W.-L., 2009, CURR PROTOC PROTEIN; Popp MWL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002604; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Sehrawat S, 2012, CELL REPORTS, V1, P461, DOI 10.1016/j.celrep.2012.03.009; SIMONS K, 1978, P NATL ACAD SCI USA, V75, P5306, DOI 10.1073/pnas.75.11.5306; Stray SJ, 2000, GLYCOBIOLOGY, V10, P649, DOI 10.1093/glycob/10.7.649; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Valkenburg SA, 2011, MICROBES INFECT, V13, P489, DOI 10.1016/j.micinf.2011.01.007; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Witte MD, 2012, P NATL ACAD SCI USA, V109, P11993, DOI 10.1073/pnas.1205427109	30	50	52	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					406	+		10.1038/nature12637	http://dx.doi.org/10.1038/nature12637			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24141948	Green Accepted, Green Submitted			2022-12-24	WOS:000327163200043
J	Lee, NN; Chalamcharla, VR; Reyes-Turcu, F; Mehta, S; Zofall, M; Balachandran, V; Dhakshnamoorthy, J; Taneja, N; Yamanaka, S; Zhou, M; Grewal, SIS				Lee, Nathan N.; Chalamcharla, Venkata R.; Reyes-Turcu, Francisca; Mehta, Sameet; Zofall, Martin; Balachandran, Vanivilasini; Dhakshnamoorthy, Jothy; Taneja, Nitika; Yamanaka, Soichiro; Zhou, Ming; Grewal, Shiv I. S.			Mtr4-like Protein Coordinates Nuclear RNA Processing for Heterochromatin Assembly and for Telomere Maintenance	CELL			English	Article							LONG NONCODING RNAS; YEAST SCHIZOSACCHAROMYCES-POMBE; DIRECTED DNA METHYLATION; MEIOTIC MESSENGER-RNAS; FISSION YEAST; POLY(A)-BINDING PROTEIN; SELECTIVE ELIMINATION; QUALITY-CONTROL; ANTISENSE RNA; S. POMBE	The regulation of protein-coding and noncoding RNAs is linked to nuclear processes, including chromatin modifications and gene silencing. However, the mechanisms that distinguish RNAs and mediate their functions are poorly understood. We describe a nuclear RNA-processing network in fission yeast with a core module comprising the Mtr4-like protein, Mtl1, and the zinc-finger protein, Red1. The Mtl1-Red1 core promotes degradation of mRNAs and noncoding RNAs and associates with different proteins to assemble heterochromatin via distinct mechanisms. Mtl1 also forms Red1-independent interactions with evolutionarily conserved proteins named Nrl1 and Ctr1, which associate with splicing factors. Whereas Nrl1 targets transcripts with cryptic introns to form heterochromatin at developmental genes and retrotransposons, Ctr1 functions in processing intron-containing telomerase RNA. Together with our discovery of widespread cryptic introns, including in noncoding RNAs, these findings reveal unique cellular strategies for recognizing regulatory RNAs and coordinating their functions in response to developmental and environmental cues.	[Lee, Nathan N.; Chalamcharla, Venkata R.; Reyes-Turcu, Francisca; Mehta, Sameet; Zofall, Martin; Balachandran, Vanivilasini; Dhakshnamoorthy, Jothy; Taneja, Nitika; Yamanaka, Soichiro; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA; [Lee, Nathan N.] NIH, Bethesda, MD 20892 USA; [Lee, Nathan N.] Johns Hopkins Univ, Grad Partnership Program, Bethesda, MD 20892 USA; [Zhou, Ming] Frederick Natl Lab Canc Res, Lab Prote & Analyt Technol, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	TANEJA, NITIKA/T-5633-2017; Mehta, Sameet/A-1936-2011; TANEJA, NITIKA/AAY-8446-2021	TANEJA, NITIKA/0000-0002-5513-5282; Mehta, Sameet/0000-0002-3029-3217; TANEJA, NITIKA/0000-0002-5513-5282; Grewal, Shiv/0000-0002-4552-9261	Intramural Research Program of the National Institutes of Health (NIH); National Cancer Institute and utilized the Helix Systems; Biowulf Linux cluster at the NIH; NATIONAL CANCER INSTITUTE [ZIABC010523] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute and utilized the Helix Systems; Biowulf Linux cluster at the NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. FitzGerald for intron analysis, R. Allshire for the cwf10-1 mutant, J. Barrowman for her valuable help in editing the manuscript, and M. Lichten for comments. This research was supported by the Intramural Research Program of the National Institutes of Health (NIH) and by the National Cancer Institute and utilized the Helix Systems and the Biowulf Linux cluster at the NIH.	Ausin I, 2012, EPIGENETICS-US, V7, P29, DOI 10.4161/epi.7.1.18782; Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Bitton DA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.90; Box JA, 2008, NATURE, V456, P910, DOI 10.1038/nature07584; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Chen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026804; Chinen M, 2010, J BIOL CHEM, V285, P5630, DOI 10.1074/jbc.M109.074393; Cho YS, 2012, MOL CELLS, V34, P315, DOI 10.1007/s10059-012-0157-4; Ding DQ, 2012, SCIENCE, V336, P732, DOI 10.1126/science.1219518; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hiriart E, 2012, EMBO J, V31, P2296, DOI 10.1038/emboj.2012.105; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kiely CM, 2011, MOL CELL BIOL, V31, P4193, DOI 10.1128/MCB.05568-11; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kim T, 2012, CELL, V150, P1158, DOI 10.1016/j.cell.2012.08.016; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Lemieux C, 2011, MOL CELL, V44, P108, DOI 10.1016/j.molcel.2011.06.035; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; St-Andre O, 2010, J BIOL CHEM, V285, P27859, DOI 10.1074/jbc.M110.150748; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; Tang W, 2012, NATURE, V484, P260, DOI 10.1038/nature10924; Tashiro S, 2013, GENES CELLS, V18, P327, DOI 10.1111/gtc.12038; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yamamoto M, 2010, P JPN ACAD B-PHYS, V86, P788, DOI 10.2183/pjab.86.788; Yamanaka S, 2013, NATURE, V493, P557, DOI 10.1038/nature11716; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108; Zhang CJ, 2013, EMBO J, V32, P1128, DOI 10.1038/emboj.2013.49; Zhang K, 2011, SCIENCE, V331, P1624, DOI 10.1126/science.1198712; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	58	125	126	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1061	1074		10.1016/j.cell.2013.10.027	http://dx.doi.org/10.1016/j.cell.2013.10.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24210919	Green Accepted, Bronze			2022-12-24	WOS:000327500600011
J	Tulchinsky, TH; Ramlawi, A; Abdeen, Z; Grotto, I; Flahault, A				Tulchinsky, Theodore H.; Ramlawi, Asad; Abdeen, Ziad; Grotto, Itamar; Flahault, Antoine			Polio lessons 2013: Israel, the West Bank, and Gaza	LANCET			English	Editorial Material							POLIOMYELITIS		[Tulchinsky, Theodore H.] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Braun Sch Publ Hlth, Jerusalem, Israel; [Ramlawi, Asad] Palestinian Author, Minist Hlth, Ramallah, West Bank, Palestine; [Abdeen, Ziad] Al Quds Univ, Al Quds Nutr & Hlth Res Inst, Jerusalem, Israel; [Grotto, Itamar] Ben Gurion Univ Negev, Fac Hlth Sci, Publ Hlth Serv, Minist Hlth, Beer Sheva, Israel; [Grotto, Itamar] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel; [Flahault, Antoine] Sorbonne Paris Cite, Descartes Sch Med, Ctr Virchow Villerme, Paris, France	Hebrew University of Jerusalem; Hadassah University Medical Center; Ben Gurion University; Ben Gurion University; UDICE-French Research Universities; Universite Paris Cite	Tulchinsky, TH (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Braun Sch Publ Hlth, Jerusalem, Israel.	tedt@hadassah.org.il	Grotto, Itamar/F-2028-2012; Abdeen, Ziad/AAC-7889-2019	Grotto, Itamar/0000-0002-3363-3715				Anis E, 2013, EURO SURVEILL, V18; [Anonymous], 2013, LANCET, V382, P1381; [Anonymous], 2013, POL ER ENDG STRAT PL; Global Polio Eradication Initiative, 2013, RAM ROT RESC; Global Polio Eradication Initiative, 2013, POL WEEK; GOLDBLUM N, 1994, B WORLD HEALTH ORGAN, V72, P783; Kew Olen M., 2012, Morbidity and Mortality Weekly Report, V61, P741; State of Palestine Ministry of Health. MOH-PHIC, 2006, COMM DIS HLTH STAT P; TULCHINSKY T, 1989, AM J PUBLIC HEALTH, V79, P1648, DOI 10.2105/AJPH.79.12.1648; WHO, 2013, IMP WILD POL DET ENV; WHO, 2013, GLOB AL RESP WILD PO; WHO, 2013, GLOB AL RESP POL DET; WHO, 2013, GLOB AL RESP POL SYR; WHO. Polio Eradication Initiative, OCC PAL TERR CERT ST	14	18	18	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1611	1612		10.1016/S0140-6736(13)62331-4	http://dx.doi.org/10.1016/S0140-6736(13)62331-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254CN	24238546				2022-12-24	WOS:000327140700005
J	Groarke, JD; Cheng, S; Moslehi, J				Groarke, John D.; Cheng, Susan; Moslehi, Javid			Cancer-Drug Discovery and Cardiovascular Surveillance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The story of impressive evolution in treatment for chronic myeloid leukemia has taken an unexpected turn, as serious adverse cardiovascular events have occurred in patients treated with the tyrosine kinase inhibitors ponatinib and nilotinib. Targeted BCR-ABL protein kinase inhibitors have revolutionized the treatment of chronic myeloid leukemia (CML) and have established tyrosine kinase inhibition as a model for cancer-drug discovery and therapy in general. In 2001, imatinib became the first such tyrosine kinase inhibitor therapy to be approved by the Food and Drug Administration (FDA). Initially developed as part of a series of compounds that inhibit the platelet-derived growth factor receptor, imatinib was also shown to have potency against ABL and KIT kinases. Despite imatinib's breakthrough success, more than 20% of patients are resistant to the drug. Therefore, second- and third-generation inhibitors dasatinib, ...	[Groarke, John D.; Moslehi, Javid] Dana Farber Canc Inst, Cardiooncol Program, Boston, MA 02115 USA; [Groarke, John D.; Cheng, Susan; Moslehi, Javid] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Groarke, John D.; Cheng, Susan; Moslehi, Javid] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Groarke, JD (corresponding author), Dana Farber Canc Inst, Cardiooncol Program, Boston, MA 02115 USA.			Cheng, Susan/0000-0002-4977-036X				Food and Drug Administration, FDA DRUG SAF COMM FD; Herndon TM, 2013, CLIN CANCER RES, V19, P4559, DOI 10.1158/1078-0432.CCR-13-0755; Sawyers CL, 2010, NEW ENGL J MED, V362, P2314, DOI 10.1056/NEJMe1004430; Tefferi A, 2013, LEUKEMIA, V27, P1939, DOI 10.1038/leu.2013.112	4	54	56	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1779	1781		10.1056/NEJMp1313140	http://dx.doi.org/10.1056/NEJMp1313140			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247HF	24180496				2022-12-24	WOS:000326607800005
J	Abramson, JD; Rosenberg, HG; Jewell, N; Wright, JM				Abramson, John D.; Rosenberg, Harriet G.; Jewell, Nicholas; Wright, James M.			Should people at low risk of cardiovascular disease take a statin?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							END-POINTS; TRIALS; OUTCOMES; WOMEN		[Abramson, John D.] Harvard Univ, Dept Hlth Care Policy, Sch Med, Ipswich, MA 01938 USA; [Rosenberg, Harriet G.] York Univ, Dept Social Sci, Toronto, ON M3J 2R7, Canada; [Jewell, Nicholas] Univ Calif Berkeley, Sch Publ Hlth, Dept Stat, Div Biostat, Berkeley, CA 94720 USA; [Wright, James M.] Univ British Columbia, Dept Anesthesiol, Therapeut Initiat, Vancouver, BC V5Z 1M9, Canada; [Wright, James M.] Univ British Columbia, Dept Pharmacol & Therapeut, Therapeut Initiat, Vancouver, BC V6T 1W5, Canada; [Wright, James M.] Univ British Columbia, Dept Med, Therapeut Initiat, Vancouver, BC, Canada	Harvard University; York University - Canada; University of California System; University of California Berkeley; University of British Columbia; University of British Columbia; University of British Columbia	Abramson, JD (corresponding author), Harvard Univ, Dept Hlth Care Policy, Sch Med, 39 Spring St, Ipswich, MA 01938 USA.	john_abramson@hms.harvard.edu						Buettner C, 2008, J GEN INTERN MED, V23, P1182, DOI 10.1007/s11606-008-0636-7; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Donnelly LA, 2008, DIABETIC MED, V25, P850, DOI 10.1111/j.1464-5491.2008.02476.x; Ebrahim S, 2012, LANCET, V380, P545, DOI 10.1016/S0140-6736(12)60694-1; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Golomb BA, 2012, ARCH INTERN MED, V172, P1180, DOI 10.1001/archinternmed.2012.2171; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1437; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Maningat P, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0291-7; Mansi I, 2013, JAMA INTERN MED, V173, P1318, DOI 10.1001/jamainternmed.2013.6184; Mansi I, 2013, EXPERT OPIN DRUG SAF, V12, P327, DOI 10.1517/14740338.2013.779667; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mikus CR, 2013, J AM COLL CARDIOL, V62, P709, DOI 10.1016/j.jacc.2013.02.074; Mora S, 2010, CIRCULATION, V121, P1069, DOI 10.1161/CIRCULATIONAHA.109.906479; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; Naci H., 2013, BMJ-BRIT MED J, V347, P15577; NICE, 2008, STAT PREV CARD EV TE, V94; Nissen SE, 2009, J AM COLL CARDIOL, V54, P2363, DOI 10.1016/j.jacc.2009.09.021; Pharmacy Checker, ZOC PRIC ORD COMP; Tatley M, 2007, DRUG SAFETY, V30, P195, DOI 10.2165/00002018-200730030-00003; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	26	154	158	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2013	347								f6123	10.1136/bmj.f6123	http://dx.doi.org/10.1136/bmj.f6123			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CI	24149819	Green Published			2022-12-24	WOS:000326293800004
J	Tanaka, G; Hou, XG; Ma, XY; Edgecombe, GD; Strausfeld, NJ				Tanaka, Gengo; Hou, Xianguang; Ma, Xiaoya; Edgecombe, Gregory D.; Strausfeld, Nicholas J.			Chelicerate neural ground pattern in a Cambrian great appendage arthropod	NATURE			English	Article							BURGESS SHALE; BRITISH-COLUMBIA; VISUAL-SYSTEMS; LEANCHOILIA; BRAIN; EYES; MORPHOLOGY; EVOLUTION; ORIGIN; SPIDER	Preservation of neural tissue in early Cambrian arthropods has recently been demonstrated(1), to a degree that segmental structures of the head can be associated with individual brain neuromeres. This association provides novel data for addressing long-standing controversies about the segmental identities of specialized head appendages in fossil taxa(2,3). Here we document neuroanatomy in the head and trunk of a 'great appendage' arthropod, Alalcomenaeus sp., from the Chengjiang biota, southwest China, providing the most complete neuroanatomical profile known from a Cambrian animal. Micro-computed tomography reveals a configuration of one optic neuropil separate from a protocerebrum contiguous with four head ganglia, succeeded by eight contiguous ganglia in an eleven-segment trunk. Arrangements of optic neuropils, the brain and ganglia correspond most closely to the nervous system of Chelicerata of all extant arthropods, supporting the assignment of 'great appendage' arthropods to the chelicerate total group(4,5). The position of the deutocerebral neuromere aligns with the insertion of the great appendage, indicating its deutocerebral innervation and corroborating a homology between the 'great appendage' and chelicera indicated by morphological similarities(4,6,7). Alalcomenaeus and Fuxianhuia protensa(1) demonstrate that the two main configurations of the brain observed in modern arthropods, those of Chelicerata and Mandibulata, respectively(8), had evolved by the early Cambrian.	[Tanaka, Gengo] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Hou, Xianguang; Ma, Xiaoya] Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China; [Ma, Xiaoya; Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Strausfeld, Nicholas J.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Strausfeld, Nicholas J.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Yunnan University; Natural History Museum London; University of Arizona; University of Arizona	Hou, XG (corresponding author), Yunnan Univ, Yunnan Key Lab Palaeobiol, Kunming 650091, Peoples R China.	xghou@ynu.edu.cn; flybrain@email.arizona.edu	Strausfeld, Nicholas James/AAF-4566-2021	Strausfeld, Nicholas James/0000-0002-1115-1774; Edgecombe, Gregory/0000-0002-9591-8011	Natural Science Foundation of China [40730211]; Research in Education and Science from the Government of Japan [21740370]; Leverhulme Trust [F/00 696/T]; Center for Insect Science, University of Arizona; Air Force Research Laboratories [FA8651-10-1-0001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research in Education and Science from the Government of Japan; Leverhulme Trust(Leverhulme Trust); Center for Insect Science, University of Arizona; Air Force Research Laboratories(United States Department of DefenseUS Air Force Research Laboratory)	We thank N. Shimobayashi, H. Maeda, and T. Kogiso for arranging and performing EDXRF analyses, and D. Andrew for advice on cladistics. This work was supported by grants from the Natural Science Foundation of China (no. 40730211), Research in Education and Science from the Government of Japan (no. 21740370), a Leverhulme Trust Research Project Grant (F/00 696/T), by the Center for Insect Science, University of Arizona, and a grant from the Air Force Research Laboratories (FA8651-10-1-0001) to N.J.S.	Brenneis G, 2010, J MORPHOL, V271, P169, DOI 10.1002/jmor.10789; Briggs DEG, 1999, PALAEONTOLOGY, V42, P953, DOI 10.1111/1475-4983.00104; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Butterfield NJ, 2002, PALEOBIOLOGY, V28, P155, DOI 10.1666/0094-8373(2002)028<0155:LGATIO>2.0.CO;2; Chen JY, 2004, LETHAIA, V37, P3, DOI 10.1080/00241160410004764; Cotton TJ, 2004, T ROY SOC EDIN-EARTH, V94, P169, DOI 10.1017/S0263593300000596; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; Edgecombe GD, 2011, ACTA PALAEONTOL POL, V56, P385, DOI 10.4202/app.2010.0080; Eriksson ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042582; Eriksson ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035625; Garcia-Bellido DC, 2007, PALAEONTOLOGY, V50, P693, DOI 10.1111/j.1475-4983.2007.00649.x; Harzsch S, 2006, DEV DYNAM, V235, P2641, DOI 10.1002/dvdy.20866; Haug JT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-162; Haug JT, 2012, PALAEONTOLOGY, V55, P369, DOI 10.1111/j.1475-4983.2011.01124.x; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou Xianguang, 1997, Fossils and Strata, V45, P1; Legg DA, 2012, P ROY SOC B-BIOL SCI, V279, P4699, DOI 10.1098/rspb.2012.1958; Lehmann T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030474; Lin C, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-7; Liu Y, 2007, GFF, V129, P263, DOI 10.1080/11035890701293263; Ma XY, 2012, NATURE, V490, P258, DOI 10.1038/nature11495; Richter Stefan, 2013, P223; Schoenemann B, 2012, LETHAIA, V45, P524, DOI 10.1111/j.1502-3931.2012.00313.x; Stein M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-99; Strausfeld N.J., 2012, ARTHROPOD BRAINS EVO; Strausfeld NJ, 2011, ARTHROPOD STRUCT DEV, V40, P276, DOI 10.1016/j.asd.2011.02.002; STRAUSFELD NJ, 1993, J COMP NEUROL, V328, P63, DOI 10.1002/cne.903280105; Yang J, 2013, NATURE, V494, P468, DOI 10.1038/nature11874; ZEIL J, 1983, CELL TISSUE RES, V229, P591	29	104	107	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					364	+		10.1038/nature12520	http://dx.doi.org/10.1038/nature12520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132294				2022-12-24	WOS:000325706300051
J	Wolfe, SM				Wolfe, Sidney M.			Selling amphetamine emblazoned athletic shirts v overselling amphetamines: a tale of two entrepreneurs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Citizen, Hlth Res Grp, Washington, DC USA		Wolfe, SM (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC USA.	Swolfe@citizen.org						Mintzes B, 2009, FUTURE MED CHEM, V1, P1555, DOI [10.4155/fmc.09.136, 10.4155/FMC.09.136]; Taylor V., 2013, NEW YORK DAILY NEWS	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2013	347								F6215	10.1136/bmj.f6215	http://dx.doi.org/10.1136/bmj.f6215			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WP	24136796				2022-12-24	WOS:000325982700008
J	Catic, A; Suh, CY; Hill, CT; Daheron, L; Henkel, T; Orford, KW; Dombkowski, DM; Liu, T; Liu, XS; Scadden, DT				Catic, Andre; Suh, Carol Y.; Hill, Cedric T.; Daheron, Laurence; Henkel, Theresa; Orford, Keith W.; Dombkowski, David M.; Liu, Tao; Liu, X. Shirley; Scadden, David T.			Genome-wide Map of Nuclear Protein Degradation Shows NCoR1 Turnover as a Key to Mitochondrial Gene Regulation	CELL			English	Article							TRANSCRIPTIONAL ACTIVATION; LIGASE SIAH2; CREB; PROTEOLYSIS; REPRESSION; HYPOXIA; ADIPOGENESIS; EXPRESSION; RECEPTORS; CHROMATIN	Transcription factor activity and turnover are functionally linked, but the global patterns by which DNA-bound regulators are eliminated remain poorly understood. We established an assay to define the chromosomal location of DNA-associated proteins that are slated for degradation by the ubiquitin-proteasome system. The genome-wide map described here ties proteolysis in mammalian cells to active enhancers and to promoters of specific gene families. Nuclear-encoded mitochondrial genes in particular correlate with protein elimination, which positively affects their transcription. We show that the nuclear receptor corepressor NCoR1 is a key target of proteolysis and physically interacts with the transcription factor CREB. Proteasome inhibition stabilizes NCoR1 in a site-specific manner and restrains mitochondrial activity by repressing CREB-sensitive genes. In conclusion, this functional map of nuclear proteolysis links chromatin architecture with local protein stability and identifies proteolytic derepression as highly dynamic in regulating the transcription of genes involved in energy metabolism.	[Catic, Andre; Suh, Carol Y.; Hill, Cedric T.; Henkel, Theresa; Orford, Keith W.; Dombkowski, David M.; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Catic, Andre; Suh, Carol Y.; Hill, Cedric T.; Daheron, Laurence; Henkel, Theresa; Orford, Keith W.; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Catic, Andre; Daheron, Laurence; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Henkel, Theresa] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Dombkowski, David M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Liu, Tao; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, Tao; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Liu, Tao; Liu, X. Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Catic, A (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	catic@post.harvard.edu; david_scadden@harvard.edu	Liu, Tao/AAO-6310-2021; Liu, Tao/G-3585-2010	Liu, Tao/0000-0002-8818-8313; Liu, Tao/0000-0002-8818-8313; Liu, Tao/0000-0003-0446-9001; Catic, Andre/0000-0002-3572-7598	Margaret Dammann Eisner Foundation; National Institute on Aging [K01-AG036744]; NIH [DK050234]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG036744] Funding Source: NIH RePORTER	Margaret Dammann Eisner Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Carlota Dao, Laura Prickett-Rice, Kat Folz-Donahue, Meredith Weglarz, Katherine Kulig, Christa Buecker, Hsu-Hsin Chen, Mark Borowsky, Caroline Woo, Youn-Kyoung Lee, Alison Brown, and Vance Morgan for support. T.H. is a fellow of the German National Academic Foundation. A.C. appreciates mentorship by Daniel Finley, Robert Kingston, Derrick Rossi, and Ron Kohanski (NIH/NIA). A.C. is an Irvington Fellow of the Cancer Research Institute and is supported by the Margaret Dammann Eisner Foundation and by National Institute on Aging grant K01-AG036744. D.T.S. is supported by NIH grant DK050234. We thank the reviewers for constructive suggestions and apologize for references we could not include.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Carlucci A, 2008, EMBO J, V27, P1073, DOI 10.1038/emboj.2008.33; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Kim H, 2011, MOL CELL, V44, P532, DOI 10.1016/j.molcel.2011.08.045; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kriegenburg F, 2008, CELL, V135, P355, DOI 10.1016/j.cell.2008.08.032; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Rubenstein EM, 2010, CELL CYCLE, V9, P4282, DOI 10.4161/cc.9.21.13741; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	38	38	38	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1380	1395		10.1016/j.cell.2013.11.016	http://dx.doi.org/10.1016/j.cell.2013.11.016			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315104	Green Accepted, Bronze			2022-12-24	WOS:000328271100020
J	Caudron, F; Barral, Y				Caudron, Fabrice; Barral, Yves			A Super-Assembly of Whi3 Encodes Memory of Deceptive Encounters by Single Cells during Yeast Courtship	CELL			English	Article							ALPHA-FACTOR PHEROMONE; SACCHAROMYCES-CEREVISIAE; MATING PHEROMONE; MAPK PATHWAYS; APLYSIA CPEB; G1 CYCLINS; PRION; GENE; PROTEINS; RNA	Cellular behavior is frequently influenced by the cell's history, indicating that single cells may memorize past events. We report that budding yeast permanently escape pheromone-induced cell-cycle arrest when experiencing a deceptive mating attempt, i.e., not reaching their putative partner within reasonable time. This acquired behavior depends on super-assembly and inactivation of the G1/S inhibitor Whi3, which liberates the G1 cyclin Cln3 from translational inhibition. Super-assembly of Whi3 is a slow response to pheromone, driven by polyQ and polyN domains, counteracted by Hsp70, and stable over generations. Unlike prion aggregates, Whi3 super-assemblies are not inherited mitotically but segregate to the mother cell. We propose that such polyQ- and polyN-based elements, termed here mnemons, act as cellular memory devices to encode previous environmental conditions.	[Caudron, Fabrice; Barral, Yves] ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Barral, Y (corresponding author), ETH, Inst Biochem, Dept Biol, Schafmattstr 18, CH-8093 Zurich, Switzerland.	yves.barral@bc.biol.ethz.ch	Caudron, Fabrice/AAE-3039-2021	Caudron, Fabrice/0000-0001-5159-1507; Barral, Yves/0000-0002-0989-3373	European Research Council	European Research Council(European Research Council (ERC)European Commission)	We would like to thank R. Dechant and M. Peter for help with cell-size measurements; M. Bayer for the 3GFP construct; B. Futcher, E. Gari, and B. Errede for strains and plasmids; the Light Microscopy and Screening Center of ETH Zurich for microscopy support; U. Kutay, P. Meraldi, R. Kroschewski, C. Weirich, and A.M. Farcas for critical reading of the manuscript; and S. Alberti, P. Picotti, Y. Feng, M. Krzyzanowski, and the whole Barral group for discussions. F.C. and Y.B. are supported by a grant of the European Research Council to Y.B.	ACHSTETTER T, 1989, MOL CELL BIOL, V9, P4507, DOI 10.1128/MCB.9.10.4507; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Arkowitz RA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001958; Blackwell E, 2003, MOL CELL BIOL, V23, P1135, DOI 10.1128/MCB.23.4.1135-1150.2003; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Colomina N, 2008, J BIOL CHEM, V283, P28670, DOI 10.1074/jbc.M804604200; COURCHESNE WE, 1989, CELL, V58, P1107, DOI 10.1016/0092-8674(89)90509-6; DIRICK L, 1991, NATURE, V351, P754, DOI 10.1038/351754a0; Dohlman HG, 2009, PROG MOL BIOL TRANSL, V86, P1, DOI 10.1016/S1877-1173(09)86001-8; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; Erdman S, 2001, GENETICS, V159, P919; Gari E, 2001, GENE DEV, V15, P2803; Guthrie C., 2004, GUIDE YEAST GENETICS, P933; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; HAGEN DC, 1986, P NATL ACAD SCI USA, V83, P1418, DOI 10.1073/pnas.83.5.1418; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Heinrich SU, 2011, P NATL ACAD SCI USA, V108, P2999, DOI 10.1073/pnas.1019368108; Houser JR, 2012, YEAST, V29, P519, DOI 10.1002/yea.2932; JENNESS DD, 1983, CELL, V35, P521, DOI 10.1016/0092-8674(83)90186-1; JENNESS DD, 1986, CELL, V46, P345, DOI 10.1016/0092-8674(86)90655-0; Jin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001763; Kabani M, 2011, PRION, V5, P277, DOI [10.4161/pri.5.4.18070, 10.4161/pri.18070]; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kilian AE, 2002, ICONIP'02: PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON NEURAL INFORMATION PROCESSING, P296; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Korenbrot JI, 2012, PROG RETIN EYE RES, V31, P442, DOI 10.1016/j.preteyeres.2012.05.002; Lee C, 2013, DEV CELL, V25, P572, DOI 10.1016/j.devcel.2013.05.007; Lee REC, 2010, P NATL ACAD SCI USA, V107, P13348, DOI 10.1073/pnas.1006610107; Mayford M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005751; Molina M, 2010, YEAST, V27, P503, DOI 10.1002/yea.1791; MOORE SA, 1984, J BIOL CHEM, V259, P1004; Nash RS, 2001, GENETICS, V157, P1469; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; SCHANDEL KA, 1994, MOL CELL BIOL, V14, P7245, DOI 10.1128/MCB.14.11.7245; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Slessareva JE, 2006, SCIENCE, V314, P1412, DOI 10.1126/science.1134041; SPRAGUE GF, 1981, J MOL BIOL, V153, P305, DOI 10.1016/0022-2836(81)90280-1; STRAZDIS JR, 1983, NATURE, V305, P543, DOI 10.1038/305543a0; Sweeny EA, 2008, PRION, V2, P135, DOI 10.4161/pri.2.4.7952; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; TYERS M, 1993, MOL CELL BIOL, V13, P5659, DOI 10.1128/MCB.13.9.5659; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568	51	98	99	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1244	1257		10.1016/j.cell.2013.10.046	http://dx.doi.org/10.1016/j.cell.2013.10.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315096	Bronze			2022-12-24	WOS:000328271100010
J	Okada-Iwabu, M; Yamauchi, T; Iwabu, M; Honma, T; Hamagami, K; Matsuda, K; Yamaguchi, M; Tanabe, H; Kimura-Someya, T; Shirouzu, M; Ogata, H; Tokuyama, K; Ueki, K; Nagano, T; Tanaka, A; Yokoyama, S; Kadowaki, T				Okada-Iwabu, Miki; Yamauchi, Toshimasa; Iwabu, Masato; Honma, Teruki; Hamagami, Ken-ichi; Matsuda, Koichi; Yamaguchi, Mamiko; Tanabe, Hiroaki; Kimura-Someya, Tomomi; Shirouzu, Mikako; Ogata, Hitomi; Tokuyama, Kumpei; Ueki, Kohjiro; Nagano, Tetsuo; Tanaka, Akiko; Yokoyama, Shigeyuki; Kadowaki, Takashi			A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ADIPONECTIN LEVELS; SKELETAL-MUSCLE; CRUCIAL ROLE; DISEASE; INFLAMMATION; MECHANISMS; EXPRESSION	Adiponectin secreted from adipocytes binds to adiponectin receptors AdipoR1 and AdipoR2, and exerts antidiabetic effects via activation of AMPK and PPAR-alpha pathways, respectively. Levels of adiponectin in plasma are reduced in obesity, which causes insulin resistance and type 2 diabetes. Thus, orally active small molecules that bind to and activate AdipoR1 and AdipoR2 could ameliorate obesity-related diseases such as type 2 diabetes. Here we report the identification of orally active synthetic small-molecule AdipoR agonists. One of these compounds, AdipoR agonist (AdipoRon), bound to both AdipoR1 and AdipoR2 in vitro. AdipoRon showed very similar effects to adiponectin in muscle and liver, such as activation of AMPK and PPAR-alpha pathways, and ameliorated insulin resistance and glucose intolerance in mice fed a high-fat diet, which was completely obliterated in AdipoR1 and AdipoR2 double-knockout mice. Moreover, AdipoRon ameliorated diabetes of genetically obese rodent model db/db mice, and prolonged the shortened lifespan of db/db mice on a high-fat diet. Thus, orally active AdipoR agonists such as AdipoRon are a promising therapeutic approach for the treatment of obesity-related diseases such as type 2 diabetes.	[Okada-Iwabu, Miki; Yamauchi, Toshimasa; Iwabu, Masato; Hamagami, Ken-ichi; Matsuda, Koichi; Yamaguchi, Mamiko; Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1130033, Japan; [Okada-Iwabu, Miki; Yamauchi, Toshimasa; Iwabu, Masato; Kadowaki, Takashi] Univ Tokyo, Dept Integrated Mol Sci Metab Dis, 22nd Century Med & Res Ctr, Tokyo 1130033, Japan; [Okada-Iwabu, Miki; Yamauchi, Toshimasa; Kadowaki, Takashi] Univ Tokyo, Dept Mol Med Sci Metab Regulat, 22nd Century Med & Res Ctr, Tokyo 1130033, Japan; [Honma, Teruki; Tanabe, Hiroaki; Kimura-Someya, Tomomi; Shirouzu, Mikako; Tanaka, Akiko; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Ogata, Hitomi; Tokuyama, Kumpei] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Nagano, Tetsuo; Tanaka, Akiko] Univ Tokyo, Open Innovat Ctr Drug Discovery, Bunkyo Ku, Tokyo 1130033, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo; RIKEN; University of Tsukuba; University of Tokyo; University of Tokyo	Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1130033, Japan.	tyamau-tky@umin.net; kadowaki-3im@h.u-tokyo.ac.jp	Kimura-Someya, Tomomi/C-4169-2017; Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016	Kimura-Someya, Tomomi/0000-0003-2232-1801; Yokoyama, Shigeyuki/0000-0003-3133-7338; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [20229008, 25221307, 23689048]; Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Translational Research Network Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Cabinet Office, Government of Japan; Grants-in-Aid for Scientific Research [24790908] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Translational Research Network Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Cabinet Office, Government of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Kubota, K. Hara, I. Takamoto, Y. Hada, T. Kobori, H. Umematsu, S. Odawara, T. Aoyama, Y. Jing, S. Wei, K. Soeda and H. Waki for technical help and support; and K. Miyata, Y. Nishibaba, M. Yuasa and A. Hayashi for technical assistance and support. This work was supported by a Grant-in-aid for Scientific Research (S) (20229008, 25221307) (to T.K.), Grant-in-aid for Young Scientists (A) (23689048) (to M.I.), Targeted Proteins Research Program (to T.K.), the Global COE Research Program (to T.K.), Translational Systems Biology and Medicine Initiative (to T.K.) and Translational Research Network Program (to M.O.-I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Funding Program for Next Generation World-Leading Researchers (NEXT Program) (to T.Y.) from Cabinet Office, Government of Japan.	Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; LeRoith D, 2008, NAT CLIN PRACT ENDOC, V4, P164, DOI 10.1038/ncpendmet0729; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osler ME, 2008, ENDOCRINOLOGY, V149, P935, DOI 10.1210/en.2007-1441; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032746	42	430	458	9	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					493	+		10.1038/nature12656	http://dx.doi.org/10.1038/nature12656			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24172895				2022-12-24	WOS:000327464200036
J	Elder, RW				Elder, Robert W.			Learning From Improbable Longevity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Elder, Robert W.] Yale Univ, Sch Med, Dept Pediat, Sect Pediat Cardiol, New Haven, CT 06510 USA; [Elder, Robert W.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University; Yale University	Elder, RW (corresponding author), Yale Univ, Sch Med, Dept Pediat, Sect Pediat Cardiol, New Haven, CT 06510 USA.	robert.elder@yale.edu		Elder, Robert/0000-0002-4956-8604				Book Wendy, 2006, Congenit Heart Dis, V1, P233, DOI 10.1111/j.1747-0803.2006.00041.x; Kirklin JW, 1993, CARDIAC SURGERY MORP; MCGOON DC, 1968, J AMER MED ASSOC, V205, P69, DOI 10.1001/jama.205.2.69	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2041	2042		10.1001/jama.2013.276685	http://dx.doi.org/10.1001/jama.2013.276685			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240928				2022-12-24	WOS:000327098900017
J	Heyman, J; Cools, T; Vandenbussche, F; Heyndrickx, KS; Van Leene, J; Vercauteren, I; Vanderauwera, S; Vandepoele, K; De Jaeger, G; Van Der Straeten, D; De Veylder, L				Heyman, Jefri; Cools, Toon; Vandenbussche, Filip; Heyndrickx, Ken S.; Van Leene, Jelle; Vercauteren, Ilse; Vanderauwera, Sandy; Vandepoele, Klaas; De Jaeger, Geert; Van Der Straeten, Dominique; De Veylder, Lieven			ERF115 Controls Root Quiescent Center Cell Division and Stem Cell Replenishment	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; PHYTOSULFOKINE; MERISTEM; GROWTH; PROLIFERATION; MAINTENANCE; COMPLEX; FATE	The quiescent center (QC) plays an essential role during root development by creating a microenvironment that preserves the stem cell fate of its surrounding cells. Despite being surrounded by highly mitotic active cells, QC cells self-renew at a low proliferation rate. Here, we identified the ERF115 transcription factor as a rate-limiting factor of QC cell division, acting as a transcriptional activator of the phytosulfokine PSK5 peptide hormone. ERF115 marks QC cell division but is restrained through proteolysis by the APC/C-CCS52A2 ubiquitin ligase, whereas QC proliferation is driven by brassinosteroid-dependent ERF115 expression. Together, these two antagonistic mechanisms delimit ERF115 activity, which is called upon when surrounding stem cells are damaged, revealing a cell cycle regulatory mechanism accounting for stem cell niche longevity.	[Heyman, Jefri; Cools, Toon; Heyndrickx, Ken S.; Van Leene, Jelle; Vercauteren, Ilse; Vanderauwera, Sandy; Vandepoele, Klaas; De Jaeger, Geert; De Veylder, Lieven] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Heyman, Jefri; Cools, Toon; Heyndrickx, Ken S.; Van Leene, Jelle; Vercauteren, Ilse; Vanderauwera, Sandy; Vandepoele, Klaas; De Jaeger, Geert; De Veylder, Lieven] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Vandenbussche, Filip; Van Der Straeten, Dominique] Univ Ghent, Dept Physiol, Lab Funct Plant Biol, Fac Sci, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University	De Veylder, L (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	lieven.deveylder@psb.vib-ugent.be	de veylder, lieven/AAM-9909-2020; Vandepoele, Klaas/E-7514-2010; Van Der Straeten, Dominique/E-7385-2016; Van Leene, Jelle/ABE-6697-2020	de veylder, lieven/0000-0003-1150-4426; Vandepoele, Klaas/0000-0003-4790-2725; Van Der Straeten, Dominique/0000-0002-7755-1420; Van Leene, Jelle/0000-0002-4932-8192; De Jaeger, Geert/0000-0001-6558-5669	Ghent University; Interuniversity Attraction Poles Programme [IUAP P7/29]; Belgian Science Policy Office; Ghent University-Bijzonder Onderzoeksfonds; Research Foundation-Flanders [G.029809, G.022.10N]; Agency for Innovation by Science and Technology	Ghent University(Ghent University); Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); Ghent University-Bijzonder Onderzoeksfonds; Research Foundation-Flanders(FWO); Agency for Innovation by Science and Technology	The authors thank M. Sauter for sharing the pskr1-3 mutant and A. Bleys and M. De Cock for help in preparing the manuscript. This work was supported by Ghent University (Multidisciplinary Research Partnership Bioinformatics: From nucleotides to networks); theInteruniversity Attraction Poles Programme (IUAP P7/29 MARS), initiated by the Belgian Science Policy Office; Ghent University-Bijzonder Onderzoeksfonds (to D. V. D. S.); and Research Foundation-Flanders (grants G.029809 and G.022.10N to D. V. D. S. and L. D. V., respectively). K. S. H. is indebted to the Agency for Innovation by Science and Technology for a predoctoral fellowship. T. C., F. V., and J.V.L. are Postdoctoral Fellows of the Research Foundation-Flanders. Microarray and sequencing data have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo under accession nos. GSE48836 and GSE48793, respectively. J.H. and L. D. V. are inventors on a patent application filed by Ghent University and Vlaams Instituut voor Biotechnologie that covers the use of ERF115 to modulate plant growth through phytosulfokine gene expression.	Amano Y, 2007, P NATL ACAD SCI USA, V104, P18333, DOI 10.1073/pnas.0706403104; Bergonie J, 1906, CR HEBD ACAD SCI, V143, P983; Boudolf V, 2009, PLANT PHYSIOL, V150, P1482, DOI 10.1104/pp.109.140269; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; CLOWES F. A. L., 1959, ANN BOT [LONDON], V23, P205; CLOWES FA, 1961, EXP CELL RES, V25, P529, DOI 10.1016/0014-4827(61)90188-4; FUJIE M, 1993, J EXP BOT, V44, P689, DOI 10.1093/jxb/44.4.689; Fulcher N, 2009, P NATL ACAD SCI USA, V106, P20984, DOI 10.1073/pnas.0909218106; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Hartmann J, 2013, PLANT J, V73, P579, DOI 10.1111/tpj.12056; Ikeda M, 2009, PLANT CELL PHYSIOL, V50, P970, DOI 10.1093/pcp/pcp048; Kidner C, 2000, PLANTA, V211, P191, DOI 10.1007/s004250000284; Kutschmar A, 2009, NEW PHYTOL, V181, P820, DOI 10.1111/j.1469-8137.2008.02710.x; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Matsubayashi Y, 2004, PLANT CELL REP, V23, P155, DOI 10.1007/s00299-004-0816-9; Ortega-Martinez O, 2007, SCIENCE, V317, P507, DOI 10.1126/science.1143409; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Stuhrwohldt N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021054; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Vanstraelen M, 2009, P NATL ACAD SCI USA, V106, P11806, DOI 10.1073/pnas.0901193106; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Yang HP, 2001, PLANT PHYSIOL, V127, P842, DOI 10.1104/pp.010452	25	186	195	10	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					860	863		10.1126/science.1240667	http://dx.doi.org/10.1126/science.1240667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24158907	Bronze			2022-12-24	WOS:000326923000039
J	Sherman, RE; Li, J; Shapley, S; Robb, M; Woodcock, J				Sherman, Rachel E.; Li, Jun; Shapley, Stephanie; Robb, Melissa; Woodcock, Janet			Expediting Drug Development - The FDA's New "Breakthrough Therapy" Designation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sherman, Rachel E.; Li, Jun; Shapley, Stephanie; Robb, Melissa; Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Sherman, RE (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.							Food and Drug Administration, GUID IND EXP PROGR S	1	92	98	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1877	1880		10.1056/NEJMp1311439	http://dx.doi.org/10.1056/NEJMp1311439			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300MP	24224621				2022-12-24	WOS:000330468300005
J	Behrman, A; Offley, W				Behrman, Amy; Offley, Will			Should influenza vaccination be mandatory for healthcare workers?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOME STAFF; IMMUNIZATION; MORTALITY; RESIDENTS; CANADA		[Behrman, Amy] Univ Penn Hlth Syst, Philadelphia, PA 19104 USA; [Offley, Will] Vancouver Gen Hosp, Emergency Dept, Vancouver, BC, Canada	University of Pennsylvania; University of British Columbia	Behrman, A (corresponding author), Univ Penn Hlth Syst, 3400 Spruce St, Philadelphia, PA 19104 USA.	behrman@mail.med.upenn.edu; willo@lynx.bc.ca						American College of Occupational and Environmental Medicine, 2008, SEAS INFL PREV HLTH; American College of Physicians, 2010, ACP POL INFL VACC HL; American Public Health Association, 2010, ANN INFL VACC REQ HL; [Anonymous], 2012, HOSP INF CONTR PREV; [Anonymous], COMPELLING NEED GAME; [Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD005187.PUB4; Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; Bernstein HH, 2010, PEDIATRICS, V126, P809, DOI 10.1542/peds.2010-2376; Bryce E, 2012, CAN J INFECT DIS MED, V23, pE93, DOI 10.1155/2012/756824; Caplan A, 2011, LANCET, V378, P310, DOI 10.1016/S0140-6736(11)61156-2; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; Centers for Disease Control and Prevention, 2013, EST SEAS INFL ASS DE; De Serres G, 2012, CMAJ, V184, P1873; deSante JE, 2010, VACCINE, V28, P2517, DOI 10.1016/j.vaccine.2010.01.042; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3037; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; Gaughan BA., 2010, AM J INFECT CONTROL, V38, pe51; Grohskopf LA, 2013, MMWR RECOMM REP, V62, P1; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; Hayward AC, 2006, BRIT MED J, V333, P1241, DOI 10.1136/bmj.39010.581354.55; Hollmeyer H, 2013, INFLUENZA OTHER RESP, V7, P604, DOI 10.1111/irv.12002; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P119; Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lemaitre M, 2009, J AM GERIATR SOC, V57, P1580, DOI 10.1111/j.1532-5415.2009.02402.x; Murphy S. L., 2013, NATL VITAL STAT REPO, V61; Neuzil KM, 2013, JAMA-J AM MED ASSOC, V310, P1681, DOI 10.1001/jama.2013.279207; Pebody R., 2013, EURO SURVEILL, V18; Rakita RM, 2010, INFECT CONT HOSP EP, V31, P881, DOI 10.1086/656210; Shefer A, 2011, MMWR-MORBID MORTAL W, V60, P8; Shugarman LR, 2006, J AM MED DIR ASSOC, V7, P562, DOI 10.1016/j.jamda.2006.06.002; Skowronski DM, 2013, EUROSURVEILLANCE, V18, P7; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2005, PEDIATR INFECT DIS J, V24, P63, DOI 10.1097/01.inf.0000148924.89558.d5; Stokes BP, 2010, MINISTERIAL REV PUBL; Talbot TR, 2010, INFECT CONT HOSP EP, V31, P987, DOI 10.1086/656558; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; van den Dool C, 2009, VACCINE, V27, P6261, DOI 10.1016/j.vaccine.2009.07.104; van den Dool C, 2008, PLOS MED, V5, P1453, DOI 10.1371/journal.pmed.0050200; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908	41	7	8	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2013	347								f6705	10.1136/bmj.f6705	http://dx.doi.org/10.1136/bmj.f6705			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254FR	24222482				2022-12-24	WOS:000327150600005
J	Guerreiro, R; Bras, J; Hardy, J				Guerreiro, Rita; Bras, Jose; Hardy, John			SnapShot: Genetics of Alzheimer's Disease	CELL			English	Editorial Material									[Guerreiro, Rita; Bras, Jose; Hardy, John] UCL, Reta Lilla Weston Inst, London WC1N 1PJ, England	University of London; University College London	Guerreiro, R (corresponding author), UCL, Reta Lilla Weston Inst, London WC1N 1PJ, England.		Guerreiro, Rita J L/A-1327-2011; Hardy, John/C-2451-2009; Bras, Jose MT/A-1428-2011	Hardy, John/0000-0002-3122-0423; Guerreiro, Rita/0000-0001-5879-3486; Bras, Jose/0000-0001-8186-0333	Alzheimers Research UK [ARUK-TRFUS2012-3] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish; Parkinson&apos;s UK [G-0907] Funding Source: Medline	Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Parkinson&quot;s UK(Parkinson&apos;s UK); Parkinson&apos;s UK(Parkinson&apos;s UK)		Bras J, 2012, NAT REV NEUROSCI, V13, P453, DOI 10.1038/nrn3271; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494	6	73	75	4	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					968	+		10.1016/j.cell.2013.10.037	http://dx.doi.org/10.1016/j.cell.2013.10.037			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209629	Bronze			2022-12-24	WOS:000326934300025
J	Hoy, WE				Hoy, Wendy E.			PERSONAL VIEW Chronic disease care in remote Aboriginal Australia has been transformed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE; TREATMENT PROGRAM; HEALTH; GAP		Univ Queensland, Sch Med, Ctr Chron Dis, Brisbane, Qld, Australia	University of Queensland	Hoy, WE (corresponding author), Univ Queensland, Sch Med, Ctr Chron Dis, Brisbane, Qld, Australia.	w.hoy@uq.edu.au	Hoy, Wendy E/A-7325-2010	Hoy, Wendy E/0000-0002-8405-1539				Andreasyan K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-483; Australia and New Zealand Dialysis and Transplant Registry, 2010, END STAG KIDN DIS IN; Australian Government Department for Health, HLTH LIF PROGR AB TO; Australian Government National Health and Medical Research Council (NHMRC), IND HLTH; Australian Government Pharmacy Guild of Australia, 2012, QUAL US MED MAX AB T; Baker PR, 2005, ADV CHRONIC KIDNEY D, V12, P22, DOI 10.1053/j.ackd.2004.10.001; Central Australian Rural Practitioners Association Inc (CARPA), 2012, CARPA REF MAN; Eades SJ, 2010, MED J AUSTRALIA, V193, P521, DOI 10.5694/j.1326-5377.2010.tb04036.x; Hoy WE, 2003, J AM SOC NEPHROL, V14, pS178, DOI 10.1097/01.ASN.0000070033.86955.48; Hoy WE, 2006, ETHNIC DIS, V16; Hoy WE, 2013, NEPHROLOGY, V18, pS1; Hoy WE, 2012, LANCET, V379, P1101, DOI 10.1016/S0140-6736(12)60458-9; Hoy WE, 2010, AUST NZ J PUBL HEAL, V34, P11, DOI 10.1111/j.1753-6405.2010.00467.x; Hoy WE, 2010, MED J AUSTRALIA, V192, P14, DOI 10.5694/j.1326-5377.2010.tb03394.x; Hoy WE, 2009, MED J AUSTRALIA, V190, P542, DOI 10.5694/j.1326-5377.2009.tb02555.x; National Aboriginal Community Controlled Health Organisation (NACCHO), 2012, AD PREV HTLH LIF CYC; National Aboriginal Community Controlled Health Organisation (NACCHO), NACCHO ABORIGINAL HL; Passey ME, 2013, MED J AUSTRALIA, V199, P39, DOI 10.5694/mja12.11848	18	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2013	347								F6127	10.1136/bmj.f6127	http://dx.doi.org/10.1136/bmj.f6127			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WQ	24141604				2022-12-24	WOS:000325982800001
J	Kirschner, N; Ginsburg, J; Sulmasy, LS				Kirschner, Neil; Ginsburg, Jack; Sulmasy, Lois Snyder		Hlth Public Policy Comm Amer Coll	Prescription Drug Abuse: Executive Summary of a Policy Position Paper From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							PAIN		[Kirschner, Neil; Ginsburg, Jack; Sulmasy, Lois Snyder] Amer Coll Physicians, Philadelphia, PA USA	American College of Physicians	Kirschner, N (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	nkirschner@acponline.org		Arora, Vineet/0000-0002-4745-7599				Centers for Disease Control and Prevention, 2013, OP DRIV CONT INCR DR; Centers for Disease Control and Prevention, 2010, NSDUH SER H; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Furrow BR, 2001, J LAW MED ETHICS, V29, P28; Girion Lisa, 2012, LOS ANGELES TIMES; Government Accountability Office, 2011, GAO12115; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Lembke A, 2012, NEW ENGL J MED, V367, P1580, DOI 10.1056/NEJMp1208498; National Institute of Drug Abuse, 2011, COMM AB PRESCR DRUGS; National Institute on Drug Abuse, 2013, TOP BRIEF DRUG AB PR; National Institute on Drug Abuse, 2011, RES REP PRESCR DRUGS; Partnership for a Drug-Free America and MetLife Foundation, 2011, 2010 PARTN ATT TRACK; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Substance Abuse and Mental Health Services Administration, 2011, NSDUH SER H	14	48	48	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 4	2014	160	3					198	+		10.7326/M13-2209	http://dx.doi.org/10.7326/M13-2209			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA2VE	24323199				2022-12-24	WOS:000330951500007
J	Moss, RH; Meehl, GA; Lemos, MC; Smith, JB; Arnold, JR; Arnott, JC; Behar, D; Brasseur, GP; Broomell, SB; Busalacchi, AJ; Dessai, S; Ebi, KL; Edmonds, JA; Furlow, J; Goddard, L; Hartmann, HC; Hurrell, JW; Katzenberger, JW; Liverman, DM; Mote, PW; Moser, SC; Kumar, A; Pulwarty, RS; Seyller, EA; Turner, BL; Washington, WM; Wilbanks, TJ				Moss, R. H.; Meehl, G. A.; Lemos, M. C.; Smith, J. B.; Arnold, J. R.; Arnott, J. C.; Behar, D.; Brasseur, G. P.; Broomell, S. B.; Busalacchi, A. J.; Dessai, S.; Ebi, K. L.; Edmonds, J. A.; Furlow, J.; Goddard, L.; Hartmann, H. C.; Hurrell, J. W.; Katzenberger, J. W.; Liverman, D. M.; Mote, P. W.; Moser, S. C.; Kumar, A.; Pulwarty, R. S.; Seyller, E. A.; Turner, B. L., II; Washington, W. M.; Wilbanks, T. J.			Hell and High Water: Practice-Relevant Adaptation Science	SCIENCE			English	Editorial Material							CLIMATE					rhm@pnnl.gov	Mote, Philip/AAB-3500-2021; Dessai, Suraje/D-4219-2009; Arnott, James/O-1029-2015; , AK/B-6517-2008	Dessai, Suraje/0000-0002-7879-9364; Arnott, James/0000-0003-3989-6724; Hurrell, James Wilson/0000-0002-3169-6384; Moss, Richard/0000-0001-5005-0063; Lemos, Maria Carmen/0000-0001-6686-730X	ESRC [ES/K006576/1] Funding Source: UKRI; Economic and Social Research Council [ES/K006576/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2013, SUCCESSFUL ADAPTATIO; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Bierbaum R, 2013, MITIG ADAPT STRAT GL, V18, P361, DOI 10.1007/s11027-012-9423-1; Brown C, 2011, J AM WATER RESOUR AS, V47, P524, DOI 10.1111/j.1752-1688.2011.00552.x; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; Council on Environmental Quality (CEQ), 2010, PROGR REP INT AD TAS; Dilling L, 2011, GLOBAL ENVIRON CHANG, V21, P680, DOI 10.1016/j.gloenvcha.2010.11.006; Dow K, 2013, NAT CLIM CHANGE, V3, P305, DOI 10.1038/nclimate1847; Hewitt C, 2012, NAT CLIM CHANGE, V2, P831, DOI 10.1038/nclimate1745; Hurrell J, 2009, B AM METEOROL SOC, V90, P1819, DOI 10.1175/2009BAMS2752.1; Kerr RA, 2011, SCIENCE, V334, P1052, DOI 10.1126/science.334.6059.1052; Kucharski F, 2013, B AM METEOROL SOC, V94, P25, DOI 10.1175/BAMS-D-11-00238.1; Lemos MC, 2012, NAT CLIM CHANGE, V2, P789, DOI [10.1038/NCLIMATE1614, 10.1038/nclimate1614]; Mearns LO, 2012, B AM METEOROL SOC, V93, P1337, DOI 10.1175/BAMS-D-11-00223.1; Meehl GA, 2014, B AM METEOROL SOC, V95, P243, DOI 10.1175/BAMS-D-12-00241.1; National Research Council, 2010, AM CLIM CHOIC INF EF; National Research Council, 2009, INF DEC CHANG CLIM; National Research Council, 2010, AM CLIM CHOIC AD IMP; National Research Council, 2012, NAT STRAT ADV CLIM M; Palmer TN, 2008, B AM METEOROL SOC, V89, P459, DOI 10.1175/BAMS-89-4-459; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Pulwarty R. S., 2009, INTEGRATED REGIONAL, P367; Smith DM, 2013, CLIM DYNAM, V41, P3325, DOI 10.1007/s00382-013-1683-2; Stern PC, 2013, NAT CLIM CHANGE, V3, P607, DOI 10.1038/nclimate1929; Tang S, 2012, WEATHER CLIM SOC, V4, P300, DOI 10.1175/WCAS-D-12-00028.1; Tompkins EL, 2008, J ENVIRON MANAGE, V88, P1580, DOI 10.1016/j.jenvman.2007.07.025; U.S. National Research Council, 2012, REV US GLOB CHANG RE; Wilby R.L., 2011, MODELLING IMPACT CLI, P34, DOI 10.1002/9781444324921.ch1; Zwiers F. W., 2013, CLIMATE SCI SERVING, P339, DOI [DOI 10.1007/978-94-007-6692-1_13, 10.1007/978-94-007-6692-1_13]	29	136	138	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					696	698		10.1126/science.1239569	http://dx.doi.org/10.1126/science.1239569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247UK	24202163	Green Submitted			2022-12-24	WOS:000326647600026
J	Shen, B; Zhao, XJ; O'Brien, KA; Stojanovic-Terpo, A; Delaney, MK; Kim, K; Cho, J; Lam, SCT; Du, XP				Shen, Bo; Zhao, Xiaojuan; O'Brien, Kelly A.; Stojanovic-Terpo, Aleksandra; Delaney, M. Keegan; Kim, Kyungho; Cho, Jaehyung; Lam, Stephen C. -T.; Du, Xiaoping			A directional switch of integrin signalling and a new anti-thrombotic strategy	NATURE			English	Article							OUTSIDE-IN; INSIDE-OUT; STRUCTURAL BASIS; TALIN-BINDING; ACTIVATION; FIBRINOGEN; ADHESION; DOMAIN; ROLES	Integrins have a critical role in thrombosis and haemostasis(1). Antagonists of the platelet integrin alpha(IIb)beta(3) are potent anti-thrombotic drugs, but also have the life-threatening adverse effect of causing bleeding(2,3). It is therefore desirable to develop new antagonists that do not cause bleeding. Integrins transmit signals bidirectionally(4,5). Inside-out signalling activates integrins through a talin-dependent mechanism(6,7). Integrin ligation mediates thrombus formation and outside-in signalling(8,9), which requires G alpha(13) and greatly expands thrombi. Here we show that G alpha(13) and talin bind to mutually exclusive but distinct sites within the integrin beta(3) cytoplasmic domain in opposing waves. The first talin-binding wave mediates inside-out signalling and also ligand-induced integrin activation, but is not required for outside-in signalling. Integrin ligation induces transient talin dissociation and G alpha(13) binding to an EXE motif (in which X denotes any residue), which selectively mediates outside-in signalling and platelet spreading. The second talin-binding wave is associated with clot retraction. An EXE-motif-based inhibitor of G alpha(13)-integrin interaction selectively abolishes outside-in signalling without affecting integrin ligation, and suppresses occlusive arterial thrombosis without affecting bleeding time. Thus, we have discovered a new mechanism for the directional switch of integrin signalling and, on the basis of this mechanism, designed a potent new anti-thrombotic drug that does not cause bleeding.	[Shen, Bo; Zhao, Xiaojuan; O'Brien, Kelly A.; Stojanovic-Terpo, Aleksandra; Delaney, M. Keegan; Kim, Kyungho; Cho, Jaehyung; Lam, Stephen C. -T.; Du, Xiaoping] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Du, XP (corresponding author), Univ Illinois, Dept Pharmacol, 835 South Wolcott Ave, Chicago, IL 60612 USA.	xdu@uic.edu	Shen, Bo/G-2012-2014	Shen, Bo/0000-0002-5237-6144; Cho, Jaehyung/0000-0003-2404-3446	National Heart, Lung, and Blood Institute [HL080264, HL062350, HL109439]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062350, R01HL080264, R01HL109439, T32HL007829] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Kozasa, B. Kreutz and C. Chow for providing purified recombinant G alpha<INF>13</INF> protein; and B. Petrich and D. Critchley for providing talin<SUP>-/-</SUP> mice. We acknowledge that H. Gong performed experiments for this project. This work is supported by grants from National Heart, Lung, and Blood Institute (HL080264, HL062350 (X. D.) and HL109439 (J.C.)).	Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Cho J, 2012, BLOOD, V120, P647, DOI 10.1182/blood-2011-08-372532; COLLER BS, 1980, BLOOD, V55, P169; Coller BS, 2001, THROMB HAEMOSTASIS, V86, P427; Delaney MK, 2012, ARTERIOSCL THROM VAS, V32, P2761, DOI 10.1161/ATVBAHA.112.254920; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Haling JR, 2011, BLOOD, V117, P1719, DOI 10.1182/blood-2010-09-305433; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Krishnadas A, 2003, PHARMACEUT RES, V20, P297, DOI 10.1023/A:1022243709003; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Marjanovic JA, 2005, J BIOL CHEM, V280, P37430, DOI 10.1074/jbc.M506518200; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; NIMURA N, 1988, ANAL CHEM, V60, P2067, DOI 10.1021/ac00170a017; O'Brien KA, 2012, ARTERIOSCL THROM VAS, V32, P2232, DOI 10.1161/ATVBAHA.112.254680; O'Brien KA, 2011, BLOOD, V118, P4215, DOI 10.1182/blood-2010-12-323204; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Serebruany VL, 2004, AM J HEMATOL, V75, P40, DOI 10.1002/ajh.10451; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; UGAROVA TP, 1993, J BIOL CHEM, V268, P21080; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Ye F, 2011, J THROMB HAEMOST, V9, P20, DOI 10.1111/j.1538-7836.2011.04355.x	30	117	125	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					131	+		10.1038/nature12613	http://dx.doi.org/10.1038/nature12613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24162846	Green Accepted			2022-12-24	WOS:000326585600046
J	Fine, AM; Nizet, V; Mandl, KD				Fine, Andrew M.; Nizet, Victor; Mandl, Kenneth D.			Participatory Medicine: A Home Score for Streptococcal Pharyngitis Enabled by Real-Time Biosurveillance. A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PREDICTION RULES; QUALITY-OF-CARE; RETAIL CLINICS; ANTIBIOTIC USE; SURVEILLANCE; VALIDATION; GUIDELINES; MANAGEMENT; CHILDREN	Background: Consensus guidelines recommend against testing or treating adults at low risk for group A streptococcal (GAS) pharyngitis. Objective: To help patients decide when to visit a clinician for the evaluation of sore throat. Design: Retrospective cohort study. Setting: A national chain of retail health clinics. Patients: 71 776 patients aged 15 years or older with pharyngitis who visited a clinic from September 2006 to December 2008. Measurements: The authors created a score using information from patient-reported clinical variables plus the incidence of local disease and compared it with the Centor score and other traditional scores that require clinician-elicited signs. Results: If patients aged 15 years or older with sore throat did not visit a clinician when the new score estimated the likelihood of GAS pharyngitis to be less than 10% instead of having clinicians manage their symptoms following guidelines that use the Centor score, 230 000 visits would be avoided in the United States each year and 8500 patients with GAS pharyngitis who would have received antibiotics would not be treated with them. Limitation: Real-time information about the local incidence of GAS pharyngitis, which is necessary to calculate the new score, is not currently available. Conclusion: A patient-driven approach to pharyngitis diagnosis that uses this new score could save hundreds of thousands of visits annually by identifying patients at home who are unlikely to require testing or treatment.	Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston Childrens Hosp, Boston, MA USA; Ctr Biomed Informat, Boston, MA USA; Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Diego	Fine, AM (corresponding author), Boston Childrens Hosp, Div Emergency Med Main 1, 300 Longwood Ave, Boston, MA 02115 USA.	andrew.fine@childrens.harvard.edu	Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422	Public Health Research Scientist Development [KO1HK000055]; Public Health Informatics Center of Excellence [PO1HK000088]; Centers for Disease Control and Prevention [1G08LM009778, RO1 LM007677]; National Library of Medicine, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007677, G08LM009778] Funding Source: NIH RePORTER	Public Health Research Scientist Development; Public Health Informatics Center of Excellence; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	By the Mentored Public Health Research Scientist Development Award KO1HK000055 and Public Health Informatics Center of Excellence Award PO1HK000088 from the Centers for Disease Control and Prevention and by 1G08LM009778 and RO1 LM007677 from the National Library of Medicine, National Institutes of Health.	Basch E, 2010, NEW ENGL J MED, V362, P865, DOI 10.1056/NEJMp0911494; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Centor RM, 2012, ARCH INTERN MED, V172, P852, DOI 10.1001/archinternmed.2012.1741; Chapin KC, 2002, J CLIN MICROBIOL, V40, P4207, DOI 10.1128/JCM.40.11.4207-4210.2002; Costello D, 2008, HEALTH AFFAIR, V27, P1299, DOI 10.1377/hlthaff.27.5.1299; Fine AM, 2007, J AM MED INFORM ASSN, V14, P206, DOI 10.1197/jamia.M2253; Fine AM, 2012, ARCH INTERN MED, V172, P847, DOI 10.1001/archinternmed.2012.950; Fine AM, 2011, ANN INTERN MED, V155, P345, DOI 10.7326/0003-4819-155-6-201109200-00002; Fine AM, 2011, ARCH PEDIAT ADOL MED, V165, P61, DOI 10.1001/archpediatrics.2010.250; Fine AM, 2010, J AM MED INFORM ASSN, V17, P85, DOI 10.1197/jamia.M3061; Kaye J, 2012, NAT REV GENET, V13, P371, DOI 10.1038/nrg3218; Kellermann AL, 2010, ANN EMERG MED, V56, P288; Klepser DG, 2012, AM J MANAG CARE, V18, pE145; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; Nakhoul GN, 2013, J GEN INTERN MED, V28, P830, DOI 10.1007/s11606-012-2245-8; Pollack CE, 2009, ARCH INTERN MED, V169, P945, DOI 10.1001/archinternmed.2009.69; Price RA, 2013, JAMA PEDIATR, V167, P112, DOI 10.1001/jamapediatrics.2013.1573; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Rudavsky R, 2009, ANN INTERN MED, V151, P315, DOI 10.7326/0003-4819-151-5-200909010-00005; Shulman ST, 2012, CLIN INFECT DIS, V55, P1279, DOI 10.1093/cid/cis847; Snellman L, 2013, HLTH CARE GUIDELINE; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; Wasson JH, 1996, JAMA-J AM MED ASSOC, V275, P641, DOI 10.1001/jama.275.8.641; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Weitzman ER, 2013, JAMA INTERN MED, V173, P345, DOI 10.1001/jamainternmed.2013.2512; Wessels MR, 2011, NEW ENGL J MED, V364, P648, DOI 10.1056/NEJMcp1009126; Woodburn JA, 2007, AM J MED QUAL, V22, P457, DOI 10.1177/1062860607309626	31	12	12	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					577	583		10.7326/0003-4819-159-9-201311050-00003	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-00003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249HX	24189592	Green Accepted			2022-12-24	WOS:000326769400001
J	Fauci, AS; Marston, HD				Fauci, Anthony S.; Marston, Hilary D.			Achieving an AIDS-free world: science and implementation	LANCET			English	Editorial Material							HIV-1 INFECTION; ANTIBODIES; PREVENTION; VACCINE		[Fauci, Anthony S.; Marston, Hilary D.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov						Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Folkers GK, 2010, JAMA-J AM MED ASSOC, V304, P350, DOI 10.1001/jama.2010.957; Granich R, 2013, CURR OPIN HIV AIDS, V8, P41, DOI 10.1097/COH.0b013e32835b80dd; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Okwundu CI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007189.pub3; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; US Department of State, 2013, RECOGNIZING THE 10TH; World Health Organization, 2013, GLOBAL UPDATE ON HIV	12	12	12	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1461	1462		10.1016/S0140-6736(13)62042-5	http://dx.doi.org/10.1016/S0140-6736(13)62042-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247MR	24152937				2022-12-24	WOS:000326622500004
J	Chiller, TM; Roy, M; Nguyen, D; Guh, A; Malani, AN; Latham, R; Peglow, S; Kerkering, T; Kaufman, D; McFadden, J; Collins, J; Kainer, M; Duwve, J; Trump, D; Blackmore, C; Tan, C; Cleveland, AA; MacCannell, T; Muehlenbachs, A; Zaki, SR; Brandt, ME; Jernigan, JA				Chiller, Tom M.; Roy, Monika; Duc Nguyen; Guh, Alice; Malani, Anurag N.; Latham, Robert; Peglow, Sheree; Kerkering, Tom; Kaufman, David; McFadden, Jevon; Collins, Jim; Kainer, Marion; Duwve, Joan; Trump, David; Blackmore, Carina; Tan, Christina; Cleveland, Angela A.; MacCannell, Tara; Muehlenbachs, Atis; Zaki, Sherif R.; Brandt, Mary E.; Jernigan, John A.		Multistate Fungal Infection	Clinical Findings for Fungal Infections Caused by Methylprednisolone Injections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTAMINATED METHYLPREDNISOLONE; EXSEROHILUM; MENINGITIS; TISSUES; STROKE; DNA	Background Since September 18, 2012, public health officials have been investigating a large outbreak of fungal meningitis and other infections in patients who received epidural, paraspinal, or joint injections with contaminated lots of methylprednisolone acetate. Little is known about infections caused by Exserohilum rostratum, the predominant outbreak-associated pathogen. We describe the early clinical course of outbreak-associated infections. Methods We reviewed medical records for outbreak cases reported to the Centers for Disease Control and Prevention before November 19, 2012, from the six states with the most reported cases (Florida, Indiana, Michigan, New Jersey, Tennessee, and Virginia). Polymerase-chain-reaction assays and immunohistochemical testing were performed on clinical isolates and tissue specimens for pathogen identification. Results Of 328 patients without peripheral-joint infection who were included in this investigation, 265 (81%) had central nervous system (CNS) infection and 63 (19%) had non-CNS infections only. Laboratory evidence of E. rostratum was found in 96 of 268 patients (36%) for whom samples were available. Among patients with CNS infections, strokes were associated with an increased severity of abnormalities in cerebrospinal fluid (P<0.001). Non-CNS infections were more frequent later in the course of the outbreak (median interval from last injection to diagnosis, 39 days for epidural abscess and 21 days for stroke; P<0.001), and such infections developed in patients with and in those without meningitis. Conclusions The initial clinical findings from this outbreak suggest that fungal infections caused by epidural and paraspinal injection of a contaminated glucocorticoid product can result in a broad spectrum of clinical disease, reflecting possible variations in the pathogenic mechanism and in host and exposure risk factors. (Funded by the Centers for Disease Control and Prevention.)	[Chiller, Tom M.; Roy, Monika; Cleveland, Angela A.; Brandt, Mary E.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA; [Duc Nguyen; Guh, Alice; MacCannell, Tara; Jernigan, John A.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Duc Nguyen] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [McFadden, Jevon] Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Career Epidemiol Field Officer Program, Off Sci & Publ Hlth Practice,Off Publ Hlth Prepar, Atlanta, GA 30333 USA; [Muehlenbachs, Atis; Zaki, Sherif R.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA; [Malani, Anurag N.] St Joseph Mercy Hlth Syst, Ann Arbor, MI USA; [Latham, Robert] St Thomas Hosp, Nashville, TN USA; [Kainer, Marion] Tennessee Dept Hlth, Nashville, TN USA; [Peglow, Sheree] Elkhart Gen Hosp, Elkhart, IN USA; [Kerkering, Tom] Virginia Tech Carilion Sch Med, Roanoke, NJ USA; [Kaufman, David] Cumberland Internal Med, Vineland, NJ USA; [McFadden, Jevon; Collins, Jim] Michigan Dept Community Hlth, Lansing, MI USA; [Duwve, Joan] Indiana State Dept Hlth, Indianapolis, IN 46202 USA; [Trump, David] Virginia Dept Hlth, Richmond, VA USA; [Blackmore, Carina] Florida Dept Hlth, Tallahassee, FL USA; [Tan, Christina] New Jersey Dept Hlth, Trenton, NJ USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Saint Joseph Mercy Health System (SJMHS); Saint Thomas Hospital; Tennessee Department Health; MDHHS - Michigan Department of Health & Human Services; Florida Department of Health; New Jersey Department of Health & Senior Services	Jernigan, JA (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, 1600 Clifton Rd,MS A-31, Atlanta, GA 30333 USA.	jqj9@cdc.gov	Cleveland, Angela Ahlquist/Q-2778-2019	Cleveland, Angela Ahlquist/0000-0003-1375-8964; Jernigan, John/0000-0001-8163-925X; Kainer, Marion/0000-0001-7678-8744	CDC	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the CDC.	Adler A, 2006, EUR J CLIN MICROBIOL, V25, P247, DOI 10.1007/s10096-006-0093-3; Bromage PR, 1978, EPIDURAL ANALGESIA, V1st; Centers for Disease Control and Prevention, 2013, MULT FUNG MEN OUTBR; Clinical and Laboratory Standards Institute , 2008, INT CRIT ID BACT FUN, V28; DALAL PM, 1989, HDB CLIN NEUROLOGY 3, V55, P411; Finks J, 2013, MMWR-MORBID MORTAL W, V62, P377; Gade L, 2013, EUKARYOT CELL, V12, P677, DOI 10.1128/EC.00046-13; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; Kerkering TM, 2013, ANN INTERN MED, V158, P504, DOI 10.7326/0003-4819-158-6-201303190-00024; Kerkering TM, 2013, ANN INTERN MED, V158, P154, DOI 10.7326/0003-4819-158-3-201302050-00568; LEFKOVITS J, 1992, AUST NZ J MED, V22, P30, DOI 10.1111/j.1445-5994.1992.tb01705.x; MCGINNIS MR, 1986, J CLIN MICROBIOL, V24, P250, DOI 10.1128/JCM.24.2.250-259.1986; Misra UK, 2011, J NEUROL SCI, V303, P22, DOI 10.1016/j.jns.2010.12.015; Munoz-Cadavid C, 2010, J CLIN MICROBIOL, V48, P2147, DOI 10.1128/JCM.00459-10; Ritter JM, 2013, AM J PATHOL, V183, P881, DOI 10.1016/j.ajpath.2013.05.007; Smith RM, 2013, NEW ENGL J MED, V369, P1598, DOI 10.1056/NEJMoa1213978; Windsor Robert E, 2003, Pain Physician, V6, P473	17	49	51	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1610	1619		10.1056/NEJMoa1304879	http://dx.doi.org/10.1056/NEJMoa1304879			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	24152260				2022-12-24	WOS:000326031100010
J	Miller, L; Arakaki, L; Ramautar, A; Bodach, S; Braunstein, SL; Kennedy, J; Steiner-Sichel, L; Ngai, S; Shepard, C; Weiss, D				Miller, Laura; Arakaki, Lola; Ramautar, Arianne; Bodach, Sara; Braunstein, Sarah L.; Kennedy, Joseph; Steiner-Sichel, Linda; Ngai, Stephanie; Shepard, Colin; Weiss, Don			Elevated Risk for Invasive Meningococcal Disease Among Persons With HIV	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CONJUGATE VACCINE; UNITED-STATES; ADULTS; INFECTION; NAIROBI; IMMUNOGENICITY; SAFETY; AIDS	Background: An association between HIV and invasive meningococcal disease (IMD) has been suggested by several previous studies but has not been fully described in the era of highly active antiretroviral therapy in the United States. Objective: To estimate the risk for IMD and death in people living with HIV/AIDS (PLWHA) in New York City (NYC) and the contribution of CD4(+) cell count and viral load (VL) to IMD risk. Design: Comparison of the incidence rate of IMD among PLWHA with that among HIV-uninfected persons. Surveillance data on IMD for patients aged 15 to 64 years from 2000 to 2011 were matched to death and HIV registries to calculate IMD risk and case-fatality ratios. A subset of PLWHA who had a CD4(+) cell count and VL measurement near the time of their IMD infection was included in age-matched case-control analyses to assess HIV markers and IMD risk. Setting: Retrospective cohort from communicable disease surveillance. Patients: 265 persons aged 15 to 64 years with IMD during 2000 to 2011. Measurements: Meningococcal and HIV data abstracted from surveillance and registry databases, including CD4(+) cell counts and VL. Results: The average annual incidence rate of IMD was 0.39 cases per 100 000 persons. The relative risk for IMD among PLWHA in NYC during 2000 to 2011 was 10.0 (95% CI, 7.2 to 14.1). Among PLWHA, patients with IMD were 5.3 times (CI, 1.4 to 20.4 times) as likely as age-matched control patients to have CD4(+) counts less than 0.200 x 10(9) cells/L. Limitation: Missing data on smoking status and comorbidity. Conclusion: People living with HIV/AIDS in NYC are at increased risk for IMD. Cost-effectiveness and vaccine efficacy studies are needed to evaluate the value of a national recommendation for routine meningococcal vaccination of PLWHA.	[Miller, Laura; Arakaki, Lola; Ramautar, Arianne; Bodach, Sara; Braunstein, Sarah L.; Kennedy, Joseph; Steiner-Sichel, Linda; Ngai, Stephanie; Shepard, Colin; Weiss, Don] New York City Dept Hlth & Mental Hyg, Queens, NY 11101 USA	New York City Department of Health & Mental Hygiene	Weiss, D (corresponding author), New York City Dept Hlth & Mental Hyg, Gotham Ctr, CN 22a,42-09 28th St,6th Floor, Queens, NY 11101 USA.	dweiss@health.nyc.gov		Arakaki, Lola/0000-0002-5281-7405	New York City Tax Levy; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U62PS003993] Funding Source: NIH RePORTER	New York City Tax Levy; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	New York City Tax Levy.	Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P72; Bilukha Oleg O., 2005, Morbidity and Mortality Weekly Report, V54, P1; Bobula SM, 2012, WORLD J AIDS, V2, P237; BRINDLE R, 1991, T ROY SOC TROP MED H, V85, P651, DOI 10.1016/0035-9203(91)90380-H; Bruce MG, 2001, JAMA-J AM MED ASSOC, V286, P688, DOI 10.1001/jama.286.6.688; Cartter ML, 2005, REVISION NATL SURVEI; Cohen C, 2010, AIDS, V24, P1351, DOI 10.1097/QAD.0b013e32833a2520; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; Cookson ST, 1998, J INFECT DIS, V178, P266, DOI 10.1086/517450; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; Drobnik A, 2013, J PUBLIC HL IN PRESS; Eavey JJ, 2010, 19 INT AIDS C WASH D; Epiquery: NYC Interactive Health Data System, 2010, EP NYC INT HLTH DAT; Fischer M, 1997, PEDIATR INFECT DIS J, V16, P979, DOI 10.1097/00006454-199710000-00015; GILKS CF, 1990, LANCET, V336, P545, DOI 10.1016/0140-6736(90)92096-Z; Hart CA, 2000, J MED MICROBIOL, V49, P947, DOI 10.1099/0022-1317-49-11-947; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Huang L, 2009, RESPIROLOGY, V14, P474, DOI 10.1111/j.1440-1843.2009.01534.x; Imrey PB, 1996, AM J EPIDEMIOL, V143, P624, DOI 10.1093/oxfordjournals.aje.a008792; KIPP W, 1992, AIDS, V6, P1557, DOI 10.1097/00002030-199212000-00031; Klugman KP, 2007, CURR OPIN INFECT DIS, V20, P11, DOI 10.1097/QCO.0b013e328012c5f1; Lujan-Zilbermann J, 2012, J PEDIATR-US, V161, P676, DOI 10.1016/j.jpeds.2012.04.005; PINNER RW, 1992, J INFECT DIS, V166, P359, DOI 10.1093/infdis/166.2.359; Rodriguez-Barradas MC, 2008, CLIN INFECT DIS, V46, P1093, DOI 10.1086/529201; Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Siberry GK, 2010, PEDIATR INFECT DIS J, V29, P391, DOI 10.1097/INF.0b013e3181c38f3b; Simon MS, 2013, ANN INTERN MED, V159, P300, DOI 10.7326/0003-4819-159-4-201308200-00674; STEPHENS DS, 1995, ANN INTERN MED, V123, P937, DOI 10.7326/0003-4819-123-12-199512150-00007; Weiss D, 2013, MMWR-MORBID MORTAL W, V61, P1048	30	45	50	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2014	160	1					30	+		10.7326/0003-4819-160-1-201401070-00731	http://dx.doi.org/10.7326/0003-4819-160-1-201401070-00731			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297IS	24166695				2022-12-24	WOS:000330249700004
J	Luce, CH; Abatzoglou, JT; Holden, ZA				Luce, C. H.; Abatzoglou, J. T.; Holden, Z. A.			The Missing Mountain Water: Slower Westerlies Decrease Orographic Enhancement in the Pacific Northwest USA	SCIENCE			English	Article							CLIMATE-CHANGE; PRECIPITATION; VARIABILITY; STREAMFLOW; SNOWPACK; FLOW; SENSITIVITY; PATTERNS; SHIFTS; TRENDS	Trends in streamflow timing and volume in the Pacific Northwest United States have been attributed to increased temperatures, because trends in precipitation at lower-elevation stations were negligible. We demonstrate that observed streamflow declines are probably associated with declines in mountain precipitation, revealing previously unexplored differential trends. Lower-troposphere winter (November to March) westerlies are strongly correlated with high-elevation precipitation but weakly correlated with low-elevation precipitation. Decreases in lower-tropospheric winter westerlies across the region from 1950 to 2012 are hypothesized to have reduced orographic precipitation enhancement, yielding differential trends in precipitation across elevations and contributing to the decline in annual streamflow. Climate projections show weakened lower-troposphere zonal flow across the region under enhanced greenhouse forcing, highlighting an additional stressor that is relevant for climate change impacts on hydrology.	[Luce, C. H.] US Forest Serv Res & Dev, Boise, ID 83702 USA; [Abatzoglou, J. T.] Univ Idaho, Dept Geog, Moscow, ID 83844 USA; [Holden, Z. A.] US Forest Serv Reg 1, Missoula, MT 59807 USA	United States Department of Agriculture (USDA); United States Forest Service; Idaho; University of Idaho	Luce, CH (corresponding author), US Forest Serv Res & Dev, 322 East Front St, Boise, ID 83702 USA.	cluce@fs.fed.us	Abatzoglou, John T/C-7635-2012; Luce, Charles/A-9267-2008; Abatzoglou, John T/ABE-6134-2020	Abatzoglou, John T/0000-0001-7599-9750; Luce, Charles/0000-0002-6938-9662; Abatzoglou, John T/0000-0001-7599-9750	NSF's Experimental Program to Stimulate Competitive Research (EPSCoR) [EPS-0814387]; NASA [NNH11ZDA001N-FIRES]	NSF's Experimental Program to Stimulate Competitive Research (EPSCoR); NASA(National Aeronautics & Space Administration (NASA))	We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups (listed in table S1 of this paper) for producing and making available their model output. The U. S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support for CMIP and led the development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We thank the reviewers for their comments and insights, which substantially improved the paper. J.T.A. was supported by NSF's Experimental Program to Stimulate Competitive Research (EPSCoR) (EPS-0814387). This work was partially supported by NASA through NNH11ZDA001N-FIRES.	Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Braganza K, 2004, CLIM DYNAM, V22, P823, DOI 10.1007/s00382-004-0413-1; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Burt TP, 2013, WATER RESOUR RES, V49, P3504, DOI 10.1002/wrcr.20297; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Clark GM, 2010, J AM WATER RESOUR AS, V46, P486, DOI 10.1111/j.1752-1688.2009.00416.x; Colle BA, 2004, J ATMOS SCI, V61, P588, DOI 10.1175/1520-0469(2004)061<0588:SOOPTC>2.0.CO;2; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Dettinger M, 2004, J HYDROMETEOROL, V5, P1102, DOI 10.1175/JHM-390.1; Fu GB, 2010, HYDROL PROCESS, V24, P866, DOI 10.1002/hyp.7527; Gedalof Z, 2004, J AM WATER RESOUR AS, V40, P1579, DOI 10.1111/j.1752-1688.2004.tb01607.x; Holden ZA, 2012, ECOHYDROLOGY, V5, P677, DOI 10.1002/eco.257; Houze RA, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000365; Hughes M, 2009, J ATMOS SCI, V66, P508, DOI 10.1175/2008JAS2689.1; Jiang Y, 2010, THEOR APPL CLIMATOL, V99, P421, DOI 10.1007/s00704-009-0152-7; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Luce CH, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039407; Lutz ER, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010687; McVicar TR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042255; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; Minder JR, 2010, J CLIMATE, V23, P2634, DOI 10.1175/2009JCLI3263.1; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; O'Gorman PA, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/025207; Panziera L, 2010, Q J ROY METEOR SOC, V136, P222, DOI 10.1002/qj.544; Pederson GT, 2013, GEOPHYS RES LETT, V40, P1811, DOI 10.1002/grl.50424; Ralph FM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026689; Regonda SK, 2005, J CLIMATE, V18, P372, DOI 10.1175/JCLI-3272.1; Salathe EP, 2010, CLIMATIC CHANGE, V102, P51, DOI 10.1007/s10584-010-9849-y; Service RF, 2004, SCIENCE, V303, P1124, DOI 10.1126/science.303.5661.1124; Siler N, 2013, J HYDROMETEOROL, V14, P122, DOI 10.1175/JHM-D-12-045.1; Smith R. B., 1979, ADV GEOPHYS, V21, P87, DOI 10.1016/S0065-2687(08)60262-9; Smith RB, 2004, J ATMOS SCI, V61, P1377, DOI 10.1175/1520-0469(2004)061<1377:ALTOOP>2.0.CO;2; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Yuter SE, 2011, J HYDROMETEOROL, V12, P329, DOI 10.1175/2010JHM1239.1	37	123	137	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1360	1364		10.1126/science.1242335	http://dx.doi.org/10.1126/science.1242335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24292627				2022-12-24	WOS:000328196000048
J	Christian, NJ; King, WC; Yanovski, SZ; Courcoulas, AP; Belle, SH				Christian, Nicholas J.; King, Wendy C.; Yanovski, Susan Z.; Courcoulas, Anita P.; Belle, Steven H.			Validity of Self-reported Weights Following Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							BODY-MASS INDEX; HEIGHT		[Christian, Nicholas J.; King, Wendy C.; Belle, Steven H.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Yanovski, Susan Z.] NIDDKD, Bethesda, MD USA; [Courcoulas, Anita P.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Christian, NJ (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, 130 DeSoto St,127 Parran Hall, Pittsburgh, PA 15261 USA.	christiann@edc.pitt.edu	King, Wendy C/AAC-5122-2022	King, Wendy C/0000-0002-0740-0029	NCATS NIH HHS [UL1 TR000005, UL1 TR000457] Funding Source: Medline; NCRR NIH HHS [UL1 RR024153, M01RR-00037, UL1 RR024996, M01 RR000037, UL1-RR024996, UL1-RR024153] Funding Source: Medline; NIDDK NIH HHS [U01 DK066557, U01-DK66555, U01-DK66585, U01 DK066471, U01-DK66568, U01 DK066667, U01 DK066555, U01-DK66667, U01-DK66471, U01 DK066526, U01 DK066585, U01-DK66526, U01 DK066568] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037, UL1RR024996, UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066568, U01DK066667, U01DK066555, U01DK066585, U01DK066526, U01DK066557, U01DK066471] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Belle SH, 2013, SURG OBES RELAT DIS, V9, P926, DOI 10.1016/j.soard.2013.01.023; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Merrill RM, 2009, PREV CHRONIC DIS, V6; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; White MA, 2007, OBESITY, V15, P2761, DOI 10.1038/oby.2007.328	6	67	67	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2454	2456		10.1001/jama.2013.281043	http://dx.doi.org/10.1001/jama.2013.281043			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24189698	Bronze, Green Accepted			2022-12-24	WOS:000328030900027
J	Starmer, AJ; Sectish, TC; Simon, DW; Keohane, C; McSweeney, ME; Chung, EY; Yoon, CS; Lipsitz, SR; Wassner, AJ; Harper, MB; Landrigan, CP				Starmer, Amy J.; Sectish, Theodore C.; Simon, Dennis W.; Keohane, Carol; McSweeney, Maireade E.; Chung, Erica Y.; Yoon, Catherine S.; Lipsitz, Stuart R.; Wassner, Ari J.; Harper, Marvin B.; Landrigan, Christopher P.			Rates of Medical Errors and Preventable Adverse Events Among Hospitalized Children Following Implementation of a Resident Handoff Bundle	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUG EVENTS; SIGN-OUT; PATIENT-CARE; HOUSE STAFF; HEALTH-CARE; CONTINUITY; SAFETY; INTERVENTION; EDUCATION; IMPACT	IMPORTANCE Handoff miscommunications are a leading cause of medical errors. Studies comprehensively assessing handoff improvement programs are lacking. OBJECTIVE To determine whether introduction of a multifaceted handoff program was associated with reduced rates of medical errors and preventable adverse events, fewer omissions of key data in written handoffs, improved verbal handoffs, and changes in resident-physician workflow. DESIGN, SETTING, AND PARTICIPANTS Prospective intervention study of 1255 patient admissions (642 before and 613 after the intervention) involving 84 resident physicians (42 before and 42 after the intervention) from July-September 2009 and November 2009-January 2010 on 2 inpatient units at Boston Children's Hospital. INTERVENTIONS Resident handoff bundle, consisting of standardized communication and handoff training, a verbal mnemonic, and a new team handoff structure. On one unit, a computerized handoff tool linked to the electronic medical record was introduced. MAIN OUTCOMES AND MEASURES The primary outcomes were the rates of medical errors and preventable adverse events measured by daily systematic surveillance. The secondary outcomes were omissions in the printed handoff document and resident time-motion activity. RESULTS Medical errors decreased from 33.8 per 100 admissions (95% CI, 27.3-40.3) to 18.3 per 100 admissions (95% CI, 14.7-21.9; P < .001), and preventable adverse events decreased from 3.3 per 100 admissions (95% CI, 1.7-4.8) to 1.5 (95% CI, 0.51-2.4) per 100 admissions (P = .04) following the intervention. There were fewer omissions of key handoff elements on printed handoff documents, especially on the unit that received the computerized handoff tool (significant reductions of omissions in 11 of 14 categories with computerized tool; significant reductions in 2 of 14 categories without computerized tool). Physicians spent a greater percentage of time in a 24-hour period at the patient bedside after the intervention (8.3%; 95% CI 7.1%-9.8%) vs 10.6%(95% CI, 9.2%-12.2%; P = .03). The average duration of verbal handoffs per patient did not change. Verbal handoffs were more likely to occur in a quiet location (33.3%; 95% CI, 14.5%-52.2% vs 67.9%; 95% CI, 50.6%-85.2%; P = .03) and private location (50.0%; 95% CI, 30%-70% vs 85.7%; 95% CI, 72.8%-98.7%; P = .007) after the intervention. CONCLUSIONS AND RELEVANCE Implementation of a handoff bundle was associated with a significant reduction in medical errors and preventable adverse events among hospitalized children. Improvements in verbal and written handoff processes occurred, and resident workflow did not change adversely.	[Starmer, Amy J.; Sectish, Theodore C.; Simon, Dennis W.; McSweeney, Maireade E.; Chung, Erica Y.; Wassner, Ari J.; Harper, Marvin B.; Landrigan, Christopher P.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Gen Pediat,Dept Med, Boston, MA 02115 USA; [Starmer, Amy J.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Portland, OR 97201 USA; [Simon, Dennis W.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Keohane, Carol; Yoon, Catherine S.; Lipsitz, Stuart R.; Landrigan, Christopher P.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Keohane, Carol; Yoon, Catherine S.; Lipsitz, Stuart R.; Landrigan, Christopher P.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Chung, Erica Y.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Providence, RI 02903 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Starmer, AJ (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Gen Pediat,Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	amy.starmer@childrens.harvard.edu	Harper, Marvin B/O-9780-2017; Ramotar, Matt W/K-2193-2019	Harper, Marvin B/0000-0003-1385-0218; Landrigan, Christopher/0000-0001-8386-4100; Wassner, Ari/0000-0003-0894-9301	Controlled Risk Insurance Company Risk Management Foundation Grant Program; Boston Children's Hospital Program for Patient Safety and Quality Research Grant Program; Agency for Healthcare Research and Quality [T32 HP10018, 1K12HS019456-01]; Child Health Corporation of America; National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) [UL1TR000128]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019456] Funding Source: NIH RePORTER	Controlled Risk Insurance Company Risk Management Foundation Grant Program; Boston Children's Hospital Program for Patient Safety and Quality Research Grant Program; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Child Health Corporation of America; National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was supported by the Controlled Risk Insurance Company Risk Management Foundation Grant Program as well as a grant from the Boston Children's Hospital Program for Patient Safety and Quality Research Grant Program. Dr Starmer was supported by grants T32 HP10018, a National Research Service Award in Pediatrics and 1K12HS019456-01 from the Oregon Comparative Effectiveness Research K12 Program through the Agency for Healthcare Research and Quality. Dr Landrigan is partially supported by the Child Health Corporation of America for his work as a member of the PRIS Network Executive Council. Some support for statistical analyses provided in part by the Oregon Clinical and Translational Research Institute (OCTRI) and grant UL1TR000128 from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH).	Arora V, 2005, QUAL SAF HEALTH CARE, V14, P401, DOI 10.1136/qshc.2005.015107; Arora V, 2006, JT COMM J QUAL PATIE, V32, P646, DOI 10.1016/S1553-7250(06)32084-3; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Cohen MD, 2010, QUAL SAF HEALTH CARE, V19, P493, DOI 10.1136/qshc.2009.033480; Desai SV, 2013, JAMA INTERN MED, V173, P649, DOI 10.1001/jamainternmed.2013.2973; Gordon M, 2011, MED EDUC, V45, P1081, DOI 10.1111/j.1365-2923.2011.04049.x; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Horwitz LI, 2007, J GEN INTERN MED, V22, P1470, DOI 10.1007/s11606-007-0331-0; Horwitz LI, 2006, ARCH INTERN MED, V166, P1173, DOI 10.1001/archinte.166.11.1173; Horwitz LI, 2009, ANN EMERG MED, V53, P701, DOI 10.1016/j.annemergmed.2008.05.007; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Kitch BT, 2008, JT COMM J QUAL PATIE, V34, P563, DOI 10.1016/S1553-7250(08)34071-9; Kripalani S, 2012, ANN INTERN MED, V157, P1, DOI 10.7326/0003-4819-157-1-201207030-00003; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Leonard M, 2004, QUAL SAF HEALTH CARE, V13, pI85, DOI 10.1136/qshc.2004.010033; Li P, 2013, J HOSP MED, V8, P456, DOI 10.1002/jhm.1988; Lipsitz SR, 2000, BIOMETRICS, V56, P528, DOI 10.1111/j.0006-341X.2000.00528.x; McDonald KM, 2007, CLOSING THE QUALITY, V7; Morimoto T, 2004, QUAL SAF HEALTH CARE, V13, P306, DOI 10.1136/qshc.2004.010611; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Patterson ES, 2004, INT J QUAL HEALTH C, V16, P125, DOI 10.1093/intqhc/mzh026; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Pizziferri L, 2005, J BIOMED INFORM, V38, P176, DOI 10.1016/j.jbi.2004.11.009; Poon EG, 2010, NEW ENGL J MED, V362, P1698, DOI 10.1056/NEJMsa0907115; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Riesenberg LA, 2009, ACAD MED, V84, P1775, DOI 10.1097/ACM.0b013e3181bf51a6; Riesenberg LA, 2009, AM J MED QUAL, V24, P196, DOI 10.1177/1062860609332512; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; The Joint Commission, SENTINEL EVENT STATI; Van Eaton EG, 2005, J AM COLL SURGEONS, V200, P538, DOI 10.1016/j.jamcollsurg.2004.11.009; Wohlauer MV, 2012, ACAD MED, V87, P411, DOI 10.1097/ACM.0b013e318248e766; Young JQ, 2011, ANN INTERN MED, V155, P309, DOI 10.7326/0003-4819-155-5-201109060-00354; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	36	185	186	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2262	2270		10.1001/jama.2013.281961	http://dx.doi.org/10.1001/jama.2013.281961			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302089				2022-12-24	WOS:000327746300011
J	Jagadeesh, RV; Surkus, AE; Junge, H; Pohl, MM; Radnik, J; Rabeah, J; Huan, HM; Schunemann, V; Bruckner, A; Beller, M				Jagadeesh, Rajenahally V.; Surkus, Annette-Enrica; Junge, Henrik; Pohl, Marga-Martina; Radnik, Joerg; Rabeah, Jabor; Huan, Heming; Schuenemann, Volker; Brueckner, Angelika; Beller, Matthias			Nanoscale Fe2O3-Based Catalysts for Selective Hydrogenation of Nitroarenes to Anilines	SCIENCE			English	Article							CHEMOSELECTIVE HYDROGENATION; IRON CATALYSTS; REDUCTION; NANOPARTICLES; EFFICIENT; PLATINUM; WATER; COORDINATION; GENERATION	Production of anilines-key intermediates for the fine chemical, agrochemical, and pharmaceutical industries-relies on precious metal catalysts that selectively hydrogenate aryl nitro groups in the presence of other easily reducible functionalities. Herein, we report convenient and stable iron oxide (Fe2O3)-based catalysts as a more earth-abundant alternative for this transformation. Pyrolysis of iron-phenanthroline complexes on carbon furnishes a unique structure in which the active Fe2O3 particles are surrounded by a nitrogen-doped carbon layer. Highly selective hydrogenation of numerous structurally diverse nitroarenes (more than 80 examples) proceeded in good to excellent yield under industrially viable conditions.	[Jagadeesh, Rajenahally V.; Surkus, Annette-Enrica; Junge, Henrik; Pohl, Marga-Martina; Radnik, Joerg; Rabeah, Jabor; Brueckner, Angelika; Beller, Matthias] Univ Rostock, Leibniz Inst Katalyse eV, D-18059 Rostock, Germany; [Huan, Heming; Schuenemann, Volker] Tech Univ Kaiserslautern, Fachbereich Phys, D-67663 Kaiserslautern, Germany	Leibniz Institut fur Katalyse e.V. an der Universitat Rostock (LIKAT); University of Rostock; University of Kaiserslautern	Beller, M (corresponding author), Univ Rostock, Leibniz Inst Katalyse eV, Albert Einstein Str 29A, D-18059 Rostock, Germany.	matthias.beller@catalysis.de	Schünemann, Volker/C-6603-2016; Radnik, Joerg/D-1396-2018; Rabeah, Jabor/GZM-0264-2022; Rajenahally Venkataswamygowda, Jagadeesh/A-5368-2016; Junge, Henrik/C-4652-2016	Radnik, Joerg/0000-0003-0302-6815; Rabeah, Jabor/0000-0003-2162-0981; Rajenahally Venkataswamygowda, Jagadeesh/0000-0001-6079-0962; Junge, Henrik/0000-0002-7603-1984; Surkus, Annette-Enrica/0000-0003-1161-9848; Bruckner, Angelika/0000-0003-4647-1273	Federal Ministry of Education and Research (BMBF); State of Mecklenburg-Vorpommern	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Mecklenburg-Vorpommern	We gratefully acknowledge the support from the Federal Ministry of Education and Research (BMBF) and the State of Mecklenburg-Vorpommern. We thank the analytical department of the Leibniz-Institute for Catalysis, Rostock for the nuclear magnetic resonance measurements. The Leibniz Institute for Catalysis has filed a patent on the catalysts reported herein. Author contributions: M.B. and R.V.J. planned the project; R.V.J. developed and prepared the catalysts; R.V.J designed and performed all catalytic hydrogenation experiments; R.V.J., M.B., and A.B. wrote the paper; A.-E.S., H.J., and M.B were involved in the development of this class of catalysts; M.-M.P. performed TEM measurements and analysis; J. Radnik did the XPS measurements; J. Rabeah and A.B. conducted EPR measurements; and H.H. and V.S. performed Mossbauer measurements.	[Anonymous], PLATINUM TODAY; Blaser H.-U., 2001, FINE CHEM HETEROGENE; Blaser HU, 2009, CHEMCATCHEM, V1, P210, DOI 10.1002/cctc.200900129; Boddien A, 2011, SCIENCE, V333, P1733, DOI 10.1126/science.1206613; Bolm C, 2004, CHEM REV, V104, P6217, DOI 10.1021/cr040664h; Bolm C, 2009, NAT CHEM, V1, P420, DOI 10.1038/nchem.315; Buchner F, 2008, J PHYS CHEM C, V112, P15458, DOI 10.1021/jp8052955; Cabrero-Antonino JR, 2013, CHEM-EUR J, V19, P8627, DOI 10.1002/chem.201300386; Corma A, 2006, SCIENCE, V313, P332, DOI 10.1126/science.1128383; Cornils B., 2002, APPL HOMOGENEOUS CAT; Driller KM, 2011, ANGEW CHEM INT EDIT, V50, P537, DOI 10.1002/anie.201005823; Enthaler S, 2008, ANGEW CHEM INT EDIT, V47, P3317, DOI 10.1002/anie.200800012; Fillol JL, 2011, NAT CHEM, V3, P807, DOI [10.1038/NCHEM.1140, 10.1038/nchem.1140]; Gartner F, 2011, CHEM-EUR J, V17, P6425, DOI 10.1002/chem.201003564; Galvis HMT, 2012, SCIENCE, V335, P835, DOI 10.1126/science.1215614; Gopalaiah K, 2013, CHEM REV, V113, P3248, DOI 10.1021/cr300236r; Hennessy ET, 2013, SCIENCE, V340, P591, DOI 10.1126/science.1233701; Hitomi Y, 2012, ANGEW CHEM INT EDIT, V51, P3448, DOI 10.1002/anie.201108933; Jagadeesh RV, 2011, CHEM COMMUN, V47, P10972, DOI 10.1039/c1cc13728j; Jaouen F, 2009, ACS APPL MATER INTER, V1, P1623, DOI 10.1021/am900219g; Koeken ACJ, 2012, ANGEW CHEM INT EDIT, V51, P7190, DOI 10.1002/anie.201200280; Lefevre M, 2009, SCIENCE, V324, P71, DOI 10.1126/science.1170051; Li J, 2011, ACS CATAL, V1, P657, DOI 10.1021/cs200105u; Li WM, 2010, J AM CHEM SOC, V132, P17056, DOI 10.1021/ja106217u; Morandi B, 2012, SCIENCE, V335, P1471, DOI 10.1126/science.1218781; Motoyama Y, 2011, CHEMCATCHEM, V3, P1578, DOI 10.1002/cctc.201100135; Ono N., 2001, NITRO GROUP ORGANIC; Pandarus V, 2011, ADV SYNTH CATAL, V353, P1306, DOI 10.1002/adsc.201000945; Plietker B., 2008, IRON CATALYSIS ORGAN; Proietti E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1427; Sun CL, 2011, CHEM REV, V111, P1293, DOI 10.1021/cr100198w; Takasaki M, 2008, ORG LETT, V10, P1601, DOI 10.1021/ol800277a; Tondreau AM, 2012, SCIENCE, V335, P567, DOI 10.1126/science.1214451; Westerhaus FA, 2013, NAT CHEM, V5, P537, DOI [10.1038/nchem.1645, 10.1038/NCHEM.1645]; Yang ZQ, 2011, ENERG ENVIRON SCI, V4, P4500, DOI 10.1039/c1ee01428e; Ziebart C, 2012, J AM CHEM SOC, V134, P20701, DOI 10.1021/ja307924a	36	732	743	39	1063	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1073	1076		10.1126/science.1242005	http://dx.doi.org/10.1126/science.1242005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288327				2022-12-24	WOS:000327518600051
J	Guttmacher, AE; Hirschfeld, S; Collins, FS				Guttmacher, Alan E.; Hirschfeld, Steven; Collins, Francis S.			The National Children's Study-A Proposed Plan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Guttmacher, Alan E.; Hirschfeld, Steven] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20892 USA; [Collins, Francis S.] NIH, Off Director, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA	Guttmacher, AE (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20892 USA.		Hirschfeld, Steven/E-2987-2016	Hirschfeld, Steven/0000-0003-0627-7249				The National Children's Study, 2012, NAT CHILDR STUD I ME	1	18	18	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1873	1875		10.1056/NEJMp1311150	http://dx.doi.org/10.1056/NEJMp1311150			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300MP	24224620	Green Published			2022-12-24	WOS:000330468300003
J	Gwynne, P				Gwynne, Peter			TECHNOLOGY Mobility machines	NATURE			English	Editorial Material							POWERED EXOSKELETON											Esquenazi A, 2012, AM J PHYS MED REHAB, V91, P911, DOI 10.1097/PHM.0b013e318269d9a3; Fineberg DB, 2013, J SPINAL CORD MED, V36, P313, DOI 10.1179/2045772313Y.0000000126; Pedrocchi A, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-66; Wiggin MB, 2011, INT C REHAB ROBOT	4	12	12	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S16	S17		10.1038/503S16a	http://dx.doi.org/10.1038/503S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24227002	Bronze			2022-12-24	WOS:000326894200008
J	Laghari, JR				Laghari, Javaid R.			Melting glaciers bring energy uncertainty	NATURE			English	Editorial Material												jlaghari@hec.gov.pk						Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Kaab A, 2012, NATURE, V488, P495, DOI 10.1038/nature11324; Teng HY, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051723; United Nations Educational Scientific and Cultural Organization, 2009, WAT CHANG WORLD; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]	5	39	39	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					617	618		10.1038/502617a	http://dx.doi.org/10.1038/502617a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24180016	Bronze			2022-12-24	WOS:000326293200022
J	Power, S; Delage, F; Chung, C; Kociuba, G; Keay, K				Power, Scott; Delage, Francois; Chung, Christine; Kociuba, Greg; Keay, Kevin			Robust twenty-first-century projections of El Nino and related precipitation variability	NATURE			English	Article							CLIMATE; OCEAN; ENSO	The El Nino-Southern Oscillation (ENSO) drives substantial variability in rainfall(1-3), severe weather(4,5), agricultural production(3,6), ecosystems(7) and disease(8) in many parts of the world. Given that further human-forced changes in the Earth's climate system seem inevitable(9,10), the possibility exists that the character of ENSO and its impacts might change over the coming century. Although this issue has been investigated many times during the past 20 years, there is very little consensus on future changes in ENSO, apart from an expectation that ENSO will continue to be a dominant source of year-to-year variability(9,11,12). Here we show that there are in fact robust projected changes in the spatial patterns of year-to-year ENSO-driven variability in both surface temperature and precipitation. These changes are evident in the two most recent generations of climate models(13,14), using four different scenarios for CO2 and other radiatively active gases(14-17). By the mid- to late twenty-first century, the projections include an intensification of both El-Nino-driven drying in the western Pacific Ocean and rainfall increases in the central and eastern equatorial Pacific. Experiments with an Atmospheric General Circulation Model reveal that robust projected changes in precipitation anomalies during El Nino years are primarily determined by a nonlinear response to surface global warming. Uncertain projected changes in the amplitude of ENSO-driven surface temperature variability have only a secondary role. Projected changes in key characteristics of ENSO are consequently much clearer than previously realized.	[Power, Scott; Delage, Francois; Chung, Christine; Kociuba, Greg; Keay, Kevin] Bur Meteorol, Ctr Australian Weather & Climate Res, Melbourne, Vic 3008, Australia	Bureau of Meteorology - Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Power, S (corresponding author), Bur Meteorol, Ctr Australian Weather & Climate Res, Melbourne, Vic 3008, Australia.	s.power@bom.gov.au	Power, Scott Brendan/AAF-3370-2019	Power, Scott Brendan/0000-0002-9596-4368	Australian Climate Change Science Program (ACCSP); Pacific-Australia Climate Change Science and Adaptation planning Program (PACCSAP); AusAID; Department of Industry, Innovation, Climate Change, Science, Research and Tertiary Education	Australian Climate Change Science Program (ACCSP); Pacific-Australia Climate Change Science and Adaptation planning Program (PACCSAP); AusAID(Australian Aid (AusAID)); Department of Industry, Innovation, Climate Change, Science, Research and Tertiary Education	We thank L. Hanson, H. Ye and A. Moise for making the CMIP data available to us, and R. Colman, A. Handasyde and H. G. Power for comments on an earlier draft. This work is supported by the Australian Climate Change Science Program (ACCSP) and the Pacific-Australia Climate Change Science and Adaptation planning Program (PACCSAP). PACCSAP is supported by AusAID, in collaboration with the Department of Industry, Innovation, Climate Change, Science, Research and Tertiary Education. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups for producing and making available their model output. For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led the development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Callaghan J, 2011, CLIM DYNAM, V37, P647, DOI 10.1007/s00382-010-0883-2; Cambers, 2011, CLIMATE CHANGE PACIF; Chung C. T. Y., 2013, CLIM DYN; Coelho CAS, 2009, J CLIMATE, V22, P6456, DOI 10.1175/2009JCLI3185.1; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Donnelly JP, 2007, NATURE, V447, P465, DOI 10.1038/nature05834; Guilyardi E, 2009, B AM METEOROL SOC, V90, P325, DOI 10.1175/2008BAMS2387.1; Hammer GL, 2001, AGR SYST, V70, P515, DOI 10.1016/S0308-521X(01)00058-0; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Kug JS, 2010, THEOR APPL CLIMATOL, V100, P275, DOI 10.1007/s00704-009-0183-0; Lorenz E.N., 1956, 1 MIT; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Meehl GA, 2007, CLIM DYNAM, V29, P779, DOI 10.1007/s00382-007-0268-3; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Power S., 1999, CLIM DYNAM, V15, P234; Power SB, 2012, J CLIMATE, V25, P3792, DOI 10.1175/JCLI-D-11-00354.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Ropelewski C. F., 2007, J CLIMATOL, V2, P268; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Vecchi GA, 2010, WIRES CLIM CHANGE, V1, P260, DOI 10.1002/wcc.33; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2; Xie SP, 2010, J CLIMATE, V23, P966, DOI 10.1175/2009JCLI3329.1; Yeh SW, 2009, NATURE, V461, P511, DOI 10.1038/nature08316	30	288	297	4	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					541	+		10.1038/nature12580	http://dx.doi.org/10.1038/nature12580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24121439				2022-12-24	WOS:000325988400052
J	Lordkipanidze, D; de Leon, MSP; Margvelashvili, A; Rak, Y; Rightmire, GP; Vekua, A; Zollikofer, CPE				Lordkipanidze, David; de Leon, Marcia S. Ponce; Margvelashvili, Ann; Rak, Yoel; Rightmire, G. Philip; Vekua, Abesalom; Zollikofer, Christoph P. E.			A Complete Skull from Dmanisi, Georgia, and the Evolutionary Biology of Early Homo	SCIENCE			English	Article							CRANIAL MORPHOLOGY; ERECTUS; HOMINID; FOSSILS; REMAINS; DIVERSITY; SHAPE; SIZE	The site of Dmanisi, Georgia, has yielded an impressive sample of hominid cranial and postcranial remains, documenting the presence of Homo outside Africa around 1.8 million years ago. Here we report on a new cranium from Dmanisi (D4500) that, together with its mandible (D2600), represents the world's first completely preserved adult hominid skull from the early Pleistocene. D4500/D2600 combines a small braincase (546 cubic centimeters) with a large prognathic face and exhibits close morphological affinities with the earliest known Homo fossils from Africa. The Dmanisi sample, which now comprises five crania, provides direct evidence for wide morphological variation within and among early Homo paleodemes. This implies the existence of a single evolving lineage of early Homo, with phylogeographic continuity across continents.	[Lordkipanidze, David; Margvelashvili, Ann; Vekua, Abesalom] Georgian Natl Museum, GE-0105 Tbilisi, Georgia; [de Leon, Marcia S. Ponce; Margvelashvili, Ann; Zollikofer, Christoph P. E.] Anthropol Inst & Museum, CH-8057 Zurich, Switzerland; [Rak, Yoel] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Rightmire, G. Philip] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	Tel Aviv University; Sackler Faculty of Medicine; Harvard University	Lordkipanidze, D (corresponding author), Georgian Natl Museum, 3 Purtseladze St, GE-0105 Tbilisi, Georgia.	dlordkipanidze@museum.ge; zolli@aim.uzh.ch	Lordkipanidze, David/AAH-6472-2020; Margvelashvili, Ann/AAJ-8955-2020		Rustaveli Georgian National Science Foundation; Swiss National Science Foundation; U.S. National Science Foundation; National Geographic Society; L.S.B. Leakey Foundation; American Philosophical Society; American School for Prehistoric Research; Rolex Award for Enterprise; BP Georgia; Fundacion Duques de Soria; A.H. Schultz Foundation; Foundation for Scientific Research (University of Zurich)	Rustaveli Georgian National Science Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); L.S.B. Leakey Foundation; American Philosophical Society; American School for Prehistoric Research; Rolex Award for Enterprise; BP Georgia; Fundacion Duques de Soria; A.H. Schultz Foundation; Foundation for Scientific Research (University of Zurich)	This research was supported by the Rustaveli Georgian National Science Foundation, the Swiss National Science Foundation, the U.S. National Science Foundation, the National Geographic Society, the L.S.B. Leakey Foundation, the American Philosophical Society, the American School for Prehistoric Research, a Rolex Award for Enterprise, BP Georgia, the Fundacion Duques de Soria, the A.H. Schultz Foundation, and the Foundation for Scientific Research (University of Zurich). We thank the Dmanisi excavation team for excellent work; special thanks go to G. Kiladze. G. Nioradze was the first H. sapiens to encounter D4500. We gratefully acknowledge the work of the late G. Bumbiashvili, who photographed skull 5 and the other Dmanisi hominids. We thank G. Nemsadze (N. Kipshidze Central Clinical Hospital of Tbilisi State Medical University) and I. Tatishvili (A. Gvamichava Oncology National Center, Tbilisi) for CT data acquisition. We also thank the reviewers for their valuable comments, which helped to improve the manuscript. Dmanisi skull 5 is deposited at the Georgian National Museum, Tbilisi, Georgia.	Agusti J, 2011, QUATERNARY SCI REV, V30, P1338, DOI 10.1016/j.quascirev.2010.04.012; Anton SC, 2004, ANNU REV ANTHROPOL, V33, P271, DOI 10.1146/annurev.anthro.33.070203.144024; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; Baab KL, 2008, J HUM EVOL, V54, P827, DOI 10.1016/j.jhevol.2007.11.003; Behrensmeyer AK, 2008, GEOL SOC AM SPEC PAP, V446, P203, DOI 10.1130/2008.2446(09); Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; Bromage TG, 2008, J CLIN PEDIATR DENT, V33, P43, DOI 10.17796/jcpd.33.1.8168115j12103nut; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Darwin Charles., 1869, ORIGIN SPECIES MEANS, V5th; Ferring R, 2011, P NATL ACAD SCI USA, V108, P10432, DOI 10.1073/pnas.1106638108; Gabounia L, 2002, CR PALEVOL, V1, P243, DOI 10.1016/S1631-0683(02)00032-5; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Gabunia L, 2002, ARCHAEOL ETHNOL ANTH, V4, P145; Gilbert WH, 2003, J HUM EVOL, V45, P255, DOI 10.1016/j.jhevol.2003.08.007; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; Hastings A, 1996, BIOL CONSERV, V78, P143, DOI 10.1016/0006-3207(96)00023-7; HILL A, 1992, NATURE, V355, P719, DOI 10.1038/355719a0; Holliday TW, 2012, CURR ANTHROPOL, V53, pS330, DOI 10.1086/667360; Holloway R. L., 2004, HUMAN FOSSIL RECORD, V3; Howell FC, 1999, J ANTHROPOL RES, V55, P191, DOI 10.1086/jar.55.2.3631209; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P709, DOI 10.1002/ajpa.10425; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P497, DOI 10.1002/ajpa.10427; Kaifu Y, 2008, J HUM EVOL, V55, P551, DOI 10.1016/j.jhevol.2008.05.002; Kaifu Y, 2010, VERTEBR PALEOBIOL PA, P143, DOI 10.1007/978-90-481-9094-2_11; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel WH, 2013, NATURE, V497, P573, DOI 10.1038/497573a; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Lordkipanidze D, 2005, NATURE, V434, P717, DOI 10.1038/434717b; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lordkipanidze D, 2006, ANAT REC PART A, V288A, P1146, DOI 10.1002/ar.a.20379; Lozano M, 2008, J HUM EVOL, V55, P713, DOI 10.1016/j.jhevol.2008.04.007; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Marques-Bonet T, 2009, ANNU REV GENOM HUM G, V10, P355, DOI 10.1146/annurev.genom.9.081307.164420; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Pontzer H, 2010, J HUM EVOL, V58, P492, DOI 10.1016/j.jhevol.2010.03.006; Reno PL, 2003, P NATL ACAD SCI USA, V100, P9404, DOI 10.1073/pnas.1133180100; Rightmire GP, 2010, VERTEBR PALEOBIOL PA, P225, DOI 10.1007/978-90-481-9036-2_14; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Rightmire GP, 2004, AM J PHYS ANTHROPOL, V124, P109, DOI 10.1002/ajpa.10346; Sherwood RJ, 2002, J HUM EVOL, V42, P153, DOI 10.1006/jhev.2000.0409; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Suwa G, 2007, ANTHROPOL SCI, V115, P133, DOI 10.1537/ase.061203; Terhune CE, 2007, J HUM EVOL, V53, P41, DOI 10.1016/j.jhevol.2007.01.006; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; Walker A., 1993, NARIOKOTOME HOMO ERE; White T.D., 1989, P97; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B., 1991, KOOBI FORA RES PROJE, V4	48	270	286	5	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					326	331		10.1126/science.1238484	http://dx.doi.org/10.1126/science.1238484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136960				2022-12-24	WOS:000325755100035
J	Ferner, R				Ferner, Robin			Raising more antibodies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MONOCLONAL-ANTIBODIES; SEPTIC SHOCK; DOUBLE-BLIND; TRIAL; BITE		Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				BARTHOLOMEW C, 1970, BMJ-BRIT MED J, V1, P666, DOI 10.1136/bmj.1.5697.666; Chan K, 2008, CAN MED ASSOC J, V179, P158, DOI 10.1503/cmaj.071844; De Genst E, 2006, DEV COMP IMMUNOL, V30, P187, DOI 10.1016/j.dci.2005.06.010; European Medicines Agency, 2013, WITHDR APPL CHANG MA; Healthy Canadians, 2013, RIT RIT HEP B VIR HB; HINDS CJ, 1992, BRIT MED J, V304, P132, DOI 10.1136/bmj.304.6820.132; Isbister GK, 2005, MED J AUSTRALIA, V182, P407, DOI 10.5694/j.1326-5377.2005.tb06760.x; Karnad DR, 1998, HEART, V79, P485, DOI 10.1136/hrt.79.5.485; MCCLOSKEY RV, 1994, ANN INTERN MED, V121, P1, DOI 10.7326/0003-4819-121-1-199407010-00001; MCGREGOR AM, 1981, BRIT MED J, V283, P1143, DOI 10.1136/bmj.283.6300.1143; Pucca MB, 2013, J IMMUNOTOXICOL; Smalligan R, 2004, BMJ-BRIT MED J, V329, P1129, DOI 10.1136/bmj.329.7475.1129; Von Behring E., 1890, DEUT MED WOCHENSCHR, V16, P1145; World Health Organization, 2011, INT NONPR NAM INN BI, P8; Younes A, 2011, NAT REV CLIN ONCOL, V8, P85, DOI 10.1038/nrclinonc.2010.189	15	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 16	2013	347								f5969	10.1136/bmj.f5969	http://dx.doi.org/10.1136/bmj.f5969			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WM	24133143				2022-12-24	WOS:000325982400001
J	Pasternak, B; Svanstrom, H; Molgaard-Nielsen, D; Melbye, M; Hviid, A				Pasternak, Bjorn; Svanstrom, Henrik; Molgaard-Nielsen, Ditte; Melbye, Mads; Hviid, Anders			Metoclopramide in Pregnancy and Risk of Major Congenital Malformations and Fetal Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NAUSEA; REGISTRATION; MEDICATIONS; COHORT	IMPORTANCE Metoclopramide, a drug frequently used for nausea and vomiting in pregnancy, is thought to be safe, but information on the risk of specific malformations and fetal death is lacking. OBJECTIVE To investigate the safety of metoclopramide use in pregnancy. DESIGN, SETTING, AND PARTICIPANTS Register-based cohort study in Denmark, 1997-2011. From a cohort of 1 222 503 pregnancies, metoclopramide-exposed and unexposed women were matched (1: 4 ratio) on the basis of age, calendar year, and propensity scores. MAIN OUTCOMES AND MEASURES Primary outcomes were major congenital malformations overall, 20 individual malformation categories (selected according to power criteria), spontaneous abortion, and stillbirth. In matched analyses, logistic regression was used to estimate prevalence odds ratios of malformations and Cox regression to estimate hazard ratios (HRs) of spontaneous abortion. RESULTS Among 28 486 women exposed to metoclopramide in the first trimester, 721 had an infant with a major congenital malformation (25.3 [95% CI, 23.5-27.1] cases per 1000 births), compared with 3024 among 113 698 unexposed women (26.6 [95% CI, 25.7-27.5] per 1000 births). There were no significant associations between metoclopramide use and malformations overall (prevalence odds ratio, 0.93 [95% CI, 0.86-1.02]) or any of the 20 individual malformation categories, eg, neural tube defects, transposition of great vessels, ventricular septal defect, atrial septal defect, tetralogy of Fallot, coarctation of the aorta, cleft lip, cleft palate, anorectal atresia/stenosis, and limb reduction (upper limit of 95% CI below 2.0 for 17 of 20 categories). Metoclopramide was not associated with increased risk of spontaneous abortion (757 cases [20.0 {95% CI, 18.5-21.4} per 1000] among 37 946 metoclopramide-exposed women and 9414 cases [62.1 {95% CI, 60.9-63.3} per 1000] among 151 661 unexposed women; HR, 0.35 [95% CI, 0.33-0.38]) and stillbirth (142 cases [3.5 {95% CI, 2.9-4.1} per 1000] among 40 306 metoclopramide-exposed women and 634 cases [3.9 {95% CI, 3.6-4.2} per 1000] among 161 098 unexposed women; HR, 0.90 [95% CI, 0.74-1.08]). CONCLUSIONS AND RELEVANCE Metoclopramide use in pregnancy was not associated with increased risk of major congenital malformations overall, any of the 20 individual malformation categories assessed, spontaneous abortion, or stillbirth. These safety data may help inform decision making when treatment with metoclopramide is considered in pregnancy.	[Pasternak, Bjorn; Svanstrom, Henrik; Molgaard-Nielsen, Ditte; Melbye, Mads; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	bjp@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127; melbye, mads/0000-0001-8264-6785	Danish Medical Research Council [11-115854]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Danish Medical Research Council grant 11-115854 (Dr Pasternak).	Agergaard Peter, 2011, Clin Epidemiol, V3, P61, DOI 10.2147/CLEP.S15627; Anderka M, 2012, BIRTH DEFECTS RES A, V94, P22, DOI 10.1002/bdra.22865; Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; [Anonymous], EUROCAT PREV TABL DE; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Berkovitch M, 2000, NEW ENGL J MED, V343, P445, DOI 10.1056/NEJM200008103430616; Berkovitch M, 2002, AM J PERINAT, V19, P311, DOI 10.1055/s-2002-34469; Briggs GG., 2008, DRUGS PREGNANCY LACT, P1197; Buhimschi CS, 2009, OBSTET GYNECOL, V113, P166, DOI 10.1097/AOG.0b013e31818d6788; Chan RL, 2010, HUM REPROD, V25, P2907, DOI 10.1093/humrep/deq260; EUROCAT, EUR GUID 1 3 REF DOC; Harrell FE., 2001, REGRESSION MODELING, P41; Jarvis S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3606; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lacroix R, 2000, AM J OBSTET GYNECOL, V182, P931, DOI 10.1016/S0002-9378(00)70349-8; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Lohse Sarah Rytter, 2010, Clin Epidemiol, V2, P247, DOI 10.2147/CLEP.S13815; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Matok I, 2009, NEW ENGL J MED, V360, P2528, DOI 10.1056/NEJMoa0807154; Mitchell AA, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P501; Niebyl JR, 2010, NEW ENGL J MED, V363, P1544, DOI 10.1056/NEJMcp1003896; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Sorensen HT, 2000, BRIT J CLIN PHARMACO, V49, P264, DOI 10.1046/j.1365-2125.2000.00127.x; WEIGEL RM, 1989, BRIT J OBSTET GYNAEC, V96, P1312, DOI 10.1111/j.1471-0528.1989.tb03229.x	26	53	54	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1601	1611		10.1001/jama.2013.278343	http://dx.doi.org/10.1001/jama.2013.278343			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24129464	Bronze			2022-12-24	WOS:000325624800023
J	Allen, R				Allen, Richard			Seconds count	NATURE			English	Editorial Material							DISPLACEMENT; SLIP		[Allen, Richard] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; [Allen, Richard] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Allen, R (corresponding author), Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA.	rallen@berkeley.edu	Allen, Richard/H-8493-2016	Allen, Richard/0000-0003-4293-9772				Allen R, 2011, SCI AM, V304, P74, DOI 10.1038/scientificamerican0411-74; Allen RM, 2012, SCIENCE, V335, P297, DOI 10.1126/science.1214650; Bose M., 2013, EARLY WARNING GEOLOG, P49, DOI DOI 10.1007/978-3-642-12233-0_3; Fujiwara T, 2011, SCIENCE, V334, P1240, DOI 10.1126/science.1211554; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Jones N, 2011, NATURE, V479, P16, DOI 10.1038/479016a; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; Noda H, 2013, NATURE, V493, P518, DOI 10.1038/nature11703; Ozawa S, 2011, NATURE, V475, P373, DOI 10.1038/nature10227; Sato M, 2011, SCIENCE, V332, P1395, DOI 10.1126/science.1207401	10	12	12	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					29	31		10.1038/502029a	http://dx.doi.org/10.1038/502029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	227IM	24137643	Bronze			2022-12-24	WOS:000325106000013
J	Erdmann, J; Stark, K; Esslinger, UB; Rumpf, PM; Koesling, D; de Wit, C; Kaiser, FJ; Braunholz, D; Medack, A; Fischer, M; Zimmermann, ME; Tennstedt, S; Graf, E; Eck, S; Aherrahrou, Z; Nahrstaedt, J; Willenborg, C; Bruse, P; Braenne, I; Nothen, MM; Hofmann, P; Braund, PS; Mergia, E; Reinhard, W; Burgdorf, C; Schreiber, S; Balmforth, AJ; Hall, AS; Bertram, L; Steinhagen-Thiessen, E; Li, SC; Marz, W; Reilly, M; Kathiresan, S; McPherson, R; Walter, U; Ott, J; Samani, NJ; Strom, TM; Meitinger, T; Hengstenberg, C; Schunkert, H				Erdmann, Jeanette; Stark, Klaus; Esslinger, Ulrike B.; Rumpf, Philipp Moritz; Koesling, Doris; de Wit, Cor; Kaiser, Frank J.; Braunholz, Diana; Medack, Anja; Fischer, Marcus; Zimmermann, Martina E.; Tennstedt, Stephanie; Graf, Elisabeth; Eck, Sebastian; Aherrahrou, Zouhair; Nahrstaedt, Janja; Willenborg, Christina; Bruse, Petra; Braenne, Ingrid; Noethen, Markus M.; Hofmann, Per; Braund, Peter S.; Mergia, Evanthia; Reinhard, Wibke; Burgdorf, Christof; Schreiber, Stefan; Balmforth, Anthony J.; Hall, Alistair S.; Bertram, Lars; Steinhagen-Thiessen, Elisabeth; Li, Shu-Chen; Maerz, Winfried; Reilly, Muredach; Kathiresan, Sekar; McPherson, Ruth; Walter, Ulrich; Ott, Jurg; Samani, Nilesh J.; Strom, Tim M.; Meitinger, Thomas; Hengstenberg, Christian; Schunkert, Heribert		CARDIoGRAM	Dysfunctional nitric oxide signalling increases risk of myocardial infarction	NATURE			English	Article							SOLUBLE GUANYLATE-CYCLASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DISEASE	Myocardial infarction, a leading cause of death intheWesternworld(1), usually occurs when the fibrous cap overlying an atherosclerotic plaque in a coronary artery ruptures. The resulting exposure of blood to the atherosclerotic material then triggers thrombus formation, which occludes the artery(2). The importance of genetic predisposition to coronary artery disease and myocardial infarction is best documented by the predictive value of a positive family history(3). Nextgeneration sequencing in families with several affected individuals has revolutionized mutation identification(4). Here we report the segregation of two private, heterozygous mutations in two functionally relatedgenes, GUCY1A3 (p.Leu163Phefs*24) andCCT7 (p.Ser525Leu), in an extended myocardial infarction family. GUCY1A3 encodes the alpha 1 subunit of soluble guanylyl cyclase (alpha 1-sGC)(5), and CCT7 encodes CCT eta, a member of the tailless complex polypeptide 1 ring complex(6), which, among other functions, stabilizes soluble guanylyl cyclase. After stimulation with nitric oxide, soluble guanylyl cyclase generates cGMP, which induces vasodilation and inhibits platelet activation(7). Wedemonstratein vitro that mutations inbothGUCY1A3 and CCT7 severely reduce alpha 1-sGC as well as beta 1-sGC protein content, and impair soluble guanylyl cyclase activity. Moreover, platelets from digenic mutation carriers contained less soluble guanylyl cyclase protein and consequently displayed reduced nitric-oxideinduced cGMP formation. Mice deficient in alpha 1-sGC protein displayed accelerated thrombus formation in themicrocirculation after local trauma. Starting with a severely affected family, we have identified a link between impaired soluble-guanylyl-cyclase-dependent nitric oxide signalling and myocardial infarction risk, possibly through accelerated thrombus formation. Reversing this defect may provide a new therapeutic target for reducing the risk of myocardial infarction.	[Erdmann, Jeanette; Medack, Anja; Tennstedt, Stephanie; Aherrahrou, Zouhair; Nahrstaedt, Janja; Willenborg, Christina; Bruse, Petra; Braenne, Ingrid] Med Univ Lubeck, Inst Integrat & Expt Genom, D-23562 Lubeck, Germany; [Erdmann, Jeanette; de Wit, Cor; Kaiser, Frank J.; Aherrahrou, Zouhair; Willenborg, Christina] German Ctr Cardiovasc Res DZHK, D-23562 Lubeck, Germany; [Stark, Klaus; Esslinger, Ulrike B.; Fischer, Marcus; Zimmermann, Martina E.] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 2, D-93053 Regensburg, Germany; [Stark, Klaus] Univ Regensburg, Dept Genet Epidemiol, D-93053 Regensburg, Germany; [Esslinger, Ulrike B.] INSERM, UMR S937, Paris, France; [Rumpf, Philipp Moritz; Reinhard, Wibke; Burgdorf, Christof; Meitinger, Thomas; Hengstenberg, Christian; Schunkert, Heribert] Deutsch Herzzentrum Munich, D-80636 Munich, Germany; [Rumpf, Philipp Moritz; Reinhard, Wibke; Burgdorf, Christof; Meitinger, Thomas; Hengstenberg, Christian; Schunkert, Heribert] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-80636 Munich, Germany; [Rumpf, Philipp Moritz; Reinhard, Wibke; Hengstenberg, Christian; Schunkert, Heribert] German Ctr Cardiovasc Res DZHK, D-80636 Munich, Germany; [Koesling, Doris; Mergia, Evanthia] Ruhr Univ Bochum, Dept Pharmacol & Toxicol, D-44801 Bochum, Germany; [de Wit, Cor] Med Univ Lubeck, Inst Physiol, D-23562 Lubeck, Germany; [Kaiser, Frank J.; Braunholz, Diana] Med Univ Lubeck, Inst Humangenet, D-23562 Lubeck, Germany; [Graf, Elisabeth; Eck, Sebastian; Strom, Tim M.; Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Graf, Elisabeth; Eck, Sebastian; Strom, Tim M.; Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Noethen, Markus M.; Hofmann, Per] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Noethen, Markus M.] Univ Bonn, Res Ctr Life & Brain, Dept Genom, D-53127 Bonn, Germany; [Hofmann, Per] Univ Basel Hosp, Div Med Genet, CH-4003 Basel, Switzerland; [Hofmann, Per] Univ Basel, Dept Biomed, CH-4003 Basel, Switzerland; [Braund, Peter S.; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England; [Braund, Peter S.; Samani, Nilesh J.] Glenfield Gen Hosp, Leicester Natl Inst Hlth Res Biomed Res Unit Card, Leicester LE1 7RH, Leics, England; [Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Balmforth, Anthony J.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Multidisciplinary Cardiovasc Res Ctr, Div Cardiovasc & Diabet Res, Leeds LS2 9JT, W Yorkshire, England; [Hall, Alistair S.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Multidisciplinary Cardiovasc Res Ctr, Div Cardiovasc & Neuronal Remodelling, Leeds LS2 9JT, W Yorkshire, England; [Bertram, Lars] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Steinhagen-Thiessen, Elisabeth] Charite, Charite Res Grp Geriatr, D-10117 Berlin, Germany; [Li, Shu-Chen] Max Planck Inst Human Dev, Ctr Lifespan Psychol, D-14195 Berlin, Germany; [Li, Shu-Chen] Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, D-68165 Mannheim, Germany; [Maerz, Winfried] Synlab Serv GmbH, Business Dev, D-68165 Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria; [Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Med Clin 5, D-68167 Mannheim, Germany; [Reilly, Muredach] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02215 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02215 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02215 USA; [Kathiresan, Sekar] Broad Inst Harvard & Massachusetts Inst Technol M, Program Med & Populat Genet, Cambridge, MA 02215 USA; [McPherson, Ruth] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Walter, Ulrich] Univ Med Mainz, CTH, D-55131 Mainz, Germany; [Walter, Ulrich] German Ctr Cardiovasc Res DZHK, D-55131 Mainz, Germany; [Ott, Jurg] Chinese Acad Sci, Inst Psychol, Beijing 100864, Peoples R China; [Ott, Jurg] Rockefeller Univ, Lab Stat Genet, New York, NY 10065 USA	University of Lubeck; German Centre for Cardiovascular Research; University of Regensburg; University of Regensburg; Institut National de la Sante et de la Recherche Medicale (Inserm); German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Ruhr University Bochum; University of Lubeck; University of Lubeck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Bonn; University of Bonn; University of Basel; University of Basel; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Kiel; University of Leeds; University of Leeds; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Technische Universitat Dresden; SYNLAB Group; SYNLAB Group; Medical University of Graz; Ruprecht Karls University Heidelberg; University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Ottawa; University of Ottawa Heart Institute; Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research; Chinese Academy of Sciences; Institute of Psychology, CAS; Rockefeller University	Hengstenberg, C (corresponding author), Deutsch Herzzentrum Munich, D-80636 Munich, Germany.	jeanette.erdmann@iieg.uni-luebeck.de; hengstenberg@dhm.mhn.de	Erdmann, Jeanette/A-4417-2009; Gudnason, Vilmundur/K-6885-2015; Walter, ulrich/W-2478-2017; Hall, Alistair/K-1953-2019; Willenborg, Christina/D-2668-2012; Tennstedt, Stephanie/F-3637-2018; Hengstenberg, Christian/U-5485-2019; Stark, Klaus/L-7367-2013; Altshuler, David M/A-4476-2009; Peters, Annette/A-6117-2011; Li, Shu-Chen/K-7838-2012; Boehm, Bernhard Otto/F-8750-2015; Meitinger, Thomas/O-1318-2015; Zimmermann, Martina/AAL-2990-2021; Erdmann, Jeanette/P-7513-2014; Bertram, Lars/K-3889-2015; de Wit, Cor/A-5560-2009	Gudnason, Vilmundur/0000-0001-5696-0084; Walter, ulrich/0000-0001-6784-2307; Willenborg, Christina/0000-0001-5217-6882; Tennstedt, Stephanie/0000-0001-9063-3087; Stark, Klaus/0000-0002-7832-1942; Altshuler, David M/0000-0002-7250-4107; Peters, Annette/0000-0001-6645-0985; Li, Shu-Chen/0000-0002-5520-5789; Zimmermann, Martina/0000-0002-6916-4404; Erdmann, Jeanette/0000-0002-4486-6231; Bertram, Lars/0000-0002-0108-124X; de Wit, Cor/0000-0003-4621-0399; Nothen, Markus/0000-0002-8770-2464; Melander, Olle/0000-0002-2581-484X; Zeller, Tanja/0000-0003-3379-2641; Meitinger, Thomas/0000-0002-8838-8403; Reilly, Muredach/0000-0002-3035-9386; Nelson, Christopher/0000-0001-8025-2897; Li, Shu-Chen/0000-0001-8409-5390; Hall, Alistair/0000-0003-0306-7887; Wagner, Arnika/0000-0002-0339-8259; Van Duijn, Cornelia/0000-0002-2374-9204; Aherrahrou, Zouhair/0000-0002-1241-8733; Kleber, Marcus/0000-0003-0663-7275	Deutsche Forschungsgemeinschaft; German Federal Ministry of Education and Research (BMBF) [01GS0417, 01GS0832]; EU [LSHM-CT-2006-037593]; ENGAGE [201413]; GEUVADIS [261123]; binational BMBF/ANR funded project CARDomics [01KU0908A]; Universitat zu Lubeck; University Hospital of Regensburg, Germany; The German Federal Ministry for Education and Research [16SV5538]; NSFC from Chinese Government [30730057]; British Heart Foundation; Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; BMBF [01EO1003]; DFG; National Institute for Health Research [NF-SI-0611-10170] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); ENGAGE; GEUVADIS; binational BMBF/ANR funded project CARDomics(French National Research Agency (ANR)); Universitat zu Lubeck; University Hospital of Regensburg, Germany; The German Federal Ministry for Education and Research; NSFC from Chinese Government; British Heart Foundation(British Heart Foundation); Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank all the family members who participated in this research. Without the continuous support of these patients over more than 15 years, the present work would not have been possible. We would like to thank S. Wrobel, S. Stark, A. Liebers, K. Franke, J. Stegmann-Frehse, M. Behrensen, M. Schmid, J. Eckhold, D. Wollner, U. Krabbe and J. Simon for technical assistance. Furthermore, we would like to thank M. Becker, N. Buchholz, I. Demuth, R. Eckardt, H. Heekeren, U. Lindenberger, M. Lovden, L. Muller, W. Nietfeld, G. Pawelec, F. Schmiedeck, T. Siedler and G. G. Wagner for their contributions to BASE-II. We also would like to thank S. Herterich and S. Gambaryan for advice, and B. Mayer, U. Hubauer, K.-H. Ameln and A. Grosshennig for help with GerMIFS. We thank WTCCC+ and the WTCCC-CAD2 investigators for access to their data. The study is supported by the Deutsche Forschungsgemeinschaft and the German Federal Ministry of Education and Research (BMBF) in the context of the German National Genome Research Network (NGFN-2 (01GS0417) and NGFN-plus (01GS0832)), the FP6 and FP7 EU-funded integrated projects Cardiogenics (LSHM-CT-2006-037593), ENGAGE (201413), and GEUVADIS (261123), the binational BMBF/ANR funded project CARDomics (01KU0908A), the local focus programs 'Kardiovaskulare Genomforschung' and 'Medizinische Genetik' of the Universitat zu Lubeck, and the University Hospital of Regensburg, Germany. The German Federal Ministry for Education and Research provided funding for BASE-II (BMBF; grant no. 16SV5538). Support by NSFC grant 30730057 from the Chinese Government (to J.O.) is gratefully acknowledged. N. J. S. holds a Chair funded by the British Heart Foundation, and is supported by the Leicester NIHR Biomedical Research Unit in Cardiovascular Disease. U. W. is supported by the BMBF(01EO1003). M. M. N. is a member of the DFG-funded Excellence Cluster ImmunoSensation.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Dekker C, 2011, EMBO J, V30, P3078, DOI 10.1038/emboj.2011.208; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Fischer M, 2005, CIRCULATION, V111, P855, DOI 10.1161/01.CIR.0000155611.41961.BB; Haenle MM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-233; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Moro MA, 1996, P NATL ACAD SCI USA, V93, P1480, DOI 10.1073/pnas.93.4.1480; Preuss UW, 2003, EUR ARCH PSY CLIN N, V253, P275, DOI 10.1007/s00406-003-0440-7; RISCH N, 1990, AM J HUM GENET, V46, P242; Ritsch A, 2010, CIRCULATION, V121, P366, DOI 10.1161/CIRCULATIONAHA.109.875013; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Wolfle SE, 2009, CARDIOVASC RES, V82, P476, DOI 10.1093/cvr/cvp060; World Health Organization, 2020, TOP 10 CAUS DEATH; Zabel U, 1998, BIOCHEM J, V335, P51, DOI 10.1042/bj3350051	28	195	200	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					432	+		10.1038/nature12722	http://dx.doi.org/10.1038/nature12722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24213632				2022-12-24	WOS:000328575300051
J	Chen, RQ; Zhang, J; Fan, N; Teng, ZQ; Wu, Y; Yang, HW; Tang, YP; Sun, H; Song, YP; Chen, C				Chen, Rongqing; Zhang, Jian; Fan, Ni; Teng, Zhao-qian; Wu, Yan; Yang, Hongwei; Tang, Ya-ping; Sun, Hao; Song, Yunping; Chen, Chu			Delta(9)-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling	CELL			English	Article							LONG-TERM POTENTIATION; CB1 CANNABINOID RECEPTORS; RAT CEREBRAL-CORTEX; ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL; CHRONIC DELTA-9-TETRAHYDROCANNABINOL; IN-VIVO; MODULATION; CYCLOOXYGENASE-2; PROSTAGLANDINS; TRANSMISSION	Marijuana has been used for thousands of years as a treatment for medical conditions. However, untoward side effects limit its medical value. Here, we show that synaptic and cognitive impairments following repeated exposure to D-9-tetrahydrocannabinol (Delta(9)-THC) are associated with the induction of cyclooxygenase-2 (COX-2), an inducible enzyme that converts arachidonic acid to prostanoids in the brain. COX-2 induction by Delta(9)-THC is mediated via CB1 receptor-coupled G protein beta gamma subunits. Pharmacological or genetic inhibition of COX-2 blocks downregulation and internalization of glutamate receptor subunits and alterations of the dendritic spine density of hippocampal neurons induced by repeated Delta(9)-THC exposures. Ablation of COX-2 also eliminates Delta(9)-THC-impaired hippocampal long-term synaptic plasticity, working, and fear memories. Importantly, the beneficial effects of decreasing beta-amyloid plaques and neurodegeneration by Delta(9)-THC in Alzheimer's disease animals are retained in the presence of COX-2 inhibition. These results suggest that the applicability of medical marijuana would be broadened by concurrent inhibition of COX-2.	[Chen, Rongqing; Zhang, Jian; Fan, Ni; Teng, Zhao-qian; Wu, Yan; Yang, Hongwei; Sun, Hao; Song, Yunping; Chen, Chu] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Chen, Chu] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Otorhinolaryngol, New Orleans, LA 70112 USA; [Tang, Ya-ping] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Cell Biol & Anat, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Chen, C (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA.	chen502@gmail.com	Teng, Zhao-Qian/AAD-1033-2021; Tang, Ya-Ping/A-1035-2011; Song, Yunping/GNM-6096-2022; Teng, Zhao-Qian/J-6260-2015	Teng, Zhao-Qian/0000-0002-7232-3381; Teng, Zhao-Qian/0000-0002-7232-3381; Chen, Rongqing/0000-0002-1668-8554; Tang, Ya-Ping/0000-0002-0445-4072	National Institutes of Health [R01NS054886, R01NS076815]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054886, R01NS076815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Xin-Yun Huang (Weill Medical College of Cornell University) for providing us with beta 1 and gamma 2 plasmids; Dr. James Pickel (NIMH transgenic core) for providing us with CB1R knockout mice; Ms. Hongmin Jin for technical support; and NIDA and MIMH Drug Supply Programs for providing Delta<SUP>9</SUP>-THC, Rimonabant, and Celebrex. This work was supported by grants from National Institutes of Health R01NS054886 and R01NS076815 to C.C.	Akaneya Y, 2006, J NEUROSCI, V26, P10209, DOI 10.1523/JNEUROSCI.3028-06.2006; Alger BE, 2009, CURR TOP BEHAV NEURO, V1, P141, DOI 10.1007/978-3-540-88955-7_6; Bahr BA, 2006, EXPERT OPIN INV DRUG, V15, P351, DOI 10.1517/13543784.15.4.351; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Brock TG, 1999, J BIOL CHEM, V274, P11660, DOI 10.1074/jbc.274.17.11660; BURSTEIN SH, 1989, MOL PHARMACOL, V35, P6; Campbell VA, 2007, BRIT J PHARMACOL, V152, P655, DOI 10.1038/sj.bjp.0707446; Carlini EA, 2004, TOXICON, V44, P461, DOI 10.1016/j.toxicon.2004.05.009; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Chen C, 2006, BIOCHEM BIOPH RES CO, V340, P435, DOI 10.1016/j.bbrc.2005.12.021; Chen C, 2002, J NEUROPHYSIOL, V87, P2851, DOI 10.1152/jn.2002.87.6.2851; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Chen X, 2011, NEUROSCIENCE, V178, P159, DOI 10.1016/j.neuroscience.2011.01.024; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Cowley TR, 2008, EUR J NEUROSCI, V27, P2999, DOI 10.1111/j.1460-9568.2008.06251.x; Dave KA, 2010, NEURON GLIA BIOL, V6, P201, DOI 10.1017/S1740925X10000244; Delaney AJ, 2007, NEURON, V56, P880, DOI 10.1016/j.neuron.2007.10.022; Du HZ, 2011, BRIT J PHARMACOL, V163, P1533, DOI 10.1111/j.1476-5381.2011.01444.x; Egashira N, 2007, J PHARMACOL SCI, V105, P361, DOI 10.1254/jphs.FP0071247; FAIRBAIRN JW, 1980, BRIT J PHARMACOL, V69, P491, DOI 10.1111/j.1476-5381.1980.tb07039.x; FAIRBAIRN JW, 1979, BRIT J PHARMACOL, V67, P379, DOI 10.1111/j.1476-5381.1979.tb08691.x; Fan N, 2010, J NEUROCHEM, V112, P691, DOI 10.1111/j.1471-4159.2009.06489.x; Ferraro L, 2001, CEREB CORTEX, V11, P728, DOI 10.1093/cercor/11.8.728; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Gowran A, 2011, CNS NEUROSCI THER, V17, P637, DOI 10.1111/j.1755-5949.2010.00195.x; Guo J, 2004, MOL PHARMACOL, V65, P665, DOI 10.1124/mol.65.3.665; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Hoffman AF, 2007, LEARN MEMORY, V14, P63, DOI 10.1101/lm.439007; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Lichtman AH, 1996, PSYCHOPHARMACOLOGY, V126, P125, DOI 10.1007/BF02246347; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Lovinger David M., 2008, V184, P435; Marchalant Y, 2008, BIOMED PHARMACOTHER, V62, P212, DOI 10.1016/j.biopha.2008.02.004; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mato S, 2005, J NEUROSCI, V25, P11619, DOI 10.1523/JNEUROSCI.2294-05.2005; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Messinis L, 2006, NEUROLOGY, V66, P737, DOI 10.1212/01.wnl.0000201279.83203.c6; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; PEREZREYES M, 1991, LIFE SCI, V48, P507, DOI 10.1016/0024-3205(91)90465-N; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pope HG, 2001, ARCH GEN PSYCHIAT, V58, P909, DOI 10.1001/archpsyc.58.10.909; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Robson P, 2001, BRIT J PSYCHIAT, V178, P107, DOI 10.1192/bjp.178.2.107; Rubino T, 2009, HIPPOCAMPUS, V19, P763, DOI 10.1002/hipo.20554; Russo EB, 2007, CHEM BIODIVERS, V4, P1614, DOI 10.1002/cbdv.200790144; Sang N, 2005, J NEUROSCI, V25, P9858, DOI 10.1523/JNEUROSCI.2392-05.2005; Sanzgiri RP, 1999, J NEUROBIOL, V41, P221, DOI 10.1002/(SICI)1097-4695(19991105)41:2<221::AID-NEU5>3.3.CO;2-1; Solowij N, 2002, JAMA-J AM MED ASSOC, V287, P1123, DOI 10.1001/jama.287.9.1123; Suarez I, 2004, DEV NEUROSCI-BASEL, V26, P45, DOI 10.1159/000080711; Suarez I, 2004, CEREBELLUM, V3, P66, DOI 10.1080/14734220310017230; Teather LA, 2002, LEARN MEMORY, V9, P41, DOI 10.1101/lm.43602; Tomasini MC, 2002, J NEUROSCI RES, V68, P449, DOI 10.1002/jnr.10242; Tonini R, 2006, J NEUROSCI, V26, P5810, DOI 10.1523/JNEUROSCI.5469-05.2006; Yao LN, 2003, P NATL ACAD SCI USA, V100, P14379, DOI 10.1073/pnas.2336093100; Zhang J, 2008, J BIOL CHEM, V283, P22601, DOI 10.1074/jbc.M800524200	59	115	120	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1154	1165		10.1016/j.cell.2013.10.042	http://dx.doi.org/10.1016/j.cell.2013.10.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267894	Green Accepted, Bronze			2022-12-24	WOS:000327500600018
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN "First do no harm" revisited	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, London WC2R 2LS, England	University of London; King's College London	Sokol, DK (corresponding author), Kings Coll London, London WC2R 2LS, England.	daniel.sokol@talk21.com						[Anonymous], 1860, FDN NEW THEORY PRACT; Daniel Michelle, 2012, J Clin Ethics, V23, P331; Gillon R, 1985, PHILOS MED ETHICS; Holmes Oliver Wendell, 1865, CURRENTS COUNTER CUR	4	37	38	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2013	347								f6426	10.1136/bmj.f6426	http://dx.doi.org/10.1136/bmj.f6426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CM	24163087				2022-12-24	WOS:000326294200010
J	Mitchell, JM				Mitchell, Jean M.			Urologists' Use of Intensity-Modulated Radiation Therapy for Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; SPECIALTY HOSPITALS; SURGERY; IMPACT	BackgroundSome urology groups have integrated intensity-modulated radiation therapy (IMRT), a radiation treatment with a high reimbursement rate, into their practice. This is permitted by the exception for in-office ancillary services in the federal prohibition against self-referral. I examined the association between ownership of IMRT services and use of IMRT to treat prostate cancer. MethodsUsing Medicare claims from 2005 through 2010, I constructed two samples: one comprising 35 self-referring urology groups in private practice and a matched control group comprising 35 non-self-referring urology groups in private practice, and the other comprising non-self-referring urologists employed at 11 National Comprehensive Cancer Network centers matched with 11 self-referring urology groups in private practice. I compared the use of IMRT in the periods before and during ownership and used a difference-in-differences analysis to evaluate changes in IMRT use according to self-referral status. ResultsThe rate of IMRT use by self-referring urologists in private practice increased from 13.1 to 32.3%, an increase of 19.2 percentage points (P<0.001). Among non-self-referring urologists, the rate of IMRT use increased from 14.3 to 15.6%, an increase of 1.3 percentage points (P=0.05). The unadjusted difference-in-differences effect was 17.9 percentage points (P<0.001). The regression-adjusted increase in IMRT use associated with self-referral was 16.4 percentage points (P<0.001). The rate of IMRT use by urologists working at National Comprehensive Cancer Network centers remained stable at 8.0% but increased by 33.0 percentage points among the 11 matched self-referring urology groups. The regression-adjusted difference-in-differences effect was 29.3 percentage points (P<0.001). ConclusionsUrologists who acquired ownership of IMRT services increased their use of IMRT substantially more than urologists who did not own such services. Allowing urologists to self-refer for IMRT may contribute to increased use of this expensive therapy. (Funded by the American Society for Radiation Oncology.)	Georgetown Univ, Washington, DC 20057 USA	Georgetown University	Mitchell, JM (corresponding author), Georgetown Univ, Old North 314,37th & O Sts NW, Washington, DC 20057 USA.	mitchejm@georgetown.edu			American Society for Radiation Oncology; Georgetown University	American Society for Radiation Oncology; Georgetown University	Supported by an unrestricted educational research contract between the American Society for Radiation Oncology and Georgetown University.	Addressing the growth of ancillary services in physicians' offices, 2010, REP C AG INC MED PRO, P213; American Cancer Society, PROST CANC OV; [Anonymous], 2008, COMP EFF THER CLIN L; Baker LC, 2010, HEALTH AFFAIR, V29, P2252, DOI 10.1377/hlthaff.2009.1099; Bishop TF, 2010, J GEN INTERN MED, V25, P1057, DOI 10.1007/s11606-010-1409-7; Carreyrou J, 2010, WALL STREET J, pA1; DRANOVE D, 1988, ECON INQ, V26, P281, DOI 10.1111/j.1465-7295.1988.tb01494.x; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gazelle GS, 2007, RADIOLOGY, V245, P517, DOI 10.1148/radiol.2452070193; HILLMAN BJ, 1992, JAMA-J AM MED ASSOC, V268, P2050, DOI 10.1001/jama.268.15.2050; Hillman BJ, 2010, HEALTH AFFAIR, V29, P2231, DOI 10.1377/hlthaff.2010.1019; Hughes DR, 2010, HEALTH AFFAIR, V29, P2244, DOI 10.1377/hlthaff.2010.0413; Jacobs BL, 2012, HLTH AFF MILLWOOD, V1, P750; Kerr RR, 2011, UROLOGY TIMES   1201, P1; Litwin MS, 2007, CANCER, V109, P2239, DOI 10.1002/cncr.22676; Management options for low-risk prostate cancer, 2010, MAN OPT LOW RISK PRO; Medicare Payment Advisory Commission, 2009, REP C IMPR INC MED P, P81; Mitchell JM, 2008, MED CARE, V46, P732, DOI 10.1097/MLR.0b013e31817892a7; Mitchell JM, 2007, MED CARE RES REV, V64, P395, DOI 10.1177/1077558707301953; Mitchell JM, 2007, HEALTH AFFAIR, V26, pW415, DOI 10.1377/hlthaff.26.3.w415; Mitchell JM, 2012, HEALTH AFFAIR, V31, P741, DOI 10.1377/hlthaff.2011.1372; Nallamothu BK, 2007, JAMA-J AM MED ASSOC, V297, P962, DOI 10.1001/jama.297.9.962; Newhouse JP, 2013, NEW ENGL J MED, V368, P1465, DOI 10.1056/NEJMp1302981; Nguyen PL, 2011, J CLIN ONCOL, V29, P1517, DOI 10.1200/JCO.2010.31.1217; Pauly MV, 1980, DOCTORS THEIR WORKSH, P1; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Shahinian VB, 2010, NEW ENGL J MED, V363, P1822, DOI 10.1056/NEJMsa0910784; Shreibati JB, 2011, HEALTH SERV RES, V46, P1362, DOI 10.1111/j.1475-6773.2011.01265.x; Sunshine J, 2010, HEALTH AFFAIR, V29, P2237, DOI 10.1377/hlthaff.2009.1081; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	31	107	108	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1629	1637		10.1056/NEJMsa1201141	http://dx.doi.org/10.1056/NEJMsa1201141			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239MZ	24152262				2022-12-24	WOS:000326031100012
J	Basu, S; Babiarz, KS; Ebrahim, S; Vellakkal, S; Stuckler, D; Goldhaber-Fiebert, JD				Basu, Sanjay; Babiarz, Kim S.; Ebrahim, Shah; Vellakkal, Sukumar; Stuckler, David; Goldhaber-Fiebert, Jeremy D.			Palm oil taxes and cardiovascular disease mortality in India: economic-epidemiologic model	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; TOTAL CHOLESTEROL; FATTY-ACIDS; RISK; HEALTH; COUNTRIES; PREVALENCE; GLUCOSE; DIET	Objective To examine the potential effect of a tax on palm oil on hyperlipidemia and on mortality due to cardiovascular disease in India. Design Economic-epidemiologic model. Modeling methods A microsimulation model of mortality due to myocardial infarction and stroke among Indian populations was constructed, incorporating nationally representative data on systolic blood pressure, total cholesterol, tobacco smoking, diabetes, and cardiovascular event history, and stratified by age, sex, and urban/rural residence. Household expenditure data were used to estimate the change in consumption of palm oil following changes in oil price and the potential substitution of alternative oils that might occur after imposition of a tax. A 20% excise tax on palm oil purchases was simulated over the period 2014-23. Main outcome measures The model was used to project future mortality due to myocardial infarction and stroke, as well as the potential effect of a tax on food insecurity, accounting for the effect of increased food prices. Results A 20% tax on palm oil purchases would be expected to avert approximately 363 000 (95% confidence interval 247 000 to 479 000) deaths from myocardial infarctions and strokes over the period 2014-23 in India (1.3% reduction in cardiovascular deaths) if people do not substitute other oils for reduced palm oil consumption. Given estimates of substitution of palm oil with other oils following a 20% price increase for palm oil, the beneficial effects of increased polyunsaturated fat consumption would be expected to enhance the projected reduction in deaths to as much as 421 000 (256 000 to 586 000). The tax would be expected to benefit men more than women and urban populations more than rural populations, given differential consumption and cardiovascular risk. In a scenario incorporating the effect of taxation on overall food expenditures, the tax may increase food insecurity by <1%, resulting in 16 000 (95% confidence interval 12 000 to 22 000) deaths. Conclusions Curtailing palm oil intake through taxation may modestly reduce hyperlipidemia and cardiovascular mortality, but with potential distributional consequences differentially benefiting male and urban populations, as well as affecting food security.	[Basu, Sanjay] Stanford Univ, Prevent Res Ctr, Stanford, CA 94305 USA; [Basu, Sanjay] Stanford Univ, Ctr Poverty & Inequal, Stanford, CA 94305 USA; [Basu, Sanjay; Babiarz, Kim S.; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Basu, Sanjay; Babiarz, Kim S.; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Primary Care, Stanford, CA 94305 USA; [Basu, Sanjay; Babiarz, Kim S.; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Outcomes Res, Stanford, CA 94305 USA; [Basu, Sanjay; Ebrahim, Shah; Stuckler, David] London Sch Hyg & Trop Med, London WC1, England; [Ebrahim, Shah; Vellakkal, Sukumar] Publ Hlth Fdn India, South Asia Network Chron Dis, Delhi, India; [Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of Oxford	Basu, S (corresponding author), Stanford Univ, Sch Med, Med Sch Off Bldg X322,1265 Welch Rd,Mail Code 541, Stanford, CA 94305 USA.	basus@stanford.edu	Vellakkal, Sukumar/AAD-4893-2020	Vellakkal, Sukumar/0000-0002-0594-1454; Vellakkal, Sukumar/0000-0003-2635-1944; Stuckler, David/0000-0002-1288-8401; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	National Institute on Aging [K01 AG037593-02, P30 AG017253]; Stanford Woods Institute for the Environment; International Development Research Centre of Canada; Economic and Social Research Council [ES/K013130/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [K01AG037593, P30AG017253] Funding Source: NIH RePORTER; ESRC [ES/K013130/1] Funding Source: UKRI	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Stanford Woods Institute for the Environment; International Development Research Centre of Canada(CGIAR); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by the National Institute on Aging (K01 AG037593-02, JGF; P30 AG017253, SB), the Stanford Woods Institute for the Environment (JDG-F), and the International Development Research Centre of Canada (SB, DS, SE, SV). The funders had no role in the study design, analysis, interpretation, or decision to submit for publication.	Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], 2011, GLOB AD TOB SURV GAT; Banks J, 1997, REV ECON STAT, V79, P527, DOI 10.1162/003465397557015; Basu S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001480; Basu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044037; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Cappuccio FP, 1997, J HUM HYPERTENS, V11, P571, DOI 10.1038/sj.jhh.1000516; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Chen BK, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-45; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Dohlman EN, 2003, INDIAS EDIBLE OIL SE; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; FAO, 2013, FAOSTAT DAT; Fletcher JM, 2011, J POLICY ANAL MANAG, V30, P655, DOI 10.1002/pam.20582; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Institute of Medicine, 2010, PROM CARD HLTH DEV W; KEYS A, 1965, METABOLIS, V14, P776, DOI 10.1016/0026-0495(65)90004-1; Kuntz KM., 2001, EC EVALUATION HLTH C, V2nd ed.; Lemar L.E., 2011, USDA NATL NUTR DATAB; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Narasinga Rao BS., 1989, NUTR VALUE INDIAN FO; National Sample Survey Organization (NSSO), 2012, NAT SAMPL SURV 2012; Pan SuWen, 2008, Journal of Agricultural and Applied Economics, V40, P821; Patel G., 2011, CONSUMER TRENDS INDI; Pearson TA, 1999, CARDIOVASC DRUG THER, V13, P95, DOI 10.1023/A:1007727924276; Praduman Kumar, 2011, Agricultural Economics Research Review, V24, P1; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P301, DOI 10.1016/j.diabres.2004.04.008; Shah B, 2010, ASSESSMENT BURDEN NO; Sovio U, 2013, EUR J PREV CARDIOL, V20, P844, DOI 10.1177/2047487312446136; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Sturm R, 2010, HEALTH AFFAIR, V29, P1052, DOI 10.1377/hlthaff.2009.0061; Sullivan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024898; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; USDA, 2013, PROD SUPPL DISTR PSD; Uusitalo U, 1996, BRIT MED J, V313, P1044, DOI 10.1136/bmj.313.7064.1044; Vega-Lopez S, 2006, AM J CLIN NUTR, V84, P54, DOI 10.1093/ajcn/84.1.54; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; Wang YC, 2012, HEALTH AFFAIR, V31, P199, DOI 10.1377/hlthaff.2011.0410; World Health Organization, 2008, DIS INJ COUNTR EST; World Health Organization, 2011, STUD GLOB AGEING AD; World Health Organization, 2012, WHO GLOB INFOBASE; Young H., 2009, REV NUTR MORTALITY I, P78; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187	49	43	44	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2013	347								f6048	10.1136/bmj.f6048	http://dx.doi.org/10.1136/bmj.f6048			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243CI	24149818	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000326293800003
J	Flight, MH				Flight, Monica Hoyos			DRUG DISCOVERY Structure-led design	NATURE			English	Editorial Material							RECEPTOR							Hoyos Flight, Monica/0000-0002-3181-0933				Chen X, 2012, J MED CHEM, V55, P7141, DOI 10.1021/jm300603y; Davie BJ, 2013, ACS CHEM NEUROSCI, V4, P1026, DOI 10.1021/cn400086m; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167	7	5	6	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					S50	S52		10.1038/502S50a	http://dx.doi.org/10.1038/502S50a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132331	Bronze			2022-12-24	WOS:000325706300002
J	Gendron, CM; Kuo, TH; Harvanek, ZM; Chung, BY; Yew, JY; Dierick, HA; Pletcher, SD				Gendron, Christi M.; Kuo, Tsung-Han; Harvanek, Zachary M.; Chung, Brian Y.; Yew, Joanne Y.; Dierick, Herman A.; Pletcher, Scott D.			Drosophila Life Span and Physiology Are Modulated by Sexual Perception and Reward	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; SENSORY PERCEPTION; EVOLUTION; MELANOGASTER; DEPRIVATION; OLFACTION; COURTSHIP; LONGEVITY; STRESS; GENE	Sensory perception can modulate aging and physiology across taxa. We found that perception of female sexual pheromones through a specific gustatory receptor expressed in a subset of foreleg neurons in male fruit flies, Drosophila melanogaster, rapidly and reversibly decreases fat stores, reduces resistance to starvation, and limits life span. Neurons that express the reward-mediating neuropeptide F are also required for pheromone effects. High-throughput whole-genome RNA sequencing experiments revealed a set of molecular processes that were affected by the activity of the longevity circuit, thereby identifying new candidate cell-nonautonomous aging mechanisms. Mating reversed the effects of pheromone perception; therefore, life span may be modulated through the integrated action of sensory and reward circuits, and healthy aging may be compromised when the expectations defined by sensory perception are discordant with ensuing experience.	[Gendron, Christi M.; Harvanek, Zachary M.; Chung, Brian Y.; Pletcher, Scott D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Gendron, Christi M.; Harvanek, Zachary M.; Chung, Brian Y.; Pletcher, Scott D.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA; [Kuo, Tsung-Han; Dierick, Herman A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Harvanek, Zachary M.] Univ Michigan, Med Scientist Training Program, Taubman Med Lib, Ann Arbor, MI 48109 USA; [Yew, Joanne Y.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Yew, Joanne Y.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Baylor College of Medicine; University of Michigan System; University of Michigan; National University of Singapore; National University of Singapore	Gendron, CM (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Biomed Sci & Res Bldg, Ann Arbor, MI 48109 USA.	spletch@umich.edu	Harvanek, Zachary M/GPJ-9798-2022; Yew, Joanne/D-6562-2014	Harvanek, Zachary/0000-0003-3702-1051; Chung, Brian/0000-0002-6423-5226	NIH [R01AG030593, TR01AG043972, R01AG023166, T32AG000114, T32GM007863, T32GM008322]; Glenn Foundation; American Federation for Aging Research; Ellison Medical Foundation; Ruth L. Kirschstein National Research Service Award from the National Institute on Aging [F32AG042253]; Glenn/AFAR Scholarship for Research in the Biology of Aging; NSF [IOS-1119473]; Alexander von Humboldt Foundation; Singapore National Research Foundation [RF001-363]; National Institute on Aging [P30-AG-013283]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102279, T32GM008322, T32GM007863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000114, P30AG013283, R01AG023166, R01AG043972, F32AG042253, R01AG030593] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; American Federation for Aging Research; Ellison Medical Foundation(Lawrence Ellison Foundation); Ruth L. Kirschstein National Research Service Award from the National Institute on Aging; Glenn/AFAR Scholarship for Research in the Biology of Aging; NSF(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Singapore National Research Foundation(National Research Foundation, Singapore); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the members of the Pletcher laboratory for Drosophila husbandry, N. Linford for comments on the revision, P. J. Lee for figure illustration, and members of the Dierick and Pletcher laboratories for suggestions on experiments and comments on the manuscript. Supported by NIH grants R01AG030593, TR01AG043972, and R01AG023166, the Glenn Foundation, the American Federation for Aging Research, and the Ellison Medical Foundation (S. D. P.); Ruth L. Kirschstein National Research Service Award F32AG042253 from the National Institute on Aging (B.Y.C.); NIH grant T32AG000114 (B.Y.C.); NIH grants T32GM007863 and T32GM008322 (Z.M.H.), a Glenn/AFAR Scholarship for Research in the Biology of Aging (Z.M.H.); NSF grant IOS-1119473 (H. A. D.); and the Alexander von Humboldt Foundation and Singapore National Research Foundation grant RF001-363 (J.Y.Y.). This work made use of the Drosophila Aging Core of the Nathan Shock Center of Excellence in the Biology of Aging, funded by National Institute on Aging grant P30-AG-013283. RNA-seq expression data are provided in table S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no competing interests. C. M. G., T.-H. K., Z.M.H., and S. D. P. conceived and designed the experiments; C. M. G., T.-H. K., Z.M.H., B.Y.C., J.Y.Y., H. A. D., and S. D. P. performed the experiments; C. M. G., T.-H. K., Z.M.H., B.Y.C., J.Y.Y., and S. D. P. analyzed the data; and C. M. G., T.-H. K., J.Y.Y., H. A. D., and S. D. P. wrote the paper.	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Ashburner M., 2004, DROSOPHILA LAB HDB; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Fernandez MD, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000541; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; KALRA SP, 1988, SYNAPSE, V2, P254, DOI 10.1002/syn.890020313; Kuo TH, 2012, PLOS GENET, V8, P640, DOI 10.1371/journal.pgen.1002684; Landis G, 2012, AGING-US, V4, P768, DOI 10.18632/aging.100499; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Linford NJ, 2011, ANNU REV CELL DEV BI, V27, P759, DOI 10.1146/annurev-cellbio-092910-154240; McGlothlin JW, 2010, EVOLUTION, V64, P2558, DOI 10.1111/j.1558-5646.2010.01012.x; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; Poon PC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000356; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Shohat-Ophir G, 2012, SCIENCE, V335, P1351, DOI 10.1126/science.1215932; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020	25	90	91	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					544	548		10.1126/science.1243339	http://dx.doi.org/10.1126/science.1243339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24292624	Green Accepted			2022-12-24	WOS:000330343700048
J	Khabbaz, RF				Khabbaz, Rima F.			Still Learning From SARS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ACUTE RESPIRATORY SYNDROME; CORONAVIRUS; INFECTION; OUTBREAK		Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Khabbaz, RF (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,Mailstop D12, Atlanta, GA 30333 USA.	rfk1@cdc.gov						[Anonymous], 2008, INT HLTH REG; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Relman DA, 2013, JAMA-J AM MED ASSOC, V309, P1531, DOI 10.1001/jama.2013.3678; Stohr K, 2003, LANCET, V361, P1730, DOI 10.1016/S0140-6736(03)13376-4; World Health Organization, 2003, GLOB AL RESP GAR SUM; World Health Organization, 2011, PAND INFL A H1N1 DON; World Health Organization, 2013, GLOB AL RESP GAR MER	10	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2013	159	11					780	+		10.7326/0003-4819-159-11-201312030-00011	http://dx.doi.org/10.7326/0003-4819-159-11-201312030-00011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276EN	24297195				2022-12-24	WOS:000328731000008
J	Hashem, Y; des Georges, A; Dhote, V; Langlois, R; Liao, HY; Grassucci, RA; Pestova, TV; Hellen, CUT; Frank, J				Hashem, Yaser; des Georges, Amedee; Dhote, Vidya; Langlois, Robert; Liao, Hstau Y.; Grassucci, Robert A.; Pestova, Tatyana V.; Hellen, Christopher U. T.; Frank, Joachim			Hepatitis-C-virus-like internal ribosome entry sites displace eIF3 to gain access to the 40S subunit	NATURE			English	Article							EUKARYOTIC TRANSLATION INITIATION; SWINE-FEVER VIRUS; ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; DOMAIN-II; MACROMOLECULAR COMPLEXES; CRYSTAL-STRUCTURE; 80S RIBOSOME; RNA; IRES	Hepatitis C virus (HCV) and classical swine fever virus (CSFV) messenger RNAs contain related (HCV-like) internal ribosome entry sites (IRESs) that promote 5'-end independent initiation of translation, requiring only a subset of the eukaryotic initiation factors (eIFs) needed for canonical initiation on cellular mRNAs(1). Initiation on HCV-like IRESs relies on their specific interaction with the 40S subunit(2-8), which places the initiation codon into the P site, where it directly base-pairs with eIF2-bound initiator methionyl transfer RNA to form a 48S initiation complex. However, all HCV-like IRESs also specifically interact with eIF3 (refs 2, 5-7, 9-12), but the role of this interaction in IRES-mediated initiation has remained unknown. During canonical initiation, eIF3 binds to the 40S subunit as a component of the 43S pre-initiation complex, and comparison of the ribosomal positions of eIF3(13) and the HCV IRES8 revealed that they overlap, so that their rearrangement would be required for formation of ribosomal complexes containing both components(13). Here we present a cryo-electron microscopy reconstruction of a 40S ribosomal complex containing eIF3 and the CSFV IRES. Remarkably, although the position and interactions of the CSFV IRES with the 40S subunit in this complex are similar to those of the HCV IRES in the 40S-IRES binary complex(8), eIF3 is completely displaced from its ribosomal position in the 43S complex, and instead interacts through its ribosome-binding surface exclusively with the apical region of domain III of the IRES. Our results suggest a role for the specific interaction of HCV-like IRESs with eIF3 in preventing ribosomal association of eIF3, which could serve two purposes: relieving the competition between the IRES and eIF3 for a common binding site on the 40S subunit, and reducing formation of 43S complexes, thereby favouring translation of viral mRNAs.	[Hashem, Yaser; des Georges, Amedee; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; [Hashem, Yaser; des Georges, Amedee; Langlois, Robert; Liao, Hstau Y.; Grassucci, Robert A.; Frank, Joachim] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Dhote, Vidya; Pestova, Tatyana V.; Hellen, Christopher U. T.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Grassucci, Robert A.; Frank, Joachim] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Columbia University	Hellen, CUT (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	christopher.hellen@downstate.edu; jf2192@columbia.edu	Georges, Amédée des/C-3588-2014	Georges, Amédée des/0000-0002-9704-3781	HHMI; National Institutes of Health (NIH) [R01 GM29169, R01 AI51340, R01 GM59660]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051340, R56AI051340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029169, R01GM059660] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Thomas for assistance in the preparation of figures and A. Jobe for critical reading of the manuscript. This work was supported by the HHMI and National Institutes of Health (NIH) grants R01GM29169 (to J.F.), NIH R01 AI51340 (to C.U.T.H.) and NIH R01 GM59660 (to T.V.P.).	Abaeva IS, 2011, EMBO J, V30, P115, DOI 10.1038/emboj.2010.302; Babaylova E, 2009, NUCLEIC ACIDS RES, V37, P1141, DOI 10.1093/nar/gkn1026; Berry KE, 2011, STRUCTURE, V19, P1456, DOI 10.1016/j.str.2011.08.002; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buratti E, 1998, NUCLEIC ACIDS RES, V26, P3179, DOI 10.1093/nar/26.13.3179; De Breyne S, 2008, RNA, V14, P367, DOI 10.1261/rna.696508; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Fletcher SP, 2002, J VIROL, V76, P5024, DOI 10.1128/JVI.76.10.5024-5033.2002; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Friis MB, 2012, J VIROL, V86, P8681, DOI 10.1128/JVI.00346-12; Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hellen CUT, 2007, J VIROL, V81, P5850, DOI 10.1128/JVI.02403-06; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Ji H, 2004, P NATL ACAD SCI USA, V101, P16990, DOI 10.1073/pnas.0407402101; Jossinet F, 2005, BIOINFORMATICS, V21, P3320, DOI 10.1093/bioinformatics/bti504; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kolupaeva VG, 2000, J VIROL, V74, P6242, DOI 10.1128/JVI.74.14.6242-6250.2000; Kolupaeva VG, 2000, RNA, V6, P1791, DOI 10.1017/S1355838200000662; Liao HY, 2010, I S BIOMED IMAGING, P169, DOI 10.1109/ISBI.2010.5490386; Locker N, 2007, EMBO J, V26, P795, DOI 10.1038/sj.emboj.7601549; Lomakin IB, 2006, EMBO J, V25, P196, DOI 10.1038/sj.emboj.7600904; Lukavsky PJ, 2000, NAT STRUCT BIOL, V7, P1105; MacKerell AD., 1998, ENCY COMPUTATIONAL C, V1, P271; Malygin AA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P53, DOI 10.1134/S0006297913010069; Melcher SE, 2003, RNA, V9, P809, DOI 10.1261/rna.5130703; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 2001, RNA, V7, P1496, DOI 10.1017/S135583820101038X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Pisarev AV, 2007, METHOD ENZYMOL, V430, P147, DOI 10.1016/S0076-6879(07)30007-4; Pisarev AV, 2004, J VIROL, V78, P4487, DOI 10.1128/JVI.78.9.4487-4497.2004; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; RIJNBRAND R, 1995, FEBS LETT, V365, P115, DOI 10.1016/0014-5793(95)00458-L; Rijnbrand R, 1997, J VIROL, V71, P451, DOI 10.1128/JVI.71.1.451-457.1997; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sun CM, 2013, NUCLEIC ACIDS RES, V41, P7512, DOI 10.1093/nar/gkt510; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; WAGENKNECHT T, 1988, J MOL BIOL, V203, P753, DOI 10.1016/0022-2836(88)90207-0; Zhang W, 2008, STRUCTURE, V16, P1770, DOI 10.1016/j.str.2008.10.011	55	131	134	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					539	+		10.1038/nature12658	http://dx.doi.org/10.1038/nature12658			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24185006	Green Accepted			2022-12-24	WOS:000327464200046
J	Shalaby, MS; Kuti, K; Walker, G				Shalaby, Mohamed Sameh; Kuti, Kamal; Walker, Gregor			Intestinal malrotation and volvulus in infants and children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEWBORN		[Shalaby, Mohamed Sameh; Kuti, Kamal; Walker, Gregor] Royal Hosp Sick Children, Dept Paediat Surg, Glasgow G3 8SJ, Lanark, Scotland	University of Glasgow	Shalaby, MS (corresponding author), Royal Hosp Sick Children, Dept Paediat Surg, Glasgow G3 8SJ, Lanark, Scotland.	mshalaby@doctors.org.uk	Shalaby, Mohamed Sameh/F-7217-2014	Shalaby, Mohamed Sameh/0000-0002-6161-5784				Applegate Kimberly E, 2009, Pediatr Radiol, V39 Suppl 2, pS161, DOI 10.1007/s00247-009-1177-x; Durkin ET, 2008, J AM COLL SURGEONS, V206, P658, DOI 10.1016/j.jamcollsurg.2007.11.020; Millar A J W, 2003, Semin Pediatr Surg, V12, P229, DOI 10.1053/j.sempedsurg.2003.08.003; MILLAR AJW, 1987, PEDIATR SURG INT, V2, P172; Orzech N, 2006, J PEDIATR SURG, V41, P1005, DOI 10.1016/j.jpedsurg.2005.12.070; POWELL DM, 1989, J PEDIATR SURG, V24, P777, DOI 10.1016/S0022-3468(89)80535-4; Radwan R, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4441; Sizemore AW, 2008, PEDIATR RADIOL, V38, P518, DOI 10.1007/s00247-008-0762-8; Walker GM, 2006, BRIT MED J, V332, P1363, DOI 10.1136/bmj.38859.614352.55; Walker GM, 2007, J PEDIATR SURG, V42, P714, DOI 10.1016/j.jpedsurg.2006.12.017	10	20	22	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 26	2013	347								f6949	10.1136/bmj.f6949	http://dx.doi.org/10.1136/bmj.f6949			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FN	24285798				2022-12-24	WOS:000327792500002
J	May, M				May, Mike			REGENERATIVE MEDICINE Rebuilding the backbone	NATURE			English	Editorial Material							INTERVERTEBRAL DISC											Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108; Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038; Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Wang ZL, 2013, SPINE, V38, P1501, DOI 10.1097/BRS.0b013e31828976c1	7	8	8	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S7	S9		10.1038/503S7a	http://dx.doi.org/10.1038/503S7a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24227006	Bronze			2022-12-24	WOS:000326894200004
J	Hoffmann, DE; Fraser, CM; Palumbo, FB; Ravel, J; Rothenberg, K; Rowthorn, V; Schwartz, J				Hoffmann, D. E.; Fraser, C. M.; Palumbo, F. B.; Ravel, J.; Rothenberg, K.; Rowthorn, V.; Schwartz, J.			Probiotics: Finding the Right Regulatory Balance	SCIENCE			English	Editorial Material									[Hoffmann, D. E.; Rothenberg, K.; Rowthorn, V.; Schwartz, J.] Univ Maryland, Sch Law, Baltimore, MD 21201 USA; [Fraser, C. M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Palumbo, F. B.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Hoffmann, DE (corresponding author), Univ Maryland, Sch Law, Baltimore, MD 21201 USA.	dhoffman@law.umaryland.edu	Ravel, Jacques/D-2530-2009	Ravel, Jacques/0000-0002-0851-2233; Fraser, Claire/0000-0003-1462-2428	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005171] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG005171, R01-HG005171] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		FDA, 2010, GUID IND EARL CLIN T; Floch MH, 2011, J CLIN GASTROENTEROL, V45, pS168, DOI 10.1097/MCG.0b013e318230928b; Gordon JI, 2012, SCIENCE, V336, P1251, DOI 10.1126/science.1224686; Grzeskowiak L, 2011, BRIT J NUTR, V105, P887, DOI 10.1017/S0007114510004496; Health Canada, 2012, PROB; Hoffmann D., 2013, FEDERAL REGULA UNPUB; *JOINT FAO UN WHO, 2001, HLTH NUTR PROP PROB; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Olle B, 2013, NAT BIOTECHNOL, V31, P309, DOI 10.1038/nbt.2548; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; Sanders ME, 2011, GUT MICROBES, V2, P127, DOI 10.4161/gmic.2.3.16174; Satine LA, 2008, FOOD DRUG LAW J, V63, P537; Schardt D., 2006, NUTR ACTION HEALTHLE; Slashinski MJ, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-28; Vaillancourt J, 2006, ENDING WAR METAPHOR, P229	15	38	42	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					314	315		10.1126/science.1244656	http://dx.doi.org/10.1126/science.1244656			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136953	Green Submitted, Green Accepted			2022-12-24	WOS:000325755100027
J	Cao, EH; Liao, MF; Cheng, YF; Julius, D				Cao, Erhu; Liao, Maofu; Cheng, Yifan; Julius, David			TRPV1 structures in distinct conformations reveal activation mechanisms	NATURE			English	Article							SPECIES-SPECIFIC SENSITIVITY; C-TYPE INACTIVATION; CAPSAICIN RECEPTOR; ION-CHANNEL; K+ CHANNEL; TARANTULA TOXIN; VOLTAGE-SENSOR; SELECTIVITY; BINDING; DOMAIN	Transient receptor potential (TRP) channels are polymodal signal detectors that respond to a wide range of physical and chemical stimuli. Elucidating how these channels integrate and convert physiological signals into channel opening is essential to understanding how they regulate cell excitability under normal and pathophysiological conditions. Here we exploit pharmacological probes (a peptide toxin and small vanilloid agonists) to determine structures of two activated states of the capsaicin receptor, TRPV1. A domain (consisting of transmembrane segments 1-4) that moves during activation of voltage-gated channels remains stationary in TRPV1, highlighting differences in gating mechanisms for these structurally related channel superfamilies. TRPV1 opening is associated with major structural rearrangements in the outer pore, including the pore helix and selectivity filter, as well as pronounced dilation of a hydrophobic constriction at the lower gate, suggesting a dual gating mechanism. Allosteric coupling between upper and lower gates may account for rich physiological modulation exhibited by TRPV1 and other TRP channels.	[Cao, Erhu; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Liao, Maofu; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, Keck Adv Microscopy Lab, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	ycheng@ucsf.edu; david.julius@ucsf.edu	Liao, Maofu/AAD-7333-2021	Liao, Maofu/0000-0002-3481-450X; Cheng, Yifan/0000-0001-9535-0369	National Institutes of Health [R01GM098672, S10RR026814, R01NS065071, R01NS047723]; National Science Foundation [DBI-0960271]; University of California, San Francisco Program for Breakthrough Biomedical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047723, R01NS065071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of California, San Francisco Program for Breakthrough Biomedical Research(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank X. Li for assistant in data acquisition using TF30 Polara and K2 Summit camera, and J.P Armache, C. Bohlen, J. Cordero-Morales and J. Osteen for discussion and reading of the manuscript. This work was supported by grants from the National Institutes of Health (R01GM098672 and S10RR026814 to Y.C. and R01NS065071 and R01NS047723 to D. J.), the National Science Foundation (DBI-0960271 to D. Agard and Y.C.) and the University of California, San Francisco Program for Breakthrough Biomedical Research (Y.C.). E. C. was a fellow of the Damon Runyon Cancer Research Foundation.	Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Bohlen CJ, 2012, TOXICON, V60, P254, DOI 10.1016/j.toxicon.2012.04.336; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Chou MZ, 2004, BIOCHEMISTRY-US, V43, P2501, DOI 10.1021/bi035981h; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Dai J, 2010, J HUM GENET, V55, P400, DOI 10.1038/jhg.2010.37; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hoshi T, 2013, J GEN PHYSIOL, V141, P151, DOI 10.1085/jgp.201210888; Hui KK, 2003, BIOPHYS J, V84, P2957, DOI 10.1016/S0006-3495(03)70022-8; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kim SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059593; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Latorre Ramon, 2007, P287; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Loukin S, 2010, J BIOL CHEM, V285, P19884, DOI 10.1074/jbc.M110.113936; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Papakosta M, 2011, J BIOL CHEM, V286, P39663, DOI 10.1074/jbc.M111.273581; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Szallasi A, 1999, MOL PHARMACOL, V56, P581, DOI 10.1124/mol.56.3.581; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Yeh BI, 2005, EMBO J, V24, P3224, DOI 10.1038/sj.emboj.7600795; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje	55	699	728	33	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					113	+		10.1038/nature12823	http://dx.doi.org/10.1038/nature12823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305161	Green Submitted, Green Accepted			2022-12-24	WOS:000327851700041
J	Califf, RM; Platt, R				Califf, Robert M.; Platt, Richard			Embedding Cardiovascular Research Into Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Califf, Robert M.] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Califf, Robert M.] Duke Univ, Duke Translat Med Inst, Durham, NC 27710 USA; [Platt, Richard] Harvard Univ, Sch Med, Dept Populat Med, Harvard Pilgrim Hlth Care Inst, Boston, MA USA	Duke University; Duke University; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School	Califf, RM (corresponding author), Duke Univ, Sch Med, Duke Translat Med Inst, 200 Trent Dr,1117 Davison Bldg,DUMC 3701, Durham, NC 27710 USA.	robert.califf@duke.edu			National Center for Complementary & Integrative Health [U54AT007748] Funding Source: NIH RePORTER; NCCIH NIH HHS [1U54AT007748-01] Funding Source: Medline	National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Antman EM, 2012, JAMA-J AM MED ASSOC, V308, P1743, DOI 10.1001/jama.2012.14841; Frobert O, 2010, INT J CARDIOL, V145, P572, DOI 10.1016/j.ijcard.2010.05.044; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Hess CN, 2013, AM HEART J, V166, P421, DOI 10.1016/j.ahj.2013.06.013; Olsen L, LEARN HEALTHC SYST W; Solomon MZ, 43 HAST CTR; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205	7	30	30	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2037	2038		10.1001/jama.2013.282771	http://dx.doi.org/10.1001/jama.2013.282771			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240926				2022-12-24	WOS:000327098900015
J	Dharmarajan, K; Hsieh, AF; Lin, Z; Bueno, H; Ross, JS; Horwitz, LI; Barreto, JA; Kim, N; Suter, LG; Bernheim, SM; Drye, EE; Krumholz, HM				Dharmarajan, Kumar; Hsieh, Angela F.; Lin, Zhenqiu; Bueno, Hector; Ross, Joseph S.; Horwitz, Leora I.; Barreto-Filho, Jose Augusto; Kim, Nancy; Suter, Lisa G.; Bernheim, Susannah M.; Drye, Elizabeth E.; Krumholz, Harlan M.			Hospital readmission performance and patterns of readmission: retrospective cohort study of Medicare admissions	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-CARE; RISK-STANDARDIZED MORTALITY; URBAN-RURAL DIFFERENCES; SAFETY-NET HOSPITALS; HEART-FAILURE; PATIENT OUTCOMES; HEALTH-CARE; RATES; REHOSPITALIZATION	Objectives To determine whether high performing hospitals with low 30 day risk standardized readmission rates have a lower proportion of readmissions from specific diagnoses and time periods after admission or instead have a similar distribution of readmission diagnoses and timing to lower performing institutions. Design Retrospective cohort study. Setting Medicare beneficiaries in the United States. Participants Patients aged 65 and older who were readmitted within 30 days after hospital admission for heart failure, acute myocardial infarction, or pneumonia in 2007-09. Main outcome measures Readmission diagnoses were classified with a modified version of the Centers for Medicare and Medicaid Services' condition categories, and readmission timing was classified by day (0-30) after hospital discharge. Hospital 30 day risk standardized readmission rates over the three years of study were calculated with public reporting methods of the US federal government, and hospitals were categorized with bootstrap analysis as having high, average, or low readmission performance for each index condition. High and low performing hospitals had >= 95% probability of having an interval estimate respectively less than or greater than the national 30 day readmission rate over the three year period of study. All remaining hospitals were considered average performers. Results For readmissions in the 30 days after the index admission, there were 320 003 after 1 291 211 admissions for heart failure (4041 hospitals), 102 536 after 517 827 admissions for acute myocardial infarction (2378 hospitals), and 208 438 after 1 135 932 admissions for pneumonia (4283 hospitals). The distribution of readmissions by diagnosis was similar across categories of hospital performance for all three conditions. High performing hospitals had fewer readmissions for all common diagnoses. Median time to readmission was similar by hospital performance for heart failure and acute myocardial infarction, though was 1.4 days longer among high versus low performing hospitals for pneumonia (P<0.001). Findings were unchanged after adjustment for other hospital characteristics potentially associated with readmission patterns. Conclusions High performing hospitals have proportionately fewer 30 day readmissions without differences in readmission diagnoses and timing, suggesting the possible benefit of strategies that lower risk of readmission globally rather than for specific diagnoses or time periods after hospital stay.	[Dharmarajan, Kumar] Columbia Univ, Med Ctr, Dept Internal Med, Div Cardiol, New York, NY 10032 USA; [Hsieh, Angela F.; Lin, Zhenqiu; Bernheim, Susannah M.; Drye, Elizabeth E.; Krumholz, Harlan M.] Yale Univ, New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA; [Bueno, Hector] Univ Gregorio Maranon, Gen Hosp, Dept Cardiol, Madrid 28007, Spain; [Ross, Joseph S.; Horwitz, Leora I.; Kim, Nancy] Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Barreto-Filho, Jose Augusto] Univ Fed Sergipe, Div Cardiol, BR-49060100 Aracaju, Sergipe, Brazil; [Drye, Elizabeth E.] Yale Univ, Sch Med, Rheumatol Sect, New Haven, CT 06520 USA	Columbia University; Yale University; General University Gregorio Maranon Hospital; Yale University; Universidade Federal de Sergipe; Yale University	Dharmarajan, K (corresponding author), Columbia Univ, Med Ctr, Dept Internal Med, Div Cardiol, 630 West 168th St,Box 93,PH 10-203, New York, NY 10032 USA.	kumar.dharmarajan@columbia.edu	Bueno, Hector/I-3910-2015; Horwitz, Leora/ABD-1292-2020; , Harlan/AAI-2875-2020; Horwitz, Leora/A-6959-2009	Bueno, Hector/0000-0003-0277-7596; Horwitz, Leora/0000-0003-1800-6040; Ross, Joseph/0000-0002-9218-3320	National Heart, Lung, and Blood Institute; National Heart, Lung, and Blood Institute [T32HL007854]; Centers of Excellence Scholar in Geriatric Medicine at Yale by the John A Hartford Foundation; American Federation for Aging Research; National Institute on Aging [K08AG032886, K08AG038336]; American Federation for Aging Research through the Paul B Beeson Career Development Award Program; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministry of Education, Brazil) [3436-10-1]; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute [1U01HL105270-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270, T32HL007854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886, K08AG038336] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centers of Excellence Scholar in Geriatric Medicine at Yale by the John A Hartford Foundation; American Federation for Aging Research; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research through the Paul B Beeson Career Development Award Program; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Heart, Lung, and Blood Institute, which had no role in the design, conduct, or analysis of the study or in the decision to submit the manuscript for publication. KD was supported by grant T32HL007854 from the National Heart, Lung, and Blood Institute and as a Centers of Excellence Scholar in Geriatric Medicine at Yale by the John A Hartford Foundation and the American Federation for Aging Research during the time that the work was conducted. JSR and LIH are supported by grants K08AG032886 and K08AG038336 from the National Institute on Aging and by the American Federation for Aging Research through the Paul B Beeson Career Development Award Program, respectively. JAB-F was supported by grant 3436-10-1 from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministry of Education, Brazil) during the time that the work was conducted. HMK is supported by grant 1U01HL105270-03 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the American Federation for Aging Research.	Ash AS, 2012, STAT ISSUES ASSESSIN; Baldrige Performance Excellence Program, 2013, 2013 2014 HLTH CAR C; Baldwin LM, 2010, J RURAL HEALTH, V26, P51, DOI 10.1111/j.1748-0361.2009.00265.x; Bernheim SM, 2007, AM HEART J, V153, P313, DOI 10.1016/j.ahj.2006.10.037; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Bradley EH, 2012, ANN INTERN MED, V156, P618, DOI 10.7326/0003-4819-156-9-201205010-00003; Bucholz EM, 2011, AM J CARDIOL, V108, P943, DOI 10.1016/j.amjcard.2011.05.023; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; Centers for Medicare and Medicaid Services, 2011, MED HOSP QUAL CHARTB; Centers for Medicare and Medicaid Services, MED HOSP COMP QUAL C; Chan L, 2006, J RURAL HEALTH, V22, P140, DOI 10.1111/j.1748-0361.2006.00022.x; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; Department of Health and Human Services, 2013, PROGR REP CMS US SEN; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; Dunlay SM, 2012, ANN INTERN MED, V157, P11, DOI 10.7326/0003-4819-157-1-201207030-00004; Epstein AM, 2011, NEW ENGL J MED, V365, P2287, DOI 10.1056/NEJMsa1101942; Evangelista LS, 2000, AM J CARDIOL, V86, P1339, DOI 10.1016/S0002-9149(00)01238-8; Gaskin DJ, 2001, HEALTH SERV RES, V36, P25; Hammill BG, 2011, CIRC-CARDIOVASC QUAL, V4, P60, DOI 10.1161/CIRCOUTCOMES.110.954693; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hartman L, 2007, J RURAL HEALTH, V23, P254, DOI 10.1111/j.1748-0361.2007.00098.x; Howie-Esquivel J, 2012, AM J CRIT CARE, V21, pE65, DOI 10.4037/ajcc2012382; Jasti H, 2008, CLIN INFECT DIS, V46, P550, DOI 10.1086/526526; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2011, JAMA-J AM MED ASSOC, V306, P45, DOI 10.1001/jama.2011.902; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Joynt KE, 2011, ANN INTERN MED, V154, P94, DOI 10.7326/0003-4819-154-2-201101180-00008; Joynt KE, 2011, CIRC-CARDIOVASC QUAL, V4, P53, DOI 10.1161/CIRCOUTCOMES.110.950964; Kaboli PJ, 2012, ANN INTERN MED, V157, P837, DOI 10.7326/0003-4819-157-12-201212180-00003; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Koehler F, 2011, CIRCULATION, V123, P1873, DOI 10.1161/CIRCULATIONAHA.111.018473; Krumholz HM, 2011, CIRC-CARDIOVASC QUAL, V4, P243, DOI 10.1161/CIRCOUTCOMES.110.957498; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Lindenauer PK, 2011, J HOSP MED, V6, P142, DOI 10.1002/jhm.890; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Lutfiyya MN, 2007, INT J QUAL HEALTH C, V19, P141, DOI 10.1093/intqhc/mzm010; National Quality Forum, 2008, NAT VOL CONS STAND H; Neupane B, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-22; O'Connor CM, 2010, AM HEART J, V159, P841, DOI 10.1016/j.ahj.2010.02.023; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Probst JC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-40; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Ross JS, 2012, HEALTH AFFAIR, V31, P1739, DOI 10.1377/hlthaff.2011.1028; Shah SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047420; Sheikh K, 2001, ARCH INTERN MED, V161, P737, DOI 10.1001/archinte.161.5.737; Skull SA, 2008, EPIDEMIOL INFECT, V136, P232, DOI 10.1017/S0950268807008564	52	64	67	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2013	347								f6571	10.1136/bmj.f6571	http://dx.doi.org/10.1136/bmj.f6571			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	258KF	24259033	hybrid, Green Published			2022-12-24	WOS:000327457400001
J	McLean, RC; Jessup, M				McLean, Rhondalyn C.; Jessup, Mariell			The Challenge of Treating Heart Failure A Diverse Disease Affecting Diverse Populations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; UPDATE		[McLean, Rhondalyn C.; Jessup, Mariell] Univ Penn, Perelman Sch Med, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA	University of Pennsylvania	Jessup, M (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Cardiovasc, 2 E Perelman Pavil,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	jessupm@uphs.upenn.edu		Jessup, Mariell/0000-0002-3010-0112				Bahrarni H, 2008, ARCH INTERN MED, V168, P2138, DOI 10.1001/archinte.168.19.2138; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hsich EM, 2009, J AM COLL CARDIOL, V54, P491, DOI 10.1016/j.jacc.2009.02.066; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; Stehlik J, 2011, J HEART LUNG TRANSPL, V30, P1078, DOI 10.1016/j.healun.2011.08.003; Thomas KL, 2011, AM HEART J, V161, P746, DOI 10.1016/j.ahj.2011.01.012; Williams SA, 2002, PSYCHOSOM MED, V64, P6, DOI 10.1097/00006842-200201000-00002	10	9	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2033	2034		10.1001/jama.2013.282773	http://dx.doi.org/10.1001/jama.2013.282773			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240924				2022-12-24	WOS:000327098900013
J	Cripton, P				Cripton, Peter			Protecting the neck	NATURE			English	Editorial Material									Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Cripton, P (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	cripton@mech.ubc.ca	Cripton, Peter Alec/AAC-8268-2020	Cripton, Peter Alec/0000-0002-5067-0833				Dressler D, 2012, AM SOC TEST MATER, V1553, P235, DOI 10.1520/STP104525; Newell RS, 2013, J BIOMECH, V46, P2837, DOI 10.1016/j.jbiomech.2013.08.013	2	2	2	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S13	S13		10.1038/503S13a	http://dx.doi.org/10.1038/503S13a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24227000				2022-12-24	WOS:000326894200006
J	Striepen, B				Striepen, Boris			Time to tackle cryptosporidiosis	NATURE			English	Editorial Material							PARVUM; PROTECTION; NITAZOXANIDE; MORTALITY; CHILDREN; HOMINIS; GENOME		Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Striepen, B (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	striepen@uga.edu		Striepen, Boris/0000-0002-7426-432X				Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Amadi B, 2002, LANCET, V360, P1375, DOI 10.1016/S0140-6736(02)11401-2; Bessoff K, 2013, ANTIMICROB AGENTS CH, V57, P1804, DOI 10.1128/AAC.02460-12; Jenkins M, 2004, J PARASITOL, V90, P1178, DOI 10.1645/GE-3333RN; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Okhuysen PC, 1998, INFECT IMMUN, V66, P441, DOI 10.1128/IAI.66.2.441-443.1998; Rossignol JFA, 2001, J INFECT DIS, V184, P103, DOI 10.1086/321008; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sheoran A, 2012, J INFECT DIS, V205, P1019, DOI 10.1093/infdis/jir874; Umejiego NN, 2008, CHEM BIOL, V15, P70, DOI 10.1016/j.chembiol.2007.12.010; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977	12	130	133	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					189	191		10.1038/503189a	http://dx.doi.org/10.1038/503189a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24236315	Bronze			2022-12-24	WOS:000326894200022
J	Williams, R; Horton, R				Williams, Roger; Horton, Richard			Liver disease in the UK: a Lancet Commission	LANCET			English	Editorial Material							ALCOHOL		[Williams, Roger] Fdn Liver Res, Inst Hepatol London, London WC1E 6HX, England; [Horton, Richard] The Lancet, London NW1 7BY, England	University of London; University College London	Williams, R (corresponding author), Fdn Liver Res, Inst Hepatol London, London WC1E 6HX, England.	r.williams@researchinliver.org.uk						[Anonymous], 2013, MEAS UN REV PAT WHO; Argo CK, 2009, CLIN LIVER DIS, V13, P511, DOI 10.1016/j.cld.2009.07.005; Cobbold JFL, 2013, FRONTLINE GASTROENTE, V4, P263, DOI 10.1136/flgastro-2013-100319; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Moriarty KJ, 2011, FRONTLINE GASTROENTE, V2, P77, DOI 10.1136/fg.2010.002105; Namgyal P, 2003, J HEPATOL, V39, pS77, DOI 10.1016/S0168-8278(03)00269-1; Office for National Statistics, 2013, STATISTICAL BULLETIN; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Sheron N, 2012, LANCET, V379, P687, DOI 10.1016/S0140-6736(12)60244-X; Williams R, 2013, LANCET, V381, P2164, DOI 10.1016/S0140-6736(13)61438-5	10	13	13	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1537	1538		10.1016/S0140-6736(13)62152-2	http://dx.doi.org/10.1016/S0140-6736(13)62152-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247NE	24209811				2022-12-24	WOS:000326623900006
J	Binswanger, IA; Blatchford, PJ; Mueller, SR; Stern, MF				Binswanger, Ingrid A.; Blatchford, Patrick J.; Mueller, Shane R.; Stern, Marc F.			Mortality After Prison Release: Opioid Overdose and Other Causes of Death, Risk Factors, and Time Trends From 1999 to 2009	ANNALS OF INTERNAL MEDICINE			English	Article							DRUG-RELATED DEATH; SUICIDE; COHORT; ADDICTION; SCOTLAND; DATABASE; INMATES; LINKAGE; HEALTH; MODEL	Background: Among former prisoners, a high rate of death has been documented in the early postrelease period, particularly from drug-related causes. Little is known about risk factors and trends in postrelease mortality in the past decade, especially given general population increases in overdose deaths from pharmaceutical opioids. Objective: To determine postrelease mortality between 1999 and 2009; cause-specific mortality rates; and whether sex, calendar year, and custody factors were risk factors for all-cause, overdose, and opioid-related deaths. Design: Cohort study. Setting: Prison system of the Washington State Department of Corrections. Participants: 76 208 persons released from prison. Measurements: Identities were linked probabilistically to the National Death Index to identify deaths and causes of death, and mortality rates were calculated. Cox proportional hazards regression estimated the effect of age, sex, race or ethnicity, whether the incarceration resulted from a violation of terms of the person's community supervision, length of incarceration, release type, and calendar year on the hazard ratio (HR) for death. Results: The all-cause mortality rate was 737 per 100 000 person-years (95% CI, 708 to 766) (n = 2462 deaths). Opioids were involved in 14.8% of all deaths. Overdose was the leading cause of death (167 per 100 000 person-years [CI, 153 to 181]), and overdose deaths in former prisoners accounted for 8.3% of the overdose deaths among persons aged 15 to 84 years in Washington from 2000 to 2009. Women were at increased risk for overdose (HR, 1.38 [CI, 1.12 to 1.69]) and opioid-related deaths (HR, 1.39 [CI, 1.09 to 179]). Limitation: The study was done in only 1 state. Conclusion: Innovation is needed to reduce the risk for overdose among former prisoners.	Univ Colorado, Sch Med, Aurora, CO 80045 USA; Colorado Sch Publ Hlth, Aurora, CO USA; Denver Hlth Med Ctr, Denver, CO USA; Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; Denver Health Medical Center; University of Washington; University of Washington Seattle	Binswanger, IA (corresponding author), Univ Colorado, Sch Med, Div Gen Internal Med, Dept Med, Mailstop B180,12631 East 17th Ave, Aurora, CO 80045 USA.	ingrid.binswanger@ucdenver.edu; Patrick.Blatchford@ucdenver.edu	Binswanger, Ingrid/X-4496-2019	Binswanger, Ingrid/0000-0001-8862-8078	National Institute on Drug Abuse of the National Institutes of Health [R21DA031041]; Robert Wood Johnson Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031041] Funding Source: NIH RePORTER	National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By the National Institute on Drug Abuse of the National Institutes of Health (R21DA031041) and the Robert Wood Johnson Foundation.	Bilgrad R, 1999, NDIPLUS CODED CAUSES; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Binswanger IA, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-3; Binswanger IA, 2011, DRUG ALCOHOL DEPEN, V117, P1, DOI 10.1016/j.drugalcdep.2010.11.029; Binswanger IA, 2010, AM J PUBLIC HEALTH, V100, P476, DOI 10.2105/AJPH.2008.149591; Bird SM, 2003, ADDICTION, V98, P185, DOI 10.1046/j.1360-0443.2003.00264.x; Bureau of Justice Statistics, 2010, WHAT IS DIFF JAILS P; Calcaterra S, 2013, DRUG ALCOHOL DEPEN, V131, P263, DOI 10.1016/j.drugalcdep.2012.11.018; Campbell CI, 2010, AM J PUBLIC HEALTH, V100, P2541, DOI 10.2105/AJPH.2009.180646; Carson EA, 2012, PRISONERS 2011; Centers for Disease Control and Prevention, 2012, WIDE RANG ONL DAT EP; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P1487; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; Cornish R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5475; Huerino PM, 2011, NDIPLUS CODED CAUSES; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Kariminia A, 2007, INT J EPIDEMIOL, V36, P310, DOI 10.1093/ije/dyl225; Kariminia A, 2007, EUR J EPIDEMIOL, V22, P417, DOI 10.1007/s10654-007-9134-1; Krinsky CS, 2009, AM J FOREN MED PATH, V30, P6, DOI 10.1097/PAF.0b013e3181873784; Lim S, 2012, AM J EPIDEMIOL, V175, P519, DOI 10.1093/aje/kwr327; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; McAuley A, 2012, DRUG-EDUC PREV POLIC, V19, P309, DOI 10.3109/09687637.2012.682232; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Merralll ELC, 2013, ADDICTION, V108, P377, DOI 10.1111/j.1360-0443.2012.04066.x; Nunn A, 2010, ADDICTION, V105, P1312, DOI 10.1111/j.1360-0443.2010.03000.x; Pratt D, 2006, LANCET, V368, P119, DOI 10.1016/S0140-6736(06)69002-8; Rosen DL, 2008, AM J PUBLIC HEALTH, V98, P2278, DOI 10.2105/AJPH.2007.121855; Seaman SR, 1998, BRIT MED J, V316, P426, DOI 10.1136/bmj.316.7129.426; Spaulding AC, 2011, AM J EPIDEMIOL, V173, P479, DOI 10.1093/aje/kwq422; Stewart LM, 2004, AUST NZ J PUBL HEAL, V28, P32, DOI 10.1111/j.1467-842X.2004.tb00629.x; Strang J, 2003, BMJ-BRIT MED J, V326, P959, DOI 10.1136/bmj.326.7396.959; Substance Abuse and Mental Health Services Administration and Center for Behavioral Health Statistics and Quality, 2013, NSDUH REP STAT EST N; Warner M, 2011, DRUG POISONING DEATH; World Health Organisation, 2010, PREV AC DRUG REL MOR, P33; Zlodre Jakov, 2012, Am J Public Health, V102, pe67, DOI 10.2105/AJPH.2012.300764	36	305	308	2	35	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					592	600		10.7326/0003-4819-159-9-201311050-00005	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	249HX	24189594	Green Accepted			2022-12-24	WOS:000326769400003
J	Wood, E; Samet, JH; Volkow, ND				Wood, Evan; Samet, Jeffrey H.; Volkow, Nora D.			Physician Education in Addiction Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEPENDENCE; HEALTH; BURDEN; CARE		[Wood, Evan] Univ British Columbia, Dept Med, Vancouver, BC V6Z 1Y6, Canada; [Samet, Jeffrey H.] Boston Univ, Sch Med, Gen Internal Med Sect, Boston, MA 02118 USA; [Volkow, Nora D.] US Natl Inst Drug Abuse, Bethesda, MD USA	University of British Columbia; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Wood, E (corresponding author), Univ British Columbia, Div Aids, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	uhri-ew@cfenet.ubc.ca		Samet, Jeffrey/0000-0002-0897-3400	Intramural NIH HHS [Z99 DA999999] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Chamorro AJ, 2012, ADDICT BIOL, V17, P505, DOI 10.1111/j.1369-1600.2012.00442.x; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Mayo-Smith M., 2009, PRINCIPLES ADDICTION, P559; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; National Center on Addiction and Substance Abuse at Columbia Uni- versity, ADD MED CLOS GAP SCI; National Center on Addiction and Substance Abuse at Columbia University, MISS OPP NAT SURV PR; Volkow ND, 2012, ANNU REV PHARMACOL, V52, P321, DOI 10.1146/annurev-pharmtox-010611-134625; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X	9	71	73	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 23	2013	310	16					1673	1674		10.1001/jama.2013.280377	http://dx.doi.org/10.1001/jama.2013.280377			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238LR	24150462	Green Accepted			2022-12-24	WOS:000325948500019
J	Louiset, E; Duparc, C; Young, J; Renouf, S; Nomigni, MT; Boutelet, I; Libe, R; Bram, Z; Groussin, L; Caron, P; Tabarin, A; Grunenberger, F; Christin-Maitre, S; Bertagna, X; Kuhn, JM; Anouar, Y; Bertherat, J; Lefebvre, H				Louiset, Estelle; Duparc, Celine; Young, Jacques; Renouf, Sylvie; Nomigni, Milene Tetsi; Boutelet, Isabelle; Libe, Rossella; Bram, Zakariae; Groussin, Lionel; Caron, Philippe; Tabarin, Antoine; Grunenberger, Fabienne; Christin-Maitre, Sophie; Bertagna, Xavier; Kuhn, Jean-Marc; Anouar, Youssef; Bertherat, Jerome; Lefebvre, Herve			Intraadrenal Corticotropin in Bilateral Macronodular Adrenal Hyperplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; PHOSPHODIESTERASE 11A PDE11A; CUSHINGS-SYNDROME; PROOPIOMELANOCORTIN TRANSCRIPTS; ADRENOCORTICAL HYPERPLASIA; IN-VIVO; RECEPTORS; TUMORS; EXPRESSION; ACTH	BackgroundBilateral macronodular adrenal hyperplasia is a rare cause of primary adrenal Cushing's syndrome. In this form of hyperplasia, hypersecretion of cortisol suppresses the release of corticotropin by pituitary corticotrophs, which results in low plasma corticotropin levels. Thus, the disease has been termed corticotropin-independent macronodular adrenal hyperplasia. We examined the abnormal production of corticotropin in these hyperplastic adrenal glands. MethodsWe obtained specimens of hyperplastic macronodular adrenal tissue from 30 patients with primary adrenal disease. The corticotropin precursor proopiomelanocortin and corticotropin expression were assessed by means of a polymerase-chain-reaction assay and immunohistochemical analysis. The production of corticotropin and cortisol was assessed in 11 specimens with the use of incubated explants and cell cultures coupled with hormone assays. Corticotropin levels were measured in adrenal and peripheral venous blood samples from 2 patients. ResultsThe expression of proopiomelanocortin messenger RNA (mRNA) was detected in all samples of hyperplastic adrenal tissue. Corticotropin was detected in steroidogenic cells arranged in clusters that were disseminated throughout the adrenal specimens. Adrenal corticotropin levels were higher in adrenal venous blood samples than in peripheral venous samples, a finding that was consistent with local production of the peptide within the hyperplastic adrenals. The release of adrenal corticotropin was stimulated by ligands of aberrant membrane receptors but not by corticotropin-releasing hormone or dexamethasone. A semiquantitative score for corticotropin immunostaining in the samples correlated with basal plasma cortisol levels. Corticotropin-receptor antagonists significantly inhibited in vitro cortisol secretion. ConclusionsCortisol secretion by the adrenals in patients with macronodular hyperplasia and Cushing's syndrome appears to be regulated by corticotropin, which is produced by a subpopulation of steroidogenic cells in the hyperplastic adrenals. Thus, the hypercortisolism associated with bilateral macronodular adrenal hyperplasia appears to be corticotropin-dependent. (Funded by the Agence Nationale de la Recherche and others.)	[Louiset, Estelle; Duparc, Celine; Renouf, Sylvie; Nomigni, Milene Tetsi; Boutelet, Isabelle; Bram, Zakariae; Kuhn, Jean-Marc; Anouar, Youssef; Lefebvre, Herve] INSERM Unite 982, Lab Neuronal & Neuroendocrine Differentiat & Comm, Inst Res & Innovat Biomed, Mont St Aignan, France; [Louiset, Estelle; Duparc, Celine; Renouf, Sylvie; Nomigni, Milene Tetsi; Boutelet, Isabelle; Bram, Zakariae; Kuhn, Jean-Marc; Anouar, Youssef; Lefebvre, Herve] Univ Rouen, Mont St Aignan, France; [Young, Jacques] Univ Paris Sud, Hop Bicetre, AP HP, Dept Endocrinol,INSERM Unite 693, F-94275 Le Kremlin Bicetre, France; [Libe, Rossella; Groussin, Lionel; Bertagna, Xavier; Bertherat, Jerome] Inst Cochin, INSERM Unite 1016, Paris, France; [Groussin, Lionel; Bertagna, Xavier; Bertherat, Jerome] Hop Cochin, Dept Endocrinol AP HP, F-75674 Paris, France; [Groussin, Lionel; Bertagna, Xavier; Bertherat, Jerome] Univ Paris 05, Paris, France; [Groussin, Lionel; Bertagna, Xavier; Bertherat, Jerome] CNRS, UMR 8104, Paris, France; [Christin-Maitre, Sophie] Hop St Antoine, AP HP, Dept Endocrinol, F-75571 Paris, France; [Caron, Philippe] Ctr Hosp Univ Larrey, Dept Endocrinol & Metab Dis, Toulouse, France; [Tabarin, Antoine] Ctr Hosp Univ Bordeaux, Hop Haut Leveque, Dept Endocrinol, Pessac, France; [Grunenberger, Fabienne] Ctr Hosp Reg Univ Strasbourg, Serv Med Interne & Nutr, Strasbourg, France; [Kuhn, Jean-Marc; Lefebvre, Herve] Rouen Univ Hosp, Dept Endocrinol Diabet & Metab Dis, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; CHU Bordeaux; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Rouen	Lefebvre, H (corresponding author), Univ Hosp Rouen, INSERM Unite 982, Dept Endocrinol, IRIB, F-76031 Rouen, France.	herve.lefebvre@chu-rouen.fr	Young, Jacques/T-2976-2018; Young, Jacques/N-5251-2019; Louiset, Estelle/N-5530-2018; Anouar, Youssef/F-9683-2017	Young, Jacques/0000-0001-9286-5631; Young, Jacques/0000-0001-9286-5631; Groussin, Lionel/0000-0003-1476-475X; Duparc, Celine/0000-0002-7301-6287; Louiset, Estelle/0000-0002-4723-095X; BERTHERAT, Jerome/0000-0003-2551-3008; Lefebvre, Herve/0000-0002-6181-9648; libe, rossella/0000-0003-2881-6362	INSERM Unite 982; Agence Nationale de la Recherche; Centre Hospitalier Universitaire de Rouen; Reseau COMETE; Assistance Publique-Hopitaux de Paris; Conseil Regional de Haute-Normandie	INSERM Unite 982; Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre Hospitalier Universitaire de Rouen; Reseau COMETE; Assistance Publique-Hopitaux de Paris; Conseil Regional de Haute-Normandie(Region Normandie)	Supported by grants from INSERM Unite 982, Agence Nationale de la Recherche (Programme blanc 2010, GePAH project), Centre Hospitalier Universitaire de Rouen, Reseau COMETE, Assistance Publique-Hopitaux de Paris, and Conseil Regional de Haute-Normandie.	Assie G, 2010, J CLIN ENDOCR METAB, V95, pE253, DOI 10.1210/jc.2009-2281; Bertherat J, 2005, J CLIN ENDOCR METAB, V90, P1302, DOI 10.1210/jc.2004-1256; Cartier D, 2003, J CLIN ENDOCR METAB, V88, P248, DOI 10.1210/jc.2002-021107; Claahsen-van der Grinten HL, 2009, INT J PEDIAT ENDOCRI, V23, P209; Connelly MA, 2009, MOL CELL ENDOCRINOL, V300, P83, DOI 10.1016/j.mce.2008.09.011; de Groot JWB, 2010, EUR J ENDOCRINOL, V163, P293, DOI 10.1530/EJE-10-0058; DEKEYZER Y, 1990, J CLIN INVEST, V86, P871, DOI 10.1172/JCI114787; Fragoso MCBV, 2003, J CLIN ENDOCR METAB, V88, P2147, DOI 10.1210/jc.2002-021362; Hiroi N, 2001, J CLIN ENDOCR METAB, V86, P2631, DOI 10.1210/jc.86.6.2631; Hsiao HP, 2009, J CLIN ENDOCR METAB, V94, P2930, DOI 10.1210/jc.2009-0516; Ivell R, 1997, MOL HUM REPROD, V3, P459, DOI 10.1093/molehr/3.6.459; Iwata M, 2012, INTERNAL MED, V51, P2181, DOI 10.2169/internalmedicine.51.7547; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; LACAZEMASMONTEIL T, 1987, P NATL ACAD SCI USA, V84, P7261, DOI 10.1073/pnas.84.20.7261; LACROIX A, 1992, NEW ENGL J MED, V327, P974, DOI 10.1056/NEJM199210013271402; Lacroix A, 1997, NEW ENGL J MED, V337, P1429, DOI 10.1056/NEJM199711133372004; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lefebvre H, 2003, J CLIN ENDOCR METAB, V88, P3035, DOI 10.1210/jc.2002-030014; Libe R, 2008, CLIN CANCER RES, V14, P4016, DOI 10.1158/1078-0432.CCR-08-0106; Louiset E, 2006, J CLIN ENDOCR METAB, V91, P4578, DOI 10.1210/jc.2006-0538; Marx C, 1997, J CLIN ENDOCR METAB, V82, P3136, DOI 10.1210/jc.82.9.3136; Mazzuco TL, 2007, ARQ BRAS ENDOCRINOL, V51, P1452, DOI 10.1590/S0004-27302007000900007; MEYER WJ, 1987, J CLIN ENDOCR METAB, V64, P98, DOI 10.1210/jcem-64-1-98; Mune T, 2002, J CLIN ENDOCR METAB, V87, P5706, DOI 10.1210/jc.2002-020067; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; REZNIK Y, 1992, NEW ENGL J MED, V327, P981, DOI 10.1056/NEJM199210013271403; Stratakis CA, 2007, NAT CLIN PRACT ENDOC, V3, P748, DOI 10.1038/ncpendmet0648; SUDA T, 1984, J CLIN ENDOCR METAB, V58, P919, DOI 10.1210/jcem-58-5-919; Swain JM, 1998, ARCH SURG-CHICAGO, V133, P541, DOI 10.1001/archsurg.133.5.541; Swords FM, 2002, MOL ENDOCRINOL, V16, P2746, DOI 10.1210/me.2002-0099; Thomas M, 2004, ENDOCRINOLOGY, V145, P4320, DOI 10.1210/en.2004-0179; Vallette-Kasic S, 2003, J CLIN ENDOCR METAB, V88, P3050, DOI 10.1210/jc.2002-021934; van Aken MO, 2005, J CLIN ENDOCR METAB, V90, P1570, DOI 10.1210/jc.2004-1281; Vezzosi D, 2007, EUR J ENDOCRINOL, V156, P21, DOI 10.1530/eje.1.02324; Vezzosi D, 2012, J CLIN ENDOCR METAB, V97, pE2063, DOI 10.1210/jc.2012-2275	36	128	135	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2115	2125		10.1056/NEJMoa1215245	http://dx.doi.org/10.1056/NEJMoa1215245			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258OB	24283225	Green Published			2022-12-24	WOS:000327467500009
J	Bao, Y; Han, JL; Hu, FB; Giovannucci, EL; Stampfer, MJ; Willett, WC; Fuchs, CS				Bao, Ying; Han, Jiali; Hu, Frank B.; Giovannucci, Edward L.; Stampfer, Meir J.; Willett, Walter C.; Fuchs, Charles S.			Association of Nut Consumption with Total and Cause-Specific Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; INFLAMMATORY MARKERS; WALNUT CONSUMPTION; METABOLIC SYNDROME; WEIGHT-GAIN; LIFE-STYLE; ALL-CAUSE	BackgroundIncreased nut consumption has been associated with a reduced risk of major chronic diseases, including cardiovascular disease and type 2 diabetes mellitus. However, the association between nut consumption and mortality remains unclear. MethodsWe examined the association between nut consumption and subsequent total and cause-specific mortality among 76,464 women in the Nurses' Health Study (1980-2010) and 42,498 men in the Health Professionals Follow-up Study (1986-2010). Participants with a history of cancer, heart disease, or stroke were excluded. Nut consumption was assessed at baseline and updated every 2 to 4 years. ResultsDuring 3,038,853 person-years of follow-up, 16,200 women and 11,229 men died. Nut consumption was inversely associated with total mortality among both women and men, after adjustment for other known or suspected risk factors. The pooled multivariate hazard ratios for death among participants who ate nuts, as compared with those who did not, were 0.93 (95% confidence interval [CI], 0.90 to 0.96) for the consumption of nuts less than once per week, 0.89 (95% CI, 0.86 to 0.93) for once per week, 0.87 (95% CI, 0.83 to 0.90) for two to four times per week, 0.85 (95% CI, 0.79 to 0.91) for five or six times per week, and 0.80 (95% CI, 0.73 to 0.86) for seven or more times per week (P<0.001 for trend). Significant inverse associations were also observed between nut consumption and deaths due to cancer, heart disease, and respiratory disease. ConclusionsIn two large, independent cohorts of nurses and other health professionals, the frequency of nut consumption was inversely associated with total and cause-specific mortality, independently of other predictors of death.	[Bao, Ying; Hu, Frank B.; Giovannucci, Edward L.; Stampfer, Meir J.; Willett, Walter C.; Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Bao, Ying; Hu, Frank B.; Giovannucci, Edward L.; Stampfer, Meir J.; Willett, Walter C.; Fuchs, Charles S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hu, Frank B.; Giovannucci, Edward L.; Stampfer, Meir J.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Frank B.; Giovannucci, Edward L.; Stampfer, Meir J.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Fuchs, Charles S.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Han, Jiali] Indiana Univ, Dept Epidemiol, Richard M Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Han, Jiali] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Bao, Y (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 181 Longwood Ave, Boston, MA 02115 USA.	ying.bao@channing.harvard.edu			National Institutes of Health; International Tree Nut Council Nutrition Research and Education Foundation; NATIONAL CANCER INSTITUTE [UM1CA167552, P50CA127003, U54CA155626, R01CA124908, P01CA087969, P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Tree Nut Council Nutrition Research and Education Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health and the International Tree Nut Council Nutrition Research and Education Foundation.	Baer HJ, 2011, AM J EPIDEMIOL, V173, P319, DOI 10.1093/aje/kwq368; Bes-Rastrollo M, 2007, OBESITY, V15, P107, DOI 10.1038/oby.2007.507; Bes-Rastrollo M, 2009, AM J CLIN NUTR, V89, P1913, DOI 10.3945/ajcn.2008.27276; Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, P126, DOI 10.1016/j.numecd.2009.08.005; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Djousse L, 2009, CLIN NUTR, V28, P10, DOI 10.1016/j.clnu.2008.08.005; Ellsworth JL, 2001, NUTR METAB CARDIOVAS, V11, P372; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fernandez-Montero A, 2013, PUBLIC HEALTH NUTR, V16, P2064, DOI 10.1017/S1368980012004442; Food and Drug Administration, 2003, QUAL HLTH CLAIMS LET; Fraser GE, 1997, ARCH INTERN MED, V157, P2249, DOI 10.1001/archinte.157.19.2249; Fraser GE, 1997, EPIDEMIOLOGY, V8, P168, DOI 10.1097/00001648-199703000-00008; GOLDSTEIN MR, 1992, ARCH INTERN MED, V152, P2507, DOI 10.1001/archinte.1992.00400240119025; Gonzalez CA, 2008, BR J NUTR, V99, P447; Gonzalez CA, 2006, BRIT J NUTR, V96, pS87, DOI 10.1017/BJN20061868; Gopinath B, 2011, AM J CLIN NUTR, V93, P1073, DOI 10.3945/ajcn.110.009977; Guasch-Ferre M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-164; Jenkins DJA, 2006, J NUTR, V136, P2987, DOI 10.1093/jn/136.12.2987; Jenkins DJA, 2011, DIABETES CARE, V34, P1706, DOI 10.2337/dc11-0338; Jiang R, 2006, AM J EPIDEMIOL, V163, P222, DOI 10.1093/aje/kwj033; Jiang R, 2002, JAMA-J AM MED ASSOC, V288, P2554, DOI 10.1001/jama.288.20.2554; Kris-Etherton PN, 2008, J NUTR, V138, p1746S; Ma YY, 2010, DIABETES CARE, V33, P227, DOI 10.2337/dc09-1156; Mann JI, 1997, HEART, V78, P450, DOI 10.1136/hrt.78.5.450; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; O'Neil CE, 2011, J AM COLL NUTR, V30, P502, DOI 10.1080/07315724.2011.10719996; Pan A, 2013, J NUTR, V143, P512, DOI 10.3945/jn.112.172171; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Sabate J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79; Salas-Salvado J, 2008, ARCH INTERN MED, V168, P2449, DOI 10.1001/archinte.168.22.2449; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Singh PN, 1998, AM J EPIDEMIOL, V148, P761, DOI 10.1093/oxfordjournals.aje.a009697; Strate LL, 2008, JAMA-J AM MED ASSOC, V300, P907, DOI 10.1001/jama.300.8.907; Tapsell LC, 2009, EUR J CLIN NUTR, V63, P1008, DOI 10.1038/ejcn.2009.19; Torabian S, 2009, J HUM NUTR DIET, V22, P64, DOI 10.1111/j.1365-277X.2008.00923.x; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Tsai CJ, 2004, AM J EPIDEMIOL, V160, P961, DOI 10.1093/aje/kwh302; Tsai CJ, 2004, AM J CLIN NUTR, V80, P76; van den Brandt PA, 2011, AM J CLIN NUTR, V94, P913, DOI 10.3945/ajcn.110.008250; Villegas R, 2008, AM J CLIN NUTR, V87, P162, DOI 10.1093/ajcn/87.1.162	41	224	230	1	91	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					2001	2011		10.1056/NEJMoa1307352	http://dx.doi.org/10.1056/NEJMoa1307352			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254KE	24256379	Green Published, Green Accepted			2022-12-24	WOS:000327163000008
J	Fica, SM; Tuttle, N; Novak, T; Li, NS; Lu, J; Koodathingal, P; Dai, Q; Staley, JP; Piccirilli, JA				Fica, Sebastian M.; Tuttle, Nicole; Novak, Thaddeus; Li, Nan-Sheng; Lu, Jun; Koodathingal, Prakash; Dai, Qing; Staley, Jonathan P.; Piccirilli, Joseph A.			RNA catalyses nuclear pre-mRNA splicing	NATURE			English	Article							METAL-ION COORDINATION; TETRAHYMENA RIBOZYME; CRYSTAL-STRUCTURE; EXON-LIGATION; ACTIVE-SITE; AGC TRIAD; SPLICEOSOME; MECHANISM; PROTEIN; STEPS	In nuclear pre-messenger RNA splicing, introns are excised by the spliceosome, a dynamic machine composed of both proteins and small nuclear RNAs (snRNAs). Over thirty years ago, after the discovery of self-splicing group II intron RNAs, the snRNAs were proposed to catalyse splicing. However, no definitive evidence for a role of either RNA or protein in catalysis by the spliceosome has been reported so far. By using metal rescue strategies in spliceosomes from budding yeast, here we show that the U6 snRNA catalyses both of the two splicing reactions by positioning divalent metals that stabilize the leaving groups during each reaction. Notably, all of the U6 catalytic metal ligands we identified correspond to the ligands observed to position catalytic, divalent metals in crystal structures of a group II intron RNA. These findings indicate that group II introns and the spliceosome share common catalytic mechanisms and probably common evolutionary origins. Our results demonstrate that RNA mediates catalysis within the spliceosome.	[Fica, Sebastian M.] Univ Chicago, Grad Program Cell & Mol Biol, Chicago, IL 60637 USA; [Fica, Sebastian M.; Koodathingal, Prakash; Staley, Jonathan P.] Univ Chicago, Cummings Life Sci Ctr, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Tuttle, Nicole; Lu, Jun; Dai, Qing; Piccirilli, Joseph A.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Novak, Thaddeus; Li, Nan-Sheng; Piccirilli, Joseph A.] Univ Chicago, Gordon Ctr Integrat Sci, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Piccirilli, JA (corresponding author), Univ Chicago, Dept Chem, 929 East 57th St, Chicago, IL 60637 USA.	jstaley@uchicago.edu; jpicciri@uchicago.edu	Dai, Qing/ABD-8444-2021; Lu, Jun/G-2224-2012	Lu, Jun/0000-0003-0858-8577	NSF; CBI Training Grant [5T32GM008720]; Chicago Biomedical Consortium; The Searle Funds at the Chicago Community Trust; National Institutes of Health [R01GM088656]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008720, R01GM088656] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); CBI Training Grant; Chicago Biomedical Consortium; The Searle Funds at the Chicago Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Guthrie for plasmids; S. -C. Cheng for anti-Cwc25p serum; D. Semlow for strains; J. Olvera for reagents and experimental assistance; R. -J. Lin for sharing unpublished data; members of the Staley and Piccirilli laboratories for discussions; and D. Herschlag, A. Macmillan and T. Nilsen for comments on the manuscript. N.T. was supported by an NSF Graduate Research Fellowship and by a CBI Training Grant (5T32GM008720). This work was funded by a grant from the Chicago Biomedical Consortium, with support from The Searle Funds at the Chicago Community Trust, to J. P. S, A. S. Mankin and E. J. Sontheimer, and by a grant from the National Institutes of Health (R01GM088656) to J. P. S. and J.A.P.	Abelson J, 2010, METHOD ENZYMOL, V472, P31, DOI [10.1016/S0076-6879(10)72017_6, 10.1016/S0076-6879(10)72017-6]; Anokhina M, 2013, EMBO J, V32, P2804, DOI 10.1038/emboj.2013.198; Beringer M, 2007, MOL CELL, V26, P311, DOI 10.1016/j.molcel.2007.03.015; Bonnal S, 2013, EMBO J, V32, P2785, DOI 10.1038/emboj.2013.213; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; Burke JE, 2012, RNA, V18, P673, DOI 10.1261/rna.031138.111; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; CECH TR, 1987, SCIENCE, V236, P1532, DOI 10.1126/science.2438771; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; CHANFREAU G, 1994, SCIENCE, V266, P1383, DOI 10.1126/science.7973729; Chiu YF, 2009, MOL CELL BIOL, V29, P5671, DOI 10.1128/MCB.00773-09; Dery Kenneth J., 2008, V488, P41, DOI 10.1007/978-1-60327-475-3_4; FABRIZIO P, 1989, GENE DEV, V3, P2137, DOI 10.1101/gad.3.12b.2137; FABRIZIO P, 1992, NUCLEIC ACIDS RES, V20, P3659, DOI 10.1093/nar/20.14.3659; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; Forconi M, 2008, BIOCHEMISTRY-US, V47, P6883, DOI 10.1021/bi800519a; Frederiksen JK, 2009, METHOD ENZYMOL, V468, P289, DOI 10.1016/S0076-6879(09)68014-9; Frederiksen JK, 2009, METHODS, V49, P148, DOI 10.1016/j.ymeth.2009.07.005; Galej WP, 2013, NATURE, V493, P638, DOI 10.1038/nature11843; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Gordon PM, 2001, NAT STRUCT BIOL, V8, P893, DOI 10.1038/nsb1001-893; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; Hilliker AK, 2004, RNA, V10, P921, DOI 10.1261/rna.7310704; Jaladat Y, 2011, RNA BIOL, V8, P372, DOI 10.4161/rna.8.3.15386; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Koodathingal P, 2010, MOL CELL, V39, P385, DOI 10.1016/j.molcel.2010.07.014; Loverix S, 2000, CHEM BIOL, V7, P651, DOI 10.1016/S1074-5521(00)00005-3; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Marcia M, 2012, CELL, V151, P497, DOI 10.1016/j.cell.2012.09.033; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Mefford MA, 2009, RNA, V15, P1386, DOI 10.1261/rna.1582609; MOORE MJ, 1993, NATURE, V365, P364, DOI 10.1038/365364a0; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; PECORARO VL, 1984, BIOCHEMISTRY-US, V23, P5262, DOI 10.1021/bi00317a026; Schellenberg MJ, 2013, NAT STRUCT MOL BIOL, V20, P728, DOI 10.1038/nsmb.2556; Schurer H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf055; Semlow DR, 2012, TRENDS BIOCHEM SCI, V37, P263, DOI 10.1016/j.tibs.2012.04.001; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Shukla GC, 2002, MOL CELL, V9, P1145, DOI 10.1016/S1097-2765(02)00505-1; Sigel RKO, 1997, J AM CHEM SOC, V119, P744, DOI 10.1021/ja962970l; Smith DJ, 2009, RNA, V15, P1, DOI 10.1261/rna.1322709; Sontheimer EJ, 1999, GENE DEV, V13, P1729, DOI 10.1101/gad.13.13.1729; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; SUN JS, 1995, GENE DEV, V9, P843, DOI 10.1101/gad.9.7.843; Tagwerker C, 2006, YEAST, V23, P623, DOI 10.1002/yea.1380; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; UMEN JG, 1995, GENE DEV, V9, P855, DOI 10.1101/gad.9.7.855; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Valadkhan S, 2009, RNA, V15, P4, DOI 10.1261/rna.1425809; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Yoshida A, 1999, NAT STRUCT BIOL, V6, P318; YU YT, 1995, RNA, V1, P46	61	223	234	0	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					229	+		10.1038/nature12734	http://dx.doi.org/10.1038/nature12734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24196718	Green Accepted			2022-12-24	WOS:000326894200044
J	Kosik, KS				Kosik, Kenneth S.			Study neuron networks to tackle Alzheimer's	NATURE			English	Editorial Material									[Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kenneth.kosik@lifesci.ucsb.edu						Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; Lambert J.-C., 2013, NATURE GENET; Peter IS, 2012, P NATL ACAD SCI USA, V109, P16434, DOI 10.1073/pnas.1207852109; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; van Rooden S., 2013, ALZHEIMERS DEMENT; Zamrini Edward, 2011, Int J Alzheimers Dis, V2011, P280289, DOI 10.4061/2011/280289	8	12	14	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					31	32		10.1038/503031a	http://dx.doi.org/10.1038/503031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24218661	Bronze			2022-12-24	WOS:000326585600014
J	Butt, N; Beyer, HL; Bennett, JR; Biggs, D; Maggini, R; Mills, M; Renwick, AR; Seabrook, LM; Possingham, HP				Butt, N.; Beyer, H. L.; Bennett, J. R.; Biggs, D.; Maggini, R.; Mills, M.; Renwick, A. R.; Seabrook, L. M.; Possingham, H. P.			Biodiversity Risks from Fossil Fuel Extraction	SCIENCE			English	Editorial Material							OIL; IMPACTS		[Butt, N.; Beyer, H. L.; Bennett, J. R.; Biggs, D.; Maggini, R.; Renwick, A. R.; Seabrook, L. M.; Possingham, H. P.] Univ Queensland, Sch Biol Sci, Australian Res Council, Ctr Excellence Environm Decis, St Lucia, Qld 4072, Australia; [Mills, M.] Univ Queensland, Global Change Inst, St Lucia, Qld 4072, Australia; [Seabrook, L. M.] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland; University of Queensland	Butt, N (corresponding author), Univ Queensland, Sch Biol Sci, Australian Res Council, Ctr Excellence Environm Decis, St Lucia, Qld 4072, Australia.	n.butt@uq.edu.au	Beyer, Hawthorne/F-8050-2013; Seabrook, Leonie M K/D-2992-2009; Butt, Nathalie/B-3558-2014; Mills, Morena/C-6546-2013; Biggs, Duan/F-9445-2011; Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Mills, Morena/AAD-8916-2019	Beyer, Hawthorne/0000-0002-5430-0784; Seabrook, Leonie M K/0000-0001-5602-5168; Butt, Nathalie/0000-0003-1517-6191; Mills, Morena/0000-0001-9865-0770; Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; Maggini, Ramona/0000-0001-7031-0096; Biggs, Duan/0000-0003-3177-4677; Bennett, Joseph/0000-0002-3901-9513				BELL F.G., 2006, MINING ITS IMPACT EN; BP, 2013, STAT REV WORLD EN; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cristescu RH, 2012, BIOL CONSERV, V149, P60, DOI 10.1016/j.biocon.2012.02.003; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Fredriksson PG, 2003, J PUBLIC ECON, V87, P1383, DOI 10.1016/S0047-2727(02)00036-1; GUZMAN HM, 1994, MAR ECOL PROG SER, V105, P231, DOI 10.3354/meps105231; Institute for Energy Research, EN INF ASS FOR; IUCN ICMM, 2004, INT MIN BIOD CONS CA; Kingston PF, 2002, SPILL SCI TECHNOL B, V7, P53, DOI 10.1016/S1353-2561(02)00051-8; Lewis M, 2011, ENVIRON POLLUT, V159, P2328, DOI 10.1016/j.envpol.2011.04.027; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; O'Rourke D, 2003, ANNU REV ENV RESOUR, V28, P587, DOI 10.1146/annurev.energy.28.050302.105617; Pedroni PM, 2013, J APPL ECOL, V50, P539, DOI 10.1111/1365-2664.12088; Quintero JD, 2011, CONSERV BIOL, V25, P1121, DOI 10.1111/j.1523-1739.2011.01769.x; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x	16	76	78	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					425	426		10.1126/science.1237261	http://dx.doi.org/10.1126/science.1237261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159031				2022-12-24	WOS:000326042600024
J	Zhu, L; Ploessl, K; Kung, HF				Zhu, Lin; Ploessl, Karl; Kung, Hank F.			Expanding the Scope of Fluorine Tags for PET Imaging	SCIENCE			English	Editorial Material							TRIFLUOROMETHYLATION; METABOLISM		[Zhu, Lin] Beijing Normal Univ, Minist Educ, Key Lab Radiopharmaceut, Beijing 100875, Peoples R China; [Zhu, Lin; Ploessl, Karl; Kung, Hank F.] Univ Penn, Dept Radiol, Philadelphia, PA 19014 USA; [Zhu, Lin] Capital Med Univ, Beijing Inst Brain Disorders, Beijing, Peoples R China; [Kung, Hank F.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19014 USA	Beijing Normal University; University of Pennsylvania; Capital Medical University; University of Pennsylvania	Zhu, L (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Radiopharmaceut, Beijing 100875, Peoples R China.	kunghf@mail.med.upenn.edu		Ploessl, Karl/0000-0001-7896-5900	NCI NIH HHS [CA-164490] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA164490] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Huiban M, 2013, NAT CHEM, V5, P941, DOI [10.1038/NCHEM.1756, 10.1038/nchem.1756]; MACNEIL JG, 1991, J FLUORINE CHEM, V55, P225, DOI 10.1016/S0022-1139(00)80126-8; Plathow C, 2008, J NUCL MED, V49, p43S, DOI 10.2967/jnumed.107.045930; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293	8	18	20	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					429	430		10.1126/science.1245011	http://dx.doi.org/10.1126/science.1245011			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159034				2022-12-24	WOS:000326042600027
J	Lapinaite, A; Simon, B; Skjaerven, L; Rakwalska-Bange, M; Gabel, F; Carlomagno, T				Lapinaite, Audrone; Simon, Bernd; Skjaerven, Lars; Rakwalska-Bange, Magdalena; Gabel, Frank; Carlomagno, Teresa			The structure of the box C/D enzyme reveals regulation of RNA methylation	NATURE			English	Article							X-RAY; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; RIBOSE METHYLATION; SITE; RESONANCE; FIBRILLARIN; RESOLUTION; PROTEINS; SYSTEM	Post-transcriptional modifications are essential to the cell life cycle, as they affect both pre-ribosomal RNA processing and ribosome assembly. The box C/D ribonucleoprotein enzyme that methylates ribosomal RNA at the 2'-O-ribose uses a multitude of guide RNAs as templates for the recognition of rRNA target sites. Two methylation guide sequences are combined on each guide RNA, the significance of which has remained unclear. Here we use a powerful combination of NMR spectroscopy and small-angle neutron scattering to solve the structure of the 390 kDa archaeal RNP enzyme bound to substrate RNA. We show that the two methylation guide sequences are located in different environments in the complex and that the methylation of physiological substrates targeted by the same guide RNA occurs sequentially. This structure provides a means for differential control of methylation levels at the two sites and at the same time offers an unexpected regulatory mechanism for rRNA folding.	[Lapinaite, Audrone; Simon, Bernd; Skjaerven, Lars; Rakwalska-Bange, Magdalena; Carlomagno, Teresa] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Gabel, Frank] Univ Grenoble Alpes, Inst Biol Struct, F-38027 Grenoble, France; [Gabel, Frank] Commisariat Energie Atom, Direct Sci Vivant, Inst Biol Struct, F-38027 Grenoble, France; [Gabel, Frank] Ctr Natl Rech Sci, Inst Biol Struct, F-38027 Grenoble, France; [Gabel, Frank] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Institut Laue-Langevin (ILL)	Carlomagno, T (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	teresa.carlomagno@embl.de	Skjærven, Lars/C-1919-2017	Skjærven, Lars/0000-0002-8176-4891; Carlomagno, Teresa/0000-0002-2437-2760; Gabel, Frank/0000-0003-3446-2601; Simon, Bernd/0000-0003-0164-5516	DFG [CA294/3-1]; EU FP7 ITN project RNPnet [289007]; EMBL	DFG(German Research Foundation (DFG)); EU FP7 ITN project RNPnet; EMBL	This work was supported by DFG grant CA294/3-1, by EU FP7 ITN project RNPnet (contract number 289007) and by the EMBL. For the SAXS and SANS experiments we thank the ESRF and ILL, BAG MX1219 and the D22 BAG system for beam-time as well as A. Martel and P. Pernot for help with the setup of the instruments. We thank J. Wohnert for the gift of <SUP>13</SUP>C-labelled SAM and C. Kreutz for the gift of [<SUP>13</SUP>C]2'OCH<INF>3</INF> substrate RNA. We thank John Kirkpatrick for the assignment of the L7Ae resonances.	Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; AMBER, 2012, AMBER 12; [Anonymous], PYMOL MOL GRAPH SYST; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BAX A, 1983, J MAGN RESON, V55, P301, DOI 10.1016/0022-2364(83)90241-X; Bleichert F, 2009, SCIENCE, V325, P1384, DOI 10.1126/science.1176099; Bower-Phipps KR, 2012, RNA, V18, P1527, DOI 10.1261/rna.033134.112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ghalei H, 2010, RNA, V16, P2341, DOI 10.1261/rna.2380410; Gosh R. E., 2006, ILL06GH05T; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471; HERSCHLAG D, 1993, BIOCHEMISTRY-US, V32, P8312, DOI 10.1021/bi00083a035; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAWAI G, 1992, BIOCHEMISTRY-US, V31, P1040, DOI 10.1021/bi00119a012; Kiss-Laszlo Z, 1998, EMBO J, V17, P797, DOI 10.1093/emboj/17.3.797; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; Lin JZ, 2011, NATURE, V469, P559, DOI 10.1038/nature09688; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; NILGES M, 1995, J MOL BIOL, V245, P645, DOI 10.1006/jmbi.1994.0053; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Nolivos S, 2005, NUCLEIC ACIDS RES, V33, P6507, DOI 10.1093/nar/gki962; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; SCHIMMANG T, 1989, EMBO J, V8, P4015, DOI 10.1002/j.1460-2075.1989.tb08584.x; Simon B, 2010, ANGEW CHEM INT EDIT, V49, P1967, DOI 10.1002/anie.200906147; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; TOLLERVEY D, 1991, EMBO J, V10, P573, DOI 10.1002/j.1460-2075.1991.tb07984.x; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Williams DJ, 2001, RNA, V7, P44, DOI 10.1017/S1355838201001558; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xue S, 2010, MOL CELL, V39, P939, DOI 10.1016/j.molcel.2010.08.022	49	120	124	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					519	+		10.1038/nature12581	http://dx.doi.org/10.1038/nature12581			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24121435				2022-12-24	WOS:000325988400047
J	Stonington, SD				Stonington, Scott D.			The Debt of Life - Thai Lessons on a Process-Oriented Ethical Logic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								In Thailand, families of dying patients often advocate for aggressive ICU care in order to pay their debt of life. Their reasoning is based on process, not outcome. Many Americans may similarly see the process of providing care as in some ways more important than cure. We love him so much, said Ms. M., standing over her father as he lay on life support in a Boston ICU where I was an intern. We want to do everything or at least I want to, she said tearfully, acknowledging the disagreement among her siblings about how to proceed. Later that morning, I presented her father's case on rounds: after a failed bone marrow transplant, he'd had a myocardial infarction, which had led to heart failure, then renal failure, then pneumonia and sepsis. He was receiving maximal doses of pressors and couldn't be weaned from the ventilator. ...	[Stonington, Scott D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Stonington, Scott D.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Stonington, SD (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA.			Stonington, Scott/0000-0002-0472-3885				Quill TE, 2009, ANN INTERN MED, V151, P345, DOI 10.7326/0003-4819-151-5-200909010-00010; Stonington SD, 2012, SOC SCI MED, V75, P836, DOI 10.1016/j.socscimed.2012.03.045	2	11	11	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1583	1585		10.1056/NEJMp1308613	http://dx.doi.org/10.1056/NEJMp1308613			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	239MZ	24152259				2022-12-24	WOS:000326031100006
J	Lazarus, MB; Jiang, JY; Kapuria, V; Bhuiyan, T; Janetzko, J; Zandberg, WF; Vocadlo, DJ; Herr, W; Walker, S				Lazarus, Michael B.; Jiang, Jiaoyang; Kapuria, Vaibhav; Bhuiyan, Tanja; Janetzko, John; Zandberg, Wesley F.; Vocadlo, David J.; Herr, Winship; Walker, Suzanne			HCF-1 Is Cleaved in the Active Site of O-GlcNAc Transferase	SCIENCE			English	Article							CELL FACTOR-I; REPEAT DOMAIN; GLYCOSYLATION; COMPLEX; PROTEINS; NUCLEAR	Host cell factor-1 (HCF-1), a transcriptional co-regulator of human cell-cycle progression, undergoes proteolytic maturation in which any of six repeated sequences is cleaved by the nutrient-responsive glycosyltransferase, O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT). We report that the tetratricopeptide-repeat domain of O-GlcNAc transferase binds the carboxyl-terminal portion of an HCF-1 proteolytic repeat such that the cleavage region lies in the glycosyltransferase active site above uridine diphosphate-GlcNAc. The conformation is similar to that of a glycosylation-competent peptide substrate. Cleavage occurs between cysteine and glutamate residues and results in a pyroglutamate product. Conversion of the cleavage site glutamate into serine converts an HCF-1 proteolytic repeat into a glycosylation substrate. Thus, protein glycosylation and HCF-1 cleavage occur in the same active site.	[Lazarus, Michael B.; Jiang, Jiaoyang; Walker, Suzanne] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Kapuria, Vaibhav; Bhuiyan, Tanja; Herr, Winship] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Zandberg, Wesley F.; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Lazarus, Michael B.; Janetzko, John] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Harvard University; Harvard Medical School; University of Lausanne; Simon Fraser University; Harvard University; Simon Fraser University	Herr, W (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	winship.herr@unil.ch; Suzanne_Walker@hms.harvard.edu	Zandberg, Wesley/AAX-5568-2021; Janetzko, John/AAQ-2602-2021; Herr, Winship/E-6491-2012; Vocadlo, David J/E-5508-2014	Janetzko, John/0000-0003-1604-2515; Herr, Winship/0000-0002-3606-4546; Vocadlo, David J/0000-0001-6897-5558; Lazarus, Michael/0000-0002-6738-2563; Kapuria, Vaibhav/0000-0003-1514-419X	National Institutes of Health (NIH) [R01GM094263]; Swiss National Science Foundation (SNSF) [31003A_130829]; University of Lausanne; Natural Sciences and Engineering Research Council of Canada (NSERC); Simon Fraser University; European Molecular Biology Organization (EMBO); NSERC PGS-M; D3; E. W. R. Steacie Memorial Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094263] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); University of Lausanne; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Simon Fraser University; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); NSERC PGS-M(Natural Sciences and Engineering Research Council of Canada (NSERC)); D3; E. W. R. Steacie Memorial Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant R01GM094263 to S. W., Swiss National Science Foundation (SNSF) grant 31003A_130829 and the University of Lausanne to W. H., and the Natural Sciences and Engineering Research Council of Canada (NSERC) and Simon Fraser University to D.J.V. M. B. L. is a Merck Fellow of the Helen Hay Whitney Foundation. V. K. is an European Molecular Biology Organization (EMBO) long-term fellowship recipient. J.J. is an NSERC PGS-M and D3 fellowship recipient. D.J.V. is a recipient of an E. W. R. Steacie Memorial Fellowship and holds a Canada Research Chair in Chemical Glycobiology. We thank A. Heroux (B.N.L.) for assistance with x-ray data collection. We thank V. Zoete for helpful discussions and M. Bogyo for reading the manuscript. Coordinates and structure factors have been deposited in the Protein Data Bank with accession nos. 4N39, 4N3A, 4N3B, and 4N3C.	Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Jiang JY, 2012, NAT CHEM BIOL, V8, P72, DOI 10.1038/nchembio.711; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; KHAN SA, 1982, J BIOL CHEM, V257, P1864; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; TWARDZIK DR, 1972, P NATL ACAD SCI USA, V69, P274, DOI 10.1073/pnas.69.1.274; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zargar ZU, 2012, TRANSCR-AUSTIN, V3, P187, DOI 10.4161/trns.20711	25	122	123	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1235	1239		10.1126/science.1243990	http://dx.doi.org/10.1126/science.1243990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311690	Green Accepted			2022-12-24	WOS:000327857900048
J	Gillman, MW; Ludwig, DS				Gillman, Matthew W.; Ludwig, David S.			How Early Should Obesity Prevention Start?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OVERWEIGHT		[Gillman, Matthew W.] Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA 02114 USA; [Gillman, Matthew W.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA USA; [Gillman, Matthew W.; Ludwig, David S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Gillman, MW (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA 02114 USA.			Ludwig, David/0000-0003-3307-8544	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD034568] Funding Source: Medline; NIDDK NIH HHS [K24 DK082730] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boeke CE, 2013, OBESITY, V21, P1430, DOI 10.1002/oby.20314; Gillman MW, 2008, OBESITY, V16, P1651, DOI 10.1038/oby.2008.260; Huh SY, 2011, PEDIATRICS, V127, pE544, DOI 10.1542/peds.2010-0740; Li HT, 2013, INT J OBESITY, V37, P893, DOI 10.1038/ijo.2012.195; Taveras EM, 2013, JAMA PEDIATR, V167, P731, DOI 10.1001/jamapediatrics.2013.85	5	137	144	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2173	2175		10.1056/NEJMp1310577	http://dx.doi.org/10.1056/NEJMp1310577			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	263II	24224559				2022-12-24	WOS:000327801100002
J	Pasternak, B; Svanstrom, H; Melbye, M; Hviid, A				Pasternak, Bjorn; Svanstrom, Henrik; Melbye, Mads; Hviid, Anders			Association Between Oral Fluoroquinolone Use and Retinal Detachment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACHILLES-TENDON; RISK	IMPORTANCE A recent study of ophthalmologic patients found a strong association between fluoroquinolone use and retinal detachment. Given the prevalent use of fluoroquinolones, this could, if confirmed in the general population, translate to many excess cases of retinal detachment that are potentially preventable. OBJECTIVE To investigate if oral fluoroquinolone use is associated with an increased risk of retinal detachment. DESIGN, SETTING, AND PARTICIPANTS A nationwide, register-based cohort study in Denmark from 1997 through 2011, using linked data on participant characteristics, filled prescriptions, and cases of retinal detachment with surgical treatment (scleral buckling, vitrectomy, or pneumatic retinopexy). The cohort included 748 792 episodes of fluoroquinolone use (660 572 [88%] ciprofloxacin) and 5 520 446 control episodes of nonuse. MAIN OUTCOMES AND MEASURES Poisson regression was used to estimate rate ratios (RRs) for incident retinal detachment, adjusting for a propensity score that included a total of 21 variables. The risk windows were classified as current use (days 1-10 from start of treatment), recent use (days 11-30), past use (days 31-60), and distant use (days 61-180). RESULTS A total of 566 cases of retinal detachment occurred, of which 465 (82%) were rhegmatogenous detachments; 72 in fluoroquinolone users and 494 in control nonusers. The crude incidence rate was 25.3 cases per 100 000 person-years in current users, 18.9 in recent users, 26.8 in past users, and 24.8 in distant users compared with 19.0 in nonusers. Compared with nonuse, fluoroquinolone use was not associated with a significantly increased risk of retinal detachment: the adjusted RRs were 1.29 (95% CI, 0.53 to 3.13) for current use; 0.97 (95% CI, 0.46 to 2.05) for recent use; 1.37 (95% CI, 0.80 to 2.35) for past use; and 1.27 (95% CI, 0.93 to 1.75) for distant use. The absolute risk difference, estimated as the adjusted number of retinal detachment cases per 1 000 000 treatment episodes, was 1.5 (95% CI, -2.4 to 11.1) for current use. CONCLUSIONS AND RELEVANCE In this cohort study based on the general Danish population, oral fluoroquinolone use was not associated with increased risk of retinal detachment. Given its limited power, this study can only rule out more than a 3-fold increase in the relative risk associated with current fluoroquinolone use; however, any differences in absolute risk are likely to be of minor, if any, clinical significance.	[Pasternak, Bjorn; Svanstrom, Henrik; Melbye, Mads; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	bjp@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127; melbye, mads/0000-0001-8264-6785	Danish Medical Research Council	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by The Danish Medical Research Council.	Andersen TF, 1999, DAN MED BULL, V46, P263; Austin PC, 2008, CIRC-CARDIOVASC QUAL, V1, P62, DOI 10.1161/CIRCOUTCOMES.108.790634; Corps AN, 2002, ARTHRITIS RHEUM, V46, P3034, DOI 10.1002/art.10617; D'Amico DJ, 2008, NEW ENGL J MED, V359, P2346, DOI 10.1056/NEJMcp0804591; Etminan M, 2012, JAMA-J AM MED ASSOC, V307, P1414, DOI 10.1001/jama.2012.383; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Kang HK, 2008, BMJ-BRIT MED J, V336, P1235, DOI 10.1136/bmj.39581.525532.47; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Mitry D, 2010, BRIT J OPHTHALMOL, V94, P678, DOI 10.1136/bjo.2009.157727; Mitry D, 2011, BRIT J OPHTHALMOL, V95, P365, DOI 10.1136/bjo.2009.172296; Nordic Medico-Statistical Committee, NOMESCO CLASS SURG P; Parson LS, 2001, 26 ANN SAS US GROUP; Pedersen CB, 2006, DAN MED BULL, V53, P441; Sendzik J, 2010, INT J ANTIMICROB AG, V35, P366, DOI 10.1016/j.ijantimicag.2009.10.009; Shakibaei M, 2001, ARCH TOXICOL, V75, P97, DOI 10.1007/s002040000203; The Center for Disease Dynamics Economics and Policy, ANT US OV; Tsai WC, 2008, ARTHRITIS RHEUM-US, V58, P1657, DOI 10.1002/art.23518; US Food and Drug Administration, POT SIGN SER RISKS N; van der Linden PD, 2003, ARCH INTERN MED, V163, P1801, DOI 10.1001/archinte.163.15.1801; van der Linden PD, 2002, BRIT MED J, V324, P1306, DOI 10.1136/bmj.324.7349.1306; Wise BL, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.05.027; Zhang YT, 2012, ARCH INTERN MED, V172, P1465, DOI 10.1001/archinternmed.2012.3717	22	33	33	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2184	2190		10.1001/jama.2013.280500	http://dx.doi.org/10.1001/jama.2013.280500			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24281462	Bronze			2022-12-24	WOS:000327404400027
J	Klaas, S				Klaas, Sara			Avoiding injury	NATURE			English	Editorial Material									[Klaas, Sara] Shriners Hosp Children, Spinal Cord Injury Serv, Chicago, IL USA		Klaas, S (corresponding author), Shriners Hosp Children, Spinal Cord Injury Serv, Chicago, IL USA.	sklaas@shrinenet.org						Cosgrove L., 2011, REPORT NO DOT HS 811	1	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S18	S18		10.1038/503S18a	http://dx.doi.org/10.1038/503S18a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24227003				2022-12-24	WOS:000326894200009
J	Cortese, DA				Cortese, Denis A.			A Health Care Encounter of the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							US HEALTH; BURDEN		[Cortese, Denis A.] Arizona State Univ, Ctr Healthcare Delivery & Policy, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe	Cortese, DA (corresponding author), Arizona State Univ, 13212 E Shea Blvd, Scottsdale, AZ 85259 USA.	Denis.Cortese@asu.edu						[Anonymous], HLTH CAR COSTS PRIM; [Anonymous], 2011, P CSEE, V31, P19; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; Cryer L, 2012, HEALTH AFFAIR, V31, P1237, DOI 10.1377/hlthaff.2011.1132; Harrington P, COMMUNITY PARTNERSHI; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Wu SY, 2000, PROJECTION CHRONIC I	7	6	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 13	2013	310	18					1937	1938		10.1001/jama.2013.281856	http://dx.doi.org/10.1001/jama.2013.281856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	250EJ	24219946				2022-12-24	WOS:000326832900015
J	Jain, Y				Jain, Yogesh			India should introduce daily drug treatment for tuberculosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PULMONARY TUBERCULOSIS; RESISTANCE; REGIMENS; RELAPSE		Jan Swasthya Sahyog, Peoples Hlth Support Grp, Bilaspur 495112, India		Jain, Y (corresponding author), Jan Swasthya Sahyog, Peoples Hlth Support Grp, Village & PO Ganiyari, Bilaspur 495112, India.							Bagcchi S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6663; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Chang KC, 2006, AM J RESP CRIT CARE, V174, P1153, DOI 10.1164/rccm.200605-637OC; Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4; Mathew R, 1997, INT J TUBERC LUNG D, V1, P509; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; Paresh Dave, 2013, National Journal of Community Medicine, V4, P189; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1	11	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 11	2013	347								f6769	10.1136/bmj.f6769	http://dx.doi.org/10.1136/bmj.f6769			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254FH	24217439				2022-12-24	WOS:000327149500011
J	Shenker, D				Shenker, Don			Employers should help prevent misuse of alcohol by employees	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Alcohol Hlth Network, London SW1P 1JH, England		Shenker, D (corresponding author), Alcohol Hlth Network, London SW1P 1JH, England.	donshenker@alcoholhealthnetwork.org.uk						Home Office, 2012, IMP ASS MIN UN PRIC; Institute of Alcohol Studies, 2009, ALC WORKPL FACTSH; Johansson E, 2009, EUR J PUBLIC HEALTH, V19, P19, DOI 10.1093/eurpub/ckn116; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; NICE (National Institute of Clinical Excellence), 2010, ALCOHOL USE DISORDER; Quanbeck Andrew, 2010, WMJ, V109, P9; Raistrick D, 2006, REV EFFECTIVENESS TR; Roche AM, 2008, ADDICTION, V103, P738, DOI 10.1111/j.1360-0443.2008.02154.x	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2013	347								f6590	10.1136/bmj.f6590	http://dx.doi.org/10.1136/bmj.f6590			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	250XQ	24201166				2022-12-24	WOS:000326890500006
J	Fang, XY; Wang, JB; O'Carroll, IP; Mitchell, M; Zuo, XB; Wang, Y; Yu, P; Liu, Y; Rausch, JW; Dyba, MA; Kjems, J; Schwieters, CD; Seifert, S; Winans, RE; Watts, NR; Stahl, SJ; Wingfield, PT; Byrd, RA; Le Grice, SFJ; Rein, A; Wang, YX				Fang, Xianyang; Wang, Jinbu; O'Carroll, Ina P.; Mitchell, Michelle; Zuo, Xiaobing; Wang, Yi; Yu, Ping; Liu, Yu; Rausch, Jason W.; Dyba, Marzena A.; Kjems, Jorgen; Schwieters, Charles D.; Seifert, Soenke; Winans, Randall E.; Watts, Norman R.; Stahl, Stephen J.; Wingfield, Paul T.; Byrd, R. Andrew; Le Grice, Stuart F. J.; Rein, Alan; Wang, Yun-Xing			An Unusual Topological Structure of the HIV-1 Rev Response Element	CELL			English	Article							GENE-EXPRESSION REQUIRES; SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; SECONDARY STRUCTURE; VIRION EXPRESSION; TRANS-ACTIVATOR; RNA; BINDING; PROTEIN	Nuclear export of unspliced and singly spliced viral mRNA is a critical step in the HIV life cycle. The structural basis by which the virus selects its own mRNA among more abundant host cellular RNAs for export has been a mystery for more than 25 years. Here, we describe an unusual topological structure that the virus uses to recognize its own mRNA. The viral Rev response element (RRE) adopts an "A"-like structure in which the two legs constitute two tracks of binding sites for the viral Rev protein and position the two primary known Rev-binding sites similar to 55 angstrom apart, matching the distance between the two RNAbinding motifs in the Rev dimer. Both the legs of the "A" and the separation between them are required for optimal RRE function. This structure accounts for the specificity of Rev for the RRE and thus the specific recognition of the viral RNA.	[Fang, Xianyang; Wang, Jinbu; Zuo, Xiaobing; Yu, Ping; Liu, Yu; Wang, Yun-Xing] NCI, Prot Nucle Acid Interact Sect, Struct Biophys Lab, HIV Drug Resistance Program,Ctr Canc Res,NIH, Frederick, MD 21702 USA; [O'Carroll, Ina P.; Rein, Alan] NCI, Retroviral Assembly Sect, HIV Drug Resistance Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Mitchell, Michelle; Wang, Yi; Rausch, Jason W.; Le Grice, Stuart F. J.] NCI, RT Biochem Sect, HIV Drug Resistance Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Yu, Ping; Dyba, Marzena A.] SAIC Frederick, Struct Biophys Lab, Frederick, MD 21702 USA; [Kjems, Jorgen] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Schwieters, Charles D.] NIH, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Seifert, Soenke; Winans, Randall E.] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Watts, Norman R.; Stahl, Stephen J.; Wingfield, Paul T.] NIAMSD, Prot Express Lab, NIH, Bethesda, MD 20892 USA; [Byrd, R. Andrew] NCI, Macromol NMR Sect, Struct Biophys Lab, Ctr Canc Res,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Aarhus University; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); United States Department of Energy (DOE); Argonne National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rein, A (corresponding author), NCI, Retroviral Assembly Sect, HIV Drug Resistance Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA.	reina@mail.nih.gov; wangyunx@mail.nih.gov	Byrd, R. Andrew/F-8042-2015; Kjems, Jorgen/I-3490-2016; O'Carroll, Ina Puleri/GZH-1001-2022	Byrd, R. Andrew/0000-0003-3625-4232; Kjems, Jorgen/0000-0003-4128-9317; O'Carroll, Ina Puleri/0000-0002-1331-9155; Wingfield, Paul/0000-0002-9515-4752; Fang, Xianyang/0000-0001-9432-9736; Winans, Randall/0000-0002-7080-7673	Intramural Research Program of the National Institutes of Health, National Cancer Institute (NCI) Center for Cancer Research; National Institute of Arthritis, Musculoskeletal and Skin Diseases; Center for Information Technology; SAIC-Frederick [HHSN26120080001E]; U.S. DOE [DE-AC02-06CH11357]; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000090] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010379, ZIABC011132] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute (NCI) Center for Cancer Research; National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Center for Information Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); SAIC-Frederick; U.S. DOE(United States Department of Energy (DOE)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Stephen Hughes, Alexander Wlodawer, and Prof. James Williamson for discussion. This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute (NCI) Center for Cancer Research; National Institute of Arthritis, Musculoskeletal and Skin Diseases; Center for Information Technology; and SAIC-Frederick under contract HHSN26120080001E. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	Bailor MH, 2011, CURR OPIN STRUC BIOL, V21, P296, DOI 10.1016/j.sbi.2011.03.009; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Chapman RL, 2002, ANTIVIR RES, V54, P149, DOI 10.1016/S0166-3542(01)00222-4; Clore GM, 2003, J AM CHEM SOC, V125, P1518, DOI 10.1021/ja028383j; COOK KS, 1991, NUCLEIC ACIDS RES, V19, P1577, DOI 10.1093/nar/19.7.1577; DALY TJ, 1993, BIOCHEMISTRY-US, V32, P10497, DOI 10.1021/bi00090a028; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; Daugherty MD, 2008, MOL CELL, V31, P824, DOI 10.1016/j.molcel.2008.07.016; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; Daugherty MD, 2010, P NATL ACAD SCI USA, V107, P12481, DOI 10.1073/pnas.1007022107; Debye P, 1915, ANN PHYS-BERLIN, V46, P809; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Funari SS, 2000, J BIOL CHEM, V275, P31283, DOI 10.1074/jbc.M004974200; Hajdin CE, 2010, RNA, V16, P1340, DOI 10.1261/rna.1837410; Hammarskjold ML, 2011, VIRUSES-BASEL, V3, P484, DOI 10.3390/v3050484; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; HEAPHY S, 1991, P NATL ACAD SCI USA, V88, P7366, DOI 10.1073/pnas.88.16.7366; Hoffmann D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038305; Holbrook SR, 2008, ANNU REV BIOPHYS, V37, P445, DOI 10.1146/annurev.biophys.36.040306.132755; Jacques DA, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-9; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; Laing C, 2009, J MOL BIOL, V390, P547, DOI 10.1016/j.jmb.2009.04.084; Landt SG, 2005, J MOL BIOL, V351, P982, DOI 10.1016/j.jmb.2005.07.001; Legiewicz M, 2008, P NATL ACAD SCI USA, V105, P14365, DOI 10.1073/pnas.0804461105; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lipfert J, 2008, STRUCTURE, V16, P1357, DOI 10.1016/j.str.2008.07.007; Lusvarghi S, 2013, NUCLEIC ACIDS RES, V41, P6637, DOI 10.1093/nar/gkt353; MALIM MH, 1991, CELL, V65, P241, DOI 10.1016/0092-8674(91)90158-U; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; McColl DJ, 1999, P NATL ACAD SCI USA, V96, P9521, DOI 10.1073/pnas.96.17.9521; Mishra SH, 2009, J MOL BIOL, V393, P369, DOI 10.1016/j.jmb.2009.07.066; Pond SJK, 2009, P NATL ACAD SCI USA, V106, P1404, DOI 10.1073/pnas.0807388106; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Reiter NJ, 2011, CURR OPIN STRUC BIOL, V21, P319, DOI 10.1016/j.sbi.2011.03.003; Schwieters CD, 2007, BIOCHEMISTRY-US, V46, P1152, DOI 10.1021/bi061943x; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Shuck-Lee D, 2008, ANTIMICROB AGENTS CH, V52, P3169, DOI 10.1128/AAC.00274-08; Srinivasakumar N, 1997, J VIROL, V71, P5841, DOI 10.1128/JVI.71.8.5841-5848.1997; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; TILEY LS, 1992, P NATL ACAD SCI USA, V89, P758, DOI 10.1073/pnas.89.2.758; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang H, 2010, BIOPHYS J, V99, P3454, DOI 10.1016/j.bpj.2010.09.051; Wang JB, 2009, J MOL BIOL, V393, P717, DOI 10.1016/j.jmb.2009.08.001; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Xu W, 1996, P NATL ACAD SCI USA, V93, P7475, DOI 10.1073/pnas.93.15.7475; ZAPP ML, 1991, P NATL ACAD SCI USA, V88, P7734, DOI 10.1073/pnas.88.17.7734; Zuo XB, 2006, P NATL ACAD SCI USA, V103, P3534, DOI 10.1073/pnas.0600022103	57	96	98	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					594	605		10.1016/j.cell.2013.10.008	http://dx.doi.org/10.1016/j.cell.2013.10.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243017	Bronze, Green Accepted			2022-12-24	WOS:000326571800014
J	Ravindran, R; Khan, N; Nakaya, HI; Li, SZ; Loebbermann, J; Maddur, MS; Park, Y; Jones, DP; Chappert, P; Davoust, J; Weiss, DS; Virgin, HW; Ron, D; Pulendran, B				Ravindran, Rajesh; Khan, Nooruddin; Nakaya, Helder I.; Li, Shuzhao; Loebbermann, Jens; Maddur, Mohan S.; Park, Youngja; Jones, Dean P.; Chappert, Pascal; Davoust, Jean; Weiss, David S.; Virgin, Herbert W.; Ron, David; Pulendran, Bali			Vaccine Activation of the Nutrient Sensor GCN2 in Dendritic Cells Enhances Antigen Presentation	SCIENCE			English	Article							INITIATION-FACTOR 2-ALPHA; YELLOW-FEVER VACCINE; CD8(+) T-CELLS; TRANSLATIONAL CONTROL; AUTOPHAGY; KINASE; STRESS; MICE; RNA; PHOSPHORYLATION	The yellow fever vaccine YF-17D is one of the most successful vaccines ever developed in humans. Despite its efficacy and widespread use in more than 600 million people, the mechanisms by which it stimulates protective immunity remain poorly understood. Recent studies using systems biology approaches in humans have revealed that YF-17D-induced early expression of general control nonderepressible 2 kinase (GCN2) in the blood strongly correlates with the magnitude of the later CD8(+) T cell response. We demonstrate a key role for virus-induced GCN2 activation in programming dendritic cells to initiate autophagy and enhanced antigen presentation to both CD4(+) and CD8(+) T cells. These results reveal an unappreciated link between virus-induced integrated stress response in dendritic cells and the adaptive immune response.	[Ravindran, Rajesh; Khan, Nooruddin; Nakaya, Helder I.; Li, Shuzhao; Loebbermann, Jens; Maddur, Mohan S.; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Khan, Nooruddin] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500046, Andhra Pradesh, India; [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Park, Youngja] Korea Univ, Coll Pharm, Seoul 339700, South Korea; [Jones, Dean P.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care, Atlanta, GA 30322 USA; [Chappert, Pascal; Davoust, Jean] INSERM, U1013, Paris, France; [Chappert, Pascal; Davoust, Jean] Univ Paris 05, Sorbonne Paris Cite, F-75743 Paris 15, France; [Weiss, David S.] Emory Univ, Div Infect Dis, Dept Med, Atlanta, GA 30329 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Ron, David] Univ Cambridge, Cambridge Metab Res Labs, Cambridge CB2 0QQ, England; [Ron, David] Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England	Emory University; University of Hyderabad; Emory University; Korea University; Emory University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Emory University; Washington University (WUSTL); University of Cambridge; University of Cambridge	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.	bpulend@emory.edu	Davoust, Jean/ABB-6720-2020; Nakaya, Helder/AAF-1738-2020; Loebbermann, Jens/K-8327-2014; Khan, Nooruddin/AAF-5417-2019; Maddur, Mohan/E-4763-2015; Pulendran, Bali/AAW-9550-2021; Nakaya, Helder I/A-1397-2010	Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108; Davoust, Jean/0000-0002-3098-7665; Maddur, Mohan/0000-0002-7085-1762; Ron, David/0000-0002-3014-5636; chappert, pascal/0000-0002-9799-4608; Virgin, Herbert/0000-0001-8580-7628; Li, Shuzhao/0000-0002-7386-2539; Pulendran, Bali/0000-0001-6517-4333	U.S. National Institutes of Health [R37 DK057665, R37 AI048638, U19 AI090023, U19 AI057266, U54 AI057157, N01 AI50019, N01 AI50025]; Bill & Melinda Gates Foundation; Wellcome Trust [084812/Z/08/Z]; NIH [U54 AI057160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090023, R37AI048638, N01AI050025, U19AI057266, R56AI048638, U54AI057157, U54AI057160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the U.S. National Institutes of Health (grants R37 DK057665, R37 AI048638, U19 AI090023, U19 AI057266, U54 AI057157, N01 AI50019, and N01 AI50025) and from the Bill & Melinda Gates Foundation to B. P., a Wellcome Trust Principal Research Fellowship (084812/Z/08/Z) to D. R, and NIH grant U54 AI057160 to H. W. V. We thank B. Cervasi and K. Gill for help with sorting and D. Levesque, D. Bonenberger, and colleagues for animal husbandry. The data presented in this manuscript are tabulated in the main paper and the supplementary materials.	Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Crotzer VL, 2009, J IMMUNOL, V182, P3335, DOI 10.4049/jimmunol.0803458; den Haan JMM, 2001, CURR OPIN IMMUNOL, V13, P437, DOI 10.1016/S0952-7915(00)00238-7; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Krishnamoorthy J, 2008, CELL CYCLE, V7, P2346, DOI 10.4161/cc.6323; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198; Martinez J, 2013, CELL METAB, V17, P895, DOI 10.1016/j.cmet.2013.05.012; McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000; Mizushima Noboru, 2008, V445, P119, DOI 10.1007/978-1-59745-157-4_7; Munz C, 2011, VIRUSES-BASEL, V3, P1166, DOI 10.3390/v3071166; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Sood R, 2000, GENETICS, V154, P787; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tey SK, 2012, BLOOD, V120, P994, DOI 10.1182/blood-2012-01-402404; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Won S, 2012, J VIROL, V86, P1802, DOI 10.1128/JVI.05660-11	31	150	159	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					313	317		10.1126/science.1246829	http://dx.doi.org/10.1126/science.1246829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24310610	Green Accepted			2022-12-24	WOS:000329718600040
J	Dowrick, C; Frances, A				Dowrick, Christopher; Frances, Allen			TOO MUCH MEDICINE Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MAJOR DEPRESSION; PRIMARY-CARE; ANTIDEPRESSANTS; SEVERITY; DISORDER; DIAGNOSIS; SYMPTOMS; EFFICACY; SUPPORT; DOCTORS		[Dowrick, Christopher] Univ Liverpool, Liverpool L69 3GL, Merseyside, England; [Frances, Allen] Duke Univ, Med Ctr, Durham, NC USA	University of Liverpool; Duke University	Dowrick, C (corresponding author), Univ Liverpool, Liverpool L69 3GL, Merseyside, England.	cfd@liv.ac.uk						Akincigil A, 2011, J AM GERIATR SOC, V59, P1042, DOI 10.1111/j.1532-5415.2011.03447.x; Barbui C, 2011, BRIT J PSYCHIAT, V198, P11, DOI 10.1192/bjp.bp.109.076448; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Bower P, 2013, BMJ-BRIT MED J, V346, pf540; Brown WA, 2007, ACTA PSYCHIAT SCAND, V115, P125, DOI 10.1111/j.1600-0447.2007.00970.x; Brugha T, 2009, ADULT PSYCHIAT MORBI; Bui Eric, 2012, Dialogues Clin Neurosci, V14, P149; Callahan C.M., 2005, REINVENTING DEPRESSI; Dowrick C, 2000, PSYCHOL MED, V30, P413, DOI 10.1017/S0033291799001531; Dowrick C, 2013, PROGRAMME GRANTS APP, V1, P1; Dowrick C, 2009, DEPRESSION; FEINBERG M, 1984, ARCH GEN PSYCHIAT, V41, P1080; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Frances A., 2013, SAVING NORMAL, DOI Morrow; Friedman RA, 2012, NEW ENGL J MED, V366, P1855, DOI 10.1056/NEJMp1201794; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P572, DOI 10.1001/archgenpsychiatry.2011.2044; Gold PW, 2013, MOL PSYCHIATR, V18, P632, DOI 10.1038/mp.2013.5; Gotzsche P.C., 2013, DEADLY MED ORG CRIME; Gunn J, 2013, J AFFECT DISORDERS, V148, P338, DOI 10.1016/j.jad.2012.12.021; Hacking Ian, 1999, SOCIAL CONSTRUCTION, P22; Healy David, 2004, LET THEM EAT PROZAC; Hemels MEH, 2002, ANN PHARMACOTHER, V36, P1375, DOI 10.1345/aph.1A331; Hetrick SE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004851.pub3; Ilyas S, 2012, BRIT J PSYCHIAT, V200, P393, DOI 10.1192/bjp.bp.111.104257; Kendler KS, 2008, AM J PSYCHIAT, V165, P1449, DOI 10.1176/appi.ajp.2008.07111757; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Khin NA, 2011, J CLIN PSYCHIAT, V72, P464, DOI 10.4088/JCP.10m06191; KIRK SA, 1994, J MIND BEHAV, V15, P71; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kokanovic R, 2010, SOCIOL HEALTH ILL, V32, P511, DOI 10.1111/j.1467-9566.2009.01228.x; Maxwell M, 2005, CHRONIC ILLN, V1, P61, DOI 10.1179/174239505X19617; McManus P, 2000, MED J AUSTRALIA, V173, P458, DOI 10.5694/j.1326-5377.2000.tb139294.x; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Mojtabai R, 2013, PSYCHOTHER PSYCHOSOM, V82, P161, DOI 10.1159/000345968; Mojtabai R, 2011, HEALTH AFFAIR, V30, P1434, DOI 10.1377/hlthaff.2010.1024; Moore M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3999; Nemeroff CB, 2007, CNS SPECTRUMS, V12, P4; Nielsen Margrethe, 2011, Int J Risk Saf Med, V23, P125, DOI 10.3233/JRS-2011-0526; Parker G, 2013, ACTA PSYCHIAT SCAND, V128, P88, DOI 10.1111/acps.12110; Pratt L.A., 2011, NCHS DATA BRIEF; Singleton N., 2001, PSYCHIAT MORBIDITY A; Thompson C, 2001, BRIT J PSYCHIAT, V179, P317, DOI 10.1192/bjp.179.4.317; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van Avendonk Marielle J P, 2012, Ned Tijdschr Geneeskd, V156, pA5101; Vasiliadis HM, 2013, CAN J PSYCHIAT, V58, P201, DOI 10.1177/070674371305800405; Wakefield, 2007, LOSS SADNESS PSYCHIA; Wakefield JC, 2013, ACTA PSYCHIAT SCAND, V127, P159, DOI 10.1111/j.1600-0447.2012.01898.x; Wakefield JC, 2013, WORLD PSYCHIATRY, V12, P44, DOI 10.1002/wps.20015; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Wierzbicka A, 2003, ETHOS, V31, P577, DOI 10.1525/eth.2003.31.4.577	51	92	92	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2013	347								f7140	10.1136/bmj.f7140	http://dx.doi.org/10.1136/bmj.f7140			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	273ZI	24322400				2022-12-24	WOS:000328574400007
J	Ohno, H; Shinoda, K; Ohyama, K; Sharp, LZ; Kajimura, S				Ohno, Haruya; Shinoda, Kosaku; Ohyama, Kana; Sharp, Louis Z.; Kajimura, Shingo			EHMT1 controls brown adipose cell fate and thermogenesis through the PRDM16 complex	NATURE			English	Article							TRANSCRIPTIONAL CONTROL; NONSHIVERING THERMOGENESIS; HISTONE METHYLTRANSFERASES; TISSUE; METHYLATION; DELETION; OBESITY; UCP1; 9Q34	Brown adipose tissue (BAT) dissipates chemical energy in the form of heat as a defence against hypothermia and obesity. Current evidence indicates that brown adipocytes arise from Myf5(+) dermotomal precursors through the action of PR domain containing protein 16 (PRDM16) transcriptional complex(1,2). However, the enzymatic component of the molecular switch that determines lineage specification of brown adipocytes remains unknown. Here we show that euchromatic histone-lysine N-methyltransferase 1 (EHMT1) is an essential BAT-enriched lysine methyltransferase in the PRDM16 transcriptional complex and controls brown adipose cell fate. Loss of EHMT1 in brown adipocytes causes a severe loss of brown fat characteristics and induces muscle differentiation in vivo through demethylation of histone 3 lysine 9 (H3K9me2 and 3) of the muscle-selective gene promoters. Conversely, EHMT1 expression positively regulates the BAT-selective thermogenic program by stabilizing the PRDM16 protein. Notably, adipose-specific deletion of EHMT1 leads to a marked reduction of BAT-mediated adaptive thermogenesis, obesity and systemic insulin resistance. These data indicate that EHMT1 is an essential enzymatic switch that controls brown adipose cell fate and energy homeostasis.	[Ohno, Haruya; Shinoda, Kosaku; Ohyama, Kana; Sharp, Louis Z.; Kajimura, Shingo] Univ Calif San Francisco, Dept Cell & Tissue Biol, UCSF Diabet Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kajimura, S (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, UCSF Diabet Ctr, 35 Med Ctr Way, San Francisco, CA 94143 USA.	skajimura@diabetes.ucsf.edu	Kajimura, Shingo/AAC-5090-2019; Shinoda, Kosaku/V-1698-2019	Kajimura, Shingo/0000-0003-0672-5910; Shinoda, Kosaku/0000-0002-1928-0749; Ohno, Haruya/0000-0001-5400-1162	National Institutes of Health [DK087853, DK97441]; DERC center [DK63720]; University of California, San Francisco Program for Breakthrough Biomedical Research program; Pew Charitable Trust; PRESTO from the Japan Science and Technology Agency; Manpei Suzuki Diabetes Foundation; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK087853, R01DK097441, P30DK063720, K99DK087853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DERC center; University of California, San Francisco Program for Breakthrough Biomedical Research program; Pew Charitable Trust; PRESTO from the Japan Science and Technology Agency; Manpei Suzuki Diabetes Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to A. Tarakhovsky, E. D. Rosen, Y. Shinkai and E. Hara for providing mice and plasmids. We thank our colleagues in the University of California, San Francisco, including Y. Qiu, A. Chawla, C. Paillart, S. Koliwad, M. Robblee, D. Scheel, S. Ohata, L. Mera, D. Lowe, S. Sonne, S. Keylin, I. Luijten, H. Hong and E. Tomoda for their assistance. This work was supported by grants from the National Institutes of Health (DK087853 and DK97441) to S. K. We acknowledge supports from the DERC center grant (DK63720), University of California, San Francisco Program for Breakthrough Biomedical Research program, the Pew Charitable Trust, and PRESTO from the Japan Science and Technology Agency to S. K. H.O. is supported by the Manpei Suzuki Diabetes Foundation. K. S. is supported by a fellowship from the Japan Society for the Promotion of Science.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cormier-Daire V, 2003, J MED GENET, V40, P300, DOI 10.1136/jmg.40.4.300; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kleefstra T, 2005, J MED GENET, V42, P299, DOI 10.1136/jmg.2004.028464; Kurn N, 2005, CLIN CHEM, V51, P1973, DOI 10.1373/clinchem.2005.053694; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shing DC, 2007, J CLIN INVEST, V117, P3696, DOI 10.1172/JCI32390; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Willemsen MH, 2011, MOL SYNDROMOL, V2, P202, DOI 10.1159/000335648; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; Yoneshiro T, 2013, INT J OBESITY, V37, P993, DOI 10.1038/ijo.2012.161	36	223	229	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					163	+		10.1038/nature12652	http://dx.doi.org/10.1038/nature12652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24196706	Green Submitted, Green Accepted			2022-12-24	WOS:000327851700052
J	Bjerrum, L; Currea, GCC; Llor, C; Lindbaek, M				Bjerrum, Lars; Cordoba Currea, Gloria Cristina; Llor, Carlos; Lindbaek, Morten			Lower threshold for rapid antigen detection testing in patients with sore throats would reduce antibiotic use	BMJ-BRITISH MEDICAL JOURNAL			English	Letter							ACUTE PHARYNGITIS		[Bjerrum, Lars; Cordoba Currea, Gloria Cristina] Univ Copenhagen, Dept Publ Hlth, Sect & Res Unit Gen Practice, DK-1014 Copenhagen K, Denmark; [Llor, Carlos] Univ Rovira & Virgili, Primary Care Ctr Jaume 1, Tarragona 43005, Spain; [Lindbaek, Morten] Univ Oslo, Inst Hlth & Soc, Dept Gen Practice, N-0317 Oslo, Norway	University of Copenhagen; Universitat Rovira i Virgili; University of Oslo	Bjerrum, L (corresponding author), Univ Copenhagen, Dept Publ Hlth, Sect & Res Unit Gen Practice, DK-1014 Copenhagen K, Denmark.	lbjerrum@sund.ku.dk	Bjerrum, Lars/ABD-2019-2020	Bjerrum, Lars/0000-0003-0969-0063; Cordoba, Gloria/0000-0002-2609-0468; Llor, Carl/0000-0001-6644-717X				Chiappini E, 2011, CLIN THER, V33, P48, DOI 10.1016/j.clinthera.2011.02.001; Fine AM, 2012, ARCH INTERN MED, V172, P847, DOI 10.1001/archinternmed.2012.950; Little P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5806; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018	4	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2013	347								f7055	10.1136/bmj.f7055	http://dx.doi.org/10.1136/bmj.f7055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263GN	24286986				2022-12-24	WOS:000327795500002
J	Wise, J				Wise, Jacqui			Polypharmacy: a necessary evil The rise of patients taking four or more drugs is an aspect of modern medicine that requires some urgent attention, finds a new report. Jacqui Wise examines its recommendations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacquiyoung1@gmail.com						Guthrie B, 2012, PRIM HEALTH CARE RES, V13, P45; Health and Social Care Information Centre, 2012, PRESCR DISP COMM STA; The King's Fund, 2013, POL MED OPT MAK IT S	3	40	43	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2013	347								f7033	10.1136/bmj.f7033	http://dx.doi.org/10.1136/bmj.f7033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263GN	24286985				2022-12-24	WOS:000327795500001
J	Wohl, DA; Golin, C; Rosen, DL; May, JM; White, BL				Wohl, David Alain; Golin, Carol; Rosen, David L.; May, Jeanine M.; White, Becky L.			Detection of Undiagnosed HIV Among State Prison Entrants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Wohl, David Alain] Univ N Carolina, Chapel Hill, NC 27599 USA; [Golin, Carol; May, Jeanine M.; White, Becky L.] Univ N Carolina, Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA; [Rosen, David L.] Univ N Carolina, Ctr Infect Dis, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wohl, DA (corresponding author), Univ N Carolina, 130 Mason Farm Rd, Chapel Hill, NC 27599 USA.	wohl@med.unc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD069204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH094250, R01MH079720, F30MH077546] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altice FL, 1998, J ACQ IMMUN DEF SYND, V18, P444, DOI 10.1097/00042560-199808150-00005; [Anonymous], 2008 HIV STD SURV RE; [Anonymous], HIV PRISONS; Braithwaite RL, 2003, AM J PUBLIC HEALTH, V93, P759, DOI 10.2105/AJPH.93.5.759; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Spaulding AC, 2009, PLOS ONE, V4, pA16, DOI 10.1371/journal.pone.0007558	6	17	17	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 27	2013	310	20					2198	2199		10.1001/jama.2013.280740	http://dx.doi.org/10.1001/jama.2013.280740			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	257RS	24281464	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000327404400030
J	Butler, J; Fonarow, GC; Gheorghiade, M				Butler, Javed; Fonarow, Gregg C.; Gheorghiade, Mihai			Need for Increased Awareness and Evidence-Based Therapies for Patients Hospitalized for Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; RATES		[Butler, Javed] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA 90024 USA; [Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60601 USA	Emory University; University of California System; University of California Los Angeles; Northwestern University; Feinberg School of Medicine	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 201 E Huron,Galter 3-150, Chicago, IL 60601 USA.	m-gheorghiade@northwestern.edu	Fonarow, Gregg C/D-5988-2014	Fonarow, Gregg C/0000-0002-3192-8093				Allen LA, 2008, JAMA-J AM MED ASSOC, V299, P2533, DOI 10.1001/jama.299.21.2533; Bradley EH, 2013, CIRC-CARDIOVASC QUAL, V6, P444, DOI 10.1161/CIRCOUTCOMES.111.000101; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2013, JAMA-J AM MED ASSOC, V309, P1125, DOI 10.1001/jama.2013.1954; Gheorghiade M, 2012, HEART FAIL REV, V17, P485, DOI 10.1007/s10741-011-9280-0; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a	8	30	30	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2035	2036		10.1001/jama.2013.282815	http://dx.doi.org/10.1001/jama.2013.282815			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240925				2022-12-24	WOS:000327098900014
J	Giles, SL; Lester, F				Giles, Sarah Louise; Lester, Felicia			Should women with HIV, or at high risk of contracting HIV, use progestogen-containing contraception?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HORMONAL CONTRACEPTION; DISEASE PROGRESSION; DEPOT MEDROXYPROGESTERONE; ACQUISITION; TRANSMISSION; SAFETY		[Giles, Sarah Louise] Uganda River Life Minist, Masaka, Uganda; [Lester, Felicia] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	University of California System; University of California San Francisco	Giles, SL (corresponding author), Uganda River Life Minist, POB 985, Masaka, Uganda.	sarahgiles35@yahoo.co.uk						Baeten JM, 2007, AIDS, V21, P1771, DOI 10.1097/QAD.0b013e328270388a; Blish CA, 2011, AM J REPROD IMMUNOL, V65, P302, DOI 10.1111/j.1600-0897.2010.00930.x; Butler AR, 2013, AIDS, V27, P105, DOI 10.1097/QAD.0b013e32835a5a52; Crook A, 2013, 20 C RETR OPP INF AT; Curtis KM, 2009, AIDS, V23, pS55, DOI 10.1097/01.aids.0000363778.58203.b6; Day S, 2013, 20 C RETR OPP INF AT; Draper BH, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005214.pub2; Hapgood JP, 2004, TRENDS PHARMACOL SCI, V25, P554, DOI 10.1016/j.tips.2004.09.005; Heffron R, 2012, LANCET INFECT DIS, V12, P19, DOI 10.1016/S1473-3099(11)70247-X; McCoy SI, 2013, AIDS, V27, P1001, DOI 10.1097/QAD.0b013e32835da401; Morrison CS, 2011, JAIDS-J ACQ IMM DEF, V57, P157, DOI 10.1097/QAI.0b013e318214ba4a; Morrison CS, 2010, AIDS, V24, P1778, DOI 10.1097/QAD.0b013e32833a2537; Phillips SJ, 2013, AIDS, V27, P787, DOI 10.1097/QAD.0b013e32835bb672; Polis C, 2013, 20 C RETR OPP INF AT, P113; Polis CB, 2013, LANCET INFECT DIS, V13, P797, DOI 10.1016/S1473-3099(13)70155-5; Polis CB, 2013, AIDS, V27, P493, DOI 10.1097/QAD.0b013e32835ad539; Polis CB, 2010, AIDS, V24, P1937, DOI 10.1097/QAD.0b013e32833b3282; Stringer EM, 2009, AIDS, V23, pS69, DOI 10.1097/01.aids.0000363779.65827.e0; Stringer EM, 2009, AIDS, V23, P1377, DOI 10.1097/QAD.0b013e32832cbca8; Stringer EM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.031; Tepper Naomi K., 2012, Morbidity and Mortality Weekly Report, V61, P449; United Nations Department of Economic and Social Affairs Population Division, WORLD CONTR US 2011; Watts DH, 2008, CONTRACEPTION, V77, P84, DOI 10.1016/j.contraception.2007.10.002; WHO, 2015, MED EL CRIT CONTR US, V5th; World Health Organization Department of Reproductive Health, 2012, WHO TECHN STAT HORM	25	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 14	2013	347								f6695	10.1136/bmj.f6695	http://dx.doi.org/10.1136/bmj.f6695			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254HF	24231179				2022-12-24	WOS:000327155000003
J	Lambrecht, BN; Hammad, H				Lambrecht, Bart N.; Hammad, Hamida			Asthma and Coagulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RECEPTOR 4		[Lambrecht, Bart N.] Univ Ghent, VIB Inflammat Res Ctr, B-9000 Ghent, Belgium; Univ Ghent, Dept Resp Med, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Lambrecht, BN (corresponding author), Univ Ghent, VIB Inflammat Res Ctr, B-9000 Ghent, Belgium.		Hammad, Hamida/J-9391-2015; Lambrecht, Bart N/K-2484-2014	Hammad, Hamida/0000-0003-3762-8603; Lambrecht, Bart N/0000-0003-4376-6834				Arnot CJ, 2010, J BIOL CHEM, V285, P19502, DOI 10.1074/jbc.M109.098186; de Boer JD, 2012, BLOOD, V119, P3236, DOI 10.1182/blood-2011-11-391532; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342	5	28	28	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1964	1966		10.1056/NEJMcibr1311045	http://dx.doi.org/10.1056/NEJMcibr1311045			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300MP	24224631	Green Published			2022-12-24	WOS:000330468300016
J	Hampton, SE				Hampton, Stephanie E.			Understanding Lakes Near and Far	SCIENCE			English	Editorial Material									Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Hampton, SE (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA.	hampton@nceas.ucsb.edu		Hampton, Stephanie/0000-0003-2389-4249	Division Of Environmental Biology [1136637] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Beisner BE, 2012, J PLANKTON RES, V34, P849, DOI 10.1093/plankt/fbs052; Edmondson W. T., 1994, Lake and Reservoir Management, V10, P75; Hampton SE, 2013, ECOLOGY, V94, P2663, DOI 10.1890/13-0996.1; Katz SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014688; Kozhova O. M., 1998, LAKE BAIKAL EVOLUTIO; Lenters J. D., 2012, EOS T AGU, V93, P427, DOI [10.1029/2012E0430004, DOI 10.1029/2012EO430004]; Lyche-Solheim A, 2013, HYDROBIOLOGIA, V704, P57, DOI 10.1007/s10750-012-1436-y; Maberly SC, 2012, FRESHWATER BIOL, V57, P233, DOI 10.1111/j.1365-2427.2011.02718.x; Moss B, 2012, SCI TOTAL ENVIRON, V434, P130, DOI 10.1016/j.scitotenv.2011.07.069; Schneider P, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045059; Solomon CT, 2013, LIMNOL OCEANOGR, V58, P849, DOI 10.4319/lo.2013.58.3.0849; Straile D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045497; Williamson CE, 2009, LIMNOL OCEANOGR, V54, P2273, DOI 10.4319/lo.2009.54.6_part_2.2273	13	12	12	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					815	816		10.1126/science.1244732	http://dx.doi.org/10.1126/science.1244732			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233716				2022-12-24	WOS:000326923000025
J	Sanford, WE; Doughten, MW; Coplen, TB; Hunt, AG; Bullen, TD				Sanford, Ward E.; Doughten, Michael W.; Coplen, Tyler B.; Hunt, Andrew G.; Bullen, Thomas D.			Evidence for high salinity of Early Cretaceous sea water from the Chesapeake Bay crater	NATURE			English	Article							GROUNDWATER; AQUIFER; FLOW	High-salinity groundwater more than 1,000 metres deep in the Atlantic coastal plain of the USA has been documented in several locations(1,2), most recentlywithin the 35-million-year-old Chesapeake Bay impact crater(3-5). Suggestions for the origin of increased salinity in the crater have included evaporite dissolution(6), osmosis(6) and evaporation from heating(7) associated with the bolide impact. Here we present chemical, isotopic and physical evidence that together indicate that groundwater in the Chesapeake crater is remnant Early Cretaceous North Atlantic (ECNA) sea water. We find that the sea water is probably 100-145 million years old and that it has an average salinity of about 70 per mil, which is twice that of modern sea water and consistent with the nearly closed ECNA basin(8). Previous evidence for temperature and salinity levels of ancient oceans have been estimated indirectly from geochemical, isotopic and palaeontological analyses of solid materials in deep sediment cores. In contrast, our study identifies ancient sea water in situ and provides a direct estimate of its age and salinity. Moreover, we suggest that it is likely that remnants of ECNA sea water persist in deep sediments at many locations along the Atlantic margin.	[Sanford, Ward E.; Doughten, Michael W.; Coplen, Tyler B.] US Geol Survey, Reston, VA 20192 USA; [Hunt, Andrew G.] US Geol Survey, Fed Ctr, Denver, CO 80225 USA; [Bullen, Thomas D.] US Geol Survey, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Sanford, WE (corresponding author), US Geol Survey, Mail Stop 431, Reston, VA 20192 USA.	wsanford@usgs.gov						Barth S, 1997, CHEM GEOL, V143, P255, DOI 10.1016/S0009-2541(97)00107-1; Beyerle U, 2000, ENVIRON SCI TECHNOL, V34, P2042, DOI 10.1021/es990840h; Bohlke, 2006, PERCHLORATE ENV OCCU, P93, DOI DOI 10.1007/0-387-31113-0_5; Brenna JT, 1997, MASS SPECTROM REV, V16, P227, DOI 10.1002/(SICI)1098-2787(1997)16:5<227::AID-MAS1>3.3.CO;2-U; Browning JV, 2009, GEOL SOC AM SPEC PAP, V458, P775, DOI 10.1130/2009.2458(33); Bullen TD, 1996, GEOCHIM COSMOCHIM AC, V60, P1807, DOI 10.1016/0016-7037(96)00052-X; Carmody R., 1997, 97234 US GEOL SURV; Cederstrom D., 1943, VIRGINIA GEOL SURV B, V58, P1; Coplen T., 2008, USGS TECHNIQUES METH, V10; Davis SN, 1998, GROUND WATER, V36, P338, DOI 10.1111/j.1745-6584.1998.tb01099.x; EVANS R, 1978, AAPG BULL, V62, P223; Friedrich O, 2008, NAT GEOSCI, V1, P453, DOI 10.1038/ngeo217; Gohn G., 2006, T AM GEOPHYS UNION, V87, P349; Gohn GS, 2008, SCIENCE, V320, P1740, DOI 10.1126/science.1158708; Gohn G.S., 2007, 20071094 US GEOL SUR; Hay WW, 1999, GEOL S AM S, P1; Ingebritsen S.E., 2006, GROUNDWATER GEOLOGIC; JONES CE, 1994, GEOCHIM COSMOCHIM AC, V58, P3061, DOI 10.1016/0016-7037(94)90179-1; MALINCONICO ML, 2009, SPEC PAP GEOL SOC AM, V458, P905; MANHEIM FT, 1981, J HYDROL, V54, P95, DOI 10.1016/0022-1694(81)90154-2; Mazurek M, 2011, APPL GEOCHEM, V26, P1035, DOI 10.1016/j.apgeochem.2011.03.124; McFarland E.R., 2005, US GEOL SURV PROF PA, pK1; McFarland E. R., 2006, 1731 US GEOL SURV; McFarland E.R., 2010, 1772 US GEOL SURV; Meisler H., 1989, 1404D US GEOL SURV; Neuzil CE, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006450; OXBURGH ER, 1986, NATURE, V324, P632, DOI 10.1038/324632a0; Plummer LN, 2012, HYDROGEOL J, V20, P1269, DOI 10.1007/s10040-012-0871-1; Poag C., 1999, CHESAPEAKE INVADER D; Poag C., 2003, CHESAPEAKE CRATER GE; Radford L., 1980, ET283731 DEP EN; Rostad CE, 2009, GEOL SOC AM SPEC PAP, V458, P891, DOI 10.1130/2009.2458(37); Sanford W, 2003, J GEOCHEM EXPLOR, V78-9, P243, DOI 10.1016/S0375-6742(03)00108-0; Sanford W.E., 2004, EOS T AM GEOPHYS UN, V85, P369, DOI DOI 10.1029/2004EO390001; Sanford WE, 2009, GEOL SOC AM SPEC PAP, V458, P867, DOI 10.1130/2009.2458(36); Sanford WE, 2005, GEOFLUIDS, V5, P185, DOI 10.1111/j.1468-8123.2005.00110.x; SPANGLER WB, 1950, AAPG BULL, V34, P100; Talawani M., 1979, DEEP DRILLING RESULT, V3, P375; Wagner T, 2008, GEOLOGY, V36, P203, DOI 10.1130/G24523A.1	39	14	16	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					252	+		10.1038/nature12714	http://dx.doi.org/10.1038/nature12714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24226889				2022-12-24	WOS:000326894200049
J	Slim, MAM				Slim, M. Atif Mohd			Harmful use of alcohol in Australasia-a sobering picture	LANCET			English	Editorial Material									Univ Auckland, Waikato Clin Sch, Peter Rothwell Acad Ctr, Waikato Hosp, Hamilton 3240, New Zealand	University of Auckland; Waikato Hospital	Slim, MAM (corresponding author), Univ Auckland, Waikato Clin Sch, Peter Rothwell Acad Ctr, Waikato Hosp, Hamilton 3240, New Zealand.	atif.matapena@gmail.com		Mohd Slim, M Atif/0000-0002-1442-8804				Davidson I., 2012, NEW ZEALND HERALD; Foundation for Alcohol Research and Education, 2013, ALCOHOL RELATED HARM; Foundation for Alcohol Research and Education, 2013, 2013 ANNUAL ALCOHOL; Health Promotion Agency, 2013, ALCOHOL ATTRIBUTABLE; Health Promotion Agency, SAY YEAH NAH CAMPAIG; IPSOS (Social Research Institute), 2013, ALCOHOL LABEL AUDIT; Kelsey J, 2012, ADDICTION, V107, P1719, DOI 10.1111/j.1360-0443.2012.03874.x; Legislative and Governance Forum on Food Regulation (convening as the Australia and New Zealand Food Regulation Ministerial Council), 2011, RESPONSE TO THE RECO	8	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1542	1543		10.1016/S0140-6736(13)61893-0	http://dx.doi.org/10.1016/S0140-6736(13)61893-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247NE	24209813				2022-12-24	WOS:000326623900009
J	Lee, TH				Lee, Thomas H.			The Word That Shall Not Be Spoken	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Physicians and health care organizations know that pain, anxiety, uncertainty, and confusion are common among patients, and we work hard to reduce these problems. So why do we avoid the word suffering, which captures so completely what patients endure? During the years when I worked in an academic integrated delivery system, my colleagues and I would frequently discuss patients' experiences and ways to improve our management of their pain and reduce their confusion as they navigated our complex organization. We knew that anxiety is inevitable for patients facing health issues, but we also knew that there is anxiety, and there is unnecessary anxiety caused, for example, by the uncertainty that weighs on patients and their families while they await a consultation for a potentially serious diagnosis, or the confusion induced when clinicians give conflicting information. We worked hard ...	Press Ganey, Wakefield, MA USA		Lee, TH (corresponding author), Press Ganey, Wakefield, MA USA.								0	19	21	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 7	2013	369	19					1777	1779		10.1056/NEJMp1309660	http://dx.doi.org/10.1056/NEJMp1309660			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247HF	24195546				2022-12-24	WOS:000326607800004
J	Wang, H; Goehring, A; Wang, KH; Penmatsa, A; Ressler, R; Gouaux, E				Wang, Hui; Goehring, April; Wang, Kevin H.; Penmatsa, Aravind; Ressler, Ryan; Gouaux, Eric			Structural basis for action by diverse antidepressants on biogenic amine transporters	NATURE			English	Article							HUMAN SEROTONIN TRANSPORTER; HIGH-AFFINITY RECOGNITION; BINDING-SITE; SELECTIVE RECOGNITION; BACTERIAL HOMOLOG; LEUT; NEUROTRANSMITTER; MECHANISM; CHLORIDE; DETERMINANTS	The biogenic amine transporters (BATs) regulate endogenous neurotransmitter concentrations and are targets for a broad range of therapeutic agents including selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and tricyclic antidepressants (TCAs)(1,2). Because eukaryotic BATs are recalcitrant to crystallographic analysis, our understanding of the mechanism of these inhibitors and antidepressants is limited. LeuT is a bacterial homologue of BATs and has proven to be a valuable paradigm for understanding relationships between their structure and function(3). However, because only approximately 25% of the amino acid sequence of LeuT is in common with that of BATs, and as LeuT is a promiscuous amino acid transporter(4), it does not recapitulate the pharmacological properties of BATs. Indeed, SSRIs and TCAs bind in the extracellular vestibule of LeuT(5-7) and act as non-competitive inhibitors of transport(5). By contrast, multiple studies demonstrate that both TCAs and SSRIs are competitive inhibitors for eukaryotic BATs and bind to the primary binding pocket(8-16). Here we engineered LeuT to harbour human BAT-like pharmacology by mutating key residues around the primary binding pocket. The final LeuBAT mutant binds the SSRI sertraline with a binding constant of 18 nM and displays high-affinity binding to a range of SSRIs, SNRIs and a TCA. We determined 12 crystal structures of LeuBAT in complex with four classes of antidepressants. The chemically diverse inhibitors have a remarkably similar mode of binding in which they straddle transmembrane helix (TM) 3, wedge between TM3/TM8 and TM1/TM6, and lock the transporter in a sodium-and chloride-bound outward-facing open conformation. Together, these studies define common and simple principles for the action of SSRIs, SNRIs and TCAs on BATs.	[Wang, Hui; Goehring, April; Wang, Kevin H.; Penmatsa, Aravind; Ressler, Ryan; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Penmatsa, Aravind/AAQ-2688-2020; Gouaux, Eric/Y-4370-2019; Wang, Hui/C-4051-2012	Gouaux, Eric/0000-0002-8549-2360; Penmatsa, Aravind/0000-0001-9519-5055	National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Michel for help in binding experiments, D. Claxton for comments and L. Vaskalis for assistance with illustrations. We also thank the beamline staff at the Advanced Light Source (beamlines 8.2.1 and 5.0.2) and Advanced Photon Source (Argonne National Laboratory, beamlines 24-ID-C and 24-ID-E). H. W. also thanks the presenters at 2012 CCP4/APS summer school for useful lectures and tutorials. This work was supported by the National Institutes of Health. E. G. is an Investigator with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen J, 2011, P NATL ACAD SCI USA, V108, P12137, DOI 10.1073/pnas.1103060108; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P815, DOI 10.1002/cmdc.200600242; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penmatsa A., 2013, NATURE          0915; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sorensen L, 2012, J BIOL CHEM, V287, P43694, DOI 10.1074/jbc.M112.342212; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Tavoulari S, 2011, J BIOL CHEM, V286, P2834, DOI 10.1074/jbc.M110.186064; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Wang H, 2012, EMBO REP, V13, P861, DOI 10.1038/embor.2012.110; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	39	102	104	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					141	+		10.1038/nature12648	http://dx.doi.org/10.1038/nature12648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24121440	Green Accepted			2022-12-24	WOS:000326585600048
J	Malhotra, A				Malhotra, Aseem			Saturated fat is not the major issue	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE; LOW-CHOLESTEROL; HEART-DISEASE; RISK; METAANALYSIS; POTASSIUM; CALORIE; STROKE		Croydon Univ Hosp, London, England	Croydon University Hospital	Malhotra, A (corresponding author), Croydon Univ Hosp, London, England.	aseem_malhotra@hotmail.com						Alonso A, 2010, HYPERTENSION, V55, P776, DOI 10.1161/HYPERTENSIONAHA.109.143461; Bae JM, 2012, J KOREAN MED SCI, V27, P58, DOI 10.3346/jkms.2012.27.1.58; British Heart Foundation, 2011, TRENDS COR HEART DIS; Champeau R., 2009, UCLA NEWSROOM; Committee on Medical Aspects of Food Policy, 1984, DIET CARD DIS REP PA; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Feinman RD, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-9; Geleijnse JM, 2003, J HUM HYPERTENS, V17, P471, DOI 10.1038/sj.jhh.1001575; KEKWICK A, 1956, LANCET, V271, P155; KEYS A, 1970, CIRCULATION, V41, pI1; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; Musunuru K, 2010, LIPIDS, V45, P907, DOI 10.1007/s11745-010-3408-1; Nago N, 2011, J EPIDEMIOL, V21, P67, DOI 10.2188/jea.JE20100065; Newman D., STATINS GIVEN 5 YEAR; Sacks FM, 1998, HYPERTENSION, V31, P131, DOI 10.1161/01.HYP.31.1.131; SIMES RJ, 1994, AUST NZ J MED, V24, P113, DOI 10.1111/j.1445-5994.1994.tb04446.x; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Wallace SK, 2009, CURR ATHEROSCLER REP, V11, P423, DOI 10.1007/s11883-009-0064-0; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	22	86	88	0	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 22	2013	347								f6340	10.1136/bmj.f6340	http://dx.doi.org/10.1136/bmj.f6340			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CI	24149521	Green Published			2022-12-24	WOS:000326293800023
J	Eggan, K				Eggan, Kevin			Picking the Lock on Pluripotency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS		[Eggan, Kevin] Howard Hughes Med Inst, Chevy Chase, MD USA; [Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02138 USA; [Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Eggan, K (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.		Eggan, Kevin/P-7119-2018					Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	5	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 28	2013	369	22					2150	2151		10.1056/NEJMcibr1311880	http://dx.doi.org/10.1056/NEJMcibr1311880			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258OB	24283230				2022-12-24	WOS:000327467500014
J	Hales, CM; Harpaz, R; Joesoef, MR; Bialek, SR				Hales, Craig M.; Harpaz, Rafael; Joesoef, M. Riduan; Bialek, Stephanie R.			Examination of Links Between Herpes Zoster Incidence and Childhood Varicella Vaccination	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; RISK-FACTORS; COMPLICATION RATES; VIRUS-INFECTIONS; OLDER-ADULTS; EPIDEMIOLOGY; EXPOSURE; SHINGLES; REACTIVATION; CONTACTS	Background: Introduction of a universal varicella vaccine program for U.S. children in 1996 sparked concern that less-frequent exposure to varicella would decrease external boosting of immunity to varicella zoster virus and thereby increase incidence of herpes zoster (HZ). Objective: To determine whether the varicella vaccination program has influenced trends in HZ incidence in the U.S. population older than 65 years. Design: Retrospective study of Medicare claims. Setting: Medicare, 1992 through 2010. Participants: 2 848 765 beneficiaries older than 65 years. Measurements: Annual HZ incidence from 1992 through 2010; rate ratios (RRs) for HZ incidence by age, sex, and race or ethnicity; and state-level varicella vaccination coverage. Results: 281 317 incident cases of HZ occurred. Age- and sex-standardized HZ incidence increased 39% from 10.0 per 1000 person-years in 1992 to 13.9 per 1000 person-years in 2010 with no evidence of a statistically significant change in the rate of in-crease after introduction of the varicella vaccination program. Before introduction of this program, HZ incidence was higher in women (RR, 1.21 [95% CI, 1.19 to 1.24]) than men and was lower in black persons (RR, 0.51 [CI, 0.48 to 0.53]) and Hispanic persons (RR, 0.76 [CI, 0.72 to 0.81]) than white persons. In a model adjusted for sex, age, and calendar year from 1997 to 2010, HZ incidence did not vary by state varicella vaccination coverage (RR, 0.9998 [CI, 0.9993 to 1.0003]). Limitation: Uncertain level and consistency of health-seeking behavior and access and uncertain accuracy of disease coding. Conclusion: Age- specific HZ incidence increased in the U.S. population older than 65 years even before implementation of the childhood varicella vaccination program. Introduction and widespread use of the vaccine did not seem to affect this increase. This information is reassuring for countries considering universal varicella vaccination.	[Hales, Craig M.; Harpaz, Rafael; Joesoef, M. Riduan; Bialek, Stephanie R.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Hales, CM (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mail Stop A-34, Atlanta, GA 30333 USA.	chales@cdc.gov		Hales, Craig/0000-0002-2355-1177	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Adams Deborah A., 2012, Morbidity and Mortality Weekly Report, V59, P1; Agency for Healthcare Research and Quality, 2008, CREAT VAL IND SOC ST; [Anonymous], 1996, US BUREAU CENSUS CUR; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Brisson M, 2002, VACCINE, V20, P2500, DOI 10.1016/S0264-410X(02)00180-9; Centers for Disease Control and Prevention, 2013, US VACC COV REP VIA; Centers for Medicare & Medicaid Services (CMS), 2001, FED REGISTER, V66, P55245; Chao DY, 2012, EPIDEMIOL INFECT, V140, P1131, DOI 10.1017/S0950268811001786; Chaves SS, 2007, PUBLIC HEALTH REP, V122, P155, DOI 10.1177/003335490712200204; Donahue J. G., 2010, American Journal of Public Health, V100, P1116, DOI 10.2105/AJPH.2009.160002; Drolet M, 2010, CAN MED ASSOC J, V182, P1731, DOI 10.1503/cmaj.091711; Fleming DM, 2004, EUR J EPIDEMIOL, V19, P1113, DOI 10.1007/s10654-004-2219-1; Fleming DM, 2004, EPIDEMIOL INFECT, V132, P1, DOI 10.1017/S0950268803001523; GARNETT GP, 1992, EPIDEMIOL INFECT, V108, P513, DOI 10.1017/S0950268800050019; Gershon AA, 1996, J INFECT DIS, V173, P450, DOI 10.1093/infdis/173.2.450; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Guris D, 2008, J INFECT DIS, V197, pS71, DOI 10.1086/522156; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Insinga RP, 2005, J GEN INTERN MED, V20, P748, DOI 10.1111/j.1525-1497.2005.0150.x; Joesoef RM, 2012, MAYO CLIN PROC, V87, P961, DOI 10.1016/j.mayocp.2012.05.021; Jumaan AO, 2005, J INFECT DIS, V191, P2002, DOI 10.1086/430325; Jumaan AO, 2003, 41 ANN M INF DIS SOC, P899; Kilgore Paul E., 2003, Journal of Medical Virology, V70, pS111, DOI 10.1002/jmv.10364; Klein RJ., 2001, HLTH PEOPLE 2010 STA, DOI DOI 10.1037/E583772012-001; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Leung J, 2011, CLIN INFECT DIS, V52, P332, DOI 10.1093/cid/ciq077; LJUNGMAN P, 1986, J INFECT DIS, V153, P840, DOI 10.1093/infdis/153.5.840; Lua PJ, 2009, VACCINE, V27, P882, DOI 10.1016/j.vaccine.2008.11.077; LUBY JP, 1977, J INFECT DIS, V135, P659, DOI 10.1093/infdis/135.4.659; Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1; Mehta SK, 2004, J MED VIROL, V72, P174, DOI 10.1002/jmv.10555; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Mullooly JP, 2005, EPIDEMIOL INFECT, V133, P245, DOI 10.1017/S095026880400281X; Opstelten W, 2006, ANN EPIDEMIOL, V16, P692, DOI 10.1016/j.annepidem.2005.12.002; Perez-Farinos N, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-59; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Russell ML, 2007, EPIDEMIOL INFECT, V135, P908, DOI 10.1017/S0950268807007893; Sadzot-Delvaux C, 2008, J INFECT DIS, V197, pS185, DOI 10.1086/522163; Schmader K, 1998, J INFECT DIS, V178, pS67, DOI 10.1086/514254; Tanuseputro P, 2011, VACCINE, V29, P8580, DOI 10.1016/j.vaccine.2011.09.024; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Tseng HF, 2011, JAMA-J AM MED ASSOC, V305, P160, DOI 10.1001/jama.2010.1983; Williams Walter W., 2012, Morbidity and Mortality Weekly Report, V61, P66; Wolfe S., 2012, EPIDEMIOLOGY PREVENT, V12; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341; Yawn BP, 2011, AM J EPIDEMIOL, V174, P1054, DOI 10.1093/aje/kwr206	49	92	95	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 3	2013	159	11					739	+		10.7326/0003-4819-159-11-201312030-00006	http://dx.doi.org/10.7326/0003-4819-159-11-201312030-00006			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	276EN	24297190	Green Accepted			2022-12-24	WOS:000328731000003
J	Hawkins, M; Malla, S; Blythe, MJ; Nieduszynski, CA; Allers, T				Hawkins, Michelle; Malla, Sunir; Blythe, Martin J.; Nieduszynski, Conrad A.; Allers, Thorsten			Accelerated growth in the absence of DNA replication origins	NATURE			English	Article							ARCHAEON HALOFERAX-VOLCANII; SEQUENCE; INITIATION; RECOMBINATION; POLYPLOIDY; PROTEINS; DYNAMICS; ELEMENTS; BINDING	DNA replication initiates at defined sites called origins, which serve as binding sites for initiator proteins that recruit the replicative machinery. Origins differ in number and structure across the three domains of life(1) and their properties determine the dynamics of chromosome replication. Bacteria and some archaea replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple origins. Initiation mechanisms that rely on homologous recombination operate in some viruses. Here we show that such mechanisms also operate in archaea. We use deep sequencing to study replication in Haloferax volcanii and identify four chromosomal origins of differing activity. Deletion of individual origins results in perturbed replication dynamics and reduced growth. However, a strain lacking all origins has no apparent defects and grows significantly faster than wild type. Origin-less cells initiate replication at dispersed sites rather than at discrete origins and have an absolute requirement for the recombinase RadA, unlike strains lacking individual origins. Our results demonstrate that homologous recombination alone can efficiently initiate the replication of an entire cellular genome. This raises the question of what purpose replication origins serve and why they have evolved.	[Hawkins, Michelle; Nieduszynski, Conrad A.; Allers, Thorsten] Univ Nottingham, Queens Med Ctr, Sch Biol, Nottingham NG7 2UH, England; [Malla, Sunir; Blythe, Martin J.] Univ Nottingham, Queens Med Ctr, Deep Seq, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Allers, T (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Biol, Nottingham NG7 2UH, England.	conrad.nieduszynski@nottingham.ac.uk; thorsten.allers@nottingham.ac.uk	Nieduszynski, Conrad/B-2170-2010	Nieduszynski, Conrad/0000-0003-2001-076X; Allers, Thorsten/0000-0002-7308-3332; Hawkins, Michelle/0000-0001-9393-8206	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E023754/1, BB/G001596/1]; Royal Society; Biotechnology and Biological Sciences Research Council [BB/E023754/1, BB/C501641/1, BB/G001596/1] Funding Source: researchfish; BBSRC [BB/G001596/1, BB/E023754/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported through the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/E023754/1, BB/G001596/1). We thank the BBSRC for a David Phillips Fellowship awarded to C.A.N. and the Royal Society for a University Research Fellowship awarded to T.A., R. Wilson for preparing libraries for sequencing, A. de Moura and I. Duggin for sharing unpublished data, and numerous colleagues for discussions.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; BRYSON V, 1952, SCIENCE, V116, P45, DOI 10.1126/science.116.3003.45; de Moura APS, 2010, NUCLEIC ACIDS RES, V38, P5623, DOI 10.1093/nar/gkq343; Delmas S, 2013, MOL MICROBIOL, V87, P168, DOI 10.1111/mmi.12091; Delmas S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000552; Dershowitz A, 2007, MOL CELL BIOL, V27, P4652, DOI 10.1128/MCB.01246-06; Duggin IG, 2008, P NATL ACAD SCI USA, V105, P16737, DOI 10.1073/pnas.0806414105; Duggin IG, 2011, EMBO J, V30, P145, DOI 10.1038/emboj.2010.301; Hartman AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009605; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; Large A, 2007, MOL MICROBIOL, V66, P1092, DOI 10.1111/j.1365-2958.2007.05980.x; Leigh JA, 2011, FEMS MICROBIOL REV, V35, P577, DOI 10.1111/j.1574-6976.2011.00265.x; Lestini R, 2010, DNA REPAIR, V9, P994, DOI 10.1016/j.dnarep.2010.06.012; Lindas AC, 2013, NAT REV MICROBIOL, V11, P627, DOI 10.1038/nrmicro3077; Matsunaga F, 2007, NUCLEIC ACIDS RES, V35, P3214, DOI 10.1093/nar/gkm212; McCready Shirley, 2005, Saline Syst, V1, P3, DOI 10.1186/1746-1448-1-3; McGeoch AT, 2008, NAT REV MOL CELL BIO, V9, P569, DOI 10.1038/nrm2426; McGlynn P, 2012, MOL MICROBIOL, V85, P12, DOI 10.1111/j.1365-2958.2012.08102.x; Muller CA, 2012, GENOME RES, V22, P1953, DOI 10.1101/gr.139477.112; MULLAKHANBHAI MF, 1975, ARCH MICROBIOL, V104, P207, DOI 10.1007/BF00447326; Newman TJ, 2013, NUCLEIC ACIDS RES, V41, P9705, DOI 10.1093/nar/gkt728; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; OGAWA T, 1984, P NATL ACAD SCI-BIOL, V81, P1040, DOI 10.1073/pnas.81.4.1040; Pelve E. A., 2013, MOL MICROBIOL; Retkute R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.068103; Robinson NP, 2005, FEBS J, V272, P3757, DOI 10.1111/j.1742-4658.2005.04768.x; ROSENSHINE I, 1989, SCIENCE, V245, P1387, DOI 10.1126/science.2818746; Sernova NV, 2008, BRIEF BIOINFORM, V9, P376, DOI 10.1093/bib/bbn031; Skovgaard O, 2011, GENOME RES, V21, P1388, DOI 10.1101/gr.117416.110; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Vujcic M, 1999, MOL CELL BIOL, V19, P6098; Wendoloski D, 2001, MICROBIOL-SGM, V147, P959, DOI 10.1099/00221287-147-4-959; Woods WG, 1997, MOL MICROBIOL, V23, P791, DOI 10.1046/j.1365-2958.1997.2651626.x	38	94	94	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					544	+		10.1038/nature12650	http://dx.doi.org/10.1038/nature12650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24185008	Green Accepted, Green Submitted			2022-12-24	WOS:000327464200047
J	Wright, CF; Middleton, A; Burton, H; Cunningham, F; Humphries, SE; Hurst, J; Birney, E; Firth, HV				Wright, Caroline F.; Middleton, Anna; Burton, Hilary; Cunningham, Fiona; Humphries, Steve E.; Hurst, Jane; Birney, Ewan; Firth, Helen V.			Policy challenges of clinical genome sequencing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INCIDENTAL FINDINGS; RECOMMENDATIONS; MUTATION; PATIENT; RISK		[Wright, Caroline F.; Middleton, Anna] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Burton, Hilary] PHG Fdn, Cambridge, England; [Cunningham, Fiona; Birney, Ewan] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Humphries, Steve E.] UCL, Ctr Cardiovasc Genet, UCL Inst Cardiovasc Sci, London, England; [Hurst, Jane] Great Ormond St Hosp Sick Children, North E Thames Genet Serv, London, England; [Firth, Helen V.] Univ Cambridge, Hosp Fdn Trust, Addenbrookes Hosp, Cambridge, England	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Wright, CF (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	caroline.wright@sanger.ac.uk	Wright, Caroline/N-5355-2015	Middleton, Anna/0000-0003-3103-8098; Humphries, Stephen E/0000-0002-8221-6547; Wright, Caroline/0000-0003-2958-5076; Birney, Ewan/0000-0001-8314-8497; Cunningham, Fiona/0000-0002-7445-2419	British Heart Foundation; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	We thank European Bioinformatics Institute for supporting the meeting which gave rise to this article, John Firth for comments on the manuscript, and all the workshop attendees and presenters for their thoughtful contributions, including Stephanie Barton, David FitzPatrick, Matthew Hurles, Eamonn Maher, Helen Parkinson, Justin Paschall, and Vincent Plagnol. SEH is supported by the British Heart Foundation.	[Anonymous], 2013, CREATING GLOBAL ALLI; Bragin E, 2013, NUCL ACIDS RES; Bredenoord AL, 2011, TRENDS GENET, V27, P41, DOI 10.1016/j.tig.2010.11.004; Burn J., 2013, BMJ-BRIT MED J, V346, P3133; Burton H, 2013, NAT GENET, V45, P349, DOI 10.1038/ng.2582; Dalgleish R, 2010, GENOME MED, V2, DOI 10.1186/gm145; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Diamandis M, 2010, MOL CANCER RES, V8, P1175, DOI 10.1158/1541-7786.MCR-10-0264; Evans DGR, 2012, CANCER PREV RES, V5, P943, DOI 10.1158/1940-6207.CAPR-11-0458; Flinter F., 2013, BMJ-BRIT MED J, V346, P3132; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gliwa C, 2013, AM J BIOETHICS, V13, P32, DOI 10.1080/15265161.2012.754062; Green R, 2013, ACMG RECOMMENDATIONS; HM Government, 2012, STRAT UK LIF SCI ON; Holtzman NA, 2013, GENET MED, V15, P750, DOI 10.1038/gim.2013.96; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Middleton A, 2013, AM J MED GENET A, V161, P2099, DOI 10.1002/ajmg.a.36067; Nherera L, 2011, HEART, V97, P1175, DOI 10.1136/hrt.2010.213975; Tachi N, 2005, PEDIATR NEUROL, V32, P288, DOI 10.1016/j.pediatrneurol.2004.11.003; Torjesen I, 2013, BMJ-BRIT MED J, V347, pf6690; van El CG, 2013, EUR J HUM GENET, V21, P580, DOI 10.1038/ejhg.2013.46; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Wolf SM, 2012, GENET MED, V14, P355, DOI 10.1038/gim.2012.26; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Wright C., 2011, NEXT STEPS SEQUENCE; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	29	40	40	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 22	2013	347								f6845	10.1136/bmj.f6845	http://dx.doi.org/10.1136/bmj.f6845			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KZ	24270507				2022-12-24	WOS:000327459500003
J	Brown, S; Zarin, D				Brown, Sandra; Zarin, Daniel			What Does Zero Deforestation Mean?	SCIENCE			English	Editorial Material									[Brown, Sandra] Winrock Int Livestock Res & Training Ctr, Ecosyst Serv Unit, Arlington, VA 22202 USA; [Zarin, Daniel] Climate & Land Use Alliance, San Francisco, CA 94104 USA		Brown, S (corresponding author), Winrock Int Livestock Res & Training Ctr, Ecosyst Serv Unit, Arlington, VA 22202 USA.	sbrown@winrock.org	Noojipady, Praveen/B-2511-2010					[Anonymous], 2008, BBC NEWS; Baker DJ, 2010, ENVIRON SCI POLICY, V13, P249, DOI 10.1016/j.envsci.2010.03.004; FAO-FRA, 2000, 33 FAOFRA; FAO-FRA, 2010, 163 FAO; GOFC-GOLD, 2012, COP181 GOFCGOLD; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; IPCC, 2007, 2006 IPCC GUID NAT G, V4; OECD/FAO (Organization for Economic Cooperation and Development/ Food and Agriculture Organization of the United Nations), 2013, OECD FAO AGR OUTL 20; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sizer N., 2013, FALSE CHOICE PALM OI; UNFCCC, CP 2010 7 ADD 1	13	52	52	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					805	807		10.1126/science.1241277	http://dx.doi.org/10.1126/science.1241277			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	251IY	24233710				2022-12-24	WOS:000326923000019
J	Ravi, B; Croxford, R; Austin, PC; Lipscombe, L; Bierman, AS; Harvey, PJ; Hawker, GA				Ravi, Bheeshma; Croxford, Ruth; Austin, Peter C.; Lipscombe, Lorraine; Bierman, Arlene S.; Harvey, Paula J.; Hawker, Gillian A.			The relation between total joint arthroplasty and risk for serious cardiovascular events in patients with moderate-severe osteoarthritis: propensity score matched landmark analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; CLINICAL CARDIOLOGY SUBCOMMITTEE; TOTAL HIP-ARTHROPLASTY; MIDDLE-AGED MEN; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; KNEE ARTHROPLASTY; MYOCARDIAL-INFARCTION; NATIONAL-HEALTH	Objective To examine whether total joint arthroplasty of the hip and knee reduces the risk for serious cardiovascular events in patients with moderate-severe osteoarthritis. Design Propensity score matched landmark analysis. Setting Ontario, Canada. Participants 2200 adults with hip or knee osteoarthritis aged 55 or more at recruitment (1996-98) and followed prospectively until death or 2011. Main outcome measure Rates of serious cardiovascular events for those who received a primary total joint arthroplasty compared with those did not within an exposure period of three years after baseline assessment. Results The propensity score matched cohort consisted of 153 matched pairs of participants with moderate-severe arthritis. Over a median follow-up period of seven years after the landmark date (start of the study), matched participants who underwent a total joint arthroplasty during the exposure period were significantly less likely than those who did not to experience a cardiovascular event (hazards ratio 0.56, 95% confidence interval 0.43 to 0.74, P<0.001). Within seven years of the exposure period the absolute risk reduction was 12.4% (95% confidence interval 1.7% to 23.1%) and number needed to treat was 8 (95% confidence interval 4 to 57 patients). Conclusions Using a propensity matched landmark analysis in a population cohort with advanced hip or knee osteoarthritis, this study found a cardioprotective benefit of primary elective total joint arthroplasty.	[Ravi, Bheeshma] Univ Toronto, Dept Surg, Div Orthopaed Surg, Toronto, ON M5S 1B2, Canada; [Ravi, Bheeshma; Austin, Peter C.; Lipscombe, Lorraine; Bierman, Arlene S.; Hawker, Gillian A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5S 1B2, Canada; [Ravi, Bheeshma; Lipscombe, Lorraine; Harvey, Paula J.; Hawker, Gillian A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Croxford, Ruth; Austin, Peter C.; Bierman, Arlene S.; Hawker, Gillian A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Lipscombe, Lorraine; Bierman, Arlene S.; Harvey, Paula J.; Hawker, Gillian A.] Univ Toronto, Dept Med, Toronto, ON M5S 1B2, Canada; [Bierman, Arlene S.] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON M5S 1B2, Canada; [Hawker, Gillian A.] Womens Coll Hosp, Dept Med, Div Rheumatol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Ravi, B (corresponding author), Univ Toronto, Womens Coll Hosp, 76 Grenville St,6th Floor,Room 6327, Toronto, ON M5S 1B2, Canada.	bheeshma.ravi@mail.utoronto.ca		Austin, Peter/0000-0003-3337-233X; Lipscombe, Lorraine/0000-0001-7412-7993	Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Heart and Stroke Foundation; FM Hill chair in academic women's medicine; Canadian Institutes of Health Research [MOP-15468]; Ministry of Health and Long-Term Care	Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); FM Hill chair in academic women's medicine; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This study was supported by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by the Institute for Clinical Evaluative Sciences or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. BR is supported in part by a doctoral award from the Canadian Institutes of Health Research. PCA is supported in part by a career investigator award from the Heart and Stroke Foundation. GAH is supported in part by the FM Hill chair in academic women's medicine, and Canadian Institutes of Health Research grant No MOP-15468. ICES received support from the Ministry of Health and Long-Term Care.	Adamson J, 2004, AGE AGEING, V33, P293, DOI 10.1093/ageing/afh090; Agency for Healthcare Research and Quality, 2002, PHYS ACT OLD AM BEN; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Anderson JR, 2008, J CLIN ONCOL, V26, P3913, DOI 10.1200/JCO.2008.16.1000; [Anonymous], 2011, GLOB ATL CARD DIS PR; Austin PC, 2011, STAT MED, V30, P1292, DOI 10.1002/sim.4200; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1146; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Bauman S, 2007, CLIN J SPORT MED, V17, P104, DOI 10.1097/JSM.0b013e3180379b6a; Bavry AA, 2011, AM J MED, V124, P614, DOI 10.1016/j.amjmed.2011.02.025; Beyersmann J, 2008, J CLIN EPIDEMIOL, V61, P1216, DOI 10.1016/j.jclinepi.2008.02.008; Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Bunker SJ, 2003, MED J AUSTRALIA, V178, P272, DOI 10.5694/j.1326-5377.2003.tb05193.x; Canadian Institute for Health Information, 2003, INT STAT CLASS DIS R; Chun BY, 1997, DIABETES CARE, V20, P704, DOI 10.2337/diacare.20.5.704; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Creamer P, 1999, ARTHRIT CARE RES, V12, P3, DOI 10.1002/1529-0131(199902)12:1<3::AID-ART2>3.0.CO;2-K; Dafni U, 2011, CIRC-CARDIOVASC QUAL, V4, P363, DOI 10.1161/CIRCOUTCOMES.110.957951; Davis MC, 2001, ANN BEHAV MED, V23, P215, DOI 10.1207/S15324796ABM2303_9; Engstrom G, 2009, OSTEOARTHR CARTILAGE, V17, P168, DOI 10.1016/j.joca.2008.07.003; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Friedman B, 2005, J AM GERIATR SOC, V53, P1978, DOI 10.1111/j.1532-5415.2005.00469.x; Graham DJ, 2006, JAMA-J AM MED ASSOC, V296, P1653, DOI 10.1001/jama.296.13.jed60058; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Haapanen N, 1997, INT J EPIDEMIOL, V26, P739, DOI 10.1093/ije/26.4.739; Han CD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-603; Hawker GA, 2000, NEW ENGL J MED, V342, P1016, DOI 10.1056/NEJM200004063421405; Hawker GA, 2004, ARTHRIT RHEUM-ARTHR, V51, P635, DOI 10.1002/art.20524; Hawker GA, 2001, MED CARE, V39, P206, DOI 10.1097/00005650-200103000-00002; Hawker GA, 2010, PROJECT ONTARIO WOME, V2; Hawker GA, 2006, ARTHRITIS RHEUM, V54, P3212, DOI 10.1002/art.22146; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Ho JE, 2003, STROKE, V34, P2812, DOI 10.1161/01.STR.0000102901.41780.5C; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1541, DOI 10.1002/art.1780381104; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Inoue R, 2011, J ORTHOP SCI, V16, P704, DOI 10.1007/s00776-011-0157-9; Jandric S, 2009, AM J PHYS MED REHAB, V88, P328, DOI 10.1097/PHM.0b013e318194fa24; Johnsen SP, 2005, ARCH INTERN MED, V165, P978, DOI 10.1001/archinte.165.9.978; Jones CA, 2007, RHEUM DIS CLIN N AM, V33, P71, DOI 10.1016/j.rdc.2006.12.008; Jones CA, 2000, J RHEUMATOL, V27, P1745; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Kritharides L, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000147; Lamb SE, 2003, J ARTHROPLASTY, V18, P575, DOI 10.1016/S0883-5403(03)00110-4; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Mahon JL, 2002, CAN MED ASSOC J, V167, P1115; Mariconda M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-222; McCarron P, 2001, PUBLIC HEALTH, V115, P12, DOI 10.1038/sj.ph.1900724; Memel DS, 2000, BRIT J GEN PRACT, V50, P645; Montin L, 2008, J CLIN NURS, V17, P40, DOI 10.1111/j.1365-2702.2007.01944.x; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; NELSON L, 1986, LANCET, V2, P473, DOI 10.1016/S0140-6736(86)90354-5; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; Ockene IS, 1997, CIRCULATION, V96, P3243, DOI 10.1161/01.CIR.96.9.3243; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Pereira MA, 1999, PREV MED, V28, P304, DOI 10.1006/pmed.1998.0431; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Prior JA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-295; Quintana JM, 2006, ARCH INTERN MED, V166, P220, DOI 10.1001/archinte.166.2.220; Quintana JM, 2008, ARCH INTERN MED, V168, P1576, DOI 10.1001/archinte.168.14.1576; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Scopaz KA, 2009, ARCH PHYS MED REHAB, V90, P1866, DOI 10.1016/j.apmr.2009.06.012; Sicard-Rosenbaum L, 2002, J GERONTOL A-BIOL, V57, pM47, DOI 10.1093/gerona/57.1.M47; Singh G, 2002, AM J MANAG CARE, V8, pS383; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stevens M, 2012, CLIN GERIATR MED, V28, P509, DOI 10.1016/j.cger.2012.05.003; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Tu K, 2008, CAN MED ASSOC J, V178, P1429, DOI 10.1503/cmaj.071283; Udell JA, 2012, ARCH INTERN MED, V172, P1086, DOI 10.1001/archinternmed.2012.2782; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEINBERGER M, 1990, SOC SCI MED, V30, P503, DOI 10.1016/0277-9536(90)90353-T; White WB, 2007, CURR PAIN HEADACHE R, V11, P428; Woolf V J, 1994, J Arthroplasty, V9, P389, DOI 10.1016/0883-5403(94)90049-3; World Health Organization, 2008, The global burden of disease: 2004 update; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zautra AJ, 2001, PSYCHOSOM MED, V63, P687, DOI 10.1097/00006842-200107000-00022	89	47	47	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 30	2013	347								f6187	10.1136/bmj.f6187	http://dx.doi.org/10.1136/bmj.f6187			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247EW	24174640	Green Published, hybrid			2022-12-24	WOS:000326599600006
J	Psaty, BM; Weiss, NS				Psaty, Bruce M.; Weiss, Noel S.			2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol A Fresh Interpretation of Old Evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK		[Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98121 USA; [Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NHLBI NIH HHS [R01 HL103612, HL103612, HL078888, HL080295, HL105756] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL103612, R01HL078888, R01HL080295, R01HL105756] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2013, PREV GUID TOOLS CV R; CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children, 2011, PEDIATRICS, V128, pS1; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Psaty BM, 1999, JAMA-J AM MED ASSOC, V282, P786, DOI 10.1001/jama.282.8.786; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	10	22	22	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 5	2014	311	5					461	462		10.1001/jama.2013.284203	http://dx.doi.org/10.1001/jama.2013.284203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302GF	24264722				2022-12-24	WOS:000330589800012
J	Zhou, XM; Levin, EJ; Pan, YP; McCoy, JG; Sharma, R; Kloss, B; Bruni, R; Quick, M; Zhou, M				Zhou, Xiaoming; Levin, Elena J.; Pan, Yaping; McCoy, Jason G.; Sharma, Ruchika; Kloss, Brian; Bruni, Renato; Quick, Matthias; Zhou, Ming			Structural basis of the alternating-access mechanism in a bile acid transporter	NATURE			English	Article							CRYSTAL-STRUCTURE; BACTERIAL HOMOLOG; STRUCTURE REFINEMENT; EXPRESSION CLONING; SODIUM SYMPORTER; OUTWARD-OPEN; SUBSTRATE; PROTEINS; FAMILY; CHOLESTEROL	Bile acids are synthesized from cholesterol in hepatocytes and secreted through the biliary tract into the small intestine, where they aid in absorption of lipids and fat-soluble vitamins. Through a process known as enterohepatic recirculation, more than 90% of secreted bile acids are then retrieved from the intestine and returned to the liver for resecretion(1). In humans, there are two Na+-dependent bile acid transporters involved in enterohepatic recirculation, the Na+-taurocholate co-transporting polypeptide (NTCP; also known as SLC10A1) expressed in hepatocytes, and the apical sodium-dependent bile acid transporter (ASBT; also known as SLC10A2) expressed on enterocytes in the terminal ileum(2). In recent years, ASBT has attracted much interest as a potential drug target for treatment of hypercholesterolaemia, because inhibition of ASBT reduces reabsorption of bile acids, thus increasing bile acid synthesis and consequently cholesterol consumption(3,4). However, a lack of three-dimensional structures of bile acid transporters hampers our ability to understand the molecular mechanisms of substrate selectivity and transport, and to interpret the wealth of existing functional data(2,5-8). The crystal structure of an ASBT homologue from Neisseria meningitidis (ASBT(NM)) in detergent was reported recently(9), showing the protein in an inward-open conformation bound to two Na+ and a taurocholic acid. However, the structural changes that bring bile acid and Na+ across the membrane are difficult to infer from a single structure. To understand the structural changes associated with the coupled transport of Na+ and bile acids, here we solved two structures of an ASBT homologue from Yersinia frederiksenii (ASBT(Yf)) in a lipid environment, which reveal that a large rigid-body rotation of a substrate-binding domain gives the conserved 'crossover' region, where two discontinuous helices cross each other, alternating accessibility from either side of the cell membrane. This result has implications for the location and orientation of the bile acid during transport, as well as for the translocation pathway for Na+.	[Zhou, Xiaoming; Levin, Elena J.; Pan, Yaping; McCoy, Jason G.; Zhou, Ming] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Zhou, Xiaoming; Sharma, Ruchika; Zhou, Ming] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Kloss, Brian; Bruni, Renato] New York Consortium Membrane Prot Struct, New York, NY 10027 USA; [Quick, Matthias] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias] Columbia Univ, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Zhou, Ming] Chinese Acad Sci, Kunming Inst Zool, Ion Channel Res & Drug Dev Ctr, Kunming 650223, Peoples R China	Baylor College of Medicine; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhou, M (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	mq2102@columbia.edu; mzhou@bcm.edu		Kloss, Brian/0000-0003-0130-8739; Bruni, Renato/0000-0002-2312-0254; Zhou, Xiaoming/0000-0001-8866-7245	US National Institutes of Health [R01DK088057, R01GM098878, U54GM095315, U54GM087519]; American Heart Association [12EIA8850017]; Cancer Prevention and Research Institute of Texas [R12MZ]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098878, U54GM095315, U54GM075026, U54GM087519] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data for this study were collected at beamlines 8.2.2 at the Advanced Light Source, X-29 at the National Synchrotron Light Source, and 24ID-E and 17ID-B at the Advanced Photon Source. This work was supported by the US National Institutes of Health (R01DK088057, R01GM098878, U54GM095315 and U54GM087519), the American Heart Association (12EIA8850017), and the Cancer Prevention and Research Institute of Texas (R12MZ). M.Z. thanks R. MacKinnon for advice and guidance on scientific directions.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alrefai WA, 2007, PHARM RES-DORDR, V24, P1803, DOI 10.1007/s11095-007-9289-1; Braun A, 2008, ATHEROSCLEROSIS, V198, P77, DOI 10.1016/j.atherosclerosis.2007.10.012; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen LH, 2012, AM J PHYSIOL-ENDOC M, V302, pE68, DOI 10.1152/ajpendo.00323.2011; da Silva TC, 2013, MOL ASPECTS MED, V34, P252, DOI 10.1016/j.mam.2012.07.004; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dawson PA, 2011, HANDB EXP PHARMACOL, V201, P169, DOI 10.1007/978-3-642-14541-4_4; Doring B, 2012, CURR TOP MEMBR, V70, P105, DOI 10.1016/B978-0-12-394316-3.00004-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jensen S, 2013, NAT STRUCT MOL BIOL, V20, P1224, DOI 10.1038/nsmb.2663; Kalayil S, 2013, P NATL ACAD SCI USA, V110, P17296, DOI 10.1073/pnas.1309071110; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kramer W, 2006, CURR MED CHEM, V13, P997, DOI 10.2174/092986706776361003; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Levin EJ, 2009, NATURE, V462, P757, DOI 10.1038/nature08558; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Tolle-Sander S, 2004, MOL PHARMACEUT, V1, P40, DOI 10.1021/mp034010t; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; West KL, 2002, J PHARMACOL EXP THER, V303, P293, DOI 10.1124/jpet.102.038711; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; WONG MH, 1994, J BIOL CHEM, V269, P1340; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	40	100	104	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 23	2014	505	7484					569	573		10.1038/nature12811	http://dx.doi.org/10.1038/nature12811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293SW	24317697	Green Accepted			2022-12-24	WOS:000329995000044
J	Lloyd, DJ; St Jean, DJ; Kurzeja, RJM; Wahl, RC; Michelsen, K; Cupples, R; Chen, M; Wu, J; Sivits, G; Helmering, J; Komorowski, R; Ashton, KS; Pennington, LD; Fotsch, C; Vazir, M; Chen, K; Chmait, S; Zhang, JD; Liu, LB; Norman, MH; Andrews, KL; Bartberger, MD; Van, G; Galbreath, EJ; Vonderfecht, SL; Wang, MH; Jordan, SR; Veniant, MM; Hale, C				Lloyd, David J.; St Jean, David J., Jr.; Kurzeja, Robert J. M.; Wahl, Robert C.; Michelsen, Klaus; Cupples, Rod; Chen, Michelle; Wu, John; Sivits, Glenn; Helmering, Joan; Komorowski, Renee; Ashton, Kate S.; Pennington, Lewis D.; Fotsch, Christopher; Vazir, Mukta; Chen, Kui; Chmait, Samer; Zhang, Jiandong; Liu, Longbin; Norman, Mark H.; Andrews, Kristin L.; Bartberger, Michael D.; Van, Gwyneth; Galbreath, Elizabeth J.; Vonderfecht, Steven L.; Wang, Minghan; Jordan, Steven R.; Veniant, Murielle M.; Hale, Clarence			Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors	NATURE			English	Article							LIVER GLUCOKINASE; ACTIVATOR; GLUCOSE; IDENTIFICATION; TRANSLOCATION; FRUCTOSE; MK-0941; DEFECT; CELLS	Glucose homeostasis is a vital and complex process, and its disruption can cause hyperglycaemia and type II diabetes mellitus(1). Glucokinase (GK), a key enzyme that regulates glucose homeostasis, converts glucose to glucose-6-phosphate(2,3) in pancreatic beta-cells, liver hepatocytes, specific hypothalamic neurons, and gut enterocytes(4). In hepatocytes, GK regulates glucose uptake and glycogen synthesis, suppresses glucose production(3,5), and is subject to the endogenous inhibitor GK regulatory protein (GKRP)(6-8). During fasting, GKRP binds, inactivates and sequesters GK in the nucleus, which removes GK from the gluconeogenic process and prevents a futile cycle of glucose phosphorylation. Compounds that directly hyperactivate GK (GK activators) lower blood glucose levels and are being evaluated clinically as potential therapeutics for the treatment of type II diabetes mellitus(1,9,10). However, initial reports indicate that an increased risk of hypoglycaemia is associated with some GK activators(11). To mitigate the risk of hypoglycaemia, we sought to increase GK activity by blocking GKRP. Here we describe the identification of two potent small-molecule GK-GKRP disruptors (AMG-1694 and AMG-3969) that normalized blood glucose levels in several rodent models of diabetes. These compounds potently reversed the inhibitory effect of GKRP on GK activity and promoted GK translocation both in vitro (isolated hepatocytes) and in vivo (liver). A co-crystal structure of full-length human GKRP in complex with AMG-1694 revealed a previously unknown binding pocket in GKRP distinct from that of the phosphofructose-binding site. Furthermore, with AMG-1694 and AMG-3969 (but not GK activators), blood glucose lowering was restricted to diabetic and not normoglycaemic animals. These findings exploit a new cellular mechanism for lowering blood glucose levels with reduced potential for hypoglycaemic risk in patients with type II diabetes mellitus.	[Lloyd, David J.; Cupples, Rod; Chen, Michelle; Wu, John; Sivits, Glenn; Helmering, Joan; Komorowski, Renee; Wang, Minghan; Veniant, Murielle M.; Hale, Clarence] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA; [St Jean, David J., Jr.; Kurzeja, Robert J. M.; Wahl, Robert C.; Michelsen, Klaus; Ashton, Kate S.; Pennington, Lewis D.; Fotsch, Christopher; Vazir, Mukta; Chen, Kui; Chmait, Samer; Zhang, Jiandong; Liu, Longbin; Norman, Mark H.; Andrews, Kristin L.; Bartberger, Michael D.; Jordan, Steven R.] Amgen Inc, Dept Therapeut Discovery, Thousand Oaks, CA 91320 USA; [Van, Gwyneth; Galbreath, Elizabeth J.; Vonderfecht, Steven L.] Amgen Inc, Dept Comparat Biol & Safety Sci, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen	Lloyd, DJ (corresponding author), Amgen Inc, Dept Metab Disorders, 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	dlloyd@amgen.com; chale@amgen.com		Galbreath, Elizabeth/0000-0003-0162-8329; Lloyd, David/0000-0001-5924-0672				AGIUS L, 1993, BIOCHEM J, V296, P785, DOI 10.1042/bj2960785; Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Anderka O, 2008, J BIOL CHEM, V283, P31333, DOI 10.1074/jbc.M805434200; Ashton K., 2012, PCT Int. Appl, Patent No. [WO 2012027261, 2012027261]; Choi JM, 2013, P NATL ACAD SCI USA, V110, P10171, DOI 10.1073/pnas.1300457110; Coghlan M, 2008, EXPERT OPIN INV DRUG, V17, P145, DOI 10.1517/13543784.17.2.145; DETHEUX M, 1991, EUR J BIOCHEM, V200, P553, DOI 10.1111/j.1432-1033.1991.tb16218.x; Eiki J, 2011, MOL PHARMACOL, V80, P1156, DOI 10.1124/mol.111.074401; Frenette R, 2002, BIOORG MED CHEM LETT, V12, P3009, DOI 10.1016/S0960-894X(02)00615-7; Fujimoto Y, 2004, AM J PHYSIOL-ENDOC M, V287, pE414, DOI 10.1152/ajpendo.00575.2003; Fyfe MCT, 2007, DIABETOLOGIA, V50, P1277, DOI 10.1007/s00125-007-0646-8; Grimsby J, 2008, CURR TOP MED CHEM, V8, P1524, DOI 10.2174/156802608786413483; Grimsby J, 2000, J BIOL CHEM, V275, P7826, DOI 10.1074/jbc.275.11.7826; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Hogan PJ, 2009, ORG PROCESS RES DEV, V13, P875, DOI 10.1021/op9000862; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; JETTON TL, 1994, J BIOL CHEM, V269, P3641; KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Meininger GE, 2011, DIABETES CARE, V34, P2560, DOI 10.2337/dc11-1200; Pfefferkorn JA, 2012, J MED CHEM, V55, P1318, DOI 10.1021/jm2014887; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shin JS, 2007, AM J PHYSIOL-REG I, V292, pR1381, DOI 10.1152/ajpregu.00260.2006; VANDERCAMMEN A, 1990, EUR J BIOCHEM, V191, P483, DOI 10.1111/j.1432-1033.1990.tb19147.x; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; Veiga-da-Cunha M, 2002, J BIOL CHEM, V277, P8466, DOI 10.1074/jbc.M105984200; Veiga-da-Cunha M, 2009, BIOCHEM J, V423, P323, DOI 10.1042/BJ20090986; Verspohl EJ, 2012, PHARMACOL REV, V64, P188, DOI 10.1124/pr.110.003319	28	75	77	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					437	+		10.1038/nature12724	http://dx.doi.org/10.1038/nature12724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24226772				2022-12-24	WOS:000328575300052
J	Li, Q; Bohin, N; Wen, T; Ng, V; Magee, J; Chen, SC; Shannon, K; Morrison, SJ				Li, Qing; Bohin, Natacha; Wen, Tiffany; Ng, Victor; Magee, Jeffrey; Chen, Shann-Ching; Shannon, Kevin; Morrison, Sean J.			Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness	NATURE			English	Article							HEMATOPOIETIC STEM; SELF-RENEWAL; RAS; ACTIVATION; PROLIFERATION; INACTIVATION; MUTATIONS; LEUKEMIA; STAT5; KRAS	'Pre-leukaemic' mutations are thought to promote clonal expansion of haematopoietic stem cells (HSCs) by increasing self-renewal and competitiveness(1); however, mutations that increase HSC proliferation tend to reduce competitiveness and self-renewal potential, raising the question of how a mutant HSC can sustainably outcompete wild-type HSCs. Activating mutations in NRAS are prevalent in human myeloproliferative neoplasms and leukaemia(2). Here we show that a single allele of oncogenic Nras(G12D) increases HSC proliferation but also increases reconstituting and self-renewal potential upon serial transplantation in irradiated mice, all prior to leukaemia initiation. Nras(G12D) also confers long-term self-renewal potential to multipotent progenitors. To explore the mechanism by which Nras(G12D) promotes HSC proliferation and self-renewal, we assessed cell-cycle kinetics using H2B-GFP label retention and 5-bromodeoxyuridine (BrdU) incorporation. Nras(G12D) had a bimodal effect on HSCs, increasing the frequency with which some HSCs divide and reducing the frequency with which others divide. This mirrored bimodal effects on reconstituting potential, as rarely dividing Nras(G12D) HSCs outcompeted wild-type HSCs, whereas frequently dividing Nras(G12D) HSCs did not. Nras(G12D) caused these effects by promoting STAT5 signalling, inducing different transcriptional responses in different subsets of HSCs. One signal can therefore increase HSC proliferation, competitiveness and self-renewal through bimodal effects on HSC gene expression, cycling and reconstituting potential.	[Li, Qing; Bohin, Natacha; Wen, Tiffany; Ng, Victor] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Magee, Jeffrey; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Magee, Jeffrey; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA; [Chen, Shann-Ching] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Shannon, Kevin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; St Jude Children's Research Hospital; University of California System; University of California San Francisco	Li, Q (corresponding author), Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA.	lqing@umich.edu; Sean.Morrison@UTSouthwestern.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329; Bohin, Natacha/0000-0001-8571-9898	Cancer Prevention and Research Institute of Texas; NIH [K08-CA-134649]; V Foundation V Scholar award; NATIONAL CANCER INSTITUTE [R37CA072614, K08CA134649, T32CA128583, P30CA046592] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation V Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	S.J.M. is a Howard Hughes Medical Institute Investigator and the Mary McDermott Cook Chair in Pediatric Genetics. This work was supported by the Cancer Prevention and Research Institute of Texas. Q. L. was supported by NIH K08-CA-134649 and V Foundation V Scholar award. Thanks to L. Hennighausen, K. Haigis and H. Hock for generously providing Stat5ab<SUP>fl</SUP>, Nras<SUP>G12D</SUP> and Col1A1-H2B-GFP; Rosa26-M2-rtTA mice. Thanks to M. Heeren and K. Rajan for help with genotyping and to R. Coolon and N. Vanderveen for mouse colony management.	Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Buza-Vidas N, 2006, GENE DEV, V20, P2018, DOI 10.1101/gad.385606; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; De Filippi P, 2009, BRIT J HAEMATOL, V147, P706, DOI 10.1111/j.1365-2141.2009.07894.x; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Itzykson R, 2013, BLOOD, V121, P2186, DOI 10.1182/blood-2012-06-440347; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Kraoua L, 2012, AM J MED GENET A, V158A, P2407, DOI 10.1002/ajmg.a.35513; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Li LX, 2010, J IMMUNOL, V184, P1728, DOI 10.4049/jimmunol.0903023; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; Liu FL, 2008, J CLIN INVEST, V118, P946, DOI 10.1172/JCI32704; Matsuda K, 2007, BLOOD, V109, P5477, DOI 10.1182/blood-2006-09-046649; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; R Development Core Team, 2009, R FDN STAT COMP; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takizawa H, 2006, BLOOD, V107, P2968, DOI 10.1182/blood-2005-05-2138; Wang JY, 2013, BLOOD, V121, P5203, DOI 10.1182/blood-2012-12-475863; Wang JY, 2010, BLOOD, V116, P5991, DOI 10.1182/blood-2010-04-281527; Ward AF, 2012, BLOOD, V120, P3397, DOI 10.1182/blood-2012-05-378596; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang YY, 2001, J CLIN INVEST, V108, P709, DOI 10.1172/JCI12758	34	82	84	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					143	+		10.1038/nature12830	http://dx.doi.org/10.1038/nature12830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24284627	Green Accepted, Green Submitted			2022-12-24	WOS:000327851700048
J	Angulo, I; Vadas, O; Garcon, F; Banham-Hall, E; Plagnol, V; Leahy, TR; Baxendale, H; Coulter, T; Curtis, J; Wu, CX; Blake-Palmer, K; Perisic, O; Smyth, D; Maes, M; Fiddler, C; Juss, J; Cilliers, D; Markelj, G; Chandra, A; Farmer, G; Kielkowska, A; Clark, J; Kracker, S; Debre, M; Picard, C; Pellier, I; Jabado, N; Morris, JA; Barcenas-Morales, G; Fischer, A; Stephens, L; Hawkins, P; Barrett, JC; Abinun, M; Clatworthy, M; Durandy, A; Doffinger, R; Chilvers, ER; Cant, AJ; Kumararatne, D; Okkenhaug, K; Williams, RL; Condliffe, A; Nejentsev, S				Angulo, Ivan; Vadas, Oscar; Garcon, Fabien; Banham-Hall, Edward; Plagnol, Vincent; Leahy, Timothy R.; Baxendale, Helen; Coulter, Tanya; Curtis, James; Wu, Changxin; Blake-Palmer, Katherine; Perisic, Olga; Smyth, Deborah; Maes, Mailis; Fiddler, Christine; Juss, Jatinder; Cilliers, Deirdre; Markelj, Gasper; Chandra, Anita; Farmer, George; Kielkowska, Anna; Clark, Jonathan; Kracker, Sven; Debre, Marianne; Picard, Capucine; Pellier, Isabelle; Jabado, Nada; Morris, James A.; Barcenas-Morales, Gabriela; Fischer, Alain; Stephens, Len; Hawkins, Phillip; Barrett, Jeffrey C.; Abinun, Mario; Clatworthy, Menna; Durandy, Anne; Doffinger, Rainer; Chilvers, Edwin R.; Cant, Andrew J.; Kumararatne, Dinakantha; Okkenhaug, Klaus; Williams, Roger L.; Condliffe, Alison; Nejentsev, Sergey			Phosphoinositide 3-Kinase delta Gene Mutation Predisposes to Respiratory Infection and Airway Damage	SCIENCE			English	Article							PTEN; ACTIVATION; PI3K; IMMUNODEFICIENCY	Genetic mutations cause primary immunodeficiencies (PIDs) that predispose to infections. Here, we describe activated PI3K-delta syndrome (APDS), a PID associated with a dominant gain-of-function mutation in which lysine replaced glutamic acid at residue 1021 (E1021K) in the p110 delta protein, the catalytic subunit of phosphoinositide 3-kinase delta (PI3K delta), encoded by the PIK3CD gene. We found E1021K in 17 patients from seven unrelated families, but not among 3346 healthy subjects. APDS was characterized by recurrent respiratory infections, progressive airway damage, lymphopenia, increased circulating transitional B cells, increased immunoglobulin M, and reduced immunoglobulin G2 levels in serum and impaired vaccine responses. The E1021K mutation enhanced membrane association and kinase activity of p110 delta. Patient-derived lymphocytes had increased levels of phosphatidylinositol 3,4,5-trisphosphate and phosphorylated AKT protein and were prone to activation-induced cell death. Selective p110 delta inhibitors IC87114 and GS-1101 reduced the activity of the mutant enzyme in vitro, which suggested a therapeutic approach for patients with APDS.	[Angulo, Ivan; Curtis, James; Wu, Changxin; Blake-Palmer, Katherine; Maes, Mailis; Fiddler, Christine; Juss, Jatinder; Clatworthy, Menna; Chilvers, Edwin R.; Condliffe, Alison; Nejentsev, Sergey] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Vadas, Oscar; Perisic, Olga; Williams, Roger L.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Garcon, Fabien; Banham-Hall, Edward; Stephens, Len; Hawkins, Phillip; Okkenhaug, Klaus] Babraham Inst, Cambridge, England; [Plagnol, Vincent] UCL, Univ Coll London Genet Inst, London, England; [Leahy, Timothy R.; Abinun, Mario; Cant, Andrew J.] Newcastle Univ, Inst Cellular Med, Primary Immunodeficiency Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Leahy, Timothy R.; Coulter, Tanya] Our Ladys Childrens Hosp, Dublin, Ireland; [Baxendale, Helen; Chandra, Anita; Doffinger, Rainer; Kumararatne, Dinakantha] Addenbrookes Hosp, Dept Clin Biochem & Immunol, Cambridge, England; [Coulter, Tanya] Trinity Coll Dublin, Sch Med, Dept Immunol, Dublin, Ireland; [Smyth, Deborah] Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Dept Med Genet,Cambridge Inst Med Res, Cambridge, England; [Cilliers, Deirdre] Oxford Univ Hosp, Dept Clin Genet, Oxford, England; [Markelj, Gasper] Univ Med Ctr, Univ Childrens Hosp, Dept Allergol Rheumatol & Clin Immunol, Ljubljana, Slovenia; [Farmer, George] Raigmore Hosp, Inverness, Scotland; [Kielkowska, Anna; Clark, Jonathan] Babraham Biosci Technol Ltd, Cambridge, England; [Kracker, Sven; Fischer, Alain; Durandy, Anne] Necker Childrens Hosp, INSERM, U768, Natl Inst Hlth & Med Res, Paris, France; [Kracker, Sven; Picard, Capucine; Fischer, Alain; Durandy, Anne] Descartes Sorbonne Paris Cite Univ Paris, Imagine Inst, Paris, France; [Debre, Marianne; Picard, Capucine; Fischer, Alain; Durandy, Anne] Necker Childrens Hosp, AP HP, Dept Immunol & Hematol, Paris, France; [Picard, Capucine; Durandy, Anne] Necker Childrens Hosp, AP HP, Ctr Primary Immunodeficiencies CEDI, Paris, France; [Pellier, Isabelle] CHU Angers, Dept Pediat, Angers, France; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Jabado, Nada] McGill Univ Hlth Ctr, Montreal, PQ, Canada; [Morris, James A.; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Hinxton, England; [Barcenas-Morales, Gabriela] Lab Inmunol, Fes Cuautitlan, Mexico	University of Cambridge; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of London; University College London; Newcastle University - UK; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Trinity College Dublin; University of Cambridge; University Medical Centre Ljubljana; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; McGill University; McGill University; Wellcome Trust Sanger Institute	Nejentsev, S (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	sn262@cam.ac.uk	Leahy, Ronan/AAL-5008-2021; Jabado, Nada/AAN-4026-2020; Durandy, Anne/H-7475-2017; Picard, Capucine/H-3914-2017; isabelle, pellier/L-5683-2015; Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019; Kracker, Sven/H-3681-2017	Leahy, Ronan/0000-0001-6419-9328; Durandy, Anne/0000-0001-7706-8466; Picard, Capucine/0000-0001-8788-5056; Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Kracker, Sven/0000-0003-4543-8236; Banham-Hall, Edward/0000-0002-9121-4690; Doffinger, R/0000-0002-9841-3617; Maes, Mailis/0000-0002-0266-6557; stephens, len/0000-0002-2771-3487; Barcenas Morales, Gabriela/0000-0003-0063-8795; Perisic, Olga/0000-0002-3842-2896; Plagnol, Vincent/0000-0002-5597-9215; Markelj, Gasper/0000-0002-7453-0173; Barrett, Jeffrey/0000-0002-1152-370X; Williams, Roger/0000-0001-7754-4207; Chilvers, Edwin/0000-0002-4230-9677; condliffe, alison/0000-0002-6697-8648; smyth, deborah/0000-0002-6330-2669; Hawkins, Phillip/0000-0002-6979-0464	European Research Council (ERC) [260477]; European Union (EU) [261441]; National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; Swiss National Science Foundation [PA00P3_134202]; European Commission [275880]; Medical Research Council [U105184308]; National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland; Wellcome Trust; Medical Research Council UK; British Lung Foundation; Biotechnology and Biological Sciences Research Council [BB/J004456/1]; Institut National de la Sante et de la Recherche Medicale; EU FP7 EUROPAD [201549]; Association Contre Le Cancer; Agence Nationale de la Recherche [2010-CSRD]; EU FP7 ERC PIDIMMUNE [249816]; PASPA-DGAPA-UNAM; GlaxoSmithKline; Roche; Novartis; Karus Therapeutics Ltd; BBSRC [BBS/E/B/0000H260, BBS/E/B/0000H329, BBS/E/B/000C0411] Funding Source: UKRI; MRC [MC_U105184308] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H260, BBS/E/B/0000H329, BBS/E/B/000C0411] Funding Source: researchfish; Medical Research Council [MC_U105184308] Funding Source: researchfish	European Research Council (ERC)(European Research Council (ERC)European Commission); European Union (EU)(CGIAREuropean Commission); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland; Wellcome Trust(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Lung Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); EU FP7 EUROPAD; Association Contre Le Cancer; Agence Nationale de la Recherche(French National Research Agency (ANR)); EU FP7 ERC PIDIMMUNE; PASPA-DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); GlaxoSmithKline(GlaxoSmithKline); Roche(Roche Holding); Novartis(Novartis); Karus Therapeutics Ltd; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	S.N. is a Wellcome Trust Senior Research Fellow in Basic Biomedical Science (095198/Z/10/Z). S.N. is also supported by the European Research Council (ERC) Starting grant 260477 and the European Union (EU) FP7 collaborative grant 261441 (PEVNET project). S.N., A. C., D. K., and R. D. are supported by the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. O.V. was supported by a Swiss National Science Foundation fellowship (grant PA00P3_134202) and a European Commission fellowship (FP7-PEOPLE-2010-IEF, no. 275880). R. L. W. was supported by the Medical Research Council (file reference U105184308). T. C. is supported by the National Children's Research Centre, Our Lady's Children's Hospital, Crumlin, Dublin, Ireland. E. B.-H. is supported by a Wellcome Trust Translational Medicine and Therapeutics award. A. C. is supported by the Medical Research Council UK and the British Lung Foundation. K.O. is supported by a strategic grant from the Biotechnology and Biological Sciences Research Council and a New Investigator Award from the Wellcome Trust. P. H. and L. S. are funded by an Institute Programme grant from the Biotechnology and Biological Sciences Research Council (BB/J004456/1). S. K. is a Centre National de la Recherche Scientifique (CNRS) researcher. A. D., A. F., and S. K. are funded by Institut National de la Sante et de la Recherche Medicale; A. D. is supported by the EU FP7 EUROPAD contract 201549, Association Contre Le Cancer, and Agence Nationale de la Recherche (grant 2010-CSRD). A. F. is supported by the EU FP7 ERC PIDIMMUNE grant 249816. G. B.-M. was supported by a sabbatical grant from PASPA-DGAPA-UNAM. E. C. is a paid consultant for GlaxoSmithKline, Roche, and Novartis; A. C. is a paid consultant for GlaxoSmithKline; P. H. and L. S are paid consultants for GlaxoSmithKline and Karus Therapeutics Ltd; K.O. is a paid consultant for GlaxoSmithKline. Requests for DNA of individual patients will require informed consent from the patients and samples will be available under a material transfer agreement. The p110 delta knockout mice are available from the Babraham Institute under a material transfer agreement. The mutation has been submitted to the ClinVar database; accession no. SCV000083058.	Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Burke JE, 2011, STRUCTURE, V19, P1127, DOI 10.1016/j.str.2011.06.003; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Durandy A, 2013, NAT REV IMMUNOL, V13, P519, DOI 10.1038/nri3466; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Janas ML, 2008, J IMMUNOL, V180, P739, DOI 10.4049/jimmunol.180.2.739; Jou ST, 2006, INT J IMMUNOGENET, V33, P361, DOI 10.1111/j.1744-313X.2006.00627.x; Kang S, 2006, P NATL ACAD SCI USA, V103, P1289, DOI 10.1073/pnas.0510772103; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; Knight ZA, 2007, NAT PROTOC, V2, P2459, DOI 10.1038/nprot.2007.361; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Omori SA, 2006, IMMUNITY, V25, P545, DOI 10.1016/j.immuni.2006.08.015; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165	25	385	409	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					866	871		10.1126/science.1243292	http://dx.doi.org/10.1126/science.1243292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24136356	Green Accepted			2022-12-24	WOS:000326923000041
J	Vigen, R; O'Donnell, CI; Baron, AE; Grunwald, GK; Maddox, TM; Bradley, SM; Barqawi, A; Woning, G; Wierman, ME; Plomondon, ME; Rumsfeld, JS; Ho, PM				Vigen, Rebecca; O'Donnell, Colin I.; Baron, Anna E.; Grunwald, Gary K.; Maddox, Thomas M.; Bradley, Steven M.; Barqawi, Al; Woning, Glenn; Wierman, Margaret E.; Plomondon, Mary E.; Rumsfeld, John S.; Ho, P. Michael			Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTRUCTIVE SLEEP-APNEA; BODY-COMPOSITION; HYPOGONADAL MEN; SEXUAL FUNCTION; REPLACEMENT; METAANALYSIS; EXPRESSION; THRESHOLD; ADHESION; BENEFITS	IMPORTANCE Rates of testosterone therapy are increasing and the effects of testosterone therapy on cardiovascular outcomes and mortality are unknown. A recent randomized clinical trial of testosterone therapy in men with a high prevalence of cardiovascular diseases was stopped prematurely due to adverse cardiovascular events raising concerns about testosterone therapy safety. OBJECTIVES To assess the association between testosterone therapy and all-cause mortality, myocardial infarction (MI), or stroke among male veterans and to determine whether this association is modified by underlying coronary artery disease. DESIGN, SETTING, AND PATIENTS A retrospective national cohort study of men with low testosterone levels (<300 ng/dL) who underwent coronary angiography in the Veterans Affairs (VA) system between 2005 and 2011. MAIN OUTCOMES AND MEASURES Primary outcome was a composite of all-cause mortality, MI, and ischemic stroke. RESULTS Of the 8709 men with a total testosterone level lower than 300 ng/dL, 1223 patients started testosterone therapy after a median of 531 days following coronary angiography. Of the 1710 outcome events, 748 men died, 443 had MIs, and 519 had strokes. Of 7486 patients not receiving testosterone therapy, 681 died, 420 had MIs, and 486 had strokes. Among 1223 patients receiving testosterone therapy, 67 died, 23 had MIs, and 33 had strokes. The absolute rate of events were 19.9% in the no testosterone therapy group vs 25.7% in the testosterone therapy group, with an absolute risk difference of 5.8% (95% CI, -1.4% to 13.1%) at 3 years after coronary angiography. In Cox proportional hazards models adjusting for the presence of coronary artery disease, testosterone therapy use as a time-varying covariate was associated with increased risk of adverse outcomes (hazard ratio, 1.29; 95% CI, 1.04 to 1.58). There was no significant difference in the effect size of testosterone therapy among those with and without coronary artery disease (test for interaction, P = .41). CONCLUSIONS AND RELEVANCE Among a cohort of men in the VA health care system who underwent coronary angiography and had a low serum testosterone level, the use of testosterone therapy was associated with increased risk of adverse outcomes. These findings may inform the discussion about the potential risks of testosterone therapy.	[Vigen, Rebecca] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [O'Donnell, Colin I.; Baron, Anna E.; Grunwald, Gary K.; Maddox, Thomas M.; Bradley, Steven M.; Wierman, Margaret E.; Plomondon, Mary E.; Rumsfeld, John S.; Ho, P. Michael] VA Eastern Colorado Hlth Care Syst, Denver, CO 80220 USA; [O'Donnell, Colin I.; Baron, Anna E.; Grunwald, Gary K.; Maddox, Thomas M.; Bradley, Steven M.; Barqawi, Al; Woning, Glenn; Wierman, Margaret E.; Plomondon, Mary E.; Rumsfeld, John S.; Ho, P. Michael] Univ Colorado Denver, Aurora, CO USA; [Maddox, Thomas M.; Bradley, Steven M.; Plomondon, Mary E.; Rumsfeld, John S.; Ho, P. Michael] Colorado Cardiovasc Outcomes Res CCOR Consortium, Denver, CO USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Ho, PM (corresponding author), VA Eastern Colorado Hlth Care Syst, Res A151, 1055 Clermont St, Denver, CO 80220 USA.	Michael.Ho@va.gov	Bradley, Steven/AID-7839-2022		Cardiovascular Outcomes Research Fellowship through a Department of Veterans Affairs Graduate Medical Education Enhancement Grant; Department of Veterans Affairs Health Services Research and Development Service Career Development Awards	Cardiovascular Outcomes Research Fellowship through a Department of Veterans Affairs Graduate Medical Education Enhancement Grant; Department of Veterans Affairs Health Services Research and Development Service Career Development Awards	Dr Vigen was supported by a Cardiovascular Outcomes Research Fellowship through a Department of Veterans Affairs Graduate Medical Education Enhancement Grant. Drs Maddox and Bradley were supported by a Department of Veterans Affairs Health Services Research and Development Service Career Development Awards.	Abbate R, 2012, THROMB RES, V129, P235, DOI 10.1016/j.thromres.2011.12.026; AJAYI AAL, 1995, CIRCULATION, V91, P2742, DOI 10.1161/01.CIR.91.11.2742; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Bolona ER, 2007, MAYO CLIN PROC, V82, P20, DOI 10.4065/82.1.20; Box TL, 2010, J GEN INTERN MED, V25, P72, DOI 10.1007/s11606-009-1130-6; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; Byrd JB, 2013, AM HEART J, V165, P434, DOI 10.1016/j.ahj.2012.12.009; Calof OM, 2005, J GERONTOL A-BIOL, V60, P1451, DOI 10.1093/gerona/60.11.1451; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Death AK, 2004, ENDOCRINOLOGY, V145, P1889, DOI 10.1210/en.2003-0789; Drager LF, 2011, CHEST, V140, P534, DOI 10.1378/chest.10-2223; Haddad RM, 2007, MAYO CLIN PROC, V82, P29; Hoyos CM, 2012, CLIN ENDOCRINOL, V77, P599, DOI 10.1111/j.1365-2265.2012.04413.x; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P381, DOI 10.1111/j.1365-2265.2005.02350.x; Jones TH, 2011, DIABETES CARE, V34, P828, DOI 10.2337/dc10-1233; Jones TH, 2009, ATHEROSCLEROSIS, V207, P318, DOI 10.1016/j.atherosclerosis.2009.04.016; Malkin CJ, 2004, HEART, V90, P871, DOI 10.1136/hrt.2003.021121; Mathur A, 2009, EUR J ENDOCRINOL, V161, P443, DOI 10.1530/EJE-09-0092; McCrohon JA, 1999, CIRCULATION, V99, P2317, DOI 10.1161/01.CIR.99.17.2317; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; Niesner K, 2013, EPIDEMIOLOGY, V24, P334, DOI 10.1097/EDE.0b013e3182821e75; Pamukcu B, 2010, ANN MED, V42, P394, DOI 10.3109/07853890.2010.497767; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Reker DM, 2001, J REHABIL RES DEV, V38, P281; Rosmond R, 1996, OBES RES, V4, P245, DOI 10.1002/j.1550-8528.1996.tb00542.x; Shores MM, 2012, J CLIN ENDOCR METAB, V97, P2050, DOI 10.1210/jc.2011-2591; Sih R, 1997, J CLIN ENDOCR METAB, V82, P1661, DOI 10.1210/jc.82.6.1661; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; Snapinn SM, 2005, AM STAT, V59, P301, DOI 10.1198/000313005X70371; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Spitzer M, 2013, NAT REV ENDOCRINOL, V9, DOI [10.1038/nrendo.2013.73-c2, 10.1038/nrendo.2013.73]; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; US Securities and Exchange Commission, ANNUAL REPORT OF AUX; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; WILSON RF, 1987, CIRCULATION, V75, P723, DOI 10.1161/01.CIR.75.4.723; Xu S, 2012, VALUE HEALTH, V15, P167, DOI 10.1016/j.jval.2011.07.010	39	648	661	2	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1829	1836		10.1001/jama.2013.280386	http://dx.doi.org/10.1001/jama.2013.280386			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24193080				2022-12-24	WOS:000326550900016
J	Yartsev, MM				Yartsev, Michael M.			Space Bats: Multidimensional Spatial Representation in the Bat	SCIENCE			English	Editorial Material							GRID CELLS; OSCILLATIONS; HIPPOCAMPUS; MAP		Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA	Princeton University	Yartsev, MM (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08540 USA.	myartsev@gmail.com		Yartsev, Michael/0000-0003-0952-2801				Andersen P., 2007, HIPPOCAMPUS BOOK; Buzsaki G, 2012, PROG NEUROBIOL, V98, P241, DOI 10.1016/j.pneurobio.2012.02.004; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Yartsev MM, 2013, SCIENCE, V340, P367, DOI 10.1126/science.1235338; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	14	2	2	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					573	574		10.1126/science.1245809	http://dx.doi.org/10.1126/science.1245809			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179214				2022-12-24	WOS:000326334300031
J	Monteferrario, D; Bolar, NA; Marneth, AE; Hebeda, KM; Bergevoet, SM; Veenstra, H; Laros-van Gorkom, BAP; MacKenzie, MA; Khandanpour, C; Botezatu, L; Fransen, E; Van Camp, G; Duijnhouwer, AL; Salemink, S; Willemsen, B; Huls, G; Preijers, F; Van Heerde, W; Jansen, JH; Kempers, MJE; Loeys, BL; Van Laer, L; Van der Reijden, BA				Monteferrario, Davide; Bolar, Nikhita A.; Marneth, Anna E.; Hebeda, Konnie M.; Bergevoet, Saskia M.; Veenstra, Hans; Laros-van Gorkom, Britta A. P.; MacKenzie, Marius A.; Khandanpour, Cyrus; Botezatu, Lacramiora; Fransen, Erik; Van Camp, Guy; Duijnhouwer, Anthonie L.; Salemink, Simone; Willemsen, Brigith; Huls, Gerwin; Preijers, Frank; Van Heerde, Waander; Jansen, Joop H.; Kempers, Marlies J. E.; Loeys, Bart L.; Van Laer, Lut; Van der Reijden, Bert A.			A Dominant-Negative GFI1B Mutation in the Gray Platelet Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALPHA-GRANULES; GROWTH-FACTOR; BONE-MARROW; NBEAL2; GFI-1B; DIFFERENTIATION; THROMBOPOIESIS; PROTEIN; CELLS; GENE	The gray platelet syndrome is a hereditary, usually autosomal recessive bleeding disorder caused by a deficiency of alpha granules in platelets. We detected a nonsense mutation in the gene encoding the transcription factor GFI1B (growth factor independent 1B) that causes autosomal dominant gray platelet syndrome. Both gray platelets and megakaryocytes had abnormal marker expression. In addition, the megakaryocytes had dysplastic features, and they were abnormally distributed in the bone marrow. The GFI1B mutant protein inhibited nonmutant GFI1B transcriptional activity in a dominant-negative manner. Our studies show that GFI1B, in addition to being causally related to the gray platelet syndrome, is key to megakaryocyte and platelet development. A large family is described with gray platelet syndrome due to an autosomal dominant inheritance pattern related to a dominant-negative mutation in GFI1B. The mutation leads to a loss in gene repression during megakaryocyte development. Platelets are formed through fragmentation of megakaryocytes that reside in the bone marrow.(1),(2) Platelet alpha granules, which are by far the most abundant platelet organelles, store proteins that stimulate platelet adhesiveness, hemostasis, and wound healing.(3),(4) The gray platelet syndrome is an inherited bleeding disorder characterized by defective production of alpha granules.(5),(6) Patients with this syndrome have reduced numbers of larger-than-normal platelets, and on light microscopy these platelets have a typical gray appearance caused by the lack of alpha granules. For a final diagnosis, the lack of alpha granules must be confirmed by means of electron microscopy.(7) Clinically, ...	[Monteferrario, Davide; Marneth, Anna E.; Bergevoet, Saskia M.; Veenstra, Hans; Huls, Gerwin; Preijers, Frank; Van Heerde, Waander; Jansen, Joop H.; Van der Reijden, Bert A.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen Ctr Mol Life Sci,Lab Hematol, NL-6525 GA Nijmegen, Netherlands; [Hebeda, Konnie M.; Willemsen, Brigith] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 GA Nijmegen, Netherlands; [Laros-van Gorkom, Britta A. P.; MacKenzie, Marius A.; Huls, Gerwin] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 GA Nijmegen, Netherlands; [Duijnhouwer, Anthonie L.] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, NL-6525 GA Nijmegen, Netherlands; [Salemink, Simone; Kempers, Marlies J. E.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Bolar, Nikhita A.; Fransen, Erik; Van Camp, Guy; Loeys, Bart L.; Van Laer, Lut] Univ Antwerp Hosp, Dept Med Genet, B-2650 Antwerp, Belgium; [Fransen, Erik] Univ Antwerp, Statua Ctr Stat, B-2020 Antwerp, Belgium; [Khandanpour, Cyrus; Botezatu, Lacramiora] Univ Hosp, Dept Hematol, Essen, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Antwerp; University of Antwerp; University of Duisburg Essen	Van der Reijden, BA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Huispost 475,Geert Grootepl Zuid 8, NL-6525 GA Nijmegen, Netherlands.	lut.vanlaer@uantwerp.be; bert.vanderreijden@radboudumc.nl	Huls, G.A./L-4398-2015; Duijnhouwer, Anthonie/P-6287-2015; Preijers, Frank/L-4586-2015; Duijnhouwer, Anthonie/AAV-1578-2020; Gorkom, B.A.P. Laros-van/L-4475-2015; Jansen, J.H./H-8054-2014; van der Reijden, Bert A/A-3543-2014; Bergevoet, Saskia M/F-4926-2016; Hebeda, K./L-4354-2015; Marneth, Anna/AAX-7358-2021; Loeys, Bart/B-3236-2017; Van Camp, Guy/F-3386-2013; van Heerde, Waander/L-4357-2015; Willemsen, Brigith K.T./F-3706-2016; MacKenzie, M.A./L-4499-2015; Fransen, Erik/C-4102-2015; Marneth, Anna/G-6236-2016; Loeys, B.L./L-4493-2015	Duijnhouwer, Anthonie/0000-0001-5064-0143; Duijnhouwer, Anthonie/0000-0001-5064-0143; Jansen, J.H./0000-0001-9459-568X; Hebeda, K./0000-0002-4181-3302; Loeys, Bart/0000-0003-3703-9518; Van Camp, Guy/0000-0001-5105-9000; van Heerde, Waander/0000-0001-7101-8775; Fransen, Erik/0000-0001-7785-4790; Marneth, Anna/0000-0001-9065-0581; Khandanpour, Cyrus/0000-0003-4655-6269				Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; BRETONGORIUS J, 1981, AM J PATHOL, V102, P10; Gunay-Aygun M, 2011, NAT GENET, V43, P732, DOI 10.1038/ng.883; Gunay-Aygun M, 2010, BLOOD, V116, P4990, DOI 10.1182/blood-2010-05-286534; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kahr WHA, 2011, NAT GENET, V43, P738, DOI 10.1038/ng.884; Kaushansky K, 2008, BLOOD, V111, P981, DOI 10.1182/blood-2007-05-088500; Khandanpour C, 2010, BLOOD, V116, P5149, DOI 10.1182/blood-2010-04-280305; KURSTJENS R, 1968, BRIT J HAEMATOL, V15, P305, DOI 10.1111/j.1365-2141.1968.tb01541.x; Lee S, 2010, J MOL BIOL, V397, P1055, DOI 10.1016/j.jmb.2010.02.006; Maynard DM, 2007, J THROMB HAEMOST, V5, P1945, DOI 10.1111/j.1538-7836.2007.02690.x; MORI K, 1984, TOHOKU J EXP MED, V143, P261, DOI 10.1620/tjem.143.261; Nurden AT, 2007, BLOOD REV, V21, P21, DOI 10.1016/j.blre.2005.12.003; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; RACCUGLIA G, 1971, AM J MED, V51, P818, DOI 10.1016/0002-9343(71)90311-1; Randrianarison-Huetz V, 2010, BLOOD, V115, P2784, DOI 10.1182/blood-2009-09-241752; Rendu F, 2001, PLATELETS, V12, P261, DOI 10.1080/09537100120068170; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; van der Meer LT, 2010, LEUKEMIA, V24, P1834, DOI 10.1038/leu.2010.195; Vassen L, 2005, NUCLEIC ACIDS RES, V33, P987, DOI 10.1093/nar/gki243; Vassen L, 2006, EMBO J, V25, P2409, DOI 10.1038/sj.emboj.7601124; WEISS HJ, 1979, BLOOD, V54, P1296; WHITE JG, 1979, AM J PATHOL, V95, P445; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	25	106	107	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					245	253		10.1056/NEJMoa1308130	http://dx.doi.org/10.1056/NEJMoa1308130			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294HK	24325358	Green Published			2022-12-24	WOS:000330035600010
J	Chang, D				Chang, Diane			Scut	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Montefiore Med Ctr, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Chang, D (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.	diachang@gmail.com						[Anonymous], 2013 US POV GUID; Benson B, 2013, CRAINS NEW YORK 0331; Bilton N, 2013, NY TIMES; College of Engineering at Georgia Tech, ROB COD LEARNS BATH; Hagman A, BESTIC EATING ASS DE; United States Department of Labor, 2014, OCC EMPL STAT OCC EM	6	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2399	2400		10.1001/jama.2013.282710	http://dx.doi.org/10.1001/jama.2013.282710			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24327036				2022-12-24	WOS:000328030900017
J	Taylor, FC; Huffman, M; Ebrahim, S				Taylor, Fiona C.; Huffman, Mark; Ebrahim, Shah			Statin Therapy for Primary Prevention of Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Taylor, Fiona C.; Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1 7HT, England; [Huffman, Mark] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Huffman, Mark] Northwestern Univ, Feinberg Sch Med, Dept Med Cardiol, Chicago, IL 60611 USA	University of London; London School of Hygiene & Tropical Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Taylor, FC (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Fac Epidemiol & Publ Hlth, Cochrane Heart Grp, Keppel St, London WC1 7HT, England.	fiona.taylor@lshtm.ac.uk		Huffman, Mark/0000-0001-7412-2519	National Heart, Lung, and Blood Institute; AstraZeneca; Wellcome Trust; National Institute of Health Research	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AstraZeneca(AstraZeneca); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research(National Institute for Health Research (NIHR))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Huffman reports receiving grant funding from the National Heart, Lung, and Blood Institute and AstraZeneca and travel accommodations from AstraZeneca. Dr Ebrahim reports receiving grant funding from Wellcome Trust and the National Institute of Health Research and royalties from Open University Press. No other disclosures were reported.	Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Golomb BA, 2012, ARCH INTERN MED, V172, P1180, DOI 10.1001/archinternmed.2012.2171; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; National Institute for Health and Clinical Excellence (NICE), 2006, TECHNOLOGY APPRAISAL; Stagnitti MN., TRENDS IN STATINS UT; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; The Health and Social Care Information Centre, PRESCRIPTIONS DISPEN	9	91	98	0	72	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2451	2452		10.1001/jama.2013.281348	http://dx.doi.org/10.1001/jama.2013.281348			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24276813				2022-12-24	WOS:000328030900026
J	Little, P; Stuart, B; Hobbs, R; Butler, CC; Hay, AD; Campbell, J; Delaney, B; Broomfield, S; Barratt, P; Hood, K; Everitt, H; Mullee, M; Williamson, I; Mant, D; Moore, M				Little, Paul; Stuart, Beth; Hobbs, Richard; Butler, Chris C.; Hay, Alastair D.; Campbell, John; Delaney, Brendan; Broomfield, Sue; Barratt, Paula; Hood, Kerenza; Everitt, Hazel; Mullee, Mark; Williamson, Ian; Mant, David; Moore, Michael		DESCARTE Investigators	Predictors of suppurative complications for acute sore throat in primary care: prospective clinical cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRESCRIBING STRATEGIES; RANDOMIZED-TRIAL; ACUTE COUGH; ANTIBIOTICS; PHARYNGITIS; INFECTIONS; VALIDATION; PENICILLIN; DIAGNOSIS; CHILDREN	Objective To document whether elements of a structured history and examination predict adverse outcome of acute sore throat. Design Prospective clinical cohort. Setting Primary care. Participants 14 610 adults with acute sore throat (<= 2 weeks' duration). Main outcome measures Common suppurative complications (quinsy or peritonsillar abscess, otitis media, sinusitis, impetigo or cellulitis) and reconsultation with new or unresolving symptoms within one month. Results Complications were assessed reliably (inter-rater k=0.95). 1.3% (177/13445) of participants developed complications overall and 14.2% (1889/13288) reconsulted with new or unresolving symptoms. Independent predictors of complications were severe tonsillar inflammation (documented among 13.0% (1652/12717); odds ratio 1.92, 95% confidence interval 1.28 to 2.89) and severe earache (5% (667/13 323); 3.02, 1.91 to 4.76), but the model including both variables had modest prognostic utility (bootstrapped area under the receiver operator curve 0.61, 0.57 to 0.65), and 70% of complications (124/177) occurred when neither was present. Clinical prediction rules for bacterial infection (Centor criteria and FeverPAIN) also predicted complications, but predictive values were also poor and most complications occurred with low scores (67% (118/175) scoring <= 2 for Centor; 126/173 (73%) scoring <= 2 for FeverPAIN). Previous medical problems, sex, temperature, and muscle aches were independently but weakly associated with reconsultation with new or unresolving symptoms. Conclusion Important suppurative complications after an episode of acute sore throat in primary care are uncommon. History and examination and scores to predict bacterial infection cannot usefully identify those who will develop complications. Clinicians will need to rely on strategies such as safety netting or delayed prescription in managing the uncertainty and low risk of complications.	[Little, Paul; Stuart, Beth; Broomfield, Sue; Barratt, Paula; Everitt, Hazel; Mullee, Mark; Williamson, Ian; Moore, Michael] Univ Southampton, Primary Care & Populat Sci Div, Southampton SO16 5ST, Hants, England; [Hobbs, Richard; Mant, David] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Butler, Chris C.; Hood, Kerenza] Cardiff Univ, Sch Med, Inst Primary Care & Publ Hlth, Wales Sch Primary Care Res, Cardiff CF10 3AX, S Glam, Wales; [Hay, Alastair D.] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol BS8 1TH, Avon, England; [Campbell, John] Univ Exeter, Sch Med, Exeter, Devon, England; [Delaney, Brendan] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England	University of Southampton; University of Oxford; Cardiff University; University of Bristol; University of Exeter; University of London; King's College London	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	p.little@soton.ac.uk	Hood, Kerenza/C-2528-2008; Campbell, John/A-5792-2011; Hay, Alastair/L-1818-2019; Moore, Michael/C-3447-2011	Hood, Kerenza/0000-0002-5268-8631; Campbell, John/0000-0002-6752-3493; Stuart, Beth/0000-0001-5432-7437; Hay, Alastair/0000-0003-3012-375X; Delaney, Brendan/0000-0002-3518-0131; Butler, Christopher/0000-0002-0102-3453; Little, Paul/0000-0003-3664-1873; hobbs, richard/0000-0001-7976-7172; Everitt, Hazel/0000-0001-7362-8403; Moore, Michael/0000-0002-5127-4509	University of Southampton; Medical Research council [G0500977]; National Institute for Health Research Service; MRC [G0500977] Funding Source: UKRI; Medical Research Council [G0500977] Funding Source: researchfish; National Institute for Health Research [CDF-2009-02-10, CL-2006-26-002, NF-SI-0611-10273] Funding Source: researchfish	University of Southampton; Medical Research council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Service; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was sponsored by the University of Southampton, funded by the Medical Research council (grant No G0500977) and through costs by the National Institute for Health Research Service Support. Neither sponsor nor funder had any role in specifying the analysis or in the write up.	Almond S, 2009, BRIT J GEN PRACT, V59, P872, DOI 10.3399/bjgp09X472971; [Anonymous], 2001, PRINCIPLES APPROPRIA; BREESE BB, 1977, AM J DIS CHILD, V131, P514, DOI 10.1001/archpedi.1977.02120180028003; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; Dagnelie CF, 1998, BRIT J GEN PRACT, V48, P959; Dagnelie CF, 1996, BRIT J GEN PRACT, V46, P589; DELMAR C, 1992, MED J AUSTRALIA, V156, P572, DOI 10.5694/j.1326-5377.1992.tb121422.x; Dobbs F, 1996, BRIT J GEN PRACT, V46, P461; Dunn N, 2007, BRIT J GEN PRACT, V57, P45; Fine AM, 2012, ARCH INTERN MED, V172, P847, DOI 10.1001/archinternmed.2012.950; Francis NA, 2012, BRIT J GEN PRACT, V62, P304, DOI 10.3399/bjgp12X649124; Fuller H, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004883; Harrel F.E., 2001, REGRESSION MODELING; Hay AD, 2004, BRIT J GEN PRACT, V54, P9; Kumar S, 2003, BMJ-BRIT MED J, V326, P138, DOI 10.1136/bmj.326.7381.138; Lindbaek M, 2005, BRIT J GEN PRACT, V55, P615; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 1997, BRIT MED J, V315, P350; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5806; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; Little P, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X658322; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; Nice, 2011, PRESCR ANT SELF LIM; Petersen I, 2007, BMJ-BRIT MED J, V335, P982, DOI 10.1136/bmj.39345.405243.BE; Standing Medical Advisory Committee (SMAC) Sub-Group on Antimicrobial resistance, 1998, PATH LEAST RES; Vincent MT, 2004, AM FAM PHYSICIAN, V69, P1465; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150	29	39	39	0	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2013	347								f6867	10.1136/bmj.f6867	http://dx.doi.org/10.1136/bmj.f6867			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263FA	24277339	Green Accepted, Green Published, hybrid			2022-12-24	WOS:000327791000004
J	Florian, MC; Nattamai, KJ; Dorr, K; Marka, G; Uberle, B; Vas, V; Eckl, C; Andra, I; Schiemann, M; Oostendorp, RAJ; Scharffetter-Kochanek, K; Kestler, HA; Zheng, Y; Geiger, H				Florian, Maria Carolina; Nattamai, Kalpana J.; Doerr, Karin; Marka, Gina; Ueberle, Bettina; Vas, Virag; Eckl, Christina; Andrae, Immanuel; Schiemann, Matthias; Oostendorp, Robert A. J.; Scharffetter-Kochanek, Karin; Kestler, Hans Armin; Zheng, Yi; Geiger, Hartmut			A canonical to non-canonical Wnt signalling switch in haematopoietic stem-cell ageing	NATURE			English	Article							PROGENITOR CELLS; TUMOR-SUPPRESSOR; PATHWAYS; CDC42; PROLIFERATION; REJUVENATION; COOPERATE; MUSCLE; NOTCH; FATE	Many organs with a high cell turnover (for example, skin, intestine and blood) are composed of short-lived cells that require continuous replenishment by somatic stem cells(1,2). Ageing results in the inability of these tissues to maintain homeostasis and it is believed that somatic stem-cell ageing is one underlying cause of tissue attrition with age or age-related diseases. Ageing of haematopoietic stem cells (HSCs) is associated with impaired haematopoiesis in the elderly(3-6). Despite a large amount of data describing the decline of HSC function on ageing, the molecular mechanisms of this process remain largely unknown, which precludes rational approaches to attenuate stem-cell ageing. Here we report an unexpected shift from canonical to non-canonical Wnt signalling in mice due to elevated expression of Wnt5a in aged HSCs, which causes stem-cell ageing. Wnt5a treatment of young HSCs induces ageing-associated stem-cell apolarity, reduction of regenerative capacity and an ageing-like myeloid-lymphoid differentiation skewing via activation of the small Rho GTPase Cdc42. Conversely, Wnt5a haploinsufficiency attenuates HSC ageing, whereas stem-cell-intrinsic reduction of Wnt5a expression results in functionally rejuvenated aged HSCs. Our data demonstrate a critical role for stem-cell-intrinsic non-canonical Wnt5a signalling in HSC ageing.	[Florian, Maria Carolina; Doerr, Karin; Marka, Gina; Ueberle, Bettina; Vas, Virag; Scharffetter-Kochanek, Karin; Geiger, Hartmut] Univ Ulm, Dept Dermatol & Allerg Dis, D-89091 Ulm, Germany; [Nattamai, Kalpana J.; Zheng, Yi; Geiger, Hartmut] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Nattamai, Kalpana J.; Zheng, Yi; Geiger, Hartmut] Univ Cincinnati, Cincinnati, OH 45229 USA; [Eckl, Christina; Oostendorp, Robert A. J.] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 3, D-81675 Munich, Germany; [Andrae, Immanuel; Schiemann, Matthias] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Kestler, Hans Armin] Univ Ulm, Dept Bioinformat & Syst Biol, Inst Neuroinformat, D-89091 Ulm, Germany	Ulm University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Technical University of Munich; University of Munich; Technical University of Munich; Ulm University	Geiger, H (corresponding author), Univ Ulm, Dept Dermatol & Allerg Dis, D-89091 Ulm, Germany.	hartmut.geiger@uni-ulm.de	Zheng, Yi/J-7235-2015; Florian, M. Carolina/AAH-5309-2019; Vas, Virag/B-8067-2016; Virag, Vas/AAD-3532-2022; Kestler, Hans A./D-5799-2012; Oostendorp, Robert A. J./K-9841-2018	Zheng, Yi/0000-0001-7089-6074; Florian, M. Carolina/0000-0002-5791-1310; Vas, Virag/0000-0001-7249-6816; Virag, Vas/0000-0001-7249-6816; Kestler, Hans A./0000-0002-4759-5254; Oostendorp, Robert A. J./0000-0002-4947-0412; Vas, Virag/0000-0002-9722-8188; Andra, Immanuel/0000-0003-1543-9158; Scharffetter-Kochanek, Karin/0000-0002-9655-685X	Deutsche Forschungsgemeinschaft [KFO 142, GE2063/1, SFB 1074]; German Federal Ministry of Education and Research; Excellence program of the Baden-Wurttemberg Foundation; National Institute of Health [HL076604, DK077762, AG040118]; Edward P. Evans foundation; European Commission (FP7 Marie Curie Initial Training Network MARRIAGE); Department of Medicine of Ulm University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040118] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Excellence program of the Baden-Wurttemberg Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward P. Evans foundation; European Commission (FP7 Marie Curie Initial Training Network MARRIAGE); Department of Medicine of Ulm University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank G. Van Zant and J. A. Cancelas for advice and critical reading of the manuscript. We thank F. Kirchhoff and D. van der Merwe for cell sorting support, A. Ruck and the Institut fur Lasertechnologien in der Medizin und Messtechnik of Ulm University for support with confocal microscopy, and the Mouse and Cancer Core in Cincinnati and the Tierforschungszentrum of the University of Ulm for supporting our animal work. The work in the laboratory of H.G. is supported by grants from the Deutsche Forschungsgemeinschaft KFO 142, GE2063/1 and SFB 1074, the German Federal Ministry of Education and Research within its joint research project SyStaR (also to H.A.K. and K.S.-K.), the Excellence program of the Baden-Wurttemberg Foundation, the National Institute of Health, HL076604, DK077762 and AG040118, the Edward P. Evans foundation and the European Commission (FP7 Marie Curie Initial Training Network MARRIAGE). M.C.F. is supported by a 'Bausteinprogramm' of the Department of Medicine of Ulm University.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Daria D, 2008, BLOOD, V111, P1894, DOI 10.1182/blood-2007-02-071746; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Li JS, 2010, CANCER BIOL THER, V10, P617, DOI 10.4161/cbt.10.6.12609; Li ZX, 2003, EXP HEMATOL, V31, P1206, DOI 10.1016/j.exphem.2003.08.008; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Luis TC, 2010, BLOOD, V116, P496, DOI 10.1182/blood-2010-04-282624; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Peterson JR, 2006, CHEM BIOL, V13, P443, DOI 10.1016/j.chembiol.2006.02.009; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Staal FJT, 2010, J CELL BIOCHEM, V109, P844, DOI 10.1002/jcb.22467; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Yang L, 2007, BLOOD, V110, P3853, DOI 10.1182/blood-2007-03-079582; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	31	201	206	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					392	+		10.1038/nature12631	http://dx.doi.org/10.1038/nature12631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24141946	Green Accepted			2022-12-24	WOS:000327163200040
J	Kadaga, R; da Silva, JB; Featherstone, L				Kadaga, Rebecca; da Silva, Jarbas Barbosa, Jr.; Featherstone, Lynne			Caring for preterm babies is a test of how we respond to our most vulnerable citizens	LANCET			English	Editorial Material									[Kadaga, Rebecca] Parliament Republ Uganda, Kampala, Uganda; [da Silva, Jarbas Barbosa, Jr.] Minist Hlth, Brasilia, DF, Brazil; [Featherstone, Lynne] Dept Int Dev, London, England		Kadaga, R (corresponding author), Parliament Republ Uganda, POB 7178, Kampala, Uganda.	ikasirye@parliament.go.ug						Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Darmstadt G, 2013, GRAND CHALLENGES BRA; Fundacao Oswaldo Cruz, 2013, RED BRAS BANC LEIT H; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Leadsom A, 2013, 1001 CRITICAL DAYS I; Ministerio da Saude, 2011, MET CANG MAN TECN; Paranjothy S, 2009, ARCH DIS CHILD, V94, P239, DOI 10.1136/adc.2007.115915; Portal de Saude Ministerio da Saude, 2013, RED CEG; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Silveira MF, 2013, REV SAUDE P IN PRESS; The Partnership for Maternal Newborn & Child Health, 2013, EV NEWB ACT PLAN END; UN Commission on Life-Saving Commodities for Women and Children, 2012, COM REP; UNICEF, 2015, COMMITTING CHILD SUR	14	1	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1613	1614		10.1016/S0140-6736(13)62305-3	http://dx.doi.org/10.1016/S0140-6736(13)62305-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254CN	24238547				2022-12-24	WOS:000327140700006
J	Cully, M				Cully, Megan			DRUG DEVELOPMENT Chemical brace	NATURE			English	Editorial Material														Cully, Megan/0000-0003-4726-134X				Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Grossman R. G., 2013, J NEUROTRAUM, DOI [10.1089/neu.2013.2968, DOI 10.1089/NEU.2013.2968]; Kempf A, 2013, PHYSIOLOGY, V28, P151, DOI 10.1152/physiol.00052.2012; Thompson CK, 2011, JOVE-J VIS EXP, DOI 10.3791/2148	6	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S10	S12		10.1038/503S10a	http://dx.doi.org/10.1038/503S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24226999	Bronze			2022-12-24	WOS:000326894200005
J	Hanf, M; Nacher, M; Guihenneuc, C; Tubert-Bitter, P; Chavance, M				Hanf, Matthieu; Nacher, Mathieu; Guihenneuc, Chantal; Tubert-Bitter, Pascale; Chavance, Michel			Global determinants of mortality in under 5s: 10 year worldwide longitudinal study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILD-MORTALITY; UNDER-5 MORTALITY; HEALTH; COUNTRIES; INFANT; SANITATION; TRENDS; INCOME; WATER	Objective To assess at country level the association of mortality in under 5s with a large set of determinants. Design Longitudinal study. Setting 193 United Nations member countries, 2000-09. Methods Yearly data between 2000 and 2009 based on 12 world development indicators were used in a multivariable general additive mixed model allowing for non-linear relations and lag effects. Main outcome measure National rate of deaths in under 5s per 1000 live births Results The model retained the variables: gross domestic product per capita; percentage of the population having access to improved water sources, having access to improved sanitation facilities, and living in urban areas; adolescent fertility rate; public health expenditure per capita; prevalence of HIV; perceived level of corruption and of violence; and mean number of years in school for women of reproductive age. Most of these variables exhibited non-linear behaviours and lag effects. Conclusions By providing a unified framework for mortality in under 5s, encompassing both high and low income countries this study showed non-linear behaviours and lag effects of known or suspected determinants of mortality in this age group. Although some of the determinants presented a linear action on log mortality indicating that whatever the context, acting on them would be a pertinent strategy to effectively reduce mortality, others had a threshold based relation potentially mediated by lag effects. These findings could help designing efficient strategies to achieve maximum progress towards millennium development goal 4, which aims to reduce mortality in under 5s by two thirds between 1990 and 2015.	[Hanf, Matthieu; Guihenneuc, Chantal; Tubert-Bitter, Pascale; Chavance, Michel] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Hanf, Matthieu; Tubert-Bitter, Pascale; Chavance, Michel] Univ Paris 11, UMRS 1018, Villejuif, France; [Nacher, Mathieu] Cayenne Gen Hosp, Ctr Invest Clin Epidemiol Clin Antilles Guyane CI, Cayenne, French Guiana; [Nacher, Mathieu] Univ Antilles Guyane, EPaT EA3593, Cayenne, French Guiana; [Tubert-Bitter, Pascale] Univ Paris 05, Sorbonne Paris Cite, EA 4064, Lab Sante Publ & Environm, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Hanf, M (corresponding author), Ctr Rech Epidemiol & Sante Populat Equipe 1 Biost, INSERM, U1018, 16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	matthieu@hanf.fr	guihenneuc, chantal/AAZ-9296-2020; Tubert-Bitter, Pascale/E-6118-2016; nacher, mathieu/AAH-4796-2021	guihenneuc, chantal/0000-0001-7237-7120; nacher, mathieu/0000-0001-9397-3204; Hanf, Matthieu/0000-0001-7133-1323	Agence Nationale de la Recherche	Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was supported by the Agence Nationale de la Recherche. The funder had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Aber JL, 1997, ANNU REV PUBL HEALTH, V18, P463, DOI 10.1146/annurev.publhealth.18.1.463; Adetunji J, 2000, B WORLD HEALTH ORGAN, V78, P1200; Alkema L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001288; Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Bureau for Development Policy, 2011, FIGHT CORR HLTH SEC; Collison D, 2007, J PUBLIC HEALTH-UK, V29, P114, DOI 10.1093/pubmed/fdm009; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Filmer D, 1999, SOC SCI MED, V49, P1309, DOI 10.1016/S0277-9536(99)00150-1; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Franco A, 2004, BMJ-BRIT MED J, V329, P1421, DOI 10.1136/bmj.329.7480.1421; Frees E.W., 2004, LONGITUDINAL PANEL D, DOI 10.1198/jasa.2006.s88; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gracey M, 2002, ACTA PAEDIATR, V91, P1, DOI 10.1080/080352502753457842; Gupta S, 2000, IMF WORKING PAPER; Hanf M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026990; Hastie T.J., 2017, STAT SCI; Ip S, 2007, 07E007 AG HEALTHC RE; Lewis M., 2006, SSRN ELECT J, DOI [10.2139/ssrn.984046, DOI 10.2139/SSRN.984046]; McGuire JW, 2006, WORLD DEV, V34, P405, DOI 10.1016/j.worlddev.2005.08.004; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; Muldoon KA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-42; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Rubin D. B., 2004, MULTIPLE IMPUTATION; Rutstein SO, 2000, B WORLD HEALTH ORGAN, V78, P1256; Schell CO, 2007, SCAND J PUBLIC HEALT, V35, P288, DOI 10.1080/14034940600979171; TOOLE MJ, 1993, LANCET, V341, P1193, DOI 10.1016/0140-6736(93)91013-C; WHO Department of Maternal Newborn Child and Adolescent Health, 2011, PREV EARL PREGN POOR; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wood AM, 2008, STAT MED, V27, P3227, DOI 10.1002/sim.3177; You D., 2012, LEVELS TRENDS CHILD	32	11	11	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 8	2013	347								f6427	10.1136/bmj.f6427	http://dx.doi.org/10.1136/bmj.f6427			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	250XT	24212105	hybrid, Green Published			2022-12-24	WOS:000326890800001
J	Hurria, A; Naylor, M; Cohen, HJ				Hurria, Arti; Naylor, Mary; Cohen, Harvey Jay			Improving the Quality of Cancer Care in an Aging Population Recommendations From an IOM Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hurria, Arti] City Hope Natl Med Ctr, Ctr Comprehens Canc, Duarte, CA USA; [Naylor, Mary] Univ Penn, Sch Nursing, New Cortland Ctr Transit & Hlth, Philadelphia, PA 19104 USA; [Cohen, Harvey Jay] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27705 USA; [Cohen, Harvey Jay] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27705 USA	City of Hope; University of Pennsylvania; Duke University; Duke University	Cohen, HJ (corresponding author), Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, POB 3003, Durham, NC 27705 USA.	harvey.cohen@duke.edu						Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; IOM, 2013, DELIVERING HIGH QUAL; National Vital Statistics System (NVSS), 2012, DEATHS LEADING CAUSE; NCI: National Cancer Institute, 2013, SEER STAT FACT SHEET; Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983; Talarico L, 2004, J CLIN ONCOL, V22, P4626, DOI 10.1200/JCO.2004.02.175	6	85	86	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1795	1796		10.1001/jama.2013.280416	http://dx.doi.org/10.1001/jama.2013.280416			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24193075				2022-12-24	WOS:000326550900007
J	Liu, SH; Brown, JD; Stanya, KJ; Homan, E; Leidl, M; Inouye, K; Bhargava, P; Gangl, MR; Dai, LL; Hatano, B; Hotamisligil, GS; Saghatelian, A; Plutzky, J; Lee, CH				Liu, Sihao; Brown, Jonathan D.; Stanya, Kristopher J.; Homan, Edwin; Leidl, Mathias; Inouye, Karen; Bhargava, Prerna; Gangl, Matthew R.; Dai, Lingling; Hatano, Ben; Hotamisligil, Goekhan S.; Saghatelian, Alan; Plutzky, Jorge; Lee, Chih-Hao			A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use	NATURE			English	Article							CIRCADIAN BEHAVIOR; ADIPOSE-TISSUE; METABOLISM; IDENTIFICATION; MASS; ALPHA; GLUCOSE; MICE	Food intake increases the activity of hepatic de novo lipogenesis, which mediates the conversion of glucose to fats for storage or use. In mice, this program follows a circadian rhythm that peaks with nocturnal feeding(1,2) and is repressed by Rev-erb alpha/beta and an HDAC3-containing complex(3-5) during the day. The transcriptional activators controlling rhythmic lipid synthesis in the dark cycle remain poorly defined. Disturbances in hepatic lipogenesis are also associated with systemic metabolic phenotypes(6-8), suggesting that lipogenesis in the liver communicates with peripheral tissues to control energy substrate homeostasis. Here we identify a PPAR delta-dependent de novo lipogenic pathway in the liver that modulates fat use by muscle via a circulating lipid. The nuclear receptor PPAR delta controls diurnal expression of lipogenic genes in the dark/feeding cycle. Liver-specific PPAR delta activation increases, whereas hepatocyte-Ppard deletion reduces, muscle fatty acid uptake. Unbiased metabolite profiling identifies phosphatidylcholine 18:0/18:1 (PC(18:0/18:1) as a serum lipid regulated by diurnal hepatic PPAR delta activity. PC(18:0/18:1) reduces postprandial lipid levels and increases fatty acid use through muscle PPAR alpha. High-fat feeding diminishes rhythmic production of PC(18:0/18:1), whereas PC(18:0/18:1) administration in db/db mice (also known as Lepr(-/-)) improves metabolic homeostasis. These findings reveal an integrated regulatory circuit coupling lipid synthesis in the liver to energy use in muscle by coordinating the activity of two closely related nuclear receptors. These data implicate alterations in diurnal hepatic PPAR delta-PC(18:0/18:1) signalling in metabolic disorders, including obesity.	[Liu, Sihao; Stanya, Kristopher J.; Inouye, Karen; Bhargava, Prerna; Gangl, Matthew R.; Dai, Lingling; Hatano, Ben; Hotamisligil, Goekhan S.; Lee, Chih-Hao] Harvard Univ, Sch Publ Hlth, Div Biol Sci, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Brown, Jonathan D.; Plutzky, Jorge] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Dept Med, Boston, MA 02115 USA; [Homan, Edwin; Leidl, Mathias; Saghatelian, Alan] Harvard Univ, Dept Chem, Cambridge, MA 02138 USA; [Dai, Lingling] Cent South Univ, XiangYa Hosp, Good Clin Practice Off, Changsha 410000, Hunan, Peoples R China; [Dai, Lingling] Cent South Univ, Inst Clin Pharmacol, Changsha 410000, Hunan, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Central South University; Central South University	Lee, CH (corresponding author), Harvard Univ, Sch Publ Hlth, Div Biol Sci, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	clee@hsph.harvard.edu	liu, sihao/A-8823-2015; Plutzky, Jorge/V-3410-2019	liu, sihao/0000-0002-4188-3693; Stanya, Kristopher/0000-0002-5369-729X	American Heart Association; American Diabetes Association; National Institutes of Health [R01DK075046, R01HL048743, K08HL105678]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, K08HL105678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. Newgard for providing shACC1 and shScramble adenovirus, U. Unluturk, X. Li and A. N. White for technical help and D. E. Cohen, S. Watkins and D. Jacobi for comments. This work is supported by the American Heart Association and the American Diabetes Association (C.-H.L.) and National Institutes of Health grants R01DK075046 (C.-H.L.), R01HL048743 (J.P.) and K08HL105678 (J.D.B.).	AGREN JJ, 1992, J LIPID RES, V33, P1871; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Brown JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021209; Brown M, 2011, BIOINFORMATICS, V27, P1108, DOI 10.1093/bioinformatics/btr079; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gillum MP, 2008, CELL, V135, P813, DOI 10.1016/j.cell.2008.10.043; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Homan EA, 2011, J AM CHEM SOC, V133, P5178, DOI 10.1021/ja111173c; Hsu FF, 1998, J AM SOC MASS SPECTR, V9, P516, DOI 10.1016/S1044-0305(98)00012-9; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kotronen A, 2010, OBESITY, V18, P937, DOI 10.1038/oby.2009.326; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Liu SH, 2011, J BIOL CHEM, V286, P1237, DOI 10.1074/jbc.M110.138115; Lobo S, 2009, J BIOL CHEM, V284, P18347, DOI 10.1074/jbc.M109.017244; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Reilly SM, 2010, CELL METAB, V12, P643, DOI 10.1016/j.cmet.2010.11.007; Ronnebaum SM, 2008, J BIOL CHEM, V283, P14248, DOI 10.1074/jbc.M800119200; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shearer J, 2005, AM J PHYSIOL-ENDOC M, V288, pE292, DOI 10.1152/ajpendo.00287.2004; Shearer J, 2008, LIPIDS, V43, P703, DOI 10.1007/s11745-008-3183-4; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Tautenhahn R, 2011, ANAL CHEM, V83, P696, DOI 10.1021/ac102980g; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319	40	156	157	3	89	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					550	+		10.1038/nature12710	http://dx.doi.org/10.1038/nature12710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24153306	Green Accepted, Green Submitted			2022-12-24	WOS:000325988400054
J	Keaney, JF; Curfman, GD; Jarcho, JA				Keaney, John F., Jr.; Curfman, Gregory D.; Jarcho, John A.			A Pragmatic View of the New Cholesterol Treatment Guidelines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								New ACC-AHA guidelines represent a substantial departure from previous recommendations for lipid management and may have a major effect on clinical practice. Overall, they will move treatment toward statins and deemphasize other agents for a broader range of patients. On November 12, 2013, updated guidelines for the treatment of high blood cholesterol levels were released by the American College of Cardiology-American Heart Association (ACC-AHA) Task Force on Practice Guidelines.(1) This update represents the first major guideline revision since the National Cholesterol Education Program released its Adult Treatment Panel III report in 2002.(2) The previous guidelines were widely accepted and applied with relative consistency. In contrast, the new guidelines have already been the subject of controversy, with some observers arguing that some elements of the recommendations are not evidence-based.(3) Nevertheless, these recommendations may have a major effect on the clinical ...	[Keaney, John F., Jr.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Keaney, JF (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.			Keaney, John/0000-0002-0866-1837				[Anonymous], 2013, PREV GUID TOOLS CV R; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Ridker PM, LANCET IN PRESS; Stone NJ, 2013, CIRCULATION	4	46	48	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2014	370	3					275	278		10.1056/NEJMms1314569	http://dx.doi.org/10.1056/NEJMms1314569			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294HK	24283199				2022-12-24	WOS:000330035600015
J	Geng, Y; Bush, M; Mosyak, L; Wang, F; Fan, QR				Geng, Yong; Bush, Martin; Mosyak, Lidia; Wang, Feng; Fan, Qing R.			Structural mechanism of ligand activation in human GABA(B) receptor	NATURE			English	Article							AMINOBUTYRIC ACID(B) RECEPTORS; PROTEIN-COUPLED RECEPTOR; N-TERMINAL DOMAIN; EXTRACELLULAR DOMAIN; GB2 SUBUNITS; GLUTAMATE; BINDING; PHARMACOLOGY; ANTAGONIST; EXPRESSION	Human GABA(B) (gamma-aminobutyric acid class B) receptor is a G-protein-coupled receptor central to inhibitory neurotransmission in the brain. It functions as an obligatory heterodimer of the subunits GBR1 and GBR2. Here we present the crystal structures of a heterodimeric complex between the extracellular domains of GBR1 and GBR2 in the apo, agonist-bound and antagonist-bound forms. The apo and antagonist-bound structures represent the resting state of the receptor; the agonist-bound complex corresponds to the active state. Both subunits adopt an open conformation at rest, and only GBR1 closes on agonist-induced receptor activation. The agonists and antagonists are anchored in the interdomain crevice of GBR1 by an overlapping set of residues. An antagonist confines GBR1 to the open conformation of the inactive state, whereas an agonist induces its domain closure for activation. Our data reveal a unique activation mechanism for GABA(B) receptor that involves the formation of a novel heterodimer interface between subunits.	[Geng, Yong; Bush, Martin; Mosyak, Lidia; Wang, Feng; Fan, Qing R.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Fan, Qing R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Fan, QR (corresponding author), Columbia Univ, Dept Pharmacol, New York, NY 10032 USA.	qf13@columbia.edu			American Heart Association [SDG0835183N]; National Institute of Health [R01GM088454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088454] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. A. Hendrickson and R. Kass for advice and support; I. Berger for the gift of pFBDM vector; K. Rajashankar, K. Perry, S. Banerjee, F. Murphy, I. Kourinov and D. Neau for help with data collection; Y. Chen for technical assistance; and M. Evelyn for reading the manuscript. This work was supported by the American Heart Association grant SDG0835183N and the National Institute of Health grant R01GM088454 (both to Q. R. F.). Q. R. F. is an Irma Hirschl Career Scientist, Pew Scholar, McKnight Scholar and Schaefer Scholar.	Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Froestl W, 2010, ADV PHARMACOL, V58, P19, DOI 10.1016/S1054-3589(10)58002-5; FRYDENVANG K, 1994, CHIRALITY, V6, P583, DOI 10.1002/chir.530060712; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Galvez T, 2000, J BIOL CHEM, V275, P41166, DOI 10.1074/jbc.M007848200; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Galvez T, 2000, MOL PHARMACOL, V57, P419, DOI 10.1124/mol.57.3.419; Geng Y, 2012, NAT NEUROSCI, V15, P970, DOI 10.1038/nn.3133; Havlickova M, 2002, MOL PHARMACOL, V62, P343, DOI 10.1124/mol.62.2.343; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kammerer RA, 1999, BIOCHEMISTRY-US, V38, P13263, DOI 10.1021/bi991018t; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kerr DIB, 1995, EUR J PHARMACOL, V287, P185, DOI 10.1016/0014-2999(95)00641-9; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; Kniazeff J, 2002, J NEUROSCI, V22, P7352; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liu JF, 2004, J BIOL CHEM, V279, P15824, DOI 10.1074/jbc.M313639200; Malitschek B, 1999, MOL PHARMACOL, V56, P448, DOI 10.1124/mol.56.2.448; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14643, DOI 10.1073/pnas.251554798; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ng GYK, 1999, J BIOL CHEM, V274, P7607, DOI 10.1074/jbc.274.12.7607; Nomura R, 2008, J BIOL CHEM, V283, P4665, DOI 10.1074/jbc.M705202200; Novotny M, 2004, PROTEINS, V54, P260, DOI 10.1002/prot.10553; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagano A, 2001, J NEUROSCI, V21, P1189; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Pin JP, 2004, BIOL CELL, V96, P335, DOI 10.1016/j.biolcel.2004.03.005; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Rondard P, 2008, EMBO J, V27, P1321, DOI 10.1038/emboj.2008.64; Roversi P, 2000, ACTA CRYSTALLOGR D, V56, P1316, DOI 10.1107/S0907444900008490; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	62	131	139	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					254	+		10.1038/nature12725	http://dx.doi.org/10.1038/nature12725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24305054	Green Accepted			2022-12-24	WOS:000328121500031
J	Alenghat, T; Osborne, LC; Saenz, SA; Kobuley, D; Ziegler, CGK; Mullican, SE; Choi, I; Grunberg, S; Sinha, R; Wynosky-Dolfi, M; Snyder, A; Giacomin, PR; Joyce, KL; Hoang, TB; Bewtra, M; Brodsky, IE; Sonnenberg, GF; Bushman, FD; Won, KJ; Lazar, MA; Artis, D				Alenghat, Theresa; Osborne, Lisa C.; Saenz, Steven A.; Kobuley, Dmytro; Ziegler, Carly G. K.; Mullican, Shannon E.; Choi, Inchan; Grunberg, Stephanie; Sinha, Rohini; Wynosky-Dolfi, Meghan; Snyder, Annelise; Giacomin, Paul R.; Joyce, Karen L.; Hoang, Tram B.; Bewtra, Meenakshi; Brodsky, Igor E.; Sonnenberg, Gregory F.; Bushman, Frederic D.; Won, Kyoung-Jae; Lazar, Mitchell A.; Artis, David			Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis	NATURE			English	Article							EXPRESSION; CELLS; HDAC3; MAINTENANCE; METABOLISM; MICROBIOTA; DISEASE; UNIFRAC; ENERGY	The development and severity of inflammatory bowel diseases and other chronic inflammatory conditions can be influenced by host genetic and environmental factors, including signals derived from commensal bacteria(1-6). However, the mechanisms that integrate these diverse cues remain undefined. Here we demonstrate that mice with an intestinal epithelial cell (IEC)-specific deletion of the epigenome-modifying enzyme histone deacetylase 3 (HDAC3(Delta IEC) mice) exhibited extensive dysregulation of IEC-intrinsic gene expression, including decreased basal expression of genes associated with antimicrobial defence. Critically, conventionally housed HDAC3(Delta IEC) mice demonstrated loss of Paneth cells, impaired IEC function and alterations in the composition of intestinal commensal bacteria. In addition, HDAC3(Delta IEC) mice showed significantly increased susceptibility to intestinal damage and inflammation, indicating that epithelial expression of HDAC3 has a central role in maintaining intestinal homeostasis. Re-derivation of HDAC3(Delta IEC) mice into germ-free conditions revealed that dysregulated IEC gene expression, Paneth cell homeostasis and intestinal barrier function were largely restored in the absence of commensal bacteria. Although the specific mechanisms through which IEC-intrinsic HDAC3 expression regulates these complex phenotypes remain to be determined, these data indicate that HDAC3 is a critical factor that integrates commensal-bacteria-derived signals to calibrate epithelial cell responses required to establish normal host-commensal relationships and maintain intestinal homeostasis.	[Alenghat, Theresa; Osborne, Lisa C.; Saenz, Steven A.; Kobuley, Dmytro; Ziegler, Carly G. K.; Grunberg, Stephanie; Sinha, Rohini; Giacomin, Paul R.; Joyce, Karen L.; Bushman, Frederic D.; Artis, David] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Alenghat, Theresa; Osborne, Lisa C.; Saenz, Steven A.; Kobuley, Dmytro; Wynosky-Dolfi, Meghan; Giacomin, Paul R.; Joyce, Karen L.; Brodsky, Igor E.; Sonnenberg, Gregory F.; Artis, David] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Alenghat, Theresa; Wynosky-Dolfi, Meghan; Snyder, Annelise; Brodsky, Igor E.; Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Mullican, Shannon E.; Lazar, Mitchell A.] Univ Penn, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Mullican, Shannon E.; Choi, Inchan; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Choi, Inchan; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Hoang, Tram B.; Bewtra, Meenakshi; Sonnenberg, Gregory F.] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Bewtra, Meenakshi] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Artis, D (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu	Osborne, Lisa/K-3027-2015; Lazar, Mitchell A/AAF-3738-2019	Osborne, Lisa/0000-0002-7170-3235; Bushman, Frederic/0000-0003-4740-4056; Giacomin, Paul/0000-0002-6326-6792; Artis, David/0000-0002-1753-4100; Won, Kyoung Jae/0000-0002-2924-9630; Ziegler, Carly/0000-0002-8279-7150	National Institutes of Health [AI061570, AI095608, AI087990, AI074878, AI095466, AI106697, AI102942, AI097333, DK043806, T32-RR007063, K08-DK093784, DP5OD012116, F31-GM082187, K08-DK084347, R21-AI105346]; Crohns and Colitis Foundation of America; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Irvington Institute Postdoctoral Fellowship of the Cancer Research Institute; Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory; NCI Comprehensive Cancer Center Support Grant [2-P30 CA016520]; National Cancer Institute; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI106697, R01AI097333, R01AI095466, R21AI087990, R01AI102942, R01AI061570, R21AI083480, U01AI095608, R21AI105346, R01AI074878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK084347, P30DK050306, R01DK043806, K08DK093784, R37DK043806, P30DK019525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM082187] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohns and Colitis Foundation of America; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Irvington Institute Postdoctoral Fellowship of the Cancer Research Institute; Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory; NCI Comprehensive Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Artis laboratory for discussions and critical reading of the manuscript. This research is supported by the National Institutes of Health (AI061570, AI095608, AI087990, AI074878, AI095466, AI106697, AI102942 and AI097333 to D. A.; DK043806 to M. A. L.; T32-RR007063, K08-DK093784 to T. A.; DP5OD012116 to G. F. S.; F31-GM082187 to S. A. S.; K08-DK084347 to M. B.; R21-AI105346 to I. E. B.), the Crohns and Colitis Foundation of America (T. A. and D. A.), the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (D. A.), and the Irvington Institute Postdoctoral Fellowship of the Cancer Research Institute (L.C.O.). We also thank S. Lukovac and R. Aoki for technical assistance, the University of Pennsylvania Matthew J. Ryan Veterinary Hospital Pathology Lab, Center for AIDS Research, the Penn Microarray Facility, the NIH/NIDDK Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306) and its core facilities (Molecular Pathology and Imaging; Molecular Biology; Cell Culture; Transgenic and Chimeric Mouse), the Functional Genomics Core of the Penn Diabetes Research Center (DRC) (P30-DK19525), the Pathology Core at the Stokes Institute, the Electron Microscopy Resource Laboratory, the Penn IBD Immunology Initiative (I<SUP>3</SUP>), and the Mucosal Immunology Studies Team (MIST) of the NIAID for sharing expertise and resources. The authors would also like to thank the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory for technical advice and support. The ACC Flow Cytometry and Cell Sorting Shared Resource is partially supported by NCI Comprehensive Cancer Center Support Grant (2-P30 CA016520). Some human tissue samples were provided by the Cooperative Human Tissue Network (funded by the National Cancer Institute).	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; Denson LA, 2013, INFLAMM BOWEL DIS, V19, P677, DOI 10.1097/MIB.0b013e31828134b3; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Donohoe DR, 2012, J CELL PHYSIOL, V227, P3169, DOI 10.1002/jcp.24054; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kim Go-Woon, 2010, Int J Cell Biol, V2010, P632739, DOI 10.1155/2010/632739; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Renz H, 2011, NAT IMMUNOL, V12, P273, DOI 10.1038/ni0411-273; Slomko H, 2012, ENDOCRINOLOGY, V153, P1025, DOI 10.1210/en.2011-1759; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476	39	151	162	4	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					153	+		10.1038/nature12687	http://dx.doi.org/10.1038/nature12687			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24185009	Green Accepted			2022-12-24	WOS:000327851700050
J	Warner, DO; Berge, K; Sun, HP; Harman, A; Hanson, A; Schroeder, DR				Warner, David O.; Berge, Keith; Sun, Huaping; Harman, Ann; Hanson, Andrew; Schroeder, Darrell R.			Substance Use Disorder Among Anesthesiology Residents, 1975-2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHEMICAL DEPENDENCY; ABUSE; PHYSICIANS; AUSTRALIA; PROGRAMS; HISTORY	IMPORTANCE Substance use disorder (SUD) among anesthesiologists and other physicians poses serious risks to both physicians and patients. Formulation of policy and individual treatment plans is hampered by lack of data regarding the epidemiology and outcomes of physician SUD. OBJECTIVE To describe the incidence and outcomes of SUD among anesthesiology residents. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of physicians who began training in United States anesthesiology residency programs from July 1, 1975, to July 1, 2009, including 44 612 residents contributing 177 848 resident-years to analysis. Follow-up for incidence and relapse was to the end of training and December 31, 2010, respectively. MAIN OUTCOMES AND MEASURES Cases of SUD (including initial SUD episode and any relapse, vital status and cause of death, and professional consequences of SUD) ascertained through training records of the American Board of Anesthesiology, including information from the Disciplinary Action Notification Service of the Federation of State Medical Boards and cause of death information from the National Death Index. RESULTS Of the residents, 384 had evidence of SUD during training, with an overall incidence of 2.16 (95% CI, 1.95-2.39) per 1000 resident-years (2.68 [95% CI, 2.41-2.98] men and 0.65 [95% CI, 0.44-0.93] women per 1000 resident-years). During the study period, an initial rate increase was followed by a period of lower rates in 1996-2002, but the highest incidence has occurred since 2003 (2.87 [95% CI, 2.42-3.39] per 1000 resident-years). The most common substance category was intravenous opioids, followed by alcohol, marijuana or cocaine, anesthetics/hypnotics, and oral opioids. Twenty-eight individuals (7.3%; 95% CI, 4.9%-10.4%) died during the training period; all deaths were related to SUD. The Kaplan-Meier estimate of the cumulative proportion of survivors experiencing at least 1 relapse by 30 years after the initial episode (based on a median follow-up of 8.9 years [interquartile range, 5.0-18.8 years]) was 43%(95% CI, 34%-51%). Rates of relapse and death did not depend on the category of substance used. Relapse rates did not change over the study period. CONCLUSIONS AND RELEVANCE Among anesthesiology residents entering primary training from 1975 to 2009, 0.86% had evidence of SUD during training. Risk of relapse over the follow-up period was high, indicating persistence of risk after training.	[Warner, David O.; Berge, Keith] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Hanson, Andrew; Schroeder, Darrell R.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Warner, David O.; Sun, Huaping; Harman, Ann] Amer Board Anesthesiol, Raleigh, NC USA	Mayo Clinic; Mayo Clinic	Warner, DO (corresponding author), Mayo Clin, Dept Anesthesiol, 200 1st St SW, Rochester, MN 55905 USA.	warner.david@mayo.edu			Mayo Foundation; National Institutes of Health Clinical and Translational Science Award at Mayo Clinic [UL1TR000135]	Mayo Foundation; National Institutes of Health Clinical and Translational Science Award at Mayo Clinic	The American Board of Anesthesiology provided support for the collection and management of the data by allowing staff time to be used for this purpose. Funds from Mayo Foundation supported the analysis of the deidentified data. The REDCap system used to abstract the data is supported by the National Institutes of Health Clinical and Translational Science Award at Mayo Clinic (grant UL1TR000135).	Alexander BH, 2000, ANESTHESIOLOGY, V93, P922, DOI 10.1097/00000542-200010000-00008; Berge KH, 2008, ANESTHESIOLOGY, V109, P762, DOI 10.1097/ALN.0b013e31818a3814; Berge KH, 2009, MAYO CLIN PROC, V84, P625, DOI 10.1016/S0025-6196(11)60751-9; Booth JV, 2002, ANESTH ANALG, V95, P1024, DOI 10.1213/01.ANE.0000026379.66419.DB; Bryson EO, 2009, J CLIN ANESTH, V21, P508, DOI 10.1016/j.jclinane.2008.12.026; Carinci AJ, 2009, PAIN PHYSICIAN, V12, P487; Collins GB, 2005, ANESTH ANALG, V101, P1457, DOI 10.1213/01.ANE.0000180837.78169.04; Domino KB, 2005, JAMA-J AM MED ASSOC, V293, P1453, DOI 10.1001/jama.293.12.1453; DuPont RL, 2009, J SUBST ABUSE TREAT, V37, P1, DOI 10.1016/j.jsat.2009.03.010; Fry RA, 2005, ANAESTH INTENS CARE, V33, P248, DOI 10.1177/0310057X0503300216; GRAVENSTEIN JS, 1983, ANESTH ANALG, V62, P467; HUGHES PH, 1992, AM J PSYCHIAT, V149, P1348; HUGHES PH, 1992, JAMA-J AM MED ASSOC, V267, P2333, DOI 10.1001/jama.267.17.2333; KLEIN RL, 1992, ANESTHESIOLOGY, V77, P806, DOI 10.1097/00000542-199210000-00026; LUTSKY I, 1993, CAN J ANAESTH, V40, P915, DOI 10.1007/BF03010092; McLellan AT, 2008, BMJ-BRIT MED J, V4, P337; MENK EJ, 1990, JAMA-J AM MED ASSOC, V263, P3060, DOI 10.1001/jama.263.22.3060; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; National Center on Addiction and Substance Abuse (CASA) at Columbia University, 2012, ADD MED CLOS GAP SCI; Oreskovich MR, 2009, MAYO CLIN PROC, V84, P576, DOI 10.1016/S0025-6196(11)60745-3; PELTON C, 1991, J PSYCHOACTIVE DRUGS, V23, P427, DOI 10.1080/02791072.1991.10471613; Skipper GE, 2009, ANESTH ANALG, V109, P891, DOI 10.1213/ane.0b013e3181adc39d; TALBOTT GD, 1987, JAMA-J AM MED ASSOC, V257, P2927, DOI 10.1001/jama.257.21.2927; WEEKS AM, 1993, ANAESTH INTENS CARE, V21, P151, DOI 10.1177/0310057X9302100203; Wilson JE, 2008, ANAESTHESIA, V63, P616, DOI 10.1111/j.1365-2044.2008.05444.x; Wischmeyer PE, 2007, ANESTH ANALG, V105, P1066, DOI 10.1213/01.ane.0000270215.86253.30	26	63	64	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	2013	310	21					2289	2296		10.1001/jama.2013.281954	http://dx.doi.org/10.1001/jama.2013.281954			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	262OV	24302092	Green Accepted, Bronze			2022-12-24	WOS:000327746300014
J	Zumla, A; George, A; Sharma, V; Herbert, N; Masham, B				Zumla, Alimuddin; George, Andrew; Sharma, Virendra; Herbert, Nick; Masham, Baroness			WHO's 2013 global report on tuberculosis: successes, threats, and opportunities	LANCET			English	Editorial Material							DIAGNOSTICS; CHALLENGES		[Zumla, Alimuddin] UCL, Div Infect & Immun, London NW3 2PF, England; [Zumla, Alimuddin] Univ Coll London Hosp NHS Fdn Trust, London NW3 2PF, England; [George, Andrew; Sharma, Virendra; Herbert, Nick; Masham, Baroness] Houses Parliament, All Party Parliamentary Grp Global TB, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Zumla, A (corresponding author), UCL, Div Infect & Immun, UCL Royal Free Campus, London NW3 2PF, England.	a.zumla@ucl.ac.uk	Oliveira, Claudia DL/G-8618-2011; ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735				Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, MDG 6 COMB HIV AIDS; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	10	153	164	1	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1765	1767		10.1016/S0140-6736(13)62078-4	http://dx.doi.org/10.1016/S0140-6736(13)62078-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259QF	24269294				2022-12-24	WOS:000327540700010
J	Doshi, P				Doshi, Peter			HIDDEN DATA Putting GlaxoSmithKline to the test over paroxetine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-TRIALS; MAJOR DEPRESSION					pdoshi@bmj.com						[Anonymous], 2013, FOX BUSINESS    1010; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; GlaxoSmithKline, DAT SHAR AGR; Hawkes N., 2013, BMJ-BRIT MED J, V347, pf5390; Jureidini J, 2003, J AM ACAD CHILD PSY, V42, P514, DOI 10.1097/01.CHI.0000046825.95464.DA; Jureidini JN, 2008, INT J RISK SAF MED, V29, P73, DOI DOI 10.3233/JRS-2008-0426; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Kmietowicz Z, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f819; Mello MM, 2013, NEW ENGL J MED, V369, P1651, DOI 10.1056/NEJMhle1309073; Newman M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6985; Nisen P, 2013, NEW ENGL J MED, V369, P475, DOI 10.1056/NEJMsr1302541; Olfson M, 2008, ARCH GEN PSYCHIAT, V65, P94, DOI 10.1001/archgenpsychiatry.2007.5; Shannon J., 2013, HUFFINGTON POST; US Department of Justice, 2012, GLAXOSMITHKLINE PLEA; Vallance P, 2013, LANCET, V382, P1073, DOI 10.1016/S0140-6736(13)62001-2; Zito JM, 2002, PEDIATRICS, V109, P721, DOI 10.1542/peds.109.5.721	16	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2013	347								f6754	10.1136/bmj.f6754	http://dx.doi.org/10.1136/bmj.f6754			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254FR	24222673				2022-12-24	WOS:000327150600014
J	Briggs, ADM; Mytton, OT; Kehlbacher, A; Tiffin, R; Rayner, M; Scarborough, P				Briggs, Adam D. M.; Mytton, Oliver T.; Kehlbacher, Ariane; Tiffin, Richard; Rayner, Mike; Scarborough, Peter			Overall and income specific effect on prevalence of overweight and obesity of 20% sugar sweetened drink tax in UK: econometric and comparative risk assessment modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-WEIGHT; BEVERAGE CONSUMPTION; REDUCE CONSUMPTION; FOOD-PRICES; HEALTH; DEMAND; IMPACT; INTERVENTION; STRATEGIES; NUTRITION	Objective To model the overall and income specific effect of a 20% tax on sugar sweetened drinks on the prevalence of overweight and obesity in the UK. Design Econometric and comparative risk assessment modelling study. Setting United Kingdom. Population Adults aged 16 and over. Intervention A 20% tax on sugar sweetened drinks. Main outcome measures The primary outcomes were the overall and income specific changes in the number and percentage of overweight (body mass index >= 25) and obese (>= 30) adults in the UK following the implementation of the tax. Secondary outcomes were the effect by age group (16-29, 30-49, and >= 50 years) and by UK constituent country. The revenue generated from the tax and the income specific changes in weekly expenditure on drinks were also estimated. Results A 20% tax on sugar sweetened drinks was estimated to reduce the number of obese adults in the UK by 1.3% (95% credible interval 0.8% to 1.7%) or 180 000 (110 000 to 247 000) people and the number who are overweight by 0.9% (0.6% to 1.1%) or 285 000 (201 000 to 364 000) people. The predicted reductions in prevalence of obesity for income thirds 1 (lowest income), 2, and 3 (highest income) were 1.3% (0.3% to 2.0%), 0.9% (0.1% to 1.6%), and 2.1% (1.3% to 2.9%). The effect on obesity declined with age. Predicted annual revenue was 276m pound (272m pound to 279m) pound, with estimated increases in total expenditure on drinks for income thirds 1, 2, and 3 of 2.1% (1.4% to 3.0%), 1.7% (1.2% to 2.2%), and 0.8% (0.4% to 1.2%). Conclusions A 20% tax on sugar sweetened drinks would lead to a reduction in the prevalence of obesity in the UK of 1.3% (around 180 000 people). The greatest effects may occur in young people, with no significant differences between income groups. Both effects warrant further exploration. Taxation of sugar sweetened drinks is a promising population measure to target population obesity, particularly among younger adults.	[Briggs, Adam D. M.; Mytton, Oliver T.; Rayner, Mike; Scarborough, Peter] Univ Oxford, Nuffield Dept Populat Hlth, British Heart Fdn, Hlth Promot Res Grp, Oxford OX3 7LF, England; [Mytton, Oliver T.] UK Hlth Forum, London WC1B 4AD, England; [Kehlbacher, Ariane; Tiffin, Richard] Univ Reading, Ctr Food Secur, Reading RG6 6AR, Berks, England	University of Oxford; University of Reading	Rayner, M (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, British Heart Fdn, Hlth Promot Res Grp, Oxford OX3 7LF, England.	mike.rayner@dph.ox.ac.uk	Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Mytton, Oliver/0000-0003-3218-9912; Tiffin, Richard/0000-0002-4455-5572; Briggs, Adam/0000-0002-2314-1039	British Heart Foundation; National Institute for Health Research; MRC [G0701865] Funding Source: UKRI; Medical Research Council [G0701865] Funding Source: researchfish; National Institute for Health Research [ACF-2011-13-012, ACF-2010-13-011] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	No explicit funding for this work was sought. MR and PS are funded by the British Heart Foundation. ADMB and OTM are National Institute for Health Research funded academic clinical fellows in public health.	Academy of Medical Royal Colleges, 2013, MEAS MED PROF PRESCR; Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; [Anonymous], 2013, DRAFT SCI OP REEV AS; [Anonymous], 2011, HLTH SURV NO IR 1 RE; [Anonymous], 2013, GUARDIAN; Armfield JM, 2013, AM J PUBLIC HEALTH, V103, P494, DOI 10.2105/AJPH.2012.300889; Bahl R., 2003, PUBLIC FINANCE REV, V31; Berardi N., 2012, IMPACT SODA TAX PRIC; Block JP, 2010, AM J PUBLIC HEALTH, V100, P1427, DOI 10.2105/AJPH.2009.175687; BLUNDELL R, 1987, J ECONOMETRICS, V34, P179, DOI 10.1016/0304-4076(87)90072-8; Briggs A., 2012, PROPOSED SUGAR SWEET, P116; British Heart Foundation Health Promotion Research Group, 2012, COR HEART DIS STAT C; British Soft Drinks Association, 2012, LONG TERM COMM LONG; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Christiansen E, 2002, EUR J CLIN INVEST, V32, P826, DOI 10.1046/j.1365-2362.2002.01036.x; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; DEATON A, 1980, AM ECON REV, V70, P312; Department for Environment Food and Rural Affairs, 2010, EXP HOUS EAT OUT FOO; Department for Environment Food and Rural Affairs, 2011, FAM FOOD DAT UK HOUS; Department for the Environment Food and Rural Affairs, 2011, LIV COSTS FOOD SURV; Dharmasena S, 2012, HEALTH ECON, V21, P669, DOI 10.1002/hec.1738; Duffey KJ, 2010, ARCH INTERN MED, V170, P420, DOI 10.1001/archinternmed.2009.545; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Edgerton DL, 1997, AM J AGR ECON, V79, P62, DOI 10.2307/1243943; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449; Finkelstein EA, 2013, J HEALTH ECON, V32, P219, DOI 10.1016/j.jhealeco.2012.10.005; Green R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3703; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Kim D, 2006, AM J PREV MED, V30, P430, DOI 10.1016/j.amepre.2005.12.007; Kosinska M, 2011, OPEN LETT; Lentschner K, 2012, FIGARO; Lin BH, 2011, ECON HUM BIOL, V9, P329, DOI 10.1016/j.ehb.2011.08.007; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Meier PS, 2013, ALCOHOL ALCOHOLISM, V48, P241, DOI 10.1093/alcalc/agt001; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; NatCen Social Research and Royal Free and University College Medical School. Department of Epidemiology and Public Health Health Survey for England, 2010, HLTH SURV ENGL 2010; National Centre for Social Research. National Diet and Nutrition Survey, 2008, NUTR DIET NUTR SURV; National Centre for Social Research Welsh Health Survey, 2010, WELSH HLTH SURV 2010; National Records of Scotland, 2012, CENS DAY US RES POP; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Nichols M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000957; Northern Ireland Neighbourhood Information Service, 2011, CENS 2011 NO IR; Office for National Statistics, 2012, POP EST ENGL WAL MID; Pomeranz JL, 2012, J PUBLIC HEALTH POL, V33, P75, DOI 10.1057/jphp.2011.46; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Scarborough P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000263; Scarborough P, 2011, BRIT J NUTR, V105, P1399, DOI 10.1017/S0007114510005076; ScotCen Social Research and University College London. Department of Epidemiology and Public Health Scottish Health Survey, 2010, SCOTT HLTH SURV 2010; Shiely F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-560; Sustain, 2013, CHILDR FUT FUND FOOD; TANNER MA, 1987, J AM STAT ASSOC, V82, P528, DOI 10.2307/2289457; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Waterlander WE, 2013, AM J CLIN NUTR, V97, P886, DOI 10.3945/ajcn.112.041632; Wojcicki JM, 2013, ACTA PAEDIATR, V102, P560, DOI 10.1111/apa.12216; Zhen C, 2013, AM J AGR EC	61	109	109	0	101	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2013	347								f6189	10.1136/bmj.f6189	http://dx.doi.org/10.1136/bmj.f6189			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247EX	24179043	hybrid, Green Published, Green Accepted			2022-12-24	WOS:000326599700003
J	Jaramillo, E; Tan, A; Yang, L; Kuo, YF; Goodwin, JS				Jaramillo, Elizabeth; Tan, Alai; Yang, Liu; Kuo, Yong-Fang; Goodwin, James S.			Variation Among Primary Care Physicians in Prostate-Specific Antigen Screening of Older Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							QUALITY INDICATORS		[Jaramillo, Elizabeth; Tan, Alai; Yang, Liu; Kuo, Yong-Fang; Goodwin, James S.] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Goodwin, JS (corresponding author), Univ Texas Med Branch, Sealy Ctr Aging, 301 Univ Blvd, Galveston, TX 77555 USA.	jsgoodwi@utmb.edu			NATIONAL CANCER INSTITUTE [K05CA134923] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER; AHRQ HHS [R24 HS022134] Funding Source: Medline; NCATS NIH HHS [UL1 TR000071, UL1TR00007] Funding Source: Medline; NCI NIH HHS [K05CA134923, K05 CA134923] Funding Source: Medline; NIA NIH HHS [P30 AG024832] Funding Source: Medline; PHS HHS [R24H5022134] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Atlas SJ, 2006, J GEN INTERN MED, V21, P973, DOI 10.1007/BF02743147; Goodwin JS, 2013, JNCI-J NATL CANCER I, V105, P743, DOI 10.1093/jnci/djt039; Lee SJ, 2011, JAMA-J AM MED ASSOC, V306, P1481, DOI 10.1001/jama.2011.1418; Singal AK, 2013, HEALTH SERV RES, V48, P95, DOI 10.1111/j.1475-6773.2012.01433.x; Tan A, 2013, J AM GERIATR SOC, V61, P380, DOI 10.1111/jgs.12151; Walter LC, 2006, JAMA-J AM MED ASSOC, V296, P2336, DOI 10.1001/jama.296.19.2336	6	28	29	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 16	2013	310	15					1622	1624		10.1001/jama.2013.277514	http://dx.doi.org/10.1001/jama.2013.277514			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EP	24129467	Green Accepted			2022-12-24	WOS:000325624800026
J	Yamaguchi, S; Shen, L; Liu, YT; Sendler, D; Zhang, Y				Yamaguchi, Shinpei; Shen, Li; Liu, Yuting; Sendler, Damian; Zhang, Yi			Role of Tet1 in erasure of genomic imprinting	NATURE			English	Article							PRIMORDIAL GERM-CELLS; DNA METHYLATION; POSTNATAL-DEVELOPMENT; GENE; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; DYNAMICS; 5-METHYLCYTOSINE; DEFICIENCY; EXPRESSION	Genomic imprinting is an allele-specific gene expression system that is important for mammalian development and function(1). The molecular basis of genomic imprinting is allele-specific DNA methylation(1,2). Although it is well known that the de novo DNA methyltransferases Dnmt3a and Dnmt3b are responsible for the establishment of genomic imprinting(3), how the methylation mark is erased during primordial germ cell (PGC) reprogramming remains unclear. Tet1 is one of the ten-eleven translocation family proteins, which have the capacity to oxidize 5-methylcytosine (5mC)(4-6), specifically expressed in reprogramming PGCs(7). Here we report that Tet1 has a critical role in the erasure of genomic imprinting. We show that despite their identical genotype, progenies derived from mating between Tet1 knockout males and wild-type females exhibit a number of variable phenotypes including placental, fetal and postnatal growth defects, and early embryonic lethality. These defects are, at least in part, caused by the dysregulation of imprinted genes, such as Peg10 and Peg3, which exhibit aberrant hypermethylation in the paternal allele of differential methylated regions (DMRs). RNA-seq reveals extensive dysregulation of imprinted genes in the next generation due to paternal loss of Tet1 function. Genome-wide DNA methylation analysis of embryonic day 13.5 PGCs and sperm of Tet1 knockout mice revealed hypermethylation of DMRs of imprinted genes in sperm, which can be traced back to PGCs. Analysis of the DNA methylation dynamics in reprogramming PGCs indicates that Tet1 functions to wipe out remaining methylation, including imprinted genes, at the late reprogramming stage. Furthermore, we provide evidence supporting the role of Tet1 in the erasure of paternal imprints in the female germ line. Thus, our study establishes a critical function of Tet1 in the erasure of genomic imprinting.	[Yamaguchi, Shinpei; Shen, Li; Liu, Yuting; Sendler, Damian; Zhang, Yi] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Yamaguchi, Shinpei; Liu, Yuting; Zhang, Yi] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yamaguchi, Shinpei; Liu, Yuting; Zhang, Yi] Boston Childrens Hosp, Dept Pediat, Div Hematol Oncol, Boston, MA 02115 USA; [Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Yi] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University	Zhang, Y (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.	yzhang@genetics.med.harvard.edu		Zhang, Yi/0000-0002-2789-0811; Yamaguchi, Shinpei/0000-0002-9377-4835	NIH [U01DK089565]; Japan Society for the Promotion of Science (JSPS); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W. Jiang for help with FACS sorting of PGCs; A. Inoue, S. Matoba and D. Cai for critical reading of the manuscript. This project is supported by NIH U01DK089565 (to Y.Z.). S.Y. is supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science (JSPS). Y.Z. is an investigator of the Howard Hughes Medical Institute.	Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Blake JA, 2009, NUCLEIC ACIDS RES, V37, pD712, DOI 10.1093/nar/gkn886; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kobayashi H, 2006, CYTOGENET GENOME RES, V113, P130, DOI 10.1159/000090824; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Piccolo FM, 2013, MOL CELL, V49, P1023, DOI 10.1016/j.molcel.2013.01.032; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shen L, 2013, CURR OPIN CELL BIOL, V25, P289, DOI 10.1016/j.ceb.2013.02.017; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Yamaguchi S, 2013, CELL RES, V23, P329, DOI 10.1038/cr.2013.22; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709	30	153	164	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					460	+		10.1038/nature12805	http://dx.doi.org/10.1038/nature12805			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24291790	Green Accepted, Green Submitted			2022-12-24	WOS:000328575300057
J	Zhang, YB; Wong, CH; Birnbaum, RY; Li, GL; Favaro, R; Ngan, CY; Lim, J; Tai, E; Poh, HM; Wong, E; Mulawadi, FH; Sung, WK; Nicolis, S; Ahituv, N; Ruan, YJ; Wei, CL				Zhang, Yubo; Wong, Chee-Hong; Birnbaum, Ramon Y.; Li, Guoliang; Favaro, Rebecca; Ngan, Chew Yee; Lim, Joanne; Tai, Eunice; Poh, Huay Mei; Wong, Eleanor; Mulawadi, Fabianus Hendriyan; Sung, Wing-Kin; Nicolis, Silvia; Ahituv, Nadav; Ruan, Yijun; Wei, Chia-Lin			Chromatin connectivity maps reveal dynamic promoter-enhancer long-range associations	NATURE			English	Article							NEURAL STEM-CELLS; REGULATORY SEQUENCES; GENE-EXPRESSION; MOUSE; PLURIPOTENT; VERTEBRATE; CIRCUITRY	In multicellular organisms, transcription regulation is one of the central mechanisms modelling lineage differentiation and cell-fate determination(1). Transcription requires dynamic chromatin configurations between promoters and their corresponding distal regulatory elements(2). It is believed that their communication occurs within large discrete foci of aggregated RNA polymerases termed transcription factories in three-dimensional nuclear space(3). However, the dynamic nature of chromatin connectivity has not been characterized at the genome-wide level. Here, through a chromatin interaction analysis with paired-end tagging approach(3-5) using an antibody that primarily recognizes the pre-initiation complexes of RNA polymerase II6, we explore the transcriptional interactomes of three mouse cells of progressive lineage commitment, including pluripotent embryonic stem cells(7), neural stem cells(8) and neurosphere stem/progenitor cells(9). Our global chromatin connectivity maps reveal approximately 40,000 long-range interactions, suggest precise enhancer-promoter associations and delineate cell-type-specific chromatin structures. Analysis of the complex regulatory repertoire shows that there are extensive colocalizations among promoters and distal-acting enhancers. Most of the enhancers associate with promoters located beyond their nearest active genes, indicating that the linear juxtaposition is not the only guiding principle driving enhancer target selection. Although promoter-enhancer interactions exhibit high cell-type specificity, promoters involved in interactions are found to be generally common and mostly active among different cells. Chromatin connectivity networks reveal that the pivotal genes of reprogramming functions are transcribed within physical proximity to each other in embryonic stem cells, linking chromatin architecture to coordinated gene expression. Our study sets the stage for the full-scale dissection of spatial and temporal genome structures and their roles in orchestrating development.	[Zhang, Yubo; Wong, Chee-Hong; Ngan, Chew Yee; Wei, Chia-Lin] Lawrence Berkeley Natl Lab, Joint Genome Inst, Sequencing Technol Grp, Walnut Creek, CA 94598 USA; [Birnbaum, Ramon Y.; Ahituv, Nadav] UCSF, Inst Human Genet, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Li, Guoliang; Ruan, Yijun] Univ Connecticut, Jackson Lab Genom Med, Farmington, CT 06030 USA; [Li, Guoliang; Ruan, Yijun] Univ Connecticut, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Li, Guoliang; Lim, Joanne; Tai, Eunice; Poh, Huay Mei; Wong, Eleanor; Mulawadi, Fabianus Hendriyan; Sung, Wing-Kin; Wei, Chia-Lin] Genome Inst Singapore, Singapore 138672, Singapore; [Favaro, Rebecca; Nicolis, Silvia] Univ Milano Bicocca, Dept Biol Sci & Biotechnol, I-20126 Milan, Italy	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; Jackson Laboratory; University of Connecticut; University of Connecticut; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Milano-Bicocca	Wei, CL (corresponding author), Lawrence Berkeley Natl Lab, Joint Genome Inst, Sequencing Technol Grp, Walnut Creek, CA 94598 USA.	cwei@lbl.gov	Favaro, Rebecca/HHZ-8978-2022; Li, Guoliang/D-8014-2012	Favaro, Rebecca/0000-0002-6195-5711; Li, Guoliang/0000-0003-1601-6640; NICOLIS, SILVIA KIRSTEN/0000-0003-0378-3808; Zhang, Yubo/0000-0002-4121-8853; Ahituv, Nadav/0000-0002-7434-8144; Sung, Wing-Kin/0000-0001-7806-7086; Wong, Eleanor/0000-0001-7094-7679; Birnbaum, Ramon/0000-0002-3792-1095; ngan, chew yee/0000-0001-6055-1072	ASTIL Regione Lombardia (SAL-19) [16874]; Telethon [GGP12152]; Cariplo [2010-0673]; AIRC [IG-5801]; NINDS [R01NS079231]; NICHD [R01HD059862]; NHGRI [R01HG005058, R01HG006768]; NIDDK [R01DK090382]; NIGMS [GM61390]; Simons Foundation SFARI [256769]; UCSF Program for Biomedical Breakthrough Research (PBBR); Agency for Science, Technology and Research (A*STAR), Singapore; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; National Institutes of Health ENCODE [R01 HG004456-01, R01HG003521-01, 1U54HG004557-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005058, R01HG004456, U54HG004557, R01HG006768, R01HG003521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061390, U01GM061390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079231] Funding Source: NIH RePORTER	ASTIL Regione Lombardia (SAL-19); Telethon(Fondazione Telethon); Cariplo(Fondazione Cariplo); AIRC(Fondazione AIRC per la ricerca sul cancro); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Simons Foundation SFARI; UCSF Program for Biomedical Breakthrough Research (PBBR); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health ENCODE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank J. Mariani for the preparation of RNA from NPC; K. Murphy and A. Ku for their assistance with zebrafish enhancer assays; and A. Visel and A. Nord for discussion and their comments on the manuscript. S.N. and R. F. were supported by grants from ASTIL Regione Lombardia (SAL-19 ref. no. 16874), Telethon (GGP12152), Cariplo (Rif. 2010-0673) and AIRC (IG-5801). N.A. is supported by NINDS grant number R01NS079231, NICHD grant number R01HD059862, NHGRI grant numbers R01HG005058 and R01HG006768, NIDDK award number R01DK090382, NIGMS award number GM61390 and Simons Foundation SFARI no. 256769. R.Y.B. is supported by NINDS grant number R01NS079231 and the UCSF Program for Biomedical Breakthrough Research (PBBR). This work was supported by Agency for Science, Technology and Research (A*STAR), Singapore, the Office of Science of the U.S. Department of Energy under contract no. DE-AC02-05CH11231 and National Institutes of Health ENCODE grants (R01 HG004456-01, R01HG003521-01 and 1U54HG004557-01) to Y.R. and C.-L.W.	Bastian M., 2009, P 3 INT C WEBLOGS SO, DOI DOI 10.13140/2.1.1341.1520; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bolli N, 2010, BLOOD, V115, P3329, DOI 10.1182/blood-2009-02-207225; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zappone MV, 2000, DEVELOPMENT, V127, P2367	30	294	305	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					306	+		10.1038/nature12716	http://dx.doi.org/10.1038/nature12716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24213634	Green Accepted			2022-12-24	WOS:000328121500042
J	Chinthapalli, K				Chinthapalli, Krishna			HEADS UP Dethroning the king of condiments	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE; DIETARY-SODIUM; SALT; METAANALYSIS; HYPERTENSION; SCIENCE; TRIALS; HEALTH					kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Alderman MH, 2010, JAMA-J AM MED ASSOC, V303, P448, DOI 10.1001/jama.2010.69; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; ELLIOTT P, 1988, BRIT MED J, V297, P319; Graudal N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2741; Graudal NA, 2012, AM J HYPERTENS, V25, P1, DOI 10.1038/ajh.2011.210; Hamlyn JM, 2013, CURR OPIN NEPHROL HY, V22, P51, DOI 10.1097/MNH.0b013e32835b36ec; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Moss Michael, 2010, NY TIMES; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SMITH WCS, 1988, BRIT MED J, V297, P329, DOI 10.1136/bmj.297.6644.329; SWALES JD, 1988, BRIT MED J, V297, P307, DOI 10.1136/bmj.297.6644.307; Taubes C, 1998, SCIENCE, V281, P898, DOI 10.1126/science.281.5379.898; TAUBES G, 1998, SCIENCE, V281, P903; Taubes G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1050; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115	15	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2013	347								f7192	10.1136/bmj.f7192	http://dx.doi.org/10.1136/bmj.f7192			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268DN	24307726				2022-12-24	WOS:000328148900015
J	Thammavongsa, V; Missiakas, DM; Schneewind, O				Thammavongsa, Vilasack; Missiakas, Dominique M.; Schneewind, Olaf			Staphylococcus aureus Degrades Neutrophil Extracellular Traps to Promote Immune Cell Death	SCIENCE			English	Article							ACTIVATION; EXPRESSION; APOPTOSIS; VIRULENCE; TOXICITY	Bacterial invasion of host tissues triggers polymorphonuclear leukocytes to release DNA [neutrophil extracellular traps (NETs)], thereby immobilizing microbes for subsequent clearance by innate defenses including macrophage phagocytosis. We report here that Staphylococcus aureus escapes these defenses by converting NETs to deoxyadenosine, which triggers the caspase-3-mediated death of immune cells. Conversion of NETs to deoxyadenosine requires two enzymes, nuclease and adenosine synthase, that are secreted by S. aureus and are necessary for the exclusion of macrophages from staphylococcal abscesses. Thus, the pathogenesis of S. aureus infections has evolved to anticipate host defenses and to repurpose them for the destruction of the immune system.	[Thammavongsa, Vilasack; Missiakas, Dominique M.; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu			National Institute of Allergy and Infectious Diseases [AI038897, AI052474, AI057153]; American Heart Association [POST4590023]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052474, T32AI007090, R01AI038897, U54AI057153] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. D. Sauer for macrophages. This work was supported by grants from the National Institute of Allergy and Infectious Diseases (AI038897, AI052474, and AI057153) and the American Heart Association (POST4590023). We declare no conflicting financial interests. V. T. performed experiments; V. T., D. M. M., and O.S. interpreted data, designed experiments, and wrote the paper.	Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Bestebroer J, 2009, BLOOD, V113, P328, DOI 10.1182/blood-2008-04-153882; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; CARSON DA, 1979, P NATL ACAD SCI USA, V76, P2430, DOI 10.1073/pnas.76.5.2430; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Franco R, 2007, CRIT REV IMMUNOL, V27, P495, DOI 10.1615/CritRevImmunol.v27.i6.10; GIBLETT ER, 1972, LANCET, V2, P1067; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; KREDICH NM, 1977, CELL, V12, P931, DOI 10.1016/0092-8674(77)90157-X; Laarman AJ, 2012, EMBO J, V31, P3607, DOI 10.1038/emboj.2012.212; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Niitsu N, 1998, BLOOD, V92, P3368, DOI 10.1182/blood.V92.9.3368.421k27_3368_3375; REDDI KK, 1960, NATURE, V187, P74, DOI 10.1038/187074a0; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Thammavongsa V, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-56; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097	20	243	259	5	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					863	866		10.1126/science.1242255	http://dx.doi.org/10.1126/science.1242255			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233725	Green Accepted			2022-12-24	WOS:000326923000040
J	Sen, M; Maillard, RA; Nyquist, K; Rodriguez-Aliaga, P; Presse, S; Martin, A; Bustamante, C				Sen, Maya; Maillard, Rodrigo A.; Nyquist, Kristofor; Rodriguez-Aliaga, Piere; Presse, Steve; Martin, Andreas; Bustamante, Carlos			The ClpXP Protease Unfolds Substrates Using a Constant Rate of Pulling but Different Gears	CELL			English	Article							HOMOMERIC RING ATPASE; AAA PLUS MOTORS; OPERATING PRINCIPLES; MACHINE; DEGRADATION; MOLECULE; FORCE; MECHANOCHEMISTRY; TRANSLOCATION; COORDINATION	ATP-dependent proteases are vital to maintain cellular protein homeostasis. Here, we study the mechanisms of force generation and intersubunit coordination in the ClpXP protease from E. coli to understandhowthesemachines couple ATPhydrolysis to mechanical protein unfolding. Single-molecule analyses reveal that phosphate release is the forcegenerating step in the ATP-hydrolysis cycle and that ClpXP translocates substrate polypeptides in bursts resulting from highly coordinated conformational changes in two to four ATPase subunits. ClpXP must use its maximum successive firing capacity of four subunits to unfold stable substrates like GFP. The average dwell duration between individual bursts of translocation is constant, regardless of the number of translocating subunits, implying that ClpXP operates with constant "rpm" but uses different "gears."	[Sen, Maya; Maillard, Rodrigo A.; Rodriguez-Aliaga, Piere; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Sen, Maya; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Maillard, Rodrigo A.; Nyquist, Kristofor; Rodriguez-Aliaga, Piere; Martin, Andreas; Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Nyquist, Kristofor; Rodriguez-Aliaga, Piere] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Martin, Andreas; Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Presse, Steve] Indiana Univ Purdue Univ, Dept Phys, Indianapolis, IN 46202 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Indiana University System; Indiana University-Purdue University Indianapolis	Martin, A (corresponding author), Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA.	a.martin@berkeley.edu; carlos@alice.berkeley.edu	Rodriguez-Aliaga, Piere/HHS-8446-2022	Rodriguez-Aliaga, Piere/0000-0002-3828-4235; Bustamante, Carlos/0000-0002-2970-0073; Martin, Andreas/0000-0003-0923-3284	NSF; Searle Scholars Program; NIH [R01-GM094497-01A1, R01-GM0325543]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-05CH11231]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790, T32GM008295, R01GM032543, R01GM071552, R01GM094497] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Searle Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Shixin Liu, Gheorghe Chistol, Ninning Liu, Christian Kaiser, and Mary Matyskiela for helpful discussions. M.S. and K.N. acknowledge support from the NSF Graduate Research Fellowship. This research was supported in part by the Searle Scholars Program (A.M.), the NIH grant R01-GM094497-01A1 (A.M.), the NIH grant R01-GM0325543 (C.B.), the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under contract no. DE-AC02-05CH11231 (C.B.), and the Howard Hughes Medical Institute (C.B.).	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Chistol G, 2012, CELL, V151, P1017, DOI 10.1016/j.cell.2012.10.031; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hwang W, 2013, CELL MOL BIOENG, V6, P65, DOI 10.1007/s12195-012-0264-5; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kalafut B, 2008, COMPUT PHYS COMMUN, V179, P716, DOI 10.1016/j.cpc.2008.06.008; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	33	96	96	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					636	646		10.1016/j.cell.2013.09.022	http://dx.doi.org/10.1016/j.cell.2013.09.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243020	Bronze, Green Accepted			2022-12-24	WOS:000326571800017
J	Park, E; Menetret, JF; Gumbart, JC; Ludtke, SJ; Li, WK; Whynot, A; Rapoport, TA; Akey, CW				Park, Eunyong; Menetret, Jean-Francois; Gumbart, James C.; Ludtke, Steven J.; Li, Weikai; Whynot, Andrew; Rapoport, Tom A.; Akey, Christopher W.			Structure of the SecY channel during initiation of protein translocation	NATURE			English	Article							ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; MESSENGER-RNA; ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; RIBOSOME BINDING; ER MEMBRANE; COMPLEX; INSERTION; VISUALIZATION	Many secretory proteins are targeted by signal sequences to a protein-conducting channel, formed by prokaryotic SecY or eukaryotic Sec61 complexes, and are translocated across the membrane during their synthesis(1,2). Crystal structures of the inactive channel show that the SecY subunit of the heterotrimeric complex consists of two halves that form an hourglass-shaped pore with a constriction in the middle of the membrane and a lateral gate that faces the lipid phase(3-5). The closed channel has an empty cytoplasmic funnel and an extracellular funnel that is filled with a small helical domain, called the plug. During initiation of translocation, a ribosome-nascent chain complex binds to the SecY (or Sec61) complex, resulting in insertion of the nascent chain. However, the mechanism of channel opening during translocation is unclear. Here we have addressed this question by determining structures of inactive and active ribosome-channel complexes with cryo-electron microscopy. Non-translating ribosome-SecY channel complexes derived from Methanocaldococcus jannaschii or Escherichia coli show the channel in its closed state, and indicate that ribosome binding per se causes only minor changes. The structure of an active E. coli ribosome-channel complex demonstrates that the nascent chain opens the channel, causing mostly rigid body movements of the amino- and carboxy-terminal halves of SecY. In this early translocation intermediate, the polypeptide inserts as a loop into the SecY channel with the hydrophobic signal sequence intercalated into the open lateral gate. The nascent chain also forms a loop on the cytoplasmic surface of SecY rather than entering the channel directly.	[Park, Eunyong; Li, Weikai; Whynot, Andrew; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Park, Eunyong; Li, Weikai; Whynot, Andrew; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Menetret, Jean-Francois; Akey, Christopher W.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Gumbart, James C.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Ludtke, Steven J.] Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Boston University; University System of Georgia; Georgia Institute of Technology; Baylor College of Medicine	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	Tom_Rapoport@hms.harvard.edu; cakey@bu.edu	Ludtke, Steven/A-4478-2008	Ludtke, Steven/0000-0002-1903-1574; Akey, Christopher/0000-0002-3059-3121	National Institutes of Health [GM067887, GM080139, GM052586, GM45377]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL097083, K99HL097083, R01HL121718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080139, R01GM052586, R01GM045377, R01GM067887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Matlack and T. Guettler for reading the manuscript. This work was supported by National Institutes of Health grants GM067887 to J.C.G., GM080139 to S.J.L., GM052586 to T.A.R. and GM45377 to C.W.A. T.A.R. is a Howard Hughes Institute investigator.	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; Armache JP, 2013, NUCLEIC ACIDS RES, V41, P1284, DOI 10.1093/nar/gks1259; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Hizlan D, 2012, CELL REPORTS, V1, P21, DOI 10.1016/j.celrep.2011.11.003; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Knyazev DG, 2013, J BIOL CHEM, V288, P17941, DOI 10.1074/jbc.M113.477893; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; NICCHITTA CV, 1993, CELL, V73, P989, DOI 10.1016/0092-8674(93)90276-V; Nijeholt JALA, 2010, J BIOL CHEM, V285, P23747, DOI 10.1074/jbc.M110.124636; Park E, 2012, J CELL BIOL, V198, P881, DOI 10.1083/jcb.201205140; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	39	117	121	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2014	506	7486					102	+		10.1038/nature12720	http://dx.doi.org/10.1038/nature12720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BA	24153188	Green Accepted, Green Submitted			2022-12-24	WOS:000330648100040
J	Yosca, TH; Rittle, J; Krest, CM; Onderko, EL; Silakov, A; Calixto, JC; Behan, RK; Green, MT				Yosca, Timothy H.; Rittle, Jonathan; Krest, Courtney M.; Onderko, Elizabeth L.; Silakov, Alexey; Calixto, Julio C.; Behan, Rachel K.; Green, Michael T.			Iron(IV)hydroxide pK(a) and the Role of Thiolate Ligation in C-H Bond Activation by Cytochrome P450	SCIENCE			English	Article							CHLOROPEROXIDASE COMPOUND-II; COUPLED ELECTRON-TRANSFER; LIVER MICROSOMAL CYTOCHROME-P-450; RESONANCE RAMAN-SPECTROSCOPY; HYDROGEN-ATOM TRANSFER; THERMOPHILIC CYTOCHROME-P450; SULFOLOBUS-SOLFATARICUS; FERRYL PROTONATION; CRYSTAL-STRUCTURE; PHOTOSYSTEM-II	Cytochrome P450 enzymes activate oxygen at heme iron centers to oxidize relatively inert substrate carbon-hydrogen bonds. Cysteine thiolate coordination to iron is posited to increase the pK(a) (where K-a is the acid dissociation constant) of compound II, an iron(IV)hydroxide complex, correspondingly lowering the one-electron reduction potential of compound I, the active catalytic intermediate, and decreasing the driving force for deleterious auto-oxidation of tyrosine and tryptophan residues in the enzyme's framework. Here, we report on the preparation of an iron(IV) hydroxide complex in a P450 enzyme (CYP158) in >= 90% yield. Using rapid mixing technologies in conjunction with Mossbauer, ultraviolet/visible, and x-ray absorption spectroscopies, we determine a pK(a) value for this compound of 11.9. Marcus theory analysis indicates that this elevated pK(a) results in a >10,000-fold reduction in the rate constant for oxidations of the protein framework, making these processes noncompetitive with substrate oxidation.	[Yosca, Timothy H.; Rittle, Jonathan; Krest, Courtney M.; Onderko, Elizabeth L.; Silakov, Alexey; Calixto, Julio C.; Behan, Rachel K.; Green, Michael T.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Green, MT (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	mtg10@psu.edu	Silakov, Alexey/D-6318-2018	Silakov, Alexey/0000-0002-9285-1253	NIH [R01-GM101390]; DOE Office of Biological and Environmental Research; NIH National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101390, P41GM103393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Latimer and E. Nelson for onsite assistance at the synchrotron. This work was supported by NIH (R01-GM101390). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the NIH National Institute of General Medical Sciences (including P41GM103393).	Ahlbrink R, 1998, BIOCHEMISTRY-US, V37, P1131, DOI 10.1021/bi9719152; Annino G, 2009, IEEE T MICROW THEORY, V57, P775, DOI 10.1109/TMTT.2009.2015028; [Anonymous], 2009, GAUSS 09 REV C 01; ATKINS WM, 1987, J AM CHEM SOC, V109, P3754, DOI 10.1021/ja00246a038; Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019; Behan RK, 2006, J AM CHEM SOC, V128, P11471, DOI 10.1021/ja062428p; Bollinger JM, 2009, CURR OPIN CHEM BIOL, V13, P51, DOI 10.1016/j.cbpa.2009.03.018; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Challand MR, 2011, NAT PROD REP, V28, P1696, DOI 10.1039/c1np00036e; DAVIES DM, 1976, BIOCHEM J, V157, P247, DOI 10.1042/bj1570247; de Visser SP, 2004, J AM CHEM SOC, V126, P8362, DOI 10.1021/ja048528h; Duschene KS, 2009, CURR OPIN CHEM BIOL, V13, P74, DOI 10.1016/j.cbpa.2009.01.022; GILSON MK, 1986, BIOPOLYMERS, V25, P2097, DOI 10.1002/bip.360251106; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; Green MT, 2009, CURR OPIN CHEM BIOL, V13, P84, DOI 10.1016/j.cbpa.2009.02.028; Green MT, 2006, J AM CHEM SOC, V128, P1902, DOI 10.1021/ja054074s; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Grinkova YV, 2013, BIOCHEM BIOPH RES CO, V430, P1223, DOI 10.1016/j.bbrc.2012.12.072; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; HANSON LK, 1976, J AM CHEM SOC, V98, P2672, DOI 10.1021/ja00425a050; Hay S, 2005, BIOCHEMISTRY-US, V44, P11891, DOI 10.1021/bi050901q; Immoos CE, 2004, INORG CHEM, V43, P3593, DOI 10.1021/ic049741h; Irebo T, 2008, J AM CHEM SOC, V130, P9194, DOI 10.1021/ja802076v; Jung C, 2005, BIOCHEM BIOPH RES CO, V338, P355, DOI 10.1016/j.bbrc.2005.08.166; KADKHODAYAN S, 1995, J BIOL CHEM, V270, P28042; Kang Y, 2009, CHEM-EUR J, V15, P10039, DOI 10.1002/chem.200901238; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Markle TF, 2008, P NATL ACAD SCI USA, V105, P8185, DOI 10.1073/pnas.0708967105; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; Mayer JM, 2011, J PHYS CHEM LETT, V2, P1481, DOI 10.1021/jz200021y; Mayer JM, 2011, ACCOUNTS CHEM RES, V44, P36, DOI 10.1021/ar100093z; Ortiz de Montellano P.R., 2004, CYTOCHROME P450 STRU, V3rd; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; Parsell TH, 2009, J AM CHEM SOC, V131, P2762, DOI 10.1021/ja8100825; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Prokop KA, 2010, ANGEW CHEM INT EDIT, V49, P5091, DOI 10.1002/anie.201001172; Reijerse E, 2012, J MAGN RESON, V214, P237, DOI 10.1016/j.jmr.2011.11.011; Rhile IJ, 2006, J AM CHEM SOC, V128, P6075, DOI 10.1021/ja054167+; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Sastri CV, 2007, P NATL ACAD SCI USA, V104, P19181, DOI 10.1073/pnas.0709471104; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schunemann V, 2004, J BIOL CHEM, V279, P10919, DOI 10.1074/jbc.M307884200; Simmons JM, 2008, DALTON T, P5132, DOI 10.1039/b803512a; Sjodin M, 2000, J AM CHEM SOC, V122, P3932, DOI 10.1021/ja993044k; Sligar SG, 2010, SCIENCE, V330, P924, DOI 10.1126/science.1197881; SONO M, 1982, J BIOL CHEM, V257, P8308; Stone KL, 2006, P NATL ACAD SCI USA, V103, P12307, DOI 10.1073/pnas.0603159103; Stone KL, 2006, J AM CHEM SOC, V128, P6147, DOI 10.1021/ja057876w; Terner J, 2006, J INORG BIOCHEM, V100, P480, DOI 10.1016/j.jinorgbio.2006.01.008; Tommos C, 2013, BIOCHEMISTRY-US, V52, P1409, DOI 10.1021/bi301613p; Warren JJ, 2012, FEBS LETT, V586, P596, DOI 10.1016/j.febslet.2011.12.014; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200; Zhang MT, 2011, J AM CHEM SOC, V133, P13224, DOI 10.1021/ja203483j; Zhao B, 2005, J BIOL CHEM, V280, P11599, DOI 10.1074/jbc.M410933200; Zhao B, 2005, J BIOL CHEM, V280, P42188, DOI 10.1074/jbc.M509220200	56	220	221	6	251	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					825	829		10.1126/science.1244373	http://dx.doi.org/10.1126/science.1244373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233717	Green Accepted			2022-12-24	WOS:000326923000029
J	Demirors, AF; Pillai, PP; Kowalczyk, B; Grzybowski, BA				Demiroers, Ahmet F.; Pillai, Pramod P.; Kowalczyk, Bartlomiej; Grzybowski, Bartosz A.			Colloidal assembly directed by virtual magnetic moulds	NATURE			English	Article							CRYSTALS; ARRAYS; MOLECULES; SYMMETRY; FORCES; GROWTH; FIELD	Interest in assemblies of colloidal particles(1-4) has long been motivated by their applications in photonics(5,6), electronics(7,8), sensors(8) and microlenses(9). Existing assembly schemes(10-15) can position colloids of one type relatively flexibly into a range of desired structures, but it remains challenging to produce multicomponent lattices, clusters with precisely controlled symmetries and three-dimensional assemblies(16). A few schemes can efficiently produce complex colloidal structures(2,17,18), but they require system-specific procedures. Here we show that magnetic field microgradients established in a paramagnetic fluid(19,20) can serve as 'virtual moulds' to act as templates for the assembly of large numbers (similar to 10(8)) of both non-magnetic and magnetic colloidal particles with micrometre precision and typical yields of 80 to 90 per cent. We illustrate the versatility of this approach by producing single-component and multicomponent colloidal arrays, complex three-dimensional structures and a variety of colloidal molecules from polymeric particles, silica particles and live bacteria and by showing that all of these structures can be made permanent. In addition, although our magnetic moulds currently resemble optical traps in that they are limited to the manipulation of micrometre-sized objects, they are massively parallel and can manipulate non-magnetic and magnetic objects simultaneously in two and three dimensions.	[Demiroers, Ahmet F.; Pillai, Pramod P.; Kowalczyk, Bartlomiej; Grzybowski, Bartosz A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Demiroers, Ahmet F.; Pillai, Pramod P.; Kowalczyk, Bartlomiej; Grzybowski, Bartosz A.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Grzybowski, BA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	grzybor@northwestern.edu	Grzybowski, Bartosz A/H-5741-2017; Pillai, Pramod/G-8334-2015; Demirörs, Ahmet/R-9614-2019	Grzybowski, Bartosz/0000-0001-6613-4261; Demirors, Ahmet/0000-0002-2748-1516	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0000989]; Non-equilibrium Energy Research Center, Energy Frontier Research Center	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Non-equilibrium Energy Research Center, Energy Frontier Research Center	We thank P. E. Fuller for his Matlab scripts. This work was supported by the Non-equilibrium Energy Research Center, which is an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under award number DE-SC0000989.	Ahn BY, 2009, SCIENCE, V323, P1590, DOI 10.1126/science.1168375; Aizenberg J, 2000, PHYS REV LETT, V84, P2997, DOI 10.1103/PhysRevLett.84.2997; Bakker CJG, 2006, MAGN RESON MED, V56, P1107, DOI 10.1002/mrm.21069; Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358; Chen Q, 2011, NATURE, V469, P381, DOI 10.1038/nature09713; Coey JMD, 2009, P NATL ACAD SCI USA, V106, P8811, DOI 10.1073/pnas.0900561106; Dong AG, 2011, NANO LETT, V11, P1804, DOI 10.1021/nl200468p; Erb RM, 2009, NATURE, V457, P999, DOI 10.1038/nature07766; Hochbaum AI, 2005, NANO LETT, V5, P457, DOI 10.1021/nl047990x; Hoogenboom JP, 2004, NANO LETT, V4, P205, DOI 10.1021/nl034867h; Jiang P, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2218832; Lu Y, 2001, ADV MATER, V13, P34, DOI 10.1002/1521-4095(200101)13:1<34::AID-ADMA34>3.3.CO;2-T; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Mirica KA, 2009, J AM CHEM SOC, V131, P10049, DOI 10.1021/ja900920s; Miszta K, 2011, NAT MATER, V10, P872, DOI [10.1038/NMAT3121, 10.1038/nmat3121]; Perro A, 2009, ANGEW CHEM INT EDIT, V48, P361, DOI 10.1002/anie.200802562; Rosensweig RE, 1997, FERROHYDRODYNAMICS; Shevkoplyas SS, 2007, LAB CHIP, V7, P1294, DOI 10.1039/b705045c; Shipway AN, 2000, CHEMPHYSCHEM, V1, P18, DOI 10.1002/1439-7641(20000804)1:1<18::AID-CPHC18>3.0.CO;2-L; Sun Z, 2011, J APPL PHYS, V109, DOI 10.1063/1.3579426; van Blaaderen A, 2003, SCIENCE, V301, P470; vanBlaaderen A, 1997, NATURE, V385, P321, DOI 10.1038/385321a0; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Xia YN, 2001, ADV MATER, V13, P409, DOI 10.1002/1521-4095(200103)13:6<409::AID-ADMA409>3.0.CO;2-C; Yang JC, 2010, NANO LETT, V10, P3173, DOI 10.1021/nl102078j; Yellen BB, 2005, P NATL ACAD SCI USA, V102, P8860, DOI 10.1073/pnas.0500409102; Yethiraj A, 2004, ADV MATER, V16, P596, DOI 10.1002/adma.200306192	27	144	144	3	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					99	103		10.1038/nature12591	http://dx.doi.org/10.1038/nature12591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24141949				2022-12-24	WOS:000326585600039
J	Johnson, A				Johnson, Andy			Radiation and Atomic Literacy for Nonscientists	SCIENCE			English	Editorial Material									Black Hills State Univ, Ctr Adv Math & Sci Educ CAMSE, Spearfish, SD 57799 USA	Black Hills State University	Johnson, A (corresponding author), Black Hills State Univ, Ctr Adv Math & Sci Educ CAMSE, 1200 Univ St, Spearfish, SD 57799 USA.	andy.johnson@bhsu.edu			Direct For Education and Human Resources [0942699] Funding Source: National Science Foundation	Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))		Brewe E, 2009, PHYS REV SPEC TOP-PH, V5, DOI 10.1103/PhysRevSTPER.5.013102; Curtright A, 2010, IEEE I SYMP SUST SYS; Eijkelhof H. M. C., 1990, RADIATION AND RISK I; Etkina E, 2010, J LEARN SCI, V19, P54, DOI 10.1080/10508400903452876; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Maidl R., 2012, PROCEEDINGS OF THE 2; Malone KL, 2008, PHYS REV SPEC TOP-PH, V4, DOI 10.1103/PhysRevSTPER.4.020107; Millar R., 1996, Physics Education, V31, P27, DOI 10.1088/0031-9120/31/1/019; Prather E., 2001, J COLL SCI TEACH, V31, P89	9	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157					436	437		10.1126/science.1230003	http://dx.doi.org/10.1126/science.1230003			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159038				2022-12-24	WOS:000326042600031
J	Feinmann, J				Feinmann, Jane			BMJ CHRISTMAS APPEAL 2013 After the typhoon: how volunteer doctors are bringing medical care to those most in need	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com							0	1	1	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 2	2013	347								f7193	10.1136/bmj.f7193	http://dx.doi.org/10.1136/bmj.f7193			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	268CV	24297998	Bronze, Green Published			2022-12-24	WOS:000328146700011
J	Hay, S				Hay, Simon			Football fever could be a dose of dengue	NATURE			English	Editorial Material									Univ Oxford, Wellcome Trust, Oxford OX1 2JD, England	University of Oxford	Hay, S (corresponding author), Univ Oxford, Wellcome Trust, Oxford OX1 2JD, England.	simon.hay@zoo.ox.ac.uk	Brady, Oliver/P-9421-2019; Hay, Simon Iain/F-8967-2015	Brady, Oliver/0000-0002-3235-2129; Hay, Simon Iain/0000-0002-0611-7272	Wellcome Trust [095066] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [1090403] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))			0	20	20	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					439	439		10.1038/503439a	http://dx.doi.org/10.1038/503439a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24284696	Bronze			2022-12-24	WOS:000327464200006
J	Landry, CR; Levy, ED; Abd Rabbo, D; Tarassov, K; Michnick, SW				Landry, Christian R.; Levy, Emmanuel D.; Abd Rabbo, Diala; Tarassov, Kirill; Michnick, Stephen W.			Extracting Insight from Noisy Cellular Networks	CELL			English	Review							PROTEIN-PROTEIN INTERACTIONS; INTERACTION MAP; IN-VIVO; YEAST; COMPLEXES; IDENTIFICATION; INTERACTOME; EVOLUTION; GRANULES; ORIGINS	Network biologists attempt to extract meaningful relationships among genes or their products from very noisy data. We argue that what we categorize as noisy data may sometimes reflect noisy biology and therefore may shield a hidden meaning about how networks evolve and how matter is organized in the cell. We present practical solutions, based on existing evolutionary and biophysical concepts, through which our understanding of cell biology can be enormously enriched.	[Landry, Christian R.] Univ Laval, Dept Biol, IBIS, Quebec City, PQ G1V 0A6, Canada; [Landry, Christian R.] Univ Laval, PROTEO, Quebec City, PQ G1V 0A6, Canada; [Levy, Emmanuel D.] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Abd Rabbo, Diala; Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Tarassov, Kirill] Zora Biosci Oy, Espoo 02150, Finland	Laval University; Laval University; Weizmann Institute of Science; Universite de Montreal	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca		Landry, Christian/0000-0003-3028-6866	Canadian Institutes of Health Research (CIHR) [MOP-GMX-152556, MOP-GMX-231013, GMX-299432, GMX-191597]; Natural Sciences and Engineering Research Council of Canada (NSERC) [194582]; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [1775/12]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	Many of the ideas discussed in this manuscript were inspired by the results of research funded by the Canadian Institutes of Health Research (CIHR) grants MOP-GMX-152556 and MOP-GMX-231013 to S.W.M. and the Natural Sciences and Engineering Research Council of Canada (NSERC) grant 194582 to S.W.M.C.R.L. is a CIHR New Investigator, and his research on PINs is funded by CIHR grants (GMX-299432 and GMX-191597) and by NSERC. E.D.L. acknowledges the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation (grant 1775/12).	Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Balaji S, 2008, TRENDS GENET, V24, P319, DOI 10.1016/j.tig.2008.04.006; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Braberg H, 2013, CELL, V154, P775, DOI 10.1016/j.cell.2013.07.033; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Brangwynne CP, 2011, SOFT MATTER, V7, P3052, DOI 10.1039/c0sm00981d; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Diss G, 2013, CELL REP, V3, P2155, DOI 10.1016/j.celrep.2013.05.004; Doolittle WF, 2013, P NATL ACAD SCI USA, V110, P5294, DOI 10.1073/pnas.1221376110; Dreze M, 2009, NAT METHODS, V6, P843, DOI [10.1038/NMETH.1394, 10.1038/nmeth.1394]; Ear PH, 2009, NAT METHODS, V6, P813, DOI [10.1038/NMETH.1389, 10.1038/nmeth.1389]; Elcock AH, 2001, P NATL ACAD SCI USA, V98, P2990, DOI 10.1073/pnas.061411798; Euskirchen G, 2004, NAT GENET, V36, P325, DOI 10.1038/ng0404-325; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Gagnon-Arsenault I, 2013, J PROTEOMICS, V81, P112, DOI 10.1016/j.jprot.2012.09.038; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Hahn MW, 2003, MOL BIOL EVOL, V20, P901, DOI 10.1093/molbev/msg096; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hyman AA, 2011, DEV CELL, V21, P14, DOI 10.1016/j.devcel.2011.06.013; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jensen LJ, 2008, SCIENCE, V322, P56, DOI 10.1126/science.1164801; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Leducq JB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003161; Levy ED, 2012, P NATL ACAD SCI USA, V109, P20461, DOI 10.1073/pnas.1209312109; Levy ED, 2012, PHILOS T R SOC B, V367, P2594, DOI 10.1098/rstb.2012.0078; Levy ED, 2010, SCIENCE, V328, P983, DOI 10.1126/science.1190993; Levy ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.260pe11; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lickwar CR, 2012, NATURE, V484, P251, DOI 10.1038/nature10985; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Maher B., 2012, FIGHTING ENCODE JUNK; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Messier V, 2013, CELL, V153, P1080, DOI 10.1016/j.cell.2013.04.035; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valdar WSJ, 2001, J MOL BIOL, V313, P399, DOI 10.1006/jmbi.2001.5034; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wodak SJ, 2013, CURR OPIN STRUC BIOL, V23, P941, DOI 10.1016/j.sbi.2013.08.002; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang JS, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.48; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503	67	37	39	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					983	989		10.1016/j.cell.2013.11.003	http://dx.doi.org/10.1016/j.cell.2013.11.003			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267884	Bronze			2022-12-24	WOS:000327500600004
J	Wilson, M; Goh, T; Voss, U; Bishopp, A; Peret, B; Bennett, M				Wilson, Michael; Goh, Tatsuaki; Voss, Ute; Bishopp, Anthony; Peret, Benjamin; Bennett, Malcolm			SnapShot: Root Development	CELL			English	Editorial Material							ARABIDOPSIS; AUXIN		[Wilson, Michael; Goh, Tatsuaki; Voss, Ute; Bishopp, Anthony; Bennett, Malcolm] Univ Nottingham, Sch Biosci, Ctr Plant Integrat Biol, Nottingham LE12 5RD, England; [Peret, Benjamin] CEA, CNRS, AMU, UMR 7265,Lab Biol Dev Plantes, F-13108 Cadarache, St Paul Lez Dur, France	University of Nottingham; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Wilson, M (corresponding author), Univ Nottingham, Sch Biosci, Ctr Plant Integrat Biol, Nottingham LE12 5RD, England.		Voss, Ute/X-3755-2019; Goh, Tatsuaki/H-4538-2011; Bennett, Malcolm/G-4004-2010	Voss, Ute/0000-0003-2124-9334; Bishopp, Anthony/0000-0003-2962-9542; Goh, Tatsuaki/0000-0002-1064-5801; Wilson, Michael/0000-0002-6323-6059; PERET, Benjamin/0000-0003-1336-0796; Bennett, Malcolm/0000-0003-0475-390X	BBSRC [BB/G023972/1, BB/D019613/1, BB/H020314/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H020314/1, BB/G023972/1, BB/D019613/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; Dello Ioio R, 2012, CURR BIOL, V22, P1699, DOI 10.1016/j.cub.2012.07.005; Grebe M, 2012, CURR OPIN PLANT BIOL, V15, P31, DOI 10.1016/j.pbi.2011.10.010; Lavenus J, 2013, TRENDS PLANT SCI, V18, P455, DOI 10.1016/j.tplants.2013.04.006; Petricka JJ, 2012, ANNU REV PLANT BIOL, V63, P563, DOI 10.1146/annurev-arplant-042811-105501	5	4	4	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1190	+		10.1016/j.cell.2013.11.007	http://dx.doi.org/10.1016/j.cell.2013.11.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267898	Bronze			2022-12-24	WOS:000327500600023
J	McCartney, M				McCartney, Margaret			How many new cancers are diagnosed after emergency admission?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2012, DAILY EXPRESS   0921; [Anonymous], 2012, BBC NEWS; Baughan P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606591; Borland S, 2012, DAILY MAIL; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; National Cancer Intelligence Network, 2013, ROUT DIAGN EXPL EM A; North West Cancer Intelligence Service, 2013, ROUT DIAGN INV DIFF; Teenage Cancer Trust, 2013, YOUNG CANC PAT 3 TIM; Teenage Cancer Trust, 2013, IMPR DIAGN REP; Tsang C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-308	12	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 20	2013	347								f6857	10.1136/bmj.f6857	http://dx.doi.org/10.1136/bmj.f6857			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	258KF	24259328				2022-12-24	WOS:000327457400009
J	Hede, K				Hede, Karyn			EMERGENCY MEDICINE The need for speed	NATURE			English	Editorial Material													Hede, Karyn/AGR-8461-2022	Hede, Karyn/0000-0003-2815-0636				Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Fehlings MG, 2010, SPINE, V35, pS166, DOI 10.1097/BRS.0b013e3181f386f6	3	3	4	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					S14	S15		10.1038/503S14a	http://dx.doi.org/10.1038/503S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24227001	Bronze			2022-12-24	WOS:000326894200007
J	Henderson, RA; Bath, PMW				Henderson, Robert A.; Bath, Philip M. W.			Is closure of patent foramen ovale to prevent ischaemic stroke ever justified?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL THERAPY; CRYPTOGENIC STROKE; TRANSCATHETER CLOSURE; RISK; METAANALYSIS; DEVICES; EVENTS	This is one of a series of occasional articles that highlight areas of practice where management lacks convincing supporting evidence. The series adviser is David Tovey, editor in chief, the Cochrane Library. To suggest a topic, please email us at practice@ bmj.com.	[Henderson, Robert A.] Univ Nottingham Hosp, Trent Cardiac Ctr, Nottingham NG5 1PB, England; [Bath, Philip M. W.] Univ Nottingham, Stroke Trials Unit, Univ Nottingham Hosp, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Henderson, RA (corresponding author), Univ Nottingham Hosp, Trent Cardiac Ctr, City Hosp Campus, Nottingham NG5 1PB, England.	robert.henderson@nuh.nhs.uk	Bath, Philip/F-9020-2011	Bath, Philip/0000-0003-2734-5132	National Institute for Health Research [NF-SI-0611-10003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Abaci A, 2013, CATHETER CARDIO INTE, V82, P1123, DOI 10.1002/ccd.24875; Agarwal S, 2012, JACC-CARDIOVASC INTE, V5, P777, DOI 10.1016/j.jcin.2012.02.021; Almekhlafi MA, 2009, NEUROLOGY, V73, P89, DOI 10.1212/WNL.0b013e3181aa2a19; Alsheikh-Ali AA, 2009, STROKE, V40, P2349, DOI 10.1161/STROKEAHA.109.547828; Botto N, 2007, STROKE, V38, P2070, DOI 10.1161/STROKEAHA.106.480863; Carroll JD, 2013, NEW ENGL J MED, V368, P1092, DOI 10.1056/NEJMoa1301440; Di Tullio MR, 2007, J AM COLL CARDIOL, V49, P797, DOI 10.1016/j.jacc.2006.08.063; Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Homma S, 2005, CIRCULATION, V112, P1063, DOI 10.1161/CIRCULATIONAHA.104.524371; Hornung M, 2013, EUR HEART J; Kent DM, 2010, STROKE, V41, pS26, DOI 10.1161/STROKEAHA.110.595140; Khairy P, 2003, ANN INTERN MED, V139, P753, DOI 10.7326/0003-4819-139-9-200311040-00010; Kitsios GD, 2012, STROKE, V43, P422, DOI 10.1161/STROKEAHA.111.631648; Krumsdorf U, 2004, J AM COLL CARDIOL, V43, P302, DOI 10.1016/j.jacc.2003.10.030; MAS JL, 1994, EUR HEART J, V15, P446, DOI 10.1093/oxfordjournals.eurheartj.a060524; Meier B, 2013, NEW ENGL J MED, V368, P1083, DOI 10.1056/NEJMoa1211716; Meissner I, 2006, J AM COLL CARDIOL, V47, P440, DOI 10.1016/j.jacc.2005.10.044; Myers PO, 2010, CHEST, V137, P164, DOI 10.1378/chest.09-0961; O'Gara PT, 2009, J AM COLL CARDIOL, V53, P2014, DOI 10.1016/j.jacc.2009.04.001; Overell JR, 2000, NEUROLOGY, V55, P1172, DOI 10.1212/WNL.55.8.1172; Stackhouse KA, 2012, J INVASIVE CARDIOL, V24, P608; STOLLBERGER C, 1993, ANN INTERN MED, V119, P461, DOI 10.7326/0003-4819-119-6-199309150-00003; Taaffe M, 2008, AM J CARDIOL, V101, P1353, DOI 10.1016/j.amjcard.2007.12.040; Taggart NW, 2011, J THORAC CARDIOV SUR, V142, P221, DOI 10.1016/j.jtcvs.2011.03.006; Thaler DE, 2013, STROKE, V44, P675, DOI 10.1161/STROKEAHA.112.677039	26	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2013	347								f6193	10.1136/bmj.f6193	http://dx.doi.org/10.1136/bmj.f6193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247ES	24167203				2022-12-24	WOS:000326599200004
J	Fernandez, IS; Bai, XC; Hussain, T; Kelley, AC; Lorsch, JR; Ramakrishnan, V; Scheres, SHW				Fernandez, Israel S.; Bai, Xiao-Chen; Hussain, Tanweer; Kelley, Ann C.; Lorsch, Jon R.; Ramakrishnan, V.; Scheres, Sjors H. W.			Molecular Architecture of a Eukaryotic Translational Initiation Complex	SCIENCE			English	Article							CRYO-EM STRUCTURE; RIBOSOMAL-SUBUNIT; CRYSTAL-STRUCTURE; TRANSFER-RNA; MECHANISMS	The last step in eukaryotic translational initiation involves the joining of the large and small subunits of the ribosome, with initiator transfer RNA (Met-tRNA(i)(Met)) positioned over the start codon of messenger RNA in the P site. This step is catalyzed by initiation factor eIF5B. We used recent advances in cryo-electron microscopy (cryo-EM) to determine a structure of the eIF5B initiation complex to 6.6 angstrom resolution from <3% of the population, comprising just 5143 particles. The structure reveals conformational changes in eIF5B, initiator tRNA, and the ribosome that provide insights into the role of eIF5B in translational initiation. The relatively high resolution obtained from such a small fraction of a heterogeneous sample suggests a general approach for characterizing the structure of other dynamic or transient biological complexes.	[Fernandez, Israel S.; Bai, Xiao-Chen; Hussain, Tanweer; Kelley, Ann C.; Ramakrishnan, V.; Scheres, Sjors H. W.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Lorsch, Jon R.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	MRC Laboratory Molecular Biology; Johns Hopkins University	Lorsch, JR (corresponding author), Eunice K Shriver Inst Child Hlth & Human Dev, Lab Mech & Regulat Prot Synth, Bethesda, MD 20892 USA.	jon.lorsch@nih.gov; ramak@mrc-lmb.cam.ac.uk; scheres@mrc-lmb.cam.ac.uk	Bai, Xiao-chen/HGV-1244-2022; Scheres, Sjors H.W./AAY-2265-2021	Bai, Xiao-chen/0000-0002-4234-5686; Scheres, Sjors H.W./0000-0002-0462-6540; Ramakrishnan, V/0000-0002-4699-2194; Lorsch, Jon/0000-0002-4521-4999; Hussain, Tanweer/0000-0003-4735-2380; Fernandez, Israel/0000-0001-7218-1603	EU FP7 Marie Curie postdoctoral fellowship; UK Medical Research Council [MC_U105184332, MC_UP_A025_1013]; Wellcome Trust [WT096570]; Agouron Institute; Jeantet Foundation; Human Frontiers Science Program [RGP 28/2009]; MRC [MC_UP_A025_1013, MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_UP_A025_1013, MC_U105184332] Funding Source: researchfish	EU FP7 Marie Curie postdoctoral fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Jeantet Foundation; Human Frontiers Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Chen for technical support with cryo-EM, G. McMullan for help in movie data acquisition, T. Darling and J. Grimmett for help with computing, D. Tourigny for discussions, and one of the reviewers for suggestions on properly modeling the P/I tRNA. X.-C. B. is supported by a EU FP7 Marie Curie postdoctoral fellowship. Supported by grants from the UK Medical Research Council (MC_U105184332 to V. R. and MC_UP_A025_1013 to S. H. W. S.); a Wellcome Trust Senior Investigator award (WT096570), the Agouron Institute, and the Jeantet Foundation (V. R.); and the Human Frontiers Science Program (grant RGP 28/2009 to V. R. and J. R. L.). The cryo-EM density maps have been deposited in the Electron Microscopy Data Bank with accession numbers EMD-2421 (for the large class with P/E tRNA) and EMD-2422 (for the small class with P/I tRNA). Fitted atomic coordinates have been deposited in the Protein Data Bank, with entry codes 4byl, 4byn, 4byo, 4byp, 4byq, 4byr, and 4bys for the large class and entry codes 4byt, 4byu, 4byv, 4byw, and 4byx for the small class.	Acker MG, 2006, J BIOL CHEM, V281, P8469, DOI 10.1074/jbc.M600210200; Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Acker MG, 2009, J MOL BIOL, V385, P491, DOI 10.1016/j.jmb.2008.10.029; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Ballesta JPG, 1996, PROG NUCLEIC ACID RE, V55, P157, DOI 10.1016/S0079-6603(08)60193-2; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kapp LD, 2004, J MOL BIOL, V335, P923, DOI 10.1016/j.jmb.2003.11.025; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Lacombe T, 2009, MOL MICROBIOL, V72, P69, DOI 10.1111/j.1365-2958.2009.06622.x; Lebaron S, 2012, NAT STRUCT MOL BIOL, V19, P744, DOI 10.1038/nsmb.2308; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Roll-Mecak A, 2001, TRENDS BIOCHEM SCI, V26, P705, DOI 10.1016/S0968-0004(01)02024-2; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; Shin BS, 2009, MOL CELL BIOL, V29, P808, DOI 10.1128/MCB.00896-08; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Trabuco LG, 2011, J STRUCT BIOL, V173, P420, DOI 10.1016/j.jsb.2010.09.024; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577	39	97	105	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					824	+	1240585	10.1126/science.1240585	http://dx.doi.org/10.1126/science.1240585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24200810	Green Accepted			2022-12-24	WOS:000326923000028
J	Roos, N; Neovius, M; Cnattingius, S; Lagerros, YT; Saaf, M; Granath, F; Stephansson, O				Roos, Nathalie; Neovius, Martin; Cnattingius, Sven; Lagerros, Ylva Trolle; Saaf, Maria; Granath, Fredrik; Stephansson, Olof			Perinatal outcomes after bariatric surgery: nationwide population based matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; PREGNANCY OUTCOMES; RISK; OBESITY; BIRTH; WEIGHT; TRENDS	Objective To compare perinatal outcomes in births of women with versus without a history of bariatric surgery. Design Population based matched cohort study. Setting Swedish national health service. Participants 1 742 702 singleton births identified in the Swedish medical birth register between 1992 and 2009. For each birth to a mother with a history of bariatric surgery (n=2562), up to five control births were matched by maternal age, parity, early pregnancy body mass index, early pregnancy smoking status, educational level, and year of delivery. Secondary control cohorts, including women eligible for bariatric surgery (body mass index >= 35 or >= 40), were matched for the same factors except body mass index. History of maternal bariatric surgery was ascertained through the Swedish national patient register from 1980 to 2009. Main outcome measures Preterm birth (<37 weeks), small for gestational age birth, large for gestational age birth, stillbirth (>= 28 weeks), and neonatal death (0-27 days). Results Post-surgery births were more often preterm than in matched controls (9.7% (243/2511) v 6.1% (750/12 379); odds ratio 1.7, 95% confidence interval 1.4 to 2.0; P<0.001). Body mass index seemed to be an effect modifier (P=0.01), and the increased risk of preterm birth was only observed in women with a body mass index <35. A history of bariatric surgery was associated with increased risks of both spontaneous (5.2% (130/2511) v 3.6% (441/12 379); odds ratio 1.5, 1.2 to 1.9; P<0.001) and medically indicated preterm birth (4.5% (113/2511) v 2.5% (309/12 379); odds ratio 1.8, 1.4 to 2.3; P<0.001). A history of bariatric surgery was also associated with an increased risk of a small for gestational age birth (5.2% (131/2507) v 3.0% (369/12 338); odds ratio 2.0, 1.5 to 2.5; P<0.001) and lower risk of a large for gestational age birth (4.2% (105/2507) v 7.3% (895/12 338); odds ratio 0.6, 0.4 to 0.7; P<0.001). No differences were detected for stillbirth or neonatal death. The increased risks for preterm and small for gestational age birth, as well as the decreased risk for large for gestational age birth, remained when post-surgery births were compared with births of women eligible for bariatric surgery. Conclusion Women with a history of bariatric surgery were at increased risk of preterm and small for gestational age births and should be regarded as a risk group during pregnancy.	[Roos, Nathalie; Neovius, Martin; Cnattingius, Sven; Lagerros, Ylva Trolle; Granath, Fredrik; Stephansson, Olof] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden; [Roos, Nathalie; Stephansson, Olof] Karolinska Inst, Div Obstet & Gynaecol, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Saaf, Maria] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Saaf, Maria] Karolinska Univ Hosp, Dept Diabet Endocrinol & Metab, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Neovius, M (corresponding author), Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden.	martin.neovius@ki.se	Lagerros, Ylva Trolle/AAH-7683-2020	Lagerros, Ylva Trolle/0000-0001-6816-7577; Neovius, Martin/0000-0003-2300-3055; Roos, Nathalie/0000-0001-9752-2355; Stephansson, Olof/0000-0003-1528-4563	Karolinska Institutet; board of postgraduate education at the Karolinska Institutet; Swedish Society of Medicine; Stockholm County Council; Abbott; Sanofi-Aventis; Itrim International; Strategic Health Resources; Cambridge Weight Plan; Novo Nordisk	Karolinska Institutet(Karolinska Institutet); board of postgraduate education at the Karolinska Institutet; Swedish Society of Medicine; Stockholm County Council(Stockholm County Council); Abbott(Abbott Laboratories); Sanofi-Aventis(Sanofi-Aventis); Itrim International; Strategic Health Resources; Cambridge Weight Plan; Novo Nordisk(Novo Nordisk)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare that SC was supported by a distinguished professor award (Karolinska Institutet); MN was supported by the strategic young scholar award in epidemiology (Karolinska Institutet); NR was supported by the board of postgraduate education at the Karolinska Institutet (Karolinska Institutet Doctoral Student Financing Fund); OS was supported by the Swedish Society of Medicine and the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet; and that SC, NR, MS, and YT-L have had no financial relationships with any organisations that might have an interest in the submitted work in the previous three years. MN has received lecture or consulting fees from Abbott, Sanofi-Aventis, Itrim International, and Strategic Health Resources; research grants from Cambridge Weight Plan and Novo Nordisk; and royalty payments for co-authoring chapters in a Swedish textbook on obesity. The authors declare that they have no other relationships or activities that could appear to have influenced the submitted work.	Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Ducarme G, 2007, INT J GYNECOL OBSTET, V98, P244, DOI 10.1016/j.ijgo.2007.02.020; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Josefsson A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.025; Kjaer MM, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.046; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lesko J, 2012, OBSTET GYNECOL, V119, P547, DOI 10.1097/AOG.0b013e318239060e; Maggard MA, 2008, JAMA-J AM MED ASSOC, V300, P2286, DOI 10.1001/jama.2008.641; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Odlind V, 2003, ACTA OBSTET GYN SCAN, V82, P516, DOI 10.1034/j.1600-0412.2003.00112.x; Patel JA, 2008, SURG OBES RELAT DIS, V4, P39, DOI 10.1016/j.soard.2007.10.008; Rao A, 2004, BEST PRACT RES CL OB, V18, P557, DOI 10.1016/j.bpobgyn.2004.04.007; Rao KR, 2012, REV ENDOCR METAB DIS, V13, P103, DOI 10.1007/s11154-012-9211-y; SFOAK, 2011, PROP NAT MED IND QUA; Singh J, 2012, J MATERN-FETAL NEO M, V25, P5, DOI 10.3109/14767058.2012.626920; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SOREG, 2012, ANN REP SOREG 2011; Stephansson O, 2001, AM J OBSTET GYNECOL, V184, P463, DOI 10.1067/mob.2001.109591; Surkan PJ, 2004, OBSTET GYNECOL, V104, P720, DOI 10.1097/01.AOG.0000141442.59573.cd; Walsh SW, 2007, TRENDS ENDOCRIN MET, V18, P365, DOI 10.1016/j.tem.2007.09.003; Wax JR, 2008, OBES SURG, V18, P540, DOI 10.1007/s11695-008-9459-1; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	28	100	104	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 12	2013	347								f6460	10.1136/bmj.f6460	http://dx.doi.org/10.1136/bmj.f6460			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254FR	24222480	Green Published, hybrid			2022-12-24	WOS:000327150600001
J	Bhandari, S				Bhandari, Sunil			PERSONAL VIEW South Asian hospitals that lack DNAR orders deny patients holistic care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bhandari, Sunil] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull HU3 2JZ, Yorks, England; [Bhandari, Sunil] Hull Royal Infirm, Dept Renal Med, Hull York Med Sch, Kingston Upon Hull HU3 2JZ, Yorks, England	University of Hull; University of York - UK	Bhandari, S (corresponding author), Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull HU3 2JZ, Yorks, England.	sunil.bhandari@hey.nhs.uk		bhandari, sunil/0000-0002-0996-9622					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2013	347								f6300	10.1136/bmj.f6300	http://dx.doi.org/10.1136/bmj.f6300			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243CM	24163086				2022-12-24	WOS:000326294200006
J	Evans, LDB; Poulter, S; Terentjev, EM; Hughes, C; Fraser, GM				Evans, Lewis D. B.; Poulter, Simon; Terentjev, Eugene M.; Hughes, Colin; Fraser, Gillian M.			A chain mechanism for flagellum growth	NATURE			English	Article							III PROTEIN EXPORT; HIGH-LEVEL EXPRESSION; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; BACTERIAL FLAGELLUM; MEMBRANE ATPASE; HOOK; SECRETION; APPARATUS	Bacteria swim by means of long flagella extending from the cell surface. These are assembled from thousands of protein subunits translocated across the cell membrane by an export machinery at the base of each flagellum. Unfolded subunits(1-3) then transit through a narrow channel at the core of the growing flagellum to the tip, where they crystallize into the nascent structure. As the flagellum lengthens outside the cell, the rate of flagellum growth does not change(4). The mystery is how subunit transit is maintained at a constant rate without a discernible energy source in the channel of the external flagellum(5). We present evidence for a simple physical mechanism for flagellum growth that harnesses the entropic force of the unfolded subunits themselves. We show that a subunit docked at the export machinery can be captured by a free subunit through head-to-tail linkage of juxtaposed amino (N)- and carboxy (C)-terminal helices. We propose that sequential rounds of linkage would generate a multisubunit chain that pulls successive subunits into and through the channel to the flagellum tip, and by isolating filaments growing on bacterial cells we reveal the predicted chain of head-to-tail linked subunits in the transit channel of flagella. Thermodynamic analysis confirms that links in the subunit chain can withstand the pulling force generated by rounds of subunit crystallization at the flagellum tip, and polymer theory predicts that as the N terminus of each unfolded subunit crystallizes, the entropic force at the subunit C terminus would increase, rapidly overcoming the threshold required to pull the next subunit from the export machinery. This pulling force would adjust automatically over the increasing length of the growing flagellum, maintaining a constant rate of subunit delivery to the tip.	[Evans, Lewis D. B.; Poulter, Simon; Hughes, Colin; Fraser, Gillian M.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Terentjev, Eugene M.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Cambridge; University of Cambridge	Fraser, GM (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	gmf25@cam.ac.uk	Terentjev, Eugene M/B-7623-2011; Fraser, Gillian/I-1846-2013	Terentjev, Eugene M/0000-0003-3517-6578; Fraser, Gillian/0000-0002-4874-8734; Evans, Lewis/0000-0001-7279-7651	Wellcome Trust; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish; EPSRC [EP/F032773/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank P. Hinchliffe for help with analysis of atomic structures, K. Yonekura and K. Namba for providing information on filament structure, H. Berg and N. Greene for discussions, A. Crow for advice on ITC, and P. Dhillon for technical assistance. The work was supported by a Wellcome Trust Programme Grant (C. H. and G.M.F.).	Abrusci P, 2013, NAT STRUCT MOL BIOL, V20, P99, DOI 10.1038/nsmb.2452; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Blundell JR, 2009, SOFT MATTER, V5, P4015, DOI 10.1039/b903583d; Blundell JR, 2011, SOFT MATTER, V7, P3967, DOI 10.1039/c0sm01322f; CHEN LL, 1991, J BIOL CHEM, V266, P18237; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; ERLANDER SR, 1960, ARCH BIOCHEM BIOPHYS, V90, P139, DOI 10.1016/0003-9861(60)90625-1; Evans LDB, 2006, P NATL ACAD SCI USA, V103, P17474, DOI 10.1073/pnas.0605197103; Evans LDB, 2009, FEMS MICROBIOL LETT, V293, P292, DOI 10.1111/j.1574-6968.2009.01535.x; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Fujii T, 2009, STRUCTURE, V17, P1485, DOI 10.1016/j.str.2009.08.017; Galan JE, 2008, NAT STRUCT MOL BIOL, V15, P127, DOI 10.1038/nsmb0208-127; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HOMMA M, 1984, J BACTERIOL, V159, P1056, DOI 10.1128/JB.159.3.1056-1059.1984; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Mescheryakov V. A., 2007, ACTA CRYSTALLOGR D, V69, P812; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Minamino T, 1999, BIOSCI BIOTECH BIOCH, V63, P1301, DOI 10.1271/bbb.63.1301; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; OHNISHI K, 1994, J BACTERIOL, V176, P2272, DOI 10.1128/JB.176.8.2272-2281.1994; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Samatey FA, 2004, NATURE, V431, P1062, DOI 10.1038/nature02997; Shaikh TR, 2005, P NATL ACAD SCI USA, V102, P1023, DOI 10.1073/pnas.0409020102; Sotta P, 2000, J CHEM PHYS, V112, P1565, DOI 10.1063/1.480704; Stafford GP, 2007, J MOL BIOL, V374, P877, DOI 10.1016/j.jmb.2007.09.080; Stafford GP, 2007, MICROBIOL-SGM, V153, P541, DOI 10.1099/mic.0.2006/002576-0; Stern AS, 2013, BIOPHYS J, V105, P182, DOI 10.1016/j.bpj.2013.05.030; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tanner DE, 2011, BIOPHYS J, V100, P2548, DOI 10.1016/j.bpj.2011.04.036; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101; Turner L, 2012, J BACTERIOL, V194, P2437, DOI 10.1128/JB.06735-11; VONDERVISZT F, 1992, J MOL BIOL, V226, P575, DOI 10.1016/0022-2836(92)90616-R; VONDERVISZT F, 1995, J MOL BIOL, V251, P520, DOI 10.1006/jmbi.1995.0453; YAMAGUCHI S, 1984, J GEN MICROBIOL, V130, P3339; Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	44	63	63	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					287	+		10.1038/nature12682	http://dx.doi.org/10.1038/nature12682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24213633	Green Submitted, Green Accepted			2022-12-24	WOS:000328121500038
J	Kendal, AR; Prieto-Alhambra, D; Arden, NK; Carr, A; Judge, A				Kendal, Adrian R.; Prieto-Alhambra, Daniel; Arden, Nigel K.; Carr, Andrew; Judge, Andrew			Mortality rates at 10 years after metal-on-metal hip resurfacing compared with total hip replacement in England: retrospective cohort analysis of hospital episode statistics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FINNISH ARTHROPLASTY REGISTER; ION LEVELS; SURFACES; NICKEL; CANCER; BONE; WEAR	Objectives To compare 10 year mortality rates among patients undergoing metal-on-metal hip resurfacing and total hip replacement in England. Design Retrospective cohort study. Setting English hospital episode statistics database linked to mortality records from the Office for National Statistics. Population All adults who underwent primary elective hip replacement for osteoarthritis from April 1999 to March 2012. The exposure of interest was prosthesis type: cemented total hip replacement, uncemented total hip replacement, and metal-on-metal hip resurfacing. Confounding variables included age, sex, Charlson comorbidity index, rurality, area deprivation, surgical volume, and year of operation. Main outcome measures All cause mortality. Propensity score matching was used to minimise confounding by indication. Kaplan-Meier plots estimated the probability of survival up to 10 years after surgery. Multilevel Cox regression modelling, stratified on matched sets, described the association between prosthesis type and time to death, accounting for variation across hospital trusts. Results 7437 patients undergoing metal-on-metal hip resurfacing were matched to 22 311 undergoing cemented total hip replacement; 8101 patients undergoing metal-on-metal hip resurfacing were matched to 24 303 undergoing uncemented total hip replacement. 10 year rates of cumulative mortality were 271 (3.6%) for metal-on-metal hip resurfacing versus 1363 (6.1%) for cemented total hip replacement, and 239 (3.0%) for metal-on-metal hip resurfacing versus 999 (4.1%) for uncemented total hip replacement. Patients undergoing metal-on-metal hip resurfacing had an increased survival probability (hazard ratio 0.51 (95% confidence interval 0.45 to 0.59) for cemented hip replacement; 0.55 (0.47 to 0.65) for uncemented hip replacement). There was no evidence for an interaction with age or sex. Conclusions Patients with hip osteoarthritis undergoing metal-on-metal hip resurfacing have reduced mortality in the long term compared with those undergoing cemented or uncemented total hip replacement. This difference persisted after extensive adjustment for confounding factors available in our data. The study results can be applied to matched populations, which exclude patients who are very old and have had complex total hip replacements. Although residual confounding is possible, the observed effect size is large. These findings require validation in external cohorts and randomised clinical trials.	[Kendal, Adrian R.; Prieto-Alhambra, Daniel; Arden, Nigel K.; Carr, Andrew; Judge, Andrew] Univ Oxford, Botnar Res Ctr, Natl Inst Hlth Res Oxford Musculoskeletal Biomed, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Prieto-Alhambra, Daniel; Arden, Nigel K.; Judge, Andrew] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Prieto-Alhambra, Daniel] URFOA IMIM, Barcelona, Spain; [Prieto-Alhambra, Daniel] RETICEF Red Temat Invest Cooperat Envejecimiento, Barcelona, Spain; [Prieto-Alhambra, Daniel] Univ Autonoma Barcelona, Jordi Gol Primary Care Res Inst, IDIAP Inst Invest Atencio Primaria, GREMPAL Grp Recerca Malalties Prevalents Aparell, E-08193 Barcelona, Spain	University of Oxford; University of Southampton; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona	Carr, A (corresponding author), Univ Oxford, Botnar Res Ctr, Natl Inst Hlth Res Oxford Musculoskeletal Biomed, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.	andrew.carr@ndorms.ox.ac.uk		Prieto-Alhambra, Daniel/0000-0002-3950-6346; Judge, Andrew/0000-0003-3015-0432	Oxford National Institute for Health Research Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford; National Institute for Health Research [ACF-2013-13-006, NF-SI-0611-10216] Funding Source: researchfish	Oxford National Institute for Health Research Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford; National Institute for Health Research(National Institute for Health Research (NIHR))	Support was received from the Oxford National Institute for Health Research Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, University of Oxford. The views expressed in this article are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health. AK and AJ had full access to the dataset under the terms of the Hospital Episode Statistics Data Re-Use Agreement. The study sponsors had no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7; Amstutz HC, 2004, J BONE JOINT SURG AM, V86A, P1874, DOI 10.2106/00004623-200409000-00003; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Breusch SJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7137; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Costa ML, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2147; Coulter G, 2012, J BONE JOINT SURG BR, V94B, P315, DOI 10.1302/0301-620X.94B3.28185; Daniel J, 2010, J BONE JOINT SURG BR, V92B, P20, DOI 10.1302/0301-620X.92B1.21530; Daniel J, 2009, J BONE JOINT SURG BR, V91B, P176, DOI 10.1302/0301-620X.91B2.21654; Daniel J, 2004, J BONE JOINT SURG BR, V86B, P177, DOI 10.1302/0301-620X.86B2.14600; de Steiger RN, 2011, J BONE JOINT SURG AM, V93A, P2287, DOI [10.2106/JBJS.J.01727, 10.2106/JBJSJ.01727]; Donaldson AJ, 2009, BRIT J ANAESTH, V102, P12, DOI 10.1093/bja/aen328; Dunstan E, 2005, J BONE JOINT SURG BR, V87B, P628, DOI 10.1302/0301-620X.87B5.15384; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Goldsmith AAJ, 2000, P I MECH ENG H, V214, P39, DOI 10.1243/0954411001535228; Heneghan C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1349; Hirsch K, 2012, COMPUT METH PROG BIO, V107, P582, DOI 10.1016/j.cmpb.2011.05.004; Isaac GH, 2006, P I MECH ENG H, V220, P119, DOI 10.1243/095441105X68953; Kmietowicz Z, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6688; Lafont ND, 1997, CAN J ANAESTH, V44, P112, DOI 10.1007/BF03012997; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; LUMB GD, 1994, SCI TOTAL ENVIRON, V148, P185, DOI 10.1016/0048-9697(94)90395-6; McMinn DJW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3319; McMinn DJW, 2009, MODERN HIP RESURFACING, P1, DOI 10.1007/978-1-84800-088-9; Medicines and Healthcare Products Regulatory Agency, 2012, MDA2012016 MHRA; Murray DW, 2012, J BONE JOINT SURG BR, V94B, P1180, DOI 10.1302/0301-620X.94B9.29462; MURRAY DW, 1995, J BONE JOINT SURG BR, V77B, P520, DOI 10.1302/0301-620X.77B4.7615593; National Institute for Health and Care Excellence, 2002, CLIN EFF COST EFF ME; National Joint Registry, 2012, 9 NAT JOINT REG ENGL; Onega T, 2006, CANCER EPIDEM BIOMAR, V15, P1532, DOI 10.1158/1055-9965.EPI-06-0127; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Puolakka TJS, 2001, ACTA ORTHOP SCAND, V72, P433, DOI 10.1080/000164701753532745; ROSENBAUM PR, 1983, J ROY STAT SOC B MET, V45, P212; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Schaffer AW, 1999, J TOXICOL-CLIN TOXIC, V37, P839, DOI 10.1081/CLT-100102463; Schmalzried TP, 1996, J ARTHROPLASTY, V11, P322, DOI 10.1016/S0883-5403(96)80085-4; Smith AJ, 2012, BRIT MED J, P344; Smith AJ, 2012, LANCET, V380, P1759, DOI 10.1016/S0140-6736(12)60989-1; Urban RM, 2004, J ARTHROPLASTY, V19, P94, DOI 10.1016/j.arth.2004.09.013; Vendittoli PA, 2006, J BONE JOINT SURG BR, V88B, P997, DOI 10.1302/0301-620X.88B8; Visuri T, 2010, ACTA ORTHOP, V81, P77, DOI 10.3109/17453671003667150; Wroblewski BM, 1999, J BONE JOINT SURG BR, V81B, P427, DOI 10.1302/0301-620X.81B3.9521	44	43	43	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2013	347								f6549	10.1136/bmj.f6549	http://dx.doi.org/10.1136/bmj.f6549			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263GF	24284336	hybrid, Green Published			2022-12-24	WOS:000327794500001
J	Luo, HM; Zhang, Y; Wang, XQ; Yu, WZ; Wen, N; Yan, DM; Wang, HQ; Wushouer, F; Wang, HB; Xu, AQ; Zheng, JS; Li, DX; Cui, H; Wang, JP; Zhu, SL; Feng, ZJ; Cui, FQ; Ning, J; Hao, LX; Fan, CX; Ning, GJ; Yu, HJ; Wang, SW; Liu, DW; Wang, DY; Fu, JP; Gou, AL; Zhang, GM; Huang, GH; Chen, YS; Mi, SS; Liu, YM; Yin, DP; Zhu, H; Fan, XC; Li, XL; Ji, YX; Li, KL; Tang, HS; Xu, WB; Wang, Y; Yang, WZ				Luo, Hui-Ming; Zhang, Yong; Wang, Xin-Qi; Yu, Wen-Zhou; Wen, Ning; Yan, Dong-Mei; Wang, Hua-Qing; Wushouer, Fuerhati; Wang, Hai-Bo; Xu, Ai-Qiang; Zheng, Jing-Shan; Li, De-Xin; Cui, Hui; Wang, Jian-Ping; Zhu, Shuang-Li; Feng, Zi-Jian; Cui, Fu-Qiang; Ning, Jing; Hao, Li-Xin; Fan, Chun-Xiang; Ning, Gui-Jun; Yu, Hong-Jie; Wang, Shi-Wen; Liu, Da-Wei; Wang, Dong-Yan; Fu, Jian-Ping; Gou, Ai-Li; Zhang, Guo-Min; Huang, Guo-Hong; Chen, Yuan-Sheng; Mi, Sha-Sha; Liu, Yan-Min; Yin, Da-Peng; Zhu, Hui; Fan, Xin-Chun; Li, Xin-Lan; Ji, Yi-Xin; Li, Ke-Li; Tang, Hai-Shu; Xu, Wen-Bo; Wang, Yu; Yang, Wei-Zhong			Identification and Control of a Poliomyelitis Outbreak in Xinjiang, China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINE-DERIVED POLIOVIRUS; ACUTE FLACCID PARALYSIS; NETHERLANDS; TRANSMISSION; CIRCULATION	BackgroundThe last case of infection with wild-type poliovirus indigenous to China was reported in 1994, and China was certified as a poliomyelitis-free region in 2000. In 2011, an outbreak of infection with imported wild-type poliovirus occurred in the province of Xinjiang. MethodsWe conducted an investigation to guide the response to the outbreak, performed sequence analysis of the poliovirus type 1 capsid protein VP1 to determine the source, and carried out serologic and coverage surveys to assess the risk of viral propagation. Surveillance for acute flaccid paralysis was intensified to enhance case ascertainment. ResultsBetween July 3 and October 9, 2011, investigators identified 21 cases of infection with wild-type poliovirus and 23 clinically compatible cases in southern Xinjiang. Wild-type poliovirus type 1 was isolated from 14 of 673 contacts of patients with acute flaccid paralysis (2.1%) and from 13 of 491 healthy persons who were not in contact with affected persons (2.6%). Sequence analysis implicated an imported wild-type poliovirus that originated in Pakistan as the cause of the outbreak. A public health emergency was declared in Xinjiang after the outbreak was confirmed. Surveillance for acute flaccid paralysis was enhanced, with daily reporting from all public and private hospitals. Five rounds of vaccination with live, attenuated oral poliovirus vaccine (OPV) were conducted among children and adults, and 43 million doses of OPV were administered. Trivalent OPV was used in three rounds, and monovalent OPV type 1 was used in two rounds. The outbreak was stopped 1.5 months after laboratory confirmation of the index case. ConclusionsThe 2011 outbreak in China showed that poliomyelitis-free countries remain at risk for outbreaks while the poliovirus circulates anywhere in the world. Global eradication of poliomyelitis will benefit all countries, even those that are currently free of poliomyelitis.	[Luo, Hui-Ming; Yu, Wen-Zhou; Wen, Ning; Wang, Hua-Qing; Wang, Hai-Bo; Zheng, Jing-Shan; Cui, Fu-Qiang; Hao, Li-Xin; Fan, Chun-Xiang; Ning, Gui-Jun; Liu, Da-Wei; Zhang, Guo-Min; Chen, Yuan-Sheng; Liu, Yan-Min; Yin, Da-Peng; Li, Ke-Li; Wang, Yu; Yang, Wei-Zhong] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing 102206, Peoples R China; [Zhang, Yong; Yan, Dong-Mei; Li, De-Xin; Zhu, Shuang-Li; Wang, Shi-Wen; Wang, Dong-Yan; Huang, Guo-Hong; Zhu, Hui; Ji, Yi-Xin; Xu, Wen-Bo] Natl Inst Viral Dis Control & Prevent, Minist Hlth Key Lab Med Virol, Beijing, Peoples R China; [Feng, Zi-Jian] Hlth Emergency Control Ctr, Beijing, Peoples R China; [Yu, Hong-Jie] Chinese Ctr Dis Control & Prevent, Div Infect Dis Control, Beijing 102206, Peoples R China; [Wang, Xin-Qi; Wushouer, Fuerhati; Cui, Hui; Ning, Jing; Gou, Ai-Li; Fan, Xin-Chun; Li, Xin-Lan; Tang, Hai-Shu] Xinjiang Uyghur Autonomous Reg Ctr Dis Control &, Jinan, Peoples R China; [Wang, Jian-Ping; Fu, Jian-Ping; Mi, Sha-Sha] Xinjiang Prod & Construct Corps, Ctr Dis Control & Prevent, Jinan, Peoples R China; [Xu, Ai-Qiang] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Yang, WZ (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China.	wenbo_xu1@aliyun.com; wangyu@chinacdc.cn; yangwz@chinacdc.cn	Yu, Hongjie/GZK-5351-2022	Yang, Weizhong/0000-0002-6599-825X; Zhang, Yong/0000-0002-2692-5437				[Anonymous], 2000, JAMA, V283, P1414; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P104; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P153; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1393; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P157; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P425; [Anonymous], 1991, WKLY EPIDEMIOL REC, V66, P49; Arya SC, 1999, J CLIN MICROBIOL, V37, P276; Aylward B, 2011, VACCINE, V29, pD80, DOI 10.1016/j.vaccine.2011.10.005; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P1198; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P145; Chiba Y, 2001, B WORLD HEALTH ORGAN, V79, P103; ConynvanSpaendonck MAE, 1996, AM J EPIDEMIOL, V143, P929, DOI 10.1093/oxfordjournals.aje.a008836; Francis PT, 2007, LANCET, V370, P129, DOI 10.1016/S0140-6736(07)61076-9; Grassly NC, 2007, LANCET, V369, P1790; Grassly NC, 2007, LANCET, V369, P1356, DOI 10.1016/S0140-6736(07)60531-5; Le Menach A, 2011, EMERG INFECT DIS, V17, P1506, DOI 10.3201/eid1708.110195; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; National Bureau of Statistics of China, 2012, CHIN STAT YB, P101; OOSTVOGEL PM, 1994, LANCET, V344, P665, DOI 10.1016/S0140-6736(94)92091-5; Oostvogel PM, 2001, J INFECT DIS, V184, P1451, DOI 10.1086/324327; Posey DL, 1997, J INFECT DIS, V175, pS258, DOI 10.1093/infdis/175.Supplement_1.S258; Prevots DR, 1998, CLIN INFECT DIS, V26, P419, DOI 10.1086/516312; WHO, 2004, POL LAB MAN; WHO, 1988, WKLY EPIDEMIOL REC, V63, P161; Zhang Y, 2010, J INFECT DIS, V202, P1780, DOI 10.1086/657410; 2010, EURO SURVEILL, V15	27	69	76	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					1981	1990		10.1056/NEJMoa1303368	http://dx.doi.org/10.1056/NEJMoa1303368			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254KE	24256377				2022-12-24	WOS:000327163000006
J	Jonsson, R; Theander, E; Sjostrom, B; Brokstad, K; Henriksson, G				Jonsson, Roland; Theander, Elke; Sjostrom, Bitte; Brokstad, Karl; Henriksson, Gunnel			Autoantibodies Present Before Symptom Onset in Primary Sjogren Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jonsson, Roland; Brokstad, Karl] Univ Bergen, Broegelmann Res Lab, Bergen, Norway; [Theander, Elke] Lund Univ, Dept Rheumatol, S-20502 Malmo, Sweden; [Sjostrom, Bitte; Henriksson, Gunnel] Lund Univ, Dept Lab Med Malmo, S-20502 Malmo, Sweden	University of Bergen; Lund University; Lund University	Henriksson, G (corresponding author), Lund Univ, Jan Waldenstroms St 59, S-20502 Malmo, Sweden.	gunnel.henriksson@med.lu.se	Brokstad, Karl Albert/AAU-9639-2020; Brokstad, Karl Albert/N-8096-2015	Brokstad, Karl Albert/0000-0003-0593-2731; Brokstad, Karl Albert/0000-0003-0593-2731				Jonsson R, 2005, ARTHRITIS ALLIED CON, P1681; Jonsson R, 2007, ANN NY ACAD SCI, V1108, P433, DOI 10.1196/annals.1422.046; Mignogna MD, 2005, J ORAL PATHOL MED, V34, P1, DOI 10.1111/j.1600-0714.2004.00264.x; Pukkala E, 2007, ACTA ONCOL, V46, P286, DOI 10.1080/02841860701203545; Theander E, 2006, ANN RHEUM DIS, V65, P796, DOI 10.1136/ard.2005.041186; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	6	142	147	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	2013	310	17					1854	1855		10.1001/jama.2013.278448	http://dx.doi.org/10.1001/jama.2013.278448			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	246PH	24193084	Bronze			2022-12-24	WOS:000326550900020
J	Eyal, N; Kuritzkes, DR				Eyal, Nir; Kuritzkes, Daniel R.			Challenges in clinical trial design for HIV-1 cure research	LANCET			English	Editorial Material							INTERRUPTION		[Eyal, Nir] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Div Med Eth, Boston, MA 02139 USA; [Kuritzkes, Daniel R.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02139 USA; [Kuritzkes, Daniel R.] Harvard Univ, Sch Med, Boston, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kuritzkes, DR (corresponding author), Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02139 USA.	dkuritzkes@partners.org						Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Cooper DA, 2008, J INFECT DIS, V197, P775, DOI 10.1086/527399; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Elliott J, 2013, 20 C RETR OPP INF AT; Eyal N, 2014, J MED ETHICS, V40, P437, DOI 10.1136/medethics-2012-100490; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Lawrence J, 2003, NEW ENGL J MED, V349, P837, DOI 10.1056/NEJMoa035103; Lo B, 2013, CURR OPIN HIV AIDS, V8, P243, DOI 10.1097/COH.0b013e32835ea1c5; Persaud D, 2013, 20 C RETR OPP INF AT; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Tolstrup M, 2013, HIV CUR S KUAL LUMP; Worthington MG, 2003, AIDS, V17, P2145, DOI 10.1097/00002030-200309260-00026	12	32	32	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1464	1465		10.1016/S0140-6736(13)62040-1	http://dx.doi.org/10.1016/S0140-6736(13)62040-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247MR	24182529				2022-12-24	WOS:000326622500006
J	Caron, SJC				Caron, Sophie J. C.			Brains Don't Play Dice-or Do They?	SCIENCE			English	Editorial Material							IMAGING REVEALS; MUSHROOM BODY; DROSOPHILA; MAP; REPRESENTATION		NYU, Dept Neurosci, New York, NY 10032 USA	New York University	Caron, SJC (corresponding author), NYU, Dept Neurosci, 701 W 168th St, New York, NY 10032 USA.	sc2992@columbia.edu						Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Honegger KS, 2011, J NEUROSCI, V31, P11772, DOI 10.1523/JNEUROSCI.1099-11.2011; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	14	1	1	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158								10.1126/science.1245982	http://dx.doi.org/10.1126/science.1245982			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179216	Bronze			2022-12-24	WOS:000326334300033
J	Lanternier, F; Pathan, S; Vincent, QB; Liu, LY; Cypowyj, S; Prando, C; Migaud, M; Taibi, L; Ammar-Khodja, A; Boudghene Stambouli, O; Guellil, B; Jacobs, F; Goffard, JC; Schepers, K; del Marmol, V; Boussofara, L; Denguezli, M; Larif, M; Bachelez, H; Michel, L; Lefranc, G; Hay, R; Jouvion, G; Chretien, F; Fraitag, S; Bougnoux, ME; Boudia, M; Abel, L; Lortholary, O; Casanova, JL; Picard, C; Grimbacher, B; Puel, A				Lanternier, Fanny; Pathan, Saad; Vincent, Quentin B.; Liu, Luyan; Cypowyj, Sophie; Prando, Carolina; Migaud, Melanie; Taibi, Lynda; Ammar-Khodja, Aomar; Boudghene Stambouli, Omar; Guellil, Boumediene; Jacobs, Frederique; Goffard, Jean-Christophe; Schepers, Kinda; del Marmol, Veronique; Boussofara, Lobna; Denguezli, Mohamed; Larif, Molka; Bachelez, Herve; Michel, Laurence; Lefranc, Gerard; Hay, Rod; Jouvion, Gregory; Chretien, Fabrice; Fraitag, Sylvie; Bougnoux, Marie-Elisabeth; Boudia, Merad; Abel, Laurent; Lortholary, Olivier; Casanova, Jean-Laurent; Picard, Capucine; Grimbacher, Bodo; Puel, Anne			Deep Dermatophytosis and Inherited CARD9 Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; ADAPTER PROTEIN CARD9; NF-KAPPA-B; TRICHOPHYTON-RUBRUM; ANTIFUNGAL IMMUNITY; IMMUNOCOMPROMISED PATIENT; STAT1 MUTATIONS; DISEASE; INNATE; INFECTION	BackgroundDeep dermatophytosis is a severe and sometimes life-threatening fungal infection caused by dermatophytes. It is characterized by extensive dermal and subcutaneous tissue invasion and by frequent dissemination to the lymph nodes and, occasionally, the central nervous system. The condition is different from common superficial dermatophyte infection and has been reported in patients with no known immunodeficiency. Patients are mostly from North African, consanguineous, multiplex families, which strongly suggests a mendelian genetic cause. MethodsWe studied the clinical features of deep dermatophytosis in 17 patients with no known immunodeficiency from eight unrelated Tunisian, Algerian, and Moroccan families. Because CARD9 (caspase recruitment domain-containing protein 9) deficiency has been reported in an Iranian family with invasive fungal infections, we also sequenced CARD9 in the patients. ResultsFour patients died, at 28, 29, 37, and 39 years of age, with clinically active deep dermatophytosis. No other severe infections, fungal or otherwise, were reported in the surviving patients, who ranged in age from 37 to 75 years. The 15 Algerian and Tunisian patients, from seven unrelated families, had a homozygous Q289X CARD9 allele, due to a founder effect. The 2 Moroccan siblings were homozygous for the R101C CARD9 allele. Both alleles are rare deleterious variants. The familial segregation of these alleles was consistent with autosomal recessive inheritance and complete clinical penetrance. ConclusionsAll the patients with deep dermatophytosis had autosomal recessive CARD9 deficiency. Deep dermatophytosis appears to be an important clinical manifestation of CARD9 deficiency. (Funded by Agence Nationale pour la Recherche and others.) Dermatophyte infections are unusual but can cause serious invasive disease. In this report, autosomal recessive CARD9 deficiency indicated a potential genetic susceptibility to deep dermatophytosis, a severe invasive fungal infection. Deep dermatophytosis is a rare, invasive, sometimes life-threatening, fungal infection caused by dermatophytes.(1) These filamentous fungi are ubiquitous and usually cause benign infections that are limited to keratinized tissues and lead to onychomycosis, tinea corporis, tinea cruris, tinea pedis, or tinea capitis.(2) In deep dermatophytosis, dermatophytes invade the dermis and hypodermis and disseminate to the skin, hair, nails, lymph nodes, and brain.(3) Deep dermatophytosis has been reported in patients with the human immunodeficiency virus and patients who are receiving immunosuppressive therapy.(3) It was first described in 1959 in otherwise apparently healthy persons as dermatophytic disease.(1) Forty-five cases have been reported ...	[Lanternier, Fanny; Vincent, Quentin B.; Liu, Luyan; Migaud, Melanie; Abel, Laurent; Casanova, Jean-Laurent; Picard, Capucine; Puel, Anne] Necker Med Sch, INSERM, U980, Lab Human Genet Infect Dis,Necker Branch,Imagine, F-75015 Paris, France; [Lanternier, Fanny; Vincent, Quentin B.; Liu, Luyan; Migaud, Melanie; Abel, Laurent; Casanova, Jean-Laurent; Picard, Capucine; Puel, Anne] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Lanternier, Fanny; Lortholary, Olivier] Necker Enfants Malades Hosp, AP HP, Infect Dis & Trop Med Unit, Paris, France; [Casanova, Jean-Laurent] Necker Enfants Malades Hosp, AP HP, Pediat Hematol Immunol Unit, Paris, France; [Bachelez, Herve] Univ Paris 05, Dermatol Unit, Paris, France; [Bachelez, Herve] Skin Res Inst, INSERM, U697, Necker Enfants Malades Hosp,U781, Paris, France; [Jouvion, Gregory; Chretien, Fabrice] Inst Pasteur, Infect & Epidemiol Dept, Paris, France; [Lortholary, Olivier] Inst Pasteur, Natl Reference Ctr Invas Mycoses & Antifungals, Mol Mycol Unit, Paris, France; [Fraitag, Sylvie] Necker Enfants Malades Hosp, AP HP, Pathol Unit, Paris, France; [Bougnoux, Marie-Elisabeth] Necker Enfants Malades Hosp, AP HP, Microbiol Unit, Paris, France; [Picard, Capucine] Necker Enfants Malades Hosp, AP HP, Study Ctr Immunodeficiency, Paris, France; [Pathan, Saad; Grimbacher, Bodo] UCL, Royal Free Hosp, London, England; [Hay, Rod] Willan House, Int Fdn Dermatol, London, England; [Cypowyj, Sophie; Prando, Carolina; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [Taibi, Lynda; Ammar-Khodja, Aomar] Mustapha Hosp, Dermatol Unit, Algiers, Algeria; [Taibi, Lynda; Ammar-Khodja, Aomar] Fac Med, Algiers, Algeria; [Boudghene Stambouli, Omar; Boudia, Merad] Dr T Damerdji Tlemcen Hosp, Dermatol Unit, Tilimsen, Algeria; [Boudghene Stambouli, Omar; Boudia, Merad] Aboubakr Belkaid Univ, Tilimsen, Algeria; [Guellil, Boumediene] Hassani Abdelkader Hosp, Dermatol Unit, Sidi Bel Abbes, Algeria; [Guellil, Boumediene] Fac Med, Djillali Liabes Univ, Sidi Bel Abbes, Algeria; [Jacobs, Frederique; Goffard, Jean-Christophe; Schepers, Kinda] Univ Libre Brussels, Erasme Hosp, Infect Dis Unit, B-1050 Brussels, Belgium; [del Marmol, Veronique] Univ Libre Brussels, Erasme Hosp, Dermatol Unit, B-1050 Brussels, Belgium; [Boussofara, Lobna; Denguezli, Mohamed; Larif, Molka] Farhat Hached Hosp, Dermatol Unit, Sousse, Tunisia; [Lefranc, Gerard] Inst Human Genet, Mol Immunogenet Unit, Natl Ctr Sci Res, UPR 1142, Montpellier, France; [Lefranc, Gerard] Univ Montpellier 2, Montpellier, France; [Grimbacher, Bodo] Univ Hosp Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Rockefeller University; Universite Abou Bekr Belkaid; University Djillali Liabes Sidi Bel Abbes; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite de Sousse; Hopital Farhat Hached; Universite de Montpellier; Universite de Montpellier; University of Freiburg	Puel, A (corresponding author), Necker Med Sch, INSERM, U980, Lab Human Genet Infect Dis,Necker Branch,Imagine, 156 Rue Vaugirard, F-75015 Paris, France.	jean-laurent.casanova@mail.rockefeller.edu; anne.puel@inserm.fr	Boussofara, Lobna/K-6428-2019; Jouvion, Grégory/AAL-2620-2021; del marmol, veronique/AAZ-8117-2020; Picard, Capucine/H-3914-2017; Puel, Anne/H-7305-2017; Abel, Laurent/H-8888-2017; Michel, Laurence/E-8605-2017; Casanova, Jean-Laurent/I-3418-2017; Migaud, Mélanie/H-8044-2017; Prando, Carolina/C-4689-2015; Lanternier, Fanny/AAQ-2815-2021; Chretien, fabrice B/D-4035-2018	Boussofara, Lobna/0000-0003-0041-8741; Picard, Capucine/0000-0001-8788-5056; Puel, Anne/0000-0003-2603-0323; Abel, Laurent/0000-0001-7016-6493; Migaud, Mélanie/0000-0003-3062-1214; Prando, Carolina/0000-0002-9570-9770; Chretien, fabrice B/0000-0002-2794-1383; sharma, vishnu/0000-0001-8266-8167; Pathan, Saad/0000-0003-3312-9049; Goffard, Jean-Christophe/0000-0002-2730-7673; PATHAN, SAAD/0000-0001-6818-8765; Casanova, Jean-Laurent/0000-0002-7782-4169; bachelez, herve/0000-0003-3567-9095; Vincent, Quentin/0000-0001-6030-5912; Denguezli, Mohamed/0000-0002-4176-2744	l'Agence Nationale pour la Recherche [ANR GENCMCD 11-BSV3-005-01]; European Commission [EURO-GENE-SCAN 223293, EURO-PADnet HEALTH-F2-2008-201549]; Marie Curie Excellence program [MEXT-CT-2006-042316]; German Federal Ministry of Education and Research [BMBF 01 EO 0308]; National Center for Research Resources; National Center for Advancing Translational Sciences [8UL1TR00004]; National Institutes of Health; Rockefeller University; INSERM, Paris Descartes University; St. Giles Foundation; French Government Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]; CMIT (French Faculties College of Infectious Diseases); INSERM; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043, UL1TR000004] Funding Source: NIH RePORTER	l'Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie Curie Excellence program; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; INSERM, Paris Descartes University; St. Giles Foundation; French Government Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases(French National Research Agency (ANR)); CMIT (French Faculties College of Infectious Diseases); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by grants from l'Agence Nationale pour la Recherche (ANR GENCMCD 11-BSV3-005-01, to Dr. Puel); the European Commission Sixth and Seventh Framework Programs (EURO-GENE-SCAN 223293 and EURO-PADnet HEALTH-F2-2008-201549); the Marie Curie Excellence program (MEXT-CT-2006-042316); the German Federal Ministry of Education and Research (BMBF 01 EO 0308); the National Center for Research Resources and the National Center for Advancing Translational Sciences (8UL1TR00004), National Institutes of Health; Rockefeller University; INSERM, Paris Descartes University; the St. Giles Foundation; the French Government Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID); and the CMIT (French Faculties College of Infectious Diseases) and INSERM (both to Dr. Lanternier). Janssen-Cilag France provided itraconazole for compassionate use in the treatment of some patients, thanks to the intervention of Dr. Bessis.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; ARAVIYSKY AN, 1975, MYCOPATHOLOGIA, V56, P47, DOI 10.1007/BF00493584; BEIRANA L., 1959, Dermatologia, Mexico, V3, P4; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; BLANK F, 1957, Dermatologica, V115, P40; BOUDGHENE-STAMBOULI O, 1992, Journal de Mycologie Medicale, V2, P106; Boudghene-Stambouli O, 1998, ANN DERMATOL VENER, V125, P705; BOUDGHENESTAMBOULI O, 1991, ANN DERMATOL VENER, V118, P17; BOUDGHENESTAMBOULI O, 1990, B SOC PATHOL EXOT, V83, P170; BOUDGHENESTAMBOULI O, 1989, ANN DERMATOL VENER, V116, P725; Casanova JL, 2013, ANNU REV GENOM HUM G, V14, P215, DOI 10.1146/annurev-genom-091212-153448; Chastain MA, 2001, CUTIS, V67, P457; Cheikhrouhou F, 2010, ANN DERMATOL VENER, V137, P208, DOI 10.1016/j.annder.2010.01.006; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; DEMIDOVICH CW, 1995, CUTIS, V55, P237; Destombes P, 1975, Bull Soc Pathol Exot Filiales, V68, P443; Dorhoi A, 2010, J EXP MED, V207, P777, DOI 10.1084/jem.20090067; Drewniak A, 2013, BLOOD, V121, P2385, DOI 10.1182/blood-2012-08-450551; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Filipe-Santos O, 2006, J EXP MED, V203, P1745, DOI 10.1084/jem.20060085; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; HADIDA E., 1959, Algerie eed., V63, P303; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hara H, 2009, TRENDS IMMUNOL, V30, P234, DOI 10.1016/j.it.2009.03.002; HIRONAGA M, 1983, ARCH DERMATOL, V119, P482, DOI 10.1001/archderm.119.6.482; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Ilkit M, 2012, MED MYCOL, V50, P449, DOI 10.3109/13693786.2012.669503; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LIAUTAUD B, 1984, B SOC PATHOL EXOT, V77, P637; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Majocchi D., 1883, B R ACAD MED ROMA, V9, P220; Marconi VC, 2010, MED MYCOL, V48, P518, DOI 10.3109/13693780903213512; Nir-Paz R, 2003, J CLIN MICROBIOL, V41, P5298, DOI 10.1128/JCM.41.11.5298-5301.2003; Oliveira H, 1960, J MEDICO, V41, P626; Pelevine A., 1927, ANN DERMATOL SYPHIL, V8, P403; Pruszkowski A, 1995, ANN DERMATOL VENER S, V122, P55; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, CURR OPIN IMMUNOL, V22, P467, DOI 10.1016/j.coi.2010.06.009; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Seebacher C, 2008, MYCOPATHOLOGIA, V166, P335, DOI 10.1007/s11046-008-9100-9; Sequeira JH., 1912, BRIT J DERMATOL, P207; Smith KJ, 2001, BRIT J DERMATOL, V145, P344, DOI 10.1046/j.1365-2133.2001.04331.x; Tejasvi T, 2005, CLIN EXP DERMATOL, V30, P506, DOI 10.1111/j.1365-2230.2005.01839.x; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; Vinh DC, 2011, LANCET INFECT DIS, V11, P780, DOI 10.1016/S1473-3099(11)70217-1	49	227	234	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1704	1714		10.1056/NEJMoa1208487	http://dx.doi.org/10.1056/NEJMoa1208487			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	243IY	24131138	Green Accepted			2022-12-24	WOS:000326311300008
J	Enquist-Newman, M; Faust, AME; Bravo, DD; Santos, CNS; Raisner, RM; Hanel, A; Sarvabhowman, P; Le, C; Regitsky, DD; Cooper, SR; Peereboom, L; Clark, A; Martinez, Y; Goldsmith, J; Cho, MY; Donohoue, PD; Luo, L; Lamberson, B; Tamrakar, P; Kim, EJ; Villari, JL; Gill, A; Tripathi, SA; Karamchedu, P; Paredes, CJ; Rajgarhia, V; Kotlar, HK; Bailey, RB; Miller, DJ; Ohler, NL; Swimmer, C; Yoshikuni, Y				Enquist-Newman, Maria; Faust, Ann Marie E.; Bravo, Daniel D.; Santos, Christine Nicole S.; Raisner, Ryan M.; Hanel, Arthur; Sarvabhowman, Preethi; Le, Chi; Regitsky, Drew D.; Cooper, Susan R.; Peereboom, Lars; Clark, Alana; Martinez, Yessica; Goldsmith, Joshua; Cho, Min Y.; Donohoue, Paul D.; Luo, Lily; Lamberson, Brigit; Tamrakar, Pramila; Kim, Edward J.; Villari, Jeffrey L.; Gill, Avinash; Tripathi, Shital A.; Karamchedu, Padma; Paredes, Carlos J.; Rajgarhia, Vineet; Kotlar, Hans Kristian; Bailey, Richard B.; Miller, Dennis J.; Ohler, Nicholas L.; Swimmer, Candace; Yoshikuni, Yasuo			Efficient ethanol production from brown macroalgae sugars by a synthetic yeast platform	NATURE			English	Article							URONIC-ACID; METABOLISM; MANNITOL; SYSTEMS	The increasing demands placed on natural resources for fuel and food production require that we explore the use of efficient, sustainable feedstocks such as brown macroalgae. The full potential of brown macroalgae as feedstocks for commercial-scale fuel ethanol production, however, requires extensive re-engineering of the alginate and mannitol catabolic pathways(1-3) in the standard industrial microbe Saccharomyces cerevisiae. Here we present the discovery of an alginate monomer (4-deoxy-L-erythro-5-hexoseulose uronate, or DEHU) transporter from the alginolytic eukaryote Asteromyces cruciatus(4). The genomic integration and overexpression of the gene encoding this transporter, together with the necessary bacterial alginate and deregulated native mannitol catabolism genes, conferred the ability of an S. cerevisiae strain to efficiently metabolize DEHU and mannitol. When this platform was further adapted to grow on mannitol and DEHU under anaerobic conditions, it was capable of ethanol fermentation from mannitol and DEHU, achieving titres of 4.6%(v/v) (36.2 g l(-1)) and yields up to 83% of the maximum theoretical yield from consumed sugars. These results show that all major sugars in brown macroalgae can be used as feedstocks for biofuels and value-added renewable chemicals in a manner that is comparable to traditional arable-land-based feedstocks.	[Enquist-Newman, Maria; Faust, Ann Marie E.; Bravo, Daniel D.; Santos, Christine Nicole S.; Raisner, Ryan M.; Hanel, Arthur; Sarvabhowman, Preethi; Le, Chi; Regitsky, Drew D.; Cooper, Susan R.; Clark, Alana; Martinez, Yessica; Goldsmith, Joshua; Cho, Min Y.; Donohoue, Paul D.; Luo, Lily; Lamberson, Brigit; Tamrakar, Pramila; Kim, Edward J.; Villari, Jeffrey L.; Gill, Avinash; Tripathi, Shital A.; Karamchedu, Padma; Paredes, Carlos J.; Rajgarhia, Vineet; Bailey, Richard B.; Ohler, Nicholas L.; Swimmer, Candace; Yoshikuni, Yasuo] Bio Architecture Lab Inc, Berkeley, CA 94710 USA; [Peereboom, Lars; Miller, Dennis J.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Kotlar, Hans Kristian] Statoil ASA, Statoil Res Ctr, N-7005 Trondheim, Norway; [Yoshikuni, Yasuo] BALChile SA, Santiago 7550000, Chile; [Yoshikuni, Yasuo] BAL Biofuels SA, Santiago 7550000, Chile	Michigan State University; Equinor	Yoshikuni, Y (corresponding author), Bio Architecture Lab Inc, 604 Bancroft Way,Suite A, Berkeley, CA 94710 USA.	candacesw@yahoo.com; yoshikuni@ba-lab.com	Yoshikuni, Yasuo/K-7741-2019; Yoshikuni, Yasuo/A-8804-2019	Yoshikuni, Yasuo/0000-0002-8372-640X; Cooper, Susan/0000-0002-1608-6713; Donohoue, Paul/0000-0003-0426-3927; bravo, daniel/0000-0003-1872-6929	DOE under an Advanced Research Projects Agency-Energy (ARPA-E) award [DE-AR0000006]; CORFO INNOVA CHILE [09CTEI-6866]; Statoil ASA; agency of the US government	DOE under an Advanced Research Projects Agency-Energy (ARPA-E) award; CORFO INNOVA CHILE; Statoil ASA; agency of the US government	We thank R. Schekman, J. H. D. Cate and P. A. Silver for critical discussion and suggestions. This work is supported by the DOE under an Advanced Research Projects Agency-Energy (ARPA-E) award (DE-AR0000006), by CORFO INNOVA CHILE (codigo 09CTEI-6866), and by Statoil ASA. This report was prepared as an account of work sponsored by an agency of the US government. Neither the US government nor any agency thereof, nor any of their employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not necessarily constitute or imply its endorsement, recommendation, or favouring by the US government or any agency thereof. The views and opinions of authors expressed herein do not necessarily state or reflect those of the US government or any agency thereof.	Chapman VJ, 1970, SEAWEEDS THEIR USES; Food and Agriculture Organization of the United Nations, 2009, EXP M FEED WORLD 205; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hilditch S, 2010, THESIS U HELSINKI; Horn SJ, 2000, J IND MICROBIOL BIOT, V25, P249, DOI 10.1038/sj.jim.7000065; Interagency Agricultural Projections Committee, 2012, USDA AGR PROJ 2021; International Energy Agency, 2012, WORLD EN OUTL 2012; Jongkees SAK, 2011, J AM CHEM SOC, V133, P19334, DOI 10.1021/ja209067v; Lau MW, 2009, P NATL ACAD SCI USA, V106, P1368, DOI 10.1073/pnas.0812364106; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/NCHEMBIO.970, 10.1038/nchembio.970]; Mairta P. K., 1971, J BIOL CHEM, V246, P425; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Noiraud N, 2001, PLANT CELL, V13, P695, DOI 10.1105/tpc.13.3.695; Patel MK., 2006, MEDIUM LONG TERM OPP; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; PREISS J, 1962, J BIOL CHEM, V237, P317; QUAIN DE, 1987, J GEN MICROBIOL, V133, P1675; Roesijadi G., 2010, PNNL19944; Santos CNS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3503; SCHAUMANN K, 1995, HELGOLANDER MEERESUN, V49, P159, DOI 10.1007/BF02368346; Stewart WM, 2005, AGRON J, V97, P1, DOI 10.2134/agronj2005.0001; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; United Nations Educational Scientific and Cultural Organization., 2012, 4 UN ED SCI CULT ORG; Valdes C., 2011, Amber Waves, V9, P38; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wheeler KA, 1996, BIOCHEM J, V315, P195, DOI 10.1042/bj3150195; World Population Prospects, 2013, 2012 REV, V1; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	31	235	246	10	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					239	+		10.1038/nature12771	http://dx.doi.org/10.1038/nature12771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24291791				2022-12-24	WOS:000329441500043
J	Francesconi, M; Lehner, B				Francesconi, Mirko; Lehner, Ben			The effects of genetic variation on gene expression dynamics during development	NATURE			English	Article							CAENORHABDITIS-ELEGANS; C. ELEGANS; SELECTION; GENOTYPE; ROLES	The development of a multicellular organism and physiological responses require massive coordinated changes in gene expression across several cell and tissue types(1-3). Polymorphic regions of the genome that influence gene expression levels have been identified by expression quantitative trait locus (eQTL) mapping in many species(4-6), including loci that have cell-dependent(7,8), tissue-dependent(9) and age-dependent(10) effects. However, there has been no comprehensive characterization of how polymorphisms influence the complex dynamic patterns of gene expression that occur during development and in physiology. Here we describe an efficient experimental design to infer gene expression dynamics from single expression profiles in different genotypes, and apply it to characterize the effect of local (cis) and distant (trans) genetic variation on gene expression at high temporal resolution throughout a 12-hour period of the development of Caenorhabditis elegans. Taking dynamic variation into account identifies >50% more cis-eQTLs, including more than 900 that alter the dynamics of expression during this period. Local sequence polymorphisms extensively affect the timing, rate, magnitude and shape of expression changes. Indeed, many local sequence variants both increase and decrease gene expression, depending on the time-point profiled. Expression dynamics during this 12-hour period are also influenced extensively in trans by distal loci. In particular, several trans loci influence genes with quite diverse dynamic expression patterns, but they do so primarily during a common time interval. Trans loci can therefore act as modifiers of expression during a particular period of development. This study provides the first characterization, to our knowledge, of the effect of local and distant genetic variation on the dynamics of gene expression throughout an extensive time period. Moreover, the approach developed here should facilitate the genetic dissection of other dynamic processes, including potentially development, physiology and disease progression in humans.	[Francesconi, Mirko; Lehner, Ben] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain; [Francesconi, Mirko; Lehner, Ben] UPF, Barcelona 08003, Spain; [Lehner, Ben] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Lehner, B (corresponding author), Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Dr Aiguader 88, Barcelona 08003, Spain.	ben.lehner@crg.eu	francesconi, mirko/O-8080-2015; Lehner, Ben/L-3413-2014; Lehner, Ben/ABH-6562-2020	francesconi, mirko/0000-0002-8702-0877; Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124	ERASysBio + ERANET 'GRAPPLE'; ERC; MICINN [BFU2008-00365, BFU2011-26206]; AGAUR; EMBO; EU [277899]; EMBL-CRG Systems Biology Program; ICREA Funding Source: Custom	ERASysBio + ERANET 'GRAPPLE'; ERC(European Research Council (ERC)European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); EMBO(European Molecular Biology Organization (EMBO)); EU(European Commission); EMBL-CRG Systems Biology Program; ICREA(ICREA)	This work was funded by ERASysBio + ERANET 'GRAPPLE', an ERC Starting Grant, MICINN BFU2008-00365 and BFU2011-26206, AGAUR, the EMBO Young Investigator Program, EU Framework 7 project 277899 4DCellFate, and by the EMBL-CRG Systems Biology Program. We thank J. Kammenga, B. Snoek, M. Sterken and F. Supek for discussions and/or comments on the manuscript.	Ackermann M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003514; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Capra EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004055; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gerrits A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000692; Gutteling EW, 2007, HEREDITY, V98, P28, DOI 10.1038/sj.hdy.6800894; Kirienko NV, 2007, DEV BIOL, V305, P674, DOI 10.1016/j.ydbio.2007.02.021; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Michaelson JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-502; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rockman MV, 2008, GENETICS, V179, P1069, DOI 10.1534/genetics.107.083873; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Tormene P, 2009, ARTIF INTELL MED, V45, P11, DOI 10.1016/j.artmed.2008.11.007; Vinuela A, 2010, GENOME RES, V20, P929, DOI 10.1101/gr.102160.109; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179	28	78	79	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					208	+		10.1038/nature12772	http://dx.doi.org/10.1038/nature12772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24270809				2022-12-24	WOS:000329441500037
J	Elahi, S; Ertelt, JM; Kinder, JM; Jiang, TT; Zhang, XZ; Xin, LJ; Chaturvedi, V; Strong, BS; Qualls, JE; Steinbrecher, KA; Kalfa, TA; Shaaban, AF; Way, SS				Elahi, Shokrollah; Ertelt, James M.; Kinder, Jeremy M.; Jiang, Tony T.; Zhang, Xuzhe; Xin, Lijun; Chaturvedi, Vandana; Strong, Beverly S.; Qualls, Joseph E.; Steinbrecher, Kris A.; Kalfa, Theodosia A.; Shaaban, Aimen F.; Way, Sing Sing			Immunosuppressive CD71(+) erythroid cells compromise neonatal host defence against infection	NATURE			English	Article							RED-BLOOD-CELLS; TUMOR-NECROSIS-FACTOR; TNF-ALPHA; IMMUNE; RESPONSES; ACTIVATION; RESISTANCE; NEWBORNS; DISTINCT; FLORA	Newborn infants are highly susceptible to infection. This defect in host defence has generally been ascribed to the immaturity of neonatal immune cells; however, the degree of hyporesponsiveness is highly variable and depends on the stimulation conditions(1-7). These discordant responses illustrate the need for a more unified explanation for why immunity is compromised in neonates. Here we show that physiologically enriched CD71(+) erythroid cells in neonatalmice and human cord blood have distinctive immunosuppressive properties. The production of innate immune protective cytokines by adult cells is diminished after transfer to neonatal mice or after co-culture with neonatal splenocytes. Neonatal CD71(+) cells express the enzyme arginase-2, and arginase activity is essential for the immunosuppressive properties of these cells because molecular inhibition of this enzyme or supplementation with L-arginine overrides immunosuppression. In addition, the ablation of CD71(+) cells in neonatal mice, or the decline in number of these cells as postnatal development progresses parallels the loss of suppression, and restored resistance to the perinatal pathogens Listeria monocytogenes and Escherichia coli(8,9). However, CD71(+) cell-mediated susceptibility to infection is counterbalanced by CD71(+) cell-mediated protection against aberrant immune cell activation in the intestine, where colonization with commensal microorganisms occurs swiftly after parturition(10,11). Conversely, circumventing such colonization by using antimicrobials or gnotobiotic germ-free mice overrides these protective benefits. Thus, CD71(+) cells quench the excessive inflammation induced by abrupt colonization with commensal microorganisms after parturition. This finding challenges the idea that the susceptibility of neonates to infection reflects immune-cell-intrinsic defects and instead highlights processes that are developmentally more essential and inadvertently mitigate innate immune protection. We anticipate that these results will spark renewed investigation into the need for immunosuppression in neonates, as well as improved strategies for augmenting host defence in this vulnerable population.	[Elahi, Shokrollah; Ertelt, James M.; Kinder, Jeremy M.; Jiang, Tony T.; Zhang, Xuzhe; Xin, Lijun; Chaturvedi, Vandana; Qualls, Joseph E.; Way, Sing Sing] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Elahi, Shokrollah; Ertelt, James M.; Kinder, Jeremy M.; Jiang, Tony T.; Zhang, Xuzhe; Xin, Lijun; Chaturvedi, Vandana; Qualls, Joseph E.; Way, Sing Sing] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45229 USA; [Strong, Beverly S.; Shaaban, Aimen F.] Cincinnati Childrens Hosp Med Ctr, Ctr Fetal Cellular & Mol Therapy, Cincinnati, OH 45229 USA; [Steinbrecher, Kris A.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol, Cincinnati, OH 45229 USA; [Kalfa, Theodosia A.] Cincinnati Childrens Hosp Med Ctr, Div Hematol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Way, SS (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	singsing.way@cchmc.org	Zhang, Xuzhe/CAA-2560-2022	Kinder, Jeremy/0000-0001-5145-1344; Qualls, Joseph/0000-0002-0113-2166; Kalfa, Theodosia/0000-0002-0426-9686; Elahi, Shokrollah/0000-0002-7215-2009; Shaaban, Aimen/0000-0002-9459-107X; Way, Sing Sing/0000-0001-8948-1952	NIAID [R01AI087830, R01AI100934]; NHLBI [R01HL103745]; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103745, R01HL116352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100934, R01AI087830, R21AI107274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Haslam, M. Hostetter, L. Muglia, J. Whitsett and C. Wilson for discussions, J. Mortensen for help with anaerobic cultures, and K. Eaton, C. Schray and the University of Michigan Unit for Laboratory Animal Medicine for providing germ-free mice. We thank the Mount Auburn OB-GYN associates, OB-GYN residents, and the University and Christ Hospital labour and delivery nursing staff for collecting cord blood, the Cell Processing and Manipulation Core for obtaining peripheral blood from adult donors, and the CCHMC Translational Research Trials Office for providing the regulatory and administrative support for studies with human cells. This research was supported by NIAID (R01AI087830 and R01AI100934) (S. S. W.) and NHLBI (R01HL103745) (A. F. S.). S. S. W. holds an Investigator in the Pathogenesis of Infectious Disease award from the Burroughs Wellcome Fund.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Akinosoglou KS, 2012, HEMATOLOGY, V17, P106, DOI 10.1179/102453312X13221316477336; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003; DUCLUZEAU R, 1983, ANN RECH VET, V14, P354; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; HAVELL EA, 1989, J IMMUNOL, V143, P2894; Hermansen MC, 2001, ARCH DIS CHILD-FETAL, V84, pF211, DOI 10.1136/fn.84.3.F211; Jackson A, 2010, J IMMUNOL, V185, P6198, DOI 10.4049/jimmunol.1001198; Kalfa TA, 2010, HAEMATOL-HEMATOL J, V95, P27, DOI 10.3324/haematol.2009.006239; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Millington Owain R, 2006, J Biol, V5, P5, DOI 10.1186/jbiol34; Mold JE, 2012, ADV IMMUNOL, V115, P73, DOI 10.1016/B978-0-12-394299-9.00003-5; Morera D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-89; Morris SM, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3135pe27; Muszynski J, 2012, TRANSFUSION, V52, P794, DOI 10.1111/j.1537-2995.2011.03348.x; NAKANE A, 1988, INFECT IMMUN, V56, P2563, DOI 10.1128/IAI.56.10.2563-2569.1988; Opiela SJ, 2008, BLOOD, V112, P1530, DOI 10.1182/blood-2007-08-106500; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Prins HA, 2001, SHOCK, V16, P113, DOI 10.1097/00024382-200116020-00005; ROTIMI VO, 1981, J MED MICROBIOL, V14, P51, DOI 10.1099/00222615-14-1-51; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; VONKONIG CHW, 1988, INFECTION, V16, pS112, DOI 10.1007/BF01639732; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002	30	238	251	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					158	+		10.1038/nature12675	http://dx.doi.org/10.1038/nature12675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24196717	Green Accepted			2022-12-24	WOS:000327851700051
J	Hoornweg, D; Bhada-Tata, P; Kennedy, C				Hoornweg, Daniel; Bhada-Tata, Perinaz; Kennedy, Chris			Waste production must peak this century	NATURE			English	Editorial Material							URBAN		[Hoornweg, Daniel] Univ Ontario, Inst Technol, Oshawa, ON, Canada; [Kennedy, Chris] Univ Toronto, Toronto, ON M5S 1A1, Canada	Ontario Tech University; University of Toronto	Hoornweg, D (corresponding author), Univ Ontario, Inst Technol, Oshawa, ON, Canada.	daniel.hoornweg@uoit.ca		Hoornweg, Daniel/0000-0002-2340-7204; Kennedy, Christopher/0000-0001-8812-4451				Ausubel JH, 2008, P NATL ACAD SCI USA, V105, P12774, DOI 10.1073/pnas.0806099105; Dyson B, 2005, WASTE MANAGE, V25, P669, DOI 10.1016/j.wasman.2004.10.005; Eriksson O, 2005, J CLEAN PROD, V13, P241, DOI 10.1016/j.jclepro.2004.02.018; Hoornweg D., 2012, WHAT WASTE GLOBAL RE; International Institute for Applied Systems Analysis, 2012, SSP DAT; International Solid Waste Association, 2012, GLOB WAST MAN; Kennedy C, 2012, J IND ECOL, V16, P780, DOI 10.1111/j.1530-9290.2012.00548.x; Kriegler E, 2012, GLOBAL ENVIRON CHANG, V22, P807, DOI 10.1016/j.gloenvcha.2012.05.005; Van Behkel R, 2009, ENVIRON SCI TECHNOL, V43, P1271, DOI 10.1021/es803319r	9	336	350	16	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					615	617		10.1038/502615a	http://dx.doi.org/10.1038/502615a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24180015	Bronze			2022-12-24	WOS:000326293200021
J	Williams, SCP				Williams, Sarah C. P.			ALZHEIMER'S DISEASE Mapping the brain's decline	NATURE			English	Editorial Material																		Braskie MN, 2011, J NEUROSCI, V31, P6764, DOI 10.1523/JNEUROSCI.5794-10.2011; Guerreiro R., 2013, NEW ENGL J MED, V386, P117; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Ryan NS, 2013, BRAIN, V136, P1399, DOI 10.1093/brain/awt065; Vemuri P, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt47	6	11	11	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					S84	S85		10.1038/502S84a	http://dx.doi.org/10.1038/502S84a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24187700				2022-12-24	WOS:000326293200003
J	Lajoie, MJ; Rovner, AJ; Goodman, DB; Aerni, HR; Haimovich, AD; Kuznetsov, G; Mercer, JA; Wang, HH; Carr, PA; Mosberg, JA; Rohland, N; Schultz, PG; Jacobson, JM; Rinehart, J; Church, GM; Isaacs, FJ				Lajoie, Marc J.; Rovner, Alexis J.; Goodman, Daniel B.; Aerni, Hans-Rudolf; Haimovich, Adrian D.; Kuznetsov, Gleb; Mercer, Jaron A.; Wang, Harris H.; Carr, Peter A.; Mosberg, Joshua A.; Rohland, Nadin; Schultz, Peter G.; Jacobson, Joseph M.; Rinehart, Jesse; Church, George M.; Isaacs, Farren J.			Genomically Recoded Organisms Expand Biological Functions	SCIENCE			English	Article							UNNATURAL AMINO-ACIDS; GENETIC-CODE; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; EVOLUTION; GENOME; PHOSPHOSERINE; REASSIGNMENT; SUPPRESSION; RIBOSOME	We describe the construction and characterization of a genomically recoded organism (GRO). We replaced all known UAG stop codons in Escherichia coli MG1655 with synonymous UAA codons, which permitted the deletion of release factor 1 and reassignment of UAG translation function. This GRO exhibited improved properties for incorporation of nonstandard amino acids that expand the chemical diversity of proteins in vivo. The GRO also exhibited increased resistance to T7 bacteriophage, demonstrating that new genetic codes could enable increased viral resistance.	[Lajoie, Marc J.; Goodman, Daniel B.; Kuznetsov, Gleb; Mosberg, Joshua A.; Rohland, Nadin; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lajoie, Marc J.; Mosberg, Joshua A.] Harvard Univ, Program Chem Biol, Cambridge, MA 02138 USA; [Rovner, Alexis J.; Haimovich, Adrian D.; Isaacs, Farren J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Rovner, Alexis J.; Aerni, Hans-Rudolf; Haimovich, Adrian D.; Rinehart, Jesse; Isaacs, Farren J.] Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA; [Goodman, Daniel B.] Harvard Massachusetts Inst Technol MIT Div Hlth S, Program Med Engn & Med Phys, Cambridge, MA 02139 USA; [Aerni, Hans-Rudolf; Rinehart, Jesse] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Mercer, Jaron A.] Harvard Univ, Cambridge, MA 02138 USA; [Wang, Harris H.] Columbia Univ, Coll Phys & Surg, Dept Syst Biol, New York, NY 10032 USA; [Carr, Peter A.] MIT, Lincoln Lab, Lexington, MA 02420 USA; [Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Jacobson, Joseph M.] MIT, Ctr Bits & Atoms, Cambridge, MA 02139 USA; [Jacobson, Joseph M.] MIT, Media Lab, Cambridge, MA 02139 USA; [Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Yale University; Yale University; Yale University; Harvard University; Columbia University; Lincoln Laboratory; Massachusetts Institute of Technology (MIT); Scripps Research Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu; farren.isaacs@yale.edu		church, george/0000-0001-6232-9969; Goodman, Daniel/0000-0003-3759-6883; Jacobson, Joseph/0000-0002-1332-3197; Mercer, Jaron/0000-0001-7078-614X	U.S. Department of Energy [DE-FG02-02ER63445]; NSF [SA5283-11210]; NIH [NIDDK-K01DK089006, 1DP5OD009172-01]; Defense Advanced Research Projects Agency [N66001-12-C-4040, N66001-12-C-4020, N66001-12-C-4211]; Arnold and Mabel Beckman Foundation; U.S. Department of Defense National Defense Science and Engineering Graduate Fellowship; NSF; Assistant Secretary of Defense for Research and Engineering [FA8721-05-C-0002];  [NIH-MSTP-TG-T32GM07205]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK089006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F31ES027304, F32ES027306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD009172] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Arnold and Mabel Beckman Foundation; U.S. Department of Defense National Defense Science and Engineering Graduate Fellowship; NSF(National Science Foundation (NSF)); Assistant Secretary of Defense for Research and Engineering; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We dedicate this paper to the memory of our friend, colleague, and gifted scientist, Tara Gianoulis. We thank R. Kolter for JC411, D. Reich for help with sequencing libraries, and C. and J. Seidman for Covaris E210; J. Aach, S. Kosuri, and U. Laserson for bioinformatics; T. Young, F. Peters, and W. Barnes for NSAA incorporation advice; I. Molineux and S. Kosuri for phage advice; S. Vassallo and P. Mali for experimental support; and D. Soll, A. Forster, T. Wu, K. Oye, C. Gregg, M. Napolitano, U. Laserson, A. Briggs, D. Mandell, and R. Chari for helpful comments. Funding was from the U.S. Department of Energy (DE-FG02-02ER63445), NSF (SA5283-11210), NIH (NIDDK-K01DK089006 to J. R.), Defense Advanced Research Projects Agency (N66001-12-C-4040, N66001-12-C-4020, N66001-12-C-4211), Arnold and Mabel Beckman Foundation (F. J. I.), U.S. Department of Defense National Defense Science and Engineering Graduate Fellowship (M. J. L.), NIH-MSTP-TG-T32GM07205 (A. D. H.), NSF graduate fellowships (H. H. W. and D. B. G.), NIH Director's Early Independence Award (1DP5OD009172-01 to H. H. W.), and the Assistant Secretary of Defense for Research and Engineering (Air Force Contract no. FA8721-05-C-0002 to P. A. C.). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. government.	Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; BAIN JD, 1992, NATURE, V356, P537, DOI 10.1038/356537a0; Carr PA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks455; EGGERTSSON G, 1988, MICROBIOL REV, V52, P354, DOI 10.1128/MMBR.52.3.354-374.1988; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106; Heineman RH, 2005, J MOL EVOL, V61, P181, DOI 10.1007/s00239-004-0304-4; Heinemann IU, 2012, FEBS LETT, V586, P3716, DOI 10.1016/j.febslet.2012.08.031; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; Krakauer DC, 2002, J THEOR BIOL, V218, P97, DOI 10.1006/jtbi.2002.3054; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Mukai T, 2010, NUCLEIC ACIDS RES, V38, P8188, DOI 10.1093/nar/gkq707; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Ngo JT, 2011, ACCOUNTS CHEM RES, V44, P677, DOI 10.1021/ar200144y; O'Donoghue P, 2012, FEBS LETT, V586, P3931, DOI 10.1016/j.febslet.2012.09.033; Ohtake K, 2012, J BACTERIOL, V194, P2606, DOI 10.1128/JB.00195-12; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Schafer MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025736; Schmidt M, 2012, FEBS LETT, V586, P2199, DOI 10.1016/j.febslet.2012.02.022; Sturino JM, 2006, NAT REV MICROBIOL, V4, P395, DOI 10.1038/nrmicro1393; Vetsigian K, 2006, P NATL ACAD SCI USA, V103, P10696, DOI 10.1073/pnas.0603780103; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	25	531	572	22	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					357	360		10.1126/science.1241459	http://dx.doi.org/10.1126/science.1241459			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136966	Green Accepted			2022-12-24	WOS:000325755100044
J	Kirmani, A; Venkatraman, D; Shin, D; Colaco, A; Wong, FNC; Shapiro, JH; Goyal, VK				Kirmani, Ahmed; Venkatraman, Dheera; Shin, Dongeek; Colaco, Andrea; Wong, Franco N. C.; Shapiro, Jeffrey H.; Goyal, Vivek K.			First-Photon Imaging	SCIENCE			English	Article							SINGLE-PHOTON DETECTION; KILOMETER-RANGE; LASER-RADAR; DETECTOR; IMAGES	Imagers that use their own illumination can capture three-dimensional (3D) structure and reflectivity information. With photon-counting detectors, images can be acquired at extremely low photon fluxes. To suppress the Poisson noise inherent in low-flux operation, such imagers typically require hundreds of detected photons per pixel for accurate range and reflectivity determination. We introduce a low-flux imaging technique, called first-photon imaging, which is a computational imager that exploits spatial correlations found in real-world scenes and the physics of low-flux measurements. Our technique recovers 3D structure and reflectivity from the first detected photon at each pixel. We demonstrate simultaneous acquisition of sub-pulse duration range and 4-bit reflectivity information in the presence of high background noise. First-photon imaging may be of considerable value to both microscopy and remote sensing.	[Kirmani, Ahmed; Venkatraman, Dheera; Shin, Dongeek; Colaco, Andrea; Wong, Franco N. C.; Shapiro, Jeffrey H.; Goyal, Vivek K.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Goyal, Vivek K.] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Boston University	Kirmani, A (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	akirmani@mit.edu; v.goyal@ieee.org	Goyal, Vivek K/B-7955-2008	Goyal, Vivek K/0000-0001-8471-7049	Defense Advanced Research Projects Agency InPho program through U.S. Army Research Office [W911NF-10-1-0404]; U.S. NSF [1161413]; Qualcomm Innovation Fellowship; Samsung Scholarship; Microsoft Ph.D. Fellowship; Direct For Computer & Info Scie & Enginr [1161413] Funding Source: National Science Foundation	Defense Advanced Research Projects Agency InPho program through U.S. Army Research Office; U.S. NSF(National Science Foundation (NSF)); Qualcomm Innovation Fellowship; Samsung Scholarship(Samsung); Microsoft Ph.D. Fellowship; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the Defense Advanced Research Projects Agency InPho program through U.S. Army Research Office award W911NF-10-1-0404, the U.S. NSF under grant number 1161413, a Qualcomm Innovation Fellowship, a Samsung Scholarship, and a Microsoft Ph.D. Fellowship. The authors thank H. S. Yang for assistance with figure preparation and the Research Laboratory of Electronics for hosting external database S1 (www.rle.mit.edu/first-photon-imaging), which contains the experiment's data and computer codes for Figs. 2 to 4, movie S2, and the parts of movie S1 that contain the mannequin data set.	Albota MA, 2002, APPL OPTICS, V41, P7671, DOI 10.1364/AO.41.007671; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Boyd S., 2004, CONVEX OPTIMIZATION; Buller GS, 2007, IEEE J SEL TOP QUANT, V13, P1006, DOI 10.1109/JSTQE.2007.902850; Busck J, 2004, APPL OPTICS, V43, P4705, DOI 10.1364/AO.43.004705; Chang CW, 2010, PROC SPIE, V7570, DOI 10.1117/12.845787; Chen SJ, 2013, APPL OPTICS, V52, P3241, DOI 10.1364/AO.52.003241; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Garnett R, 2005, IEEE T IMAGE PROCESS, V14, P1747, DOI 10.1109/TIP.2005.857261; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Gol'tsman GN, 2001, APPL PHYS LETT, V79, P705, DOI 10.1063/1.1388868; Harmany ZT, 2012, IEEE T IMAGE PROCESS, V21, P1084, DOI 10.1109/TIP.2011.2168410; Hernandez-Marin S, 2007, IEEE T PATTERN ANAL, V29, P2170, DOI 10.1109/TPAMI.2007.1122; Jack M, 2011, PROC SPIE, V8033, DOI 10.1117/12.888134; Jiang W, 2003, J STRUCT BIOL, V144, P114, DOI 10.1016/j.jsb.2003.09.028; McCarthy A, 2013, OPT EXPRESS, V21, P22098, DOI 10.1364/OE.21.022098; McCarthy A, 2013, OPT EXPRESS, V21, P8904, DOI 10.1364/OE.21.008904; NICOLAS JC, 1994, J BIOLUM CHEMILUM, V9, P139, DOI 10.1002/bio.1170090307; O'Brien M. E., 2005, Lincoln Laboratory Journal, V15, P37; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Pellegrini S, 2000, MEAS SCI TECHNOL, V11, P712, DOI 10.1088/0957-0233/11/6/314; Savage N, 2009, NAT PHOTONICS, V3, P738, DOI 10.1038/nphoton.2009.232; Schwarz B., 2010, NATURE PHOTON, V4, P429, DOI 10.1038/nphoton.2010.14; Snyder D, 1975, RANDOM POINT PROCESS; Srivastava A, 2003, J MATH IMAGING VIS, V18, P17, DOI 10.1023/A:1021889010444; Wallace AM, 2001, COMPUT CONTROL ENG J, V12, P157, DOI 10.1049/cce:20010403	27	255	267	28	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					58	61		10.1126/science.1246775	http://dx.doi.org/10.1126/science.1246775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24292628				2022-12-24	WOS:000329162000046
J	Simon, MD; Pinter, SF; Fang, R; Sarma, K; Rutenberg-Schoenberg, M; Bowman, SK; Kesner, BA; Maier, VK; Kingston, RE; Lee, JT				Simon, Matthew D.; Pinter, Stefan F.; Fang, Rui; Sarma, Kavitha; Rutenberg-Schoenberg, Michael; Bowman, Sarah K.; Kesner, Barry A.; Maier, Verena K.; Kingston, Robert E.; Lee, Jeannie T.			High-resolution Xist binding maps reveal two-step spreading during X-chromosome inactivation	NATURE			English	Article							FACULTATIVE HETEROCHROMATIN; RNA; GENE; CHROMATIN; LOCALIZATION; ANNOTATION; DOMAINS; DESIGN	TheXist long noncodingRNA(lncRNA) is essential for X-chromosome inactivation (XCI), the process by which mammals compensate for unequal numbers of sex chromosomes(1-3). During XCI, Xist coats the future inactiveXchromosome(Xi)(4) and recruitsPolycomb repressive complex 2 (PRC2) to the X-inactivation centre (Xic)(5). How Xist spreads silencing on a 150-megabases scale is unclear. Here we generate high-resolution maps of Xist binding on the X chromosome across a developmental time course using CHART-seq. In female cells undergoing XCI de novo, Xist follows a two-step mechanism, initially targeting gene-rich islands before spreading to intervening gene-poor domains. Xist is depleted from genes that escape XCI but may concentrate near escapee boundaries. Xist binding is linearly proportional to PRC2 density and H3 lysine 27 trimethylation (H3K27me3), indicating co-migration of Xist and PRC2. Interestingly, when Xist is acutely stripped off from the Xi in post-XCI cells, Xist recovers quickly within both gene-rich and gene-poor domains on a timescale of hours instead of days, indicating a previously primed Xi chromatin state. We conclude that Xist spreading takes distinct stage-specific forms. During initial establishment, Xist follows a two-step mechanism, but during maintenance, Xist spreads rapidly to both gene-rich and gene-poor regions.	[Simon, Matthew D.; Pinter, Stefan F.; Sarma, Kavitha; Bowman, Sarah K.; Kesner, Barry A.; Maier, Verena K.; Kingston, Robert E.; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Simon, Matthew D.; Pinter, Stefan F.; Sarma, Kavitha; Bowman, Sarah K.; Kesner, Barry A.; Maier, Verena K.; Kingston, Robert E.; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Simon, Matthew D.; Fang, Rui; Rutenberg-Schoenberg, Michael] Yale Univ, Dept Mol Biophys & Biochem, West Haven, CT 06516 USA; [Simon, Matthew D.; Fang, Rui; Rutenberg-Schoenberg, Michael] Yale Univ, Inst Chem Biol, West Haven, CT 06516 USA; [Pinter, Stefan F.; Sarma, Kavitha; Kesner, Barry A.; Maier, Verena K.; Lee, Jeannie T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Yale University; Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Simon, MD (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	matthew.simon@yale.edu; kingston@molbio.mgh.harvard.edu; lee@molbio.mgh.harvard.edu	Pinter, Stefan/O-9228-2019; Simon, Matthew/ABF-9127-2020	Pinter, Stefan/0000-0003-4750-1403; Simon, Matthew/0000-0001-7423-5265	Yale University; Deutsche Forschungsgemeinschaft; MGH Fund for Medical Discovery; National Institutes of Health [F32-GM090765, RO1-GM043901, RO1-GM090278]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090765, T32GM007223, R01GM043901, R01GM090278] Funding Source: NIH RePORTER	Yale University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MGH Fund for Medical Discovery; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Overton, I. Tikhonova and A. Lopez, and the MGH Bioinformatics Core. We also acknowledge funding from Yale University start-up funds to M. D. S., the Deutsche Forschungsgemeinschaft to S. F. P. and V. K. M., the MGH Fund for Medical Discovery to S. F. P., and the National Institutes of Health (grant F32-GM090765 to K. S., RO1-GM043901 to R. E. K., and RO1-GM090278 to J. T. L.). J. T. L. is an Investigator of the Howard Hughes Medical Institute.	Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Bowman SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-466; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Calabrese JM, 2012, CELL, V151, P951, DOI 10.1016/j.cell.2012.10.037; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chadwick BP, 2003, HUM MOL GENET, V12, P2167, DOI 10.1093/hmg/ddg229; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Disteche CM, 2012, ANNU REV GENET, V46, P537, DOI 10.1146/annurev-genet-110711-155454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; FLICKINGER JL, 1992, NUCLEIC ACIDS RES, V20, P2382, DOI 10.1093/nar/20.9.2382; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huang WC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr592; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kuhn RM, 2007, NUCLEIC ACIDS RES, V35, pD668, DOI 10.1093/nar/gkl928; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lyon MF, 2003, SEMIN CELL DEV BIOL, V14, P313, DOI 10.1016/j.semcdb.2003.09.015; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pinter SF, 2012, GENOME RES, V22, P1864, DOI 10.1101/gr.133751.111; Pontier DB, 2011, HUM GENET, V130, P223, DOI 10.1007/s00439-011-1008-7; Sarma Kavitha, 2010, Proc Natl Acad Sci U S A, V107, P22196, DOI 10.1073/pnas.1009785107; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wernersson R, 2005, NUCLEIC ACIDS RES, V33, pW611, DOI 10.1093/nar/gki399; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Yildirim E, 2012, NAT STRUCT MOL BIOL, V19, P56, DOI 10.1038/nsmb.2195; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	43	270	291	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					465	+		10.1038/nature12719	http://dx.doi.org/10.1038/nature12719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24162848	Green Submitted, Green Accepted			2022-12-24	WOS:000328575300058
J	Schwartz, S; Agarwala, SD; Mumbach, MR; Jovanovic, M; Mertins, P; Shishkin, A; Tabach, Y; Mikkelsen, TS; Satija, R; Ruvkun, G; Carr, SA; Lander, ES; Fink, GR; Regev, A				Schwartz, Schraga; Agarwala, Sudeep D.; Mumbach, Maxwell R.; Jovanovic, Marko; Mertins, Philipp; Shishkin, Alexander; Tabach, Yuval; Mikkelsen, Tarjei S.; Satija, Rahul; Ruvkun, Gary; Carr, Steven A.; Lander, Eric S.; Fink, Gerald R.; Regev, Aviv			High-Resolution Mapping Reveals a Conserved, Widespread, Dynamic mRNA Methylation Program in Yeast Meiosis	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR-RNA; N-6-METHYLADENOSINE; TRANSCRIPTION; IME4; DIVERGENCE; M(6)A-SEQ; SEQUENCES; RESIDUES; PATHWAY	N-6-methyladenosine (m(6)A) is the most ubiquitous mRNA base modification, but little is known about its precise location, temporal dynamics, and regulation. Here, we generated genomic maps of m(6)A sites in meiotic yeast transcripts at nearly single-nucleotide resolution, identifying 1,308 putatively methylated sites within 1,183 transcripts. We validated eight out of eight methylation sites in different genes with direct genetic analysis, demonstrated that methylated sites are significantly conserved in a related species, and built a model that predicts methylated sites directly from sequence. Sites vary in their methylation profiles along a dense meiotic time course and are regulated both locally, via predictable methylatability of each site, and globally, through the core meiotic circuitry. The methyltransferase complex components localize to the yeast nucleolus, and this localization is essential for mRNA methylation. Our data illuminate a conserved, dynamically regulated methylation program in yeast meiosis and provide an important resource for studying the function of this epitranscriptomic modification.	[Schwartz, Schraga; Mumbach, Maxwell R.; Jovanovic, Marko; Mertins, Philipp; Shishkin, Alexander; Mikkelsen, Tarjei S.; Satija, Rahul; Carr, Steven A.; Lander, Eric S.; Fink, Gerald R.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Agarwala, Sudeep D.; Fink, Gerald R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tabach, Yuval; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Tabach, Yuval; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Fink, GR (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	gfink@wi.mit.edu; aregev@broadinstitute.org	Carr, Steven A./AAH-8366-2019; Tabach, Yuval/Q-8488-2019; Mikkelsen, Tarjei S/A-1306-2007; Satija, Rahul/AAF-9564-2019	Mikkelsen, Tarjei S/0000-0002-8133-3135; Schwartz, Schraga/0000-0002-3671-9709; Mumbach, Maxwell/0000-0002-5570-6663	National Institutes of Health [GM035010, U54 HG003067]; Broad Institute Funds; NHGRI Pioneer Award; HHMI; HFSP fellowship; NATIONAL CANCER INSTITUTE [R01CA119176, DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035010, R01GM035010, R01GM098647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute Funds; NHGRI Pioneer Award; HHMI(Howard Hughes Medical Institute); HFSP fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank Lindsey Dollard and Anna Symbor-Nagrabska for expert technical assistance; Hannah Blitzblau, Mitchell Guttman, and Dmitry Ter-Ovanesyan for fruitful discussions and technical advice; and Leslie Gaffney for making the figures beautiful. The anti-Fob1 antibody was kindly provided by Dr. Stephen Bell. G.R.F. is an American Cancer Society Professor of Genetics. This work was supported by National Institutes of Health Grants GM035010 (G.R.F) and U54 HG003067 (E.S.L.) and Broad Institute Funds. A.R. was supported by an NHGRI Pioneer Award and HHMI. S.S. was supported by an HFSP fellowship.	Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732; Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bokar JA, 1997, RNA, V3, P1233; Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; BRINGMANN P, 1987, FEBS LETT, V213, P309, DOI 10.1016/0014-5793(87)81512-0; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; DESROSIERS RC, 1975, BIOCHEMISTRY-US, V14, P4367, DOI 10.1021/bi00691a004; DIMOCK K, 1977, BIOCHEMISTRY-US, V16, P471, DOI 10.1021/bi00622a021; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Falk JE, 2010, DEV CELL, V19, P599, DOI 10.1016/j.devcel.2010.09.006; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; NARAYAN P, 1988, SCIENCE, V242, P1159, DOI 10.1126/science.3187541; NARAYAN P, 1994, NUCLEIC ACIDS RES, V22, P419, DOI 10.1093/nar/22.3.419; POTASHKIN JA, 1990, MOL CELL BIOL, V10, P3524, DOI 10.1128/MCB.10.7.3524; Saletore Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-175; SCHIBLER U, 1977, J MOL BIOL, V115, P695, DOI 10.1016/0022-2836(77)90110-3; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Tabach Y, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.50; Tabach Y, 2013, NATURE, V493, P694, DOI 10.1038/nature11779; van Werven FJ, 2012, CELL, V150, P1170, DOI 10.1016/j.cell.2012.06.049; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	35	422	454	2	77	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1409	1421		10.1016/j.cell.2013.10.047	http://dx.doi.org/10.1016/j.cell.2013.10.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24269006	Bronze, Green Submitted, Green Accepted			2022-12-24	WOS:000328271100022
J	Popova, OP; Jenniskens, P; Emel'yanenko, V; Kartashova, A; Biryukov, E; Khaibrakhmanov, S; Shuvalov, V; Rybnov, Y; Dudorov, A; Grokhovsky, VI; Badyukov, DD; Yin, QZ; Gural, PS; Albers, J; Granvik, M; Evers, LG; Kuiper, J; Kharlamov, V; Solovyov, A; Rusakov, YS; Korotkiy, S; Serdyuk, I; Korochantsev, AV; Larionov, MY; Glazachev, D; Mayer, AE; Gisler, G; Gladkovsky, SV; Wimpenny, J; Sanborn, ME; Yamakawa, A; Verosub, KL; Rowland, DJ; Roeske, S; Botto, NW; Friedrich, JM; Zolensky, ME; Le, L; Ross, D; Ziegler, K; Nakamura, T; Ahn, I; Lee, JI; Zhou, Q; Li, XH; Li, QL; Liu, Y; Tang, GQ; Hiroi, T; Sears, D; Weinstein, IA; Vokhmintsev, AS; Ishchenko, AV; Schmitt-Kopplin, P; Hertkorn, N; Nagao, K; Haba, MK; Komatsu, M; Mikouchi, T				Popova, Olga P.; Jenniskens, Peter; Emel'yanenko, Vacheslav; Kartashova, Anna; Biryukov, Eugeny; Khaibrakhmanov, Sergey; Shuvalov, Valery; Rybnov, Yurij; Dudorov, Alexandr; Grokhovsky, Victor I.; Badyukov, Dmitry D.; Yin, Qing-Zhu; Gural, Peter S.; Albers, Jim; Granvik, Mikael; Evers, Laslo G.; Kuiper, Jacob; Kharlamov, Vladimir; Solovyov, Andrey; Rusakov, Yuri S.; Korotkiy, Stanislav; Serdyuk, Ilya; Korochantsev, Alexander V.; Larionov, Michail Yu.; Glazachev, Dmitry; Mayer, Alexander E.; Gisler, Galen; Gladkovsky, Sergei V.; Wimpenny, Josh; Sanborn, Matthew E.; Yamakawa, Akane; Verosub, Kenneth L.; Rowland, Douglas J.; Roeske, Sarah; Botto, Nicholas W.; Friedrich, Jon M.; Zolensky, Michael E.; Le, Loan; Ross, Daniel; Ziegler, Karen; Nakamura, Tomoki; Ahn, Insu; Lee, Jong Ik; Zhou, Qin; Li, Xian-Hua; Li, Qiu-Li; Liu, Yu; Tang, Guo-Qiang; Hiroi, Takahiro; Sears, Derek; Weinstein, Ilya A.; Vokhmintsev, Alexander S.; Ishchenko, Alexei V.; Schmitt-Kopplin, Phillipe; Hertkorn, Norbert; Nagao, Keisuke; Haba, Makiko K.; Komatsu, Mutsumi; Mikouchi, Takashi		Chelyabinsk Airburst Consortiu	Chelyabinsk Airburst, Damage Assessment, Meteorite Recovery, and Characterization	SCIENCE			English	Article							L-CHONDRITES; METEOROIDS; PHOSPHATES; ITOKAWA; ORIGIN; FAMILY	The asteroid impact near the Russian city of Chelyabinsk on 15 February 2013 was the largest airburst on Earth since the 1908 Tunguska event, causing a natural disaster in an area with a population exceeding one million. Because it occurred in an era with modern consumer electronics, field sensors, and laboratory techniques, unprecedented measurements were made of the impact event and the meteoroid that caused it. Here, we document the account of what happened, as understood now, using comprehensive data obtained from astronomy, planetary science, geophysics, meteorology, meteoritics, and cosmochemistry and from social science surveys. A good understanding of the Chelyabinsk incident provides an opportunity to calibrate the event, with implications for the study of near-Earth objects and developing hazard mitigation strategies for planetary protection.	[Popova, Olga P.; Shuvalov, Valery; Rybnov, Yurij; Kharlamov, Vladimir; Glazachev, Dmitry] Russian Acad Sci, Inst Dynam Geospheres, Moscow 119334, Russia; [Jenniskens, Peter; Gural, Peter S.; Albers, Jim] SETI Inst, Mountain View, CA 94043 USA; [Emel'yanenko, Vacheslav; Kartashova, Anna] Russian Acad Sci, Inst Astron, Moscow 119017, Russia; [Biryukov, Eugeny] South Ural State Univ, Dept Theoret Mech, Chelyabinsk 454080, Russia; [Khaibrakhmanov, Sergey; Dudorov, Alexandr; Mayer, Alexander E.] Chelyabinsk State Univ, Chelyabinsk 454001, Russia; [Grokhovsky, Victor I.; Larionov, Michail Yu.; Weinstein, Ilya A.; Vokhmintsev, Alexander S.; Ishchenko, Alexei V.] Ural Fed Univ, Inst Phys & Technol, Ekaterinburg 620002, Russia; [Badyukov, Dmitry D.; Korochantsev, Alexander V.] RAS, Vernadsky Inst Geochem & Analyt Chem, Moscow 119991, Russia; [Yin, Qing-Zhu; Wimpenny, Josh; Sanborn, Matthew E.; Yamakawa, Akane; Verosub, Kenneth L.; Roeske, Sarah; Botto, Nicholas W.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Granvik, Mikael] Univ Helsinki, Dept Phys, Helsinki 00014, Finland; [Evers, Laslo G.; Kuiper, Jacob] Koninklijk Nederlands Meteorol Inst, NL-3730 AE De Bilt, Netherlands; [Evers, Laslo G.] Delft Univ Technol, Fac Civil Engn & Geosci, Dept Geosci & Engn, NL-2600 GA Delft, Netherlands; [Solovyov, Andrey] Tomsk State Univ, Tomsk 634050, Russia; [Rusakov, Yuri S.] Res & Prod Assoc Typhoon, Obninsk 249032, Russia; [Korotkiy, Stanislav] Support Fdn Astron Ka Dar, Razvilka 142717, Russia; [Weinstein, Ilya A.] Social & Youth Initiat Org, Sci & Technol Ctr, Moscow 119415, Russia; [Gisler, Galen] Univ Oslo, N-0316 Oslo, Norway; [Gladkovsky, Sergei V.] Russian Acad Sci, Inst Engn Sci, Urals Branch, Ekaterinburg 620049, Russia; [Rowland, Douglas J.] Univ Calif Davis, Ctr Mol & Genom Imaging, Davis, CA 95616 USA; [Friedrich, Jon M.] Amer Museum Nat Hist, Dept Earth & Planetary Sci, New York, NY 10024 USA; [Friedrich, Jon M.] Fordham Univ, Dept Chem, Bronx, NY 10458 USA; [Zolensky, Michael E.; Le, Loan; Ross, Daniel] NASA, Johnson Space Ctr, Houston, TX 77058 USA; [Le, Loan; Ross, Daniel] Jacobs Technol, Houston, TX 77058 USA; [Ziegler, Karen] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Nakamura, Tomoki; Ahn, Insu] Tohoku Univ, Dept Earth & Planetary Mat Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Lee, Jong Ik] Korea Polar Res Inst, Div Polar Earth Syst Sci, Inchon 406840, South Korea; [Zhou, Qin] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; [Zhou, Qin; Li, Xian-Hua; Li, Qiu-Li; Liu, Yu; Tang, Guo-Qiang] Chinese Acad Sci, Inst Geol & Geophys, State Key Lab Lithospher Evolut, Beijing 100029, Peoples R China; [Hiroi, Takahiro] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Schmitt-Kopplin, Phillipe; Hertkorn, Norbert] Helmoltz Zentrum Muenchen, D-85764 Obeschleissheim, Germany; [Schmitt-Kopplin, Phillipe] Tech Univ Munich, D-85354 Freising Weihenstephan, Germany; [Nagao, Keisuke; Haba, Makiko K.] Univ Tokyo, Geochem Res Ctr, Bunkyo Ku, Tokyo 1130033, Japan; [Komatsu, Mutsumi] Waseda Univ, Waseda Inst Adv Study, Shinjuku Ku, Tokyo 1698050, Japan; [Mikouchi, Takashi] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan	Russian Academy of Sciences; Sadovsky Institute of Geosphere Dynamics of the Russian Academy of Sciences; Institute of Astronomy of the Russian Academy of Sciences; Russian Academy of Sciences; South Ural State University; Chelyabinsk State University; Ural Federal University; Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry; University of California System; University of California Davis; University of Helsinki; Royal Netherlands Meteorological Institute; Delft University of Technology; Tomsk State University; University of Oslo; Russian Academy of Sciences; Institute of Engineering Science, RAS (Ural Branch); University of California System; University of California Davis; American Museum of Natural History (AMNH); Fordham University; National Aeronautics & Space Administration (NASA); University of New Mexico; Tohoku University; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); Chinese Academy of Sciences; National Astronomical Observatory, CAS; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Brown University; Technical University of Munich; University of Tokyo; Waseda University; University of Tokyo	Jenniskens, P (corresponding author), SETI Inst, 189 Bernardo Ave, Mountain View, CA 94043 USA.	petrus.m.jenniskens@nasa.gov	Popova, Olga P/K-1885-2012; Glazachev, Dmitry/Y-5615-2018; Biryukov, Eugeny/AAJ-1432-2020; Grokhovsky, Victor I/B-4388-2014; Gladkovsky, Sergei/E-5731-2016; Rowland, Douglas J/F-3104-2014; Komatsu, Mutsumi/N-9483-2019; Yin, Qing-Zhu/B-8198-2009; Kartashova, Anna/N-3468-2013; Emel'yanenko, Vacheslav/A-4087-2014; Zhou, Qin/AFK-0169-2022; Dudorov, Alexander E./P-4773-2015; Soloviev, Andrey V./P-1761-2014; Larionov, Mikhail/F-7770-2017; Khaibrakhmanov, Sergey A/G-7264-2015; Weinstein, Ilya A./K-8178-2012; haba, makiko/GRX-2377-2022; Schmitt-Kopplin, Philippe/H-6271-2011; Shuvalov, Valery/C-6618-2014; Shuvalov, Valery/ABC-5902-2020; Solovyov, Andrey/G-8268-2014; Zhou, Qin/AAF-7236-2022; Mikouchi, Takashi/AAY-7355-2021; Evers, Läslo/E-5707-2011; Hertkorn, Norbert/AAA-5990-2022; Mayer, Alexander/I-3069-2013; Li, Qiuli/A-8874-2012; Ishchenko, Aleksey/E-1017-2014; Solovyov, Andrey/U-3916-2018; Badyukov, Dmitry/AAN-7296-2020; Vokhmintsev, Alexander/E-1013-2014	Glazachev, Dmitry/0000-0001-9475-3430; Gladkovsky, Sergei/0000-0002-3542-6242; Rowland, Douglas J/0000-0001-8059-6905; Komatsu, Mutsumi/0000-0003-4659-8418; Yin, Qing-Zhu/0000-0002-4445-5096; Kartashova, Anna/0000-0003-4320-5105; Zhou, Qin/0000-0001-8562-9737; Larionov, Mikhail/0000-0003-1172-6950; Khaibrakhmanov, Sergey A/0000-0002-4439-6831; Weinstein, Ilya A./0000-0002-5573-7128; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Zhou, Qin/0000-0001-8562-9737; Evers, Läslo/0000-0003-2825-6211; Mayer, Alexander/0000-0002-8765-6373; Li, Qiuli/0000-0002-7280-5508; Ishchenko, Aleksey/0000-0002-9883-6652; Granvik, Mikael/0000-0002-5624-1888; Biryukov, Eugeny/0000-0002-2428-1770; Sanborn, Matthew/0000-0003-3218-1195; Zolensky, Michael/0000-0002-3181-1303; Popova, Olga/0000-0003-4874-6701; Wimpenny, Josh/0000-0002-7637-0978; Mikouchi, Takashi/0000-0002-9998-8754; Vokhmintsev, Alexander/0000-0003-2529-3770; Haba, Makiko/0000-0003-2554-7849	Institute for Dynamics of Geospheres; Federal Targeted Program Scientific and Educational Human Resources of Innovation-Driven Russia; RAS Presidium Program Fundamental Problems of Investigation and Exploration of the Solar System; NASA; Grants-in-Aid for Scientific Research [11J08649] Funding Source: KAKEN	Institute for Dynamics of Geospheres; Federal Targeted Program Scientific and Educational Human Resources of Innovation-Driven Russia; RAS Presidium Program Fundamental Problems of Investigation and Exploration of the Solar System; NASA(National Aeronautics & Space Administration (NASA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Russian Academy of Sciences (RAS) field study of the Chelyabinsk airburst was supported by the Institute for Dynamics of Geospheres and grants of the Federal Targeted Program Scientific and Educational Human Resources of Innovation-Driven Russia and the RAS Presidium Program Fundamental Problems of Investigation and Exploration of the Solar System. The office of Chelyabinsk Oblast Governor Mikhail Yurevich provided assistance. S. Petukhov and I. Talyukin from the Universe History Museum in Dedovsk contributed samples, as did M. Boslough of Sandia National Laboratories. U. Johann (Astrium Satellites GmbH) calculated the Chebarkul hole position from Pleiades 1A satellite observations. D. F. Blake provided use of a petrographic microscope. P.J. acknowledges support from the NASA Near Earth Object Observation Program, Q.Z.Y. and M.E.Z. from the NASA Cosmochemistry Program, and M. G. from the Academy of Finland.	Amelin Y, 2005, SCIENCE, V310, P839, DOI 10.1126/science.1117919; [Anonymous], 1977, EFFECTS NUCL WEAPONS; Bischoff A., 2006, METEORITES EARLY SOL, P679; Borovicka J., 2013, 3423 CBET INT ASTR U; Boslough MBE, 1997, ANN NY ACAD SCI, V822, P236, DOI 10.1111/j.1749-6632.1997.tb48345.x; Bottke W. F., 2000, ICARUS, V156, P339; Christie DR, 2010, INFRASOUND MONITORING FOR ATMOSPHERIC STUDIES, P29, DOI 10.1007/978-1-4020-9508-5_2; CLAYTON RN, 1991, GEOCHIM COSMOCHIM AC, V55, P2317, DOI 10.1016/0016-7037(91)90107-G; Connelly JN, 2012, SCIENCE, V338, P651, DOI 10.1126/science.1226919; Consolmagno GJ, 2008, CHEM ERDE-GEOCHEM, V68, P1, DOI 10.1016/j.chemer.2008.01.003; Dunn TL, 2013, ICARUS, V222, P273, DOI 10.1016/j.icarus.2012.11.007; Ens TA, 2012, J ATMOS SOL-TERR PHY, V80, P208, DOI 10.1016/j.jastp.2012.01.018; Friedrich JM, 2004, GEOCHIM COSMOCHIM AC, V68, P2889, DOI 10.1016/j.gca.2004.01.010; Friedrich JM, 2003, GEOCHIM COSMOCHIM AC, V67, P2467, DOI 10.1016/S0016-7307(03)00024-3; GOPEL C, 1994, EARTH PLANET SC LETT, V121, P153, DOI 10.1016/0012-821X(94)90038-8; HARTMETZ CP, 1987, METEORITICS, V22, P400; Huang MW, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/483562; Jenniskens P, 2012, SCIENCE, V338, P1583, DOI 10.1126/science.1227163; McDonough W, 2003, TREATISE GEOCHEMISTR, V2, P547, DOI DOI 10.1016/B0-08-043751-6/02015-6; Michel P, 2006, ASTRON ASTROPHYS, V449, P817, DOI 10.1051/0004-6361:20054319; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Nazarov M. A., 2013, CHELYABINSK METEORIT; Nemtchinov IV, 1997, ICARUS, V130, P259, DOI 10.1006/icar.1997.5821; Nesvorny D, 2002, ICARUS, V157, P155, DOI 10.1006/icar.2002.6830; Popova O, 2011, METEORIT PLANET SCI, V46, P1525, DOI 10.1111/j.1945-5100.2011.01247.x; Reddy V, 2011, ICARUS, V216, P184, DOI 10.1016/j.icarus.2011.08.027; ReVelle DO, 2001, ESA SPEC PUBL, V495, P507; Rochette P, 2003, METEORIT PLANET SCI, V38, P251, DOI 10.1111/j.1945-5100.2003.tb00263.x; Schmitt-Kopplin P, 2010, P NATL ACAD SCI USA, V107, P2763, DOI 10.1073/pnas.0912157107; Schunova E, 2012, ICARUS, V220, P1050, DOI 10.1016/j.icarus.2012.06.042; SEARS DW, 1973, NATURE-PHYS SCI, V242, P25, DOI 10.1038/physci242025a0; STOFFLER D, 1991, GEOCHIM COSMOCHIM AC, V55, P3845, DOI 10.1016/0016-7037(91)90078-J; Svetsov V., 2008, CATASTROPHIC EVENTS, P227; Tagliaferri E., 1998, HAZARDS DUE COMETS A, P199; Terada K, 2009, ASTROPHYS J LETT, V699, pL68, DOI 10.1088/0004-637X/699/2/L68; Trinquier A, 2007, ASTROPHYS J, V655, P1179, DOI 10.1086/510360; Troiano J, 2011, GEOCHIM COSMOCHIM AC, V75, P6511, DOI 10.1016/j.gca.2011.08.033; WASSON JT, 1988, PHILOS T R SOC A, V325, P535, DOI 10.1098/rsta.1988.0066; Zinn J, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010575	39	393	412	6	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1069	1073		10.1126/science.1242642	http://dx.doi.org/10.1126/science.1242642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24200813	Green Submitted, Green Published			2022-12-24	WOS:000327518600050
J	Good, MC; Vahey, MD; Skandarajah, A; Fletcher, DA; Heald, R				Good, Matthew C.; Vahey, Michael D.; Skandarajah, Arunan; Fletcher, Daniel A.; Heald, Rebecca			Cytoplasmic Volume Modulates Spindle Size During Embryogenesis	SCIENCE			English	Article							FUNCTION IN-VITRO; MITOTIC SPINDLE; EGG EXTRACTS; ELEGANS EMBRYOS; CELL GEOMETRY; LENGTH; XENOPUS; MICROTUBULES; GROWTH; DYNAMICS	Rapid and reductive cell divisions during embryogenesis require that intracellular structures adapt to a wide range of cell sizes. The mitotic spindle presents a central example of this flexibility, scaling with the dimensions of the cell to mediate accurate chromosome segregation. To determine whether spindle size regulation is achieved through a developmental program or is intrinsically specified by cell size or shape, we developed a system to encapsulate cytoplasm from Xenopus eggs and embryos inside cell-like compartments of defined sizes. Spindle size was observed to shrink with decreasing compartment size, similar to what occurs during early embryogenesis, and this scaling trend depended on compartment volume rather than shape. Thus, the amount of cytoplasmic material provides a mechanism for regulating the size of intracellular structures.	[Good, Matthew C.; Heald, Rebecca] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Good, Matthew C.; Vahey, Michael D.; Skandarajah, Arunan; Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Good, Matthew C.; Vahey, Michael D.; Skandarajah, Arunan; Fletcher, Daniel A.] Univ Calif Berkeley, Biophys Grp, Berkeley, CA 94720 USA; [Good, Matthew C.] Univ Calif Berkeley, Miller Inst Basic Res Sci, Berkeley, CA 94720 USA; [Fletcher, Daniel A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Fletcher, DA (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	fletch@berkeley.edu; bheald@berkeley.edu	Good, Matthew C/GLS-0964-2022	Good, Matthew/0000-0002-6367-1034; Heald, Rebecca/0000-0001-6671-6528	Miller Institute for Basic Science Research; NIH [GM074751, GM098766]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098766, R01GM074751] Funding Source: NIH RePORTER	Miller Institute for Basic Science Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by fellowships from the Miller Institute for Basic Science Research (M. C. G.), NIH (M. D. V.), and NSF (A. S.). This work was also supported by NIH grants (GM074751, D. A. F.) and (GM098766, R. H.). We thank J. Wilbur, K. Helmke, F. Nedelec, K. Weis, M. Welch, H. Ramage, K. Nyberg, N. Metrakos, the Berkeley BioChIP NSF Research Experience for Undergraduates program, and members of the Heald and Fletcher labs. The authors declare no competing financial interests. Data described can be found in the main figures and supplementary materials.	Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Brugues J, 2012, CELL, V149, P554, DOI 10.1016/j.cell.2012.03.027; Brun L, 2009, P NATL ACAD SCI USA, V106, P21173, DOI 10.1073/pnas.0910774106; Chan YHM, 2012, SCIENCE, V337, P1186, DOI 10.1126/science.1223539; Conklin EG, 1912, J EXP ZOOL, V12, P1, DOI 10.1002/jez.1400120102; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Decker M, 2011, CURR BIOL, V21, P1259, DOI 10.1016/j.cub.2011.06.002; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Goehring NW, 2012, CURR BIOL, V22, pR330, DOI 10.1016/j.cub.2012.03.046; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Greenan G, 2010, CURR BIOL, V20, P353, DOI 10.1016/j.cub.2009.12.050; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Hara Y, 2013, MOL BIOL CELL, V24, P1411, DOI 10.1091/mbc.E12-07-0528; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Kafri R, 2013, NATURE, V494, P480, DOI 10.1038/nature11897; Laan L, 2012, CELL, V148, P502, DOI 10.1016/j.cell.2012.01.007; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Lattao R, 2012, J CELL SCI, V125, P584, DOI 10.1242/jcs.101469; Levy DL, 2012, ANNU REV CELL DEV BI, V28, P113, DOI 10.1146/annurev-cellbio-092910-154158; Loughlin R, 2011, CELL, V147, P1397, DOI 10.1016/j.cell.2011.11.014; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Pinot M, 2009, CURR BIOL, V19, P954, DOI 10.1016/j.cub.2009.04.027; Pinot M, 2012, P NATL ACAD SCI USA, V109, P11705, DOI 10.1073/pnas.1121583109; Reber SB, 2013, NAT CELL BIOL, V15, P1116, DOI 10.1038/ncb2834; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Wilbur JD, 2013, ELIFE, V2, DOI 10.7554/eLife.00290; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092	30	175	177	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					856	860		10.1126/science.1243147	http://dx.doi.org/10.1126/science.1243147			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233724	Green Accepted			2022-12-24	WOS:000326923000038
J	Le Saout, S; Hoffmann, M; Shi, YC; Hughes, A; Bernard, C; Brooks, TM; Bertzky, B; Butchart, SHM; Stuart, SN; Badman, T; Rodrigues, ASL				Le Saout, Soizic; Hoffmann, Michael; Shi, Yichuan; Hughes, Adrian; Bernard, Cyril; Brooks, Thomas M.; Bertzky, Bastian; Butchart, Stuart H. M.; Stuart, Simon N.; Badman, Tim; Rodrigues, Ana S. L.			Protected Areas and Effective Biodiversity Conservation	SCIENCE			English	Editorial Material							TARGETS		[Le Saout, Soizic; Bernard, Cyril; Rodrigues, Ana S. L.] CNRS, CEFE, UMR5175, F-34293 Montpellier, France; [Hoffmann, Michael; Shi, Yichuan; Hughes, Adrian; Brooks, Thomas M.; Stuart, Simon N.; Badman, Tim] Int Union Conservat Nat, CH-1196 Gland, Switzerland; [Hoffmann, Michael; Shi, Yichuan; Bertzky, Bastian; Stuart, Simon N.] World Conservat Monitoring Ctr, United Nations Environm Programme, Cambridge CB3 0DL, England; [Brooks, Thomas M.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia; [Butchart, Stuart H. M.] BirdLife Int, Cambridge CB3 0NA, England; [Stuart, Simon N.] Conservat Int, Arlington, VA 22202 USA; [Stuart, Simon N.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Stuart, Simon N.] Al Ain Zoo, Abu Dhabi, U Arab Emirates	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Tasmania; BirdLife International; Conservation International; University of Bath	Rodrigues, ASL (corresponding author), CNRS, CEFE, UMR5175, F-34293 Montpellier, France.	ana.rodrigues@cefe.cnrs.fr	Butchart, Stuart HM/Y-2711-2018; Rodrigues, Ana/GYQ-6273-2022; Bertzky, Bastian/I-6909-2013; Rodrigues, Ana S.L./A-5914-2009; Butchart, Stuart/AAJ-1852-2021; Hoffmann, Michael/E-6419-2010	Bertzky, Bastian/0000-0001-7025-4733; Rodrigues, Ana S.L./0000-0003-4775-0127; Butchart, Stuart/0000-0002-1140-4049; Hoffmann, Michael/0000-0003-4785-2254; Hughes, Adrian/0000-0002-0807-6646; Brooks, Thomas/0000-0001-8159-3116				Bertzky B., 2012, PROTECTED PLANET REP; Bertzky B., 2013, TERRESTRIAL BIODIVER; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Courchamp F, 2003, SCIENCE, V302, P1532, DOI 10.1126/science.1089492; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Hartley A. J., 2007, ASSESSMENT AFRICAN P; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; IUCN (International Union for Conservation of Nature), 2012, 2012 IUCN RED LIST T; IUCN U.-W., 2012, WORLD DAT PROT AR WD; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Moilanen A., 2009, SPATIAL CONSERVATION; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; SCBD, 2010, COP 10 DEC X 2 STRAT	18	339	365	7	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					803	805		10.1126/science.1239268	http://dx.doi.org/10.1126/science.1239268			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	251IY	24233709				2022-12-24	WOS:000326923000018
J	Phillips, A; Baker, J; Lundgren, J				Phillips, Andrew; Baker, Jason; Lundgren, Jens			Are antiretrovirals enough for people living with HIV?	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; RENAL-FUNCTION; INFECTION; RISK; THERAPY; EXPOSURE		[Phillips, Andrew] UCL, Res Dept Infect & Populat Hlth, London NW3 2PF, England; [Baker, Jason] Univ Minnesota, Dept Med, Hennepin Cty Med Ctr, Minneapolis, MN 55455 USA; [Lundgren, Jens] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark	University of London; University College London; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Rigshospitalet; University of Copenhagen	Phillips, A (corresponding author), UCL, Res Dept Infect & Populat Hlth, Royal Free Campus, London NW3 2PF, England.	andrew.phillips@ucl.ac.uk	Lundgren, Jens/AAE-6876-2019; Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807; Lundgren, Jens/0000-0001-8901-7850				Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Borges AH, 2013, AIDS, V27, P1433, DOI 10.1097/QAD.0b013e32835f6b0c; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Piketty C, 2012, J CLIN ONCOL, V30, P4360, DOI 10.1200/JCO.2012.44.5486; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Trevillyan JM, 2013, SEX HEALTH, V10, P97, DOI 10.1071/SH12081	12	2	3	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	2013	382	9903					1466	1467		10.1016/S0140-6736(13)62072-3	http://dx.doi.org/10.1016/S0140-6736(13)62072-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	247MR	24182530				2022-12-24	WOS:000326622500007
J	Serrano-Saiz, E; Poole, RJ; Felton, T; Zhang, FF; De La Cruz, ED; Hobert, O				Serrano-Saiz, Esther; Poole, Richard J.; Felton, Terry; Zhang, Feifan; De La Cruz, Estanisla Daniel; Hobert, Oliver			Modular Control of Glutamatergic Neuronal Identity in C. elegans by Distinct Homeodomain Proteins	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; RECEPTOR GENE-EXPRESSION; HOMEOBOX GENE; NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; DIFFERENTIATION; IDENTIFICATION; TRANSPORTER; BEHAVIOR; SPECIFICATION	The choice of using one of many possible neurotransmitter systems is a critical step in defining the identity of an individual neuron type. We show here that the key defining feature of glutamatergic neurons, the vesicular glutamate transporter EAT-4/VGLUT, is expressed in 38 of the 118 anatomically defined neuron classes of the C. elegans nervous system. We show that distinct cis-regulatory modules drive expression of eat-4/VGLUT in distinct glutamatergic neuron classes. We identify 13 different transcription factors, 11 of them homeodomain proteins, that act in distinct combinations in 25 different glutamatergic neuron classes to initiate and maintain eat-4/VGLUT expression. We show that the adoption of a glutamatergic phenotype is linked to the adoption of other terminal identity features of a neuron, including cotransmitter phenotypes. Examination of mouse orthologs of these homeodomain proteins resulted in the identification of mouse LHX1 as a regulator of glutamatergic neurons in the brainstem.	[Serrano-Saiz, Esther; Poole, Richard J.; Felton, Terry; Zhang, Feifan; De La Cruz, Estanisla Daniel; Hobert, Oliver] Columbia Univ, Med Ctr, HHMI, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Poole, Richard J.; Felton, Terry] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	Columbia University; Howard Hughes Medical Institute; University of London; University College London	Serrano-Saiz, E (corresponding author), Columbia Univ, Med Ctr, HHMI, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	es2754@columbia.edu; or38@columbia.edu	Serrano-Saiz, Esther/AAO-7791-2021; Saiz, Esther Serrano/AAJ-8469-2020	Saiz, Esther Serrano/0000-0003-0077-878X; Poole, Richard/0000-0001-6414-2479; Hobert, Oliver/0000-0002-7634-2854	NIH [R01NS039996-05, R01NS050266-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266, R01NS039996] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Q. Chen for expert assistance in generating transgenic strains, A. Goldsmith for generating the eat-4 locus reporter, members of the C. elegans community for providing strains, A. Boyanov for expert assistance in whole-genome sequencing, G. Minevich for initial identification of three mutants that affect ser-2 expression in OLL, J. Crissman, L. Khrimian, M. Peterson, J. Hou, B. Wu and U. Aghayeva for help with generating strains, M. Oren for examining eat-4 expression in the male tail, J. Dodd for providing LHX antibody, several colleagues cited in the text for communicating unpublished results and members of the Hobert lab, Iva Greenwald and Piali Sengupta for comments on the manuscript. This work was funded by the NIH (R01NS039996-05; R01NS050266-03). O. H. is an Investigator of the Howard Hughes Medical Institute.	Acampora D, 2001, PROG NEUROBIOL, V64, P69, DOI 10.1016/S0301-0082(00)00042-3; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Badea TC, 2003, J NEUROSCI, V23, P2314; Baird-Titus JM, 2006, J MOL BIOL, V356, P1137, DOI 10.1016/j.jmb.2005.12.007; Baran R, 1999, DEVELOPMENT, V126, P2241; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; BOULIN T, 2006, REPORTER GENE FUSION, P1, DOI [10.1895/wormbook.1.106.1, DOI 10.1895/WORMBOOK.1.106.1]; Brandt JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034014; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Brockie Penelope J, 2006, WormBook, P1; Burglin TR, 2001, DEVELOPMENT, V128, P779; Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chang HC, 2011, NATURE, V480, P525, DOI 10.1038/nature10643; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Duerr JS, 2008, J COMP NEUROL, V506, P398, DOI 10.1002/cne.21551; Duggan A, 1998, DEVELOPMENT, V125, P4107; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Guillermin ML, 2011, GENETICS, V189, P1327, DOI 10.1534/genetics.111.133835; Hobert O, 1998, J NEUROSCI, V18, P2084; Hobert O, 2011, ANNU REV CELL DEV BI, V27, P681, DOI 10.1146/annurev-cellbio-092910-154226; Jafari G, 2011, J NEUROSCI, V31, P8948, DOI 10.1523/JNEUROSCI.1692-11.2011; Kage E, 2005, CURR BIOL, V15, P1554, DOI 10.1016/j.cub.2005.07.057; Kagoshima H, 2013, DEV BIOL, V380, P314, DOI 10.1016/j.ydbio.2013.04.009; Kim K, 2010, DEVELOPMENT, V137, P963, DOI 10.1242/dev.044719; Kratsios P, 2012, NAT NEUROSCI, V15, P205, DOI 10.1038/nn.2989; Kwan KM, 2002, GENESIS, V32, P118, DOI 10.1002/gene.10074; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lee D, 2008, MOL CELLS, V25, P50; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Nolan KM, 2002, GENE DEV, V16, P3061, DOI 10.1101/gad.1027702; Ohnishi N, 2011, EMBO J, V30, P1376, DOI 10.1038/emboj.2011.13; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; Q Ma, 2006, TRANSCRIPTION FACTOR; Sarafi-Reinach TR, 2001, DEVELOPMENT, V128, P3269; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Seal RP, 2006, CURR OPIN PHARMACOL, V6, P114, DOI 10.1016/j.coph.2005.12.001; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Zhao Y, 2007, P NATL ACAD SCI USA, V104, P13182, DOI 10.1073/pnas.0705464104	54	154	156	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					659	673		10.1016/j.cell.2013.09.052	http://dx.doi.org/10.1016/j.cell.2013.09.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243022	Green Accepted, Bronze			2022-12-24	WOS:000326571800019
J	Vaniman, DT; Bish, DL; Ming, DW; Bristow, TF; Morris, RV; Blake, DF; Chipera, SJ; Morrison, SM; Treiman, AH; Rampe, EB; Rice, M; Achilles, CN; Grotzinger, JP; McLennan, SM; Williams, J; Bell, JF; Newsom, HE; Downs, RT; Maurice, S; Sarrazin, P; Yen, AS; Morookian, JM; Farmer, JD; Stack, K; Milliken, RE; Ehlmann, BL; Sumner, DY; Berger, G; Crisp, JA; Hurowitz, JA; Anderson, R; Des Marais, DJ; Stolper, EM; Edgett, KS; Gupta, S; Spanovich, N				Vaniman, D. T.; Bish, D. L.; Ming, D. W.; Bristow, T. F.; Morris, R. V.; Blake, D. F.; Chipera, S. J.; Morrison, S. M.; Treiman, A. H.; Rampe, E. B.; Rice, M.; Achilles, C. N.; Grotzinger, J. P.; McLennan, S. M.; Williams, J.; Bell, J. F., III; Newsom, H. E.; Downs, R. T.; Maurice, S.; Sarrazin, P.; Yen, A. S.; Morookian, J. M.; Farmer, J. D.; Stack, K.; Milliken, R. E.; Ehlmann, B. L.; Sumner, D. Y.; Berger, G.; Crisp, J. A.; Hurowitz, J. A.; Anderson, R.; Des Marais, D. J.; Stolper, E. M.; Edgett, K. S.; Gupta, S.; Spanovich, N.		MSL Sci Team	Mineralogy of a Mudstone at Yellowknife Bay, Gale Crater, Mars	SCIENCE			English	Article							CHEMCAM INSTRUMENT SUITE; OMEGA/MARS EXPRESS; MERIDIANI-PLANUM; CLAY-MINERALS; BASSANITE; WATER; SURFACE; SYSTEM; TRANSFORMATIONS; CONSTRAINTS	Sedimentary rocks at Yellowknife Bay (Gale crater) on Mars include mudstone sampled by the Curiosity rover. The samples, John Klein and Cumberland, contain detrital basaltic minerals, calcium sulfates, iron oxide or hydroxides, iron sulfides, amorphous material, and trioctahedral smectites. The John Klein smectite has basal spacing of similar to 10 angstroms, indicating little interlayer hydration. The Cumberland smectite has basal spacing at both similar to 13.2 and similar to 10 angstroms. The larger spacing suggests a partially chloritized interlayer or interlayer magnesium or calcium facilitating H2O retention. Basaltic minerals in the mudstone are similar to those in nearby eolian deposits. However, the mudstone has far less Fe-forsterite, possibly lost with formation of smectite plus magnetite. Late Noachian/Early Hesperian or younger age indicates that clay mineral formation on Mars extended beyond Noachian time.	[Vaniman, D. T.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Bish, D. L.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Ming, D. W.; Morris, R. V.; Rampe, E. B.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Bristow, T. F.; Blake, D. F.; Des Marais, D. J.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Chipera, S. J.] Chesapeake Energy, Oklahoma City, OK 73154 USA; [Morrison, S. M.; Downs, R. T.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Treiman, A. H.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Rice, M.; Grotzinger, J. P.; Stack, K.; Ehlmann, B. L.; Stolper, E. M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Achilles, C. N.] ESCG UTC Aerosp Syst, Houston, TX 77058 USA; [McLennan, S. M.; Hurowitz, J. A.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Williams, J.; Newsom, H. E.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Bell, J. F., III; Farmer, J. D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Maurice, S.; Berger, G.] Univ Toulouse, CNRS, IRAP, F-31400 Toulouse, France; [Sarrazin, P.] SETI Inst, Mountain View, CA 94043 USA; [Yen, A. S.; Morookian, J. M.; Ehlmann, B. L.; Crisp, J. A.; Anderson, R.; Spanovich, N.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Milliken, R. E.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Sumner, D. Y.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Edgett, K. S.] Malin Space Sci Syst, San Diego, CA 92121 USA; [Gupta, S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England	Indiana University System; Indiana University Bloomington; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Arizona; California Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of New Mexico; Arizona State University; Arizona State University-Tempe; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Brown University; University of California System; University of California Davis; Imperial College London	Vaniman, DT (corresponding author), Planetary Sci Inst, Tucson, AZ 85719 USA.	dvaniman@psi.edu	Stipp, Susan L.S./B-8494-2019; De Pablo, Miguel Ángel/J-6442-2014; Franz, Heather B/F-3508-2012; Hayes, Alexander G/P-2024-2014; Malakhov, Alexey Vladimirovich/F-7953-2017; Lemmon, Mark T/E-9983-2010; FABRE, Cécile/B-5827-2012; Crisp, Joy/H-8287-2016; BERGER, Gilles/F-7118-2016; Balic-Zunic, Tonci/A-6362-2013; Blanco, Juan Jose/E-3627-2014; Harri, Ari-Matti/C-7142-2012; Muller, Jan-Peter/Q-8886-2019; Rodriguez-Manfredi, Jose/AAG-9826-2021; Prats, Benito/F-9467-2019; Rodriguez-Manfredi, Jose/L-8001-2014; Farmer, Jack D/B-9343-2019; GEFFROY, Claude/AAB-9152-2019; Glavin, Daniel P/D-6194-2012; Martin-Torres, Javier/G-6329-2015; Avalos, Juan Jose Blanco/AAB-9447-2021; Bish, David/AAY-7618-2020; Floyd, Melissa/D-4626-2012; Gómez, Felipe/L-7315-2014; Stack Morgan, Kathryn/AGY-7985-2022; Teinturier, Samuel/AAS-8663-2020; Navarro-González, Rafael/D-1748-2009; Gomez-Elvira, Javier/K-5829-2014; szopa, cyril/C-6865-2015; Benna, Mehdi/F-3489-2012; Romeral Planelló, Julio J./T-1788-2017; Dworkin, Jason P./C-9417-2012; Sumner, Dawn Y/E-8744-2011; Steele, Andrew/A-3573-2013; Ramos, Miguel/K-2230-2014; Zorzano, María-Paz/F-2184-2015; Gasnault, Olivier/F-4327-2010; Vicenzi, Edward/T-9430-2017	Stipp, Susan L.S./0000-0001-7009-643X; De Pablo, Miguel Ángel/0000-0002-4496-2741; Hayes, Alexander G/0000-0001-6397-2630; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Lemmon, Mark T/0000-0002-4504-5136; FABRE, Cécile/0000-0001-8627-4050; Crisp, Joy/0000-0002-3202-4416; Balic-Zunic, Tonci/0000-0003-1687-1233; Blanco, Juan Jose/0000-0002-8666-0696; Harri, Ari-Matti/0000-0001-8541-2802; Muller, Jan-Peter/0000-0002-5077-3736; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Prats, Benito/0000-0003-3869-3351; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; GEFFROY, Claude/0000-0002-2731-9658; Glavin, Daniel P/0000-0001-7779-7765; Martin-Torres, Javier/0000-0001-6479-2236; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Gómez, Felipe/0000-0001-9977-7060; Teinturier, Samuel/0000-0003-1755-9524; Navarro-González, Rafael/0000-0002-6078-7621; Gomez-Elvira, Javier/0000-0002-9068-9846; szopa, cyril/0000-0002-0090-4056; Romeral Planelló, Julio J./0000-0002-2205-067X; Dworkin, Jason P./0000-0002-3961-8997; Sumner, Dawn Y/0000-0002-7343-2061; Steele, Andrew/0000-0001-9643-2841; Ramos, Miguel/0000-0003-3648-6818; Zorzano, María-Paz/0000-0002-4492-9650; Gupta, Sanjeev/0000-0001-6415-1332; Johnson, Jeffrey/0000-0002-5586-4901; Edgett, Kenneth/0000-0001-7197-5751; Gasnault, Olivier/0000-0002-6979-9012; Vicenzi, Edward/0000-0003-2085-6546; Rice, Melissa/0000-0002-8370-4139; BERGER, Gilles/0000-0003-4806-5594; McLennan, Scott/0000-0003-4259-7178; Morrison, Shaunna/0000-0002-1712-8057	NASA Mars Science Laboratory Mission; National Aeronautics and Space Administration; Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/J005339/1, ST/I003118/1, ST/J005169/1] Funding Source: researchfish	NASA Mars Science Laboratory Mission; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	This paper was significantly improved by comments and recommendations from two anonymous reviewers. Support from the NASA Mars Science Laboratory Mission is gratefully acknowledged. Some of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration.	Anderson RC, 2012, SPACE SCI REV, V170, P57, DOI 10.1007/s11214-012-9898-9; Bell III J. F., 2013, LUNAR PLANET SCI C, V44; Bell III J. F., 2012, LUNAR PLANET SCI C, V43; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bish DL, 2013, SCIENCE, V341, DOI 10.1126/science.1238932; Bish DL, 2003, ICARUS, V164, P96, DOI 10.1016/S0019-1035(03)00140-4; Blake DF, 2013, SCIENCE, V341, DOI 10.1126/science.1239505; Blake D, 2012, SPACE SCI REV, V170, P341, DOI 10.1007/s11214-012-9905-1; Bristow TF, 2011, CLAY CLAY MINER, V59, P339, DOI 10.1346/CCMN.2011.0590401; BURNS RG, 1993, GEOCHIM COSMOCHIM AC, V57, P4555, DOI 10.1016/0016-7037(93)90182-V; Campbell JL, 2012, SPACE SCI REV, V170, P319, DOI 10.1007/s11214-012-9873-5; CHANG HK, 1986, CLAY CLAY MINER, V34, P407, DOI 10.1346/CCMN.1986.0340408; Chipera SJ, 2002, J APPL CRYSTALLOGR, V35, P744, DOI 10.1107/S0021889802017405; Douglas S, 2002, GEOLOGY, V30, P1075, DOI 10.1130/0091-7613(2002)030<1075:MBIEPO>2.0.CO;2; Edgett K. S., 2013, LUNAR PLANET SCI C, V44; Glamoclija M., 2010, ASTR SCI C 2010 EV L; Glotch T, 2008, PHYS CHEM MINER, V35, P569, DOI 10.1007/s00269-008-0249-z; Grotzinger JP, 2014, SCIENCE, V343, DOI 10.1126/science.1242777; Grotzinger J, 2009, NAT GEOSCI, V2, P231, DOI 10.1038/ngeo480; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; GUNATILAKA A, 1985, J U KUWAIT-SCI, V12, P157; Hahn B. C., 2011, LUNAR PLANET SCI C, V42; HARDIE LA, 1967, AM MINERAL, V52, P171; Janchen J, 2006, ICARUS, V180, P353, DOI 10.1016/j.icarus.2005.10.010; JONES BF, 1983, CLAY CLAY MINER, V31, P161, DOI 10.1346/CCMN.1983.0310301; KELLER LP, 1994, GEOCHIM COSMOCHIM AC, V58, P5589, DOI 10.1016/0016-7037(94)90252-6; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; Malin M. C., 2010, LUNAR PLANET SCI C, V41; Maurice S, 2012, SPACE SCI REV, V170, P95, DOI 10.1007/s11214-012-9912-2; McAdam A.C., 2004, 2 C EARL MARS GEOL H; McLennan SM, 2014, SCIENCE, V343, DOI 10.1126/science.1244734; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; McQuivey R. S., 1969, US GEOL SURV PROF D, V650-D, pD244; Mees F, 2005, SEDIMENT GEOL, V181, P225, DOI 10.1016/j.sedgeo.2005.09.002; Milliken RE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041870; Milliken R. E., 2010, LUNAR PLANET SCI C, V41; Ming DW, 2014, SCIENCE, V343, DOI 10.1126/science.1245267; Mirwald PW, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2826321; Morris R. V., 2013, LUNAR PLANET SCI C, V44; Morrison S. M., 2013, LUNAR PLANET SCI C, V44; Murchie SL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003342; Nambu, 1968, J JPN ASS MINERAL, V59, P143, DOI [10.2465/ganko1941.59.143, DOI 10.2465/GANKO1941.59.143]; Oetzel M, 2000, ZKG INT, V53, P354; PEVEAR DR, 1982, CLAY CLAY MINER, V30, P241, DOI 10.1346/CCMN.1982.0300401; Rice MS, 2010, ICARUS, V205, P375, DOI 10.1016/j.icarus.2009.03.035; Rice M. S., 2011, AM GEOPH UN FALL M; RICH CI, 1968, CLAY CLAY MINER, V16, P15, DOI 10.1346/CCMN.1968.0160104; Robertson K, 2013, ICARUS, V223, P407, DOI 10.1016/j.icarus.2012.10.028; SKIPPER NT, 1991, J CHEM PHYS, V94, P7434, DOI 10.1063/1.460175; SLINGERLAND R, 1986, ANNU REV EARTH PL SC, V14, P113, DOI 10.1146/annurev.ea.14.050186.000553; Squyres SW, 2012, SCIENCE, V336, P570, DOI 10.1126/science.1220476; Squyres SW, 2005, EARTH PLANET SC LETT, V240, P1, DOI 10.1016/j.epsl.2005.09.038; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Sutley SJ., 2007, USGS DIGITAL SPECTRA; Thomson BJ, 2011, ICARUS, V214, P413, DOI 10.1016/j.icarus.2011.05.002; Vaniman D. T., 2009, LUNAR PLANET SCI C, V40; Vaniman D. T., 2006, WORKSH SULF REC ATM; Vaniman DT, 2006, AM MINERAL, V91, P1628, DOI 10.2138/am.2006.2092; Wiens RC, 2012, SPACE SCI REV, V170, P167, DOI 10.1007/s11214-012-9902-4; WORKU T, 1992, MINERAL MAG, V56, P258, DOI 10.1180/minmag.1992.056.383.15; Wray JJ, 2010, ICARUS, V209, P416, DOI 10.1016/j.icarus.2010.06.001; Zolotov MY, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002882	64	430	435	8	320	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1243480	10.1126/science.1243480	http://dx.doi.org/10.1126/science.1243480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24324271	Green Accepted			2022-12-24	WOS:000330039300003
J	Chung, WS; Clarke, LE; Wang, GX; Stafford, BK; Sher, A; Chakraborty, C; Joung, J; Foo, LC; Thompson, A; Chen, CF; Smith, SJ; Barres, BA				Chung, Won-Suk; Clarke, Laura E.; Wang, Gordon X.; Stafford, Benjamin K.; Sher, Alexander; Chakraborty, Chandrani; Joung, Julia; Foo, Lynette C.; Thompson, Andrew; Chen, Chinfei; Smith, Stephen J.; Barres, Ben A.			Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways	NATURE			English	Article							CELL CORPSE ENGULFMENT; RETINAL WAVES; RECEPTOR; PHAGOCYTOSIS; KINASE; SEGREGATION; REFINEMENT; CLEARANCE; MICROGLIA; ROLES	To achieve its precise neural connectivity, the developing mammalian nervous system undergoes extensive activity-dependent synapse remodelling. Recently, microglial cells have been shown to be responsible for a portion of synaptic pruning, but the remaining mechanisms remain unknown. Here we report a new role for astrocytes in actively engulfing central nervous system synapses. This process helps to mediate synapse elimination, requires the MEGF10 and MERTK phagocytic pathways, and is strongly dependent on neuronal activity. Developing mice deficient in both astrocyte pathways fail to refine their retinogeniculate connections normally and retain excess functional synapses. Finally, we show that in the adult mouse brain, astrocytes continuously engulf both excitatory and inhibitory synapses. These studies reveal a novel role for astrocytes in mediating synapse elimination in the developing and adult brain, identify MEGF10 and MERTK as critical proteins in the synapse remodelling underlying neural circuit refinement, and have important implications for understanding learning and memory as well as neurological disease processes.	[Chung, Won-Suk; Clarke, Laura E.; Chakraborty, Chandrani; Joung, Julia; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Wang, Gordon X.; Smith, Stephen J.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Stafford, Benjamin K.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Sher, Alexander] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Sher, Alexander] Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA; [Foo, Lynette C.] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore; [Thompson, Andrew; Chen, Chinfei] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA	Stanford University; Stanford University; University of Michigan System; University of Michigan; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Harvard University; Boston Children's Hospital; Harvard Medical School	Chung, WS (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	wschung@stanford.edu	Chung, Won-Suk/B-9011-2016; Joung, Julia/HCH-8944-2022	Chung, Won-Suk/0000-0003-1060-9007; Wang, Gordon/0000-0002-2707-7118; Smith, Stephen/0000-0002-2290-8701; Sher, Alexander/0000-0001-6655-6456	NIH [NS069375, 5 R21NS072556]; Damon Runyon Cancer Research Foundation [DRG 2020-09]; EMBO ALTF fellowship; Mcknight Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075252, R21NS072556, P30NS069375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; EMBO ALTF fellowship; Mcknight Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Vollrath for discussions and MERTK antibody. We also thank H. M. Lee for helping us set up electrophysiology experiments as well as for discussions. Part of the data was acquired at Stanford Neuroscience Microscopy Service (NMS), supported by NIH NS069375. W.-S.C. was supported in part by a postdoctoral fellowship from the Damon Runyon Cancer Research Foundation (DRG 2020-09). L. E. C. was supported in part by an EMBO ALTF fellowship. This work was supported by grants from the NIH (5 R21NS072556, B. A. B.) and a Brain Disorder Award from the Mcknight Foundation to B. A. B. We thank V. and S. Coates for their generous support.	Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Beletskii A, 2005, BIOTECHNIQUES, V39, P894, DOI 10.2144/000112001; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hochreiter-Hufford A., 2013, COLD SPRING HARB PER, V5; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Huberman AD, 2002, J NEUROSCI, V22, P9419; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Peters A., 1976, FINE STRUCTURE NERVO; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; SHATZ CJ, 1986, ANNU REV NEUROSCI, V9, P171, DOI 10.1146/annurev.ne.09.030186.001131; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tasdemir-Yilmaz O., GENES DEV IN PRESS; Tung TT, 2013, J BIOCHEM, V153, P483, DOI 10.1093/jb/mvt014; Wang G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002671; Wu HH, 2009, NAT NEUROSCI, V12, P1534, DOI 10.1038/nn.2446; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	39	673	686	9	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					394	+		10.1038/nature12776	http://dx.doi.org/10.1038/nature12776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24270812	Green Submitted, Green Accepted			2022-12-24	WOS:000328575300043
J	Lim, XH; Tan, SH; Koh, WLC; Chau, RMW; Yan, KS; Kuo, CJ; van Amerongen, R; Klein, AM; Nusse, R				Lim, Xinhong; Tan, Si Hui; Koh, Winston Lian Chye; Chau, Rosanna Man Wah; Yan, Kelley S.; Kuo, Calvin J.; van Amerongen, Renee; Klein, Allon Moshe; Nusse, Roel			Interfollicular Epidermal Stem Cells Self-Renew via Autocrine Wnt Signaling	SCIENCE			English	Article							HAIR FOLLICLE; PROGENITOR CELLS; EXPRESSION; REVEALS; LABEL; SKIN	The skin is a classical example of a tissue maintained by stem cells. However, the identity of the stem cells that maintain the interfollicular epidermis and the source of the signals that control their activity remain unclear. Using mouse lineage tracing and quantitative clonal analyses, we showed that the Wnt target gene Axin2 marks interfollicular epidermal stem cells. These Axin2-expressing cells constitute the majority of the basal epidermal layer, compete neutrally, and require Wnt/beta-catenin signaling to proliferate. The same cells contribute robustly to wound healing, with no requirement for a quiescent stem cell subpopulation. By means of double-labeling RNA in situ hybridization in mice, we showed that the Axin2-expressing cells themselves produce Wnt signals as well as long-range secreted Wnt inhibitors, suggesting an autocrine mechanism of stem cell self-renewal.	[Lim, Xinhong; van Amerongen, Renee; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol,Sch Med, Stanford, CA 94305 USA; [Tan, Si Hui] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; [Koh, Winston Lian Chye; Chau, Rosanna Man Wah] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Yan, Kelley S.; Kuo, Calvin J.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Klein, Allon Moshe] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Harvard University; Harvard Medical School	Klein, AM (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA.	allon_klein@hms.harvard.edu; rnusse@stanford.edu	van Amerongen, Renee/G-2945-2017; Koh, Lian Chye Winston/GYD-5873-2022; van Amerongen, Renee/N-6645-2019	van Amerongen, Renee/0000-0002-8808-2092; Koh, Lian Chye Winston/0000-0003-4611-6490; van Amerongen, Renee/0000-0002-8808-2092; Kuo, Calvin/0000-0002-7427-5985; Tan, Si Hui/0000-0002-0809-0085	HHMI; California Institute of Regenerative Medicine [TR1-01249]; NIH [NIH 1U01DK085527, 1R01DK085720, 5K08DK096048]; A*STAR, Singapore; Scientific Interface from the Burroughs Wellcome Fund; Burroughs Wellcome Fund; European Molecular Biology Organization [ALTF 122-2007]; Dutch Cancer Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, K08DK096048, R01DK085720, U01DK085527] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Burroughs Wellcome Fund(Burroughs Wellcome Fund); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the HHMI, California Institute of Regenerative Medicine grant TR1-01249, and NIH grants NIH 1U01DK085527, 1R01DK085720, and 5K08DK096048. We thank L. De Simone, A. E. Marcy, and P. H. Chia for cell quantification assistance; C. Logan, S. J. Habib, and A. Oro for manuscript comments; and J. Akech and L.-C. Wang at Advanced Cell Diagnostics for assistance with RNA in situ hybridization. X. L., S. H. T., W. L. C. K., and R. M. W. C. are supported by National Science Scholarships from A*STAR, Singapore. A. M. K. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. K.S.Y. has a Burroughs Wellcome Fund Career Award for Medical Scientists. R. v. A. was supported by a European Molecular Biology Organization long-term fellowship (ALTF 122-2007) and a Dutch Cancer Society fellowship.	Barrantes ID, 2006, MOL CELL BIOL, V26, P2317, DOI 10.1128/MCB.26.6.2317-2326.2006; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; BICKENBACH JR, 1986, CELL TISSUE KINET, V19, P325, DOI 10.1111/j.1365-2184.1986.tb00684.x; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Choi Y. S., 2013, CELL STEM CELL, DOI [10.1016/j.stem.2013.10.00, DOI 10.1016/J.STEM.2013.10.00]; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Du G, 2011, EXP DERMATOL, V20, P273, DOI 10.1111/j.1600-0625.2010.01244.x; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jorizzo J. L., 2012, DERMATOLOGY, P869; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032331; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; MACKENZIE IC, 1970, NATURE, V226, P653, DOI 10.1038/226653a0; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; POTTEN CS, 1974, CELL TISSUE KINET, V7, P77, DOI 10.1111/j.1365-2184.1974.tb00401.x; Radoja N, 2006, PHYSIOL GENOMICS, V27, P65, DOI 10.1152/physiolgenomics.00031.2006; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Schluter H, 2013, J INVEST DERMATOL, V133, P1669, DOI 10.1038/jid.2013.42; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; Witte F, 2009, GENE EXPR PATTERNS, V9, P215, DOI 10.1016/j.gep.2008.12.009; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122	25	241	247	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1226	1230		10.1126/science.1239730	http://dx.doi.org/10.1126/science.1239730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311688	Green Accepted			2022-12-24	WOS:000327857900046
J	Deris, JB; Kim, M; Zhang, ZG; Okano, H; Hermsen, R; Groisman, A; Hwa, T				Deris, J. Barrett; Kim, Minsu; Zhang, Zhongge; Okano, Hiroyuki; Hermsen, Rutger; Groisman, Alexander; Hwa, Terence			The Innate Growth Bistability and Fitness Landscapes of Antibiotic-Resistant Bacteria	SCIENCE			English	Editorial Material												hwa@ucsd.edu	Hwa, Terence/J-4012-2013; Hermsen, Rutger/A-4739-2012; Groisman, Alexander/AAU-7843-2021; Hwa, Terry/GOJ-9904-2022	Hwa, Terence/0000-0003-1837-6842; Hermsen, Rutger/0000-0003-4633-4877; 	NATIONAL CANCER INSTITUTE [U54CA143803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095903] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA143803, 1 U54 CA143803] Funding Source: Medline; NIGMS NIH HHS [R01 GM095903, R01-GM095903] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	119	122	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1068	1068		10.1126/science.1237435	http://dx.doi.org/10.1126/science.1237435			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288338	Green Accepted			2022-12-24	WOS:000327518600049
J	Nardone, A; Delpech, V; Gill, ON; Fenton, KA; Anderson, J				Nardone, Anthony; Delpech, Valerie; Gill, O. Noel; Fenton, Kevin A.; Anderson, Jane			HIV in the UK: test, test, and test again	LANCET			English	Editorial Material							TRANSMISSION; MEN; SEX		[Nardone, Anthony; Delpech, Valerie; Gill, O. Noel] Publ Hlth England, Hlth Protect Directorate, Ctr Dis Surveillance & Control, HIV & STI Dept, London NW9 5EQ, England; [Fenton, Kevin A.; Anderson, Jane] Publ Hlth England, Hlth Wellbeing Directorate, London NW9 5EQ, England	Public Health England; Public Health England	Nardone, A (corresponding author), Publ Hlth England, Hlth Protect Directorate, Ctr Dis Surveillance & Control, HIV & STI Dept, London NW9 5EQ, England.	anthony.nardone@phe.gov.uk	Anderson, Jane/A-1632-2012	Anderson, Jane/0000-0001-5294-8707; Nardone, Anthony/0000-0003-1138-0937; delpech, valerie/0000-0002-9952-8109				Birrell PJ, 2013, LANCET INFECT DIS, V13, P313, DOI 10.1016/S1473-3099(12)70341-9; British HIV Association British Association of Sexual Health and HIV British Infection Society, UK NAT GUID HIV TEST; Brown AE, 2013, HIV MED, V14, P563, DOI 10.1111/hiv.12066; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Department of Health, 2013, MOD HIV RUL BETT PRO; Ellis S, 2012, CLIN MED, V12, P430, DOI 10.7861/clinmedicine.12-5-430; Hartney T, 2014, HIV MED, V15, P251, DOI 10.1111/hiv.12099; Health Protection Agency, 2012, HIV UK 2012 REP; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; National Institute for Health and Care Excellence, 2011, INCR UPT HIV TEST ME; Ogunyemi A, 2013, PUBL HLTH ENGL C WAR; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Public Health England, 2011, TIM TEST HIV EXP HEA; Sullivan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052845	14	10	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1687	1688		10.1016/S0140-6736(13)62377-6	http://dx.doi.org/10.1016/S0140-6736(13)62377-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259PX	24267988				2022-12-24	WOS:000327539900009
J	Koel, BF; Burke, DF; Bestebroer, TM; van der Vliet, S; Zondag, GCM; Vervaet, G; Skepner, E; Lewis, NS; Spronken, MIJ; Russell, CA; Eropkin, MY; Hurt, AC; Barr, IG; de Jong, JC; Rimmelzwaan, GF; Osterhaus, ADME; Fouchier, RAM; Smith, DJ				Koel, Bjorn F.; Burke, David F.; Bestebroer, Theo M.; van der Vliet, Stefan; Zondag, Gerben C. M.; Vervaet, Gaby; Skepner, Eugene; Lewis, Nicola S.; Spronken, Monique I. J.; Russell, Colin A.; Eropkin, Mikhail Y.; Hurt, Aeron C.; Barr, Ian G.; de Jong, Jan C.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Smith, Derek J.			Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution	SCIENCE			English	Article							A VIRUSES; HEMAGGLUTININ; ANTIBODY; RECOGNITION	The molecular basis of antigenic drift was determined for the hemagglutinin (HA) of human influenza A/H3N2 virus. From 1968 to 2003, antigenic change was caused mainly by single amino acid substitutions, which occurred at only seven positions in HA immediately adjacent to the receptor binding site. Most of these substitutions were involved in antigenic change more than once. Equivalent positions were responsible for the recent antigenic changes of influenza B and A/H1N1 viruses. Substitution of a single amino acid at one of these positions substantially changed the virus-specific antibody response in infected ferrets. These findings have potentially far-reaching consequences for understanding the evolutionary mechanisms that govern influenza viruses.	[Koel, Bjorn F.; Bestebroer, Theo M.; van der Vliet, Stefan; Vervaet, Gaby; Spronken, Monique I. J.; de Jong, Jan C.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Smith, Derek J.] Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Netherlands; [Burke, David F.; Skepner, Eugene; Lewis, Nicola S.; Smith, Derek J.] Univ Cambridge, Dept Zool, Ctr Pathogen Evolut, Cambridge CB2 3EJ, England; [Burke, David F.; Skepner, Eugene; Lewis, Nicola S.; Russell, Colin A.; Smith, Derek J.] Univ Cambridge, WHO Collaborating Ctr Modeling Evolut & Control E, Cambridge CB2 3EJ, England; [Zondag, Gerben C. M.] BaseClear BV, NL-2333 CC Leiden, Netherlands; [Zondag, Gerben C. M.] Leiden Univ, Luris, NL-2333 AA Leiden, Netherlands; [Russell, Colin A.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Eropkin, Mikhail Y.] All Union Influenza Res Inst, St Petersburg 197376, Russia; [Hurt, Aeron C.; Barr, Ian G.] VIDRL, WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic 3051, Australia; [Smith, Derek J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; University of Cambridge; University of Cambridge; Leiden University; Leiden University - Excl LUMC; University of Cambridge; Victorian Infectious Diseases Reference Laboratory; World Health Organization; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Fouchier, RAM (corresponding author), Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl; dsmith@zoo.cam.ac.uk	Russell, Colin/ABE-7106-2020; Smith, Derek/Z-3075-2019; Burke, David F/C-2091-2013; Fouchier, Ron A/A-1911-2014	Smith, Derek/0000-0002-2393-1890; Burke, David F/0000-0001-8830-3951; Fouchier, Ron A/0000-0001-8095-2869; Hurt, Aeron/0000-0003-1826-4314; Eropkin, Mikhail/0000-0002-3306-847X; Russell, Colin/0000-0002-2113-162X; Barr, Ian/0000-0002-7351-418X	NWO VICI grant; National Institute of Allergy and Infectious Diseases [HHSN266200700010C]; NIH [DP1-OD000490-01]; European Union [223498, 278976]; Human Frontier Science Program [P0050/2008]; Australian Government Department of Health and Aging; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	NWO VICI grant(Netherlands Organization for Scientific Research (NWO)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Human Frontier Science Program(Human Frontier Science Program); Australian Government Department of Health and Aging(Australian GovernmentDepartment of Health & Ageing); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Aban, G. van Amerongen, C. Baas, R. van Beek, M. de Graaf, S. Herfst, S. James, M. Linster, K. Sutherland-Cash, and C. Whittleston for excellent technical assistance and discussions. D.F.B. and D.J.S. acknowledge the use of the CamGrid distributed computing resource. Supported by an NWO VICI grant, National Institute of Allergy and Infectious Diseases contract HHSN266200700010C, NIH Director's Pioneer Award DP1-OD000490-01, European Union FP7 program EMPERIE (223498), European Union FP7 program ANTIGONE (278976), and program grant P0050/2008 from the Human Frontier Science Program. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Aging. A.D.M.E.O. (on behalf of Viroclinics Biosciences B.V.) has advisory affiliations with GSK, Novartis, and Roche. A.D.M.E.O. and G.F.R. are consultants for Viroclinics Biosciences BV. A/H3N2 virus sequences were previously published by Smith et al. (16). The sequences of the influenza A/H1N1 and B viruses used in this study are available from the GISAID EpiFlu Database (www.gisaid.org) and are listed in table S6.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Akazawa M, 2003, VALUE HEALTH, V6, P107, DOI 10.1046/j.1524-4733.2003.00209.x; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; de Wit E, 2007, J GEN VIROL, V88, P1281, DOI 10.1099/vir.0.82452-0; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; VIRELIZIER JL, 1975, J IMMUNOL, V115, P434; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Zhai WW, 2007, J MOL EVOL, V65, P340, DOI 10.1007/s00239-007-9019-7	21	357	374	5	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					976	979		10.1126/science.1244730	http://dx.doi.org/10.1126/science.1244730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264991				2022-12-24	WOS:000327223500042
J	Hazel, J; Krutkramelis, K; Mooney, P; Tomschik, M; Gerow, K; Oakey, J; Gatlin, JC				Hazel, James; Krutkramelis, Kaspars; Mooney, Paul; Tomschik, Miroslav; Gerow, Ken; Oakey, John; Gatlin, J. C.			Changes in Cytoplasmic Volume Are Sufficient to Drive Spindle Scaling	SCIENCE			English	Article							MITOTIC SPINDLE; MICROTUBULE ASTERS; CELL; TRANSITION; POSITION; GROWTH; SIZE	The mitotic spindle must function in cell types that vary greatly in size, and its dimensions scale with the rapid, reductive cell divisions that accompany early stages of development. The mechanism responsible for this scaling is unclear, because uncoupling cell size from a developmental or cellular context has proven experimentally challenging. We combined microfluidic technology with Xenopus egg extracts to characterize spindle assembly within discrete, geometrically defined volumes of cytoplasm. Reductions in cytoplasmic volume, rather than developmental cues or changes in cell shape, were sufficient to recapitulate spindle scaling observed in Xenopus embryos. Thus, mechanisms extrinsic to the spindle, specifically a limiting pool of cytoplasmic component(s), play a major role in determining spindle size.	[Hazel, James; Mooney, Paul; Tomschik, Miroslav; Gatlin, J. C.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Krutkramelis, Kaspars; Oakey, John] Univ Wyoming, Dept Chem & Petr Engn, Laramie, WY 82071 USA; [Gerow, Ken] Univ Wyoming, Dept Stat, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming; University of Wyoming	Gatlin, JC (corresponding author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.	jgatlin@uwyo.edu	, Miroslav/AAD-9416-2020	, Miroslav/0000-0002-0758-6169; Gatlin, Jesse/0000-0002-5417-225X	NIH [R01 GM102428, R15 GM101636, P20RR016474, P20GM103432]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102428, R15GM101636, P20GM103432] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Salmon and T. Mitchison for their insightful reviews of the manuscript; M. Wuhr for comments on the work and for providing access to raw data originally presented in (2); L. Edens, C. Geisler, D. Fay, and D. Levy in the Molecular Biology Department at the University of Wyoming for their critical review of the manuscript and helpful suggestions; and A. Groen for providing labeled anti-NuMA used in these studies. This work was supported by NIH grants R01 GM102428 (to J.C.G.) and R15 GM101636 (to J.O.) and by the NIH-funded Wyoming IDeA Networks of Biomedical Research Excellence program (P20RR016474 and P20GM103432).	Bird SL, 2013, MOL BIOL CELL, V24, P2506, DOI 10.1091/mbc.E13-03-0150; Chan YHM, 2010, ORGANOGENESIS, V6, P88, DOI 10.4161/org.6.2.11464; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Decker M, 2011, CURR BIOL, V21, P1259, DOI 10.1016/j.cub.2011.06.002; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Gatlin JC, 2009, CURR BIOL, V19, P287, DOI 10.1016/j.cub.2009.01.055; Goehring NW, 2012, CURR BIOL, V22, pR330, DOI 10.1016/j.cub.2012.03.046; Hara Y, 2009, CURR BIOL, V19, P1549, DOI 10.1016/j.cub.2009.07.050; Holy TE, 1997, P NATL ACAD SCI USA, V94, P6228, DOI 10.1073/pnas.94.12.6228; Hyman A. A., 2008, NOVART FDN SYMP, V237, P164; Kiyomitsu T, 2012, NAT CELL BIOL, V14, P311, DOI 10.1038/ncb2440; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Ludington WB, 2012, CURR BIOL, V22, P2173, DOI 10.1016/j.cub.2012.09.040; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Mitchison T, 2012, CYTOSKELETON, V69, P738, DOI 10.1002/cm.21050; Montorzi M, 2000, MOL REPROD DEV, V55, P75, DOI 10.1002/(SICI)1098-2795(200001)55:1<75::AID-MRD10>3.0.CO;2-Z; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Tolic-Norrelykke IM, 2004, CURR BIOL, V14, P1181, DOI 10.1016/j.cub.2004.06.029; Wilbur JD, 2013, ELIFE, V2, DOI 10.7554/eLife.00290; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092; Wuhr M, 2009, CELL CYCLE, V8, P1115; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024	25	134	135	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					853	856		10.1126/science.1243110	http://dx.doi.org/10.1126/science.1243110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233723	Green Accepted			2022-12-24	WOS:000326923000037
J	Goddeeris, MM; Wu, BM; Venzke, D; Yoshida-Moriguchi, T; Saito, F; Matsumura, K; Moore, SA; Campbell, KP				Goddeeris, Matthew M.; Wu, Biming; Venzke, David; Yoshida-Moriguchi, Takako; Saito, Fumiaki; Matsumura, Kiichiro; Moore, Steven A.; Campbell, Kevin P.			LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy	NATURE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; ALPHA-DYSTROGLYCAN; ABNORMAL GLYCOSYLATION; LAMININ-BINDING; DISRUPTION; MUTATIONS; EXPRESSION; MEMBRANE; COMPLEX; CELLS	The dense glycan coat that surrounds every cell is essential for cellular development and physiological function(1), and it is becoming appreciated that its composition is highly dynamic. Post-translational addition of the polysaccharide repeating unit [-3-xylose-alpha 1,3-glucuronic acid-beta 1-](n) by like-acetylglucosaminyltransferase (LARGE) is required for the glycoprotein dystroglycan to function as a receptor for proteins in the extracellular matrix(2,3). Reductions in the amount of [-3-xylose-alpha 1,3-glucuronic acid-beta 1-](n) (hereafter referred to as LARGE-glycan) on dystroglycan result in heterogeneous forms of muscular dystrophy(4). However, neither patient nor mouse studies has revealed a clear correlation between glycosylation status and phenotype(5,6). This disparity can be attributed to our lack of knowledge of the cellular function of the LARGE-glycan repeat. Here we show that coordinated upregulation of Large and dystroglycan in differentiating mouse muscle facilitates rapid extension of LARGE-glycan repeat chains. Using synthesized LARGE-glycan repeats we show a direct correlation between LARGE-glycan extension and its binding capacity for extracellular matrix ligands. Blocking Large upregulation during muscle regeneration results in the synthesis of dystroglycan with minimal LARGE-glycan repeats in association with a less compact basement membrane, immature neuromuscular junctions and dysfunctional muscle predisposed to dystrophy. This was consistent with the finding that patients with increased clinical severity of disease have fewer LARGE-glycan repeats. Our results reveal that the LARGE-glycan of dystroglycan serves as a tunable extracellular matrix protein scaffold, the extension of which is required for normal skeletal muscle function.	[Goddeeris, Matthew M.; Wu, Biming; Venzke, David; Yoshida-Moriguchi, Takako; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Goddeeris, Matthew M.; Wu, Biming; Venzke, David; Yoshida-Moriguchi, Takako; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol, Iowa City, IA 52242 USA; [Saito, Fumiaki; Matsumura, Kiichiro] Teikyo Univ, Sch Med, Dept Neurol & Neurosci, Itabashi Ku, Tokyo 1738605, Japan; [Moore, Steven A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; Teikyo University; University of Iowa; University of Iowa; University of Iowa	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	kevin-campbell@uowa.edu		Venzke, David/0000-0001-8180-9562; Campbell, Kevin/0000-0003-2066-5889; Moore, Steven/0000-0002-6353-7900	NIH/NIAMS Ruth L. Kirschstein National Research Science Award [F32 AR057289-01]; NIH [T32-DK07690-16]; American Reinvestment and Recovery Act Grant [1RC2NS069521-01]; Muscular Dystrophy Association Research Grant [157538]; Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant [1U54NS053672]; NCNP (Ministry of Health and Welfare, Japan); MEXT [23591256, 24501357, 25430075]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672, RC2NS069521] Funding Source: NIH RePORTER	NIH/NIAMS Ruth L. Kirschstein National Research Science Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Reinvestment and Recovery Act Grant; Muscular Dystrophy Association Research Grant; Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant; NCNP (Ministry of Health and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M. M. G. was supported by a NIH/NIAMS Ruth L. Kirschstein National Research Science Award (F32 AR057289-01) and NIH grant (T32-DK07690-16). The work was supported by American Reinvestment and Recovery Act Grant (1RC2NS069521-01), a Muscular Dystrophy Association Research Grant (157538), and a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center Grant (1U54NS053672). F. S. and K. M. were supported by an Intramural Research Grant (23-5) for Neurological and Psychiatric Disorders of NCNP (Ministry of Health and Welfare, Japan) and a MEXT Grant-in-Aid for Scientific Research (C 23591256, 24501357, 25430075). We thank P. Yurchenco for his gift of alpha 1LG4-5 producing cells; J. Levy for microscopy expertise; M. B. Zimmerman for assisting with statistical analysis; R. Crawford for technical expertise; H. Nguyen for illustrations; J. Hartner for oversight of Large<SUP>KD</SUP> mouse targeting; J. Shao and R. Nessler of the University of Iowa Central Microscopy Core for their contributions to imaging; and J. Sanes, G. Valdez, D. Glass, C. Blaumueller and Campbell laboratory colleagues for discussions. K. P. C. is an Investigator of the Howard Hughes Medical Institute.	Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beedle AM, 2012, J CLIN INVEST, V122, P3330, DOI 10.1172/JCI63004; Behrens DT, 2012, J BIOL CHEM, V287, P18700, DOI 10.1074/jbc.M111.336073; Breloy I, 2012, J BIOL CHEM, V287, P18275, DOI 10.1074/jbc.M111.280297; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Brown SC, 2004, AM J PATHOL, V164, P727, DOI 10.1016/S0002-9440(10)63160-4; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Groh S, 2009, J BIOL CHEM, V284, P19178, DOI 10.1074/jbc.C109.010728; GURNETT CA, 1995, J BIOL CHEM, V270, P9035, DOI 10.1074/jbc.270.16.9035; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hsu NY, 2007, RAPID COMMUN MASS SP, V21, P2137, DOI 10.1002/rcm.3072; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jimenez-Mallebrera C, 2009, BRAIN PATHOL, V19, P596, DOI 10.1111/j.1750-3639.2008.00198.x; Jurado LAP, 1999, GENOMICS, V58, P171, DOI 10.1006/geno.1999.5819; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kanagawa M, 2005, FEBS LETT, V579, P4792, DOI 10.1016/j.febslet.2005.07.059; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; KOSTROMINOVA TY, 1995, J CELL BIOCHEM, V58, P527, DOI 10.1002/jcb.240580416; Leschziner A, 2000, J NEUROCHEM, V74, P70, DOI 10.1046/j.1471-4159.2000.0740070.x; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Masaki T, 2001, ACTA NEUROPATHOL, V101, P174; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Montanaro F, 1998, J NEUROSCI, V18, P1250; Muntoni F, 2011, CURR OPIN NEUROL, V24, P437, DOI 10.1097/WCO.0b013e32834a95e3; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Osawa T, 2003, J ELECTRON MICROSC, V52, P435, DOI 10.1093/jmicro/52.4.435; Pereboev AV, 2001, BBA-GEN SUBJECTS, V1527, P54, DOI 10.1016/S0304-4165(01)00147-7; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003; Willer T, 2002, GLYCOBIOLOGY, V12, P771, DOI 10.1093/glycob/cwf086; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	46	74	76	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					136	+		10.1038/nature12605	http://dx.doi.org/10.1038/nature12605			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24132234	Green Accepted			2022-12-24	WOS:000326585600047
J	Xie, D; Boyle, AP; Wu, LF; Zhai, J; Kawli, T; Snyder, M				Xie, Dan; Boyle, Alan P.; Wu, Linfeng; Zhai, Jie; Kawli, Trupti; Snyder, Michael			Dynamic trans-Acting Factor Colocalization in Human Cells	CELL			English	Article							PROTEIN INTERACTION NETWORK; ZINC-FINGER PROTEINS; REGULATORY NETWORK; BINDING-SITES; DROSOPHILA; DIFFERENTIATION; EXPRESSION; MODENCODE; ELEMENTS; GENOME	Different trans-acting factors (TFs) collaborate and act in concert at distinct loci to perform accurate regulation of their target genes. To date, the cobinding of TF pairs has been investigated in a limited context both in terms of the number of factors within a cell type and across cell types and the extent of combinatorial colocalizations. Here, we use an approach to analyze TF colocalization within a cell type and across multiple cell lines at an unprecedented level. We extend this approach with largescale mass spectrometry analysis of immunoprecipitations of 50 TFs. Our combined approach reveals large numbers of interesting TF-TF associations. We observe extensive change in TF colocalizations both within a cell type exposed to different conditions and across multiple cell types. We show distinct functional annotations and properties of different TF cobinding patterns and provide insights into the complex regulatory landscape of the cell.	[Xie, Dan; Boyle, Alan P.; Wu, Linfeng; Zhai, Jie; Kawli, Trupti; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Boyle, Alan/I-1848-2014	Boyle, Alan/0000-0002-2081-1105; Snyder, Michael/0000-0003-0784-7987	NHGRI [U54HG004558, U54HG006996]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003156, K99HG007356, U54HG006996, U54HG004558] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the ENCODE consortium for providing data used in these analyses. The HeLa cells used in this study were derived from Henrietta Lacks, and we are grateful to her and her family for their contributions to biomedical research. This project is funded by NHGRI grants U54HG004558 and U54HG006996. M. P. S. is a cofounder and scientific advisory board (SAB) member of Personalis. He is on the SAB of Genapsys.	Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Chikina MD, 2012, BIOINFORMATICS, V28, P607, DOI 10.1093/bioinformatics/bts009; Choi H, 2012, CURR PROTOC BIOINFOR, V39, P8151; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hietakangas V, 2003, MOL CELL BIOL, V23, P1278, DOI 10.1128/MCB.23.4.1278-1291.2003; Higo S, 2010, J BIOL CHEM, V285, P31337, DOI 10.1074/jbc.M110.155788; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; IGARASHI K, 1995, P NATL ACAD SCI USA, V92, P7445, DOI 10.1073/pnas.92.16.7445; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Rosnoblet C, 2011, BIOCHEM BIOPH RES CO, V413, P206, DOI 10.1016/j.bbrc.2011.08.059; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Vesanto J, 2005, SOM TOOLBOX IMPLEMEN; Xie D, 2008, GENOME RES, V18, P1325, DOI 10.1101/gr.072769.107; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48	31	100	101	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					713	724		10.1016/j.cell.2013.09.043	http://dx.doi.org/10.1016/j.cell.2013.09.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243024	Bronze, Green Accepted			2022-12-24	WOS:000326571800023
J	Acevedo, A; Brodsky, L; Andino, R				Acevedo, Ashley; Brodsky, Leonid; Andino, Raul			Mutational and fitness landscapes of an RNA virus revealed through population sequencing	NATURE			English	Article							NUCLEOTIDE SUBSTITUTIONS; SUBSTRATE RECOGNITION; PROTEIN; POLYMERASE; ATTENUATION; DNA	RNA viruses exist as genetically diverse populations(1). It is thought that diversity and genetic structure of viral populations determine the rapid adaptation observed in RNA viruses(2) and hence their pathogenesis(3). However, our understanding of the mechanisms underlying virus evolution has been limited by the inability to accurately describe the genetic structure of virus populations. Next-generation sequencing technologies generate data of sufficient depth to characterize virus populations, but are limited in their utility because most variants are present at very low frequencies and are thus indistinguishable from next-generation sequencing errors. Here we present an approach that reduces next-generation sequencing errors and allows the description of virus populations with unprecedented accuracy. Using this approach, we define the mutation rates of poliovirus and uncover the mutation landscape of the population. Furthermore, by monitoring changes in variant frequencies on serially passaged populations, we determined fitness values for thousands of mutations across the viral genome. Mapping of these fitness values onto three-dimensional structures of viral proteins offers a powerful approach for exploring structure-function relationships and potentially uncovering new functions. To our knowledge, our study provides the first single-nucleotide fitness landscape of an evolving RNA virus and establishes a general experimental platform for studying the genetic changes underlying the evolution of virus populations.	[Acevedo, Ashley; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94122 USA; [Brodsky, Leonid] Univ Haifa, Tauber Bioinformat Res Ctr, IL-31905 Haifa, Israel; [Brodsky, Leonid] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31905 Haifa, Israel	University of California System; University of California San Francisco; University of Haifa; University of Haifa	Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94122 USA.	raul.andino@ucsf.edu			National Science Foundation; NIAID [AI091575, AI36178, AI40085]; DARPA Prophecy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040085, R56AI036178, R21AI040085, R21AI036178, P01AI091575, R01AI036178] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DARPA Prophecy; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Frydman, S. Bianco, H. Dawes, K. Ehmsen and members of the Andino laboratory for critical reading of the manuscript and G. Schroth, M. Harrison, P. Wassam and T. Collins for technical advice. This work was financially supported by a National Science Foundation graduate research fellowship to A.A., NIAID AI091575, AI36178 and AI40085 to R.A., and DARPA Prophecy to R.A. and L.B.	Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair WS, 1996, VIROLOGY, V218, P1, DOI 10.1006/viro.1996.0160; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Cuevas JM, 2012, MOL BIOL EVOL, V29, P17, DOI 10.1093/molbev/msr179; Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; DEWALT PG, 1990, VIROLOGY, V174, P504, DOI 10.1016/0042-6822(90)90104-Y; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-44; Gelman A, 2004, BAYESIAN DATA ANAL, V2nd, DOI [10.2307/2988417, DOI 10.2307/2988417]; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; GOULD S J, 1970, Journal of the History of Biology, V3, P189, DOI 10.1007/BF00137351; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; HAMMERLE T, 1991, J BIOL CHEM, V266, P5412; HELLEN CUT, 1992, J VIROL, V66, P3330, DOI 10.1128/JVI.66.6.3330-3338.1992; Herold J, 2000, J VIROL, V74, P6394, DOI 10.1128/JVI.74.14.6394-6400.2000; Hobson SD, 2001, EMBO J, V20, P1153, DOI 10.1093/emboj/20.5.1153; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kimura M, 1983, NEUTRAL THEORY MOL E, P55; Lama J, 1998, J GEN VIROL, V79, P1911, DOI 10.1099/0022-1317-79-8-1911; LAMA J, 1995, J BIOL CHEM, V270, P14430, DOI 10.1074/jbc.270.24.14430; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lou D. I., P NATL ACAD IN PRESS; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Orr HA, 2000, GENETICS, V155, P961; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4	39	242	245	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					686	+		10.1038/nature12861	http://dx.doi.org/10.1038/nature12861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24284629	Green Accepted			2022-12-24	WOS:000330321000042
J	Masoudi, A; Raetz, CRH; Zhou, P; Pemble, CW				Masoudi, Ali; Raetz, Christian R. H.; Zhou, Pei; Pemble, Charles W.			Chasing acyl carrier protein through a catalytic cycle of lipid A production	NATURE			English	Article							N-ACYLTRANSFERASE; BINDING; REVEAL; CRYSTALLOGRAPHY; BIOSYNTHESIS; RECOGNITION; MECHANISM; COMPLEX; SYSTEM; SUITE	Acyl carrier protein represents one of the most highly conserved proteins across all domains of life and is nature's way of transporting hydrocarbon chains in vivo. Notably, type II acyl carrier proteins serve as a crucial interaction hub in primary cellular metabolism(1) by communicating transiently between partner enzymes of the numerous biosynthetic pathways(2,3). However, the highly transient nature of such interactions and the inherent conformational mobility of acyl carrier protein(2) have stymied previous attempts to visualize structurally acyl carrier protein tied to an overall catalytic cycle. This is essential to understanding a fundamental aspect of cellular metabolism leading to compounds that are not only useful to the cell, but also of therapeutic value. For example, acyl carrier protein is central to the biosynthesis of the lipid A (endotoxin) component of lipopolysaccharides in Gram-negative microorganisms, which is required for their growth and survival(4,5), and is an activator of the mammalian host's immune system(6,7), thus emerging as an important therapeutic target(8-10). During lipid A synthesis (Raetz pathway), acyl carrier protein shuttles acyl intermediates linked to its prosthetic 4'-phosphopantetheine group(2) among four acyltransferases, including LpxD(11). Here we report the crystal structures of three forms of Escherichia coli acyl carrier protein engaging LpxD, which represent stalled substrate and liberated products along the reaction coordinate. The structures show the intricate interactions at the interface that optimally position acyl carrier protein for acyl delivery and that directly involve the pantetheinyl group. Conformational differences among the stalled acyl carrier proteins provide the molecular basis for the association-dissociation process. An unanticipated conformational shift of 4'-phosphopantetheine groups within the LpxD catalytic chamber shows an unprecedented role of acyl carrier protein in product release.	[Masoudi, Ali; Raetz, Christian R. H.; Zhou, Pei] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Pemble, Charles W.] Duke Univ, Med Ctr, HumanVaccine Inst, Durham, NC 27710 USA; [Pemble, Charles W.] Duke Univ, Med Ctr, Duke Macromol Crystallog Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Pemble, CW (corresponding author), Duke Univ, Med Ctr, HumanVaccine Inst, Durham, NC 27710 USA.	charles.pemble@duke.edu	Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416; Masoudi, Ali/0000-0001-5691-9495	US Department of Energy, Office of Science and the Office of Basic Energy Sciences [W-31-109-Eng-38]; National Institutes of Health [GM-51310, AI-055588]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051310] Funding Source: NIH RePORTER	US Department of Energy, Office of Science and the Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge our co-author Christian R. H. Raetz, who shaped the lipid field with his curiosity and efforts, introducing many scientists to the field during his renowned career. We thank R. Brennan and W. Todd Lowther for reviewing the manuscript. Finally, we thank Z. Guan for the help with the mass spectrometry of ACP, H.-S. Chung and other members of Raetz laboratory, as well as J. M. Burg, for discussions. Crystal screening, data collection and data processing were conducted in collaboration with the Duke Macromolecular X-ray Crystallography Shared Resource. Diffraction data were collected remotely at the Southeast Regional Collaborative Access Team 22-BM and 22-ID beamlines at the Advanced Photon Source, Argonne National Laboratory, supported by the US Department of Energy, Office of Science and the Office of Basic Energy Sciences under Contract number W-31-109-Eng-38. This work was supported by National Institutes of Health grants GM-51310 and AI-055588 awarded to C.R.H.R. and P.Z.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal V, 2012, P NATL ACAD SCI USA, V109, P17406, DOI 10.1073/pnas.1207028109; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Babu M, 2010, STRUCTURE, V18, P1450, DOI 10.1016/j.str.2010.08.015; Bartling CM, 2008, BIOCHEMISTRY-US, V47, P5290, DOI 10.1021/bi800240r; Bartling CM, 2009, BIOCHEMISTRY-US, V48, P8672, DOI 10.1021/bi901025v; BELUNIS CJ, 1995, J BIOL CHEM, V270, P27646, DOI 10.1074/jbc.270.46.27646; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buetow L, 2007, P NATL ACAD SCI USA, V104, P4321, DOI 10.1073/pnas.0606356104; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREDERICK AF, 1988, FEBS LETT, V238, P43, DOI 10.1016/0014-5793(88)80222-9; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; HOLAK TA, 1988, EUR J BIOCHEM, V175, P9, DOI 10.1111/j.1432-1033.1988.tb14159.x; Jenkins RJ, 2012, ACS CHEM BIOL, V7, P1170, DOI 10.1021/cb300094a; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; KELLY TM, 1993, J BIOL CHEM, V268, P19866; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Ploskon E, 2010, CHEM BIOL, V17, P776, DOI 10.1016/j.chembiol.2010.05.024; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qiu XY, 2004, ACTA CRYSTALLOGR D, V60, P1545, DOI 10.1107/S0907444904015422; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; STOKES GB, 1974, ARCH BIOCHEM BIOPHYS, V162, P638, DOI 10.1016/0003-9861(74)90226-4; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Williams AH, 2006, P NATL ACAD SCI USA, V103, P10877, DOI 10.1073/pnas.0604465103; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	42	56	57	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					422	+		10.1038/nature12679	http://dx.doi.org/10.1038/nature12679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24196711	Green Accepted			2022-12-24	WOS:000329621800047
J	Johnson, SC; Yanos, ME; Kayser, EB; Quintana, A; Sangesland, M; Castanza, A; Uhde, L; Hui, J; Wall, VZ; Gagnidze, A; Oh, K; Wasko, BM; Ramos, FJ; Palmiter, RD; Rabinovitch, PS; Morgan, PG; Sedensky, MM; Kaeberlein, M				Johnson, Simon C.; Yanos, Melana E.; Kayser, Ernst-Bernhard; Quintana, Albert; Sangesland, Maya; Castanza, Anthony; Uhde, Lauren; Hui, Jessica; Wall, Valerie Z.; Gagnidze, Arni; Oh, Kelly; Wasko, Brian M.; Ramos, Fresnida J.; Palmiter, Richard D.; Rabinovitch, Peter S.; Morgan, Philip G.; Sedensky, Margaret M.; Kaeberlein, Matt			mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome	SCIENCE			English	Article							COMPLEX-I DEFICIENCY; SUBUNIT; NDUFS4; MICE	Mitochondrial dysfunction contributes to numerous health problems, including neurological and muscular degeneration, cardiomyopathies, cancer, diabetes, and pathologies of aging. Severe mitochondrial defects can result in childhood disorders such as Leigh syndrome, for which there are no effective therapies. We found that rapamycin, a specific inhibitor of the mechanistic target of rapamycin (mTOR) signaling pathway, robustly enhances survival and attenuates disease progression in a mouse model of Leigh syndrome. Administration of rapamycin to these mice, which are deficient in the mitochondrial respiratory chain subunit Ndufs4 [NADH dehydrogenase (ubiquinone) Fe-S protein 4], delays onset of neurological symptoms, reduces neuroinflammation, and prevents brain lesions. Although the precise mechanism of rescue remains to be determined, rapamycin induces a metabolic shift toward amino acid catabolism and away from glycolysis, alleviating the buildup of glycolytic intermediates. This therapeutic strategy may prove relevant for a broad range of mitochondrial diseases.	[Johnson, Simon C.; Yanos, Melana E.; Sangesland, Maya; Castanza, Anthony; Uhde, Lauren; Hui, Jessica; Wall, Valerie Z.; Gagnidze, Arni; Oh, Kelly; Wasko, Brian M.; Ramos, Fresnida J.; Rabinovitch, Peter S.; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Yanos, Melana E.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Kayser, Ernst-Bernhard; Morgan, Philip G.; Sedensky, Margaret M.] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Quintana, Albert] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Quintana, Albert] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaeberlein, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@uw.edu	Quintana, Albert/N-5544-2015; Wasko, Brian/N-2580-2019; Castanza, Anthony/AAQ-7137-2021; Wasko, Brian/J-9814-2019	Quintana, Albert/0000-0003-1674-7160; Castanza, Anthony/0000-0001-9795-0720; Wasko, Brian/0000-0002-7090-086X; Johnson, Simon/0000-0002-1942-3674; Zebertavage, Lauren/0000-0003-2507-4084; Sangesland, Maya/0000-0001-8316-039X	University of Washington School of Medicine; Department of Pathology; NIH [T32AG000057, T32ES007032]; Amgen Scholar summer research scholarship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057, R01AG039390] Funding Source: NIH RePORTER	University of Washington School of Medicine; Department of Pathology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Scholar summer research scholarship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the University of Washington School of Medicine and Department of Pathology for funding to M. K. that allowed these studies to be performed. Supported by NIH training grant T32AG000057 (S.C.J., M.E.Y., and F.J.R.), NIH training grant T32ES007032 (B.M.W.), and an Amgen Scholar summer research scholarship (M.S.).	Arii J, 2000, AM J NEURORADIOL, V21, P1502; Blagosklonny MV, 2010, CELL CYCLE, V9, P683, DOI 10.4161/cc.9.4.10766; Breuer ME, 2013, IUBMB LIFE, V65, P202, DOI 10.1002/iub.1127; Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Patel KP, 2012, MOL GENET METAB, V106, P384, DOI 10.1016/j.ymgme.2012.03.016; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Scacco S, 2000, J BIOL CHEM, V275, P17578, DOI 10.1074/jbc.M001174200; Schleit J, 2013, AGING CELL, V12, P1050, DOI 10.1111/acel.12130; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P23, DOI 10.1016/j.critrevonc.2005.03.012; VANERVEN PMM, 1987, CLIN NEUROL NEUROSUR, V89, P217, DOI 10.1016/S0303-8467(87)80020-3	15	329	334	11	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1524	1528		10.1126/science.1244360	http://dx.doi.org/10.1126/science.1244360			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24231806	Green Accepted			2022-12-24	WOS:000328644300063
J	Vermeulen, L; Morrissey, E; van der Heijden, M; Nicholson, AM; Sottoriva, A; Buczacki, S; Kemp, R; Tavare, S; Winton, DJ				Vermeulen, Louis; Morrissey, Edward; van der Heijden, Maartje; Nicholson, Anna M.; Sottoriva, Andrea; Buczacki, Simon; Kemp, Richard; Tavare, Simon; Winton, Douglas J.			Defining Stem Cell Dynamics in Models of Intestinal Tumor Initiation	SCIENCE			English	Article							CLONAL EVOLUTION; TUMORIGENESIS; POPULATIONS; PROGRESSION; MUTATIONS; CANCER; LGR5	Cancer is a disease in which cells accumulate genetic aberrations that are believed to confer a clonal advantage over cells in the surrounding tissue. However, the quantitative benefit of frequently occurring mutations during tumor development remains unknown. We quantified the competitive advantage of Apc loss, Kras activation, and P53 mutations in the mouse intestine. Our findings indicate that the fate conferred by these mutations is not deterministic, and many mutated stem cells are replaced by wild-type stem cells after biased, but still stochastic events. Furthermore, P53 mutations display a condition-dependent advantage, and especially in colitis-affected intestines, clones harboring mutations in this gene are favored. Our work confirms the previously theoretical notion that the tissue architecture of the intestine suppresses the accumulation of mutated lineages.	[Vermeulen, Louis; Morrissey, Edward; van der Heijden, Maartje; Nicholson, Anna M.; Buczacki, Simon; Kemp, Richard; Tavare, Simon; Winton, Douglas J.] Univ Cambridge, Cambridge Inst, Canc Res UK, Cambridge CB2 0RE, England; [Vermeulen, Louis; van der Heijden, Maartje] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, NL-1105 AZ Amsterdam, Netherlands; [Sottoriva, Andrea] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Tavare, Simon] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam; University of Southern California; University of Southern California	Vermeulen, L (corresponding author), Univ Cambridge, Cambridge Inst, Canc Res UK, Robinson Way, Cambridge CB2 0RE, England.	l.vermeulen@amc.uva.nl	Vermeulen, Louis/B-7488-2008	Vermeulen, Louis/0000-0002-6066-789X; Morrissey, Edward/0000-0003-1021-5358; Sottoriva, Andrea/0000-0001-6709-9533; Kemp, Richard/0000-0002-0121-7709; Buczacki, Simon/0000-0002-2975-416X	Cancer Research UK; Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society); Cancer Research UK [19556, 17044] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society); Cancer Research UK(Cancer Research UK)	We thank the Cambridge Institute Biological Resource Unit for animal husbandry and F. De Sousa E Melo, J. P. Medema, and P. Calabrese for useful discussion. This work was supported by Cancer Research UK; L.V. received a fellowship from the Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society). We declare no competing financial interests.	Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Calabrese P, 2004, AM J PATHOL, V164, P1337, DOI 10.1016/S0002-9440(10)63220-8; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fischer JM, 2012, ONCOGENE, V31, P2028, DOI 10.1038/onc.2011.385; Kozar S, 2013, CELL STEM CELL, V13, P626, DOI 10.1016/j.stem.2013.08.001; Leedham SJ, 2009, GASTROENTEROLOGY, V136, P542, DOI 10.1053/j.gastro.2008.10.086; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Michor F, 2004, CELL CYCLE, V3, P358; Nowak MA, 2003, P NATL ACAD SCI USA, V100, P14966, DOI 10.1073/pnas.2535419100; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016	18	269	271	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					995	998		10.1126/science.1243148	http://dx.doi.org/10.1126/science.1243148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264992				2022-12-24	WOS:000327223500047
J	De Vlaminck, I; Khush, KK; Strehl, C; Kohli, B; Luikart, H; Neff, NF; Okamoto, J; Snyder, TM; Cornfield, DN; Nicolls, MR; Weill, D; Bernstein, D; Valantine, HA; Quake, SR				De Vlaminck, Iwijn; Khush, Kiran K.; Strehl, Calvin; Kohli, Bitika; Luikart, Helen; Neff, Norma F.; Okamoto, Jennifer; Snyder, Thomas M.; Cornfield, David N.; Nicolls, Mark R.; Weill, David; Bernstein, Daniel; Valantine, Hannah A.; Quake, Stephen R.			Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy	CELL			English	Article							TRANSPLANT RECIPIENTS; INFECTION; DIAGNOSIS; VIRUSES; HEART; PHARMACOKINETICS; CYTOMEGALOVIRUS; POLYOMAVIRUS; BIOMARKERS; MICROBIOTA	There are few substantive methods to measure the health of the immune system, and the connection between immune strength and the viral component of the microbiome is poorly understood. Organ transplant recipients are treated with posttransplant therapies that combine immunosuppressive and antiviral drugs, offering a window into the effects of immune modulation on the virome. We used sequencing of cell-free DNA in plasma to investigate drug-virome interactions in a cohort of organ transplant recipients (656 samples, 96 patients) and find that antivirals and immunosuppressants strongly affect the structure of the virome in plasma. We observe marked virome compositional dynamics at the onset of the therapy and find that the total viral load increases with immunosuppression, whereas the bacterial component of the microbiome remains largely unaffected. The data provide insight into the relationship between the human virome, the state of the immune system, and the effects of pharmacological treatment and offer a potential application of the virome state to predict immunocompetence.	[De Vlaminck, Iwijn; Neff, Norma F.; Okamoto, Jennifer; Snyder, Thomas M.; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [De Vlaminck, Iwijn; Neff, Norma F.; Okamoto, Jennifer; Snyder, Thomas M.; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [De Vlaminck, Iwijn; Neff, Norma F.; Okamoto, Jennifer; Snyder, Thomas M.; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Khush, Kiran K.; Strehl, Calvin; Kohli, Bitika; Luikart, Helen; Valantine, Hannah A.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Cornfield, David N.; Nicolls, Mark R.; Weill, David] Stanford Univ, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Bernstein, Daniel] Stanford Univ, Sch Med, Div Pediat Cardiol, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	quake@stanford.edu	De Vlaminck, Iwijn/P-6479-2015; Nicolls, Mark/K-6085-2019	De Vlaminck, Iwijn/0000-0001-6085-7311; Bernstein, Daniel/0000-0001-7761-5853; Snyder, Thomas/0000-0001-7256-7821; Khush, Kiran/0000-0001-9697-5926	NIH [RC4AI092673, K23HL091143]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095686, R01HL070628, P01HL108797, K23HL091143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC4AI092673] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000251] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant RC4AI092673 and K23HL091143 (K.K.) and the Howard Hughes Medical Institute.	Avivi I, 2004, BIOL BLOOD MARROW TR, V10, P186, DOI 10.1016/j.bbmt.2003.11.001; Bruno B, 2003, BIOL BLOOD MARROW TR, V9, P341, DOI 10.1016/S1083-8791(03)00102-2; Budde K, 2011, CLIN PHARMACOL THER, V90, P316, DOI 10.1038/clpt.2011.111; CHESTERS PM, 1983, J INFECT DIS, V147, P676, DOI 10.1093/infdis/147.4.676; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Fishman JA, 2007, CLIN TRANSPLANT, V21, P149, DOI 10.1111/j.1399-0012.2006.00618.x; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; JUSKO WJ, 1995, CLIN PHARMACOL THER, V57, P281, DOI 10.1016/0009-9236(95)90153-1; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Madsen CD., 2002, HIV CLIN TRIALS, V3, P287, DOI DOI 10.1310/hct.2002.3.4.004; Marboe CC, 2005, J HEART LUNG TRANSPL, V24, pS219, DOI 10.1016/j.healun.2005.04.001; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Oksanen J., 2007, VEGAN PACKAGE COMMUN; Potena L, 2007, J CLIN MICROBIOL, V45, P1804, DOI 10.1128/JCM.01362-06; Razonable RR, 2011, MAYO CLIN PROC, V86, P1009, DOI 10.4065/mcp.2011.0309; Razonable RR, 2005, J INFECT DIS, V192, P1331, DOI [10.1086/466529, 10.1086/466532]; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rossano JW, 2009, J HEART LUNG TRANSPL, V28, P26, DOI 10.1016/j.healun.2008.10.001; Saraiva F, 2011, TRANSPL P, V43, P1908, DOI 10.1016/j.transproceed.2011.03.010; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Slifkin M, 2004, DRUGS, V64, P2763, DOI 10.2165/00003495-200464240-00004; Snyder TM, 2011, P NATL ACAD SCI USA, V108, P6229, DOI 10.1073/pnas.1013924108; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; TeKippe EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050937; Thom K, 2007, J MED VIROL, V79, P1, DOI 10.1002/jmv.20756; Touinssi M, 2001, J CLIN VIROL, V21, P135, DOI 10.1016/S1386-6532(01)00157-3; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Venkataramanan R, 1995, CLIN PHARMACOKINET, V29, P404, DOI 10.2165/00003088-199529060-00003; Weber G, 2002, NAT GENET, V30, P141, DOI 10.1038/ng818; Wieland E, 2010, THER DRUG MONIT, V32, P560, DOI 10.1097/FTD.0b013e3181efb3d2; Wylie KM, 2012, TRANSL RES, V160, P283, DOI 10.1016/j.trsl.2012.03.006; Xia LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027992; Xu YH, 2003, GENOMICS, V81, P329, DOI 10.1016/S0888-7543(02)00043-5; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; zur Hausen H, 2009, CURR TOP MICROBIOL, V331, P109	39	284	292	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1178	1187		10.1016/j.cell.2013.10.034	http://dx.doi.org/10.1016/j.cell.2013.10.034			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267896	Green Accepted, Bronze			2022-12-24	WOS:000327500600020
J	Willsey, AJ; Sanders, SJ; Li, MF; Dong, S; Tebbenkamp, AT; Muhle, RA; Reilly, SK; Lin, L; Fertuzinhos, S; Miller, JA; Murtha, MT; Bichsel, C; Niu, W; Cotney, J; Ercan-Sencicek, AG; Gockley, J; Gupta, AR; Han, WQ; He, X; Hoffman, EJ; Klei, L; Lei, J; Liu, WZ; Liu, L; Lu, C; Xu, XM; Zhu, Y; Mane, SM; Lein, ES; Wei, LP; Noonan, JP; Roeder, K; Devlin, B; Sestan, N; State, MW				Willsey, A. Jeremy; Sanders, Stephan J.; Li, Mingfeng; Dong, Shan; Tebbenkamp, Andrew T.; Muhle, Rebecca A.; Reilly, Steven K.; Lin, Leon; Fertuzinhos, Sofia; Miller, Jeremy A.; Murtha, Michael T.; Bichsel, Candace; Niu, Wei; Cotney, Justin; Ercan-Sencicek, A. Gulhan; Gockley, Jake; Gupta, Abha R.; Han, Wenqi; He, Xin; Hoffman, Ellen J.; Klei, Lambertus; Lei, Jing; Liu, Wenzhong; Liu, Li; Lu, Cong; Xu, Xuming; Zhu, Ying; Mane, Shrikant M.; Lein, Ed S.; Wei, Liping; Noonan, James P.; Roeder, Kathryn; Devlin, Bernie; Sestan, Nenad; State, Matthew W.			Coexpression Networks Implicate Human Midfetal Deep Cortical Projection Neurons in the Pathogenesis of Autism	CELL			English	Article							SPECTRUM DISORDERS; NOVO MUTATIONS; GENES; RISK; CNVS	Autism spectrum disorder (ASD) is a complex developmental syndrome of unknown etiology. Recent studies employing exome- and genome-wide sequencing have identified nine high-confidence ASD (hcASD) genes. Working from the hypothesis that ASD-associated mutations in these biologically pleiotropic genes will disrupt intersecting developmental processes to contribute to a common phenotype, we have attempted to identify time periods, brain regions, and cell types in which these genes converge. We have constructed coexpression networks based on the hcASD "seed'' genes, leveraging a rich expression data set encompassing multiple human brain regions across human development and into adulthood. By assessing enrichment of an independent set of probable ASD (pASD) genes, derived from the same sequencing studies, we demonstrate a key point of convergence in midfetal layer 5/6 cortical projection neurons. This approach informs when, where, and in what cell types mutations in these specific genes may be productively studied to clarify ASD pathophysiology.	[Willsey, A. Jeremy; Sanders, Stephan J.; Dong, Shan; Muhle, Rebecca A.; Reilly, Steven K.; Niu, Wei; Cotney, Justin; Gockley, Jake; Liu, Wenzhong; Noonan, James P.; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Willsey, A. Jeremy; Sanders, Stephan J.; State, Matthew W.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Li, Mingfeng; Tebbenkamp, Andrew T.; Fertuzinhos, Sofia; Bichsel, Candace; Han, Wenqi; Xu, Xuming; Zhu, Ying; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Li, Mingfeng; Tebbenkamp, Andrew T.; Muhle, Rebecca A.; Fertuzinhos, Sofia; Bichsel, Candace; Niu, Wei; Han, Wenqi; Xu, Xuming; Zhu, Ying; Noonan, James P.; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Dong, Shan; Wei, Liping] Peking Univ, Sch Life Sci, Ctr Bioinformat, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Muhle, Rebecca A.; Niu, Wei; Ercan-Sencicek, A. Gulhan; Gupta, Abha R.; Hoffman, Ellen J.; State, Matthew W.] Yale Univ, Sch Med, Child Study Ctr, New Haven, CT 06510 USA; [Lin, Leon] Yale Univ, Dept Computat Biol & Bioinformat, New Haven, CT 06511 USA; [Miller, Jeremy A.; Lein, Ed S.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Murtha, Michael T.; Ercan-Sencicek, A. Gulhan; Hoffman, Ellen J.; State, Matthew W.] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT 06510 USA; [Gupta, Abha R.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [He, Xin; Roeder, Kathryn] Carnegie Mellon Univ, Ray & Stephanie Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Lei, Jing; Liu, Li; Lu, Cong; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Mane, Shrikant M.] Yale Univ, Sch Med, Yale Ctr Genom Anal, New Haven, CT 06417 USA; [Wei, Liping] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA	Yale University; University of California System; University of California San Francisco; Yale University; Yale University; Peking University; Yale University; Yale University; Allen Institute for Brain Science; Yale University; Yale University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Yale University; National Institute of Biological Sciences, Beijing; Yale University	Devlin, B (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA.	devlinbj@upmc.edu; nenad.sestan@yale.edu; matthew.state@ucsf.edu	Noonan, James/ABF-1320-2021; Liu, Li/G-1897-2015; Sanders, Stephan/S-8645-2019; Zhu, Ying/T-2268-2019; State, Matthew/W-2256-2019; Cotney, Justin L/ABE-8500-2021; Hoffman, Ellen J/N-3421-2017; DONG, Shan/GVS-5706-2022; Willsey, A Jeremy/H-3001-2019	Cotney, Justin L/0000-0001-8230-2157; Hoffman, Ellen J/0000-0002-5083-1369; Willsey, A Jeremy/0000-0002-9922-3612; Zhu, Ying/0000-0002-6594-3734; Lei, Jing/0000-0003-3104-9387; Reilly, Steven/0000-0003-3140-1483; Lin, Zhixiang/0000-0001-9301-947X; Tebbenkamp, Andrew/0000-0002-9015-3427; State, Matthew/0000-0003-1624-8302; Dong, Shan/0000-0001-9130-0225; Gockley, Jake/0000-0001-7993-5308; Sanders, Stephan/0000-0001-9112-5148; Roeder, Kathryn/0000-0002-8869-6254	Overlook International Foundation; Simons Foundation; Kavli Foundation; National Institute of Mental Health [RC2 MH089956, U01 MH081896, R37 MH057881]; Foster-Davis Foundation Inc. (NARSAD DI); Howard Hughes Medical Institute; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057881, RC2MH089956, U01MH081896, T32MH018268, R25MH077823] Funding Source: NIH RePORTER	Overlook International Foundation; Simons Foundation; Kavli Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Foster-Davis Foundation Inc. (NARSAD DI); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to the families participating in the Simons Foundation Autism Research Initiative (SFARI) Simplex Collection (SSC). This work was supported by a gift from the Overlook International Foundation (to M. W. S., N. S., B. D., K. R., and J. N.), as well as grants from the Simons Foundation (to M. W. S., N. S., K. R., and J. N.), the Kavli Foundation (to N. S.), the National Institute of Mental Health (RC2 MH089956 to M. W. S., U01 MH081896 to N. S., and R37 MH057881 to B. D. and K. R.), the Foster-Davis Foundation Inc. (NARSAD DI to N. S.), the Howard Hughes Medical Institute (International Student Research Fellowship to both S. J. S. and W. H.), and the Canadian Institutes of Health Research (Doctoral Foreign Study Award to A. J. W.). We would like to thank the SSC principal investigators (A. L. Beaudet, R. Bernier, J. Constantino, E. H. Cook, Jr, E. Fombonne, D. Geschwind, D. E. Grice, A. Klin, D. H. Ledbetter, C. Lord, C. L. Martin, D. M. Martin, R. Maxim, J. Miles, O. Ousley, B. Peterson, J. Piggot, C. Saulnier, M. W. State, W. Stone, J. S. Sutcliffe, C. A. Walsh, and E. Wijsman) and the coordinators and staff at the SSC clinical sites; the SFARI staff, in particular M. Benedetti; the Rutgers University Cell and DNA repository for accessing biomaterials; the Yale Center of Genomic Analysis, in particular J. Overton, S. Umlauf, I. Tikhonova, and A. Lopez, for generating sequencing data; T. Brooks-Boone, N. Wright-Davis, and M. Wojciechowski for their help in administering the project at Yale; and H. Rankin for unwavering support.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; He X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003671; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003443; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schmidt E.F., 2013, COLD SPRING HARB PRO, V2013; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013	27	562	568	2	81	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					997	1007		10.1016/j.cell.2013.10.020	http://dx.doi.org/10.1016/j.cell.2013.10.020			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267886	Green Accepted, Bronze			2022-12-24	WOS:000327500600006
J	Hughes, KA; Houde, AE; Price, AC; Rodd, FH				Hughes, Kimberly A.; Houde, Anne E.; Price, Anna C.; Rodd, F. Helen			Mating advantage for rare males in wild guppy populations	NATURE			English	Article							FREQUENCY-DEPENDENT SELECTION; SEXUAL SELECTION; POECILIA-RETICULATA; COLOR POLYMORPHISM; SPERM TRANSFER; EVOLUTION; FAMILIARITY; SUCCESS; TRAITS; CHOICE	To understand the processes that maintain genetic diversity is a long-standing challenge in evolutionary biology, with implications for predicting disease resistance, response to environmental change, and population persistence(1-3). Simple population genetic models are not sufficient to explain the high levels of genetic diversity sometimes observed in ecologically important traits(2). In guppies (Poecilia reticulata), male colour pattern is both diverse and heritable, and is arguably one of the most extreme examples of morphological polymorphism known(4,5). Negative frequency-dependent selection (NFDS), a form of selection in which genotypes are favoured when they are rare(6), can potentially maintain such extensive polymorphism, but few experimental studies have confirmed its operation in nature(7,8). Here we use highly replicated experimental manipulations of natural populations to show that males with rare colour patterns have higher reproductive fitness, demonstrating NFDS mediated by sexual selection. Rare males acquired more mates and sired more offspring compared to common males and, as previously reported, had higher rates of survival(8). Orange colour, implicated in other studies of sexual selection in guppies, did predict male reproductive success, but only in one of three populations. These data support the hypothesis that NFDS maintains diversity in the colour patterns of male guppies through two selective agents, mates and predators. Similar field-based manipulations of genotype frequencies could provide a powerful approach to reveal the underlying ecological and behavioural mechanisms that maintain genetic and phenotypic diversity.	[Hughes, Kimberly A.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Houde, Anne E.] Lake Forest Coll, Dept Biol, Lake Forest, IL 60045 USA; [Price, Anna C.; Rodd, F. Helen] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3G5, Canada	State University System of Florida; Florida State University; University of Toronto	Hughes, KA (corresponding author), Florida State Univ, Dept Biol Sci, 319 Stadium Dr, Tallahassee, FL 32306 USA.	kahughes@bio.fsu.edu			National Science Foundation; Natural Sciences and Engineering Research Council (NSERC) of Canada; Direct For Biological Sciences [0934451] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0743990] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Olendorf for help with field work and genotyping; D. Punzalan, K. Dixon, M. Bryant, T. Pitcher, C. Baril, A. Inman and C. Hurt for field work; C. Gibson, K. McGhee for photographs in Fig. 1 and for animal rearing; J. Koprivnikar for animal rearing; and A. Vanesyan for collecting morphology data. D. Reznick provided advice on field experiments, and D. Punzalan, K. Dixon and M. Fitzpatrick commented on manuscript drafts. In Trinidad, we thank the Sinanan family for accommodation, and I. Ramnarine and the government of Trinidad for permission to collect guppies and to work in the Quare watershed. This work was supported by grants from the National Science Foundation (to K. A. H. and A. E. H.) and the Natural Sciences and Engineering Research Council (NSERC) of Canada (to F.H.R.).	Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Bleay C, 2007, P ROY SOC B-BIOL SCI, V274, P2019, DOI 10.1098/rspb.2007.0361; Brooks R, 2001, EVOLUTION, V55, P1002, DOI 10.1554/0014-3820(2001)055[1002:DAISSA]2.0.CO;2; Dijkstra PD, 2005, BEHAV ECOL SOCIOBIOL, V58, P136, DOI 10.1007/s00265-005-0919-5; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Evans JP, 2003, NATURE, V421, P360, DOI 10.1038/nature01367; Evans JP, 2003, BIOL J LINN SOC, V78, P605, DOI 10.1046/j.0024-4066.2002.00193.x; FARR JA, 1977, EVOLUTION, V31, P162, DOI 10.1111/j.1558-5646.1977.tb00993.x; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Hampton KJ, 2009, ETHOLOGY, V115, P475, DOI 10.1111/j.1439-0310.2009.01634.x; Houde A.E., 1997, SEX COLOR MATE CHOIC; Hughes KA, 1999, ANIM BEHAV, V58, P907, DOI 10.1006/anbe.1999.1225; Hughes KA, 2005, J EVOLUTION BIOL, V18, P35, DOI 10.1111/j.1420-9101.2004.00806.x; Johnson AM, 2010, ETHOLOGY, V116, P448, DOI 10.1111/j.1439-0310.2010.01763.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kokko H, 2007, P ROY SOC B-BIOL SCI, V274, P1317, DOI 10.1098/rspb.2007.0043; Lewontin RC, 1974, GENETIC BASIS EVOLUT; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Matthews IM, 2000, J FISH BIOL, V56, P1381, DOI 10.1111/j.1095-8649.2000.tb02150.x; Maynard Smith J., 1982, pi; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Olendorf R, 2004, MOL ECOL NOTES, V4, P668, DOI 10.1111/j.1471-8286.2004.00777.x; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; Petit C., 1969, EVOLUTIONARY BIOL, V3; Pires MN, 2010, BIOL J LINN SOC, V99, P784, DOI 10.1111/j.1095-8312.2010.01391.x; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; ROSENTHAL HL, 1952, BIOL BULL, V102, P30, DOI 10.2307/1538621; SAS Institute, 2011, SAS STAT 9 3 US GUID; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHUSTER SM, 1991, NATURE, V350, P608, DOI 10.1038/350608a0; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Takahashi Y, 2010, EVOLUTION, V64, P3620, DOI 10.1111/j.1558-5646.2010.01083.x; Turelli M, 2004, GENETICS, V166, P1053, DOI 10.1534/genetics.166.2.1053; Zajitschek SRK, 2008, AM NAT, V172, P843, DOI 10.1086/593001	34	117	120	0	264	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					108	+		10.1038/nature12717	http://dx.doi.org/10.1038/nature12717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24172904				2022-12-24	WOS:000326585600041
J	Attanasio, C; Nord, AS; Zhu, YW; Blow, MJ; Li, ZR; Liberton, DK; Morrison, H; Plajzer-Frick, I; Holt, A; Hosseini, R; Phouanenavong, S; Akiyama, JA; Shoukry, M; Afzal, V; Rubin, EM; FitzPatrick, DR; Ren, B; Hallgrimsson, B; Pennacchio, LA; Visel, A				Attanasio, Catia; Nord, Alex S.; Zhu, Yiwen; Blow, Matthew J.; Li, Zirong; Liberton, Denise K.; Morrison, Harris; Plajzer-Frick, Ingrid; Holt, Amy; Hosseini, Roya; Phouanenavong, Sengthavy; Akiyama, Jennifer A.; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; FitzPatrick, David R.; Ren, Bing; Hallgrimsson, Benedikt; Pennacchio, Len A.; Visel, Axel			Fine Tuning of Craniofacial Morphology by Distant-Acting Enhancers	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; CLEFT-LIP; GENE-EXPRESSION; SONIC HEDGEHOG; CRANIAL BASE; PALATE; REVEALS; HERITABILITY; MUTATIONS; FAMILY	The shape of the human face and skull is largely genetically determined. However, the genomic basis of craniofacial morphology is incompletely understood and hypothesized to involve protein-coding genes, as well as gene regulatory sequences. We used a combination of epigenomic profiling, in vivo characterization of candidate enhancer sequences in transgenic mice, and targeted deletion experiments to examine the role of distant-acting enhancers in craniofacial development. We identified complex regulatory landscapes consisting of enhancers that drive spatially complex developmental expression patterns. Analysis of mouse lines in which individual craniofacial enhancers had been deleted revealed significant alterations of craniofacial shape, demonstrating the functional importance of enhancers in defining face and skull morphology. These results demonstrate that enhancers are involved in craniofacial development and suggest that enhancer sequence variation contributes to the diversity of human facial morphology.	[Attanasio, Catia; Nord, Alex S.; Zhu, Yiwen; Plajzer-Frick, Ingrid; Holt, Amy; Hosseini, Roya; Phouanenavong, Sengthavy; Akiyama, Jennifer A.; Shoukry, Malak; Afzal, Veena; Rubin, Edward M.; Pennacchio, Len A.; Visel, Axel] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Blow, Matthew J.; Rubin, Edward M.; Pennacchio, Len A.; Visel, Axel] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Li, Zirong; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Li, Zirong; Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Liberton, Denise K.; Hallgrimsson, Benedikt] Univ Calgary, Dept Cell Biol & Anat, McCaig Bone & Joint Inst, Calgary, AB T2N 4N1, Canada; [Morrison, Harris; FitzPatrick, David R.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [FitzPatrick, David R.] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Hallgrimsson, Benedikt] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB T2N 4N1, Canada	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Calgary; University of Edinburgh; Alberta Childrens Hospital; University of Calgary	Visel, A (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	avisel@lbl.gov	Visel, Axel/A-9398-2009; Hallgrimsson, Benedikt/A-9616-2008; attanasio, catia/D-5042-2017; wang, edwin/G-5372-2010; Blow, Matthew/G-6369-2012	Visel, Axel/0000-0002-4130-7784; Hallgrimsson, Benedikt/0000-0002-7192-9103; attanasio, catia/0000-0001-8077-5719; Blow, Matthew/0000-0002-8844-9149; Nord, Alexander/0000-0003-4259-7514; Liberton, Denise/0000-0002-2885-8864; Pennacchio, Len/0000-0002-8748-3732; FitzPatrick, David R./0000-0003-4861-969X	NIDCR FaceBase grant [U01DE020060]; National Human Genome Research Institute [R01HG003988, U54HG006997]; Swiss National Science Foundation; F32 NIH/National Institute of General Medical Sciences National Research Service Award [GM105202]; NIH [U54HG006997, 1R01DE021708, 1R01DE01963, 1U01DE020054, R01HG003991]; Natural Sciences and Engineering Research Council of Canada [238992-11]; UK Medical Research Council; Ludwig Institute for Cancer Research; NIH; Department of Energy [DE-AC02-05CH11231]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006997, R01HG003988, R01HG003991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019638, U01DE020060, U01DE020054, R01DE021708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105202] Funding Source: NIH RePORTER; Medical Research Council [MC_U127561093, MC_PC_U127561093] Funding Source: researchfish; MRC [MC_U127561093, MC_PC_U127561093] Funding Source: UKRI	NIDCR FaceBase grant; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); F32 NIH/National Institute of General Medical Sciences National Research Service Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ludwig Institute for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank J. Harkes and M. Satyanarayanan for development of the OPT viewer; S. Shen and H. Hochheiser for integration of the OPT viewer and data sets into FaceBase; and J. Murray, M. Marazita, J. Manak, B. Schutte, and all FaceBase members for help in the selection of relevant craniofacial intervals and comments on results. A. V. and L. A. P. were supported by NIDCR FaceBase grant U01DE020060 and by National Human Genome Research Institute grants R01HG003988 and U54HG006997. C. A. was supported by a Swiss National Science Foundation advanced researcher fellowship. A. S. N. was supported by a F32 NIH/National Institute of General Medical Sciences National Research Service Award fellowship GM105202. B. H. was supported by NIH 1R01DE021708, NIH 1R01DE01963, NIH 1U01DE020054, and Natural Sciences and Engineering Research Council of Canada #238992-11 grants. D. R. F. and H. M. were supported by a UK Medical Research Council core program grant. B. R. was supported by the Ludwig Institute for Cancer Research and NIH grants U54HG006997 and R01HG003991. B. H. was supported by NIH 1R01DE01963. Research was conducted at the E. O. Lawrence Berkeley National Laboratory and performed under Department of Energy contract DE-AC02-05CH11231, University of California. ChIP-Seq data are available through GEO (accession no. GSE49413) and FaceBase. org. In vivo reporter data are available through the Vista Enhancer Browser (http://enhancer.lbl.gov) and FaceBase. org. OPT data, including raw images and interactive 3D viewing option, is available through http://facebase.org. All enhancer reporter vectors, as well as archived surplus LacZ-stained embryos for selected enhancers, are available from the authors. Craniofacial enhancer knockout lines are available through the Mutant Mouse Regional Resource Centers (Delta hs1431, MMRRC 03895; Delta hs746, MMRRC 03888; and Delta hs586, MMRRCC 03894).	Alappat S, 2003, CELL RES, V13, P429, DOI 10.1038/sj.cr.7290185; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Balczerski B, 2012, DEV BIOL, V371, P203, DOI 10.1016/j.ydbio.2012.08.011; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Betancur P, 2010, P NATL ACAD SCI USA, V107, P3570, DOI 10.1073/pnas.0906596107; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Boehringer S, 2011, EUR J HUM GENET, V19, P1192, DOI 10.1038/ejhg.2011.110; Christensen K, 2004, BRIT MED J, V328, P1405, DOI 10.1136/bmj.38106.559120.7C; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Dixon MJ, 1996, HUM MOL GENET, V5, P1391, DOI 10.1093/hmg/5.Supplement_1.1391; Feng WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008066; Hallgrimsson B, 2007, EVOL DEV, V9, P76, DOI 10.1111/j.1525-142X.2006.00139.x; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hochheiser H, 2011, DEV BIOL, V355, P175, DOI 10.1016/j.ydbio.2011.02.033; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Johannsdottir B, 2005, AM J ORTHOD DENTOFAC, V127, P200, DOI 10.1016/j.ajodo.2004.07.033; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kayser M, 2009, FORENSIC SCI INT-GEN, V3, P154, DOI 10.1016/j.fsigen.2009.01.012; KOHN LAP, 1991, ANNU REV ANTHROPOL, V20, P261, DOI 10.1146/annurev.an.20.100191.001401; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Koyama E, 1996, DEV DYNAM, V206, P59, DOI 10.1002/(SICI)1097-0177(199605)206:1<59::AID-AJA6>3.0.CO;2-#; Leslie EJ, 2012, BIRTH DEFECTS RES A, V94, P934, DOI 10.1002/bdra.23076; Lieberman DE, 2008, J ANAT, V212, P720, DOI 10.1111/j.1469-7580.2008.00900.x; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; MacKenzie A, 1997, MECH DEVELOP, V62, P29, DOI 10.1016/S0925-4773(96)00646-6; Manfredi C, 1997, AM J ORTHOD DENTOFAC, V111, P44, DOI 10.1016/S0889-5406(97)70301-9; Mangold E, 2011, TRENDS MOL MED, V17, P725, DOI 10.1016/j.molmed.2011.07.007; Mangold E, 2009, AM J MED GENET A, V149A, P2680, DOI 10.1002/ajmg.a.33136; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mitsiadis TA, 2003, DEVELOPMENT, V130, P4451, DOI 10.1242/dev.00631; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nikopensius T, 2009, AM J MED GENET A, V149A, P2551, DOI 10.1002/ajmg.a.33024; Oram KF, 2003, ANAT REC PART A, V271A, P189, DOI 10.1002/ar.a.10027; Paternoster L, 2012, AM J HUM GENET, V90, P478, DOI 10.1016/j.ajhg.2011.12.021; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Simoes-Costa M, 2013, GENOME RES, V23, P1069, DOI 10.1101/gr.157586.113; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Suzuki S, 2009, AM J HUM GENET, V84, P406, DOI 10.1016/j.ajhg.2009.02.002; Tucker AS, 1999, DEVELOPMENT, V126, P221; Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wehby GL, 2010, ORAL DIS, V16, P3, DOI 10.1111/j.1601-0825.2009.01588.x; Yanagisawa H, 2003, DEVELOPMENT, V130, P1069, DOI 10.1242/dev.00337; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011; Young NM, 2010, DEVELOPMENT, V137, P3405, DOI 10.1242/dev.052340; Yuan QP, 2011, AM J MED GENET A, V155A, P1469, DOI 10.1002/ajmg.a.33940; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	60	156	159	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 25	2013	342	6157							1241006	10.1126/science.1241006	http://dx.doi.org/10.1126/science.1241006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239RH	24159046	Green Accepted			2022-12-24	WOS:000326042600032
J	Ding, YL; Tang, Y; Kwok, CK; Zhang, Y; Bevilacqua, PC; Assmann, SM				Ding, Yiliang; Tang, Yin; Kwok, Chun Kit; Zhang, Yu; Bevilacqua, Philip C.; Assmann, Sarah M.			In vivo genome-wide profiling of RNA secondary structure reveals novel regulatory features	NATURE			English	Article							RIBOSOMAL-RNA; ENVIRONMENTAL RESPONSES; OXYGEN DEPRIVATION; PRIMER EXTENSION; TRANSLATION; POLYADENYLATION; TRANSCRIPTOME; PREDICTION; INTRON	RNA structure has critical roles in processes ranging from ligand sensing to the regulation of translation, polyadenylation and splicing(1-4). However, a lack of genome-wide in vivo RNA structural data has limited our understanding of how RNA structure regulates gene expression in living cells. Here we present a high-throughput, genome-wide in vivo RNA structure probing method, structure-seq, in which dimethyl sulphate methylation of unprotected adenines and cytosines is identified by next-generation sequencing. Application of this method to Arabidopsis thaliana seedlings yielded the first in vivo genome-wide RNA structure map at nucleotide resolution for any organism, with quantitative structural information across more than 10,000 transcripts. Our analysis reveals a three-nucleotide periodic repeat pattern in the structure of coding regions, as well as a less-structured region immediately upstream of the start codon, and shows that these features are strongly correlated with translation efficiency. We also find patterns of strong and weak secondary structure at sites of alternative polyadenylation, as well as strong secondary structure at 59 splice sites that correlates with unspliced events. Notably, in vivo structures of messenger RNAs annotated for stress responses are poorly predicted in silico, whereas mRNA structures of genes related to cell function maintenance are well predicted. Global comparison of several structural features between these two categories shows that the mRNAs associated with stress responses tend to have more single-strandedness, longer maximal loop length and higher free energy per nucleotide, features that may allow these RNAs to undergo conformational changes in response to environmental conditions. Structure-seq allows the RNA structurome and its biological roles to be interrogated on a genome-wide scale and should be applicable to any organism.	[Ding, Yiliang; Tang, Yin; Assmann, Sarah M.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Ding, Yiliang; Kwok, Chun Kit; Bevilacqua, Philip C.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Ding, Yiliang; Tang, Yin; Kwok, Chun Kit; Bevilacqua, Philip C.; Assmann, Sarah M.] Penn State Univ, Ctr RNA Mol Biol, University Pk, PA 16802 USA; [Tang, Yin; Zhang, Yu; Assmann, Sarah M.] Penn State Univ, Bioinformat & Genom Grad Program, University Pk, PA 16802 USA; [Zhang, Yu] Penn State Univ, Dept Stat, University Pk, PA 16802 USA; [Bevilacqua, Philip C.; Assmann, Sarah M.] Penn State Univ, Plant Biol Grad Program, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Assmann, SM (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	pcb5@psu.edu; sma3@psu.edu	DING, YILIANG/B-2242-2015; Tang, Yin/M-5401-2018	KWOK, Chun Kit/0000-0001-9175-8543; Ding, Yiliang/0000-0003-4161-6365; Bevilacqua, Philip/0000-0001-8074-3434	Human Frontier Science Program (HFSP) [RGP0002/2009-C]; Penn State Eberly College of Science; Penn State Huck Institutes HITS; National Science Foundation [OCI-0821527]	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Penn State Eberly College of Science; Penn State Huck Institutes HITS; National Science Foundation(National Science Foundation (NSF))	This research is supported by Human Frontier Science Program (HFSP) grant RGP0002/2009-C, the Penn State Eberly College of Science, and a Penn State Huck Institutes HITS grant to P.C.B. and S.M.A. We thank F. Pugh, Y. Li, A. Chan and K. Yen for help with Illumina sequencing; D. Mathews and A. Spasic for advice on RNA structure analysis; M. Axtell for reading of the manuscript; and P. Raghavan for access to the CyberSTAR server, funded by the National Science Foundation through grant OCI-0821527. We also thank L. Song, D. Chadalavada and S. Ghosh for discussions.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Branco-Price C, 2005, ANN BOT-LONDON, V96, P647, DOI 10.1093/aob/mci217; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Buratti E, 2004, MOL CELL BIOL, V24, P1387, DOI 10.1128/MCB.24.3.1387-1400.2004; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; Hajdin CE, 2013, P NATL ACAD SCI USA, V110, P5498, DOI 10.1073/pnas.1219988110; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jin YF, 2011, RNA BIOL, V8, P450, DOI 10.4161/rna.8.3.15388; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAWLEY PD, 1963, BIOCHEM J, V89, P127, DOI 10.1042/bj0890127; Li F, 2012, PLANT CELL, V24, P4346, DOI 10.1105/tpc.112.104232; Loke JC, 2005, PLANT PHYSIOL, V138, P1457, DOI 10.1104/pp.105.060541; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Misra VK, 2002, J MOL BIOL, V317, P507, DOI 10.1006/jmbi.2002.5422; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; Oh E, 2012, NAT CELL BIOL, V14, P802, DOI 10.1038/ncb2545; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; SENECOFF JF, 1992, PLANT MOL BIOL, V18, P219, DOI 10.1007/BF00034951; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Shen YJ, 2011, GENOME RES, V21, P1478, DOI 10.1101/gr.114744.110; Smith CJ, 2012, PHLEBOLOGY, V27, P305, DOI 10.1258/phleb.2012.012J06; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; WEEKS KM, 1991, CELL, V66, P577, DOI 10.1016/0092-8674(81)90020-9; Wells SE, 2000, METHOD ENZYMOL, V318, P479; ZAUG AJ, 1995, RNA, V1, P363; Zemora G, 2010, RNA BIOL, V7, P634, DOI 10.4161/rna.7.6.13554; Zheng Q, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001141	37	496	511	9	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					696	+		10.1038/nature12756	http://dx.doi.org/10.1038/nature12756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24270811				2022-12-24	WOS:000330321000044
J	Liu, HJ; Zhang, H; Niedzwiedzki, DM; Prado, M; He, GN; Gross, ML; Blankenship, RE				Liu, Haijun; Zhang, Hao; Niedzwiedzki, Dariusz M.; Prado, Mindy; He, Guannan; Gross, Michael L.; Blankenship, Robert E.			Phycobilisomes Supply Excitations to Both Photosystems in a Megacomplex in Cyanobacteria	SCIENCE			English	Article							TIME-RESOLVED FLUORESCENCE; ENERGY-TRANSFER; MASS-SPECTROMETRY; MOLECULAR CHARACTERIZATION; CROSS-LINKING; PROTEIN; POLYPEPTIDE; PEPTIDES; DATABASE	In photosynthetic organisms, photons are captured by light-harvesting antenna complexes, and energy is transferred to reaction centers where photochemical reactions take place. We describe here the isolation and characterization of a fully functional megacomplex composed of a phycobilisome antenna complex and photosystems I and II from the cyanobacterium Synechocystis PCC 6803. A combination of in vivo protein cross-linking, mass spectrometry, and time-resolved spectroscopy indicates that the megacomplex is organized to facilitate energy transfer but not intercomplex electron transfer, which requires diffusible intermediates and the cytochrome b(6)f complex. The organization provides a basis for understanding how phycobilisomes transfer excitation energy to reaction centers and how the energy balance of two photosystems is achieved, allowing the organism to adapt to varying ecophysiological conditions.	[Liu, Haijun; Prado, Mindy; Blankenship, Robert E.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Liu, Haijun; Zhang, Hao; Niedzwiedzki, Dariusz M.; Prado, Mindy; He, Guannan; Blankenship, Robert E.] Washington Univ, Photosynthet Antenna Res Ctr, St Louis, MO 63130 USA; [Zhang, Hao; He, Guannan; Gross, Michael L.; Blankenship, Robert E.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Blankenship, RE (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	blankenship@wustl.edu	Niedzwiedzki, Dariusz/B-9035-2008; Zhang, Hao/A-7420-2012	Niedzwiedzki, Dariusz/0000-0002-1976-9296; Zhang, Hao/0000-0002-6129-6410; Liu, Haijun/0000-0003-0537-0302	Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Basic Energy Science [DE-SC 0001035]; National Institute of General Medical Science [8 P41 GM103422-35]; DOE; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center; U.S. Department of Energy (DOE), Office of Basic Energy Science(United States Department of Energy (DOE)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Bricker and H. Pakrasi for the HT3 strain, G. Ajlani and D. Kirilovsky for the Lambda AB strain, all the other members of the Gross and Blankenship laboratories for collegial discussions, and H. Rohrs and M. Plasencia for help with LC-MS/MS instrumentation. The research was supported by the Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Basic Energy Science (grant no. DE-SC 0001035 to R.E.B) and National Institute of General Medical Science (grant no. 8 P41 GM103422-35 to M.L.G). H.L., D.M.N, M.P., and G.H. were funded by the DOE grant, H.Z. was funded equally by the DOE and NIH grants, and instrumentation was made available from both DOE and NIH grants. Additional data are available in the supplementary materials. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE (Proteomics Identifications Database) partner repository (29) with the data set identifier PXD000545.	Ajlani G, 1998, EUR J BIOCHEM, V257, P154, DOI 10.1046/j.1432-1327.1998.2570154.x; BIGGINS J, 1989, PHOTOSYNTH RES, V20, P1, DOI 10.1007/BF00028620; BRUCE D, 1985, BIOCHIM BIOPHYS ACTA, V810, P295, DOI 10.1016/0005-2728(85)90213-0; CAPUANO V, 1991, J BIOL CHEM, V266, P7239; Chen M, 2011, TRENDS PLANT SCI, V16, P427, DOI 10.1016/j.tplants.2011.03.011; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; GANTT E, 1966, BROOKHAVEN SYM BIOL, P393; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.biophys.14.1.47; GLAZER AN, 1975, ARCH MICROBIOL, V104, P15, DOI 10.1007/BF00447294; Gobets B, 2001, BIOPHYS J, V81, P407, DOI 10.1016/S0006-3495(01)75709-8; HASTINGS G, 1994, BIOCHEMISTRY-US, V33, P3185, DOI 10.1021/bi00177a007; HOUMARD J, 1990, P NATL ACAD SCI USA, V87, P2152, DOI 10.1073/pnas.87.6.2152; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kirilovsky D, 2013, PHOTOCH PHOTOBIO SCI, V12, P1135, DOI 10.1039/c3pp25406b; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; MULLINEAUX CW, 1992, BIOCHIM BIOPHYS ACTA, V1100, P285, DOI 10.1016/0167-4838(92)90483-T; Petrotchenko EV, 2010, MASS SPECTROM REV, V29, P862, DOI 10.1002/mas.20293; REDLINGER T, 1981, PLANT PHYSIOL, V68, P1375, DOI 10.1104/pp.68.6.1375; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Soukoulis V, 1999, BIOPHYS J, V76, P2711, DOI 10.1016/S0006-3495(99)77423-0; TANDEAUDEMARSAC N, 1977, P NATL ACAD SCI USA, V74, P1635; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yokono M, 2011, BBA-BIOENERGETICS, V1807, P847, DOI 10.1016/j.bbabio.2011.03.014; Zhao J., 1992, RES PHOTOSYNTHESIS, V1, P25; Zheng CX, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006841	28	219	225	1	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1104	1107		10.1126/science.1242321	http://dx.doi.org/10.1126/science.1242321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288334	Green Accepted			2022-12-24	WOS:000327518600060
J	Jones, W; Klin, A				Jones, Warren; Klin, Ami			Attention to eyes is present but in decline in 2-6-month-old infants later diagnosed with autism	NATURE			English	Article							SPECTRUM DISORDERS; CHILDREN	Deficits in eye contact have been a hallmark of autism(1,2) since the condition's initial description(3). They are cited widely as a diagnostic feature(4) and figure prominently in clinical instruments(5); however, the early onset of these deficits has not been known. Here we show in a prospective longitudinal study that infants later diagnosed with autism spectrum disorders (ASDs) exhibit mean decline in eye fixation from 2 to 6 months of age, a pattern not observed in infants who do not develop ASD. These observations mark the earliest known indicators of social disability in infancy, but also falsify a prior hypothesis: in the first months of life, this basic mechanism of social adaptive action-eye looking-is not immediately diminished in infants later diagnosed with ASD; instead, eye looking appears to begin at normative levels prior to decline. The timing of decline highlights a narrow developmental window and reveals the early derailment of processes that would otherwise have a key role in canalizing typical social development. Finally, the observation of this decline in eye fixation-rather than outright absence-offers a promising opportunity for early intervention that could build on the apparent preservation of mechanisms subserving reflexive initial orientation towards the eyes.	[Jones, Warren; Klin, Ami] Childrens Healthcare Atlanta, Marcus Autism Ctr, Atlanta, GA 30329 USA; [Jones, Warren; Klin, Ami] Emory Univ, Sch Med, Dept Pediat, Div Autism & Related Disabil, Atlanta, GA 30022 USA; [Jones, Warren; Klin, Ami] Emory Univ, Ctr Translat Social Neurosci, Atlanta, GA 30022 USA	Children's Healthcare of Atlanta (CHOA); Emory University; Emory University	Jones, W (corresponding author), Childrens Healthcare Atlanta, Marcus Autism Ctr, Atlanta, GA 30329 USA.	warren.jones@emory.edu; ami.klin@emory.edu			Simons Foundation; National Institute of Mental Health [R01 MH083727]; Marcus Foundation; Whitehead Foundation; Georgia Research Alliance; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100029, R01MH083727] Funding Source: NIH RePORTER	Simons Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Marcus Foundation; Whitehead Foundation; Georgia Research Alliance; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Simons Foundation and the National Institute of Mental Health (R01 MH083727). Additional support was provided by the Marcus Foundation, the Whitehead Foundation, and the Georgia Research Alliance. We wish to thank the families and children for their time and participation. We also wish to thank S. Habayeb, S. Glazer, M. Ly, T. Tsang, J. Jones, A. Trubanova, J. Borjon, J. Moriuchi, K. Rice, J. Northrup, L. Edwards, J. Xu, S. Shultz, A. Krasno, C. Zampella, K. Knoch, D. Lin, K. Carr and A. Blank for their assistance in data collection and processing; P. Lewis, J. Paredes, P. Gorrindo and M. Ackerman for assistance in designing and building laboratory hardware and software; G. Ramsay and C. McCracken for discussions of data analysis and statistics; I. Zilber, A. Margolis, D. Blum, M. Dye, D. Simeone, A. Smith and K. O'Loughlin for project supervision, coordination, and data collection; T. Babitz for administrative support; and K. Chawarska, C. Saulnier, K. Bearss, S. Macari, R. Paul, A. Carney, T. Goldsmith, A. Steiner, G. Gengoux, D. Goudreau, E. Loring, J. McGrath and A. Gupta for their contributions to the clinical characterization of the samples.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; [Anonymous], 2006, MONOGR SOC RES CHILD, V71, P65; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Chawarska K, 2007, J CHILD PSYCHOL PSYC, V48, P128, DOI 10.1111/j.1469-7610.2006.01685.x; Constantino JN, 2013, MOL PSYCHIATR, V18, P137, DOI 10.1038/mp.2012.9; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; Grice SJ, 2005, CORTEX, V41, P342, DOI 10.1016/S0010-9452(08)70271-5; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Hall P, 2009, ANN STAT, V37, P3307, DOI 10.1214/09-AOS686; Horn G, 2001, P NATL ACAD SCI USA, V98, P5282, DOI 10.1073/pnas.091094798; Johnson M. H., 2004, THEORIES INFANT DEV, P121, DOI DOI 10.1002/9780470752180.CH5; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Jones W, 2009, J AM ACAD CHILD PSY, V48, P471, DOI 10.1097/CHI.0b013e31819f6c0d; Kanner L, 1943, NERV CHILD, V2, P217; Klin A, 2003, PHILOS T R SOC B, V358, P345, DOI 10.1098/rstb.2002.1202; Klin A, 2007, J AUTISM DEV DISORD, V37, P748, DOI 10.1007/s10803-006-0229-4; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Liu BT, 2009, J AM STAT ASSOC, V104, P704, DOI 10.1198/jasa.2009.0115; Lord C., 2008, AUTISM DIAGNOSTIC OB, V2nd; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; Oyama S., 2000, ONTOGENY INFORM, V2nd; Ozonoff S, 2011, PEDIATRICS, V128, pE488, DOI 10.1542/peds.2010-2825; Ramsay J. O, 2006, FUNCTIONAL DATA ANAL; Salva OR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018802; Shultz S, 2011, P NATL ACAD SCI USA, V108, P21270, DOI 10.1073/pnas.1109304108; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Speer LL, 2007, AUTISM, V11, P265, DOI 10.1177/1362361307076925; State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989; Steer CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012633; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Tang R, 2008, BIOMETRIKA, V95, P875, DOI 10.1093/biomet/asn047; Volkmar FR, 2004, J CHILD PSYCHOL PSYC, V45, P135, DOI 10.1046/j.0021-9630.2003.00317.x; Yao F, 2005, J AM STAT ASSOC, V100, P577, DOI 10.1198/016214504000001745; Zee DS., 1999, NEUROLOGY EYE MOVEME	37	665	694	18	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					427	+		10.1038/nature12715	http://dx.doi.org/10.1038/nature12715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24196715	Green Accepted			2022-12-24	WOS:000328575300050
J	Hasson, SA; Kane, LA; Yamano, K; Huang, CH; Sliter, DA; Buehler, E; Wang, CX; Heman-Ackah, SM; Hessa, T; Guha, R; Martin, SE; Youle, RJ				Hasson, Samuel A.; Kane, Lesley A.; Yamano, Koji; Huang, Chiu-Hui; Sliter, Danielle A.; Buehler, Eugen; Wang, Chunxin; Heman-Ackah, Sabrina M.; Hessa, Tara; Guha, Rajarshi; Martin, Scott E.; Youle, Richard J.			High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy	NATURE			English	Article							MITOCHONDRIA; RECRUITMENT; SENSITIVITY; ACTIVATION; MUTATIONS; PROMOTES; COMPLEX	An increasing body of evidence points to mitochondrial dysfunction as a contributor to the molecular pathogenesis of neurodegenerative diseases such as Parkinson's disease(1). Recent studies of the Parkinson's disease associated genes PINK1 (ref. 2) and parkin (PARK2, ref. 3) indicate that they may act in a quality control pathway preventing the accumulation of dysfunctional mitochondria(4-8). Here we elucidate regulators that have an impact on parkin translocation to damaged mitochondria with genome-wide small interfering RNA (siRNA) screens coupled to high-content microscopy. Screening yielded gene candidates involved in diverse cellular processes that were subsequently validated in low-throughput assays. This led to characterization of TOMM7 as essential for stabilizing PINK1 on the outer mitochondrial membrane following mitochondrial damage. We also discovered that HSPA1L (HSP70 family member) and BAG4 have mutually opposing roles in the regulation of parkin translocation. The screens revealed that SIAH3, found to localize to mitochondria, inhibits PINK1 accumulation after mitochondrial insult, reducing parkin translocation. Overall, our screens provide a rich resource to understand mitochondrial quality control.	[Hasson, Samuel A.; Kane, Lesley A.; Yamano, Koji; Huang, Chiu-Hui; Sliter, Danielle A.; Wang, Chunxin; Hessa, Tara; Youle, Richard J.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Hasson, Samuel A.; Buehler, Eugen; Guha, Rajarshi; Martin, Scott E.] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA; [Heman-Ackah, Sabrina M.] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA	Youle, RJ (corresponding author), NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.	youler@ninds.nih.gov	Huang, Chiu-Hui/O-1061-2018; Wang, Chunxin/B-9312-2016	Huang, Chiu-Hui/0000-0003-1485-5731; Wang, Chunxin/0000-0001-6015-6806; Hasson, Samuel/0000-0003-2258-0678	Japan Society for Promotion of Science; NIGMS Research Associate Program; NIH, NINDS; Trans-NIH RNAi initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003123] Funding Source: NIH RePORTER	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIGMS Research Associate Program; NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Trans-NIH RNAi initiative; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Tuzmen for qRT-PCR assistance; C. Klumpp for automation; D. Maric for FACS sorting; C. Smith for microscopy assistance; H. Jaffe for mass spectrometry analyses; R. Fields (NINDS) for lentivirus assistance; N. Malik for iPS-derived neurons; the NINDS DNA Sequencing Facility; K. Mihara for the TOMM7 antibody and A. Koretsky and N. Caplen for support. Research was supported by the Japan Society for Promotion of Science Postdoctoral Fellowship for Research Abroad (K.Y.), the NIGMS Research Associate Program, the Intramural Research Program of the NIH, NINDS and the Trans-NIH RNAi initiative.	Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Buehler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051942; Buehler E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00428; Burman JL, 2012, P NATL ACAD SCI USA, V109, P10438, DOI 10.1073/pnas.1120688109; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kato H, 2008, BIOCHEM BIOPH RES CO, V369, P958, DOI 10.1016/j.bbrc.2008.02.150; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Marine S, 2012, J BIOMOL SCREEN, V17, P370, DOI 10.1177/1087057111427348; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Schultz Nikolaus, 2011, Silence, V2, P3, DOI 10.1186/1758-907X-2-3; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Simpson JC, 2012, NAT CELL BIOL, V14, P764, DOI 10.1038/ncb2510; Sudbery I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-175; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107	30	249	265	8	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					291	+		10.1038/nature12748	http://dx.doi.org/10.1038/nature12748			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24270810	Green Accepted, Green Published			2022-12-24	WOS:000328121500039
J	Temmerman, S; Meire, P; Bouma, TJ; Herman, PMJ; Ysebaert, T; De Vriend, HJ				Temmerman, Stijn; Meire, Patrick; Bouma, Tjeerd J.; Herman, Peter M. J.; Ysebaert, Tom; De Vriend, Huib J.			Ecosystem-based coastal defence in the face of global change	NATURE			English	Article							MARSH RESTORATION; SEA-LEVEL; MANAGEMENT; SEDIMENTATION; CARBON	The risk of flood disasters is increasing for many coastal societies owing to global and regional changes in climate conditions, sea-level rise, land subsidence and sediment supply. At the same time, in many locations, conventional coastal engineering solutions such as sea walls are increasingly challenged by these changes and their maintenance may become unsustainable. We argue that flood protection by ecosystem creation and restoration can provide a more sustainable, cost-effective and ecologically sound alternative to conventional coastal engineering and that, in suitable locations, it should be implemented globally and on a large scale.	[Temmerman, Stijn; Meire, Patrick] Univ Antwerp, Ecosyst Management Res Grp, B-2610 Antwerp, Belgium; [Bouma, Tjeerd J.; Herman, Peter M. J.; Ysebaert, Tom] Royal Netherlands Inst Sea Res, Spatial Ecol Res Grp, NL-4400 AC Yerseke, Netherlands; [Ysebaert, Tom] Inst Marine Resources & Ecosyst Studies IMARES, NL-4400 AB Yerseke, Netherlands; [De Vriend, Huib J.] Delft Univ Technol, NL-3311 JG Dordrecht, Netherlands; [De Vriend, Huib J.] EcoShape, NL-3311 JG Dordrecht, Netherlands	University of Antwerp; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Wageningen University & Research; Delft University of Technology	Temmerman, S (corresponding author), Univ Antwerp, Ecosyst Management Res Grp, B-2610 Antwerp, Belgium.	stijn.temmerman@uantwerpen.be	Bouma, Tjeerd J/A-9841-2011; Temmerman, Stijn/C-5521-2009; Herman, Peter M.J./A-9018-2011	Herman, Peter M.J./0000-0003-2188-6341; Temmerman, Stijn/0000-0003-3346-9115; Bouma, Tjeerd/0000-0001-7824-7546	Research Foundation - Flanders (FWO); Research Fund of the University of Antwerp (BOF); Waterwegen Zeekanaal NV; EU [FP7.2009-1, 244104]; STW [07324]; Singapore-Delft Water Alliance; innovation program Building	Research Foundation - Flanders (FWO)(FWO); Research Fund of the University of Antwerp (BOF); Waterwegen Zeekanaal NV; EU(European Commission); STW(Technologiestichting STW); Singapore-Delft Water Alliance; innovation program Building	We gratefully acknowledge financial support to our research that is related to this article by the Research Foundation - Flanders (FWO), the Research Fund of the University of Antwerp (BOF), Waterwegen & Zeekanaal NV, the EU-funded THESUES project (FP7.2009-1, Contract 244104), STW grant 07324, the Singapore-Delft Water Alliance, the innovation program Building with Nature and its contributors (including the Netherlands Ministry of Infrastructure and the Environment, the European Fund for Regional Development, the Municipality of Dordrecht and the partners of the EcoShape consortium).	Balke T, 2013, J APPL ECOL, V50, P740, DOI 10.1111/1365-2664.12067; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Broekx S, 2011, NAT HAZARDS, V57, P245, DOI 10.1007/s11069-010-9610-x; Burden A, 2013, ESTUAR COAST SHELF S, V120, P12, DOI 10.1016/j.ecss.2013.01.014; Carniello L, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001157; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; Ecoshape, 2012, OYST REEFS TID FLAT; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Friess DA, 2012, BIOL REV, V87, P346, DOI 10.1111/j.1469-185X.2011.00198.x; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Kabat P, 2009, NAT GEOSCI, V2, P450, DOI 10.1038/ngeo572; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Lin N, 2012, NAT CLIM CHANGE, V2, P462, DOI 10.1038/NCLIMATE1389; Maris T, 2007, HYDROBIOLOGIA, V588, P31, DOI 10.1007/s10750-007-0650-5; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Nicholls R., 2007, RANKING WORLDS CITIE, DOI [https://doi.org/10.1787/011766488208, DOI 10.1787/011766488208]; Resio DT, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.2982120; Schmitt K, 2013, J COAST CONSERV, V17, P545, DOI 10.1007/s11852-013-0253-4; Scyphers SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022396; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Struyf E, 2007, BIOGEOCHEMISTRY, V82, P41, DOI 10.1007/s10533-006-9051-5; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Temmerman S, 2004, MAR GEOL, V212, P1, DOI 10.1016/j.margeo.2004.10.021; Temmerman S, 2012, GLOBAL PLANET CHANGE, V92-93, P267, DOI 10.1016/j.gloplacha.2012.06.001; Teuchies J, 2012, SCI TOTAL ENVIRON, V419, P187, DOI 10.1016/j.scitotenv.2012.01.016; Turner RK, 2007, GLOBAL ENVIRON CHANG, V17, P397, DOI 10.1016/j.gloenvcha.2007.05.006; United States Environmental Protection agency, 2013, SAN FRANC BAY DELT W; van Slobbe E, 2013, NAT HAZARDS, V65, P947, DOI 10.1007/s11069-012-0342-y; Vandenbruwaene W, 2011, GEOMORPHOLOGY, V130, P115, DOI 10.1016/j.geomorph.2011.03.004; Verspagen JMH, 2006, ECOL APPL, V16, P313, DOI 10.1890/04-1953; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; Wolters M, 2005, BIOL CONSERV, V123, P249, DOI 10.1016/j.biocon.2004.11.013; Zhang KQ, 2012, ESTUAR COAST SHELF S, V102, P11, DOI 10.1016/j.ecss.2012.02.021	35	842	871	34	630	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					79	83		10.1038/nature12859	http://dx.doi.org/10.1038/nature12859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305151				2022-12-24	WOS:000327851700028
J	Chung, CY; Khurana, V; Auluck, PK; Tardiff, DF; Mazzulli, JR; Soldner, F; Baru, V; Lou, YL; Freyzon, Y; Cho, S; Mungenast, AE; Muffat, J; Mitalipova, M; Pluth, MD; Jui, NT; Schule, B; Lippard, SJ; Tsai, LH; Krainc, D; Buchwald, SL; Jaenisch, R; Lindquist, S				Chung, Chee Yeun; Khurana, Vikram; Auluck, Pavan K.; Tardiff, Daniel F.; Mazzulli, Joseph R.; Soldner, Frank; Baru, Valeriya; Lou, Yali; Freyzon, Yelena; Cho, Sukhee; Mungenast, Alison E.; Muffat, Julien; Mitalipova, Maisam; Pluth, Michael D.; Jui, Nathan T.; Schuele, Birgitt; Lippard, Stephen J.; Tsai, Li-Huei; Krainc, Dimitri; Buchwald, Stephen L.; Jaenisch, Rudolf; Lindquist, Susan			Identification and Rescue of alpha-Synuclein Toxicity in Parkinson Patient-Derived Neurons	SCIENCE			English	Article							NEURODEGENERATION; NITRATION; NETWORK; STRESS; RISK	The induced pluripotent stem (iPS) cell field holds promise for in vitro disease modeling. However, identifying innate cellular pathologies, particularly for age-related neurodegenerative diseases, has been challenging. Here, we exploited mutation correction of iPS cells and conserved proteotoxic mechanisms from yeast to humans to discover and reverse phenotypic responses to alpha-synuclein (alpha syn), a key protein involved in Parkinson's disease (PD). We generated cortical neurons from iPS cells of patients harboring alpha syn mutations, who are at high risk of developing PD dementia. Genetic modifiers from unbiased screens in a yeast model of alpha syn toxicity led to identification of early pathogenic phenotypes in patient neurons. These included nitrosative stress, accumulation of endoplasmic reticulum (ER)-associated degradation substrates, and ER stress. A small molecule identified in a yeast screen (NAB2), and the ubiquitin ligase Nedd4 it affects, reversed pathologic phenotypes in these neurons.	[Chung, Chee Yeun; Khurana, Vikram; Auluck, Pavan K.; Tardiff, Daniel F.; Soldner, Frank; Baru, Valeriya; Lou, Yali; Freyzon, Yelena; Muffat, Julien; Mitalipova, Maisam; Jaenisch, Rudolf; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Khurana, Vikram; Mazzulli, Joseph R.; Krainc, Dimitri] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Khurana, Vikram; Auluck, Pavan K.; Mazzulli, Joseph R.; Krainc, Dimitri] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Auluck, Pavan K.] Massachusetts Gen Hosp, Dept Pathol Neuropathol, Boston, MA 02114 USA; [Baru, Valeriya; Lou, Yali; Tsai, Li-Huei; Lindquist, Susan] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Cho, Sukhee; Mungenast, Alison E.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Pluth, Michael D.; Jui, Nathan T.; Lippard, Stephen J.; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Schuele, Birgitt] Parkinsons Inst, Sunnyvale, CA 94085 USA; [Jaenisch, Rudolf; Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Muffat, Julien/P-2298-2014; Mazzulli, joseph/AAS-4480-2020; Pluth, Michael/A-7222-2012	Muffat, Julien/0000-0003-1889-7023; Khurana, Vikram/0000-0002-4018-5527; Schuele, Birgitt/0000-0002-9952-5776; Mungenast, Alison/0000-0003-1020-0471; Pluth, Michael/0000-0003-3604-653X	Howard Hughes Medical Institute; JPB Foundation; NIH/National Institute on Aging [K01 AG038546]; American Brain Foundation; Parkinson's Disease Foundation; NIH [5 R01CA084198]; NSF; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134, K01AG038546] Funding Source: NIH RePORTER; Division Of Chemistry [0907905] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); JPB Foundation; NIH/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Brain Foundation; Parkinson's Disease Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank D. Dickson, L. Golbe, and J. Trojanowki for postmorterm tissue or data; D. Pincus for the UPR reporter; I. Cheeseman, J. Kim, J. Pruszak, P. Wisniewski, and W. Salmon for important technical advice; R. Alagappan, T. Lungiangwa, and P. Xu for superb technical assistance; and S. Santagata, L. Whitesell, M. Feany, D. Landgraf, and L. Clayton for fruitful discussion and critical comments on the manuscript. Grant support was provided by a Howard Hughes Medical Institute Collaborative Innovation Award (S.L.), JPB Foundation grants (S.L.), NIH/National Institute on Aging grant K01 AG038546 (C.Y.C.), an American Brain Foundation and Parkinson's Disease Foundation Clinician-Scientist Development Award (V.K.), NIH grant 5 R01CA084198 (R.J.), and the NSF (S.J.L.). Whitehead Institute for Biomedical Research has filed a patent application, on which authors V.K., C.Y.C., and S.L. are inventors, relating to the use of yeast- and iPS cell-based models of synucleinopathies and associated phenotypes for identifying compounds. In addition, author S.L. is an inventor on patents and patent applications filed by The University of Chicago relating to methods of screening for compounds that decrease alpha-synuclein-associated toxicity using yeast that expresses alpha-synuclein. All the yeast plasmids and strains and NAB2 are available under a Uniform Biological Material Transfer Agreement from the Whitehead Institute. Author contributions: C.Y.C., V.K., and S.L. conceptualized the study, designed the experiments, and wrote the paper. V.K. developed the human iPS cell-derived cortical synucleinopathy model, assisted by Y.L. Pluripotent cell lines, advice on experimental design, and technical expertise were provided by F.S., J.R.M., J.M., M.M., and R.J. F.S. reprogrammed the WIBR-IPS-SYN<SUP>TRPL</SUP> line from fibroblasts provided by B.S. C.Y.C. developed the rat cortical synucleinopathy model, assisted by V.B. The mKate2-tagged constructs were generated by Y.F. C.Y.C. and V.K. performed all experiments except Fig. 1, D and E, Fig. 2E, and fig. S5, A and B (P.K.A.); Fig. 4A (D.F.T.); Fig. 4C and fig. S6C (J.R.M./D.K.); fig. S2, H and I (A.E.M./S.C./L.-H.T.); and fig. S1 (Y.F./Y.L.). The small molecule NAB2 was synthesized by N.T.J. and S.L.B., based on a yeast screen performed by D.F.T. FL2 dye synthesis and technical advice were provided by M.D.P. and S.J.L.	Alcalay RN, 2012, NEUROLOGY, V78, P1434, DOI 10.1212/WNL.0b013e318253d54b; Byers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026159; Castello PR, 2008, P NATL ACAD SCI USA, V105, P8203, DOI 10.1073/pnas.0709461105; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Donovan P, 2013, INT J BIOCHEM CELL B, V45, P706, DOI 10.1016/j.biocel.2012.12.006; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gomez-Tortosa E, 2002, ACTA NEUROPATHOL, V103, P495, DOI 10.1007/s00401-001-0495-3; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Haynes CM, 2002, J CELL BIOL, V158, P91, DOI 10.1083/jcb.200201053; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Markopoulou K, 2008, ACTA NEUROPATHOL, V116, P25, DOI 10.1007/s00401-008-0372-4; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pluth MD, 2011, ANNU REV BIOCHEM, V80, P333, DOI 10.1146/annurev-biochem-061009-091643; Saito T, 2011, CEREB CORTEX, V21, P588, DOI 10.1093/cercor/bhq125; Sarver A, 2005, MOL BIOL CELL, V16, P4781, DOI 10.1091/mbc.E05-05-0436; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210	28	343	361	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					983	987		10.1126/science.1245296	http://dx.doi.org/10.1126/science.1245296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24158904	Green Submitted, Green Accepted			2022-12-24	WOS:000327223500044
J	Ragsdale, EJ; Muller, MR; Rodelsperger, C; Sommer, RJ				Ragsdale, Erik J.; Mueller, Manuela R.; Roedelsperger, Christian; Sommer, Ralf J.			A Developmental Switch Coupled to the Evolution of Plasticity Acts through a Sulfatase	CELL			English	Article							NEMATODE PRISTIONCHUS-PACIFICUS; LA REUNION ISLAND; PHENOTYPIC PLASTICITY; MODEL SYSTEM; ACTIVE-SITE; N. SP; DIPLOGASTRIDAE; ORIGIN; SEX; ARYLSULFATASE	Developmental plasticity has been suggested to facilitate phenotypic diversity, but the molecular mechanisms underlying this relationship are little understood. We analyzed a feeding dimorphism in Pristionchus nematodes whereby one of two alternative adult mouth forms is executed after an irreversible developmental decision. By integrating developmental genetics with functional tests in phenotypically divergent populations and species, we identified a regulator of plasticity, eud-1, that acts in a developmental switch. eud-1 mutations eliminate one mouth form, whereas overexpression of eud-1 fixes it. EUD-1 is a sulfatase that acts dosage dependently, is necessary and sufficient to control the sexual dimorphism of feeding forms, and has a conserved function in Pristionchus evolution. It is epistatic to known signaling cascades and results from lineage-specific gene duplications. EUD-1 thus executes a developmental switch for morphological plasticity in the adult stage, showing that regulatory pathways can evolve by terminal addition of new genes.	[Ragsdale, Erik J.; Mueller, Manuela R.; Roedelsperger, Christian; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, D-72076 Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, D-72076 Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de	, roedelsberg/Q-3831-2019; Ragsdale, Erik J./AAB-4536-2019	, roedelsberg/0000-0002-7905-9675; Ragsdale, Erik J./0000-0002-9367-8552	Max Planck Society; Alexander von Humboldt Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was funded by the Max Planck Society and by a fellowship from the Alexander von Humboldt Foundation awarded to E.J.R. We thank Gabi Eberhardt for support in next-generation sequencing, and we thank Vahan Serobyan for assistance with RNA-seq experiments. We also thank Adrian Streit and Benjamin Schlager for conceptual discussions and helpful suggestions on the project.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Antebi A, 2000, GENE DEV, V14, P1512; Bento G, 2010, NATURE, V466, P494, DOI 10.1038/nature09164; Bose N, 2012, ANGEW CHEM INT EDIT, V51, P12438, DOI 10.1002/anie.201206797; Brakefield PM, 1998, AM NAT, V152, P853, DOI 10.1086/286213; Carroll BT, 2006, J BIOL CHEM, V281, P35989, DOI 10.1074/jbc.M606086200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; DODGSON KS, 1953, BIOCHEM J, V55, P315, DOI 10.1042/bj0550315; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; GLOSSL J, 1979, BIOCHEM J, V181, P37; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; Hattori K, 2006, J BIOCHEM, V139, P355, DOI 10.1093/jb/mvj041; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Herrmann Matthias, 2006, Front Zool, V3, P14, DOI 10.1186/1742-9994-3-14; Herrmann M, 2010, BIOL J LINN SOC, V100, P170, DOI 10.1111/j.1095-8312.2010.01410.x; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kanzaki N, 2013, J NEMATOL, V45, P172; Kanzaki N, 2013, ZOOL SCI, V30, P680, DOI 10.2108/zsj.30.680; Kanzaki N, 2013, J NEMATOL, V45, P78; Kanzaki N, 2012, J NEMATOL, V44, P80; Kanzaki N, 2012, ZOOL SCI, V29, P403, DOI 10.2108/zsj.29.403; Kiontke K, 2010, CURR BIOL, V20, pR710, DOI 10.1016/j.cub.2010.07.009; Litjens T, 1996, AM J HUM GENET, V58, P1127; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Miller SW, 2003, EVOL DEV, V5, P251, DOI 10.1046/j.1525-142X.2003.03032.x; Mitsunaga-Nakatsubo K, 2009, DEV GENES EVOL, V219, P281, DOI 10.1007/s00427-009-0289-5; Moczek AP, 2007, EVOL DEV, V9, P299, DOI 10.1111/j.1525-142X.2007.00162.x; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; Morgan K, 2012, MOL ECOL, V21, P250, DOI 10.1111/j.1365-294X.2011.05382.x; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Pigliucci M., 2001, SYN ECO EVO; Pires da Silva A., 2006, C ELEGANS RES COMMUN; Ragsdale EJ, 2013, ZOOL J LINN SOC-LOND, V168, P671, DOI 10.1111/zoj.12041; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Schlager B, 2009, GENESIS, V47, P300, DOI 10.1002/dvg.20499; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Serobyan V, 2013, EVOL DEV, V15, P161, DOI 10.1111/ede.12030; Sommer RJ, 2013, MOL ECOL, V22, P2380, DOI 10.1111/mec.12286; Sudhaus W., 2003, Journal of Nematode Morphology and Systematics, V6, P43; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Waldow A, 1999, J BIOL CHEM, V274, P12284, DOI 10.1074/jbc.274.18.12284; West-Eberhard Mary Jane, 2003, pi; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Wilkins A.S., 2002, EVOLUTION DEV PATHWA	47	116	116	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					922	933		10.1016/j.cell.2013.09.054	http://dx.doi.org/10.1016/j.cell.2013.09.054			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209628	Bronze			2022-12-24	WOS:000326934300020
J	Yu, HJ; Wu, JT; Cowling, BJ; Liao, QH; Fang, VJ; Zhou, S; Wu, P; Zhou, H; Lau, EHY; Guo, DH; Ni, MY; Peng, ZB; Feng, LZ; Jiang, H; Luo, HM; Li, Q; Feng, ZJ; Wang, Y; Yang, WZ; Leung, GM				Yu, Hongjie; Wu, Joseph T.; Cowling, Benjamin J.; Liao, Qiaohong; Fang, Vicky J.; Zhou, Sheng; Wu, Peng; Zhou, Hang; Lau, Eric H. Y.; Guo, Danhuai; Ni, Michael Y.; Peng, Zhibin; Feng, Luzhao; Jiang, Hui; Luo, Huiming; Li, Qun; Feng, Zijian; Wang, Yu; Yang, Weizhong; Leung, Gabriel M.			Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study	LANCET			English	Article							HUMAN INFECTIONS; HONG-KONG; RISK-FACTORS; RESPIRATORY DROPLET; CHINA; FERRETS; OUTBREAK; EXPOSURE; DISEASE; HEALTH	Background Transmission of the novel avian influenza A H7N9 virus seems to be predominantly between poultry and people. In the major Chinese cities of Shanghai, Hangzhou, Huzhou, and Nanjing-where most human cases of infection have occurred-live poultry markets (LPMs) were closed in April, 2013, soon after the initial outbreak, as a precautionary public health measure. Our objective was to quantify the effect of LPM closure in these cities on poultry-to-person transmission of avian influenza A H7N9 virus. Methods We obtained information about every laboratory-confirmed human case of avian influenza A H7N9 virus infection reported in the four cities by June 7, 2013, from a database built by the Chinese Center for Disease Control and Prevention. We used data for age, sex, location, residence type (rural or urban area), and dates of illness onset. We obtained information about LPMs from official sources. We constructed a statistical model to explain the patterns in incidence of cases reported in each city on the basis of the assumption of a constant force of infection before LPM closure, and a different constant force of infection after closure. We fitted the model with Markov chain Monte Carlo methods. Findings 85 human cases of avian influenza A H7N9 virus infection were reported in Shanghai, Hangzhou, Huzhou, and Nanjing by June 7, 2013, of which 60 were included in our main analysis. Closure of LPMs reduced the mean daily number of infections by 99% (95% credibility interval 93-100%) in Shanghai, by 99% (92-100%) in Hangzhou, by 97% (68-100%) in Huzhou, and by 97% (81-100%) in Nanjing. Because LPMs were the predominant source of exposure to avian influenza A H7N9 virus for confirmed cases in these cities, we estimated that the mean incubation period was 3.3 days (1.4-5.7). Interpretation LPM closures were effective in the control of human risk of avian influenza A H7N9 virus infection in the spring of 2013. In the short term, LPM closure should be rapidly implemented in areas where the virus is identified in live poultry or people. In the long term, evidence-based discussions and deliberations about the role of market rest days and central slaughtering of all live poultry should be renewed.	[Yu, Hongjie; Liao, Qiaohong; Zhou, Sheng; Zhou, Hang; Peng, Zhibin; Feng, Luzhao; Jiang, Hui] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Luo, Huiming] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China; [Li, Qun; Feng, Zijian] Chinese Ctr Dis Control & Prevent, Publ Hlth Emergency Ctr, Beijing, Peoples R China; [Wang, Yu; Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Off Director, Beijing, Peoples R China; [Wu, Joseph T.; Cowling, Benjamin J.; Fang, Vicky J.; Wu, Peng; Lau, Eric H. Y.; Ni, Michael Y.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Div Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China; [Guo, Danhuai] Chinese Acad Sci, Comp Network Informat Ctr, Sci Data Ctr, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; University of Hong Kong; Chinese Academy of Sciences; Computer Network Information Center, CAS	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Div Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk; yangwz@chinacdc.cn	Cowling, Benjamin John/C-4263-2009; Wu, Joseph/ABD-5880-2021; Guo, Danhuai/AAE-9112-2020; Guo, Dan/S-8823-2019; Yu, Hongjie/GZK-5351-2022; Lau, Eric/AAJ-6588-2021	Cowling, Benjamin John/0000-0002-6297-7154; Lau, Eric/0000-0002-6688-9637; Ni, Michael/0000-0002-1217-5858; Yang, Weizhong/0000-0002-6599-825X; Leung, Gabriel/0000-0002-2503-6283; Wu, Peng/0000-0003-1157-9401	Ministry of Science and Technology, China; Research Fund for the Control of Infectious Disease; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Harvard Center for Communicable Disease Dynamics; US National Institutes of Health; Hong Kong University Grants Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Research Fund for the Control of Infectious Disease; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Harvard Center for Communicable Disease Dynamics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong University Grants Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Ministry of Science and Technology, China; Research Fund for the Control of Infectious Disease; Hong Kong University Grants Committee; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; Harvard Center for Communicable Disease Dynamics; and the US National Institutes of Health.	Ai J, 2013, EUROSURVEILLANCE, V18, P4, DOI 10.2807/1560-7917.ES2013.18.26.20510; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Arima Y, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.005, 10.5365/WPSAR.2013.4.2.005]; Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Centre for Health Protection Hong Kong Special Administrative Region, 2013, NOT ADD HUM CAS AV I; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, EUROSURVEILLANCE, V18, P2; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Food and Agriculture Organization World Organisation for Animal Health World Health Organization United Nations Children's Fund World Bank UN System Influenza Coordinator, 2008, CONTR ON WORLD ON HL; Fournie G, 2011, J R SOC INTERFACE, V8, P1079, DOI 10.1098/rsif.2010.0510; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gebski V, 2012, EPIDEMIOL INFECT, V140, P2131, DOI 10.1017/S0950268812000179; Gelman A, 1996, STAT SINICA, V6, P733; Han J, 2013, EUROSURVEILLANCE, V18, P6; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Horby P, 2013, NATURE, V496, P399, DOI 10.1038/496399a; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jonges M, 2013, EUROSURVEILLANCE, V18, P2; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Lau EHY, 2007, EMERG INFECT DIS, V13, P1340, DOI 10.3201/eid1309.061549; Leung YHC, 2012, EMERG INFECT DIS, V18, P1339, DOI 10.3201/eid1808.111879; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liao QY, 2009, EPIDEMICS-NETH, V1, P207, DOI 10.1016/j.epidem.2009.09.002; Martin V, 2011, PREV VET MED, V102, P196, DOI 10.1016/j.prevetmed.2011.07.007; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Mullaney R, 2003, AVIAN DIS, V47, P1096, DOI 10.1637/0005-2086-47.s3.1096; Murhekar M, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.008, 10.5365/WPSAR.2013.4.2.008]; Oladokun AT, 2012, PAN AFR MED J, V13; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shardell M, 2007, CLIN INFECT DIS, V45, P901, DOI 10.1086/521255; Shortridge KF, 1999, VACCINE, V17, pS26, DOI 10.1016/S0264-410X(99)00102-4; The Central People's Government of the People's Republic of China, CONTR PREV INFL H7N9; The Central People's Government of the People's Republic of China, 1 BATCH LIV POULTR R; The Central People's Government of the People's Republic of China, AGR DEP FUJ PROV TAK; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; WHO, 2003, CUM NUMB CONF HUM CA; Wu Y, 2013, SCI CHINA LIFE SCI, V56, P493, DOI 10.1007/s11427-013-4496-y; Xu JG, 2013, LANCET, V381, P1815, DOI 10.1016/S0140-6736(13)60950-2; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	43	208	232	4	122	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 8	2014	383	9916					541	548		10.1016/S0140-6736(13)61904-2	http://dx.doi.org/10.1016/S0140-6736(13)61904-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA5KH	24183056	Green Accepted			2022-12-24	WOS:000331136400030
J	Parsa, A; Kao, WHL; Xie, DW; Astor, BC; Li, M; Hsu, CY; Feldman, HI; Parekh, RS; Kusek, JW; Greene, TH; Fink, JC; Anderson, AH; Choi, MJ; Wright, JT; Lash, JP; Freedman, BI; Ojo, A; Winkler, CA; Raj, DS; Kopp, JB; He, J; Jensvold, NG; Tao, KX; Lipkowitz, MS; Appel, LJ				Parsa, Afshin; Kao, W. H. Linda; Xie, Dawei; Astor, Brad C.; Li, Man; Hsu, Chi-yuan; Feldman, Harold I.; Parekh, Rulan S.; Kusek, John W.; Greene, Tom H.; Fink, Jeffrey C.; Anderson, Amanda H.; Choi, Michael J.; Wright, Jackson T., Jr.; Lash, James P.; Freedman, Barry I.; Ojo, Akinlolu; Winkler, Cheryl A.; Raj, Dominic S.; Kopp, Jeffrey B.; He, Jiang; Jensvold, Nancy G.; Tao, Kaixiang; Lipkowitz, Michael S.; Appel, Lawrence J.		AASK Study Investigators; CRIC Study Investigators	APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAGE RENAL-DISEASE; BASE-LINE CHARACTERISTICS; RACIAL-DIFFERENCES; INSUFFICIENCY COHORT; FUNCTION DECLINE; GENE; MYH9; GFR; PARTICIPANTS; CKD	BackgroundAmong patients in the United States with chronic kidney disease, black patients are at increased risk for end-stage renal disease, as compared with white patients. MethodsIn two studies, we examined the effects of variants in the gene encoding apolipoprotein L1 (APOL1) on the progression of chronic kidney disease. In the African American Study of Kidney Disease and Hypertension (AASK), we evaluated 693 black patients with chronic kidney disease attributed to hypertension. In the Chronic Renal Insufficiency Cohort (CRIC) study, we evaluated 2955 white patients and black patients with chronic kidney disease (46% of whom had diabetes) according to whether they had 2 copies of high-risk APOL1 variants (APOL1 high-risk group) or 0 or 1 copy (APOL1 low-risk group). In the AASK study, the primary outcome was a composite of end-stage renal disease or a doubling of the serum creatinine level. In the CRIC study, the primary outcomes were the slope in the estimated glomerular filtration rate (eGFR) and the composite of end-stage renal disease or a reduction of 50% in the eGFR from baseline. ResultsIn the AASK study, the primary outcome occurred in 58.1% of the patients in the APOL1 high-risk group and in 36.6% of those in the APOL1 low-risk group (hazard ratio in the high-risk group, 1.88; P<0.001). There was no interaction between APOL1 status and trial interventions or the presence of baseline proteinuria. In the CRIC study, black patients in the APOL1 high-risk group had a more rapid decline in the eGFR and a higher risk of the composite renal outcome than did white patients, among those with diabetes and those without diabetes (P<0.001 for all comparisons). ConclusionsRenal risk variants in APOL1 were associated with the higher rates of end-stage renal disease and progression of chronic kidney disease that were observed in black patients as compared with white patients, regardless of diabetes status. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.)	[Parsa, Afshin; Fink, Jeffrey C.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Kao, W. H. Linda; Li, Man; Appel, Lawrence J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Choi, Michael J.; Appel, Lawrence J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Kao, W. H. Linda; Appel, Lawrence J.] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Xie, Dawei; Feldman, Harold I.; Anderson, Amanda H.; Tao, Kaixiang] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xie, Dawei; Feldman, Harold I.; Anderson, Amanda H.; Tao, Kaixiang] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Astor, Brad C.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Hsu, Chi-yuan] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Parekh, Rulan S.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Parekh, Rulan S.] Univ Hlth Network, Toronto, ON, Canada; [Kusek, John W.; Kopp, Jeffrey B.] NIDDK, NIH, Bethesda, MD 20892 USA; [Winkler, Cheryl A.] NCI, Ctr Canc Res, SAIC Frederick, Frederick, MD USA; [Greene, Tom H.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Wright, Jackson T., Jr.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [Lash, James P.] Univ Illinois, Coll Med, Chicago, IL USA; [Freedman, Barry I.] Wake Forest Sch Med, Winston Salem, NC USA; [Ojo, Akinlolu] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Raj, Dominic S.] George Washington Univ, Sch Med, Washington, DC USA; [Lipkowitz, Michael S.] Georgetown Univ, Sch Med, Washington, DC USA; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Hsu, Chi-yuan; Jensvold, Nancy G.] Kaiser Permanente No Calif, Oakland, CA USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Utah System of Higher Education; University of Utah; Case Western Reserve University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Wake Forest University; University of Michigan System; University of Michigan; George Washington University; Georgetown University; Tulane University; Kaiser Permanente	Appel, LJ (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-642, Baltimore, MD 21287 USA.	lappel@jhmi.edu	Kopp, Jeffrey B/O-2681-2015; Soliman, Elsayed Z/AAD-7135-2020; Li, Man/AAX-3400-2020; He, Jiang/AAF-5303-2020; Appel, Larry/GLT-2608-2022; Parekh, Rulan/AAQ-4411-2020	Kopp, Jeffrey B/0000-0001-9052-186X; Soliman, Elsayed Z/0000-0001-5632-8150; Li, Man/0000-0002-3839-0281; He, Jiang/0000-0002-8286-9652; Parekh, Rulan/0000-0001-6313-5752; Greene, Tom/0000-0002-3706-7570; Fink, Jeffrey/0000-0002-5622-5052	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CANCER INSTITUTE [ZIABC010022] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887, UL1RR024989, M01RR000080, P20RR011104, M01RR000071, UL1RR024131, M01RR016500, M01RR000827, K12RR023250, M01RR000052, UL1RR025005, UL1RR024134, UL1RR029879, P20RR011145, UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061028, U01DK060963, K24DK002818, ZIADK043308, U01DK060902, U01DK061021, U01DK061022, U01DK060984, U01DK060980, U01DK060990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson AH, 2012, AM J KIDNEY DIS, V60, P250, DOI 10.1053/j.ajkd.2012.04.012; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Appel LJ, 2003, J AM SOC NEPHROL, V14, pS166, DOI 10.1097/01.ASN.0000070081.15137.C0; Barbour SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2422, DOI 10.1093/ndt/gfq283; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Choi AI, 2009, AM J MED, V122, P672, DOI 10.1016/j.amjmed.2008.11.021; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Derose SF, 2013, AM J KIDNEY DIS, V62, P236, DOI 10.1053/j.ajkd.2013.01.019; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Fischer MJ, 2011, AM J KIDNEY DIS, V58, P214, DOI 10.1053/j.ajkd.2011.05.010; Foster MC, 2013, J AM SOC NEPHROL, V24, P1484, DOI 10.1681/ASN.2013010113; Freedman BI, 2010, J AM SOC NEPHROL, V21, P1422, DOI 10.1681/ASN.2010070730; Freedman BI, 2009, NEPHROL DIAL TRANSPL, V24, P3366, DOI 10.1093/ndt/gfp316; Friedman DJ, 2011, J AM SOC NEPHROL, V22, P2098, DOI 10.1681/ASN.2011050519; Genovese G, 2013, NAT REV NEPHROL, V9, P240, DOI 10.1038/nrneph.2013.34; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; Hall YN, 2005, KIDNEY INT, V68, P2310, DOI 10.1111/j.1523-1755.2005.00691.x; Hsu CY, 2003, J AM SOC NEPHROL, V14, P2902, DOI 10.1097/01.ASN.0000091586.46532.B4; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Lash, 2011, CLIN J AM SOC NEPHRO, V6, P2548; Lash JP, 2009, CLIN J AM SOC NEPHRO, V4, P1302, DOI 10.2215/CJN.00070109; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Lipkowitz MS, 2013, KIDNEY INT, V83, P114, DOI 10.1038/ki.2012.263; Lipworth L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048407; Madhavan SM, 2011, J AM SOC NEPHROL, V22, P2119, DOI 10.1681/ASN.2011010069; Matsha TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052529; MCCLELLAN W, 1988, AM J KIDNEY DIS, V12, P285, DOI 10.1016/S0272-6386(88)80221-X; McClellan W, 2006, J AM SOC NEPHROL, V17, P1710, DOI 10.1681/ASN.2005111200; Pays E, 2009, CURR OPIN IMMUNOL, V21, P493, DOI 10.1016/j.coi.2009.05.024; Peralta CA, 2013, AM J KIDNEY DIS, V62, P261, DOI 10.1053/j.ajkd.2013.01.012; Pollak MR, 2012, CURR OPIN NEPHROL HY, V21, P179, DOI 10.1097/MNH.0b013e32835012ab; Reeves-Daniel AM, 2011, AM J TRANSPLANT, V11, P1025, DOI 10.1111/j.1600-6143.2011.03513.x; Sika M, 2007, AM J KIDNEY DIS, V50, P78, DOI 10.1053/j.ajkd.2007.03.004; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; WALKER WG, 1992, JAMA-J AM MED ASSOC, V268, P3085, DOI 10.1001/jama.268.21.3085; Wright JT, 2006, JAMA-J AM MED ASSOC, V295, P2726	42	505	515	12	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2183	2196		10.1056/NEJMoa1310345	http://dx.doi.org/10.1056/NEJMoa1310345			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263II	24206458	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000327801100005
J	Fustin, JM; Doi, M; Yamaguchi, Y; Hida, H; Nishimura, S; Yoshida, M; Isagawa, T; Morioka, MS; Kakeya, H; Manabe, I; Okamura, H				Fustin, Jean-Michel; Doi, Masao; Yamaguchi, Yoshiaki; Hida, Hayashi; Nishimura, Shinichi; Yoshida, Minoru; Isagawa, Takayuki; Morioka, Masaki Suimye; Kakeya, Hideaki; Manabe, Ichiro; Okamura, Hitoshi			RNA-Methylation-Dependent RNA Processing Controls the Speed of the Circadian Clock	CELL			English	Article							PRE-MESSENGER-RNA; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; S-ADENOSYLHOMOCYSTEINE; TRANSCRIPTION; OSCILLATION; MECHANISM; LIVER; ABUNDANCE	The eukaryotic biological clock involves a negative transcription-translation feedback loop in which clock genes regulate their own transcription and that of output genes of metabolic significance. While around 10% of the liver transcriptome is rhythmic, only about a fifth is driven by de novo transcription, indicating mRNA processing is a major circadian component. Here, we report that inhibition of transmethylation reactions elongates the circadian period. RNA sequencing then reveals methylation inhibition causes widespread changes in the transcription of the RNA processing machinery, associated with m(6)A-RNA methylation. We identify m(6)A sites on many clock gene transcripts and show that specific inhibition of m(6)A methylation by silencing of the m(6)A methylase Mettl3 is sufficient to elicit circadian period elongation and RNA processing delay. Analysis of the circadian nucleocytoplasmic distribution of clock genes Per2 and Arntl then revealed an uncoupling between steady-state pre-mRNA and cytoplasmic mRNA rhythms when m(6)A methylation is inhibited.	[Fustin, Jean-Michel; Doi, Masao; Yamaguchi, Yoshiaki; Hida, Hayashi; Okamura, Hitoshi] Kyoto Univ, Dept Syst Biol, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Nishimura, Shinichi; Kakeya, Hideaki] Kyoto Univ, Dept Syst Chemotherapy & Mol Sci, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Yoshida, Minoru] RIKEN, Chem Genet Lab, Wako, Saitama 3510198, Japan; [Isagawa, Takayuki; Morioka, Masaki Suimye; Manabe, Ichiro] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan	Kyoto University; Kyoto University; RIKEN; University of Tokyo	Okamura, H (corresponding author), Kyoto Univ, Dept Syst Biol, Grad Sch Pharmaceut Sci, Sakyo Ku, 46-29 Yoshida Shimo Adachi Cho, Kyoto 6068501, Japan.	okamurah@pharm.kyoto-u.ac.jp	Nishimura, Shinichi/AGE-1316-2022; Yamaguchi, Yoshiaki/K-9418-2013; Yoshida, Minoru/C-8049-2014; Manabe, Ichiro/E-1529-2014; Doi, Masao/J-9267-2019; Manabe, Ichiro/AAE-5105-2021; Fustin, Jean-Michel/R-6621-2019; Kakeya, Hideaki/B-3527-2012	Nishimura, Shinichi/0000-0002-5998-3780; Yamaguchi, Yoshiaki/0000-0003-4126-542X; Yoshida, Minoru/0000-0002-4376-5674; Doi, Masao/0000-0001-6264-9217; Fustin, Jean-Michel/0000-0002-6200-6075; Okamura, Hitoshi/0000-0002-3013-4881; Kakeya, Hideaki/0000-0002-4293-7331	Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS [24111526, 24240058, 25560426, 23390203]; SRF; Takeda Science Foundation; Grants-in-Aid for Scientific Research [21228003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SRF; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Satchin Panda from the Salk Institute for the kind gift of U2OS Arntl-luc cells. This work was supported by Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; by grants from JSPS (24111526, 24240058, and 25560426), SRF, and the Takeda Science Foundation (to H.O.). This work was also supported by the Funding Program for Next Generation World-Leading Researchers (NEXT program) from the JSPS (to M. D.) and by Grants-in-Aid for Scientific Research from the JSPS (23390203) (to I.M).	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BACKLUND PS, 1986, EUR J BIOCHEM, V160, P245, DOI 10.1111/j.1432-1033.1986.tb09963.x; Carmel R., 2001, HOMOCYSTEINE HLTH DI; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Cole MD, 2009, ONCOGENE, V28, P1169, DOI 10.1038/onc.2008.463; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Doi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1316; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fernandez-Sanchez ME, 2009, MOL CELL BIOL, V29, P6182, DOI 10.1128/MCB.00973-09; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Miyazaki K, 2007, GENES CELLS, V12, P1225, DOI 10.1111/j.1365-2443.2007.01129.x; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ripperger JA, 2011, FEBS LETT, V585, P1406, DOI 10.1016/j.febslet.2011.04.047; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; ROSBASH M, 1995, CURR OPIN GENET DEV, V5, P662, DOI 10.1016/0959-437X(95)80037-9; SCHALINSKE KL, 1992, BIOFACTORS, V3, P265; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valekunja UK, 2013, P NATL ACAD SCI USA, V110, P1554, DOI 10.1073/pnas.1214168110; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Wilkins AK, 2007, PLOS COMPUT BIOL, V3, P2476, DOI 10.1371/journal.pcbi.0030242; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	39	621	642	5	134	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					793	806		10.1016/j.cell.2013.10.026	http://dx.doi.org/10.1016/j.cell.2013.10.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209618	Bronze			2022-12-24	WOS:000326934300010
J	Wan, J; Wang, SW; Haynes, K; Denburg, MR; Shin, DB; Gelfand, JM				Wan, Joy; Wang, Shuwei; Haynes, Kevin; Denburg, Michelle R.; Shin, Daniel B.; Gelfand, Joel M.			Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPROVEMENT NETWORK THIN; IGA NEPHROPATHY; MYOCARDIAL-INFARCTION; RENAL IMPAIRMENT; PREVALENCE; INVOLVEMENT; VALIDATION; MORTALITY; CONSENSUS; VALIDITY	Objective To determine the risk of chronic kidney disease in patients with psoriasis. Design Population based cohort study and nested cross sectional study. Setting Electronic medical records database based in United Kingdom. Participants Cohort study: patients with psoriasis aged 18-90 each matched to up to five patients without psoriasis based on age, practice, and time of visit. Nested study: patients with psoriasis aged 25-64 with confirmed data on psoriasis severity, each matched to up to 10 patients without psoriasis based on age and practice. Main outcome measures Cohort study: incident moderate to advanced (stage 3 through 5) chronic kidney disease. Nested study: baseline prevalence of chronic kidney disease. Results 136 529 patients with mild psoriasis and 7354 patients with severe psoriasis based on treatment patterns were matched to 689 702 unaffected patients. The adjusted hazard ratios (95% confidence intervals) for incident chronic kidney disease were 1.05 (1.02 to 1.07), 0.99 (0.97 to 1.02), and 1.93 (1.79 to 2.08) in the overall, mild, and severe psoriasis groups, respectively. Age was a significant effect modifier in the severe psoriasis group, with age specific adjusted hazard ratios (95% confidence intervals) of 3.82 (3.15 to 4.64) and 2.00 (1.86 to 2.17) for patients aged 30 and 60, respectively. In the nested analysis of 8731 patients with psoriasis with measurements of affected body surface area matched to 87 310 patients without psoriasis, the adjusted odds ratios (95% confidence intervals) for chronic kidney disease were 0.89 (0.72 to 1.10), 1.36 (1.06 to 1.74), and 1.58 (1.07 to 2.34) in the mild, moderate, and severe psoriasis groups, respectively. Conclusions Moderate to severe psoriasis is associated with an increased risk of chronic kidney disease independent of traditional risk factors.	[Wan, Joy; Wang, Shuwei; Shin, Daniel B.; Gelfand, Joel M.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Haynes, Kevin; Shin, Daniel B.; Gelfand, Joel M.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Denburg, Michelle R.] Childrens Hosp Philadelphia, Dept Nephrol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Gelfand, JM (corresponding author), Univ Penn, Dept Dermatol, 1471 Penn Tower,1 Convent Ave, Philadelphia, PA 19104 USA.	joel.gelfand@uphs.upenn.edu		Gelfand, Joel/0000-0003-3480-2661	National Institute of Arthritis and Musculoskeletal and Skin Diseases [K24AR064310, T32-AR07465]; National Heart, Lung, and Blood Institute [R01-HL089744]; National Institute of Diabetes and Digestive and Kidney Diseases [K23-DK093556, T35-DK060441, UL1TR000003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR064310, T32AR007465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK093556, T35DK060441] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases K24AR064310 (JMG) and training grant T32-AR07465 (SW), the National Heart, Lung, and Blood Institute R01-HL089744 (JMG), and the National Institute of Diabetes and Digestive and Kidney Diseases K23-DK093556 (MRD) and training grant T35-DK060441 (JW) and UL1TR000003 (KH). Funding sources had no role in the study, and researchers were independent from funders.	Abuabara K, 2010, BRIT J DERMATOL, V163, P586, DOI 10.1111/j.1365-2133.2010.09941.x; Ahuja TS, 1998, AM J NEPHROL, V18, P425, DOI 10.1159/000013388; [Anonymous], 2006, PSOR PSOR ARTHR POCK; Archibald G, 2007, NEPHROL DIAL TRANSPL, V22, P2455, DOI 10.1093/ndt/gfm268; Azfar RS, 2012, ARCH DERMATOL, V148, P995, DOI 10.1001/archdermatol.2012.1401; Booth N, 1994, Health Libr Rev, V11, P177; Brauchli YB, 2009, BRIT J DERMATOL, V160, P1048, DOI 10.1111/j.1365-2133.2008.09020.x; Bruce IN, 2000, JCR-J CLIN RHEUMATOL, V6, P6, DOI 10.1097/00124743-200002000-00001; Cassano N, 2011, EUR J DERMATOL, V21, P264, DOI 10.1684/ejd.2011.1274; CECCHI R, 1992, DERMATOLOGY, V185, P93, DOI 10.1159/000247420; Denburg MR, 2010, PHARMACOEPIDEM DR S, V19, pS105; Dervisoglu E, 2012, INT UROL NEPHROL, V44, P509, DOI 10.1007/s11255-011-9966-1; Dommasch ED, 2010, BRIT J DERMATOL, V162, P835, DOI 10.1111/j.1365-2133.2009.09589.x; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; IMAI H, 1995, CLIN NEPHROL, V44, P64; Kaftan O, 1996, DERMATOLOGY, V192, P189, DOI 10.1159/000246358; KAJI T, 1994, CLIN NEPHROL, V42, P63; Kim MK, 1998, CLIN EXP DERMATOL, V23, P295; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; Kurd SK, 2009, J AM ACAD DERMATOL, V60, P218, DOI 10.1016/j.jaad.2008.09.022; Langan SM, 2012, J INVEST DERMATOL, V132, P556, DOI 10.1038/jid.2011.365; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; MADEDDU P, 1988, NEPHRON, V48, P222, DOI 10.1159/000184916; Mehta NN, 2010, EUR HEART J, V31, P1000, DOI 10.1093/eurheartj/ehp567; Moynihan R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4298; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Office for National Statistics, 2011, OFF NAT STAT STAT B; Pearce DJ, 2005, J DERMATOL TREAT, V16, P319, DOI 10.1080/09546630500335977; Perazella MA, 2010, SEMIN NEPHROL, V30, P570, DOI 10.1016/j.semnephrol.2010.09.005; Seminara NM, 2011, BRIT J DERMATOL, V164, P602, DOI 10.1111/j.1365-2133.2010.10134.x; Singh NP, 2005, RENAL FAILURE, V27, P123, DOI 10.1081/JDI-200042811; Sirolli V, 2000, NEPHRON, V86, P89, DOI 10.1159/000045718; Smith CH, 2005, BRIT J DERMATOL, V153, P486, DOI 10.1111/j.1365-2133.2005.06893.x; Szepietowski JC, 2000, J EUR ACAD DERMATOL, V14, P513, DOI 10.1046/j.1468-3083.2000.00119.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Widemann BC, 2006, ONCOLOGIST, V11, P694, DOI 10.1634/theoncologist.11-6-694; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Yang YW, 2011, BRIT J DERMATOL, V165, P1037, DOI 10.1111/j.1365-2133.2011.10494.x; Yeung H, 2013, JAMA DERMATOL, V149, P1173, DOI 10.1001/jamadermatol.2013.5015; Zadrazil J, 2006, J NEPHROL, V19, P382	42	117	119	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 15	2013	347								f5961	10.1136/bmj.f5961	http://dx.doi.org/10.1136/bmj.f5961			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238WK	24129480	hybrid, Green Published			2022-12-24	WOS:000325982200009
J	Hsiao, EY; McBride, SW; Hsien, S; Sharon, G; Hyde, ER; McCue, T; Codelli, JA; Chow, J; Reisman, SE; Petrosino, JF; Patterson, PH; Mazmanian, SK				Hsiao, Elaine Y.; McBride, Sara W.; Hsien, Sophia; Sharon, Gil; Hyde, Embriette R.; McCue, Tyler; Codelli, Julian A.; Chow, Janet; Reisman, Sarah E.; Petrosino, Joseph F.; Patterson, Paul H.; Mazmanian, Sarkis K.			Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders	CELL			English	Article							GASTROINTESTINAL DYSFUNCTION; SPECTRUM DISORDERS; GUT MICROBIOTA; AUTISM; CHILDREN; BRAIN; MOUSE; ACTIVATION; MICROFLORA; PREGNANCY	Neurodevelopmental disorders, including autism spectrum disorder (ASD), are defined by core behavioral impairments; however, subsets of individuals display a spectrum of gastrointestinal (GI) abnormalities. We demonstrate GI barrier defects and microbiota alterations in the maternal immune activation (MIA) mouse model that is known to display features of ASD. Oral treatment of MIA offspring with the human commensal Bacteroides fragilis corrects gut permeability, alters microbial composition, and ameliorates defects in communicative, stereotypic, anxiety-like and sensorimotor behaviors. MIA offspring display an altered serum metabolomic profile, and B. fragilis modulates levels of several metabolites. Treating naive mice with a metabolite that is increased by MIA and restored by B. fragilis causes certain behavioral abnormalities, suggesting that gut bacterial effects on the host metabolome impact behavior. Taken together, these findings support a gut-microbiome-brain connection in a mouse model of ASD and identify a potential probiotic therapy for GI and particular behavioral symptoms in human neurodevelopmental disorders.	[Hsiao, Elaine Y.; McBride, Sara W.; Hsien, Sophia; Sharon, Gil; Chow, Janet; Patterson, Paul H.; Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Hsiao, Elaine Y.; Codelli, Julian A.; Reisman, Sarah E.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Hyde, Embriette R.; McCue, Tyler; Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagenom & Microbiome Res, Houston, TX 77030 USA	California Institute of Technology; California Institute of Technology; Baylor College of Medicine	Hsiao, EY (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	ehsiao@caltech.edu; php@caltech.edu; sarkis@caltech.edu	Petrosino, Joseph F./AAF-1621-2019; Mazmanian, Sarkis/ABD-7729-2021	Mazmanian, Sarkis/0000-0003-2713-1513; Hsien, Sophia/0000-0002-1662-9378; Sharon, Gil/0000-0002-4605-9943	Caltech Innovation Fellowship; Autism Speaks Weatherstone Fellowship; NIH/NRSA Predoctoral Fellowship; Human Frontiers Science Program Fellowship; DOD Graduate Fellowship; NSF Graduate Research Fellowship; Autism Speaks Trailblazer Award; Caltech Innovation Initiative; Caltech Grubstake Awards; Congressionally Directed Medical Research Award; Weston Havens Award; Callie D. McGrath Charitable Foundation; NIMH [MH100556]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100556] Funding Source: NIH RePORTER	Caltech Innovation Fellowship; Autism Speaks Weatherstone Fellowship; NIH/NRSA Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program Fellowship(Human Frontier Science Program); DOD Graduate Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Autism Speaks Trailblazer Award; Caltech Innovation Initiative; Caltech Grubstake Awards; Congressionally Directed Medical Research Award; Weston Havens Award; Callie D. McGrath Charitable Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge Reyna Sauza, Jaime Rodriguez, and Taren Thron for caring for the animals; Dr. Michael Fischbach (UCSF) for advising on pathways of 4EPS and indolepyruvate synthesis; Dr. Nadim Ajami (Baylor) for providing helpful comments on the manuscript; Greg Donaldson (Caltech) for conducting experiments on microbial viability; Dr. Kym Faull (UCLA) for conducting pilot GC/MS experiments; Dr. Alessio Fasano (Massachusetts General) for conducting pilot microbiota sequencing experiments; and Dr. Jerrold Turner (U Chicago) for providing histological analysis of intestinal sections. This work was supported by a Caltech Innovation Fellowship (to E.Y.H.), Autism Speaks Weatherstone Fellowship (to E.Y.H.), NIH/NRSA Predoctoral Fellowship (to E.Y.H.), Human Frontiers Science Program Fellowship (to G. S.), DOD Graduate Fellowship (to J.A.C.), NSF Graduate Research Fellowship (to J.A.C.), Autism Speaks Trailblazer Award (to P. H. P. and S. K. M.), Caltech Innovation Initiative (to P. H. P. and S. K. M.), Caltech Grubstake Awards (to P. H. P. and S. K. M), Congressionally Directed Medical Research Award (to P. H. P. and S. K. M.), Weston Havens Award (to P. H. P. and S. K. M.), Callie D. McGrath Charitable Foundation awards (to P. H. P.) and NIMH grant MH100556 (to P. H. P. and S.K.M.).	Abdallah MW, 2013, WORLD J BIOL PSYCHIA, V14, P528, DOI 10.3109/15622975.2011.639803; Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; Altieri L, 2011, BIOMARKERS, V16, P252, DOI 10.3109/1354750X.2010.548010; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral FA, 2008, P NATL ACAD SCI USA, V105, P2193, DOI 10.1073/pnas.0711891105; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Atladottir HO, 2009, PEDIATRICS, V124, P687, DOI 10.1542/peds.2008-2445; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Bauman MD, 2014, BIOL PSYCHIAT, V75, P332, DOI 10.1016/j.biopsych.2013.06.025; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; Blumberg R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004184; Boukthir Samir, 2010, Tunis Med, V88, P685; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brown AS, 2014, MOL PSYCHIATR, V19, P259, DOI 10.1038/mp.2012.197; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Bull G, 2003, MED SCI MONITOR, V9, P422; Campanozzi A, 2007, BRAIN DEV-JPN, V29, P25, DOI 10.1016/j.braindev.2006.05.008; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Comi AM, 1999, J CHILD NEUROL, V14, P388, DOI 10.1177/088307389901400608; Coury DL, 2012, PEDIATRICS, V130, pS160, DOI 10.1542/peds.2012-0900N; Croen LA, 2008, BIOL PSYCHIAT, V64, P583, DOI 10.1016/j.biopsych.2008.05.006; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; de Magistris L, 2010, J PEDIATR GASTR NUTR, V51, P418, DOI 10.1097/MPG.0b013e3181dcc4a5; Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Finegold SM, 2012, ANAEROBE, V18, P260, DOI 10.1016/j.anaerobe.2011.12.018; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Gondalia SV, 2012, AUTISM RES, V5, P419, DOI 10.1002/aur.1253; Gorrindo P, 2012, AUTISM RES, V5, P101, DOI 10.1002/aur.237; Graff LA, 2009, INFLAMM BOWEL DIS, V15, P1105, DOI 10.1002/ibd.20873; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Ibrahim SH, 2009, PEDIATRICS, V124, P680, DOI 10.1542/peds.2008-2933; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Keszthelyi D, 2009, NEUROGASTROENT MOTIL, V21, P1239, DOI 10.1111/j.1365-2982.2009.01370.x; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Lafaye A, 2004, J MASS SPECTROM, V39, P655, DOI 10.1002/jms.635; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006354; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Motil KJ, 2012, J PEDIATR GASTR NUTR, V55, P292, DOI 10.1097/MPG.0b013e31824b6159; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Persico AM, 2013, NEUROTOXICOL TERATOL, V36, P82, DOI 10.1016/j.ntt.2012.09.002; Rao A. Ravishankar, 2009, P1; Robertson MA, 2008, J AUTISM DEV DISORD, V38, P1066, DOI 10.1007/s10803-007-0482-1; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Shi LM, 2009, BRAIN BEHAV IMMUN, V23, P116, DOI 10.1016/j.bbi.2008.07.012; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Smith EA, 1997, MICROBIAL ECOL, V33, P180, DOI 10.1007/s002489900020; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Tillisch K, 2013, GASTROENTEROLOGY, V144, P1394, DOI 10.1053/j.gastro.2013.02.043; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585	65	1879	2030	40	725	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 19	2013	155	7					1451	1463		10.1016/j.cell.2013.11.024	http://dx.doi.org/10.1016/j.cell.2013.11.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	275QW	24315484	Green Accepted, Bronze			2022-12-24	WOS:000328693300004
J	Corbett-Detig, RB; Zhou, J; Clark, AG; Hartl, DL; Ayroles, JF				Corbett-Detig, Russell B.; Zhou, Jun; Clark, Andrew G.; Hartl, Daniel L.; Ayroles, Julien F.			Genetic incompatibilities are widespread within species	NATURE			English	Article							HYBRID MALE-STERILITY; DOBZHANSKY-MULLER INCOMPATIBILITIES; SYNTHETIC POPULATION RESOURCE; DROSOPHILA-MELANOGASTER; COMPLEX TRAIT; EPISTASIS; EVOLUTION; GENOME; DISSECTION; DISCOVERY	The importance of epistasis-non-additive interactions between alleles-in shaping population fitness has long been a controversial topic, hampered in part by lack of empirical evidence(1-4). Traditionally, epistasis is inferred on the basis of non-independence of genotypic values between loci for a given trait. However, epistasis for fitness should also have a genomic footprint(5-7). To capture this signal, we have developed a simple approach that relies on detecting genotype ratio distortion as a sign of epistasis, and we apply this method to a large panel of Drosophila melanogaster recombinant inbred lines(8,9). Here we confirm experimentally that instances of genotype ratio distortion represent loci with epistatic fitness effects; we conservatively estimate that any two haploid genomes in this study are expected to harbour 1.15 pairs of epistatically interacting alleles. This observation has important implications for speciation genetics, as it indicates that the raw material to drive reproductive isolation is segregating contemporaneously within species and does not necessarily require, as proposed by the Dobzhansky-Muller model, the emergence of incompatible mutations independently derived and fixed in allopatry. The relevance of our result extends beyond speciation, as it demonstrates that epistasis is widespread but that it may often go undetected owing to lack of statistical power or lack of genome-wide scope of the experiments.	[Corbett-Detig, Russell B.; Zhou, Jun; Hartl, Daniel L.; Ayroles, Julien F.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Clark, Andrew G.; Ayroles, Julien F.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Ayroles, Julien F.] Harvard Univ, Harvard Soc Fellows, Cambridge, MA 02138 USA	Harvard University; Cornell University; Cornell University; Harvard University	Ayroles, JF (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	ayroles@fas.harvard.edu	Corbett-Detig, Russ/Y-9659-2019	Clark, Andrew/0000-0001-7159-8511	NIH [GM065169, GM084236, HD059060]; Harvard Society; Harvard Milton Funds; Harvard Prize Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084236, R01GM065169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Society; Harvard Milton Funds; Harvard Prize Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to T. Long, S. Macdonald and E. King for creating the DSPR and sharing the RILs and founder strains with us. We thank C. Jones, B. de Bivort, T. Sackton, S. D. Kocher, J. Grenier and N.E. Soltis for comments and discussions. We thank X. Shi for technical assistance. This work was supported by grants: NIH GM065169 and GM084236 to D. L. H., HD059060 to A. G. C., and Harvard Society of Fellows Fellowship and Harvard Milton Funds to J. F. A. R.B.C.-D. was supported by a Harvard Prize Fellowship.	Ackermann M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002463; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; CHEVERUD JM, 1995, GENETICS, V139, P1455; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Coyne JA, 2004, SPECIATION, V37; Cutter AD, 2012, TRENDS ECOL EVOL, V27, P209, DOI 10.1016/j.tree.2011.11.004; Demuth JP, 2005, AM NAT, V165, P524, DOI 10.1086/429276; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobzhansky T., 1937; Dockendorff TC, 2000, MOL GEN GENET, V263, P137, DOI 10.1007/s004380050040; Fitzpatrick BM, 2008, AM NAT, V171, P491, DOI 10.1086/528991; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Kasai S, 2003, BIOCHEM BIOPH RES CO, V300, P894, DOI 10.1016/S0006-291X(02)02950-9; King EG, 2012, GENOME RES, V22, P1558, DOI 10.1101/gr.134031.111; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; Orr HA, 2001, EVOLUTION, V55, P1085; PALOPOLI MF, 1994, GENETICS, V138, P329; Payseur BA, 2005, GENETICS, V171, P1905, DOI 10.1534/genetics.105.046193; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Presgraves DC, 2007, MOL BIOL EVOL, V24, P306, DOI 10.1093/molbev/msl157; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Reed LK, 2004, P NATL ACAD SCI USA, V101, P9009, DOI 10.1073/pnas.0403106101; Tao Y, 2003, GENETICS, V164, P1383; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	37	126	128	0	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					135	+		10.1038/nature12678	http://dx.doi.org/10.1038/nature12678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24196712	Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000327851700046
J	Liao, MF; Cao, EH; Julius, D; Cheng, YF				Liao, Maofu; Cao, Erhu; Julius, David; Cheng, Yifan			Structure of the TRPV1 ion channel determined by electron cryo-microscopy	NATURE			English	Article							HIGH-LEVEL EXPRESSION; CRYSTAL-STRUCTURE; VOLTAGE; PORE; RECEPTOR; VISUALIZATION; SELECTIVITY; MUTATIONS; REVEALS; SYSTEM	Transient receptor potential (TRP) channels are sensors for a wide range of cellular and environmental signals, but elucidating how these channels respond to physical and chemical stimuli has been hampered by a lack of detailed structural information. Here we exploit advances in electron cryo-microscopy to determine the structure of a mammalian TRP channel, TRPV1, at 3.4 angstrom resolution, breaking the side-chain resolution barrier for membrane proteins without crystallization. Like voltage-gated channels, TRPV1 exhibits four-fold symmetry around a central ion pathway formed by transmembrane segments 5-6 (S5-S6) and the intervening pore loop, which is flanked by S1-S4 voltage-sensor-like domains. TRPV1 has a wide extracellular 'mouth' with a short selectivity filter. The conserved 'TRP domain' interacts with the S4-S5 linker, consistent with its contribution to allosteric modulation. Subunit organization is facilitated by interactions among cytoplasmic domains, including amino-terminal ankyrin repeats. These observations provide a structural blueprint for understanding unique aspects of TRP channel function.	[Liao, Maofu; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, Keck Adv Microscopy Lab, San Francisco, CA 94158 USA; [Cao, Erhu; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	david.julius@ucsf.edu; ycheng@ucsf.edu	Liao, Maofu/AAD-7333-2021	Liao, Maofu/0000-0002-3481-450X; Cheng, Yifan/0000-0001-9535-0369	National Institutes of Health [R01GM098672, S10RR026814, R01NS065071, R01NS047723]; National Science Foundation [DBI-0960271]; University of California, San Francisco Program for Breakthrough Biomedical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047723, R01NS065071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); University of California, San Francisco Program for Breakthrough Biomedical Research(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank X. Li for assistance with data acquisition using TF30 Polara and K2 Summit camera, S. Zhou and D. King for help with protein microsequencing and J.P Armache, C. Bohlen, J. Cordero-Morales and J. Osteen for discussion and reading of the manuscript. This work was supported by grants from the National Institutes of Health (R01GM098672 and S10RR026814 to Y.C. and R01NS065071 and R01NS047723 to D. J.), the National Science Foundation (DBI-0960271 to D. Agard and Y.C.) and the University of California, San Francisco Program for Breakthrough Biomedical Research (Y.C.). E. C. was a fellow of the Damon Runyon Cancer Research Foundation.	Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Booth DS, 2011, JOVE-J VIS EXP, DOI 10.3791/3227; Boukalova S, 2013, BBA-MOL CELL RES, V1833, P520, DOI 10.1016/j.bbamcr.2012.11.017; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Inada H, 2012, BIOCHEMISTRY-US, V51, P6195, DOI 10.1021/bi300279b; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Loukin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019533; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popot JL, 2011, ANNU REV BIOPHYS, V40, P379, DOI 10.1146/annurev-biophys-042910-155219; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Salazar H, 2009, NAT STRUCT MOL BIOL, V16, P704, DOI 10.1038/nsmb.1633; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Susankova K, 2007, J NEUROSCI, V27, P7578, DOI 10.1523/JNEUROSCI.1956-07.2007; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2004, J BIOL CHEM, V279, P15223, DOI 10.1074/jbc.M312076200; Yao J, 2010, BIOPHYS J, V99, P1743, DOI 10.1016/j.bpj.2010.07.022; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	55	1106	1158	43	588	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					107	+		10.1038/nature12822	http://dx.doi.org/10.1038/nature12822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305160	Bronze, Green Submitted, Green Accepted			2022-12-24	WOS:000327851700040
J	Ge, XY; Li, JL; Yang, XL; Chmura, AA; Zhu, GJ; Epstein, JH; Mazet, JK; Hu, B; Zhang, W; Peng, C; Zhang, YJ; Luo, CM; Tan, B; Wang, N; Zhu, Y; Crameri, G; Zhang, SY; Wang, LF; Daszak, P; Shi, ZL				Ge, Xing-Yi; Li, Jia-Lu; Yang, Xing-Lou; Chmura, Aleksei A.; Zhu, Guangjian; Epstein, Jonathan H.; Mazet, Jonna K.; Hu, Ben; Zhang, Wei; Peng, Cheng; Zhang, Yu-Ji; Luo, Chu-Ming; Tan, Bing; Wang, Ning; Zhu, Yan; Crameri, Gary; Zhang, Shu-Yi; Wang, Lin-Fa; Daszak, Peter; Shi, Zheng-Li			Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor	NATURE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; FUNCTIONAL RECEPTOR; ADAPTATION; DIVERSITY; ORIGIN	The 2002-3 pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV) was one of the most significant public health events in recent history(1). An ongoing outbreak of Middle East respiratory syndrome coronavirus(2) suggests that this group of viruses remains a key threat and that their distribution is wider than previously recognized. Although bats have been suggested to be the natural reservoirs of both viruses(3-5), attempts to isolate the progenitor virus of SARS-CoV from bats have been unsuccessful. Diverse SARS-like coronaviruses (SL-CoVs) have now been reported from bats in China, Europe and Africa(5-8), but none is considered a direct progenitor of SARS-CoV because of their phylogenetic disparity from this virus and the inability of their spike proteins to use the SARS-CoV cellular receptor molecule, the human angiotensin converting enzyme II (ACE2)(9,10). Here we report whole-genome sequences of two novel bat coronaviruses from Chinese horseshoe bats (family: Rhinolophidae) in Yunnan, China: RsSHC014 and Rs3367. These viruses are far more closely related to SARS-CoV than any previously identified bat coronaviruses, particularly in the receptor binding domain of the spike protein. Most importantly, we report the first recorded isolation of a live SL-CoV (bat SL-CoV-WIV1) from bat faecal samples in Vero E6 cells, which has typical coronavirus morphology, 99.9% sequence identity to Rs3367 and uses ACE2 from humans, civets and Chinese horseshoe bats for cell entry. Preliminary in vitro testing indicates that WIV1 also has a broad species tropism. Our results provide the strongest evidence to date that Chinese horseshoe bats are natural reservoirs of SARS-CoV, and that intermediate hosts may not be necessary for direct human infection by some bat SL-CoVs. They also highlight the importance of pathogen-discovery programs targeting high-risk wildlife groups in emerging disease hotspots as a strategy for pandemic preparedness.	[Ge, Xing-Yi; Li, Jia-Lu; Yang, Xing-Lou; Hu, Ben; Zhang, Wei; Peng, Cheng; Zhang, Yu-Ji; Luo, Chu-Ming; Tan, Bing; Wang, Ning; Zhu, Yan; Shi, Zheng-Li] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Ctr Emerging Infect Dis, Wuhan 430071, Peoples R China; [Chmura, Aleksei A.; Zhu, Guangjian; Epstein, Jonathan H.; Daszak, Peter] EcoHlth Alliance, New York, NY 10001 USA; [Mazet, Jonna K.] Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA; [Crameri, Gary; Wang, Lin-Fa] CSIRO Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; [Zhang, Shu-Yi] E China Normal Univ, Coll Life Sci, Shanghai 200062, Peoples R China; [Wang, Lin-Fa] Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore 169857, Singapore	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; EcoHealth Alliance; University of California System; University of California Davis; Commonwealth Scientific & Industrial Research Organisation (CSIRO); East China Normal University; National University of Singapore	Daszak, P (corresponding author), EcoHlth Alliance, New York, NY 10001 USA.	daszak@ecohealthalliance.org; zlshi@wh.iov.cn	wang, lin/GSE-3040-2022; yang, xinglou/AAW-6969-2020; Shi, Zhengli/A-1013-2013; Chmura, Aleksei/K-9971-2018; daszak, peter/U-4588-2017; Crameri, Gary/H-8441-2013	Shi, Zhengli/0000-0001-8089-163X; Chmura, Aleksei/0000-0001-5544-0431; daszak, peter/0000-0002-2046-5695; Li, Jialu/0000-0001-9772-3886; Li, Jialu/0000-0002-6411-6876; Yang, Xing-Lou/0000-0002-5317-8983; Wang, Lin-Fa/0000-0003-2752-0535	State Key Program for Basic Research [2011CB504701, 2010CB530100]; National Natural Science Foundation of China [81290341, 31321001]; Scientific and technological basis special project [2013FY113500]; CSIRO OCE Science Leaders Award; National Institute of Allergy and Infectious Diseases (NIAID) [R01AI079231]; National Institutes of Health (NIH)/National Science Foundation (NSF) 'Ecology and Evolution of Infectious Diseases' award from the NIH Fogarty International Center [R01TW005869]; NIH Fogarty International Center; Office of the Secretary of the Department of Health and Human Services [R56TW009502]; United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT; FOGARTY INTERNATIONAL CENTER [R56TW009502, R01TW005869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079231, R01AI110964] Funding Source: NIH RePORTER	State Key Program for Basic Research(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and technological basis special project; CSIRO OCE Science Leaders Award; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)/National Science Foundation (NSF) 'Ecology and Evolution of Infectious Diseases' award from the NIH Fogarty International Center(National Science Foundation (NSF)); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of the Secretary of the Department of Health and Human Services; United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT(United States Agency for International Development (USAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge financial support from the State Key Program for Basic Research (2011CB504701 and 2010CB530100), National Natural Science Foundation of China (81290341 and 31321001), Scientific and technological basis special project (2013FY113500), CSIRO OCE Science Leaders Award, National Institute of Allergy and Infectious Diseases (NIAID) award number R01AI079231, a National Institutes of Health (NIH)/National Science Foundation (NSF) 'Ecology and Evolution of Infectious Diseases' award from the NIH Fogarty International Center (R01TW005869), an award from the NIH Fogarty International Center supported by International Influenza Funds from the Office of the Secretary of the Department of Health and Human Services (R56TW009502), and United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT. The contents are the responsibility of the authors and do not necessarily reflect the views of NIAID, NIH, NSF, USAID or the United States Government. We thank X. Che from Zhujiang Hospital, Southern Medical University, for providing human SARS patient sera.	Anthony SJ, 2013, J GEN VIROL, V94, P1028, DOI 10.1099/vir.0.049759-0; Becker MM, 2008, P NATL ACAD SCI USA, V105, P19944, DOI 10.1073/pnas.0808116105; Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Cui J, 2007, EMERG INFECT DIS, V13, P1526, DOI 10.3201/eid1310.070448; Luna LKD, 2007, J CLIN MICROBIOL, V45, P1049, DOI 10.1128/JCM.02426-06; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Hon CC, 2008, J VIROL, V82, P1819, DOI 10.1128/JVI.01926-07; Hou YX, 2010, ARCH VIROL, V155, P1563, DOI 10.1007/s00705-010-0729-6; Ithete NL, 2013, EMERG INFECT DIS, V19, P1697, DOI 10.3201/eid1910.130946; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2010, J VIROL, V84, P11385, DOI 10.1128/JVI.01121-10; Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Li Y, 2010, J VIROL, V84, P3889, DOI 10.1128/JVI.02497-09; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07; Ren W, 2006, J GEN VIROL, V87, P3355, DOI 10.1099/vir.0.82220-0; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Wu KL, 2012, J BIOL CHEM, V287, P8904, DOI 10.1074/jbc.M111.325803; Yuan JF, 2010, J GEN VIROL, V91, P1058, DOI 10.1099/vir.0.016378-0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	29	994	1058	11	289	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					535	+		10.1038/nature12711	http://dx.doi.org/10.1038/nature12711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24172901	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000327464200045
J	Stieglitz, B; Rana, RR; Koliopoulos, MG; Morris-Davies, AC; Schaeffer, V; Christodoulou, E; Howell, S; Brown, NR; Dikic, I; Rittinger, K				Stieglitz, Benjamin; Rana, Rohini R.; Koliopoulos, Marios G.; Morris-Davies, Aylin C.; Schaeffer, Veronique; Christodoulou, Evangelos; Howell, Steven; Brown, Nicholas R.; Dikic, Ivan; Rittinger, Katrin			Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP	NATURE			English	Article							RING DOMAIN; E3 LIGASE; REVEALS; PARKIN; MECHANISM; PROTEIN; INSIGHTS; SHARPIN; FAMILY; HHARI	Linear ubiquitin chains are important regulators of cellular signalling pathways that control innate immunity and inflammation through nuclear factor (NF)-kappa B activation and protection against tumour necrosis factor-alpha-induced apoptosis(1-5). They are synthesized by HOIP, which belongs to the RBR (RING-between-RING) family of E3 ligases and is the catalytic component of LUBAC (linear ubiquitin chain assembly complex), a multisubunit E3 ligase(6). RBR family members act as RING/HECT hybrids, employing RING1 to recognize ubiquitin-loaded E2 while a conserved cysteine in RING2 subsequently forms a thioester intermediate with the transferred or 'donor' ubiquitin(7). Here we report the crystal structure of the catalytic core of HOIP in its apo form and in complex with ubiquitin. The carboxy-terminal portion of HOIP adopts a novel fold that, together with a zinc-finger, forms a ubiquitin-binding platform that orients the acceptor ubiquitin and positions its alpha-amino group for nucleophilic attack on the E3 similar to ubiquitin thioester. The C-terminal tail of a second ubiquitin molecule is located in close proximity to the catalytic cysteine, providing a unique snapshot of the ubiquitin transfer complex containing both donor and acceptor ubiquitin. These interactions are required for activation of the NF-kappa B pathway in vivo, and they explain the determinants of linear ubiquitin chain specificity by LUBAC.	[Stieglitz, Benjamin; Rana, Rohini R.; Koliopoulos, Marios G.; Morris-Davies, Aylin C.; Christodoulou, Evangelos; Howell, Steven; Brown, Nicholas R.; Rittinger, Katrin] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Schaeffer, Veronique; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Main, Germany	MRC National Institute for Medical Research; Goethe University Frankfurt	Rittinger, K (corresponding author), Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England.	katrin.rittinger@nimr.mrc.ac.uk	Rittinger, Katrin/D-2586-2014; Rittinger, Katrin/N-3344-2019; Stieglitz, Benjamin/AAY-4140-2020; Dikic, Ivan/O-4650-2015	Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435; Stieglitz, Benjamin/0000-0003-3634-6997; Dikic, Ivan/0000-0001-8156-9511; Schaeffer, Veronique/0000-0002-2564-9012; Koliopoulos, Marios/0000-0002-9535-1529; Christodoulou, Evangelos/0000-0001-8464-1558	Medical Research Council [U117565398]; Wellcome Foundation [094112/Z/10/Z]; European Research Council (ERC) under the European Union; ERC [250241-LineUb]; Medical Research Council [MC_U117565398] Funding Source: researchfish; MRC [MC_U117565398] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Foundation; European Research Council (ERC) under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Strekopytov for inductively coupled plasma mass spectrometry experiments, I. Taylor for help with analytical ultracentrifugation, L. Haire for help with crystallization, S. Martin for circular dichroism spectroscopy, S. Caswell for help with cloning, C. Bayart for technical assistance, P. Walker for data collection, S. Smerdon for discussions and advice, and the Diamond Light Source for synchrotron access. This work was supported by the Medical Research Council (grant U117565398) and the Wellcome Foundation (grant 094112/Z/10/Z) to K.R., and the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013) and ERC grant agreement 250241-LineUb to I.D.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Raasi Shahri, 2005, V301, P47; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Walczak H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-23; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Wenzel DM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-24; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	37	137	141	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					422	+		10.1038/nature12638	http://dx.doi.org/10.1038/nature12638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24141947	Green Accepted, Green Submitted			2022-12-24	WOS:000327163200047
J	Barreto, JA; Wang, Y; Dodson, JA; Desai, MM; Sugeng, L; Geirsson, A; Krumholz, HM				Barreto-Filho, Jose Augusto; Wang, Yun; Dodson, John A.; Desai, Mayur M.; Sugeng, Lissa; Geirsson, Arnar; Krumholz, Harlan M.			Trends in Aortic Valve Replacement for Elderly Patients in the United States, 1999-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROFILING HOSPITAL PERFORMANCE; VALVULAR HEART-DISEASE; ACC/AHA 2006 GUIDELINES; ASSOCIATION TASK-FORCE; 30-DAY MORTALITY-RATES; QUALITY-OF-CARE; RACIAL DISPARITIES; MECHANICAL VALVE; SURGERY; MANAGEMENT	IMPORTANCE There is a need to describe contemporary outcomes of surgical aortic valve replacement (AVR) as the population ages and transcatheter options emerge. OBJECTIVE To assess procedure rates and outcomes of surgical AVR over time. DESIGN, SETTING, AND PARTICIPANTS A serial cross-sectional cohort study of 82 755 924 Medicare fee-for-service beneficiaries undergoing AVR in the United States between 1999 and 2011. MAIN OUTCOMES AND MEASURES Procedure rates for surgical AVR alone and with coronary artery bypass graft (CABG) surgery, 30-day and 1-year mortality, and 30-day readmission rates. RESULTS The AVR procedure rate increased by 19 (95% CI, 19-20) procedures per 100 000 person-years over the 12-year period (P<.001), with an age-, sex-, and race-adjusted rate increase of 1.6% (95% CI, 1.0%-1.8%) per year. Mortality decreased at 30 days (absolute decrease, 3.4%; 95% CI, 3.0%-3.8%; adjusted annual decrease, 4.1%; 95% CI, 3.7%-4.4%) per year and at 1 year (absolute decrease, 2.6%; 95% CI, 2.1%-3.2%; adjusted annual decrease, 2.5%; 95% CI, 2.3%-2.8%). Thirty-day all-cause readmission also decreased by 1.1% (95% CI, 0.9%-1.3%) per year. Aortic valve replacement with CABG surgery decreased, women and black patients had lower procedure and higher mortality rates, and mechanical prosethetic implants decreased, but 23.9% of patients 85 years and older continued to receive a mechanical prosthesis in 2011. CONCLUSIONS AND RELEVANCE Between 1999 and 2011, the rate of surgical AVR for elderly patients in the United States increased and outcomes improved substantially. Medicare data preclude the identification of the causes of the findings and the trends in procedure rates and outcomes cannot be causally linked. Nevertheless, the findings may be a useful benchmark for outcomes with surgical AVR for older patients eligible for surgery considering newer transcatheter treatments.	[Barreto-Filho, Jose Augusto] Univ Fed Sergipe, Div Cardiol, Aracaju, Sergipe, Brazil; [Barreto-Filho, Jose Augusto] Clin & Hosp Sao Lucas, Aracaju, Sergipe, Brazil; [Barreto-Filho, Jose Augusto; Wang, Yun; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Wang, Yun] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wang, Yun; Sugeng, Lissa; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Dodson, John A.] Brigham & Womens Hosp, Dept Internal Med, Div Aging, Boston, MA 02115 USA; [Desai, Mayur M.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06510 USA; [Desai, Mayur M.; Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Geirsson, Arnar] Yale Univ, Sch Med, Sect Cardiac Surg, Dept Surg, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA	Universidade Federal de Sergipe; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Harvard University; Brigham & Women's Hospital; Yale University; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020; Geirsson, Arnar/S-4735-2019	Desai, Mayur/0000-0001-6616-0945; Sugeng, Lissa/0000-0002-5614-691X; Sugeng, Lissa/0000-0001-6406-3690	National Heart, Lung, and Blood Institute [U01HL105270-04]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministry of Education, Brazil) [3436-10-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant U01HL105270-04 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. During the time that this work was conducted, Dr Barreto-Filho was a postdoctoral fellow at Yale University supported by grant 3436-10-1 from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministry of Education, Brazil).	Aoyagi S, 2010, HEART VESSELS, V25, P522, DOI 10.1007/s00380-010-0009-0; Ashikhmina EA, 2011, CIRCULATION, V124, P1070, DOI 10.1161/CIRCULATIONAHA.110.987560; Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259; Barnett SD, 2009, J THORAC CARDIOV SUR, V137, P1422, DOI 10.1016/j.jtcvs.2008.08.071; BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901; Bonow R O, 1998, J Heart Valve Dis, V7, P672; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015; Carabello BA, 2009, LANCET, V373, P956, DOI 10.1016/S0140-6736(09)60211-7; Chen J, 2011, JAMA-J AM MED ASSOC, V306, P1669, DOI 10.1001/jama.2011.1474; Cohn LH, 2007, CURR OPIN CARDIOL, V22, P92, DOI 10.1097/HCO.0b013e32802086bc; Dunning J, 2011, J THORAC CARDIOV SUR, V142, P776, DOI 10.1016/j.jtcvs.2011.04.048; Edwards FH, 2001, J AM COLL CARDIOL, V37, P885, DOI 10.1016/S0735-1097(00)01202-X; Eicheldinger C, 2008, HEALTH CARE FINANC R, V29, P27; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Goodney PP, 2003, ANN THORAC SURG, V76, P1131, DOI 10.1016/S0003-4975(03)00827-0; Grube E, 2008, CIRC-CARDIOVASC INTE, V1, P167, DOI 10.1161/CIRCINTERVENTIONS.108.819839; HAMMERMEISTER KE, 1993, NEW ENGL J MED, V328, P1289, DOI 10.1056/NEJM199305063281801; Iung B, 1993, J Heart Valve Dis, V2, P430; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Kaiser Family Foundation, MED ADV 2010 DAT SPO; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Kodali SK, 2012, CIRCULATION, V125, P975, DOI 10.1161/CIRCULATIONAHA.111.087965; Kressin NR, 2001, ANN INTERN MED, V135, P352, DOI 10.7326/0003-4819-135-5-200109040-00012; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Kuller LH, 2005, NEW ENGL J MED, V353, P2081; Langanay T, 2012, ANN THORAC SURG, V93, P70, DOI 10.1016/j.athoracsur.2011.07.033; Lee R, 2011, ANN THORAC SURG, V91, P677, DOI 10.1016/j.athoracsur.2010.11.009; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Supino Phyllis G, 2006, Heart Fail Clin, V2, P379, DOI 10.1016/j.hfc.2006.09.010; Thourani VH, 2008, ANN THORAC SURG, V86, P1458, DOI 10.1016/j.athoracsur.2008.06.036; Tillquist MN, 2011, PATIENT PREFER ADHER, V5, P91, DOI 10.2147/PPA.S16420; Trivedi AN, 2006, JAMA-J AM MED ASSOC, V296, P1998, DOI 10.1001/jama.296.16.1998; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Vaishnava P, 2011, NAT REV CARDIOL, V8, P173, DOI 10.1038/nrcardio.2010.203	42	114	117	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 20	2013	310	19					2078	2085		10.1001/jama.2013.282437	http://dx.doi.org/10.1001/jama.2013.282437			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253OQ	24240935	Green Accepted, Bronze			2022-12-24	WOS:000327098900024
J	Kasowski, M; Kyriazopoulou-Panagiotopoulou, S; Grubert, F; Zaugg, JB; Kundaje, A; Liu, YL; Boyle, AP; Zhang, QC; Zakharia, F; Spacek, DV; Li, JJ; Xie, D; Olarerin-George, A; Steinmetz, LM; Hogenesch, JB; Kellis, M; Batzoglou, S; Snyder, M				Kasowski, Maya; Kyriazopoulou-Panagiotopoulou, Sofia; Grubert, Fabian; Zaugg, Judith B.; Kundaje, Anshul; Liu, Yuling; Boyle, Alan P.; Zhang, Qiangfeng Cliff; Zakharia, Fouad; Spacek, Damek V.; Li, Jingjing; Xie, Dan; Olarerin-George, Anthony; Steinmetz, Lars M.; Hogenesch, John B.; Kellis, Manolis; Batzoglou, Serafim; Snyder, Michael			Extensive Variation in Chromatin States Across Humans	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTOR-BINDING; HUMAN GENE-EXPRESSION; DISEASES; TRAITS; YEAST	The majority of disease-associated variants lie outside protein-coding regions, suggesting a link between variation in regulatory regions and disease predisposition. We studied differences in chromatin states using five histone modifications, cohesin, and CTCF in lymphoblastoid lines from 19 individuals of diverse ancestry. We found extensive signal variation in regulatory regions, which often switch between active and repressed states across individuals. Enhancer activity is particularly diverse among individuals, whereas gene expression remains relatively stable. Chromatin variability shows genetic inheritance in trios, correlates with genetic variation and population divergence, and is associated with disruptions of transcription factor binding motifs. Overall, our results provide insights into chromatin variation among humans.	[Kasowski, Maya; Grubert, Fabian; Zaugg, Judith B.; Kundaje, Anshul; Boyle, Alan P.; Zhang, Qiangfeng Cliff; Zakharia, Fouad; Spacek, Damek V.; Li, Jingjing; Xie, Dan; Steinmetz, Lars M.; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Kasowski, Maya] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Kyriazopoulou-Panagiotopoulou, Sofia; Kundaje, Anshul; Batzoglou, Serafim] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Kundaje, Anshul; Kellis, Manolis] MIT, Dept Comp Sci, Cambridge, MA 02139 USA; [Kundaje, Anshul; Kellis, Manolis] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Olarerin-George, Anthony; Hogenesch, John B.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Liu, Yuling] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; Yale University; Stanford University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Pennsylvania; European Molecular Biology Laboratory (EMBL); Stanford University	Snyder, M (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	mpsnyder@stanford.edu	Kundaje, Anshul/Y-2739-2019; Kellis, Manolis/ABE-7385-2020; Zhang, Qiangfeng/C-2902-2011; Li, Jingjing/B-5136-2016; Kundaje, Anshul/Y-2598-2019; Boyle, Alan/I-1848-2014	Kundaje, Anshul/0000-0003-3084-2287; Kellis, Manolis/0000-0001-7113-9630; Li, Jingjing/0000-0001-6025-9522; Kundaje, Anshul/0000-0003-3084-2287; Boyle, Alan/0000-0002-2081-1105; Snyder, Michael/0000-0003-0784-7987; Olarerin-George, Anthony/0000-0002-6109-3824; Steinmetz, Lars/0000-0002-3962-2865; Zaugg, Judith B./0000-0001-8324-4040	NIH; Genetics Department, Stanford University; Vera Moulton Wall Center for Pulmonary Vascular Disease; NIH MSTP TG [T32GM07205]; Siebel Scholars Foundation; KAUST-Stanford Academic Excellence Alliance program; Swiss National Foundation; Janggen-Poehn Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, R01HG004037, K99HG007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; Direct For Biological Sciences [0644282] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetics Department, Stanford University; Vera Moulton Wall Center for Pulmonary Vascular Disease; NIH MSTP TG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siebel Scholars Foundation; KAUST-Stanford Academic Excellence Alliance program; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Janggen-Poehn Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded by grants from the NIH and Genetics Department, Stanford University, Vera Moulton Wall Center for Pulmonary Vascular Disease and NIH MSTP TG T32GM07205 (M. K.), the Siebel Scholars Foundation (S.-K.P.), the KAUST-Stanford Academic Excellence Alliance program (S.-K.P. and S. B.), the Swiss National Foundation, and the Janggen-Poehn Foundation (J.B.Z.). Data sets are available at the Gene Expression Omnibus (GEO) database with accession no. GSE50893. We thank S. Montgomery, W. Huber, C. Bustamante, H. Tang, S. Anders, G. Euskirchen, B. Altshuler, M. Eaton, and L. Ward. M. S. is a founder and member of the science advisory board for Personalis and a science advisory board member for Genapsys and AxioMx. S. B. is a founder and advisor for DNAnexus and serves on the advisory boards of 23andMe and Eve Biomedical. Genotype calls and BAM files with mapped sequencing reads for the San individuals are available through a data access agreement for transfer of genetic data by contacting M.S.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duan SW, 2008, BIOINFORMATION, V3, P139, DOI 10.6026/97320630003139; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934	20	251	254	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					750	752		10.1126/science.1242510	http://dx.doi.org/10.1126/science.1242510			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24136358	Green Accepted, Green Submitted			2022-12-24	WOS:000326647600047
J	Mante, V; Sussillo, D; Shenoy, KV; Newsome, WT				Mante, Valerio; Sussillo, David; Shenoy, Krishna V.; Newsome, William T.			Context-dependent computation by recurrent dynamics in prefrontal cortex	NATURE			English	Article							PERCEPTUAL DECISION; PARIETAL CORTEX; AREA MT; ATTENTION; MEMORY; SELECTION; MODEL	Prefrontal cortex is thought to have a fundamental role in flexible, context-dependent behaviour, but the exact nature of the computations underlying this role remains largely unknown. In particular, individual prefrontal neurons often generate remarkably complex responses that defy deep understanding of their contribution to behaviour. Here we study prefrontal cortex activity in macaque monkeys trained to flexibly select and integrate noisy sensory inputs towards a choice. We find that the observed complexity and functional roles of single neurons are readily understood in the framework of a dynamical process unfolding at the level of the population. The population dynamics can be reproduced by a trained recurrent neural network, which suggests a previously unknown mechanism for selection and integration of task-relevant inputs. This mechanism indicates that selection and integration are two aspects of a single dynamical process unfolding within the same prefrontal circuits, and potentially provides a novel, general framework for understanding context-dependent computations.	[Mante, Valerio; Newsome, William T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Mante, Valerio; Shenoy, Krishna V.; Newsome, William T.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Sussillo, David; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Sussillo, David; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Mante, V (corresponding author), Univ Zurich, ETH Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland.	valerio@ini.phys.ethz.ch; sussillo@stanford.edu	Newsome, William T./W-7171-2019	Sussillo, David/0000-0003-1620-1264	HHMI; Air Force Research Laboratory [FA9550-07-1-0537]; NIH Director's Pioneer Award [1DP1OD006409]; DARPA REPAIR [N66001-10-C-2010]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Air Force Research Laboratory; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA REPAIR; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Powell, S. Fong and J. Brown for technical assistance, L. Abbott, for conversations on non-normal dynamics, and L. Stryer, S. Hohl, S. Ganguli, M. Sahani, R. Kiani, C. Moore and T. Bhattacharya for discussions. V. M. and W.T.N. were supported by HHMI and the Air Force Research Laboratory (FA9550-07-1-0537); D. S. and K. V. S. by an NIH Director's Pioneer Award (1DP1OD006409) and DARPA REPAIR (N66001-10-C-2010).	Afshar A, 2011, NEURON, V71, P555, DOI 10.1016/j.neuron.2011.05.047; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Deco G, 2003, EUR J NEUROSCI, V18, P2374, DOI 10.1046/j.1460-9568.2003.02956.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Ganguli S, 2008, P NATL ACAD SCI USA, V105, P18970, DOI 10.1073/pnas.0804451105; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; Huk AC, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00086; Katzner S, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.012.2009; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Machens CK, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00126; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Martens J., 2011, P 28 INT C MACH LEAR, P1033; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2006, CURR OPIN NEUROBIOL, V16, P159, DOI 10.1016/j.conb.2006.03.009; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Roy JE, 2010, J NEUROSCI, V30, P8519, DOI 10.1523/JNEUROSCI.4837-09.2010; Salinas E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-47; Sasaki R, 2009, NEURON, V62, P147, DOI 10.1016/j.neuron.2009.02.019; Schall JD, 2002, PHILOS T ROY SOC B, V357, P1073, DOI 10.1098/rstb.2002.1098; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; SEJNOWSKI TJ, 1976, BIOL CYBERN, V22, P203, DOI 10.1007/BF00365086; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Sigala N, 2008, P NATL ACAD SCI USA, V105, P11969, DOI 10.1073/pnas.0802569105; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Sussillo D, 2013, NEURAL COMPUT, V25, P626, DOI 10.1162/NECO_a_00409; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Zenon A, 2012, NATURE, V489, P434, DOI 10.1038/nature11497; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	50	711	713	2	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					78	+		10.1038/nature12742	http://dx.doi.org/10.1038/nature12742			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201281	Green Accepted			2022-12-24	WOS:000326585600035
J	Maures, TJ; Booth, LN; Benayoun, BA; Izrayelit, Y; Schroeder, FC; Brunet, A				Maures, Travis J.; Booth, Lauren N.; Benayoun, Berenice A.; Izrayelit, Yevgeniy; Schroeder, Frank C.; Brunet, Anne			Males Shorten the Life Span of C. elegans Hermaphrodites via Secreted Compounds	SCIENCE			English	Article							LARVAL DEVELOPMENT; CAENORHABDITIS; PHEROMONE; LONGEVITY; EVOLUTION; INSULIN	How an individual's longevity is affected by the opposite sex is still largely unclear. In the nematode Caenorhabditis elegans, the presence of males accelerated aging and shortened the life span of individuals of the opposite sex (hermaphrodites), including long-lived or sterile hermaphrodites. The male-induced demise could occur without mating and required only exposure of hermaphrodites to medium in which males were once present. Such communication through pheromones or other diffusible substances points to a nonindividual autonomous mode of aging regulation. The male-induced demise also occurred in other species of nematodes, suggesting an evolutionary conserved process whereby males may induce the disposal of the opposite sex to save resources for the next generation or to prevent competition from other males.	[Maures, Travis J.; Booth, Lauren N.; Benayoun, Berenice A.; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Izrayelit, Yevgeniy; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA; [Izrayelit, Yevgeniy; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Brunet, Anne] Glenn Labs Biol Aging Stanford, Stanford, CA 94305 USA	Stanford University; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Brunet, A (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	abrunet1@stanford.edu	Benayoun, Bérénice A./K-7048-2012	Benayoun, Bérénice A./0000-0002-7401-4777; Schroeder, Frank/0000-0002-4420-0237	Glenn Foundation for Medical Research; Helen Hay Whitney Foundation; Stanford Dean's Fellowship [R01GM088290, T32GM008500];  [R01AG031198];  [DP1AG044848];  [F32AG37254];  [T32HG000044]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500, R01GM088290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031198, F32AG037254, DP1AG044848] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; Helen Hay Whitney Foundation; Stanford Dean's Fellowship; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Brunet laboratory, S. Kim, A. Fire, and A. Villeneuve for helpful suggestions and J. Lim and S. Zimmerman for critical reading of the manuscript. We thank N. Kosovilka and the Protein and Nucleic Acid Facility facility for the microarray experiments and T. Stiernagle from the Caenorhabditis Genetics Center. Supported by R01AG031198, DP1AG044848, the Glenn Foundation for Medical Research (A. B.), postdoctoral fellowship F32AG37254 (T. J. M.), T32HG000044 and the Helen Hay Whitney Foundation (L. N. B.), Stanford Dean's Fellowship (BAB), R01GM088290 (F. C. S.), and T32GM008500 (Y.I.).	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Chow DK, 2006, EXP GERONTOL, V41, P252, DOI 10.1016/j.exger.2005.12.004; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Gems D, 2000, GENETICS, V154, P1597; Glenn CF, 2004, J GERONTOL A-BIOL, V59, P1251, DOI 10.1093/gerona/59.12.1251; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Izrayelit Y, 2012, ACS CHEM BIOL, V7, P1321, DOI 10.1021/cb300169c; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Jin CY, 2011, CELL METAB, V14, P161, DOI 10.1016/j.cmet.2011.07.001; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Ludewig AH, 2013, P NATL ACAD SCI USA, V110, P5522, DOI 10.1073/pnas.1214467110; Ludewig Andreas H, 2013, WormBook, P1, DOI 10.1895/wormbook.1.155.1; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Maures TJ, 2011, AGING CELL, V10, P980, DOI 10.1111/j.1474-9726.2011.00738.x; McGee MD, 2011, AGING CELL, V10, P699, DOI 10.1111/j.1474-9726.2011.00713.x; McGrath PT, 2011, NATURE, V477, P321, DOI 10.1038/nature10378; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; van Swinderen B, 2002, GENETICS, V161, P109	30	100	104	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2014	343	6170					541	544		10.1126/science.1244160	http://dx.doi.org/10.1126/science.1244160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298SC	24292626	Green Accepted			2022-12-24	WOS:000330343700047
J	Julien, JP; Cupo, A; Sok, D; Stanfield, RL; Lyumkis, D; Deller, MC; Klasse, PJ; Burton, DR; Sanders, RW; Moore, JP; Ward, AB; Wilson, IA				Julien, Jean-Philippe; Cupo, Albert; Sok, Devin; Stanfield, Robyn L.; Lyumkis, Dmitry; Deller, Marc C.; Klasse, Per-Johan; Burton, Dennis R.; Sanders, Rogier W.; Moore, John P.; Ward, Andrew B.; Wilson, Ian A.			Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer	SCIENCE			English	Article							N-GLYCAN RECOGNITION; MOLECULAR ARCHITECTURE; POTENT NEUTRALIZATION; GLYCOPROTEIN COMPLEX; V3 LOOP; GP120; VIRUS; ANTIBODY; BROAD; REGION	HIV-1 entry into CD4(+) target cells is mediated by cleaved envelope glycoprotein (Env) trimers that have been challenging to characterize structurally. Here, we describe the crystal structure at 4.7 angstroms of a soluble, cleaved Env trimer that is stabilized and antigenically near-native (termed the BG505 SOSIP. 664 gp140 trimer) in complex with a potent broadly neutralizing antibody, PGT122. The structure shows a prefusion state of gp41, the interaction between the component gp120 and gp41 subunits, and how a close association between the gp120 V1/V2/V3 loops stabilizes the trimer apex around the threefold axis. The complete epitope of PGT122 on the trimer involves gp120 V1, V3, and several surrounding glycans. This trimer structure advances our understanding of how Env functions and is presented to the immune system, and provides a blueprint for structure-based vaccine design.	[Julien, Jean-Philippe; Stanfield, Robyn L.; Lyumkis, Dmitry; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Julien, Jean-Philippe; Sok, Devin; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Julien, Jean-Philippe; Sok, Devin; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Cupo, Albert; Klasse, Per-Johan; Sanders, Rogier W.; Moore, John P.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Sok, Devin; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Lyumkis, Dmitry] Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Deller, Marc C.; Wilson, Ian A.] Scripps Res Inst, Joint Ctr Struct Genom, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02129 USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Cornell University; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Amsterdam; Academic Medical Center Amsterdam; Scripps Research Institute	Moore, JP (corresponding author), Cornell Univ, Weill Med Coll, New York, NY 10021 USA.	jpm2003@med.cornell.edu; abward@scripps.edu; wilson@scripps.edu	Ibrahim, Essam Hassan/G-1960-2018; Ward, Andrew B/F-9203-2014; Stanfield, Robyn/AAH-3190-2019; Ward, Andrew/ABD-7728-2021; Klasse, P.J./AEX-0142-2022	Ibrahim, Essam Hassan/0000-0003-0130-2257; Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Klasse, P.J./0000-0001-8222-278X; Julien, Jean-Philippe/0000-0001-7602-3995; Deller, Marc/0000-0001-8070-6502	NIH [P01 AI82362, R01 AI084817, R37 AI36082, R01 AI33292]; International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center; CHAVI-ID [UM1 AI100663]; Netherlands Organization for Scientific Research; European Research Council; Canadian Institutes of Health Research fellowship; Ragon Institute; U.S. NIH National Institute of General Medical Sciences (NIGMS) Biomedical Technology Research Center program [GM103310]; NIH NIGMS via a Protein Structure Initiative [U54 GM094586]; U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Cancer Institute (NCI) [Y1-CO-1020]; NIGMS [Y1-GM-1104]; DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program [P41RR001209]; NIGMS; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, R01AI084817, R01AI033292, P01AI082362, R37AI036082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, U54GM094586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center; CHAVI-ID; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); Ragon Institute; U.S. NIH National Institute of General Medical Sciences (NIGMS) Biomedical Technology Research Center program; NIH NIGMS via a Protein Structure Initiative; U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Hua, L. Kong, P. S. Lee, X. Zhu, R. Pejchal, H. Tien, T. Clayton, K. Saye, and J. Korzun, for technical assistance, previous contributions to the Env trimer project, and insightful discussions and C. R. King and W. Koff for support and encouragement. This work was supported by NIH grant P01 AI82362 (J. P. M., I. A. W.), as well as the International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center (D. R. B., I. A. W., J. P. M., A. B. W.), CHAVI-ID UM1 AI100663 (D. R. B., I. A. W., AB. W.), NIH grant R01 AI084817 (I. A. W.), NIH grant R37 AI36082 (J. P. M.), NIH grant R01 AI33292 (D. R. B.), a Vidi grant from the Netherlands Organization for Scientific Research (R. W. S.), a Starting Investigator Grant from the European Research Council (R. W. S.), Canadian Institutes of Health Research fellowship (J.-P.J.), and the Ragon Institute. D. L. is supported by the U.S. NIH National Institute of General Medical Sciences (NIGMS) Biomedical Technology Research Center program (grant GM103310). The Joint Center of Structural Genomics is supported by NIH NIGMS via a Protein Structure Initiative grant U54 GM094586 (I. A. W.). Use of the Advanced Photon Source for data collection was supported by the U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. GM/CA CAT has been funded in whole or in part with federal funds from the National Cancer Institute (NCI) (grant Y1-CO-1020) and NIGMS (grant Y1-GM-1104). Extensive crystal screening was also carried out at the Stanford Synchrotron Radiation Lightsource (SSRL) and at the Canadian Light Source (CLS). SSRL, a Directorate of the SLAC National Accelerator Laboratory and an Office of Science User Facility, is operated for the U.S. DOE Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program (P41RR001209); and the NIGMS. CLS is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. The content is the responsibility of the authors and does not necessarily reflect the official views of the NIGMS, NCI, or NIH. Coordinates and structure factors have been deposited with the Protein Data Bank under accession code 4NCO. The International AIDS Vaccine Initiative has previously filed a patent relating to the BG505 SOSIP. 664 trimer: U.S. Provisional Application no. 61/772,739, titled "HIV-1 envelope glycoprotein," with inventors M. Caulfield, A. C., H. Dean, S. Hoffenberg, C. R. King, P. J. K., A. Marozsan, J. P. M., R. S., A. B. W., I. A. W., J.-P. J., but no patents have been filed on any work described here. Materials and information will be provided under a Materials Transfer Agreement. This is manuscript 25054 from The Scripps Research Institute.	[Anonymous], THE PYMOL MOLECULAR; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Cohen J, 2013, SCIENCE, V341, P443, DOI 10.1126/science.341.6145.443; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Henderson R, 2013, P NATL ACAD SCI USA, V110, P18037, DOI 10.1073/pnas.1314449110; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Khayat R, 2013, J VIROL, V87, P9865, DOI 10.1128/JVI.01222-13; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; Kolchinsky P, 2001, J VIROL, V75, P3435, DOI 10.1128/JVI.75.7.3435-3443.2001; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mao YD, 2013, P NATL ACAD SCI USA, V110, pE4178, DOI 10.1073/pnas.1316666110; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Rosen O, 2006, P NATL ACAD SCI USA, V103, P13950, DOI 10.1073/pnas.0606312103; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Sadjadpour R, 2013, J VIROL, V87, P8798, DOI 10.1128/JVI.00878-13; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Stanfield RL, 1999, STRUCTURE, V7, P131, DOI 10.1016/S0969-2126(99)80020-3; Subramaniam S, 2013, P NATL ACAD SCI USA, V110, pE4172, DOI 10.1073/pnas.1313802110; SULLIVAN N, 1993, J VIROL, V67, P3674, DOI 10.1128/JVI.67.6.3674-3679.1993; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; van Heel M, 2013, P NATL ACAD SCI USA, V110, pE4175, DOI 10.1073/pnas.1314353110; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Xiang SH, 2010, J VIROL, V84, P3147, DOI 10.1128/JVI.02587-09; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	56	645	671	3	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1477	1483		10.1126/science.1245625	http://dx.doi.org/10.1126/science.1245625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24179159	Green Accepted			2022-12-24	WOS:000328644300050
J	Klampfl, T; Gisslinger, H; Harutyunyan, AS; Nivarthi, H; Rumi, E; Milosevic, JD; Them, NCC; Berg, T; Gisslinger, B; Pietra, D; Chen, D; Vladimer, GI; Bagienski, K; Milanesi, C; Casetti, IC; Sant'Antonio, E; Ferretti, V; Elena, C; Schischlik, F; Cleary, C; Six, M; Schalling, M; Schonegger, A; Bock, C; Malcovati, L; Pascutto, C; Superti-Furga, G; Cazzola, M; Kralovics, R				Klampfl, Thorsten; Gisslinger, Heinz; Harutyunyan, Ashot S.; Nivarthi, Harini; Rumi, Elisa; Milosevic, Jelena D.; Them, Nicole C. C.; Berg, Tiina; Gisslinger, Bettina; Pietra, Daniela; Chen, Doris; Vladimer, Gregory I.; Bagienski, Klaudia; Milanesi, Chiara; Casetti, Ilaria Carola; Sant'Antonio, Emanuela; Ferretti, Virginia; Elena, Chiara; Schischlik, Fiorella; Cleary, Ciara; Six, Melanie; Schalling, Martin; Schoenegger, Andreas; Bock, Christoph; Malcovati, Luca; Pascutto, Cristiana; Superti-Furga, Giulio; Cazzola, Mario; Kralovics, Robert			Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL WORKING GROUP; GAIN-OF-FUNCTION; PRIMARY MYELOFIBROSIS; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; PROGNOSTIC MODEL; PREDICT SURVIVAL; COMPETING RISKS; JAK2; DISORDERS	Background Approximately 50 to 60% of patients with essential thrombocythemia or primary myelofibrosis carry a mutation in the Janus kinase 2 gene (JAK2), and an additional 5 to 10% have activating mutations in the thrombopoietin receptor gene (MPL). So far, no specific molecular marker has been identified in the remaining 30 to 45% of patients. MethodsWe performed whole-exome sequencing to identify somatically acquired mutations in six patients who had primary myelofibrosis without mutations in JAK2 or MPL. Resequencing of CALR, encoding calreticulin, was then performed in cohorts of patients with myeloid neoplasms. ResultsSomatic insertions or deletions in exon 9 of CALR were detected in all patients who underwent whole-exome sequencing. Resequencing in 1107 samples from patients with myeloproliferative neoplasms showed that CALR mutations were absent in polycythemia vera. In essential thrombocythemia and primary myelofibrosis, CALR mutations and JAK2 and MPL mutations were mutually exclusive. Among patients with essential thrombocythemia or primary myelofibrosis with nonmutated JAK2 or MPL, CALR mutations were detected in 67% of those with essential thrombocythemia and 88% of those with primary myelofibrosis. A total of 36 types of insertions or deletions were identified that all cause a frameshift to the same alternative reading frame and generate a novel C-terminal peptide in the mutant calreticulin. Overexpression of the most frequent CALR deletion caused cytokine-independent growth in vitro owing to the activation of signal transducer and activator of transcription 5 (STAT5) by means of an unknown mechanism. Patients with mutated CALR had a lower risk of thrombosis and longer overall survival than patients with mutated JAK2. ConclusionsMost patients with essential thrombocythemia or primary myelofibrosis that was not associated with a JAK2 or MPL alteration carried a somatic mutation in CALR. The clinical course in these patients was more indolent than that in patients with the JAK2 V617F mutation. (Funded by the MPN Research Foundation and Associazione Italiana per la Ricerca sul Cancro.)	[Klampfl, Thorsten; Harutyunyan, Ashot S.; Nivarthi, Harini; Milosevic, Jelena D.; Them, Nicole C. C.; Berg, Tiina; Chen, Doris; Vladimer, Gregory I.; Bagienski, Klaudia; Schischlik, Fiorella; Cleary, Ciara; Six, Melanie; Schoenegger, Andreas; Bock, Christoph; Superti-Furga, Giulio; Kralovics, Robert] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Gisslinger, Heinz; Gisslinger, Bettina; Schalling, Martin; Kralovics, Robert] Med Univ Vienna, Div Hematol & Blood Coagulat, Dept Internal Med 1, Vienna, Austria; [Rumi, Elisa; Pietra, Daniela; Milanesi, Chiara; Casetti, Ilaria Carola; Sant'Antonio, Emanuela; Ferretti, Virginia; Elena, Chiara; Malcovati, Luca; Pascutto, Cristiana; Cazzola, Mario] Fdn Ist Ricovero & Cura Carattere Sci Policlin Sa, Dept Hematol Oncol, Pavia, Italy; [Malcovati, Luca; Cazzola, Mario] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; University of Pavia	Kralovics, R (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14,AKH BT25-3, A-1090 Vienna, Austria.	robert.kralovics@cemm.oeaw.ac.at	Feenstra, Jelena D Milosevic/K-2114-2012; Schalling, Martin/F-1518-2015; Rumi, Elisa/J-7424-2016; Malcovati, Luca/CAJ-1695-2022; Pietra, Daniela/F-3931-2016; Ferretti, Virginia/ABA-6196-2021; Bock, Christoph/AAE-7618-2019; Harutyunyan, Ashot S/M-3528-2014; Cazzola, Mario/AAQ-8854-2021; Superti-Furga, Giulio/AAE-5681-2019; Superti-Furga, Giulio/F-4755-2015; Vladimer, Gregory/X-4547-2018	Feenstra, Jelena D Milosevic/0000-0001-7420-3298; Schalling, Martin/0000-0001-5011-2922; Rumi, Elisa/0000-0002-7572-9504; Malcovati, Luca/0000-0002-1460-1611; Pietra, Daniela/0000-0002-6575-8766; Ferretti, Virginia/0000-0003-0130-915X; Bock, Christoph/0000-0001-6091-3088; Harutyunyan, Ashot S/0000-0002-9050-9315; Cazzola, Mario/0000-0001-6984-8817; Superti-Furga, Giulio/0000-0002-0570-1768; Vladimer, Gregory/0000-0003-4205-7585; milanesi, chiara/0000-0003-0391-4126; Klampfl, Thorsten/0000-0002-6666-9773; Chen, Doris/0000-0001-8835-0280; Kralovics, Robert/0000-0002-6997-8539; ELENA, CHIARA/0000-0002-0058-7142; CASETTI, ILARIA CAROLA/0000-0001-5232-9543	MPN Research Foundation; Associazione Italiana per la Ricerca sul Cancro [1005]	MPN Research Foundation; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	Supported by grants from the MPN Research Foundation (to Dr. Kralovics) and Associazione Italiana per la Ricerca sul Cancro (Special Program Molecular Clinical Oncology 5 per Mille, project 1005, to Dr. Cazzola).	Abdel-Wahab O, 2011, LEUKEMIA, V25, P1219, DOI 10.1038/leu.2011.82; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Campbell PJ, 2006, BLOOD, V107, P2098, DOI 10.1182/blood-2005-08-3395; Carbuccia N, 2009, LEUKEMIA, V23, P2183, DOI 10.1038/leu.2009.141; Coe H, 2010, J BIOL CHEM, V285, P6725, DOI 10.1074/jbc.M109.054015; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Guglielmelli P, 2011, BLOOD, V118, P5227, DOI 10.1182/blood-2011-06-363424; Harutyunyan A, 2011, NEW ENGL J MED, V364, P488, DOI 10.1056/NEJMc1012718; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Klampfl T, 2011, BLOOD, V118, P167, DOI 10.1182/blood-2011-01-331678; Kralovics R, 2008, LEUKEMIA, V22, P1841, DOI 10.1038/leu.2008.233; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lasho TL, 2012, BLOOD, V120, P4168, DOI 10.1182/blood-2012-05-429696; Malcovati L, 2009, BLOOD, V114, P3538, DOI 10.1182/blood-2009-05-222331; Passamonti F, 2010, LEUKEMIA, V24, P1574, DOI 10.1038/leu.2010.148; Passamonti F, 2012, BLOOD, V120, P1197, DOI 10.1182/blood-2012-01-403279; Passamonti F, 2011, BLOOD, V117, P2813, DOI 10.1182/blood-2010-11-316810; Passamonti F, 2010, BLOOD, V115, P1703, DOI 10.1182/blood-2009-09-245837; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Rumi E, 2013, BLOOD, V121, P4388, DOI 10.1182/blood-2013-02-486050; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Schafer AI, 2004, NEW ENGL J MED, V350, P1211, DOI 10.1056/NEJMra035363; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Si JT, 2008, CANCER RES, V68, P3733, DOI 10.1158/0008-5472.CAN-07-2509; Swerdlow E., 2008, WHO CLASSIFICATION T; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Yue X, 2012, J IMMUNOL, V189, P279, DOI 10.4049/jimmunol.1103405	32	1302	1377	6	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25					2379	2390		10.1056/NEJMoa1311347	http://dx.doi.org/10.1056/NEJMoa1311347			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274DQ	24325356	Bronze			2022-12-24	WOS:000328586000006
J	Markson, JS; Piechura, JR; Puszynska, AM; O'Shea, EK				Markson, Joseph S.; Piechura, Joseph R.; Puszynska, Anna M.; O'Shea, Erin K.			Circadian Control of Global Gene Expression by the Cyanobacterial Master Regulator RpaA	CELL			English	Article							ELONGATUS PCC 7942; SYNECHOCOCCUS-ELONGATUS; TRANSCRIPTIONAL REGULATION; OUTPUT PATHWAYS; CELL-DIVISION; IN-VITRO; CLOCK; PHOSPHORYLATION; OSCILLATOR; RHYTHM	The cyanobacterial circadian clock generates genome-wide transcriptional oscillations and regulates cell division, but the underlying mechanisms are not well understood. Here, we show that the response regulator RpaA serves as the master regulator of these clock outputs. Deletion of rpaA abrogates gene expression rhythms globally and arrests cells in a dawn-like expression state. Although rpaA deletion causes core oscillator failure by perturbing clock gene expression, rescuing oscillator function does not restore global expression rhythms. We show that phosphorylated RpaA regulates the expression of not only clock components, generating feedback on the core oscillator, but also a small set of circadian effectors that, in turn, orchestrate genome-wide transcriptional rhythms. Expression of constitutively active RpaA is sufficient to switch cells from a dawn-like to a dusk-like expression state as well as to block cell division. Hence, complex global circadian phenotypes can be generated by controlling the phosphorylation of a single transcription factor.	[Markson, Joseph S.; Piechura, Joseph R.; Puszynska, Anna M.; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Piechura, Joseph R.; Puszynska, Anna M.; O'Shea, Erin K.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Markson, Joseph S.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [O'Shea, Erin K.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu		Markson, Joseph/0000-0002-3167-3887	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank Vikram Vijayan for the 48 hr wild-type gene expression time course and for code, technical assistance, and discussion; Andrian Gutu for Phos-tag western blots; and Andrian Gutu, Xu Zhou, Abbas Rizvi, Brian Zid, Michael Rust (University of Chicago), Guogang Dong (UCSD), and Susan Golden (UCSD) for discussion and advice. We thank Richard Losick, Bodo Stern, and Andrian Gutu for comments on the manuscript and Takao Kondo (Nagoya University) and Susan Golden for plasmids and strains. This work was supported by the Howard Hughes Medical Institute.	Abruzzi KC, 2011, GENE DEV, V25, P2374, DOI [10.1101/gad.178079.111, 10.1101/gad.174110.111]; Ashby MK, 1999, FEMS MICROBIOL LETT, V181, P253, DOI 10.1016/S0378-1097(99)00547-9; Dong GG, 2010, CELL, V140, P529, DOI 10.1016/j.cell.2009.12.042; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Edery I, 2011, GENE DEV, V25, P2321, DOI 10.1101/gad.180984.111; Gutu A, 2013, MOL CELL, V50, P288, DOI 10.1016/j.molcel.2013.02.022; Hanaoka M, 2008, PLANT J, V56, P327, DOI 10.1111/j.1365-313X.2008.03600.x; Hanaoka M, 2012, J BIOL CHEM, V287, P26321, DOI 10.1074/jbc.M111.338251; Hosokawa N, 2011, P NATL ACAD SCI USA, V108, P15396, DOI 10.1073/pnas.1019612108; Ito H, 2009, P NATL ACAD SCI USA, V106, P14168, DOI 10.1073/pnas.0902587106; Johnson CH, 2011, ANNU REV BIOPHYS, V40, P143, DOI 10.1146/annurev-biophys-042910-155317; Joshua S, 2005, BBA-BIOENERGETICS, V1709, P58, DOI 10.1016/j.bbabio.2005.06.005; Kim YI, 2012, P NATL ACAD SCI USA, V109, P17765, DOI 10.1073/pnas.1216401109; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kutsuna S, 2005, MOL MICROBIOL, V57, P1474, DOI 10.1111/j.1365-2958.2005.04781.x; Marbouty M, 2009, J BACTERIOL, V191, P6178, DOI 10.1128/JB.00723-09; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Moronta-Barrios F, 2012, MICROBIOL-SGM, V158, P1229, DOI 10.1099/mic.0.057679-0; Munshi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060143; Murayama Y, 2008, J BACTERIOL, V190, P1691, DOI 10.1128/JB.01693-07; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nakajima M, 2010, FEBS LETT, V584, P898, DOI 10.1016/j.febslet.2010.01.016; Nakamichi N, 2012, P NATL ACAD SCI USA, V109, P17123, DOI 10.1073/pnas.1205156109; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Paddock ML, 2013, P NATL ACAD SCI USA, V110, pE3849, DOI 10.1073/pnas.1315170110; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Taniguchi Y, 2007, GENE DEV, V21, P60, DOI 10.1101/gad.1488107; Taniguchi Y, 2010, P NATL ACAD SCI USA, V107, P3263, DOI 10.1073/pnas.0909924107; Teng SW, 2013, SCIENCE, V340, P737, DOI 10.1126/science.1230996; Vijayan V, 2013, J BACTERIOL, V195, P665, DOI 10.1128/JB.02012-12; Vijayan V, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r47; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Woelfle MA, 2007, P NATL ACAD SCI USA, V104, P18819, DOI 10.1073/pnas.0706069104; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yang Q, 2010, SCIENCE, V327, P1522, DOI 10.1126/science.1181759; Zwicker D, 2010, P NATL ACAD SCI USA, V107, P22540, DOI 10.1073/pnas.1007613107	42	90	92	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1396	1408		10.1016/j.cell.2013.11.005	http://dx.doi.org/10.1016/j.cell.2013.11.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315105	Green Accepted, Bronze			2022-12-24	WOS:000328271100021
J	Pollier, J; Moses, T; Gonzalez-Guzman, M; De Geyter, N; Lippens, S; Vanden Bossche, R; Marhavy, P; Kremer, A; Morreel, K; Guerin, CJ; Tava, A; Oleszek, W; Thevelein, JM; Campos, N; Goormachtig, S; Goossens, A				Pollier, Jacob; Moses, Tessa; Gonzalez-Guzman, Miguel; De Geyter, Nathan; Lippens, Saskia; Vanden Bossche, Robin; Marhavy, Peter; Kremer, Anna; Morreel, Kris; Guerin, Christopher J.; Tava, Aldo; Oleszek, Wieslaw; Thevelein, Johan M.; Campos, Narciso; Goormachtig, Sofie; Goossens, Alain			The protein quality control system manages plant defence compound synthesis	NATURE			English	Article							3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; TRITERPENOID GLYCOSIDES; MEDICAGO; BIOSYNTHESIS; DEGRADATION; SAPONINS; GENE; IDENTIFICATION; EVOLUTION; SOFTWARE	Jasmonates are ubiquitous oxylipin-derived phytohormones that are essential in the regulation of many development, growth and defence processes. Across the plant kingdom, jasmonates act as elicitors of the production of bioactive secondary metabolites that serve in defence against attackers(1-3). Knowledge of the conserved jasmonate perception and early signalling machineries is increasing(3-6), but the downstream mechanisms that regulate defence metabolism remain largely unknown. Here we show that, in the legume Medicago truncatula, jasmonate recruits the endoplasmic-reticulum-associated degradation (ERAD) quality control system to manage the production of triterpene saponins, widespread bioactive compounds that share a biogenic origin with sterols(7-9). An ERAD-type RING membrane-anchor E3 ubiquitin ligase is co-expressed with saponin synthesis enzymes to control the activity of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), the rate-limiting enzyme in the supply of the ubiquitous terpene precursor isopentenyl diphosphate. Thus, unrestrained bioactive saponin accumulation is prevented and plant development and integrity secured. This control apparatus is equivalent to the ERAD system that regulates sterol synthesis in yeasts and mammals but that uses distinct E3 ubiquitin ligases, of the HMGR degradation 1 (HRD1) type, to direct destruction of HMGR(10-13). Hence, the general principles for the management of sterol and triterpene saponin biosynthesis are conserved across eukaryotes but can be controlled by divergent regulatory cues.	[Pollier, Jacob; Moses, Tessa; Gonzalez-Guzman, Miguel; De Geyter, Nathan; Vanden Bossche, Robin; Marhavy, Peter; Morreel, Kris; Goormachtig, Sofie; Goossens, Alain] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Pollier, Jacob; Moses, Tessa; Gonzalez-Guzman, Miguel; De Geyter, Nathan; Vanden Bossche, Robin; Marhavy, Peter; Morreel, Kris; Goormachtig, Sofie; Goossens, Alain] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Moses, Tessa; Thevelein, Johan M.] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Louvain, Belgium; [Moses, Tessa; Thevelein, Johan M.] VIB, Dept Mol Microbiol, B-3001 Louvain, Belgium; [Lippens, Saskia; Kremer, Anna; Guerin, Christopher J.] VIB, VIB Bio Imaging Core Gent, B-9052 Ghent, Belgium; [Lippens, Saskia; Kremer, Anna; Guerin, Christopher J.] VIB, Inflammat Res Ctr, B-9052 Ghent, Belgium; [Tava, Aldo] Ctr Ric Prod Foraggere & Lattiero Casearie, Consiglio Ric & Sperimentaz Agr, I-26900 Lodi, Italy; [Oleszek, Wieslaw] State Res Inst, Inst Soil Sci & Plant Cultivat, Dept Biochem, PL-24100 Pulawy, Poland; [Campos, Narciso] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; [Campos, Narciso] Consorci CSIC IRTA UAB UB, Ctr Recerca Agrigen, Dept Mol Genet, Barcelona 08193, Spain	Flanders Institute for Biotechnology (VIB); Ghent University; KU Leuven; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Institute of Soil Science & Plant Cultivation; University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA	Goossens, A (corresponding author), VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	alain.goossens@psb.vib-ugent.be	Gonzalez-Guzman, Miguel/N-6878-2019; Gonzalez-Guzman, Miguel/F-2318-2014; Guerin, Christopher/AAM-3233-2020; Moses, Tessa/AAU-7383-2021; Thevelein, Johan M./AAK-4203-2021; Pollier, Jacob/B-3091-2012; Campos, Narciso/L-3608-2017	Gonzalez-Guzman, Miguel/0000-0003-1000-9255; Gonzalez-Guzman, Miguel/0000-0003-1000-9255; Moses, Tessa/0000-0001-9366-4727; Pollier, Jacob/0000-0002-1134-9238; Campos, Narciso/0000-0002-9685-0549; Oleszek, Wieslaw/0000-0002-4189-6603; Thevelein, Johan/0000-0002-2626-0180; Lippens, Saskia/0000-0002-8261-3462; Marhavy, Peter/0000-0002-0178-2230; Goormachtig, Sofie/0000-0001-6195-9889; Goossens, Alain/0000-0002-1599-551X; Aldo, Tava/0000-0003-4657-4053	Agency for Innovation by Science and Technology in Flanders [SBO040093]; European Union [222716]; Spanish Ministerio de Economia y Competitividad [BFU2011-24208]; VIB International PhD Fellowship Program; Agency for Innovation by Science and Technology	Agency for Innovation by Science and Technology in Flanders; European Union(European Commission); Spanish Ministerio de Economia y Competitividad(Spanish Government); VIB International PhD Fellowship Program; Agency for Innovation by Science and Technology	We thank W. Ardiles-Diaz, S. Carbonelle, R. Dasseville, R. De Rycke and L. Ingelbrecht for technical assistance, and R. Dixon, H. Ezura, R. Hampton, A. Stolz and D. Wolf for providing plant and yeast materials. This research has received funding from the Agency for Innovation by Science and Technology in Flanders ('Strategisch Basisonderzoek' Combiplan project SBO040093), the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement number 222716 SMARTCELL and the Spanish Ministerio de Economia y Competitividad under grant BFU2011-24208. T. M. and N.D.G. are indebted to the VIB International PhD Fellowship Program and the Agency for Innovation by Science and Technology for predoctoral fellowships, respectively. J.P. and S. L. are postdoctoral fellows of the Research Foundation Flanders (FWO).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bassard JE, 2012, PLANT CELL, V24, P4465, DOI 10.1105/tpc.112.102566; Bialy Z, 2006, J AGR FOOD CHEM, V54, P2520, DOI 10.1021/jf0581628; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; De Sutter V, 2005, PLANT J, V44, P1065, DOI 10.1111/j.1365-313X.2005.02586.x; Dixon RA, 2003, PLANT PHYSIOL, V131, P878, DOI 10.1104/pp.102.017319; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; He J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-441; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hemmerlin A, 2013, PLANT SCI, V203, P41, DOI 10.1016/j.plantsci.2012.12.008; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kevei Z, 2007, PLANT CELL, V19, P3974, DOI 10.1105/tpc.107.053975; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kobayashi T, 2002, THEOR APPL GENET, V104, P779, DOI 10.1007/s00122-001-0838-4; Leivar P, 2011, PLANT CELL, V23, P1494, DOI 10.1105/tpc.110.074278; Memelink J, 2009, PHYTOCHEMISTRY, V70, P1560, DOI 10.1016/j.phytochem.2009.09.004; Morreel K, 2006, PLANT J, V47, P224, DOI 10.1111/j.1365-313X.2006.02786.x; Morreel K, 2010, ANAL CHEM, V82, P8095, DOI 10.1021/ac100968g; Moses T, 2013, NEW PHYTOL, V200, P27, DOI 10.1111/nph.12325; Mylona P, 2008, PLANT CELL, V20, P201, DOI 10.1105/tpc.107.056531; OLESZEK W, 1990, J SCI FOOD AGR, V53, P477, DOI 10.1002/jsfa.2740530406; OLESZEK W, 1990, J AGR FOOD CHEM, V38, P1810, DOI 10.1021/jf00099a006; Osbourn A, 2011, NAT PROD REP, V28, P1261, DOI 10.1039/c1np00015b; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pollier J, 2011, J NAT PROD, V74, P1462, DOI 10.1021/np200218r; Post J, 2012, PLANT PHYSIOL, V158, P1406, DOI 10.1104/pp.111.187880; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Suzuki H, 2002, PLANT J, V32, P1033, DOI 10.1046/j.1365-313X.2002.01497.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tava A, 2005, J AGR FOOD CHEM, V53, P9954, DOI 10.1021/jf052468x; Tava A, 2011, J AGR FOOD CHEM, V59, P6142, DOI 10.1021/jf2005854; Tava A, 2009, J AGR FOOD CHEM, V57, P2826, DOI 10.1021/jf8036984; Underwood BA, 2006, PLANT BIOTECHNOL J, V4, P317, DOI 10.1111/j.1467-7652.2006.00183.x; van Damme D, 2006, PLANT CELL, V18, P3502, DOI 10.1105/tpc.106.040923; Van Leene J, 2007, MOL CELL PROTEOMICS, V6, P1226, DOI 10.1074/mcp.M700078-MCP200; Vuylsteke M, 2007, NAT PROTOC, V2, P1399, DOI 10.1038/nprot.2007.174; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wilke SA, 2013, J NEUROSCI, V33, P507, DOI 10.1523/JNEUROSCI.1600-12.2013; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	50	84	86	2	158	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					148	+		10.1038/nature12685	http://dx.doi.org/10.1038/nature12685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24213631	Green Accepted, Green Submitted			2022-12-24	WOS:000327851700049
J	Viaud, S; Saccheri, F; Mignot, G; Yamazaki, T; Daillere, R; Hannani, D; Enot, DP; Pfirschke, C; Engblom, C; Pittet, MJ; Schlitzer, A; Ginhoux, F; Apetoh, L; Chachaty, E; Woerther, PL; Eberl, G; Berard, M; Ecobichon, C; Clermont, D; Bizet, C; Gaboriau-Routhiau, V; Cerf-Bensussan, N; Opolon, P; Yessaad, N; Vivier, E; Ryffel, B; Elson, CO; Dore, J; Kroemer, G; Lepage, P; Boneca, IG; Ghiringhelli, F; Zitvogel, L				Viaud, Sophie; Saccheri, Fabiana; Mignot, Gregoire; Yamazaki, Takahiro; Daillere, Romain; Hannani, Dalil; Enot, David P.; Pfirschke, Christina; Engblom, Camilla; Pittet, Mikael J.; Schlitzer, Andreas; Ginhoux, Florent; Apetoh, Lionel; Chachaty, Elisabeth; Woerther, Paul-Louis; Eberl, Gerard; Berard, Marion; Ecobichon, Chantal; Clermont, Dominique; Bizet, Chantal; Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine; Opolon, Paule; Yessaad, Nadia; Vivier, Eric; Ryffel, Bernhard; Elson, Charles O.; Dore, Joel; Kroemer, Guido; Lepage, Patricia; Boneca, Ivo Gomperts; Ghiringhelli, Francois; Zitvogel, Laurence			The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide	SCIENCE			English	Article							BARRIER; CELLS	Cyclophosphamide is one of several clinically important cancer drugs whose therapeutic efficacy is due in part to their ability to stimulate antitumor immune responses. Studying mouse models, we demonstrate that cyclophosphamide alters the composition of microbiota in the small intestine and induces the translocation of selected species of Gram-positive bacteria into secondary lymphoid organs. There, these bacteria stimulate the generation of a specific subset of "pathogenic" T helper 17 (pT(H)17) cells and memory T(H)1 immune responses. Tumor-bearing mice that were germ-free or that had been treated with antibiotics to kill Gram-positive bacteria showed a reduction in pT(H)17 responses, and their tumors were resistant to cyclophosphamide. Adoptive transfer of pT(H)17 cells partially restored the antitumor efficacy of cyclophosphamide. These results suggest that the gut microbiota help shape the anticancer immune response.	[Viaud, Sophie; Saccheri, Fabiana; Yamazaki, Takahiro; Daillere, Romain; Hannani, Dalil; Zitvogel, Laurence] INSERM, U1015, Equipe Labellisee Ligue Natl Canc, Inst Gustave Roussy, Villejuif, France; [Zitvogel, Laurence] Inst Gustave Roussy, Ctr Invest Clin Biotherapie, CICBT 507, Villejuif, France; [Viaud, Sophie; Daillere, Romain; Zitvogel, Laurence] Univ Paris Sud, Le Kremlin Bicetre, France; [Mignot, Gregoire; Apetoh, Lionel; Ghiringhelli, Francois] INSERM, U866, Ctr Georges Francois Leclerc, Dijon, France; [Mignot, Gregoire; Apetoh, Lionel; Ghiringhelli, Francois] INSERM, Grp Avenir, Dijon, France; [Ghiringhelli, Francois] Univ Bourgogne, Fac Med, Dijon, France; [Enot, David P.; Kroemer, Guido] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France; [Enot, David P.; Kroemer, Guido] Inst Gustave Roussy, Metab & Cell Biol, Villejuif, France; [Pfirschke, Christina; Engblom, Camilla; Pittet, Mikael J.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Pfirschke, Christina; Engblom, Camilla; Pittet, Mikael J.] Harvard Univ, Sch Med, Boston, MA USA; [Schlitzer, Andreas; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN Agcy Sci, Singapore, Singapore; [Chachaty, Elisabeth; Woerther, Paul-Louis] Inst Gustave Roussy, Microbiol Serv, Villejuif, France; [Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, Paris, France; [Berard, Marion] Inst Pasteur, Animalerie Cent, Paris, France; [Ecobichon, Chantal; Boneca, Ivo Gomperts] Inst Pasteur, Unit Biol & Genet Bacterial Cell Wall, Paris, France; [Ecobichon, Chantal; Boneca, Ivo Gomperts] INSERM, Grp Avenir, Paris, France; [Clermont, Dominique; Bizet, Chantal] Inst Pasteur, Collect Inst Pasteur, Paris, France; [Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine; Dore, Joel; Lepage, Patricia] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Gaboriau-Routhiau, Valerie; Cerf-Bensussan, Nadine] Univ Paris 05, INSERM, U989, F-75730 Paris, France; [Opolon, Paule] Inst Gustave Roussy, IFR54, Villejuif, France; [Opolon, Paule] Inst Gustave Roussy, IRCIV, Lab Pathol Expt, Villejuif, France; [Yessaad, Nadia; Vivier, Eric] Aix Marseille Univ UM2, Ctr Immunol Marseille Luminy, Marseille, France; [Yessaad, Nadia; Vivier, Eric] INSERM, UMR 1104, F-13258 Marseille, France; [Yessaad, Nadia; Vivier, Eric] Ctr Natl Rech Sci, UMR 7280, Marseille, France; [Yessaad, Nadia; Vivier, Eric] Hop Conception, Assistance Publ Hop Marseille, Marseille, France; [Ryffel, Bernhard] Univ Orleans, CNRS, Lab Mol & Expt Immunol & Neurogenet, UMR 7355, Orleans, France; [Elson, Charles O.] Univ Alabama Birmingham, Birmingham, AL USA; [Dore, Joel; Lepage, Patricia] AgroParisTech, Micalis UMR1319, F-78352 Jouy En Josas, France; [Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France; [Kroemer, Guido] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Georges-Francois Leclerc; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Agency for Science Technology & Research (A*STAR); UNICANCER; Gustave Roussy; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; University of Alabama System; University of Alabama Birmingham; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Zitvogel, L (corresponding author), INSERM, U1015, Equipe Labellisee Ligue Natl Canc, Inst Gustave Roussy, Villejuif, France.	laurence.zitvogel@gustaveroussy.fr	Vivier, Eric/F-8939-2010; Eberl, Gerard/A-1160-2013; Mignot, Grégoire/R-4976-2017; Pittet, Mikael/ABD-6300-2021; Kroemer, Guido/AAY-9859-2020; Boneca, Ivo G/H-1677-2014; Dore, Joel/ABA-8921-2020; KROEMER, Guido/B-4263-2013; GABORIAU-ROUTHIAU, Valérie/H-9493-2017; Lepage, Patricia/D-4362-2014; WOERTHER, Paul-Louis/AAC-4637-2019; Schlitzer, Andreas/R-2237-2016; Cerf-Bensussan, nadine/H-9505-2017; Woerther, Paul-Louis/ABD-9084-2020; Apetoh, Lionel/G-3310-2014; Apetoh, Lionel/AIC-2384-2022; Hannani, Dalil/AAH-4598-2019	Vivier, Eric/0000-0001-7022-8287; Mignot, Grégoire/0000-0002-0682-0152; Boneca, Ivo G/0000-0001-8122-509X; KROEMER, Guido/0000-0002-9334-4405; GABORIAU-ROUTHIAU, Valérie/0000-0002-7662-4034; Lepage, Patricia/0000-0002-9501-6771; Schlitzer, Andreas/0000-0001-7662-3712; Cerf-Bensussan, nadine/0000-0003-0665-1245; Woerther, Paul-Louis/0000-0002-6957-9482; Apetoh, Lionel/0000-0002-2774-438X; Apetoh, Lionel/0000-0002-2774-438X; Hannani, Dalil/0000-0001-5097-1401; ZITVOGEL, laurence/0000-0003-1596-0998; ghiringhelli, francois/0000-0002-5465-8305; Eberl, Gerard/0000-0002-1119-5638	Institut National du Cancer (INCa); la Ligue contre le cancer (LIGUE labelisee); SIRIC Socrates; LABEX; PACRI Onco-Immunology; European Research Council [202283]; NIH [P01DK071176]; NATIONAL CANCER INSTITUTE [P50CA086355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK071176] Funding Source: NIH RePORTER	Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); la Ligue contre le cancer (LIGUE labelisee); SIRIC Socrates; LABEX; PACRI Onco-Immunology; European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Angelique (Institut Pasteur), C. Flament, M. Vetizou (Gustave Roussy), and K. LeRoux (INRA) for technical assistance. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by Institut National du Cancer (INCa), la Ligue contre le cancer (LIGUE labelisee, L.Z., G.K.), SIRIC Socrates, LABEX, and PACRI Onco-Immunology, European Research Council Advanced Grant (to G.K.), and European Research Council starting grant (PGNfromSHAPEtoVIR no. 202283 to I.G.B.), and partially supported by NIH grant P01DK071176 (C.O.E.).	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Fishman N, 2006, AM J INFECT CONTROL, V34, pS64, DOI 10.1016/j.ajic.2006.05.229; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Ghiringhelli F, 2004, EUR J IMMUNOL, V34, P336, DOI 10.1002/eji.200324181; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Rice LB, 2006, AM J INFECT CONTROL, V34, pS11, DOI 10.1016/j.ajic.2006.05.220; Schiavoni G, 2011, CANCER RES, V71, P768, DOI 10.1158/0008-5472.CAN-10-2788; Sistigu A, 2011, SEMIN IMMUNOPATHOL, V33, P369, DOI 10.1007/s00281-011-0245-0; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Viaud S, 2011, CANCER RES, V71, P661, DOI 10.1158/0008-5472.CAN-10-1259; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yang J, 2013, EUR J PHARMACOL, V714, P120, DOI 10.1016/j.ejphar.2013.06.006; Zwielehner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028654	24	1146	1243	26	346	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					971	976		10.1126/science.1240537	http://dx.doi.org/10.1126/science.1240537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264990	Green Accepted			2022-12-24	WOS:000327223500041
J	Taylor, MS; LaCava, J; Mita, P; Molloy, KR; Huang, CRL; Li, DH; Adney, EM; Jiang, H; Burns, KH; Chait, BT; Rout, MP; Boeke, JD; Dai, LX				Taylor, Martin S.; LaCava, John; Mita, Paolo; Molloy, Kelly R.; Huang, Cheng Ran Lisa; Li, Donghui; Adney, Emily M.; Jiang, Hua; Burns, Kathleen H.; Chait, Brian T.; Rout, Michael P.; Boeke, Jef D.; Dai, Lixin			Affinity Proteomics Reveals Human Host Factors Implicated in Discrete Stages of LINE-1 Retrotransposition	CELL			English	Article							PRIMED REVERSE TRANSCRIPTION; LONG INTERSPERSED ELEMENT-1; HUMAN L1 RETROTRANSPOSITION; ORF1 PROTEIN; RNA INTERFERENCE; DNA-REPLICATION; CULTURED-CELLS; ENDONUCLEASE; COMPLEXES; REQUIREMENTS	LINE-1s are active human DNA parasites that are agents of genome dynamics in evolution and disease. These streamlined elements require host factors to complete their life cycles, whereas hosts have developed mechanisms to combat retrotransposition's mutagenic effects. As such, endogenous L1 expression levels are extremely low, creating a roadblock for detailed interactomic analyses. Here, we describe a system to express and purify highly active L1 RNP complexes from human suspension cell culture and characterize the copurified proteome, identifying 37 high-confidence candidate interactors. These data sets include known interactors PABPC1 and MOV10 and, with in-cell imaging studies, suggest existence of at least three types of compositionally and functionally distinct L1 RNPs. Among the findings, UPF1, a key nonsense-mediated decay factor, and PCNA, the polymerase-delta-associated sliding DNA clamp, were identified and validated. PCNA interacts with ORF2p via a PIP box motif; mechanistic studies suggest that this occurs during or immediately after target-primed reverse transcription.	[Taylor, Martin S.; Mita, Paolo; Huang, Cheng Ran Lisa; Li, Donghui; Adney, Emily M.; Boeke, Jef D.; Dai, Lixin] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Taylor, Martin S.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [LaCava, John; Jiang, Hua; Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10021 USA; [Mita, Paolo; Huang, Cheng Ran Lisa; Li, Donghui; Adney, Emily M.; Boeke, Jef D.; Dai, Lixin] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Molloy, Kelly R.; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; [Huang, Cheng Ran Lisa; Li, Donghui; Adney, Emily M.; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Rockefeller University; Johns Hopkins University; Rockefeller University; Johns Hopkins University; Johns Hopkins University	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA.	jboeke@jhmi.edu; lxdai@jhmi.edu	Li, Donghui/AAE-9310-2021; Rout, Michael/Y-7090-2018; LaCava, John P/H-2840-2013	LaCava, John P/0000-0002-6307-7713; Burns, Kathleen/0000-0003-1620-3761; Taylor, Martin/0000-0003-1560-9276; Rout, Michael/0000-0003-2010-706X; Taylor, Martin/0000-0001-5824-142X	NIH [U54 GM103511, R01 GM36481, U54 GM103520, P41 GM103314]; NATIONAL CANCER INSTITUTE [R01CA163705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103314, U54GM103520, U54GM103511, T32GM007814, P50GM107632, R01GM036481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jeffrey Han for gifts of antibodies and helpful discussions; Phil Cole and Carolyn Machamer for helpful discussion and critical reading of the manuscript; Jennifer Wang, Chih-Yung Lee, and Geraldine Seydoux for assistance with confocal microscopy and helpful discussions; and Yana Li, Dan Leahy, Jennifer Kavran, and Jacqueline McCabe for help with suspension cell culture. The DNA template for artwork in Figure 7 was adapted from http://www.dragonartz.net with permission. This work was supported in part by NIH grant U54 GM103511 to M.P.R. and B.T.C., grants R01 GM36481 and U54 GM103520 to J.D.B., and grant P41 GM103314 to B.T.C.	Alisch RS, 2006, GENE DEV, V20, P210, DOI 10.1101/gad.1380406; An WF, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-2; Arjan-Odedra S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-53; Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Beattie TR, 2011, BIOCHEM SOC T, V39, P70, DOI 10.1042/BST0390070; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Belancio VP, 2007, GENE, V390, P98, DOI 10.1016/j.gene.2006.07.029; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Buzdin A, 2002, GENOMICS, V80, P402, DOI 10.1006/geno.2002.6843; Cost GJ, 2002, EMBO J, V21, P5899, DOI 10.1093/emboj/cdf592; Coufal NG, 2011, P NATL ACAD SCI USA, V108, P20382, DOI 10.1073/pnas.1100273108; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Dai LX, 2012, MOL CELL BIOL, V32, P4323, DOI 10.1128/MCB.06785-11; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Domanski Michal, 2012, Biotechniques, V0, P1, DOI 10.2144/000113864; Doucet AJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001150; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Fuchs G, 2006, NAT STRUCT MOL BIOL, V13, P1002, DOI 10.1038/nsmb1156; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Goodier JL, 2013, NUCLEIC ACIDS RES, V41, P7401, DOI 10.1093/nar/gkt512; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Goodier JL, 2010, HUM MOL GENET, V19, P1712, DOI 10.1093/hmg/ddq048; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hernan R, 2000, BIOTECHNIQUES, V28, P789, DOI 10.2144/00284pf01; Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Khazina E, 2011, NAT STRUCT MOL BIOL, V18, P1006, DOI 10.1038/nsmb.2097; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Kubota T, 2013, MOL CELL, V50, P273, DOI 10.1016/j.molcel.2013.02.012; Kulpa DA, 2005, HUM MOL GENET, V14, P3237, DOI 10.1093/hmg/ddi354; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; LUAN DD, 1995, MOL CELL BIOL, V15, P3882; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Mandal PK, 2013, HUM MOL GENET, V22, P3730, DOI 10.1093/hmg/ddt225; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; O'Donnell KA, 2013, P NATL ACAD SCI USA, V110, pE2706, DOI 10.1073/pnas.1302504110; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Peddigari S, 2013, NUCLEIC ACIDS RES, V41, P575, DOI 10.1093/nar/gks1075; Repanas K, 2007, NUCLEIC ACIDS RES, V35, P4914, DOI 10.1093/nar/gkm516; Repanas K, 2009, PROTEINS, V74, P917, DOI 10.1002/prot.22201; Rosenbaum J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003906; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shigeoka T, 2012, NUCLEIC ACIDS RES, V40, P6887, DOI 10.1093/nar/gks344; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Simbulan-Rosenthal CM, 1999, MOL CELL BIOCHEM, V193, P137, DOI 10.1023/A:1006988832729; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Soifer HS, 2005, NUCLEIC ACIDS RES, V33, P846, DOI 10.1093/nar/gki223; Suzuki J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000461; Tackett AJ, 2005, J PROTEOME RES, V4, P1752, DOI 10.1021/pr050225e; Tani H, 2012, RNA BIOL, V9, P1370, DOI 10.4161/rna.22360; Ulrich HD, 2011, FEBS LETT, V585, P2861, DOI 10.1016/j.febslet.2011.05.028; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Weichenrieder O, 2004, STRUCTURE, V12, P975, DOI 10.1016/j.str.2004.04.011; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	70	122	124	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1034	1048		10.1016/j.cell.2013.10.021	http://dx.doi.org/10.1016/j.cell.2013.10.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267889	Green Accepted, Bronze			2022-12-24	WOS:000327500600009
J	Carter, ME; Soden, ME; Zweifel, LS; Palmiter, RD				Carter, Matthew E.; Soden, Marta E.; Zweifel, Larry S.; Palmiter, Richard D.			Genetic identification of a neural circuit that suppresses appetite	NATURE			English	Article							CANINE ADENOVIRUS VECTORS; FOS-LIKE IMMUNOREACTIVITY; PARABRACHIAL NUCLEUS; THERMOSENSORY PATHWAY; RAT-BRAIN; NEURONS; EXPRESSION; IMMUNE; AMYGDALA; PEPTIDE	Appetite suppression occurs after a meal and in conditions when it is unfavourable to eat, such as during illness or exposure to toxins. A brain region proposed to play a role in appetite suppression is the parabrachial nucleus(1-3), a heterogeneous population of neurons surrounding the superior cerebellar peduncle in the brainstem. The parabrachial nucleus is thought to mediate the suppression of appetite induced by the anorectic hormones amylin and cholecystokinin(2), as well as by lithium chloride and lipopolysaccharide, compounds that mimic the effects of toxic foods and bacterial infections, respectively(4-6). Hyperactivity of the parabrachial nucleus is also thought to cause starvation after ablation of orexigenic agouti-related peptide neurons in adult mice(1,7). However, the identities of neurons in the parabrachial nucleus that regulate feeding are unknown, as are the functionally relevant downstream projections. Here we identify calcitonin gene-related peptide-expressing neurons in the outer external lateral subdivision of the parabrachial nucleus that project to the laterocapsular division of the central nucleus of the amygdala as forming a functionally important circuit for suppressing appetite. Using genetically encoded anatomical, optogenetic(8) and pharmacogenetic(9) tools, we demonstrate that activation of these neurons projecting to the central nucleus of the amygdala suppresses appetite. In contrast, inhibition of these neurons increases food intake in circumstances when mice do not normally eat and prevents starvation in adult mice whose agouti-related peptide neurons are ablated. Taken together, our data demonstrate that this neural circuit from the parabrachial nucleus to the central nucleus of the amygdala mediates appetite suppression in conditions when it is unfavourable to eat. This neural circuit may provide targets for therapeutic intervention to overcome or promote appetite.	[Carter, Matthew E.; Palmiter, Richard D.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Carter, Matthew E.; Palmiter, Richard D.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Soden, Marta E.; Zweifel, Larry S.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Soden, Marta E.; Zweifel, Larry S.] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	palmiter@uw.edu	Zweifel, Larry/O-3284-2017	Zweifel, Larry/0000-0003-3465-5331; Carter, Matthew/0000-0003-1802-090X; Soden, Marta/0000-0002-0695-8653	Hilda and Preston Davis Foundation; National Institutes of Health [R01MH094536, R01DA024908]; Klarman Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024908] Funding Source: NIH RePORTER	Hilda and Preston Davis Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klarman Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Roth for hM<INF>3</INF>Dq-mCherry and hM<INF>4</INF>Di-mCherry constructs, and K. Deisseroth for mCherry and ChR2-mCherry constructs. E. Allen, J. Resnick, M. Soleiman and S. Padilla assisted with histology, E. Allen and A. Rainwater assisted with animal husbandry, and J. Shulkin provided suggestions and advice. We thank members of the Palmiter and Zweifel laboratories for feedback on the manuscript. M. E. C. is financed by a fellowship from the Hilda and Preston Davis Foundation. L.S.Z. is financed by a grant from the National Institutes of Health (R01MH094536). R. D. P is supported in part by grants from the National Institutes of Health (R01DA024908) and the Klarman Family Foundation.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Becskei C, 2007, BRAIN RES, V1162, P76, DOI 10.1016/j.brainres.2007.06.016; CHAMBERLIN NL, 1994, J NEUROSCI, V14, P6500; D'Hanis W, 2007, J COMP NEUROL, V505, P268, DOI 10.1002/cne.21495; DiPatrizio NV, 2008, J NEUROSCI, V28, P9702, DOI 10.1523/JNEUROSCI.1171-08.2008; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Elmquist JK, 1996, J COMP NEUROL, V371, P85, DOI 10.1002/(SICI)1096-9861(19960715)371:1<85::AID-CNE5>3.0.CO;2-H; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Geerling JC, 2007, J COMP NEUROL, V504, P379, DOI 10.1002/cne.21452; Geerling JC, 2011, BRAIN RES, V1375, P19, DOI 10.1016/j.brainres.2010.11.028; Hermanson O, 1996, J COMP NEUROL, V368, P45, DOI 10.1002/(SICI)1096-9861(19960422)368:1<45::AID-CNE4>3.0.CO;2-K; JACOBS JW, 1981, SCIENCE, V213, P457, DOI 10.1126/science.6264603; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Lenth RV, 2001, AM STAT, V55, P187, DOI 10.1198/000313001317098149; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Nakamura K, 2008, NAT NEUROSCI, V11, P62, DOI 10.1038/nn2027; Nakamura K, 2010, P NATL ACAD SCI USA, V107, P8848, DOI 10.1073/pnas.0913358107; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Paues J, 2006, NEUROSCIENCE, V141, P287, DOI 10.1016/j.neuroscience.2006.03.041; Paues J, 2001, NEUROREPORT, V12, P2399, DOI 10.1097/00001756-200108080-00023; Paxinos G, 2013, MOUSE BRAIN STEREOTA; Richard S, 2005, J COMP NEUROL, V481, P210, DOI 10.1002/cne.20384; Rosen AM, 2011, J NEUROPHYSIOL, V105, P1889, DOI 10.1152/jn.00836.2010; SCHWABER JS, 1988, J COMP NEUROL, V270, P416, DOI 10.1002/cne.902700310; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Tokita K, 2012, J NEUROPHYSIOL, V108, P2179, DOI 10.1152/jn.00465.2012; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; YAMAMOTO T, 1992, NEUROREPORT, V3, P1049, DOI 10.1097/00001756-199212000-00004; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	34	370	379	8	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					111	+		10.1038/nature12596	http://dx.doi.org/10.1038/nature12596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24121436	Green Accepted			2022-12-24	WOS:000326585600042
J	Delgado-Baquerizo, M; Maestre, FT; Gallardol, A; Bowker, MA; Wallenstein, MD; Quero, JL; Ochoa, V; Gozalo, B; Garcia-Gomez, M; Soliveres, S; Garcia-Palacios, P; Berdugo, M; Valencia, E; Escolar, C; Arredondol, T; Barraza-Zepeda, C; Bran, D; Carreiral, JA; Chaiebll, M; Conceicao, AA; Derak, M; Eldridge, DL; Escudero, A; Espinosa, CI; Gaitan, J; Gatica, MG; Gomez-Gonzalez, S; Guzman, E; Gutierrez, JR; Florentino, A; Hepper, E; Hernandez, RM; Huber-Sannwald, E; Jankju, M; Liu, JS; Mau, RL; Miriti, M; Monerris, J; Naseri, K; Noumi, Z; Polo, V; Prina, A; Pucheta, E; Ramirez, E; Ramirez-Collantes, DA; Romao, R; Tighe, M; Torres, D; Torres-Diaz, C; Ungar, ED; Val, J; Wamiti, W; Wang, DL; Zaady, E				Delgado-Baquerizo, Manuel; Maestre, Fernando T.; Gallardol, Antonio; Bowker, Matthew A.; Wallenstein, Matthew D.; Luis Quero, Jose; Ochoa, Victoria; Gozalo, Beatriz; Garcia-Gomez, Miguel; Soliveres, Santiago; Garcia-Palacios, Pablo; Berdugo, Miguel; Valencia, Enrique; Escolar, Cristina; Arredondo, Turin; Barraza-Zepeda, Claudia; Bran, Donald; Antonio Carreiral, Jose; Chaieb, Mohamed; Conceicao, Abel A.; Derak, Mchich; Eldridge, David J.; Escudero, Adrian; Espinosa, Carlos I.; Gaitan, Juan; Gatica, M. Gabriel; Gomez-Gonzalez, Susana; Guzman, Elizabeth; Gutierrez, Julio R.; Florentino, Adriana; Hepper, Estela; Hernandez, Rosa M.; Huber-Sannwald, Elisabeth; Jankju, Mohammad; Liu, Jushan; Mau, Rebecca L.; Miriti, Maria; Monerris, Jorge; Naseri, Kamal; Noumi, Zouhaier; Polo, Vicente; Prina, Anibal; Pucheta, Eduardo; Ramirez, Elizabeth; Ramirez-Collantes, David A.; Romao, Roberto; Tighe, Matthew; Torres, Duiio; Torres-Diaz, Cristian; Ungar, Eugene D.; Val, James; Wamiti, Wanyoike; Wang, Deli; Zaady, Eli			Decoupling of soil nutrient cycles as a function of aridity in global drylands	NATURE			English	Article							DISSOLVED ORGANIC NITROGEN; BIOGEOCHEMICAL CYCLES; PHOSPHORUS; CARBON; MATTER; TRANSFORMATIONS; SHRUBLANDS; RETENTION; FEEDBACKS; RESPONSES	The biogeochemical cycles of carbon (C), nitrogen (N) and phosphorus (P) are interlinked by primary production, respiration and decomposition in terrestrial ecosystems(1). It has been suggested that the C, N and P cycles could become uncoupled under rapid climate change because of the different degrees of control exerted on the supply of these elements by biological and geochemical processes(1-5). Climatic controls on biogeochemical cycles are particularly relevant in arid, semi-arid and dry sub-humid ecosystems (drylands) because their biological activity is mainly driven by water availability(6-8). The increase in aridity predicted for the twenty-first century in many drylands worldwide(9-11) may therefore threaten the balance between these cycles, differentially affecting the availability of essential nutrients(12-14). Here we evaluate how aridity affects the balance between C, N and P in soils collected from 224 dryland sites from all continents except Antarctica. We find a negative effect of aridity on the concentration of soil organic C and total N, but a positive effect on the concentration of inorganic P. Aridity is negatively related to plant cover, which may favour the dominance of physical processes such as rock weathering, a major source of P to ecosystems, over biological processes that provide more C and N, such as litter decomposition(12-14). Our findings suggest that any predicted increase in aridity with climate change will probably reduce the concentrations of N and C in global drylands, but increase that of P. These changes would uncouple the C, N and P cycles in drylands and could negatively affect the provision of key services provided by these ecosystems.	[Delgado-Baquerizo, Manuel; Gallardol, Antonio] Univ Pablo Olavide, Dept Sistemas Fis Quim & Nat, Seville 41013, Spain; [Delgado-Baquerizo, Manuel; Maestre, Fernando T.; Luis Quero, Jose; Ochoa, Victoria; Gozalo, Beatriz; Garcia-Gomez, Miguel; Soliveres, Santiago; Berdugo, Miguel; Valencia, Enrique; Escolar, Cristina; Escudero, Adrian; Polo, Vicente] Univ Rey Juan Carlos, Dept Biol & Geol, Area Biodiversidad & Conservac, Escuela Super Ciencias Expt & Tecnol, Mostoles 28933, Spain; [Bowker, Matthew A.] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Wallenstein, Matthew D.; Garcia-Palacios, Pablo] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Luis Quero, Jose] Univ Cordoba, Dept Ingn Forestal, E-14071 Cordoba, Spain; [Garcia-Palacios, Pablo] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Arredondo, Turin; Huber-Sannwald, Elisabeth] Inst Potosino Invest Cient Tecnol, Div Ciencias Ambientales, San Luis Potosi 78210, Mexico; [Barraza-Zepeda, Claudia; Gutierrez, Julio R.] Univ La Serena, Dept Biol, Coquimbo Region 1700000, Chile; [Bran, Donald; Gaitan, Juan] Inst Nacl Tecnol Agropecuaria, Estn Expt San Carlos Bariloche 277, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Antonio Carreiral, Jose] Univ Jaen, Dept Biol Anim Biol Vegetal & Ecol, Jaen 23071, Spain; [Chaieb, Mohamed; Noumi, Zouhaier] Univ Sfax, Fac Sci, Unite Rech Plant Divers & Ecosyst Arid Environm, Sfax 3018, Tunisia; [Conceicao, Abel A.; Romao, Roberto] Univ Estadual Feira de Santana, Dept Ciencias Biol, Bairro Novo Horizonte 44036, Feira De Santan, Brazil; [Derak, Mchich] Direct Reg Eaux & Forets & Lutte Desertificat Rif, Tetouan 93000, Morocco; [Eldridge, David J.] Univ New S Wales, Sch Biol Earth Environm Sci, Sydney, NSW 2052, Australia; [Espinosa, Carlos I.; Guzman, Elizabeth] Univ Tecn Particular Loja, Inst Ecol, Marcelino Champagnat, Loja, Ecuador; [Gatica, M. Gabriel; Pucheta, Eduardo] Univ Nacl San Juan, Dept Biol, Fac Ciencias Exactas Fis & Nat, Rivadavia, San Juan, Argentina; [Gomez-Gonzalez, Susana; Torres-Diaz, Cristian] Univ Bio Bio 447, Dept Ciencias Basicas, Lab Genom & Biodiversidad, Chillan 3780000, Chile; [Florentino, Adriana] Cent Univ Venezuela, Fac Agron, Inst Edafol, Caracas 1051, Venezuela; [Hepper, Estela; Prina, Anibal] Univ Nacl La Pampa, Fac Agron, RA-6300 Santa Rosa, La Pampa, Argentina; [Hernandez, Rosa M.; Ramirez, Elizabeth] Univ Expt Simon Rodriguez, Ctr Agroecol Trop, Lab Biogeoquim, Caracas 47925, Venezuela; [Jankju, Mohammad; Naseri, Kamal] Ferdowsi Univ Mashhad, Dept Range & Watershed Management, Fac Nat Resources & Environm, Mashhad 917751363, Iran; [Liu, Jushan; Wang, Deli] NE Normal Univ, Inst Grassland Sci, Changchun 130024, Jilin Province, Peoples R China; [Liu, Jushan; Wang, Deli] Minist Educ, Key Lab Vegetat Ecol, Changchun 130024, Jilin Province, Peoples R China; [Mau, Rebecca L.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 36011 USA; [Miriti, Maria] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Monerris, Jorge] Univ Quebec, Dept Sci Biol, Montreal, PQ H2X 3Y5, Canada; [Ramirez-Collantes, David A.] Int Potato Ctr, Prod Syst & Environm Sub Program, Lima, Peru; [Tighe, Matthew] Univ New England, Sch Environm & Rural Sci, Dept Agron & Soil Sci, Armidale, NSW 2351, Australia; [Torres, Duiio] Univ Centroccidental Lisandro Alvarado, Dept Quim & Suelos, Barquisimeto 3001, Venezuela; [Ungar, Eugene D.] Agr Res Org, Volcani Ctr, Inst Plant Sci, Dept Agron & Nat Resources, IL-50250 Bet Dagan, Israel; [Val, James] Off Environm & Heritage, Buronga, NSW 2739, Australia; [Wamiti, Wanyoike] Natl Museums Kenya, Dept Zool, Nairobi 7842000500, Kenya; [Zaady, Eli] Agr Res Org, Dept Nat Resources & Agron, Minist Agr, IL-85280 Negev, Israel	Universidad Pablo de Olavide; Universidad Rey Juan Carlos; Northern Arizona University; Colorado State University; Universidad de Cordoba; Colorado State University; Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad de La Serena; Instituto Nacional de Tecnologia Agropecuaria (INTA); Universidad de Jaen; Universite de Sfax; Faculty of Sciences Sfax; Universidade Estadual de Feira de Santana; University of New South Wales Sydney; Universidad Tecnica Particular de Loja; Universidad Nacional de San Juan; University of Central Venezuela; Ferdowsi University Mashhad; Northeast Normal University - China; Northern Arizona University; University System of Ohio; Ohio State University; University of Quebec; University of Quebec Montreal; CGIAR; International Potato Center (CIP); University of New England; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Office of Environment & Heritage - New South Wales	Delgado-Baquerizo, M (corresponding author), Univ Pablo Olavide, Dept Sistemas Fis Quim & Nat, Carretera Utrera,Kilometro 1, Seville 41013, Spain.	mdelbaq@upo.es	Barraza Zepeda, Claudia Elizabeth/P-7311-2015; Conceição, Abel A/A-7544-2012; Bowker, Matthew/B-6258-2014; Gutierrez, Julio R/A-8367-2011; García-Palacios, Pablo/K-7567-2014; Codina, Santiago Soliveres/A-2291-2016; Wallenstein, Matthew D/S-3512-2016; Valencia, Enrique/AAR-1438-2021; Espinosa, Carlos Ivan/AAI-1305-2019; DELGADO-BAQUERIZO, MANUEL/GLS-0346-2022; Pérez, Jose Luis Quero/M-1074-2013; DE LA FUENTE, JOSÉ ANTONIO CARREIRA/A-7484-2011; Hernández, Rosa/GRF-5998-2022; Farzam, Mohammad/AAU-7275-2020; Delgado-Baquerizo, Manuel/L-3653-2017; Gómez-González, Susana/AAL-2631-2021; Wallenstein, Matthew/C-6441-2008; Gallardo, Antonio/L-3941-2017; Maestre, Fernando T./A-6825-2008; Tighe, Matt/AAC-5369-2019; Escudero, Adrián/H-5046-2015; Huber-Sannwald, Elisabeth/D-2507-2009; GOMEZ-GONZALEZ, SUSANA/J-7637-2018; Ramirez, David/Q-5522-2017; Arredondo Moreno, Jose Tulio/A-9972-2015; Alvarez, Sergio/H-9727-2015	Conceição, Abel A/0000-0001-7461-0133; Bowker, Matthew/0000-0002-5891-0264; García-Palacios, Pablo/0000-0002-6367-4761; Codina, Santiago Soliveres/0000-0001-9661-7192; Wallenstein, Matthew D/0000-0002-6219-1442; Espinosa, Carlos Ivan/0000-0002-5330-4505; DELGADO-BAQUERIZO, MANUEL/0000-0002-6499-576X; Pérez, Jose Luis Quero/0000-0001-5553-506X; DE LA FUENTE, JOSÉ ANTONIO CARREIRA/0000-0002-5995-076X; Farzam, Mohammad/0000-0003-1947-0187; Delgado-Baquerizo, Manuel/0000-0002-6499-576X; Gómez-González, Susana/0000-0002-3779-8701; Wallenstein, Matthew/0000-0002-6219-1442; Gallardo, Antonio/0000-0002-2674-4265; Maestre, Fernando T./0000-0002-7434-4856; Tighe, Matt/0000-0003-1027-0082; Escudero, Adrián/0000-0002-1427-5465; GOMEZ-GONZALEZ, SUSANA/0000-0002-3779-8701; Ramirez, David/0000-0003-4546-9745; Arredondo Moreno, Jose Tulio/0000-0003-1969-9942; bran, donaldo/0000-0001-7749-2726; Alvarez, Sergio/0000-0001-7204-502X; Prina, Anibal/0000-0003-3522-9342; Gatica, Gabriel/0000-0003-2883-2565; Huber- Sannwald, Elisabeth/0000-0002-8321-1270; Barraza Zepeda, Claudia Elizabeth/0000-0002-8766-0700; Gutierrez, Julio/0000-0002-1099-1341; Berdugo, Miguel/0000-0003-1053-8907; Valencia, Enrique/0000-0003-3359-0759; Wamiti, Wanyoike/0000-0001-7300-2101; Vicente, Polo/0000-0002-0994-5372; Hernandez Hernandez, Rosa Mary/0000-0003-0689-8862; gaitan, juan/0000-0003-2889-1418	European Research Council (ERC) under the European Community [242658]; Ministry of Science and Innovation of the Spanish Government [CGL2010-21381]; CYTED [Accion 407AC0323]; Pablo de Olavide University	European Research Council (ERC) under the European Community(European Research Council (ERC)); Ministry of Science and Innovation of the Spanish Government(Spanish Government); CYTED; Pablo de Olavide University	We thank M. Scheffer, N. J. Gotelli and R. Bardgett for comments on previous versions of the manuscript, and all the technicians and colleagues who helped with the field surveys and laboratory analyses. This research is supported by the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. 242658 (BIOCOM), and by the Ministry of Science and Innovation of the Spanish Government, grant no. CGL2010-21381. CYTED funded networking activities (EPES, Accion 407AC0323). M.D.-B. was supported by a PhD fellowship from the Pablo de Olavide University.	Anderson J. M., 1993, TROPICAL SOIL BIOL F; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Blanco H., 2010, PRINCIPLES SOIL CONS; BOWMAN RA, 1978, SOIL SCI, V125, P49, DOI 10.1097/00010694-197801000-00008; Carreira JA, 1997, BIOGEOCHEMISTRY, V39, P87, DOI 10.1023/A:1005871404474; Cerda A, 1997, J ARID ENVIRON, V36, P37, DOI 10.1006/jare.1995.0198; Chantigny M. H, 2006, SOIL SAMPLING METHOD; Cornelis W. S., 2006, DRYLAND ECOHYDROLOGY; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Cross AF, 2001, BIOGEOCHEMISTRY, V52, P155, DOI 10.1023/A:1006437504494; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Delgado-Baquerizo M, 2011, PEDOSPHERE, V21, P309, DOI 10.1016/S1002-0160(11)60131-8; Eldridge DJ, 2010, ECOSYSTEMS, V13, P499, DOI 10.1007/s10021-010-9335-4; Evans SE, 2013, ECOSYSTEMS, V16, P20, DOI 10.1007/s10021-012-9593-4; Feng S, 2013, ATMOS CHEM PHYS, V13, P10081, DOI 10.5194/acp-13-10081-2013; Finzi AC, 2011, FRONT ECOL ENVIRON, V9, P61, DOI 10.1890/100001; Food and Agriculture Organization (FAO), 1989, AR ZON FOR GUID FIEL; Gao XJ, 2008, GLOBAL PLANET CHANGE, V62, P195, DOI 10.1016/j.gloplacha.2008.02.002; Grace J.B., 2006, STRUCT EQ MOD NAT; Helmut G., 2005, CAUSES PROGR DESERTI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Johnson P.M., 2006, GOVERNING GLOBAL DES; Kandeler E., 2007, SOIL MICROBIOLOGY EC, V3rd ed., P53; LAJTHA K, 1988, SOIL SCI, V146, P160, DOI 10.1097/00010694-198809000-00003; Li J, 2007, BIOGEOCHEMISTRY, V85, P317, DOI 10.1007/s10533-007-9142-y; Liebig J., 1842, CHEM ITS APPL AGR PH; Maestre FT, 2012, PHILOS T R SOC B, V367, P3062, DOI 10.1098/rstb.2011.0323; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Maestre FT, 2003, ECOLOGY, V84, P3186, DOI 10.1890/02-0635; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; MARSHALL KC, 1975, ANNU REV PHYTOPATHOL, V13, P357, DOI 10.1146/annurev.py.13.090175.002041; MCGILL WB, 1981, GEODERMA, V26, P267, DOI 10.1016/0016-7061(81)90024-0; Michael B., 2003, HUMAN IMPACT ENV SUS; Morford SL, 2011, NATURE, V477, P78, DOI 10.1038/nature10415; Nannipieri P, 2011, SOIL BIOL, V26, P215, DOI 10.1007/978-3-642-15271-9_9; Neff JC, 2003, FRONT ECOL ENVIRON, V1, P205, DOI 10.1890/1540-9295(2003)001[0205:BITCDO]2.0.CO;2; OADES JM, 1988, BIOGEOCHEMISTRY, V5, P35, DOI 10.1007/BF02180317; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Reynolds JF, 1999, ECOL MONOGR, V69, P69, DOI 10.1890/0012-9615(1999)069[0069:IODODS]2.0.CO;2; ROBERTS TL, 1985, CAN J SOIL SCI, V65, P651, DOI 10.4141/cjss85-071; Robertson GP, 2015, SOIL MICROBIOLOGY EC, V4th, P421, DOI [10.1016/B978-0-08-047514-1.50017-2, 10.1016/b978-0-12-415955-6.00014-1, DOI 10.1016/B978-0-12-415955-6.00014-1]; Rovira P, 2002, GEODERMA, V107, P109, DOI 10.1016/S0016-7061(01)00143-4; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schimel DS, 2010, SCIENCE, V327, P418, DOI 10.1126/science.1184946; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schlesinger W.M., 1996, BIOGEOCHEMISTRY ANAL; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; SCHOENAU JJ, 1989, BIOGEOCHEMISTRY, V8, P223, DOI 10.1007/BF00002890; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; SHIPLEY B, 2001, CAUSE CORRELATION BI; Sinsabaugh R. L., 2002, ENZYMES ENV; Stotzky G, 1972, CRC Crit Rev Microbiol, V2, P59, DOI 10.3109/10408417209108383; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; Tiessen H., 1993, SOIL SAMPL METHODS A, V7, P5; Tietjen T, 2003, AQUAT ECOL, V37, P331, DOI 10.1023/B:AECO.0000007044.52801.6b; Vicente-Serrano SM, 2012, ECOL MONOGR, V82, P407, DOI 10.1890/11-2164.1; Vitousek, 2004, NUTR CYCLING LIMITAT; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Whitford W., 2002, ECOLOGY DESERT SYSTE; Yerima P. K., 2005, INTRO SOIL SCI SOILS; Zomer R., 2006, CARBON LAND WATER GL	72	530	581	75	1060	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					672	+		10.1038/nature12670	http://dx.doi.org/10.1038/nature12670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24172979				2022-12-24	WOS:000326293200045
J	Ho, YC; Shan, L; Hosmane, NN; Wang, J; Laskey, SB; Rosenbloom, DIS; Lai, J; Blankson, JN; Siliciano, JD; Siliciano, RF				Ho, Ya-Chi; Shan, Liang; Hosmane, Nina N.; Wang, Jeffrey; Laskey, Sarah B.; Rosenbloom, Daniel I. S.; Lai, Jun; Blankson, Joel N.; Siliciano, Janet D.; Siliciano, Robert F.			Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; LONG TERMINAL REPEAT; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; RNA-POLYMERASE; IN-VIVO; TYPE-1; PROMOTER	Antiretroviral therapy fails to cure HIV-1 infection because latent proviruses persist in resting CD4(+) T cells. T cell activation reverses latency, but <1% of proviruses are induced to release infectious virus after maximum in vitro activation. The noninduced proviruses are generally considered defective but have not been characterized. Analysis of 213 noninduced proviral clones from treated patients showed 88.3% with identifiable defects but 11.7% with intact genomes and normal long terminal repeat (LTR) function. Using direct sequencing and genome synthesis, we reconstructed full-length intact noninduced proviral clones and demonstrated growth kinetics comparable to reconstructed induced proviruses from the same patients. Noninduced proviruses have unmethylated promoters and are integrated into active transcription units. Thus, it cannot be excluded that they may become activated in vivo. The identification of replication-competent noninduced proviruses indicates that the size of the latent reservoir-and, hence, the barrier to cure-may be up to 60-fold greater than previously estimated.	[Ho, Ya-Chi; Shan, Liang; Hosmane, Nina N.; Laskey, Sarah B.; Lai, Jun; Blankson, Joel N.; Siliciano, Janet D.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Wang, Jeffrey] Louisiana State Univ, Sch Med, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Rosenbloom, Daniel I. S.] Harvard Univ, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Harvard University; Howard Hughes Medical Institute; Johns Hopkins University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu	Shan, Liang/ABB-9210-2021	Ho, Ya-Chi/0000-0002-7046-0147	amfAR as part of the amfAR Research Collaboration on HIV Eradication (ARCHE); Martin Delaney CARE and DARE Collaboratories (National Institutes of Health [NIH] [AI096113, AI096109]; NIH [AI043222]; Johns Hopkins Center for AIDS Research; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096109, U19AI096113, R01AI043222, P30AI094189, R37AI051178] Funding Source: NIH RePORTER	amfAR as part of the amfAR Research Collaboration on HIV Eradication (ARCHE); Martin Delaney CARE and DARE Collaboratories (National Institutes of Health [NIH]; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Center for AIDS Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all study participants. We thank S. Alireza Rabi, Gregory Laird, and Drs. Stuart Ray and Joel Pomerantz for critical advice; Linda Alston for patient recruitment; David Walker for advice on CpG methylation; and Dr. Gautam Sahu for PCR suggestions. This work was supported by amfAR as part of the amfAR Research Collaboration on HIV Eradication (ARCHE) and also by the Martin Delaney CARE and DARE Collaboratories (National Institutes of Health [NIH] Grants AI096113 and AI096109), by NIH Grant AI043222, by the Johns Hopkins Center for AIDS Research, and by the Howard Hughes Medical Institute. Y.-C.H. is a Howard Hughes Medical Institute International Student Research Fellow.	Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; BEBENEK K, 1989, J BIOL CHEM, V264, P16948; Blazkova J, 2012, J VIROL, V86, P5390, DOI 10.1128/JVI.00040-12; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; Burnett JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000260; Chakraborty AK, 2010, NAT REV IMMUNOL, V10, P59, DOI 10.1038/nri2688; Chavez L, 2011, METHODS, V53, P47, DOI 10.1016/j.ymeth.2010.05.009; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Cujec TP, 1997, GENE DEV, V11, P2645, DOI 10.1101/gad.11.20.2645; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Durand CM, 2012, J INFECT DIS, V205, P1014, DOI 10.1093/infdis/jir884; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; He GC, 2002, MOL CELL BIOL, V22, P2965, DOI 10.1128/MCB.22.9.2965-2973.2002; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lenasi T, 2008, CELL HOST MICROBE, V4, P123, DOI 10.1016/j.chom.2008.05.016; Li B, 2007, J VIROL, V81, P193, DOI 10.1128/JVI.01231-06; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sanchez G, 1997, J VIROL, V71, P2233, DOI 10.1128/JVI.71.3.2233-2240.1997; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; SELBY MJ, 1990, CELL, V62, P769, DOI 10.1016/0092-8674(90)90121-T; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shan L, 2011, J VIROL, V85, P5384, DOI 10.1128/JVI.02536-10; Siliciano Janet D, 2005, Methods Mol Biol, V304, P3; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Spivak AM, 2011, J VIROL, V85, P10399, DOI 10.1128/JVI.05409-11; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900; Tyagi M, 2010, J VIROL, V84, P6425, DOI 10.1128/JVI.01519-09; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; VICENZI E, 1994, J VIROL, V68, P7879, DOI 10.1128/JVI.68.12.7879-7890.1994; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2007, CYTOKINE, V39, P63, DOI 10.1016/j.cyto.2007.05.017; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758	58	907	921	4	85	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					540	551		10.1016/j.cell.2013.09.020	http://dx.doi.org/10.1016/j.cell.2013.09.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243014	Green Accepted, Bronze			2022-12-24	WOS:000326571800010
J	ter Steege, H; Nigel, CA; Sabatier, D; Baraloto, C; Salomao, RP; Guevara, JE; Phillips, OL; Castilho, CV; Magnusson, WE; Molino, JF; Monteagudo, A; Vargas, PN; Montero, JC; Feldpausch, TR; Coronado, ENH; Killeen, TJ; Mostacedo, B; Vasquez, R; Assis, RL; Terborgh, J; Wittmann, F; Andrade, A; Laurance, WF; Laurance, SGW; Marimon, BS; Marimon, BH; Vieira, ICG; Amaral, IL; Brienen, R; Castellanos, H; Lopez, DC; Duivenvoorden, JF; Mogollon, HF; Matos, FDD; Davila, N; Garcia-Villacorta, R; Diaz, PRS; Costa, F; Emilio, T; Levis, C; Schietti, J; Souza, P; Alonso, A; Dallmeier, F; Montoya, AJD; Piedade, MTF; Araujo-Murakami, A; Arroyo, L; Gribel, R; Fine, PVA; Peres, CA; Toledo, M; Gerardo, AAC; Baker, TR; Ceron, C; Engel, J; Henkel, TW; Maas, P; Petronelli, P; Stropp, J; Zartman, CE; Daly, D; Neill, D; Silveira, M; Paredes, MR; Chave, J; Lima, DD; Jorgensen, PM; Fuentes, A; Schongart, J; Valverde, FC; Di Fiore, A; Jimenez, EM; Mora, MCP; Phillips, JF; Rivas, G; van Andel, TR; von Hildebrand, P; Hoffman, B; Zent, EL; Malhi, Y; Prieto, A; Rudas, A; Ruschell, AR; Silva, N; Vos, V; Zent, S; Oliveira, AA; Schutz, AC; Gonzales, T; Nascimento, MT; Ramirez-Angulo, H; Sierra, R; Tirado, M; Medina, MNU; van der Heijden, G; Vela, CIA; Torre, EV; Vriesendorp, C; Wang, O; Young, KR; Baider, C; Balslev, H; Ferreira, C; Mesones, I; Torres-Lezama, A; Giraldo, LEU; Zagt, R; Alexiades, MN; Hernandez, L; Huamantupa-Chuquimaco, I; Milliken, W; Cuenca, WP; Pauletto, D; Sandoval, EV; Gamarra, LV; Dexter, KG; Feeley, K; Lopez-Gonzalez, G; Silman, MR				ter Steege, Hans; Pitman, Nigel C. A.; Sabatier, Daniel; Baraloto, Christopher; Salomao, Rafael P.; Guevara, Juan Ernesto; Phillips, Oliver L.; Castilho, Carolina V.; Magnusson, William E.; Molino, Jean-Franois; Monteagudo, Abel; Nunez Vargas, Percy; Carlos Montero, Juan; Feldpausch, Ted R.; Coronado, Euridice N. Honorio; Killeen, Tim J.; Mostacedo, Bonifacio; Vasquez, Rodolfo; Assis, Rafael L.; Terborgh, John; Wittmann, Florian; Andrade, Ana; Laurance, William F.; Laurance, Susan G. W.; Marimon, Beatriz S.; Marimon, Ben-Hur, Jr.; Guimaraes Vieira, Ima Celia; Amaral, Ieda Leao; Brienen, Roel; Castellanos, Hernan; Cardenas Lopez, Dairon; Duivenvoorden, Joost F.; Mogollon, Hugo F.; de Almeida Matos, Francisca Dionizia; Davila, Nallarett; Garcia-Villacorta, Roosevelt; Stevenson Diaz, Pablo Roberto; Costa, Flavia; Emilio, Thaise; Levis, Carolina; Schietti, Juliana; Souza, Priscila; Alonso, Alfonso; Dallmeier, Francisco; Duque Montoya, Alvaro Javier; Fernandez Piedade, Maria Teresa; Araujo-Murakami, Alejandro; Arroyo, Luzmila; Gribel, Rogerio; Fine, Paul V. A.; Peres, Carlos A.; Toledo, Marisol; Gerardo, A. Aymard C.; Baker, Tim R.; Ceron, Carlos; Engel, Julien; Henkel, Terry W.; Maas, Paul; Petronelli, Pascal; Stropp, Juliana; Eugene Zartman, Charles; Daly, Doug; Neill, David; Silveira, Marcos; Rios Paredes, Marcos; Chave, Jerome; de Andrade Lima, Diogenes; Jorgensen, Peter Moller; Fuentes, Alfredo; Schoengart, Jochen; Cornejo Valverde, Fernando; Di Fiore, Anthony; Jimenez, Eliana M.; Penuela Mora, Maria Cristina; Fernando Phillips, Juan; Rivas, Gonzalo; van Andel, Tinde R.; von Hildebrand, Patricio; Hoffman, Bruce; Zent, Eglee L.; Malhi, Yadvinder; Prieto, Adriana; Rudas, Agustin; Ruschell, Ademir R.; Silva, Natalino; Vos, Vincent; Zent, Stanford; Oliveira, Alexandre A.; Cano Schutz, Angela; Gonzales, Therany; Nascimento, Marcelo Trindade; Ramirez-Angulo, Hirma; Sierra, Rodrigo; Tirado, Milton; Umana Medina, Maria Natalia; van der Heijden, Geertje; Vela, Cesar I. A.; Vilanova Torre, Emilio; Vriesendorp, Corine; Wang, Ophelia; Young, Kenneth R.; Baider, Claudia; Balslev, Henrik; Ferreira, Cid; Mesones, Italo; Torres-Lezama, Armando; Urrego Giraldo, Ligia Estela; Zagt, Roderick; Alexiades, Miguel N.; Hernandez, Lionel; Huamantupa-Chuquimaco, Isau; Milliken, William; Palacios Cuenca, Walter; Pauletto, Daniela; Valderrama Sandoval, Elvis; Valenzuela Gamarra, Luis; Dexter, Kyle G.; Feeley, Ken; Lopez-Gonzalez, Gabriela; Silman, Miles R.			Hyperdominance in the Amazonian Tree Flora	SCIENCE			English	Article							SPECIES ABUNDANCE; RAIN-FOREST; PATTERNS; DIVERSIFICATION; DISTRIBUTIONS; DIVERSITY; RARITY; GENUS; SIZE	The vast extent of the Amazon Basin has historically restricted the study of its tree communities to the local and regional scales. Here, we provide empirical data on the commonness, rarity, and richness of lowland tree species across the entire Amazon Basin and Guiana Shield (Amazonia), collected in 1170 tree plots in all major forest types. Extrapolations suggest that Amazonia harbors roughly 16,000 tree species, of which just 227 (1.4%) account for half of all trees. Most of these are habitat specialists and only dominant in one or two regions of the basin. We discuss some implications of the finding that a small group of species-less diverse than the North American tree flora-accounts for half of the world's most diverse tree community.	[ter Steege, Hans; Maas, Paul; van Andel, Tinde R.; Hoffman, Bruce] Naturalis Biodivers Ctr, Leiden, Netherlands; [ter Steege, Hans] Univ Utrecht, Ecol & Biodivers Grp, NL-3508 TC Utrecht, Netherlands; [Pitman, Nigel C. A.; Terborgh, John] Duke Univ, Ctr Trop Conservat, Nicholas Sch Environm, Durham, NC 27708 USA; [Pitman, Nigel C. A.; Vriesendorp, Corine] Field Museum, Chicago, IL 60605 USA; [Sabatier, Daniel; Molino, Jean-Franois] Inst Dev Res, UMR Architecture Fonctionnement & Evolut Plantes, Montpellier, France; [Salomao, Rafael P.] Museu Paraense Emilio Goeldi Cordenadoria Bot, Minist Ciencia Tecnol & Inovacao, Belem, Para, Brazil; [Guevara, Juan Ernesto; Fine, Paul V. A.; Mesones, Italo] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Phillips, Oliver L.; Feldpausch, Ted R.; Coronado, Euridice N. Honorio; Brienen, Roel; Baker, Tim R.; Lopez-Gonzalez, Gabriela] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Castilho, Carolina V.] Embrapa Roraima, Boa Vista, RR, Brazil; [Magnusson, William E.; Carlos Montero, Juan; Assis, Rafael L.; de Almeida Matos, Francisca Dionizia; Costa, Flavia; Emilio, Thaise; Levis, Carolina; Schietti, Juliana; Souza, Priscila; Fernandez Piedade, Maria Teresa; Eugene Zartman, Charles; de Andrade Lima, Diogenes; Ferreira, Cid] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Monteagudo, Abel; Vasquez, Rodolfo; Valenzuela Gamarra, Luis] Jardin Bot Missouri, Oxapampa, Peru; [Nunez Vargas, Percy] Univ Nacl San Antonio Abad del Cusco, Cuzco, Peru; [Carlos Montero, Juan] BOLFOR Bolivia Sustainable Forest Management Proj, Casilla 6204, Santa Cruz, Bolivia; [Feldpausch, Ted R.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4RJ, Devon, England; [Coronado, Euridice N. Honorio] Inst Invest Amazonia Peruana, Iquitos, Peru; [Killeen, Tim J.] WWF, Washington, DC 20037 USA; [Mostacedo, Bonifacio] Univ Autonoma Gabriel Rene Moreno, Fac Ciencias Agr, Santa Cruz, Bolivia; [Assis, Rafael L.] Norwegian Univ Life Sci UMB, Dept Ecol & Nat Resource Management, As, Norway; [Wittmann, Florian; Schoengart, Jochen] Max Planck Inst Chem, D-55128 Mainz, Germany; [Andrade, Ana] Inst Nacl de Pesquisas da Amazonia, Projeto Dinam Biol Fragmentos Florestais, Manaus, Amazonas, Brazil; [Laurance, William F.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci TESS, Cairns, Qld, Australia; [Laurance, William F.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Laurance, Susan G. W.; Marimon, Beatriz S.; Marimon, Ben-Hur, Jr.] Univ Estado Mato Grosso, Nova Xavantina, MT, Brazil; [Guimaraes Vieira, Ima Celia] Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [Amaral, Ieda Leao] INPA, Projeto TEAM Trop Ecol Assessment & Monitoring Ma, Manaus, Amazonas, Brazil; [Castellanos, Hernan; Hernandez, Lionel] Univ Nacl Expt Guayana, Puerto Ordaz, Bolivar, Venezuela; [Cardenas Lopez, Dairon] SINCHI Inst Amazon Invest Cient, Bogota, Colombia; [Duivenvoorden, Joost F.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Mogollon, Hugo F.] Endangered Species Coalit, Silver Spring, MD 20901 USA; [Davila, Nallarett] Univ Estadual Campinas, Campinas, SP, Brazil; [Garcia-Villacorta, Roosevelt] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Garcia-Villacorta, Roosevelt] Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland; [Stevenson Diaz, Pablo Roberto; Cano Schutz, Angela; Umana Medina, Maria Natalia] Univ Los Andes, Lab Ecol Bosques Trop & Primatol, Bogota, DF, Colombia; [Alonso, Alfonso; Dallmeier, Francisco] Smithsonian Conservat Biol Inst, Washington, DC 20013 USA; [Duque Montoya, Alvaro Javier; Urrego Giraldo, Ligia Estela] Univ Nacl Colombia, Dept Ciencias Forest, Sede Medellin, Colombia; [Araujo-Murakami, Alejandro; Arroyo, Luzmila] Museo Hist Nat Noel Kempff Mercado, Santa Cruz, Bolivia; [Gribel, Rogerio] Inst Pesquisas Jardim Bot Rio de Janeiro, Rio De Janeiro, Brazil; [Peres, Carlos A.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Toledo, Marisol] Univ Autonoma Gabriel Rene Moreno, Inst Boliviano Invest Forestal, Santa Cruz, Bolivia; [Ceron, Carlos] Univ Cent Ecuador, Herbario Alfredo Paredes QAP, Quito, Ecuador; [Henkel, Terry W.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA; [Petronelli, Pascal] La Rech Agron Dev CIRAD, UMR Ecofog, Kourou, French Guiana; [Stropp, Juliana] Commiss European Communities, Land Resource & Management Unit, Joint Res Ctr, I-21027 Ispra, VA, Italy; [Daly, Doug] New York Bot Garden, Bronx, NY 10458 USA; [Neill, David] Univ Estatal Amaz, Puyo, Ecuador; [Silveira, Marcos] Univ Fed Acre, Museu Univ, Rio Branco, AC, Brazil; [Rios Paredes, Marcos] Serv Biodiversidad EIRL, Iquitos, Peru; [Chave, Jerome] CNRS, F-31000 Toulouse, France; [Chave, Jerome] Univ Toulouse 3, UMR EDB 5174, F-31000 Toulouse, France; [Jorgensen, Peter Moller; Fuentes, Alfredo] Missouri Bot Garden, St Louis, MO 63166 USA; [Fuentes, Alfredo] Herbario Nacl Bolivia, La Paz, Bolivia; [Cornejo Valverde, Fernando] Andes Amazon Biodivers Program, Madre De Dios, Peru; [Di Fiore, Anthony] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Jimenez, Eliana M.; Penuela Mora, Maria Cristina] Univ Nacl Colombia Sede Amazonia, Grp Ecol Ecosistemas Terrestres Trop, Leticia, Amazonas, Brazil; [Fernando Phillips, Juan; von Hildebrand, Patricio] Fdn Puerto Rastrojo, Bogota, Colombia; [Rivas, Gonzalo] Univ Florida, Gainesville, FL 32611 USA; [Zent, Eglee L.; Zent, Stanford] Inst Venezolano Invest Cient, Lab Human Ecol, Caracas 1020A, Venezuela; [Malhi, Yadvinder] Univ Oxford, Environm Change Inst, Sch Geog & Environm, Oxford, England; [Prieto, Adriana; Rudas, Agustin] Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Colombia; [Ruschell, Ademir R.] Embrapa Amazonia Oriental, Belem, Para, Brazil; [Silva, Natalino] Univ Fed Rural Amazonia, Belem, Para, Brazil; [Vos, Vincent] Univ Autonoma Beni, Riberalta, Bolivia; [Oliveira, Alexandre A.; Baider, Claudia] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil; [Gonzales, Therany] Amazon Ctr Environm Educ & Res Fdn, Madre De Dios, Peru; [Nascimento, Marcelo Trindade] Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, BR-28013620 Campos Dos Goyatacazes, RJ, Brazil; [Ramirez-Angulo, Hirma; Vilanova Torre, Emilio] Univ Los Andes, INDEFOR Res Inst Forestry Dev, Merida, Venezuela; [Sierra, Rodrigo; Tirado, Milton] Geoinformat & Sistemas Cia Ltda GeoIS, Quito, Ecuador; [van der Heijden, Geertje] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53202 USA; [van der Heijden, Geertje] Smithsonian Trop Res Inst, Panama City 084303092, Panama; [Vela, Cesar I. A.] Univ Nacl San Antonio Abad del Cusco, Fac Ciencias Forest & Medio Ambiente, Puerto Maldonado, Madre De Dios, Peru; [Wang, Ophelia] No Arizona Univ, Flagstaff, AZ 86011 USA; [Young, Kenneth R.] Univ Texas Austin, Austin, TX 78712 USA; [Baider, Claudia] Minist Agro Ind & Food Secur, Mauritius Herbarium Agr Serv, Reduit, Mauritius; [Balslev, Henrik] Univ Aarhus, Aarhus, Denmark; [Torres-Lezama, Armando] Univ Los Andes, Merida, Venezuela; [Zagt, Roderick] Tropenbos Int, Wageningen, Netherlands; [Alexiades, Miguel N.] Univ Kent, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England; [Huamantupa-Chuquimaco, Isau] Univ Nacl San Antonio Abad del Cusco, Herbario CUZ, Cuzco, Peru; [Milliken, William] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Palacios Cuenca, Walter] Univ Tecn Norte Herbario Nacl Euador, Quito, Ecuador; [Pauletto, Daniela] Serv Florestal Brasileiro, Santarem, PA, Brazil; [Valderrama Sandoval, Elvis] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Valderrama Sandoval, Elvis] Univ Nacl Amazonia Peruana, Fac Biol, Iquitos, Peru; [Dexter, Kyle G.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JN, Midlothian, Scotland; [Feeley, Ken] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Feeley, Ken] Fairchild Trop Bot Garden, Coral Gables, FL 33156 USA; [Silman, Miles R.] Wake Forest Univ, Biol Dept, Winston Salem, NC 27106 USA; [Silman, Miles R.] Wake Forest Univ, Ctr Energy Environm & Sustainabil, Winston Salem, NC 27106 USA	Naturalis Biodiversity Center; Utrecht University; Duke University; Field Museum of Natural History (Chicago); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Museu Paraense Emilio Goeldi; University of California System; University of California Berkeley; University of Leeds; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Institute Nacional de Pesquisas da Amazonia; Universidad Nacional de San Antonio Abad del Cusco; University of Exeter; World Wildlife Fund; Norwegian University of Life Sciences; Max Planck Society; Institute Nacional de Pesquisas da Amazonia; James Cook University; James Cook University; Universidade do Estado de Mato Grosso; Museu Paraense Emilio Goeldi; Institute Nacional de Pesquisas da Amazonia; University of Amsterdam; Universidade Estadual de Campinas; University of Edinburgh; Universidad de los Andes (Colombia); Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Universidad Nacional de Colombia; Jardim Botanico do Rio de Janeiro; University of East Anglia; Universidad Central del Ecuador; California State University System; California State Polytechnic University, Humboldt; CIRAD; European Commission Joint Research Centre; EC JRC ISPRA Site; New York Botanical Garden; Universidade Federal do Acre (UFAC); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Missouri Botanical Gardens; University of Texas System; University of Texas Austin; State University System of Florida; University of Florida; Venezuelan Institute Science Research; University of Oxford; Universidad Nacional de Colombia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal Rural da Amazonia (UFRA); Universidade de Sao Paulo; Universidade Estadual do Norte Fluminense; University of Los Andes Venezuela; University of Wisconsin System; University of Wisconsin Milwaukee; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Nacional de San Antonio Abad del Cusco; Northern Arizona University; University of Texas System; University of Texas Austin; Aarhus University; University of Los Andes Venezuela; University of Kent; Universidad Nacional de San Antonio Abad del Cusco; Royal Botanic Gardens, Kew; University of Missouri System; University of Missouri Saint Louis; Universidad Nacional de la Amazonia Peruana; University of Edinburgh; State University System of Florida; Florida International University; Wake Forest University; Wake Forest University	ter Steege, H (corresponding author), Naturalis Biodivers Ctr, Leiden, Netherlands.	hans.tersteege@naturalis.nl	Junior, Ben Hur Marimon/E-7330-2013; Balslev, Hendrik/AAE-4071-2020; Feldpausch, Ted/ABH-3123-2020; Steege, Hans ter/B-5866-2011; Laurance, William F/B-2709-2012; van der Heijden, Geertje/AAB-4102-2019; Schietti, Juliana/B-8226-2015; Gribel, Rogerio/C-5392-2013; Brienen, Roel/AAU-9959-2020; Molino, Jean-François/C-5011-2009; Piedade, Maria Teresa/C-5372-2013; Vos, Vincent/ABA-1492-2020; de Castilho, Carolina Volkmer/I-6618-2019; Feldpausch, Ted/D-3436-2009; Fuentes, Alfredo F./FNZ-7942-2022; Schietti, Juliana/AAV-7451-2020; Vieira, Ima C.G./H-6897-2012; Aymard, Gerardo/ABE-9203-2020; Peres, Carlos Augusto/N-8275-2019; de Oliveira, Alexandre Adalardo/G-8830-2012; Magnusson, William E/J-9408-2014; Coronado, Eurídice Nora Honorio/K-3412-2015; Stropp, Juliana/AAF-7946-2020; Costa, Flavia/K-4386-2014; Vos, Vincent Antoine/I-7209-2019; Oliveira, Alexandre/ABH-1255-2020; Pitman, Nigel C A/A-7681-2008; Emilio, Thaise/A-6221-2013; Cano, Ángela/N-9392-2017; Marimon, Beatriz/J-6389-2012; Baider, Claudia/C-2570-2009; Baraloto, Christopher/ABG-2500-2020; Balslev, Henrik/J-9191-2013; Junior, Ben Hur Marimon/AAT-9354-2020; Pauletto, Daniela/AAX-4777-2020; Schongart, Jochen/I-2659-2016; Dexter, Kyle G/D-5589-2018; Feeley, Kenneth James/A-7631-2009; Phillips, Oliver/A-1523-2011; Ruschel, ademir/AAL-8382-2021; Laurance, Susan/G-6021-2011; Nascimento, Marcelo T/D-2824-2013; Vilanova, Emilio/AAG-9543-2020; Peres, Carlos A./ABE-8361-2020; Silveira, Marcos/H-7906-2013; Peres, Carlos A./B-1276-2013; SALOMÃO, RAFAEL/AAU-1306-2020; Zent, Eglee/O-7640-2014	Feldpausch, Ted/0000-0002-6631-7962; Steege, Hans ter/0000-0002-8738-2659; Laurance, William F/0000-0003-4430-9408; van der Heijden, Geertje/0000-0002-2110-5173; Schietti, Juliana/0000-0002-1687-4373; Gribel, Rogerio/0000-0002-0850-5578; Brienen, Roel/0000-0002-5397-5755; Molino, Jean-François/0000-0001-8853-7133; Piedade, Maria Teresa/0000-0002-7320-0498; Vos, Vincent/0000-0002-0388-8530; de Castilho, Carolina Volkmer/0000-0002-1064-2758; Feldpausch, Ted/0000-0002-6631-7962; Schietti, Juliana/0000-0002-1687-4373; Vieira, Ima C.G./0000-0003-1233-318X; Aymard, Gerardo/0000-0001-9405-0508; de Oliveira, Alexandre Adalardo/0000-0001-5526-8109; Magnusson, William E/0000-0003-1988-3950; Coronado, Eurídice Nora Honorio/0000-0003-2314-590X; Stropp, Juliana/0000-0002-2831-4066; Costa, Flavia/0000-0002-9600-4625; Vos, Vincent Antoine/0000-0002-0388-8530; Oliveira, Alexandre/0000-0001-5526-8109; Pitman, Nigel C A/0000-0002-9211-2880; Emilio, Thaise/0000-0001-5415-1822; Cano, Ángela/0000-0002-5090-7730; Marimon, Beatriz/0000-0003-3105-2914; Baider, Claudia/0000-0002-2203-2076; Baraloto, Christopher/0000-0001-7322-8581; Balslev, Henrik/0000-0002-7101-7120; Pauletto, Daniela/0000-0003-1855-6077; Dexter, Kyle G/0000-0001-9232-5221; Feeley, Kenneth James/0000-0002-3618-1144; Phillips, Oliver/0000-0002-8993-6168; Ruschel, ademir/0000-0002-0352-5238; Laurance, Susan/0000-0002-2831-2933; Nascimento, Marcelo T/0000-0003-4492-3344; Vilanova, Emilio/0000-0001-6289-5127; Peres, Carlos A./0000-0002-1588-8765; Silveira, Marcos/0000-0003-0485-7872; Peres, Carlos A./0000-0002-1588-8765; SALOMÃO, RAFAEL/0000-0003-0947-0132; Schongart, Jochen/0000-0002-7696-9657; Fine, Paul/0000-0002-0550-5628; Penuela Mora, Maria Cristina/0000-0002-9611-1359; Sabatier, Daniel/0000-0003-0883-1530; Young, Kenneth R./0000-0003-0866-1260; Engel, Julien/0000-0002-8078-9309; Sierra, Rodrigo/0000-0002-1146-2943; Zent, Eglee/0000-0002-7475-7335; Mostacedo, Bonifacio/0000-0003-3806-2445; Valenzuela Gamarra, Luis/0000-0002-6191-0580; Milliken, William/0000-0002-3926-6661; Neill, David Alan/0000-0002-5143-9430; Jimenez, Eliana M./0000-0002-8610-1771; Fuentes, Alfredo/0000-0003-4848-4182; Lopez-Gonzalez, Gabriela/0000-0002-0814-8830; Hernandez, Lionel/0000-0002-7279-1003	Alberta Mennega Stichting; ALCOA Suriname; Banco de la Republica; Center for Agricultural Research in Suriname; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Plano Nacional de Pos-Graduacao); Conselho Nacional de Desenvovimento Cientifico e Tecnologico of Brazil (CNPq) projects Programa de Pesquisas Ecologicas de Longa Duracao (PELD) [558069/2009-6]; Programa de Apoio a Nucleos de Excelencia da Fundacao de Amparo a Pesquisa do Estado do Amazonas (PRONEX-FAPEAM) [1600/2006]; Areas Umidas; MAUA; PELD [403792/2012-6]; PPBio; CENBAM; Universal [479599/2008-4, 307807-2009-6]; Fundacao de Amparo A Pesquisa Do Estado Do Amazonas (APEAM) projects [DCR/2006]; Hidroveg; FAPESP; PRONEX; CNPq; Colciencias; Duke University; Ecopetrol; FEPIM [044/2003]; Field Museum; Conservation International/DC (TEAM/INPA Manuas), Gordon; Betty Moore Foundation; Guyana Forestry Commission; Investissement d'Avenir grant of the French Agence Nationale de la Recherche (ANR) (Centre d'Etude de la Biodiversite Amazonienne) [ANR-10-LABX-0025]; Margaret Mee Amazon Trust; Miquel fonds; National Geographic Society [7754-04, 8047-06]; Netherlands Foundation for the Advancement of Tropical Research WOTRO grants [WB85- 335, W84-581]; Primate Conservation Incorporated; French Ministry of Ecology and Sustainable Development; Shell Prospecting and Development Peru; Smithsonian Institution's Biological Diversity of the Guiana Shield Program; Stichting het van Eeden-fonds; the Body Shop; Ministry of the Environment of Ecuador; TROBIT; Tropenbos International; NSF [NSF-0743457, NSF-0101775]; USAID; Variety Woods Guyana; WWF-Brazil; WWF-Guianas; XIIeme Contrat de Plan Etat Region-Guyane (French Government and European Union); European Union; UK Natural Environment Research Council; Gordon and Betty Moore Foundation; U.S. National Geographic Society; European Research Council Advanced Grant; Royal Society Wolfson Research Merit Award; Natural Environment Research Council [NE/B504630/1, NE/I021160/1, NE/B503384/1, NE/I027797/1] Funding Source: researchfish; NERC [NE/I027797/1, NE/I021160/1] Funding Source: UKRI; Division Of Environmental Biology [0918591] Funding Source: National Science Foundation	Alberta Mennega Stichting; ALCOA Suriname; Banco de la Republica; Center for Agricultural Research in Suriname; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Plano Nacional de Pos-Graduacao); Conselho Nacional de Desenvovimento Cientifico e Tecnologico of Brazil (CNPq) projects Programa de Pesquisas Ecologicas de Longa Duracao (PELD)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Apoio a Nucleos de Excelencia da Fundacao de Amparo a Pesquisa do Estado do Amazonas (PRONEX-FAPEAM); Areas Umidas; MAUA; PELD; PPBio; CENBAM; Universal; Fundacao de Amparo A Pesquisa Do Estado Do Amazonas (APEAM) projects; Hidroveg; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PRONEX; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Duke University; Ecopetrol; FEPIM; Field Museum; Conservation International/DC (TEAM/INPA Manuas), Gordon; Betty Moore Foundation(Gordon and Betty Moore Foundation); Guyana Forestry Commission; Investissement d'Avenir grant of the French Agence Nationale de la Recherche (ANR) (Centre d'Etude de la Biodiversite Amazonienne)(French National Research Agency (ANR)); Margaret Mee Amazon Trust; Miquel fonds; National Geographic Society(National Geographic Society); Netherlands Foundation for the Advancement of Tropical Research WOTRO grants; Primate Conservation Incorporated; French Ministry of Ecology and Sustainable Development; Shell Prospecting and Development Peru; Smithsonian Institution's Biological Diversity of the Guiana Shield Program(Smithsonian InstitutionSmithsonian National Museum of Natural History); Stichting het van Eeden-fonds; the Body Shop; Ministry of the Environment of Ecuador; TROBIT; Tropenbos International; NSF(National Science Foundation (NSF)); USAID(United States Agency for International Development (USAID)); Variety Woods Guyana; WWF-Brazil; WWF-Guianas; XIIeme Contrat de Plan Etat Region-Guyane (French Government and European Union); European Union(European Commission); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); U.S. National Geographic Society(National Geographic Society); European Research Council Advanced Grant(European Research Council (ERC)); Royal Society Wolfson Research Merit Award(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This paper is the result of the work of hundreds of different scientists and research institutions in the Amazon over the past 80 years. Without their hard work this analysis would have been impossible. This work was supported by Alberta Mennega Stichting; ALCOA Suriname; Banco de la Republica; Center for Agricultural Research in Suriname; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Plano Nacional de Pos-Graduacao); Conselho Nacional de Desenvovimento Cientifico e Tecnologico of Brazil (CNPq) projects Programa de Pesquisas Ecologicas de Longa Duracao (PELD) (558069/2009-6), Programa de Apoio a Nucleos de Excelencia da Fundacao de Amparo a Pesquisa do Estado do Amazonas (PRONEX-FAPEAM) (1600/2006), Areas Umidas, and MAUA; PELD (403792/2012-6), PPBio, CENBAM, Universal (479599/2008-4), and Universal 307807-2009-6; Fundacao de Amparo A Pesquisa Do Estado Do Amazonas (APEAM) projects DCR/2006, Hidroveg with FAPESP, and PRONEX with CNPq; FAPESP; Colciencias; Duke University; Ecopetrol; FEPIM 044/2003; the Field Museum; Conservation International/DC (TEAM/INPA Manuas), Gordon and Betty Moore Foundation; Guyana Forestry Commission; Investissement d'Avenir grant of the French Agence Nationale de la Recherche (ANR) (Centre d'Etude de la Biodiversite Amazonienne ANR-10-LABX-0025); Margaret Mee Amazon Trust; Miquel fonds; National Geographic Society (7754-04, 8047-06 to P.M.J.); Netherlands Foundation for the Advancement of Tropical Research WOTRO grants WB85- 335 and W84-581; Primate Conservation Incorporated; Programme Ecosystemes Tropicaux (French Ministry of Ecology and Sustainable Development; Shell Prospecting and Development Peru; Smithsonian Institution's Biological Diversity of the Guiana Shield Program; Stichting het van Eeden-fonds; the Body Shop; the Ministry of the Environment of Ecuador; TROBIT; Tropenbos International; NSF (NSF-0743457 and NSF-0101775 to P.M.J.); USAID; Variety Woods Guyana; WWF-Brazil; WWF-Guianas; XIIeme Contrat de Plan Etat Region-Guyane (French Government and European Union); and grants to RAINFOR from the European Union, UK Natural Environment Research Council, the Gordon and Betty Moore Foundation, and U.S. National Geographic Society. O.L.P. is supported by a European Research Council Advanced Grant and a Royal Society Wolfson Research Merit Award. A summary of the data is given in appendix 1. Plot metadata are given in appendix 4.	Adeney J. M., 2009, THESIS DUKE U DURHAM; BALEE W, 1990, BIOTROPICA, V22, P36, DOI 10.2307/2388717; Bebber DP, 2010, P NATL ACAD SCI USA, V107, P22169, DOI 10.1073/pnas.1011841108; BLACK GA, 1950, BOT GAZ, V111, P413, DOI 10.1086/335612; Cavers S, 2013, J BIOGEOGR, V40, P615, DOI 10.1111/jbi.12097; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Couvreur TLP, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-44; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Erickson CL, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P157, DOI 10.1007/978-0-387-74907-5_11; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; Feeley KJ, 2009, P NATL ACAD SCI USA, V106, P12382, DOI 10.1073/pnas.0900698106; Fine PVA, 2005, EVOLUTION, V59, P1464; Gomez-Navarro C, 2009, AM J BOT, V96, P1300, DOI 10.3732/ajb.0800378; Haripersaud P, 2010, TAXON, V59, P592, DOI 10.1002/tax.592024; Hopkins MJG, 2007, J BIOGEOGR, V34, P1400, DOI 10.1111/j.1365-2699.2007.01737.x; Hubbell SP, 2008, P NATL ACAD SCI USA, V105, P11498, DOI 10.1073/pnas.0801915105; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; iPlant Collaborative, TAX NAM RES SERV VER; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Levis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048559; Lopez-Gonzalez G, 2011, J VEG SCI, V22, P610, DOI 10.1111/j.1654-1103.2011.01312.x; Lozano FD, 2005, BIOL CONSERV, V126, P146, DOI 10.1016/j.biocon.2005.04.024; Maas PJM, 2011, NORD J BOT, V29, P257, DOI 10.1111/j.1756-1051.2011.01092.x; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; McMichael CH, 2012, SCIENCE, V336, P1429, DOI 10.1126/science.1219982; Montoya E, 2011, QUATERNARY RES, V76, P335, DOI 10.1016/j.yqres.2011.06.014; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; NASA, VIS EARTH; PETERS CM, 2000, IMPERFECT BALANCE LA, P203; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PIRES JM, 1953, BOT GAZ, V114, P467, DOI 10.1086/335790; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; PITMAN NCA, 2000, THESIS DUKE U DURHAM; Pitman NCA, 2013, ECOGRAPHY, V36, P114, DOI 10.1111/j.1600-0587.2012.00083.x; Posey D. A., 1985, Agroforestry Systems, V3, P139, DOI 10.1007/BF00122640; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; R Development Core Team, 2012, R LANG ENV STAT COMP; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Rollet B., 1993, BOIS FORTS TROPIQUES, V236, P43; Schwartz MW, 2001, ECOL LETT, V4, P464, DOI 10.1046/j.1461-0248.2001.00241.x; ter Steege H., AMAZON TREE DIVERSIT; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Ter Steege H, 2011, AM J BOT, V98, P31, DOI 10.3732/ajb.1000215; Warren RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017342	46	740	773	10	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					325	+		10.1126/science.1243092	http://dx.doi.org/10.1126/science.1243092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136971	Green Submitted			2022-12-24	WOS:000325755100034
J	Fu, G; Casas, J; Rigaud, S; Rybakin, V; Lambolez, F; Brzostek, J; Hoerter, JAH; Paster, W; Acuto, O; Cheroutre, H; Sauer, K; Gascoigne, NRJ				Fu, Guo; Casas, Javier; Rigaud, Stephanie; Rybakin, Vasily; Lambolez, Florence; Brzostek, Joanna; Hoerter, John A. H.; Paster, Wolfgang; Acuto, Oreste; Cheroutre, Hilde; Sauer, Karsten; Gascoigne, Nicholas R. J.			Themis sets the signal threshold for positive and negative selection in T-cell development	NATURE			English	Article							TYROSINE PHOSPHATASE SHP-1; THYMOCYTE SELECTION; MULTIPLE COMMON; SELF-PEPTIDES; RECEPTOR; TCR; ACTIVATION; PROTEIN; IDENTIFICATION; STRENGTH	Development of a self-tolerant T-cell receptor (TCR) repertoire with the potential to recognize the universe of infectious agents depends on proper regulation of TCR signalling. The repertoire is whittled down during T-cell development in the thymus by the ability of quasi-randomly generated TCRs to interact with selfpeptides presented by major histocompatibility complex (MHC) proteins. Low-affinity TCR interactions with self-MHC proteins generate weak signals that initiate 'positive selection', causing maturation of CD4- or CD8ab-expressing 'single-positive' thymocytes from CD4(+)CD8 alpha beta(+) 'double-positive' precursors(1). These develop into mature naive T cells of the secondary lymphoid organs. TCR interaction with high-affinity agonist self-ligands results in 'negative selection' by activation-induced apoptosis or 'agonist selection' of functionally differentiated self-antigen-experienced T cells(2,3). Here we show that positive selection is enabled by the ability of the T-cell-specific protein Themis(4-9) to specifically attenuate TCR signal strength via SHP1 recruitment and activation in response to low-but not high-affinity TCR engagement. Themis acts as an analog-to-digital converter translating graded TCR affinity into clear-cut selection outcome. By dampening mild TCR signals Themis increases the affinity threshold for activation, enabling positive selection of T cells with a naive phenotype in response to low-affinity self-antigens.	[Fu, Guo; Casas, Javier; Rigaud, Stephanie; Rybakin, Vasily; Brzostek, Joanna; Hoerter, John A. H.; Sauer, Karsten; Gascoigne, Nicholas R. J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Casas, Javier; Rybakin, Vasily; Brzostek, Joanna; Gascoigne, Nicholas R. J.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117545, Singapore; [Casas, Javier; Rybakin, Vasily; Brzostek, Joanna; Gascoigne, Nicholas R. J.] Natl Univ Singapore, Immunol Programme, Singapore 117545, Singapore; [Lambolez, Florence; Cheroutre, Hilde] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Paster, Wolfgang; Acuto, Oreste] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Sauer, Karsten] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; National University of Singapore; National University of Singapore; La Jolla Institute for Immunology; University of Oxford; Scripps Research Institute	Gascoigne, NRJ (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	micnrjg@nus.edu.sg	Rybakin, Vasily/J-6310-2019; Casas, Javier/K-7190-2015	Rybakin, Vasily/0000-0002-5093-1757; Casas, Javier/0000-0002-6413-8127; Paster, Wolfgang/0000-0002-5537-2886; Brzostek, Joanna/0000-0002-5621-2649	NIH [AI073870, DK094173, GM065230, DP1OD006433, GM100785, AI070845, T32AI07244]; Wellcome Trust [GR076558MA]; National University of Singapore; Spanish Ministerio de Ciencia e Innovacion (MICIIN); American Chemical Society; The Leukemia & Lymphoma Society Scholar Award [1440-11]; National Institute of Allergy and Infectious Diseases, the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070845, R56AI073870, R01AI073870, T32AI007244, R01AI064584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK094173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100785, R01GM065230] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006433] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); National University of Singapore(National University of Singapore); Spanish Ministerio de Ciencia e Innovacion (MICIIN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); American Chemical Society(American Chemical Society); The Leukemia & Lymphoma Society Scholar Award; National Institute of Allergy and Infectious Diseases, the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank X. L. Chen and Y. Xing for technical advice. We thank J. Ampudia, S. Vallee, J. Hu and S. Feldstein for help, and the National Institutes of Health (NIH) Tetramer Core Facility for production of MHC-I tetramers. Supported by NIH grants AI073870, DK094173 and GM065230 to N.R.J.G., DP1OD006433 to H. C., GM100785 and AI070845 to K. S.; Wellcome Trust Grant GR076558MA to O.A., and by the National University of Singapore. J. C. was supported by a fellowship from the Spanish Ministerio de Ciencia e Innovacion (MICIIN), J. A. H. H. by the Irving S. Sigal Fellowship of the American Chemical Society and NIH training grant T32AI07244, and K. S. by The Leukemia & Lymphoma Society Scholar Award 1440-11. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases, the NIH, or other funding agencies. This is manuscript number 21592 from The Scripps Research Institute.	Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Carter JD, 1999, INT IMMUNOL, V11, P1999, DOI 10.1093/intimm/11.12.1999; Cheroutre H, 2008, CURR OPIN IMMUNOL, V20, P185, DOI 10.1016/j.coi.2008.03.009; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fu G, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002058; Fu G, 2009, J IMMUNOL METHODS, V350, P194, DOI 10.1016/j.jim.2009.07.009; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Hammond KJL, 2001, J IMMUNOL, V167, P1164, DOI 10.4049/jimmunol.167.3.1164; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huang YH, 2007, SCIENCE, V316, P886, DOI 10.1126/science.1138684; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Johnson DJ, 2013, J EXP MED, V210, P1419, DOI 10.1084/jem.20122239; Juang J, 2010, J EXP MED, V207, P1223, DOI 10.1084/jem.20092170; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Lesourne R, 2012, J IMMUNOL, V189, P1154, DOI 10.4049/jimmunol.1200123; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Lorenz U, 2009, IMMUNOL REV, V228, P342, DOI 10.1111/j.1600-065X.2008.00760.x; Mariathasan S, 2001, J IMMUNOL, V167, P4966, DOI 10.4049/jimmunol.167.9.4966; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Minoo P, 2004, BLOOD, V103, P1398, DOI 10.1182/blood-2003-07-2617; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Paster W, 2013, J IMMUNOL, V190, P3749, DOI 10.4049/jimmunol.1203389; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Plas DR, 1999, J IMMUNOL, V162, P5680; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Rybakin V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043191; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Simoneau M, 2008, J BIOL CHEM, V283, P25544, DOI 10.1074/jbc.M804177200; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Zhang JY, 1999, J IMMUNOL, V163, P3012	44	85	86	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					441	+		10.1038/nature12718	http://dx.doi.org/10.1038/nature12718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24226767	Green Accepted			2022-12-24	WOS:000328575300053
J	Bui, KH; von Appen, A; DiGuilio, AL; Ori, A; Sparks, L; Mackmull, MT; Bock, T; Hagen, W; Andres-Pons, A; Glavy, JS; Beck, M				Bui, Khanh Huy; von Appen, Alexander; DiGuilio, Amanda L.; Ori, Alessandro; Sparks, Lenore; Mackmull, Marie-Therese; Bock, Thomas; Hagen, Wim; Andres-Pons, Amparo; Glavy, Joseph S.; Beck, Martin			Integrated Structural Analysis of the Human Nuclear Pore Complex Scaffold	CELL			English	Article							CRYOELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE; ELECTRON-MICROSCOPY; MASS-SPECTROMETRY; DOMAIN TOPOLOGY; NUCLEOPORIN; MEMBRANE; PHOSPHORYLATION; COMPONENTS; PROTEINS	The nuclear pore complex (NPC) is a fundamental component of all eukaryotic cells that facilitates nucleocytoplasmic exchange of macromolecules. It is assembled from multiple copies of about 30 nucleoporins. Due to its size and complex composition, determining the structure of the NPC is an enormous challenge, and the overall architecture of the NPC scaffold remains elusive. In this study, we have used an integrated approach based on electron tomography, single-particle electron microscopy, and crosslinking mass spectrometry to determine the structure of a major scaffold motif of the human NPC, the Nup107 subcomplex, in both isolation and integrated into the NPC. We show that 32 copies of the Nup107 subcomplex assemble into two reticulated rings, one each at the cytoplasmic and nuclear face of the NPC. This arrangement may explain how changes of the diameter are realized that would accommodate transport of huge cargoes.	[Bui, Khanh Huy; von Appen, Alexander; Ori, Alessandro; Sparks, Lenore; Mackmull, Marie-Therese; Bock, Thomas; Hagen, Wim; Andres-Pons, Amparo; Beck, Martin] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [DiGuilio, Amanda L.; Glavy, Joseph S.] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA	European Molecular Biology Laboratory (EMBL); Stevens Institute of Technology	Glavy, JS (corresponding author), Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, 507 River St, Hoboken, NJ 07030 USA.	jglavy@stevens.edu; martin.beck@embl.de	Ori, Alessandro/B-7067-2011; Ori, Alessandro/M-8586-2019; Lemke, Edward A/J-3337-2015; Thomas, Bock/I-2444-2017; Beck, Martin/B-5589-2011	Ori, Alessandro/0000-0002-3046-0871; Ori, Alessandro/0000-0002-3046-0871; Lemke, Edward A/0000-0002-0634-0503; Thomas, Bock/0000-0001-7448-3162; Beck, Martin/0000-0002-7397-1321; Bui, Khanh Huy/0000-0003-2814-9889; Mackmull, Marie-Therese/0000-0003-2928-1144; Glavy, Joseph/0000-0003-3716-3965; Andres-Pons, Amparo/0000-0001-5801-4024; von Appen, Alexander/0000-0001-6528-2123; Bock, Thomas Klaus Christian/0000-0002-9314-5318; Hagen, Wim/0000-0001-6229-2692	Swiss National Science Foundation; European Molecular Biology Organization, and Marie Curie Actions; Alexander von Humboldt Foundation and Marie Curie Actions; Robert Crooks Stanley Fellowship at Stevens Institute of Technology; European Research Council [309271-NPCAtlas]; EMBL's mechanical workshop	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Molecular Biology Organization, and Marie Curie Actions; Alexander von Humboldt Foundation and Marie Curie Actions(Alexander von Humboldt Foundation); Robert Crooks Stanley Fellowship at Stevens Institute of Technology; European Research Council(European Research Council (ERC)European Commission); EMBL's mechanical workshop	We thank Drs. Katja Beck and Edward A. Lemke for critical advice, reading of the manuscript, and numerous insightful discussions. We thank Drs. Carsten Sachse, Virginia VanDelinder, Thomas Cattabiani, and Iain Mattaj for critical reading of the manuscript; Ulrike Kutay for reagents; Peer Bork, Tommy E. White, Jan Kosinski, and John Briggs for critical advice. We gratefully acknowledge support from EMBL's mechanical workshop, electron microscopy and proteomics core facilities, and the centre for statistical data analysis and, in particular, want to thank James Riches, Drs. Jeroen Krijgsveld, and Bernd Klaus. K.H.B was supported by postdoctoral fellowships from the Swiss National Science Foundation, the European Molecular Biology Organization, and Marie Curie Actions. A.O. was supported by postdoctoral fellowships from the Alexander von Humboldt Foundation and Marie Curie Actions. A.L.D. was supported by the Robert Crooks Stanley Fellowship at Stevens Institute of Technology. M.B. acknowledges funding by the European Research Council (309271-NPCAtlas).	Adams RL, 2013, CELL, V152, P1218, DOI 10.1016/j.cell.2013.02.042; AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6; AKEY CW, 1989, J CELL BIOL, V109, P955, DOI 10.1083/jcb.109.3.955; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Antonin W, 2011, NUCLEUS-AUSTIN, V2, P87, DOI 10.4161/nucl.2.2.14637; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Bilokapic S, 2012, P NATL ACAD SCI USA, V109, P15241, DOI 10.1073/pnas.1205151109; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Dultz E, 2010, J CELL BIOL, V191, P15, DOI 10.1083/jcb.201007076; Flemming D, 2010, NAT STRUCT MOL BIOL, V17, P775, DOI 10.1038/nsmb.1811; Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104; GOLDBERG MW, 1993, J CELL SCI, V106, P261; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Kampmann M, 2011, NAT STRUCT MOL BIOL, V18, P643, DOI 10.1038/nsmb.2056; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Miller BR, 2000, MOL BIOL CELL, V11, P3381, DOI 10.1091/mbc.11.10.3381; Mitchell JM, 2010, J CELL BIOL, V191, P505, DOI 10.1083/jcb.201007098; Nagy V, 2009, P NATL ACAD SCI USA, V106, P17693, DOI 10.1073/pnas.0909373106; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Sachdev R, 2012, MOL BIOL CELL, V23, P740, DOI 10.1091/mbc.E11-09-0761; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Schwarz-Herion K, 2007, J MOL BIOL, V370, P796, DOI 10.1016/j.jmb.2007.05.030; Senger S, 2011, DEVELOPMENT, V138, P2133, DOI 10.1242/dev.057372; Seo HS, 2009, P NATL ACAD SCI USA, V106, P14281, DOI 10.1073/pnas.0907453106; Solmaz SR, 2011, CELL, V147, P590, DOI 10.1016/j.cell.2011.09.034; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Tagliazucchi M, 2013, P NATL ACAD SCI USA, V110, P3363, DOI 10.1073/pnas.1212909110; Talamas JA, 2011, J CELL BIOL, V194, P27, DOI 10.1083/jcb.201012154; Thierbach K, 2013, STRUCTURE, V21, P1672, DOI 10.1016/j.str.2013.07.004; UNWIN PNT, 1982, J CELL BIOL, V93, P63, DOI 10.1083/jcb.93.1.63; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	52	241	244	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1233	1243		10.1016/j.cell.2013.10.055	http://dx.doi.org/10.1016/j.cell.2013.10.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315095	Bronze			2022-12-24	WOS:000328271100009
J	Toettcher, JE; Weiner, OD; Lim, WA				Toettcher, Jared E.; Weiner, Orion D.; Lim, Wendell A.			Using Optogenetics to Interrogate the Dynamic Control of Signal Transmission by the Ras/Erk Module	CELL			English	Article							KINASE PATHWAY; GROWTH-FACTOR; LIVING CELLS; ERK; ACTIVATION; FEEDBACK; NETWORK; COMPLEX; TRANSLOCATION; TRANSDUCTION	The complex, interconnected architecture of cell-signaling networks makes it challenging to disentangle how cells process extracellular information to make decisions. We have developed an optogenetic approach to selectively activate isolated intracellular signaling nodes with light and use this method to follow the flow of information from the signaling protein Ras. By measuring dose and frequency responses in single cells, we characterize the precision, timing, and efficiency with which signals are transmitted from Ras to Erk. Moreover, we elucidate how a single pathway can specify distinct physiological outcomes: by combining distinct temporal patterns of stimulation with proteomic profiling, we identify signaling programs that differentially respond to Ras dynamics, including a paracrine circuit that activates STAT3 only after persistent (>1 hr) Ras activation. Optogenetic stimulation provides a powerful tool for analyzing the intrinsic transmission properties of pathway modules and identifying how they dynamically encode distinct outcomes.	[Toettcher, Jared E.; Lim, Wendell A.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [Toettcher, Jared E.; Weiner, Orion D.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Toettcher, Jared E.; Weiner, Orion D.; Lim, Wendell A.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiner, OD (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA.	orion.weiner@ucsf.edu; lim@cmp.ucsf.edu	Weiner, Orion D/F-2576-2011	Weiner, Orion D/0000-0002-1778-6543	Cancer Research Institute Postdoctoral Fellowship; NIH [GM096164, GM55040, GM62583, PN2EY016546, P50GM081879, GM084040]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040, R01GM096164, R01GM062583, P50GM081879, R01GM084040] Funding Source: NIH RePORTER	Cancer Research Institute Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. El-Samad, D. Sivak, and members of the Lim and Weiner labs. This work was supported by a Cancer Research Institute Postdoctoral Fellowship (J.E.T.); NIH grant GM096164 (W.A.L. and O.D.W.); the Howard Hughes Medical Institute and NIH grants GM55040, GM62583, PN2EY016546, and P50GM081879 (W.A.L.); and NIH grant GM084040 (O.D.W.).	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; BISHOP JM, 1994, COLD SPRING HARB SYM, V59, P165, DOI 10.1101/SQB.1994.059.01.020; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Davies MA, 2012, CLIN CANCER RES, V18, P1120, DOI 10.1158/1078-0432.CCR-11-2436; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/nmeth.1428, 10.1038/NMETH.1428]; Koronakis V, 2011, P NATL ACAD SCI USA, V108, P14449, DOI 10.1073/pnas.1107666108; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li W, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1308; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Oppenheim A. V., 1997, SIGNALS SYSTEMS; Park JI, 2003, MOL CELL BIOL, V23, P543, DOI 10.1128/MCB.23.2.543-554.2003; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rusnati M, 2009, SENSORS-BASEL, V9, P6471, DOI 10.3390/s90806471; Samoilov M, 2002, J PHYS CHEM A, V106, P10205, DOI 10.1021/jp025846z; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Toettcher JE, 2011, NAT METHODS, V8, P837, DOI [10.1038/NMETH.1700, 10.1038/nmeth.1700]; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241	46	346	351	3	99	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1422	1434		10.1016/j.cell.2013.11.004	http://dx.doi.org/10.1016/j.cell.2013.11.004			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315106	Green Accepted, Bronze			2022-12-24	WOS:000328271100023
J	Wellings, K; Jones, KG; Mercer, CH; Tanton, C; Clifton, S; Datta, J; Copas, AJ; Erens, B; Gibson, LJ; Macdowall, W; Sonnenberg, P; Phelps, A; Johnson, AM				Wellings, Kaye; Jones, Kyle G.; Mercer, Catherine H.; Tanton, Clare; Clifton, Soazig; Datta, Jessica; Copas, Andrew J.; Erens, Bob; Gibson, Lorna J.; Macdowall, Wendy; Sonnenberg, Pam; Phelps, Andrew; Johnson, Anne M.			The prevalence of unplanned pregnancy and associated factors in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)	LANCET			English	Article							UNINTENDED PREGNANCY; WOMEN; CONTRACEPTION; FERTILITY; INTENTION; ABORTION; DEPRESSION; CATEGORIES; BIRTH; RATES	Background Unplanned pregnancy is a key public health indicator. We describe the prevalence of unplanned pregnancy, and associated factors, in a general population sample in Britain (England, Scotland, and Wales). Method We did a probability sample survey, the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3), of 15 162 men and women aged 16-74 years in Britain, including 5686 women of child-bearing age (16-44 years) who were included in the pregnancy analysis, between Sept 6, 2010, and Aug 31, 2012. We describe the planning status of pregnancies with known outcomes in the past year, and report the annual population prevalence of unplanned pregnancy, using a validated, multicriteria, multi-outcome measure (the London Measure of Unplanned Pregnancy). We set the findings in the context of secular trends in reproductive health-related events, and patterns across the life course. Findings 9.7% of women aged 16-44 years had pregnancies with known outcome in the year before interview, of which 16.2% (95% CI 13.1-19.9) scored as unplanned, 29.0% (25.2-33.2) as ambivalent, and 54.8% (50.3-59.2) as planned, giving an annual prevalence estimate for unplanned pregnancy of 1.5% (1.2-1.9). Pregnancies in women aged 16-19 years were most commonly unplanned (45.2% [30.8-60.5]). However, most unplanned pregnancies were in women aged 20-34 years (62.4% [50.2-73.2]). Factors strongly associated with unplanned pregnancy were first sexual intercourse before 16 years of age (age-adjusted odds ratio 2.85 [95% CI 1.77-4.57], current smoking (2.47 [1.46-4.18]), recent use of drugs other than cannabis (3.41 [1.64-7.11]), and lower educational attainment. Unplanned pregnancy was also associated with lack of sexual competence at first sexual intercourse (1.90 [1.14-3.08]), reporting higher frequency of sex (2.11 [1.25-3.57] for five or more times in the past 4 weeks), receiving sex education mainly from a non-school-based source (1.84 [1.12-3.00]), and current depression (1.96 [1.10-3.47]). Interpretation The increasing intervals between first sexual intercourse, cohabitation, and childbearing means that, on average, women in Britain spend about 30 years of their life needing to avert an unplanned pregnancy. Our data off er scope for primary prevention aimed at reducing the rate of unplanned conceptions, and secondary prevention aimed at modification of health behaviours and health disorders in unplanned pregnancy that might be harmful for mother and child.	[Wellings, Kaye; Datta, Jessica; Erens, Bob; Gibson, Lorna J.; Macdowall, Wendy] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England; [Jones, Kyle G.; Mercer, Catherine H.; Tanton, Clare; Clifton, Soazig; Copas, Andrew J.; Erens, Bob; Sonnenberg, Pam; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, London, England; [Clifton, Soazig; Erens, Bob; Phelps, Andrew] NatCen Social Res, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Wellings, K (corresponding author), Ctr Sexual & Reprod Hlth Res, Dept Publ Hlth & Policy, 15 Tavistock Pl, London WC1H 9SH, England.	kaye.wellings@lshtm.ac.uk	Weatherburn, Peter/AAC-2701-2019	Johnson, Anne/0000-0003-1330-7100; Clifton, Soazig/0000-0002-4171-0805; Erens, Robert/0000-0002-3054-504X; Tanton, Clare/0000-0002-4612-1858; Macdowall, Wendy/0000-0001-5868-8336; Mercer, Catherine/0000-0002-4220-5034; Jones, Kyle/0000-0002-7127-1612; Copas, Andrew/0000-0001-8968-5963; Sonnenberg, Pam/0000-0002-1067-1583; Erens, Bob/0000-0002-4430-954X	UK Medical Research Council; Wellcome Trust; Economic and Social Research Council; Department of Health; Medical Research Council [G0701757] Funding Source: researchfish; National Institute for Health Research [MET-11-19-101, NF-SI-0508-10244] Funding Source: researchfish; MRC [G0701757] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Grants from the UK Medical Research Council and the Wellcome Trust, with support from the Economic and Social Research Council and the Department of Health.	Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; Bachrach CA, 1999, FAM PLANN PERSPECT, V31, P251, DOI 10.2307/2991577; Bajos N, 2003, HUM REPROD, V18, P994, DOI 10.1093/humrep/deg215; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Cameron ST, 2013, CONTRACEPTION, V88, P128, DOI 10.1016/j.contraception.2012.10.032; Campbell A A, 2000, Matern Child Health J, V4, P163, DOI 10.1023/A:1009519329226; Carson C, 2013, FERTIL STERIL, V99, P456, DOI 10.1016/j.fertnstert.2012.10.029; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Finer LB, 2013, CONTRACEPTION, V87, P126, DOI 10.1016/j.contraception.2012.12.005; FLEISSIG A, 1991, BRIT MED J, V302, P147, DOI 10.1136/bmj.302.6769.147; Font-Ribera L, 2008, J URBAN HEALTH, V85, P125, DOI 10.1007/s11524-007-9233-z; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Gipson JD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4996; Goto A, 2002, SOC SCI MED, V54, P1065, DOI 10.1016/S0277-9536(01)00081-8; Hale GE, 2009, BEST PRACT RES CL OB, V23, P7, DOI 10.1016/j.bpobgyn.2008.10.001; Harrison Ayanna T., 2012, Morbidity and Mortality Weekly Report, V61, P25; Joyce T, 2000, Matern Child Health J, V4, P171, DOI 10.1023/A:1009571313297; Kavanaugh ML, 2009, PERSPECT SEX REPRO H, V41, P238, DOI 10.1363/4123809; Krause EL, 2012, MED ANTHROPOL Q, V26, P361, DOI 10.1111/j.1548-1387.2012.01223.x; Kuroki LM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.049; Lakha F, 2006, LANCET, V368, P1782, DOI 10.1016/S0140-6736(06)69737-7; Lanzi RG, 2009, J CHILD ADOL PS NURS, V22, P194, DOI 10.1111/j.1744-6171.2009.00199.x; Luker KC, 1999, FAM PLANN PERSPECT, V31, P248, DOI 10.2307/2991574; Mercer CH, 2013, LANCET; Miller WB, 2013, POP STUD-J DEMOG, V67, P25, DOI 10.1080/00324728.2012.738823; Mohllajee AP, 2007, OBSTET GYNECOL, V109, P678, DOI 10.1097/01.AOG.0000255666.78427.c5; Moos MK, 2003, CONTRACEPTION, V67, P115, DOI 10.1016/S0010-7824(02)00472-9; Morof D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035381; Mosher WD, 2012, INTENDED UNINTENDED, V55; Office for National Statistics, 2010, STAT OCC CLASS 2010, V1-3; Oringanje C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005215.pub2; Payne R. A., 2012, Health Statistics Quarterly, P22; Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [10.1097/AOG.0b013e318273eb56, http://10.1097/AOG.0b013e318273eb56]; Rocca CH, 2010, DEMOGR RES, V23, P293, DOI 10.4054/DemRes.2010.23.11; Roehr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6763; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Santelli JS, 2009, STUD FAMILY PLANN, V40, P87, DOI 10.1111/j.1728-4465.2009.00192.x; Schunmann C, 2006, CONTRACEPTION, V73, P520, DOI 10.1016/j.contraception.2005.12.009; Schwartz A, 2010, WOMEN HEALTH ISS, V20, P371, DOI 10.1016/j.whi.2010.06.005; Shah PS, 2011, MATERN CHILD HLTH J, V15, P205, DOI 10.1007/s10995-009-0546-2; Speizer IS, 2004, PERSPECT SEX REPRO H, V36, P198; United Nations Population Fund, STAT WORLD POP 1997; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4	45	252	257	2	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1807	1816		10.1016/S0140-6736(13)62071-1	http://dx.doi.org/10.1016/S0140-6736(13)62071-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259QF	24286786	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000327540700025
J	Davoli, T; Xu, AW; Mengwasser, KE; Sack, LM; Yoon, JC; Park, PJ; Elledge, SJ				Davoli, Teresa; Xu, Andrew Wei; Mengwasser, Kristen E.; Sack, Laura M.; Yoon, John C.; Park, Peter J.; Elledge, Stephen J.			Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome	CELL			English	Article							REVEALS; MUTATIONS; RESOURCE	Aneuploidy has been recognized as a hallmark of cancer for more than 100 years, yet no general theory to explain the recurring patterns of aneuploidy in cancer has emerged. Here, we develop Tumor Suppressor and Oncogene (TUSON) Explorer, a computational method that analyzes the patterns of mutational signatures in tumors and predicts the likelihood that any individual gene functions as a tumor suppressor (TSG) or oncogene (OG). By analyzing >8,200 tumor-normal pairs, we provide statistical evidence suggesting that many more genes possess cancer driver properties than anticipated, forming a continuum of oncogenic potential. Integrating our driver predictions with information on somatic copy number alterations, we find that the distribution and potency of TSGs (STOP genes), OGs, and essential genes (GO genes) on chromosomes can predict the complex patterns of aneuploidy and copy number variation characteristic of cancer genomes. We propose that the cancer genome is shaped through a process of cumulative haploinsufficiency and triplosensitivity.	[Davoli, Teresa; Mengwasser, Kristen E.; Sack, Laura M.; Elledge, Stephen J.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; [Davoli, Teresa; Xu, Andrew Wei; Mengwasser, Kristen E.; Sack, Laura M.; Yoon, John C.; Park, Peter J.; Elledge, Stephen J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Yoon, John C.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Xu, Andrew Wei; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	wang, edwin/G-5372-2010	Park, Peter/0000-0001-9378-960X; Davoli, Teresa/0000-0003-4116-9745; Sack, Laura/0000-0003-1186-1335	DOD Breast Cancer Innovator Award; NIH [U54LM008748, K08DK081612]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044664, T32GM007753] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	DOD Breast Cancer Innovator Award(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Simon Forbes and Michael Stratton (Wellcome Trust Sanger Institute, UK) for the data from the Cosmic dataset (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/), Eric Wooten for help on data extraction, and Chad Creighton and Kim Rathmell for allowing access to their unpublished data on KICH SCNAs. We also thank Andrew Futreal, Semin Lee, David Livingston, David Page, Mary-Claire King, Jim Lupski, Rameen Beroukhim, Matt Meyerson, Atanas Kamburov, and Paul Edwards for helpful advice and Bert Vogelstein, Judith Glaven, and members of the Elledge lab for helpful comments on the manuscript. This work was funded by a DOD Breast Cancer Innovator Award and NIH grant to S.J.E., U54LM008748 to P.J.P., and K08DK081612 to J.C.Y. S.J.E. is an investigator with the Howard Hughes Medical Institute. We apologize to our colleagues whose papers we could not cite due to space limitations.	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bianchi NO, 2009, MUTAT RES-REV MUTAT, V682, P21, DOI 10.1016/j.mrrev.2009.02.001; Boveri T, 1929, ORIGIN MALIGNANT TUM; Conti P, 2007, AUTOIMMUN REV, V6, P131, DOI 10.1016/j.autrev.2006.08.015; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kowalski J, 2007, CANCER GENET CYTOGEN, V178, P26, DOI 10.1016/j.cancergencyto.2007.06.004; Lai K, 2009, DEV DYNAM, V238, P76, DOI 10.1002/dvdy.21815; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mosig MO, 2001, GENETICS, V157, P1683; Ozery-Flato M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r61; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Shannon C., 1964, MATH THEORY COMMUNIC; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Willig TN, 2000, CURR OPIN HEMATOL, V7, P85, DOI 10.1097/00062752-200003000-00003; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	37	472	480	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					948	962		10.1016/j.cell.2013.10.011	http://dx.doi.org/10.1016/j.cell.2013.10.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24183448	Bronze, Green Accepted			2022-12-24	WOS:000326934300022
J	Arpaia, N; Campbell, C; Fan, XY; Dikiy, S; van der Veeken, J; deRoos, P; Liu, H; Cross, JR; Pfeffer, K; Coffer, PJ; Rudensky, AY				Arpaia, Nicholas; Campbell, Clarissa; Fan, Xiying; Dikiy, Stanislav; van der Veeken, Joris; deRoos, Paul; Liu, Hui; Cross, Justin R.; Pfeffer, Klaus; Coffer, Paul J.; Rudensky, Alexander Y.			Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation	NATURE			English	Article							CHAIN FATTY-ACIDS; RECEPTOR; RELB; INDUCTION	Intestinal microbes provide multicellular hosts with nutrients and confer resistance to infection. The delicate balance between pro-and anti-inflammatory mechanisms, essential for gut immune homeostasis, is affected by the composition of the commensal microbial community. Regulatory T cells (T-reg cells) expressing transcription factor Foxp3 have a key role in limiting inflammatory responses in the intestine(1). Although specific members of the commensal microbial community have been found to potentiate the generation of anti-inflammatory T-reg or pro-inflammatory T helper 17 (T(H)17) cells(2-6), the molecular cues driving this process remain elusive. Considering the vital metabolic function afforded by commensal microorganisms, we reasoned that their metabolic by-products are sensed by cells of the immune system and affect the balance between pro-and anti-inflammatory cells. We tested this hypothesis by exploring the effect of microbial metabolites on the generation of anti-inflammatory T-reg cells. We found that in mice a short-chain fatty acid (SCFA), butyrate, produced by commensal microorganisms during starch fermentation, facilitated extrathymic generation of T-reg cells. A boost in T-reg-cell numbers after provision of butyrate was due to potentiation of extrathymic differentiation of T-reg cells, as the observed phenomenon was dependent on intronic enhancer CNS1 (conserved non-coding sequence 1), essential for extrathymic but dispensable for thymic T-reg-cell differentiation(1,7). In addition to butyrate, de novo T-reg-cell generation in the periphery was potentiated by propionate, another SCFA of microbial origin capable of histone deacetylase (HDAC) inhibition, but not acetate, which lacks this HDAC-inhibitory activity. Our results suggest that bacterial metabolites mediate communication between the commensal microbiota and the immune system, affecting the balance between pro- and anti-inflammatory mechanisms.	[Arpaia, Nicholas; Campbell, Clarissa; Fan, Xiying; Dikiy, Stanislav; van der Veeken, Joris; deRoos, Paul; Coffer, Paul J.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Arpaia, Nicholas; Campbell, Clarissa; Fan, Xiying; Dikiy, Stanislav; van der Veeken, Joris; deRoos, Paul; Coffer, Paul J.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA; [Arpaia, Nicholas; Campbell, Clarissa; Fan, Xiying; Dikiy, Stanislav; van der Veeken, Joris; deRoos, Paul; Coffer, Paul J.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Liu, Hui; Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, New York, NY 10065 USA; [Pfeffer, Klaus] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Heinrich Heine University Dusseldorf; Utrecht University; Utrecht University Medical Center	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Dikiy, Stanislav/GWR-2104-2022; Coffer, Paul/AAF-7970-2020; Arpaia, Nicholas/R-2549-2018	Pfeffer, Klaus/0000-0002-5652-6330; Arpaia, Nicholas/0000-0002-0657-0528; Dikiy, Stanislav/0000-0002-8287-6561; Fan, Xiying/0000-0003-3090-381X; Cross, Justin/0000-0002-6356-057X; Campbell, Clarissa/0000-0002-1918-0318	Damon Runyon Cancer Research Foundation [DRG-2143-13]; Ludwig Center at Memorial Sloan Kettering Cancer Center; US National Institutes of Health (NIH) [T32 A1007621, R37 AI034206]; NATIONAL CANCER INSTITUTE [T32CA009149, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206, T32AI007621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Ludwig Center at Memorial Sloan Kettering Cancer Center; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Robert Black Fellowship of the Damon Runyon Cancer Research Foundation DRG-2143-13 (N.A.), Ludwig Center at Memorial Sloan Kettering Cancer Center and the US National Institutes of Health (NIH) grant T32 A1007621(N.A.) and R37 AI034206 (A.Y.R.). A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Annison G, 2003, J NUTR, V133, P3523, DOI 10.1093/jn/133.11.3523; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; MacDonald KPA, 2007, BLOOD, V109, P5049, DOI 10.1182/blood-2007-01-067249; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Shih VFS, 2012, NAT IMMUNOL, V13, P1162, DOI 10.1038/ni.2446; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Song XM, 2012, CELL REPORTS, V1, P665, DOI 10.1016/j.celrep.2012.04.012; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Torii T, 2010, ANN CLIN BIOCHEM, V47, P447, DOI 10.1258/acb.2010.010047; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Zhang HT, 2012, IMMUNOL CELL BIOL, V90, P95, DOI 10.1038/icb.2011.101; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhu HC, 2012, CELL IMMUNOL, V274, P12, DOI 10.1016/j.cellimm.2012.02.012	25	2406	2504	41	519	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					451	+		10.1038/nature12726	http://dx.doi.org/10.1038/nature12726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24226773	Green Accepted			2022-12-24	WOS:000328575300055
J	Sancak, Y; Markhard, AL; Kitami, T; Kovacs-Bogdan, E; Kamer, KJ; Udeshi, ND; Carr, SA; Chaudhuri, D; Clapham, DE; Li, AA; Calvo, SE; Goldberger, O; Mootha, VK				Sancak, Yasemin; Markhard, Andrew L.; Kitami, Toshimori; Kovacs-Bogdan, Erika; Kamer, Kimberli J.; Udeshi, Namrata D.; Carr, Steven A.; Chaudhuri, Dipayan; Clapham, David E.; Li, Andrew A.; Calvo, Sarah E.; Goldberger, Olga; Mootha, Vamsi K.			EMRE Is an Essential Component of the Mitochondrial Calcium Uniporter Complex	SCIENCE			English	Article							CA2+ UPTAKE; PROTEIN; MICU1; MCU	The mitochondrial uniporter is a highly selective calcium channel in the organelle's inner membrane. Its molecular components include the EF-hand-containing calcium-binding proteins mitochondrial calcium uptake 1 (MICU1) and MICU2 and the pore-forming subunit mitochondrial calcium uniporter (MCU). We sought to achieve a full molecular characterization of the uniporter holocomplex (uniplex). Quantitative mass spectrometry of affinity-purified uniplex recovered MICU1 and MICU2, MCU and its paralog MCUb, and essential MCU regulator (EMRE), a previously uncharacterized protein. EMRE is a 10-kilodalton, metazoan-specific protein with a single transmembrane domain. In its absence, uniporter channel activity was lost despite intact MCU expression and oligomerization. EMRE was required for the interaction of MCU with MICU1 and MICU2. Hence, EMRE is essential for in vivo uniporter current and additionally bridges the calcium-sensing role of MICU1 and MICU2 with the calcium-conducting role of MCU.	[Sancak, Yasemin; Markhard, Andrew L.; Kitami, Toshimori; Kovacs-Bogdan, Erika; Kamer, Kimberli J.; Li, Andrew A.; Calvo, Sarah E.; Goldberger, Olga; Mootha, Vamsi K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Dept Syst Biol, Boston, MA 02115 USA; [Sancak, Yasemin; Kitami, Toshimori; Udeshi, Namrata D.; Carr, Steven A.; Calvo, Sarah E.; Mootha, Vamsi K.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Chaudhuri, Dipayan; Clapham, David E.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Cardiol,Childrens Hosp, Boston, MA 02115 USA; [Chaudhuri, Dipayan; Clapham, David E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Chaudhuri, Dipayan] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Mootha, VK (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Dept Syst Biol, Boston, MA 02115 USA.	vamsi@hms.harvard.edu	Carr, Steven A./AAH-8366-2019; Clapham, David/R-5974-2019; Clapham, David/S-1123-2019; Kitami, Toshimori/N-7460-2019	Clapham, David/0000-0002-4459-9428; Kitami, Toshimori/0000-0001-8418-5230; Li, Andrew/0000-0002-1295-8115; Chaudhuri, Dipayan/0000-0003-0605-7334	Helen Hay Whitney Foundation; NIH [F32HL107021, DK080261]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL107021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Z. Grabarek and D. M. Shechner for helpful discussions. Y.S. received support from the Helen Hay Whitney Foundation. D. C. received support from NIH F32HL107021. D. E. C. is an Investigator of the Howard Hughes Medical Institute. This work was supported by grants to V. K. M from NIH DK080261 and a gift from W. Dan and Pat Wright.	Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bick AG, 2012, SCIENCE, V336, P886, DOI 10.1126/science.1214977; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Feng SJ, 2013, P NATL ACAD SCI USA, V110, P11011, DOI 10.1073/pnas.1309531110; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palty R, 2004, J BIOL CHEM, V279, P25234, DOI 10.1074/jbc.M401229200; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556	20	429	441	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1379	1382		10.1126/science.1242993	http://dx.doi.org/10.1126/science.1242993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24231807	Green Accepted			2022-12-24	WOS:000328196000053
J	Guo, YM; Li, SS; Tian, ZX; Pan, XC; Zhang, JL; Williams, G				Guo, Yuming; Li, Shanshan; Tian, Zhaoxing; Pan, Xiaochuan; Zhang, Jinliang; Williams, Gail			The burden of air pollution on years of life lost in Beijing, China, 2004-08: retrospective regression analysis of daily deaths	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EMERGENCY-ROOM VISITS; DAILY MORTALITY; TIME-SERIES; FINE; AGE; ASSOCIATION; DISEASE; CITIES; SEX	Objectives To better understand the burden of air pollution on deaths, we examined the effects of air pollutants on years of life lost (YLL) in Beijing, China. Design Retrospective regression analysis using daily time series. Setting 8 urban districts in Beijing, China. Participants 80 515 deaths (48 802 male, 31 713 female) recorded by the Beijing death classification system during 2004-08. Main outcome measures Associations between daily YLL and ambient air pollutants (particulate matter with aerodynamic diameter < 2.5 mu m (PM2.5), PM10, SO2, and NO2), after adjusting for long term trends, seasonality, day of the week, and weather conditions. We also examined mortality risk related to air pollutants. Results Mean concentrations of daily PM2.5, PM10, SO2 and NO2 were 105.1 mu g/m(3), 144.6 mu g/m(3), 48.6 mu g/m(3), and 64.2 mu g/m(3), respectively. All air pollutants had significant effects on years of life lost when we used single pollutant models. An interquartile range (IQR) increase in PM2.5, PM10, SO2, and NO2 was related to YLL increases of 15.8, 15.8, 16.2, and 15.1 years, respectively. The effects of air pollutants on YLL appeared acutely and lasted for two days (lag 0-1); these effects associated with an IQR increase in PM2.5 were greater in women than men (11.1 (95% confidence interval 4.7 to 17.5) v 4.7 (-2.9 to 12.3) YLL) and in people aged up to 65 years than those older than 65 years (12.0 (2.9 to 21) v 3.8 (-0.9 to 8.6) YLL). The mortality risk associated with an IQR increase in PM2.5 was greater for people older than 65 years (2.5% (95% confidence interval 0.6% to 4.5%) increase of mortality) than those aged up to 65 years (0.7% (-0.8% to 2.2%)). Conclusions YLL provides a complementary measure for examining the effect of air pollutants on mortality. Increased YLL are associated with increased air pollution. This study highlights the need to reduce air pollution in Beijing, China, to protect the health of the population.	[Guo, Yuming; Li, Shanshan; Williams, Gail] Univ Queensland, Dept Epidemiol & Biostat, Sch Populat Hlth, Brisbane, Qld 4006, Australia; [Tian, Zhaoxing] Peking Univ, Hosp 3, Emergency Dept, Beijing 100191, Peoples R China; [Pan, Xiaochuan] Peking Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Beijing 100871, Peoples R China; [Zhang, Jinliang] Chinese Res Inst Environm Sci, Environm Stand Inst, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China	University of Queensland; Peking University; Peking University; Chinese Research Academy of Environmental Sciences	Guo, YM (corresponding author), Univ Queensland, Dept Epidemiol & Biostat, Sch Populat Hlth, Brisbane, Qld 4006, Australia.	y.guo1@uq.edu.au; tjtzx@126.com	Williams, Gail/S-8833-2019; Guo, Yuming/I-8353-2018	Williams, Gail/0000-0002-4822-5263; Guo, Yuming/0000-0002-1766-6592; Li, Shanshan/0000-0002-9021-8470	National Natural Science Foundation of China [81172745]; Australia National Health and Medical Research Council [APP1030259]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Australia National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study is funded by the National Natural Science Foundation of China (# 81172745), and the Australia National Health and Medical Research Council (# APP1030259).	Anderson HR, 1996, BMJ-BRIT MED J, V312, P665; [Anonymous], 2010, R LANG ENV STAT COMP; Bell ML, 2004, ANNU REV PUBL HEALTH, V25, P247, DOI 10.1146/annurev.publhealth.25.102802.124329; Bennett WD, 1996, AM J RESP CRIT CARE, V153, P1641, DOI 10.1164/ajrccm.153.5.8630615; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Chan CK, 2008, ATMOS ENVIRON, V42, P1, DOI 10.1016/j.atmosenv.2007.09.003; Chen RJ, 2012, ENVIRON RES, V118, P101, DOI 10.1016/j.envres.2012.07.003; Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425; Davis MC, 1999, ANN BEHAV MED, V21, P83, DOI 10.1007/BF02895038; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Guo YM, 2009, SCI TOTAL ENVIRON, V407, P4826, DOI 10.1016/j.scitotenv.2009.05.022; Johnston FH, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8446; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Leitte AM, 2011, ENVIRON HEALTH PERSP, V119, P508, DOI 10.1289/ehp.1002203; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu LQ, 2013, ENVIRON RES, V121, P52, DOI 10.1016/j.envres.2012.10.009; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Ouyang YD, 2013, LANCET RESP MED, V1, P12, DOI 10.1016/S2213-2600(12)70065-6; Qiu H, 2013, ATMOS ENVIRON, V64, P296, DOI 10.1016/j.atmosenv.2012.09.060; Roosli M, 2005, INT J EPIDEMIOL, V34, P1029, DOI 10.1093/ije/dyi106; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Schwartz J, 2000, AM J EPIDEMIOL, V151, P440, DOI 10.1093/oxfordjournals.aje.a010228; Seeman TE, 2002, PSYCHOSOM MED, V64, P395, DOI 10.1097/00006842-200205000-00004; WEHNER B, 2004, GEOPHYS RES LETT, V31, DOI DOI 10.1029/2004GL021596; Wen M, 2007, J GEN INTERN MED, V22, P1674, DOI 10.1007/s11606-007-0400-4; WHO, 2006, INDIAN J MED RES; World Health Organization, 2010, LIF TABL WHO MEMB ST; Yue D, 2009, J GEOPHYS RES, V114, P1; Zanobetti A, 2003, ENVIRON HEALTH PERSP, V111, P1188, DOI 10.1289/ehp.5712	31	163	171	8	95	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2013	347								f7139	10.1136/bmj.f7139	http://dx.doi.org/10.1136/bmj.f7139			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	273ZI	24322399	Green Published, hybrid			2022-12-24	WOS:000328574400006
J	Shim, J; Mukherjee, T; Mondal, BC; Liu, T; Young, GC; Wijewarnasuriya, DP; Banerjee, U				Shim, Jiwon; Mukherjee, Tina; Mondal, Bama Charan; Liu, Ting; Young, Gloria Chin; Wijewarnasuriya, Dinali Priasha; Banerjee, Utpal			Olfactory Control of Blood Progenitor Maintenance	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; AMINOBUTYRIC-ACID GABA; DROSOPHILA-LYMPH GLAND; INTRACELLULAR CA2+; BETA-CELLS; DUAL ROLE; CALCIUM; NICHE; RECEPTORS; DIFFERENTIATION	Drosophila hematopoietic progenitor maintenance involves both near neighbor and systemic interactions. This study shows that olfactory receptor neurons (ORNs) function upstream of a small set of neurosecretory cells that express GABA. Upon olfactory stimulation, GABA from these neurosecretory cells is secreted into the circulating hemolymph and binds to metabotropic GABAB receptors expressed on blood progenitors within the hematopoietic organ, the lymph gland. The resulting GABA signal causes high cytosolic Ca2+, which is necessary and sufficient for progenitor maintenance. Thus, the activation of an odorant receptor is essential for blood progenitor maintenance, and consequently, larvae raised on minimal odor environments fail to sustain a pool of hematopoietic progenitors. This study links sensory perception and the effects of its deprivation on the integrity of the hematopoietic and innate immune systems in Drosophila.	[Shim, Jiwon; Mukherjee, Tina; Mondal, Bama Charan; Liu, Ting; Young, Gloria Chin; Wijewarnasuriya, Dinali Priasha; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Shim, Jiwon; Banerjee, Utpal] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu	Shim, Jiwon/AAQ-4501-2021	Shim, Jiwon/0000-0003-2409-1130; Mondal, Bama Charan/0000-0001-9694-7714	NHLBI grant [R01 HL067395]; California Institute for Regenerative Medicine postdoctoral fellowship [TG2-01169]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067395] Funding Source: NIH RePORTER	NHLBI grant; California Institute for Regenerative Medicine postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank members of the Banerjee lab and J. Wang (UCSD) for helpful discussions. We acknowledge the Bloomington, VDRC, DGRC, and NIG Drosophila stock centers and the DSHB hybridoma bank. We thank the following individuals for stocks and reagents: I. Ando, K. Brueckner, T. Clandinin, S. Cohen, C. Evans, J. Fessler, G. Hasan, A. Hofmann, F.R. Jackson, Y.-N. Jan, T. Kitamoto, G. Korge, P. Leopold, D. Naessel, K. Ngo, S. Noselli, E. Olson, E. Rulifson, S. Sinenko, and J. Wang. This work was supported by NHLBI grant R01 HL067395 to U.B.; The Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research awards to U. B. and J. S.; and a California Institute for Regenerative Medicine postdoctoral fellowship TG2-01169 to J.S.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Asahina K, 2008, CURR BIOL, V18, P1153, DOI 10.1016/j.cub.2008.06.075; Bao Jun, 1994, Journal of Biomedical Science, V1, P237, DOI 10.1007/BF02253308; Benmimoun B, 2012, DEVELOPMENT, V139, P1713, DOI 10.1242/dev.080259; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Das S, 2011, P NATL ACAD SCI USA, V108, pE646, DOI 10.1073/pnas.1106411108; Dragojlovic-Munther M, 2012, DEVELOPMENT, V139, P3752, DOI 10.1242/dev.074203; Erecinska M, 1996, J NEUROCHEM, V67, P2325; FERKANY JW, 1978, LIFE SCI, V22, P2121, DOI 10.1016/0024-3205(78)90456-3; Gancz D, 2013, ANNU REV CELL DEV BI, V29, P137, DOI 10.1146/annurev-cellbio-101512-122331; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; JACKSON FR, 1990, J NEUROCHEM, V54, P1068, DOI 10.1111/j.1471-4159.1990.tb02359.x; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Krzemien J, 2010, DEV BIOL, V346, P310, DOI 10.1016/j.ydbio.2010.08.003; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Li Ke, 2008, Neurosci Bull, V24, P195, DOI 10.1007/s12264-008-0109-3; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; Mendez-Ferrer S, 2009, CURR OPIN HEMATOL, V16, P235, DOI 10.1097/MOH.0b013e32832bd0f5; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Minakhina S, 2010, DEVELOPMENT, V137, P27, DOI 10.1242/dev.043943; Mondal BC, 2011, CELL, V147, P1589, DOI 10.1016/j.cell.2011.11.041; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Muto Akira, 2011, Commun Integr Biol, V4, P566, DOI 10.4161/cib.4.5.15848; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; NILSSON M, 1993, NEUROSCIENCE, V54, P605, DOI 10.1016/0306-4522(93)90232-5; Ohmasa M, 2004, NEUROSCI RES, V49, P219, DOI 10.1016/j.neures.2004.02.015; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; PARRAMON M, 1995, J NEUROSCI RES, V41, P65, DOI 10.1002/jnr.490410108; Pennetier D, 2012, P NATL ACAD SCI USA, V109, P3389, DOI 10.1073/pnas.1109407109; Roberts MR, 2007, PLANT SIGNAL BEHAV, V2, P408, DOI 10.4161/psb.2.5.4335; Schwirtlich M, 2010, FASEB J, V24, P1218, DOI 10.1096/fj.09-143586; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Sinenko SA, 2012, EMBO REP, V13, P83, DOI 10.1038/embor.2011.223; Sinenko SA, 2009, DEV CELL, V16, P756, DOI 10.1016/j.devcel.2009.03.003; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Steidl U, 2004, BLOOD, V104, P81, DOI 10.1182/blood-2004-01-0373; Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Strous RD, 2006, AUTOIMMUN REV, V6, P54, DOI 10.1016/j.autrev.2006.07.002; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tokusumi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041604; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x	53	72	72	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1141	1153		10.1016/j.cell.2013.10.032	http://dx.doi.org/10.1016/j.cell.2013.10.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267893	Bronze, Green Accepted			2022-12-24	WOS:000327500600017
J	Tata, PR; Mou, HM; Pardo-Saganta, A; Zhao, R; Prabhu, M; Law, BM; Vinarsky, V; Cho, JL; Breton, S; Sahay, A; Medoff, BD; Rajagopal, J				Tata, Purushothama Rao; Mou, Hongmei; Pardo-Saganta, Ana; Zhao, Rui; Prabhu, Mythili; Law, Brandon M.; Vinarsky, Vladimir; Cho, Josalyn L.; Breton, Sylvie; Sahay, Amar; Medoff, Benjamin D.; Rajagopal, Jayaraj			Dedifferentiation of committed epithelial cells into stem cells in vivo	NATURE			English	Article							PROGENITOR CELLS; LUNG DEVELOPMENT; REGENERATION; ORIGIN; AIRWAY; EXPRESSION; TRANSDIFFERENTIATION; MAINTENANCE; REVERT; REPAIR	Cellular plasticity contributes to the regenerative capacity of plants, invertebrates, teleost fishes and amphibians. In vertebrates, differentiated cells are known to revert into replicating progenitors, but these cells do not persist as stable stem cells. Here we present evidence that differentiated airway epithelial cells can revert into stable and functional stem cells in vivo. After the ablation of airway stem cells, we observed a surprising increase in the proliferation of committed secretory cells. Subsequent lineage tracing demonstrated that the luminal secretory cells had dedifferentiated into basal stem cells. Dedifferentiated cells were morphologically indistinguishable from stem cells and they functioned as well as their endogenous counterparts in repairing epithelial injury. Single secretory cells clonally dedifferentiated into multipotent stem cells when they were cultured ex vivo without basal stem cells. By contrast, direct contact with a single basal stem cell was sufficient to prevent secretory cell dedifferentiation. In analogy to classical descriptions of amphibian nuclear reprogramming, the propensity of committed cells to dedifferentiate is inversely correlated to their state of maturity. This capacity of committed cells to dedifferentiate into stem cells may have a more general role in the regeneration of many tissues and in multiple disease states, notably cancer.	[Tata, Purushothama Rao; Mou, Hongmei; Pardo-Saganta, Ana; Zhao, Rui; Prabhu, Mythili; Law, Brandon M.; Vinarsky, Vladimir; Sahay, Amar; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Tata, Purushothama Rao; Mou, Hongmei; Pardo-Saganta, Ana; Zhao, Rui; Prabhu, Mythili; Law, Brandon M.; Vinarsky, Vladimir; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Tata, Purushothama Rao; Mou, Hongmei; Pardo-Saganta, Ana; Zhao, Rui; Prabhu, Mythili; Law, Brandon M.; Vinarsky, Vladimir; Cho, Josalyn L.; Medoff, Benjamin D.; Rajagopal, Jayaraj] Massachusetts Gen Hosp, Dept Internal Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Tata, Purushothama Rao; Mou, Hongmei; Pardo-Saganta, Ana; Zhao, Rui; Prabhu, Mythili; Law, Brandon M.; Vinarsky, Vladimir; Sahay, Amar; Rajagopal, Jayaraj] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Cho, Josalyn L.; Medoff, Benjamin D.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Breton, Sylvie] Massachusetts Gen Hosp, Ctr Syst Biol, Program Membrane Biol, Boston, MA 02214 USA; [Breton, Sylvie] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02214 USA; [Breton, Sylvie] Harvard Univ, Sch Med, Boston, MA 02214 USA; [Sahay, Amar] Harvard Univ, Dept Psychiat, Sch Med, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Rajagopal, J (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	jrajagopal@partners.org	Cho, Josalyn/ABF-8931-2021; Sahay, Amar/J-3696-2014; Zhao, Rui/J-7110-2014	Cho, Josalyn/0000-0002-0367-4495; Medoff, Benjamin/0000-0002-2558-0449; Pardo-Saganta, Ana/0000-0002-5926-6255; Tata, Purushothama Rao/0000-0003-4837-0337	Harvard Stem Cell Institute Seed Grant; National Institutes of Health-National Heart, Lung, and Blood Institute Early Career Research New Faculty [5P30HL101287-02]; Harvard Stem Cell Institute (HSCI) Junior Investigator Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118185, P30HL101287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH086615] Funding Source: NIH RePORTER	Harvard Stem Cell Institute Seed Grant; National Institutes of Health-National Heart, Lung, and Blood Institute Early Career Research New Faculty; Harvard Stem Cell Institute (HSCI) Junior Investigator Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work in this manuscript was supported by a Harvard Stem Cell Institute Seed Grant and a National Institutes of Health-National Heart, Lung, and Blood Institute Early Career Research New Faculty (P30) award (5P30HL101287-02) and a Harvard Stem Cell Institute (HSCI) Junior Investigator Grant to J.R. J.R. is a New York Stem Cell Foundation-Robertson Investigator. We wish to extend our thanks to W. Anderson, Y. Dor, Q. Zhou, A. Brack, J. Galloway and all members of the Rajagopal laboratory for their constructive criticism. We thank the members of the HSCI flow cytometry core facility for help with cell sorting.	Blanpain C, 2013, NAT CELL BIOL, V15, P126, DOI 10.1038/ncb2657; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Cho JL, 2012, J IMMUNOL, V189, P2879, DOI 10.4049/jimmunol.1102483; Dabeva MD, 1998, CANCER RES, V58, P5825; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kim JK, 2012, AM J RESP CELL MOL, V47, P864, DOI 10.1165/rcmb.2012-0164OC; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Song H, 2012, P NATL ACAD SCI USA, V109, P17531, DOI 10.1073/pnas.1207238109; Sugimoto K, 2011, TRENDS CELL BIOL, V21, P212, DOI 10.1016/j.tcb.2010.12.004; Tata P. R., 2013, AM J RESPIR CELL MOL; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Weber T, 2011, GLIA, V59, P615, DOI 10.1002/glia.21129; Wolff G., 1895, REGEN URODELENLINSE, V1, P380	35	421	426	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					218	+		10.1038/nature12777	http://dx.doi.org/10.1038/nature12777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24196716	Green Accepted, Green Submitted			2022-12-24	WOS:000326894200042
J	Flemr, M; Malik, R; Franke, V; Nejepinska, J; Sedlacek, R; Vlahovicek, K; Svoboda, P				Flemr, Matyas; Malik, Radek; Franke, Vedran; Nejepinska, Jana; Sedlacek, Radislav; Vlahovicek, Kristian; Svoboda, Petr			A Retrotransposon-Driven Dicer Isoform Directs Endogenous Small Interfering RNA Production in Mouse Oocytes	CELL			English	Article							DOUBLE-STRANDED-RNA; MICRORNA BIOGENESIS; GENE; PROTEIN; MICROPROCESSOR; METHYLATION; EXPRESSION; DOMAINS; SIRNAS; CELLS	In mammals, a single Dicer participates in biogenesis of small RNAs in microRNA (miRNA) and RNAi pathways. In mice, endogenous RNAi is highly active in oocytes, but not in somatic cells, which we ascribe here to an oocyte-specific Dicer isoform (Dicer(O)). Dicer(O) lacks the N-terminal DExD helicase domain and has higher cleavage activity than the full-length Dicer in somatic cells (Dicer(S)). Unlike Dicer(S), Dicer(O) efficiently produces small RNAs from long double-stranded (dsRNA) substrates. Expression of the Dicer(O) isoform is driven by an intronic MT-C retrotransposon promoter, deletion of which causes loss of Dicer(O) and female sterility. Oocytes from females lacking the MT-C element show meiotic spindle defects and increased levels of endogenous small interfering RNA (endo-siRNA) targets, phenocopying the maternal Dicer null phenotype. The alternative Dicer isoform, whose phylogenetic origin demonstrates evolutionary plasticity of RNA-silencing pathways, is the main determinant of endogenous RNAi activity in the mouse female germline.	[Flemr, Matyas; Malik, Radek; Nejepinska, Jana; Sedlacek, Radislav; Svoboda, Petr] Acad Sci Czech Republ, Inst Mol Genet, CR-14220 Prague, Czech Republic; [Franke, Vedran; Vlahovicek, Kristian] Univ Zagreb, Div Biol, Dept Mol Biol, Bioinformat Grp,Fac Sci, Zagreb 10000, Croatia; [Vlahovicek, Kristian] Univ Oslo, Dept Informat, NO-0316 Oslo, Norway	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Zagreb; University of Oslo	Svoboda, P (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Videnska 1083, CR-14220 Prague, Czech Republic.	svobodap@img.cas.cz	Svoboda, Petr/G-3890-2012; Sedlacek, Radislav/G-4408-2014; Urbanova, Jana/G-2748-2014; Vlahoviček, Kristian/D-9661-2011; Malik, Radek/G-3578-2014	Svoboda, Petr/0000-0002-4370-3705; Urbanova, Jana/0000-0001-9778-6289; Vlahoviček, Kristian/0000-0002-5705-2464; Malik, Radek/0000-0002-6783-1146; Franke, Vedran/0000-0003-3606-6792	Czech Science Foundation [GACR P305/10/2215, GACR P305/12/G034]; EMBO Young Investigator Program [1488/2006, 1431/2006]; GACR [204/09/0085]; MEYS [LM2011032]; project BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University [CZ.1.05/1.1.00/02.0109]; EC Seventh Framework Program [315997]; Croatian MSES [119-0982913-1211]; Academy of Sciences of the Czech Republic [M200521202];  [RVO 68378050]	Czech Science Foundation(Grant Agency of the Czech Republic); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); GACR(Grant Agency of the Czech Republic); MEYS; project BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University; EC Seventh Framework Program; Croatian MSES(Ministry of Science, Education and Sports, Republic of Croatia); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); 	We thank W. Filipowicz, G.J. Hannon, and K. Podolska for reagents and material; K. Burdova, V. Libova, M. Moravec, I. Necheva, and V. Urban for technical help; M. Dowle and F. Hahne for help with bioinformatics; and W. Filipowicz, D. T. Odom, and R. M. Schultz for discussions and comments. The main support was provided by the Czech Science Foundation grant GACR P305/10/2215 and the EMBO Young Investigator Program (installation grant 1488/2006) to P. S., GACR 204/09/0085 to J.N.; LM2011032 (MEYS) and the project BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University (CZ.1.05/1.1.00/02.0109; European Regional Development Fund) to R. S.; and the EC Seventh Framework Program (Integra-Life grant 315997 to K. V.), EMBO Young Investigator Program (installation grant 1431/2006 to K. V.), and Croatian MSES grant 119-0982913-1211 to K. V. and V. F. Collaboration between P.S.'s and K.V.'s groups is supported by The Academy of Sciences of the Czech Republic international collaboration project M200521202. P. S. is a member of the Centre for RNA Biology funded by the Czech Science Foundation grant GACR P305/12/G034. The work was institutionally supported by RVO 68378050.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Flemr M, 2010, BIOL REPROD, V82, P1008, DOI 10.1095/biolreprod.109.082057; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kaneda M, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-9; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nagy A., 2003, MANIPULATING MOUSE E; Nejepinska J, 2012, NUCLEIC ACIDS RES, V40, P399, DOI 10.1093/nar/gkr702; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Podolska K, 2014, J BIOMOL SCREEN, V19, P417, DOI 10.1177/1087057113497400; Sawh AN, 2013, CELL REP, V4, P454, DOI 10.1016/j.celrep.2013.07.013; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Shenoy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006971; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Sinkkonen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012175; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Stein P, 2003, DEV BIOL, V256, P187, DOI 10.1016/S0012-1606(02)00122-7; Stein P, 2005, DEV BIOL, V286, P464, DOI 10.1016/j.ydbio.2005.08.015; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Svoboda P, 2001, BIOCHEM BIOPH RES CO, V287, P1099, DOI 10.1006/bbrc.2001.5707; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016	46	168	177	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					807	816		10.1016/j.cell.2013.10.001	http://dx.doi.org/10.1016/j.cell.2013.10.001			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209619	Bronze			2022-12-24	WOS:000326934300011
J	Roy, MG; Livraghi-Butrico, A; Fletcher, AA; McElwee, MM; Evans, SE; Boerner, RM; Alexander, SN; Bellinghausen, LK; Song, AS; Petrova, YM; Tuvim, MJ; Adachi, R; Romo, I; Bordt, AS; Bowden, MG; Sisson, JH; Woodruff, PG; Thornton, DJ; Rousseau, K; De la Garza, MM; Moghaddam, SJ; Karmouty-Quintana, H; Blackburn, MR; Drouin, SM; Davis, CW; Terrell, KA; Grubb, BR; O'Neal, WK; Flores, SC; Cota-Gomez, A; Lozupone, CA; Donnelly, JM; Watson, AM; Hennessy, CE; Keith, RC; Yang, IV; Barthel, L; Henson, PM; Janssen, WJ; Schwartz, DA; Boucher, RC; Dickey, BF; Evans, CM				Roy, Michelle G.; Livraghi-Butrico, Alessandra; Fletcher, Ashley A.; McElwee, Melissa M.; Evans, Scott E.; Boerner, Ryan M.; Alexander, Samantha N.; Bellinghausen, Lindsey K.; Song, Alfred S.; Petrova, Youlia M.; Tuvim, Michael J.; Adachi, Roberto; Romo, Irlanda; Bordt, Andrea S.; Bowden, M. Gabriela; Sisson, Joseph H.; Woodruff, Prescott G.; Thornton, David J.; Rousseau, Karine; De la Garza, Maria M.; Moghaddam, Seyed J.; Karmouty-Quintana, Harry; Blackburn, Michael R.; Drouin, Scott M.; Davis, C. William; Terrell, Kristy A.; Grubb, Barbara R.; O'Neal, Wanda K.; Flores, Sonia C.; Cota-Gomez, Adela; Lozupone, Catherine A.; Donnelly, Jody M.; Watson, Alan M.; Hennessy, Corinne E.; Keith, Rebecca C.; Yang, Ivana V.; Barthel, Lea; Henson, Peter M.; Janssen, William J.; Schwartz, David A.; Boucher, Richard C.; Dickey, Burton F.; Evans, Christopher M.			Muc5b is required for airway defence	NATURE			English	Article							MUCOCILIARY CLEARANCE; CYSTIC-FIBROSIS; OTITIS-MEDIA; CLARA CELLS; MUCIN; DISEASE; ASTHMA; EXPRESSION; MICE; LUNG	Respiratory surfaces are exposed to billions of particulates and pathogens daily. A protective mucus barrier traps and eliminates them through mucociliary clearance (MCC)(1,2). However, excessive mucus contributes to transient respiratory infections and to the pathogenesis of numerous respiratory diseases(1). MUC5AC and MUC5B are evolutionarily conserved genes that encode structurally related mucin glycoproteins, the principal macromolecules in airway mucus(1,3). Genetic variants are linked to diverse lung diseases(4-6), but specific roles for MUC5AC and MUC5B in MCC, and the lasting effects of their inhibition, are unknown. Here we show that mouse Muc5b (but not Muc5ac) is required for MCC, for controlling infections in the airways and middle ear, and for maintaining immune homeostasis in mouse lungs, whereas Muc5ac is dispensable. Muc5b deficiency caused materials to accumulate in upper and lower airways. This defect led to chronic infection by multiple bacterial species, including Staphylococcus aureus, and to inflammation that failed to resolve normally(7). Apoptotic macrophages accumulated, phagocytosis was impaired, and interleukin-23 (IL-23) production was reduced in Muc5b(-/-) mice. By contrast, in mice that transgenically overexpress Muc5b, macrophage functions improved. Existing dogma defines mucous phenotypes in asthma and chronic obstructive pulmonary disease (COPD) as driven by increased MUC5AC, with MUC5B levels either unaffected or increased in expectorated sputum(1,8). However, in many patients, MUC5B production at airway surfaces decreases by as much as 90%(9-11). By distinguishing a specific role for Muc5b in MCC, and by determining its impact on bacterial infections and inflammation in mice, our results provide a refined framework for designing targeted therapies to control mucin secretion and restore MCC.	[Roy, Michelle G.; McElwee, Melissa M.; Evans, Scott E.; Alexander, Samantha N.; Bellinghausen, Lindsey K.; Song, Alfred S.; Petrova, Youlia M.; Tuvim, Michael J.; Adachi, Roberto; Romo, Irlanda; De la Garza, Maria M.; Moghaddam, Seyed J.; Dickey, Burton F.; Evans, Christopher M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Livraghi-Butrico, Alessandra; Davis, C. William; Terrell, Kristy A.; Grubb, Barbara R.; O'Neal, Wanda K.; Boucher, Richard C.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Fletcher, Ashley A.; Flores, Sonia C.; Cota-Gomez, Adela; Lozupone, Catherine A.; Donnelly, Jody M.; Watson, Alan M.; Hennessy, Corinne E.; Keith, Rebecca C.; Yang, Ivana V.; Barthel, Lea; Henson, Peter M.; Janssen, William J.; Schwartz, David A.; Evans, Christopher M.] Univ Colorado, Sch Med, Aurora, CO 80045 USA; [Boerner, Ryan M.; Karmouty-Quintana, Harry; Blackburn, Michael R.; Drouin, Scott M.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Houston, TX 77030 USA; [Romo, Irlanda] Inst Tecnol & Estudios Super Monterrey, Monterrey 64849, Nuevo Leon, Mexico; [Bordt, Andrea S.; Bowden, M. Gabriela] Texas A&M Hlth Sci Ctr, Houston, TX 77030 USA; [Bowden, M. Gabriela] Univ Houston Downtown, Houston, TX 77002 USA; [Sisson, Joseph H.] Univ Nebraska Med Ctr, Omaha, NE 68198 USA; [Woodruff, Prescott G.] Univ Calif San Francisco, San Francisco, CA 27599 USA; [Thornton, David J.; Rousseau, Karine] Univ Manchester, Manchester M13 9PT, Lancs, England; [Barthel, Lea; Henson, Peter M.; Janssen, William J.] Natl Jewish Hlth, Denver, CO 80206 USA	University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Health Science Center Houston; Tecnologico de Monterrey; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Houston System; University of Houston; University of Houston Downtown; University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California San Francisco; University of Manchester; National Jewish Health	Evans, CM (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	Christopher.Evans@ucdenver.edu	Moghaddam, Seyed Javad/A-9701-2014; Lozupone, Catherine/AAD-9317-2020; , BRIC Small Animal Imaging Facility/AEV-1023-2022; Karmouty-Quintana, Harry/ABC-9144-2020; Yang, Ivana V/P-3059-2018	Moghaddam, Seyed Javad/0000-0002-5350-307X; , BRIC Small Animal Imaging Facility/0000-0002-0535-3214; Karmouty-Quintana, Harry/0000-0003-4753-9823; Yang, Ivana V/0000-0002-1018-489X; Keith, Rebecca/0000-0001-9660-5909; Thornton, David/0000-0001-7148-1970; Evans, Christopher/0000-0001-5600-7314; Tuvim, Michael/0000-0001-8126-7716; Evans, Scott/0000-0003-4503-0644; Cota-Gomez, Adela/0000-0001-7607-6122; Blackburn, Michael/0000-0002-1394-9966; Adachi, Roberto/0000-0002-0146-0768	National Institutes of Health [R01 HL080396, R01 AA008769, R01 HL109517, R01 HL114381, R01 HL097000, P01 HL108808, P01 HL110873, P50 HL107168, P30DK065988]; Medical Research Council [G1000450]; Cystic Fibrosis Foundation [06IO, RDP R026-CR11]; National Institutes of Health Cancer Center [CA016672, CA046934];  [CA016086]; MRC [G1000450] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA016672, P30CA016086, P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095372, R01HL109517, R01HL080396, P01HL110873, R01HL097591, R01HL114381, R01HL117976, DP2HL123229, R01HL097000, P01HL107202, P01HL108808, P50HL107168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988, K01DK090285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank F. Ttofali, D. Harper, D. Raclawska, V. Mdoe, C. Ramsey and J. Parker-Thornburg for their assistance. We also thank K. Naff and the MD Anderson Cancer Center Department of Veterinary Medicine and Surgery for support in animal care. This work was supported by the National Institutes of Health Grants R01 HL080396 (C.M.E.); R01 AA008769 (J.H.S.), R01 HL109517 (W.J.J.); R01 HL114381 (P.M.H.); R01 HL097000 (B.F.D.), P01 HL108808, P01 HL110873, P50 HL107168, P30DK065988 (R.C.B.), Medical Research Council Grant G1000450 (D.J.T.) and Cystic Fibrosis Foundation Grants 06IO (C.M.E.) and RDP R026-CR11 (R.C.B.). Additional support was provided by National Institutes of Health Cancer Center Support Grants CA016672 for the MD Anderson Cancer Center and CA046934 for the University of Colorado transgenic mouse facilities; by CA016086 for the UNC Biomedical Research Imaging Center Small Animal Imaging Facility, and for the UNC Michael Hooker Microscopy Facility funded by an anonymous private donor.	Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Coote K, 2004, EXP LUNG RES, V30, P59, DOI 10.1080/01902140490252885; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dillard P, 2007, AM J RESP CRIT CARE, V175, P1250, DOI 10.1164/rccm.200701-049OC; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Evans CM, 2004, AM J RESP CELL MOL, V31, P382, DOI 10.1165/rcmb.2004-0060OC; Evans SE, 2010, AM J RESP CELL MOL, V42, P40, DOI 10.1165/rcmb.2008-0260OC; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; GOODMAN RM, 1978, AM REV RESPIR DIS, V117, P205; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Hendley JO, 2002, NEW ENGL J MED, V347, P1169, DOI 10.1056/NEJMcp010944; Innes AL, 2006, CHEST, V130, P1102, DOI 10.1378/chest.130.4.1102; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kamio K, 2005, AM J RESP CRIT CARE, V171, P949, DOI 10.1164/rccm.200409-1168OC; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Lee TA, 2007, J GEN INTERN MED, V22, P62, DOI 10.1007/s11606-007-0118-3; Lozupone C, 2013, AM J RESP CRIT CARE, V187, P1110, DOI 10.1164/rccm.201211-2145OC; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Marsh DG, 1997, NAT GENET, V15, P389; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Moghaddam SJ, 2008, AM J RESP CELL MOL, V38, P629, DOI 10.1165/rcmb.2007-0366OC; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; ORIORDAN TG, 1992, AM REV RESPIR DIS, V146, P598, DOI 10.1164/ajrccm/146.3.598; Patnode ML, 2013, J BIOL CHEM, V288, P26533, DOI 10.1074/jbc.M113.485409; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Roy MG, 2011, AM J RESP CELL MOL, V44, P755, DOI 10.1165/rcmb.2010-0020OC; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; STEINKAMP JA, 1982, SCIENCE, V215, P64, DOI 10.1126/science.7053559; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Voronina VA, 2009, J CELL BIOL, V185, P225, DOI 10.1083/jcb.200809144; Ward PP, 2003, MOL CELL BIOL, V23, P178, DOI 10.1128/MCB.23.1.178-185.2003; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; WEINBERG ED, 1974, SCIENCE, V184, P952, DOI 10.1126/science.184.4140.952; WEINBERG ED, 1984, PHYSIOL REV, V64, P65, DOI 10.1152/physrev.1984.64.1.65; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	51	468	481	9	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					412	+		10.1038/nature12807	http://dx.doi.org/10.1038/nature12807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24317696	Green Accepted			2022-12-24	WOS:000329621800045
J	Watanabe, S; Rost, BR; Camacho-Perez, M; Davis, MW; Sohl-Kielczynski, B; Rosenmund, C; Jorgensen, EM				Watanabe, Shigeki; Rost, Benjamin R.; Camacho-Perez, Marcial; Davis, M. Wayne; Soehl-Kielczynski, Berit; Rosenmund, Christian; Jorgensen, Erik M.			Ultrafast endocytosis at mouse hippocampal synapses	NATURE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; SYNAPTIC VESICLE ENDOCYTOSIS; TRANSMITTER RELEASE; AUTAPTIC CULTURES; FUSION; MEMBRANE; EXOCYTOSIS; TRANSMISSION; RETRIEVAL; MECHANISM	To sustain neurotransmission, synaptic vesicles and their associated proteins must be recycled locally at synapses. Synaptic vesicles are thought to be regenerated approximately 20 s after fusion by the assembly of clathrin scaffolds or in approximately 1 s by the reversal of fusion pores via 'kiss-and-run' endocytosis. Here we use optogenetics to stimulate cultured hippocampal neurons with a single stimulus, rapidly freeze them after fixed intervals and examine the ultrastructure using electron microscopy-'flash-and-freeze' electron microscopy. Docked vesicles fuse and collapse into the membrane within 30 ms of the stimulus. Compensatory endocytosis occurs within 50 to 100 ms at sites flanking the active zone. Invagination is blocked by inhibition of actin polymerization, and scission is blocked by inhibiting dynamin. Because intact synaptic vesicles are not recovered, this form of recycling is not compatible with kiss-and-run endocytosis; moreover, it is 200-fold faster than clathrin-mediated endocytosis. It is likely that 'ultrafast endocytosis' is specialized to restore the surface area of the membrane rapidly.	[Watanabe, Shigeki; Davis, M. Wayne; Jorgensen, Erik M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Watanabe, Shigeki; Davis, M. Wayne; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Rost, Benjamin R.; Camacho-Perez, Marcial; Soehl-Kielczynski, Berit; Rosenmund, Christian] Charite, Neurosci Res Ctr, D-10117 Berlin, Germany	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	christian.rosenmund@charite.de; jorgensen@biology.utah.edu	Rosenmund, Christian/AAC-3596-2020; Rost, Benjamin/AHD-2242-2022	Rosenmund, Christian/0000-0002-3905-2444; Rost, Benjamin/0000-0003-1906-0081; Camacho Perez, Marcial/0000-0002-2367-1259; Davis, Mikel/0000-0003-1867-1593; Watanabe, Shigeki/0000-0001-7580-8141	EMBO; US National Institutes of Health [NS034307]; European Research Council [249939 SYNVGLUT]; German Research Council [EXC 257, SFB 665, SFB958]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034307, R01NS034307] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); German Research Council(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank D. Lorenz and A. Muenster-Wandowski for providing access to electron microscopes. We would like to thank P. Hegemann and F. Schneider for providing the Cheta TC construct, A. Felies for cell cultures, B. Brokowski for generating lentivirus, E. Hujber for image processing and freezing calculations, C. Ebeling for calculating the time constant for synaptic vesicle collapse, and J. Iwasa for drawing the model figure. We would like to thank C. Tomova and Leica Microsystems for providing us with technical details of the controller of the high-pressure freezer for precise temporal control of light stimulation. We thank EMBO for providing the travel funds (S. W.). The research was funded by the US National Institutes of Health (NS034307; E. M. J.), European Research Council grant (249939 SYNVGLUT; C. R.), and German Research Council grants (EXC 257, SFB 665, SFB958; C. R.). E. M. J. is an Investigator of the Howard Hughes Medical Institute and is an Alexander von Humboldt Scholar.	Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Armbruster M, 2013, ELIFE, V2, DOI 10.7554/eLife.00845; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; CECCARELLI B, 1972, J CELL BIOL, V54, P30, DOI 10.1083/jcb.54.1.30; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Gu MY, 2013, ELIFE, V2, DOI 10.7554/eLife.00190; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; He LM, 2009, NATURE, V459, P93, DOI 10.1038/nature07860; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Jakobsson J, 2008, P NATL ACAD SCI USA, V105, P6445, DOI 10.1073/pnas.0710267105; Kim SH, 2009, J NEUROSCI, V29, P3865, DOI 10.1523/JNEUROSCI.5639-08.2009; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maeno-Hikichi Y, 2011, J NEUROSCI, V31, P1093, DOI 10.1523/JNEUROSCI.2800-10.2011; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Matthews G, 2008, J NEUROSCI, V28, P5403, DOI 10.1523/JNEUROSCI.0935-08.2008; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Park H, 2012, SCIENCE, V335, P1362, DOI 10.1126/science.1216937; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Renden R, 2007, J NEUROPHYSIOL, V98, P3349, DOI 10.1152/jn.00898.2007; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Rost BR, 2010, EUR J NEUROSCI, V32, P939, DOI 10.1111/j.1460-9568.2010.07387.x; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sato K, 2009, P NATL ACAD SCI USA, V106, P1139, DOI 10.1073/pnas.0809541106; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Siksou L, 2009, EUR J NEUROSCI, V30, P49, DOI 10.1111/j.1460-9568.2009.06811.x; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Teng HB, 1999, J NEUROSCI, V19, P4855; TORRITARELLI F, 1985, J CELL BIOL, V101, P1386, DOI 10.1083/jcb.101.4.1386; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Yamada H, 2009, BIOCHEM BIOPH RES CO, V390, P1142, DOI 10.1016/j.bbrc.2009.10.105; Zhang Q, 2007, P NATL ACAD SCI USA, V104, P17843, DOI 10.1073/pnas.0706906104	54	322	323	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					242	+		10.1038/nature12809	http://dx.doi.org/10.1038/nature12809			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24305055	Green Accepted			2022-12-24	WOS:000328121500029
J	Imayoshi, I; Isomura, A; Harima, Y; Kawaguchi, K; Kori, H; Miyachi, H; Fujiwara, T; Ishidate, F; Kageyama, R				Imayoshi, Itaru; Isomura, Akihiro; Harima, Yukiko; Kawaguchi, Kyogo; Kori, Hiroshi; Miyachi, Hitoshi; Fujiwara, Takahiro; Ishidate, Fumiyoshi; Kageyama, Ryoichiro			Oscillatory Control of Factors Determining Multipotency and Fate in Mouse Neural Progenitors	SCIENCE			English	Article							STEM-CELLS; ACHAETE-SCUTE; FACTOR OLIG2; HES1; EXPRESSION; GENES; ROLES; OLIGODENDROCYTES; DIFFERENTIATION; TRANSCRIPTION	The basic helix-loop-helix transcription factors Ascl1/Mash1, Hes1, and Olig2 regulate fate choice of neurons, astrocytes, and oligodendrocytes, respectively. These same factors are coexpressed by neural progenitor cells. Here, we found by time-lapse imaging that these factors are expressed in an oscillatory manner by mouse neural progenitor cells. In each differentiation lineage, one of the factors becomes dominant. We used optogenetics to control expression of Ascl1 and found that, although sustained Ascl1 expression promotes neuronal fate determination, oscillatory Ascl1 expression maintains proliferating neural progenitor cells. Thus, the multipotent state correlates with oscillatory expression of several fate-determination factors, whereas the differentiated state correlates with sustained expression of a single factor.	[Imayoshi, Itaru; Isomura, Akihiro; Harima, Yukiko; Miyachi, Hitoshi; Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Imayoshi, Itaru] Kyoto Univ, Hakubi Ctr, Kyoto 6068302, Japan; [Imayoshi, Itaru; Fujiwara, Takahiro; Ishidate, Fumiyoshi; Kageyama, Ryoichiro] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, World Premier Int Res Initiat, Kyoto 6068501, Japan; [Imayoshi, Itaru] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan; [Isomura, Akihiro; Harima, Yukiko; Kori, Hiroshi; Kageyama, Ryoichiro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kawaguchi, Saitama 3320012, Japan; [Kawaguchi, Kyogo] Univ Tokyo, Grad Sch Sci, Dept Phys, Tokyo 1130033, Japan; [Kori, Hiroshi] Ochanomizu Univ, Dept Informat Sci, Tokyo 1128610, Japan	Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tokyo; Ochanomizu University	Imayoshi, I (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan.	iimayosh@virus.kyoto-u.ac.jp; rkageyam@virus.kyoto-u.ac.jp	Kori, Hiroshi/AAD-3700-2019; Kawaguchi, Kyogo/AAF-5133-2021; Fujiwara, Takahiro/G-2755-2012	Fujiwara, Takahiro/0000-0001-5576-759X; Kageyama, Ryoichiro/0000-0002-5985-1120; Kawaguchi, Kyogo/0000-0001-9395-9875	Core Research for Evolutional Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology [22123002]; Japan Society for Promotion of Science (JSPS) [24240049]; Takeda Foundation;  [JSPS 24680035]; Grants-in-Aid for Scientific Research [12J08031] Funding Source: KAKEN	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Foundation(Takeda Science Foundation (TSF)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to F. Guillemot, J. Johnson, H. Takebayashi, K. Ikenaka, D. Melton, A. Miyawaki, A. Sakaue-Sawano, Q. Lu, and Y. Yang for reagents and S. Kitano, M. Sakamoto, H. Shimojo, and Center for Meso-Bio Single-Molecule Imaging (CeMI), WPI-iCeMS, Kyoto University for technical help. This work was supported by Core Research for Evolutional Science and Technology (R. K. and H. K.), Grant-in-Aid for Scientific Research on Innovative Areas (Ministry of Education, Culture, Sports, Science, and Technology 22123002) (R. K.), Scientific Research (A) [Japan Society for Promotion of Science (JSPS) 24240049] (R. K.) and Young Scientists (A) (JSPS 24680035) (I. I.), and Takeda Foundation (R. K.). I. I. and R. K. designed the project and wrote the manuscript. A. I. developed the light-induced gene expression system. I. I., A. I., Y. H., and H. M. performed experiments, and T. F. and F. I. conducted fluorescent imaging analyses. K. K. and H. K. performed computer simulation. A national (Japanese) patent application, "Optogenetic control of proliferation and differentiation of stem cells" (2013-193582), has been filed by Kyoto University.	Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Fukuda S, 2004, CELL DEATH DIFFER, V11, P196, DOI 10.1038/sj.cdd.4401332; Gokhan S, 2005, J NEUROSCI, V25, P8311, DOI 10.1523/JNEUROSCI.1850-05.2005; Hindley C, 2012, DEVELOPMENT, V139, P1718, DOI 10.1242/dev.077552; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; Levison SW, 1997, J NEUROSCI RES, V48, P83, DOI 10.1002/(SICI)1097-4547(19970415)48:2<83::AID-JNR1>3.0.CO;2-8; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Marshall CAG, 2002, J NEUROSCI, V22, P9821; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Parras CM, 2007, J NEUROSCI, V27, P4233, DOI 10.1523/JNEUROSCI.0126-07.2007; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Wang X, 2012, NAT METHODS, V9, P266, DOI [10.1038/NMETH.1892, 10.1038/nmeth.1892]; Wu YY, 2003, DEV DYNAM, V226, P675, DOI 10.1002/dvdy.10278; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	37	331	337	6	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1203	1208		10.1126/science.1242366	http://dx.doi.org/10.1126/science.1242366			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24179156	Green Published			2022-12-24	WOS:000327857900039
J	Johannessen, CM; Johnson, LA; Piccioni, F; Townes, A; Frederick, DT; Donahue, MK; Narayan, R; Flaherty, KT; Wargo, JA; Root, DE; Garraway, LA				Johannessen, Cory M.; Johnson, Laura A.; Piccioni, Federica; Townes, Aisha; Frederick, Dennie T.; Donahue, Melanie K.; Narayan, Rajiv; Flaherty, Keith T.; Wargo, Jennifer A.; Root, David E.; Garraway, Levi A.			A melanocyte lineage program confers resistance to MAP kinase pathway inhibition	NATURE			English	Article							IMPROVED SURVIVAL; MEK INHIBITION; BRAF; EXPRESSION; MICROPHTHALMIA; TRANSCRIPTION; MUTATIONS; ONCOGENE; REVEALS; RAF-1	Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth(1). RAF and MEK inhibitors show remarkable clinical efficacy in BRAF(V600E) melanoma(2,3); however, resistance to these agents remains a formidable challenge(2,4). Global characterization of resistance mechanisms may inform the development of more effective therapeutic combinations. Here we carried out systematic gain-of-function resistance studies by expressing more than 15,500 genes individually in a BRAF(V600E) melanoma cell line treated with RAF, MEK, ERK or combined RAF-MEK inhibitors. These studies revealed a cyclic-AMP-dependent melanocytic signalling network not previously associated with drug resistance, including G-protein-coupled receptors, adenyl cyclase, protein kinase A and cAMP response element binding protein(CREB). Preliminary analysis of biopsies from BRAF (V600E) melanoma patients revealed that phosphorylated (active) CREB was suppressed by RAF-MEK inhibition but restored in relapsing tumours. Expression of transcription factors activated downstream of MAP kinase and cAMP pathways also conferred resistance, including c-FOS, NR4A1, NR4A2 and MITF. Combined treatment with MAPK-pathway and histone-deacetylase inhibitors suppressed MITF expression and cAMP-mediated resistance. Collectively, these data suggest that oncogenic dysregulation of a melanocyte lineage dependency can cause resistance to RAF-MEK-ERK inhibition, which may be overcome by combining signalling-and chromatin-directed therapeutics.	[Johannessen, Cory M.; Johnson, Laura A.; Piccioni, Federica; Townes, Aisha; Donahue, Melanie K.; Narayan, Rajiv; Root, David E.; Garraway, Levi A.] Broad Inst Harvard Univ & Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Johannessen, Cory M.; Johnson, Laura A.; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Johannessen, Cory M.; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Frederick, Dennie T.; Flaherty, Keith T.; Wargo, Jennifer A.] Massachusetts Gen Hosp, Dept Surg Oncol Med Oncol & Dermatol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Garraway, LA (corresponding author), Broad Inst Harvard Univ & Massachusetts Inst Tech, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	Levi_Garraway@dfci.harvard.edu			National Institutes of Health (NIH) [DP2 OD002750]; Melanoma Research Alliance; Starr Cancer Consortium; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NCI Skin Cancer SPORE [P50CA93683]; LINCS Program [U54 HG006093]; NATIONAL CANCER INSTITUTE [P01CA163222, P50CA093683, R33CA155554] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006093, U01HG006492] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Starr Cancer Consortium; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NCI Skin Cancer SPORE; LINCS Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) Director's New Innovator Award (DP2 OD002750, L. A. G.), Melanoma Research Alliance (L. A. G.), Starr Cancer Consortium (L. A. G.), Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (L. A. G.), the NCI Skin Cancer SPORE (P50CA93683, L. A. G.) and the LINCS Program (U54 HG006093).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Aronov AM, 2009, J MED CHEM, V52, P6362, DOI 10.1021/jm900630q; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Frederick DT, 2013, CLIN CANCER RES, V19, P1225, DOI 10.1158/1078-0432.CCR-12-1630; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; Hayward NK, 2003, ONCOGENE, V22, P3053, DOI 10.1038/sj.onc.1206445; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Jane-Valbuena J, 2010, CANCER RES, V70, P2075, DOI 10.1158/0008-5472.CAN-09-3092; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PHAM CD, 1995, ONCOGENE, V10, P1683; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Smith MP, 2013, JNCI-J NATL CANCER I, V105, P33, DOI 10.1093/jnci/djs471; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; WALTON KM, 1992, MOL ENDOCRINOL, V6, P647, DOI 10.1210/me.6.4.647; Wood KC, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002612; Wu M, 2000, GENE DEV, V14, P301; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yokoyama S, 2008, PIGM CELL MELANOMA R, V21, P457, DOI 10.1111/j.1755-148X.2008.00480.x	26	326	333	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					138	+		10.1038/nature12688	http://dx.doi.org/10.1038/nature12688			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24185007	Green Submitted, Green Accepted			2022-12-24	WOS:000327851700047
J	Iida, N; Dzutsev, A; Stewart, CA; Smith, L; Bouladoux, N; Weingarten, RA; Molina, DA; Salcedo, R; Back, T; Cramer, S; Dai, RM; Kiu, H; Cardone, M; Naik, S; Patri, AK; Wang, E; Marincola, FM; Frank, KM; Belkaid, Y; Trinchieri, G; Goldszmid, RS				Iida, Noriho; Dzutsev, Amiran; Stewart, C. Andrew; Smith, Loretta; Bouladoux, Nicolas; Weingarten, Rebecca A.; Molina, Daniel A.; Salcedo, Rosalba; Back, Timothy; Cramer, Sarah; Dai, Ren-Ming; Kiu, Hiu; Cardone, Marco; Naik, Shruti; Patri, Anil K.; Wang, Ena; Marincola, Francesco M.; Frank, Karen M.; Belkaid, Yasmine; Trinchieri, Giorgio; Goldszmid, Romina S.			Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment	SCIENCE			English	Article							OXIDATIVE STRESS; DENDRITIC CELLS; IMMUNE-SYSTEM; MICROBIOTA; INFLAMMATION; APOPTOSIS; ACTIVATION; CALIBRATE; SIGNALS; IMPACT	The gut microbiota influences both local and systemic inflammation. Inflammation contributes to development, progression, and treatment of cancer, but it remains unclear whether commensal bacteria affect inflammation in the sterile tumor microenvironment. Here, we show that disruption of the microbiota impairs the response of subcutaneous tumors to CpG-oligonucleotide immunotherapy and platinum chemotherapy. In antibiotics-treated or germ-free mice, tumor-infiltrating myeloid-derived cells responded poorly to therapy, resulting in lower cytokine production and tumor necrosis after CpG-oligonucleotide treatment and deficient production of reactive oxygen species and cytotoxicity after chemotherapy. Thus, optimal responses to cancer therapy require an intact commensal microbiota that mediates its effects by modulating myeloid-derived cell functions in the tumor microenvironment. These findings underscore the importance of the microbiota in the outcome of disease treatment.	[Iida, Noriho; Dzutsev, Amiran; Stewart, C. Andrew; Smith, Loretta; Salcedo, Rosalba; Back, Timothy; Cramer, Sarah; Dai, Ren-Ming; Kiu, Hiu; Cardone, Marco; Trinchieri, Giorgio; Goldszmid, Romina S.] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA; [Dzutsev, Amiran; Dai, Ren-Ming] Leidos Biomed Res Inc, Frederick Natl Lab, Frederick, MD 21702 USA; [Bouladoux, Nicolas; Naik, Shruti; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, Bethesda, MD 20892 USA; [Weingarten, Rebecca A.; Frank, Karen M.] NIH, Microbiol Serv, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA; [Molina, Daniel A.] Tech Resources Int Inc, Bethesda, MD 20817 USA; [Patri, Anil K.] Leidos Biomed Res Inc, Nanotechnol Characterizat Lab, Adv Technol Program, Frederick Natl Lab, Frederick, MD 21702 USA; [Wang, Ena; Marincola, Francesco M.] NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Marincola, Francesco M.] Sidra Med & Res Ctr, Doha, Qatar	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Sidra Medical & Research Center	Trinchieri, G (corresponding author), NCI, Canc & Inflammat Program, Frederick, MD 21702 USA.	trinchig@mail.nih.gov; rgoldszmid@mail.nih.gov	Stewart, Charles/G-2470-2012; Nanotechnology Characterization Lab, (NCL)/K-8454-2012; Trinchieri, Giorgio/F-9369-2015	Trinchieri, Giorgio/0000-0001-5892-7464; Bouladoux, Nicolas/0000-0003-1593-671X; Belkaid, Yasmine/0000-0001-9962-3571	NIH (NCI); NIH (Center for Cancer Research); NIH (NIAID); Japanese Society for Promotion of Science (JSPS) Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH; NATIONAL CANCER INSTITUTE [ZIABC011153, ZIABC010793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115] Funding Source: NIH RePORTER	NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (Center for Cancer Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Japanese Society for Promotion of Science (JSPS) Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We greatly appreciate the support of D. Trageser-Cessler and A. Cesar in the NIAID germ-free facility; H. Zhou in the NIH Center for Human Immunology; T. Plona and K. Pike in the Laboratory of Molecular Technology, Leidos Biomedical Research, Inc.; and R. Winkler-Pickett, M. Karwan, and D. Zhao in the Cancer and Inflammation Program, CCR/NCI. We thank D. Klinman and A. Hurwitz for advice and R. Germain for critically reviewing the manuscript. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This research was supported by the Intramural Research Program of the NIH (NCI, Center for Cancer Research, and NIAID) and the Japanese Society for Promotion of Science (JSPS) Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH. The 16S sequences were deposited in the Sequence Read Archive (SRA) under accession PRJNA221649. Array data were deposited at the Gene Expression Omnibus (GEO) with accession no. GSE51414.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Conklin Kenneth A, 2004, Integr Cancer Ther, V3, P294, DOI 10.1177/1534735404270335; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Fang J, 2007, J DRUG TARGET, V15, P475, DOI 10.1080/10611860701498286; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Huang Y, 2012, GENES IMMUN, V13, P311, DOI 10.1038/gene.2011.87; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Jenq RR, 2012, J EXP MED, V209, P902, DOI 10.1084/jem.20112408; Kim S, 2008, J CELL BIOCHEM, V105, P971, DOI 10.1002/jcb.21905; Laurent A, 2005, CANCER RES, V65, P948; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; McAleer JP, 2012, IMMUNITY, V37, P10, DOI 10.1016/j.immuni.2012.07.001; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Peran L, 2007, BRIT J NUTR, V97, P96, DOI 10.1017/S0007114507257770; Shirota Y, 2012, J IMMUNOL, V188, P1592, DOI 10.4049/jimmunol.1101304; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Simizu S, 1998, J BIOL CHEM, V273, P26900, DOI 10.1074/jbc.273.41.26900; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	25	1231	1313	23	404	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					967	970		10.1126/science.1240527	http://dx.doi.org/10.1126/science.1240527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24264989	Green Accepted			2022-12-24	WOS:000327223500040
J	Toledo, LI; Altmeyer, M; Rask, MB; Lukas, C; Larsen, DH; Povlsen, LK; Bekker-Jensen, S; Mailand, N; Bartek, J; Lukas, J				Toledo, Luis Ignacio; Altmeyer, Matthias; Rask, Maj-Britt; Lukas, Claudia; Larsen, Dorthe Helena; Povlsen, Lou Klitgaard; Bekker-Jensen, Simon; Mailand, Niels; Bartek, Jiri; Lukas, Jiri			ATR Prohibits Replication Catastrophe by Preventing Global Exhaustion of RPA	CELL			English	Article							COMMON FRAGILE SITES; HUMAN-CELLS; PROTEIN-A; STRESS; RESTART; MODEL; FORKS; INHIBITORS; ORIGINS; DOMAINS	ATR, activated by replication stress, protects replication forks locally and suppresses origin firing globally. Here, we show that these functions of ATR are mechanistically coupled. Although initially stable, stalled forks in ATR-deficient cells undergo nucleus-wide breakage after unscheduled origin firing generates an excess of single-stranded DNA that exhausts the nuclear pool of RPA. Partial reduction of RPA accelerated fork breakage, and forced elevation of RPA was sufficient to delay such "replication catastrophe'' even in the absence of ATR activity. Conversely, unscheduled origin firing induced breakage of stalled forks even in cells with active ATR. Thus, ATR-mediated suppression of dormant origins shields active forks against irreversible breakage via preventing exhaustion of nuclear RPA. This study elucidates how replicating genomes avoid destabilizing DNA damage. Because cancer cells commonly feature intrinsically high replication stress, this study also provides a molecular rationale for their hypersensitivity to ATR inhibitors.	[Toledo, Luis Ignacio; Altmeyer, Matthias; Rask, Maj-Britt; Lukas, Claudia; Larsen, Dorthe Helena; Lukas, Jiri] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Chromosome Stabil & Dynam Grp,Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Povlsen, Lou Klitgaard; Bekker-Jensen, Simon; Mailand, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ubiquitin Signaling Grp,Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Bartek, Jiri] Danish Canc Soc, Res Ctr, Genome Integr Unit, DK-2100 Copenhagen, Denmark; [Bartek, Jiri] Palacky Univ, Fac Med, Inst Mol & Translat Med, Olomouc 77515, Czech Republic	Novo Nordisk Foundation; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Danish Cancer Society; Palacky University Olomouc	Lukas, J (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Chromosome Stabil & Dynam Grp,Ctr Prot Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	jiri.lukas@cpr.ku.dk	Toledo, Luis/M-6685-2019; Altmeyer, Matthias/AAE-8186-2019; Larsen, Dorthe Helena/E-9771-2010; Larsen, Dorthe Helena/Z-6206-2019; Toledo, Luis/R-2065-2016; Bartek, Jiri/G-5870-2014	Toledo, Luis/0000-0001-9509-9944; Altmeyer, Matthias/0000-0003-3780-1170; Larsen, Dorthe Helena/0000-0002-8280-1252; Larsen, Dorthe Helena/0000-0002-8280-1252; Toledo, Luis/0000-0001-9509-9944; Bekker-Jensen, Simon/0000-0002-7308-4597; Lukas, Claudia/0000-0001-7169-6883; Lukas, Jiri/0000-0001-9087-506X	Novo Nordisk Foundation; Danish Cancer Society; European Commission; Danish National Research Foundation; EMBO; Novo Nordisk Fonden [NNF12OC0002290] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Jiri Lukas, PI Niels Mailand] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); European Commission(European CommissionEuropean Commission Joint Research Centre); Danish National Research Foundation(Danmarks Grundforskningsfond); EMBO(European Molecular Biology Organization (EMBO)); Novo Nordisk Fonden(Novo Nordisk Foundation); Novo Nordisk Foundation Center for Protein Research	We thank Drs. Oskar Fernandez-Capetillo (CNIO, Madrid) and Marc S. Wold (University of Iowa) for reagents and members of the Lukas lab for helpful comments on the manuscript. This work was supported by the Novo Nordisk Foundation, Danish Cancer Society, European Commission (Projects DDResponse and Biomedreg), and Danish National Research Foundation. L. I. T. and M. A. are recipients of long-term EMBO fellowships. We dedicate this paper to the memory of Gabe Hayes, our handling editor at Cell, who tragically passed away. Gabe's unrestrained support of science and scientists, his insight, and his guidance of authors and reviewers will be sorely missed.	Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Brown EJ, 2000, GENE DEV, V14, P397; Cayrou C, 2010, CHROMOSOME RES, V18, P137, DOI 10.1007/s10577-009-9105-3; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Debatisse M, 2012, TRENDS GENET, V28, P22, DOI 10.1016/j.tig.2011.10.003; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; El Achkar E, 2005, P NATL ACAD SCI USA, V102, P18069, DOI 10.1073/pnas.0506497102; Fang Y, 2004, EMBO J, V23, P3164, DOI 10.1038/sj.emboj.7600315; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Forment JV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023517; Friedel AM, 2009, CURR OPIN CELL BIOL, V21, P237, DOI 10.1016/j.ceb.2009.01.017; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gillespie PJ, 2010, CELL CYCLE, V9, P3218, DOI 10.4161/cc.9.16.12644; Givalos N, 2007, MODERN PATHOL, V20, P159, DOI 10.1038/modpathol.3800719; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Hurley PJ, 2007, ONCOGENE, V26, P2535, DOI 10.1038/sj.onc.1210049; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Jossen Rachel, 2013, Frontiers in Genetics, V4, DOI 10.3389/fgene.2013.00026; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Matos J, 2013, CELL REP, V4, P76, DOI 10.1016/j.celrep.2013.05.039; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Naim V, 2013, NAT CELL BIOL, V15, P1008, DOI 10.1038/ncb2793; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Sorensen CS, 2012, NUCLEIC ACIDS RES, V40, P477, DOI 10.1093/nar/gkr697; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Thompson R, 2013, BRIT J CLIN PHARMACO, V76, P358, DOI 10.1111/bcp.12139; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Ying SM, 2013, NAT CELL BIOL, V15, P1001, DOI 10.1038/ncb2773; Yu DH, 2013, CELL BIOCHEM BIOPHYS, V67, P175, DOI 10.1007/s12013-013-9530-y	38	500	503	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1088	1103		10.1016/j.cell.2013.10.043	http://dx.doi.org/10.1016/j.cell.2013.10.043			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267891	Bronze			2022-12-24	WOS:000327500600013
J	Bloodgood, BL; Sharma, N; Browne, HA; Trepman, AZ; Greenberg, ME				Bloodgood, Brenda L.; Sharma, Nikhil; Browne, Heidi Adlman; Trepman, Alissa Z.; Greenberg, Michael E.			The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition	NATURE			English	Article							FACTOR MESSENGER-RNA; NEUROTROPHIC FACTOR; NEURONAL-ACTIVITY; SYNAPSES; INTERNEURONS; EXPRESSION; MEMORY; CELLS	A heterogeneous population of inhibitory neurons controls the flow of information through a neural circuit(1-3). Inhibitory synapses that form on pyramidal neuron dendrites modulate the summation of excitatory synaptic potentials(4-6) and prevent the generation of dendritic calcium spikes(7,8). Precisely timed somatic inhibition limits both the number of action potentials and the time window during which firing can occur(8,9). The activity-dependent transcription factor NPAS4 regulates inhibitory synapse number and function in cell culture(10), but how this transcription factor affects the inhibitory inputs that form on distinct domains of a neuron in vivo was unclear. Here we show that in the mouse hippocampus behaviourally driven expression of NPAS4 coordinates the redistribution of inhibitory synapses made onto a CA1 pyramidal neuron, simultaneously increasing inhibitory synapse number on the cell body while decreasing the number of inhibitory synapses on the apical dendrites. This rearrangement of inhibition is mediated in part by the NPAS4 target gene brain derived neurotrophic factor (Bdnf), which specifically regulates somatic, and not dendritic, inhibition. These findings indicate that sensory stimuli, by inducing NPAS4 and its target genes, differentially control spatial features of neuronal inhibition in a way that restricts the output of the neuron while creating a dendritic environment that is permissive for plasticity.	[Bloodgood, Brenda L.; Sharma, Nikhil; Browne, Heidi Adlman; Trepman, Alissa Z.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Bloodgood, Brenda L.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Sharma, Nikhil] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; University of California System; University of California San Diego; Harvard University	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	Michael_Greenberg@hms.harvard.edu	Core, Vector/CAF-4832-2022	Bloodgood, Brenda/0000-0002-4797-9119	Helen Hay Whitney Foundation; L'Oreal USA Fellowship for Women in Science; Medical Foundation/Charles A. King Trust Postdoctoral Fellowship; NSF graduate student research fellowship; National Institutes of Health [NS028829];  [P30 NS047101]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS028829, R37NS028829, P01NS047572] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; L'Oreal USA Fellowship for Women in Science; Medical Foundation/Charles A. King Trust Postdoctoral Fellowship; NSF graduate student research fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Greenberg laboratory for comments, suggestions and critical reading of the manuscript. We thank A. Mardinly for observations and comments on NPAS4 protein induction, P. Greer and S. Flavell for observations and comments on Npas4 mRNA induction in response to enriched environment and B. Cruz Moreno for help with sectioning. We thank M. During for the gift of the AAV-Cre-GFP plasmid. GFP-gephyrin images were collected at the UCSD Neuroscience Microscopy Shared Facility sponsored by grant P30 NS047101. This work was funded by Helen Hay Whitney Foundation, L'Oreal USA Fellowship for Women in Science and The Medical Foundation/Charles A. King Trust Postdoctoral Fellowship (B. L. B.), NSF graduate student research fellowship (N.S.) and National Institutes of Health grant NS028829 (M.E.G.).	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Baldelli P, 2005, J NEUROSCI, V25, P3358, DOI 10.1523/JNEUROSCI.4227-04.2005; Brigadski T, 2005, J NEUROSCI, V25, P7601, DOI 10.1523/JNEUROSCI.1776-05.2005; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Danglot L, 2006, HIPPOCAMPUS, V16, P1032, DOI 10.1002/hipo.20225; Dean C, 2012, J NEUROSCI, V32, P5398, DOI 10.1523/JNEUROSCI.4515-11.2012; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lein ES, 2000, J NEUROSCI, V20, P1470; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu GS, 2004, NAT NEUROSCI, V7, P373, DOI 10.1038/nn1206; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Marty S, 2000, J NEUROSCI, V20, P8087; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Pattabiraman PP, 2005, MOL CELL NEUROSCI, V28, P556, DOI 10.1016/j.mcn.2004.11.010; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rocamora N, 1996, J NEUROSCI, V16, P4411; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; TURNER DA, 1990, J PHYSIOL-LONDON, V422, P333, DOI 10.1113/jphysiol.1990.sp017987; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015	30	181	184	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					121	+		10.1038/nature12743	http://dx.doi.org/10.1038/nature12743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201284	Green Accepted			2022-12-24	WOS:000326585600044
J	Lindeboom, JJ; Nakamura, M; Hibbel, A; Shundyak, K; Gutierrez, R; Ketelaar, T; Emons, AMC; Mulder, BM; Kirik, V; Ehrhardt, DW				Lindeboom, Jelmer J.; Nakamura, Masayoshi; Hibbel, Anneke; Shundyak, Kostya; Gutierrez, Ryan; Ketelaar, Tijs; Emons, Anne Mie C.; Mulder, Bela M.; Kirik, Viktor; Ehrhardt, David W.			A Mechanism for Reorientation of Cortical Microtubule Arrays Driven by Microtubule Severing	SCIENCE			English	Article							OUTER EPIDERMAL WALL; MAIZE COLEOPTILES; PLASMA-MEMBRANE; GAMMA-TUBULIN; GROWTH-RATE; KATANIN; LIGHT; ORGANIZATION; NUCLEATION; DYNAMICS	Environmental and hormonal signals cause reorganization of microtubule arrays in higher plants, but the mechanisms driving these transitions have remained elusive. The organization of these arrays is required to direct morphogenesis. We discovered that microtubule severing by the protein katanin plays a crucial and unexpected role in the reorientation of cortical arrays, as triggered by blue light. Imaging and genetic experiments revealed that phototropin photoreceptors stimulate katanin-mediated severing specifically at microtubule intersections, leading to the generation of new microtubules at these locations. We show how this activity serves as the basis for a mechanism that amplifies microtubules orthogonal to the initial array, thereby driving array reorientation. Our observations show how severing is used constructively to build a new microtubule array.	[Lindeboom, Jelmer J.; Nakamura, Masayoshi; Gutierrez, Ryan; Kirik, Viktor; Ehrhardt, David W.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Lindeboom, Jelmer J.; Hibbel, Anneke; Ketelaar, Tijs; Emons, Anne Mie C.; Mulder, Bela M.] Wageningen Univ, Cell Biol Lab, NL-6708 PB Wageningen, Netherlands; [Hibbel, Anneke] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Shundyak, Kostya; Mulder, Bela M.] Fundamenteel Onderzoek Materie FOM Inst Atom & Mo, NL-1098 XG Amsterdam, Netherlands; [Gutierrez, Ryan; Ehrhardt, David W.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Kirik, Viktor] Illinois State Univ, Sch Biol Sci, Normal, IL 61790 USA	Carnegie Institution for Science; Wageningen University & Research; Max Planck Society; Stanford University; Illinois State University	Ehrhardt, DW (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	ehrhardt@stanford.edu	Nakamura, Masayoshi/D-1979-2017; Mulder, Bela/C-1070-2012	Nakamura, Masayoshi/0000-0002-7107-4942; Lindeboom, Jelmer J/0000-0003-4294-4838; Mulder, Bela/0000-0002-8620-5749; Hibbel, Anneke/0000-0003-4074-2343	NSF [1158372]; Carnegie Institution for Science; research program of the Stichting voor Fundamenteel Onderzoek der Materie (FOM); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); European Union NEST program CASPIC award [28974]; TOYOBO BIOFOUNDATION; Human Frontier Science Program; Direct For Biological Sciences [1158372] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM102839] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Carnegie Institution for Science; research program of the Stichting voor Fundamenteel Onderzoek der Materie (FOM); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union NEST program CASPIC award; TOYOBO BIOFOUNDATION; Human Frontier Science Program(Human Frontier Science Program); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.W.E., J.J.L., M.N., and V. K. designed experimental strategy. J.J.L., M.N., A. H., and V. K. carried out experiments. J.J.L., M.N., A. H., and D. W. E. analyzed data. K. S., R. G., J.J.L., B. M. M., and D. W. E. designed and created image-analysis tools. D. W. E., J.J.L., and M.N. wrote the manuscript. B. M. M., A. H., R. G., V. K., T. K., and A. M. C. E. edited the manuscript. We thank W. Briggs, A. Murphy, R. Hangarter, E. Spalding, T. Hashimoto, M. Janson, and S. Shaw for advice and discussions. This work was supported by NSF award 1158372 (D. W. E.); the Carnegie Institution for Science (D. W. E.); the research program of the Stichting voor Fundamenteel Onderzoek der Materie (FOM), which is financially supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (B. M. M.); the European Union NEST program CASPIC award 28974 (J.J.L. and K. S.); TOYOBO BIOFOUNDATION (M.N.); and the Human Frontier Science Program (M.N.).	Allard JF, 2010, BIOPHYS J, V99, P1082, DOI 10.1016/j.bpj.2010.05.037; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Burk DH, 2007, J INTEGR PLANT BIOL, V49, P1174, DOI 10.1111/j.1672-9072.2007.00544.x; Casanova M, 2009, MOL MICROBIOL, V71, P1353, DOI 10.1111/j.1365-2958.2009.06594.x; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; Dixit R, 2004, PLANT CELL, V16, P3274, DOI 10.1105/tpc.104.026930; Eren EC, 2010, MOL BIOL CELL, V21, P2674, DOI 10.1091/mbc.E10-02-0136; GALLAGHER S, 1988, P NATL ACAD SCI USA, V85, P8003, DOI 10.1073/pnas.85.21.8003; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Hamant O, 2013, CURR BIOL, V23, pR206, DOI 10.1016/j.cub.2013.01.031; Hawkins RJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011911; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kirik A, 2012, PLANT CELL, V24, P1158, DOI 10.1105/tpc.111.094367; LASKOWSKI MJ, 1990, PLANTA, V181, P44, DOI 10.1007/BF00202323; Lin DS, 2013, CURR BIOL, V23, P290, DOI 10.1016/j.cub.2013.01.022; Lindeboom JJ, 2013, PLANT PHYSIOL, V161, P1189, DOI 10.1104/pp.112.204057; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Nakamura M, 2004, PLANT CELL PHYSIOL, V45, P1330, DOI 10.1093/pcp/pch300; Nakamura M, 2010, NAT CELL BIOL, V12, P1064, DOI 10.1038/ncb2110; Nakamura M, 2009, J CELL SCI, V122, P2208, DOI 10.1242/jcs.044131; NICK P, 1990, PLANTA, V181, P162, DOI 10.1007/BF02411533; Oda Y, 2012, SCIENCE, V337, P1333, DOI 10.1126/science.1222597; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Rasband W. S., 2012, LIBRARY; Rasi MQ, 2009, MOL BIOL CELL, V20, P379, DOI 10.1091/mbc.E07-10-1007; Roll-Mecak A, 2006, J CELL BIOL, V175, P849, DOI 10.1083/jcb.200611149; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Sambade A, 2012, PLANT CELL, V24, P192, DOI 10.1105/tpc.111.093849; Sharp DJ, 2012, J CELL SCI, V125, P2561, DOI 10.1242/jcs.101139; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Shi XQ, 2010, P NATL ACAD SCI USA, V107, P11709, DOI 10.1073/pnas.1007138107; SHIBAOKA H, 1994, ANNU REV PLANT PHYS, V45, P527, DOI 10.1146/annurev.pp.45.060194.002523; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Stoppin-Mellet V, 2002, BIOCHEM J, V365, P337, DOI 10.1042/BJ20020689; Tindemans SH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031910; Tindemans SH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.058103; Tran PT, 1997, J CELL BIOL, V138, P105, DOI 10.1083/jcb.138.1.105; Ueda K, 2000, PROTOPLASMA, V213, P28, DOI 10.1007/BF01280502; Uyttewaal M, 2012, CELL, V149, P439, DOI 10.1016/j.cell.2012.02.048; Vineyard L, 2013, PLANT CELL, V25, P662, DOI 10.1105/tpc.112.107326; WALKER RA, 1989, J CELL BIOL, V108, P931, DOI 10.1083/jcb.108.3.931; Wightman R, 2008, PLANT J, V54, P794, DOI 10.1111/j.1365-313X.2008.03444.x; ZANDOMENI K, 1993, PROTOPLASMA, V173, P103, DOI 10.1007/BF01378999	52	172	180	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1202	+	1245533	10.1126/science.1245533	http://dx.doi.org/10.1126/science.1245533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24200811				2022-12-24	WOS:000327857900038
J	Yin, P; Li, QX; Yan, CY; Liu, Y; Liu, JJ; Yu, F; Wang, Z; Long, JF; He, JH; Wang, HW; Wang, JW; Zhu, JK; Shi, YG; Yan, NE				Yin, Ping; Li, Quanxiu; Yan, Chuangye; Liu, Ying; Liu, Junjie; Yu, Feng; Wang, Zheng; Long, Jiafu; He, Jianhua; Wang, Hong-Wei; Wang, Jiawei; Zhu, Jian-Kang; Shi, Yigong; Yan, Nieng			Structural basis for the modular recognition of single-stranded RNA by PPR proteins	NATURE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; CYTOPLASMIC MALE-STERILITY; RESTORES FERTILITY; BINDING; IDENTIFICATION; MECHANISM; REVEALS; INSIGHT; TERMINI; RICE	Pentatricopeptide repeat (PPR) proteins represent a large family of sequence-specific RNA-binding proteins that are involved in multiple aspects of RNA metabolism. PPR proteins, which are found in exceptionally large numbers in the mitochondria and chloroplasts of terrestrial plants(1-5), recognize single-stranded RNA (ssRNA) in a modular fashion(6-8). The maize chloroplast protein PPR10 binds to two similar RNA sequences from the ATPI-ATPH and PSAJ-RPL33 intergenic regions, referred to as ATPH and PSAJ, respectively(9,10). By protecting the target RNA elements from 5' or 3' exonucleases, PPR10 defines the corresponding 5' and 3' messenger RNA termini(9-11). Despite rigorous functional characterizations, the structural basis of sequence-specific ssRNA recognition by PPR proteins remains to be elucidated. Here we report the crystal structures of PPR10 in RNA-free and RNA-bound states at resolutions of 2.85 and 2.45 angstrom, respectively. In the absence of RNA binding, the nineteen repeats of PPR10 are assembled into a right-handed superhelical spiral. PPR10 forms an antiparallel, intertwined homodimer and exhibits considerable conformational changes upon binding to its target ssRNA, an 18-nucleotide PSAJ element. Six nucleotides of PSAJ are specifically recognized by six corresponding PPR10 repeats following the predicted code. The molecular basis for the specific and modular recognition of RNA bases A, G and U is revealed. The structural elucidation of RNA recognition by PPR proteins provides an important framework for potential biotechnological applications of PPR proteins in RNA-related research areas.	[Yin, Ping; Li, Quanxiu; Liu, Ying; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Yin, Ping; Li, Quanxiu; Yan, Chuangye; Liu, Ying; Liu, Junjie; Wang, Hong-Wei; Wang, Jiawei; Shi, Yigong; Yan, Nieng] Tsinghua Univ, Ctr Struct Biol, Sch Life Sci, Beijing 100084, Peoples R China; [Yin, Ping; Li, Quanxiu; Yan, Chuangye; Liu, Ying; Liu, Junjie; Wang, Hong-Wei; Wang, Jiawei; Shi, Yigong; Yan, Nieng] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Yan, Chuangye; Liu, Junjie; Wang, Hong-Wei; Shi, Yigong] Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China; [Yu, Feng; He, Jianhua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201204, Peoples R China; [Wang, Zheng; Long, Jiafu] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Wang, Zheng; Long, Jiafu] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Zhu, Jian-Kang] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Ctr Plant Stress Biol, Shanghai 200032, Peoples R China; [Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Nankai University; Nankai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Yan, NE (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Long, Jiafu/B-7420-2012; Zhu, Jian-Kang/F-7658-2011; Wang, Jiawei/D-1144-2010; Yan, Chuangye/AAJ-5832-2021	Long, Jiafu/0000-0002-6625-0147; Zhu, Jian-Kang/0000-0001-5134-731X; Wang, Jiawei/0000-0001-9893-8539; Liu, Jun-Jie/0000-0002-8982-107X; Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology [2011CB910501]; National Natural Science Foundation of China [91017011, 31070644, 31021002, 31200567]; Howard Hughes Medical Institute	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank X. Yu and Y. Chen at the Institute of Biophysics, Chinese Academy of Sciences, for technical support. We thank K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU for on-site assistance. This work was supported by funds from the Ministry of Science and Technology (grant number 2011CB910501 for N.Y.), and Projects 91017011 (N.Y.), 31070644 (N.Y.), 31021002 (Y. S., N.Y., J.W.) and 31200567 (P. Y.) of the National Natural Science Foundation of China. The research of N.Y. was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Cushing DA, 2005, PLANTA, V221, P424, DOI 10.1007/s00425-004-1452-x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Desloire S, 2003, EMBO REP, V4, P588, DOI 10.1038/sj.embor.embor848; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipovska A, 2012, MOL BIOSYST, V8, P699, DOI 10.1039/c2mb05392f; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Hu J, 2012, PLANT CELL, V24, P109, DOI 10.1105/tpc.111.093211; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P2712, DOI 10.1093/nar/gkr1084; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Nakamura T, 2012, PLANT CELL PHYSIOL, V53, P1171, DOI 10.1093/pcp/pcs069; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Prikryl J, 2011, P NATL ACAD SCI USA, V108, P415, DOI 10.1073/pnas.1012076108; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; Yagi Y, 2013, RNA BIOL, V10, P1419, DOI 10.4161/rna.24908; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Zhelyazkova P, 2012, NUCLEIC ACIDS RES, V40, P3092, DOI 10.1093/nar/gkr1137	37	238	252	6	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					168	+		10.1038/nature12651	http://dx.doi.org/10.1038/nature12651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24162847				2022-12-24	WOS:000327851700053
J	Conlon, BP; Nakayasu, ES; Fleck, LE; LaFleur, MD; Isabella, VM; Coleman, K; Leonard, SN; Smith, RD; Adkins, JN; Lewis, K				Conlon, B. P.; Nakayasu, E. S.; Fleck, L. E.; LaFleur, M. D.; Isabella, V. M.; Coleman, K.; Leonard, S. N.; Smith, R. D.; Adkins, J. N.; Lewis, K.			Activated ClpP kills persisters and eradicates a chronic biofilm infection	NATURE			English	Article							TANDEM MASS-SPECTRA; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; MULTIDRUG TOLERANCE; PSEUDOMONAS-AERUGINOSA; BACTERIAL PERSISTENCE; IN-VIVO; CELLS; ANTIBIOTICS; RESISTANCE	Chronic infections are difficult to treat with antibiotics but are caused primarily by drug-sensitive pathogens. Dormant persister cells that are tolerant to killing by antibiotics are responsible for this apparent paradox. Persisters are phenotypic variants of normal cells and pathways leading to dormancy are redundant, making it challenging to develop anti-persister compounds. Biofilms shield persisters from the immune system, suggesting that an antibiotic for treating a chronic infection should be able to eradicate the infection on its own. We reasoned that a compound capable of corrupting a target in dormant cells will kill persisters. The acyldepsipeptide antibiotic (ADEP4) has been shown to activate the ClpP protease, resulting in death of growing cells. Here we show that ADEP4-activated ClpP becomes a fairly nonspecific protease and kills persisters by degrading over 400 proteins, forcing cells to self-digest. Null mutants of clpP arise with high probability, but combining ADEP4 with rifampicin produced complete eradication of Staphylococcus aureus biofilms in vitro and in a mouse model of a chronic infection. Our findings indicate a general principle for killing dormant cells-activation and corruption of a target, rather than conventional inhibition. Eradication of a biofilm in an animal model by activating a protease suggests a realistic path towards developing therapies to treat chronic infections.	[Conlon, B. P.; Fleck, L. E.; Isabella, V. M.; Lewis, K.] Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA; [Nakayasu, E. S.; Smith, R. D.; Adkins, J. N.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [LaFleur, M. D.; Coleman, K.] Arietis Corp, Boston, MA 02118 USA; [Leonard, S. N.] Northeastern Univ, Sch Pharm, Bouve Coll Hlth Sci, Boston, MA 02115 USA	Northeastern University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Northeastern University	Lewis, K (corresponding author), Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA.	k.lewis@neu.edu	Smith, Richard D/J-3664-2012; Nakayasu, Ernesto S./AAJ-8374-2020	Smith, Richard D/0000-0002-2381-2349; Nakayasu, Ernesto S./0000-0002-4056-2695; Conlon, Brian/0000-0002-2155-8375	NIH [T-RO1 AI085585]; Arietis Corporation; NIH-NIAID IAA [Y1-AI-8401, P41 GM103493-11]; DOE [DE-AC05-76RLO 1830]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085585, R22AI008401, R01AI008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061162, P41GM103493] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arietis Corporation; NIH-NIAID IAA; DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Wright and C. Blinn of AstraZeneca for assisting with the establishment of the mouse infection model, R. E. Lee, M. Pollastri and Z. Maglika for critical discussions and advice, I. Keren and S. Rowe for reading of the manuscript, H. Brewer, V. Petyuk and D. Camp II for assistance with proteomics, and Z. Zheng for assistance with ChemDraw. This work was supported by NIH award T-RO1 AI085585 to K.L., by Arietis Corporation to M.D.L and K.C., by the NIH-NIAID IAA Y1-AI-8401 to J.N.A. and P41 GM103493-11 to R.D.S. Proteomic analysis was performed in the EMSL, a DOE-BER national scientific user facility at Pacific Northwest National Laboratory (PNNL). PNNL is a multi-program national laboratory operated by Battelle Memorial Institute for the DOE under contract DE-AC05-76RLO 1830.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Bigger JW, 1944, LANCET, V2, P497; BLASER J, 1985, J ANTIMICROB CHEMOTH, V15, P125, DOI 10.1093/jac/15.suppl_A.125; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Buske PJ, 2013, MOL MICROBIOL, V89, P249, DOI 10.1111/mmi.12272; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Germain E, 2013, MOL CELL, V52, P248, DOI 10.1016/j.molcel.2013.08.045; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gurnev PA, 2012, FEBS LETT, V586, P2529, DOI 10.1016/j.febslet.2012.06.021; Harrison JJ, 2009, ANTIMICROB AGENTS CH, V53, P2253, DOI 10.1128/AAC.00043-09; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Hung C, 2013, MBIO, V4, DOI 10.1128/mBio.00645-13; HUSSAIN M, 1991, J MED MICROBIOL, V34, P143, DOI 10.1099/00222615-34-3-143; Johnson PJT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003123; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731; Kirstein J, 2009, EMBO MOL MED, V1, P37, DOI 10.1002/emmm.200900002; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Leung E, 2011, CHEM BIOL, V18, P1167, DOI 10.1016/j.chembiol.2011.07.023; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lewis K, 2012, NATURE, V485, P439, DOI 10.1038/485439a; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Mayampurath AM, 2008, BIOINFORMATICS, V24, P1021, DOI 10.1093/bioinformatics/btn063; Michalik S, 2009, PROTEOMICS, V9, P4468, DOI 10.1002/pmic.200900168; Michel K.H., 1985, US Pat., Patent No. [4492650, 4,492,650]; Miyazaki M, 2011, ANTIMICROB AGENTS CH, V55, P1819, DOI 10.1128/AAC.01536-10; Monroe ME, 2008, COMPUT BIOL CHEM, V32, P215, DOI 10.1016/j.compbiolchem.2008.02.006; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	50	437	459	7	258	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					365	+		10.1038/nature12790	http://dx.doi.org/10.1038/nature12790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24226776	Green Accepted			2022-12-24	WOS:000327163200034
J	Rasaiyaah, J; Tan, CP; Fletcher, AJ; Price, AJ; Blondeau, C; Hilditch, L; Jacques, DA; Selwood, DL; James, LC; Noursadeghi, M; Towers, GJ				Rasaiyaah, Jane; Tan, Choon Ping; Fletcher, Adam J.; Price, Amanda J.; Blondeau, Caroline; Hilditch, Laura; Jacques, David A.; Selwood, David L.; James, Leo C.; Noursadeghi, Mahdad; Towers, Greg J.			HIV-1 evades innate immune recognition through specific cofactor recruitment	NATURE			English	Article							GMP-AMP SYNTHASE; CYCLOSPORINE-A; GENE DELIVERY; RNA-BINDING; CLEAVAGE; CYCLOPHILIN; SENSOR; POLYADENYLATION; INFECTION; CELLS	Human immunodeficiency virus (HIV)-1 is able to replicate in primary human macrophages without stimulating innate immunity despite reverse transcription of genomic RNA into double-stranded DNA, an activity that might be expected to trigger innate pattern recognition receptors. We reasoned that if correctly orchestrated HIV-1 uncoating and nuclear entry is important for evasion of innate sensors then manipulation of specific interactions between HIV-1 capsid and host factors that putatively regulate these processes should trigger pattern recognition receptors and stimulate type 1 interferon (IFN) secretion. Here we show that HIV-1 capsid mutants N74D and P90A, which are impaired for interaction with cofactors cleavage and polyadenylation specificity factor subunit 6 (CPSF6) and cyclophilins (Nup358 and CypA), respectively(1,2), cannot replicate in primary human monocyte-derived macrophages because they trigger innate sensors leading to nuclear translocation of NF-kappa B and IRF3, the production of soluble type 1 IFN and induction of an antiviral state. Depletion of CPSF6 with short hairpin RNA expression allows wild-type virus to trigger innate sensors and IFN production. In each case, suppressed replication is rescued by IFN-receptor blockade, demonstrating a role for IFN in restriction. IFN production is dependent on viral reverse transcription but not integration, indicating that a viral reverse transcription product comprises the HIV-1 pathogen-associated molecular pattern. Finally, we show that we can pharmacologically induce wild-type HIV-1 infection to stimulate IFN secretion and an antiviral state using a non-immunosuppressive cyclosporine analogue. We conclude that HIV-1 has evolved to use CPSF6 and cyclophilins to cloak its replication, allowing evasion of innate immune sensors and induction of a cell-autonomous innate immune response in primary human macrophages.	[Rasaiyaah, Jane; Tan, Choon Ping; Fletcher, Adam J.; Blondeau, Caroline; Hilditch, Laura; Noursadeghi, Mahdad; Towers, Greg J.] UCL, MRC, Ctr Med Mol Virol, Div Infect & Immun, London WC1E 6BT, England; [Price, Amanda J.; Jacques, David A.; James, Leo C.] MRC, Mol Biol Lab, Prot & Nucle Acid Chem Div, Cambridge CB2 0QH, England; [Selwood, David L.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London	Towers, GJ (corresponding author), UCL, MRC, Ctr Med Mol Virol, Div Infect & Immun, 90 Gower St, London WC1E 6BT, England.	m.noursadeghi@ucl.ac.uk; g.towers@ucl.ac.uk	Blondeau, Caroline/D-4269-2017	Selwood, David/0000-0002-6817-5064; Noursadeghi, Mahdad/0000-0002-4774-0853; Fletcher, Adam/0000-0003-1742-6588; Jacques, David/0000-0002-6426-4510; Towers, Gregory/0000-0002-7707-0264	Wellcome Trust [090940]; Medical Research Council; MRC Confidence in Concept Award; National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre; MRC [MC_U105181010, MC_PC_12024, G9721629, G0501446, G0900950, G0801172] Funding Source: UKRI; Medical Research Council [G0900950B, G0501446, G9721629B, G0900950, MC_U105181010, MC_PC_12024, G0801172, G9721629] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Confidence in Concept Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to J. W. Chin, S. Goodbourn, K. Lee, O. Perisic and V. KewalRamani for reagents and advice. This work was funded by Wellcome Trust Senior Fellowship 090940 to G.J.T., the Medical Research Council, an MRC Confidence in Concept Award to G.J.T. and D.S. and the National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Ambrose Z, 2012, J VIROL, V86, P4708, DOI 10.1128/JVI.05887-11; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Besnier C, 2002, P NATL ACAD SCI USA, V99, P11920, DOI 10.1073/pnas.172384599; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; Dube H, 2012, BIOCHEM J, V441, P901, DOI 10.1042/BJ20111301; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Hori T, 2013, J VIROL, V87, P7726, DOI 10.1128/JVI.00124-13; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Iyer SR, 2009, J VIROL, V83, P8662, DOI 10.1128/JVI.00874-09; Lee K, 2012, J VIROL, V86, P3851, DOI 10.1128/JVI.06607-11; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Liu JP, 2011, TRANSPL INFECT DIS, V13, P24, DOI 10.1111/j.1399-3062.2010.00556.x; Lynn DJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-117; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; MIKOL V, 1993, J MOL BIOL, V234, P1119, DOI 10.1006/jmbi.1993.1664; Morner A, 1999, J VIROL, V73, P2343; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Ruepp MD, 2011, WIRES RNA, V2, P79, DOI 10.1002/wrna.35; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Shi J, 2011, J VIROL, V85, P542, DOI 10.1128/JVI.01406-10; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tsang J, 2009, AIDS, V23, P2255, DOI 10.1097/QAD.0b013e328331a4ce; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang Q, 2011, RNA BIOL, V8, P748, DOI 10.4161/rna.8.5.16040; Zhang FW, 2006, VIROLOGY, V353, P396, DOI 10.1016/j.virol.2006.05.035; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	32	313	323	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					402	+		10.1038/nature12769	http://dx.doi.org/10.1038/nature12769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24196705	Green Accepted, Green Published			2022-12-24	WOS:000327163200042
J	Ellison, CE; Bachtrog, D				Ellison, Christopher E.; Bachtrog, Doris			Dosage Compensation via Transposable Element Mediated Rewiring of a Regulatory Network	SCIENCE			English	Article							DROSOPHILA-PSEUDOOBSCURA; Y-CHROMOSOME; SELFISH DNA; EVOLUTION; GENE; ADAPTATION	Transposable elements (TEs) may contribute to evolutionary innovations through the rewiring of networks by supplying ready-to-use cis regulatory elements. Genes on the Drosophila X chromosome are coordinately regulated by the male specific lethal (MSL) complex to achieve dosage compensation in males. We show that the acquisition of dozens of MSL binding sites on evolutionarily new X chromosomes was facilitated by the independent co-option of a mutant helitron TE that attracts the MSL complex (TE domestication). The recently formed neo-X recruits helitrons that provide dozens of functional, but suboptimal, MSL binding sites, whereas the older XR chromosome has ceased acquisition and appears to have fine-tuned the binding affinities of more ancient elements for the MSL complex. Thus, TE-mediated rewiring of regulatory networks through domestication and amplification may be followed by fine-tuning of the cis-regulatory element supplied by the TE and erosion of nonfunctional regions.	[Ellison, Christopher E.; Bachtrog, Doris] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bachtrog, D (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	dbachtrog@berkeley.edu			NIH [R01GM076007, R01GM093182]; Packard Fellowship; National Center for Biotechnology Information [PRJNA77213]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM103186, R01GM076007, R01GM093182] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship(The David & Lucile Packard Foundation); National Center for Biotechnology Information; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grants (R01GM076007 and R01GM093182) and a Packard Fellowship to D. B. and a NIH postdoctoral fellowship to C. E. E. All DNA-sequencing reads generated in this study are deposited at the National Center for Biotechnology Information Short Reads Archive (www.ncbi.nlm.nih.gov/sra) under the accession no. SRS402821. The genome assemblies are available at the National Center for Biotechnology Information under BioProject PRJNA77213. We thank Z. Walton and A. Gorchakov for technical assistance.	Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Alekseyenko AA, 2013, GENE DEV, V27, P853, DOI 10.1101/gad.215426.113; Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Bringaud F, 2007, PLOS PATHOG, V3, P1291, DOI 10.1371/journal.ppat.0030136; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; CHARLESWORTH B, 1983, GENET RES, V42, P1, DOI 10.1017/S0016672300021455; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; HICKEY DA, 1982, GENETICS, V101, P519; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Jurka J., 2012, REPBASE REPORTS, V12, P1376; Kapitonov VV, 2007, TRENDS GENET, V23, P521, DOI 10.1016/j.tig.2007.08.004; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Marin I, 1996, NATURE, V383, P160, DOI 10.1038/383160a0; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; STEINEMANN M, 1992, P NATL ACAD SCI USA, V89, P7591, DOI 10.1073/pnas.89.16.7591; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Zhou Q, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001711; Zhou Q, 2012, SCIENCE, V337, P341, DOI 10.1126/science.1225385	26	105	109	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					846	850		10.1126/science.1239552	http://dx.doi.org/10.1126/science.1239552			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233721	Green Accepted			2022-12-24	WOS:000326923000035
J	Han, K; Holder, JL; Schaaf, CP; Lu, H; Chen, HM; Kang, H; Tang, JR; Wu, ZY; Hao, S; Cheung, SW; Yu, P; Sun, H; Breman, AM; Patel, A; Lu, HC; Zoghbi, HY				Han, Kihoon; Holder, J. Lloyd, Jr.; Schaaf, Christian P.; Lu, Hui; Chen, Hongmei; Kang, Hyojin; Tang, Jianrong; Wu, Zhenyu; Hao, Shuang; Cheung, Sau Wai; Yu, Peng; Sun, Hao; Breman, Amy M.; Patel, Ankita; Lu, Hui-Chen; Zoghbi, Huda Y.			SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties	NATURE			English	Article							AUTISM SPECTRUM DISORDER; SCAFFOLDING PROTEIN SHANK3; 22Q13.3 DELETION SYNDROME; BIPOLAR DISORDER; PSYCHIATRIC-DISORDERS; POSTSYNAPTIC DENSITY; GENE; MUTATIONS; DYSFUNCTION; PROFILIN	Mutations in SHANK3 and large duplications of the region spanning SHANK3 both cause a spectrum of neuropsychiatric disorders, indicating that proper SHANK3 dosage is critical for normal brain function. However, SHANK3 overexpression per se has not been established as a cause of human disorders because 22q13 duplications involve several genes. Here we report that Shank3 transgenic mice modelling a human SHANK3 duplication exhibit manic-like behaviour and seizures consistent with synaptic excitatory/inhibitory imbalance. We also identified two patients with hyperkinetic disorders carrying the smallest SHANK3-spanning duplications reported so far. These findings indicate that SHANK3 overexpression causes a hyperkinetic neuropsychiatric disorder. To probe the mechanism underlying the phenotype, we generated a Shank3 in vivo interactome and found that Shank3 directly interacts with the Arp2/3 complex to increase F-actin levels in Shank3 transgenic mice. The mood-stabilizing drug valproate, but not lithium, rescues the manic-like behaviour of Shank3 transgenic mice raising the possibility that this hyperkinetic disorder has a unique pharmacogenetic profile.	[Han, Kihoon; Schaaf, Christian P.; Lu, Hui; Kang, Hyojin; Cheung, Sau Wai; Yu, Peng; Breman, Amy M.; Patel, Ankita; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Han, Kihoon; Lu, Hui; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Han, Kihoon; Holder, J. Lloyd, Jr.; Schaaf, Christian P.; Lu, Hui; Chen, Hongmei; Kang, Hyojin; Tang, Jianrong; Wu, Zhenyu; Hao, Shuang; Yu, Peng; Sun, Hao; Lu, Hui-Chen; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Holder, J. Lloyd, Jr.; Chen, Hongmei; Tang, Jianrong; Wu, Zhenyu; Hao, Shuang; Sun, Hao; Lu, Hui-Chen; Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Holder, J. Lloyd, Jr.] Baylor Coll Med, Div Neurol & Dev Neurosci, Houston, TX 77030 USA; [Chen, Hongmei; Sun, Hao; Lu, Hui-Chen] Texas Childrens Hosp, Cain Fdn Labs, Houston, TX 77030 USA; [Cheung, Sau Wai; Breman, Amy M.; Patel, Ankita] Baylor Coll Med, Med Genet Labs, Houston, TX 77030 USA; [Lu, Hui-Chen; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Lu, Hui-Chen; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.edu	Holder, J. Lloyd/AFT-0389-2022; Han, Kihoon/AAE-8919-2019; Schaaf, Christian P/AAJ-7318-2021	Han, Kihoon/0000-0002-5925-2152; Schaaf, Christian P/0000-0002-2148-7490; Sun, Hao/0000-0002-3670-2886; Breman, Amy/0000-0003-0299-0100; Zoghbi, Huda/0000-0002-0700-3349; Holder, Jimmy/0000-0001-5595-0458	Howard Hughes Medical Institute; National Institutes of Health (NIH) ARRA grant [1R01NS070302]; Baylor Intellectual and Developmental Disabilities Research Center [P30HD024064]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110784]; Thrasher Research Fund; NIH [2T32NS043124]; Ting Tsung and Wei Fong Chao Foundation; Joan and Stanford Alexander family; Doris Duke Clinical Scientist Development Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS043124, R01NS070302, R01NS048884] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health (NIH) ARRA grant; Baylor Intellectual and Developmental Disabilities Research Center; Cancer Prevention and Research Institute of Texas (CPRIT); Thrasher Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ting Tsung and Wei Fong Chao Foundation; Joan and Stanford Alexander family; Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to the patients and families who participated in this study; to J. W. Belmont and N. Miller for contributing patients to this study; G. Feng for sharing Shank3B mice; G. Schuster for injection of Shank3 BAC; and C. Spencer for behavioural assays training. This project was supported by The Howard Hughes Medical Institute (H.Y.Z.), National Institutes of Health (NIH) ARRA grant (1R01NS070302) (H.Y.Z.), the Baylor Intellectual and Developmental Disabilities Research Center (P30HD024064) confocal, electrophysiology and mouse neurobehavioral cores, and the Cancer Prevention and Research Institute of Texas (CPRIT) RP110784. J. L. H. was supported by an Early Career Award from the Thrasher Research Fund, NIH 2T32NS043124 and the Ting Tsung and Wei Fong Chao Foundation; C. P. S. was supported by the Joan and Stanford Alexander family, the Ting Tsung and Wei Fong Chao Foundation and the Doris Duke Clinical Scientist Development Award.	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Belmaker RH, 2004, NEW ENGL J MED, V351, P476, DOI 10.1056/NEJMra035354; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bonaglia MC, 2006, J MED GENET, V43, P822, DOI 10.1136/jmg.2005.038604; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DUNNER DL, 1974, ARCH GEN PSYCHIAT, V30, P229; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Failla P, 2007, CLIN GENET, V71, P599, DOI 10.1111/j.1399-0004.2007.00819.x; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Giesemann T, 2003, J NEUROSCI, V23, P8330; Gitlin M, 2006, MOL PSYCHIATR, V11, P227, DOI 10.1038/sj.mp.4001793; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Grabrucker AM, 2011, TRENDS CELL BIOL, V21, P594, DOI 10.1016/j.tcb.2011.07.003; Han K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000187; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jope RS, 1999, MOL PSYCHIATR, V4, P117, DOI 10.1038/sj.mp.4000494; Leibenluft E, 2008, ANNU REV CLIN PSYCHO, V4, P163, DOI 10.1146/annurev.clinpsy.4.022007.141216; Lu H, 2009, J NEUROSCI, V29, P12664, DOI 10.1523/JNEUROSCI.1984-09.2009; Magloczky Z, 2005, TRENDS NEUROSCI, V28, P334, DOI 10.1016/j.tins.2005.04.002; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Martinowich K, 2009, J CLIN INVEST, V119, P726, DOI 10.1172/JCI37703; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Neuhoff H, 2005, EUR J NEUROSCI, V21, P15, DOI 10.1111/j.1460-9568.2004.03814.x; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sato D, 2012, AM J HUM GENET, V90, P879, DOI 10.1016/j.ajhg.2012.03.017; Schloesser RJ, 2012, TRENDS NEUROSCI, V35, P36, DOI 10.1016/j.tins.2011.11.009; Shaltiel G, 2008, MOL PSYCHIATR, V13, P858, DOI 10.1038/mp.2008.20; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 2011, COLD SPRING HARB PER; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	55	249	267	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					72	+		10.1038/nature12630	http://dx.doi.org/10.1038/nature12630			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24153177	Green Accepted			2022-12-24	WOS:000326585600034
J	Barends, TRM; Foucar, L; Botha, S; Doak, RB; Shoeman, RL; Nass, K; Koglin, JE; Williams, GJ; Boutet, S; Messerschmidt, M; Schlichting, I				Barends, Thomas R. M.; Foucar, Lutz; Botha, Sabine; Doak, R. Bruce; Shoeman, Robert L.; Nass, Karol; Koglin, Jason E.; Williams, Garth J.; Boutet, Sebastien; Messerschmidt, Marc; Schlichting, Ilme			De novo protein crystal structure determination from X-ray free-electron laser data	NATURE			English	Article							SERIAL FEMTOSECOND CRYSTALLOGRAPHY; ROOM-TEMPERATURE; RADIATION-DAMAGE; PHOTOSYSTEM-II; DIFFRACTION; NANOCRYSTALLOGRAPHY; SOFTWARE	The determination of protein crystal structures is hampered by the need for macroscopic crystals. X-ray free-electron lasers (FELs) provide extremely intense pulses of femtosecond duration, which allow data collection from nanometre- to micrometre-sized crystals(1-4) in a 'diffraction-before-destruction' approach. So far, all protein structure determinations carried out using FELs have been based on previous knowledge of related, known structures(1-5). Here we show that X-ray FEL data can be used for de novo protein structure determination, that is, without previous knowledge about the structure. Using the emerging technique of serial femtosecond crystallography(1-4,6), we performed single-wavelength anomalous scattering measurements on microcrystals of the well-established model system lysozyme, in complex with a lanthanide compound. Using Monte-Carlo integration(6,7), we obtained high-quality diffraction intensities from which experimental phases could be determined, resulting in an experimental electron density map good enough for automated building of the protein structure. This demonstrates the feasibility of determining novel protein structures using FELs. We anticipate that serial femtosecond crystallography will become an important tool for the structure determination of proteins that are difficult to crystallize, such as membrane proteins(1,2,8).	[Barends, Thomas R. M.; Foucar, Lutz; Botha, Sabine; Doak, R. Bruce; Shoeman, Robert L.; Nass, Karol; Schlichting, Ilme] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Doak, R. Bruce] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Koglin, Jason E.; Williams, Garth J.; Boutet, Sebastien; Messerschmidt, Marc] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA	Max Planck Society; Arizona State University; Arizona State University-Tempe; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Barends, TRM (corresponding author), Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany.	thomas.barends@mpimf-heidelberg.mpg.de; ilme.schlichting@mpimf-heidelberg.mpg.de	Messerschmidt, Marc/F-3796-2010; Nass, Karol/K-1970-2012; Schlichting, Ilme/I-1339-2013; Messerschmidt, Marc/Y-8929-2019	Messerschmidt, Marc/0000-0002-8641-3302; Nass, Karol/0000-0001-8843-1566; Messerschmidt, Marc/0000-0002-8641-3302	LCLS Ultrafast Science Instruments (LUSI) project; US Department of Energy, Office of Basic Energy Sciences; Max Planck Society; EU	LCLS Ultrafast Science Instruments (LUSI) project; US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Max Planck Society(Max Planck SocietyFoundation CELLEX); EU(European Commission)	Portions of this research were carried out at the Linac Coherent Light Source, a National User Facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. The CXI instrument was funded by the LCLS Ultrafast Science Instruments (LUSI) project funded by the US Department of Energy, Office of Basic Energy Sciences. We acknowledge support from the Max Planck Society and from the EU for an Incoming Scientist Award to R. B. D. We thank the staff at the LCLS for their support and are grateful to S. Pesch and R. van Gessel (Bracco Imaging Konstanz and Singen, Germany) for the gift of the sample of gadoteridol. We thank H. Zimmermann for suggestions, W. Kabsch for discussions and J. Wray for critically reading the manuscript. In addition, we acknowledge L. Hammon and C. Patty for laboratory support, and the MCC staff for the beam they provided. We are indebted to C. Roome and F. Koeck for computing support.	Amann J, 2012, NAT PHOTONICS, V6, P693, DOI [10.1038/NPHOTON.2012.180, 10.1038/nphoton.2012.180]; Banumathi S, 2004, ACTA CRYSTALLOGR D, V60, P1085, DOI 10.1107/S0907444904007917; Barends TRM, 2013, ACTA CRYSTALLOGR D, V69, P838, DOI 10.1107/S0907444913002448; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Foucar L, 2012, COMPUT PHYS COMMUN, V183, P2207, DOI 10.1016/j.cpc.2012.04.023; Girard E, 2002, ACTA CRYSTALLOGR D, V58, P1, DOI 10.1107/S0907444901016444; Johansson LC, 2012, NAT METHODS, V9, P263, DOI [10.1038/NMETH.1867, 10.1038/nmeth.1867]; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kern J, 2012, P NATL ACAD SCI USA, V109, P9721, DOI 10.1073/pnas.1204598109; Kirian RA, 2011, ACTA CRYSTALLOGR A, V67, P131, DOI 10.1107/S0108767310050981; Kirian RA, 2010, OPT EXPRESS, V18, P5713, DOI 10.1364/OE.18.005713; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; Panjikar S, 2002, J APPL CRYSTALLOGR, V35, P261, DOI 10.1107/S0021889802002509; Ravelli RBG, 2003, STRUCTURE, V11, P217, DOI 10.1016/S0969-2126(03)00006-6; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sierra RG, 2012, ACTA CRYSTALLOGR D, V68, P1584, DOI 10.1107/S0907444912038152; Son SK, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.218102; Spence JCH, 2011, OPT EXPRESS, V19, P2866, DOI 10.1364/OE.19.002866; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Weiss MS, 2001, STRUCTURE, V9, P771, DOI 10.1016/S0969-2126(01)00647-5; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312	30	215	221	4	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					244	+		10.1038/nature12773	http://dx.doi.org/10.1038/nature12773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24270807				2022-12-24	WOS:000329441500044
J	Cameron, JC; Wilson, SC; Bernstein, SL; Kerfeld, CA				Cameron, Jeffrey C.; Wilson, Steven C.; Bernstein, Susan L.; Kerfeld, Cheryl A.			Biogenesis of a Bacterial Organelle: The Carboxysome Assembly Pathway	CELL			English	Article							SALMONELLA-TYPHIMURIUM; SYNECHOCOCCUS PCC7942; CARBONIC-ANHYDRASE; PHOTOSYSTEM-II; PROTEIN; CYANOBACTERIUM; SHELL; ETHANOLAMINE; ENTERICA; MUTANT	The carboxysome is a protein-based organelle for carbon fixation in cyanobacteria, keystone organisms in the global carbon cycle. It is composed of thousands of subunits including hexameric and pentameric proteins that form a shell to encapsulate the enzymes ribulose 1,5-bisphosphate carboxylase/oxygenase and carbonic anhydrase. Here, we describe the stages of carboxysome assembly and the requisite gene products necessary for progression through each. Our results demonstrate that, unlike membrane-bound organelles of eukaryotes, in carboxysomes the interior of the compartment forms first, at a distinct site within the cell. Subsequently, shell proteins encapsulate this procarboxysome, inducing budding and distribution of functional organelles within the cell. We propose that the principles of carboxysome assembly that we have uncovered extend to diverse bacterial microcompartments.	[Cameron, Jeffrey C.; Wilson, Steven C.; Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Bernstein, Susan L.; Kerfeld, Cheryl A.] US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Kerfeld, Cheryl A.] Univ Calif Berkeley, Synthet Biol Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kerfeld, CA (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	ckerfeld@lbl.gov		Wilson, Steven/0000-0002-7382-3388	NSF Emerging Frontiers Program [EF1105897]	NSF Emerging Frontiers Program	We thank members of the Kerfeld laboratory for helpful discussions. We thank Dr. Gustaf Sandh for construction of the Delta K2-O deletion plasmid and Patrick Shih for generating BglBrick modified neutral site vectors. We thank Dr. Kent McDonald, Reena Zalpuri, and Desiree Stanley for assistance with electron microscopy. We thank Dr. Susan Golden for providing pAM2314, pAM1573, and pAM2991 vectors and Dr. David Savage for providing pDFS648. Funding for this work was provided by the NSF Emerging Frontiers Program (EF1105897).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bonacci W, 2012, P NATL ACAD SCI USA, V109, P478, DOI 10.1073/pnas.1108557109; Bove AM, 2013, BIOCHEMISTRY-US, V52, P1419, DOI 10.1021/bi301651n; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; Cai F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007521; CANNON GC, 1991, J BACTERIOL, V173, P1565, DOI 10.1128/jb.173.4.1565-1568.1991; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Choudhary S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033342; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; Fan CG, 2012, P NATL ACAD SCI USA, V109, P14995, DOI 10.1073/pnas.1207516109; Goclaw-Binder H, 2012, ENVIRON MICROBIOL, V14, P680, DOI 10.1111/j.1462-2920.2011.02620.x; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Iancu CV, 2010, J MOL BIOL, V396, P105, DOI 10.1016/j.jmb.2009.11.019; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; KRALL JP, 1992, PHYSIOL PLANTARUM, V86, P180, DOI 10.1111/j.1399-3054.1992.tb01328.x; Long BM, 2007, J BIOL CHEM, V282, P29323, DOI 10.1074/jbc.M703896200; Long BM, 2010, PLANT PHYSIOL, V153, P285, DOI 10.1104/pp.110.154948; Ludwig M, 2000, J PHYCOL, V36, P1109, DOI 10.1046/j.1529-8817.2000.00028.x; MARCO E, 1994, APPL ENVIRON MICROB, V60, P1018, DOI 10.1128/AEM.60.3.1018-1020.1994; MARCUS Y, 1992, PLANTA, V187, P511, DOI 10.1007/BF00199970; Marsh JA, 2013, CELL, V153, P461, DOI 10.1016/j.cell.2013.02.044; ORUS MI, 1995, PLANT PHYSIOL, V107, P1159, DOI 10.1104/pp.107.4.1159; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; PRICE GD, 1989, PLANT PHYSIOL, V91, P514, DOI 10.1104/pp.91.2.514; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Rae BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043871; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; So AKC, 2002, PLANTA, V214, P456, DOI 10.1007/s004250100638; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Takahashi S, 2005, BBA-BIOENERGETICS, V1708, P352, DOI 10.1016/j.bbabio.2005.04.003; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	43	174	181	4	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1131	1140		10.1016/j.cell.2013.10.044	http://dx.doi.org/10.1016/j.cell.2013.10.044			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267892	Bronze			2022-12-24	WOS:000327500600016
J	Thalmann, O; Shapiro, B; Cui, P; Schuenemann, VJ; Sawyer, SK; Greenfield, DL; Germonpre, MB; Sablin, MV; Lopez-Giraldez, F; Domingo-Roura, X; Napierala, H; Uerpmann, HP; Loponte, DM; Acosta, AA; Giemsch, L; Schmitz, RW; Worthington, B; Buikstra, JE; Druzhkova, A; Graphodatsky, AS; Ovodov, ND; Wahlberg, N; Freedman, AH; Schweizer, RM; Koepfli, KP; Leonard, JA; Meyer, M; Krause, J; Paabo, S; Green, RE; Wayne, RK				Thalmann, O.; Shapiro, B.; Cui, P.; Schuenemann, V. J.; Sawyer, S. K.; Greenfield, D. L.; Germonpre, M. B.; Sablin, M. V.; Lopez-Giraldez, F.; Domingo-Roura, X.; Napierala, H.; Uerpmann, H-P.; Loponte, D. M.; Acosta, A. A.; Giemsch, L.; Schmitz, R. W.; Worthington, B.; Buikstra, J. E.; Druzhkova, A.; Graphodatsky, A. S.; Ovodov, N. D.; Wahlberg, N.; Freedman, A. H.; Schweizer, R. M.; Koepfli, K. -P.; Leonard, J. A.; Meyer, M.; Krause, J.; Paabo, S.; Green, R. E.; Wayne, R. K.			Complete Mitochondrial Genomes of Ancient Canids Suggest a European Origin of Domestic Dogs	SCIENCE			English	Article							EVOLUTION; MULTIPLE; GENETICS; WOLVES; WOLF; DNA	The geographic and temporal origins of the domestic dog remain controversial, as genetic data suggest a domestication process in East Asia beginning 15,000 years ago, whereas the oldest doglike fossils are found in Europe and Siberia and date to >30,000 years ago. We analyzed the mitochondrial genomes of 18 prehistoric canids from Eurasia and the New World, along with a comprehensive panel of modern dogs and wolves. The mitochondrial genomes of all modern dogs are phylogenetically most closely related to either ancient or modern canids of Europe. Molecular dating suggests an onset of domestication there 18,800 to 32,100 years ago. These findings imply that domestic dogs are the culmination of a process that initiated with European hunter-gatherers and the canids with whom they interacted.	[Thalmann, O.; Wahlberg, N.] Univ Turku, Dept Biol, Sect Genet & Physiol, SF-20500 Turku, Finland; [Shapiro, B.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Cui, P.; Sawyer, S. K.; Meyer, M.; Paabo, S.] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Schuenemann, V. J.; Uerpmann, H-P.; Krause, J.] Univ Tubingen, Inst Archaeol Sci, Tubingen, Germany; [Greenfield, D. L.; Freedman, A. H.; Schweizer, R. M.; Wayne, R. K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Germonpre, M. B.] Royal Belgian Inst Nat Sci, Operat Direct Earth & Hist Life, B-1000 Brussels, Belgium; [Sablin, M. V.] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Lopez-Giraldez, F.] Yale Univ, Yale Ctr Genome Anal, West Haven, CT 06516 USA; [Domingo-Roura, X.] IRTA, Genet Conservacio, Barcelona 08348, Spain; [Napierala, H.] Univ Munich, Inst Palaeoanat & Hist Vet Med, D-80539 Munich, Germany; [Napierala, H.] ArchaeoBioCtr LMU, D-80539 Munich, Germany; [Loponte, D. M.; Acosta, A. A.] Consejo Nacl Invest Cient & Tecn, Inst Nacl Antropol & Pensamiento Latinoamer, RA-1033 Buenos Aires, DF, Argentina; [Giemsch, L.; Schmitz, R. W.] Landschaftsverband Rheinland LVR Landesmuseum Bon, D-53115 Bonn, Germany; [Giemsch, L.] Univ Bonn, Inst Archaeol & Cultural Anthropol, Dept Prehist & Protohist, D-53113 Bonn, Germany; [Worthington, B.] Southeastern Archaeological Res ,Inc, Newberry, FL 32669 USA; [Buikstra, J. E.] Arizona State Univ, Sch Human Evolut & Social Change, Ctr Bioarchaeol Res, Tempe, AZ 85287 USA; [Druzhkova, A.; Graphodatsky, A. S.] Russian Acad Sci, Dept Genom Div & Evolut, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia; [Ovodov, N. D.] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, Novosibirsk, Russia; [Koepfli, K. -P.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg 199034, Russia; [Leonard, J. A.] Conservat & Evolutionary Genet Grp EBD CSIC, Estn Biol Donana, Seville 41093, Spain; [Green, R. E.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of Turku; University of California System; University of California Santa Cruz; Max Planck Society; Eberhard Karls University of Tubingen; University of California System; University of California Los Angeles; Royal Belgian Institute of Natural Sciences; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Yale University; IRTA; University of Munich; University of Munich; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Bonn; Arizona State University; Arizona State University-Tempe; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Saint Petersburg State University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of California System; University of California Santa Cruz	Thalmann, O (corresponding author), Univ Turku, Dept Biol, Sect Genet & Physiol, Itainen Pitkakatu 4, SF-20500 Turku, Finland.	olatha@utu.fi; rwayne@eeb.ucla.edu	López-Giráldez, Francesc/A-5251-2011; Koepfli, Klaus-Peter/AAT-9320-2020; Germonpré, Mietje/O-5952-2014; Krause, Johannes/AFP-2642-2022; Krause, Johannes/E-6640-2015; OBRIEN, STEPHEN/ABD-1346-2020; Graphodatsky, Alexander/B-4922-2010; Mikhail, Sablin/K-7835-2013; Druzhkova, Anna/N-2011-2015; Wahlberg, Niklas/B-7765-2008; Leonard, Jennifer/A-7894-2010	López-Giráldez, Francesc/0000-0001-7476-9822; Germonpré, Mietje/0000-0001-8865-0937; Krause, Johannes/0000-0001-9144-3920; Krause, Johannes/0000-0001-5475-4690; Graphodatsky, Alexander/0000-0002-8282-1085; Mikhail, Sablin/0000-0002-2773-7454; Wahlberg, Niklas/0000-0002-1259-3363; Leonard, Jennifer/0000-0003-0291-7819; Green, Richard/0000-0003-0516-5827; Sawyer, Susanna/0000-0002-8477-6089; Freedman, Adam/0000-0003-4714-3925; Thalmann, Olaf/0000-0003-1700-0130; Shapiro, Beth/0000-0002-2733-7776; Schweizer, Rena/0000-0002-8812-8177	E. Aaltonen foundation; Turun Yliopistosaatio; Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Russian Foundation for Basic Research; NSF [OPP 9617068, EF-1021387]; Carl Zeiss Foundation; Max Planck Society; Marie Curie Intra European Fellowship within the 7th European Community Framework Program; Division Of Environmental Biology [1021397] Funding Source: National Science Foundation	E. Aaltonen foundation; Turun Yliopistosaatio; Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NSF(National Science Foundation (NSF)); Carl Zeiss Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); Marie Curie Intra European Fellowship within the 7th European Community Framework Program(European Commission); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Mitochondrial sequences have been deposited at the NCBI database with the accession numbers (KF661036 to KF661096), and a complete alignment is available as a supplementary file. We would like to thank all colleagues who provided samples for this study, the Illinois State Museum and the Center for American Archeology for allowing us to sample the material from the Koster site, and the American Museum of Natural History, New York. O.T. is grateful to D. Wegmann and D. Schwochow-Thalmann for helpful discussions and comments on the manuscript; M. Bruneaux for help with R; and A. v. Haeseler for helpful advice with TREE-PUZZLE and IQ-TREE. We thank D. Ward, M. Riesenberg, J. Beier, I. Bergmann, H. Mutlu, and S. Bealek for assistance with ancient DNA extractions. R. E. G. is president of Dovetail Genomics. Financial support for this study was provided from the E. Aaltonen foundation and the Turun Yliopistosaatio to O.T.; Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences, and Russian Foundation for Basic Research grants to A. S. G.; and NSF support to R. K. W. and B. S. (OPP 9617068, EF-1021387). J. K. and V. J. S. were supported by the Carl Zeiss Foundation. This work was further supported by the Max Planck Society. O.T. is financed by a Marie Curie Intra European Fellowship within the 7th European Community Framework Program. The authors declare no conflict of interest.	Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Baales M., 1996, MONGRAPHIEN RGZM MAI, V38, P106; Crockford SJ, 2012, J ARCHAEOL SCI, V39, P2797, DOI 10.1016/j.jas.2012.04.033; Ding ZL, 2012, HEREDITY, V108, P507, DOI 10.1038/hdy.2011.114; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Malmstrom H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-71; Napierala H, 2012, INT J OSTEOARCHAEOL, V22, P127, DOI 10.1002/oa.1182; NOBIS G, 1979, UMSCHAU, V79, P610; OLSEN SJ, 1977, SCIENCE, V197, P533, DOI 10.1126/science.197.4303.533; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; van Asch B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1142; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814	24	326	340	1	317	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					871	874		10.1126/science.1243650	http://dx.doi.org/10.1126/science.1243650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	24233726				2022-12-24	WOS:000326923000042
J	Kim, HS; Mendiratta, S; Kim, J; Pecot, CV; Larsen, JE; Zubovych, I; Seo, BY; Kim, J; Eskiocak, B; Chung, H; McMillan, E; Wu, S; De Brabander, J; Komurov, K; Toombs, JE; Wei, SG; Peyton, M; Williams, N; Gazdar, AF; Posner, BA; Brekken, RA; Sood, AK; Deberardinis, RJ; Roth, MG; Minna, JD; White, MA				Kim, Hyun Seok; Mendiratta, Saurabh; Kim, Jiyeon; Pecot, Chad Victor; Larsen, Jill E.; Zubovych, Iryna; Seo, Bo Yeun; Kim, Jimi; Eskiocak, Banu; Chung, Hannah; McMillan, Elizabeth; Wu, Sherry; De Brabander, Jef; Komurov, Kakajan; Toombs, Jason E.; Wei, Shuguang; Peyton, Michael; Williams, Noelle; Gazdar, Adi F.; Posner, Bruce A.; Brekken, Rolf A.; Sood, Anil K.; Deberardinis, Ralph J.; Roth, Michael G.; Minna, John D.; White, Michael A.			Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer	CELL			English	Article							PROTEIN; APOPTOSIS; GENE; INFLAMMASOMES; RIPOPTOSOME; INHIBITORS; ASSEMBLES; COATOMER; SURVIVAL; PLATFORM	Context-specific molecular vulnerabilities that arise during tumor evolution represent an attractive intervention target class. However, the frequency and diversity of somatic lesions detected among lung tumors can confound efforts to identify these targets. To confront this challenge, we have applied parallel screening of chemical and genetic perturbations within a panel of molecularly annotated NSCLC lines to identify intervention opportunities tightly linked to molecular response indicators predictive of target sensitivity. Anchoring this analysis on a matched tumor/normal cell model from a lung adenocarcinoma patient identified three distinct target/response-indicator pairings that are represented with significant frequencies (6%-16%) in the patient population. These include NLRP3 mutation/inflammasome activation-dependent FLIP addiction, co-occurring KRAS and LKB1 mutation-driven COPI addiction, and selective sensitivity to a synthetic indolotriazine that is specified by a seven-gene expression signature. Target efficacies were validated in vivo, and mechanism-of-action studies informed generalizable principles underpinning cancer cell biology.	[Kim, Hyun Seok; Mendiratta, Saurabh; Seo, Bo Yeun; Kim, Jimi; Eskiocak, Banu; Chung, Hannah; McMillan, Elizabeth; White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Kim, Jiyeon; Deberardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Larsen, Jill E.; Toombs, Jason E.; Peyton, Michael; Gazdar, Adi F.; Brekken, Rolf A.; Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Zubovych, Iryna; De Brabander, Jef; Wei, Shuguang; Williams, Noelle; Posner, Bruce A.; Roth, Michael G.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Pecot, Chad Victor; Wu, Sherry] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Komurov, Kakajan] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Cincinnati Children's Hospital Medical Center	White, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Sood, Anoop Kumar/A-7344-2013; Kim, Jimi/AAL-8563-2021; Larsen, Jill E/G-3787-2010	Sood, Anoop Kumar/0000-0001-5702-4108; Larsen, Jill E/0000-0001-7806-3931; Kim, Jimi/0000-0002-6764-9934; Roth, Michael/0000-0002-9056-332X	NIH [CA71443, CA129451, CA176284, CA148225, CA70907]; Robert Welch Foundation [I-1414]; Logenbaugh Foundation; CPRIT [RP101496, RP110708];  [P30CA142543]; NATIONAL CANCER INSTITUTE [T32CA009666, RC2CA148225, R01CA157996, U54CA151668, U01CA176284, P30CA142543, R01CA071443, P50CA070907, P30CA016672, R01CA129451] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027805] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); Logenbaugh Foundation; CPRIT; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank John Heymach and Lauren Byers (MD Anderson) for sharing HCC4017-SNP array data; Robert Collins for sharing Exome-seq data from normal tissue samples; and Peter Hammerman for sharing TCGA gene expression data. This study was supported by grants from the NIH (CA71443, CA129451, CA176284, CA148225, and CA70907), the Robert Welch Foundation (I-1414), the Logenbaugh Foundation, and CPRIT (RP101496, RP110708). Shared facilities were supported in part by P30CA142543. M.A.W., M.G.R., B.A.P., and J.D.M. are members of the NCI Cancer Target and Discovery (CTD<SUP>2</SUP>) Network.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Gazdar AF, 2010, JNCI-J NATL CANCER I, V102, P1310, DOI 10.1093/jnci/djq279; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Guedat P, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S14; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jacob LS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001225; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; Lebreton S, 2008, BIOORG MED CHEM LETT, V18, P5879, DOI 10.1016/j.bmcl.2008.07.003; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Masumoto J, 2006, BIOCHEM BIOPH RES CO, V346, P968, DOI 10.1016/j.bbrc.2006.06.002; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Petersen SL, 2010, P NATL ACAD SCI USA, V107, P11936, DOI 10.1073/pnas.1005667107; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Safa Ahmad R, 2011, Cancers (Basel), V3, P1639, DOI 10.3390/cancers3021639; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; WATHELET MG, 1988, FEBS LETT, V231, P164, DOI 10.1016/0014-5793(88)80724-5; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Young RM, 2013, GENE DEV, V27, P1115, DOI 10.1101/gad.198630.112; Zhao LQ, 2011, MOL CANCER THER, V10, P2415, DOI 10.1158/1535-7163.MCT-11-0401	48	126	130	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					552	566		10.1016/j.cell.2013.09.041	http://dx.doi.org/10.1016/j.cell.2013.09.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243015	Green Accepted, Bronze			2022-12-24	WOS:000326571800011
J	Hassler, DM; Zeitlin, C; Wimmer-Schweingruber, RF; Ehresmann, B; Rafkin, S; Eigenbrode, JL; Brinza, DE; Weigle, G; Bottcher, S; Bohm, E; Burmeister, S; Guo, JN; Kohler, J; Martin, C; Reitz, G; Cucinotta, FA; Kim, MH; Grinspoon, D; Bullock, MA; Posner, A; Gomez-Elvira, J; Vasavada, A; Grotzinger, JP				Hassler, Donald M.; Zeitlin, Cary; Wimmer-Schweingruber, Robert F.; Ehresmann, Bent; Rafkin, Scot; Eigenbrode, Jennifer L.; Brinza, David E.; Weigle, Gerald; Boettcher, Stephan; Boehm, Eckart; Burmeister, Soenke; Guo, Jingnan; Koehler, Jan; Martin, Cesar; Reitz, Guenther; Cucinotta, Francis A.; Kim, Myung-Hee; Grinspoon, David; Bullock, Mark A.; Posner, Arik; Gomez-Elvira, Javier; Vasavada, Ashwin; Grotzinger, John P.		MSL Sci Team	Mars' Surface Radiation Environment Measured with the Mars Science Laboratory's Curiosity Rover	SCIENCE			English	Article							IONIZING-RADIATION; MARTIAN SOIL; ORIGIN; RISKS; SPACE; BIOSIGNATURES; DESTRUCTION; PERCHLORATE; MODEL; CO2	The Radiation Assessment Detector (RAD) on the Mars Science Laboratory's Curiosity rover began making detailed measurements of the cosmic ray and energetic particle radiation environment on the surface of Mars on 7 August 2012. We report and discuss measurements of the absorbed dose and dose equivalent from galactic cosmic rays and solar energetic particles on the martian surface for similar to 300 days of observations during the current solar maximum. These measurements provide insight into the radiation hazards associated with a human mission to the surface of Mars and provide an anchor point with which to model the subsurface radiation environment, with implications for microbial survival times of any possible extant or past life, as well as for the preservation of potential organic biosignatures of the ancient martian environment.	[Hassler, Donald M.; Zeitlin, Cary; Ehresmann, Bent; Rafkin, Scot; Bullock, Mark A.] SW Res Inst, Boulder, CO 80302 USA; [Wimmer-Schweingruber, Robert F.; Boettcher, Stephan; Boehm, Eckart; Burmeister, Soenke; Guo, Jingnan; Koehler, Jan; Martin, Cesar] Univ Kiel, D-24118 Kiel, Germany; [Eigenbrode, Jennifer L.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Brinza, David E.; Vasavada, Ashwin; Grotzinger, John P.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Weigle, Gerald] SW Res Inst, San Antonio, TX 78238 USA; [Reitz, Guenther] German Aerosp Ctr DLR, D-51147 Cologne, Germany; [Cucinotta, Francis A.] Univ Nevada, Las Vegas, NV 89154 USA; [Kim, Myung-Hee] Univ Space Res Assoc, Houston, TX 77058 USA; [Grinspoon, David] Denver Museum Nat & Sci, Denver, CO 80205 USA; [Posner, Arik] NASA Headquarters, Washington, DC 20546 USA; [Gomez-Elvira, Javier] Ctr Astrobiol INTA CSIC, Madrid 28850, Spain	University of Kiel; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Southwest Research Institute; Helmholtz Association; German Aerospace Centre (DLR); Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Hassler, DM (corresponding author), SW Res Inst, Boulder, CO 80302 USA.	hassler@boulder.swri.edu	Teinturier, Samuel/AAS-8663-2020; De Pablo, Miguel Ángel/J-6442-2014; Gómez, Felipe/L-7315-2014; Stipp, Susan L.S./B-8494-2019; Cucinotta, Francis/AAZ-5941-2020; Navarro-González, Rafael/D-1748-2009; Glavin, Daniel P/D-6194-2012; Blanco, Juan Jose/E-3627-2014; Gomez-Elvira, Javier/K-5829-2014; Martin-Torres, Javier/G-6329-2015; Benna, Mehdi/F-3489-2012; Rodriguez-Manfredi, Jose/AAG-9826-2021; Nikiforov, Sergei/ABI-1265-2020; Ramos, Miguel/K-2230-2014; IMPMC, ROCKS @/U-8478-2017; GEFFROY, Claude/AAB-9152-2019; Lemmon, Mark T/E-9983-2010; Prats, Benito/F-9467-2019; Franz, Heather B/F-3508-2012; Muñoz, Guillermo M/L-6370-2014; Hayes, Alexander G/P-2024-2014; Guo, Jingnan/ABB-3749-2021; Avalos, Juan Jose Blanco/AAB-9447-2021; Reitz, Guenther/ABC-8921-2021; szopa, cyril/C-6865-2015; Wimmer-Schweingruber, Robert/AAQ-5794-2021; FABRE, Cécile/B-5827-2012; Rodriguez-Manfredi, Jose/L-8001-2014; Dworkin, Jason P./C-9417-2012; Muller, Jan-Peter/Q-8886-2019; Harri, Ari-Matti/C-7142-2012; Balic-Zunic, Tonci/A-6362-2013; Zorzano, María-Paz/F-2184-2015; Eigenbrode, Jennifer L/D-4651-2012; Steele, Andrew/A-3573-2013; Malakhov, Alexey/F-7953-2017; Gasnault, Olivier/F-4327-2010	Teinturier, Samuel/0000-0003-1755-9524; De Pablo, Miguel Ángel/0000-0002-4496-2741; Gómez, Felipe/0000-0001-9977-7060; Stipp, Susan L.S./0000-0001-7009-643X; Navarro-González, Rafael/0000-0002-6078-7621; Glavin, Daniel P/0000-0001-7779-7765; Blanco, Juan Jose/0000-0002-8666-0696; Gomez-Elvira, Javier/0000-0002-9068-9846; Martin-Torres, Javier/0000-0001-6479-2236; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Nikiforov, Sergei/0000-0002-7221-8602; Ramos, Miguel/0000-0003-3648-6818; GEFFROY, Claude/0000-0002-2731-9658; Lemmon, Mark T/0000-0002-4504-5136; Prats, Benito/0000-0003-3869-3351; Muñoz, Guillermo M/0000-0001-7003-7368; Hayes, Alexander G/0000-0001-6397-2630; Guo, Jingnan/0000-0002-8707-076X; Avalos, Juan Jose Blanco/0000-0002-8666-0696; szopa, cyril/0000-0002-0090-4056; Wimmer-Schweingruber, Robert/0000-0002-7388-173X; FABRE, Cécile/0000-0001-8627-4050; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Dworkin, Jason P./0000-0002-3961-8997; Muller, Jan-Peter/0000-0002-5077-3736; Harri, Ari-Matti/0000-0001-8541-2802; Balic-Zunic, Tonci/0000-0003-1687-1233; Zorzano, María-Paz/0000-0002-4492-9650; Eigenbrode, Jennifer L/0000-0003-3089-1986; Steele, Andrew/0000-0001-9643-2841; Matthia, Daniel/0000-0003-1507-0143; Malakhov, Alexey/0000-0003-4292-7077; Gasnault, Olivier/0000-0002-6979-9012	NASA under Jet Propulsion Laboratory (JPL) [1273039]; Deutsches Zentrum fur Luft-und Raumfahrt (DLR); DLR's Space Administration [50QM0501, 50 QM1201]; NASA; UK Space Agency [ST/I003118/1] Funding Source: researchfish	NASA under Jet Propulsion Laboratory (JPL); Deutsches Zentrum fur Luft-und Raumfahrt (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); DLR's Space Administration; NASA(National Aeronautics & Space Administration (NASA)); UK Space Agency	This paper is dedicated to Dr. Michael J. Wargo at NASA HQ, who passed away unexpectedly on 4 August 2013. Mike was Chief Exploration Scientist in the Human Exploration and Operations Mission Directorate (HEOMD) and an enthusiastic supporter of collaborative projects between Science and Exploration. He was a strong supporter of RAD and a valuable member of both the science and exploration communities. He was a good friend and a wonderful human being, and he will be greatly missed. RAD is supported by NASA under Jet Propulsion Laboratory (JPL) subcontract 1273039 to Southwest Research Institute and in Germany by Deutsches Zentrum fur Luft-und Raumfahrt (DLR) and DLR's Space Administration grant numbers 50QM0501 and 50 QM1201 to the Christian Albrechts University, Kiel. Part of this research was carried out at JPL, California Institute of Technology, under a contract with NASA. We extend sincere gratitude to J. Simmonds and J. Crisp at JPL; G. Allen, M. Meyer, C. Moore, V. Friedensen, and R. Williams at NASA HQ; and H. Witte at DLR in Germany for their unwavering support of RAD over the years. The authors also thank the reviewers for their careful and thoughtful comments and suggestions. The data used in this paper are archived in the NASA Planetary Data System's Planetary Plasma Interactions (PPI) node at the University of California, Los Angeles. The archival volume includes the full binary raw data files, detailed descriptions of the structures therein, and higher-level data products in human-readable form. The PPI node is hosted at http://ppi.pds.nasa.gov.	Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; [Anonymous], 1991, Ann ICRP, V21, P1; Baumstark-Khan, 2001, ASTROBIOLOGY QUEST C, P260; Benner SA, 2000, P NATL ACAD SCI USA, V97, P2425, DOI 10.1073/pnas.040539497; Cane HV, 2010, AIP CONF PROC, V1216, P687, DOI 10.1063/1.3395960; Cane HV, 2000, SPACE SCI REV, V93, P55, DOI 10.1023/A:1026532125747; Catling DC, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003425; CLARK BC, 1993, GEOCHIM COSMOCHIM AC, V57, P4575, DOI 10.1016/0016-7037(93)90183-W; Court RW, 2007, GEOCHIM COSMOCHIM AC, V71, P2547, DOI 10.1016/j.gca.2007.03.001; Cucinotta F, 2013, 2013217375 NASA; Cucinotta FA, 2002, J RADIAT RES, V43, pS35; Cucinotta FA, 2001, RADIAT RES, V156, P682, DOI 10.1667/0033-7587(2001)156[0682:SRCRAU]2.0.CO;2; Cucinotta FA, 2007, RADIAT ENVIRON BIOPH, V46, P101, DOI 10.1007/s00411-007-0099-y; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Cucinotta FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074988; Cucinotta FA, 2011, RADIAT RES, V176, P102, DOI 10.1667/RR2540.1; Dartnell LR, 2007, BIOGEOSCIENCES, V4, P545, DOI 10.5194/bg-4-545-2007; Dartnell LR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027494; Dartnell LR, 2012, ANAL BIOANAL CHEM, V403, P131, DOI 10.1007/s00216-012-5829-6; Dartnell LR, 2011, ASTROBIOLOGY, V11, P997, DOI 10.1089/ast.2011.0663; Dartnell LR, 2011, ASTROBIOLOGY, V11, P551, DOI 10.1089/ast.2010.0528; De Angelis G, 2004, ADV SPACE RES, V34, P1328, DOI 10.1016/j.asr.2003.09.059; Drake B. G., 2010, AER C 2010 IEEE, P1, DOI [DOI 10.1109/AERO.2010.5446736, 10.1109/AERO.2010.5446736]; Ehresmann B, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016616; Ehresmann B., 2012, THESIS CHRISTIAN ALB; Gerakines PA, 2013, ASTROBIOLOGY, V13, P647, DOI 10.1089/ast.2012.0943; Glavin DP, 2013, J GEOPHYS RES-PLANET, V118, P1955, DOI 10.1002/jgre.20144; GLEESON LJ, 1968, ASTROPHYS J, V154, P1011, DOI 10.1086/149822; Gomez-Elvira J, 2012, SPACE SCI REV, V170, P583, DOI 10.1007/s11214-012-9921-1; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; Hassler DM, 2012, SPACE SCI REV, V170, P503, DOI 10.1007/s11214-012-9913-1; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Hess VF, 1912, PHYS Z, V13, P1084; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; KAHN R, 1985, ICARUS, V62, P175, DOI 10.1016/0019-1035(85)90116-2; Kamide Y, 2013, SPACE WEATHER, V11, P140, DOI 10.1002/swe.20045; Kim M.-H. Y., 2012, AGU M SAN FRANC; Kim MHY, 2009, ADV SPACE RES, V44, P1428, DOI 10.1016/j.asr.2009.07.028; Kim YS, 2013, J AM CHEM SOC, V135, P4910, DOI 10.1021/ja3122922; Kminek G, 2006, EARTH PLANET SC LETT, V245, P1, DOI 10.1016/j.epsl.2006.03.008; Lammer H., 2002, ASTROBIOLOGY QUEST C; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; Leshin LA, 2013, SCIENCE, V341, DOI 10.1126/science.1238937; McKenna-Lawlor S, 2012, PLANET SPACE SCI, V63-64, P123, DOI 10.1016/j.pss.2011.06.017; Mileikowsky C, 2000, ICARUS, V145, P391, DOI 10.1006/icar.1999.6317; Nealy J. E., 1993, 3300 NASA; O'Neill PM, 2010, IEEE T NUCL SCI, V57, P3148, DOI 10.1109/TNS.2010.2083688; Onsager TG, 1996, P SOC PHOTO-OPT INS, V2812, P281, DOI 10.1117/12.254075; Pace NR, 2001, P NATL ACAD SCI USA, V98, P805, DOI 10.1073/pnas.98.3.805; Pavlov AA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052166; Pavlov AK, 2002, PLANET SPACE SCI, V50, P669, DOI 10.1016/S0032-0633(01)00113-1; Pizzarello S., 2006, METEORITES EARLY SOL, P625; Quinn RC, 2013, ASTROBIOLOGY, V13, P515, DOI 10.1089/ast.2013.0999; Saganti PB, 2004, SPACE SCI REV, V110, P143, DOI 10.1023/B:SPAC.0000021010.20082.1a; Schneider S. I., 2009, ASP C SERIES, V420; Schofield JT, 1997, SCIENCE, V278, P1752, DOI 10.1126/science.278.5344.1752; Simonsen L, 1990, 2979 NASA; Simonsen L.C., 1991, 3079 NASA; SIMPSON JA, 1983, ANNU REV NUCL PART S, V33, P323, DOI 10.1146/annurev.ns.33.120183.001543; Slaba TC, 2010, RADIAT MEAS, V45, P173, DOI 10.1016/j.radmeas.2010.01.005; Steele A, 2012, SCIENCE, V337, P212, DOI 10.1126/science.1220715; Summons RE, 2011, ASTROBIOLOGY, V11, P157, DOI 10.1089/ast.2010.0506; Task Group on the Biological Effects of Space Radiation National Research Council, 1996, RAD HAZ CREWS INT MI; von Rosenvinge TT, 2008, SPACE SCI REV, V136, P391, DOI 10.1007/s11214-007-9300-5; Webster CR, 2013, SCIENCE, V341, P260, DOI 10.1126/science.1237961; Wilson J. W., 1995, 3495 NASA STI PROGR; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989	68	388	395	8	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1244797	10.1126/science.1244797	http://dx.doi.org/10.1126/science.1244797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24324275	Green Accepted, Green Published			2022-12-24	WOS:000330039300005
J	Ming, DW; Archer, PD; Glavin, DP; Eigenbrode, JL; Franz, HB; Sutter, B; Brunner, AE; Stern, JC; Freissinet, C; McAdam, AC; Mahaffy, PR; Cabane, M; Coll, P; Campbell, JL; Atreya, SK; Niles, PB; Bell, JF; Bish, DL; Brinckerhoff, WB; Buch, A; Conrad, PG; Des Marais, DJ; Ehlmann, BL; Fairen, AG; Farley, K; Flesch, GJ; Francois, P; Gellert, R; Grant, JA; Grotzinger, JP; Gupta, S; Herkenhoff, KE; Hurowitz, JA; Leshin, LA; Lewis, KW; McLennan, SM; Miller, KE; Moersch, J; Morris, RV; Navarro-Gonzalez, R; Pavlov, AA; Perrett, GM; Pradler, I; Squyres, SW; Summons, RE; Steele, A; Stolper, EM; Sumner, DY; Szopa, C; Teinturier, S; Trainer, MG; Treiman, AH; Vaniman, DT; Vasavada, AR; Webster, CR; Wray, JJ; Yingst, RA				Ming, D. W.; Archer, P. D., Jr.; Glavin, D. P.; Eigenbrode, J. L.; Franz, H. B.; Sutter, B.; Brunner, A. E.; Stern, J. C.; Freissinet, C.; McAdam, A. C.; Mahaffy, P. R.; Cabane, M.; Coll, P.; Campbell, J. L.; Atreya, S. K.; Niles, P. B.; Bell, J. F., III; Bish, D. L.; Brinckerhoff, W. B.; Buch, A.; Conrad, P. G.; Des Marais, D. J.; Ehlmann, B. L.; Fairen, A. G.; Farley, K.; Flesch, G. J.; Francois, P.; Gellert, R.; Grant, J. A.; Grotzinger, J. P.; Gupta, S.; Herkenhoff, K. E.; Hurowitz, J. A.; Leshin, L. A.; Lewis, K. W.; McLennan, S. M.; Miller, K. E.; Moersch, J.; Morris, R. V.; Navarro-Gonzalez, R.; Pavlov, A. A.; Perrett, G. M.; Pradler, I.; Squyres, S. W.; Summons, R. E.; Steele, A.; Stolper, E. M.; Sumner, D. Y.; Szopa, C.; Teinturier, S.; Trainer, M. G.; Treiman, A. H.; Vaniman, D. T.; Vasavada, A. R.; Webster, C. R.; Wray, J. J.; Yingst, R. A.		MSL Sci Team	Volatile and Organic Compositions of Sedimentary Rocks in Yellowknife Bay, Gale Crater, Mars	SCIENCE			English	Article							MARTIAN SOIL; PERCHLORATE; HYDROGEN; DIOXIDE; SURFACE; ANALOG	H2O, CO2, SO2, O-2, H-2, H2S, HCl, chlorinated hydrocarbons, NO, and other trace gases were evolved during pyrolysis of two mudstone samples acquired by the Curiosity rover at Yellowknife Bay within Gale crater, Mars. H2O/OH-bearing phases included 2:1 phyllosilicate(s), bassanite, akaganeite, and amorphous materials. Thermal decomposition of carbonates and combustion of organic materials are candidate sources for the CO2. Concurrent evolution of O-2 and chlorinated hydrocarbons suggests the presence of oxychlorine phase(s). Sulfides are likely sources for sulfur-bearing species. Higher abundances of chlorinated hydrocarbons in the mudstone compared with Rocknest windblown materials previously analyzed by Curiosity suggest that indigenous martian or meteoritic organic carbon sources may be preserved in the mudstone; however, the carbon source for the chlorinated hydrocarbons is not definitively of martian origin.	[Ming, D. W.; Niles, P. B.; Morris, R. V.] NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA; [Archer, P. D., Jr.; Sutter, B.] Jacobs, Houston, TX 77058 USA; [Glavin, D. P.; Eigenbrode, J. L.; Franz, H. B.; Brunner, A. E.; Stern, J. C.; Freissinet, C.; McAdam, A. C.; Mahaffy, P. R.; Brinckerhoff, W. B.; Conrad, P. G.; Pavlov, A. A.; Trainer, M. G.] NASA, Goddard Space Flight Ctr, Planetary Environments Lab, Greenbelt, MD 20771 USA; [Franz, H. B.] Univ Maryland Baltimore Cty, Ctr Res & Explorat Space Sci & Technol, Baltimore, MD 21250 USA; [Brunner, A. E.] Univ Maryland, Dept Astron, Ctr Res & Explorat Space Sci & Technol, College Pk, MD 20742 USA; [Freissinet, C.] NASA, Goddard Space Flight Ctr, NASA Postdoctoral Program, Greenbelt, MD 20771 USA; [Cabane, M.] Univ Versailles St Quentin, Univ Paris 06, Lab Atmospheres, UMR CNRS 8970, F-75005 Paris, France; [Coll, P.; Francois, P.; Szopa, C.; Teinturier, S.] Univ Paris Diderot, Univ Paris Est Creteil, Lab Interuniv Syst Atmospher, F-94000 Creteil, France; [Coll, P.; Francois, P.; Szopa, C.; Teinturier, S.] CNRS, F-94000 Creteil, France; [Campbell, J. L.; Gellert, R.; Perrett, G. M.; Pradler, I.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Atreya, S. K.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Bell, J. F., III] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Bish, D. L.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Buch, A.] Ecole Cent Paris, Lab Genie Procedes & Mat, F-92295 Chatenay Malabry, France; [Des Marais, D. J.] NASA, Ames Res Ctr, Dept Space Sci, Moffett Field, CA 94035 USA; [Ehlmann, B. L.; Farley, K.; Grotzinger, J. P.; Stolper, E. M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Ehlmann, B. L.; Flesch, G. J.; Vasavada, A. R.; Webster, C. R.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Fairen, A. G.; Squyres, S. W.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Grant, J. A.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Gupta, S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Herkenhoff, K. E.] US Geol Survey, Flagstaff, AZ 86001 USA; [Hurowitz, J. A.; McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Leshin, L. A.] Rensselaer Polytech Inst, Dept Earth & Environm Sci, Troy, NY 12180 USA; [Leshin, L. A.] Rensselaer Polytech Inst, Sch Sci, Troy, NY 12180 USA; [Lewis, K. W.] Princeton Univ, Princeton, NJ 08544 USA; [Miller, K. E.; Summons, R. E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Moersch, J.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Navarro-Gonzalez, R.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Steele, A.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Sumner, D. Y.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Treiman, A. H.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Vaniman, D. T.; Yingst, R. A.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Wray, J. J.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Guelph; University of Michigan System; University of Michigan; Arizona State University; Arizona State University-Tempe; Indiana University System; Indiana University Bloomington; UDICE-French Research Universities; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; Smithsonian Institution; Imperial College London; United States Department of the Interior; United States Geological Survey; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Princeton University; Massachusetts Institute of Technology (MIT); University of Tennessee System; University of Tennessee Knoxville; Universidad Nacional Autonoma de Mexico; Carnegie Institution for Science; University of California System; University of California Davis; University System of Georgia; Georgia Institute of Technology	Ming, DW (corresponding author), NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA.	douglas.w.ming@nasa.gov	Moersch, Jeffrey E/F-7189-2010; Benna, Mehdi/F-3489-2012; Bish, David/AAY-7618-2020; Lemmon, Mark T/E-9983-2010; Eigenbrode, Jennifer L/D-4651-2012; Ramos, Miguel/K-2230-2014; Brinckerhoff, William/F-3453-2012; Farley, Kenneth/AAE-7735-2020; Steele, Andrew/A-3573-2013; Summons, Roger Everett/AAL-3789-2020; Rodriguez-Manfredi, Jose/L-8001-2014; Muller, Jan-Peter/Q-8886-2019; Prats, Benito/F-9467-2019; Wray, James J/B-8457-2008; Dworkin, Jason P./C-9417-2012; Zorzano, María-Paz/F-2184-2015; De Pablo, Miguel Ángel/J-6442-2014; Harri, Ari-Matti/C-7142-2012; Hayes, Alexander G/P-2024-2014; Sumner, Dawn Y/E-8744-2011; Webster, Chris/M-9315-2019; Martin-Torres, Javier/G-6329-2015; Blanco, Juan Jose/E-3627-2014; Avalos, Juan Jose Blanco/AAB-9447-2021; Franz, Heather B/F-3508-2012; Teinturier, Samuel/AAS-8663-2020; szopa, cyril/C-6865-2015; Glavin, Daniel P/D-6194-2012; Gómez, Felipe/L-7315-2014; Gomez-Elvira, Javier/K-5829-2014; Stern, Jennifer/E-3135-2012; Navarro-González, Rafael/D-1748-2009; Rodriguez-Manfredi, Jose/AAG-9826-2021; Stipp, Susan L.S./B-8494-2019; Balic-Zunic, Tonci/A-6362-2013; FABRE, Cécile/B-5827-2012; GEFFROY, Claude/AAB-9152-2019; Trainer, Melissa G/E-1477-2012; Vicenzi, Edward/T-9430-2017; McAdam, Amy/E-1556-2012; Gasnault, Olivier/F-4327-2010; Malakhov, Alexey/F-7953-2017	Moersch, Jeffrey E/0000-0003-3433-9419; Lemmon, Mark T/0000-0002-4504-5136; Eigenbrode, Jennifer L/0000-0003-3089-1986; Ramos, Miguel/0000-0003-3648-6818; Brinckerhoff, William/0000-0001-5121-2634; Steele, Andrew/0000-0001-9643-2841; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Muller, Jan-Peter/0000-0002-5077-3736; Prats, Benito/0000-0003-3869-3351; Wray, James J/0000-0001-5559-2179; Dworkin, Jason P./0000-0002-3961-8997; Zorzano, María-Paz/0000-0002-4492-9650; De Pablo, Miguel Ángel/0000-0002-4496-2741; Harri, Ari-Matti/0000-0001-8541-2802; Hayes, Alexander G/0000-0001-6397-2630; Sumner, Dawn Y/0000-0002-7343-2061; Martin-Torres, Javier/0000-0001-6479-2236; Blanco, Juan Jose/0000-0002-8666-0696; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Teinturier, Samuel/0000-0003-1755-9524; szopa, cyril/0000-0002-0090-4056; Glavin, Daniel P/0000-0001-7779-7765; Gómez, Felipe/0000-0001-9977-7060; Gomez-Elvira, Javier/0000-0002-9068-9846; Stern, Jennifer/0000-0002-0162-8807; Navarro-González, Rafael/0000-0002-6078-7621; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Stipp, Susan L.S./0000-0001-7009-643X; Balic-Zunic, Tonci/0000-0003-1687-1233; FABRE, Cécile/0000-0001-8627-4050; GEFFROY, Claude/0000-0002-2731-9658; Gupta, Sanjeev/0000-0001-6415-1332; Vicenzi, Edward/0000-0003-2085-6546; Buch, Arnaud/0000-0002-2097-7252; Wilson, Sharon/0000-0001-8872-8546; McAdam, Amy/0000-0001-9120-2991; Gasnault, Olivier/0000-0002-6979-9012; McLennan, Scott/0000-0003-4259-7178; Johnson, Jeffrey/0000-0002-5586-4901; Malakhov, Alexey/0000-0003-4292-7077; Grant, John/0000-0001-8276-1281; Farley, Kenneth/0000-0002-7846-7546; Campbell, John/0000-0002-6752-3493	National Aeronautics and Space Administration (NASA); French Space Agency (CNES); Canadian Space Agency; UK Space Agency; NASA ROSES MSL Participating Scientist Program; UK Space Agency [ST/I003118/1, ST/J005169/1] Funding Source: researchfish	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); French Space Agency (CNES)(Centre National D'etudes Spatiales); Canadian Space Agency(Canadian Space Agency); UK Space Agency; NASA ROSES MSL Participating Scientist Program; UK Space Agency	We are indebted to the Mars Science Laboratory Project engineering and management teams for making this mission possible and enhancing science operations. Much of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration (NASA). NASA provided support for the development of SAM. Data from these SAM experiments are archived in the Planetary Data System (pds.nasa.gov). Essential contributions to the successful operation of SAM on Mars and the acquisition of this data were provided by the SAM development, operations, and testbed teams. Development and operation of the SAM and APXS instruments were also supported by funds from the French Space Agency (CNES) and the Canadian Space Agency. Work in the UK was funded by the UK Space Agency. B. L. E., J.L.E., K. F., D. P. G., J.E.G., K. E. M., S. M. M., J.M., P.B.N., and R. E. S. acknowledge funding support from the NASA ROSES MSL Participating Scientist Program.	Anderson MS, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4757861; Archer P.D., 2013, PLANETARY SCI, V2, P2, DOI [10.1186/2191-2521-2-2, DOI 10.1186/2191-2521-2-2]; ARUTYUNOV VS, 1991, KINET CATAL+, V32, P1112; Baba A. A., 2011, J APPL SCI TECHNOL, V16, P104; Benner SA, 2000, P NATL ACAD SCI USA, V97, P2425, DOI 10.1073/pnas.040539497; BIEMANN K, 1976, SCIENCE, V194, P72, DOI 10.1126/science.194.4260.72; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; Biemann K, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003869; BIGHAM JM, 2002, SOIL MINERALOGY ENV; BINNS D, 1991, J CHEM PHYS, V95, P4940, DOI 10.1063/1.461710; Blake DF, 2013, SCIENCE, V341, DOI 10.1126/science.1239505; Blake D, 2012, SPACE SCI REV, V170, P341, DOI 10.1007/s11214-012-9905-1; Campbell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002959; Cannon KM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051952; Flynn GJ, 1996, EARTH MOON PLANETS, V72, P469, DOI 10.1007/BF00117551; Gellert R., 2013, 44 LUN PLAN SCI C HO; Glavin DP, 2013, J GEOPHYS RES-PLANET, V118, P1955, DOI 10.1002/jgre.20144; Grotzinger JP, 2014, SCIENCE, V343, DOI 10.1126/science.1242777; Hanley J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051239; Hassler DM, 2014, SCIENCE, V343, DOI 10.1126/science.1244797; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; INGRAHAM TR, 1972, CAN METALL QUART, V11, P407, DOI 10.1179/000844372795257575; Janchen J, 2009, ICARUS, V200, P463, DOI 10.1016/j.icarus.2008.12.006; Kminek G, 2006, EARTH PLANET SC LETT, V245, P1, DOI 10.1016/j.epsl.2006.03.008; Leshin LA, 2013, SCIENCE, V341, DOI 10.1126/science.1238937; Mahaffy PR, 2012, SPACE SCI REV, V170, P401, DOI 10.1007/s11214-012-9879-z; MARVIN GG, 1945, IND ENG CHEM, V17, P474, DOI 10.1021/i560144a004; McLennan SM, 2014, SCIENCE, V343, DOI 10.1126/science.1244734; -Mikuli AM, 2008, J THERM ANAL CALORIM, V91, P529, DOI 10.1007/s10973-007-8511-z; Ming D. W., 2009, 40 LUN PLAN SCI C HO; Navarro-Gonzalez R, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003880; Navarro-Gonzalez R, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003599; Nealson KH, 1999, PHILOS T R SOC B, V354, P1923, DOI 10.1098/rstb.1999.0532; Potter PE, 2005, MUD MUDSTONES; Quinn RC, 1999, ORIGINS LIFE EVOL B, V29, P59, DOI 10.1023/A:1006506022182; RUDLOFF WK, 1970, J PHYS CHEM-US, V74, P3317, DOI 10.1021/j100712a002; Schwertmann U., 2007, IRON OXIDES LAB PREP; Steele A, 2012, SCIENCE, V337, P212, DOI 10.1126/science.1220715; Steele A, 2012, AM MINERAL, V97, P1256, DOI 10.2138/am.2012.4148; Steininger H, 2012, PLANET SPACE SCI, V71, P9, DOI 10.1016/j.pss.2012.06.015; Summons RE, 2011, ASTROBIOLOGY, V11, P157, DOI 10.1089/ast.2010.0506; Sutter B, 2012, ICARUS, V218, P290, DOI 10.1016/j.icarus.2011.12.002; The National Institute of Standards and Technology/Environmental Protection Agency/National Institutes of Health (NIST/EPA/NIH) Mass Spectral Database, 2011, MASS SPECTR DAT NIST; Vaniman DT, 2014, SCIENCE, V343, DOI 10.1126/science.1243480; Yen AS, 2005, NATURE, V436, P49, DOI 10.1038/nature03637; Yen AS, 2000, SCIENCE, V289, P1909, DOI 10.1126/science.289.5486.1909; Zent AP, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003001	47	268	270	11	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1245267	10.1126/science.1245267	http://dx.doi.org/10.1126/science.1245267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24324276	Green Submitted, Green Accepted			2022-12-24	WOS:000330039300006
J	Archer, SL				Archer, Stephen L.			Mitochondrial Dynamics - Mitochondrial Fission and Fusion in Human Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PULMONARY ARTERIAL-HYPERTENSION; PARKINSONS-DISEASE; MITOFUSIN 2; ENDOPLASMIC-RETICULUM; EMBRYONIC-DEVELOPMENT; ENZYMATIC-ACTIVITY; MAMMALIAN-CELLS; S-NITROSYLATION; GTPASE DRP1; PINK1	Mitochondria fuse and divide in response to cell demands and environment. Alterations in mitochondrial dynamics underlie various human diseases, including cancer and neurologic and cardiovascular diseases. Defining the alterations may identify potential therapeutic targets. Mitochondria are mobile organelles that exist in dynamic networks. They continuously join by the process of fusion and divide by the process of fission. Mitochondria are derived from eubacterial endosymbionts that are capable of aerobic respiration; this finding was proposed independently by Merezhkovsky in 1905 and by Margulis in 1967.(1) First described as bioblasts by Altmann in 1890, it was Benda's 1898 observation of their heterogeneous morphologic features, sometimes ball-shaped and other times linear, that inspired the name mitochondrion, from the Greek words mitos (meaning thread) and chondrion (meaning granule).(2) Lewis and Lewis's 1914 observations established the field of mitochondrial ...	Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Archer, SL (corresponding author), Queens Univ, Dept Med, Etherington Hall,Rm 3041,94 Stuart St, Kingston, ON K7L 3N6, Canada.	stephen.archer@queensu.ca			NHLBI NIH HHS [R01 HL071115] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071115] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Bossy B, 2010, J ALZHEIMERS DIS, V20, pS513, DOI 10.3233/JAD-2010-100552; Brooks AI, 1999, BRAIN RES, V823, P1, DOI 10.1016/S0006-8993(98)01192-5; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Cherra SJ, 2009, AUTOPHAGY, V5, P1213, DOI 10.4161/auto.5.8.10050; Chiang YY, 2009, MODERN PATHOL, V22, P1139, DOI 10.1038/modpathol.2009.83; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cribbs JT, 2009, METHOD ENZYMOL, V457, P231, DOI 10.1016/S0076-6879(09)05013-7; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Grunewald A, 2009, EXP NEUROL, V219, P266, DOI 10.1016/j.expneurol.2009.05.027; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hong ZG, 2013, CIRC RES, V112, P802, DOI 10.1161/CIRCRESAHA.111.300285; Hoppins S, 2012, SCIENCE, V337, P1052, DOI 10.1126/science.1224709; Horn SR, 2011, MOL BIOL CELL, V22, P1207, DOI 10.1091/mbc.E10-07-0567; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Inoue-Yamauchi A, 2012, BIOCHEM BIOPH RES CO, V421, P81, DOI 10.1016/j.bbrc.2012.03.118; Ishihara N, 2013, ANTIOXID REDOX SIGN, V19, P389, DOI 10.1089/ars.2012.4830; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jin HS, 2011, AM J HYPERTENS, V24, P1127, DOI 10.1038/ajh.2011.131; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein CJ, 2011, ARCH NEUROL-CHICAGO, V68, P1295, DOI 10.1001/archneurol.2011.225; Knoll AH, 2012, P NATL ACAD SCI USA, V109, P1022, DOI 10.1073/pnas.1120472109; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lewis MR, 1914, SCIENCE, V39, P330, DOI 10.1126/science.39.1000.330; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Nakamura T, 2010, APOPTOSIS, V15, P1354, DOI 10.1007/s10495-010-0476-x; O'Rourke B, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00007; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003; Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Papanicolaou KN, 2012, CIRC RES, V111, P1012, DOI 10.1161/CIRCRESAHA.112.274142; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; Rojo M, 2002, J CELL SCI, V115, P1663; Ryan JJ, 2013, AM J RESP CRIT CARE, V187, P865, DOI 10.1164/rccm.201209-1687OC; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Semenza GL, 2011, NEW ENGL J MED, V365, P968; Sharp WW, 2003, FASEB J; Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Varadi A, 2004, J CELL SCI, V117, P4389, DOI 10.1242/jcs.01299; Voelkel NF, 2012, EUR RESPIR J, V40, P1555, DOI 10.1183/09031936.00046612; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748; Yang CY, 2012, INT J BIOCHEM CELL B, V44, P1346, DOI 10.1016/j.biocel.2012.05.006; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang J, 2010, AUTOPHAGY, V6, P405, DOI 10.4161/auto.6.3.11245; Zhang ZY, 2011, MOL BIOL CELL, V22, P2235, DOI 10.1091/mbc.E10-12-0933; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004; Zorzano A, 2009, APPL PHYSIOL NUTR ME, V34, P433, DOI 10.1139/H09-049; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zuchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797; Zunino R, 2009, J BIOL CHEM, V284, P17783, DOI 10.1074/jbc.M901902200	102	630	661	9	190	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 5	2013	369	23					2236	2251		10.1056/NEJMra1215233	http://dx.doi.org/10.1056/NEJMra1215233			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	263II	24304053				2022-12-24	WOS:000327801100010
J	Betley, JN; Cao, ZFH; Ritola, KD; Sternson, SM				Betley, J. Nicholas; Cao, Zhen Fang Huang; Ritola, Kimberly D.; Sternson, Scott M.			Parallel, Redundant Circuit Organization for Homeostatic Control of Feeding Behavior	CELL			English	Article							IN-VIVO; NEURONAL POPULATIONS; HYPOTHALAMUS; HORMONE; NUCLEUS; POMC; CONNECTIONS; PATHWAY; SWITCH; MICE	Neural circuits for essential natural behaviors are shaped by selective pressure to coordinate reliable execution of flexible goal-directed actions. However, the structural and functional organization of survival-oriented circuits is poorly understood due to exceptionally complex neuroanatomy. This is exemplified by AGRP neurons, which are a molecularly defined population that is sufficient to rapidly coordinate voracious food seeking and consumption behaviors. Here, we use cell-type-specific techniques for neural circuit manipulation and projection-specific anatomical analysis to examine the organization of this critical homeostatic circuit that regulates feeding. We show that AGRP neuronal circuits use a segregated, parallel, and redundant output configuration. AGRP neuron axon projections that target different brain regions originate from distinct subpopulations, several of which are sufficient to independently evoke feeding. The concerted anatomical and functional analysis of AGRP neuron projection populations reveals a constellation of core forebrain nodes, which are part of an extended circuit that mediates feeding behavior.	[Betley, J. Nicholas; Cao, Zhen Fang Huang; Ritola, Kimberly D.; Sternson, Scott M.] HHMI, Janelia Farm Res Campus, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Sternson, SM (corresponding author), HHMI, Janelia Farm Res Campus, 19700 Helix Dr, Ashburn, VA 20147 USA.	sternsons@janelia.hhmi.org			Howard Hughes Medical Institute; HHMI Janelia Farm Graduate Scholar program	Howard Hughes Medical Institute(Howard Hughes Medical Institute); HHMI Janelia Farm Graduate Scholar program	This research was funded by the Howard Hughes Medical Institute. Z.F.H.C. was funded by the HHMI Janelia Farm Graduate Scholar program. We thank A. Wardlaw, K. Morris, and J. Rouchard for mouse breeding, genotyping, and viral injections; M. Copeland for histology; S. Supekar and E. Betley for executing automated bouton counting; S. Brenner-Morton and T. Jessell for Islet1(2) antibody; M. Myers for Lepr-IRES-Cre mice; E. Callaway for rabies viral reagents.	Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; CHRONWALL BM, 1985, PEPTIDES, V6, P1, DOI 10.1016/0196-9781(85)90128-7; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; DELGADO JMR, 1953, AM J PHYSIOL, V172, P162, DOI 10.1152/ajplegacy.1952.172.1.162; Diano S, 1998, J NEUROENDOCRINOL, V10, P731, DOI 10.1046/j.1365-2826.1998.00204.x; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Hahn JD, 2010, BRAIN RES REV, V64, P14, DOI 10.1016/j.brainresrev.2010.02.002; Hess WR, 1957, FUNCTIONAL ORG DIENC; Huang CC, 2013, ELIFE, V2, DOI 10.7554/eLife.00400; KELLY J, 1977, PHARMACOL BIOCHEM BE, V7, P537, DOI 10.1016/0091-3057(77)90250-7; KIRCHGESSNER AL, 1988, PHYSIOL BEHAV, V42, P517, DOI 10.1016/0031-9384(88)90153-9; KOW LM, 1977, BRAIN RES, V123, P75, DOI 10.1016/0006-8993(77)90644-8; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; KRUK MR, 1983, BRAIN RES, V260, P61, DOI 10.1016/0006-8993(83)90764-3; KUYPERS HGJM, 1977, NEUROSCI LETT, V6, P127, DOI 10.1016/0304-3940(77)90007-6; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Napadow V, 2013, CEREB CORTEX, V23, P806, DOI 10.1093/cercor/bhs073; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Risold PY, 1997, BRAIN RES REV, V24, P197, DOI 10.1016/S0165-0173(97)00007-6; ROELING TAP, 1994, NEUROSCIENCE, V59, P1001, DOI 10.1016/0306-4522(94)90302-6; Shin JW, 2008, J COMP NEUROL, V511, P628, DOI 10.1002/cne.21870; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stratford TR, 2013, BRAIN RES, V1490, P128, DOI 10.1016/j.brainres.2012.10.043; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Tinbergen N, 1989, STUDY INSTINCT; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wittmann G, 2009, J COMP NEUROL, V515, P313, DOI 10.1002/cne.22017; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2012, P NATL ACAD SCI USA, V109, P3155, DOI 10.1073/pnas.1120501109; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039	41	364	369	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1337	1350		10.1016/j.cell.2013.11.002	http://dx.doi.org/10.1016/j.cell.2013.11.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315102	Green Accepted, Bronze			2022-12-24	WOS:000328271100017
J	Doulatov, S; Daley, GQ				Doulatov, Sergei; Daley, George Q.			A Stem Cell Perspective on Cellular Engineering	SCIENCE			English	Editorial Material							HEMATOPOIETIC PROGENITORS; DIFFERENTIATION CULTURES; FIBROBLASTS		[Doulatov, Sergei] Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Broad Inst, Boston, MA 02115 USA; Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Doulatov, S (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Stem Cell Transplantat Program, Div Pediat Hematol Oncol,Manton Ctr Orphan Dis Re, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu						Choi KD, 2012, CELL REP, V2, P553, DOI 10.1016/j.celrep.2012.08.002; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888	12	22	22	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					700	702		10.1126/science.1238363	http://dx.doi.org/10.1126/science.1238363			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202165				2022-12-24	WOS:000326647600028
J	Le, TBK; Imakaev, MV; Mirny, LA; Laub, MT				Le, Tung B. K.; Imakaev, Maxim V.; Mirny, Leonid A.; Laub, Michael T.			High-Resolution Mapping of the Spatial Organization of a Bacterial Chromosome	SCIENCE			English	Article							ESCHERICHIA-COLI CHROMOSOME; DROSOPHILA GENOME; DNA; PROTEINS; ARCHITECTURE; PRINCIPLES; DYNAMICS; DOMAINS; COMPLEX	Chromosomes must be highly compacted and organized within cells, but how this is achieved in vivo remains poorly understood. We report the use of chromosome conformation capture coupled with deep sequencing (Hi-C) to map the structure of bacterial chromosomes. Analysis of Hi-C data and polymer modeling indicates that the Caulobacter crescentus chromosome consists of multiple, largely independent spatial domains that are probably composed of supercoiled plectonemes arrayed into a bottle brush-like fiber. These domains are stable throughout the cell cycle and are reestablished concomitantly with DNA replication. We provide evidence that domain boundaries are established by highly expressed genes and the formation of plectoneme-free regions, whereas the histone-like protein HU and SMC (structural maintenance of chromosomes) promote short-range compaction and the colinearity of chromosomal arms, respectively. Collectively, our results reveal general principles for the organization and structure of chromosomes in vivo.	[Le, Tung B. K.; Laub, Michael T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Imakaev, Maxim V.; Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Mirny, Leonid A.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Laub, Michael T.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Mirny, LA (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	leonid@mit.edu; laub@mit.edu	Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410; Imakaev, Maxim/0000-0002-5320-2728; Le, Tung BK/0000-0003-4764-8851; Laub, Michael/0000-0002-8288-7607	NIH [R01GM082899, U54CA143874]; NATIONAL CANCER INSTITUTE [U54CA143874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082899] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Hi-C data were deposited in the Gene Expression Omnibus (accession no. GSE45966). We thank M. Umbarger for help in optimizing Hi-C and G. Fudenberg, A. Goloborodko, M. Hu, and T. Maxwell for discussions. M. T. L. is an Early Career Scientist of the Howard Hughes Medical Institute. T. B. K. L is a Gordon and Betty Moore Foundation postdoctoral fellow of the Life Sciences Research Foundation. This work was supported by NIH grants to M. T. L. (R01GM082899) and L. A. M. (U54CA143874).	Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Booker BM, 2010, MOL MICROBIOL, V78, P1348, DOI 10.1111/j.1365-2958.2010.07394.x; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P4474, DOI 10.1073/pnas.73.12.4474; Graumann PL, 2009, CHROMOSOME RES, V17, P265, DOI 10.1007/s10577-008-9014-x; Guo FS, 2007, P NATL ACAD SCI USA, V104, P4309, DOI 10.1073/pnas.0611686104; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Niki H, 2000, GENE DEV, V14, P212; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Schwartz MA, 2011, MOL MICROBIOL, V82, P1359, DOI 10.1111/j.1365-2958.2011.07836.x; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Valens M, 2004, EMBO J, V23, P4330, DOI 10.1038/sj.emboj.7600434; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Volkov A, 2003, MOL CELL BIOL, V23, P5638, DOI 10.1128/MCB.23.16.5638-5650.2003	22	359	362	1	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					731	734		10.1126/science.1242059	http://dx.doi.org/10.1126/science.1242059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24158908	Green Accepted, Green Submitted			2022-12-24	WOS:000326647600041
J	McVicker, G; van de Geijn, B; Degner, JF; Cain, CE; Banovich, NE; Raj, A; Lewellen, N; Myrthil, M; Gilad, Y; Pritchard, JK				McVicker, Graham; van de Geijn, Bryce; Degner, Jacob F.; Cain, Carolyn E.; Banovich, Nicholas E.; Raj, Anil; Lewellen, Noah; Myrthil, Marsha; Gilad, Yoav; Pritchard, Jonathan K.			Identification of Genetic Variants That Affect Histone Modifications in Human Cells	SCIENCE			English	Article							HUMAN GENOME; METHYLTRANSFERASE ACTIVITY; EXPRESSION VARIATION; CHROMATIN-STRUCTURE; DYNAMICS; LINEAGE; STATE	Histone modifications are important markers of function and chromatin state, yet the DNA sequence elements that direct them to specific genomic locations are poorly understood. Here, we identify hundreds of quantitative trait loci, genome-wide, that affect histone modification or RNA polymerase II (Pol II) occupancy in Yoruba lymphoblastoid cell lines (LCLs). In many cases, the same variant is associated with quantitative changes in multiple histone marks and Pol II, as well as in deoxyribonuclease I sensitivity and nucleosome positioning. Transcription factor binding site polymorphisms are correlated overall with differences in local histone modification, and we identify specific transcription factors whose binding leads to histone modification in LCLs. Furthermore, variants that affect chromatin at distal regulatory sites frequently also direct changes in chromatin and gene expression at associated promoters.	[McVicker, Graham; van de Geijn, Bryce; Degner, Jacob F.; Cain, Carolyn E.; Banovich, Nicholas E.; Raj, Anil; Gilad, Yoav; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [McVicker, Graham; Lewellen, Noah; Myrthil, Marsha; Pritchard, Jonathan K.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [van de Geijn, Bryce; Degner, Jacob F.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Raj, Anil; Pritchard, Jonathan K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Pritchard, Jonathan K.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Chicago; Howard Hughes Medical Institute; Stanford University; University of Chicago; Stanford University; Stanford University	Gilad, Y (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	gilad@uchicago.edu; pritch@stanford.edu		McVicker, Graham/0000-0003-0991-0951; Raj, Anil/0000-0003-4412-0883; Banovich, Nicholas/0000-0003-2604-3247	NIH [HG007036, HG006123, GM007197, MH084703]; NSF [DGE-0638477]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006123, U01HG007036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084703] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Ruthenberg, B. Howie, and members of the Pritchard, Przeworski, Stephens, and Gilad laboratories for discussions and three anonymous reviewers for comments. This work was supported by grants from the NIH (HG007036, HG006123, GM007197 and MH084703), by an NSF predoctoral award (DGE-0638477 to B.v.d.G.), and by the Howard Hughes Medical Institute. ChIP-seq data have been deposited in the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession GSE47991. RNA-seq, DNase-seq, and MNase-seq data were previously deposited with accessions GSE19480, GSE31388, and GSE36979. J.K.P. is on the scientific advisory boards for 23andMe and DNANexus with stock options.	Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035	23	296	298	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					747	749		10.1126/science.1242429	http://dx.doi.org/10.1126/science.1242429			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24136359	Green Accepted			2022-12-24	WOS:000326647600046
J	McLellan, JS; Chen, M; Joyce, MG; Sastry, M; Stewart-Jones, GBE; Yang, YP; Zhang, BS; Chen, L; Srivatsan, S; Zheng, AQ; Zhou, TQ; Graepel, KW; Kumar, A; Moin, S; Boyington, JC; Chuang, GY; Soto, C; Baxa, U; Bakker, AQ; Spits, H; Beaumont, T; Zheng, ZZ; Xia, NS; Ko, SY; Todd, JP; Rao, S; Graham, BS; Kwong, PD				McLellan, Jason S.; Chen, Man; Joyce, M. Gordon; Sastry, Mallika; Stewart-Jones, Guillaume B. E.; Yang, Yongping; Zhang, Baoshan; Chen, Lei; Srivatsan, Sanjay; Zheng, Anqi; Zhou, Tongqing; Graepel, Kevin W.; Kumar, Azad; Moin, Syed; Boyington, Jeffrey C.; Chuang, Gwo-Yu; Soto, Cinque; Baxa, Ulrich; Bakker, Arjen Q.; Spits, Hergen; Beaumont, Tim; Zheng, Zizheng; Xia, Ningshao; Ko, Sung-Youl; Todd, John-Paul; Rao, Srinivas; Graham, Barney S.; Kwong, Peter D.			Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus	SCIENCE			English	Article							NEUTRALIZATION; ANTIBODIES; PROTEIN; EPITOPE	Respiratory syncytial virus (RSV) is the leading cause of hospitalization for children under 5 years of age. We sought to engineer a viral antigen that provides greater protection than currently available vaccines and focused on antigenic site empty set, a metastable site specific to the prefusion state of the RSV fusion (F) glycoprotein, as this site is targeted by extremely potent RSV-neutralizing antibodies. Structure-based design yielded stabilized versions of RSV F that maintained antigenic site empty set when exposed to extremes of pH, osmolality, and temperature. Six RSV F crystal structures provided atomic-level data on how introduced cysteine residues and filled hydrophobic cavities improved stability. Immunization with site empty set-stabilized variants of RSV F in mice and macaques elicited levels of RSV-specific neutralizing activity many times the protective threshold.	[McLellan, Jason S.; Chen, Man; Joyce, M. Gordon; Sastry, Mallika; Stewart-Jones, Guillaume B. E.; Yang, Yongping; Zhang, Baoshan; Chen, Lei; Srivatsan, Sanjay; Zheng, Anqi; Zhou, Tongqing; Graepel, Kevin W.; Kumar, Azad; Moin, Syed; Boyington, Jeffrey C.; Chuang, Gwo-Yu; Soto, Cinque; Ko, Sung-Youl; Todd, John-Paul; Rao, Srinivas; Graham, Barney S.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Baxa, Ulrich] SAIC Frederick Inc, Electron Microscope Lab, Adv Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Bakker, Arjen Q.; Spits, Hergen; Beaumont, Tim] AIMM Therapeut, Acad Med Ctr, NL-1105 BA Amsterdam, Netherlands; [Zheng, Zizheng; Xia, Ningshao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen 361005, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Amsterdam; Academic Medical Center Amsterdam; Xiamen University	Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nih.gov; pdkwong@nih.gov	Graham, Barney S./AAC-5898-2019; Zhou, Tongqing/A-6880-2010; Spits, Hergen/N-2581-2019; Kumar, Azad/AAD-2093-2020	Graham, Barney S./0000-0001-8112-0853; Zhou, Tongqing/0000-0002-3935-4637; Spits, Hergen/0000-0003-3269-8338; Moin, Syed/0000-0001-8789-9167; Baxa, Ulrich/0000-0002-7263-5078; Xia, Ningshao/0000-0003-0179-5266; McLellan, Jason/0000-0003-3991-542X	National Institute of Allergy and Infectious Diseases; National Natural Science Foundation of China [81161120419, 812111615]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005061] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. M. Salazar for poly-ICLC; J. Stuckey for assistance with figures; I. S. Georgiev and M. Pancera for assistance with immunogen design; G. J. Nabel, R. A. Seder, L. Shapiro, and members of the Structural Biology Section; Structural Bioinformatics Core Section; and Viral Pathogenesis Laboratory at the Vaccine Research Center for helpful comments; and J. Chrzas, J. Gonczy, U. Chinte, and staff at SER-CAT (Southeast Regional Collaborative Access Team) for help with x-ray diffraction data collection. The data presented in this manuscript are tabulated in the main paper and supplementary materials. Atomic coordinates and structure factors of the reported crystal structures have been deposited in the Protein Data Bank under accession codes 4MMQ to 4MMV. Support for this work was provided by the Intramural Research Program (National Institute of Allergy and Infectious Diseases) and the National Natural Science Foundation of China (81161120419 and 812111615). Use of insertion device 22 (SER-CAT) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. H. S. and T. B. are inventors on an international patent application describing the technology used to isolate D25 and AM22 (Means and methods for influencing the stability of antibody producing cells, WO2007067046A1). A. Q. B. and T. B. are inventors on international patent applications for antibody D25 (RSV-specific binding molecules and means for producing them, WO2008147196A2) and antibody AM22 (RSV-specific binding molecule, WO2011043643A1). J. S. M., M. G. J., B.Z., B. S. G., and P. D. K. are inventors on U. S. patent applications describing the use of prefusion-stabilized RSV F glycoproteins as vaccine antigens (Prefusion RSV F proteins and their use, 61/798,389 and 61/863,909). J. S. M., M. C., Z.Z., N.X., and B. S. G. are inventors on a Chinese patent application for antibody 5C4 and its epitope (Anti-RSV high neutralization antibody and the peptide can be used for prevention of RSV infection and related disease, 201310082338.1). Reagents from the NIH are subject to nonrestrictive materials transfer agreements.	Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Beaumont T., 2012, Patent Application, Patent No. [12/898,325, 12898325]; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Delany I, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012476; Dormitzer PR, 2012, NAT REV MICROBIOL, V10, P807, DOI 10.1038/nrmicro2893; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; EFIMOV VP, 1994, J MOL BIOL, V242, P470, DOI 10.1006/jmbi.1994.1595; GARTEN W, 1983, J GEN VIROL, V64, P2127, DOI 10.1099/0022-1317-64-10-2127; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Liljeroos L, 2013, P NATL ACAD SCI USA, V110, P11133, DOI 10.1073/pnas.1309070110; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2011, J MOL BIOL, V409, P853, DOI 10.1016/j.jmb.2011.04.044; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Miroshnikov KA, 1998, PROTEIN ENG, V11, P329, DOI 10.1093/protein/11.4.329; Mora M, 2006, CURR OPIN MICROBIOL, V9, P532, DOI 10.1016/j.mib.2006.07.003; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Nabel GJ, 2009, SCIENCE, V326, P53, DOI 10.1126/science.1177637; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pancera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055701; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Spits H., 2010, Patent Application, Patent No. [12/600,950, 12600950]; Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	33	549	624	7	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					592	598		10.1126/science.1243283	http://dx.doi.org/10.1126/science.1243283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179220	Green Accepted			2022-12-24	WOS:000326334300041
J	Kandoth, C; McLellan, MD; Vandin, F; Ye, K; Niu, BF; Lu, C; Xie, MC; Zhang, QY; McMichael, JF; Wyczalkowski, MA; Leiserson, MDM; Miller, CA; Welch, JS; Walter, MJ; Wendl, MC; Ley, TJ; Wilson, RK; Raphael, BJ; Ding, L				Kandoth, Cyriac; McLellan, Michael D.; Vandin, Fabio; Ye, Kai; Niu, Beifang; Lu, Charles; Xie, Mingchao; Zhang, Qunyuan; McMichael, Joshua F.; Wyczalkowski, Matthew A.; Leiserson, Mark D. M.; Miller, Christopher A.; Welch, John S.; Walter, Matthew J.; Wendl, Michael C.; Ley, Timothy J.; Wilson, Richard K.; Raphael, Benjamin J.; Ding, Li			Mutational landscape and significance across 12 major cancer types	NATURE			English	Article							SOMATIC POINT MUTATIONS; BRCA2 MUTATIONS; HUMAN BREAST; SURVIVAL; PATHWAYS; ASSOCIATION; DISCOVERY; EVOLUTION; PBRM1	The Cancer Genome Atlas (TCGA) has used the latest sequencing and analysis methods to identify somatic variants across thousands of tumours. Here we present data and analytical results for point mutations and small insertions/deletions from 3,281 tumours across 12 tumour types as part of the TCGA Pan-Cancer effort. We illustrate the distributions of mutation frequencies, types and contexts across tumour types, and establish their links to tissues of origin, environmental/carcinogen influences, and DNA repair defects. Using the integrated data sets, we identified 127 significantly mutated genes from well-known(for example, mitogen-activated protein kinase, phosphatidylinositol-3-OH kinase, Wnt/beta-catenin and receptor tyrosine kinase signalling pathways, and cell cycle control) and emerging (for example, histone, histone modification, splicing, metabolism and proteolysis) cellular processes in cancer. The average number of mutations in these significantly mutated genes varies across tumour types; most tumours have two to six, indicating that the number of driver mutations required during oncogenesis is relatively small. Mutations in transcriptional factors/regulators show tissue specificity, whereas histone modifiers are often mutated across several cancer types. Clinical association analysis identifies genes having a significant effect on survival, and investigations of mutations with respect to clonal/subclonal architecture delineate their temporal orders during tumorigenesis. Taken together, these results lay the groundwork for developing new diagnostics and individualizing cancer treatment.	[Kandoth, Cyriac; McLellan, Michael D.; Ye, Kai; Niu, Beifang; Lu, Charles; Xie, Mingchao; Zhang, Qunyuan; McMichael, Joshua F.; Wyczalkowski, Matthew A.; Miller, Christopher A.; Wendl, Michael C.; Ley, Timothy J.; Wilson, Richard K.; Ding, Li] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Vandin, Fabio; Leiserson, Mark D. M.; Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Ye, Kai; Zhang, Qunyuan; Wendl, Michael C.; Ley, Timothy J.; Wilson, Richard K.; Ding, Li] Washington Univ, Dept Genet, St Louis, MO 63108 USA; [Welch, John S.; Walter, Matthew J.; Ley, Timothy J.; Ding, Li] Washington Univ, Dept Med, St Louis, MO 63108 USA; [Welch, John S.; Walter, Matthew J.; Ley, Timothy J.; Wilson, Richard K.; Ding, Li] Washington Univ, Siteman Canc Ctr, St Louis, MO 63108 USA; [Wendl, Michael C.] Washington Univ, Dept Math, St Louis, MO 63108 USA	Washington University (WUSTL); Brown University; Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Ding, L (corresponding author), Washington Univ, Genome Inst, St Louis, MO 63108 USA.	lding@genome.wustl.edu	Ye, Kai/GSD-9856-2022; Wilson, Richard K./AAF-4139-2019; Miller, Christopher A./A-1060-2009; Walter, Matthew J/S-7758-2018; Ye, Kai/B-3640-2012; wang, edwin/G-5372-2010	Ye, Kai/0000-0002-2851-6741; Wilson, Richard K./0000-0002-1992-1358; Miller, Christopher A./0000-0003-4266-6700; MCLELLAN, MICHAEL/0000-0002-2703-8784; Wyczalkowski, Matthew/0000-0003-4197-551X; Kandoth, Cyriac/0000-0002-1345-3573	National Cancer Institute [R01CA180006, PO1CA101937]; National Human Genome Research Institute [R01HG005690, U54HG003079, U01HG006517]; National Science Foundation [IIS-1016648]; NATIONAL CANCER INSTITUTE [P01CA101937, R01CA180006] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005690, U01HG006517, U54HG003079] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Cancer Institute grants R01CA180006 to L. D. and PO1CA101937 to T.J.L., and National Human Genome Research Institute grants R01HG005690 to B.J.R., U54HG003079 to R. K. W., and U01HG006517 to L. D., and National Science Foundation grant IIS-1016648 to B.J.R. We gratefully acknowledge the contributions from TCGA Research Network and its TCGA Pan-Cancer Analysis Working Group. We also thank M. Bharadwaj for technical assistance.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bolton KL, 2012, JAMA-J AM MED ASSOC, V307, P382, DOI 10.1001/jama.2012.20; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Ma ZY, 2011, IEEE T PATTERN ANAL, V33, P2160, DOI 10.1109/TPAMI.2011.63; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Myung JK, 2012, ONCOL REP, V28, P1639, DOI 10.3892/or.2012.1994; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Roth A, 2012, BIOINFORMATICS, V28, P907, DOI 10.1093/bioinformatics/bts053; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tao MH, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12431; Vandin F, 2012, GENOME RES, V22, P375, DOI 10.1101/gr.120477.111; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456	38	2796	2887	10	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					333	+		10.1038/nature12634	http://dx.doi.org/10.1038/nature12634			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24132290	hybrid, Green Accepted, Green Published			2022-12-24	WOS:000325706300045
J	Lu, G; Middleton, RE; Sun, HH; Naniong, M; Ott, CJ; Mitsiades, CS; Wong, KK; Bradner, JE; Kaelin, WG				Lu, Gang; Middleton, Richard E.; Sun, Huahang; Naniong, MarkVic; Ott, Christopher J.; Mitsiades, Constantine S.; Wong, Kwok-Kin; Bradner, James E.; Kaelin, William G., Jr.			The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins	SCIENCE			English	Article							B-CELL LYMPHOMA; MULTIPLE-MYELOMA; MAMMALIAN-CELLS; EXPRESSION; POMALIDOMIDE; DIFFERENTIATION; THALIDOMIDE; IDENTIFICATION; SURVIVAL; TARGET	Thalidomide-like drugs such as lenalidomide are clinically important treatments for multiple myeloma and show promise for other B cell malignancies. The biochemical mechanisms underlying their antitumor activity are unknown. Thalidomide was recently shown to bind to, and inhibit, the cereblon ubiquitin ligase. Cereblon loss in zebrafish causes fin defects reminiscent of the limb defects seen in children exposed to thalidomide in utero. Here we show that lenalidomide-bound cereblon acquires the ability to target for proteasomal degradation two specific B cell transcription factors, Ikaros family zinc finger proteins 1 and 3 (IKZF1 and IKZF3). Analysis of myeloma cell lines revealed that loss of IKZF1 and IKZF3 is both necessary and sufficient for lenalidomide's therapeutic effect, suggesting that the antitumor and teratogenic activities of thalidomide-like drugs are dissociable.	[Lu, Gang; Middleton, Richard E.; Sun, Huahang; Naniong, MarkVic; Ott, Christopher J.; Mitsiades, Constantine S.; Wong, Kwok-Kin; Bradner, James E.; Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Middleton, Richard E.; Sun, Huahang; Naniong, MarkVic; Wong, Kwok-Kin] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02215 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	william_kaelin@dfci.harvard.edu		wong, kwok kin/0000-0001-6323-235X	NIH; Leukemia and Lymphoma Society; Multiple Myeloma Research Foundation; Celgene, the manufacturer of lenalidomide and pomalidomide; NATIONAL CANCER INSTITUTE [R01CA068490, R01CA076120] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Multiple Myeloma Research Foundation; Celgene, the manufacturer of lenalidomide and pomalidomide; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Vidal and A. MacWilliams at Dana-Farber Cancer Institute for the ORF cDNA collection and for help with recombination cloning. This work was supported by a grant (W. G. K.) and F32 fellowship (G. L.) from NIH. C.J.O. is supported by a Leukemia and Lymphoma Society Fellowship award, and J.E.B. and C. S. M. are supported by the Multiple Myeloma Research Foundation. W. G. K. is a Howard Hughes Medical Institute Investigator. C. S. M. has received consulting fees from Celgene, the manufacturer of lenalidomide and pomalidomide. The primary and secondary luciferase screen data are presented in the supplementary materials.	Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Broyl A, 2013, BLOOD, V121, P624, DOI 10.1182/blood-2012-06-438101; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Ferreiros-Vidal I, 2013, BLOOD, V121, P1769, DOI 10.1182/blood-2012-08-450114; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Heintel D, 2013, BRIT J HAEMATOL, V161, P695, DOI 10.1111/bjh.12338; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kastner P, 2013, AM J BLOOD RES, V3, P1; Laubach J, 2011, ANNU REV MED, V62, P249, DOI 10.1146/annurev-med-070209-175325; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Martiniani Roberta, 2012, Adv Hematol, V2012, P842945, DOI 10.1155/2012/842945; Merkenschlager M, 2010, FEBS LETT, V584, P4910, DOI 10.1016/j.febslet.2010.09.042; Monticelli S, 2012, NAT IMMUNOL, V13, P719, DOI 10.1038/ni.2377; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Richardson PG, 2009, J CLIN ONCOL, V27, P5713, DOI 10.1200/JCO.2009.22.2679; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Terpos E, 2013, ONCOTARGETS THER, V6, P531, DOI 10.2147/OTT.S34498; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang GJ, 2004, NAT MED, V10, P643, DOI 10.1038/nm1047; Zhang LH, 2013, BRIT J HAEMATOL, V160, P487, DOI 10.1111/bjh.12172; Zhu YX, 2013, LEUKEMIA LYMPHOMA, V54, P683, DOI 10.3109/10428194.2012.728597; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	29	887	949	12	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					305	309		10.1126/science.1244917	http://dx.doi.org/10.1126/science.1244917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24292623	Green Accepted			2022-12-24	WOS:000329718600038
J	Costantino, L; Sotiriou, SK; Rantala, JK; Magin, S; Mladenov, E; Helleday, T; Haber, JE; Iliakis, G; Kallioniemi, OP; Halazonetis, TD				Costantino, Lorenzo; Sotiriou, Sotirios K.; Rantala, Juha K.; Magin, Simon; Mladenov, Emil; Helleday, Thomas; Haber, James E.; Iliakis, George; Kallioniemi, Olli P.; Halazonetis, Thanos D.			Break-Induced Replication Repair of Damaged Forks Induces Genomic Duplications in Human Cells	SCIENCE			English	Article							ONCOGENE-INDUCED SENESCENCE; DNA-POLYMERASE DELTA; INSTABILITY	In budding yeast, one-ended DNA double-strand breaks (DSBs) and damaged replication forks are repaired by break-induced replication (BIR), a homologous recombination pathway that requires the Pol32 subunit of DNA polymerase delta. DNA replication stress is prevalent in cancer, but BIR has not been characterized in mammals. In a cyclin E overexpression model of DNA replication stress, POLD3, the human ortholog of POL32, was required for cell cycle progression and processive DNA synthesis. Segmental genomic duplications induced by cyclin E overexpression were also dependent on POLD3, as were BIR-mediated recombination events captured with a specialized DSB repair assay. We propose that BIR repairs damaged replication forks in mammals, accounting for the high frequency of genomic duplications in human cancers.	[Costantino, Lorenzo; Sotiriou, Sotirios K.; Halazonetis, Thanos D.] Univ Geneva, Dept Mol Biol, CH-1205 Geneva, Switzerland; [Rantala, Juha K.] VTT Tech Res Ctr Finland, Turku 20521, Finland; [Magin, Simon; Mladenov, Emil; Iliakis, George] Univ Duisburg Essen, Sch Med, Inst Med Radiat Biol, D-45122 Essen, Germany; [Helleday, Thomas] Karolinska Inst, Dept Med Biochem & Biophys, S-17121 Stockholm, Sweden; [Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Haber, James E.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Kallioniemi, Olli P.] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki 00140, Finland	University of Geneva; VTT Technical Research Center Finland; University of Duisburg Essen; Karolinska Institutet; Brandeis University; Brandeis University; University of Helsinki	Halazonetis, TD (corresponding author), Univ Geneva, Dept Mol Biol, CH-1205 Geneva, Switzerland.	thanos.halazonetis@unige.ch	Magin, Simon/GRJ-8271-2022; Kallioniemi, Olli P/H-5111-2011	Kallioniemi, Olli P/0000-0002-3231-0332; Magin, Simon/0000-0002-6173-1304; Sotiriou, Sotirios/0000-0003-4690-0568; Helleday, Thomas/0000-0002-7384-092X; Rantala, Juha/0000-0002-4999-5585; Costantino, Lorenzo/0000-0002-4230-485X	European Commission; Swiss National Science Foundation; German Federal Ministry of Education and Research; European Space Agency; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076020, R37GM020056] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Space Agency(European Space AgencyEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Bartek for the U2OS cells inducibly overexpressing cyclin E and J. Stark for the systems to monitor SDSA and SSA. This work was supported by the European Commission Projects GENICA (T. D. H. and O.P.K.) and ONIDDAC (T. D. H.), the Swiss National Science Foundation (T. D. H.), the German Federal Ministry of Education and Research (G. I.), and the European Space Agency (G. I.). siRNA screening data has been deposited in PubChem (accession no. AID 720710).	Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Donnianni RA, 2013, P NATL ACAD SCI USA, V110, P13475, DOI 10.1073/pnas.1309800110; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Huang QM, 2010, BIOCHEM BIOPH RES CO, V391, P542, DOI 10.1016/j.bbrc.2009.11.094; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Kanel DP, 2012, PLOS GENET, V8, P447, DOI 10.1371/journal.pgen.1002659; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Malkova A, 2005, MOL CELL BIOL, V25, P933, DOI 10.1128/MCB.25.3.933-944.2005; McBride DJ, 2012, J PATHOL, V227, P446, DOI 10.1002/path.4042; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mizuno K, 2013, NATURE, V493, P246, DOI 10.1038/nature11676; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Reynolds N, 1998, CURR GENET, V34, P250, DOI 10.1007/s002940050394; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076	29	312	314	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					88	91		10.1126/science.1243211	http://dx.doi.org/10.1126/science.1243211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24310611	Green Accepted			2022-12-24	WOS:000329162000054
J	Miller, JF; Neufang, M; Solway, A; Brandt, A; Trippel, M; Mader, I; Hefft, S; Merkow, M; Polyn, SM; Jacobs, J; Kahana, MJ; Schulze-Bonhage, A				Miller, Jonathan F.; Neufang, Markus; Solway, Alec; Brandt, Armin; Trippel, Michael; Mader, Irina; Hefft, Stefan; Merkow, Max; Polyn, Sean M.; Jacobs, Joshua; Kahana, Michael J.; Schulze-Bonhage, Andreas			Neural Activity in Human Hippocampal Formation Reveals the Spatial Context of Retrieved Memories	SCIENCE			English	Article							PLACE CELLS; PATH-INTEGRATION; THETA RHYTHM; FREE-RECALL; SEARCH; NAVIGATION; NEURONS; PATTERNS; MODEL; TIME	In many species, spatial navigation is supported by a network of place cells that exhibit increased firing whenever an animal is in a certain region of an environment. Does this neural representation of location form part of the spatiotemporal context into which episodic memories are encoded? We recorded medial temporal lobe neuronal activity as epilepsy patients performed a hybrid spatial and episodic memory task. We identified place-responsive cells active during virtual navigation and then asked whether the same cells activated during the subsequent recall of navigation-related memories without actual navigation. Place-responsive cell activity was reinstated during episodic memory retrieval. Neuronal firing during the retrieval of each memory was similar to the activity that represented the locations in the environment where the memory was initially encoded.	[Miller, Jonathan F.; Jacobs, Joshua] Drexel Univ, Philadelphia, PA 19104 USA; [Neufang, Markus; Brandt, Armin; Trippel, Michael; Mader, Irina; Hefft, Stefan; Schulze-Bonhage, Andreas] Univ Med Ctr, Epilepsy Ctr, Freiburg, Germany; [Solway, Alec; Merkow, Max; Polyn, Sean M.; Kahana, Michael J.] Univ Penn, Philadelphia, PA 19104 USA	Drexel University; University of Freiburg; University of Pennsylvania	Kahana, MJ (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	kahana@psych.upenn.edu; andreas.schulze-bonhage@uniklinik-freiburg.de	Schulze-Bonhage, Andreas/AAJ-3107-2020; Jacobs, Joshua/E-9500-2013	Jacobs, Joshua/0000-0003-1807-6882	NIH [MH-061975]; Brain and Behavior Research Foundation; German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB 780-TP3]; Federal Ministry of Education and Research (Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie, Germany) [BCNT TP B3]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061975, R01MH055687] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Federal Ministry of Education and Research (Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie, Germany); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was sponsored by NIH grant MH-061975, the Brain and Behavior Research Foundation, German Research Foundation (Deutsche Forschungsgemeinschaft) grant SFB 780-TP3, and Federal Ministry of Education and Research (Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie, Germany) grant BCNT TP B3. We are most grateful to J. Stein and H. Urbach for help with localizing electrode locations in postoperative magnetic resonance imaging. We thank the patients and their families for their participation in this research.	[Anonymous], 1983, CANADIAN PSYCHOL; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Howard MW, 2012, HIPPOCAMPUS, V22, P1833, DOI 10.1002/hipo.22018; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Jacobs J, 2010, P NATL ACAD SCI USA, V107, P6487, DOI 10.1073/pnas.0911213107; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Manning JR, 2012, J NEUROSCI, V32, P8871, DOI 10.1523/JNEUROSCI.5321-11.2012; Manning JR, 2011, P NATL ACAD SCI USA, V108, P12893, DOI 10.1073/pnas.1015174108; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Miller JF, 2013, J EXP PSYCHOL LEARN, V39, P773, DOI 10.1037/a0029684; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1994, J NEUROSCI, V14, P7235; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Polyn SM, 2008, TRENDS COGN SCI, V12, P24, DOI 10.1016/j.tics.2007.10.010; Polyn SM, 2009, PSYCHOL REV, V116, P129, DOI 10.1037/a0014420; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	29	184	186	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1111	1114		10.1126/science.1244056	http://dx.doi.org/10.1126/science.1244056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288336	Green Accepted			2022-12-24	WOS:000327518600062
J	Mead, S; Gandhi, S; Beck, J; Caine, D; Gallujipali, D; Carswell, C; Hyare, H; Joiner, S; Ayling, H; Lashley, T; Linehan, JM; Al-Doujaily, H; Sharps, B; Revesz, T; Sandberg, MK; Reilly, MM; Koltzenburg, M; Forbes, A; Rudge, P; Brandner, S; Warren, JD; Wadsworth, JDF; Wood, NW; Holton, JL; Collinge, J				Mead, Simon; Gandhi, Sonia; Beck, Jon; Caine, Diana; Gallujipali, Dillip; Carswell, Christopher; Hyare, Harpreet; Joiner, Susan; Ayling, Hilary; Lashley, Tammaryn; Linehan, Jacqueline M.; Al-Doujaily, Huda; Sharps, Bernadette; Revesz, Tamas; Sandberg, Malin K.; Reilly, Mary M.; Koltzenburg, Martin; Forbes, Alastair; Rudge, Peter; Brandner, Sebastian; Warren, Jason D.; Wadsworth, Jonathan D. F.; Wood, Nicholas W.; Holton, Janice L.; Collinge, John			A Novel Prion Disease Associated with Diarrhea and Autonomic Neuropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CREUTZFELDT-JAKOB-DISEASE; FATAL FAMILIAL INSOMNIA; PROTEIN GENE; TRANSGENIC MICE; VARIANT; PRNP; MUTATIONS; PHENOTYPE; CLASSIFICATION; AMYLOIDOSIS	BackgroundHuman prion diseases, although variable in clinicopathological phenotype, generally present as neurologic or neuropsychiatric conditions associated with rapid multifocal central nervous system degeneration that is usually dominated by dementia and cerebellar ataxia. Approximately 15% of cases of recognized prion disease are inherited and associated with coding mutations in the gene encoding prion protein (PRNP). The availability of genetic diagnosis has led to a progressive broadening of the recognized spectrum of disease. MethodsWe used longitudinal clinical assessments over a period of 20 years at one hospital combined with genealogical, neuropsychological, neurophysiological, neuroimaging, pathological, molecular genetic, and biochemical studies, as well as studies of animal transmission, to characterize a novel prion disease in a large British kindred. We studied 6 of 11 affected family members in detail, along with autopsy or biopsy samples obtained from 5 family members. ResultsWe identified a PRNP Y163X truncation mutation and describe a distinct and consistent phenotype of chronic diarrhea with autonomic failure and a length-dependent axonal, predominantly sensory, peripheral polyneuropathy with an onset in early adulthood. Cognitive decline and seizures occurred when the patients were in their 40s or 50s. The deposition of prion protein amyloid was seen throughout peripheral organs, including the bowel and peripheral nerves. Neuropathological examination during end-stage disease showed the deposition of prion protein in the form of frequent cortical amyloid plaques, cerebral amyloid angiopathy, and tauopathy. A unique pattern of abnormal prion protein fragments was seen in brain tissue. Transmission studies in laboratory mice were negative. ConclusionsAbnormal forms of prion protein that were found in multiple peripheral tissues were associated with diarrhea, autonomic failure, and neuropathy. (Funded by the U.K. Medical Research Council and others.) Prions cause a variety of CNS illnesses, such as Creutzfeldt-Jakob disease. In this British kindred, a prion-associated process was associated with chronic diarrhea and autonomic dysfunction, a finding that extends the known disorders caused by these aberrant proteins. The prion diseases are transmissible, fatal, neurodegenerative disorders that may be inherited or acquired or that may occur spontaneously as sporadic Creutzfeldt-Jakob disease.(1) The transmissible agent, or prion, is thought to comprise misfolded and aggregated forms of the normal cell-surface prion protein. Prion propagation is thought to occur by means of seeded protein polymerization, a process involving the binding and templated misfolding of normal cellular prion protein. Similar processes are increasingly recognized as relevant to other, more common neurodegenerative diseases. In prion and other neurodegenerative disorders, the aggregates of misfolded protein in the central nervous system are highly heterogeneous, occurring ...	[Mead, Simon; Beck, Jon; Carswell, Christopher; Joiner, Susan; Linehan, Jacqueline M.; Al-Doujaily, Huda; Sharps, Bernadette; Sandberg, Malin K.; Brandner, Sebastian; Wadsworth, Jonathan D. F.; Collinge, John] UCL, Inst Neurol, MRC, Prion Unit, London WC1E 6BT, England; [Gandhi, Sonia; Wood, Nicholas W.] UCL, Inst Neurol, Dept Mol Neurosci, London WC1E 6BT, England; [Warren, Jason D.] UCL, Inst Neurol, Dementia Res Ctr, Dept Neurodegenerat Dis, London WC1E 6BT, England; [Reilly, Mary M.] UCL, Inst Neurol, MRC, Ctr Neuromuscular Dis, London WC1E 6BT, England; [Mead, Simon; Caine, Diana; Gallujipali, Dillip; Hyare, Harpreet; Rudge, Peter; Collinge, John] Natl Hosp Neurol & Neurosurg, Natl Prion Clin, London, England; [Forbes, Alastair] UCL Hosp Natl Hlth Serv Trust, London, England; [Ayling, Hilary; Lashley, Tammaryn; Revesz, Tamas; Holton, Janice L.] Queen Sq Brain Bank, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Collinge, J (corresponding author), UCL Inst Neurol, MRC Prion Unit, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Holton, Janice L/F-6831-2011; GAJULAPALLI, RAMA DILIP/K-5585-2019; Koltzenburg, Martin/C-1349-2008; Wood, Nicholas W/C-2505-2009; Revesz, Tamas/A-8732-2010; Beck, Jon/GRX-8457-2022; Brandner, Sebastian/J-4562-2014; Lashley, Tammaryn/D-2583-2009	Holton, Janice L/0000-0002-3882-5249; GAJULAPALLI, RAMA DILIP/0000-0003-2872-7132; Koltzenburg, Martin/0000-0001-9181-5966; Wood, Nicholas W/0000-0002-9500-3348; Revesz, Tamas/0000-0003-2501-0259; Brandner, Sebastian/0000-0002-9821-0342; Wadsworth, Jonathan/0000-0002-4797-2259; Reilly, Mary/0000-0003-0686-905X; Forbes, Alastair/0000-0001-7416-9843; Lashley, Tammaryn/0000-0001-7389-0348; Warren, Jason/0000-0002-5405-0826; Mead, Simon/0000-0002-4326-1468	U.K. Medical Research Council (MRC); Reta Lila Weston Institute of Neurological Studies; Alzheimer's Research UK; Multiple System Atrophy Trust; National Institute for Health Research (NIHR) Biomedical Research Centre at the University College London Hospitals NHS Foundation Trust and University College London; NIHR Dementia Biomedical Research Unit; National Institutes of Neurological Diseases and Stroke and Office of Rare Diseases Research [U54NS065712]; Wellcome Trust Senior Clinical Fellowship; Wellcome Trust/MRC Neuro-degeneration award [WT089698]; MRC [G0802497, MC_U123160655, MC_U123192748, MC_U123160651, MR/K000608/1] Funding Source: UKRI; Medical Research Council [MC_U123192748, MC_U123160651, G0802497, MR/K000608/1, MC_U123160655] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10376] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065712] Funding Source: NIH RePORTER	U.K. Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Reta Lila Weston Institute of Neurological Studies; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Multiple System Atrophy Trust; National Institute for Health Research (NIHR) Biomedical Research Centre at the University College London Hospitals NHS Foundation Trust and University College London; NIHR Dementia Biomedical Research Unit; National Institutes of Neurological Diseases and Stroke and Office of Rare Diseases Research; Wellcome Trust Senior Clinical Fellowship(Wellcome Trust); Wellcome Trust/MRC Neuro-degeneration award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the U.K. Medical Research Council (MRC) (in part to Dr. Reilly), the Reta Lila Weston Institute of Neurological Studies (to Dr. Holton and Ms. Ayling), Alzheimer's Research UK (to Drs. Holton, Revesz, and Lashley), the Multiple System Atrophy Trust (to Drs. Holton and Revesz), the National Institute for Health Research (NIHR) Biomedical Research Centre at the University College London Hospitals NHS Foundation Trust and University College London, the NIHR Dementia Biomedical Research Unit, the National Institutes of Neurological Diseases and Stroke and Office of Rare Diseases Research (U54NS065712, to Dr. Reilly), a Wellcome Trust Senior Clinical Fellowship (to Dr. Warren), and a Wellcome Trust/MRC Neuro-degeneration award (WT089698).	Beck JA, 2010, HUM MUTAT, V31, pE1551, DOI 10.1002/humu.21281; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cortelli P, 1991, Clin Auton Res, V1, P15, DOI 10.1007/BF01826053; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Edgeworth JA, 2011, J GEN VIROL, V92, P718, DOI 10.1099/vir.0.027201-0; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Hill AF, 2006, BRAIN, V129, P676, DOI 10.1093/brain/awl013; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Jansen C, 2010, ACTA NEUROPATHOL, V119, P189, DOI 10.1007/s00401-009-0609-x; Jayadev S, 2011, ANN NEUROL, V69, P712, DOI 10.1002/ana.22264; Joiner S, 2002, J NEUROL NEUROSUR PS, V73, P597, DOI 10.1136/jnnp.73.5.597; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Lee AM, 2011, VIROLOGY, V411, P1, DOI 10.1016/j.virol.2010.12.012; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; Montagna P, 2003, LANCET NEUROL, V2, P167, DOI 10.1016/S1474-4422(03)00323-5; Plante-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0; PORTALUPPI F, 1994, HYPERTENSION, V23, P569, DOI 10.1161/01.HYP.23.5.569; Stohr J, 2011, P NATL ACAD SCI USA, V108, P21223, DOI 10.1073/pnas.1117827108; Trifilo MJ, 2006, SCIENCE, V313, P94, DOI 10.1126/science.1128635; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wadsworth JDF, 2008, P NATL ACAD SCI USA, V105, P3885, DOI 10.1073/pnas.0800190105	28	83	87	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 14	2013	369	20					1904	1914		10.1056/NEJMoa1214747	http://dx.doi.org/10.1056/NEJMoa1214747			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	251AN	24224623	Green Accepted			2022-12-24	WOS:000326899000001
J	Pearce, LR; Atanassova, N; Banton, MC; Bottomley, B; van der Klaauw, AA; Revelli, JP; Hendricks, A; Keogh, JM; Henning, E; Doree, D; Jeter-Jones, S; Garg, S; Bochukova, EG; Bounds, R; Ashford, S; Gayton, E; Hindmarsh, PC; Shield, JPH; Crowne, E; Barford, D; Wareham, NJ; O'Rahilly, S; Murphy, MP; Powell, DR; Barroso, I; Farooqi, IS				Pearce, Laura R.; Atanassova, Neli; Banton, Matthew C.; Bottomley, Bill; van der Klaauw, Agatha A.; Revelli, Jean-Pierre; Hendricks, Audrey; Keogh, Julia M.; Henning, Elana; Doree, Deon; Jeter-Jones, Sabrina; Garg, Sumedha; Bochukova, Elena G.; Bounds, Rebecca; Ashford, Sofie; Gayton, Emma; Hindmarsh, Peter C.; Shield, Julian P. H.; Crowne, Elizabeth; Barford, David; Wareham, Nick J.; O'Rahilly, Stephen; Murphy, Michael P.; Powell, David R.; Barroso, Ines; Farooqi, I. Sadaf		Uk10k Consortium	KSR2 Mutations Are Associated with Obesity, Insulin Resistance, and Impaired Cellular Fuel Oxidation	CELL			English	Article							KINASE SUPPRESSOR; SYNAPTIC PLASTICITY; ENERGY-EXPENDITURE; MAPK SCAFFOLD; GENE ENCODES; AMP-KINASE; RAS; ACTIVATION; SPECTRUM; MODULATION	Kinase suppressor of Ras 2 (KSR2) is an intracellular scaffolding protein involved in multiple signaling pathways. Targeted deletion of Ksr2 leads to obesity in mice, suggesting a role in energy homeostasis. We explored the role of KSR2 in humans by sequencing 2,101 individuals with severe early-onset obesity and 1,536 controls. We identified multiple rare variants in KSR2 that disrupt signaling through the Raf-MEK-ERK pathway and impair cellular fatty acid oxidation and glucose oxidation in transfected cells; effects that can be ameliorated by the commonly prescribed antidiabetic drug, metformin. Mutation carriers exhibit hyperphagia in childhood, low heart rate, reduced basal metabolic rate and severe insulin resistance. These data establish KSR2 as an important regulator of energy intake, energy expenditure, and substrate utilization in humans. Modulation of KSR2-mediated effects may represent a novel therapeutic strategy for obesity and type 2 diabetes.	[Pearce, Laura R.; Atanassova, Neli; Banton, Matthew C.; van der Klaauw, Agatha A.; Keogh, Julia M.; Henning, Elana; Garg, Sumedha; Bochukova, Elena G.; Bounds, Rebecca; Ashford, Sofie; O'Rahilly, Stephen; Barroso, Ines; Farooqi, I. Sadaf] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; [Pearce, Laura R.; Atanassova, Neli; Banton, Matthew C.; van der Klaauw, Agatha A.; Keogh, Julia M.; Henning, Elana; Garg, Sumedha; Bochukova, Elena G.; Bounds, Rebecca; Ashford, Sofie; O'Rahilly, Stephen; Barroso, Ines; Farooqi, I. Sadaf] Wellcome Trust MRC Inst Metab Sci, NIHR Cambridge Biomed Res Ctr, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Bottomley, Bill; Hendricks, Audrey; Gayton, Emma; Barroso, Ines; Uk10k Consortium] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Revelli, Jean-Pierre; Doree, Deon; Jeter-Jones, Sabrina; Powell, David R.] Lexicon Pharmaceut, The Woodlands, TX 77381 USA; [Hindmarsh, Peter C.] UCL, Inst Child Hlth, London WC1E 6BT, England; [Shield, Julian P. H.; Crowne, Elizabeth] Univ Bristol, Bristol BS2 8BJ, Avon, England; [Shield, Julian P. H.; Crowne, Elizabeth] Bristol Royal Hosp Children, Bristol BS2 8BJ, Avon, England; [Barford, David] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; [Wareham, Nick J.] Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Murphy, Michael P.] Wellcome Trust Res Labs, MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Lexicon Pharmaceuticals; University of London; University College London; University of Bristol; Bristol Royal Hospital For Children; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute	Farooqi, IS (corresponding author), Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England.	isf20@cam.ac.uk	Murphy, Michael P/C-2120-2009; Shield, Julian PH/D-6297-2014; Hendricks, Audrey/I-4127-2016; Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	Murphy, Michael P/0000-0003-1115-9618; Shield, Julian PH/0000-0003-2601-7575; Hendricks, Audrey/0000-0002-7152-0287; O'Rahilly, Stephen/0000-0003-2199-4449; Barford, David/0000-0001-8810-950X; Barroso, Ines/0000-0001-5800-4520; van der Klaauw, Agatha/0000-0001-6971-8828; Bochukova, Elena/0000-0003-0275-1548; Farooqi, Sadaf/0000-0001-7609-3504; Banton, Matthew/0000-0002-9199-7170; Pearce, Laura/0000-0002-7768-6851; Kelly, Kirsten/0000-0003-4234-543X	Wellcome Trust [098497/Z/12/Z, 077016/Z/05/Z, 096106/Z/11/Z]; Medical Research Council [MC_U106179471]; NIHR Cambridge Biomedical Research Centre; European Research Council; MRC [G0600717, G0502115, MC_UU_12015/1, MC_UU_12012/1, G0900554, MC_UP_1201/6] Funding Source: UKRI; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [G0600717B, G0502115, MC_UP_1201/6, MC_UU_12012/1, MC_UU_12015/1, G0900554, G0600717, MC_UU_12012/5/B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268, NF-SI-0512-10135, NF-SI-0507-10380] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We are indebted to the participants and their families for their participation and to the physicians involved in the Genetics of Obesity Study (GOOS). We thank Brian Lam for help with flow cytometry; Matthew Gratian, Margaret Robinson, and Patrycia Kozik for microscopy advice and Pamela Pun for assistance using the Seahorse XF analyzer. This work was supported by the Wellcome Trust (098497/Z/12/Z; 077016/Z/05/Z; 096106/Z/11/Z) (ISF and LRP), Medical Research Council (MC_U106179471) (NW), NIHR Cambridge Biomedical Research Centre (ISF, IB and SOR), and European Research Council (ISF). This study makes use of data generated by the UK10K Consortium (WT091310). A full list of the investigators who contributed to the generation of the data is available from http://www.UK10K.org.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Brommage R, 2008, OBESITY, V16, P2362, DOI 10.1038/oby.2008.361; Canal F, 2011, FASEB J, V25, P2362, DOI 10.1096/fj.10-173153; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; CUNNINGHAM JJ, 1991, AM J CLIN NUTR, V54, P963, DOI 10.1093/ajcn/54.6.963; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Dougherty MK, 2009, MOL CELL, V34, P652, DOI 10.1016/j.molcel.2009.06.001; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fernandez MR, 2012, MOL CELL BIOL, V32, P3718, DOI 10.1128/MCB.06754-11; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Guerra C, 1998, J CLIN INVEST, V102, P1724, DOI 10.1172/JCI4532; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Joneson T, 1998, J BIOL CHEM, V273, P7743, DOI 10.1074/jbc.273.13.7743; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Lanctot AA, 2013, DEV CELL, V25, P241, DOI 10.1016/j.devcel.2013.04.006; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Liu L, 2009, BBA-PROTEINS PROTEOM, V1794, P1485, DOI 10.1016/j.bbapap.2009.06.016; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Revelli JP, 2011, OBESITY, V19, P1010, DOI 10.1038/oby.2010.282; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Schuler AM, 2005, MOL GENET METAB, V85, P7, DOI 10.1016/j.ymgme.2004.09.006; Shalin SC, 2006, NEURON, V50, P765, DOI 10.1016/j.neuron.2006.04.029; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; WILLIAMS DRR, 1995, DIABETIC MED, V12, P30, DOI 10.1111/j.1464-5491.1995.tb02058.x; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X	43	112	114	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					765	777		10.1016/j.cell.2013.09.058	http://dx.doi.org/10.1016/j.cell.2013.09.058			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209692	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000326934300008
J	Raina, JB; Tapiolas, DM; Foret, S; Lutz, A; Abrego, D; Ceh, J; Seneca, FO; Clode, PL; Bourne, DG; Willis, BL; Motti, CA				Raina, Jean-Baptiste; Tapiolas, Dianne M.; Foret, Sylvain; Lutz, Adrian; Abrego, David; Ceh, Janja; Seneca, Francois O.; Clode, Peta L.; Bourne, David G.; Willis, Bette L.; Motti, Cherie A.			DMSP biosynthesis by an animal and its role in coral thermal stress response	NATURE			English	Article							PARTICULATE DIMETHYLSULFONIOPROPIONATE DMSP; GREAT-BARRIER-REEF; DIMETHYL SULFIDE; SULFUR-COMPOUNDS; SOLAR-RADIATION; ACROPORA; BACTERIA; PRIMERS; CLIMATE; QUANTIFICATION	Globally, reef-building corals are the most prolific producers of dimethylsulphoniopropionate (DMSP)(1,2), a central molecule in the marine sulphur cycle and precursor of the climate-active gas dimethylsulphide(3,4). At present, DMSP production by corals is attributed entirely to their algal endosymbiont, Symbiodinium(2). Combining chemical, genomic and molecular approaches, we show that coral juveniles produce DMSP in the absence of algal symbionts. DMSP levels increased up to 54% over time in newly settled coral juveniles lacking algal endosymbionts, and further increases, up to 76%, were recorded when juveniles were subjected to thermal stress. We uncovered coral orthologues of two algal genes recently identified in DMSP biosynthesis, strongly indicating that corals possess the enzymatic machinery necessary for DMSP production. Our results overturn the paradigm that photosynthetic organisms are the sole biological source of DMSP, and highlight the double jeopardy represented by worldwide declining coral cover, as the potential to alleviate thermal stress through coral-produced DMSP declines correspondingly.	[Raina, Jean-Baptiste; Lutz, Adrian; Seneca, Francois O.; Willis, Bette L.] James Cook Univ, AIMS JCU, Townsville, Qld 4811, Australia; [Raina, Jean-Baptiste; Seneca, Francois O.; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Raina, Jean-Baptiste; Tapiolas, Dianne M.; Lutz, Adrian; Abrego, David; Seneca, Francois O.; Bourne, David G.; Motti, Cherie A.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Raina, Jean-Baptiste; Foret, Sylvain; Lutz, Adrian; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Foret, Sylvain] Australian Natl Univ, Canberra, ACT 2601, Australia; [Lutz, Adrian] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia; [Ceh, Janja] Murdoch Univ, Sch Biol Sci & Biotechnol, Perth, WA 6050, Australia; [Clode, Peta L.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, WA 6009, Australia; [Clode, Peta L.] Univ Western Australia, Oceans Inst, Crawley, WA 6009, Australia	James Cook University; James Cook University; Australian Institute of Marine Science; James Cook University; Australian National University; James Cook University; Murdoch University; University of Western Australia; University of Western Australia	Raina, JB (corresponding author), James Cook Univ, AIMS JCU, Townsville, Qld 4811, Australia.	j.raina@aims.gov.au	Motti, Cherie/A-2588-2012; Bourne, David G/B-5073-2008; FORET, Sylvain/B-9207-2012; Clode, Peta L/C-4482-2011; Abrego, David/AAT-8120-2020; Lutz, Adrian/O-9805-2016; Seneca, Francois/F-9040-2010	Bourne, David G/0000-0002-1492-8710; Abrego, David/0000-0003-3311-2730; Lutz, Adrian/0000-0002-8392-3921; Clode, Peta/0000-0002-5188-4737; Seneca, Francois/0000-0002-8908-1227; Motti, Cherie/0000-0002-3292-2785; Raina, Jean-Baptiste/0000-0002-7508-0004	AMMRF Centre for Microscopy, Characterisation and Analysis (UWA); ARC Centre of Excellence for Coral Reef Studies; AIMS	AMMRF Centre for Microscopy, Characterisation and Analysis (UWA); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); AIMS	The authors would like to thank D. Yellowlees, R. Stocker, M. Garren, A. Johnston, W. Dunlap, H. Harrison, P. Warner and E. Botte for valuable comments on the manuscript. We specially thank K. Ritchie for her advice and encouragement. We also thank J. Hicks, P. Barron (Bruker Biospin), A. Negri, T. Harder, J. Tebben, M. Logan and J. Pollock for their assistance. This work was supported by the AMMRF Centre for Microscopy, Characterisation and Analysis (UWA), the ARC Centre of Excellence for Coral Reef Studies and AIMS.	AYERS GP, 1991, NATURE, V353, P834, DOI 10.1038/353834a0; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; BIGG EK, 1978, ATMOS ENVIRON, V12, P1643, DOI 10.1016/0004-6981(78)90313-X; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Broadbent AD, 2004, MAR FRESHWATER RES, V55, P849, DOI 10.1071/MF04114; Broadbent AD, 2002, ESTUAR COAST SHELF S, V55, P547, DOI 10.1006/ecss.2002.1021; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Fischer E, 2012, BIOGEOCHEMISTRY, V110, P31, DOI 10.1007/s10533-012-9719-y; Gage DA, 1997, NATURE, V387, P891, DOI 10.1038/43160; Gomez-Consarnau L, 2012, ENVIRON MICROBIOL, V14, P2361, DOI 10.1111/j.1462-2920.2012.02804.x; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Ito T, 2011, J PHYCOL, V47, P517, DOI 10.1111/j.1529-8817.2011.00977.x; Leahy SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070400; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Lyon BR, 2011, PLANT PHYSIOL, V157, P1926, DOI 10.1104/pp.111.185025; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; McLenon AL, 2012, BIOGEOCHEMISTRY, V110, P17, DOI 10.1007/s10533-012-9733-0; Modini RL, 2009, ATMOS CHEM PHYS, V9, P7607, DOI 10.5194/acp-9-7607-2009; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Quinn PK, 2011, NATURE, V480, P51, DOI 10.1038/nature10580; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Schafer H, 2007, APPL ENVIRON MICROB, V73, P2580, DOI 10.1128/AEM.02074-06; Sherwood AR, 2008, MOL ECOL RESOUR, V8, P1011, DOI 10.1111/j.1755-0998.2008.02138.x; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Sievert SM, 2007, OCEANOGRAPHY, V20, P117, DOI 10.5670/oceanog.2007.55; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Strychar KB, 2004, PHYCOLOGIA, V43, P768, DOI 10.2216/i0031-8884-43-6-768.1; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Suzuki G, 2008, MAR ECOL PROG SER, V355, P149, DOI 10.3354/meps07253; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takai K, 2000, APPL ENVIRON MICROB, V66, P5066, DOI 10.1128/AEM.66.11.5066-5072.2000; Tapiolas DM, 2013, J EXP MAR BIOL ECOL, V443, P85, DOI 10.1016/j.jembe.2013.02.037; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Vallina SM, 2007, SCIENCE, V315, P506, DOI 10.1126/science.1133680; Van Alstyne K, 2009, CORAL REEFS, V28, P167, DOI 10.1007/s00338-008-0443-y; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Veal CJ, 2010, LIMNOL OCEANOGR-METH, V8, P241, DOI 10.4319/lom.2010.8.241; Veron J. E., 2000, CORALS WORLD, V1-3; Vogt C, 1998, MICROBIOL RES, V153, P219; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; Yost DM, 2012, CORAL REEFS, V31, P561, DOI 10.1007/s00338-011-0870-z; Yost DM, 2010, J EXP MAR BIOL ECOL, V395, P72, DOI 10.1016/j.jembe.2010.08.016	51	183	191	19	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					677	+		10.1038/nature12677	http://dx.doi.org/10.1038/nature12677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24153189				2022-12-24	WOS:000326293200046
J	Kane, M; Yadav, SS; Bitzegeio, J; Kutluay, SB; Zang, T; Wilson, SJ; Schoggins, JW; Rice, CM; Yamashita, M; Hatziioannou, T; Bieniasz, PD				Kane, Melissa; Yadav, Shalini S.; Bitzegeio, Julia; Kutluay, Sebla B.; Zang, Trinity; Wilson, Sam J.; Schoggins, John W.; Rice, Charles M.; Yamashita, Masahiro; Hatziioannou, Theodora; Bieniasz, Paul D.			MX2 is an interferon-induced inhibitor of HIV-1 infection	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS; NUCLEAR IMPORT; NONDIVIDING CELLS; LENTIVIRAL VECTOR; GENE; REPLICATION; DETERMINANTS; RESTRICTION; MACROPHAGES; PROTEIN	HIV-1 replication can be inhibited by type I interferon (IFN), and the expression of a number of gene products with anti-HIV-1 activity is induced by type I IFN1,2. However, none of the known antiretroviral proteins can account for the ability of type I IFN to inhibit early, preintegration phases of the HIV-1 replication cycle in human cells(3,4). Here, by comparing gene expression profiles in cell lines that differ in their ability to support the inhibitory action of IFN-alpha at early steps of the HIV-1 replication cycle, we identify myxovirus resistance 2 (MX2) as an interferon-induced inhibitor of HIV-1 infection. Expression of MX2 reduces permissiveness to a variety of lentiviruses, whereas depletion of MX2 using RNA interference reduces the anti-HIV-1 potency of IFN-alpha. HIV-1 reverse transcription proceeds normally in MX2-expressing cells, but 2-long terminal repeat circular forms of HIV-1 DNA are less abundant, suggesting that MX2 inhibits HIV-1 nuclear import, or destabilizes nuclear HIV-1 DNA. Consistent with this notion, mutations in the HIV-1 capsid protein that are known, or suspected, to alter the nuclear import pathways used by HIV-1 confer resistance to MX2, whereas preventing cell division increases MX2 potency. Overall, these findings indicate that MX2 is an effector of the anti-HIV-1 activity of type-I IFN, and suggest that MX2 inhibits HIV-1 infection by inhibiting capsid-dependent nuclear import of subviral complexes.	[Kane, Melissa; Yadav, Shalini S.; Bitzegeio, Julia; Kutluay, Sebla B.; Zang, Trinity; Wilson, Sam J.; Yamashita, Masahiro; Hatziioannou, Theodora; Bieniasz, Paul D.] Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Kane, Melissa; Yadav, Shalini S.; Bitzegeio, Julia; Kutluay, Sebla B.; Zang, Trinity; Wilson, Sam J.; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, New York, NY 10065 USA; [Yadav, Shalini S.; Zang, Trinity; Wilson, Sam J.; Bieniasz, Paul D.] Howard Hughes Med Inst, New York, NY 10016 USA; [Schoggins, John W.; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Bieniasz, PD (corresponding author), Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA.	pbienias@adarc.org		Wilson, Sam/0000-0002-6065-0895; Kane, Melissa/0000-0002-4580-1210	National Institutes of Health [R37AI64003, R01AI078788, R01AI100720, AI091707, AI057158, DK095031]; Greenberg Medical Research Institute; Starr Foundation; Howard Hughes Medical Institute; MRC [G0801822, MR/K024752/1] Funding Source: UKRI; Medical Research Council [G0801822, MR/K024752/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100720, R01AI078788, R01AI091707, U54AI057158, R37AI064003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenberg Medical Research Institute; Starr Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of The Rockefeller University Genomics Resource Center for assistance with the microarray experiments and members of the Bieniasz laboratory for discussion and advice. This work was supported by grants from the National Institutes of Health; R37AI64003 (to P.D.B.), R01AI078788 (to T.H.) R01AI100720 (to M.Y.), AI091707 to C.M.R., AI057158 (to I. Lipkin, Northeast Biodefense Center, subcontracted to C.M.R.) and DK095031 to J.W.S., the Greenberg Medical Research Institute and the Starr Foundation (C.M.R.) and by the Howard Hughes Medical Institute.	Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Bitzegeio J, 2013, J VIROL, V87, P3549, DOI 10.1128/JVI.03219-12; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Goujon C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-23; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hatziioannou T, 2004, J VIROL, V78, P6005, DOI 10.1128/JVI.78.11.6005-6012.2004; Hatziioannou T, 2003, EMBO J, V22, P385, DOI 10.1093/emboj/cdg042; HO DD, 1985, LANCET, V1, P602; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Kemler I, 2002, J VIROL, V76, P11889, DOI 10.1128/JVI.76.23.11889-11903.2002; King MC, 2004, P NATL ACAD SCI USA, V101, P8957, DOI 10.1073/pnas.0403167101; Koh Y, 2013, J VIROL, V87, P648, DOI 10.1128/JVI.01148-12; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Melen K, 1996, J BIOL CHEM, V271, P23478, DOI 10.1074/jbc.271.38.23478; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Rihn SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003461; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; Stoye JP, 1998, REV SCI TECH OIE, V17, P269, DOI 10.20506/rst.17.1.1080; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yamashita M, 2009, J VIROL, V83, P9835, DOI 10.1128/JVI.01084-09	30	357	366	6	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					563	+		10.1038/nature12653	http://dx.doi.org/10.1038/nature12653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24121441	Green Accepted			2022-12-24	WOS:000325988400057
J	Raymond, PA; Hartmann, J; Lauerwald, R; Sobek, S; McDonald, C; Hoover, M; Butman, D; Striegl, R; Mayorga, E; Humborg, C; Kortelainen, P; Durr, H; Meybeck, M; Ciais, P; Guth, P				Raymond, Peter A.; Hartmann, Jens; Lauerwald, Ronny; Sobek, Sebastian; McDonald, Cory; Hoover, Mark; Butman, David; Striegl, Robert; Mayorga, Emilio; Humborg, Christoph; Kortelainen, Pirkko; Duerr, Hans; Meybeck, Michel; Ciais, Philippe; Guth, Peter			Global carbon dioxide emissions from inland waters	NATURE			English	Article							SIZE DISTRIBUTION; LAKES; RESERVOIRS; ABUNDANCE; STREAMS; FLUXES; BUDGET; LAND; TRENDS; RIVERS	Carbon dioxide (CO2) transfer from inland waters to the atmosphere, known as CO2 evasion, is a component of the global carbon cycle. Global estimates of CO2 evasion have been hampered, however, by the lack of a framework for estimating the inland water surface area and gas transfer velocity and by the absence of a global CO2 database. Here we report regional variations in global inland water surface area, dissolved CO2 and gas transfer velocity. We obtain global CO2 evasion rates of 1.8(-0.25)(+0.25) petagrams of carbon (Pg C) per year from streams and rivers and 0.32(-0.26)(+0.52) Pg C yr(-1) from lakes and reservoirs, where the upper and lower limits are respectively the 5th and 95th confidence interval percentiles. The resulting global evasion rate of 2.1 Pg C yr(-1) is higher than previous estimates owing to a larger stream and river evasion rate. Our analysis predicts global hotspots in stream and river evasion, with about 70 per cent of the flux occurring over just 20 per cent of the land surface. The source of inland water CO2 is still not known with certainty and new studies are needed to research the mechanisms controlling CO2 evasion globally.	[Raymond, Peter A.; Hoover, Mark; Butman, David] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Hartmann, Jens; Lauerwald, Ronny] Univ Hamburg, Inst Geol, D-20146 Hamburg, Germany; [Lauerwald, Ronny] Univ Libre Bruxelles, Dept Earth & Environm Sci, B-1050 Brussels, Belgium; [Sobek, Sebastian] Uppsala Univ, Dept Ecol & Genet, SE-75236 Uppsala, Sweden; [McDonald, Cory] Wisconsin Dept Nat Resources, Madison, WI 53716 USA; [Butman, David; Striegl, Robert] US Geol Survey, Natl Res Program, Boulder, CO 80303 USA; [Mayorga, Emilio] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Humborg, Christoph] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Kortelainen, Pirkko] Finnish Environm Inst, FI-00251 Helsinki, Finland; [Duerr, Hans] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada; [Meybeck, Michel] Univ Paris 06, Unite Mixte Rech CNRS UPMC Sisyphe, F-75252 Paris 05, France; [Ciais, Philippe] LSCE IPSL, F-91191 Gif Sur Yvette, France; [Guth, Peter] US Naval Acad, Dept Oceanog, Annapolis, MD 21402 USA	Yale University; University of Hamburg; Universite Libre de Bruxelles; Uppsala University; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; Stockholm University; Finnish Environment Institute; University of Waterloo; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); United States Department of Defense; United States Navy; United States Naval Academy	Raymond, PA (corresponding author), Yale Univ, Sch Forestry & Environm Studies, 195 Prospect St, New Haven, CT 06511 USA.	peter.raymond@yale.edu	Hartmann, Jens/AAB-3313-2020; Ciais, Philippe/A-6840-2011; Butman, David/T-9380-2019; Raymond, Peter A/C-4087-2009; Dürr, Hans/F-6370-2010; Kortelainen, Pirkko/AAN-7045-2020; Humborg, Christoph/C-4756-2015; Hartmann, Jens/A-6306-2008	Hartmann, Jens/0000-0003-1878-9321; Ciais, Philippe/0000-0001-8560-4943; Raymond, Peter A/0000-0002-8564-7860; Dürr, Hans/0000-0001-5787-3994; Humborg, Christoph/0000-0002-0649-5599; Hartmann, Jens/0000-0003-1878-9321; Kortelainen, Pirkko/0000-0002-1448-0688; Butman, David/0000-0003-3520-7426; McDonald, Cory/0000-0002-1208-8471; Lauerwald, Ronny/0000-0001-5554-0897; Mayorga, Emilio/0000-0003-2574-4623	NASA [NNX11AH68G]; L-IPSL labex program; Formas; EU project GeoCarbon [U4603EUU1104]; DFG [EXC 177, DFG HA 4472/6-1]	NASA(National Aeronautics & Space Administration (NASA)); L-IPSL labex program; Formas(Swedish Research Council Formas); EU project GeoCarbon; DFG(German Research Foundation (DFG))	P.A.R. and M.H were partly funded by a NASA grant (NNX11AH68G) to P.A.R. P.A.R. also received support from a fellowship from L-IPSL labex program. S.S. was supported by Formas. R.L. and J.H. were funded by the EU project GeoCarbon (U4603EUU1104) and by DFG (EXC 177 and DFG HA 4472/6-1). This represents a contribution to the RECCAP process. R.S. and D.B. are part of the Inland Water Science Group of the USGS LandCarbon Project.	Abril G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002457; Abril G, NATURE IN PRESS; Alin SR, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001398; Aufdenkampe AK, 2011, FRONT ECOL ENVIRON, V9, P53, DOI 10.1890/100014; Barros N, 2011, NAT GEOSCI, V4, P593, DOI 10.1038/ngeo1211; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Buffam I, 2011, GLOBAL CHANGE BIOL, V17, P1193, DOI 10.1111/j.1365-2486.2010.02313.x; Butman D, 2011, NAT GEOSCI, V4, P839, DOI [10.1038/ngeo1294, 10.1038/NGEO1294]; Christensen TR, 2007, PHILOS T R SOC A, V365, P1643, DOI 10.1098/rsta.2007.2035; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; COLE JJ, 1994, SCIENCE, V265, P1568, DOI 10.1126/science.265.5178.1568; Cole JJ, 2001, MAR FRESHWATER RES, V52, P101, DOI 10.1071/MF00084; Davidson EA, 2010, J GEOPHYS RES-BIOGEO, V115, DOI [10.1029/20091G001202, 10.1029/2009JG001202]; Dodds PS, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.016115; Downing J., 2009, ENCY INLAND WATERS, P469, DOI DOI 10.1016/B978-012370626-3.00025-9; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Downing JA, 2012, INLAND WATERS, V2, P229, DOI 10.5268/IW-2.4.502; Duarte CM, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000637; Fekete BM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/1999GB001254; Frankignoulle M, 1998, SCIENCE, V282, P434, DOI 10.1126/science.282.5388.434; Humborg C, 2010, GLOBAL CHANGE BIOL, V16, P1966, DOI 10.1111/j.1365-2486.2009.02092.x; Jarvis A., 2008, EOS T AGU, V89, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Johnson MS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034619; Jonsson A, 2007, J HYDROL, V334, P141, DOI 10.1016/j.jhydrol.2006.10.003; KEMPE S, 1984, J GEOPHYS RES-ATMOS, V89, P4657, DOI 10.1029/JD089iD03p04657; KLING GW, 1991, SCIENCE, V251, P298, DOI 10.1126/science.251.4991.298; Kortelainen P, 2006, GLOBAL CHANGE BIOL, V12, P1554, DOI 10.1111/j.1365-2486.2006.01167.x; Lauerwald R, 2013, CHEM GEOL, V337, P114, DOI 10.1016/j.chemgeo.2012.11.011; Lauerwald R, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001820; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Leopold L.B., 1953, HYDRAULIC GEOMETRY S; Maberly SC, 2013, NAT CLIM CHANGE, V3, P391, DOI [10.1038/NCLIMATE1748, 10.1038/nclimate1748]; McDonald CP, 2013, GLOBAL BIOGEOCHEM CY, V27, P285, DOI 10.1002/gbc.20032; McDonald CP, 2012, LIMNOL OCEANOGR, V57, P597, DOI 10.4319/lo.2012.57.2.0597; Meybeck M, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002540; Meybeck M., 1995, PHYS CHEM LAKES, P1, DOI DOI 10.1007/978-3-642-85132-2_1; PARK PK, 1969, SCIENCE, V166, P867, DOI 10.1126/science.166.3907.867; Prigent C, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007847; Raymond P.A., 2012, LIMNOL OCEANOGR FLUI, V2, P41, DOI [10.1215/21573689-1597669, DOI 10.1215/21573689-1597669]; Raymond PA, 1997, ESTUARIES, V20, P381, DOI 10.2307/1352351; Raymond PA, 2008, NATURE, V451, P449, DOI 10.1038/nature06505; Read JS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051886; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/NGEO1830, 10.1038/ngeo1830]; Richey JE, 2004, SCOPE SER, V62, P329; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Sabine CL, 2004, SCOPE SER, V62, P17; Striegl RG, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2012GB004306; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298	50	1271	1348	82	993	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					355	359		10.1038/nature12760	http://dx.doi.org/10.1038/nature12760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24256802	Green Submitted			2022-12-24	WOS:000327163200032
J	Jin, FL; Li, Y; Dixon, JR; Selvaraj, S; Ye, Z; Lee, AY; Yen, CA; Schmitt, AD; Espinoza, CA; Ren, B				Jin, Fulai; Li, Yan; Dixon, Jesse R.; Selvaraj, Siddarth; Ye, Zhen; Lee, Ah Young; Yen, Chia-An; Schmitt, Anthony D.; Espinoza, Celso A.; Ren, Bing			A high-resolution map of the three-dimensional chromatin interactome in human cells	NATURE			English	Article							GENE-EXPRESSION; ORGANIZATION; GENOMES; PRINCIPLES; LANDSCAPE; ENHANCERS; INSIGHTS	A large number of cis-regulatory sequences have been annotated in the human genome(1,2), but defining their target genes remains a challenge(3). One strategy is to identify the long-range looping interactions at these elements with the use of chromosome conformation capture (3C)-based techniques(4). However, previous studies lack either the resolution or coverage to permit a whole-genome, unbiased view of chromatin interactions. Here we report a comprehensive chromatin interaction map generated in human fibroblasts using a genome-wide 3C analysis method (Hi-C)(5). We determined over one million long-range chromatin interactions at 5-10-kb resolution, and uncovered general principles of chromatin organization at different types of genomic features. We also characterized the dynamics of promoter-enhancer contacts after TNF-alpha signalling in these cells. Unexpectedly, we found that TNF-alpha-responsive enhancers are already in contact with their target promoters before signalling. Such pre-existing chromatin looping, which also exists in other cell types with different extracellular signalling, is a strong predictor of gene induction. Our observations suggest that the three-dimensional chromatin landscape, once established in a particular cell type, is relatively stable and could influence the selection or activation of target genes by a ubiquitous transcription activator in a cell-specific manner.	[Jin, Fulai; Li, Yan; Dixon, Jesse R.; Selvaraj, Siddarth; Ye, Zhen; Lee, Ah Young; Yen, Chia-An; Schmitt, Anthony D.; Espinoza, Celso A.; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Dixon, Jesse R.] Univ Calif San Diego, UCSD Med Scientist Training Program, Sch Med, La Jolla, CA 92093 USA; [Selvaraj, Siddarth] Univ Calif San Diego, UCSD Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Schmitt, Anthony D.] Univ Calif San Diego, UCSD Biomed Sci Grad Program, Sch Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Moores Canc Ctr, Dept Cellular & Mol Med,Inst Genome Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Dixon, Jesse/AAT-2914-2020	Dixon, Jesse/0000-0002-6273-2181; Jin, Fulai/0000-0003-0025-4337	Ludwig Institute for Cancer Research; California Institute of Regenerative Medicine [RN2-00905]; US National Institutes of Health [P50 GM085764-03, U01 ES017166]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, T32GM008666, T32GM007198] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. K. Glass for sharing the GRO-seq protocol, and S. Kuan and L. Edsall for assistance with high-throughput DNA sequencing and the initial processing. This work is supported by funds from the Ludwig Institute for Cancer Research, the California Institute of Regenerative Medicine (RN2-00905) and US National Institutes of Health (P50 GM085764-03 and U01 ES017166).	Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/nmeth.2148, 10.1038/NMETH.2148]; Jin FL, 2011, TRANSCR-AUSTIN, V2, P226, DOI 10.4161/trns.2.5.17712; Jin FL, 2011, P NATL ACAD SCI USA, V108, P5290, DOI 10.1073/pnas.1017214108; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mercer TR, 2013, NAT GENET, V45, P852, DOI 10.1038/ng.2677; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	30	864	882	1	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					290	294		10.1038/nature12644	http://dx.doi.org/10.1038/nature12644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24141950	Green Accepted			2022-12-24	WOS:000326894200057
J	Colautti, RI; Barrett, SCH				Colautti, Robert I.; Barrett, Spencer C. H.			Rapid Adaptation to Climate Facilitates Range Expansion of an Invasive Plant	SCIENCE			English	Article							LOOSESTRIFE LYTHRUM-SALICARIA; PURPLE LOOSESTRIFE; NORTH-AMERICA; EVOLUTION; POPULATIONS; CONSTRAINTS; HYPOTHESIS; LYTHRACEAE; PHENOLOGY; HERBIVORY	Adaptation to climate, evolving over contemporary time scales, could facilitate rapid range expansion across environmental gradients. Here, we examine local adaptation along a climatic gradient in the North American invasive plant Lythrum salicaria. We show that the evolution of earlier flowering is adaptive at the northern invasion front where it increases fitness as much as, or more than, the effects of enemy release and the evolution of increased competitive ability. However, early flowering decreases investment in vegetative growth, which reduces fitness by a factor of 3 in southern environments where the North American invasion commenced. Our results demonstrate that local adaptation can evolve quickly during range expansion, overcoming environmental constraints on propagule production.	[Colautti, Robert I.; Barrett, Spencer C. H.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada	University of Toronto	Colautti, RI (corresponding author), Univ British Columbia, Dept Bot, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	rob.colautti@botany.ubc.ca	Colautti, Robert/AAT-1270-2021; Barrett, Spencer CH/M-3751-2013; Barrett, Spencer C.H./S-5782-2019	Colautti, Robert/0000-0003-4213-0711; Barrett, Spencer C.H./0000-0002-7762-3455	Ontario Government; University of Toronto; Canada Research Chair's program; Ontario Premier's Discovery Award; Natural Sciences and Engineering Research Council of Canada	Ontario Government; University of Toronto(University of Toronto); Canada Research Chair's program(Canada Research Chairs); Ontario Premier's Discovery Award; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank D. Carr and A. Weis for assistance at BEF and KSR, respectively, and K. Pols (Millson Forestry Service) and G. Paquette for assistance in Timmins. We also thank S. Yakimowski, M. Johnson, J. Alexander, J. Stinchcombe, K. Rice, K. Dlugosch, and L. Rieseberg for helpful comments. This work was supported by Ontario Government and University of Toronto graduate scholarships (to R. I. C.), the Canada Research Chair's program and an Ontario Premier's Discovery Award for funding (to S. C. H. B.), and the Natural Sciences and Engineering Research Council of Canada for graduate and postdoctoral funding to R. I. C. and Discovery Grants to S. C. H. B. The Original data and analysis are available from the Dryad Data Repository (DOI: 10.5061/dryad.878m3).	Alexander JM, 2009, ECOLOGY, V90, P612, DOI 10.1890/08-0453.1; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Chun YJ, 2009, MOL ECOL, V18, P3020, DOI 10.1111/j.1365-294X.2009.04254.x; Clewley GD, 2012, J APPL ECOL, V49, P1287, DOI 10.1111/j.1365-2664.2012.02209.x; Colautti RI, 2011, EVOLUTION, V65, P2514, DOI 10.1111/j.1558-5646.2011.01313.x; Colautti RI, 2010, INT J PLANT SCI, V171, P960, DOI 10.1086/656444; Colautti RI, 2010, P ROY SOC B-BIOL SCI, V277, P1799, DOI 10.1098/rspb.2009.2231; Colautti RI, 2009, EVOL APPL, V2, P187, DOI 10.1111/j.1752-4571.2008.00053.x; De Poorter M., 2004, 100 ESPECIES EXOTICA, P1; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Houghton-Thompson J, 2005, ANN BOT-LONDON, V96, P877, DOI 10.1093/aob/mci240; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Hunt-Joshi TR, 2004, ECOL APPL, V14, P1574, DOI 10.1890/03-5181; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Montague JL, 2008, J EVOLUTION BIOL, V21, P234, DOI 10.1111/j.1420-9101.2007.01456.x; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Schat M, 2005, ENVIRON ENTOMOL, V34, P906, DOI 10.1603/0046-225X-34.4.906; Thompson DW., 1987, SPREAD IMPACT CONTRO; Willis AJ, 1999, BIOCONTROL SCI TECHN, V9, P567, DOI 10.1080/09583159929523	21	291	295	7	423	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					364	366		10.1126/science.1242121	http://dx.doi.org/10.1126/science.1242121			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136968				2022-12-24	WOS:000325755100046
J	McLennan, SM; Anderson, RB; Bell, JF; Bridges, JC; Calef, F; Campbell, JL; Clark, BC; Clegg, S; Conrad, P; Cousin, A; Des Marais, DJ; Dromart, G; Dyar, MD; Edgar, LA; Ehlmann, BL; Fabre, C; Forni, O; Gasnault, O; Gellert, R; Gordon, S; Grant, JA; Grotzinger, JP; Gupta, S; Herkenhoff, KE; Hurowitz, JA; King, PL; Le Mouelic, S; Leshin, LA; Leveille, R; Lewis, KW; Mangold, N; Maurice, S; Ming, DW; Morris, RV; Nachon, M; Newsom, HE; Ollila, AM; Perrett, GM; Rice, MS; Schmidt, ME; Schwenzer, SP; Stack, K; Stolper, EM; Sumner, DY; Treiman, AH; VanBommel, S; Vaniman, DT; Vasavada, A; Wiens, RC; Yingst, RA				McLennan, S. M.; Anderson, R. B.; Bell, J. F., III; Bridges, J. C.; Calef, F., III; Campbell, J. L.; Clark, B. C.; Clegg, S.; Conrad, P.; Cousin, A.; Des Marais, D. J.; Dromart, G.; Dyar, M. D.; Edgar, L. A.; Ehlmann, B. L.; Fabre, C.; Forni, O.; Gasnault, O.; Gellert, R.; Gordon, S.; Grant, J. A.; Grotzinger, J. P.; Gupta, S.; Herkenhoff, K. E.; Hurowitz, J. A.; King, P. L.; Le Mouelic, S.; Leshin, L. A.; Leveille, R.; Lewis, K. W.; Mangold, N.; Maurice, S.; Ming, D. W.; Morris, R. V.; Nachon, M.; Newsom, H. E.; Ollila, A. M.; Perrett, G. M.; Rice, M. S.; Schmidt, M. E.; Schwenzer, S. P.; Stack, K.; Stolper, E. M.; Sumner, D. Y.; Treiman, A. H.; VanBommel, S.; Vaniman, D. T.; Vasavada, A.; Wiens, R. C.; Yingst, R. A.		MSL Sci Team	Elemental Geochemistry of Sedimentary Rocks at Yellowknife Bay, Gale Crater, Mars	SCIENCE			English	Article							CHEMCAM INSTRUMENT SUITE; CLAY MINERAL FORMATION; SILICICLASTIC SEDIMENTS; ROVER; PETROGENESIS; PROVENANCE; CHEMISTRY; PROFILES; HISTORY; ONTARIO	Sedimentary rocks examined by the Curiosity rover at Yellowknife Bay, Mars, were derived from sources that evolved from an approximately average martian crustal composition to one influenced by alkaline basalts. No evidence of chemical weathering is preserved, indicating arid, possibly cold, paleoclimates and rapid erosion and deposition. The absence of predicted geochemical variations indicates that magnetite and phyllosilicates formed by diagenesis under low-temperature, circumneutral pH, rock-dominated aqueous conditions. Analyses of diagenetic features (including concretions, raised ridges, and fractures) at high spatial resolution indicate that they are composed of iron-and halogen-rich components, magnesium-iron-chlorine-rich components, and hydrated calcium sulfates, respectively. Composition of a cross-cutting dike-like feature is consistent with sedimentary intrusion. The geochemistry of these sedimentary rocks provides further evidence for diverse depositional and diagenetic sedimentary environments during the early history of Mars.	[McLennan, S. M.; Hurowitz, J. A.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Anderson, R. B.; Herkenhoff, K. E.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Bell, J. F., III; Edgar, L. A.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Bridges, J. C.] Univ Leicester, Dept Phys & Astron, Space Res Ctr, Leicester LE1 7RH, Leics, England; [Calef, F., III; Ehlmann, B. L.; Vasavada, A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Campbell, J. L.; Gellert, R.; Perrett, G. M.; VanBommel, S.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Clark, B. C.] Space Sci Inst, Boulder, CO 80301 USA; [Clegg, S.; Cousin, A.] Los Alamos Natl Lab, Div Chem, Los Alamos, NM 87545 USA; [Conrad, P.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Des Marais, D. J.] NASA, Ames Res Ctr, Dept Space Sci, Moffett Field, CA 94035 USA; [Dromart, G.] Univ Lyon, Lab Geol Lyon, F-69364 Lyon, France; [Dyar, M. D.] Mt Holyoke Coll, Dept Astron, S Hadley, MA 01075 USA; [Ehlmann, B. L.; Grotzinger, J. P.; Rice, M. S.; Stack, K.; Stolper, E. M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Fabre, C.] Fac Sci, CNRS Georesources, UMR 7359, F-54506 Vandoeuvre Les Nancy, France; [Forni, O.; Gasnault, O.] Univ Toulouse, IRAP, UPS OMP CNRS, F-31028 Toulouse 4, France; [Gordon, S.; Newsom, H. E.; Ollila, A. M.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Grant, J. A.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Sci, Washington, DC 20560 USA; [Gupta, S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [King, P. L.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Le Mouelic, S.; Mangold, N.; Nachon, M.] LPGN CNRS UMR 6112, Lab Planetol & Geodynam, F-4432 Nantes, France; [Le Mouelic, S.; Mangold, N.; Nachon, M.] Univ Nantes, F-4432 Nantes, France; [Leshin, L. A.] Rensselaer Polytech Inst, Sch Sci, Troy, NY 12180 USA; [Leveille, R.] Canadian Space Agcy, St Hubert, PQ J3Y 8Y9, Canada; [Lewis, K. W.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Maurice, S.] Observ Midi Pyrenees, F-31400 Toulouse, France; [Ming, D. W.; Morris, R. V.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Schmidt, M. E.] Brock Univ, Dept Earth Sci, St Catharines, ON L2S 3A1, Canada; [Schwenzer, S. P.] Open Univ, CEPSAR, Milton Keynes MK7 6AA, Bucks, England; [Sumner, D. Y.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Treiman, A. H.] Lunar Planetary Sci Inst, Houston, TX 77058 USA; [Vaniman, D. T.; Yingst, R. A.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Wiens, R. C.] Los Alamos Natl Lab, Int Space & Response Div, Los Alamos, NM 87545 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; University of Leicester; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Guelph; United States Department of Energy (DOE); Los Alamos National Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Ecole Normale Superieure de Lyon (ENS de LYON); Mount Holyoke College; California Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lorraine; University of New Mexico; Smithsonian Institution; Imperial College London; Australian National University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite; Rensselaer Polytechnic Institute; Canadian Space Agency; Princeton University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Brock University; Open University - UK; University of California System; University of California Davis; United States Department of Energy (DOE); Los Alamos National Laboratory	McLennan, SM (corresponding author), SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA.	scott.mclennan@stonybrook.edu	Ramos, Miguel/K-2230-2014; Stack Morgan, Kathryn/AGY-7985-2022; Teinturier, Samuel/AAS-8663-2020; Benna, Mehdi/F-3489-2012; Dworkin, Jason P./C-9417-2012; szopa, cyril/C-6865-2015; Hayes, Alexander G/P-2024-2014; Navarro-González, Rafael/D-1748-2009; Balic-Zunic, Tonci/A-6362-2013; Sumner, Dawn Y/E-8744-2011; Zorzano, María-Paz/F-2184-2015; Schwenzer, Susanne P/H-6992-2019; Romeral Planelló, Julio J./T-1788-2017; Rodriguez-Manfredi, Jose/L-8001-2014; Gomez-Elvira, Javier/K-5829-2014; Prats, Benito/F-9467-2019; Harri, Ari-Matti/C-7142-2012; Muller, Jan-Peter/Q-8886-2019; Franz, Heather B/F-3508-2012; King, Penelope/A-1791-2011; Blanco, Juan Jose/E-3627-2014; Steele, Andrew/A-3573-2013; Avalos, Juan Jose Blanco/AAB-9447-2021; GEFFROY, Claude/AAB-9152-2019; Rodriguez-Manfredi, Jose/AAG-9826-2021; Lemmon, Mark T/E-9983-2010; FABRE, Cécile/B-5827-2012; Gómez, Felipe/L-7315-2014; Glavin, Daniel P/D-6194-2012; Stipp, Susan L.S./B-8494-2019; De Pablo, Miguel Ángel/J-6442-2014; Malakhov, Alexey Vladimirovich/F-7953-2017; Martin-Torres, Javier/G-6329-2015; Gasnault, Olivier/F-4327-2010; Vicenzi, Edward/T-9430-2017	Ramos, Miguel/0000-0003-3648-6818; Teinturier, Samuel/0000-0003-1755-9524; Dworkin, Jason P./0000-0002-3961-8997; szopa, cyril/0000-0002-0090-4056; Hayes, Alexander G/0000-0001-6397-2630; Navarro-González, Rafael/0000-0002-6078-7621; Balic-Zunic, Tonci/0000-0003-1687-1233; Sumner, Dawn Y/0000-0002-7343-2061; Zorzano, María-Paz/0000-0002-4492-9650; Schwenzer, Susanne P/0000-0002-9608-0759; Romeral Planelló, Julio J./0000-0002-2205-067X; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Gomez-Elvira, Javier/0000-0002-9068-9846; Prats, Benito/0000-0003-3869-3351; Harri, Ari-Matti/0000-0001-8541-2802; Muller, Jan-Peter/0000-0002-5077-3736; King, Penelope/0000-0002-8364-9168; Blanco, Juan Jose/0000-0002-8666-0696; Steele, Andrew/0000-0001-9643-2841; Avalos, Juan Jose Blanco/0000-0002-8666-0696; GEFFROY, Claude/0000-0002-2731-9658; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Lemmon, Mark T/0000-0002-4504-5136; FABRE, Cécile/0000-0001-8627-4050; Gómez, Felipe/0000-0001-9977-7060; Glavin, Daniel P/0000-0001-7779-7765; Stipp, Susan L.S./0000-0001-7009-643X; De Pablo, Miguel Ángel/0000-0002-4496-2741; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Martin-Torres, Javier/0000-0001-6479-2236; Gasnault, Olivier/0000-0002-6979-9012; Vicenzi, Edward/0000-0003-2085-6546; Clegg, Sam/0000-0002-0338-0948; Wilson, Sharon/0000-0001-8872-8546; Gupta, Sanjeev/0000-0001-6415-1332; Johnson, Jeffrey/0000-0002-5586-4901; McLennan, Scott/0000-0003-4259-7178; Rice, Melissa/0000-0002-8370-4139; Campbell, John/0000-0002-6752-3493; Grant, John/0000-0001-8276-1281; Le Mouelic, Stephane/0000-0001-5260-1367	French Space Agency; NASA; CNES; Canadian Space Agency; NSERC (Canada); United Kingdom Space Agency (UK); Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/J005339/1, ST/J005169/1, ST/I003118/1] Funding Source: researchfish	French Space Agency(Centre National D'etudes Spatiales); NASA(National Aeronautics & Space Administration (NASA)); CNES(Centre National D'etudes Spatiales); Canadian Space Agency(Canadian Space Agency); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); United Kingdom Space Agency (UK); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	Much of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. Development and operation of the ChemCam and APXS instruments were also supported by funds from the French Space Agency, CNES, and the Canadian Space Agency. Organizations supporting research include NASA, the Canadian Space Agency, NSERC (Canada), and the United Kingdom Space Agency (UK). Chemical data presented here are derived from archived data sets in the NASA Planetary Data System (PDS), http://pds-geosciences.wustl.edu/missions/msl. We are grateful to the MSL engineering and management teams for making the mission and this scientific investigation possible and to science team members who contributed to mission operations. S. M. M. thanks Lamont-Doherty Earth Observatory of Columbia University, and especially S. Hemming, for hospitality during a sabbatical when the manuscript was being prepared.	Basaltic Volcanism Study Project, 1981, BAS VOLC TERR PLAN; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Blake DF, 2013, SCIENCE, V341, DOI 10.1126/science.1239505; Chan LH, 2002, EARTH PLANET SC LETT, V201, P187, DOI 10.1016/S0012-821X(02)00707-0; Chan MA, 2007, GEOFLUIDS, V7, P356, DOI 10.1111/j.1468-8123.2007.00187.x; Clark BC, 2005, EARTH PLANET SC LETT, V240, P73, DOI 10.1016/j.epsl.2005.09.040; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; Fedo CM, 1997, PRECAMBRIAN RES, V84, P17, DOI 10.1016/S0301-9268(96)00058-7; Gellert R., 2013, LUNAR PLANET SCI C, V44; Griffith LL, 1997, J GEOPHYS RES-PLANET, V102, P9135, DOI 10.1029/96JE02939; Grotzinger JP, 2014, SCIENCE, V343, DOI 10.1126/science.1242777; Grotzinger J. P., 2012, SEPM SPEC PUBL, V12; Hanson G. N., 1993, PROCESSES CONTROLLIN, V284, P21; Hazen RM, 2008, AM MINERAL, V93, P1693, DOI 10.2138/am.2008.2955; Hurowitz JA, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002515; Hurowitz JA, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002391; Hurowitz JA, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002795; Hutchison R., 2004, METEORITES PETROLOGI; King PL, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002482; Knoll AH, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE002949; Lu FH, 2002, CHEM GEOL, V192, P149, DOI 10.1016/S0009-2541(02)00009-8; MARTIN JM, 1979, MAR CHEM, V7, P173, DOI 10.1016/0304-4203(79)90039-2; Martinez NC, 2010, GEOLOGY, V38, P159, DOI 10.1130/G30487.1; Maurice S, 2012, SPACE SCI REV, V170, P95, DOI 10.1007/s11214-012-9912-2; McGlynn IO, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003861; McGlynn IO, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003712; McLennan S., 2008, MARTIAN SURFACE COMP, P541, DOI [DOI 10.1017/CBO9780511536076.025, 10.1017/CBO9780511536076.025]; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; McSween HY, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002698; Melosh H.J., 2011, PLANETARY SURFACE PR, DOI 10.1017/CBO9780511977848; MICHALOPOULOS P, 1995, SCIENCE, V270, P614, DOI 10.1126/science.270.5236.614; Ming DW, 2014, SCIENCE, V343, DOI 10.1126/science.1245267; Murchie SL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003342; Naumov MV, 2005, GEOFLUIDS, V5, P165, DOI 10.1111/j.1468-8123.2005.00092.x; Nekvasil H, 2009, METEORIT PLANET SCI, V44, P853, DOI 10.1111/j.1945-5100.2009.tb00773.x; Nesbitt HW, 2009, PRECAMBRIAN RES, V174, P16, DOI 10.1016/j.precamres.2009.06.006; Nesbitt H.W., 2003, GEOCHEMISTRY SEDIMEN, V4, P39; NESBITT HW, 1982, NATURE, V299, P715, DOI 10.1038/299715a0; Nesbitt HW, 1996, J GEOL, V104, P525, DOI 10.1086/629850; NESBITT HW, 1992, AM J SCI, V292, P740, DOI 10.2475/ajs.292.10.740; Nesbitt HW, 1996, SEDIMENTOLOGY, V43, P341, DOI 10.1046/j.1365-3091.1996.d01-12.x; Ollila A. M., 2013, LUNAR PLANET SCI C, V44; Saha S, 2010, SEDIMENT GEOL, V228, P1, DOI 10.1016/j.sedgeo.2010.03.009; Schmidt M. E., 2013, LUNAR PLANET SCI C; SLINGERLAND R, 1986, ANNU REV EARTH PL SC, V14, P113, DOI 10.1146/annurev.ea.14.050186.000553; Squyres SW, 2012, SCIENCE, V336, P570, DOI 10.1126/science.1220476; Squyres S. W., 2005, SEDIMENTARY GEOLOGY; STAMATELOPOULOUSEYMOUR K, 1980, CAN J EARTH SCI, V17, P1576, DOI 10.1139/e80-164; STEWART AD, 1993, T ROY SOC EDIN-EARTH, V84, P73, DOI 10.1017/S0263593300005939; Stolper EM, 2013, SCIENCE, V341, DOI 10.1126/science.1239463; SUTTNER LJ, 1986, J SEDIMENT PETROL, V56, P329; Taylor S.R., 1985, CONTINENTAL CRUST IT; Taylor SR, 2009, PLANETARY CRUSTS: THEIR COMPOSITION, ORIGIN AND EVOLUTION, P1; Tosca NJ, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003700; Tosca NJ, 2005, EARTH PLANET SC LETT, V240, P122, DOI 10.1016/j.epsl.2005.09.042; Vaniman DT, 2014, SCIENCE, V343, DOI 10.1126/science.1243480; Wang A, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002516; Wiens RC, 2012, SPACE SCI REV, V170, P167, DOI 10.1007/s11214-012-9902-4; Yen AS, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002797; Yen AS, 2005, NATURE, V436, P49, DOI 10.1038/nature03637; Young GM, 1999, GEOL SOC AM BULL, V111, P264, DOI 10.1130/0016-7606(1999)111<0264:PAPOTG>2.3.CO;2; Young GM, 1998, J SEDIMENT RES, V68, P448, DOI 10.2110/jsr.68.448	62	230	235	9	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1244734	10.1126/science.1244734	http://dx.doi.org/10.1126/science.1244734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24324274	Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000330039300004
J	Meyer, M; Fu, QM; Aximu-Petri, A; Glocke, I; Nickel, B; Arsuaga, JL; Martinez, I; Gracia, A; de Castro, JMB; Carbonell, E; Paabo, S				Meyer, Matthias; Fu, Qiaomei; Aximu-Petri, Ayinuer; Glocke, Isabelle; Nickel, Birgit; Arsuaga, Juan-Luis; Martinez, Ignacio; Gracia, Ana; Maria Bermudez de Castro, Jose; Carbonell, Eudald; Paeaebo, Svante			A mitochondrial genome sequence of a hominin from Sima de los Huesos	NATURE			English	Article							MIDDLE-PLEISTOCENE SITE; DNA; ATAPUERCA; ANCIENT; SIERRA; EVOLUTION; (SIERRA; SPAIN).; CAVE; ALIGNMENT	Excavations of a complex of caves in the Sierra de Atapuerca in northern Spain have unearthed hominin fossils that range in age from the early Pleistocene to the Holocene(1). One of these sites, the 'Sima de los Huesos' ('pit of bones'), has yielded the world's largest assemblage of Middle Pleistocene hominin fossils(2,3), consisting of at least 28 individuals(4) dated to over 300,000 years ago(5). The skeletal remains share a number of morphological features with fossils classified as Homo heidelbergensis and also display distinct Neanderthal-derived traits(6-8). Here we determine an almost complete mitochondrial genome sequence of a hominin from Sima de los Huesos and show that it is closely related to the lineage leading to mitochondrial genomes of Denisovans(9,10), an eastern Eurasian sister group to Neanderthals. Our results pave the way for DNA research on hominins from the Middle Pleistocene.	[Meyer, Matthias; Fu, Qiaomei; Aximu-Petri, Ayinuer; Glocke, Isabelle; Nickel, Birgit; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Fu, Qiaomei] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China; [Arsuaga, Juan-Luis; Martinez, Ignacio; Gracia, Ana] Univ Complutense Madrid, Inst Salud Carlos III, Ctr Invest Evoluc & Comportamiento Humanos, Madrid 28029, Spain; [Arsuaga, Juan-Luis] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, E-28040 Madrid, Spain; [Martinez, Ignacio; Gracia, Ana] Univ Alcala, Dept Geog & Geol, Area Paleontol, Madrid 28871, Spain; [Maria Bermudez de Castro, Jose] Ctr Nacl Invest Evoluc Humana, Burgos 09002, Spain; [Carbonell, Eudald] Inst Catala Paleoecol Humana & Evolucio Social, Tarragona 43007, Spain; [Carbonell, Eudald] Univ Rovira & Virgili, Dept Hist & Hist Art, Area Prehist, Tarragona 43002, Spain	Max Planck Society; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Complutense University of Madrid; Instituto de Salud Carlos III; Complutense University of Madrid; Universidad de Alcala; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili	Meyer, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Deutsch Pl 6, D-04103 Leipzig, Germany.	mmeyer@eva.mpg.de	Carbonell, Eudald/G-3003-2015	Bermudez de Castro, Jose Maria/0000-0003-1314-3273; martinez, ignacio/0000-0002-1835-9199; Arsuaga, Juan Luis/0000-0001-5361-2295	Max Planck ?Society; Presidential Innovation Fund; Junta de Castilla y Leon; Fundacion Atapuerca; Spanish Ministerio de Ciencia e Innovacion [CGL2009-12703-C03]; Spanish Ministerio de Economia y Competitividad [CGL2012-38434-C03]	Max Planck ?Society(Max Planck SocietyFoundation CELLEX); Presidential Innovation Fund; Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion Atapuerca; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government)	We thank J. Dabney, M. Dannemann, C. de Filippo, S. Lippold, K. Prufer, M. Slatkin, M. Stiller, C. Valdiosera and B. Viola for discussions and comments on the manuscript; G. Renaud and U. Stenzel for help with sequence data processing; B. Hober and A. Weihmann for performing the sequencing runs; M. Gansauge, P. Korlevic, R. Rodriguez and I. Urena for help in the laboratory; M. Schreiber for help with graphics; J. Trueba for providing the fossil image; M. Cruz Ortega for restoration of the fossil and the rest of the members of the Sima de los Huesos excavation team ?for decades of continuous efforts. Genetics work was funded by the Max Planck ?Society and its Presidential Innovation Fund. Field work at the Sierra de Atapuerca sites is funded by the Junta de Castilla y Leon and the Fundacion Atapuerca. ?Research was supported by Spanish Ministerio de Ciencia e Innovacion (project CGL2009-12703-C03) and Spanish Ministerio de Economia y Competitividad (project CGL2012-38434-C03).	Arsuaga JL, 1997, J HUM EVOL, V33, P109, DOI 10.1006/jhev.1997.0132; ARSUAGA JL, 1993, NATURE, V362, P534, DOI 10.1038/362534a0; Arsuaga JL, 1997, J HUM EVOL, V33, P219, DOI 10.1006/jhev.1997.0133; Arsuaga JL, 1997, SCIENCE, V277, P1086, DOI 10.1126/science.277.5329.1086; Bischoff JL, 1997, J HUM EVOL, V33, P129, DOI 10.1006/jhev.1997.0130; Bjork A, 2011, MOL BIOL EVOL, V28, P615, DOI 10.1093/molbev/msq227; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Carbonell E, 2005, P NATL ACAD SCI USA, V102, P5674, DOI 10.1073/pnas.0501841102; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carretero JM, 2012, J HUM EVOL, V62, P242, DOI 10.1016/j.jhevol.2011.11.004; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; deCastro JMB, 1997, J HUM EVOL, V33, P333, DOI 10.1006/jhev.1997.0110; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kircher M, 2012, METHODS MOL BIOL, V840, P197, DOI 10.1007/978-1-61779-516-9_23; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Arsuaga JL, 2010, P NATL ACAD SCI USA, V107, P8910, DOI 10.1073/pnas.0914614107; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Martinez I, 1997, J HUM EVOL, V33, P283, DOI 10.1006/jhev.1997.0155; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Ortega AI, 2013, GEOMORPHOLOGY, V196, P122, DOI 10.1016/j.geomorph.2012.05.031; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Renaud G, 2013, BIOINFORMATICS, V29, P1208, DOI 10.1093/bioinformatics/btt117; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stone AC, 2010, PHILOS T R SOC B, V365, P3277, DOI 10.1098/rstb.2010.0096; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311; Valdiosera C, 2006, BIOL LETT-UK, V2, P601, DOI 10.1098/rsbl.2006.0515; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Zsurka G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-270	51	317	327	5	267	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					403	+		10.1038/nature12788	http://dx.doi.org/10.1038/nature12788			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24305051	Green Accepted			2022-12-24	WOS:000329621800043
J	Fujita, Y; Venterink, HO; van Bodegom, PM; Douma, JC; Heil, GW; Holzel, N; Jablonska, E; Kotowski, W; Okruszko, T; Pawlikowski, P; de Ruiter, PC; Wassen, MJ				Fujita, Yuki; Venterink, Harry Olde; van Bodegom, Peter M.; Douma, Jacob C.; Heil, Gerrit W.; Hoelzel, Norbert; Jablonska, Ewa; Kotowski, Wiktor; Okruszko, Tomasz; Pawlikowski, Pawel; de Ruiter, Peter C.; Wassen, Martin J.			Low investment in sexual reproduction threatens plants adapted to phosphorus limitation	NATURE			English	Article							BIOLOGICAL STOICHIOMETRY; ENDANGERED PLANTS; LIFE-HISTORY; NITROGEN; TRAITS; PATTERNS; ACQUISITION; STRATEGIES; ALLOCATION; DATABASE	Plant species diversity in Eurasian wetlands and grasslands depends not only on productivity but also on the relative availability of nutrients, particularly of nitrogen and phosphorus(1-4). Here we show that the impacts of nitrogen: phosphorus stoichiometry on plant species richness can be explained by selected plant life-history traits, notably by plant investments in growth versus reproduction. In 599 Eurasian sites with herbaceous vegetation we examined the relationship between the local nutrient conditions and community-mean life-history traits. We found that compared with plants in nitrogen-limited communities, plants in phosphorus-limited communities invest little in sexual reproduction (for example, less investment in seed, shorter flowering period, longer lifespan) and have conservative leaf economy traits (that is, a low specific leaf area and a high leaf dry-matter content). Endangered species were more frequent in phosphorus-limited ecosystems and they too invested little in sexual reproduction. The results provide new insight into how plant adaptations to nutrient conditions can drive the distribution of plant species in natural ecosystems and can account for the vulnerability of endangered species.	[Fujita, Yuki] KWR Watercycle Res Inst, NL-3430 BB Nieuwegein, Netherlands; [Venterink, Harry Olde] Vrije Univ Brussel, B-1050 Brussels, Belgium; [van Bodegom, Peter M.] Vrije Univ Amsterdam, Dept Ecol Sci, NL-1081 HV Amsterdam, Netherlands; [Douma, Jacob C.] Wageningen Univ, Ctr Crop Syst Anal, NL-6708 PB Wageningen, Netherlands; [Heil, Gerrit W.] Univ Utrecht, Fac Sci, NL-3584 CC Utrecht, Netherlands; [Hoelzel, Norbert] Univ Munster, Fac Geosci, Inst Landscape Ecol, D-48149 Munster, Germany; [Jablonska, Ewa; Kotowski, Wiktor; Pawlikowski, Pawel] Univ Warsaw, Inst Bot, Dept Plant Ecol & Environm Conservat, Warsaw, Poland; [Okruszko, Tomasz] Warsaw Univ Life Sci, Fac Civil & Environm Engn, PL-02722 Warsaw, Poland; [de Ruiter, Peter C.] Wageningen Univ, NL-6700 AC Wageningen, Netherlands; [Wassen, Martin J.] Univ Utrecht, Copernicus Inst Sustainable Dev, Fac Geosci, NL-3508 TC Utrecht, Netherlands	KWR Watercycle Research Institute; Vrije Universiteit Brussel; Vrije Universiteit Amsterdam; Wageningen University & Research; Utrecht University; University of Munster; University of Warsaw; Warsaw University of Life Sciences; Wageningen University & Research; Utrecht University	Wassen, MJ (corresponding author), Univ Utrecht, Copernicus Inst Sustainable Dev, Fac Geosci, POB 80115, NL-3508 TC Utrecht, Netherlands.	m.j.wassen@uu.nl	Hölzel, Norbert/H-8753-2013; Douma, Jacob C./C-9721-2014; olde Venterink, Harry/K-9547-2015; van Bodegom, Peter M./N-8150-2015; Wassen, Martin J./L-9228-2013; Jabłońska, Ewa/AGH-5998-2022	Hölzel, Norbert/0000-0002-6367-3400; Douma, Jacob C./0000-0002-8779-838X; olde Venterink, Harry/0000-0002-8963-1153; van Bodegom, Peter M./0000-0003-0771-4500; Wassen, Martin J./0000-0002-9735-2103; Jabłońska, Ewa/0000-0002-2138-8927; Kotowski, Wiktor/0000-0002-1486-2408; Okruszko, Tomasz/0000-0002-5103-1638	Utrecht Centre of Geosciences; Polish Ministry of Science and Higher Education [N304 010 31/0414]	Utrecht Centre of Geosciences; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	We would like to thank N. A. Soudzilovskaia for obtaining the Russian Red List of plant species, M. Soons, D. Ertsen and D. van der Goes for permission to use their vegetation records, T. Markus and M. Stoete for drawing figures and J. Burrough for editing the near-final draft. Y.F. was funded by the Utrecht Centre of Geosciences, and the research in the Rospuda river valley was financed by the Polish Ministry of Science and Higher Education Grant no. N304 010 31/0414.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Agren GI, 2004, ECOL LETT, V7, P185, DOI 10.1111/j.1461-0248.2004.00567.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Cade BS, 1999, ECOLOGY, V80, P311, DOI 10.1890/0012-9658(1999)080[0311:EEOLFW]2.0.CO;2; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Centraal Bureau voor Statistiek, DUTCH BOT DAT BIOBAS; Ceulemans T, 2011, J APPL ECOL, V48, P1155, DOI 10.1111/j.1365-2664.2011.02023.x; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Farnsworth EJ, 2008, AM J BOT, V95, P943, DOI 10.3732/ajb.0800013; FENNER M, 1986, J ECOL, V74, P385, DOI 10.2307/2260262; Fujita Y, 2010, OIKOS, V119, P1665, DOI 10.1111/j.1600-0706.2010.18427.x; Grace J.B., 2006, STRUCT EQ MOD NAT; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Gusewell S, 2005, NEW PHYTOL, V166, P537, DOI 10.1111/j.1469-8137.2005.01320.x; Gusewell S, 2005, FUNCT ECOL, V19, P344, DOI 10.1111/j.0269-8463.2005.00967.x; Hodgson J.-G., 1995, ELECT COMP PLANT ECO; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Howell DC., 2012, STAT METHODS PSYCHOL; Icelandic Institute of Natural History, VAL HAPL; JNCC, VASC PLANT RED DAT L; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Klaus VH, 2011, PERSPECT PLANT ECOL, V13, P287, DOI 10.1016/j.ppees.2011.07.001; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klimesova J, 2009, J VEG SCI, V20, P511, DOI 10.1111/j.1654-1103.2009.01050.x; Klotz S, 2002, BIOLFLOR DATENBANK B; KUNIN WE, 1993, TRENDS ECOL EVOL, V8, P298, DOI 10.1016/0169-5347(93)90259-R; LAHTI T, 1991, BIOL CONSERV, V55, P299, DOI 10.1016/0006-3207(91)90034-7; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Lambers H, 2010, PLANT SOIL, V334, P11, DOI 10.1007/s11104-010-0444-9; Lannes LS, 2012, NEW PHYTOL, V196, P816, DOI 10.1111/j.1469-8137.2012.04363.x; Mirek Z., 2006, RED LIST PLANTS FUNG; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; Niklas KJ, 2005, ECOL LETT, V8, P636, DOI 10.1111/j.1461-0248.2005.00759.x; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Pugnaire F.I., 2007, FUNCTIONAL PLANT ECO; Royal Botanic Gardens Kew, 2011, SEED INF DAT SID VER; Schnittler M., 1996, SCHRIFTENREIHE VEGET, V28, P709; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Sokal RR., 2012, BIOMETRY PRINCIPLES; Sprent J.I., 2001, NODULATION LEGUMES; State Committee for Environmental Protection of the Novosibirsk region, RED LIST PLANTS NOV; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Swedish Species Information Centre, ARTDATABANKEN; Tamis W. L. M., 2004, Gorteria, V30, P101; VANANDEL J, 1977, J ECOL, V65, P747, DOI 10.2307/2259377; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Venterink HO, 2011, PLANT SOIL, V345, P1, DOI 10.1007/s11104-011-0796-9; Venterink HO, 2010, FUNCT ECOL, V24, P877, DOI 10.1111/j.1365-2435.2010.01692.x; Venterink HO, 2003, ECOLOGY, V84, P2191, DOI 10.1890/01-0639; Venterink HO, 2001, J ECOL, V89, P1033, DOI 10.1111/j.1365-2745.2001.00616.x; Vergeer P, 2003, J ECOL, V91, P600, DOI 10.1046/j.1365-2745.2003.00785.x; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Willby NJ, 2001, NEW PHYTOL, V152, P463, DOI 10.1046/j.0028-646X.2001.00274.x	59	123	131	12	302	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					82	+		10.1038/nature12733	http://dx.doi.org/10.1038/nature12733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24240278				2022-12-24	WOS:000329163300028
J	Herwig, P; Zawatzky, K; Grieser, M; Heber, O; Jordon-Thaden, B; Krantz, C; Novotny, O; Repnow, R; Schurig, V; Schwalm, D; Vager, Z; Wolf, A; Trapp, O; Kreckel, H				Herwig, Philipp; Zawatzky, Kerstin; Grieser, Manfred; Heber, Oded; Jordon-Thaden, Brandon; Krantz, Claude; Novotny, Oldrich; Repnow, Roland; Schurig, Volker; Schwalm, Dirk; Vager, Zeev; Wolf, Andreas; Trapp, Oliver; Kreckel, Holger			Imaging the Absolute Configuration of a Chiral Epoxide in the Gas Phase	SCIENCE			English	Article							MOLECULES; RESOLUTION	In chemistry and biology, chirality, or handedness, refers to molecules that exist in two spatial configurations that are incongruent mirror images of one another. Almost all biologically active molecules are chiral, and the correct determination of their absolute configuration is essential for the understanding and the development of processes involving chiral molecules. Anomalous x-ray diffraction and vibrational optical activity measurements are broadly used to determine absolute configurations of solid or liquid samples. Determining absolute configurations of chiral molecules in the gas phase is still a formidable challenge. Here we demonstrate the determination of the absolute configuration of isotopically labeled (R,R)-2,3-dideuterooxirane by foil-induced Coulomb explosion imaging of individual molecules. Our technique provides unambiguous and direct access to the absolute configuration of small gas-phase species, including ions and molecular fragments.	[Herwig, Philipp; Grieser, Manfred; Jordon-Thaden, Brandon; Krantz, Claude; Novotny, Oldrich; Repnow, Roland; Schwalm, Dirk; Wolf, Andreas; Kreckel, Holger] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Zawatzky, Kerstin; Trapp, Oliver] Heidelberg Univ, Inst Organ Chem, D-69120 Heidelberg, Germany; [Heber, Oded; Schwalm, Dirk; Vager, Zeev] Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel; [Novotny, Oldrich] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Schurig, Volker] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Weizmann Institute of Science; Columbia University; Eberhard Karls University of Tubingen	Trapp, O (corresponding author), Heidelberg Univ, Inst Organ Chem, D-69120 Heidelberg, Germany.	trapp@oci.uni-heidelberg.de; holger.kreckel@mpi-hd.mpg.de	Kreckel, Holger/F-4969-2010; Wolf, Andreas/O-4440-2017; Novotny, Oldrich/K-6691-2013; Trapp, Oliver/AAB-9707-2019; Trapp, Oliver/A-2114-2014	Kreckel, Holger/0000-0003-0511-0738; Wolf, Andreas/0000-0003-1198-9013; Novotny, Oldrich/0000-0003-2520-343X; Trapp, Oliver/0000-0002-3594-5181; 	Max-Planck Society; Ruprecht-Karls Universitat Heidelberg; NASA; NSF; European Research Council [StG 307163, StG 258740]; Weizmann Institute	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Ruprecht-Karls Universitat Heidelberg; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Weizmann Institute	This work was supported by the Max-Planck Society and the Ruprecht-Karls Universitat Heidelberg. O.N. was supported, in part, by grants from NASA and the NSF. H.K. and O.T. were supported by the European Research Council under Grant Agreements StG 307163 and StG 258740, respectively. D.S. acknowledges support by the Weizmann Institute through the Joseph Meyerhoff program. We thank B. F. Straub for support in the quantum-chemical calculations and F. Rominger for x-ray structure analysis. We thank G. Helmchen and H. Wadepohl for helpful discussions. We are grateful for the support from the Max-Planck-Institut fur Kernphysik accelerator staff, and we thank O. Koschorreck for assistance with the CEI detector electronics. Metrical parameters for the crystal structures of compounds [triphenylsilyl propargyl alcohol, 2, (S,S)-3 and (S,S)-4] are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC 964292, CCDC 964293, CCDC 964294, and CCDC 964295, respectively.	ADDADI L, 1982, NATURE, V296, P21, DOI 10.1038/296021a0; Barron LD, 2010, CHEM PHYS LETT, V492, P199, DOI 10.1016/j.cplett.2010.03.090; BARRON LD, 1973, J AM CHEM SOC, V95, P603, DOI 10.1021/ja00783a058; BERKOVITCHYELLIN Z, 1982, NATURE, V296, P27, DOI 10.1038/296027a0; BIJVOET JM, 1951, NATURE, V168, P271, DOI 10.1038/168271a0; EVANS D, 1965, NATURE, V208, P1203, DOI 10.1038/2081203b0; Fang HB, 1998, J PHYS CHEM B, V102, P7311, DOI 10.1021/jp981960z; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Freedman TB, 2003, CHIRALITY, V15, P743, DOI 10.1002/chir.10287; GAO Y, 1987, J AM CHEM SOC, V109, P5765, DOI 10.1021/ja00253a032; Haesler J, 2007, NATURE, V446, P526, DOI 10.1038/nature05653; He YA, 2011, APPL SPECTROSC, V65, P699, DOI 10.1366/11-06321; Herwig P, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.062513; Inokuma Y, 2013, NATURE, V495, P461, DOI 10.1038/nature11990; Jordon-Thaden B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.193003; Klyne W., 1978, ATLAS STEREOCHEMISTR, V2; Klyne W., 1978, ATLAS STEREOCHEMISTR, V1; Lammich L, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062904; NIKOLAEV VS, 1965, SOV PHYS USPEKHI, V8, P269, DOI 10.1070/PU1965v008n02ABEH003043; PARIKH JR, 1967, J AM CHEM SOC, V89, P5505, DOI 10.1021/ja00997a067; Pitzer M, 2013, SCIENCE, V341, P1096, DOI 10.1126/science.1240362; SCHWAB JM, 1986, J CHEM SOC CHEM COMM, P872, DOI 10.1039/c39860000872; SCHWAB JM, 1989, J AM CHEM SOC, V111, P1057, DOI 10.1021/ja00185a041; Stephens PJ, 2008, CHIRALITY, V20, P643, DOI 10.1002/chir.20477; STEPHENS PJ, 1985, J PHYS CHEM-US, V89, P748, DOI 10.1021/j100251a006; VAGER Z, 1989, SCIENCE, V244, P426, DOI 10.1126/science.244.4903.426; Wester R, 2002, J CHEM PHYS, V116, P7000, DOI 10.1063/1.1461812; Wester R, 1998, NUCL INSTRUM METH A, V413, P379, DOI 10.1016/S0168-9002(98)00553-1	28	98	97	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1084	1086		10.1126/science.1246549	http://dx.doi.org/10.1126/science.1246549			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288330				2022-12-24	WOS:000327518600054
J	Naumova, N; Imakaev, M; Fudenberg, G; Zhan, Y; Lajoie, BR; Mirny, LA; Dekker, J				Naumova, Natalia; Imakaev, Maxim; Fudenberg, Geoffrey; Zhan, Ye; Lajoie, Bryan R.; Mirny, Leonid A.; Dekker, Job			Organization of the Mitotic Chromosome	SCIENCE			English	Article							METAPHASE CHROMOSOMES; NUCLEAR-ORGANIZATION; CHROMATIN-STRUCTURE; TOPOISOMERASE-II; GENE-REGULATION; MOUSE GENOME; MODEL; CONDENSATION; CONFORMATION; LANDSCAPE	Mitotic chromosomes are among the most recognizable structures in the cell, yet for over a century their internal organization remains largely unsolved. We applied chromosome conformation capture methods, 5C and Hi-C, across the cell cycle and revealed two distinct three-dimensional folding states of the human genome. We show that the highly compartmentalized and cell type-specific organization described previously for nonsynchronous cells is restricted to interphase. In metaphase, we identified a homogenous folding state that is locus-independent, common to all chromosomes, and consistent among cell types, suggesting a general principle of metaphase chromosome organization. Using polymer simulations, we found that metaphase Hi-C data are inconsistent with classic hierarchical models and are instead best described by a linearly organized longitudinally compressed array of consecutive chromatin loops.	[Naumova, Natalia; Zhan, Ye; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Syst Biol, Worcester, MA 01605 USA; [Imakaev, Maxim; Fudenberg, Geoffrey; Mirny, Leonid A.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Imakaev, Maxim; Fudenberg, Geoffrey; Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Fudenberg, Geoffrey] Harvard Univ, Program Biophys, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Mirny, LA (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leonid@mit.edu; job.dekker@umassmed.edu	Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410; Imakaev, Maxim/0000-0002-5320-2728; Fudenberg, Geoffrey/0000-0001-5905-6517	National Cancer Institute (Physical Sciences-Oncology Center at MIT) [U54CA143874]; National Human Genome Research Institute [HG003143]; Human Frontier Science Program; W. M. Keck Foundation; NATIONAL CANCER INSTITUTE [U54CA143874] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	National Cancer Institute (Physical Sciences-Oncology Center at MIT); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Human Frontier Science Program(Human Frontier Science Program); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	All data will be made publicly available through the Gene Expression Omnibus. This work was supported by grants from the National Cancer Institute (Physical Sciences-Oncology Center at MIT U54CA143874 to L.A.M.) and the National Human Genome Research Institute (HG003143 to J.D.), the Human Frontier Science Program (to J.D.), and a W. M. Keck Foundation distinguished young scholar in medical research grant (to J.D.). We thank J. A. Stamatoyannopoulos and R. Humbert for designing part of the 5C primers; C. Smith and A. Hawkins for technical help; J. Benanti for providing HFF1 cell stock and discussion; M. Walhout, Dekker lab, and Mirny lab members for discussions; and the UMMS deep sequencing core for sequencing 5C and Hi-C libraries. The data are available at ArrayExpress database www.ebi.ac.uk/arrayexpress, accession no. E-MTAB-1948. Information about Gene Expression Omnibus accession nos. can be found in the supplementary materials. Data visualizations can also be found at http://hic.umassmed.edu and http://mirnylab.mit.edu.	ADACHI Y, 1991, CELL, V64, P137, DOI 10.1016/0092-8674(91)90215-K; Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; BAK AL, 1977, P NATL ACAD SCI USA, V74, P1595, DOI 10.1073/pnas.74.4.1595; BELMONT AS, 1987, J CELL BIOL, V105, P77, DOI 10.1083/jcb.105.1.77; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Deng WL, 2010, CURR OPIN GENET DEV, V20, P548, DOI 10.1016/j.gde.2010.06.007; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; DUPRAW EJ, 1966, NATURE, V209, P577, DOI 10.1038/209577a0; EARNSHAW WC, 1983, J CELL BIOL, V96, P84, DOI 10.1083/jcb.96.1.84; Flemming W, 1878, SCHRIFTEN NATURWISSE, V3, P23; Follmer NE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003135; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Fudenberg G, 2012, CURR OPIN GENET DEV, V22, P115, DOI 10.1016/j.gde.2012.01.006; Fussner E, 2012, EMBO REP, V13, P992, DOI 10.1038/embor.2012.139; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/nmeth.2148, 10.1038/NMETH.2148]; JACKSON DA, 1990, EMBO J, V9, P567, DOI 10.1002/j.1460-2075.1990.tb08144.x; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Konig P, 2007, CHROMOSOMA, V116, P349, DOI 10.1007/s00412-007-0101-0; Li G, 1998, J CELL BIOL, V140, P975, DOI 10.1083/jcb.140.5.975; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lua R, 2004, POLYMER, V45, P717, DOI 10.1016/j.polymer.2003.10.073; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Maeshima K, 2010, COLD SH Q B, V75, P439, DOI 10.1101/sqb.2010.75.034; Maeshima K, 2008, J BIOCHEM, V143, P145, DOI 10.1093/jb/mvm214; Markaki Y, 2010, COLD SH Q B, V75, P475, DOI 10.1101/sqb.2010.75.042; Marko JF, 1997, MOL BIOL CELL, V8, P2217, DOI 10.1091/mbc.8.11.2217; Marko JF, 2008, CHROMOSOME RES, V16, P469, DOI 10.1007/s10577-008-1233-7; MARSDEN MPF, 1979, CELL, V17, P849, DOI 10.1016/0092-8674(79)90325-8; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Rosa A, 2010, BIOPHYS J, V98, P2410, DOI 10.1016/j.bpj.2010.01.054; Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; SEDAT J, 1977, COLD SPRING HARB SYM, V42, P331, DOI 10.1101/SQB.1978.042.01.035; SIKORAV JL, 1994, BIOPHYS J, V66, P827, DOI 10.1016/S0006-3495(94)80859-8; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Strukov YG, 2003, J CELL BIOL, V162, P23, DOI 10.1083/jcb.200303098; Strukov YG, 2009, BIOPHYS J, V96, P1617, DOI 10.1016/j.bpj.2008.10.051; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029225; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	50	578	588	5	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					948	953		10.1126/science.1236083	http://dx.doi.org/10.1126/science.1236083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24200812	Green Accepted, Green Published			2022-12-24	WOS:000327223500035
J	Barouch, DH; Whitney, JB; Moldt, B; Klein, F; Oliveira, TY; Liu, JY; Stephenson, KE; Chang, HW; Shekhar, K; Gupta, S; Nkolola, JP; Seaman, MS; Smith, KM; Borducchi, EN; Cabral, C; Smith, JY; Blackmore, S; Sanisetty, S; Perry, JR; Beck, M; Lewis, MG; Rinaldi, W; Chakraborty, AK; Poignard, P; Nussenzweig, MC; Burton, DR				Barouch, Dan H.; Whitney, James B.; Moldt, Brian; Klein, Florian; Oliveira, Thiago Y.; Liu, Jinyan; Stephenson, Kathryn E.; Chang, Hui-Wen; Shekhar, Karthik; Gupta, Sanjana; Nkolola, Joseph P.; Seaman, Michael S.; Smith, Kaitlin M.; Borducchi, Erica N.; Cabral, Crystal; Smith, Jeffrey Y.; Blackmore, Stephen; Sanisetty, Srisowmya; Perry, James R.; Beck, Matthew; Lewis, Mark G.; Rinaldi, William; Chakraborty, Arup K.; Poignard, Pascal; Nussenzweig, Michel C.; Burton, Dennis R.			Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys	NATURE			English	Article							RECOMBINANT ADENOVIRUS VECTORS; ANTIRETROVIRAL THERAPY; HIV-1; BROAD; VACCINE; CHALLENGES; RESPONSES; MEMORY	Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with extraordinary potency and breadth have recently been described. In humanized mice, combinations of monoclonal antibodies have been shown to suppress viraemia, but the therapeutic potential of these monoclonal antibodies has not yet been evaluated in primates with an intact immune system. Here we show that administration of a cocktail of HIV-1-specific monoclonal antibodies, as well as the single glycan-dependent monoclonal antibody PGT121, resulted in a rapid and precipitous decline of plasma viraemia to undetectable levels in rhesus monkeys chronically infected with the pathogenic simian-human immunodeficiency virus SHIV-SF162P3. A single monoclonal antibody infusion afforded up to a 3.1 log decline of plasma viral RNA in 7 days and also reduced proviral DNA in peripheral blood, gastrointestinal mucosa and lymph nodes without the development of viral resistance. Moreover, after monoclonal antibody administration, host Gag-specific T-lymphocyte responses showed improved functionality. Virus rebounded in most animals after a median of 56 days when serum monoclonal antibody titres had declined to undetectable levels, although, notably, a subset of animals maintained long-term virological control in the absence of further monoclonal antibody infusions. These data demonstrate a profound therapeutic effect of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys as well as an impact on host immune responses. Our findings strongly encourage the investigation of monoclonal antibody therapy for HIV-1 in humans.	[Barouch, Dan H.; Whitney, James B.; Liu, Jinyan; Stephenson, Kathryn E.; Chang, Hui-Wen; Nkolola, Joseph P.; Seaman, Michael S.; Smith, Kaitlin M.; Borducchi, Erica N.; Cabral, Crystal; Smith, Jeffrey Y.; Blackmore, Stephen; Sanisetty, Srisowmya; Perry, James R.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.; Chakraborty, Arup K.; Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Moldt, Brian; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, La Jolla, CA 92037 USA; [Klein, Florian; Oliveira, Thiago Y.; Nussenzweig, Michel C.] Rockefeller Univ, New York, NY 10065 USA; [Shekhar, Karthik; Gupta, Sanjana; Chakraborty, Arup K.] MIT, Cambridge, MA 02139 USA; [Beck, Matthew] New England Primate Res Ctr, Southborough, MA 01776 USA; [Lewis, Mark G.] Bioqual Inc, Rockville, MD 20852 USA; [Rinaldi, William] Alpha Genesis Inc, Yemassee, SC 29945 USA; [Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY 10065 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Scripps Research Institute; Rockefeller University; Massachusetts Institute of Technology (MIT); BIOQUAL Inc.; Howard Hughes Medical Institute	Barouch, DH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Nussenzweig, Michel/AAE-7292-2019; poignard, pascal/AAB-4613-2020; poignard, pascal/N-6678-2013; Chang, Hui-Wen/C-9058-2017; Barouch, Dan/Y-3918-2019; Oliveira, Thiago Y/HGA-3848-2022; Oliveira, Thiago Y/ABF-5186-2020; Gupta, Sanjana/L-1014-2019	Chang, Hui-Wen/0000-0001-8877-1886; Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Stephenson, Kathryn/0000-0002-3440-4105; Poignard, Pascal/0000-0002-0021-7192	National Institutes of Health [AI055332, AI060354, AI078526, AI084794, AI095985, AI096040, AI10063, AI100148, AI100663]; Bill and Melinda Gates Foundation [OPP1033091, OPP1033115, OPP1040741, OPP1040753]; Ragon Institute of MGH, MIT, and Harvard; Lundbeck Foundation; Stavros Niarchos Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663, U19AI096040, R01AI084794, U19AI066305, R01AI055332, P01AI100148, P30AI060354, R37AI055332, T32AI007387, U19AI078526, U19AI095985, R56AI091514] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD012217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ragon Institute of MGH, MIT, and Harvard; Lundbeck Foundation(Lundbeckfonden); Stavros Niarchos Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Brinkman, M. Ferguson, C. Gittens, R. Geleziunas, R. Hamel, K. Kelly, J. Kramer, A. McNally, D. Montefiori, L. Nogueira, L. Parenteau, M. Pensiero, L. Peter, M. Shetty, D. Sok, K. Stanley, F. Stephens, W. Wagner, B. Walker, A. West and J. Yalley-Ogunro for advice, assistance and reagents. The SIVmac239 Gag peptide pool was obtained from the NIH AIDS Research and Reference Reagent Program. We acknowledge support from the National Institutes of Health (AI055332, AI060354, AI078526, AI084794, AI095985, AI096040, AI10063, AI100148, AI100663); the Bill and Melinda Gates Foundation (OPP1033091, OPP1033115, OPP1040741, OPP1040753); the Ragon Institute of MGH, MIT, and Harvard; the Lundbeck Foundation; and the Stavros Niarchos Foundation. M.C.N. is a Howard Hughes Medical Institute investigator. M.C.N. and D. R. B. are co-inventors on patents covering the monoclonal antibodies used in the present study.	Andrade A, 2013, J INFECT DIS, V208, P884, DOI 10.1093/infdis/jit272; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cornall A, 2010, J VIROL METHODS, V165, P90, DOI 10.1016/j.jviromet.2010.01.010; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Gautam R, 2012, J VIROL, V86, P8516, DOI 10.1128/JVI.00644-12; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jaworski JP, 2013, J VIROL, V87, P10447, DOI 10.1128/JVI.00049-13; Jayaraman P, 2007, J VIROL, V81, P822, DOI 10.1128/JVI.01759-06; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kraft Z, 2007, J VIROL, V81, P6402, DOI 10.1128/JVI.00424-07; Li HL, 2011, J VIROL, V85, P11007, DOI 10.1128/JVI.05346-11; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; MONTEFIORI D, 2004, EVALUATING NEUTRALIZ; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Nishimura Y, 2010, J VIROL, V84, P4769, DOI 10.1128/JVI.02279-09; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Stephenson KE, 2012, J VIROL, V86, P9583, DOI 10.1128/JVI.00996-12; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; Whitney JB, 2009, J VIROL, V83, P10840, DOI 10.1128/JVI.01202-09; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	39	484	526	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					224	+		10.1038/nature12744	http://dx.doi.org/10.1038/nature12744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24172905	Green Submitted, Green Accepted			2022-12-24	WOS:000326894200043
J	Dang, I; Gorelik, R; Sousa-Blin, C; Derivery, E; Guerin, C; Linkner, J; Nemethova, M; Dumortier, JG; Giger, FA; Chipysheva, TA; Ermilova, VD; Vacher, S; Campanacci, V; Herrada, I; Planson, AG; Fetics, S; Henriot, V; David, V; Oguievetskaia, K; Lakisic, G; Pierre, F; Steffen, A; Boyreau, A; Peyrieras, N; Rottner, K; Zinn-Justin, S; Cherfils, J; Bieche, I; Alexandrova, AY; David, NB; Small, JV; Faix, J; Blanchoin, L; Gautreau, A				Dang, Irene; Gorelik, Roman; Sousa-Blin, Carla; Derivery, Emmanuel; Guerin, Christophe; Linkner, Joern; Nemethova, Maria; Dumortier, Julien G.; Giger, Florence A.; Chipysheva, Tamara A.; Ermilova, Valeria D.; Vacher, Sophie; Campanacci, Valerie; Herrada, Isaline; Planson, Anne-Gaelle; Fetics, Susan; Henriot, Veronique; David, Violaine; Oguievetskaia, Ksenia; Lakisic, Goran; Pierre, Fabienne; Steffen, Anika; Boyreau, Adeline; Peyrieras, Nadine; Rottner, Klemens; Zinn-Justin, Sophie; Cherfils, Jacqueline; Bieche, Ivan; Alexandrova, Antonina Y.; David, Nicolas B.; Small, J. Victor; Faix, Jan; Blanchoin, Laurent; Gautreau, Alexis			Inhibitory signalling to the Arp2/3 complex steers cell migration	NATURE			English	Article							ACTIN POLYMERIZATION; MOTILITY; NETWORKS; DYNAMICS; PROTEIN; LAMELLIPODIA; NUCLEATION; PREDICTION; VERTEBRATE; ALIGNMENT	Cell migration requires the generation of branched actin networks that power the protrusion of the plasma membrane inlamellipodia(1,2). The actin-related proteins 2 and 3 (Arp2/3) complex is the molecular machine that nucleates these branched actin networks(3). This machine is activated at the leading edge of migrating cells by Wiskott-Aldrich syndrome protein (WASP)-family verprolin-homologous protein (WAVE, also known as SCAR). The WAVE complex is itself directly activated by the small GTPase Rac, which induces lamellipodia(4-6). However, how cells regulate the directionality of migration is poorly understood. Here we identify a new protein, Arpin, that inhibits the Arp2/3 complex in vitro, and show that Rac signalling recruits and activates Arpin at the lamellipodial tip, like WAVE. Consistently, after depletion of the inhibitory Arpin, lamellipodia protrude faster and cells migrate faster. A major role of this inhibitory circuit, however, is to control directional persistence of migration. Indeed, Arpin depletion in both mammalian cells and Dictyostelium discoideum amoeba resulted in straighter trajectories, whereas Arpin microinjection in fish keratocytes, one of the most persistent systems of cell migration, induced these cells to turn. The coexistence of the Rac-Arpin-Arp2/3 inhibitory circuit with the Rac-WAVE-Arp2/3 activatory circuit can account for this conserved role of Arpin in steering cell migration.	[Dang, Irene; Gorelik, Roman; Sousa-Blin, Carla; Derivery, Emmanuel; Henriot, Veronique; David, Violaine; Oguievetskaia, Ksenia; Lakisic, Goran; Pierre, Fabienne; Gautreau, Alexis] CNRS, Grp Cytoskeleton Cell Morphogenesis, Lab Enzymol & Biochim Struct, UPR3082, F-91190 Gif Sur Yvette, France; [Guerin, Christophe; Blanchoin, Laurent] CNRS CEA INRA UJF, Lab Physiol Cellulaire & Vegetale, Inst Rech Technol & Sci Vivant IRTSV, F-38054 Grenoble, France; [Linkner, Joern; Faix, Jan] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Nemethova, Maria; Small, J. Victor] Inst Mol Biotechnol, A-1030 Vienna, Austria; [Dumortier, Julien G.; Giger, Florence A.; David, Nicolas B.] Inst Biol ENS, ENS, CNRS UMR8197, INSERM U1024, F-75005 Paris, France; [Chipysheva, Tamara A.; Ermilova, Valeria D.; Alexandrova, Antonina Y.] Russian Acad Med Sci, NN Blokhin Canc Res Ctr, Inst Carcinogenesis, Moscow 115478, Russia; [Vacher, Sophie; Bieche, Ivan] Hop Rene Huguenin, Inst Curie, Oncogenet Lab, F-92210 St Cloud, France; [Campanacci, Valerie; Planson, Anne-Gaelle; Fetics, Susan; Cherfils, Jacqueline] CNRS, Grp Small Prot G, Lab Enzymol & Biochim Struct, UPR3082, F-91190 Gif Sur Yvette, France; [Herrada, Isaline; Zinn-Justin, Sophie] CEA Saclay, CNRS URA2096, Lab Biol Struct & Radiobiol IBiTec S, F-91190 Gif Sur Yvette, France; [Steffen, Anika; Rottner, Klemens] Univ Bonn, Inst Genet, D-53115 Bonn, Germany; [Boyreau, Adeline; Peyrieras, Nadine] CNRS, Inst Neurobiol Alfred Fessard, Inst Syst Complexes & NeD, UPR3294, F-91190 Gif Sur Yvette, France; [Rottner, Klemens] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Hannover Medical School; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences; Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Bonn; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Helmholtz Association; Helmholtz-Center for Infection Research	Gautreau, A (corresponding author), CNRS, Grp Cytoskeleton Cell Morphogenesis, Lab Enzymol & Biochim Struct, UPR3082, F-91190 Gif Sur Yvette, France.	alexis.gautreau@lebs.cnrs-gif.fr	Alexandrova, Antonina/R-7449-2019; Bièche, Ivan/O-7399-2017; David, Violaine/E-3892-2019; Dumortier, Julien/M-7469-2013; Gautreau, Alexis/AAT-2751-2020; David, Nicolas/A-1699-2008; Planson, Anne-Gaëlle/AAK-9595-2021; Rottner, Klemens/AAE-5030-2020	Bièche, Ivan/0000-0002-2430-5429; David, Violaine/0000-0003-0127-1200; Dumortier, Julien/0000-0002-1483-4028; Gautreau, Alexis/0000-0002-2369-4362; David, Nicolas/0000-0003-1166-6732; Steffen, Anika/0000-0002-2933-0543; Campanacci, Valerie/0000-0001-6407-6395; Peyrieras, Nadine/0000-0002-4905-6414; LAKISIC, Goran/0000-0002-0079-5072; VACHER, Sophie/0000-0002-0042-6023; Dang, Irene/0000-0003-2467-0191; Rottner, Klemens/0000-0003-4244-4198; Giger, Florence/0000-0002-9408-4959; Planson, Anne-Gaelle/0000-0003-4343-3386	Agence Nationale pour la Recherche [ANR-08-BLAN-0012-CSD 8, ANR-08-PCVI-0010-03, ANR-11-BSV8-0010-02]; Association pour la Recherche sur le Cancer [SFI20101201512, PDF20111204331, SFI20111203770]; Bio-Emergences IBISA facility; Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/46451/2008]; Austrian Science Fund [FWF P21292-B09]; Deutsche Forschungsgemeinschaft [FA 330/5-1]; Russian Ministry of Education and Science [8066, 2012-1.1-12-000-1002-064]; Austrian Science Fund (FWF) [I 516] Funding Source: researchfish	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Bio-Emergences IBISA facility; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Austrian Science Fund(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	A.G. acknowledges his PhD supervisor M. Arpin, the name of the here identified protein is a tribute to her mentoring. We thank G. Romet-Lemonne, E. Portnoy and F. Marletaz for suggestions. We acknowledge support from Agence Nationale pour la Recherche (ANR-08-BLAN-0012-CSD 8 to A. G. and L. B., ANR-08-PCVI-0010-03 to A. G., ANR-11-BSV8-0010-02 to A. G., J.C. and S.Z.-J.), Association pour la Recherche sur le Cancer (SFI20101201512 to A. G., PDF20111204331 to R. G., SFI20111203770 to N.B.D.), the Bio-Emergences IBISA facility and Fundacao para a Ciencia e a Tecnologia (SFRH/BPD/46451/2008 to C.S.-B.), the Austrian Science Fund (FWF P21292-B09 to J.V.S.), the Deutsche Forschungsgemeinschaft (FA 330/5-1 to J.F.) and grant number 8066, code 2012-1.1-12-000-1002-064 from the Russian Ministry of Education and Science to A.Y.A.	Allard J, 2013, CURR OPIN CELL BIOL, V25, P107, DOI 10.1016/j.ceb.2012.08.012; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Castro-Castro A, 2011, EMBO J, V30, P3913, DOI 10.1038/emboj.2011.310; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Derivery E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002462; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Dumontier M, 2000, J CELL SCI, V113, P2253; Dumortier JG, 2012, P NATL ACAD SCI USA, V109, P16945, DOI 10.1073/pnas.1205870109; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Li A, 2011, DEV CELL, V21, P722, DOI 10.1016/j.devcel.2011.07.008; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Maritzen T, 2012, P NATL ACAD SCI USA, V109, P10382, DOI 10.1073/pnas.1206468109; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; Millard TH, 2003, CELL MOTIL CYTOSKEL, V54, P81, DOI 10.1002/cm.10087; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Schirenbeck A, 2005, NAT CELL BIOL, V7, P619, DOI 10.1038/ncb1266; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Steffen A., 2013, J CELL SCI; Suetsugu S, 2012, TRENDS CELL BIOL, V22, P141, DOI 10.1016/j.tcb.2012.01.001; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034	46	145	156	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					281	+		10.1038/nature12611	http://dx.doi.org/10.1038/nature12611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24132237	Green Submitted			2022-12-24	WOS:000326894200055
J	Shcheglovitov, A; Shcheglovitova, O; Yazawa, M; Portmann, T; Shu, R; Sebastiano, V; Krawisz, A; Froehlich, W; Bernstein, JA; Hallmayer, JF; Dolmetsch, RE				Shcheglovitov, Aleksandr; Shcheglovitova, Olesya; Yazawa, Masayuki; Portmann, Thomas; Shu, Rui; Sebastiano, Vittorio; Krawisz, Anna; Froehlich, Wendy; Bernstein, Jonathan A.; Hallmayer, Joachim F.; Dolmetsch, Ricardo E.			SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients	NATURE			English	Article							SCAFFOLDING PROTEIN SHANK3; CORTICAL-NEURONS; HUMAN FIBROBLASTS; MUTATIONS; HAPLOINSUFFICIENCY; GENERATION; CONVERSION; BEHAVIORS; FAMILY; CELLS	Phelan-McDermid syndrome (PMDS) is a complex neurodevelopmental disorder characterized by global developmental delay, severely impaired speech, intellectual disability, and an increased risk of autism spectrum disorders (ASDs)(1). PMDS is caused by heterozygous deletions of chromosome 22q13.3. Among the genes in the deleted region is SHANK3, which encodes a protein in the postsynaptic density (PSD)(2,3). Rare mutations in SHANK3 have been associated with idiopathic ASDs(4-7), non-syndromic intellectual disability(8), and schizophrenia(9). Although SHANK3 is considered to be the most likely candidate gene for the neurological abnormalities in PMDS patients(10), the cellular and molecular phenotypes associated with this syndrome in human neurons are unknown. We generated induced pluripotent stem (iPS) cells from individuals with PMDS and autism and used them to produce functional neurons. We show that PMDS neurons have reduced SHANK3 expression and major defects in excitatory, but not inhibitory, synaptic transmission. Excitatory synaptic transmission in PMDS neurons can be corrected by restoring SHANK3 expression or by treating neurons with insulin-like growth factor 1 (IGF1). IGF1 treatment promotes formation of mature excitatory synapses that lack SHANK3 but contain PSD95 and N-methyl-D-aspartate (NMDA) receptors with fast deactivation kinetics. Our findings provide direct evidence for a disruption in the ratio of cellular excitation and inhibition in PMDS neurons, and point to a molecular pathway that can be recruited to restore it.	[Shcheglovitov, Aleksandr; Shcheglovitova, Olesya; Yazawa, Masayuki; Portmann, Thomas; Shu, Rui; Krawisz, Anna] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Sebastiano, Vittorio] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Sebastiano, Vittorio] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Froehlich, Wendy; Bernstein, Jonathan A.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Froehlich, Wendy; Hallmayer, Joachim F.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Dolmetsch, Ricardo E.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Novartis	Dolmetsch, RE (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	Ricardo.dolmetsch@novartis.com		Krawisz, Anna/0000-0002-1462-3773	National Institutes of Health (NIH) [NS069375]; California Institute for Regenerative Medicine CIRM; Autism Science Foundation; Phelan-McDermid Syndrome Foundation; Swiss National Science Foundation; Japan Society for the Promotion of Research Abroad; American Heart Association; National Institute of Mental Health (NIMH) [R33MH087898]; NIH [5DP1OD3889]; CIRM [RT2-01906]; Simons Foundation; JDH; Flora foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine CIRM(California Institute for Regenerative Medicine); Autism Science Foundation; Phelan-McDermid Syndrome Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Japan Society for the Promotion of Research Abroad; American Heart Association(American Heart Association); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Simons Foundation; JDH; Flora foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to participants and their families for their support; M. Adam for assistance with recruitment; to X. Jia, A. Cherry, C. Bangs, P. Jones, and J. Williams for assistance with tissue culture; P. Liao for help with multiplex ligation-dependent probe amplification (MLPA); M. Fabian for astrocyte preparations; H.N. Nguyen for consultations on the neural differentiation protocol and spectral karyotyping (SKY); V. Vu and G. Lin for help with data analysis; T. Sudhof, T. Boeckers, A. Grabruker, C. Garner and C. Sala for antibodies; R. Xavier for SHANK3 complementary DNA; R. Reijo-Pera and members of the Dolmetsch laboratory for commenting on the manuscript; E. Nigh for editing the manuscript. We also thank the Stanford Neuroscience Microscopy Service (supported by National Institutes of Health (NIH) NS069375). Support for this study came from the California Institute for Regenerative Medicine CIRM, the Autism Science Foundation and the Phelan-McDermid Syndrome Foundation (to A. S.), the Swiss National Science Foundation (to T. P.), the Japan Society for the Promotion of Research Abroad and American Heart Association (to M.Y.), the National Institute of Mental Health (NIMH) grant R33MH087898 (to J. F. H.); NIH Pioneer Award (5DP1OD3889), CIRM (grant RT2-01906) and Simons Foundation (to R. E. D.). We are also grateful for funding from the JDH research fund, N. Juaw, B. and F. Horowitz, M. McCafferey, B. and J. Packard, P. Kwan and K. Wang, and the Flora foundation.	Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Boccuto L, 2013, EUR J HUM GENET, V21, P310, DOI 10.1038/ejhg.2012.175; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Nathanson JL, 2009, NEUROSCIENCE, V161, P441, DOI 10.1016/j.neuroscience.2009.03.032; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Phelan K, 2011, MOL SYNDROMOL, V2, P186, DOI 10.1159/000334260; Rinaldi T, 2007, P NATL ACAD SCI USA, V104, P13501, DOI 10.1073/pnas.0704391104; Sheng M, 2000, J CELL SCI, V113, P1851; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323	32	315	334	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					267	+		10.1038/nature12618	http://dx.doi.org/10.1038/nature12618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24132240	Green Accepted			2022-12-24	WOS:000326894200052
J	Rico, F; Gonzalez, L; Casuso, I; Puig-Vidal, M; Scheuring, S				Rico, Felix; Gonzalez, Laura; Casuso, Ignacio; Puig-Vidal, Manel; Scheuring, Simon			High-Speed Force Spectroscopy Unfolds Titin at the Velocity of Molecular Dynamics Simulations	SCIENCE			English	Article							MUSCLE PROTEIN TITIN; IMMUNOGLOBULIN DOMAINS; SINGLE MOLECULES; IG DOMAIN; MICROSCOPY; AFM; KINETICS; BONDS	The mechanical unfolding of the muscle protein titin by atomic force microscopy was a landmark in our understanding of single-biomolecule mechanics. Molecular dynamics simulations offered atomic-level descriptions of the forced unfolding. However, experiment and simulation could not be directly compared because they differed in pulling velocity by orders of magnitude. We have developed high-speed force spectroscopy to unfold titin at velocities reached by simulation (similar to 4 millimeters per second). We found that a small beta-strand pair of an immunoglobulin domain dynamically unfolds and refolds, buffering pulling forces up to similar to 100 piconewtons. The distance to the unfolding transition barrier is larger than previously estimated but is in better agreement with atomistic predictions. The ability to directly compare experiment and simulation is likely to be important in studies of biomechanical processes.	[Rico, Felix; Casuso, Ignacio; Scheuring, Simon] Aix Marseille Univ, INSERM, U1006, F-13009 Marseille, France; [Gonzalez, Laura; Puig-Vidal, Manel] Univ Barcelona, Dept Elect, Bioelect Grp, E-08028 Barcelona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Barcelona	Scheuring, S (corresponding author), Aix Marseille Univ, INSERM, U1006, Parc Sci & Technol Luminy,163 Ave Luminy, F-13009 Marseille, France.	simon.scheuring@inserm.fr	Scheuring, Simon/L-9843-2018; Rico, Felix/K-6505-2012; Vidal, Manuel Puig/N-5017-2014; Casuso, Ignacio/E-5574-2016	Scheuring, Simon/0000-0003-3534-069X; Rico, Felix/0000-0002-7757-8340; Vidal, Manuel Puig/0000-0002-6074-9246; Gonzalez-Claramonte, Laura/0000-0002-1422-2734; Casuso, Ignacio/0000-0001-7192-0136	European Research Council [310080]; Agence National de la Recherche [ANR-12-BS10-009-01]; Spanish Ministerio de Economia y Competitividad [BES-2010-031186]; STSM COST Action [TD1002-10006]	European Research Council(European Research Council (ERC)European Commission); Agence National de la Recherche(French National Research Agency (ANR)); Spanish Ministerio de Economia y Competitividad(Spanish Government); STSM COST Action	We thank A. Sastre and J. Otero for helpful discussions. Supported by European Research Council starting grant 310080 and Agence National de la Recherche grant ANR-12-BS10-009-01. L. G. was a recipient of travel grants (FPI grant BES-2010-031186 from the Spanish Ministerio de Economia y Competitividad and STSM COST Action TD1002-10006).	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Berkovich R, 2012, P NATL ACAD SCI USA, V109, P14416, DOI 10.1073/pnas.1212167109; Best RB, 2003, J MOL BIOL, V330, P867, DOI 10.1016/S0022-2836(03)00618-1; Best RB, 2003, ANAL CHIM ACTA, V479, P87, DOI 10.1016/S0003-2670(02)01572-6; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Casuso I, 2012, NAT NANOTECHNOL, V7, P525, DOI [10.1038/nnano.2012.109, 10.1038/NNANO.2012.109]; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; Friddle RW, 2012, P NATL ACAD SCI USA, V109, P13573, DOI 10.1073/pnas.1202946109; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hummer G, 2003, BIOPHYS J, V85, P5, DOI 10.1016/S0006-3495(03)74449-X; Izrailev S, 1997, BIOPHYS J, V72, P1568, DOI 10.1016/S0006-3495(97)78804-0; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Lannon H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.128301; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; MARUYAMA K, 1977, J BIOCHEM, V82, P317; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Redondo-Morata L, 2012, LANGMUIR, V28, P6403, DOI 10.1021/la3005147; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039; Yew ZT, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031923; Zhang XH, 2002, BIOPHYS J, V83, P2270, DOI 10.1016/S0006-3495(02)73987-8	35	181	183	5	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					741	743		10.1126/science.1239764	http://dx.doi.org/10.1126/science.1239764			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202172	Green Submitted			2022-12-24	WOS:000326647600044
J	Emerling, BM; Hurov, JB; Poulogiannis, G; Tsukazawa, KS; Choo-Wing, R; Wulf, GM; Bell, EL; Shim, HS; Lamia, KA; Rameh, LE; Bellinger, G; Sasaki, AT; Asara, JM; Yuan, X; Bullock, A; DeNicola, GM; Song, JX; Brown, V; Signoretti, S; Cantley, LC				Emerling, Brooke M.; Hurov, Jonathan B.; Poulogiannis, George; Tsukazawa, Kazumi S.; Choo-Wing, Rayman; Wulf, Gerburg M.; Bell, Eric L.; Shim, Hye-Seok; Lamia, Katja A.; Rameh, Lucia E.; Bellinger, Gary; Sasaki, Atsuo T.; Asara, John M.; Yuan, Xin; Bullock, Andrea; DeNicola, Gina M.; Song, Jiaxi; Brown, Victoria; Signoretti, Sabina; Cantley, Lewis C.			Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null Tumors	CELL			English	Article							INOSITOL POLYPHOSPHATE 4-PHOSPHATASE; METASTATIC BREAST-CANCER; SUBSTRATE-SPECIFICITY; SENESCENCE; SUPPRESSOR; PTDINS5P; MICE; ACTIVATION; PATHWAY; SYSTEM	Here, we show that a subset of breast cancers express high levels of the type 2 phosphatidylinositol-5-phosphate 4-kinases alpha and/or beta (PI5P4K alpha and beta) and provide evidence that these kinases are essential for growth in the absence of p53. Knocking down PI5P4K alpha and beta in a breast cancer cell line bearing an amplification of the gene encoding PI5P4K beta and deficient for p53 impaired growth on plastic and in xenografts. This growth phenotype was accompanied by enhanced levels of reactive oxygen species (ROS) leading to senescence. Mice with homozygous deletion of both TP53 and PIP4K2B were not viable, indicating a synthetic lethality for loss of these two genes. Importantly however, PIP4K2A(-/-), PIP4K2B(+/-), and TP53(-/-) mice were viable and had a dramatic reduction in tumor formation compared to TP53(-/-) littermates. These results indicate that inhibitors of PI5P4Ks could be effective in preventing or treating cancers with mutations in TP53.	[Emerling, Brooke M.; Poulogiannis, George; Tsukazawa, Kazumi S.; Choo-Wing, Rayman; Shim, Hye-Seok; DeNicola, Gina M.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Emerling, Brooke M.; Poulogiannis, George; Tsukazawa, Kazumi S.; Choo-Wing, Rayman; Wulf, Gerburg M.; Shim, Hye-Seok; Asara, John M.; Yuan, Xin; Bullock, Andrea; DeNicola, Gina M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Emerling, Brooke M.; Choo-Wing, Rayman; Bellinger, Gary; Cantley, Lewis C.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Hurov, Jonathan B.] Agios Pharmaceut, Cambridge, MA 02139 USA; [Bell, Eric L.] MIT, Dept Biol, Paul F Glenn Lab, Cambridge, MA 02139 USA; [Lamia, Katja A.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Rameh, Lucia E.] Boston Univ, Dept Med, Sch Med, Boston, MA 02118 USA; [Sasaki, Atsuo T.] Univ Cincinnati, Coll Med, UC Neurosci Inst, Dept Internal Med,Brain Tumor Ctr, Cincinnati, OH 45267 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Song, Jiaxi; Brown, Victoria; Signoretti, Sabina] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Song, Jiaxi; Brown, Victoria; Signoretti, Sabina] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Cornell University; Agios Pharmaceuticals; Massachusetts Institute of Technology (MIT); Scripps Research Institute; Boston University; University System of Ohio; University of Cincinnati; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cantley, LC (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	lcantley@med.cornell.edu	Poulogiannis, George/AAY-2210-2021; Wulf, Gerburg/AAS-6713-2021; Poulogiannis, George/AAE-1966-2019; Cantley, Lewis C/D-1800-2014	Poulogiannis, George/0000-0002-0529-8614; Cantley, Lewis C/0000-0002-1298-7653; Sasaki, Atsuo/0000-0003-2963-4501; DeNicola, Gina/0000-0001-6611-6696	NIH [R01 GM041890]; DF/HCC Career Development Award; Stand Up to Cancer Dream Team Translational Research Grant; Entertainment Industry Foundation [SU2C-AACR-DT0209]; NIH DK [R01-63219]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DF/HCC Career Development Award; Stand Up to Cancer Dream Team Translational Research Grant; Entertainment Industry Foundation; NIH DK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Rodrick Bronson and the entire HMS Rodent Histopathology Core for technical help with the mouse histopathology and discussions concerning the project. Also, we would like to thank Jared Johnson for cloning expertise and the Nikon Imaging Center at Harvard Medical School for help with light microscopy. This work was supported by NIH grant R01 GM041890 to L. C. C., DF/HCC Career Development Award to B. M. E., and by a Stand Up to Cancer Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation (SU2C-AACR-DT0209). G. P. is a Pfizer Fellow of the Life Sciences Research Foundation. NIH DK R01-63219 supports L.E.R.	Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Dearth LR, 2007, CARCINOGENESIS, V28, P289, DOI 10.1093/carcin/bgl132; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Hurov JB, 2001, MOL CELL BIOL, V21, P3206, DOI 10.1128/MCB.21.9.3206-3219.2001; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Jones DR, 2013, FASEB J, V27, P1644, DOI 10.1096/fj.12-218842; Lamia KA, 2004, MOL CELL BIOL, V24, P5080, DOI 10.1128/MCB.24.11.5080-5087.2004; Luoh SW, 2004, ONCOGENE, V23, P1354, DOI 10.1038/sj.onc.1207251; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Morrison LE, 2007, GENE CHROMOSOME CANC, V46, P397, DOI 10.1002/gcc.20419; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; NORRIS FA, 1995, J BIOL CHEM, V270, P16128, DOI 10.1074/jbc.270.27.16128; Norris FA, 1997, J BIOL CHEM, V272, P23859, DOI 10.1074/jbc.272.38.23859; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Sarkes D, 2010, BIOCHEM J, V428, P375, DOI 10.1042/BJ20100129; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, NEW ENGL J MED, V317, P955, DOI 10.1056/NEJM198710083171509; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Wilson JRF, 2010, J MED GENET, V47, P771, DOI 10.1136/jmg.2010.078113; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	34	111	118	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					844	857		10.1016/j.cell.2013.09.057	http://dx.doi.org/10.1016/j.cell.2013.09.057			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209622	Green Accepted, Bronze			2022-12-24	WOS:000326934300014
J	Barouch, DH; Stephenson, KE; Borducchi, EN; Smith, K; Stanley, K; McNally, AG; Liu, JY; Abbink, P; Maxfield, LF; Seaman, MS; Dugast, AS; Alter, G; Ferguson, M; Li, WJ; Earl, PL; Moss, B; Giorgi, EE; Szinger, JJ; Eller, LA; Billings, EA; Rao, M; Tovanabutra, S; Sanders-Buell, E; Weijtens, M; Pau, MG; Schuitemaker, H; Robb, ML; Kim, JH; Korber, BT; Michael, NL				Barouch, Dan H.; Stephenson, Kathryn E.; Borducchi, Erica N.; Smith, Kaitlin; Stanley, Kelly; McNally, Anna G.; Liu, Jinyan; Abbink, Peter; Maxfield, Lori F.; Seaman, Michael S.; Dugast, Anne-Sophie; Alter, Galit; Ferguson, Melissa; Li, Wenjun; Earl, Patricia L.; Moss, Bernard; Giorgi, Elena E.; Szinger, James J.; Eller, Leigh Anne; Billings, Erik A.; Rao, Mangala; Tovanabutra, Sodsai; Sanders-Buell, Eric; Weijtens, Mo; Pau, Maria G.; Schuitemaker, Hanneke; Robb, Merlin L.; Kim, Jerome H.; Korber, Bette T.; Michael, Nelson L.			Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys	CELL			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTE RESPONSES; IMMUNE CONTROL; BREADTH; AIDS; IMMUNOGENICITY; DIVERSITY; INFECTION; MACAQUES; COVERAGE	The global diversity of HIV-1 represents a critical challenge facing HIV-1 vaccine development. HIV-1 mosaic antigens are bioinformatically optimized immunogens designed for improved coverage of HIV-1 diversity. However, the protective efficacy of such global HIV-1 vaccine antigens has not previously been evaluated. Here, we demonstrate the capacity of bivalent HIV-1 mosaic antigens to protect rhesus monkeys against acquisition of infection following heterologous challenges with the difficult-to-neutralize simian-human immunodeficiency virus SHIV-SF162P3. Adenovirus/poxvirus and adenovirus/adenovirus vector-based vaccines expressing HIV-1 mosaic Env, Gag, and Pol afforded a significant reduction in the per-exposure acquisition risk following repetitive, intrarectal SHIV-SF162P3 challenges. Protection against acquisition of infection correlated with vaccine-elicited binding, neutralizing, and functional nonneutralizing antibodies, suggesting that the coordinated activity of multiple antibody functions may contribute to protection against difficult-to-neutralize viruses. These data demonstrate the protective efficacy of HIV-1 mosaic antigens and suggest a potential strategy for the development of a global HIV-1 vaccine.	[Barouch, Dan H.; Stephenson, Kathryn E.; Borducchi, Erica N.; Smith, Kaitlin; Stanley, Kelly; McNally, Anna G.; Liu, Jinyan; Abbink, Peter; Maxfield, Lori F.; Seaman, Michael S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Barouch, Dan H.; Dugast, Anne-Sophie; Alter, Galit] Ragon Inst MGH Massachusetts Inst Technol & Harva, Boston, MA 02114 USA; [Ferguson, Melissa] Alpha Genesis Inc, Yemassee, SC 29945 USA; [Li, Wenjun] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Earl, Patricia L.; Moss, Bernard] NIAID, Bethesda, MD 20892 USA; [Giorgi, Elena E.; Szinger, James J.; Korber, Bette T.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Eller, Leigh Anne; Billings, Erik A.; Rao, Mangala; Tovanabutra, Sodsai; Sanders-Buell, Eric; Robb, Merlin L.; Kim, Jerome H.; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Rockville, MD 20850 USA; [Weijtens, Mo; Pau, Maria G.; Schuitemaker, Hanneke] Crucell Holland BV, NL-2301 CA Leiden, Netherlands	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Johnson & Johnson	Barouch, DH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Li, Wenjun/F-5634-2015; Barouch, Dan/Y-3918-2019; Dugast, AnneSophie/L-9541-2015	Li, Wenjun/0000-0001-5335-7386; Korber, Bette/0000-0002-2026-5757; Szinger, James/0000-0002-6605-9940; Moss, Bernard/0000-0002-2154-8564; Stephenson, Kathryn/0000-0002-3440-4105	U.S. Military Research and Material Command; U.S. Military HIV Research Program [W81XWH-07-2-0067]; National Institutes of Health [AI052074, AI060354, AI078526, AI084794, AI095985, AI096040, AI100645]; NIAID Division of Intramural Research; Ragon Institute of MGH, MIT, and Harvard; Bill and Melinda Gates Foundation [OPP1033091, OPP1040741]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000416, T32AI007387, U19AI096040, U19AI078526, R01AI084794, P30AI060354, UM1AI100663, T32AI052074, UM1AI100645, U19AI095985] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD012217] Funding Source: NIH RePORTER	U.S. Military Research and Material Command; U.S. Military HIV Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ragon Institute of MGH, MIT, and Harvard; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Pensiero, S. Blackmore, R. Bradsky, C. Cabral, A. Cheung, J. Goudsmit, R. Hamel, B. Hibl, S. Howell, M. Iampietro, K. Kelly, D. Lynch, M. Marovich, C. Miller, J. Nkolola, A. O'Sullivan, L. Parenteau, J. Perry, W. Rinaldi, J. Sadoff, A. SanMiguel, N. Simmons, J. Smith, F. Stephens, D. van Manen, G. Westergaard, and L. Wyatt for generous advice, assistance, and reagents. The HIV-1 PTE peptides were obtained from the NIH AIDS Research and Reference Reagent Program. We acknowledge support from the U.S. Military Research and Material Command and the U.S. Military HIV Research Program (W81XWH-07-2-0067); the National Institutes of Health (AI052074, AI060354, AI078526, AI084794, AI095985, AI096040, and AI100645); the NIAID Division of Intramural Research; the Ragon Institute of MGH, MIT, and Harvard; and the Bill and Melinda Gates Foundation (OPP1033091 and OPP1040741). M. W., M. G. P., and H. S. are employees of Crucell. Beth Israel Deaconess Medical Center and Los Alamos National Laboratory are co-owners of an HIV-1 mosaic antigen patent that has been licensed to Crucell. The opinions in this manuscript are those of the authors and do not reflect the views of the U.S. Department of the Army or the Department of Defense.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Ackerman ME, 2011, J IMMUNOL METHODS, V366, P8, DOI 10.1016/j.jim.2010.12.016; Barnett SW, 2010, J VIROL, V84, P5975, DOI 10.1128/JVI.02533-09; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fischer W, 2012, J VIROL, V86, P13217, DOI 10.1128/JVI.01862-12; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hudgens MG, 2009, BIOMETRICS, V65, P1223, DOI 10.1111/j.1541-0420.2009.01189.x; Hudgens MG, 2009, J INFECT DIS, V200, P609, DOI 10.1086/600891; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Montefiori D.C., 2004, CURRENT PROTOC IMMUN, V64; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Reimann KA, 1996, J VIROL, V70, P3198, DOI 10.1128/JVI.70.5.3198-3206.1996; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Ren WZ, 2013, J VIROL, V87, P6137, DOI 10.1128/JVI.00178-13; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Siddappa NB, 2011, J MED PRIMATOL, V40, P120, DOI 10.1111/j.1600-0684.2010.00454.x; Siddappa NB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011689; Stephenson KE, 2013, IMMUNOL REV, V254, P295, DOI 10.1111/imr.12073; Stephenson KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12; Stephenson KE, 2012, J VIROL, V86, P9583, DOI 10.1128/JVI.00996-12; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Walker BD, 2001, NAT IMMUNOL, V2, P473, DOI 10.1038/88656; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	37	267	284	2	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					531	539		10.1016/j.cell.2013.09.061	http://dx.doi.org/10.1016/j.cell.2013.09.061			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243013	Bronze, Green Accepted			2022-12-24	WOS:000326571800009
J	Grotzinger, JP; Sumner, DY; Kah, LC; Stack, K; Gupta, S; Edgar, L; Rubin, D; Lewis, K; Schieber, J; Mangold, N; Milliken, R; Conrad, PG; DesMarais, D; Farmer, J; Siebach, K; Calef, F; Hurowitz, J; McLennan, SM; Ming, D; Vaniman, D; Crisp, J; Vasavada, A; Edgett, KS; Malin, M; Blake, D; Gellert, R; Mahaffy, P; Wiens, RC; Maurice, S; Grant, JA; Wilson, S; Anderson, RC; Beegle, L; Arvidson, R; Hallet, B; Sletten, RS; Rice, M; Bell, J; Griffes, J; Ehlmann, B; Anderson, RB; Bristow, TF; Dietrich, WE; Dromart, G; Eigenbrode, J; Fraeman, A; Hardgrove, C; Herkenhoff, K; Jandura, L; Kocurek, G; Lee, S; Leshin, LA; Leveille, R; Limonadi, D; Maki, J; McCloskey, S; Meyer, M; Minitti, M; Newsom, H; Oehler, D; Okon, A; Palucis, M; Parker, T; Rowland, S; Schmidt, M; Squyres, S; Steele, A; Stolper, E; Summons, R; Treiman, A; Williams, R; Yingst, A				Grotzinger, J. P.; Sumner, D. Y.; Kah, L. C.; Stack, K.; Gupta, S.; Edgar, L.; Rubin, D.; Lewis, K.; Schieber, J.; Mangold, N.; Milliken, R.; Conrad, P. G.; DesMarais, D.; Farmer, J.; Siebach, K.; Calef, F., III; Hurowitz, J.; McLennan, S. M.; Ming, D.; Vaniman, D.; Crisp, J.; Vasavada, A.; Edgett, K. S.; Malin, M.; Blake, D.; Gellert, R.; Mahaffy, P.; Wiens, R. C.; Maurice, S.; Grant, J. A.; Wilson, S.; Anderson, R. C.; Beegle, L.; Arvidson, R.; Hallet, B.; Sletten, R. S.; Rice, M.; Bell, J., III; Griffes, J.; Ehlmann, B.; Anderson, R. B.; Bristow, T. F.; Dietrich, W. E.; Dromart, G.; Eigenbrode, J.; Fraeman, A.; Hardgrove, C.; Herkenhoff, K.; Jandura, L.; Kocurek, G.; Lee, S.; Leshin, L. A.; Leveille, R.; Limonadi, D.; Maki, J.; McCloskey, S.; Meyer, M.; Minitti, M.; Newsom, H.; Oehler, D.; Okon, A.; Palucis, M.; Parker, T.; Rowland, S.; Schmidt, M.; Squyres, S.; Steele, A.; Stolper, E.; Summons, R.; Treiman, A.; Williams, R.; Yingst, A.		MSL Sci Team	A Habitable Fluvio-Lacustrine Environment at Yellowknife Bay, Gale Crater, Mars	SCIENCE			English	Article							SEDIMENTARY-ROCKS; MERIDIANI-PLANUM; WATER ACTIVITY; LIFE; BASIN; HYDROGEN; DEPOSITS; ORIGIN; SOIL; DUST	The Curiosity rover discovered fine-grained sedimentary rocks, which are inferred to represent an ancient lake and preserve evidence of an environment that would have been suited to support a martian biosphere founded on chemolithoautotrophy. This aqueous environment was characterized by neutral pH, low salinity, and variable redox states of both iron and sulfur species. Carbon, hydrogen, oxygen, sulfur, nitrogen, and phosphorus were measured directly as key biogenic elements; by inference, phosphorus is assumed to have been available. The environment probably had a minimum duration of hundreds to tens of thousands of years. These results highlight the biological viability of fluvial-lacustrine environments in the post-Noachian history of Mars.	[Grotzinger, J. P.; Stack, K.; Siebach, K.; Rice, M.; Griffes, J.; Ehlmann, B.; Stolper, E.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Sumner, D. Y.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Kah, L. C.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; [Gupta, S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Edgar, L.; Farmer, J.; Bell, J., III; Minitti, M.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Rubin, D.] US Geol Survey, Santa Cruz, CA 95060 USA; [Lewis, K.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Schieber, J.] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Mangold, N.] LPGN CNRS UMR6112, LPGN, F-44322 Nantes, France; [Mangold, N.] Univ Nantes, F-44322 Nantes, France; [Milliken, R.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Conrad, P. G.; Mahaffy, P.; Eigenbrode, J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [DesMarais, D.; Blake, D.; Bristow, T. F.] NASA, Ames Res Ctr, Dept Space Sci, Moffett Field, CA 94035 USA; [Calef, F., III; Crisp, J.; Vasavada, A.; Anderson, R. C.; Beegle, L.; Ehlmann, B.; Jandura, L.; Lee, S.; Limonadi, D.; Maki, J.; McCloskey, S.; Okon, A.; Parker, T.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Hurowitz, J.; McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Ming, D.; Oehler, D.] NASA, Lyndon B Johnson Space Ctr, Jacobs Technol, Houston, TX 77058 USA; [Vaniman, D.; Williams, R.; Yingst, A.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Edgett, K. S.; Malin, M.; Hardgrove, C.] Malin Space Sci Syst, San Diego, CA 92121 USA; [Gellert, R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Wiens, R. C.] Los Alamos Natl Lab, Los Alamos, NM 87544 USA; [Maurice, S.] Univ Toulouse, CNRS, IRAP, F-31400 Toulouse, France; [Grant, J. A.; Wilson, S.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Arvidson, R.; Fraeman, A.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Hallet, B.; Sletten, R. S.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Anderson, R. B.; Herkenhoff, K.] US Geol Survey, Flagstaff, AZ 86001 USA; [Dietrich, W. E.; Palucis, M.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Dromart, G.] Univ Lyon, Lab Geol Lyon, F-69364 Lyon, France; [Kocurek, G.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Leshin, L. A.] Rensselaer Polytech Inst, Sch Sci, Troy, NY 12180 USA; [Leveille, R.] Canadian Space Agcy, St Hubert, PQ J3Y 8Y9, Canada; [Meyer, M.] NASA Headquarters, Washington, DC 20546 USA; [Newsom, H.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Rowland, S.] Univ Hawaii Manoa, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Schmidt, M.] Brock Univ, Dept Earth Sci, St Catharines, ON L2S 3A1, Canada; [Squyres, S.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Steele, A.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Summons, R.] MIT, Dept Earth & Planetary Sci, Cambridge, MA 02139 USA; [Treiman, A.] Lunar & Planetary Inst, Houston, TX 77058 USA	California Institute of Technology; University of California System; University of California Davis; University of Tennessee System; University of Tennessee Knoxville; Imperial College London; Arizona State University; Arizona State University-Tempe; United States Department of the Interior; United States Geological Survey; Princeton University; Indiana University System; Indiana University Bloomington; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Le Mans Universite; Nantes Universite; Universite d'Angers; Nantes Universite; Brown University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Guelph; United States Department of Energy (DOE); Los Alamos National Laboratory; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Smithsonian Institution; Washington University (WUSTL); University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey; University of California System; University of California Berkeley; Ecole Normale Superieure de Lyon (ENS de LYON); University of Texas System; University of Texas Austin; Rensselaer Polytechnic Institute; Canadian Space Agency; National Aeronautics & Space Administration (NASA); University of New Mexico; University of Hawaii System; University of Hawaii Manoa; Brock University; Cornell University; Carnegie Institution for Science; Massachusetts Institute of Technology (MIT)	Grotzinger, JP (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	grotz@gps.caltech.edu	Blanco, Juan Jose/E-3627-2014; Prats, Benito/F-9467-2019; Gómez, Felipe/L-7315-2014; Sumner, Dawn Y/E-8744-2011; Teinturier, Samuel/AAS-8663-2020; FABRE, Cécile/B-5827-2012; De Pablo, Miguel Ángel/J-6442-2014; Avalos, Juan Jose Blanco/AAB-9447-2021; Kah, Linda C/J-3754-2019; Navarro-González, Rafael/D-1748-2009; Malakhov, Alexey Vladimirovich/F-7953-2017; Summons, Roger Everett/AAL-3789-2020; Steele, Andrew/A-3573-2013; Rodriguez-Manfredi, Jose/L-8001-2014; Gomez-Elvira, Javier/K-5829-2014; Eigenbrode, Jennifer L/D-4651-2012; Floyd, Melissa/D-4626-2012; Dworkin, Jason P./C-9417-2012; Beegle, Luther/AAU-5538-2021; Harri, Ari-Matti/C-7142-2012; Zorzano, María-Paz/F-2184-2015; Stipp, Susan L.S./B-8494-2019; Hayes, Alexander G/P-2024-2014; Rodriguez-Manfredi, Jose/AAG-9826-2021; Crisp, Joy/H-8287-2016; Stack Morgan, Kathryn/AGY-7985-2022; Farmer, Jack D/B-9343-2019; szopa, cyril/C-6865-2015; Glavin, Daniel P/D-6194-2012; Lemmon, Mark T/E-9983-2010; Balic-Zunic, Tonci/A-6362-2013; Martin-Torres, Javier/G-6329-2015; GEFFROY, Claude/AAB-9152-2019; Ramos, Miguel/K-2230-2014; Benna, Mehdi/F-3489-2012; Vicenzi, Edward/T-9430-2017	Blanco, Juan Jose/0000-0002-8666-0696; Prats, Benito/0000-0003-3869-3351; Gómez, Felipe/0000-0001-9977-7060; Sumner, Dawn Y/0000-0002-7343-2061; Teinturier, Samuel/0000-0003-1755-9524; FABRE, Cécile/0000-0001-8627-4050; De Pablo, Miguel Ángel/0000-0002-4496-2741; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Kah, Linda C/0000-0001-7172-2033; Navarro-González, Rafael/0000-0002-6078-7621; Malakhov, Alexey Vladimirovich/0000-0003-4292-7077; Steele, Andrew/0000-0001-9643-2841; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Gomez-Elvira, Javier/0000-0002-9068-9846; Eigenbrode, Jennifer L/0000-0003-3089-1986; Dworkin, Jason P./0000-0002-3961-8997; Harri, Ari-Matti/0000-0001-8541-2802; Zorzano, María-Paz/0000-0002-4492-9650; Stipp, Susan L.S./0000-0001-7009-643X; Hayes, Alexander G/0000-0001-6397-2630; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Crisp, Joy/0000-0002-3202-4416; szopa, cyril/0000-0002-0090-4056; Glavin, Daniel P/0000-0001-7779-7765; Lemmon, Mark T/0000-0002-4504-5136; Balic-Zunic, Tonci/0000-0003-1687-1233; Martin-Torres, Javier/0000-0001-6479-2236; GEFFROY, Claude/0000-0002-2731-9658; Ramos, Miguel/0000-0003-3648-6818; Beegle, Luther/0000-0002-4944-4353; Edgett, Kenneth/0000-0001-7197-5751; Siebach, Kirsten/0000-0002-6628-6297; Gupta, Sanjeev/0000-0001-6415-1332; Fraeman, Abigail/0000-0003-4017-5158; Wilson, Sharon/0000-0001-8872-8546; Williams, Rebecca/0000-0003-1571-6952; Johnson, Jeffrey/0000-0002-5586-4901; McLennan, Scott/0000-0003-4259-7178; Rice, Melissa/0000-0002-8370-4139; Grant, John/0000-0001-8276-1281; Vicenzi, Edward/0000-0003-2085-6546; Rubin, David/0000-0003-1169-1452	NASA; Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/J005339/1, ST/J005169/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	We are indebted to the MSL Project engineering and management teams for their exceptionally skilled and diligent efforts in making the mission as effective as possible and enhancing science operations. We are also grateful to all those MSL Science Team members who participated in tactical and strategic operations. Without the support of both the engineering and science teams, the data presented here could not have been collected. Some of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. Data presented in this paper are archived in the Planetary Data System (pds.nasa.gov).	Anderson R. B., 2010, MARS, V5, P76, DOI [DOI 10.1555/MARS.2010.0004, 10.1555/mars.2010.0004]; Andrews-Hanna JC, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003709; Aspler LB, 2004, PRECAMBRIAN RES, V129, P225, DOI 10.1016/j.precamres.2003.10.004; Attewell P., 1976, PRINCIPLES ENG GEOLO, P1045, DOI [10.1007/978-94-009-5707-7, DOI 10.1007/978-94-009-5707-7]; Bekker A, 2010, ECON GEOL, V105, P467, DOI 10.2113/gsecongeo.105.3.467; Bell III J. F., 2008, MARTIAN SURFACE COMP; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bridges NT, 2012, SOC SEDIMENT GEOL SP, V102, P169; Bristow TF, 2011, CLAY CLAY MINER, V59, P339, DOI 10.1346/CCMN.2011.0590401; CHRISTENSEN PR, 1986, J GEOPHYS RES-SOLID, V91, P3533, DOI 10.1029/JB091iB03p03533; COLLINSON JD, 1983, SEDIMENT GEOL, V34, P145, DOI 10.1016/0037-0738(83)90084-2; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; Cosgrove JW, 2001, AAPG BULL, V85, P737; Dartnell LR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027494; Demergasso C, 2004, FEMS MICROBIOL ECOL, V48, P57, DOI 10.1016/j.femsec.2003.12.013; ElTabakh M, 1997, SEDIMENTOLOGY, V44, P767, DOI 10.1046/j.1365-3091.1997.d01-47.x; Fairen AG, 2010, P NATL ACAD SCI USA, V107, P12095, DOI 10.1073/pnas.1002889107; Fendrihan S, 2012, GEOBIOLOGY, V10, P424, DOI 10.1111/j.1472-4669.2012.00337.x; Fisher JA, 2007, SEDIMENT GEOL, V195, P55, DOI 10.1016/j.sedgeo.2006.07.005; Fraeman AA, 2013, GEOLOGY, V41, P1103, DOI 10.1130/G34613.1; Fralick P., 2012, SEPM SPECIAL PUBLICA, V102; FRIEDMANN EI, 1982, SCIENCE, V215, P1045, DOI 10.1126/science.215.4536.1045; Furniss G, 1998, J SEDIMENT RES, V68, P104, DOI 10.2110/jsr.68.104; Gottschalk G., 1994, MICROBIAL METABOLISM; Grant WD, 2004, PHILOS T R SOC B, V359, P1249, DOI 10.1098/rstb.2004.1502; Grotzinger J. P., 2012, SEPM SPECIAL PUBLICA, V102; Grotzinger J.P., 2000, CARBONATE SEDIMENTAT, P3, DOI [DOI 10.2110/PEC.00.67.0003, 10.2110/pec.00.67.0003]; Grotzinger J, 2009, NAT GEOSCI, V2, P231, DOI 10.1038/ngeo480; Grotzinger JP, 2012, SPACE SCI REV, V170, P5, DOI 10.1007/s11214-012-9892-2; GROTZINGER JP, 1989, SOC ECON PA, V44, P79, DOI 10.2110/pec.89.44.0079; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Hurst A, 2003, GEOL SOC SPEC PUBL, V216, P123, DOI 10.1144/GSL.SP.2003.216.01.09; Hurst A, 2011, EARTH-SCI REV, V106, P215, DOI 10.1016/j.earscirev.2011.02.004; Huuse M., 2007, AM ASS PETROLEUM GEO, V87; Irwin RP, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002460; James H. L., 1982, MIN DEP EV BIOSPH DA, V3; Kane IA, 2010, MAR PETROL GEOL, V27, P1200, DOI 10.1016/j.marpetgeo.2010.02.009; Kieffer H., 1992, MARS; Kim JD, 2013, P NATL ACAD SCI USA, V110, P10073, DOI 10.1073/pnas.1308958110; Kish A, 2009, ENVIRON MICROBIOL, V11, P1066, DOI 10.1111/j.1462-2920.2008.01828.x; Klein H. P., 1977, Journal of Geophysical Research, V82, P4677, DOI 10.1029/JS082i028p04677; Knoll AH, 2006, ELEMENTS, V2, P169, DOI 10.2113/gselements.2.3.169; Leshin LA, 2013, SCIENCE, V341, DOI 10.1126/science.1238937; Lopez-Archilla AI, 2001, MICROB ECOL, V41, P20; MACDONALD GA, 1953, AM J SCI, V251, P169, DOI 10.2475/ajs.251.3.169; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Mangold N, 2009, GEOMORPHOLOGIE, P23; MCCORMICK DS, 1993, J SEDIMENT PETROL, V63, P398; McLennan SM, 2014, SCIENCE, V343, DOI 10.1126/science.1244734; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; Meslin PY, 2013, SCIENCE, V341, DOI 10.1126/science.1238670; Milliken RE, 2008, GEOLOGY, V36, P847, DOI 10.1130/G24967A.1; Milliken RE, 2010, PHILOS MAG, V90, P2293, DOI 10.1080/14786430903575132; Milman-Barris MS, 2008, CONTRIB MINERAL PETR, V155, P739, DOI 10.1007/s00410-007-0268-7; Ming DW, 2014, SCIENCE, V343, DOI 10.1126/science.1245267; Morris RV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002791; Morris RV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002584; Murchie SL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003342; Nealson KH, 1997, ANNU REV EARTH PL SC, V25, P403, DOI 10.1146/annurev.earth.25.1.403; Nealson KH, 1999, PHILOS T R SOC B, V354, P1923, DOI 10.1098/rstb.1999.0532; OYAMA VI, 1977, NATURE, V265, P110, DOI 10.1038/265110a0; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; PLUMMER PS, 1981, J SEDIMENT PETROL, V51, P1147; Pollock MD, 2006, J SEDIMENT RES, V76, P310, DOI 10.2110/jsr.2006.021; Potter PE, 2005, MUD MUDSTONES; Pratt BR, 1998, SEDIMENT GEOL, V117, P1, DOI 10.1016/S0037-0738(98)00023-2; Ross JA, 2011, SEDIMENTOLOGY, V58, P1693, DOI 10.1111/j.1365-3091.2011.01230.x; Rossi M, 2003, J BACTERIOL, V185, P3683, DOI 10.1128/JB.185.13.3683-3689.2003; SADLER PM, 1981, J GEOL, V89, P569, DOI 10.1086/628623; Sarna-Wojcicki A, 1981, US GEOLOGICAL SURVEY, V1250, P577; Schlegel HG, 1993, GEN MICROBIOLOGY, V7th; Schmidt M. E., 2013, LUNAR PLANET SCI C; Schoonen MAA, 2001, ASTROBIOLOGY, V1, P133, DOI 10.1089/153110701753198909; SCHRAUZER GN, 1976, J AM CHEM SOC, V98, P3508, DOI 10.1021/ja00428a019; SMITH ND, 1972, J SEDIMENT PETROL, V42, P624; Sousa DZ, 2013, APPL ENVIRON MICROB, V79, P4239, DOI 10.1128/AEM.00035-13; Squyres SW, 2005, EARTH PLANET SC LETT, V240, P1, DOI 10.1016/j.epsl.2005.09.038; Stetter KO, 1999, FEBS LETT, V452, P22, DOI 10.1016/S0014-5793(99)00663-8; Stolper EM, 2013, SCIENCE, V341, DOI 10.1126/science.1239463; Summers DP, 2012, ASTROBIOLOGY, V12, P107, DOI 10.1089/ast.2011.0646; Taylor SR, 2009, PLANETARY CRUSTS: THEIR COMPOSITION, ORIGIN AND EVOLUTION, P1; Thomson BJ, 2011, ICARUS, V214, P413, DOI 10.1016/j.icarus.2011.05.002; Tosca NJ, 2008, SCIENCE, V320, P1204, DOI 10.1126/science.1155432; Vaniman DT, 2014, SCIENCE, V343, DOI 10.1126/science.1243480; Williams JP, 2009, ENVIRON MICROBIOL, V11, P3292, DOI 10.1111/j.1462-2920.2009.02079.x; Williams RME, 2013, SCIENCE, V340, P1068, DOI 10.1126/science.1237317; Winston D., 1977, FLUVIAL SEDIMENTOLOG, V5, P343; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Yen AS, 2005, NATURE, V436, P49, DOI 10.1038/nature03637	90	293	298	9	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1242777	10.1126/science.1242777	http://dx.doi.org/10.1126/science.1242777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24324272	Green Submitted, Green Accepted			2022-12-24	WOS:000330039300002
J	Frieden, TR; King, SMC; Wright, JS				Frieden, Thomas R.; King, Sallyann M. Coleman; Wright, Janet S.			Protocol-Based Treatment of Hypertension A Critical Step on the Pathway to Progress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-PRESSURE; TRENDS		[Frieden, Thomas R.; King, Sallyann M. Coleman; Wright, Janet S.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA.	tfrieden@cdc.gov		Frieden, Thomas/0000-0002-4759-2256				Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Handler J, 2011, J AM SOC HYPERTENS, V5, P197, DOI 10.1016/j.jash.2011.03.002; Hypertension Detection Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.1979.03300230018021; Jaffe MG, 2013, JAMA-J AM MED ASSOC, V310, P699, DOI 10.1001/jama.2013.108769; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Luepker RV, 2012, CIRCULATION, V126, P1852, DOI 10.1161/CIRCULATIONAHA.112.098517; Valderrama Amy L., 2012, Morbidity and Mortality Weekly Report, V61, P703	7	47	47	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2014	311	1					21	22		10.1001/jama.2013.282615	http://dx.doi.org/10.1001/jama.2013.282615			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	282HN	24231925				2022-12-24	WOS:000329161400010
J	Kruse, AC; Ring, AM; Manglik, A; Hu, JX; Hu, K; Eitel, K; Hubner, H; Pardon, E; Valant, C; Sexton, PM; Christopoulos, A; Felder, CC; Gmeiner, P; Steyaert, J; Weis, WI; Garcia, KC; Wess, J; Kobilka, BK				Kruse, Andrew C.; Ring, Aaron M.; Manglik, Aashish; Hu, Jianxin; Hu, Kelly; Eitel, Katrin; Huebner, Harald; Pardon, Els; Valant, Celine; Sexton, Patrick M.; Christopoulos, Arthur; Felder, Christian C.; Gmeiner, Peter; Steyaert, Jan; Weis, William I.; Garcia, K. Christopher; Wess, Juergen; Kobilka, Brian K.			Activation and allosteric modulation of a muscarinic acetylcholine receptor	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; SITE-DIRECTED MUTAGENESIS; BINDING-SITE; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; AMINO-ACIDS; IDENTIFICATION; NANOBODY; LIGANDS	Despite recent advances in crystallography and the availability of G-protein-coupled receptor (GPCR) structures, little is known about the mechanism of their activation process, as only the beta(2) adrenergic receptor (beta(2)AR) and rhodopsin have been crystallized in fully active conformations. Here we report the structure of an agonist-bound, active state of the human M2 muscarinic acetylcholine receptor stabilized by a G-protein mimetic camelid antibody fragment isolated by conformational selection using yeast surface display. In addition to the expected changes in the intracellular surface, the structure reveals larger conformational changes in the extracellular region and orthosteric binding site than observed in the active states of the beta(2)AR and rhodopsin. We also report the structure of the M2 receptor simultaneously bound to the orthosteric agonist iperoxo and the positive allosteric modulator LY2119620. This structure reveals that LY2119620 recognizes a largely pre-formed binding site in the extracellular vestibule of the iperoxo-bound receptor, inducing a slight contraction of this outer binding pocket. These structures offer important insights into the activation mechanism and allosteric modulation of muscarinic receptors.	[Kruse, Andrew C.; Ring, Aaron M.; Manglik, Aashish; Weis, William I.; Garcia, K. Christopher; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ring, Aaron M.; Weis, William I.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Hu, Jianxin; Hu, Kelly; Wess, Juergen] NIDDKD, Mol Signaling Sect, Bioorgan Chem Lab, Bethesda, MD 20892 USA; [Eitel, Katrin; Huebner, Harald; Gmeiner, Peter] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91052 Erlangen, Germany; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Pardon, Els; Steyaert, Jan] VIB, Struct Biol Res Ctr, B-1050 Brussels, Belgium; [Valant, Celine; Sexton, Patrick M.; Christopoulos, Arthur] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Valant, Celine; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Felder, Christian C.] Eli Lilly & Co, Neurosci, Indianapolis, IN 46285 USA	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Erlangen Nuremberg; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Monash University; Eli Lilly	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.	kobilka@stanford.edu	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008; steyaert, jan/GQP-7811-2022; Gmeiner, Peter/N-5275-2015; Steyaert, Jan/H-4662-2011; Weis, William I/G-1437-2011	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Steyaert, Jan/0000-0002-3825-874X; Weis, William I/0000-0002-5583-6150; Valant, Celine/0000-0002-2509-7465; Gmeiner, Peter/0000-0002-4127-197X; Kobilka, Brian/0000-0001-5958-3990; Pardon, Els/0000-0002-2466-0172; Felder, Christian/0000-0003-1134-8881; Ring, Aaron/0000-0003-3699-2446	National Science Foundation [1223785]; Stanford Medical Scientist Training Program; American Heart Association; Ruth L. Kirschstein National Research Service Award; National Institutes of Health [NS02847123, GM08311806]; Mathers Foundation; Deutsche Forschungsgemeinschaft [GM 13/10-1]; National Health and Medical Research Council (NHMRC) of Australia [519461]; NHMRC; Howard Hughes Medical Institute; Intramural Research Program, NIDDK; NIH; US Department of Health and Human Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM106990, T32GM008294] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Stanford Medical Scientist Training Program; American Heart Association(American Heart Association); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural Research Program, NIDDK; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the National Science Foundation (graduate fellowship to A. C. K., and Award 1223785 to B. K. K.), the Stanford Medical Scientist Training Program (A. M. and A. M. R.), the American Heart Association (A. M.), the Ruth L. Kirschstein National Research Service Award (A. M. R.), National Institutes of Health grants NS02847123 and GM08311806 (B. K. K.), the Mathers Foundation (B. K. K., W. I. W. and K. C. G.), the Deutsche Forschungsgemeinschaft for the grant GM 13/10-1 (K. E., H. H., P. G.), the National Health and Medical Research Council (NHMRC) of Australia program grant 519461 (P. M. S. and A. C.), NHMRC Principal Research Fellowships (P. M. S. and A. C.), and the Howard Hughes Medical Institute (K. C. G.). This work was supported in part by the Intramural Research Program, NIDDK, NIH, US Department of Health and Human Services (J.H., K. H. and J.W.). We thank K. Leach for performing ERK assays, and B. Davie and P. Scammells for synthesis of iperoxo. We thank H. Xiao, C. H. Croy and D. A. Schober for functional characterization of LY2119620. We thank T. S. Kobilka for preparation of affinity chromatography reagents and F. S. Thian for help with cell culture.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; Broach JR, 1996, NATURE, V384, P14; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Canals M, 2012, J BIOL CHEM, V287, P650, DOI 10.1074/jbc.M111.314278; Chee MJS, 2008, J BIOL CHEM, V283, P33337, DOI 10.1074/jbc.M804671200; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; De Amici M, 2010, MED RES REV, V30, P463, DOI 10.1002/med.20166; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Digby GJ, 2010, MOL BIOSYST, V6, P1345, DOI 10.1039/c002938f; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Heitz F, 1999, EUR J PHARMACOL, V380, P183, DOI 10.1016/S0014-2999(99)00439-2; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; HUDGINS PM, 1972, J PHARMACOL EXP THER, V182, P303; Ichlyama S, 2006, FEBS LETT, V580, P23, DOI 10.1016/j.febslet.2005.11.042; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kloeckner J, 2010, TETRAHEDRON LETT, V51, P3470, DOI 10.1016/j.tetlet.2010.04.130; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; KUBO T, 1986, FEBS LETT, V209, P367, DOI 10.1016/0014-5793(86)81144-9; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; LIU J, 1995, P NATL ACAD SCI USA, V92, P11642, DOI 10.1073/pnas.92.25.11642; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Mohr K, 2003, RECEPTOR CHANNEL, V9, P229, DOI 10.1080/10606820308264; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETERSON GL, 1984, P NATL ACAD SCI-BIOL, V81, P4993, DOI 10.1073/pnas.81.15.4993; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SHAPIRO RA, 1989, BIOCHEMISTRY-US, V28, P8946, DOI 10.1021/bi00448a039; SPALDING TA, 1994, J BIOL CHEM, V269, P4092; Valant C, 2012, MOL PHARMACOL, V81, P41, DOI 10.1124/mol.111.074872; Vogel WK, 1997, MOL PHARMACOL, V52, P1087, DOI 10.1124/mol.52.6.1087; WESS J, 1992, J BIOL CHEM, V267, P19313; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	48	640	656	11	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					101	+		10.1038/nature12735	http://dx.doi.org/10.1038/nature12735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24256733	Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000327851700039
J	Smith, SL; Smith, IT; Branco, T; Hausser, M				Smith, Spencer L.; Smith, Ikuko T.; Branco, Tiago; Haeusser, Michael			Dendritic spikes enhance stimulus selectivity in cortical neurons in vivo	NATURE			English	Article							MOUSE VISUAL-CORTEX; PYRAMIDAL NEURONS; BARREL CORTEX; SYNAPTIC INTEGRATION; RECEPTIVE-FIELDS; BASAL DENDRITES; STRIATE CORTEX; INPUT; ORGANIZATION; POTENTIALS	Neuronal dendrites are electrically excitable: they can generate regenerative events such as dendritic spikes in response to sufficiently strong synaptic input(1-3). Although such events have been observed in many neuronal types(4-9), it is not well understood how active dendrites contribute to the tuning of neuronal output in vivo. Here we show that dendritic spikes increase the selectivity of neuronal responses to the orientation of a visual stimulus (orientation tuning). We performed direct patch-clamp recordings from the dendrites of pyramidal neurons in the primary visual cortex of lightly anaesthetized and awake mice, during sensory processing. Visual stimulation triggered regenerative local dendritic spikes that were distinct from back-propagating action potentials. These events were orientation tuned and were suppressed by either hyperpolarization of membrane potential or intracellular blockade of NMDA(N-methyl-D-aspartate) receptors. Both of these manipulations also decreased the selectivity of subthreshold orientation tuning measured at the soma, thus linking dendritic regenerative events to somatic orientation tuning. Together, our results suggest that dendritic spikes that are triggered by visual input contribute to a fundamental cortical computation: enhancing orientation selectivity in the visual cortex. Thus, dendritic excitability is an essential component of behaviourally relevant computations in neurons.	[Smith, Spencer L.; Smith, Ikuko T.; Branco, Tiago; Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Smith, Spencer L.; Smith, Ikuko T.; Branco, Tiago; Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Smith, Spencer L.; Smith, Ikuko T.] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Smith, Spencer L.; Smith, Ikuko T.] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Branco, Tiago] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	University of London; University College London; University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; MRC Laboratory Molecular Biology	Smith, SL (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	slab@unc.edu; m.hausser@ucl.ac.uk	Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957	Long-Term Fellowship; Career Development Award from the Human Frontier Science Program; Klingenstein Fellowship; Helen Lyng White Fellowship; Wellcome Trust; Royal Society; MRC; ERC; Gatsby Charitable Foundation; MRC [MC_UP_1201/1] Funding Source: UKRI; Medical Research Council [MC_UP_1201/1] Funding Source: researchfish	Long-Term Fellowship; Career Development Award from the Human Frontier Science Program; Klingenstein Fellowship(Klingenstein Philanthropies); Helen Lyng White Fellowship; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); Gatsby Charitable Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to B. Clark, P. Latham, M. London, D. Ringach, A. Roth, C. Schmidt-Hieber and C. Wilms for discussions and comments on the manuscript. This work was supported by the following: a Long-Term Fellowship and a Career Development Award from the Human Frontier Science Program and a Klingenstein Fellowship (S. L. S.); a Helen Lyng White Fellowship (I. T. S.); a Wellcome Trust and Royal Society Fellowship and MRC Programme Leader Track (T. B.); and by grants from the Wellcome Trust, ERC and Gatsby Charitable Foundation (M.H.).	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; FASANO G, 1987, MON NOT R ASTRON SOC, V225, P155, DOI 10.1093/mnras/225.1.155; FERSTER D, 1992, J NEUROSCI, V12, P1262; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; HIRSCH JA, 1995, NATURE, V378, P612, DOI 10.1038/378612a0; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; JAHR CE, 1990, J NEUROSCI, V10, P3178; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lavzin M, 2012, NATURE, V490, P397, DOI 10.1038/nature11451; LLINAS R, 1968, SCIENCE, V160, P1132, DOI 10.1126/science.160.3832.1132; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; VOLGUSHEV M, 1992, NEUROREPORT, V3, P679, DOI 10.1097/00001756-199208000-00006; Waters J, 2006, J NEUROSCI, V26, P8267, DOI 10.1523/JNEUROSCI.2152-06.2006; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X	38	231	237	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					115	+		10.1038/nature12600	http://dx.doi.org/10.1038/nature12600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24162850	Green Published, Green Accepted			2022-12-24	WOS:000326585600043
J	Xie, LL; Kang, HY; Xu, QW; Chen, MJ; Liao, YH; Thiyagarajan, M; O'Donnell, J; Christensen, DJ; Nicholson, C; Iliff, JJ; Takano, T; Deane, R; Nedergaard, M				Xie, Lulu; Kang, Hongyi; Xu, Qiwu; Chen, Michael J.; Liao, Yonghong; Thiyagarajan, Meenakshisundaram; O'Donnell, John; Christensen, Daniel J.; Nicholson, Charles; Iliff, Jeffrey J.; Takano, Takahiro; Deane, Rashid; Nedergaard, Maiken			Sleep Drives Metabolite Clearance from the Adult Brain	SCIENCE			English	Article							EXTRACELLULAR-SPACE; ALZHEIMERS-DISEASE; IN-VIVO; TRANSGENIC MICE; DIFFUSION; DEPRIVATION; DISRUPTION; MECHANISMS; TORTUOSITY; NETWORKS	The conservation of sleep across all animal species suggests that sleep serves a vital function. We here report that sleep has a critical function in ensuring metabolic homeostasis. Using real-time assessments of tetramethylammonium diffusion and two-photon imaging in live mice, we show that natural sleep or anesthesia are associated with a 60% increase in the interstitial space, resulting in a striking increase in convective exchange of cerebrospinal fluid with interstitial fluid. In turn, convective fluxes of interstitial fluid increased the rate of beta-amyloid clearance during sleep. Thus, the restorative function of sleep may be a consequence of the enhanced removal of potentially neurotoxic waste products that accumulate in the awake central nervous system.	[Xie, Lulu; Kang, Hongyi; Xu, Qiwu; Chen, Michael J.; Liao, Yonghong; Thiyagarajan, Meenakshisundaram; O'Donnell, John; Christensen, Daniel J.; Iliff, Jeffrey J.; Takano, Takahiro; Deane, Rashid; Nedergaard, Maiken] Univ Rochester, Med Ctr, Dept Neurosurg, Div Glial Dis & Therapeut,Ctr Translat Neuromed, Rochester, NY 14642 USA; [Nicholson, Charles] NYU, Langone Med Ctr, Dept Neurosci & Physiol, New York, NY 10016 USA	University of Rochester; New York University; NYU Langone Medical Center	Nedergaard, M (corresponding author), Univ Rochester, Med Ctr, Dept Neurosurg, Div Glial Dis & Therapeut,Ctr Translat Neuromed, Rochester, NY 14642 USA.	nedergaard@urmc.rochester.edu	Ebben, Matthew R/I-4561-2012; Xie, Lulu/N-7359-2014	Ebben, Matthew R/0000-0002-4399-7010; Xie, Lulu/0000-0002-3340-6483; Nicholson, Charles/0000-0002-7346-0484; O'Donnell, John/0000-0002-0774-9028; Takano, Takahiro/0000-0002-6235-6673	NIH/National Institute of Neurological Disorders and Stroke [NS078167, NS078304, NS028642]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028642, R01NS078304, R01NS075177, R01NS078167] Funding Source: NIH RePORTER	NIH/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH/National Institute of Neurological Disorders and Stroke (NS078167 and NS078304 to M.N. and NS028642 to C.N.). We thank S. Veasey for comments on the manuscript.	AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Barbera J, 2008, SLEEP MED, V9, P906, DOI 10.1016/j.sleep.2007.10.010; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; BORBELY AA, 1985, BRAIN MECH SLEEP, P35; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Hobson JA, 2005, NATURE, V437, P1254, DOI 10.1038/nature04283; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kinney JP, 2013, J COMP NEUROL, V521, P448, DOI 10.1002/cne.23181; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Larson ME, 2012, J NEUROSCI, V32, P10253, DOI 10.1523/JNEUROSCI.0581-12.2012; Malow Beth A, 2004, Epilepsy Curr, V4, P193, DOI 10.1111/j.1535-7597.2004.04509.x; MATTSON MP, 1994, ANN NY ACAD SCI, V747, P50; MCBAIN CJ, 1990, SCIENCE, V249, P674, DOI 10.1126/science.2382142; Montagna P, 2003, LANCET NEUROL, V2, P167, DOI 10.1016/S1474-4422(03)00323-5; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; NICHOLSON C, 1993, J NEUROSCI METH, V48, P199, DOI 10.1016/0165-0270(93)90092-6; O'Donnell J, 2012, NEUROCHEM RES, V37, P2496, DOI 10.1007/s11064-012-0818-x; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stickgold R, 2006, NATURE, V444, P559, DOI 10.1038/nature05309; Sykova E, 2005, P NATL ACAD SCI USA, V102, P479, DOI 10.1073/pnas.0408235102; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yao XM, 2008, J NEUROSCI, V28, P5460, DOI 10.1523/JNEUROSCI.0257-08.2008	34	2253	2347	34	761	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					373	377		10.1126/science.1241224	http://dx.doi.org/10.1126/science.1241224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136970	Green Accepted			2022-12-24	WOS:000325755100049
J	Li, MH; Chen, SW; Li, YD; Chen, YC; Cheng, YS; Hu, DJ; Tan, HQ; Wu, Q; Wang, W; Sun, ZK; Wei, XE; Zhang, JY; Qiao, RH; Zong, WH; Zhang, Y; Lou, W; Chen, ZY; Zhu, Y; Peng, DR; Ding, SX; Xu, XF; Hou, XH; Jia, WP				Li, Ming-Hua; Chen, Shi-Wen; Li, Yong-Dong; Chen, Yuan-Chang; Cheng, Ying-Sheng; Hu, Ding-Jun; Tan, Hua-Qiao; Wu, Qian; Wang, Wu; Sun, Zhen-Kui; Wei, Xiao-Er; Zhang, Jia-Yin; Qiao, Rui-Hua; Zong, Wen-Hong; Zhang, Yin; Lou, Wei; Chen, Zhi-Yuan; Zhu, Yu; Peng, De-Rong; Ding, Sui-Xin; Xu, Xue-Fan; Hou, Xu-Hong; Jia, Wei-Ping			Prevalence of Unruptured Cerebral Aneurysms in Chinese Adults Aged 35 to 75 Years	ANNALS OF INTERNAL MEDICINE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; CT ANGIOGRAPHY; MR-ANGIOGRAPHY; SUBARACHNOID HEMORRHAGE; DIAGNOSTIC-ACCURACY; DIGITAL-SUBTRACTION; NATURAL COURSE; RISK; MANAGEMENT	Background: The reported prevalence of unruptured cerebral aneurysms (UCAs) varies widely. Objective: To measure the prevalence of UCAs by using 3-dimensional time-of-flight magnetic resonance angiography in adults aged 35 to 75 years. Design: Cross-sectional study done between June 2007 and June 2011. Setting: Two communities chosen at random from 2 districts (1 urban and 1 suburban) in Shanghai, China. Participants: 4813 adults aged 35 to 75 years. Measurements: Three-dimensional time-of-flight magnetic resonance angiography, interpreted by 3 observers blinded to the participants' information, was used to identify the location and size of UCAs and to estimate the overall, age-specific, and sex-specific prevalence. Results: 369 UCAs were found in 336 participants (130 men and 206 women); 4477 participants had no evidence of UCAs. The prevalence was 7.0% overall (95% CI, 6.3% to 7.7%), with 5.5% for men (CI, 4.6% to 6.4%) and 8.4% for women (CI, 7.3% to 9.5%). The overall prevalence of UCAs was higher in women than in men (P < 0.001) and peaked at ages 55 to 64 years in men and women. The UCAs were mostly located in the internal carotid artery (81%), and 90.2% had a maximum diameter less than 5 mm. Mean diameter was larger in women than in men (3.7 mm vs. 3.2 mm; P < 0.009). Limitation: Participants were from 2 communities selected from 2 districts in Shanghai, and adults older than 75 years were not studied. Conclusion: The overall prevalence of UCAs was 7.0% in Chinese adults aged 35 to 75 years, and most lesions had a diameter less than 5 mm.	Shanghai Jiao Tong Univ, Peoples Hosp 6, Inst Diagnost & Intervent Radiol, Shanghai 200233, Peoples R China; Linfen Community Hlth Care Ctr, Shanghai, Peoples R China; Huayan Community Hlth Care Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Li, YD (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.	shliminghua@163.com; dr_liyongdong@sina.com.cn; wpjia@sjtu.edu.cn			National Natural Science Foundation of China [81171440, 30970793]; Twelfth Five-Year National Science and Technology Support Program of China [2011BAI08B14, 2011BAI08B06]; Shanghai Important Subject Fund of Medicine [05III023, 074119505]; Program for Shanghai Outstanding Medical Academic Leader [06016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Twelfth Five-Year National Science and Technology Support Program of China; Shanghai Important Subject Fund of Medicine; Program for Shanghai Outstanding Medical Academic Leader	By National Natural Science Foundation of China (grants 81171440 and 30970793), Twelfth Five-Year National Science and Technology Support Program of China (grants 2011BAI08B14 and 2011BAI08B06), Shanghai Important Subject Fund of Medicine (grants 05III023 and 074119505), and Program for Shanghai Outstanding Medical Academic Leader (grant LJ 06016).	Atlas SW, 1997, RADIOLOGY, V203, P807, DOI 10.1148/radiology.203.3.9169709; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Bouthillier A, 1996, NEUROSURGERY, V38, P425, DOI 10.1097/00006123-199603000-00001; Bowen BC, 2007, RADIOLOGY, V245, P357, DOI 10.1148/radiol.2452061706; Brisman JL, 2006, NEW ENGL J MED, V355, P928, DOI 10.1056/NEJMra052760; Broderick JP, 2009, STROKE, V40, P1952, DOI 10.1161/STROKEAHA.108.542571; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Harrod CG, 2006, MED HYPOTHESES, V66, P736, DOI 10.1016/j.mehy.2005.09.051; Horikoshi T, 2002, NEUROL MED-CHIR, V42, P105, DOI 10.2176/nmc.42.105; Ishibashi T, 2009, STROKE, V40, P313, DOI 10.1161/STROKEAHA.108.521674; Iwamoto H, 1999, STROKE, V30, P1390, DOI 10.1161/01.STR.30.7.1390; Jayaraman MV, 2004, RADIOLOGY, V230, P510, DOI 10.1148/radiol.2302021465; Kojima M, 1998, NEUROSURGERY, V43, P776, DOI 10.1097/00006123-199810000-00026; Korogi Y, 1996, RADIOLOGY, V199, P199, DOI 10.1148/radiology.199.1.8633146; Li MH, 2011, NEUROLOGY, V77, P667, DOI 10.1212/WNL.0b013e3182299f5a; Li MH, 2009, STROKE, V40, P3127, DOI 10.1161/STROKEAHA.109.553800; Li Q, 2009, RADIOLOGY, V252, P808, DOI 10.1148/radiol.2523081911; McKinney AM, 2008, AM J NEURORADIOL, V29, P594, DOI 10.3174/ajnr.A0848; Metens T, 2000, RADIOLOGY, V216, P39, DOI 10.1148/radiology.216.1.r00jl1139; Meyers PM, 2009, STROKE, V40, pE366, DOI 10.1161/STROKEAHA.108.527572; Mhurchu CN, 2001, STROKE, V32, P606, DOI 10.1161/01.STR.32.3.606; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Morita A, 2010, NEUROL MED-CHIR, V50, P777, DOI 10.2176/nmc.50.777; Nieuwkamp DJ, 2011, STROKE, V42, P902, DOI 10.1161/STROKEAHA.110.602722; Okahara M, 2002, STROKE, V33, P1803, DOI 10.1161/01.STR.0000019510.32145.A9; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Romijn M, 2008, AM J NEURORADIOL, V29, P134, DOI 10.3174/ajnr.A0741; Schwab KE, 2008, NEUROSURGERY, V63, P29, DOI 10.1227/01.NEU.0000335068.53190.46; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wardlaw JM, 2000, BRAIN, V123, P205, DOI 10.1093/brain/123.2.205; White PM, 2001, RADIOLOGY, V219, P739, DOI 10.1148/radiology.219.3.r01ma16739; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Winn HR, 2002, J NEUROSURG, V96, P43, DOI 10.3171/jns.2002.96.1.0043; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	36	128	166	1	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8					514	+		10.7326/0003-4819-159-8-201310150-00004	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24126645				2022-12-24	WOS:000326751200014
J	Tang, L; El-Din, TMG; Payandeh, J; Martinez, GQ; Heard, TM; Scheuer, T; Zheng, N; Catterall, WA				Tang, Lin; El-Din, Tamer M. Gamal; Payandeh, Jian; Martinez, Gilbert Q.; Heard, Teresa M.; Scheuer, Todd; Zheng, Ning; Catterall, William A.			Structural basis for Ca2+ selectivity of a voltage-gated calcium channel	NATURE			English	Article							CRYSTAL-STRUCTURE; ION SELECTIVITY; SODIUM-CHANNEL; CONCERTED ACTION; FROG-MUSCLE; PERMEATION; CONDUCTION; LOCUS; PORE; BACTERIORHODOPSIN	Voltage-gated calcium (Ca-V) channels catalyse rapid, highly selective influx of Ca2+ into cells despite a 70-fold higher extracellular concentration of Na+. How Ca-V channels solve this fundamental biophysical problem remains unclear. Here we report physiological and crystallographic analyses of a calcium selectivity filter constructed in the homotetrameric bacterial Na-V channel Na(V)Ab. Our results reveal interactions of hydrated Ca2+ with two high-affinity Ca2+-binding sites followed by a third lower-affinity site that would coordinate Ca2+ as it moves inward. At the selectivity filter entry, Site 1 is formed by four carboxyl side chains, which have a critical role in determining Ca2+ selectivity. Four carboxyls plus four backbone carbonyls form Site 2, which is targeted by the blocking cations Cd2+ and Mn2+, with single occupancy. The lower-affinity Site 3 is formed by four backbone carbonyls alone, which mediate exit into the central cavity. This pore architecture suggests a conduction pathway involving transitions between two main states with one or two hydrated Ca2+ ions bound in the selectivity filter and supports a 'knock-off' mechanism of ion permeation through a stepwise-binding process. The multi-ion selectivity filter of our Ca(V)Ab model establishes a structural framework for understanding the mechanisms of ion selectivity and conductance by vertebrate Ca-V channels.	[Tang, Lin; El-Din, Tamer M. Gamal; Payandeh, Jian; Martinez, Gilbert Q.; Heard, Teresa M.; Scheuer, Todd; Zheng, Ning; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Tang, Lin; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nzheng@uw.edu; wcatt@uw.edu			National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) [R01NS015751]; National Heart, Lung, and Blood Institute (NHLBI) of the NIH [R01HL112808]; National Research Service Award from training grant [T32GM008268]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112808, R01HL117896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015751] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute (NHLBI) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Service Award from training grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the beamline staff at the Advanced Light Source (BL8.2.1 and BL8.2.2) for their assistance during data collection. Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) under award number R01NS015751 (W. A. C.), the National Heart, Lung, and Blood Institute (NHLBI) of the NIH under award number R01HL112808 (W. A. C. and N.Z.) and a National Research Service Award from training grant T32GM008268 (T. M. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was also supported by the Howard Hughes Medical Institute (N.Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; Alam A, 2009, NAT STRUCT MOL BIOL, V16, P35, DOI 10.1038/nsmb.1537; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P565, DOI 10.1113/jphysiol.1984.sp015351; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; ARMSTRONG CM, 1991, ANN NY ACAD SCI, V635, P18, DOI 10.1111/j.1749-6632.1991.tb36477.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chen XH, 1997, J BIOL CHEM, V272, P30002, DOI 10.1074/jbc.272.48.30002; Cibulsky SM, 2000, J GEN PHYSIOL, V116, P349, DOI 10.1085/jgp.116.3.349; Cibulsky SM, 2003, BIOPHYS J, V84, P1709, DOI 10.1016/S0006-3495(03)74979-0; Cloues RK, 2000, J GEN PHYSIOL, V116, P569, DOI 10.1085/jgp.116.4.569; Dang TX, 1998, J GEN PHYSIOL, V111, P185, DOI 10.1085/jgp.111.2.185; DeLano W. L., 2002, PYMOL MOL VIEWER V 1; Derebe MG, 2011, P NATL ACAD SCI USA, V108, P598, DOI 10.1073/pnas.1013636108; El-Din TMG, 2013, J GEN PHYSIOL, V142, P181, DOI 10.1085/jgp.201311012; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2005, PROTEIN SCI, V14, P836, DOI 10.1110/ps.041167605; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; KIM MS, 1993, FEBS LETT, V318, P145, DOI 10.1016/0014-5793(93)80009-J; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lopin KV, 2010, J MEMBRANE BIOL, V235, P131, DOI 10.1007/s00232-010-9264-3; MCCLESKEY EW, 1985, P NATL ACAD SCI USA, V82, P7149, DOI 10.1073/pnas.82.20.7149; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Shaya D., J MOL BIOL; Williamson AV, 1999, BIOPHYS J, V77, P2575, DOI 10.1016/S0006-3495(99)77092-X; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	42	220	224	6	155	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					56	+		10.1038/nature12775	http://dx.doi.org/10.1038/nature12775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24270805	Green Accepted			2022-12-24	WOS:000329163300022
J	Adamala, K; Szostak, JW				Adamala, Katarzyna; Szostak, Jack W.			Nonenzymatic Template-Directed RNA Synthesis Inside Model Protocells	SCIENCE			English	Article							CITRATE	Efforts to recreate a prebiotically plausible protocell, in which RNA replication occurs within a fatty acid vesicle, have been stalled by the destabilizing effect of Mg2+ on fatty acid membranes. Here we report that the presence of citrate protects fatty acid membranes from the disruptive effects of high Mg2+ ion concentrations while allowing RNA copying to proceed, while also protecting single-stranded RNA from Mg2+-catalyzed degradation. This combination of properties has allowed us to demonstrate the chemical copying of RNA templates inside fatty acid vesicles, which in turn allows for an increase in copying efficiency by bathing the vesicles in a continuously refreshed solution of activated nucleotides.	[Adamala, Katarzyna; Szostak, Jack W.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Boston, MA 02114 USA; [Adamala, Katarzyna; Szostak, Jack W.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Adamala, Katarzyna] Univ Roma Tre, Dipartimento Biol, Rome, Italy	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Roma Tre University	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, 185 Cambridge St, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu		Adamala, Kate/0000-0003-1066-7207	NASA [NNX07AJ09G]	NASA(National Aeronautics & Space Administration (NASA))	We thank A. Engelhart, C. Hentrich, A. Larsen, N. Kamat, and A. Bjorkbom for discussions and help with manuscript preparation and A. Gifford for help with vesicle leakage experiments. This work was supported in part by NASA Exobiology grant NNX07AJ09G. J.W.S. is an investigator of the Howard Hughes Medical Institute. Raw data are presented in the supplementary materials. The instructions for assembling the Liposome Dialyzer are available at http://molbio.mgh.harvard.edu/szostakweb/.	Bowman JC, 2012, CURR OPIN STRUC BIOL, V22, P262, DOI 10.1016/j.sbi.2012.04.006; Butch C, 2013, J AM CHEM SOC, V135, P13440, DOI 10.1021/ja405103r; Covington AK, 2009, J SOLUTION CHEM, V38, P1449, DOI 10.1007/s10953-009-9459-3; Deamer DW, 2005, TOP CURR CHEM, V259, P1, DOI 10.1007/b136806; Deck C, 2011, NAT CHEM, V3, P603, DOI [10.1038/NCHEM.1086, 10.1038/nchem.1086]; GEBICKI JM, 1973, NATURE, V243, P232, DOI 10.1038/243232a0; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; JOHNSON CK, 1965, ACTA CRYSTALLOGR, V18, P1004, DOI 10.1107/S0365110X6500244X; JOYCE GF, 1989, NATURE, V338, P217, DOI 10.1038/338217a0; Mansy SS, 2008, P NATL ACAD SCI USA, V105, P13351, DOI 10.1073/pnas.0805086105; Szostak J. W., 2012, J SYST CHEM, V3, P2, DOI [10.1186/1759-2208-3-2, DOI 10.1186/1759-2208-3-2]; WALSER M, 1961, J PHYS CHEM-US, V65, P159, DOI 10.1021/j100819a045	12	195	202	5	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1098	1100		10.1126/science.1241888	http://dx.doi.org/10.1126/science.1241888			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288333	Green Accepted			2022-12-24	WOS:000327518600058
J	Schulz, D; Schwalb, B; Kiesel, A; Baejen, C; Torkler, P; Gagneur, J; Soeding, J; Cramer, P				Schulz, Daniel; Schwalb, Bjoern; Kiesel, Anja; Baejen, Carlo; Torkler, Phillipp; Gagneur, Julien; Soeding, Johannes; Cramer, Patrick			Transcriptome Surveillance by Selective Termination of Noncoding RNA Synthesis	CELL			English	Article							CRYPTIC UNSTABLE TRANSCRIPTS; POLYMERASE-II TRANSCRIPTION; BINDING PROTEINS NRD1; ANTISENSE TRANSCRIPTION; PERVASIVE TRANSCRIPTION; BIDIRECTIONAL PROMOTERS; DIVERGENT TRANSCRIPTION; QUALITY-CONTROL; YEAST; REVEALS	Pervasive transcription of eukaryotic genomes stems to a large extent from bidirectional promoters that synthesize mRNA and divergent noncoding RNA (ncRNA). Here, we show that ncRNA transcription in the yeast S. cerevisiae is globally restricted by early termination that relies on the essential RNA-binding factor Nrd1. Depletion of Nrd1 from the nucleus results in 1,526 Nrd1-unterminated transcripts (NUTs) that originate from nucleosome-depleted regions (NDRs) and can deregulate mRNA synthesis by antisense repression and transcription interference. Transcriptome-wide Nrd1-binding maps reveal divergent NUTs at most promoters and antisense NUTs in most 30 regions of genes. Nrd1 and its partner Nab3 preferentially bind RNA motifs that are depleted in mRNAs and enriched in ncRNAs and some mRNAs whose synthesis is controlled by transcription attenuation. These results define a global mechanism for transcriptome surveillance that selectively terminates ncRNA synthesis to provide promoter directionality and to suppress antisense transcription.	[Schulz, Daniel; Schwalb, Bjoern; Kiesel, Anja; Baejen, Carlo; Torkler, Phillipp; Gagneur, Julien; Soeding, Johannes; Cramer, Patrick] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Schulz, Daniel; Schwalb, Bjoern; Kiesel, Anja; Baejen, Carlo; Torkler, Phillipp; Gagneur, Julien; Soeding, Johannes; Cramer, Patrick] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Soeding, J (corresponding author), Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	soeding@lmb.uni-muenchen.de; cramer@lmb.uni-muenchen.de	Söding, Johannes/A-3341-2013	Söding, Johannes/0000-0001-9642-8244; Gagneur, Julien/0000-0002-8924-8365; Torkler, Phillipp/0000-0002-1450-5806; Schulz, Daniel/0000-0002-0913-1678; Schwalb, Bjorn/0000-0003-2987-2622	Bavarian Network for Molecular Biosystems (BaySysNet); Deutsche Forschungsgemeinschaft [SFB646, GRK1721, QBM]; Bundes-ministerium fur Bildung und Forschung (BMBF, ebio); Bavarian Network for Systems Biology (BaySysNet); DFG [SFB646, GRK1721, QBM, TR5, SFB960, CIPSM, NIM]; Deutsches Konsortium fur Translationale Krebsforschung DKTK; Jung-Stiftung; Vallee Foundation	Bavarian Network for Molecular Biosystems (BaySysNet); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundes-ministerium fur Bildung und Forschung (BMBF, ebio)(Federal Ministry of Education & Research (BMBF)); Bavarian Network for Systems Biology (BaySysNet); DFG(German Research Foundation (DFG)); Deutsches Konsortium fur Translationale Krebsforschung DKTK; Jung-Stiftung; Vallee Foundation	We would like to thank Stefan Krebs and Alexander Graf for sequencing and Galaxy maintenance, Christophe Jung for image analysis, and Domenico Libri for critically reading the manuscript. J.G. was supported by the Bavarian Network for Molecular Biosystems (BaySysNet). J.S. was supported by the Deutsche Forschungsgemeinschaft (SFB646, GRK1721, QBM), the Bundes-ministerium fur Bildung und Forschung (BMBF, ebio), and the Bavarian Network for Systems Biology (BaySysNet). P.C. was supported by the DFG (SFB646, TR5, SFB960, GRK1721, CIPSM, NIM, QBM), an Advanced Investigator Grant of the European Research Council, the Deutsches Konsortium fur Translationale Krebsforschung DKTK, the Jung-Stiftung, and the Vallee Foundation.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Castelnuovo M, 2013, NAT STRUCT MOL BIOL, V20, P851, DOI 10.1038/nsmb.2598; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Colin J, 2011, GENET RES INT, V2011, DOI 10.4061/2011/653494; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hani J, 1998, NUCLEIC ACIDS RES, V26, P689, DOI 10.1093/nar/26.3.689; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Honorine R, 2011, NUCLEIC ACIDS RES, V39, P2809, DOI 10.1093/nar/gkq1192; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Kubicek K, 2012, GENE DEV, V26, P1891, DOI 10.1101/gad.192781.112; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Marquardt S, 2011, TRANSCR-AUSTIN, V2, P145, DOI 10.4161/trns.2.3.16298; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Murray SC, 2012, NUCLEIC ACIDS RES, V40, P2432, DOI 10.1093/nar/gkr1121; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Peters JM, 2012, GENE DEV, V26, P2621, DOI 10.1101/gad.196741.112; Porrua O, 2012, EMBO J, V31, P3935, DOI 10.1038/emboj.2012.237; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Windhager L, 2012, GENOME RES, V22, P2031, DOI 10.1101/gr.131847.111; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87	67	144	146	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1075	1087		10.1016/j.cell.2013.10.024	http://dx.doi.org/10.1016/j.cell.2013.10.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24210918	Green Published, Bronze			2022-12-24	WOS:000327500600012
J	Dror, RO; Green, HF; Valant, C; Borhani, DW; Valcourt, JR; Pan, AC; Arlow, DH; Canals, M; Lane, JR; Rahmani, R; Baell, JB; Sexton, PM; Christopoulos, A; Shaw, DE				Dror, Ron O.; Green, Hillary F.; Valant, Celine; Borhani, David W.; Valcourt, James R.; Pan, Albert C.; Arlow, Daniel H.; Canals, Meritxell; Lane, J. Robert; Rahmani, Raphael; Baell, Jonathan B.; Sexton, Patrick M.; Christopoulos, Arthur; Shaw, David E.			Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs	NATURE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; FORCE-FIELD; SUBTYPE SELECTIVITY; AMINO-ACIDS; SITE; DYNAMICS; BINDING; IDENTIFICATION; LIGANDS; TRANSMEMBRANE	The design of G-protein-coupled receptor (GPCR) allosteric modulators, an active area of modern pharmaceutical research, has proved challenging because neither the binding modes nor the molecular mechanisms of such drugs are known(1,2). Here we determine binding sites, bound conformations and specific drug-receptor interactions for several allosteric modulators of the M2 muscarinic acetylcholine receptor (M2 receptor), a prototypical family A GPCR, using atomic-level simulations in which the modulators spontaneously associate with the receptor. Despite substantial structural diversity, all modulators form cation-p interactions with clusters of aromatic residues in the receptor extracellular vestibule, approximately 15 angstrom from the classical, 'orthosteric' ligand-binding site. We validate the observed modulator binding modes through radioligand binding experiments on receptor mutants designed, on the basis of our simulations, either to increase or to decrease modulator affinity. Simulations also revealed mechanisms that contribute to positive and negative allosteric modulation of classical ligand binding, including coupled conformational changes of the two binding sites and electrostatic interactions between ligands in these sites. These observations enabled the design of chemical modifications that substantially alter a modulator's allosteric effects. Our findings thus provide a structural basis for the rational design of allosteric modulators targeting muscarinic and possibly other GPCRs.	[Dror, Ron O.; Green, Hillary F.; Borhani, David W.; Valcourt, James R.; Pan, Albert C.; Arlow, Daniel H.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Valant, Celine; Canals, Meritxell; Lane, J. Robert; Rahmani, Raphael; Baell, Jonathan B.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Valant, Celine; Canals, Meritxell; Lane, J. Robert; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; Monash University; Monash University; Columbia University	Dror, RO (corresponding author), DE Shaw Res, 120 West 45th St,39th Floor, New York, NY 10036 USA.	Ron.Dror@DEShawResearch.com; Arthur.Christopoulos@Monash.edu; David.Shaw@DEShawResearch.com	Baell, Jonathan/E-5844-2017; rahmani, raphael/D-1185-2012; Sexton, Patrick M/B-1319-2008; Borhani, David/O-2692-2019; Christopoulos, Arthur/B-6207-2013	Baell, Jonathan/0000-0003-2114-8242; rahmani, raphael/0000-0002-2946-2562; Sexton, Patrick M/0000-0001-8902-2473; Borhani, David/0000-0002-8486-8792; Christopoulos, Arthur/0000-0003-4442-3294; Valcourt, James/0000-0001-6861-6088; Lane, J. Robert/0000-0002-7361-7875; Valant, Celine/0000-0002-2509-7465; Dror, Ron/0000-0002-6418-2793; Canals, Meritxell/0000-0002-7942-5006	National Health and Medical Research Council (NHMRC) of Australia [519461]; NHMRC	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank T. Mildorf, A. Kruse and B. Kobilka for comments; J. Klepeis, B. Gregersen, J.-L. Li, K. Palmo, A. Donchev and particularly A. Taube for advice and support related to force fields and quantum mechanical calculations; Z. Fan for assistance with statistical analysis; A. Lerer and T. O'Donnell for assistance with simulation and analysis software; A. Philippsen for creating the video; A. Stewart for assistance with mutagenesis and cell line generation; K. Ban and J. Harjani for assistance with chemical synthesis; J. Swarbrick for recording and analysing the two-dimensional NMR data; B. Sleebs and S. Marcuccio for provision of synthetic reagents; J. Dang for advice on analytical chemistry; and M. Kirk and R. Kastleman for editorial assistance. Portions of this work were financed by Program Grant no. 519461 from the National Health and Medical Research Council (NHMRC) of Australia, with synthetic chemistry infrastructure support from the Australian Federal Education Investment Fund Super Science Initiative and Victoria's Science Agenda Investment Fund. A. C. and P. M. S. are Principal Research Fellows of the NHMRC; J. B. B. is a Senior Research Fellow of the NHMRC; J. R. L. is a Career Development Awardee of the NHMRC.	Avlani V, 2004, J PHARMACOL EXP THER, V308, P1062, DOI 10.1124/jpet.103.059840; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bock A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2028; BOURNE PE, 1985, J CRYST SPECTROSC, V15, P453, DOI 10.1007/BF01171049; Buch I, 2011, P NATL ACAD SCI USA, V108, P10184, DOI 10.1073/pnas.1103547108; CALDWELL JW, 1995, J AM CHEM SOC, V117, P4177, DOI 10.1021/ja00119a037; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Daiss JO, 2002, ORGANOMETALLICS, V21, P803, DOI 10.1021/om010847j; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dror RO, 2009, P C HIGH PERF COMP N; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; EVERETT AJ, 1957, J CHEM SOC, P1120, DOI 10.1039/jr9570001120; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Filmore D., 2004, MOD DRUG DISCOV, V7, P24; Gao ZG, 2003, MOL PHARMACOL, V63, P1021, DOI 10.1124/mol.63.5.1021; Gnagey AL, 1999, MOL PHARMACOL, V56, P1245, DOI 10.1124/mol.56.6.1245; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakubik J, 2010, PHARMACEUTICALS, V3, P2838, DOI 10.3390/ph3092838; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; Lazareno S, 2002, MOL PHARMACOL, V62, P1492, DOI 10.1124/mol.62.6.1492; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MATSUI H, 1995, MOL PHARMACOL, V47, P88; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Schneider H., 1991, J AM CHEM SOC, V20, P7698; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Silvano E, 2010, MOL PHARMACOL, V78, P925, DOI 10.1124/mol.110.065755; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Trankle C, 2003, MOL PHARMACOL, V64, P180, DOI 10.1124/mol.64.1.180; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Yanamala N, 2010, PHARMACEUTICALS-BASE, V3, P3324, DOI 10.3390/ph3103324	52	303	305	7	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					295	+		10.1038/nature12595	http://dx.doi.org/10.1038/nature12595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24121438				2022-12-24	WOS:000326894200058
J	Shyh-Chang, N; Zhu, H; de Soysa, TY; Shinoda, G; Seligson, MT; Tsanov, KM; Nguyen, L; Asara, JM; Cantley, LC; Daley, GQ				Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Liem Nguyen; Asara, John M.; Cantley, Lewis C.; Daley, George Q.			Lin28 Enhances Tissue Repair by Reprogramming Cellular Metabolism	CELL			English	Article							GENOME-WIDE ASSOCIATION; MEMBRANE VOLTAGE; GROWTH; REGENERATION; LIN-28; CELLS; MICE; TRANSLATION; EXPRESSION; AMPUTATION	Regeneration capacity declines with age, but why juvenile organisms show enhanced tissue repair remains unexplained. Lin28a, a highly conserved RNA-binding protein expressed during embryogenesis, plays roles in development, pluripotency, and metabolism. To determine whether Lin28a might influence tissue repair in adults, we engineered the reactivation of Lin28a expression in several models of tissue injury. Lin28a reactivation improved hair regrowth by promoting anagen in hair follicles and accelerated regrowth of cartilage, bone, and mesenchyme after ear and digit injuries. Lin28a inhibits let-7 microRNA biogenesis; however, let-7 repression was necessary but insufficient to enhance repair. Lin28a bound to and enhanced the translation of mRNAs for several metabolic enzymes, thereby increasing glycolysis and oxidative phosphorylation (OxPhos). Lin28a-mediated enhancement of tissue repair was negated by OxPhos inhibition, whereas a pharmacologically induced increase in OxPhos enhanced repair. Thus, Lin28a enhances tissue repair in some adult tissues by reprogramming cellular bioenergetics.	[Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Daley, George Q.] Boston Childrens Hosp, Stem Cell Transplantat Program, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Shyh-Chang, Ng; Zhu, Hao; de Soysa, T. Yvanka; Shinoda, Gen; Seligson, Marc T.; Tsanov, Kaloyan M.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Shyh-Chang, Ng; Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02115 USA; [Zhu, Hao] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; [Zhu, Hao; Liem Nguyen] Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dept Pediat, Dallas, TX 75390 USA; [Zhu, Hao; Liem Nguyen] Univ Texas SW Med Ctr Dallas, Childrens Res Inst, Dept Internal Med, Dallas, TX 75390 USA; [Cantley, Lewis C.] Cornell Weill Med Coll, Dept Med, New York, NY 10065 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University	Daley, GQ (corresponding author), Boston Childrens Hosp, Stem Cell Transplantat Program, Div Pediat Hematol Oncol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	/AAD-2039-2020; Cantley, Lewis C/D-1800-2014; Zhu, Hao/L-5114-2013; Tsanov, Kaloyan M/J-6852-2012	/0000-0001-9007-4844; Cantley, Lewis C/0000-0002-1298-7653; Zhu, Hao/0000-0002-8417-9698; DE SOYSA, TARJA/0000-0003-1394-3086; Shyh-Chang, Ng/0000-0003-3138-9525	A*STAR National Science Scholarship; Graduate Training in Cancer Research Grant; American Cancer Society Postdoctoral Fellowship; NIH; CPRIT; Herchel Smith Graduate Fellowship; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [K08CA157727] Funding Source: NIH RePORTER	A*STAR National Science Scholarship(Agency for Science Technology & Research (A*STAR)); Graduate Training in Cancer Research Grant; American Cancer Society Postdoctoral Fellowship(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Herchel Smith Graduate Fellowship; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank John Powers, Costas Lyssiotis, Charles Kaufman, Jessica Lehoczky, and Clifford Tabin for invaluable feedback and discussions; Jin Zhang and the lab of Marcia Haigis for help with the Seahorse Analyzer; Min Yuan and Susanne Breitkopf for help with metabolomics; Samar Shah and Akiko Yabuuchi for help with the mouse work; Asher Bomer for help with the scratch assays; James Thornton for help with northern blots; and Roderick Bronson and the Harvard Medical School Rodent Histopathology Core for mouse tissue pathology. This work was supported by an A*STAR National Science Scholarship to N.S.-C., a Graduate Training in Cancer Research Grant, an American Cancer Society Postdoctoral Fellowship, an NIH K08 grant, and a CPRIT award to H.Z.; a Herchel Smith Graduate Fellowship to K. M. T.; and a grant from the Ellison Medical Foundation to G. Q. D. G. Q. D. is an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research.	Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Anchelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016955; Anderson SP, 2002, HEPATOLOGY, V36, P544, DOI 10.1053/jhep.2002.35276; Angione AR, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-33; Beane WS, 2011, CHEM BIOL, V18, P77, DOI 10.1016/j.chembiol.2010.11.012; Chadwick RB, 2007, WOUND REPAIR REGEN, V15, P275, DOI 10.1111/j.1524-475X.2007.00216.x; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Darwin C., 1887, VARIATION ANIMALS PL; DEUCHAR EM, 1976, J EMBRYOL EXP MORPH, V35, P345; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; GOSS RJ, 1975, J MORPHOL, V146, P533, DOI 10.1002/jmor.1051460408; Gourevitch DL, 2009, WOUND REPAIR REGEN, V17, P447, DOI 10.1111/j.1524-475X.2009.00492.x; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Leinonen JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048785; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Liu J, 2011, P NATL ACAD SCI USA, V108, P14560, DOI 10.1073/pnas.1111056108; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; McBrearty BA, 1998, P NATL ACAD SCI USA, V95, P11792, DOI 10.1073/pnas.95.20.11792; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nakamura Y, 2012, AM J PATHOL, V180, P583, DOI 10.1016/j.ajpath.2011.10.006; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Ong KK, 2011, J CLIN ENDOCR METAB, V96, pE125, DOI 10.1210/jc.2010-0941; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; PEARSON RD, 1984, ACTA BIOTHEOR, V33, P51, DOI 10.1007/BF00045846; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x; Shah MV, 2011, MECH DEVELOP, V128, P342, DOI 10.1016/j.mod.2011.07.001; Shinoda G, 2013, STEM CELLS, V31, P1563, DOI 10.1002/stem.1423; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Widen E, 2010, AM J HUM GENET, V86, P773, DOI 10.1016/j.ajhg.2010.03.010; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; YOUNG HE, 1983, ANAT RECORD, V206, P295, DOI 10.1002/ar.1092060308; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	57	244	254	4	151	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					778	792		10.1016/j.cell.2013.09.059	http://dx.doi.org/10.1016/j.cell.2013.09.059			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209617	Green Accepted, Bronze			2022-12-24	WOS:000326934300009
J	Sok, D; Burton, DR				Sok, Devin; Burton, Dennis R.			SnapShot: Broadly Neutralizing Antibodies	CELL			English	Editorial Material							VACCINES; VIRUSES		[Sok, Devin; Burton, Dennis R.] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Sok, D (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100663] Funding Source: NIH RePORTER; NIAID NIH HHS [UM1 AI100663] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bellini WJ, 2011, VIRUS RES, V162, P72, DOI 10.1016/j.virusres.2011.09.023; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; EKLERT DC, 2012, CURR OPIN VIROL, V2, P134; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Tahara M, 2013, J VIROL, V87, P666, DOI 10.1128/JVI.02033-12; Thera MA, 2012, ANNU REV MED, V63, P345, DOI 10.1146/annurev-med-022411-192402	10	6	26	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					728	+		10.1016/j.cell.2013.10.009	http://dx.doi.org/10.1016/j.cell.2013.10.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243025	Bronze, Green Accepted			2022-12-24	WOS:000326571800025
J	Ding, BS; Cao, ZW; Lis, R; Nolan, DJ; Guo, PP; Simons, M; Penfold, ME; Shido, K; Rabbany, SY; Rafii, S				Ding, Bi-Sen; Cao, Zhongwei; Lis, Raphael; Nolan, Daniel J.; Guo, Peipei; Simons, Michael; Penfold, Mark E.; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin			Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis	NATURE			English	Article							BETA-ARRESTIN; CELLS; RECEPTOR; INJURY; REPAIR; ANGIOGENESIS; CXCR4	Chemical or traumatic damage to the liver is frequently associated with aberrant healing (fibrosis) that overrides liver regeneration(1-5). The mechanism by which hepatic niche cells differentially modulate regeneration and fibrosis during liver repair remains to be defined(6-8). Hepatic vascular niche predominantly represented by liver sinusoidal endothelial cells deploys paracrine trophogens, known as angiocrine factors, to stimulate regeneration(9-15). Nevertheless, it is not known how pro-regenerative angiocrine signals from liver sinusoidal endothelial cells is subverted to promote fibrosis(16,17). Here, by combining an inducible endothelial-cell-specific mouse gene deletion strategy and complementary models of acute and chronic liver injury, we show that divergent angiocrine signals from liver sinusoidal endothelial cells stimulate regeneration after immediate injury and provoke fibrosis after chronic insult. The pro-fibrotic transition of vascular niche results from differential expression of stromal-derived factor-1 receptors, CXCR7 and CXCR4 (refs 18-21), in liver sinusoidal endothelial cells. After acute injury, CXCR7 upregulation in liver sinusoidal endothelial cells acts with CXCR4 to induce transcription factor Id1, deploying pro-regenerative angiocrine factors and triggering regeneration. Inducible deletion of Cxcr7 in sinusoidal endothelial cells (Cxcr7(i Delta EC/i Delta EC)) from the adult mouse liver impaired liver regeneration by diminishing Id1-mediated production of angiocrine factors(9-11). By contrast, after chronic injury inflicted by iterative hepatotoxin (carbon tetrachloride) injection and bile duct ligation, constitutive FGFR1 signalling in liver sinusoidal endothelial cells counterbalanced CXCR7-dependent pro-regenerative response and augmented CXCR4 expression. This predominance of CXCR4 over CXCR7 expression shifted angiocrine response of liver sinusoidal endothelial cells, stimulating proliferation of desmin(+) hepatic stellate-like cells(22,23) and enforcing apro-fibrotic vascular niche. Endothelial-cell-specific ablation of either Fgfr1 (Fgfr1(i Delta EC/i Delta EC)) or Cxcr4 (Cxcr4(i Delta EC/i Delta EC)) in mice restored the pro-regenerative pathway and prevented FGFR1-mediated maladaptive subversion of angiocrine factors. Similarly, selective CXCR7 activation in liver sinusoidal endothelial cells abrogated fibrogenesis. Thus, we demonstrate that in response to liver injury, differential recruitment of pro-regenerative CXCR7-Id1 versus pro-fibrotic FGFR1-CXCR4 angiocrine pathways in vascular niche balances regeneration and fibrosis. These results provide a therapeutic roadmap to achieve hepatic regeneration without provoking fibrosis(1,2,4).	[Ding, Bi-Sen; Cao, Zhongwei; Lis, Raphael; Nolan, Daniel J.; Guo, Peipei; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, Howard Hughes Med Inst, Dept Med Genet, New York, NY 10065 USA; [Nolan, Daniel J.] Angiocrine Biosci, New York, NY 10065 USA; [Simons, Michael] Yale Univ, Sch Med, Yale Cardiovasc Res Ctr, New Haven, CT 06510 USA; [Penfold, Mark E.] ChemoCentryx Inc, Mountain View, CA 94043 USA; [Rabbany, Sina Y.] Hofstra Univ, Bioengn Program, Hempstead, NY 11549 USA	Cornell University; Howard Hughes Medical Institute; Yale University; Hofstra University	Rafii, S (corresponding author), Weill Cornell Med Coll, Ansary Stem Cell Inst, Howard Hughes Med Inst, Dept Med Genet, New York, NY 10065 USA.	bid2004@med.cornell.edu; srafii@med.cornell.edu	Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734	National Scientist Development Grant from the American Heart Association [12SDG1213004]; New York Stem Cell Foundation; Ansary Stem Cell Institute; Howard Hughes Medical Institute; Empire State Stem Cell Board; New York State Department of Health [C024180, C026438, C026878, C028117]; National Heart, Lung, and Blood Institute [R01HL097797, R01HL119872, RC2HL101846, R01 HL053793]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK095039]; National Cancer Institute [U54CA163167]; Qatar National Priorities Research Foundation [NPRP08-663-3-140]; Qatar Foundation; Tri-Institutional Weill Cornell Starr Stem Cell Scholar Program; NATIONAL CANCER INSTITUTE [U54CA163167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101846, R01HL053793, R01HL097797, R01HL119872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095039] Funding Source: NIH RePORTER	National Scientist Development Grant from the American Heart Association; New York Stem Cell Foundation; Ansary Stem Cell Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Empire State Stem Cell Board; New York State Department of Health; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Qatar National Priorities Research Foundation; Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Tri-Institutional Weill Cornell Starr Stem Cell Scholar Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to T. Hla for reading the manuscript, R. Berahovich and K. Eggan for their suggestions on CXCR7 signalling for liver repair, R. H. Adams for providing mouse inducible endothelial-cell-specific Cre (Cdh5-PAC-Cre<SUP>ERT2</SUP>) line and Y.-R. Zou for offering the floxed Cxcr4 mouse line. B.-S.D. is supported by a National Scientist Development Grant from the American Heart Association (number 12SDG1213004) and a Druckenmiller Fellowship from the New York Stem Cell Foundation. S. R. is supported by the Ansary Stem Cell Institute, the Howard Hughes Medical Institute, Empire State Stem Cell Board and New York State Department of Health grants (C024180, C026438, C026878, C028117), National Heart, Lung, and Blood Institute grants R01HL097797, R01HL119872 and RC2HL101846, National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK095039, National Cancer Institute grant U54CA163167, Qatar National Priorities Research Foundation grant NPRP08-663-3-140 and the Qatar Foundation BioMedical Research Program. R. L., P. G. and K. S. are supported by Empire State Stem Cell Board and New York State Department of Health training grants (C026878). D.N. is supported by the Tri-Institutional Weill Cornell Starr Stem Cell Scholar Program. M. S. is supported by National Heart, Lung, and Blood Institute grant R01 HL053793.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bohm F, 2010, GASTROENTEROLOGY, V139, P1385, DOI 10.1053/j.gastro.2010.06.069; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Diehl AM, 2012, NAT MED, V18, P497, DOI 10.1038/nm.2719; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Huebert RC, 2010, HEPATOLOGY, V52, P238, DOI 10.1002/hep.23628; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Sakaguchi TF, 2008, CURR BIOL, V18, P1565, DOI 10.1016/j.cub.2008.08.065; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Woo DH, 2012, GASTROENTEROLOGY, V142, P602, DOI 10.1053/j.gastro.2011.11.030; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Yu SH, 2011, DEV DYNAM, V240, P384, DOI 10.1002/dvdy.22549; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	32	378	405	2	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					97	+		10.1038/nature12681	http://dx.doi.org/10.1038/nature12681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24256728	Green Accepted			2022-12-24	WOS:000329163300031
J	Xu, R; de Vries, RP; Zhu, XY; Nycholat, CM; McBride, R; Yu, WL; Paulson, JC; Wilson, IA				Xu, Rui; de Vries, Robert P.; Zhu, Xueyong; Nycholat, Corwin M.; McBride, Ryan; Yu, Wenli; Paulson, James C.; Wilson, Ian A.			Preferential Recognition of Avian-Like Receptors in Human Influenza A H7N9 Viruses	SCIENCE			English	Article							HUMAN INFECTION; BINDING; TRANSMISSION; SPECIFICITY; HEMAGGLUTININS; FERRETS; DETERMINANT; COMPLEXES; ORIGIN; ACID	The 2013 outbreak of avian-origin H7N9 influenza in eastern China has raised concerns about its ability to transmit in the human population. The hemagglutinin glycoprotein of most human H7N9 viruses carries Leu(226), a residue linked to adaptation of H2N2 and H3N2 pandemic viruses to human receptors. However, glycan array analysis of the H7 hemagglutinin reveals negligible binding to humanlike alpha 2-6-linked receptors and strong preference for a subset of avian-like alpha 2-3-linked glycans recognized by all avian H7 viruses. Crystal structures of H7N9 hemagglutinin and six hemagglutinin-glycan complexes have elucidated the structural basis for preferential recognition of avian-like receptors. These findings suggest that the current human H7N9 viruses are poorly adapted for efficient human-to-human transmission.	[Xu, Rui; Zhu, Xueyong; Yu, Wenli; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [de Vries, Robert P.; Nycholat, Corwin M.; McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [de Vries, Robert P.; Nycholat, Corwin M.; McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Paulson, JC (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	jpaulson@scripps.edu; wilson@scripps.edu	de Vries, Robert/K-7212-2013; McBride, Ryan/E-6812-2011; Paulson, James/AAG-3565-2019; Zhu, Xueyong/ABE-3068-2021	de Vries, Robert/0000-0002-1586-4464	NIH [R56 AI099275]; Skaggs Institute for Chemical Biology; Centers for Disease Control; Netherlands Organization for Scientific Research (NWO); National Institute of General Medical Sciences (NIGMS) [GM62116]; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; DOE Office of Biological and Environmental Research; NIH, NIGMS [P41GM103393]; National Center for Research Resources (NCRR) [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, U54GM062116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH R56 AI099275 (I. A. W.) and the Skaggs Institute for Chemical Biology, the Scripps Microarray Core Facility, and a contract from the Centers for Disease Control (J.C.P.). R.P.d.V. is a recipient of a Rubicon grant from the Netherlands Organization for Scientific Research (NWO). Several glycans used for HA binding assays were provided by the Consortium for Functional Glycomics (www.functionalglycomics.org/) funded by National Institute of General Medical Sciences (NIGMS) grant GM62116 (J.C.P.). X-ray diffraction data were collected at the Advanced Photon Source beamline 23ID-B (GM/CA CAT) and the Stanford Synchrotron Radiation Lightsource (SSRL) beamline 12-2. GM/CA CAT is funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the NIGMS (Y1-GM-1104). Use of the Advanced Photon Source was supported by the U.S. Department of Energy (DOE), Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. The SSRL is a Directorate of Stanford Linear Accelerator Center National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. DOE Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the NIH, NIGMS (including P41GM103393) and the National Center for Research Resources (NCRR, P41RR001209). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS, NCRR, or NIH. This is publication 24079 from the Scripps Research Institute. Coordinates and structure factors are deposited in the PDB (4N5J, 4N5K, 4N60, 4N61, 4N62, 4N63, and 4N64).	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Gambaryan AS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-85; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Kahn RE, 2013, VECTOR-BORNE ZOONOT, V13, P347, DOI 10.1089/vbz.2013.999.ceezad; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Matrosovich M, 2009, REV SCI TECH OIE, V28, P203, DOI 10.20506/rst.28.1.1870; Morens DM, 2013, NEW ENGL J MED, V368, P2345, DOI 10.1056/NEJMp1307009; Paulson JC, 2013, VIRUS RES, V178, P99, DOI 10.1016/j.virusres.2013.02.015; Ramos I, 2013, J GEN VIROL, V94, P2417, DOI 10.1099/vir.0.056184-0; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059550, 10.1371/journal.pone.0049597]; Steinhauer DA, 2013, NATURE, V499, P412, DOI 10.1038/nature12455; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; World Health Organization, 2013, OV EM CHAR AV INFL A; Xiong X, 2013, VIRUS RES, V178, P12, DOI 10.1016/j.virusres.2013.08.007; Xiong XL, 2013, NATURE, V499, P496, DOI 10.1038/nature12372; Xu R., 2012, STRUCTURAL GLYCOMICS, P235; Xu R, 2010, J VIROL, V84, P1715, DOI 10.1128/JVI.02162-09; Yang H, 2013, J VIROL, V87, P12433, DOI 10.1128/JVI.01854-13; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	35	120	127	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1230	1235		10.1126/science.1243761	http://dx.doi.org/10.1126/science.1243761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311689	Green Accepted			2022-12-24	WOS:000327857900047
J	Nel, A; Roques, P; Nel, P; Prokin, AA; Bourgoin, T; Prokop, J; Szwedo, J; Azar, D; Desutter-Grandcolas, L; Wappler, T; Garrouste, R; Coty, D; Huang, DY; Engel, MS; Kirejtshuk, AG				Nel, Andre; Roques, Patrick; Nel, Patricia; Prokin, Alexander A.; Bourgoin, Thierry; Prokop, Jakub; Szwedo, Jacek; Azar, Dany; Desutter-Grandcolas, Laure; Wappler, Torsten; Garrouste, Romain; Coty, David; Huang, Diying; Engel, Michael S.; Kirejtshuk, Alexander G.			The earliest known holometabolous insects	NATURE			English	Article							EVOLUTION; DIVERSIFICATION; INSIGHTS; FOSSILS; LAND; SIZE	The Eumetabola (Endopterygota (alsoknown as Holometabola) plus Paraneoptera)(1) have the highest number of species of any clade, and greatly contribute to animal species biodiversity(2,3). The palaeoeco-logical circumstances that favoured their emergence and success remain an intriguing question(3-6). Recent molecular phylogenetic analyses have suggested a wide range of dates for the initial appearance of the Holometabola, from the Middle Devonian epoch (391 million years (Myr) ago) to the Late Pennsylvanian epoch (311 Myr ago(7-12)), and Hemiptera (310 Myr ago(13)). Palaeoenvironments greatly changed over these periods, with global cooling and increasing complexity of green forests(14). The Pennsylvanian-period crown-eumetabolan fossil record remains notably incomplete(15-1)9, particularly as several fossils have been erroneously considered to be stemHolometabola(1,15,20,21) (Supplementary Information); the earliest definitive beetles are from the start of the Permian period(21,22). The emergence of the hymenopterids, sister group to other Holometabola, is dated between 350 and 309 Myr ago(8,9,12), incongruent with their current earliest record(Middle Triassic epoch)(1,20). Here we describe five fossils-aGzhelian-age stem coleopterid, a holometabolous larva of uncertain ordinal affinity, a stem hymenopterid, and early Hemiptera and Psocodea, all from the Moscovian age-and reveal a notable penecontemporaneous breadth of early eumetabolan insects. These discoveries are more congruent with current hypotheses of clade divergence. Eumetabola experienced episodes of diversification during the Bashkirian-Moscovian and the Kasimovian-Gzhelian ages. This cladogenetic activity is perhaps related to notable episodes of drying resulting from glaciations, leading to the eventual demise in Euramerica of coal-swamp ecosystems, evidenced by floral turnover during this interval(23,24). These ancient species were of very small size, living in the shadow of Palaeozoic-era 'giant' insects. Although these discoveries reveal unexpected Pennsylvanian eumetabolan diversity, the lineage radiated more successfully only after the mass extinctions at the end of the Permian period, giving rise to the familiar crown groups of their respective clades.	[Nel, Andre; Roques, Patrick; Nel, Patricia; Bourgoin, Thierry; Azar, Dany; Desutter-Grandcolas, Laure; Garrouste, Romain; Coty, David; Kirejtshuk, Alexander G.] Museum Natl Hist Nat, CNRS, UMR 7205, F-75231 Paris, France; [Nel, Patricia] AgroParisTech, Dept Sci Vie & Sante, F-75231 Paris 05, France; [Prokin, Alexander A.] Russian Acad Sci, Papanin Inst Biol Inland Waters, Borok 152742, Yaroslavl Oblas, Russia; [Prokop, Jakub] Charles Univ Prague, Fac Sci, Dept Zool, CZ-12844 Prague 2, Czech Republic; [Szwedo, Jacek] Polish Acad Sci, Museum & Inst Zool, Dept Palaeozool, PL-00679 Warsaw, Poland; [Azar, Dany] Lebanese Univ, Fac Sci 2, Dept Nat Sci, Fanar, Fanar Matn, Lebanon; [Wappler, Torsten] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Huang, Diying] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China; [Engel, Michael S.] Univ Kansas, Div Entomol, Nat Hist Museum, Lawrence, KS 66045 USA; [Engel, Michael S.] Univ Kansas, Dept Ecol Evolutionary Biol, Lawrence, KS 66045 USA; [Kirejtshuk, Alexander G.] Russian Acad Sci, Zool Inst, St Petersburg, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Papanin Institute for Biology of Inland Waters; Russian Academy of Sciences; Charles University Prague; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Lebanese University; University of Bonn; Chinese Academy of Sciences; University of Kansas; University of Kansas; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences	Nel, A (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7205, CP 50,45 Rue Buffon, F-75231 Paris, France.	anel@mnhn.fr	Engel, Michael S/C-5461-2012; Szwedo, Jacek/O-1442-2019; Bourgoin, Thierry/L-5146-2019; Azar, Dany/AAF-7387-2020; Prokop, Jakub/B-1432-2008; GARROUSTE, Romain/AAK-3692-2021; Prokin, Alexander A/Q-6136-2016; Wappler, Torsten/D-4287-2011; Wappler, Torsten/P-6831-2019; Szwedo, Jacek/B-4774-2013	Engel, Michael S/0000-0003-3067-077X; Szwedo, Jacek/0000-0002-2796-9538; Bourgoin, Thierry/0000-0001-9277-2478; Azar, Dany/0000-0002-4485-197X; Prokop, Jakub/0000-0001-6996-7832; GARROUSTE, Romain/0000-0002-0880-5781; Prokin, Alexander A/0000-0002-9345-5607; Wappler, Torsten/0000-0003-1592-0988; Wappler, Torsten/0000-0003-1592-0988; Szwedo, Jacek/0000-0002-2796-9538; Nel, Patricia/0000-0002-7530-5138	Grant Agency of the Czech Republic [P210/10/0633]; German Science Foundation [WA 1492/6-1]; Russian Foundation of Basic Research [12-04-00663-a]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); German Science Foundation(German Research Foundation (DFG)); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	We thank C. C. Labandeira for comments on the first version of the manuscript that helped to improve the paper. We are grateful to A. P. Rasnitsyn, S. I. Golovach and B. R. Striganova, M. Fikacek, A. A. Przhiboro, R. Beutel, T. Hornschemeyer and V. Krassilov for early discussions. C. Garrouste and P. A. Kirejtshuk assisted in the preparation of illustrations for this publication. Financial support was provided by the Grant Agency of the Czech Republic no. P210/10/0633 (to J. P.) and the German Science Foundation WA 1492/6-1 (to T. W.). The study was supported by the program for visiting researchers and professors of the Smithsonian Institution National Museum of Natural History (NMNH) and partly carried out within the framework of the program of the Presidium of the Russian Academy of Sciences Problems of the origin of life and formation of the biosphere'. A. A. P. and A. G. K. were supported by the Russian Foundation of Basic Research (grant 12-04-00663-a). This paper is a participation to the team project Biodiversity: Origin, Structure, Evolution and Geology' allotted to D. A. by the Lebanese University.	Beckemeyer RJ, 2007, AFR INVERTEBR, V48, P23; BERNAYS EA, 1986, PHYSIOL ENTOMOL, V11, P377, DOI 10.1111/j.1365-3032.1986.tb00428.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Clapham ME, 2012, P NATL ACAD SCI USA, V109, P10927, DOI 10.1073/pnas.1204026109; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; Garrouste R, 2012, NATURE, V488, P82, DOI 10.1038/nature11281; Grimaldi D, 2005, EVOLUTION OF THE INS; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; Ilger JM, 2011, ZOOKEYS, P91, DOI 10.3897/zookeys.130.1422; Kirejtshuk A. G., J SYST PALAEONTOLOGY; Kukalova-Peck J, 2004, EUR J ENTOMOL, V101, P95, DOI 10.14411/eje.2004.018; Kukalova-Peck J, 2012, EUR J ENTOMOL, V109, P633, DOI 10.14411/eje.2012.075; Labandeir CC, 2011, ENTOMOL AM-NY, V117, P9, DOI 10.1664/10-RA-011.1; Mayhew PJ, 2007, BIOL REV, V82, P425, DOI 10.1111/j.1469-185X.2007.00018.x; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; Nel A, 2007, ANN SOC ENTOMOL FR, V43, P349, DOI 10.1080/00379271.2007.10697531; Nel A, 2012, J MORPHOL, V273, P480, DOI 10.1002/jmor.11036; Nel P, 2012, J SYST PALAEONTOL, V10, P385, DOI 10.1080/14772019.2011.598578; Ogg J., 2012, THE GEOLOGIC TIME SC, P603; PHILLIPS TL, 1984, INT J COAL GEOL, V3, P205, DOI 10.1016/0166-5162(84)90019-3; Rasnitsyn A.P., 2002, HIST INSECTS; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Song N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058400; Warnock RCM, 2012, BIOL LETTERS, V8, P156, DOI 10.1098/rsbl.2011.0710; Wheat CW, 2013, SYST BIOL, V62, P93, DOI 10.1093/sysbio/sys074; Wiegmann Brian M., 2009, P260; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Yang AS, 2001, EVOL DEV, V3, P59, DOI 10.1046/j.1525-142x.2001.003002059.x; Yeates DK, 2012, AUST J ENTOMOL, V51, P79, DOI 10.1111/j.1440-6055.2012.00857.x	30	135	139	1	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					257	+		10.1038/nature12629	http://dx.doi.org/10.1038/nature12629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24132233				2022-12-24	WOS:000326894200050
J	Crickmore, MA; Vosshall, LB				Crickmore, Michael A.; Vosshall, Leslie B.			Opposing Dopaminergic and GABAergic Neurons Control the Duration and Persistence of Copulation in Drosophila	CELL			English	Article							SEXUAL-BEHAVIOR; NEURAL MECHANISMS; MANTIS-RELIGIOSA; PRAYING-MANTIS; IN-VIVO; MELANOGASTER; EXPRESSION; COURTSHIP; MALES; CELLS	Behavioral persistence is a major factor in determining when and under which circumstances animals will terminate their current activity and transition into more profitable, appropriate, or urgent behavior. We show that, for the first 5 min of copulation in Drosophila, stressful stimuli do not interrupt mating, whereas 10 min later, even minor perturbations are sufficient to terminate copulation. This decline in persistence occurs as the probability of successful mating increases and is promoted by approximately eight sexually dimorphic, GABAergic interneurons of the male abdominal ganglion. When these interneurons were silenced, persistence increased and males copulated far longer than required for successful mating. When these interneurons were stimulated, persistence decreased and copulations were shortened. In contrast, dopaminergic neurons of the ventral nerve cord promote copulation persistence and extend copulation duration. Thus, copulation duration in Drosophila is a product of gradually declining persistence controlled by opposing neuronal populations using conserved neurotransmission systems.	[Crickmore, Michael A.; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Vosshall, Leslie B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie.vosshall@rockefeller.edu		Vosshall, Leslie/0000-0002-6060-8099	Marco Stoffel Mind, Brain, and Behavior Fellowship; Helen Hay Whitney Postdoctoral Fellowship	Marco Stoffel Mind, Brain, and Behavior Fellowship; Helen Hay Whitney Postdoctoral Fellowship	We thank Kevin J. Lee, Gaby Maimon, Alex Nectow, Dragana Rogulja, Vanessa Ruta, and members of the Vosshall Lab for discussion and comments on the manuscript; David Anderson, Barry Dickson, Yuh Nung Jan, Tzumin Lee, Julie Simpson, and Markus Noll for providing fly stocks; Daisuke Yamamoto and Brian Oliver for antibodies; Alison Hill, Sarah Puhr, and Stephen Conway for expert technical assistance; Roman Corfas and Ben Matthews for help with the simulated wind experiments; and Dragana Rogulja and Mike Young for help measuring circadian rhythms. Rachel Zipursky helped initiate experiments with the decapitated males in Figures 1F and 1G. Veronica Burnham helped with heat shock of copulating pairs in Figure 3B. L. B. V. is an investigator of the Howard Hughes Medical Institute. M. A. C. was supported by Marco Stoffel Mind, Brain, and Behavior and Helen Hay Whitney Postdoctoral Fellowships.	Acebes A, 2004, CURR BIOL, V14, P704, DOI 10.1016/j.cub.2004.04.003; Atkinson J.W., 1970, DYNAMICS ACTION; Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Beaver LM, 2004, CURR BIOL, V14, P1492, DOI 10.1016/j.cub.2004.08.022; Boisvert MJ, 2006, CURR BIOL, V16, P1636, DOI 10.1016/j.cub.2006.06.064; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buchmann J, 2007, ENDOCRINOLOGY, V148, P1561, DOI 10.1210/en.2006-1244; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Carlson N.R., 2007, PSYCHOL SCI BEHAV; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; GRANT B, 1983, EVOLUTION, V37, P854, DOI 10.1111/j.1558-5646.1983.tb05607.x; Hall JK, 2008, CURR OPIN OPHTHALMOL, V19, P454, DOI 10.1097/ICU.0b013e328310da01; Hempel LU, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-113; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; Kim WJ, 2012, NAT NEUROSCI, V15, P876, DOI 10.1038/nn.3104; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEFEVRE G, 1962, GENETICS, V42, P1719; Linklater JR, 2007, EVOLUTION, V61, P2027, DOI 10.1111/j.1558-5646.2007.00157.x; MACBEAN IT, 1967, GENETICS, V56, P233; Mazzi D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-132; Met Office, 2010, FACT SHEET 6 BEAUF S; Ostrovsky A., 2010, DROSOPHILA NEUROBIOL; Pavlov I.P., 1927, CONDITIONED REFLEXES; Perry CJ, 2013, ANNU REV ENTOMOL, V58, P543, DOI 10.1146/annurev-ento-120811-153631; Prokop P, 2005, ETHOLOGY, V111, P836, DOI 10.1111/j.1439-0310.2005.01113.x; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Roeder KD, 1935, BIOL BULL-US, V69, P203, DOI 10.2307/1537420; RUBIN HB, 1967, J EXP ANAL BEHAV, V10, P219, DOI 10.1901/jeab.1967.10-219; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tayler TD, 2012, P NATL ACAD SCI USA, V109, P20697, DOI 10.1073/pnas.1218246109; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Xue L, 2000, P NATL ACAD SCI USA, V97, P3272, DOI 10.1073/pnas.060018897; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	42	45	46	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					881	893		10.1016/j.cell.2013.09.055	http://dx.doi.org/10.1016/j.cell.2013.09.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209625	Green Accepted, Bronze			2022-12-24	WOS:000326934300017
J	Gammon, K				Gammon, Katharine			INFLAMMATION A complex problem	NATURE			English	Editorial Material																		Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639	4	8	8	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					S86	S87		10.1038/502S86a	http://dx.doi.org/10.1038/502S86a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243CC	24187701				2022-12-24	WOS:000326293200004
J	Haydon, MJ; Mielczarek, O; Robertson, FC; Hubbard, KE; Webb, AAR				Haydon, Michael J.; Mielczarek, Olga; Robertson, Fiona C.; Hubbard, Katharine E.; Webb, Alex A. R.			Photosynthetic entrainment of the Arabidopsis thaliana circadian clock	NATURE			English	Article							PSEUDO-RESPONSE REGULATORS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; PHYTOCHROME-A; PROTEIN; ENCODES; LIGHT; TRANSCRIPTION; OSCILLATORS; HOMEOSTASIS	Circadian clocks provide a competitive advantage in an environment that is heavily influenced by the rotation of the Earth(1,2), by driving daily rhythms in behaviour, physiology and metabolism in bacteria, fungi, plants and animals(3,4). Circadian clocks comprise transcription-translation feedback loops, which are entrained by environmental signals such as light and temperature to adjust the phase of rhythms to match the local environment(3). The production of sugars by photosynthesis is a key metabolic output of the circadian clock in plants(2,5). Here we show that these rhythmic, endogenous sugar signals can entrain circadian rhythms in Arabidopsis thaliana by regulating the gene expression of circadian clock components early in the photoperiod, thus defining a 'metabolic dawn'. By inhibiting photosynthesis, we demonstrate that endogenous oscillations in sugar levels provide metabolic feedback to the circadian oscillator through the morning-expressed gene PSEUDO-RESPONSE REGULATOR 7 (PRR7), and we identify that prr7 mutants are insensitive to the effects of sucrose on the circadian period. Thus, photosynthesis has a marked effect on the entrainment and maintenance of robust circadian rhythms in A. thaliana, demonstrating that metabolism has a crucial role in regulation of the circadian clock.	[Haydon, Michael J.; Mielczarek, Olga; Robertson, Fiona C.; Hubbard, Katharine E.; Webb, Alex A. R.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge	Webb, AAR (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	aarw2@cam.ac.uk	Hubbard, Katharine/ABF-1833-2021; Haydon, Michael/B-9326-2014	Hubbard, Katharine/0000-0002-4862-0466; Haydon, Michael/0000-0003-2486-9387; Webb, Alex/0000-0003-0261-4375	BBSRC [BB/H006826/1]; Biotechnology and Biological Sciences Research Council [BB/D017904/1, BB/H006826/1] Funding Source: researchfish; BBSRC [BB/D017904/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC grant BB/H006826/1. We thank J. O'Neill, J. Davies and J. Hibberd for comments on the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Cho YH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001263; Dalchau N, 2011, P NATL ACAD SCI USA, V108, P5104, DOI 10.1073/pnas.1015452108; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DENG XW, 1992, CELL, V71, P791, DOI 10.1016/0092-8674(92)90555-Q; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Fukushima A, 2009, P NATL ACAD SCI USA, V106, P7251, DOI 10.1073/pnas.0900952106; Gibson SI, 2001, BIOCHEM BIOPH RES CO, V280, P196, DOI 10.1006/bbrc.2000.4062; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Gould PD, 2009, PLANT J, V58, P893, DOI 10.1111/j.1365-313X.2009.03819.x; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hudson ME, 2003, PLANT J, V34, P453, DOI 10.1046/j.1365-313X.2003.01741.x; Jacobsen SE, 1996, P NATL ACAD SCI USA, V93, P9292, DOI 10.1073/pnas.93.17.9292; James AB, 2008, SCIENCE, V322, P1832, DOI 10.1126/science.1161403; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; Johnson Carl Hirschie, 1992, P209; JOHNSON CH, 1991, PLANT PHYSIOL, V97, P1122, DOI 10.1104/pp.97.3.1122; Kato T, 2007, BIOSCI BIOTECH BIOCH, V71, P834, DOI 10.1271/bbb.60642; Knight H, 2008, PLANT PHYSIOL, V148, P293, DOI 10.1104/pp.108.123901; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109; Lehman A, 1996, CELL, V85, P183, DOI 10.1016/S0092-8674(00)81095-8; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Michael TP, 2003, P NATL ACAD SCI USA, V100, P6878, DOI 10.1073/pnas.1131995100; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P686, DOI 10.1093/pcp/pci086; Nakamichi N, 2012, P NATL ACAD SCI USA, V109, P17123, DOI 10.1073/pnas.1205156109; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Noordally ZB, 2013, SCIENCE, V339, P1316, DOI 10.1126/science.1230397; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Para A, 2007, PLANT CELL, V19, P3462, DOI 10.1105/tpc.107.054775; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063	45	252	258	13	253	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 31	2013	502	7473					689	+		10.1038/nature12603	http://dx.doi.org/10.1038/nature12603			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243CC	24153186	Green Accepted			2022-12-24	WOS:000326293200049
J	Kronke, J; Udeshi, ND; Narla, A; Grauman, P; Hurst, SN; McConkey, M; Svinkina, T; Heckl, D; Comer, E; Li, XY; Ciarlo, C; Hartman, E; Munshi, N; Schenone, M; Schreiber, SL; Carr, SA; Ebert, BL				Kroenke, Jan; Udeshi, Namrata D.; Narla, Anupama; Grauman, Peter; Hurst, Slater N.; McConkey, Marie; Svinkina, Tanya; Heckl, Dirk; Comer, Eamon; Li, Xiaoyu; Ciarlo, Christie; Hartman, Emily; Munshi, Nikhil; Schenone, Monica; Schreiber, Stuart L.; Carr, Steven A.; Ebert, Benjamin L.			Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells	SCIENCE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; UBIQUITIN LIGASE; IKAROS GENE; TRANSCRIPTION FACTOR; AIOLOS; LYMPHOMA; DIFFERENTIATION; IDENTIFICATION; POMALIDOMIDE; ACTIVATION	Lenalidomide is a drug with clinical efficacy in multiple myeloma and other B cell neoplasms, but its mechanism of action is unknown. Using quantitative proteomics, we found that lenalidomide causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase. IKZF1 and IKZF3 are essential transcription factors in multiple myeloma. A single amino acid substitution of IKZF3 conferred resistance to lenalidomide-induced degradation and rescued lenalidomide-induced inhibition of cell growth. Similarly, we found that lenalidomide-induced interleukin-2 production in T cells is due to depletion of IKZF1 and IKZF3. These findings reveal a previously unknown mechanism of action for a therapeutic agent: alteration of the activity of an E3 ubiquitin ligase, leading to selective degradation of specific targets.	[Kroenke, Jan; Narla, Anupama; Grauman, Peter; Hurst, Slater N.; McConkey, Marie; Heckl, Dirk; Ebert, Benjamin L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Udeshi, Namrata D.; Svinkina, Tanya; Comer, Eamon; Li, Xiaoyu; Ciarlo, Christie; Hartman, Emily; Schenone, Monica; Schreiber, Stuart L.; Carr, Steven A.; Ebert, Benjamin L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Munshi, Nikhil] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute	Ebert, BL (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	bebert@partners.org	Carr, Steven A./AAH-8366-2019; Munshi, Nikhil/ABE-2338-2021; Heckl, Dirk/GMW-5407-2022	Kronke, Jan/0000-0002-4649-0506	NIH [R01HL082945, P01 CA108631]; Leukemia and Lymphoma Society Scholar Award; Evans Foundation grant; Starr Cancer Consortium; SPARC consortium; National Human Genome Research Institute [RL1-HG004671]; German Research Foundation (DFG) [Kr-3886/1-1]; German Cancer Aid; Celgene; NATIONAL CANCER INSTITUTE [P01CA108631, P01CA155258, P50CA100707, P01CA078378] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Evans Foundation grant; Starr Cancer Consortium; SPARC consortium; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); German Research Foundation (DFG)(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe); Celgene(Bristol-Myers SquibbCelgene Corporation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Y.-T. Tai (Dana-Faber Cancer Institute) for technical assistance with primary multiple myeloma samples. This work was supported by funding from the NIH (R01HL082945, P01 CA108631), a Leukemia and Lymphoma Society Scholar Award, an Evans Foundation grant, and a grant from the Starr Cancer Consortium to B. L. E. In addition, the work was supported by a grant from the SPARC consortium and by an National Human Genome Research Institute (RL1-HG004671) initiative in genome-based drug discovery. J.K. was supported by the German Research Foundation (DFG, Kr-3886/1-1). D. H. was supported by the German Cancer Aid. B. L. E. and N.M. have received consulting fees from Celgene. The authors (J.K., N.D.U., S. A. C., and B. L. E.) and the Broad Institute have filed a patent application (number 61/902,066) pertaining to the prediction of therapeutic response to lenalidomide and related compounds.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Chanan-Khan A, 2006, J CLIN ONCOL, V24, P5343, DOI 10.1200/JCO.2005.05.0401; Cortes M, 1999, CURR OPIN IMMUNOL, V11, P167, DOI 10.1016/S0952-7915(99)80028-4; Cortes M, 2004, J EXP MED, V199, P209, DOI 10.1084/jem.20031571; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Habermann TM, 2009, BRIT J HAEMATOL, V145, P344, DOI 10.1111/j.1365-2141.2009.07626.x; Haslett PAJ, 1998, J EXP MED, V187, P1885, DOI 10.1084/jem.187.11.1885; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nuckel H, 2009, BRIT J HAEMATOL, V144, P268, DOI 10.1111/j.1365-2141.2008.07442.x; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rajkumar SV, 2005, BLOOD, V106, P4050, DOI 10.1182/blood-2005-07-2817; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	27	997	1073	27	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2014	343	6168					301	305		10.1126/science.1244851	http://dx.doi.org/10.1126/science.1244851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	289YN	24292625	Green Accepted			2022-12-24	WOS:000329718600037
J	Raghavan, M; Skoglund, P; Graf, KE; Metspalu, M; Albrechtsen, A; Moltke, I; Rasmussen, S; Stafford, TW; Orlando, L; Metspalu, E; Karmin, M; Tambets, K; Rootsi, S; Magi, R; Campos, PF; Balanovska, E; Balanovsky, O; Khusnutdinova, E; Litvinov, S; Osipova, LP; Fedorova, SA; Voevoda, MI; DeGiorgio, M; Sicheritz-Ponten, T; Brunak, S; Demeshchenko, S; Kivisild, T; Villems, R; Nielsen, R; Jakobsson, M; Willerslev, E				Raghavan, Maanasa; Skoglund, Pontus; Graf, Kelly E.; Metspalu, Mait; Albrechtsen, Anders; Moltke, Ida; Rasmussen, Simon; Stafford, Thomas W., Jr.; Orlando, Ludovic; Metspalu, Ene; Karmin, Monika; Tambets, Kristiina; Rootsi, Siiri; Maegi, Reedik; Campos, Paula F.; Balanovska, Elena; Balanovsky, Oleg; Khusnutdinova, Elza; Litvinov, Sergey; Osipova, Ludmila P.; Fedorova, Sardana A.; Voevoda, Mikhail I.; DeGiorgio, Michael; Sicheritz-Ponten, Thomas; Brunak, Soren; Demeshchenko, Svetlana; Kivisild, Toomas; Villems, Richard; Nielsen, Rasmus; Jakobsson, Mattias; Willerslev, Eske			Upper Palaeolithic Siberian genome reveals dual ancestry of Native Americans	NATURE			English	Article							MITOCHONDRIAL-DNA; HUNTER-GATHERERS; GENETIC HISTORY; ANCIENT; RADIOCARBON; SEQUENCE; ORIGINS; DIVERSITY; ACCURACY; CAVE	The origins of the First Americans remain contentious. Although Native Americans seem to be genetically most closely related to east Asians(1-3), there is no consensus with regard to which specific Old World populations they are closest to(4-8). Here we sequence the draft genome of an approximately 24,000-year-old individual (MA-1), from Mal'ta in south-central Siberia(9), to an average depth of 1x. To our knowledge this is the oldest anatomically modern human genome reported to date. The MA-1 mitochondrial genome belongs to haplogroup U, which has also been found at high frequency among Upper Palaeolithic and Mesolithic European hunter-gatherers(10-12), and the Y chromosome of MA-1 is basal to modern-day western Eurasians and near the root of most Native American lineages(5). Similarly, we find autosomal evidence that MA-1 is basal to modern-day western Eurasians and genetically closely related to modern-day Native Americans, with no close affinity to east Asians. This suggests that populations related to contemporary western Eurasians had a more north-easterly distribution 24,000 years ago than commonly thought. Furthermore, we estimate that 14 to 38% of Native American ancestry may originate through gene flow from this ancient population. This is likely to have occurred after the divergence of Native American ancestors from east Asian ancestors, but before the diversification of Native American populations in the New World. Gene flow from the MA-1 lineage into Native American ancestors could explain why several crania from the First Americans have been reported as bearing morphological characteristics that do not resemble those of east Asians(2,13). Sequencing of another south-central Siberian, Afontova Gora-2 dating to approximately 17,000 years ago(14), revealed similar autosomal genetic signatures as MA-1, suggesting that the region was continuously occupied by humans throughout the Last Glacial Maximum. Our findings reveal that western Eurasian genetic signatures in modern-day Native Americans derive not only from post-Columbian admixture, as commonly thought, but also from a mixed ancestry of the First Americans.	[Raghavan, Maanasa; Stafford, Thomas W., Jr.; Orlando, Ludovic; Campos, Paula F.; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Skoglund, Pontus; Jakobsson, Mattias] Uppsala Univ, Dept Evolutionary Biol, S-75236 Uppsala, Sweden; [Graf, Kelly E.] Texas A&M Univ, Ctr Study Amer 1, College Stn, TX 77845 USA; [Metspalu, Mait; Karmin, Monika; Tambets, Kristiina; Rootsi, Siiri; Litvinov, Sergey; Kivisild, Toomas; Villems, Richard] Estonian Bioctr, Evolutionary Biol Grp, EE-51010 Tartu, Estonia; [Metspalu, Mait; DeGiorgio, Michael; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Metspalu, Mait; Metspalu, Ene; Karmin, Monika; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Albrechtsen, Anders; Moltke, Ida] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Moltke, Ida] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Rasmussen, Simon] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Stafford, Thomas W., Jr.] Univ Aarhus, Dept Phys & Astron, AMS Dating Ctr 14C, DK-8000 Aarhus, Denmark; [Maegi, Reedik] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Balanovska, Elena; Balanovsky, Oleg] Russian Acad Med Sci, Res Ctr Med Genet, Moscow 115479, Russia; [Balanovsky, Oleg] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 119991, Russia; [Khusnutdinova, Elza; Litvinov, Sergey] Russian Acad Sci, Ufa Sci Ctr, Inst Biochem & Genet, Ufa 450054, Bashkorostan, Russia; [Khusnutdinova, Elza] Bashkir State Univ, Biol Dept, Ufa 450054, Bashkorostan, Russia; [Osipova, Ludmila P.; Voevoda, Mikhail I.] Russian Acad Sci, Siberian Branch, Ctr Brain Neurobiol & Neurogenet, Inst Cytol & Genet, Novosibirsk 630090, Russia; [Fedorova, Sardana A.] Russian Acad Med Sci, Yakut Res Ctr Complex Med Problems, Dept Mol Genet, Sakha 677010, Yakutia, Russia; [Fedorova, Sardana A.] North Eastern Fed Univ, Sakha 677010, Yakutia, Russia; [Voevoda, Mikhail I.] North Eastern Fed Univ, Sakha 677010, Yakutia, Russia; [Sicheritz-Ponten, Thomas; Brunak, Soren] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark; [Demeshchenko, Svetlana] State Hermitage Museum, St Petersburg 190000, Russia; [Kivisild, Toomas] Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 1QH, England; [Villems, Richard] Estonian Acad Sci, EE-10130 Tallinn, Estonia; [Jakobsson, Mattias] Uppsala Univ, Sci Life Lab, S-75236 Uppsala, Sweden	University of Copenhagen; Uppsala University; Texas A&M University System; Texas A&M University College Station; Estonian Biocentre; University of California System; University of California Berkeley; University of Tartu; University of Copenhagen; University of Chicago; Technical University of Denmark; Aarhus University; University of Tartu; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Russian Academy of Medical Sciences; North-Eastern Federal University in Yakutsk; North-Eastern Federal University in Yakutsk; Technical University of Denmark; State Hermitage Museum; University of Cambridge; Estonian Academy of Sciences; Uppsala University	Willerslev, E (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen, Denmark.	ewillerslev@snm.ku.dk	Tambets, Kristiina/M-2568-2019; Jakobsson, Mattias/A-6116-2011; Willerslev, Eske/A-9619-2011; Metspalu, Mait/G-8671-2015; Rasmussen, Simon/AAA-2308-2020; Rasmussen, Simon/G-6258-2016; Albrechtsen, Anders/K-4281-2013; Fedorova, Sardana/K-5445-2017; Kivisild, Toomas/P-5889-2017; Balanovsky, Oleg/G-1549-2014; Voevoda, Mikhail/N-6713-2015; Osipova, Ludmila P/O-6480-2014; Litvinov, Sergey/L-1738-2013; Mägi, Reedik/AAJ-9679-2021; Khusnutdinova, Elza Kamilevna/A-4810-2013; Campos, Paula/ABF-9898-2021; Moltke, Ida/C-6158-2011; Orlando, Ludovic/A-8932-2013; Willerslev, Eske/AAA-5686-2019; Campos, Paula F/B-1634-2010; Sicheritz-Ponten, Thomas/A-4325-2017; Nielsen, Rasmus/D-4405-2009; Brunak, Soren/O-6621-2016	Tambets, Kristiina/0000-0002-8173-6380; Jakobsson, Mattias/0000-0001-7840-7853; Willerslev, Eske/0000-0002-7081-6748; Metspalu, Mait/0000-0003-3099-9161; Rasmussen, Simon/0000-0001-6323-9041; Rasmussen, Simon/0000-0001-6323-9041; Albrechtsen, Anders/0000-0001-7306-031X; Kivisild, Toomas/0000-0002-6297-7808; Voevoda, Mikhail/0000-0001-9425-413X; Osipova, Ludmila P/0000-0001-7602-1156; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Moltke, Ida/0000-0001-7052-8554; Orlando, Ludovic/0000-0003-3936-1850; Campos, Paula F/0000-0003-1285-4671; Skoglund, Pontus/0000-0002-3021-5913; Magi, Reedik/0000-0002-2964-6011; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Karmin, Monika/0000-0001-9827-5579; Raghavan, Maanasa/0000-0003-1997-0739; Nielsen, Rasmus/0000-0003-0513-6591; Fedorova, Sardana/0000-0002-6952-3868; Brunak, Soren/0000-0003-0316-5866	Danish National Research Foundation; Lundbeck Foundation; Arctic Social Sciences Program, National Science Foundation [PLR-1003725]; European Regional Development Fund (European Union) through the Centre of Excellence in Genomics to Estonian Biocentre; University of Tartu and Estonian Basic Research grant [SF0270177As08]; Estonian Science Foundation [8973]; Baltic-American Freedom Foundation Research Scholarship program; Government of Russian Federation [14.B25.31.0033]; US National Science Foundation [DBI-1103639]; Swedish National Infrastructure for Computing (SNIC-UPPMAX) [b2012063]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; Villum Fonden [00007171] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Arctic Social Sciences Program, National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); European Regional Development Fund (European Union) through the Centre of Excellence in Genomics to Estonian Biocentre; University of Tartu and Estonian Basic Research grant; Estonian Science Foundation; Baltic-American Freedom Foundation Research Scholarship program; Government of Russian Federation; US National Science Foundation(National Science Foundation (NSF)); Swedish National Infrastructure for Computing (SNIC-UPPMAX); Novo Nordisk Fonden(Novo Nordisk Foundation); Villum Fonden(Villum Fonden); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Hermitage State Museum for providing access to the Mal'ta and Afontova Gora-2 human remains. We also thank the Danish National High-Throughput DNA Sequencing Centre and T. Reisberg for technical assistance. This work was supported by the Danish National Research Foundation and the Lundbeck Foundation (E. W. and M. R.) and the Arctic Social Sciences Program, National Science Foundation (grant PLR-1003725 to K. E. G.). R. V., M. M., M. K., E. M., K. T., S. Ro. and R. M. were supported by the European Regional Development Fund (European Union) through the Centre of Excellence in Genomics to Estonian Biocentre and University of Tartu and Estonian Basic Research grant SF0270177As08. M. M. thanks the Estonian Science Foundation grant no. 8973 and Baltic-American Freedom Foundation Research Scholarship program and M. I. V. thanks the Government of Russian Federation grant no. 14.B25.31.0033 (to E. I. Rogaev). M. D. was supported by the US National Science Foundation (grant DBI-1103639). Computational analyses were carried out at the High Performance Computing Center, University of Tartu, and the Swedish National Infrastructure for Computing (SNIC-UPPMAX, project b2012063).	Abramova Z.A., 1995, LART PALEOLITHIQUE D; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Astakhov S. N., 1999, PALEOLIT ENISEIA PAL; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bradley B, 2004, WORLD ARCHAEOL, V36, P459, DOI 10.1080/0043824042000303656; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Dulik MC, 2012, AM J HUM GENET, V90, P229, DOI 10.1016/j.ajhg.2011.12.014; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; GAMBLE C, 1982, MAN, V17, P92, DOI 10.2307/2802103; Gerasimov M. M., 1964, THE ARCHAEOLOGY AND, P5; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hubbe M, 2011, AM J PHYS ANTHROPOL, V144, P442, DOI 10.1002/ajpa.21425; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Lipson M., 2013, MOL BIOL EVOL; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Owsley D. W., 2002, CLAIMING THE STONES; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; POWELL R, 2002, OXFORD PRACTICAL APP; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Regueiro M, 2013, AM J PHYS ANTHROPOL, V150, P333, DOI 10.1002/ajpa.22207; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Schurr TG, 2004, ANNU REV ANTHROPOL, V33, P551, DOI 10.1146/annurev.anthro.33.070203.143932; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; STAFFORD TW, 1988, GEOCHIM COSMOCHIM AC, V52, P2257, DOI 10.1016/0016-7037(88)90128-7; STAFFORD TW, 1991, J ARCHAEOL SCI, V18, P35, DOI 10.1016/0305-4403(91)90078-4; STAFFORD TW, 1987, RADIOCARBON, V29, P24; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Surakka I, 2010, GENOME RES, V20, P1344, DOI 10.1101/gr.106534.110; Svensson EM, 2007, ANIM GENET, V38, P378, DOI 10.1111/j.1365-2052.2007.01620.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turner C G 2nd, 1984, Acta Anthropogenet, V8, P23; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wall JD, 2011, MOL BIOL EVOL, V28, P2231, DOI 10.1093/molbev/msr049; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; White R, 2006, J ARCHAEOL METHOD TH, V13, P251, DOI 10.1007/s10816-006-9023-z; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	64	431	445	0	207	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					87	+		10.1038/nature12736	http://dx.doi.org/10.1038/nature12736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24256729	Green Accepted, Green Submitted			2022-12-24	WOS:000329163300029
J	Wang, X; Lu, ZK; Gomez, A; Hon, GC; Yue, YN; Han, DL; Fu, Y; Parisien, M; Dai, Q; Jia, GF; Ren, B; Pan, T; He, C				Wang, Xiao; Lu, Zhike; Gomez, Adrian; Hon, Gary C.; Yue, Yanan; Han, Dali; Fu, Ye; Parisien, Marc; Dai, Qing; Jia, Guifang; Ren, Bing; Pan, Tao; He, Chuan			N-6-methyladenosine-dependent regulation of messenger RNA stability	NATURE			English	Article							BINDING PROTEIN; SITES; DOMAIN; N6-METHYLADENOSINE; TRANSLATION; METHYLATION; SEQUENCES; GRANULES; DECAY; GENE	N-6-methyladenosine (m(6)A) is the most prevalent internal (non-cap) modification present in the messenger RNA of all higher eukaryotes(1,2). Although essential to cell viability and development(3-5), the exact role of m(6)A modification remains to be determined. The recent discovery of two m(6)A demethylases in mammalian cells highlighted the importance of m(6)A in basic biological functions and disease(6-8). Here we show that m(6)A is selectively recognized by the human YTH domain family 2 (YTHDF2) 'reader' protein to regulate mRNA degradation. We identified over 3,000 cellular RNA targets of YTHDF2, most of which are mRNAs, but which also include non-coding RNAs, with a conserved core motif of G(m(6)A)C. We further establish the role of YTHDF2 in RNA metabolism, showing that binding of YTHDF2 results in the localization of bound mRNA from the translatable pool to mRNA decay sites, such as processing bodies(9). The carboxy-terminal domain of YTHDF2 selectively binds to m(6)A-containing mRNA, whereas the amino-terminal domain is responsible for the localization of the YTHDF2-mRNA complex to cellular RNA decay sites. Our results indicate that the dynamic m(6)A modification is recognized by selectively binding proteins to affect the translation status and lifetime of mRNA.	[Wang, Xiao; Lu, Zhike; Gomez, Adrian; Yue, Yanan; Han, Dali; Fu, Ye; Dai, Qing; Jia, Guifang; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Wang, Xiao; Lu, Zhike; Gomez, Adrian; Yue, Yanan; Han, Dali; Fu, Ye; Parisien, Marc; Dai, Qing; Jia, Guifang; Pan, Tao; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Hon, Gary C.; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Cellular & Mol Med,UCSD Moores Canc Ctr, La Jolla, CA 92093 USA; [Hon, Gary C.; Ren, Bing] Univ Calif San Diego, Sch Med, Inst Genome Med, La Jolla, CA 92093 USA; [Parisien, Marc; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Jia, Guifang] Peking Univ, Dept Chem Biol, Beijing 100871, Peoples R China; [Jia, Guifang] Peking Univ, Synthet & Funct Biomol Ctr, Coll Chem & Mol Engn, Beijing 100871, Peoples R China	University of Chicago; University of Chicago; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Chicago; Peking University; Peking University	He, C (corresponding author), Univ Chicago, Dept Chem, 929 East 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Han, Dali/I-4145-2016; Dai, Qing/ABD-8444-2021	Fu, Ye/0000-0002-3807-9717; Wang, Xiao/0000-0002-3090-9894; Fu, Ye/0000-0003-4434-6014; Parisien, Marc/0000-0003-2924-5960	National Institutes of Health [GM071440]; EUREKA [GM088599]; National Science Foundation [CHE-1048528]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG006699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088599, R01GM071440] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1048528] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUREKA; National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is supported by National Institutes of Health GM071440 (C. H.) and EUREKA GM088599 (T. P. and C. H.). The Mass Spectrometry Facility of the University of Chicago is funded by National Science Foundation (CHE-1048528). We thank A. E. Kulozik, W. Filipowicz and J. A. Steitz for providing the sequence and plasmids of the tether reporter. We thank Dr. G. Zheng and W. Clark for help in polysome profiling. We also thank S. F. Reichard for editing the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bokar JA, 1997, RNA, V3, P1233; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Cardelli M, 2006, J GERONTOL A-BIOL, V61, P547, DOI 10.1093/gerona/61.6.547; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; Clement Sandra L., 2008, V419, P121, DOI 10.1007/978-1-59745-033-1_8; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Dandekar T., 2002, RNA MOTIFS REGULATOR, P1; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Morris D. R., 1997, MRNA FORMATION FUNCT; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Stoilov P, 2002, TRENDS BIOCHEM SCI, V27, P495, DOI 10.1016/S0968-0004(02)02189-8; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TUCK MT, 1992, INT J BIOCHEM, V24, P379, DOI 10.1016/0020-711X(92)90028-Y; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	41	2090	2182	38	510	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					117	+		10.1038/nature12730	http://dx.doi.org/10.1038/nature12730			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24284625	Green Accepted			2022-12-24	WOS:000329163300035
J	Yu, CC; Fornoni, A; Weins, A; Hakroush, S; Maiguel, D; Sageshima, J; Chen, L; Ciancio, G; Faridi, MH; Behr, D; Campbell, KN; Chang, JM; Chen, HC; Oh, J; Faul, C; Arnaout, MA; Fiorina, P; Gupta, V; Greka, A; Burke, GW; Mundel, P				Yu, Chih-Chuan; Fornoni, Alessia; Weins, Astrid; Hakroush, Samy; Maiguel, Dony; Sageshima, Junichiro; Chen, Linda; Ciancio, Gaetano; Faridi, Mohd Hafeez; Behr, Daniel; Campbell, Kirk N.; Chang, Jer-Ming; Chen, Hung-Chun; Oh, Jun; Faul, Christian; Arnaout, M. Amin; Fiorina, Paolo; Gupta, Vineet; Greka, Anna; Burke, George W., III; Mundel, Peter			Abatacept in B7-1-Positive Proteinuric Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RHEUMATOID-ARTHRITIS; INTEGRIN ACTIVATION; PODOCYTES; TALIN	Abatacept (cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion protein [CTLA-4-Ig]) is a costimulatory inhibitor that targets B7-1 (CD80). The present report describes five patients who had focal segmental glomerulosclerosis (FSGS) (four with recurrent FSGS after transplantation and one with primary FSGS) and proteinuria with B7-1 immunostaining of podocytes in kidney-biopsy specimens. Abatacept induced partial or complete remissions of proteinuria in these patients, suggesting that B7-1 may be a useful biomarker for the treatment of some glomerulopathies. Our data indicate that abatacept may stabilize 1-integrin activation in podocytes and reduce proteinuria in patients with B7-1-positive glomerular disease.	[Yu, Chih-Chuan; Weins, Astrid; Hakroush, Samy; Maiguel, Dony; Arnaout, M. Amin; Greka, Anna; Mundel, Peter] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Yu, Chih-Chuan; Weins, Astrid; Hakroush, Samy; Behr, Daniel; Arnaout, M. Amin; Greka, Anna; Mundel, Peter] Harvard Univ, Sch Med, Boston, MA USA; [Weins, Astrid] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Fiorina, Paolo] Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Yu, Chih-Chuan] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chang, Jer-Ming; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Dept Internal Med, Kaohsiung, Taiwan; [Fornoni, Alessia; Maiguel, Dony; Faridi, Mohd Hafeez; Faul, Christian; Gupta, Vineet] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Sageshima, Junichiro; Chen, Linda; Ciancio, Gaetano; Burke, George W., III] Univ Miami, Miller Sch Med, Lilian Jean Kaplan Div Kidney Pancreas Transplant, Miami Transplant Inst,Dept Surg, Miami, FL 33136 USA; [Campbell, Kirk N.] Mt Sinai Sch Med, Div Nephrol, New York, NY USA; [Oh, Jun] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Hamburg, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Kaohsiung Medical University; Kaohsiung Medical University; University of Miami; University of Miami; Icahn School of Medicine at Mount Sinai; University of Hamburg; University Medical Center Hamburg-Eppendorf	Mundel, P (corresponding author), Massachusetts Gen Hosp, Div Nephrol, 149 13th St, Charlestown, MA 02129 USA.	mundel.peter@mgh.harvard.edu	Oh, Jun/K-4039-2013; Faul, Christian/AAG-7800-2022; Faul, Christian/AFL-7858-2022; Fiorina, Paolo/B-4532-2019	Faul, Christian/0000-0002-7512-0977; Faul, Christian/0000-0002-7512-0977; Hakroush, Samy/0000-0002-2843-3567; Fiorina, Paolo/0000-0002-1093-7724; fornoni, Alessia/0000-0002-1313-7773	National Institutes of Health [DK57683, DK062472, DK093783, DK068253, HL109582, DK0903616, DK090316, DK083511, DK093746]; Boston Area Diabetes Endocrinology Research Center; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK057521]; Deutsche Forschungsgemeinschaft [HA 6334/1-1]; NephCure Foundation; Transplant Foundation of South Florida; American Society of Nephrology; NephCure Young Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000460] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091218, R01DK048549, R56DK093746, K08DK083511, R01DK088327, P30DK057521, R01DK084195, R01DK090316, K08DK093783, K01DK068253, R01DK062472, R01DK057683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area Diabetes Endocrinology Research Center; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NephCure Foundation; Transplant Foundation of South Florida; American Society of Nephrology; NephCure Young Investigator Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (DK57683 and DK062472, to Dr. Mundel; DK093783, to Dr. Weins; DK068253 and HL109582, to Dr. Gupta; DK0903616, to Drs. Fornoni and Burke; and DK090316, DK083511, and DK093746, to Dr. Greka), the Boston Area Diabetes Endocrinology Research Center and the National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, to Dr. Greka), Deutsche Forschungsgemeinschaft (HA 6334/1-1, to Dr. Hakroush), and the NephCure Foundation and Transplant Foundation of South Florida (to Drs. Fornoni and Burke), and by an American Society of Nephrology Gottschalk Career Development Award and a NephCure Young Investigator Award (to Dr. Greka).	Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Gupta V, 2007, BLOOD, V109, P3513, DOI 10.1182/blood-2005-11-056689; Hoi AY, 2012, EXPERT OPIN BIOL TH, V12, P1399, DOI 10.1517/14712598.2012.713934; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075	15	249	268	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25					2416	2423		10.1056/NEJMoa1304572	http://dx.doi.org/10.1056/NEJMoa1304572			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274DQ	24206430	Green Accepted, Bronze			2022-12-24	WOS:000328586000009
J	Valentim, CLL; Cioli, D; Chevalier, FD; Cao, XH; Taylor, AB; Holloway, SP; Pica-Mattoccia, L; Guidi, A; Basso, A; Tsai, IJ; Berriman, M; Carvalho-Queiroz, C; Almeida, M; Aguilar, H; Frantz, DE; Hart, PJ; LoVerde, PT; Anderson, TJC				Valentim, Claudia L. L.; Cioli, Donato; Chevalier, Frederic D.; Cao, Xiaohang; Taylor, Alexander B.; Holloway, Stephen P.; Pica-Mattoccia, Livia; Guidi, Alessandra; Basso, Annalisa; Tsai, Isheng J.; Berriman, Matthew; Carvalho-Queiroz, Claudia; Almeida, Marcio; Aguilar, Hector; Frantz, Doug E.; Hart, P. John; LoVerde, Philip T.; Anderson, Timothy J. C.			Genetic and Molecular Basis of Drug Resistance and Species-Specific Drug Action in Schistosome Parasites	SCIENCE			English	Article							HYCANTHONE RESISTANCE; PLASMODIUM-FALCIPARUM; MANSONI; OXAMNIQUINE; SULFOTRANSFERASE; MECHANISMS; LINKAGE; GENOME	Oxamniquine resistance evolved in the human blood fluke (Schistosoma mansoni) in Brazil in the 1970s. We crossed parental parasites differing similar to 500-fold in drug response, determined drug sensitivity and marker segregation in clonally derived second-generation progeny, and identified a single quantitative trait locus (logarithm of odds = 31) on chromosome 6. A sulfotransferase was identified as the causative gene by using RNA interference knockdown and biochemical complementation assays, and we subsequently demonstrated independent origins of loss-of-function mutations in field-derived and laboratory-selected resistant parasites. These results demonstrate the utility of linkage mapping in a human helminth parasite, while crystallographic analyses of protein-drug interactions illuminate the mode of drug action and provide a framework for rational design of oxamniquine derivatives that kill both S. mansoni and S. haematobium, the two species responsible for >99% of schistosomiasis cases worldwide.	[Valentim, Claudia L. L.; Cao, Xiaohang; Taylor, Alexander B.; Holloway, Stephen P.; Carvalho-Queiroz, Claudia; Hart, P. John; LoVerde, Philip T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Valentim, Claudia L. L.; Cao, Xiaohang; Taylor, Alexander B.; Holloway, Stephen P.; Carvalho-Queiroz, Claudia; Hart, P. John; Anderson, Timothy J. C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Valentim, Claudia L. L.; Chevalier, Frederic D.; Almeida, Marcio; Anderson, Timothy J. C.] Texas Biomed Res Inst, San Antonio, TX 78245 USA; [Cioli, Donato; Pica-Mattoccia, Livia; Guidi, Alessandra; Basso, Annalisa] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Tsai, Isheng J.; Berriman, Matthew] Wellcome Trust Sanger Inst, Hinxton, England; [Aguilar, Hector; Frantz, Doug E.] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Hart, P. John] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Texas Biomedical Research Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Wellcome Trust Sanger Institute; University of Texas System; University of Texas at San Antonio (UTSA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Hart, PJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	pjhart@biochem.uthscsa.edu; loverde@uthscsa.edu; tanderso@txbiomedgenetics.org	Tsai, Isheng J/H-6606-2014; Guidi, Alessandra/P-1348-2018; Tsai, Isheng Jason/ABB-8273-2021; Berriman, Matthew/A-7618-2011; CHEVALIER, Frédéric D./E-6852-2010; Guidi, Alessandra/AEO-0770-2022	Tsai, Isheng Jason/0000-0002-2123-5058; Berriman, Matthew/0000-0002-9581-0377; CHEVALIER, Frédéric D./0000-0003-2611-8106; Guidi, Alessandra/0000-0002-2537-1428; Taylor, Alexander/0000-0003-3517-6033	NIH [5R21-AI096277, 5R21-AI072704, R01-AI097576]; World Health Organization [HQNTD1206356]; Research Facilities Improvement Program Grant from National Center for Research Resources (NIH) [C06 RR013556]; Wellcome Trust [098051]; Robert A. Welch Foundation [AQ-1399]; NIH-National Institute of Allergy and Infectious Diseases [HHSN272201000005I]; University of Texas Health Science Center, San Antonio, Office of the Vice President for Research; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR013556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072704, R21AI096277, R01AI097576] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Health Organization(World Health Organization); Research Facilities Improvement Program Grant from National Center for Research Resources (NIH); Wellcome Trust(Wellcome TrustEuropean Commission); Robert A. Welch Foundation(The Welch Foundation); NIH-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Texas Health Science Center, San Antonio, Office of the Vice President for Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by NIH (5R21-AI096277, 5R21-AI072704, R01-AI097576) and World Health Organization (HQNTD1206356) in facilities constructed with support from Research Facilities Improvement Program Grant (C06 RR013556) from National Center for Research Resources (NIH). Work at Wellcome Trust Sanger Institute was supported by the Wellcome Trust (grant 098051). P.J.H. was funded by the Robert A. Welch Foundation (AQ-1399). B. glabrata snails were supplied by Fred Lewis (Biomedical Research Institute, Rockville, MD) under NIH-National Institute of Allergy and Infectious Diseases contract no. HHSN272201000005I. We thank W. Le Clec'h and C. Valle (capillary sequencing), Z. Lai (RNA sequencing), N. Holroyd (coordinated genome sequencing), Q. Bickle (RNAi support), and G. Anderson (movie compilation). The X-ray Crystallography Core Laboratory is supported by the University of Texas Health Science Center, San Antonio, Office of the Vice President for Research. The authors declare no competing financial interests. Data deposition: Illumina sequence reads (www.ebi.ac.uk/ena/accession#ERP000160); GenBank accessions (KF733459-61), RNAseq data (www.ncbi.nlm.nih.gov/geo/, GSE51847), structural data (www.wwpdb.org/, accession 4MUA, 4MUB)	Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; CIOLI D, 1985, LIFE SCI, V37, P161, DOI 10.1016/0024-3205(85)90419-9; CIOLI D, 1992, EXP PARASITOL, V75, P425, DOI 10.1016/0014-4894(92)90255-9; Criscione CD, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r71; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; DRESCHER KM, 1993, MEM I OSWALDO CRUZ, V88, P89, DOI 10.1590/S0074-02761993000100014; FOSTER R, 1973, T ROY SOC TROP MED H, V67, P674, DOI 10.1016/0035-9203(73)90038-2; Gentile R, 2008, ACTA TROP, V108, P175, DOI 10.1016/j.actatropica.2008.09.003; Gower CM, 2004, EVOLUTION, V58, P1178, DOI 10.1111/j.0014-3820.2004.tb01698.x; Greenberg RM, 2013, PARASITOLOGY, V140, P1534, DOI 10.1017/S0031182013000231; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hotez PJ, 2006, DIS CONTROL PRIORITI, V2nd; Kalbe M, 2004, PARASITOLOGY, V128, P635, DOI 10.1017/S0031182004005037; KATZ N., 1973, Revista da Sociedade Brasileira de Medicina Tropical, V7, P381, DOI 10.1590/S0037-86821973000600008; Lawton SP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-131; LEWIS FA, 1986, J PARASITOL, V72, P813, DOI 10.2307/3281829; Negishi M, 2001, ARCH BIOCHEM BIOPHYS, V390, P149, DOI 10.1006/abbi.2001.2368; Osei-Atweneboana MY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000998; Pica-Mattoccia L, 2006, MEM I OSWALDO CRUZ, V101, P307, DOI 10.1590/S0074-02762006000900048; PICAMATTOCCIA L, 1993, EXP PARASITOL, V77, P445, DOI 10.1006/expr.1993.1104; PicaMattoccia L, 1997, PARASITOL RES, V83, P687, DOI 10.1007/s004360050320; PICAMATTOCCIA L, 1992, MOL BIOCHEM PARASIT, V55, P167, DOI 10.1016/0166-6851(92)90137-9; Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455; Ranford-Cartwright LC, 2012, INT J PARASITOL, V42, P529, DOI 10.1016/j.ijpara.2012.03.004; ROGERS SH, 1971, SCIENCE, V172, P1057, DOI 10.1126/science.172.3987.1057; Schwab AE, 2005, AM J TROP MED HYG, V73, P234, DOI 10.4269/ajtmh.2005.73.234; Sibley LD, 2009, INT J PARASITOL, V39, P915, DOI 10.1016/j.ijpara.2009.02.011; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; VARIN L, 1987, ANAL BIOCHEM, V161, P176, DOI 10.1016/0003-2697(87)90669-5	30	101	105	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1385	1389		10.1126/science.1243106	http://dx.doi.org/10.1126/science.1243106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24263136	Green Accepted			2022-12-24	WOS:000328196000055
J	Rosenfeldt, MT; O'Prey, J; Morton, JP; Nixon, C; MacKay, G; Mrowinska, A; Au, A; Rai, TS; Zheng, L; Ridgway, R; Adams, PD; Anderson, KI; Gottlieb, E; Sansom, OJ; Ryan, KM				Rosenfeldt, Mathias T.; O'Prey, Jim; Morton, Jennifer P.; Nixon, Colin; MacKay, Gillian; Mrowinska, Agata; Au, Amy; Rai, Taranjit Singh; Zheng, Liang; Ridgway, Rachel; Adams, Peter D.; Anderson, Kurt I.; Gottlieb, Eyal; Sansom, Owen J.; Ryan, Kevin M.			p53 status determines the role of autophagy in pancreatic tumour development	NATURE			English	Article							CELL; SUPPRESSION; PROGRESSION; PRINCIPLES; DISEASE; GROWTH; CANCER; DAMAGE	Macroautophagy (hereafter referred to as autophagy) is a process in which organelles termed autophagosomes deliver cytoplasmic constituents to lysosomes for degradation(1). Autophagy has a major role in cellular homeostasis and has been implicated in various forms of human disease(2-4). The role of autophagy in cancer seems to be complex, with reports indicating both pro-tumorigenic and tumour-suppressive roles(3,5-12). Here we show, in a humanized genetically-modified mouse model of pancreatic ductal adenocarcinoma(PDAC), that autophagy's role in tumour development is intrinsically connected to the status of the tumour suppressor p53. Mice with pancreases containing an activated oncogenic allele of Kras (also called Ki-Ras)-the most common mutational event in PDAC(13)-develop a small number of pre-cancerous lesions that stochastically develop into PDAC over time. However, mice also lacking the essential autophagy genes Atg5 or Atg7 accumulate low-grade, pre-malignant pancreatic intraepithelial neoplasia lesions, but progression to high-grade pancreatic intraepithelial neoplasias and PDAC is blocked. In marked contrast, in mice containing oncogenic Kras and lacking p53, loss of autophagy no longer blocks tumour progression, but actually accelerates tumour onset, with metabolic analysis revealing enhanced glucose uptake and enrichment of anabolic pathways, which can fuel tumour growth. These findings provide considerable insight into the role of autophagy in cancer and have important implications for autophagy inhibition in cancer therapy. In this regard, we also show that treatment of mice with the autophagy inhibitor hydroxychloroquine, which is currently being used in several clinical trials(14), significantly accelerates tumour formation in mice containing oncogenic Kras but lacking p53.	[Rosenfeldt, Mathias T.; O'Prey, Jim; Morton, Jennifer P.; Nixon, Colin; MacKay, Gillian; Mrowinska, Agata; Au, Amy; Zheng, Liang; Ridgway, Rachel; Anderson, Kurt I.; Gottlieb, Eyal; Sansom, Owen J.; Ryan, Kevin M.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Rai, Taranjit Singh; Adams, Peter D.] Univ Glasgow, Inst Canc Studies, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute; University of Glasgow	Ryan, KM (corresponding author), Canc Res UK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.ryan@beatson.gla.ac.uk	Gottlieb, Eyal/G-6450-2010; Singh, Taranjit/ABE-8233-2020; Rai, Taranjit Singh/A-3659-2012; Morton, Jennifer/AAJ-5113-2021; Morton, Jennifer P/E-1633-2011; Rosenfeldt, Mathias/ABE-4736-2022	Gottlieb, Eyal/0000-0002-9770-0956; Singh, Taranjit/0000-0002-7276-7492; Rai, Taranjit Singh/0000-0002-7276-7492; Morton, Jennifer/0000-0001-5766-9141; Morton, Jennifer P/0000-0001-5766-9141; Rosenfeldt, Mathias/0000-0001-7650-8458; Anderson, Kurt/0000-0002-9324-9598; Ryan, Kevin M./0000-0002-1059-9681; Zheng, Liang/0000-0002-5346-4111; Sansom, Owen J./0000-0001-9540-3010; Adams, Peter/0000-0002-0684-1770	Cancer Research UK; Pancreatic Cancer Research Fund; Cancer Research UK [16566, 15565, 12481, 15816, 11650] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Pancreatic Cancer Research Fund; Cancer Research UK(Cancer Research UK)	We are grateful to M. Komatsu for providing the Atg7 floxed mice that were used in this study, and we thank M. O'Prey for help with fluorescent microscopy; G. Gillen for help with PET; T. McBryan for help with statistics; C. Frezza for help with metabolic studies; and A. Rosenwald for help and advice on pathology. This work was supported by Cancer Research UK and the Pancreatic Cancer Research Fund.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Caldwell ME, 2012, ONCOGENE, V31, P1599, DOI 10.1038/onc.2011.350; Crighton D, 2004, BBA-REV CANCER, V1705, P3, DOI 10.1016/j.bbcan.2004.09.001; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mah LY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008821; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Rosenfeldt MT, 2012, AUTOPHAGY, V8, P963, DOI 10.4161/auto.20186; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	33	509	526	8	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					296	+		10.1038/nature12865	http://dx.doi.org/10.1038/nature12865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24305049				2022-12-24	WOS:000328121500040
J	Arora, VK; Schenkein, E; Murali, R; Subudhi, SK; Wongvipat, J; Balbas, MD; Shah, N; Cai, L; Efstathiou, E; Logothetis, C; Zheng, DY; Sawyers, CL				Arora, Vivek K.; Schenkein, Emily; Murali, Rajmohan; Subudhi, Sumit K.; Wongvipat, John; Balbas, Minna D.; Shah, Neel; Cai, Ling; Efstathiou, Eleni; Logothetis, Chris; Zheng, Deyou; Sawyers, Charles L.			Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade	CELL			English	Article							PROSTATE-CANCER; INCREASED SURVIVAL; LUNG-CANCER; ABIRATERONE; ENZALUTAMIDE; INHIBITION; GEFITINIB; MUTATION; GROWTH	The treatment of advanced prostate cancer has been transformed by novel antiandrogen therapies such as enzalutamide. Here, we identify induction of glucocorticoid receptor (GR) expression as a common feature of drug-resistant tumors in a credentialed preclinical model, a finding also confirmed in patient samples. GR substituted for the androgen receptor (AR) to activate a similar but distinguishable set of target genes and was necessary for maintenance of the resistant phenotype. The GR agonist dexamethasone was sufficient to confer enzalutamide resistance, whereas a GR antagonist restored sensitivity. Acute AR inhibition resulted in GR upregulation in a subset of prostate cancer cells due to relief of AR-mediated feedback repression of GR expression. These findings establish a mechanism of escape from AR blockade through expansion of cells primed to drive AR target genes via an alternative nuclear receptor upon drug exposure.	[Arora, Vivek K.; Schenkein, Emily; Murali, Rajmohan; Wongvipat, John; Balbas, Minna D.; Shah, Neel; Cai, Ling; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Arora, Vivek K.; Subudhi, Sumit K.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Murali, Rajmohan] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Balbas, Minna D.; Shah, Neel] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Efstathiou, Eleni; Logothetis, Chris] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	sawyersc@mskcc.org	Sawyers, Charles/G-5327-2016; Murali, Rajmohan/A-7960-2008	Subudhi, Sumit/0000-0001-5208-7732; Zheng, Deyou/0000-0003-4354-5337; Murali, Rajmohan/0000-0001-6988-4295	CDMRP Physician Research Training Award [PC102106]; NIH [R01CA155169, P50CA09262, U01 CA141502]; Howard Hughes Medical Institute; Medivation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA155169, P50CA092629, U01CA141502] Funding Source: NIH RePORTER	CDMRP Physician Research Training Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medivation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Phil Iaquinta, Brett Carver, Yu Chen, Phil Watson, Haley Hieronymus, Bea Darimont, and Howard Scher for helpful discussions. We thank Tom Scanlan (Portland, Oregon) for generously providing compound 15, Yu Chen for generously providing the pMItDT-EGFP vector, Agnes Viales and Liping Sun of the MSKCC Genomics Core Facility for ChIP-seq library prep and sequencing, Jeffrey Zhao for assistance with microarray data analysis, Ouathek Ouerfelli of the MSKCC organic synthesis core for synthesizing ORG34517, HuiYong Zhao and Philicia Moonsamy for technical assistance with xenograft experiments, Marina Asher of the MSKCC Pathology Core Facility for assistance with IHC, and Anuradha Gopalan for providing the tissue microarray of primary untreated prostate cancer. The work is funded by CDMRP Physician Research Training Award PC102106, NIH R01CA155169, NIH P50CA09262, U01 CA141502, and the Howard Hughes Medical Institute. The human tissue acquisition study at MDACC was given financial support from Medivation. V.K.A. is funded by a Young Investigator Award from the Prostate Cancer Foundation. C.L.S. and J.W. are coinventors of enzalutamide and ARN-509 and may be entitled to royalties.	Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Clegg NJ, 2012, CANCER RES, V72, P1494, DOI 10.1158/0008-5472.CAN-11-3948; DAVIES P, 1990, J MOL ENDOCRINOL, V5, P117, DOI 10.1677/jme.0.0050117; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Efstathiou E, 2012, J CLIN ONCOL, V30, P637, DOI 10.1200/JCO.2010.33.7675; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fleseriu M, 2012, J CLIN ENDOCR METAB, V97, P2039, DOI 10.1210/jc.2011-3350; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph JD, 2013, CANCER DISCOV, V3, DOI 10.1158/2159-8290.CD-13-0226; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Sahu B, 2013, CANCER RES, V73, P1570, DOI 10.1158/0008-5472.CAN-12-2350; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; TANNOCK I, 1989, J CLIN ONCOL, V7, P590, DOI 10.1200/JCO.1989.7.5.590; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Wang JC, 2006, GENE DEV, V20, P689, DOI 10.1101/gad.1400506; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249	29	623	657	4	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1309	1322		10.1016/j.cell.2013.11.012	http://dx.doi.org/10.1016/j.cell.2013.11.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315100	Green Accepted, Bronze			2022-12-24	WOS:000328271100015
J	Burzyn, D; Kuswanto, W; Kolodin, D; Shadrach, JL; Cerletti, M; Jang, Y; Sefik, E; Tan, TG; Wagers, AJ; Benoist, C; Mathis, D				Burzyn, Dalia; Kuswanto, Wilson; Kolodin, Dmitriy; Shadrach, Jennifer L.; Cerletti, Massimiliano; Jang, Young; Sefik, Esen; Tan, Tze Guan; Wagers, Amy J.; Benoist, Christophe; Mathis, Diane			A Special Population of Regulatory T Cells Potentiates Muscle Repair	CELL			English	Article							GROWTH-FACTOR; UNIQUE POPULATION; SYSTEM; DIFFERENTIATION; AMPHIREGULIN; REGENERATION; CYTOKINE; SURVIVAL; SUBSETS; MICE	Long recognized to be potent suppressors of immune responses, Foxp3(+)CD4(+) regulatory T (Treg) cells are being rediscovered as regulators of nonimmunological processes. We describe a phenotypically and functionally distinct population of Treg cells that rapidly accumulated in the acutely injured skeletal muscle of mice, just as invading myeloid-lineage cells switched from a proinflammatory to a proregenerative state. A Treg population of similar phenotype accumulated in muscles of genetically dystrophic mice. Punctual depletion of Treg cells during the repair process prolonged the proinflammatory infiltrate and impaired muscle repair, while treatments that increased or decreased Treg activities diminished or enhanced (respectively) muscle damage in a dystrophy model. Muscle Treg cells expressed the growth factor Amphiregulin, which acted directly on muscle satellite cells in vitro and improved muscle repair in vivo. Thus, Treg cells and their products may provide new therapeutic opportunities for wound repair and muscular dystrophies.	[Burzyn, Dalia; Kuswanto, Wilson; Kolodin, Dmitriy; Sefik, Esen; Tan, Tze Guan; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Shadrach, Jennifer L.; Cerletti, Massimiliano; Jang, Young; Wagers, Amy J.] Harvard Univ, Cambridge, MA 02138 USA; [Shadrach, Jennifer L.; Wagers, Amy J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute	Mathis, D (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	cbdm@hms.harvard.edu		Sefik, Esen/0000-0002-6807-3498	NIH [R37AI051530, RO1DK092541, R01AG033053, UO1HL100402]; Kaneb Fellowship; NSF fellowship; Boehringer Ingelheim Fonds Fellowship; A*STAR Graduate Scholarship (Singapore); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092541, P30DK036836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033053] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kaneb Fellowship; NSF fellowship(National Science Foundation (NSF)); Boehringer Ingelheim Fonds Fellowship(Boehringer Ingelheim); A*STAR Graduate Scholarship (Singapore)(Agency for Science Technology & Research (A*STAR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Florence, K. Rothamel, N. Asinovski, A. Ortiz-Lopez, D. Jepson, K. Hattori, J. Ericson, S. Davis, H. Paik, R. Cruse, J. LaVecchio, and G. Buruzula for experimental support. Cell sorting was performed at the HSCI/DRC Flow Core (NIH P30DK036836). This work benefited from public data generated by the Immunological Genome Project (http://www.immgen.org) and was funded by NIH grants R37AI051530 and RO1DK092541 (to C.B. and D.M.) and R01AG033053 and UO1HL100402 (to A.J.W.). A.J.W. is an Early Career Scientist at the Howard Hughes Institute. D.B. was supported by a Kaneb Fellowship, D.K. by an NSF fellowship, E.S. by a Boehringer Ingelheim Fonds Fellowship, and T.G.T. by an A*STAR Graduate Scholarship (Singapore).	Andrechek ER, 2002, MOL CELL BIOL, V22, P4714, DOI 10.1128/MCB.22.13.4714-4722.2002; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Bosurgi L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00062; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cipolletta D, 2011, SEMIN IMMUNOL, V23, P431, DOI 10.1016/j.smim.2011.06.002; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; Golding JP, 2007, EXP CELL RES, V313, P341, DOI 10.1016/j.yexcr.2006.10.019; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Horikawa M, 1999, FEBS LETT, V459, P100, DOI 10.1016/S0014-5793(99)01213-2; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Layland J, 2005, FASEB J, V19, P1137, DOI 10.1096/fj.04-2519fje; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shao JY, 2010, ENDOCRINOLOGY, V151, P3728, DOI 10.1210/en.2010-0319; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Tabebordbar M, 2013, ANNU REV PATHOL-MECH, V8, P441, DOI 10.1146/annurev-pathol-011811-132450; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	30	701	715	4	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1282	1295		10.1016/j.cell.2013.10.054	http://dx.doi.org/10.1016/j.cell.2013.10.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315098	Green Accepted, Bronze			2022-12-24	WOS:000328271100013
J	Sharon, I; Banfield, JF				Sharon, Itai; Banfield, Jillian F.			Genomes from Metagenomics	SCIENCE			English	Editorial Material							METABOLISM; BACTERIA		[Sharon, Itai; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sharon, I (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu	Sharon, Itai/M-4472-2019	Sharon, Itai/0000-0003-0705-2316; Banfield, Jill/0000-0001-8203-8771				Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Castelle CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3120; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kantor RS, 2013, MBIO, V4, DOI 10.1128/mBio.00708-13; Mardis E, 2002, GENOME RES, V12, P669, DOI 10.1101/gr.032102; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Swan BK, 2013, P NATL ACAD SCI USA, V110, P11463, DOI 10.1073/pnas.1304246110; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041	15	98	105	5	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1057	1058		10.1126/science.1247023	http://dx.doi.org/10.1126/science.1247023			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288324				2022-12-24	WOS:000327518600046
J	Blomberg, R; Kries, H; Pinkas, DM; Mittl, PRE; Grutter, MG; Privett, HK; Mayo, SL; Hilvert, D				Blomberg, Rebecca; Kries, Hajo; Pinkas, Daniel M.; Mittl, Peer R. E.; Gruetter, Markus G.; Privett, Heidi K.; Mayo, Stephen L.; Hilvert, Donald			Precision is essential for efficient catalysis in an evolved Kemp eliminase	NATURE			English	Article							TRIOSEPHOSPHATE ISOMERASE; ENZYME CATALYSIS; TRANSITION-STATE; BASE CATALYSIS; ANTIBODY; DESIGN; ORIENTATION; SPECIFICITY; MUTAGENESIS; EVOLUTION	Linus Pauling established the conceptual framework for understanding and mimicking enzymes more than six decades ago(1). The notion that enzymes selectively stabilize the rate-limiting transition state of the catalysed reaction relative to the bound ground state reduces the problem of design to one of molecular recognition. Nevertheless, past attempts to capitalize on this idea, for example by using transition state analogues to elicit antibodies with catalytic activities(2), have generally failed to deliver true enzymatic rates. The advent of computational design approaches, combined with directed evolution, has provided an opportunity to revisit this problem. Starting from a computationally designed catalyst for the Kemp elimination(3)-a well-studied model system for proton transfer from carbon-we show that an artificial enzyme can be evolved that accelerates an elementary chemical reaction 6 x 10(8)-fold, approaching the exceptional efficiency of highly optimized natural enzymes such as triosephosphate isomerase. A 1.09 angstrom resolution crystal structure of the evolved enzyme indicates that familiar catalytic strategies such as shape complementarity and precisely placed catalytic groups can be successfully harnessed to afford such high rate accelerations, making us optimistic about the prospects of designing more sophisticated catalysts.	[Blomberg, Rebecca; Kries, Hajo; Pinkas, Daniel M.; Hilvert, Donald] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland; [Mittl, Peer R. E.; Gruetter, Markus G.] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Privett, Heidi K.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Mayo, Stephen L.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; California Institute of Technology; California Institute of Technology	Hilvert, D (corresponding author), ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland.	hilvert@org.chem.ethz.ch	Pinkas, Daniel/AAE-3210-2020; Mittl, Peer/E-5352-2017	Pinkas, Daniel/0000-0002-4740-6695; Kries, Hajo/0000-0002-4919-2811	Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF; ETH Zurich; Defense Advanced Research Projects Agency (DARPA); Fonds des Verbandes der chemischen Industrie; Stipendienfonds der Schweizer Chemischen Industrie; Studienstiftung des deutschen Volkes; National Security Science and Engineering Faculty Fellowship	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF; ETH Zurich(ETH Zurich); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Fonds des Verbandes der chemischen Industrie; Stipendienfonds der Schweizer Chemischen Industrie; Studienstiftung des deutschen Volkes; National Security Science and Engineering Faculty Fellowship	The authors are grateful to A. Aires-Trapote and C. Mayer for experimental assistance. We also thank C. Stutz and B. Blattmann for help in protein crystallization, and the beamline staff at the Swiss Light Source for support during data collection. This work was supported by the Swiss National Science Foundation (SNSF), the National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF, the ETH Zurich, and the Defense Advanced Research Projects Agency (DARPA). Fellowships from the Fonds des Verbandes der chemischen Industrie (to R.B.), the Stipendienfonds der Schweizer Chemischen Industrie (to H.K.), the Studienstiftung des deutschen Volkes (to R.B. and H.K.), and the National Security Science and Engineering Faculty Fellowship (to S.L.M.) are gratefully acknowledged.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Allen BD, 2010, P NATL ACAD SCI USA, V107, P19838, DOI 10.1073/pnas.1012985107; BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013; BRYAN P, 1986, P NATL ACAD SCI USA, V83, P3743, DOI 10.1073/pnas.83.11.3743; CASEY ML, 1973, J ORG CHEM, V38, P2294, DOI 10.1021/jo00953a006; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Debler EW, 2005, P NATL ACAD SCI USA, V102, P4984, DOI 10.1073/pnas.0409207102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frushicheva MP, 2010, P NATL ACAD SCI USA, V107, P16869, DOI 10.1073/pnas.1010381107; Gamper M, 2000, BIOCHEMISTRY-US, V39, P14087, DOI 10.1021/bi0016570; GANDOUR RD, 1981, BIOORG CHEM, V10, P169, DOI 10.1016/0045-2068(81)90020-1; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Hu YF, 2004, J AM CHEM SOC, V126, P8197, DOI 10.1021/ja0490727; Iranpoor N, 2006, TETRAHEDRON LETT, V47, P8247, DOI 10.1016/j.tetlet.2006.09.120; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khersonsky O, 2012, P NATL ACAD SCI USA, V109, P10358, DOI 10.1073/pnas.1121063109; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kikuchi K, 2006, BIOORGAN MED CHEM, V14, P6189, DOI 10.1016/j.bmc.2006.05.071; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; Kiss G, 2010, PROTEIN SCI, V19, P1760, DOI 10.1002/pro.462; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Korendovych IV, 2011, P NATL ACAD SCI USA, V108, P6823, DOI 10.1073/pnas.1018191108; Kries H, 2013, CURR OPIN CHEM BIOL, V17, P221, DOI 10.1016/j.cbpa.2013.02.012; Lassila JK, 2006, P NATL ACAD SCI USA, V103, P16710, DOI 10.1073/pnas.0607691103; Leung DW, 1989, TECHNIQUE, V1, P11; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; Na J, 1996, J AM CHEM SOC, V118, P6462, DOI 10.1021/ja953550j; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; PUTMAN SJ, 1972, BIOCHEM J, V129, P301, DOI 10.1042/bj1290301; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Richard JP, 2012, BIOCHEMISTRY-US, V51, P2652, DOI 10.1021/bi300195b; RICHARD JP, 1984, J AM CHEM SOC, V106, P4926, DOI 10.1021/ja00329a050; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; THORN SN, 1995, NATURE, V373, P228, DOI 10.1038/373228a0; Voigt CA, 2000, J MOL BIOL, V299, P789, DOI 10.1006/jmbi.2000.3758; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Wierenga RK, 2010, CELL MOL LIFE SCI, V67, P3961, DOI 10.1007/s00018-010-0473-9; WOLFENDEN R, 1974, MOL CELL BIOCHEM, V3, P207, DOI 10.1007/BF01686645	47	206	212	1	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					418	+		10.1038/nature12623	http://dx.doi.org/10.1038/nature12623			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24132235				2022-12-24	WOS:000327163200046
J	Miura, SK; Martins, A; Zhang, KX; Graveley, BR; Zipursky, SL				Miura, Satoru K.; Martins, Andre; Zhang, Kelvin X.; Graveley, Brenton R.; Zipursky, S. Lawrence			Probabilistic Splicing of Dscam1 Establishes Identity at the Level of Single Neurons	CELL			English	Article							DROSOPHILA SENSORY NEURONS; DENDRITIC SELF-AVOIDANCE; AXON GUIDANCE; EXPRESSION; BINDING; PROTOCADHERINS; RECOGNITION; SPECIFICITY; DIVERSITY; REPULSION	The Drosophila Dscam1 gene encodes a vast number of cell recognition molecules through alternative splicing. These exhibit isoform-specific homophilic binding and regulate self-avoidance, the tendency of neurites from the same cell to repel one another. Genetic experiments indicate that different cells must express different isoforms. How this is achieved is unknown, as expression of alternative exons in vivo has not been shown. Here, we modified the endogenous Dscam1 locus to generate splicing reporters for all variants of exon 4. We demonstrate that splicing does not occur in a cell-type-specific fashion, that cells sharing the same anatomical location in different individuals express different exon 4 variants, and that the splicing pattern in a given neuron can change over time. We conclude that splicing is probabilistic. This is compatible with a widespread role in neural circuit assembly through self-avoidance and is incompatible with models in which specific isoforms of Dscam1 mediate homophilic recognition between processes of different cells.	[Miura, Satoru K.; Martins, Andre; Zhang, Kelvin X.; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Martins, Andre] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, P-4099003 Oporto, Portugal; [Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Inst Syst Genom, Dept Genet & Dev Biol, Farmington, CT 06030 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidade do Porto; University of Connecticut	Miura, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu	Graveley, Brenton R/C-3108-2013; Miura, Satoru/GZH-1685-2022	Miura, Satoru/0000-0002-6698-9435; Graveley, Brenton/0000-0001-5777-5892; Zipursky, Stephen/0000-0001-5630-7181	Nakajima Foundation; Canadian Institutes of Health Research (CIHR) Fellowship; University of California-Los Angeles Computational Bioscience Initiative Fellowship; National Institutes of Health [5R01GM067842, 5R01DC006485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006485] Funding Source: NIH RePORTER	Nakajima Foundation; Canadian Institutes of Health Research (CIHR) Fellowship(Canadian Institutes of Health Research (CIHR)); University of California-Los Angeles Computational Bioscience Initiative Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Yasushi Hiromi, Yuh Nung Jan, Aljoscha Nern, Barret Pfeiffer, and Gerald Rubin for reagents, members of our laboratory for discussion, and Edward De Robertis, Wesley Grueber, Daisuke Hattori, Kelsey Martin, and Alex Plocik for their comments on the manuscript. We also thank Orkun Akin and Josh Trachtenberg for their help with the 2-photon microscope, Jinfei Ni for his early work in generating the reporter constructs, Wei Wu for her initial assistance in assessment of the transgenic flies, and GenetiVision and Genetic Services for their injection services. This work was supported by a fellowship from the Nakajima Foundation to S.K.M., Canadian Institutes of Health Research (CIHR) Fellowship and University of California-Los Angeles Computational Bioscience Initiative Fellowship to K.X.Z., and National Institutes of Health grants to B.R.G (5R01GM067842) and S.L.Z (5R01DC006485). S.L.Z. is an investigator of Howard Hughes Medical Institute.	Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Forbes EM, 2011, NEURAL COMPUT, V23, P2746, DOI 10.1162/NECO_a_00186; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Han C, 2012, NEURON, V73, P64, DOI 10.1016/j.neuron.2011.10.036; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Kaneko R, 2006, J BIOL CHEM, V281, P30551, DOI 10.1074/jbc.M605677200; KRAMER AP, 1985, J NEUROSCI, V5, P768; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Millard SS, 2010, NEURON, V67, P761, DOI 10.1016/j.neuron.2010.08.030; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Wu W, 2012, NEURON, V74, P261, DOI 10.1016/j.neuron.2012.02.029; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zipursky SL, 2013, ANNU REV NEUROSCI, V36, P547, DOI 10.1146/annurev-neuro-062111-150414; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	29	65	65	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1166	1177		10.1016/j.cell.2013.10.018	http://dx.doi.org/10.1016/j.cell.2013.10.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267895	Bronze, Green Accepted			2022-12-24	WOS:000327500600019
J	Han, JH; Zhang, H; Zhang, HL; Wang, ZQ; Zhou, H; Zhang, ZG				Han, Junhong; Zhang, Hui; Zhang, Honglian; Wang, Zhiquan; Zhou, Hui; Zhang, Zhiguo			A Cul4 E3 Ubiquitin Ligase Regulates Histone Hand-Off during Nucleosome Assembly	CELL			English	Article							DNA-REPLICATION; PROTEIN COMPLEXES; STRUCTURAL BASIS; H3 METHYLATION; UBIQUITYLATION; ACETYLATION; CRL4(CDT2); ASF1; LYSINE-56; PCNA	Nucleosome assembly following DNA replication and gene transcription is important to maintain genome stability and epigenetic information. Newly synthesized histones H3-H4 first bind histone chaperone Asf1 and are then transferred to other chaperones for nucleosome assembly. However, it is unknown how H3-H4 is transferred from the Asf1-H3-H4 complex to other chaperones because Asf1 binds H3-H4 with high affinity. Here, we show that yeast Rtt101(Mms1) E3 ubiquitin ligase preferentially binds and ubiquitylates new histone H3 acetylated at lysine 56. Inactivation of Rtt101 or mutating H3 lysine residues ubiquitylated by the Rtt101(Mms1) ligase impairs nucleosome assembly and promotes Asf1-H3 interactions. Similar phenotypes occur in human cells in which the ortholog of Rtt101(Mms1), Cul4A(DDB1), is depleted. These results indicate that the transfer of H3-H4 from the Asf1-H3-H4 complex to other histone chaperones is regulated by a conserved E3 ligase and provide evidence for crosstalk between histone acetylation and ubiquitylation in nucleosome assembly.	[Han, Junhong; Zhang, Hui; Zhang, Honglian; Wang, Zhiquan; Zhou, Hui; Zhang, Zhiguo] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Zhang, ZG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu	Wang, Zhiquan/X-9242-2018; wang, jian/AAG-7378-2019	Wang, Zhiquan/0000-0002-8243-7251; Han, Junhong/0000-0002-3371-8698	NIH [GM72719, GM81838]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072719, R01GM081838] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Burgess, Lou, Katzmann, van Deursen, Ekker, and Wu and Mr. Dahlin for critical reading of this manuscript. We thank Dr. Kamura for plasmids and Dr. Verreault for a yeast histone purification protocol. This work is supported by NIH grants (GM72719 and GM81838).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Corpet A, 2011, EMBO J, V30, P480, DOI 10.1038/emboj.2010.335; Donham DC, 2011, NUCLEIC ACIDS RES, V39, P5449, DOI 10.1093/nar/gkr097; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Han JH, 2010, GENE DEV, V24, P1485, DOI 10.1101/gad.1887310; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Nakagawa T, 2011, MOL CELL, V43, P381, DOI 10.1016/j.molcel.2011.05.033; Nakano S, 2011, CELL, V147, P1525, DOI 10.1016/j.cell.2011.11.053; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Silva AC, 2012, J BIOL CHEM, V287, P1709, DOI 10.1074/jbc.M111.316489; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Winkler DD, 2012, NUCLEIC ACIDS RES, V40, P10139, DOI 10.1093/nar/gks812; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	52	96	104	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					817	829		10.1016/j.cell.2013.10.014	http://dx.doi.org/10.1016/j.cell.2013.10.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209620	Green Accepted, Bronze			2022-12-24	WOS:000326934300012
J	Mesmin, B; Bigay, J; von Filseck, JM; Lacas-Gervais, S; Drin, G; Antonny, B				Mesmin, Bruno; Bigay, Joelle; von Filseck, Joachim Moser; Lacas-Gervais, Sandra; Drin, Guillaume; Antonny, Bruno			A Four-Step Cycle Driven by PI(4)P Hydrolysis Directs Sterol/PI(4)P Exchange by the ER-Golgi Tether OSBP	CELL			English	Article							OXYSTEROL-BINDING-PROTEIN; MEMBRANE CONTACT SITES; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; LIPID-TRANSFER; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; NONVESICULAR TRAFFICKING; STRUCTURAL BASIS; FFAT MOTIF; TRANSPORT	Several proteins at endoplasmic reticulum (ER)-Golgi membrane contact sites contain a PH domain that interacts with the Golgi phosphoinositide PI(4) P, a FFAT motif that interacts with the ER protein VAP-A, and a lipid transfer domain. This architecture suggests the ability to both tether organelles and transport lipids between them. We show that in oxysterol binding protein (OSBP) these two activities are coupled by a four-step cycle. Membrane tethering by the PH domain and the FFAT motif enables sterol transfer by the lipid transfer domain (ORD), followed by back transfer of PI(4) P by the ORD. Finally, PI(4) P is hydrolyzed in cis by the ER protein Sac1. The energy provided by PI(4) P hydrolysis drives sterol transfer and allows negative feedback when PI(4) P becomes limiting. Other lipid transfer proteins are tethered by the same mechanism. Thus, OSBP-mediated back transfer of PI(4) P might coordinate the transfer of other lipid species at the ER-Golgi interface.	[Mesmin, Bruno; Bigay, Joelle; von Filseck, Joachim Moser; Drin, Guillaume; Antonny, Bruno] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Mesmin, Bruno; Bigay, Joelle; von Filseck, Joachim Moser; Drin, Guillaume; Antonny, Bruno] CNRS, F-06560 Valbonne, France; [Lacas-Gervais, Sandra] Univ Nice Sophia Antipolis, Ctr Commun Microscopie Appl, F-06000 Nice, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Antonny, B (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France.	antonny@ipmc.cnrs.fr	Antonny, Bruno/ABH-7434-2020; Mesmin, Bruno/N-9246-2017	Antonny, Bruno/0000-0002-9166-8668; DRIN, Guillaume/0000-0002-3484-4581; Moser von Filseck, Joachim/0000-0001-9118-2986; Mesmin, Bruno/0000-0002-5437-3246; Joelle, BIGAY/0000-0002-7487-3416	CNRS; Agence Nationale de la Recherche [ANR-10-JCJC-1503-01, ANR-11-LABX-0028-01]; ERC [268888]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission)	We thank Celine Thonont, Frederic Brau, Julie Cazareth, and Nathalie Leroudier for technical assistance; Fabien Alpy, Scott Emr, and Franck Perez for reagents; Alenka Copic for comments on the manuscript; and all members of the laboratory for discussions. This work is supported by the CNRS, the Agence Nationale de la Recherche ("jeune chercheur" ANR-10-JCJC-1503-01 and "Investments for the Future" ANR-11-LABX-0028-01), and by an ERC advanced grant (268888).	Arita M, 2013, J VIROL, V87, P4252, DOI 10.1128/JVI.03546-12; Beh CT, 2012, J BIOL CHEM, V287, P11481, DOI 10.1074/jbc.R111.338400; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Furuita K, 2010, J BIOL CHEM, V285, P12961, DOI 10.1074/jbc.M109.082602; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kim YJ, 2013, TRENDS CELL BIOL, V23, P270, DOI 10.1016/j.tcb.2013.01.009; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Mesmin B, 2013, CELL MOL LIFE SCI, V70, P3405, DOI 10.1007/s00018-012-1247-3; Mikitova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030455; Mousley CJ, 2012, CELL, V148, P702, DOI 10.1016/j.cell.2011.12.026; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039	39	452	461	3	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					830	843		10.1016/j.cell.2013.09.056	http://dx.doi.org/10.1016/j.cell.2013.09.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209621	Bronze			2022-12-24	WOS:000326934300013
J	McConnell, MJ; Lindberg, MR; Brennand, KJ; Piper, JC; Voet, T; Cowing-Zitron, C; Shumilina, S; Lasken, RS; Vermeesch, JR; Hall, IM; Gage, FH				McConnell, Michael J.; Lindberg, Michael R.; Brennand, Kristen J.; Piper, Julia C.; Voet, Thierry; Cowing-Zitron, Chris; Shumilina, Svetlana; Lasken, Roger S.; Vermeesch, Joris R.; Hall, Ira M.; Gage, Fred H.			Mosaic Copy Number Variation in Human Neurons	SCIENCE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; PLURIPOTENT STEM-CELLS; L1 RETROTRANSPOSITION; HUMAN BRAIN; SOMATIC MOSAICISM; HUMAN TISSUES; DNA; ANEUPLOIDY; INSTABILITY; DELETION	We used single-cell genomic approaches to map DNA copy number variation (CNV) in neurons obtained from human induced pluripotent stem cell (hiPSC) lines and postmortem human brains. We identified aneuploid neurons, as well as numerous subchromosomal CNVs in euploid neurons. Neurotypic hiPSC-derived neurons had larger CNVs than fibroblasts, and several large deletions were found in hiPSC-derived neurons but not in matched neural progenitor cells. Single-cell sequencing of endogenous human frontal cortex neurons revealed that 13 to 41% of neurons have at least one megabase-scale de novo CNV, that deletions are twice as common as duplications, and that a subset of neurons have highly aberrant genomes marked by multiple alterations. Our results show that mosaic CNV is abundant in human neurons.	[McConnell, Michael J.; Brennand, Kristen J.; Piper, Julia C.; Cowing-Zitron, Chris; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [McConnell, Michael J.; Piper, Julia C.] Salk Inst Biol Studies, Crick Jacobs Ctr Theoret & Computat Biol, La Jolla, CA 92037 USA; [Voet, Thierry; Vermeesch, Joris R.] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Voet, Thierry] Wellcome Trust Sanger Inst, Single Cell Genom Ctr, Cambridge CB10 1SA, England; [Lasken, Roger S.] J Craig Venter Inst, San Diego, CA 92121 USA; [Lasken, Roger S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [McConnell, Michael J.; Lindberg, Michael R.; Shumilina, Svetlana; Hall, Ira M.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [McConnell, Michael J.] Univ Virginia, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA; [McConnell, Michael J.; Hall, Ira M.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA	Salk Institute; Salk Institute; KU Leuven; Wellcome Trust Sanger Institute; J. Craig Venter Institute; University of California System; University of California San Diego; University of Virginia; University of Virginia; University of Virginia	Hall, IM (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	irahall@virginia.edu; gage@salk.edu	Brennand, Kristen J/J-8704-2012; Voet, Thierry/E-8877-2017; Brennand, Kristen J/U-5470-2019	Brennand, Kristen J/0000-0003-0993-5956; Voet, Thierry/0000-0003-1204-9963; Vermeesch, Joris/0000-0002-3071-1191; Lindberg, Michael/0000-0002-7393-8214	Center for Academic Research and Training in Anthropogeny (CARTA); Crick-Jacobs Junior Fellowship; University of Leuven (KU Leuven) SymBioSys grant [PFV/10/016]; Mather's Family Foundation; NIH [R01 MH095741, DP20D006493-01]; J.P.B. Foundation; Annette Merle-Smith; Helmsley Foundation; Burroughs Wellcome Fund; National Institute for Child Health and Human Development (NIH) Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD [HHSN2752009000011C, N01-HD-9-011]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095741] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006493] Funding Source: NIH RePORTER	Center for Academic Research and Training in Anthropogeny (CARTA); Crick-Jacobs Junior Fellowship; University of Leuven (KU Leuven) SymBioSys grant; Mather's Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J.P.B. Foundation; Annette Merle-Smith; Helmsley Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute for Child Health and Human Development (NIH) Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Husband (Salk), L. Moore (Salk), S. Jackmaert (KU Leuven), R. Layer (University of Virginia) and R. Clark (University of Virginia) for technical assistance; A. Prorock and Y. Bao (UVA Sequencing Core) for DNA sequencing; and all members of the Gage laboratory for critical feedback on the project. We thank M. L. Gage for editorial comments. F. H. G. thanks the Center for Academic Research and Training in Anthropogeny (CARTA) for support and perspective. This work was supported by a Crick-Jacobs Junior Fellowship to M.J.M.; a University of Leuven (KU Leuven) SymBioSys grant (PFV/10/016) to J.R.V. and T. V.; a Mather's Family Foundation grant, a NIH TR01 (R01 MH095741), the J.P.B. Foundation, Annette Merle-Smith, and a Helmsley Foundation grant to F. H. G.; and an NIH New Innovator Award (DP20D006493-01) and Burroughs Wellcome Fund Career Award to I. M. H. Human tissue was obtained from the National Institute for Child Health and Human Development (NIH) Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD, contract HHSN2752009000011C, ref. no. N01-HD-9-011. The hiPSC lines used in this study are available from the Coriell Cell Repository. Microarray data have been deposited in the National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GSE51538), and DNA sequence data have been deposited in the NCBI Short-Read Archive (SRP030642).	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Bushman DM, 2013, SEMIN CELL DEV BIOL, V24, P357, DOI 10.1016/j.semcdb.2013.02.003; Callinan PA, 2005, J MOL BIOL, V348, P791, DOI 10.1016/j.jmb.2005.02.043; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lasken RS, 2009, BIOCHEM SOC T, V37, P450, DOI 10.1042/BST0370450; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Maeda T, 2004, BIOCHEM BIOPH RES CO, V319, P1117, DOI 10.1016/j.bbrc.2004.05.093; Martin SL, 2009, NATURE, V460, P1087, DOI 10.1038/4601087a; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ostertag EM, 2005, NATURE, V435, P890, DOI 10.1038/435890a; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Shibata Y, 2012, SCIENCE, V336, P82, DOI 10.1126/science.1213307; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558	33	379	388	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					632	637		10.1126/science.1243472	http://dx.doi.org/10.1126/science.1243472			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179226	Green Accepted			2022-12-24	WOS:000326334300052
J	Wapinski, OL; Vierbuchen, T; Qu, K; Lee, QY; Chanda, S; Fuentes, DR; Giresi, PG; Ng, YH; Marro, S; Neff, NF; Drechsel, D; Martynoga, B; Castro, DS; Webb, AE; Sudhof, TC; Brunet, A; Guillemot, F; Chang, HY; Wernig, M				Wapinski, Orly L.; Vierbuchen, Thomas; Qu, Kun; Lee, Qian Yi; Chanda, Soham; Fuentes, Daniel R.; Giresi, Paul G.; Ng, Yi Han; Marro, Samuele; Neff, Norma F.; Drechsel, Daniela; Martynoga, Ben; Castro, Diogo S.; Webb, Ashley E.; Suedhof, Thomas C.; Brunet, Anne; Guillemot, Francois; Chang, Howard Y.; Wernig, Marius			Hierarchical Mechanisms for Direct Reprogramming of Fibroblasts to Neurons	CELL			English	Article							ACHAETE-SCUTE HOMOLOG-1; FUNCTIONAL-NEURONS; TRANSCRIPTIONAL ACTIVATION; DEFINED FACTORS; STEM-CELLS; CONVERSION; CHROMATIN; DEMETHYLASES; FINGER; GENOME	Direct lineage reprogramming is a promising approach for human disease modeling and regenerative medicine, with poorly understood mechanisms. Here, we reveal a hierarchical mechanism in the direct conversion of fibroblasts into induced neuronal (iN) cells mediated by the transcription factors Ascl1, Brn2, and Myt1l. Ascl1 acts as an "on-target" pioneer factor by immediately occupying most cognate genomic sites in fibroblasts. In contrast, Brn2 and Myt1l do not access fibroblast chromatin productively on their own; instead, Ascl1 recruits Brn2 to Ascl1 sites genome wide. A unique trivalent chromatin signature in the host cells predicts the permissiveness for Ascl1 pioneering activity among different cell types. Finally, we identified Zfp238 as a key Ascl1 target gene that can partially substitute for Ascl1 during iN cell reprogramming. Thus, a precise match between pioneer factors and the chromatin context at key target genes is determinative for transdifferentiation to neurons and likely other cell types.	[Wapinski, Orly L.; Qu, Kun; Giresi, Paul G.; Suedhof, Thomas C.; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Wapinski, Orly L.; Qu, Kun; Giresi, Paul G.; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Wapinski, Orly L.; Vierbuchen, Thomas; Fuentes, Daniel R.; Brunet, Anne; Chang, Howard Y.; Wernig, Marius] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Vierbuchen, Thomas; Lee, Qian Yi; Chanda, Soham; Fuentes, Daniel R.; Ng, Yi Han; Marro, Samuele; Wernig, Marius] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Vierbuchen, Thomas; Lee, Qian Yi; Chanda, Soham; Fuentes, Daniel R.; Ng, Yi Han; Marro, Samuele; Wernig, Marius] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Lee, Qian Yi; Neff, Norma F.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ng, Yi Han] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Webb, Ashley E.; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Drechsel, Daniela; Martynoga, Ben; Guillemot, Francois] Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England; [Castro, Diogo S.] Inst Gulbenkian Ciencias, Div Mol Neurobiol, P-2780156 Oeiras, Portugal	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; MRC National Institute for Medical Research; Instituto Gulbenkian de Ciencia	Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu; wernig@stanford.edu	Guillemot, Francois/AAV-1482-2021; Marro, Samuele G./I-4493-2014; Castro, Diogo S/I-6217-2016; Qu, Kun/G-3359-2012	Marro, Samuele G./0000-0002-9326-6945; Castro, Diogo S/0000-0001-8178-9565; Chanda, Soham/0000-0002-2327-6224; Vierbuchen, Thomas/0000-0002-5690-5680; Lee, Qian Yi/0000-0001-9200-0910; Fuentes, Daniel/0000-0002-0412-6933	National Institutes of Health [RC4NS073015]; National Science Foundation; California Institute for Regenerative Medicine predoctoral fellowship; Agency of Science, Technology, and Research of Singapore; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); California Institute for Regenerative Medicine predoctoral fellowship; Agency of Science, Technology, and Research of Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. C. Tsai, M. Kareta, and P. Lovelace for their invaluable initial help with sequencing protocols, cell culture, and cell sorting. We thank other members of the Chang and Wernig labs for their discussions and support. This work was supported by the National Institutes of Health (RC4NS073015) (to M. W. and H. Y. C.), the National Science Foundation (to O. L. W.), and a California Institute for Regenerative Medicine predoctoral fellowship (to T. V.). Q. Y. L. and Y. H. N. are supported by the Agency of Science, Technology, and Research of Singapore. T. C. S. is a Howard Hughes Medical Institute Investigator. H. Y. C. is an Early Career Scientist of the Howard Hughes Medical Institute. M. W. is a New York Stem Cell Foundation-Robertson Investigator.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Castro DS, 2011, CELL CYCLE, V10, P4026, DOI 10.4161/cc.10.23.18578; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dominguez MH, 2013, CEREB CORTEX, V23, P2632, DOI 10.1093/cercor/bhs252; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fong AP, 2012, DEV CELL, V22, P721, DOI 10.1016/j.devcel.2012.01.015; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; KIM JG, 1992, MOL CELL BIOL, V12, P5632, DOI 10.1128/MCB.12.12.5632; Krishnan S, 2013, STRUCTURE, V21, P98, DOI 10.1016/j.str.2012.10.018; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Vierbuchen T, 2012, MOL CELL, V47, P827, DOI 10.1016/j.molcel.2012.09.008; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weiner JA, 1997, J COMP NEUROL, V381, P130, DOI 10.1002/(SICI)1096-9861(19970505)381:2<130::AID-CNE2>3.0.CO;2-4; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	40	377	388	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					621	635		10.1016/j.cell.2013.09.028	http://dx.doi.org/10.1016/j.cell.2013.09.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243019	Green Accepted, Bronze			2022-12-24	WOS:000326571800016
J	Munoz-Espin, D; Canamero, M; Maraver, A; Gomez-Lopez, G; Contreras, J; Murillo-Cuesta, S; Rodriguez-Baeza, A; Varela-Nieto, I; Ruberte, J; Collado, M; Serrano, M				Munoz-Espin, Daniel; Canamero, Marta; Maraver, Antonio; Gomez-Lopez, Gonzalo; Contreras, Julio; Murillo-Cuesta, Silvia; Rodriguez-Baeza, Alfonso; Varela-Nieto, Isabel; Ruberte, Jesus; Collado, Manuel; Serrano, Manuel			Programmed Cell Senescence during Mammalian Embryonic Development	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; REPLICATIVE SENESCENCE; ENDOLYMPHATIC DUCT; CANCER DEVELOPMENT; ANIMAL DEVELOPMENT; TUMOR SUPPRESSION; TGF-BETA; DEATH; MICE; P53	Cellular senescence disables proliferation in damaged cells, and it is relevant for cancer and aging. Here, we show that senescence occurs during mammalian embryonic development at multiple locations, including the mesonephros and the endolymphatic sac of the inner ear, which we have analyzed in detail. Mechanistically, senescence in both structures is strictly dependent on p21, but independent of DNA damage, p53, or other cell-cycle inhibitors, and it is regulated by the TGF-beta/SMAD and PI3K/FOXO pathways. Developmentally programmed senescence is followed by macrophage infiltration, clearance of senescent cells, and tissue remodeling. Loss of senescence due to the absence of p21 is partially compensated by apoptosis but still results in detectable developmental abnormalities. Importantly, the mesonephros and endolymphatic sac of human embryos also show evidence of senescence. We conclude that the role of developmentally programmed senescence is to promote tissue remodeling and propose that this is the evolutionary origin of damage-induced senescence.	[Munoz-Espin, Daniel; Maraver, Antonio; Collado, Manuel; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain; [Canamero, Marta] Spanish Natl Canc Res Ctr CNIO, Histopathol Unit, E-28029 Madrid, Spain; [Gomez-Lopez, Gonzalo] Spanish Natl Canc Res Ctr CNIO, Bioinformat Unit, E-28029 Madrid, Spain; [Contreras, Julio] Univ Complutense Madrid, Sch Vet Med, Dept Anat, E-28040 Madrid, Spain; [Contreras, Julio; Murillo-Cuesta, Silvia; Varela-Nieto, Isabel] CSIC UAM, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain; [Contreras, Julio; Murillo-Cuesta, Silvia; Varela-Nieto, Isabel] Ctr Biomed Network Res Rare Dis CIBERER, E-46010 Valencia, Spain; [Rodriguez-Baeza, Alfonso] Univ Autonoma Barcelona, Fac Med, Dept Ciencies Morfol, E-08193 Barcelona, Spain; [Ruberte, Jesus] Univ Autonoma Barcelona, Sch Vet Med, Dept Anat & Anim Hlth, Ctr Anim Biotechnol & Gene Therapy CBATEG, E-08193 Barcelona, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Barcelona; University of Barcelona; Autonomous University of Barcelona	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain.	mserrano@cnio.es	Ruberte, Jesus/AAS-9240-2021; Maraver, Antonio/G-2666-2015; Rodriguez, Julio Contreras/AAB-6492-2019; Murillo-Cuesta, Silvia/T-5828-2019; Murillo-Cuesta, Silvia/C-3557-2016; Serrano, Manuel/H-2634-2015; Collado, Manuel/K-8140-2014; Rodríguez-Baeza, Alfonso/L-8284-2014; /AAI-3238-2021; Varela-Nieto, Isabel/G-5289-2015; Gomez-Lopez, Gonzalo/D-9123-2016	Rodriguez, Julio Contreras/0000-0002-2145-4090; Murillo-Cuesta, Silvia/0000-0002-8706-4327; Serrano, Manuel/0000-0001-7177-9312; Collado, Manuel/0000-0002-0330-0880; Rodríguez-Baeza, Alfonso/0000-0002-9181-5613; Varela-Nieto, Isabel/0000-0003-3077-0500; Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Maraver, Antonio/0000-0002-5527-5680; RUBERTE, JESUS/0000-0003-1540-1432	Juan de la Cierva Program; Miguel Servet Program; CNIO; MICINN (SAF); Regional Government of Madrid; European Research Council (Advanced ERC Grant); Botin Foundation; Ramon Areces Foundation; AXA Foundation; MINECO [SAF2011-24391]; Fundacion de Investigacion Medica Mutua Madrilena; AFHELO (European Union)	Juan de la Cierva Program; Miguel Servet Program; CNIO; MICINN (SAF)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid; European Research Council (Advanced ERC Grant)(European Research Council (ERC)); Botin Foundation; Ramon Areces Foundation; AXA Foundation; MINECO(Spanish Government); Fundacion de Investigacion Medica Mutua Madrilena; AFHELO (European Union)	We thank Marcos Malumbres, Oscar Fernandez-Capetillo, Mirna Perez-Moreno, and Donatello Castellano for sharing critical reagents. We also thank for excellent technical support the CNIO Genomics, Animal Facility, Histopathology, Confocal Microscopy, and Molecular Imaging Units. D. M.-E. has been funded by the Juan de la Cierva Program. A. M. and M. Collado were funded by the Miguel Servet Program. S. M.-C. holds a CIBERER (ISCIII) postdoctoral contract. Work in the laboratory of M. S. is funded by the CNIO and by grants from the MICINN (SAF), the Regional Government of Madrid, the European Research Council (Advanced ERC Grant), the Botin Foundation, the Ramon Areces Foundation, and the AXA Foundation. Work in the I.V.-N. group is supported by grants from MINECO (SAF2011-24391), Fundacion de Investigacion Medica Mutua Madrilena (2012), and AFHELO (FP7, European Union).	Abad M, 2007, J BIOL CHEM, V282, P31060, DOI 10.1074/jbc.M701639200; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Camp V, 1996, ANAT EMBRYOL, V194, P341; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Conradt B, 2009, ANNU REV GENET, V43, P493, DOI 10.1146/annurev.genet.42.110807.091533; CUNLIFFEBEAMER TL, 1976, LAB ANIM SCI, V26, P895; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Davidson A.J., 2008, STEMBOOK; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gorgoulis VG, 2010, CURR OPIN CELL BIOL, V22, P816, DOI 10.1016/j.ceb.2010.07.013; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hirota Y, 2011, P NATL ACAD SCI USA, V108, P18073, DOI 10.1073/pnas.1108180108; Hoenicke L, 2012, CARCINOGENESIS, V33, P1123, DOI 10.1093/carcin/bgs124; HULTCRANTZ M, 1987, ACTA OTO-LARYNGOL, V104, P406, DOI 10.3109/00016488709128268; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kim HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017949; Kim YM, 2013, AGING CELL, V12, P622, DOI 10.1111/acel.12087; Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Kurita T, 2010, DIFFERENTIATION, V80, P99, DOI 10.1016/j.diff.2010.06.007; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lafferty-Whyte K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-532; Lezmi S, 2011, VET PATHOL, V48, P964, DOI 10.1177/0300985810391113; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lo WWM, 1997, AM J NEURORADIOL, V18, P881; Nacher V, 2006, J VASC RES, V43, P581, DOI 10.1159/000096076; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Orvis GD, 2007, DEV BIOL, V306, P493, DOI 10.1016/j.ydbio.2007.03.027; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Rovillain E, 2011, ONCOGENE, V30, P2356, DOI 10.1038/onc.2010.611; Sainio K., 2003, KIDNEY, P75; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Vazquez MD, 1998, ANAT HISTOL EMBRYOL, V27, P283, DOI 10.1111/j.1439-0264.1998.tb00194.x; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	51	796	815	6	111	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1104	1118		10.1016/j.cell.2013.10.019	http://dx.doi.org/10.1016/j.cell.2013.10.019			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24238962	Bronze, Green Published			2022-12-24	WOS:000327500600014
J	Wu, XB; Sharp, PA				Wu, Xuebing; Sharp, Phillip A.			Divergent Transcription: A Driving Force for New Gene Origination?	CELL			English	Review							LONG NONCODING RNAS; BIDIRECTIONAL PROMOTERS; HUMAN GENOME; U1 SNRNP; CHROMATIN INTERACTIONS; MUTATIONAL ASYMMETRY; MAMMALIAN GENOMES; ACTIVE PROMOTERS; SUPER-ENHANCERS; MESSENGER-RNAS	The mammalian genome is extensively transcribed, a large fraction of which is divergent transcription from promoters and enhancers that is tightly coupled with active gene transcription. Here, we propose that divergent transcription may shape the evolution of the genome by new gene origination.	[Wu, Xuebing; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Wu, Xuebing] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu	Wu, Xuebing/C-9152-2013	Wu, Xuebing/0000-0003-0369-5269	United States Public Health Service grants from the National Institutes of Health [RO1-GM34277, R01-CA133404]; Koch Institute Support from the National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [R01CA133404, P01CA042063, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085319, R01GM034277] Funding Source: NIH RePORTER	United States Public Health Service grants from the National Institutes of Health; Koch Institute Support from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all the Sharp lab members, especially Andrea Kriz, Anthony Chiu, Albert Almada, Mohini Jangi, and Jesse Zamudio for comments and Christopher Burge, Qifang Liu, Jianrong Wang, and Jeremy Wilusz for critical reading of the manuscript. This work was supported by United States Public Health Service grants RO1-GM34277 and R01-CA133404 from the National Institutes of Health (P.A.S.) and partially by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute. X.W. is a Howard Hughes Medical Institute International Student Research fellow.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Anamika K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038769; Andersen PK, 2012, GENE DEV, V26, P2169, DOI 10.1101/gad.189126.112; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Chen SD, 2013, NAT REV GENET, V14, P645, DOI 10.1038/nrg3521; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Edelman LB, 2012, CURR OPIN GENET DEV, V22, P110, DOI 10.1016/j.gde.2012.01.010; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Ghamari A, 2013, GENE DEV, V27, P767, DOI 10.1101/gad.216200.113; Gotea V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057323; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Janssen JWG, 2000, BLOOD, V95, P2691; Janssen JWG, 2002, INT J CANCER, V102, P608, DOI 10.1002/ijc.10765; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kalitsis P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-498; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kruesi WS, 2013, ELIFE, V2, DOI 10.7554/eLife.00808; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Leyden J, 2006, BRIT J CANCER, V94, P1204, DOI 10.1038/sj.bjc.6603054; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Li YY, 2006, PLOS COMPUT BIOL, V2, P687, DOI 10.1371/journal.pcbi.0020074; Long M., 2013, ANN REV GENET; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Majewski J, 2003, AM J HUM GENET, V73, P688, DOI 10.1086/378134; McVicker G, 2010, GENOME RES, V20, P1503, DOI 10.1101/gr.106666.110; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Moss AC, 2006, BIOCHEM BIOPH RES CO, V345, P216, DOI 10.1016/j.bbrc.2006.04.094; Mugal CF, 2009, MOL BIOL EVOL, V26, P131, DOI 10.1093/molbev/msn245; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Park C, 2012, EMBO REP, V13, P1123, DOI 10.1038/embor.2012.165; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Piontkivska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-189; Polak P, 2008, GENOME RES, V18, P1216, DOI 10.1101/gr.076570.108; Polak P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-187; Preker P, 2011, NUCLEIC ACIDS RES, V39, P7179, DOI 10.1093/nar/gkr370; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tay SK, 2009, P NATL ACAD SCI USA, V106, P12019, DOI 10.1073/pnas.0904569106; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wakano C, 2012, BBA-GENE REGUL MECH, V1819, P688, DOI 10.1016/j.bbagrm.2012.02.006; Wang GZ, 2011, GENOME BIOL EVOL, V3, P320, DOI [10.1093/gbe/evr049, 10.1093/gbe/evr025]; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xie C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002942; Xu Chao, 2012, BMC Syst Biol, V6 Suppl 1, pS21, DOI 10.1186/1752-0509-6-S1-S21; Yang LD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-65	77	115	118	0	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					990	996		10.1016/j.cell.2013.10.048	http://dx.doi.org/10.1016/j.cell.2013.10.048			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267885	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000327500600005
J	Jones, OR; Scheuerlein, A; Salguero-Gomez, R; Camarda, CG; Schaible, R; Casper, BB; Dahlgren, JP; Ehrlen, J; Garcia, MB; Menges, ES; Quintana-Ascencio, PF; Caswell, H; Baudisch, A; Vaupel, JW				Jones, Owen R.; Scheuerlein, Alexander; Salguero-Gomez, Roberto; Camarda, Carlo Giovanni; Schaible, Ralf; Casper, Brenda B.; Dahlgren, Johan P.; Ehrlen, Johan; Garcia, Maria B.; Menges, Eric S.; Quintana-Ascencio, Pedro F.; Caswell, Hal; Baudisch, Annette; Vaupel, James W.			Diversity of ageing across the tree of life	NATURE			English	Article							HISTORY VARIATION; SENESCENCE; MORTALITY; AGE; REPRODUCTION; LONGEVITY; SELECTION; EVOLUTION; MODELS; PLANTS	Evolution drives, and is driven by, demography. A genotype moulds its phenotype's age patterns of mortality and fertility in an environment; these two patterns in turn determine the genotype's fitness in that environment. Hence, to understand the evolution of ageing, age patterns of mortality and reproduction need to be compared for species across the tree of life. However, few studies have done so and only for a limited range of taxa. Here we contrast standardized patterns over age for 11 mammals, 12 other vertebrates, 10 invertebrates, 12 vascular plants and a green alga. Although it has been predicted that evolution should inevitably lead to increasing mortality and declining fertility with age after maturity, there is great variation among these species, including increasing, constant, decreasing, humped and bowed trajectories for both long-and short-lived species. This diversity challenges theoreticians to develop broader perspectives on the evolution of ageing and empiricists to study the demography of more species.	[Jones, Owen R.; Dahlgren, Johan P.; Vaupel, James W.] Max Planck Odense Ctr Biodemog Aging, DK-5230 Odense M, Denmark; [Jones, Owen R.; Dahlgren, Johan P.; Caswell, Hal] Univ Southern Denmark, Dept Biol, DK-5230 Odense M, Denmark; [Scheuerlein, Alexander; Salguero-Gomez, Roberto; Schaible, Ralf; Caswell, Hal; Baudisch, Annette; Vaupel, James W.] Max Planck Inst Demog Res, D-18057 Rostock, Germany; [Salguero-Gomez, Roberto] Univ Queensland, Ctr Biodivers & Conservat Sci, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Camarda, Carlo Giovanni] Inst Natl Etud Demog, F-75980 Paris 20, France; [Casper, Brenda B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Ehrlen, Johan] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Garcia, Maria B.] CSIC, Pyrenean Inst Ecol, Zaragoza 50059, Spain; [Menges, Eric S.] Archbold Biol Stn, Venus, FL 33960 USA; [Quintana-Ascencio, Pedro F.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Caswell, Hal] Woods Hole Oceanog Inst, Biol Dept MS 34, Woods Hole, MA 02543 USA; [Caswell, Hal] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1090 GE Amsterdam, Netherlands; [Vaupel, James W.] Duke Univ, Duke Populat Res Inst, Durham, NC 27705 USA	University of Southern Denmark; Max Planck Society; University of Queensland; University of Pennsylvania; Stockholm University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); State University System of Florida; University of Central Florida; Woods Hole Oceanographic Institution; University of Amsterdam; Duke University	Jones, OR (corresponding author), Max Planck Odense Ctr Biodemog Aging, Campusvej 55, DK-5230 Odense M, Denmark.	jones@biology.sdu.dk	Andersen, Mette Adalheidur/D-5608-2017; Baudisch, Annette/ABA-2290-2020; Jones, Owen/B-8439-2008; Scheuerlein, Alexander/AAK-1111-2021; Salguero-Gómez, Rob/N-6016-2016; Quintana-Ascencio, Pedro F/F-7263-2013; Salguero-Gomez, Rob/AAB-8488-2022; Garcia, Maria Begoña/B-6630-2015	Jones, Owen/0000-0001-5720-4686; Salguero-Gómez, Rob/0000-0002-6085-4433; Garcia, Maria Begoña/0000-0003-4231-6006; Ehrlen, Johan/0000-0001-8539-8967; Vaupel, James/0000-0003-0783-3905; Caswell, Hal/0000-0003-4394-6894; Dahlgren, Johan/0000-0002-1125-9769; Baudisch, Annette/0000-0002-4202-089X	NIH [PO1 AG-031719]; Alexander von Humboldt Foundation; European Research Council [322989]; ARC [DP110100727]; Max Planck Society; NATIONAL INSTITUTE ON AGING [P01AG031719] Funding Source: NIH RePORTER; Natural Environment Research Council [NE/G004854/1] Funding Source: researchfish; NERC [NE/G004854/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Research Council(European Research Council (ERC)European Commission); ARC(Australian Research Council); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Alberts for data on baboon demography, J. Curtsinger for data on Drosophila demography and O. Burger, D. Levitis, B. Pietrzak, F. Quade, F. Ringelhan and L. Vinicius for contributing published data about various species. J. W. V. and A. S. acknowledge support from NIH grant PO1 AG-031719. H. C. acknowledges a Research Award from the Alexander von Humboldt Foundation and Advanced Grant 322989 from the European Research Council. R.S.-G. acknowledges support from ARC DP110100727. A. B. acknowledges funding from the Max Planck Society to establish the Max Planck Research Group 'Modeling the Evolution of Aging'.	Baudisch A, 2008, DEMOGR RES MONOGR, P1, DOI 10.1007/978-3-540-76656-8; Baudisch A, 2013, J ECOL, V101, P596, DOI 10.1111/1365-2745.12084; Baudisch A, 2012, SCIENCE, V338, P618, DOI 10.1126/science.1226467; Baudisch A, 2011, METHODS ECOL EVOL, V2, P375, DOI 10.1111/j.2041-210X.2010.00087.x; Baudisch A, 2010, DEMOGR RES, V23, P655, DOI 10.4054/DemRes.2010.23.23; BELL G, 1984, EVOLUTION, V38, P300, DOI 10.1111/j.1558-5646.1984.tb00289.x; Burger O, 2012, P NATL ACAD SCI USA, V109, P18210, DOI 10.1073/pnas.1215627109; BUSS LW, 1988, PALEOBIOLOGY, V14, P313, DOI 10.1017/S0094837300012069; Caswell H., 1985, P187; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Caswell H, 2013, J ECOL, V101, P585, DOI 10.1111/1365-2745.12088; Caswell H, 2012, THEOR ECOL-NETH, V5, P403, DOI 10.1007/s12080-011-0132-2; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Charmantier A, 2006, P NATL ACAD SCI USA, V103, P6587, DOI 10.1073/pnas.0511123103; Charnov EL, 2001, P NATL ACAD SCI USA, V98, P9460, DOI 10.1073/pnas.161294498; Chen JJ, 2007, J GERONTOL A-BIOL, V62, P126, DOI 10.1093/gerona/62.2.126; Chiang CL, 1984, LIFE TABLE ITS APPL; Cohen AA, 2004, BIOL REV, V79, P733, DOI 10.1017/S1464793103006432; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Finch C.E., 1994, LONGEVITY SENESCENCE; Finch CE, 2009, GERONTOLOGY, V55, P307, DOI 10.1159/000215589; Franco M, 1996, PHILOS T R SOC B, V351, P1341, DOI 10.1098/rstb.1996.0117; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; GAILLARD JM, 1989, OIKOS, V56, P59, DOI 10.2307/3566088; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Horvitz CC, 2008, AM NAT, V172, P203, DOI 10.1086/589453; Jones OR, 2008, ECOL LETT, V11, P664, DOI 10.1111/j.1461-0248.2008.01187.x; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kirkwood TBL, 2011, PHILOS T R SOC B, V366, P64, DOI 10.1098/rstb.2010.0275; Martinez DE, 1998, EXP GERONTOL, V33, P217, DOI 10.1016/S0531-5565(97)00113-7; MARTINEZ DE, 1992, P NATL ACAD SCI USA, V89, P9920, DOI 10.1073/pnas.89.20.9920; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Medawar P., 1952, UNSOLVED PROBLEM BIO; MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; ORIVE ME, 1995, AM NAT, V145, P90, DOI 10.1086/285729; Pearl R, 1935, Q REV BIOL, V10, P60, DOI 10.1086/394476; PEDERSEN B, 1995, THEOR POPUL BIOL, V47, P292, DOI 10.1006/tpbi.1995.1013; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Salguero-Gomez R, 2013, J ECOL, V101, P545, DOI 10.1111/1365-2745.12089; SCHAFFER WM, 1974, ECOLOGY, V55, P291, DOI 10.2307/1935217; Shefferson RP, 2013, J ECOL, V101, P577, DOI 10.1111/1365-2745.12079; Stearns S.C., 1992, pi; Tuomi J, 2013, J ECOL, V101, P566, DOI 10.1111/1365-2745.12086; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	49	527	545	11	431	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					169	+		10.1038/nature12789	http://dx.doi.org/10.1038/nature12789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24317695	Green Accepted, Green Published, Green Submitted			2022-12-24	WOS:000329441500029
J	Mukherjee, S; Zheng, H; Derebe, MG; Callenberg, KM; Partch, CL; Rollins, D; Propheter, DC; Rizo, J; Grabe, M; Jiang, QX; Hooper, LV				Mukherjee, Sohini; Zheng, Hui; Derebe, Mehabaw G.; Callenberg, Keith M.; Partch, Carrie L.; Rollins, Darcy; Propheter, Daniel C.; Rizo, Josep; Grabe, Michael; Jiang, Qiu-Xing; Hooper, Lora V.			Antibacterial membrane attack by a pore-forming intestinal C-type lectin	NATURE			English	Article							ANTIMICROBIAL PEPTIDES; PROMOTES; CHANNELS; SOLVENT	Human body-surface epithelia coexist in close association with complex bacterial communities and are protected by a variety of antibacterial proteins. C-type lectins of the RegIII family are bactericidal proteins that limit direct contact between bacteria and the intestinal epithelium and thus promote tolerance to the intestinal microbiota(1,2). RegIII lectins recognize their bacterial targets by binding peptidoglycan carbohydrate(1,3), but the mechanism by which they kill bacteria is unknown. Here we elucidate the mechanistic basis for RegIII bactericidal activity. We show that human RegIII alpha (also known as HIP/PAP) binds membrane phospholipids and kills bacteria by forming a hexameric membrane-permeabilizing oligomeric pore. We derive a three-dimensional model of the RegIII alpha pore by docking the RegIII alpha crystal structure into a cryo-electron microscopic map of the pore complex, and show that the model accords with experimentally determined properties of the pore. Lipopolysaccharide inhibits RegIII alpha pore-forming activity, explaining why RegIII alpha is bactericidal for Gram-positive but not Gram-negative bacteria. Our findings identify C-type lectins as mediators of membrane attack in the mucosal immune system, and provide detailed insight into an antibacterial mechanism that promotes mutualism with the resident microbiota.	[Mukherjee, Sohini; Derebe, Mehabaw G.; Rollins, Darcy; Propheter, Daniel C.; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Zheng, Hui; Jiang, Qiu-Xing] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Callenberg, Keith M.; Grabe, Michael] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Callenberg, Keith M.; Grabe, Michael] Univ Pittsburgh, PhD Program Computat Biol, Joint Carnegie Mellon Univ, Pittsburgh, PA 15261 USA; [Partch, Carrie L.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Santa Cruz; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	qiu-xing.jiang@utsouthwestern.edu; lora.hooper@utsouthwestern.edu	Jiang, Qiu-Xing/ABF-1143-2021; Jiang, Qiu-Xing/AAI-8579-2020	Propheter, Daniel/0000-0002-8665-0885	NIH [R01 DK070855, R01GM088745, GM093271, R01 NS40944, C06 RR30414]; Welch Foundation [I-1684]; NSF CAREER [MCB0845286]; Helen Hay Whitney Fellowship; Burroughs Wellcome Foundation New Investigators in the Pathogenesis of Infectious Diseases Award; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR030414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855, F32DK100074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093271, R01GM088745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040944] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Helen Hay Whitney Fellowship; Burroughs Wellcome Foundation New Investigators in the Pathogenesis of Infectious Diseases Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Craig for assistance with the liposome disruption assays. The MODE-K cell line was provided by D. Kaiserlian, INSERM U851, Lyon, France. We thank E. Egelman for sharing his programs and for offering advice on cryoEM data analysis. This work was supported by NIH R01 DK070855 (L. V. H.), NIH R01GM088745 and GM093271 (Q.-X.J.), NIH R01 NS40944 (J.R.), Welch Foundation (I-1684 to Q.-X.J.), NSF CAREER MCB0845286 (M. G.), a Helen Hay Whitney Fellowship (S. M.), a Burroughs Wellcome Foundation New Investigators in the Pathogenesis of Infectious Diseases Award (L. V. H.), and the Howard Hughes Medical Institute (L. V. H.). Part of this work was performed in laboratories constructed with support from NIH grant C06 RR30414.	Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Callenberg KM, 2012, J GEN PHYSIOL, V140, P55, DOI 10.1085/jgp.201110766; Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fuller N, 2003, BIOPHYS J, V85, P1667, DOI 10.1016/S0006-3495(03)74596-2; Henriksen J, 2006, BIOPHYS J, V90, P1639, DOI 10.1529/biophysj.105.067652; Ho MR, 2006, J BIOL CHEM, V281, P33566, DOI 10.1074/jbc.M604513200; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Kraft CA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.299pl4; Kucerka N, 2006, BIOPHYS J, V90, pL83, DOI 10.1529/biophysj.106.086017; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Lodish H, 2000, MOL CELL BIOL; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Mukherjee S, 2009, J BIOL CHEM, V284, P4881, DOI 10.1074/jbc.M808077200; Nielsen C, 1998, BIOPHYS J, V74, P1966, DOI 10.1016/S0006-3495(98)77904-4; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; SHRAKE A, 1973, J MOL BIOL, V79, P351, DOI 10.1016/0022-2836(73)90011-9; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; WHITE SH, 1978, BIOPHYS J, V23, P337, DOI 10.1016/S0006-3495(78)85453-8; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j	27	199	204	5	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					103	+		10.1038/nature12729	http://dx.doi.org/10.1038/nature12729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24256734	Green Accepted			2022-12-24	WOS:000329163300032
J	Manolaridis, I; Kulkarni, K; Dodd, RB; Ogasawara, S; Zhang, ZG; Bineva, G; O'Reilly, N; Hanrahan, SJ; Thompson, AJ; Cronin, N; Iwata, S; Barford, D				Manolaridis, Ioannis; Kulkarni, Kiran; Dodd, Roger B.; Ogasawara, Satoshi; Zhang, Ziguo; Bineva, Ganka; O'Reilly, Nicola; Hanrahan, Sarah J.; Thompson, Andrew J.; Cronin, Nora; Iwata, So; Barford, David			Mechanism of farnesylated CAAX protein processing by the intramembrane protease Rce1	NATURE			English	Article							SECONDARY STRUCTURE; STRUCTURAL BASIS; A-FACTOR; CRYSTAL-STRUCTURE; RAS; ENDOPROTEOLYSIS; LOCALIZATION; TRAFFICKING; SPECIFICITY; REVEALS	CAAX proteins have essential roles in multiple signalling pathways, controlling processes such as proliferation, differentiation and carcinogenesis(1). The similar to 120 mammalian CAAX proteins function at cellular membranes and include the Ras superfamily of small GTPases, nuclear lamins, the gamma-subunit of heterotrimeric GTPases, and several protein kinases and phosphatases(2). The proper localization of CAAX proteins to cell membranes is orchestrated by a series of post-translational modifications of the carboxy-terminal CAAX motifs(3) (where C is cysteine, A is an aliphatic amino acid and X is any amino acid). These reactions involve prenylation of the cysteine residue, cleavage at the AAX tripeptide and methylation of the carboxyl-prenylated cysteine residue. The major CAAX protease activity is mediated by Rce1 (Ras and a-factor converting enzyme 1), an intramembrane protease (IMP) of the endoplasmic reticulum(4,5). Information on the architecture and proteolytic mechanism of Rce1 has been lacking. Here we report the crystal structure of a Methano-coccus maripaludis homologue of Rce1, whose endopeptidase specificity for farnesylated peptides mimics that of eukaryotic Rce1. Its structure, comprising eight transmembrane alpha-helices, and catalytic site are distinct from those of other IMPs. The catalytic residues are located similar to 10 angstrom into the membrane and are exposed to the cytoplasm and membrane through a conical cavity that accommodates the prenylated CAAX substrate. We propose that the farnesyl lipid binds to a site at the opening of two transmembrane alpha-helices, which results in the scissile bond being positioned adjacent to a glutamate-activated nucleophilic water molecule. This study suggests that Rce1 is the founding member of a novel IMP family, the glutamate IMPs.	[Manolaridis, Ioannis; Kulkarni, Kiran; Dodd, Roger B.; Zhang, Ziguo; Hanrahan, Sarah J.; Thompson, Andrew J.; Cronin, Nora; Barford, David] Inst Canc Res, London SW3 6JB, England; [Ogasawara, Satoshi; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Ogasawara, Satoshi; Iwata, So] JST, Res Accelerat Program, Membrane Prot Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Bineva, Ganka; O'Reilly, Nicola] Canc Res UK London Res Inst, London WC2A 3LY, England; [Iwata, So] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Kyoto University; Japan Science & Technology Agency (JST); Cancer Research UK; Imperial College London	Barford, D (corresponding author), Inst Canc Res, 237 Fulham Rd, London SW3 6JB, England.	dbarford@mrc-lmb.cam.ac.uk	Thompson, Andrew/B-1463-2014	Thompson, Andrew/0000-0003-2413-3281; Barford, David/0000-0001-8810-950X; Zhang, Ziguo/0000-0002-7268-9631; Dodd, Roger/0000-0003-4268-1863; Bineva-Todd, Ganka/0000-0001-8926-9417; O'Reilly, Nicola/0000-0002-4204-6491	Cancer Research UK; Japan Science and Technology agency; BBSRC [BB/G023425/1]; MRC [MC_UP_1201/6] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023425/1] Funding Source: researchfish; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [MC_UP_1201/6] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Japan Science and Technology agency(Japan Science & Technology Agency (JST)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Cancer Research UK grant to D. B. Part of this work was supported by the research acceleration program of the Japan Science and Technology agency and by BBSRC BB/G023425/1 (S. I.). We thank staff at the I04-1 Diamond Light Source for help with data collection, J. Yang for advice and discussions, I. De Moraes for support and T. Daviter for help with the circular dichroism experiments.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Bergo MO, 2004, J BIOL CHEM, V279, P4729, DOI 10.1074/jbc.M310081200; Bergo MO, 2002, MOL CELL BIOL, V22, P171, DOI 10.1128/MCB.22.1.171-181.2002; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Christiansen JR, 2011, P NATL ACAD SCI USA, V108, P8862, DOI 10.1073/pnas.1103627108; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Day PW, 2007, NAT METHODS, V4, P927, DOI 10.1038/NMETH1112; Dolence JM, 2000, BIOCHEMISTRY-US, V39, P4096, DOI 10.1021/bi9923611; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Hollander I, 2000, ANAL BIOCHEM, V286, P129, DOI 10.1006/abio.2000.4795; Hollander IJ, 2003, BBA-PROTEINS PROTEOM, V1649, P24, DOI 10.1016/S1570-9639(03)00150-X; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kjos M, 2010, J BACTERIOL, V192, P2068, DOI 10.1128/JB.01553-09; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Pei JM, 2001, TRENDS BIOCHEM SCI, V26, P275, DOI 10.1016/S0968-0004(01)01813-8; Plummer LJ, 2006, J BIOL CHEM, V281, P4596, DOI 10.1074/jbc.M506284200; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt WK, 1998, P NATL ACAD SCI USA, V95, P11175, DOI 10.1073/pnas.95.19.11175; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Trueblood CE, 2000, MOL CELL BIOL, V20, P4381, DOI 10.1128/MCB.20.12.4381-4392.2000; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vinothkumar KR, 2010, EMBO J, V29, P3797, DOI 10.1038/emboj.2010.243; Wahlstrom AM, 2007, BLOOD, V109, P763, DOI 10.1182/blood-2006-05-024752; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179	51	116	123	3	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 12	2013	504	7479					301	+		10.1038/nature12754	http://dx.doi.org/10.1038/nature12754			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	267TQ	24291792	Green Accepted			2022-12-24	WOS:000328121500041
J	Ridker, PM; Cook, NR				Ridker, Paul M.; Cook, Nancy R.			Statins: new American guidelines for prevention of cardiovascular disease	LANCET			English	Editorial Material							EVENTS; ROSUVASTATIN; TRIAL; ATORVASTATIN; CORONARY; AVERAGE; WOMEN; MEN		[Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, Boston, MA 02215 USA.	pridker@partners.org		Venkatasubramanian, Siddharth/0000-0002-5860-0768				Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Goff DC, 2013, J AM COLL CARDIOL, V2014, P63, DOI DOI 10.1016/J.JACC.2013.11.005; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Langer RD, 2003, ANN EPIDEMIOL, V13, pS107, DOI 10.1016/S1047-2797(03)00047-4; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2013, JAMA-J AM MED ASSOC, V310, P1123, DOI 10.1001/jama.2013.276529; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002	15	353	363	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1762	1765		10.1016/S0140-6736(13)62388-0	http://dx.doi.org/10.1016/S0140-6736(13)62388-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	259QF	24268611				2022-12-24	WOS:000327540700009
J	Mace, G				Mace, Georgina			Ecology must evolve	NATURE			English	Editorial Material									[Mace, Georgina] UCL, Ctr Biodivers & Environm Res, London WC1E 6BT, England	University of London; University College London	Mace, G (corresponding author), UCL, Ctr Biodivers & Environm Res, London WC1E 6BT, England.	g.mace@ucl.ac.uk	Mace, Georgina M/I-3072-2016	Mace, Georgina M/0000-0001-8965-5211				British Ecological Society, 2013, 100 INFL PAP; Carpenter SR, 2009, BIOSCIENCE, V59, P699, DOI 10.1525/bio.2009.59.8.11; Hampton SE, 2011, BIOSCIENCE, V61, P900, DOI 10.1525/bio.2011.61.11.9; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Michener WK, 2012, TRENDS ECOL EVOL, V27, P85, DOI 10.1016/j.tree.2011.11.016; Purves D, 2013, NATURE, V493, P295, DOI 10.1038/493295a; Reichman OJ, 2011, SCIENCE, V331, P703, DOI 10.1126/science.1197962; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025	9	27	32	3	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					191	192		10.1038/503191a	http://dx.doi.org/10.1038/503191a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	250YX	24236316	Bronze			2022-12-24	WOS:000326894200023
J	Schoggins, JW; MacDuff, DA; Imanaka, N; Gainey, MD; Shrestha, B; Eitson, JL; Mar, KB; Richardson, RB; Ratushny, AV; Litvak, V; Dabelic, R; Manicassamy, B; Aitchison, JD; Aderem, A; Elliott, RM; Garcia-Sastre, A; Racaniello, V; Snijder, EJ; Yokoyama, WM; Diamond, MS; Virgin, HW; Rice, CM				Schoggins, John W.; MacDuff, Donna A.; Imanaka, Naoko; Gainey, Maria D.; Shrestha, Bimmi; Eitson, Jennifer L.; Mar, Katrina B.; Richardson, R. Blake; Ratushny, Alexander V.; Litvak, Vladimir; Dabelic, Rea; Manicassamy, Balaji; Aitchison, John D.; Aderem, Alan; Elliott, Richard M.; Garcia-Sastre, Adolfo; Racaniello, Vincent; Snijder, Eric J.; Yokoyama, Wayne M.; Diamond, Michael S.; Virgin, Herbert W.; Rice, Charles M.			Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity	NATURE			English	Article							CYCLIC GMP-AMP; INTERFERON-STIMULATED GENES; WEST-NILE-VIRUS; FLUORESCENT PROTEIN; IN-VITRO; IDENTIFICATION; 2ND-MESSENGER; INFECTION; EFFECTORS; MICE	The type I interferon (IFN) response protects cells from viral infection by inducing hundreds of interferon-stimulated genes (ISGs), some of which encode direct antiviral effectors(1-3). Recent screening studies have begun to catalogue ISGs with antiviral activity against several RNA and DNA viruses(4-13). However, antiviral ISG specificity across multiple distinct classes of viruses remains largely unexplored. Here we used an ectopic expression assay to screen a library of more than 350 human ISGs for effects on 14 viruses representing 7 families and 11 genera. We show that 47 genes inhibit one or more viruses, and 25 genes enhance virus infectivity. Comparative analysis reveals that the screened ISGs target positive-sense single-stranded RNA viruses more effectively than negative-sense single-stranded RNA viruses. Gene clustering highlights the cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS, also known as MB21D1) as a gene whose expression also broadly inhibits several RNA viruses. In vitro, lentiviral delivery of enzymatically active cGAS triggers a STING-dependent, IRF3-mediated antiviral program that functions independently of canonical IFN/STAT1 signalling. In vivo, genetic ablation of murine cGAS reveals its requirement in the antiviral response to two DNA viruses, and an unappreciated contribution to the innate control of an RNA virus. These studies uncover new paradigms for the preferential specificity of IFN-mediated antiviral pathways spanning several virus families.	[Schoggins, John W.; Imanaka, Naoko; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [MacDuff, Donna A.; Diamond, Michael S.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Gainey, Maria D.; Yokoyama, Wayne M.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Gainey, Maria D.; Yokoyama, Wayne M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Shrestha, Bimmi; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Shrestha, Bimmi; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Eitson, Jennifer L.; Mar, Katrina B.; Richardson, R. Blake] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Ratushny, Alexander V.; Litvak, Vladimir; Aitchison, John D.; Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Ratushny, Alexander V.; Aitchison, John D.] Inst Syst Biol, Seattle, WA 98109 USA; [Dabelic, Rea; Racaniello, Vincent] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA; [Manicassamy, Balaji] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Elliott, Richard M.] Univ St Andrews, Sch Biol, St Andrews KY16 9ST, Fife, Scotland; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Snijder, Eric J.] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands	Rockefeller University; Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; Center for Infectious Disease Research; Institute for Systems Biology (ISB); Columbia University; University of Chicago; University of St Andrews; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rice, CM (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.	john.schoggins@utsouthwestern.edu; ricec@rockefeller.edu	MacDuff, Donna/AAD-2786-2019; Diamond, Michael/AAH-1733-2019; Snijder, Eric J./E-6073-2018	MacDuff, Donna/0000-0002-6183-6827; Diamond, Michael/0000-0002-8791-3165; Snijder, Eric J./0000-0003-3297-2309; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Manicassamy, Balaji/0000-0003-1964-0967; Mar, Katrina/0000-0003-3640-2418; Virgin, Herbert/0000-0001-8580-7628	National Institutes of Health [AI091707, AI057158, DK095031, AI057160, HHSN272200900041CU19, AI104972, AI083025, AI095611]; CEIRS [AI057160, HHSN266200700010C, GM076547, GM103511]; Greenberg Medical Research Institute; Starr Foundation; Ronald A. Shellow, M.D. Memorial Fund;  [T32 AR007279]; Medical Research Council [G0801822] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160, R01AI104972, U01AI095611, U54AI057158, R01AI025032, R00AI095320, R01AI032972, T32AI005284, R01AI091707, R01AI102597, U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103511, P50GM076547] Funding Source: NIH RePORTER; MRC [G0801822] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CEIRS; Greenberg Medical Research Institute; Starr Foundation; Ronald A. Shellow, M.D. Memorial Fund; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the following investigators for contributing viral molecular clones or viral stocks: R. Cattaneo (MV), P. Collins (PIV3, HMPV, RSV), I Frolov (VEEV), M. Heise (SINV), S. Higgs (ONNV), P. Traktman (VV), J. L. Whitton (CVB). We thank E. Jouanguy and J.-L. Casanova for STAT1<SUP>-/-</SUP> fibroblasts. We acknowledge the support of C. Zhao, X. Wang and W. Zhang at The Rockefeller University Genomics Resource Center. We thank E. Castillo, B. Flatley, A. Webson, E. Duan and A. McLees for laboratory support, and D. Kraemalmeyer for managing mouse colonies. This work was supported in part by National Institutes of Health grants AI091707 to C.M.R., AI057158 to I. Lipkin (Northeast Biodefense Center, subcontract to C.M.R.), DK095031 to J.W.S., AI057160 to H.W.V., HHSN272200900041CU19 to M.S.D. and H.W.V., AI104972 to M. S. D., AI083025, AI095611 and CEIRS contract HHSN266200700010C to A.G-S., GM076547 and GM103511 to J.D.A. and AI057160 to W.M.Y., an investigator of the Howard Hughes Medical Institute. M.D.G. is supported by T32 AR007279. Additional funding was provided by the Greenberg Medical Research Institute, the Starr Foundation and the Ronald A. Shellow, M. D. Memorial Fund (C.M.R.).	Biacchesi S, 2004, VIROLOGY, V321, P247, DOI 10.1016/j.virol.2003.12.020; Brault AC, 2004, INSECT MOL BIOL, V13, P625, DOI 10.1111/j.0962-1075.2004.00521.x; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; del Valle JR, 2007, J VIROL, V81, P10597, DOI 10.1128/JVI.00923-07; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493; Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13; Feuer R, 2002, J VIROL, V76, P4430, DOI 10.1128/JVI.76.9.4430-4440.2002; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fusco DN, 2013, GASTROENTEROLOGY, V144, P1438, DOI 10.1053/j.gastro.2013.02.026; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Karki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037398; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Meng XZ, 2012, J VIROL, V86, P4538, DOI 10.1128/JVI.06140-11; Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shi XH, 2010, J VIROL, V84, P8460, DOI 10.1128/JVI.00902-10; Simmons JD, 2010, J VIROL, V84, P11429, DOI 10.1128/JVI.00577-10; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Teterina NL, 2010, J VIROL, V84, P1477, DOI 10.1128/JVI.01578-09; van den Born E, 2007, J GEN VIROL, V88, P1196, DOI 10.1099/vir.0.82590-0; Wilson SJ, 2012, CELL HOST MICROBE, V12, P585, DOI 10.1016/j.chom.2012.08.012; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07; Zhao H, 2012, J HEPATOL, V56, P326, DOI 10.1016/j.jhep.2011.07.026	39	594	610	9	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 30	2014	505	7485					691	+		10.1038/nature12862	http://dx.doi.org/10.1038/nature12862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298JV	24284630	Green Accepted			2022-12-24	WOS:000330321000043
J	Murayama, Y; Uhlmann, F				Murayama, Yasuto; Uhlmann, Frank			Biochemical reconstitution of topological DNA binding by the cohesin ring	NATURE			English	Article							SISTER-CHROMATID COHESION; STRAND-BREAK REPAIR; FISSION YEAST; IN-VITRO; SACCHAROMYCES-CEREVISIAE; ATP HYDROLYSIS; S-PHASE; COMPLEX; CONDENSIN; PROTEIN	Cohesion between sister chromatids, mediated by the chromosomal cohesin complex, is a prerequisite for faithful chromosome segregation in mitosis. Cohesin also has vital roles in DNA repair and transcriptional regulation. The ring-shaped cohesin complex is thought to encircle sister DNA strands, but its molecular mechanism of action is poorly understood and the biochemical reconstitution of cohesin activity in vitro has remained an unattained goal. Here we reconstitute cohesin loading onto DNA using purified fission yeast cohesin and its loader complex, Mis4(Scc2)-Ssl3(Scc4) (Schizosaccharomyces pombe gene names appear throughout with their more commonly known Saccharomyces cerevisiae counterparts added in superscript). Incubation of cohesin with DNA leads to spontaneous topological loading, but this remains inefficient. The loader contacts cohesin at multiple sites around the ring circumference, including the hitherto enigmatic Psc3(Scc3) subunit, and stimulates cohesin's ATPase, resulting in efficient topological loading. The in vitro reconstitution of cohesin loading onto DNA provides mechanistic insight into the initial steps of the establishment of sister chromatid cohesion and other chromosomal processes mediated by cohesin.	[Murayama, Yasuto; Uhlmann, Frank] Canc Res UK London Res Inst, Chromosome Segregat Lab, London WC2A 3LY, England	Cancer Research UK	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Chromosome Segregat Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	frank.uhlmann@cancer.org.uk		Uhlmann, Frank/0000-0002-3527-6619	European Research Council; Japanese Society for the Promotion of Science (JSPS); Cancer Research UK [15671] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cancer Research UK(Cancer Research UK)	We are grateful to N. O'Reilly for peptide synthesis, A. Alidoust and N. Patel for fermentation and J. Hurwitz, T. Toda and members of the Chromosome Segregation Laboratory for discussion and comments on the manuscript. This work was supported by the European Research Council. Y.M. was supported by the Japanese Society for the Promotion of Science (JSPS).	Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bermudez VP, 2012, P NATL ACAD SCI USA, V109, P9366, DOI 10.1073/pnas.1206840109; Bernard P, 2006, CURR BIOL, V16, P875, DOI 10.1016/j.cub.2006.03.037; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Furuya K, 1998, GENE DEV, V12, P3408, DOI 10.1101/gad.12.21.3408; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2001, CURR BIOL, V11, P268, DOI 10.1016/S0960-9822(01)00066-5; Matsuyama A, 2008, BIOCHEM BIOPH RES CO, V374, P315, DOI 10.1016/j.bbrc.2008.07.015; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Onn I, 2011, P NATL ACAD SCI USA, V108, P12198, DOI 10.1073/pnas.1107504108; Pezzi N, 2000, FASEB J, V14, P581, DOI 10.1096/fasebj.14.3.581; Sakai A, 2003, EMBO J, V22, P2764, DOI 10.1093/emboj/cdg247; Schmidt CK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r52; SHIBATA T, 1981, J BIOL CHEM, V256, P7557; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222	45	183	184	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					367	+		10.1038/nature12867	http://dx.doi.org/10.1038/nature12867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24291789	Green Accepted			2022-12-24	WOS:000329621800035
J	Matsuo, Y; Granneman, S; Thoms, M; Manikas, RG; Tollervey, D; Hurt, E				Matsuo, Yoshitaka; Granneman, Sander; Thoms, Matthias; Manikas, Rizos-Georgios; Tollervey, David; Hurt, Ed			Coupled GTPase and remodelling ATPase activities form a checkpoint for ribosome export	NATURE			English	Article							NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; BIOGENESIS FACTORS; ADAPTER PROTEIN; RNA-BINDING; MATURATION; SUBUNIT; ASSOCIATION; COMPLEX; KINASE	Eukaryotic ribosomes are assembled by a complex pathway that extends from the nucleolus to the cytoplasm and is powered by many energy-consuming enzymes(1-3). Nuclear export is a key, irreversible step in pre-ribosome maturation(4-8), but mechanisms underlying the timely acquisition of export competence remain poorly understood. Here we show that a conserved Saccharomyces cerevisiae GTPase Nug2 (also known as Nog2, and as NGP-1, GNL2 or nucleostemin 2 in human(9)) has a key role in the timing of export competence. Nug2 binds the inter-subunit face of maturing, nucleoplasmic pre-60S particles, and the location clashes with the position of Nmd3, a key pre-60S export adaptor(10). Nug2 and Nmd3 are not present on the same pre-60S particles, with Nug2 binding before Nmd3. Depletion of Nug2 causes premature Nmd3 binding to the pre-60S particles, whereas mutations in the G-domain of Nug2 block Nmd3 recruitment, resulting in severe 60S export defects. Two pre-60S remodelling factors, the Rea1 ATPase and its co-substrate Rsa4, are present on Nug2-associated particles, and both show synthetic lethal interactions with nug2 mutants. Release of Nug2 from pre-60S particles requires both its K+-dependent GTPase activity and the remodelling ATPase activity of Rea1. We conclude that Nug2 is a regulatory GTPase that monitors pre-60S maturation, with release from its placeholder site linked to recruitment of the nuclear export machinery.	[Matsuo, Yoshitaka; Thoms, Matthias; Manikas, Rizos-Georgios; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Granneman, Sander; Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Granneman, Sander] Univ Edinburgh, Ctr Synthet & Syst Biol, Edinburgh EH9 3JD, Midlothian, Scotland	Ruprecht Karls University Heidelberg; University of Edinburgh; University of Edinburgh	Hurt, E (corresponding author), Heidelberg Univ, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni.heidelberg.de	Tollervey, David/AAR-6662-2020; Ed Hurt, Dr./AAE-8874-2019; Granneman, Sander/A-3150-2015	Tollervey, David/0000-0003-2894-2772; Ed Hurt, Dr./0000-0002-4535-8255; Granneman, Sander/0000-0003-4387-1271; Thoms, Matthias/0000-0001-8084-6097	Alexander von Humboldt Foundation; Wellcome Trust [077248]; Deutsche Forschungsgemeinschaft [DFG Hu363/10-4]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Remacha, M. Fromont- Racine, A. W. Johnson, C. Dargemont, M. Seedorf and J. Warner for antibodies. We thank the GenePool at the University of Edinburgh for performing the MiSeq sequencing, and E. Petfalski for performing the initial crosslinking experiments. We thank E. Thomson for careful reading the manuscript. This work was supported by a postdoctoral fellowship from Alexander von Humboldt Foundation to Y.M., and by the Wellcome Trust to S. G. and D. T. (077248), and by grants from the Deutsche Forschungsgemeinschaft to E. H. (DFG Hu363/10-4).	Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Ash MR, 2012, FEBS LETT, V586, P2218, DOI 10.1016/j.febslet.2012.06.030; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bassler J, 2006, J BIOL CHEM, V281, P24737, DOI 10.1074/jbc.M604261200; Bassler J, 2010, MOL CELL, V38, P712, DOI 10.1016/j.molcel.2010.05.024; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bradatsch B, 2012, NAT STRUCT MOL BIOL, V19, P1234, DOI 10.1038/nsmb.2438; Bussiere C, 2012, J CELL BIOL, V197, P747, DOI 10.1083/jcb.201112131; Chennupati V, 2011, BIOCHEMISTRY-US, V50, P4521, DOI 10.1021/bi200425b; de la Cruz J, 2005, NUCLEIC ACIDS RES, V33, P5728, DOI 10.1093/nar/gki887; Dembowski JA, 2013, NUCLEIC ACIDS RES, V41, P7889, DOI 10.1093/nar/gkt545; Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035; Ferreira-Cerca S, 2012, NAT STRUCT MOL BIOL, V19, P1316, DOI 10.1038/nsmb.2403; Frey S, 2001, J BIOL CHEM, V276, P15905, DOI 10.1074/jbc.M009430200; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Hung NJ, 2006, MOL CELL BIOL, V26, P3718, DOI 10.1128/MCB.26.10.3718-3727.2006; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KIKKAWA S, 1990, J BIOL CHEM, V265, P21536; Lafontaine DLJ, 2010, TRENDS BIOCHEM SCI, V35, P267, DOI 10.1016/j.tibs.2009.12.006; Lapik YR, 2007, MOL CELL BIOL, V27, P7735, DOI 10.1128/MCB.01161-07; Lebreton A, 2006, J CELL BIOL, V173, P349, DOI 10.1083/jcb.200510080; Lebreton A, 2006, J BIOL CHEM, V281, P27099, DOI 10.1074/jbc.M602199200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; Sengupta J, 2010, J CELL BIOL, V189, P1079, DOI 10.1083/jcb.201001124; Staley JP, 2009, CURR OPIN CELL BIOL, V21, P109, DOI 10.1016/j.ceb.2009.01.003; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tsai RYL, 2009, INT J BIOCHEM CELL B, V41, P2122, DOI 10.1016/j.biocel.2009.05.020; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; Vilardell J, 1997, MOL CELL BIOL, V17, P1959, DOI 10.1128/MCB.17.4.1959; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WERTHEIMER AM, 1977, BIOCHEM BIOPH RES CO, V78, P565, DOI 10.1016/0006-291X(77)90216-9; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013	47	94	96	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2014	505	7481					112	+		10.1038/nature12731	http://dx.doi.org/10.1038/nature12731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282IB	24240281	Green Accepted			2022-12-24	WOS:000329163300034
J	Furusawa, Y; Obata, Y; Fukuda, S; Endo, TA; Nakato, G; Takahashi, D; Nakanishi, Y; Uetake, C; Kato, K; Kato, T; Takahashi, M; Fukuda, NN; Murakami, S; Miyauchi, E; Hino, S; Atarashi, K; Onawa, S; Fujimura, Y; Lockett, T; Clarke, JM; Topping, DL; Tomita, M; Hori, S; Ohara, O; Morita, T; Koseki, H; Kikuchi, J; Honda, K; Hase, K; Ohno, H				Furusawa, Yukihiro; Obata, Yuuki; Fukuda, Shinji; Endo, Takaho A.; Nakato, Gaku; Takahashi, Daisuke; Nakanishi, Yumiko; Uetake, Chikako; Kato, Keiko; Kato, Tamotsu; Takahashi, Masumi; Fukuda, Noriko N.; Murakami, Shinnosuke; Miyauchi, Eiji; Hino, Shingo; Atarashi, Koji; Onawa, Satoshi; Fujimura, Yumiko; Lockett, Trevor; Clarke, Julie M.; Topping, David L.; Tomita, Masaru; Hori, Shohei; Ohara, Osamu; Morita, Tatsuya; Koseki, Haruhiko; Kikuchi, Jun; Honda, Kenya; Hase, Koji; Ohno, Hiroshi			Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells	NATURE			English	Article							ARABIDOPSIS-THALIANA; METABOLIC DYNAMICS; GUT MICROBIOTA; INHIBITION; COLONIZATION; INFLAMMATION; RECEPTORS; RESPONSES; COLITIS; SUBSETS	Gut commensal microbes shape the mucosal immune system by regulating the differentiation and expansion of several types of T cell(1-5). Clostridia, a dominant class of commensal microbe, can induce colonic regulatory T (T-reg) cells, which have a central role in the suppression of inflammatory and allergic responses(3). However, the molecular mechanisms by which commensal microbes induce colonic T-reg cells have been unclear. Here we show that a large bowel microbial fermentation product, butyrate, induces the differentiation of colonic T-reg cells in mice. A comparative NMR-based metabolome analysis suggests that the luminal concentrations of short-chain fatty acids positively correlates with the number of T-reg cells in the colon. Among short-chain fatty acids, butyrate induced the differentiation of T-reg cells in vitro and in vivo, and ameliorated the development of colitis induced by adoptive transfer of CD4(+) CD45RB(hi) T cells in Rag1(-/-) mice. Treatment of naive T cells under the T-reg-cell-polarizing conditions with butyrate enhanced histone H3 acetylation in the promoter and conserved non-coding sequence regions of the Foxp3 locus, suggesting a possible mechanism for how microbial-derived butyrate regulates the differentiation of T-reg cells. Our findings provide new insight into the mechanisms by which host-microbe interactions establish immunological homeostasis in the gut.	[Furusawa, Yukihiro; Obata, Yuuki; Fukuda, Shinji; Endo, Takaho A.; Nakato, Gaku; Takahashi, Daisuke; Uetake, Chikako; Kato, Keiko; Kato, Tamotsu; Takahashi, Masumi; Miyauchi, Eiji; Atarashi, Koji; Onawa, Satoshi; Hori, Shohei; Ohara, Osamu; Koseki, Haruhiko; Honda, Kenya; Hase, Koji; Ohno, Hiroshi] RIKEN Ctr Integrat Med Sci IMS RCAI, Wako, Kanagawa 2300045, Japan; [Furusawa, Yukihiro; Obata, Yuuki; Fujimura, Yumiko; Hase, Koji] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; [Obata, Yuuki; Koseki, Haruhiko; Ohno, Hiroshi] Chiba Univ, Grad Sch Med, Chiba 2608670, Japan; [Fukuda, Shinji; Nakanishi, Yumiko; Fukuda, Noriko N.; Murakami, Shinnosuke; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Yamagata 9970052, Japan; [Kato, Keiko; Koseki, Haruhiko; Kikuchi, Jun] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 2300045, Japan; [Hino, Shingo] Shizuoka Univ, Fac Agr, Shizuoka 4228529, Japan; [Atarashi, Koji; Hase, Koji] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Lockett, Trevor; Clarke, Julie M.; Topping, David L.] CSIRO Food & Nutr Sci, Preventat Hlth Natl Res Flagship, Adelaide, SA 5000, Australia; [Kikuchi, Jun] RIKEN Ctr Sustainable Resource Sci, Kanagawa 2300045, Japan; [Honda, Kenya] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Tokyo; Chiba University; Keio University; Yokohama City University; Shizuoka University; Japan Science & Technology Agency (JST); Commonwealth Scientific & Industrial Research Organisation (CSIRO); RIKEN; Japan Science & Technology Agency (JST)	Ohno, H (corresponding author), RIKEN Ctr Integrat Med Sci IMS RCAI, Wako, Kanagawa 2300045, Japan.	sfukuda@sfc.keio.ac.jp; hase@ims.u-tokyo.ac.jp; ohno@rcai.riken.jp	Ohno, Hiroshi/L-7899-2014; Takahashi, Daisuke/C-3799-2019; Kikuchi, Jun/M-5512-2015; Atarashi, Koji/I-5363-2014; Honda, Kenya/N-5297-2015; Hori, Shohei/O-6163-2019; Lockett, Trevor J/H-8970-2013; Clarke, Julie M/H-6762-2013; Koseki, Haruhiko/I-3825-2014; topping, david l/H-7969-2013; Kikuchi, Jun/O-4725-2019; Ohara, Osamu/G-5448-2015; Endo, Takaho/B-5763-2017	Ohno, Hiroshi/0000-0001-8776-9661; Takahashi, Daisuke/0000-0001-8624-1160; Kikuchi, Jun/0000-0002-6809-394X; Atarashi, Koji/0000-0001-5422-0736; Hori, Shohei/0000-0001-8770-4593; Lockett, Trevor J/0000-0002-8063-071X; Clarke, Julie M/0000-0003-4676-0366; Koseki, Haruhiko/0000-0001-8424-5854; topping, david l/0000-0002-8481-9384; Kikuchi, Jun/0000-0002-6809-394X; Ohara, Osamu/0000-0002-3328-9571; Endo, Takaho/0000-0002-2801-2463; Hase, Koji/0000-0001-9550-2334; Kato, Tamotsu/0000-0002-8407-4327; Fukuda, Shinji/0000-0001-5161-9880; Murakami, Shinnosuke/0000-0002-1101-9255; HINO, Shingo/0000-0003-2644-2301; Obata, Yuuki/0000-0001-5461-3521	Japanese Ministry of Education, Culture, Sports, Science and Technology [24117524, 21022049, 20113003]; The Japan Society for the Promotion of Science [24890293, 252667, 24380072, 24658129, 22689017, 21390155]; The Japan Science and Technology Agency; RIKEN; RIKEN RCAI Young Chief Investigator program; Institute for Fermentation, Osaka; Mishima Kaiun Memorial Foundation; The Takeda Science Foundation; The Mitsubishi Foundation; The Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [24117723, 24117524] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); The Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); RIKEN; RIKEN RCAI Young Chief Investigator program; Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); The Takeda Science Foundation(Takeda Science Foundation (TSF)); The Mitsubishi Foundation; The Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank P. Carninci, Y. Shinkai and M. Yoshida for discussion; Y. Chiba and S. Yamada for technical support; H. Sugahara for technical advice; and P. D. Burrows for critical reading and editing of the manuscript. This work was supported in part by grants from Japanese Ministry of Education, Culture, Sports, Science and Technology (24117524 to S. F.; 21022049 to K. Ha.; 20113003 to H.O.), The Japan Society for the Promotion of Science (24890293 to Y. F.; 252667 to Y.O.; 24380072 and 24658129 to S. F.; 22689017 to K. Ha.; 21390155 to H.O.), The Japan Science and Technology Agency (K. Ha., K. A. and K. Ho.), RIKEN President's Special Research Grant (H.O.), RIKEN RCAI Young Chief Investigator program (K. Ha.), the Institute for Fermentation, Osaka (S. F.), the Mishima Kaiun Memorial Foundation (S. F.), The Takeda Science Foundation (S. F. and H.O.), The Mitsubishi Foundation (H.O.), and The Uehara Memorial Foundation (S. F. and K.Ha.).	Akiyama Kenji, 2008, In Silico Biology, V8, P339; Annison G, 2003, J NUTR, V133, P3523, DOI 10.1093/jn/133.11.3523; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Date Y, 2010, J BIOSCI BIOENG, V110, P87, DOI 10.1016/j.jbiosc.2010.01.004; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Fukuda S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004893; Furusawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029012; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; ITOH K, 1985, LAB ANIM, V19, P111, DOI 10.1258/002367785780942589; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kruger NJ, 2008, NAT PROTOC, V3, P1001, DOI 10.1038/nprot.2008.64; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Morita T, 1998, J NUTR, V128, P1156, DOI 10.1093/jn/128.7.1156; Obata Y, 2012, J IMMUNOL, V188, P2427, DOI 10.4049/jimmunol.1101128; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sannasiddappa TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023227; SCHEPPACH W, 1992, GASTROENTEROLOGY, V103, P51, DOI 10.1016/0016-5085(92)91094-K; Sekiyama Y, 2010, ANAL CHEM, V82, P1643, DOI 10.1021/ac9019076; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thibault R, 2007, GASTROENTEROLOGY, V133, P1916, DOI 10.1053/j.gastro.2007.08.041; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	50	2777	2912	42	527	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 19	2013	504	7480					446	+		10.1038/nature12721	http://dx.doi.org/10.1038/nature12721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273ZR	24226770				2022-12-24	WOS:000328575300054
J	Boets, B; Op de Beeck, HP; Vandermosten, M; Scott, SK; Gillebert, CR; Mantini, D; Bulthe, J; Sunaert, S; Wouters, J; Ghesquiere, P				Boets, Bart; Op de Beeck, Hans P.; Vandermosten, Maaike; Scott, Sophie K.; Gillebert, Celine R.; Mantini, Dante; Bulthe, Jessica; Sunaert, Stefan; Wouters, Jan; Ghesquiere, Pol			Intact But Less Accessible Phonetic Representations in Adults with Dyslexia	SCIENCE			English	Article							SPEECH; ORGANIZATION; CONNECTIVITY; LANGUAGE; CHILDREN	Dyslexia is a severe and persistent reading and spelling disorder caused by impairment in the ability to manipulate speech sounds. We combined functional magnetic resonance brain imaging with multivoxel pattern analysis and functional and structural connectivity analysis in an effort to disentangle whether dyslexics' phonological deficits are caused by poor quality of the phonetic representations or by difficulties in accessing intact phonetic representations. We found that phonetic representations are hosted bilaterally in primary and secondary auditory cortices and that their neural quality (in terms of robustness and distinctness) is intact in adults with dyslexia. However, the functional and structural connectivity between the bilateral auditory cortices and the left inferior frontal gyrus (a region involved in higher-level phonological processing) is significantly hampered in dyslexics, suggesting deficient access to otherwise intact phonetic representations.	[Boets, Bart] Katholieke Univ Leuven, B-3000 Louvain, Belgium; [Boets, Bart; Vandermosten, Maaike; Ghesquiere, Pol] Katholieke Univ Leuven, Parenting & Special Educ Res Unit, B-3000 Louvain, Belgium; [Op de Beeck, Hans P.; Bulthe, Jessica] Katholieke Univ Leuven, Lab Biol Psychol, B-3000 Louvain, Belgium; [Scott, Sophie K.] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Gillebert, Celine R.; Mantini, Dante] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Mantini, Dante] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, CH-8092 Zurich, Switzerland; [Sunaert, Stefan] Katholieke Univ Leuven, Dept Radiol, B-3000 Louvain, Belgium; [Wouters, Jan] Katholieke Univ Leuven, Dept Neurosci, ExpORL, B-3000 Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; University of London; University College London; University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich; KU Leuven; KU Leuven	Boets, B (corresponding author), Katholieke Univ Leuven, B-3000 Louvain, Belgium.	bart.boets@ppw.kuleuven.be	Wouters, Jan/D-1800-2015; Mantini, Dante/D-6989-2014; Ghesquière, Pol/B-9226-2009; Boets, Bart/AAB-1646-2020; Scott, Sophie K/A-1843-2010; Vandermosten, Maaike/AAC-2979-2021; Sunaert, Stefan/E-8031-2011	Wouters, Jan/0000-0002-0093-698X; Mantini, Dante/0000-0001-6485-5559; Ghesquière, Pol/0000-0001-9056-7550; Boets, Bart/0000-0002-4718-667X; Scott, Sophie K/0000-0001-7510-6297; Vandermosten, Maaike/0000-0002-9928-1580; Sunaert, Stefan/0000-0002-1177-4680; Op de Beeck, Hans/0000-0002-2250-212X; Gillebert, Celine/0000-0001-6686-7262	KU Leuven [OT/07/034, IDO/10/003]; Research Foundation Flanders [G0331.08]; European Research Council [ERC-2011-Stg-284101]; Federal Research Action [IUAP/PAI P7/11]; Queen Fabiola Foundation; Wellcome Trust [098771/Z/12/Z, 101253/Z/13/Z, WT090961MA]; Royal Society [101253/Z/13/Z]	KU Leuven(KU Leuven); Research Foundation Flanders(FWO); European Research Council(European Research Council (ERC)European Commission); Federal Research Action; Queen Fabiola Foundation; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	Supported by KU Leuven (OT/07/034, IDO/10/003), Research Foundation Flanders (G0331.08, postdoctoral fellowship of B. B. and M. V.), European Research Council (grant ERC-2011-Stg-284101), Federal Research Action (IUAP/PAI P7/11), Queen Fabiola Foundation, Wellcome Trust [Sir Henry Wellcome fellowship of C. R. G. (098771/Z/12/Z), Sir Henry Dale fellowship of D. M. (101253/Z/13/Z), and grant WT090961MA of S. K. S.], and the Royal Society (D. M.: 101253/Z/13/Z). Matlab scripts are available in the supplementary materials. We thank R. Peeters and H. Poelmans for assistance. B. B., H.P.O.d.B., M. V., S. K. S., S. S., J.W., and P. G. designed the study; B. B. and M. V. collected the data; B. B. analyzed the data and wrote the manuscript; H.P.O.d.B. and J.B. contributed to MVPA analyses; M. V. and S. S. contributed to DTI analyses; C. R. G. and D. M. contributed to functional connectivity analyses; and all authors discussed the results and commented on the manuscript.	Boets B, 2010, BRIT J DEV PSYCHOL, V28, P5, DOI 10.1348/026151010X485223; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; De Smedt B, 2010, NEUROPSYCHOLOGIA, V48, P3973, DOI 10.1016/j.neuropsychologia.2010.10.018; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Gillebert CR, 2013, NEUROSCIENTIST, V19, P509, DOI 10.1177/1073858412463168; Goswami U, 2000, Dyslexia, V6, P133, DOI 10.1002/(SICI)1099-0909(200004/06)6:2<133::AID-DYS160>3.0.CO;2-A; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Jehee JFM, 2011, J NEUROSCI, V31, P8210, DOI 10.1523/JNEUROSCI.6153-09.2011; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Obleser J, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00232; Op de Beeck HP, 2008, J NEUROSCI, V28, P10111, DOI 10.1523/JNEUROSCI.2511-08.2008; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Ramus F, 2012, COGN NEUROPSYCHOL, V29, P104, DOI 10.1080/02643294.2012.677420; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011; van der Mark S, 2011, NEUROIMAGE, V54, P2426, DOI 10.1016/j.neuroimage.2010.10.002; Vandermosten M, 2012, NEUROSCI BIOBEHAV R, V36, P1532, DOI 10.1016/j.neubiorev.2012.04.002; Vandermosten M, 2012, BRAIN, V135, P935, DOI 10.1093/brain/awr363; Vandermosten M, 2010, P NATL ACAD SCI USA, V107, P10389, DOI 10.1073/pnas.0912858107; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161	25	233	236	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1251	1254		10.1126/science.1244333	http://dx.doi.org/10.1126/science.1244333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24311693	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000327857900052
J	Dickey, SW; Baker, RP; Cho, S; Urban, S				Dickey, Seth W.; Baker, Rosanna P.; Cho, Sangwoo; Urban, Sinisa			Proteolysis inside the Membrane Is a Rate-Governed Reaction Not Driven by Substrate Affinity	CELL			English	Article							RHOMBOID PROTEASE; INTRAMEMBRANE PROTEOLYSIS; ESCHERICHIA-COLI; GAMMA-SECRETASE; PROVIDENCIA-STUARTII; MECHANISM; SPECIFICITY; CATALYSIS; IDENTIFICATION; GLYCOSYLASE	Enzymatic cleavage of transmembrane anchors to release proteins from the membrane controls diverse signaling pathways and is implicated in more than a dozen diseases. How catalysis works within the viscous, water-excluding, two-dimensional membrane is unknown. We developed an inducible reconstitution system to interrogate rhomboid proteolysis quantitatively within the membrane in real time. Remarkably, rhomboid proteases displayed no physiological affinity for substrates (K-d similar to 190 mu M/0.1 mol%). Instead, similar to 10,000-fold differences in proteolytic efficiency with substrate mutants and diverse rhomboid proteases were reflected in k(cat) values alone. Analysis of gate-open mutant and solvent isotope effects revealed that substrate gating, not hydrolysis, is rate limiting. Ultimately, a single proteolytic event within the membrane normally takes minutes. Rhomboid intramembrane proteolysis is thus a slow, kinetically controlled reaction not driven by transmembrane protein-protein affinity. These properties are unlike those of other studied proteases or membrane proteins but are strikingly reminiscent of one subset of DNA-repair enzymes, raising important mechanistic and drug-design implications.	[Dickey, Seth W.; Baker, Rosanna P.; Cho, Sangwoo; Urban, Sinisa] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Urban, S (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Room 507 PCTB,725 North Wolfe St, Baltimore, MD 21205 USA.	surban@jhmi.edu	Dickey, Seth/AIC-7671-2022	Baker, Rosanna/0000-0002-9970-6278	NIH [2R01AI066025, GM-103485]; Howard Hughes Medical Institute; David and Lucile Packard Foundation; NSF [DMR-0936384]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445, P41GM103485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant 2R01AI066025, the Howard Hughes Medical Institute, and the David and Lucile Packard Foundation. Part of this research was conducted using instruments at the Malaria Research Institute Biophysics Core (CD spectrometer), and CHESS (beamline supported by NSF grant DMR-0936384 and NIH grant GM-103485).	Adrain C, 2012, NAT REV MOL CELL BIO, V13, P489, DOI 10.1038/nrm3392; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/NCHEMBIO.1021, 10.1038/nchembio.1021]; Casci T, 1999, CANCER METAST REV, V18, P181, DOI 10.1023/A:1006313122373; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Doucet A, 2008, MOL CELL PROTEOMICS, V7, P1925, DOI 10.1074/mcp.R800012-MCP200; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; ELROD JP, 1980, J AM CHEM SOC, V102, P3917, DOI 10.1021/ja00531a039; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fleig L, 2012, MOL CELL, V47, P558, DOI 10.1016/j.molcel.2012.06.008; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Gallio M, 2002, P NATL ACAD SCI USA, V99, P12208, DOI 10.1073/pnas.192138799; HUMMEL JP, 1962, BIOCHIM BIOPHYS ACTA, V63, P530, DOI 10.1016/0006-3002(62)90124-5; Huntington JA, 2012, BBA-PROTEINS PROTEOM, V1824, P246, DOI 10.1016/j.bbapap.2011.07.005; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Lazareno-Saez C, 2013, J MOL BIOL, V425, P1127, DOI 10.1016/j.jmb.2013.01.019; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li XC, 2009, P NATL ACAD SCI USA, V106, P14837, DOI 10.1073/pnas.0903289106; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Makinoshima H, 2006, MICROBES INFECT, V8, P1882, DOI 10.1016/j.micinf.2006.02.021; Moin SM, 2012, ELIFE, V1, DOI 10.7554/eLife.00173; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Rather PN, 1999, J BACTERIOL, V181, P7185, DOI 10.1128/JB.181.23.7185-7191.1999; SCHNAITM.CA, 1970, J BACTERIOL, V104, P890, DOI 10.1128/JB.104.2.890-901.1970; SCHNAITM.CA, 1970, J BACTERIOL, V104, P882, DOI 10.1128/JB.104.2.882-889.1970; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2008, BIOL CHEM, V389, P1107, DOI 10.1515/BC.2008.122; Urban S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-231; Urban S, 2010, BIOCHEM J, V425, P501, DOI 10.1042/BJ20090861; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Vinothkumar KR, 2010, EMBO J, V29, P3797, DOI 10.1038/emboj.2010.243; Wilderman PJ, 2002, J BACTERIOL, V184, P4792, DOI 10.1128/JB.184.17.4792-4799.2002; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Xue Y, 2012, BIOCHEMISTRY-US, V51, P3723, DOI 10.1021/bi300368b; Xue Y, 2012, J BIOL CHEM, V287, P3099, DOI 10.1074/jbc.M111.310482; Zhang DN, 2006, BIOCHEMISTRY-US, V45, P14175, DOI 10.1021/bi061218m; Zhou YZ, 2012, STRUCTURE, V20, P1255, DOI 10.1016/j.str.2012.04.022	47	98	99	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1270	1281		10.1016/j.cell.2013.10.053	http://dx.doi.org/10.1016/j.cell.2013.10.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315097	Green Accepted, Bronze			2022-12-24	WOS:000328271100012
J	Ryan, SD; Dolatabadi, N; Chan, SF; Zhang, XF; Akhtar, MW; Parker, J; Soldner, F; Sunico, CR; Nagar, S; Talantova, M; Lee, B; Lopez, K; Nutter, A; Shan, B; Molokanova, E; Zhang, YY; Han, XM; Nakamura, T; Masliah, E; Yates, JR; Nakanishi, N; Andreyev, AY; Okamoto, S; Jaenisch, R; Ambasudhan, R; Lipton, SA				Ryan, Scott D.; Dolatabadi, Nima; Chan, Shing Fai; Zhang, Xiaofei; Akhtar, Mohd Waseem; Parker, James; Soldner, Frank; Sunico, Carmen R.; Nagar, Saumya; Talantova, Maria; Lee, Brian; Lopez, Kevin; Nutter, Anthony; Shan, Bing; Molokanova, Elena; Zhang, Yaoyang; Han, Xuemei; Nakamura, Tomohiro; Masliah, Eliezer; Yates, John R., III; Nakanishi, Nobuki; Andreyev, Aleksander Y.; Okamoto, Shu-ichi; Jaenisch, Rudolf; Ambasudhan, Rajesh; Lipton, Stuart A.			Isogenic Human iPSC Parkinson's Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1 alpha Transcription	CELL			English	Article							PROTEIN S-NITROSYLATION; PLURIPOTENT STEM-CELLS; ALPHA-SYNUCLEIN; NITRIC-OXIDE; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL-FUNCTION; MEF2; PARAQUAT; NEURONS; DIFFERENTIATION	Parkinson's disease (PD) is characterized by loss of A9 dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). An association has been reported between PD and exposure to mitochondrial toxins, including environmental pesticides paraquat, maneb, and rotenone. Here, using a robust, patient-derived stem cell model of PD allowing comparison of A53T alpha-synuclein (alpha-syn) mutant cells and isogenic mutation-corrected controls, we identify mitochondrial toxin-induced perturbations in A53T alpha-syn A9 DA neurons (hNs). We report a pathway whereby basal and toxin-induced nitrosative/oxidative stress results in S-nitrosylation of transcription factor MEF2C in A53T hNs compared to corrected controls. This redox reaction inhibits the MEF2-CPGC1 alpha transcriptional network, contributing to mitochondrial dysfunction and apoptotic cell death. Our data provide mechanistic insight into gene-environmental interaction (GxE) in the pathogenesis of PD. Furthermore, using small-molecule high-throughput screening, we identify the MEF2C-PGC1 alpha pathway as a therapeutic target to combat PD.	[Ryan, Scott D.; Dolatabadi, Nima; Chan, Shing Fai; Zhang, Xiaofei; Akhtar, Mohd Waseem; Parker, James; Sunico, Carmen R.; Nagar, Saumya; Talantova, Maria; Lee, Brian; Lopez, Kevin; Nutter, Anthony; Molokanova, Elena; Nakamura, Tomohiro; Nakanishi, Nobuki; Okamoto, Shu-ichi; Ambasudhan, Rajesh; Lipton, Stuart A.] Sanford Burnham Med Res Inst, Del E Web Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Soldner, Frank; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Shan, Bing; Zhang, Yaoyang; Han, Xuemei; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Andreyev, Aleksander Y.] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92039 USA; [Masliah, Eliezer; Lipton, Stuart A.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92039 USA	Sanford Burnham Prebys Medical Discovery Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu; rajesh@sbmri.org; slipton@sbmri.org		Andreyev, Alexander Y./0000-0002-9246-9943; Zhang, Yaoyang/0000-0001-5363-9834; Nagar, Saumya/0000-0002-9111-477X; Lipton, Stuart/0000-0002-3490-1259; Ryan, Scott/0000-0001-9829-4649	NIH [P01 HD29587, P01 ES016738, P30 NS076411]; United Mitochondrial Disease Foundation; Parkinson Society of Canada Fellowship;  [R37 CA084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198, R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS076411, R01NS086890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Mitochondrial Disease Foundation; Parkinson Society of Canada Fellowship; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants P01 HD29587, P01 ES016738, and P30 NS076411 (to S.A.L.); R37 CA084198 (to R.J.); United Mitochondrial Disease Foundation grant (to R.A.); and a Parkinson Society of Canada Fellowship (to S.D.R.).	Bonneh-Barkay D, 2005, ANTIOXID REDOX SIGN, V7, P649, DOI 10.1089/ars.2005.7.649; Chavarria C, 2013, ARCH BIOCHEM BIOPHYS, V533, P25, DOI 10.1016/j.abb.2013.02.009; Cho EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024027; Clark J, 2009, ANTIOXID REDOX SIGN, V11, P509, DOI 10.1089/ARS.2008.2241; Cooper O., 2012, SCI TRANSL MED, V4; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gomez C, 2007, FRONT BIOSCI-LANDMRK, V12, P1079, DOI 10.2741/2128; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Huang K, 2000, EMBO J, V19, P2615, DOI 10.1093/emboj/19.11.2615; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jones AWE, 2012, MITOCHONDRION, V12, P86, DOI 10.1016/j.mito.2011.09.009; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; LEIFER D, 1993, P NATL ACAD SCI USA, V90, P1546, DOI 10.1073/pnas.90.4.1546; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Li Z, 2008, J NEUROSCI, V28, P6557, DOI 10.1523/JNEUROSCI.0134-08.2008; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Moran JM, 2010, J BIOCHEM MOL TOXIC, V24, P402, DOI 10.1002/jbt.20348; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Nakamura T, 2013, NEURON, V78, P596, DOI 10.1016/j.neuron.2013.05.005; Nelson KJ, 2010, METHOD ENZYMOL, V473, P95, DOI 10.1016/S0076-6879(10)73004-4; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; Okamoto S, 2002, P NATL ACAD SCI USA, V99, P3974, DOI 10.1073/pnas.022036399; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Schildknecht S, 2013, J NEUROCHEM, V125, P491, DOI 10.1111/jnc.12226; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Shimizu K, 2001, BRAIN RES, V906, P135, DOI 10.1016/S0006-8993(01)02577-X; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Thiruchelvam MJ, 2004, EUR J NEUROSCI, V19, P845, DOI 10.1111/j.0953-816X.2004.03139.x; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wang Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002566; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	52	303	307	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1351	1364		10.1016/j.cell.2013.11.009	http://dx.doi.org/10.1016/j.cell.2013.11.009			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24290359	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000328271100018
J	Smetacek, V; Zingone, A				Smetacek, Victor; Zingone, Adriana			Green and golden seaweed tides on the rise	NATURE			English	Article							LARGEST MACROALGAL BLOOM; HARMFUL ALGAL BLOOMS; YELLOW SEA; ULVA-PROLIFERA; WATERS; ENTEROMORPHA; SARGASSUM; RESPONSES; GROWTH; REGION	Sudden beaching of huge seaweed masses smother the coastline and form rotting piles on the shore. The number of reports of these events in previously unaffected areas has increased worldwide in recent years. These 'seaweed tides' can harm tourism-based economies, smother aquaculture operations or disrupt traditional artisanal fisheries. Coastal eutrophication is the obvious, ultimate explanation for the increase in seaweed biomass, but the proximate processes that are responsible for individual beaching events are complex and require dedicated study to develop effective mitigation strategies. Harvesting the macroalgae, a valuable raw material, before they beach could well be developed into an effective solution.	[Smetacek, Victor] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, D-27570 Bremerhaven, Germany; [Zingone, Adriana] Ecol & Evolut Plankton, Stn Zool Anton Dohrn, I-80121 Naples, Italy	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Stazione Zoologica Anton Dohrn di Napoli	Smetacek, V (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Handelshafen 12, D-27570 Bremerhaven, Germany.	victor.smetacek@awi.de; zingone@szn.it	Zingone, Adriana/E-4518-2010	Zingone, Adriana/0000-0001-5946-6532				Ackah-Baidoo A, 2013, COMMUNITY DEV J, V48, P406, DOI 10.1093/cdj/bst022; Algae Industry Magazine, 2013, OLM OP ALG BIOR BRIT; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; [Anonymous], 2011, OPEN OCEAN J, DOI [10.2174/1874252101105010001, DOI 10.2174/1874252101105010001]; Back S, 2000, ANN BOT FENN, V37, P155; Blomster J, 2002, AM J BOT, V89, P1756, DOI 10.3732/ajb.89.11.1756; Charlier Roger H., 2008, International Journal of Environmental Studies, V65, P197, DOI 10.1080/00207230701791448; deVlas J., 2009, WADDEN SEA ECOSYSTEM, P1; Diaz M, 2013, ENVIRON INNOV SOC TR, V8, P62, DOI 10.1016/j.eist.2013.04.002; Fletcher RL., 1996, MARINE BENTHIC VEGET, P7, DOI [10.1007/978-3-642-61398-2_2, DOI 10.1007/978-3-642-61398-2_2]; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; GEERTZHANSEN O, 1993, AQUAT BOT, V46, P101, DOI 10.1016/0304-3770(93)90039-Y; GEOHAB, 2001, GLOB EC OC HARMF ALG; Gower JFR, 2011, INT J REMOTE SENS, V32, P1917, DOI 10.1080/01431161003639660; Gower J, 2013, REMOTE SENS LETT, V4, P764, DOI 10.1080/2150704X.2013.796433; Harder T, 2004, MAR ECOL PROG SER, V274, P133, DOI 10.3354/meps274133; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Hemphill A., 2013, CHANGE IS AIR SEAWEE; Hu CM, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005561; Jacobs A., 2013, NY TIMES; Jing L., 2013, S CHINA MORNING POST; JOHNSON DL, 1977, J EXP MAR BIOL ECOL, V28, P255, DOI 10.1016/0022-0981(77)90095-8; Kamermans Pauline, 2002, Aquatic Ecology, V36, P425, DOI 10.1023/A:1016551911754; Keesing JK, 2011, MAR POLLUT BULL, V62, P1169, DOI 10.1016/j.marpolbul.2011.03.040; Laffoley D., 2011, PROTECTION MANAGEMEN, P1; LAPOINTE BE, 1995, LIMNOL OCEANOGR, V40, P625, DOI 10.4319/lo.1995.40.3.0625; Arroyo NL, 2012, J EXP MAR BIOL ECOL, V420, P77, DOI 10.1016/j.jembe.2012.03.020; Lin HZ, 2011, ENVIRON SCI TECHNOL, V45, P5996, DOI 10.1021/es200579q; Liu DY, 2013, ESTUAR COAST SHELF S, V129, P2, DOI 10.1016/j.ecss.2013.05.021; Liu F, 2013, MAR ENVIRON RES, V83, P38, DOI 10.1016/j.marenvres.2012.10.007; McDiarmid J., 2011, W GHANAS FISHERFOLK; Nelson TA, 2003, J PHYCOL, V39, P874, DOI 10.1046/j.1529-8817.2003.02157.x; Norkko A, 1996, MAR ECOL PROG SER, V131, P143, DOI 10.3354/meps131143; Norkko A, 1996, MAR ECOL PROG SER, V140, P141, DOI 10.3354/meps140141; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; *S ATL FISH MAN CO, 2002, FISH MAN PLAN PEL SA; Saltmarsh M, 2010, NY TIMES; Samuel Henry, 2013, TELEGRAPH; Sfriso A, 1996, BIORESOURCE TECHNOL, V58, P299, DOI 10.1016/S0960-8524(96)00120-4; Sun S., 2008, NATURE PRECEDINGS, DOI 10101/npre.2008.2266.1; Teichberg M, 2010, GLOBAL CHANGE BIOL, V16, P2624, DOI 10.1111/j.1365-2486.2009.02108.x; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Viscusi G., 2011, BOSTON GLOBE; Williams A, 2010, ENVIRON MANAGE, V46, P738, DOI 10.1007/s00267-010-9558-3; Yabe T, 2009, LIMNOLOGY, V10, P239, DOI 10.1007/s10201-009-0278-4; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8; Zhang JH, 2013, J APPL PHYCOL, V25, P795, DOI 10.1007/s10811-012-9972-4; Zhang XW, 2010, J APPL PHYCOL, V22, P173, DOI 10.1007/s10811-009-9437-6	48	459	496	37	366	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 5	2013	504	7478					84	88		10.1038/nature12860	http://dx.doi.org/10.1038/nature12860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264BK	24305152	Green Published			2022-12-24	WOS:000327851700029
J	Zhang, YJJ; Reddy, MC; Ioerger, TR; Rothchild, AC; Dartois, V; Schuster, BM; Trauner, A; Wallis, D; Galaviz, S; Huttenhower, C; Sacchettini, JC; Behar, SM; Rubin, EJ				Zhang, Yanjia J.; Reddy, Manchi C.; Ioerger, Thomas R.; Rothchild, Alissa C.; Dartois, Veronique; Schuster, Brian M.; Trauner, Andrej; Wallis, Deeann; Galaviz, Stacy; Huttenhower, Curtis; Sacchettini, James C.; Behar, Samuel M.; Rubin, Eric J.			Tryptophan Biosynthesis Protects Mycobacteria from CD4 T-Cell-Mediated Killing	CELL			English	Article							INTERFERON-GAMMA; INDOLEAMINE 2,3-DIOXYGENASE; IMMUNE-RESPONSE; NITRIC-OXIDE; TUBERCULOSIS; PERSISTENCE; EXPRESSION; INFECTION; SURVIVAL; MACROPHAGES	Bacteria that cause disease rely on their ability to counteract and overcome host defenses. Here, we present a genome-scale study of Mycobacterium tuberculosis (Mtb) that uncovers the bacterial determinants of surviving host immunity, sets of genes we term "counteractomes." Through this analysis, we found that CD4 T cells attempt to contain Mtb growth by starving it of tryptophan-a mechanism that successfully limits infections by Chlamydia and Leishmania, natural tryptophan auxotrophs. Mtb, however, can synthesize tryptophan under stress conditions, and thus, starvation fails as an Mtb-killing mechanism. We then identify a small-molecule inhibitor of Mtb tryptophan synthesis, which converts Mtb into a tryptophan auxotroph and restores the efficacy of a failed host defense. Together, our findings demonstrate that the Mtb immune counteractomes serve as probes of host immunity, uncovering immune-mediated stresses that can be leveraged for therapeutic discovery.	[Zhang, Yanjia J.; Schuster, Brian M.; Trauner, Andrej; Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Reddy, Manchi C.; Wallis, Deeann; Galaviz, Stacy; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77842 USA; [Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci, College Stn, TX 77842 USA; [Rothchild, Alissa C.; Behar, Samuel M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Dartois, Veronique] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Huttenhower, Curtis] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Worcester; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Rubin, EJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	erubin@hsph.harvard.edu	Rothchild, Alissa/AAM-2635-2020	Rothchild, Alissa/0000-0001-7484-1193; Trauner, Andrej/0000-0002-6260-9829; Rubin, Eric/0000-0001-5120-962X; Behar, Samuel/0000-0002-3374-6699	National Institutes of Health [T32 GM007753, R01 AI 098637, P01 AI095208]; Herchel Smith Graduate Fellowship of Harvard; Wolfe-Welch Chair; Cambridge University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106725, R01AI098637, P01AI095208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herchel Smith Graduate Fellowship of Harvard; Wolfe-Welch Chair; Cambridge University(University of Cambridge); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael DeJesus, Chris Sassetti, and Justin Pritchard for their ongoing collaboration and thoughtful conversations about genomic profiling in Mtb. We thank Xiaohua Li and Spandana Valluru for technical support. Noman Sidddiqi and Larry Pipkin manage and run our BL3 facility; we thank them for their support. We thank our tremendous scientific community, including Marcia Goldberg, Laurence Rahme, Sarah Fortune, and Barry Bloom, for its constant support and feedback. The project described was supported by the National Institutes of Health (T32 GM007753 to Y.J.Z., R01 AI 098637 to S.M.B., and P01 AI095208 to J.C.S. and E.J.R.), the Herchel Smith Graduate Fellowship of Harvard and Cambridge University (to Y.J.Z.), and the Wolfe-Welch Chair (to J.C.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AlberatiGiani D, 1997, J IMMUNOL, V159, P419; [Anonymous], 2011, GLOB TUB CONTR 2011; BAKER TI, 1966, J BIOL CHEM, V241, P5577; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; Coggins JR, 2003, BIOCHEM SOC T, V31, P548, DOI 10.1042/BST0310548; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gallegos AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002052; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Ibana JA, 2011, INFECT IMMUN, V79, P4425, DOI 10.1128/IAI.05659-11; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Lesic B, 2007, PLOS PATHOG, V3, P1229, DOI 10.1371/journal.ppat.0030126; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parish T, 2003, J BACTERIOL, V185, P6702, DOI 10.1128/JB.185.22.6702-6706.2003; Pavelka MS, 2003, INFECT IMMUN, V71, P4190, DOI 10.1128/IAI.71.7.4190-4192.2003; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TARSHIS MS, 1953, AM REV TUBERC PULM, V67, P391; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; WHO, 2007, WHO TECH REP SER, V935, P1; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zhang YJJ, 2013, CELL MICROBIOL, V15, P1079, DOI 10.1111/cmi.12140; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946	46	216	221	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1296	1308		10.1016/j.cell.2013.10.045	http://dx.doi.org/10.1016/j.cell.2013.10.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315099	Bronze, Green Accepted			2022-12-24	WOS:000328271100014
J	Fierer, N; Ladau, J; Clemente, JC; Leff, JW; Owens, SM; Pollard, KS; Knight, R; Gilbert, JA; McCulley, RL				Fierer, Noah; Ladau, Joshua; Clemente, Jose C.; Leff, Jonathan W.; Owens, Sarah M.; Pollard, Katherine S.; Knight, Rob; Gilbert, Jack A.; McCulley, Rebecca L.			Reconstructing the Microbial Diversity and Function of Pre-Agricultural Tallgrass Prairie Soils in the United States	SCIENCE			English	Article							COMMUNITIES; VERRUCOMICROBIA; DISTRIBUTIONS; CULTIVATION; BACTERIA	Native tallgrass prairie once dominated much of the midwestern United States, but this biome and the soil microbial diversity that once sustained this highly productive system have been almost completely eradicated by decades of agricultural practices. We reconstructed the soil microbial diversity that once existed in this biome by analyzing relict prairie soils and found that the biogeographical patterns were largely driven by changes in the relative abundance of Verrucomicrobia, a poorly studied bacterial phylum that appears to dominate many prairie soils. Shotgun metagenomic data suggested that these spatial patterns were associated with strong shifts in carbon dynamics. We show that metagenomic approaches can be used to reconstruct below-ground biogeochemical and diversity gradients in endangered ecosystems; such information could be used to improve restoration efforts, given that even small changes in below-ground microbial diversity can have important impacts on ecosystem processes.	[Fierer, Noah; Leff, Jonathan W.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Fierer, Noah; Leff, Jonathan W.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Ladau, Joshua; Pollard, Katherine S.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94158 USA; [Clemente, Jose C.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Clemente, Jose C.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Owens, Sarah M.; Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Owens, Sarah M.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94143 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [McCulley, Rebecca L.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Francisco; The J David Gladstone Institutes; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Chicago; University of Kentucky	Fierer, N (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	noah.fierer@colorado.edu	Knight, Rob/D-1299-2010; Gilbert, Jack/AAF-3270-2019	Knight, Rob/0000-0002-0975-9019; Owens, Sarah/0000-0002-9946-2787	NSF [DEB-0953331, DMS-1069303]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [3300]; U.S. Department of Energy [DE-AC02-06CH11357]; USDA National Research Initiative [2005-35101-15335/17371]	NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); U.S. Department of Energy(United States Department of Energy (DOE)); USDA National Research Initiative(United States Department of Agriculture (USDA))	We thank K. McLauchlan and three anonymous reviewers for their critical feedback on earlier versions of the manuscript; R. Jackson for his help with soil collection and analyses; and J. Henley for her help with the laboratory analyses. Supported by NSF grants DEB-0953331 (N.F.) and DMS-1069303 (K. S. P.), the Howard Hughes Medical Institute (R. K.), Gordon and Betty Moore Foundation grant 3300 (K. S. P.), U.S. Department of Energy contract DE-AC02-06CH11357 (J. A. G.), and USDA National Research Initiative 2005-35101-15335/17371 (R. L. M.). All amplicon data have been deposited in the European Nucleotide Archive under accession number ERP003610; the accession number for the shotgun metagenomic data is ERP003954. Data have also been made available through the Dryad data depository.	Allison VJ, 2007, SOIL BIOL BIOCHEM, V39, P505, DOI 10.1016/j.soilbio.2006.08.021; [Anonymous], 2010, MAPPING SPECIES DIST; Baer SG, 2002, ECOL APPL, V12, P1688, DOI 10.1890/1051-0761(2002)012[1688:CIESAF]2.0.CO;2; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bradford MA, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P189; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; da Rocha UN, 2010, J SOIL SEDIMENT, V10, P326, DOI 10.1007/s11368-009-0160-3; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2012, NAT METHODS, V9, P549, DOI 10.1038/nmeth.2041; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Gilbert Jack A, 2011, Microb Inform Exp, V1, P5, DOI 10.1186/2042-5783-1-5; Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709; Harris J, 2009, SCIENCE, V325, P573, DOI 10.1126/science.1172975; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Herlemann DPR, 2013, MBIO, V4, DOI 10.1128/mBio.00569-12; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Huggins DR, 1998, SOIL TILL RES, V47, P219, DOI 10.1016/S0167-1987(98)00108-1; Jangid K, 2010, SOIL BIOL BIOCHEM, V42, P302, DOI 10.1016/j.soilbio.2009.11.008; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Kardol P, 2010, TRENDS ECOL EVOL, V25, P670, DOI 10.1016/j.tree.2010.09.001; Ladau J, 2013, ISME J, V7, P1669, DOI 10.1038/ismej.2013.37; Martinson EJ, 2011, PHYS GEOGR, V32, P583, DOI 10.2747/0272-3646.32.6.583; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; Sims P. L., 2000, N AM TERRESTRIAL VEG, P325	29	327	355	26	516	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					621	624		10.1126/science.1243768	http://dx.doi.org/10.1126/science.1243768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179225				2022-12-24	WOS:000326334300049
J	Fanucchi, S; Shibayama, Y; Burd, S; Weinberg, MS; Mhlanga, MM				Fanucchi, Stephanie; Shibayama, Youtaro; Burd, Shaun; Weinberg, Marc S.; Mhlanga, Musa M.			Chromosomal Contact Permits Transcription between Coregulated Genes	CELL			English	Article							RANGE DNA INTERACTIONS; DOUBLE-STRAND BREAKS; INTERCHROMOSOMAL ASSOCIATIONS; CHROMATIN INTERACTIONS; TAL EFFECTORS; HUMAN-CELLS; IN-VIVO; GENOME; ORGANIZATION; EXPRESSION	Transcription of coregulated genes occurs in the context of long-range chromosomal contacts that form multigene complexes. Such contacts and transcription are lost in knockout studies of transcription factors and structural chromatin proteins. To ask whether chromosomal contacts are required for cotranscription in multigene complexes, we devised a strategy using TALENs to cleave and disrupt gene loops in a well-characterized multigene complex. Monitoring this disruption using RNA FISH and immunofluorescence microscopy revealed that perturbing the site of contact had a direct effect on transcription of other interacting genes. Unexpectedly, this effect on cotranscription was hierarchical, with dominant and subordinate members of the multigene complex engaged in both intra-and interchromosomal contact. This observation reveals the profound influence of these chromosomal contacts on the transcription of coregulated genes in a multigene complex.	[Fanucchi, Stephanie; Shibayama, Youtaro; Burd, Shaun; Mhlanga, Musa M.] CSIR, Gene Express & Biophys Grp, Synthet Biol Emerging Res Area, Biosci Unit, ZA-0001 Pretoria, Gauteng, South Africa; [Mhlanga, Musa M.] Univ Lisbon, Fac Med, Inst Mol Med, Unidade Biofis & Expressao Genet, P-1649028 Lisbon, Portugal; [Weinberg, Marc S.] Univ Witwatersrand, Antiviral Gene Therapy Res Unit, Dept Mol Med & Haematol, Sch Pathol,Fac Hlth Sci, ZA-2193 Johannesburg, Gauteng, South Africa; [Weinberg, Marc S.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Council for Scientific & Industrial Research (CSIR) - South Africa; Universidade de Lisboa; University of Witwatersrand; Scripps Research Institute	Mhlanga, MM (corresponding author), CSIR, Gene Express & Biophys Grp, Synthet Biol Emerging Res Area, Biosci Unit, ZA-0001 Pretoria, Gauteng, South Africa.	yoda@mhlangalab.org	Weinberg, Marc/B-4669-2009; Mhlanga, Musa/D-1283-2011	Weinberg, Marc/0000-0002-1997-2171; Mhlanga, Musa/0000-0003-1381-3409	Claude Leon Foundation, South Africa; Council for Industrial and Scientific Research (CSIR, South Africa) [PGV2KYP07]; Emerging Research Area Program of The Department of Science and Technology (DST, South Africa); Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [PTDC/SAU- GMG/115652/2009]	Claude Leon Foundation, South Africa; Council for Industrial and Scientific Research (CSIR, South Africa); Emerging Research Area Program of The Department of Science and Technology (DST, South Africa); Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology)	We thank all members of the Gene Expression and Biophysics Laboratory. We thank A. Lenox for experimental help and advice. We thank A. Premo for assistance with graphics and cartoons and S. Barichievy, A. Gontijo, F. Brombacher, P. Tomancak, and D. Henriques for comments on the manuscript. S. F. and Y. S. are recipients of postdoctoral fellowships from the Claude Leon Foundation, South Africa. This research is supported by grant PGV2KYP07 from the Council for Industrial and Scientific Research (CSIR, South Africa) and by a grant from the Emerging Research Area Program of The Department of Science and Technology (DST, South Africa) and grant PTDC/SAU- GMG/115652/2009 from the Fundacao para a Ciencia e a Tecnologia (FCT, Portugal), all to M.M.M.	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Barbieri M, 2013, BIOCHEM SOC T, V41, P508, DOI 10.1042/BST20120238; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cisse II, 2013, SCIENCE, V341, P664, DOI 10.1126/science.1239053; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Harewood L, 2010, GENOME RES, V20, P554, DOI 10.1101/gr.103622.109; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Larkin JD, 2013, J CELL SCI, V126, P2052, DOI 10.1242/jcs.123653; Larkin JD, 2012, MOL CELL BIOL, V32, P2738, DOI 10.1128/MCB.00179-12; Levesque MJ, 2013, NAT METHODS, V10, P246, DOI [10.1038/NMETH.2372, 10.1038/nmeth.2372]; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Orlova DY, 2012, J CELL BIOCHEM, V113, P3313, DOI 10.1002/jcb.24208; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001661; Papantonis A., 2010, PLOS BIOL, V8; Papantonis A, 2012, EMBO J, V31, P4404, DOI 10.1038/emboj.2012.288; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sandhu KS, 2012, CELL REP, V2, P1207, DOI 10.1016/j.celrep.2012.09.022; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106	41	141	147	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					606	620		10.1016/j.cell.2013.09.051	http://dx.doi.org/10.1016/j.cell.2013.09.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243018	Bronze			2022-12-24	WOS:000326571800015
J	Fites, JS; Ramsey, JP; Holden, WM; Collier, SP; Sutherland, DM; Reinert, LK; Gayek, AS; Dermody, TS; Aune, TM; Oswald-Richter, K; Rollins-Smith, LA				Fites, J. Scott; Ramsey, Jeremy P.; Holden, Whitney M.; Collier, Sarah P.; Sutherland, Danica M.; Reinert, Laura K.; Gayek, A. Sophia; Dermody, Terence S.; Aune, Thomas M.; Oswald-Richter, Kyra; Rollins-Smith, Louise A.			The Invasive Chytrid Fungus of Amphibians Paralyzes Lymphocyte Responses	SCIENCE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; SACCHAROMYCES-CEREVISIAE; IMMUNE DEFENSES; CELL-DEATH; CHYTRIDIOMYCOSIS; DECLINES; FROGS; PATHOGENESIS; EXPRESSION; INFECTION	The chytrid fungus, Batrachochytrium dendrobatidis, causes chytridiomycosis and is a major contributor to global amphibian declines. Although amphibians have robust immune defenses, clearance of this pathogen is impaired. Because inhibition of host immunity is a common survival strategy of pathogenic fungi, we hypothesized that B. dendrobatidis evades clearance by inhibiting immune functions. We found that B. dendrobatidis cells and supernatants impaired lymphocyte proliferation and induced apoptosis; however, fungal recognition and phagocytosis by macrophages and neutrophils was not impaired. Fungal inhibitory factors were resistant to heat, acid, and protease. Their production was absent in zoospores and reduced by nikkomycin Z, suggesting that they may be components of the cell wall. Evasion of host immunity may explain why this pathogen has devastated amphibian populations worldwide.	[Fites, J. Scott; Rollins-Smith, Louise A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Ramsey, Jeremy P.; Holden, Whitney M.; Collier, Sarah P.; Sutherland, Danica M.; Reinert, Laura K.; Gayek, A. Sophia; Dermody, Terence S.; Aune, Thomas M.; Oswald-Richter, Kyra; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Dermody, Terence S.; Rollins-Smith, Louise A.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Aune, Thomas M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Rollins-Smith, LA (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	louise.rollins-smith@vanderbilt.edu		Sutherland, Danica/0000-0001-9328-4994	NSF [IOS-0619536, IOS-0843207, IOS-1121758]; NIH [AI044924, AI007281, AI038296, 1K01HL103179-01]; The Foundation for Sarcoidosis Research; Vanderbilt University; NSF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044924, R01AI038296, R37AI038296, T32AI007281, R56AI044924] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Foundation for Sarcoidosis Research; Vanderbilt University; NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NSF grants IOS-0619536, IOS-0843207, and IOS-1121758 (to L. A. R-S.); NIH grants AI044924 (to T. M. A.), AI007281 (to D. M. S.), AI038296 (to T. S. D.), 1K01HL103179-01, The Foundation for Sarcoidosis Research (to K.O-R.) and a dissertation enhancement grant from Vanderbilt University (to J.S.F.). W. M. H. was supported by an individual NSF Graduate Research Fellowship. We thank J. Galgiani, director of the Valley Fever Center for Excellence of the University of Arizona, for the gift of nikkomycin Z under a Materials Transfer Agreement. Anti-Xenopus monoclonal antibodies were provided by the University of Rochester Xenopus laevis Research Resource for Immunobiology. All data necessary to understand this manuscript are presented in the main text or supplementary materials.	Ben-Ami R, 2010, BRIT J HAEMATOL, V150, P406, DOI 10.1111/j.1365-2141.2010.08283.x; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Campanelli AP, 2003, J INFECT DIS, V187, P1496, DOI 10.1086/374646; Collette JR, 2011, CURR OPIN MICROBIOL, V14, P668, DOI 10.1016/j.mib.2011.09.007; Collins JP, 2010, DIS AQUAT ORGAN, V92, P93, DOI 10.3354/dao02307; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; GAUGHRAN JP, 1994, J BACTERIOL, V176, P5857, DOI 10.1128/JB.176.18.5857-5860.1994; Joneson S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002338; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1111/j.1574-6976.2002.tb00613.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Mazzoni R, 2003, EMERG INFECT DIS, V9, P995; Morales H, 2003, CELL STRESS CHAPERON, V8, P265, DOI 10.1379/1466-1268(2003)008<0265:BSUTSE>2.0.CO;2; Pericolini E, 2009, J IMMUNOL, V182, P6003, DOI 10.4049/jimmunol.0803833; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; ROLLINSSMITH LA, 1984, IMMUNOLOGY, V52, P491; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Vecchiarelli A, 2012, MYCOPATHOLOGIA, V173, P375, DOI 10.1007/s11046-011-9513-8; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Woodhams Douglas C., 2008, Herpetological Review, V39, P66	29	129	130	0	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					366	369		10.1126/science.1243316	http://dx.doi.org/10.1126/science.1243316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24136969	Green Accepted			2022-12-24	WOS:000325755100047
J	Tauxe, GM; MacWilliam, D; Boyle, SM; Guda, T; Ray, A				Tauxe, Genevieve M.; MacWilliam, Dyan; Boyle, Sean Michael; Guda, Tom; Ray, Anandasankar			Targeting a Dual Detector of Skin and CO2 to Modify Mosquito Host Seeking	CELL			English	Article							VECTOR ANOPHELES-GAMBIAE; MM-X TRAPS; CARBON-DIOXIDE; MALARIA MOSQUITO; AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; AVOIDANCE-BEHAVIOR; FLIGHT MANEUVERS; RECEPTOR NEURONS; MAXILLARY PALP	Female mosquitoes that transmit deadly diseases locate human hosts by detecting exhaled CO2 and skin odor. The identities of olfactory neurons and receptors required for attraction to skin odor remain a mystery. Here, we show that the CO2-sensitive olfactory neuron is also a sensitive detector of human skin odorants in both Aedes aegypti and Anopheles gambiae. We demonstrate that activity of this neuron is important for attraction to skin odor, establishing it as a key target for intervention. We screen similar to 0.5 million compounds in silico and identify several CO2 receptor ligands, including an antagonist that reduces attraction to skin and an agonist that lures mosquitoes to traps as effectively as CO2. Analysis of the CO2 receptor ligand space provides a foundation for understanding mosquito host-seeking behavior and identifies odors that are potentially safe, pleasant, and affordable for use in a new generation of mosquito control strategies worldwide.	[Tauxe, Genevieve M.; MacWilliam, Dyan; Boyle, Sean Michael; Guda, Tom; Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Ray, Anandasankar] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Ray, A (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	anand.ray@ucr.edu		Ray, Anandasankar/0000-0003-4133-2581	NSF IGERT fellowship; University of California Global Health Institute; Bill and Melinda Gates Foundation; NIH (NIAID) [RO1AI087785, R56AI099778]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099778, R01AI087785] Funding Source: NIH RePORTER	NSF IGERT fellowship(National Science Foundation (NSF)); University of California Global Health Institute; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J.S. Perecko for building behavior equipment; L.B. Vosshall for kindly providing orco mutants; S.T. Chen for preliminary studies; J.S. McElfresh and W. van der Goes van Naters for assistance with EAG; K.A. Klinger, E.S. Lacey, M.C. Wirth, W.E. Walton, and B.J. White for providing mosquitoes; R.T. Carde and members of the Ray lab for useful discussions. S.M.B. was partly supported by an NSF IGERT fellowship. G.M.T. was partly supported by a summer research fellowship from the University of California Global Health Institute and the Bill and Melinda Gates Foundation. This work was supported by grants to A.R. from the NIH (NIAID), award numbers RO1AI087785 and R56AI099778. A.R., S.M.B., and D.M. are listed as inventors on pending patent applications filed by the University of California, Riverside. A.R. is a founding member of Olfactor Labs Inc., that has licensed pending patents from the University.	Belsito D, 2012, FOOD CHEM TOXICOL, V50, pS517, DOI 10.1016/j.fct.2012.04.019; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bjostad L., 1998, METHODS CHEM ECOLOGY, V1, P339; Boyle SM, 2013, ELIFE, V2, DOI 10.7554/eLife.01120; Carde RT, 2010, ECOL CONT VECTOR-BOR, V2, P115; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cooperband MF, 2006, MED VET ENTOMOL, V20, P11, DOI 10.1111/j.1365-2915.2006.00613.x; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dekker T, 2011, J EXP BIOL, V214, P3480, DOI 10.1242/jeb.055186; Dormont L, 2013, J CHEM ECOL, V39, P569, DOI 10.1007/s10886-013-0286-z; Erdelyan CNG, 2012, INSECT MOL BIOL, V21, P119, DOI 10.1111/j.1365-2583.2011.01120.x; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; Geier M, 1999, J EXP BIOL, V202, P1639; Ghaninia M, 2008, J EXP BIOL, V211, P3020, DOI 10.1242/jeb.016360; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Grant AJ, 1996, CIBA F SYMP, V200, P233; HEALY TP, 1995, MED VET ENTOMOL, V9, P331, DOI 10.1111/j.1365-2915.1995.tb00143.x; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Karatzoglou A, 2006, J STAT SOFTW, V15; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Kwon HW, 2006, P NATL ACAD SCI USA, V103, P13526, DOI 10.1073/pnas.0601107103; Lacey ES, 2011, MED VET ENTOMOL, V25, P94, DOI 10.1111/j.1365-2915.2010.00921.x; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Mboera LEG, 2000, B ENTOMOL RES, V90, P155, DOI 10.1017/S0007485300000262; Munch D, 2013, CHEM SENSES, V38, P293, DOI 10.1093/chemse/bjs138; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; SCHRECK CE, 1982, J CHEM ECOL, V8, P429, DOI 10.1007/BF00987791; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Smallegange RC, 2010, ECOL CONT VECTOR-BOR, V2, P143; Smallegange RC, 2010, J MED ENTOMOL, V47, P338, DOI 10.1603/ME09015; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Xue RD, 2008, J AM MOSQUITO CONTR, V24, P249, DOI 10.2987/5701.1	48	98	106	3	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1365	1379		10.1016/j.cell.2013.11.013	http://dx.doi.org/10.1016/j.cell.2013.11.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315103	Bronze, Green Accepted			2022-12-24	WOS:000328271100019
J	Norman, TM; Lord, ND; Paulsson, J; Losick, R				Norman, Thomas M.; Lord, Nathan D.; Paulsson, Johan; Losick, Richard			Memory and modularity in cell-fate decision making	NATURE			English	Article							STOCHASTIC GENE-EXPRESSION; BACILLUS-SUBTILIS; SINGLE-CELL; MASTER REGULATOR; POPULATION HETEROGENEITY; EPIGENETIC INHERITANCE; BIOFILM FORMATION; NOISE; SWITCH; PROTEIN	Genetically identical cells sharing an environment can display markedly different phenotypes. It is often unclear how much of this variation derives from chance, external signals, or attempts by individual cells to exert autonomous phenotypic programs. By observing thousands of cells for hundreds of consecutive generations under constant conditions, we dissect the stochastic decision between a solitary, motile state and a chained, sessile state in Bacillus subtilis. We show that the motile state is 'memoryless', exhibiting no autonomous control over the time spent in the state. In contrast, the time spent as connected chains of cells is tightly controlled, enforcing coordination among related cells in the multicellular state. We show that the three-protein regulatory circuit governing the decision is modular, as initiation and maintenance of chaining are genetically separable functions. As stimulation of the same initiating pathway triggers biofilm formation, we argue that autonomous timing allows a trial commitment to multicellularity that external signals could extend.	[Norman, Thomas M.; Lord, Nathan D.; Paulsson, Johan] Harvard Univ, Sch Med, Dept Systemat Bot, Boston, MA 02115 USA; [Losick, Richard] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Paulsson, J (corresponding author), Harvard Univ, Sch Med, Dept Systemat Bot, Boston, MA 02115 USA.	Johan_Paulsson@hms.harvard.edu; losick@mcb.harvard.edu		Lord, Nathan/0000-0001-9553-2779	National Science Foundation [ECS-0335765]; NIH [GM18568, GM081563]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018568, R37GM018568, R01GM081563] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Lindner for sharing an early version of the microfluidic mother machine with our groups. We thank Y. Chai for discussions and C. Saenz, V. Lien, S. Hickman, J. Tresback and J. Deng for technical help with microfluidic fabrication. This work was performed in part at the Harvard Medical School Microfluidics Facility and in part at the Center for Nanoscale Systems(CNS), a member of the National Nanotechnology Infrastructure Network (NNIN), which is supported by the National Science Foundation under NSF award no. ECS-0335765. CNS is part of Harvard University. This work was supported by grants from the NIH to R.L. (GM18568) and J.P (GM081563).	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Aldous D., 1989, PROBABILITY APPROXIM; BAI U, 1993, GENE DEV, V7, P139, DOI 10.1101/gad.7.1.139; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Beauregard PB, 2013, P NATL ACAD SCI USA, V110, pE1621, DOI 10.1073/pnas.1218984110; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Chai YR, 2010, MOL MICROBIOL, V78, P218, DOI 10.1111/j.1365-2958.2010.07335.x; Chai YR, 2010, GENE DEV, V24, P754, DOI 10.1101/gad.1915010; Chen R, 2009, J BACTERIOL, V191, P5775, DOI 10.1128/JB.00521-09; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DELANGE RJ, 1976, J BIOL CHEM, V251, P705; Diard M, 2013, NATURE, V494, P353, DOI 10.1038/nature11913; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Huang GH, 2006, P NATL ACAD SCI USA, V103, P12813, DOI 10.1073/pnas.0605270103; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kolodkin-Gal I, 2013, GENE DEV, V27, P887, DOI 10.1101/gad.215244.113; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Mather W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.208101; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; MUTH EJ, 1980, IEEE T RELIAB, V29, P160, DOI 10.1109/TR.1980.5220764; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Newman JA, 2013, J BIOL CHEM, V288, P10766, DOI 10.1074/jbc.M113.455592; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Robert L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.12; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rubinstein SM, 2012, MOL MICROBIOL, V86, P426, DOI 10.1111/j.1365-2958.2012.08201.x; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Teng SW, 2013, SCIENCE, V340, P737, DOI 10.1126/science.1230996; Tolkamp BJ, 2010, APPL ANIM BEHAV SCI, V124, P1, DOI 10.1016/j.applanim.2010.02.004; Ullman G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0025; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; WEHRLI M, 1995, DEVELOPMENT, V121, P2451	51	155	155	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					481	+		10.1038/nature12804	http://dx.doi.org/10.1038/nature12804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24256735	Green Accepted, Green Submitted			2022-12-24	WOS:000327464200034
J	Tardiff, DF; Jui, NT; Khurana, V; Tambe, MA; Thompson, ML; Chung, CY; Kamadurai, HB; Kim, HT; Lancaster, AK; Caldwell, KA; Caldwell, GA; Rochet, JC; Buchwald, SL; Lindquist, S				Tardiff, Daniel F.; Jui, Nathan T.; Khurana, Vikram; Tambe, Mitali A.; Thompson, Michelle L.; Chung, Chee Yeun; Kamadurai, Hari B.; Kim, Hyoung Tae; Lancaster, Alex K.; Caldwell, Kim A.; Caldwell, Guy A.; Rochet, Jean-Christophe; Buchwald, Stephen L.; Lindquist, Susan			Yeast Reveal a "Druggable" Rsp5/Nedd4 Network that Ameliorates alpha-Synuclein Toxicity in Neurons	SCIENCE			English	Article							VESICLE TRAFFICKING; PROTEIN; PHOSPHORYLATION; CEREVISIAE; DEFECTS; VPS35	alpha-Synuclein (alpha-syn) is a small lipid-binding protein implicated in several neurodegenerative diseases, including Parkinson's disease, whose pathobiology is conserved from yeast to man. There are no therapies targeting these underlying cellular pathologies, or indeed those of any major neurodegenerative disease. Using unbiased phenotypic screens as an alternative to target-based approaches, we discovered an N-aryl benzimidazole (NAB) that strongly and selectively protected diverse cell types from alpha-syn toxicity. Three chemical genetic screens in wild-type yeast cells established that NAB promoted endosomal transport events dependent on the E3 ubiquitin ligase Rsp5/Nedd4. These same steps were perturbed by alpha-syn itself. Thus, NAB identifies a druggable node in the biology of alpha-syn that can correct multiple aspects of its underlying pathology, including dysfunctional endosomal and endoplasmic reticulum-to-Golgi vesicle trafficking.	[Tardiff, Daniel F.; Khurana, Vikram; Chung, Chee Yeun; Lancaster, Alex K.; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jui, Nathan T.; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Khurana, Vikram] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Khurana, Vikram] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Tambe, Mitali A.; Rochet, Jean-Christophe] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Thompson, Michelle L.; Caldwell, Kim A.; Caldwell, Guy A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Kamadurai, Hari B.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38018 USA; [Kim, Hyoung Tae] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Lindquist, Susan] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Alabama System; University of Alabama Tuscaloosa; St Jude Children's Research Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Tambe, Mitali/AGX-3558-2022; Lancaster, Alexander K/K-2855-2013; Kamadurai, Hari/K-4056-2013	Tambe, Mitali/0000-0001-9389-2308; Lancaster, Alexander K/0000-0002-0002-9263; Thompson, Michelle/0000-0001-8134-9017; Khurana, Vikram/0000-0002-4018-5527; Caldwell, Kim/0000-0003-1580-6122; Caldwell, Guy/0000-0002-8283-9090; Kamadurai, Hari/0000-0001-8218-7777; Rochet, Jean-Christophe/0000-0002-6484-1541; Kim, Hyoung Tae/0000-0002-0270-2749; HyoungTae, Kim/0000-0002-2482-6064; Kamadurai, Hari/0000-0001-9021-0279	NIH [5R01GM069530, GM58160]; National Research Service Award (NRSA) fellowship [F32NS061419, F32GM099817]; JPB Foundation; Eleanor Schwartz Charitable Foundation; HHMI; Bachmann-Strauss Dystonia & Parkinson Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069530, R01GM058160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS061419, R15NS075684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG038546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award (NRSA) fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Eleanor Schwartz Charitable Foundation; HHMI(Howard Hughes Medical Institute); Bachmann-Strauss Dystonia & Parkinson Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Kumar for providing the plasmid Tn7 library; B. Wendland and L. Hicke for the Rsp5 antibody; the WIBR Genome Technology Core for Illumina Sequencing; B. Schulman (B. Schulman and H.B.K. were funded by NIH grant 5R01GM069530) and A. Goldberg for help with in vitro ubiquitination assays; T. DiCesare for graphics support; and members of the Lindquist Lab for helpful comments on the manuscript. S.L. is an investigator for HHMI. D.F.T. was funded by a National Research Service Award (NRSA) fellowship F32NS061419 and research supported by the JPB Foundation (D.F.T. and S.L.), the Eleanor Schwartz Charitable Foundation, and an HHMI Collaborative Innovation Award (D.F.T., V.K., C.Y.C., and S.L.; G.A.C., K.A.C., and M.L.T.; and J.-C.R. and M.A.T.). N.T.J. was funded by a NRSA fellowship (F32GM099817), and N.T.J. and S.L.B. were funded by NIH grant GM58160. H.T.K. was funded by the Bachmann-Strauss Dystonia & Parkinson Foundation. Genome sequencing data are deposited in the National Center for Biotechnology Information under BioProject accession number PRJNA222476. WIBR and MIT have filed a patent application, on which D.F.T., N.T.J., S.L.B., and S.L. are inventors, relating to use of compounds described here in treatment of neurodegenerative diseases. In addition, S.L. is an inventor on patents and patent applications filed by the University of Chicago relating to methods of screening for compounds that decrease alpha-syn-associated toxicity using yeast that express alpha-syn. All the yeast plasmids and strains and NAB are available under a Uniform Biological Material Transfer Agreement from the Whitehead Institute.	Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Esposito G, 2012, DEV NEUROBIOL, V72, P134, DOI 10.1002/dneu.20916; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kumar Anuj, 2008, V416, P117, DOI 10.1007/978-1-59745-321-9_8; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; MacDonald C, 2012, TRAFFIC, V13, P586, DOI 10.1111/j.1600-0854.2011.01326.x; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Menant A, 2006, EMBO J, V25, P4436, DOI 10.1038/sj.emboj.7601330; Omura F, 2001, FEMS MICROBIOL LETT, V194, P207, DOI 10.1016/S0378-1097(00)00532-2; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sancenon V, 2012, HUM MOL GENET, V21, P2432, DOI 10.1093/hmg/dds058; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith AM, 2010, PHARMACOL THERAPEUT, V127, P156, DOI 10.1016/j.pharmthera.2010.04.012; Soper JH, 2011, J MOL NEUROSCI, V43, P391, DOI 10.1007/s12031-010-9455-5; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tardiff DF, 2012, J BIOL CHEM, V287, P4107, DOI 10.1074/jbc.M111.308668; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Zabrocki P, 2008, BBA-MOL CELL RES, V1783, P1767, DOI 10.1016/j.bbamcr.2008.06.010; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	25	189	194	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	2013	342	6161					979	983		10.1126/science.1245321	http://dx.doi.org/10.1126/science.1245321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EZ	24158909	Green Accepted, Green Submitted			2022-12-24	WOS:000327223500043
J	Nakamura, Y; Oscherwitz, J; Cease, KB; Chan, SM; Munoz-Planillo, R; Hasegawa, M; Villaruz, AE; Cheung, GYC; McGavin, MJ; Travers, JB; Otto, M; Inohara, N; Nunez, G				Nakamura, Yuumi; Oscherwitz, Jon; Cease, Kemp B.; Chan, Susana M.; Munoz-Planillo, Raul; Hasegawa, Mizuho; Villaruz, Amer E.; Cheung, Gordon Y. C.; McGavin, Martin J.; Travers, Jeffrey B.; Otto, Michael; Inohara, Naohiro; Nunez, Gabriel			Staphylococcus delta-toxin induces allergic skin disease by activating mast cells	NATURE			English	Article							AUREUS; VIRULENCE; IGE; MICE; IDENTIFICATION; DEFICIENT; RESPONSES; RELEASE; GROWTH; PHASE	Atopic dermatitis is a chronic inflammatory skin disease that affects 15-30% of children and approximately 5% of adults in industrialized countries(1). Although the pathogenesis of atopic dermatitis is not fully understood, the disease is mediated by an abnormal immunoglobulin E immune response in the setting of skin barrier dysfunction(2). Mast cells contribute to immunoglobulin-E-mediated allergic disorders including atopic dermatitis(3). Upon activation, mast cells release their membrane-bound cytosolic granules leading to the release of several molecules that are important in the pathogenesis of atopic dermatitis and host defence(4). More than 90% of patients with atopic dermatitis are colonized with Staphylococcus aureus in the lesional skin whereas most healthy individuals do not harbour the pathogen(5). Several staphylococcal exotoxins can act as superantigens and/or antigens in models of atopic dermatitis(6). However, the role of these staphylococcal exotoxins in disease pathogenesis remains unclear. Here we report that culture supernatants of S. aureus contain potent mast-cell degranulation activity. Biochemical analysis identified delta-toxin as the mast cell degranulation-inducing factor produced by S. aureus. Mast cell degranulation induced by delta-toxin depended on phosphoinositide 3-kinase and calcium (Ca2+) influx; however, unlike that mediated by immunoglobulin-E crosslinking, it did not require the spleen tyrosine kinase. In addition, immunoglobulin-E enhanced delta-toxin-induced mast cell degranulation in the absence of antigen. Furthermore, S. aureus isolates recovered from patients with atopic dermatitis produced large amounts of delta-toxin. Skin colonization with S. aureus, but not a mutant deficient in delta-toxin, promoted immunoglobulin-E and interleukin-4 production, as well as inflammatory skin disease. Furthermore, enhancement of immunoglobulin E production and dermatitis by delta-toxin was abrogated in Kit(W-sh/W-sh) mast-cell-deficient mice and restored by mast cell reconstitution. These studies identify delta-toxin as a potent inducer of mast cell degranulation and suggest a mechanistic link between S. aureus colonization and allergic skin disease.	[Nakamura, Yuumi; Chan, Susana M.; Munoz-Planillo, Raul; Hasegawa, Mizuho; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Nakamura, Yuumi; Chan, Susana M.; Munoz-Planillo, Raul; Hasegawa, Mizuho; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Oscherwitz, Jon; Cease, Kemp B.] Univ Michigan, Sch Med, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Oscherwitz, Jon; Cease, Kemp B.] VA Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA; [Villaruz, Amer E.; Cheung, Gordon Y. C.; Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, US Natl Inst Hlth, Bethesda, MD 20892 USA; [McGavin, Martin J.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [McGavin, Martin J.] Univ Western Ontario, Ctr Human Immunol, London, ON N6A 5C1, Canada; [Travers, Jeffrey B.] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Western University (University of Western Ontario); Western University (University of Western Ontario); Indiana University System; Indiana University Bloomington	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	gabriel.nunez@umich.edu	Nakamura, Yuumi/H-8459-2017; Nuñez, Gabriel/A-7160-2014	Nakamura, Yuumi/0000-0001-6256-8302; McGavin, Martin/0000-0001-5955-0689; Travers, Jeffrey/0000-0001-7232-1039; Otto, Michael/0000-0002-2222-4115	Chiba University Global COE Program; Cell Science Research Foundation; Kanae Foundation for the Promotion of Medical Science; Department of Veterans Affairs [I01BX000429]; National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NIH [R01AR059688, R01HL062996]; University of Michigan's Cancer Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059688] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000429] Funding Source: NIH RePORTER	Chiba University Global COE Program; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Kanae Foundation for the Promotion of Medical Science; Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Cancer Center(University of Michigan System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank S. Koonse for animal husbandry, J. Whitfield for enzyme-linked immunosorbent assays, S. Meshinchi for electron microscopy, V. Basrur for mass spectrometry, K. Kidwell for advice with statistical analysis, M. K. Oyoshi and R. S. Geha for experimental advice, V. Y. Tan for help with constructing the LAC P3-lux strain and A. Burberry for reviewing the manuscript. Y.N. was supported by fellowships from the Chiba University Global COE Program, the Cell Science Research Foundation and the Kanae Foundation for the Promotion of Medical Science. J.O. and K.B.C. were supported by Department of Veterans Affairs Merit Award I01BX000429. A.E.V., G.Y.C.C. and M.O. were supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). This work supported by NIH grants R01AR059688 to G.N. and R01HL062996 to J.B.T. and funds to the Michigan Comprehensive Cancer Center Immunology Monitoring Core from the University of Michigan's Cancer Center Support Grant.	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; Elias PM, 2008, J INVEST DERMATOL, V128, P1067, DOI 10.1038/jid.2008.88; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; LEUNG DYM, 1993, J INVEST DERMATOL, V100, P225, DOI 10.1111/1523-1747.ep12468941; LEUNG DYM, 1990, J ALLERGY CLIN IMMUN, V85, P927, DOI 10.1016/0091-6749(90)90079-J; Liu FT, 2011, CLIN REV ALLERG IMMU, V41, P298, DOI 10.1007/s12016-011-8252-4; Luong TT, 2007, J MICROBIOL METH, V70, P186, DOI 10.1016/j.mimet.2007.04.007; MACK D, 1994, INFECT IMMUN, V62, P3244, DOI 10.1128/IAI.62.8.3244-3253.1994; MILLER RD, 1973, APPL MICROBIOL, V25, P800, DOI 10.1128/AEM.25.5.800-806.1973; Morfeldt E, 1996, MOL MICROBIOL, V21, P1227, DOI 10.1046/j.1365-2958.1996.751447.x; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Rudikoff D, 1998, LANCET, V351, P1715, DOI 10.1016/S0140-6736(97)12082-7; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; Seidl K, 2011, ANTIMICROB AGENTS CH, V55, P5631, DOI 10.1128/AAC.05251-11; Selander C, 2009, J IMMUNOL, V182, P4208, DOI 10.4049/jimmunol.0800885; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Sugiyama Y, 2009, J CLIN MICROBIOL, V47, P1528, DOI 10.1128/JCM.01497-08; Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704; Travers JB, 2010, J ALLERGY CLIN IMMUN, V125, P146, DOI 10.1016/j.jaci.2009.09.052; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Williams H, 2006, J ALLERGY CLIN IMMUN, V118, P209, DOI 10.1016/j.jaci.2006.04.043; Yamada N, 2003, J INVEST DERMATOL, V121, P1425, DOI 10.1046/j.1523-1747.2003.12613.x; Yeung M, 2011, MICROBES INFECT, V13, P189, DOI 10.1016/j.micinf.2010.10.023	34	309	329	6	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	2013	503	7476					397	+		10.1038/nature12655	http://dx.doi.org/10.1038/nature12655			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KG	24172897	Green Accepted			2022-12-24	WOS:000327163200041
J	Kilpinen, H; Waszak, SM; Gschwind, AR; Raghav, SK; Witwicki, RM; Orioli, A; Migliavacca, E; Wiederkehr, M; Gutierrez-Arcelus, M; Panousis, NI; Yurovsky, A; Lappalainen, T; Romano-Palumbo, L; Planchon, A; Bielser, D; Bryois, J; Padioleau, I; Udin, G; Thurnheer, S; Hacker, D; Core, LJ; Lis, JT; Hernandez, N; Reymond, A; Deplancke, B; Dermitzakis, ET				Kilpinen, Helena; Waszak, Sebastian M.; Gschwind, Andreas R.; Raghav, Sunil K.; Witwicki, Robert M.; Orioli, Andrea; Migliavacca, Eugenia; Wiederkehr, Michael; Gutierrez-Arcelus, Maria; Panousis, Nikolaos I.; Yurovsky, Alisa; Lappalainen, Tuuli; Romano-Palumbo, Luciana; Planchon, Alexandra; Bielser, Deborah; Bryois, Julien; Padioleau, Ismael; Udin, Gilles; Thurnheer, Sarah; Hacker, David; Core, Leighton J.; Lis, John T.; Hernandez, Nouria; Reymond, Alexandre; Deplancke, Bart; Dermitzakis, Emmanouil T.			Coordinated Effects of Sequence Variation on DNA Binding, Chromatin Structure, and Transcription	SCIENCE			English	Article								DNA sequence variation has been associated with quantitative changes in molecular phenotypes such as gene expression, but its impact on chromatin states is poorly characterized. To understand the interplay between chromatin and genetic control of gene regulation, we quantified allelic variability in transcription factor binding, histone modifications, and gene expression within humans. We found abundant allelic specificity in chromatin and extensive local, short-range, and long-range allelic coordination among the studied molecular phenotypes. We observed genetic influence on most of these phenotypes, with histone modifications exhibiting strong context-dependent behavior. Our results implicate transcription factors as primary mediators of sequence-specific regulation of gene expression programs, with histone modifications frequently reflecting the primary regulatory event.	[Kilpinen, Helena; Gutierrez-Arcelus, Maria; Panousis, Nikolaos I.; Yurovsky, Alisa; Lappalainen, Tuuli; Romano-Palumbo, Luciana; Planchon, Alexandra; Bielser, Deborah; Bryois, Julien; Padioleau, Ismael; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Kilpinen, Helena; Waszak, Sebastian M.; Gschwind, Andreas R.; Migliavacca, Eugenia; Gutierrez-Arcelus, Maria; Panousis, Nikolaos I.; Yurovsky, Alisa; Lappalainen, Tuuli; Bryois, Julien; Padioleau, Ismael; Deplancke, Bart; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Kilpinen, Helena; Gutierrez-Arcelus, Maria; Panousis, Nikolaos I.; Yurovsky, Alisa; Lappalainen, Tuuli; Bryois, Julien; Padioleau, Ismael; Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet & Genom Geneva, CH-1211 Geneva, Switzerland; [Waszak, Sebastian M.; Raghav, Sunil K.; Udin, Gilles; Deplancke, Bart] Swiss Fed Inst Technol EPFL, Sch Life Sci, Inst Bioengn, Lab Syst Biol & Genet, CH-1015 Lausanne, Switzerland; [Gschwind, Andreas R.; Witwicki, Robert M.; Orioli, Andrea; Migliavacca, Eugenia; Wiederkehr, Michael; Hernandez, Nouria; Reymond, Alexandre] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1011 Lausanne, Switzerland; [Thurnheer, Sarah; Hacker, David] Swiss Fed Inst Technol EPFL, Sch Life Sci, Prot Express Core Facil, CH-1015 Lausanne, Switzerland; [Core, Leighton J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Dermitzakis, Emmanouil T.] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia	University of Geneva; Swiss Institute of Bioinformatics; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Cornell University; King Abdulaziz University	Hernandez, N (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1011 Lausanne, Switzerland.	nouria.hernandez@unil.ch; alexandre.reymond@unil.ch; bart.deplancke@epfl.ch; emmanouil.dermitzakis@unige.ch	Waszak, Sebastian M./D-7828-2015; Kutalik, Zoltan/HHZ-5697-2022; Padioleau, Ismaël/AAE-8927-2019; Lappalainen, Tuuli/AAE-6532-2020; Raghav, Sunil/AAL-1121-2021	Waszak, Sebastian M./0000-0003-3042-9521; Kutalik, Zoltan/0000-0001-8285-7523; Padioleau, Ismaël/0000-0003-4935-3248; Lappalainen, Tuuli/0000-0002-7746-8109; Gschwind, Andreas/0000-0002-0769-6907; Hernandez, Nouria/0000-0003-1465-4585; Deplancke, Bart/0000-0001-9935-843X; Kilpinen, Helena/0000-0001-6692-6154; Bryois, Julien/0000-0002-4747-2166; Panousis, Nikolaos/0000-0003-2890-5592; Reymond, Alexandre/0000-0003-1030-8327	Swiss National Science Foundation [CRSI33_130326, 31003A_132958, 31003A_130342, 31003A_129835]; European Research Council; Louis-Jeantet Foundation; European Molecular Biology Organization fellowship ALTF [2010-337]; doctoral school of the Faculty of Biology and Medicine, University of Lausanne; NCCR Frontiers in Genetics Program; Japanese-Swiss Science and Technology Cooperation Program (Japan Science and Technology Agency/ETH Zurich); Ecole Polytechnique Federale de Lausanne; NIH [HG004845, GM25232]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025232, R01GM025232] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council(European Research Council (ERC)European Commission); Louis-Jeantet Foundation; European Molecular Biology Organization fellowship ALTF; doctoral school of the Faculty of Biology and Medicine, University of Lausanne; NCCR Frontiers in Genetics Program; Japanese-Swiss Science and Technology Cooperation Program (Japan Science and Technology Agency/ETH Zurich); Ecole Polytechnique Federale de Lausanne; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by Swiss National Science Foundation grants CRSI33_130326 (E. T. D., B. D., A. R., N.H.), 31003A_132958 (N. H.), 31003A_130342 (E. T. D.), and 31003A_129835 (A. R.); the European Research Council (E. T. D.); the Louis-Jeantet Foundation (E. T. D.); European Molecular Biology Organization fellowship ALTF 2010-337 (H. K.); a fellowship from the doctoral school of the Faculty of Biology and Medicine, University of Lausanne (R. M. W.); the NCCR Frontiers in Genetics Program (M. G.-A., J.B., E. T. D., B. D.); the Japanese-Swiss Science and Technology Cooperation Program (Japan Science and Technology Agency/ETH Zurich) (B. D.); Ecole Polytechnique Federale de Lausanne (B. D.); and NIH grants HG004845 and GM25232 (J.T.L.). The computations were performed at the Vital-IT (www.vital-it.ch) Center for High-Performance Computing of the Swiss Institute of Bioinformatics. All data in this publication are available through ArrayExpress (www.ebi.ac.uk/arrayexpress/) under accession numbers E-MTAB-1883 (RNA-seq), E-MTAB-1884 (CHiP-seq), and E-MTAB-1885 (GRO-seq). The authors declare no competing financial interests.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hobert O, 2011, CURR BIOL, V21, pR146, DOI 10.1016/j.cub.2011.01.005; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Spivakov M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r49; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006	22	248	251	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					744	747		10.1126/science.1242463	http://dx.doi.org/10.1126/science.1242463			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24136355	Green Accepted, Green Submitted			2022-12-24	WOS:000326647600045
J	Malik, S; Roeder, RG				Malik, Sohail; Roeder, Robert G.			Have Your PIC!	SCIENCE			English	Editorial Material							RNA-POLYMERASE-II; TRANSCRIPTION INITIATION; MEDIATOR COACTIVATOR; COMPLEX; MECHANISM; ARCHITECTURE		[Malik, Sohail; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA	Rockefeller University	Malik, S (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, 1230 York Ave, New York, NY 10065 USA.	maliks@rockefeller.edu; roeder@rockefeller.edu						Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Malik S, 2007, P NATL ACAD SCI USA, V104, P6182, DOI 10.1073/pnas.0608717104; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Treutlein B, 2012, MOL CELL, V46, P136, DOI 10.1016/j.molcel.2012.02.008; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023	15	1	1	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 8	2013	342	6159					706	707		10.1126/science.1246170	http://dx.doi.org/10.1126/science.1246170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247UK	24202169				2022-12-24	WOS:000326647600032
J	Mastny, M; Heuck, A; Kurzbauer, R; Heiduk, A; Boisguerin, P; Volkmer, R; Ehrmann, M; Rodrigues, CDA; Rudner, DZ; Clausen, T				Mastny, Markus; Heuck, Alexander; Kurzbauer, Robert; Heiduk, Anja; Boisguerin, Prisca; Volkmer, Rudolf; Ehrmann, Michael; Rodrigues, Christopher D. A.; Rudner, David Z.; Clausen, Tim			CtpB Assembles a Gated Protease Tunnel Regulating Cell-Cell Signaling during Spore Formation in Bacillus subtilis	CELL			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTOR; PDZ DOMAIN; INTRAMEMBRANE PROTEOLYSIS; ACTIVATION MECHANISM; GENE-EXPRESSION; STRESS-RESPONSE; DEGS PROTEASE; SPORULATION; COMPLEX; PRO-SIGMA(K)	Spore formation in Bacillus subtilis relies on a regulated intramembrane proteolysis (RIP) pathway that synchronizes mother-cell and forespore development. To address the molecular basis of this SpoIV transmembrane signaling, we carried out a structure- function analysis of the activating protease CtpB. Crystal structures reflecting distinct functional states show that CtpB constitutes a ring-like protein scaffold penetrated by two narrow tunnels. Access to the proteolytic sites sequestered within these tunnels is controlled by PDZ domains that rearrange upon substrate binding. Accordingly, CtpB resembles a minimal version of a self-compartmentalizing protease regulated by a unique allosteric mechanism. Moreover, biochemical analysis of the PDZgated channel combined with sporulation assays reveal that activation of the SpoIV RIP pathway is induced by the concerted activity of CtpB and a second signaling protease, SpoIVB. This proteolytic mechanism is of broad relevance for cell-cell communication, illustrating how distinct signaling pathways can be integrated into a single RIP module.	[Mastny, Markus; Heuck, Alexander; Kurzbauer, Robert; Clausen, Tim] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Heiduk, Anja; Boisguerin, Prisca; Volkmer, Rudolf] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Ehrmann, Michael] Univ Duisburg Essen, Ctr Med Biotechnol, D-45117 Essen, Germany; [Ehrmann, Michael] Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales; [Rodrigues, Christopher D. A.; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen; Cardiff University; Harvard University; Harvard Medical School	Clausen, T (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	clausen@imp.univie.ac.at	Ehrmann, Michael/A-7307-2012; Rodrigues, Christopher/AAA-5112-2021; Boisguerin, Prisca/AAG-6565-2020	Ehrmann, Michael/0000-0002-1927-260X; Boisguerin, Prisca/0000-0002-6955-1340; Volkmer, Rudolf/0000-0003-4710-1143; Rodrigues, Christopher/0000-0003-4541-0145; Clausen, Tim/0000-0003-1582-6924	Austrian Science Fund [W1221]; EMBO Long-Term Fellowship; Deutsche Forschungsgemeinschaft [VO885/2]; National Institute of Health [GM086466]; Boehringer Ingelheim; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086466] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the beamline staff at the DESY, SLS, and ESRF for their assistance during data collection and Mathias Madalinski for peptide synthesis. We thank members of the Clausen lab for support and encouragement. This work was supported by grants from the Austrian Science Fund (W1221 "DK Structure and Interaction of Biological Macromolecules'' to M.M.), EMBO Long-Term Fellowship (A H.), Deutsche Forschungsgemeinschaft (M.E.; VO885/2 to R.V and P.B.), and the National Institute of Health (GM086466 to D.Z.R.). The IMP is funded by Boehringer Ingelheim.	Boisguerin P, 2007, CHEMBIOCHEM, V8, P2302, DOI 10.1002/cbic.200700518; Brandstetter H, 2001, NATURE, V414, P466, DOI 10.1038/35106609; Campo N, 2007, J BACTERIOL, V189, P6021, DOI 10.1128/JB.00399-07; Campo N, 2006, MOL CELL, V23, P25, DOI 10.1016/j.molcel.2006.05.019; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; CUTTING S, 1990, CELL, V62, P239, DOI 10.1016/0092-8674(90)90362-I; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Fokine A, 2008, J BIOL CHEM, V283, P7242, DOI 10.1074/jbc.M709398200; Goettig P, 2005, J BIOL CHEM, V280, P33387, DOI 10.1074/jbc.M505030200; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; HARA H, 1991, J BACTERIOL, V173, P4799, DOI 10.1128/jb.173.15.4799-4813.1991; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Hoa NT, 2002, J BACTERIOL, V184, P191, DOI 10.1128/JB.184.1.191-199.2002; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; KROOS L, 1989, SCIENCE, V243, P526, DOI 10.1126/science.2492118; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; LOSICK R, 1992, NATURE, V355, P601, DOI 10.1038/355601a0; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Pan Q, 2003, J BACTERIOL, V185, P6051, DOI 10.1128/JB.185.20.6051-6056.2003; Rawlings ND, 2002, NUCLEIC ACIDS RES, V30, P343, DOI 10.1093/nar/30.1.343; Resnekov O, 1998, P NATL ACAD SCI USA, V95, P3162, DOI 10.1073/pnas.95.6.3162; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Rudner DZ, 2002, GENE DEV, V16, P1007, DOI 10.1101/gad.977702; Sohn J, 2009, MOL CELL, V33, P64, DOI 10.1016/j.molcel.2008.12.017; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; TAKAHASHI M, 1988, FEBS LETT, V240, P6, DOI 10.1016/0014-5793(88)80330-2; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Zhou RB, 2005, MOL MICROBIOL, V58, P835, DOI 10.1111/j.1365-2958.2005.04870.x	33	23	24	2	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					647	658		10.1016/j.cell.2013.09.050	http://dx.doi.org/10.1016/j.cell.2013.09.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243021	Green Published, hybrid			2022-12-24	WOS:000326571800018
J	Whiteus, C; Freitas, C; Grutzendler, J				Whiteus, Christina; Freitas, Catarina; Grutzendler, Jaime			Perturbed neural activity disrupts cerebral angiogenesis during a postnatal critical period	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELLS; BARREL CORTEX; MECHANISM; ISCHEMIA; SEIZURES; SYSTEM	During the neonatal period, activity-dependent neural-circuit remodelling coincides with growth and refinement of the cerebral microvasculature(1,2). Whether neural activity also influences the patterning of the vascular bed is not known. Here we show in neonatal mice, that neither reduction of sensory input through whisker trimming nor moderately increased activity by environmental enrichment affects cortical microvascular development. Unexpectedly, chronic stimulation by repetitive sounds, whisker deflection or motor activity led to a near arrest of angiogenesis in barrel, auditory and motor cortices, respectively. Chemically induced seizures also caused robust reductions in microvascular density. However, altering neural activity in adult mice did not affect the vasculature. Histological analysis and time-lapse in vivo two-photon microscopy revealed that hyperactivity did not lead to cell death or pruning of existing vessels but rather to reduced endothelial proliferation and vessel sprouting. This anti-angiogenic effect was prevented by administration of the nitric oxide synthase (NOS) inhibitor L-NAME and in mice with neuronal and inducible NOS deficiency, suggesting that excessive nitric oxide released from hyperactive interneurons and glia inhibited vessel growth. Vascular deficits persisted long after cessation of hyperstimulation, providing evidence for a critical period after which proper microvascular patterning cannot be re-established. Reduced microvascular density diminished the ability of the brain to compensate for hypoxic challenges, leading to dendritic spine loss in regions distant from capillaries. Therefore, excessive sensorimotor stimulation and repetitive neural activation during early childhood may cause lifelong deficits in microvascular reserve, which could have important consequences for brain development, function and pathology.	[Whiteus, Christina; Freitas, Catarina; Grutzendler, Jaime] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06511 USA; [Whiteus, Christina; Grutzendler, Jaime] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University	Grutzendler, J (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06511 USA.	jaime.grutzendler@yale.edu	Freitas, Catarina M/A-2555-2017	Freitas, Catarina M/0000-0002-3393-5326	AHA [10POST2570007];  [R01AG027855];  [R01HL106815];  [F31NS068041]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS068041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027855] Funding Source: NIH RePORTER	AHA(American Heart Association); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors appreciate the expert advice of W. Sessa, M. Simons and F. Moraes. A. Schain helped with design of ImageJ macros and G. P. Flowers critically read the manuscript. This study was supported by the following Grants: R01AG027855 and R01HL106815 (J.G.); F31NS068041 (C.W.) and AHA# 10POST2570007 (C.F.).	Arida RM, 1999, EPILEPSY RES, V34, P99, DOI 10.1016/S0920-1211(98)00092-8; Beloozerova IN, 2003, J NEUROSCI, V23, P1087; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Buskila Y, 2010, J NEUROPHYSIOL, V103, P1322, DOI 10.1152/jn.00676.2009; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Devor A, 2011, J NEUROSCI, V31, P13676, DOI 10.1523/JNEUROSCI.1968-11.2011; Dunning HS, 1937, J COMP NEUROL, V67, P433, DOI 10.1002/cne.900670305; Etzel RA, 1997, PEDIATRICS, V100, P724; Harb R, 2013, J CEREBR BLOOD F MET, V33, P146, DOI 10.1038/jcbfm.2012.152; Heller R, 1999, ATHEROSCLEROSIS, V144, P49, DOI 10.1016/S0021-9150(99)00041-6; Jones MK, 2004, BIOCHEM BIOPH RES CO, V318, P520, DOI 10.1016/j.bbrc.2004.04.055; Kasischke KA, 2011, J CEREBR BLOOD F MET, V31, P68, DOI 10.1038/jcbfm.2010.158; Keilhoff G, 1996, NEUROSCIENCE, V75, P1193, DOI 10.1016/0306-4522(96)00330-2; Lam CK, 2010, NATURE, V465, P478, DOI 10.1038/nature09001; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Margolis DJ, 2012, NAT NEUROSCI, V15, P1539, DOI 10.1038/nn.3240; Oviedo HV, 2010, NAT NEUROSCI, V13, P1413, DOI 10.1038/nn.2659; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Perrenoud Q, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00036; Rao S, 2013, NATURE, V494, P243, DOI 10.1038/nature11823; Ridnour LA, 2005, P NATL ACAD SCI USA, V102, P13147, DOI 10.1073/pnas.0502979102; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Sorrells SF, 2009, NEURON, V64, P33, DOI 10.1016/j.neuron.2009.09.032; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Strata F, 2005, P NATL ACAD SCI USA, V102, P19156, DOI 10.1073/pnas.0509520102; van den Tweel ERW, 2005, J NEUROIMMUNOL, V167, P64, DOI 10.1016/j.jneuroim.2005.06.031; Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074; Wei L, 2001, STROKE, V32, P2179, DOI 10.1161/hs0901.094282; Whitaker VR, 2007, J CEREBR BLOOD F MET, V27, P57, DOI 10.1038/sj.jcbfm.9600318; Wykes RC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004190; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	36	81	84	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2014	505	7483					407	+		10.1038/nature12821	http://dx.doi.org/10.1038/nature12821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288OR	24305053	Green Accepted			2022-12-24	WOS:000329621800044
J	Parikshak, NN; Luo, R; Zhang, A; Won, H; Lowe, JK; Chandran, V; Horvath, S; Geschwind, DH				Parikshak, Neelroop N.; Luo, Rui; Zhang, Alice; Won, Hyejung; Lowe, Jennifer K.; Chandran, Vijayendran; Horvath, Steve; Geschwind, Daniel H.			Integrative Functional Genomic Analyses Implicate Specific Molecular Pathways and Circuits in Autism	CELL			English	Article							COMMON GENETIC-VARIANTS; DE-NOVO MUTATIONS; TRANSCRIPTIONAL REGULATION; INTELLECTUAL DISABILITY; BRAIN-DEVELOPMENT; MESSENGER-RNAS; SPECTRUM; NETWORK; COEXPRESSION; PATTERNS	Genetic studies have identified dozens of autism spectrum disorder (ASD) susceptibility genes, raising two critical questions: (1) do these genetic loci converge on specific biological processes, and (2) where does the phenotypic specificity of ASD arise, given its genetic overlap with intellectual disability (ID)? To address this, we mapped ASD and ID risk genes onto coexpression networks representing developmental trajectories and transcriptional profiles representing fetal and adult cortical laminae. ASD genes tightly coalesce in modules that implicate distinct biological functions during human cortical development, including early transcriptional regulation and synaptic development. Bioinformatic analyses suggest that translational regulation by FMRP and transcriptional coregulation by common transcription factors connect these processes. At a circuit level, ASD genes are enriched in superficial cortical layers and glutamatergic projection neurons. Furthermore, we show that the patterns of ASD and ID risk genes are distinct, providing a biological framework for further investigating the pathophysiology of ASD.	[Parikshak, Neelroop N.; Won, Hyejung; Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Program Neurobehav Genet, Los Angeles, CA 90095 USA; [Parikshak, Neelroop N.; Zhang, Alice; Geschwind, Daniel H.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA 90095 USA; [Luo, Rui; Horvath, Steve; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Luo, Rui; Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Ctr Autism Treatment & Res, Los Angeles, CA 90095 USA; [Chandran, Vijayendran; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Program Neurobehav Genet, Los Angeles, CA 90095 USA.	dhg@ucla.edu		Parikshak, Neel/0000-0003-2027-1871	Simons Foundation Autism Research Initiative; Autism Genetic Resource Exchange; Brain Span consortium; Allen Brain Institute; NIMH Training; NRSA Fellowship [T32MH073526, F30MH099886]; NIMH [5R37MH060233, 5R01MH094714]; Autism Center for Excellence network grant [9R01MH100027]; Simons Foundation [SFARI 206744]; Medical Scientist Training Program at UCLA; NINDS Informatics Center for Neurogenetics and Neurogenomics [P30NS062691]; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH099886, R01MH094714, RC2MH089921, R37MH060233, T32MH073526, R01MH100027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative; Autism Genetic Resource Exchange; Brain Span consortium; Allen Brain Institute; NIMH Training; NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Autism Center for Excellence network grant; Simons Foundation; Medical Scientist Training Program at UCLA; NINDS Informatics Center for Neurogenetics and Neurogenomics; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Simons Foundation Autism Research Initiative (http://www.sfari.org) and the Autism Genetic Resource Exchange (http://www.agre.org) and all families involved for making this work possible. We gratefully acknowledge data resources from the Brain Span consortium and the Allen Brain Institute http://www.brain-map.org). This work was supported by a NIMH Training and NRSA Fellowship (T32MH073526 and F30MH099886, N.N.P.), NIMH grants (5R37MH060233 and 5R01MH094714, D. H. G.), an Autism Center for Excellence network grant (9R01MH100027), the Simons Foundation (SFARI 206744, D. H. G.), and the Medical Scientist Training Program at UCLA. We thank the NINDS Informatics Center for Neurogenetics and Neurogenomics (funded by grant P30NS062691) at UCLA for computing resources, and we specifically thank Yeongshnn Ong and Giovanni Coppola for making the interactive network available. We thank Jason Chen, Michael Gandal, and Jason Stein for critically reading the manuscript, as well as Willsey et al. (2013) for sharing their findings prior to publication.	Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Ben-David E, 2013, MOL PSYCHIATR, V18, P1054, DOI 10.1038/mp.2012.148; Berg JM, 2012, GENOME BIOL, V13, DOI [10.1186/gb4034, 10.1186/gb-2012-13-7-247]; Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; BrainSpan, 2013, BRAINSPAN ATL DEV HU; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Csardi N., 2006, INT J COMP SYST, V1695, P1; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de la Torre-Ubieta L, 2011, NEURON, V72, P22, DOI 10.1016/j.neuron.2011.09.018; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Denaxa M, 2012, CELL REP, V2, P1351, DOI 10.1016/j.celrep.2012.10.003; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Ecker C, 2012, ARCH GEN PSYCHIAT, V69, P195, DOI 10.1001/archgenpsychiatry.2011.1251; Feng WJ, 2013, CELL STEM CELL, V13, P62, DOI 10.1016/j.stem.2013.05.002; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gratten J, 2013, NAT GENET, V45, P234, DOI 10.1038/ng.2555; Halgren C, 2012, CLIN GENET, V82, P248, DOI 10.1111/j.1399-0004.2011.01755.x; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; Lubs HA, 2012, AM J HUM GENET, V90, P579, DOI 10.1016/j.ajhg.2012.02.018; Luo R, 2012, AM J HUM GENET, V91, P38, DOI 10.1016/j.ajhg.2012.05.011; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Matson JL, 2009, RES DEV DISABIL, V30, P1107, DOI 10.1016/j.ridd.2009.06.003; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Potts RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024515; Ramani AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.19; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rubenstein JLR, 2011, J CHILD PSYCHOL PSYC, V52, P339, DOI 10.1111/j.1469-7610.2010.02307.x; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Srinivasan K, 2012, P NATL ACAD SCI USA, V109, P19071, DOI 10.1073/pnas.1216793109; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tuoc TC, 2013, DEV CELL, V25, P256, DOI 10.1016/j.devcel.2013.04.005; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zheng XF, 2012, STEM CELLS, V30, P910, DOI 10.1002/stem.1070	66	638	646	1	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1008	1021		10.1016/j.cell.2013.10.031	http://dx.doi.org/10.1016/j.cell.2013.10.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267887	Bronze, Green Accepted			2022-12-24	WOS:000327500600007
J	Shingai, M; Nishimura, Y; Klein, F; Mouquet, H; Donau, OK; Plishka, R; Buckler-White, A; Seaman, M; Piatak, M; Lifson, JD; Dimitrov, DS; Nussenzweig, MC; Martin, MA				Shingai, Masashi; Nishimura, Yoshiaki; Klein, Florian; Mouquet, Hugo; Donau, Olivia K.; Plishka, Ronald; Buckler-White, Alicia; Seaman, Michael; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Dimitrov, Dimiter S.; Nussenzweig, Michel C.; Martin, Malcolm A.			Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia	NATURE			English	Article							SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS; NEUTRALIZING ANTIBODIES; PASSIVE TRANSFER; RHESUS MACAQUES; POTENT NEUTRALIZATION; HIV-1; BROAD; PROTECTION; CHALLENGE; THERAPY	Neutralizing antibodies can confer immunity to primate lentiviruses by blocking infection in macaque models of AIDS(1-4). However, earlier studies of anti-human immunodeficiency virus type 1 (HIV-1) neutralizing antibodies administered to infected individuals or humanized mice reported poor control of virus replication and the rapid emergence of resistant variants(5-7). A new generation of anti-HIV-1 monoclonal antibodies, possessing extraordinary potency and breadth of neutralizing activity, has recently been isolated from infected individuals(8). These neutralizing antibodies target different regions of the HIV-1 envelope glycoprotein including the CD4-binding site, glycans located in the V1/V2, V3 and V4 regions, and the membrane proximal external region of gp41 (refs 9-14). Here we have examined two of the new antibodies, directed to the CD4-binding site and the V3 region (3BNC117 and 10-1074, respectively), for their ability to block infection and suppress viraemia in macaques infected with the R5 tropic simian-human immunodeficiency virus (SHIV)-AD8, which emulates many of the pathogenic and immunogenic properties of HIV-1 during infections of rhesus macaques(15,16). Either antibody alone can potently block virus acquisition. When administered individually to recently infected macaques, the 10-1074 antibody caused a rapid decline in virus load to undetectable levels for 4-7 days, followed by virus rebound during which neutralization-resistant variants became detectable. When administered together, a single treatment rapidly suppressed plasma viraemia for 3-5 weeks in some long-term chronically SHIV-infected animals with low CD41 T-cell levels. A second cycle of anti-HIV-1 monoclonal antibody therapy, administered to two previously treated animals, successfully controlled virus rebound. These results indicate that immunotherapy or a combination of immunotherapy plus conventional antiretroviral drugs might be useful as a treatment for chronically HIV-1-infected individuals experiencing immune dysfunction.	[Shingai, Masashi; Nishimura, Yoshiaki; Donau, Olivia K.; Plishka, Ronald; Buckler-White, Alicia; Martin, Malcolm A.] NIAID, Lab Mol Microbiol, NIH, Bethesda, MD 20892 USA; [Klein, Florian; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Mouquet, Hugo] Inst Pasteur, Dept Immunol, Lab Humoral Response Pathogens, F-75015 Paris, France; [Seaman, Michael] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Dimitrov, Dimiter S.; Nussenzweig, Michel C.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rockefeller University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@mail.rockefeller.edu; malm@nih.gov	Mouquet, Hugo/M-2750-2014; Nussenzweig, Michel/AAE-7292-2019	Mouquet, Hugo/0000-0002-4230-610X; 	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC011155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148, ZIAAI000998] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Tomioka and R. Kruthers for determining plasma viral RNA loads and B. Skopets, W. Magnanelli and R. Petros for diligently assisting in the maintenance of animals and assisting with procedures. We also thank D. R. Burton, The Scripps Institute, for providing anti-dengue virus neutralizing monoclonal antibody (DEN-3). This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) and, in part, with federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E.	Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Endo Y, 2000, J VIROL, V74, P6935, DOI 10.1128/JVI.74.15.6935-6945.2000; Gautam R, 2012, J VIROL, V86, P8516, DOI 10.1128/JVI.00644-12; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Horwitz J. A., 2013, P NATL ACAD SCI US; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; Nishimura Y, 2010, J VIROL, V84, P4769, DOI 10.1128/JVI.02279-09; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Polis MA, 2001, LANCET, V358, P1760, DOI 10.1016/S0140-6736(01)06802-7; Sadjadpour R, 2013, J VIROL, V87, P8798, DOI 10.1128/JVI.00878-13; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, P NATL ACAD SCI USA, V108, P20125, DOI 10.1073/pnas.1117531108; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	30	348	379	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 14	2013	503	7475					277	+		10.1038/nature12746	http://dx.doi.org/10.1038/nature12746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	250YX	24172896	Green Accepted			2022-12-24	WOS:000326894200054
J	Farley, KA; Malespin, C; Mahaffy, P; Grotzinger, JP; Vasconcelos, PM; Milliken, RE; Malin, M; Edgett, KS; Pavlov, AA; Hurowitz, JA; Grant, JA; Miller, HB; Arvidson, R; Beegle, L; Calef, F; Conrad, PG; Dietrich, WE; Eigenbrode, J; Gellert, R; Gupta, S; Hamilton, V; Hassler, DM; Lewis, KW; McLennan, SM; Ming, D; Navarro-Gonzalez, R; Schwenzer, SP; Steele, A; Stolper, EM; Sumner, DY; Vaniman, D; Vasavada, A; Williford, K; Wimmer-Schweingruber, RF				Farley, K. A.; Malespin, C.; Mahaffy, P.; Grotzinger, J. P.; Vasconcelos, P. M.; Milliken, R. E.; Malin, M.; Edgett, K. S.; Pavlov, A. A.; Hurowitz, J. A.; Grant, J. A.; Miller, H. B.; Arvidson, R.; Beegle, L.; Calef, F.; Conrad, P. G.; Dietrich, W. E.; Eigenbrode, J.; Gellert, R.; Gupta, S.; Hamilton, V.; Hassler, D. M.; Lewis, K. W.; McLennan, S. M.; Ming, D.; Navarro-Gonzalez, R.; Schwenzer, S. P.; Steele, A.; Stolper, E. M.; Sumner, D. Y.; Vaniman, D.; Vasavada, A.; Williford, K.; Wimmer-Schweingruber, R. F.		MSL Sci Team	In Situ Radiometric and Exposure Age Dating of the Martian Surface	SCIENCE			English	Article							GALE CRATER; MARS; EVOLUTION; HISTORY; ORIGIN; CHRONOLOGY; ISOTOPES; FIELD	We determined radiogenic and cosmogenic noble gases in a mudstone on the floor of Gale Crater. A K-Ar age of 4.21 +/- 0.35 billion years represents a mixture of detrital and authigenic components and confirms the expected antiquity of rocks comprising the crater rim. Cosmic-ray-produced He-3, Ne-21, and Ar-36 yield concordant surface exposure ages of 78 +/- 30 million years. Surface exposure occurred mainly in the present geomorphic setting rather than during primary erosion and transport. Our observations are consistent with mudstone deposition shortly after the Gale impact or possibly in a later event of rapid erosion and deposition. The mudstone remained buried until recent exposure by wind-driven scarp retreat. Sedimentary rocks exposed by this mechanism may thus offer the best potential for organic biomarker preservation against destruction by cosmic radiation.	[Farley, K. A.; Grotzinger, J. P.; Miller, H. B.; Stolper, E. M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Malespin, C.; Mahaffy, P.; Pavlov, A. A.; Conrad, P. G.; Eigenbrode, J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Vasconcelos, P. M.] Univ Queensland, Sch Earth Sci, Brisbane, Qld 4072, Australia; [Milliken, R. E.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Malin, M.; Edgett, K. S.] Malin Space Sci Syst, San Diego, CA 92121 USA; [Hurowitz, J. A.; McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Grant, J. A.] Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Arvidson, R.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Beegle, L.; Calef, F.; Vasavada, A.; Williford, K.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Dietrich, W. E.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Gellert, R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Gupta, S.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Hamilton, V.; Hassler, D. M.] SW Res Inst, Boulder, CO 80302 USA; [Lewis, K. W.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Ming, D.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Navarro-Gonzalez, R.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City 04510, DF, Mexico; [Schwenzer, S. P.] CEPSAR, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England; [Steele, A.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Sumner, D. Y.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Vaniman, D.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Wimmer-Schweingruber, R. F.] Univ Kiel, D-24098 Kiel, Germany	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Queensland; Brown University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Smithsonian Institution; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Berkeley; University of Guelph; Imperial College London; Princeton University; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Universidad Nacional Autonoma de Mexico; Carnegie Institution for Science; University of California System; University of California Davis; University of Kiel	Farley, KA (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	farley@gps.caltech.edu	Wimmer-Schweingruber, Robert/AAQ-5794-2021; szopa, cyril/C-6865-2015; Muller, Jan-Peter/Q-8886-2019; Harri, Ari-Matti/C-7142-2012; Pavlov, Alexander A./F-3779-2012; Franz, Heather B/F-3508-2012; Eigenbrode, Jennifer L/D-4651-2012; Schwenzer, Susanne P/H-6992-2019; Zorzano, María-Paz/F-2184-2015; Blanco, Juan Jose/E-3627-2014; Rodriguez-Manfredi, Jose/AAG-9826-2021; Prats, Benito/F-9467-2019; Steele, Andrew/A-3573-2013; Farley, Kenneth/AAE-7735-2020; Stipp, Susan L.S./B-8494-2019; Martin-Torres, Javier/G-6329-2015; Gomez-Elvira, Javier/K-5829-2014; Ramos, Miguel/K-2230-2014; De Pablo, Miguel Ángel/J-6442-2014; Hayes, Alexander G/P-2024-2014; Rodriguez-Manfredi, Jose/L-8001-2014; Benna, Mehdi/F-3489-2012; Lemmon, Mark T/E-9983-2010; Balic-Zunic, Tonci/A-6362-2013; Beegle, Luther/AAU-5538-2021; Dworkin, Jason P./C-9417-2012; FABRE, Cécile/B-5827-2012; Navarro-González, Rafael/D-1748-2009; Avalos, Juan Jose Blanco/AAB-9447-2021; Sumner, Dawn Y/E-8744-2011; Gómez, Felipe/L-7315-2014; Williford, Kenneth/L-4436-2017; Glavin, Daniel P/D-6194-2012; Vicenzi, Edward/T-9430-2017; Malakhov, Alexey/F-7953-2017	Wimmer-Schweingruber, Robert/0000-0002-7388-173X; szopa, cyril/0000-0002-0090-4056; Muller, Jan-Peter/0000-0002-5077-3736; Harri, Ari-Matti/0000-0001-8541-2802; Pavlov, Alexander A./0000-0001-8771-1646; Eigenbrode, Jennifer L/0000-0003-3089-1986; Schwenzer, Susanne P/0000-0002-9608-0759; Zorzano, María-Paz/0000-0002-4492-9650; Blanco, Juan Jose/0000-0002-8666-0696; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Prats, Benito/0000-0003-3869-3351; Steele, Andrew/0000-0001-9643-2841; Stipp, Susan L.S./0000-0001-7009-643X; Martin-Torres, Javier/0000-0001-6479-2236; Gomez-Elvira, Javier/0000-0002-9068-9846; Ramos, Miguel/0000-0003-3648-6818; De Pablo, Miguel Ángel/0000-0002-4496-2741; Hayes, Alexander G/0000-0001-6397-2630; Rodriguez-Manfredi, Jose/0000-0003-0461-9815; Lemmon, Mark T/0000-0002-4504-5136; Balic-Zunic, Tonci/0000-0003-1687-1233; Dworkin, Jason P./0000-0002-3961-8997; FABRE, Cécile/0000-0001-8627-4050; Navarro-González, Rafael/0000-0002-6078-7621; Avalos, Juan Jose Blanco/0000-0002-8666-0696; Sumner, Dawn Y/0000-0002-7343-2061; Gómez, Felipe/0000-0001-9977-7060; Williford, Kenneth/0000-0003-0633-408X; Glavin, Daniel P/0000-0001-7779-7765; Vicenzi, Edward/0000-0003-2085-6546; Gupta, Sanjeev/0000-0001-6415-1332; Wilson, Sharon/0000-0001-8872-8546; Farley, Kenneth/0000-0002-7846-7546; Malakhov, Alexey/0000-0003-4292-7077; Grant, John/0000-0001-8276-1281; Edgett, Kenneth/0000-0001-7197-5751; McLennan, Scott/0000-0003-4259-7178; Beegle, Luther/0000-0002-4944-4353	National Aeronautics and Space Administration; Science and Technology Facilities Council [ST/J005193/1] Funding Source: researchfish; UK Space Agency [ST/J005339/1, ST/J005169/1, ST/I003118/1] Funding Source: researchfish	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	The authors are indebted to the Mars Science Laboratory (MSL) Project engineering and management teams for their exceptionally skilled and diligent efforts in making the mission as effective as possible and enhancing science operations. We are also grateful to all those MSL team members who participated in tactical and strategic operations. Without the support of both the engineering and science teams, the data presented here could not have been collected. Three anonymous reviewers provided many helpful suggestions. Some of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. Data presented in this paper are archived in the Planetary Data System (pds.nasa.gov).	Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; Anderson RC, 2012, SPACE SCI REV, V170, P57, DOI 10.1007/s11214-012-9898-9; Bachmann O, 2002, J PETROL, V43, P1469, DOI 10.1093/petrology/43.8.1469; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bogard D, 2009, METEORIT PLANET SCI, V44, P905, DOI 10.1111/j.1945-5100.2009.tb00777.x; Bridges JC, 2012, EARTH PLANET SC LETT, V359, P117, DOI 10.1016/j.epsl.2012.09.044; Carr MH, 2010, EARTH PLANET SC LETT, V294, P185, DOI 10.1016/j.epsl.2009.06.042; CERLING TE, 1994, ANNU REV EARTH PL SC, V22, P273, DOI 10.1146/annurev.ea.22.050194.001421; Dartnell LR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027494; Deer W.A., 2001, ROCK FORMING MINERAL, V4; Eggleton R.E., 1962, ADV ASTRONAUT SCI, V8, P70; Eugster O, 2003, CHEM ERDE-GEOCHEM, V63, P3, DOI 10.1078/0009-2819-00021; Grant JA, 2012, PLANET SPACE SCI, V72, P44, DOI 10.1016/j.pss.2012.05.020; Grant JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046844; Greeley R., 1987, GEOLOGIC MAP E EQUAT, V1-~802-B; Grotzinger JP, 2014, SCIENCE, V343, DOI 10.1126/science.1242777; Hartmann WK, 2005, ICARUS, V174, P294, DOI 10.1016/j.icarus.2004.11.023; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Ivanov BA, 2001, SPACE SCI REV, V96, P87, DOI 10.1023/A:1011941121102; KELLER LP, 1994, GEOCHIM COSMOCHIM AC, V58, P5589, DOI 10.1016/0016-7037(94)90252-6; LAL D, 1993, GEOCHIM COSMOCHIM AC, V57, P4627, DOI 10.1016/0016-7037(93)90188-3; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Le Deit L, 2013, J GEOPHYS RES-PLANET, V118, P2439, DOI 10.1002/2012JE004322; Mangold N, 2012, ICARUS, V220, P530, DOI 10.1016/j.icarus.2012.05.026; MARTI K, 1992, ANNU REV EARTH PL SC, V20, P221, DOI 10.1146/annurev.ea.20.050192.001253; McLennan SM, 2014, SCIENCE, V343, DOI 10.1126/science.1244734; Ming DW, 2014, SCIENCE, V343, DOI 10.1126/science.1245267; Pavlov AA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052166; Rao MN, 2002, ICARUS, V156, P352, DOI 10.1006/icar.2001.6809; Scott D. H., 1995, GEOLOGIC TOPOGRAPHIC; Thomson BJ, 2011, ICARUS, V214, P413, DOI 10.1016/j.icarus.2011.05.002; Vaniman DT, 2014, SCIENCE, V343, DOI 10.1126/science.1243480; WARD WR, 1973, SCIENCE, V181, P260, DOI 10.1126/science.181.4096.260; Williams RME, 2013, SCIENCE, V340, P1068, DOI 10.1126/science.1237317; Wray JJ, 2013, INT J ASTROBIOL, V12, P25, DOI 10.1017/S1473550412000328	35	173	174	0	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 24	2014	343	6169							1247166	10.1126/science.1247166	http://dx.doi.org/10.1126/science.1247166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294IR	24324273				2022-12-24	WOS:000330039300007
J	Lyumkis, D; Julien, JP; de Val, N; Cupo, A; Potter, CS; Klasse, PJ; Burton, DR; Sanders, RW; Moore, JP; Carragher, B; Wilson, IA; Ward, AB				Lyumkis, Dmitry; Julien, Jean-Philippe; de Val, Natalia; Cupo, Albert; Potter, Clinton S.; Klasse, Per-Johan; Burton, Dennis R.; Sanders, Rogier W.; Moore, John P.; Carragher, Bridget; Wilson, Ian A.; Ward, Andrew B.			Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer	SCIENCE			English	Article							NEUTRALIZING ANTIBODIES; MOLECULAR ARCHITECTURE; GLYCOPROTEIN COMPLEX; CRYSTAL-STRUCTURE; GP120; VIRUS; RESOLUTION; RECOGNITION; DISPLAY; BINDING	The HIV-1 envelope glycoprotein (Env) trimer contains the receptor binding sites and membrane fusion machinery that introduce the viral genome into the host cell. As the only target for broadly neutralizing antibodies (bnAbs), Env is a focus for rational vaccine design. We present a cryo-electron microscopy reconstruction and structural model of a cleaved, soluble Env trimer (termed BG505 SOSIP.664 gp140) in complex with a CD4 binding site (CD4bs) bnAb, PGV04, at 5.8 angstrom resolution. The structure reveals the spatial arrangement of Env components, including the V1/V2, V3, HR1, and HR2 domains, as well as shielding glycans. The structure also provides insights into trimer assembly, gp120-gp41 interactions, and the CD4bs epitope cluster for bnAbs, which covers a more extensive area and defines a more complex site of vulnerability than previously described.	[Lyumkis, Dmitry; Potter, Clinton S.; Carragher, Bridget] Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA; [Lyumkis, Dmitry; Julien, Jean-Philippe; de Val, Natalia; Potter, Clinton S.; Carragher, Bridget; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Julien, Jean-Philippe; de Val, Natalia; Burton, Dennis R.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Julien, Jean-Philippe; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Cupo, Albert; Klasse, Per-Johan; Sanders, Rogier W.; Moore, John P.] Cornell Univ, Weill Med Coll, York, NY 10021 USA; [Burton, Dennis R.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Neutralizing Antibody Ctr, Int AIDS Vaccine Initiat IAVI, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Amsterdam; Academic Medical Center Amsterdam	Carragher, B (corresponding author), Scripps Res Inst, Natl Resource Automated Mol Microscopy, La Jolla, CA 92037 USA.	bcarr@scripps.edu; wilson@scripps.edu; abward@scripps.edu	de Val, Natalia/AAF-4822-2019; Ward, Andrew/ABD-7728-2021; Ward, Andrew B/F-9203-2014; Klasse, P.J./AEX-0142-2022	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Klasse, P.J./0000-0001-8222-278X; Julien, Jean-Philippe/0000-0001-7602-3995; Carragher, Bridget/0000-0002-0624-5020	NIH [HIVRAD P01 AI82362, R01 AI36082]; International AIDS Vaccine Initiative Neutralizing Antibody Consortium; Scripps CHAVI-ID [UM1 AI100663]; Netherlands Organization for Scientific Research; European Research Council; Canadian Institutes of Health Research fellowship; Biomedical Technology Research Center program of the National Institute of General Medical Sciences [GM103310]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036082, UM1AI100663, P01AI082362, R01AI084817, R01AI036082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative Neutralizing Antibody Consortium; Scripps CHAVI-ID; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); Canadian Institutes of Health Research fellowship(Canadian Institutes of Health Research (CIHR)); Biomedical Technology Research Center program of the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Cheng and X. Li for providing raw frame alignment scripts prior to publication, R. Henderson for making the makestack_HRnoise.exe program available for use to assess the overfitting of the EM data, J. Korzun for technical assistance, J.-C. Ducom (TSRI) for support with computational resources, and C. R. King and W. Koff for support and encouragement. Supported by NIH grants HIVRAD P01 AI82362 (J. P. M., I. A. W., and A. B. W.) and R01 AI36082 (I. A. W.); the International AIDS Vaccine Initiative Neutralizing Antibody Consortium (D. R. B., J. P. M., I. A. W., A. B. W.); Scripps CHAVI-ID (UM1 AI100663) (D. R. B., I. A. W., A. B. W.); a Vidi grant from the Netherlands Organization for Scientific Research (R. W. S.); a Starting Investigator Grant from the European Research Council (R. W. S.); and a Canadian Institutes of Health Research fellowship (J.-P.J.). The EM work was conducted at the National Resource for Automated Molecular Microscopy at The Scripps Research Institute, which is supported by the Biomedical Technology Research Center program (GM103310) of the National Institute of General Medical Sciences (B. C., C. S. P.). 3D visualizations were generated using the UCSF Chimera package. The EM reconstructions have been deposited in the Electron Microscopy Data Bank under accession codes EMD-5779, EMD-5780, EMD-5781, and EMD-5782. The structure coordinates have been deposited in the Protein Data Bank under accession code 3J5M. Sharing of other materials will be subject to standard material transfer agreements. Raw EM data will be provided upon request. The content is the responsibility of the authors and does not necessarily reflect the official views of NIGMS or NIH. IAVI has previously filed a patent relating to the BG505 SOSIP.664 trimer: U.S. Prov. Appln. No. 61/772,739, titled "HIV-1 envelope glycoprotein," with inventors M. Caulfield, A. C., H. Dean, S. Hoffenberg, C. R. King, P.-J.K., A. Marozsan, J. P. M., R. W. S., A. B. W., I. A. W., and J.-P.J. This is manuscript 25060 from The Scripps Research Institute.	Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Campbell MG, 2012, STRUCTURE, V20, P1823, DOI 10.1016/j.str.2012.08.026; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Cohen J, 2013, SCIENCE, V341, P443, DOI 10.1126/science.341.6145.443; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Henderson R, 2013, P NATL ACAD SCI USA, V110, P18037, DOI 10.1073/pnas.1314449110; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Joyce MG, 2013, J VIROL, V87, P2294, DOI 10.1128/JVI.02717-12; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Khayat R, 2013, J VIROL, V87, P9865, DOI 10.1128/JVI.01222-13; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Li Y, 2008, J VIROL, V82, P638, DOI 10.1128/JVI.01691-07; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Mao YD, 2013, P NATL ACAD SCI USA, V110, pE4178, DOI 10.1073/pnas.1316666110; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Subramaniam S, 2013, P NATL ACAD SCI USA, V110, pE4172, DOI 10.1073/pnas.1313802110; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; van Heel M, 2013, P NATL ACAD SCI USA, V110, pE4175, DOI 10.1073/pnas.1314353110; Wang WB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-14; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003	51	535	559	3	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 20	2013	342	6165					1484	1490		10.1126/science.1245627	http://dx.doi.org/10.1126/science.1245627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	274ZI	24179160	Green Accepted			2022-12-24	WOS:000328644300051
J	Steinhubl, SR; Muse, ED; Topol, EJ				Steinhubl, Steven R.; Muse, Evan D.; Topol, Eric J.			Can Mobile Health Technologies Transform Health Care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Steinhubl, Steven R.; Muse, Evan D.; Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Steinhubl, SR (corresponding author), Scripps Translat Sci Inst, 3344 N Torrey Pines Ct,Ste 300, La Jolla, CA 92037 USA.	steinhub@scripps.edu		Topol, Eric/0000-0002-1478-4729	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000110, UL1TR000109] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		[Anonymous], BRIT MED J; [Anonymous], HEALTH CARE EXPENSES; [Anonymous], NCI CANCER BULLETIN; Centers for Disease Control and Prevention, NATIONAL AMBULATORY; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Sinsky CA, 2013, ANN FAM MED, V11, P272, DOI 10.1370/afm.1531; Wolf JA, 2013, JAMA DERMATOL, V149, P422, DOI 10.1001/jamadermatol.2013.2382	8	258	262	3	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	2013	310	22					2395	2396		10.1001/jama.2013.281078	http://dx.doi.org/10.1001/jama.2013.281078			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	266NN	24158428				2022-12-24	WOS:000328030900015
J	Cheerambathur, DK; Gassmann, R; Cook, B; Oegema, K; Desai, A				Cheerambathur, Dhanya K.; Gassmann, Reto; Cook, Brian; Oegema, Karen; Desai, Arshad			Crosstalk Between Microtubule Attachment Complexes Ensures Accurate Chromosome Segregation	SCIENCE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; KINETOCHORE; DYNEIN; COMPONENTS; INTERFACE; MECHANISM; PROTEIN	The microtubule-based mitotic spindle segregates chromosomes during cell division. During chromosome segregation, the centromeric regions of chromosomes build kinetochores that establish end-coupled attachments to spindle microtubules. Here, we used the Caenorhabditis elegans embryo as a model system to examine the crosstalk between two kinetochore protein complexes implicated in temporally distinct stages of attachment formation. The kinetochore dynein module, which mediates initial lateral microtubule capture, inhibited microtubule binding by the Ndc80 complex, which ultimately forms the end-coupled attachments that segregate chromosomes. The kinetochore dynein module directly regulated Ndc80, independently of phosphorylation by Aurora B kinase, and this regulation was required for accurate segregation. Thus, the conversion from initial dynein-mediated, lateral attachments to correctly oriented, Ndc80-mediated end-coupled attachments is actively controlled.	[Cheerambathur, Dhanya K.; Gassmann, Reto; Cook, Brian; Oegema, Karen; Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Desai, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	abdesai@ucsd.edu	Gassmann, Reto/M-6488-2013	Gassmann, Reto/0000-0002-0360-2977; Cook, Brian/0000-0002-5777-3464; Cheerambathur, Dhanya/0000-0001-8525-8366	NIH [GM074215]; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Japanese National BioResource Project for the ndc-80 deletion strain, K. Corbett for helpful discussions, and B. Green for comments on the manuscript. The data described here are tabulated in the main paper and the supplementary materials. This work was supported by an NIH grant (GM074215) to A. D; A. D. and K.O. receive salary and other support from the Ludwig Institute for Cancer Research.	Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Barisic M, 2010, MOL BIOL CELL, V21, P1968, DOI 10.1091/mbc.E09-04-0356; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Civril F, 2010, STRUCTURE, V18, P616, DOI 10.1016/j.str.2010.02.014; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Lampert F, 2013, J CELL BIOL, V200, P21, DOI 10.1083/jcb.201210091; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Scaerou F, 1999, J CELL SCI, V112, P3757; Schmidt JC, 2012, DEV CELL, V23, P968, DOI 10.1016/j.devcel.2012.09.012; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Stein KK, 2007, GENETICS, V175, P107, DOI 10.1534/genetics.106.059105; Umbreit NT, 2012, P NATL ACAD SCI USA, V109, P16113, DOI 10.1073/pnas.1209615109; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034	27	60	77	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 6	2013	342	6163					1239	1242		10.1126/science.1246232	http://dx.doi.org/10.1126/science.1246232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	264DT	24231804	Green Accepted			2022-12-24	WOS:000327857900049
J	Sonnenberg, P; Clifton, S; Beddows, S; Field, N; Soldan, K; Tanton, C; Mercer, CH; da Silva, FC; Alexander, S; Copas, AJ; Phelps, A; Erens, B; Prah, P; Macdowall, W; Wellings, K; Ison, CA; Johnson, AM				Sonnenberg, Pam; Clifton, Soazig; Beddows, Simon; Field, Nigel; Soldan, Kate; Tanton, Clare; Mercer, Catherine H.; da Silva, Filomeno Coelho; Alexander, Sarah; Copas, Andrew J.; Phelps, Andrew; Erens, Bob; Prah, Philip; Macdowall, Wendy; Wellings, Kaye; Ison, Catherine A.; Johnson, Anne M.			Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)	LANCET			English	Article							ANTI-HIV; HEALTH; URINE; MEN; PARTNERSHIPS; BEHAVIOR; WOMEN	Background Population-based estimates of prevalence, risk distribution, and intervention uptake inform delivery of control programmes for sexually transmitted infections (STIs). We undertook the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) after implementation of national sexual health strategies, and describe the epidemiology of four STIs in Britain (England, Scotland, and Wales) and the uptake of interventions. Methods Between Sept 6, 2010 and Aug 31, 2012, we did a probability sample survey of 15 162 women and men aged 16-74 years in Britain. Participants were interviewed with computer-assisted face-to-face and self-completion questionnaires. Urine from a sample of participants aged 16-44 years who reported at least one sexual partner over the lifetime was tested for the presence of Chlamydia trachomatis, type-specific human papillomavirus (HPV), Neisseria gonorrhoeae, and HIV antibody. We describe age-specific and sex-specific prevalences of infection and intervention uptake, in relation to demographic and behavioural factors, and explore changes since Natsal-1 (1990-91) and Natsal-2 (1999-2001). Findings Of 8047 eligible participants invited to provide a urine sample, 4828 (60%) agreed. We excluded 278 samples, leaving 4550 (94%) participants with STI test results. Chlamydia prevalence was 1.5% (95% CI 1.1-2.0) in women and 1.1% (0.7-1.6) in men. Prevalences in individuals aged 16-24 years were 3.1% (2.2-4.3) in women and 2.3% (1.5-3.4) in men. Area-level deprivation and higher numbers of partners, especially without use of condoms, were risk factors. However, 60.4% (45.5-73.7) of chlamydia in women and 43.3% (25.9-62.5) in men was in individuals who had had one partner in the past year. Among sexually active 16-24-year-olds, 54.2% (51.4-56.9) of women and 34.6% (31.8-37.4) of men reported testing for chlamydia in the past year, with testing higher in those with more partners. High-risk HPV was detected in 15.9% (14.4-17.5) of women, similar to in Natsal-2. Coverage of HPV catch-up vaccination was 61.5% (58.2-64.7). Prevalence of HPV types 16 and 18 in women aged 18-20 years was lower in Natsal-3 than Natsal-2 (5.8% [3.9-8.6] vs 11.3% [6.8-18.2]; age-adjusted odds ratio 0.44 [0.21-0.94]). Gonorrhoea (<0.1% prevalence in women and men) and HIV (0.1% prevalence in women and 0.2% in men) were uncommon and restricted to participants with recognised high-risk factors. Since Natsal-2, substantial increases were noted in attendance at sexual health clinics (from 6.7% to 21.4% in women and from 7.7% to 19.6% in men) and HIV testing (from 8.7% to 27.6% in women and from 9.2% to 16.9% in men) in the past 5 years. Interpretation STIs were distributed heterogeneously, requiring general and infection-specific interventions. Increases in testing and attendance at sexual health clinics, especially in people at highest risk, are encouraging. However, STIs persist both in individuals accessing and those not accessing services. Our findings provide empirical evidence to inform future sexual health interventions and services.	[Sonnenberg, Pam; Clifton, Soazig; Field, Nigel; Tanton, Clare; Mercer, Catherine H.; Copas, Andrew J.; Erens, Bob; Prah, Philip; Johnson, Anne M.] UCL, Res Dept Infect & Populat Hlth, Mortimer Market Ctr, London WC1E 6JB, England; [Clifton, Soazig; Phelps, Andrew] NatCen Social Res, London, England; [Beddows, Simon; da Silva, Filomeno Coelho] Publ Hlth England, Virus Reference Dept, London, England; [Soldan, Kate] Publ Hlth England, Ctr Infect Dis Surveillance & Control, London, England; [Alexander, Sarah; Ison, Catherine A.] Publ Hlth England, Sexually Transmitted Bacteria Reference Unit, London, England; [Erens, Bob] Univ London London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1E 7HT, England; [Macdowall, Wendy; Wellings, Kaye] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Res, London WC1E 7HT, England	University of London; University College London; Public Health England; Public Health England; Public Health England; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Sonnenberg, P (corresponding author), UCL, Res Dept Infect & Populat Hlth, Mortimer Market Ctr, London WC1E 6JB, England.	p.sonnenberg@ucl.ac.uk	Field, Nigel/ABG-3948-2020; King, Carina/C-8883-2016	Mercer, Catherine/0000-0002-4220-5034; Johnson, Anne/0000-0003-1330-7100; Sonnenberg, Pam/0000-0002-1067-1583; Field, Nigel/0000-0002-2825-6652; Macdowall, Wendy/0000-0001-5868-8336; Beddows, Simon/0000-0002-6879-6215; Erens, Robert/0000-0002-3054-504X; Prah, Philip/0000-0002-4742-9686; Clifton, Soazig/0000-0002-4171-0805; Copas, Andrew/0000-0001-8968-5963; Erens, Bob/0000-0002-4430-954X; Tanton, Clare/0000-0002-4612-1858; Soldan, Kate/0000-0002-0361-3174	UK Medical Research Council; Wellcome Trust; Economic and Social Research Council; Department of Health; Medical Research Council [G0701757] Funding Source: researchfish; National Institute for Health Research [CL-2010-18-010, NF-SI-0508-10244] Funding Source: researchfish; MRC [G0701757] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Grants from the UK Medical Research Council and the Wellcome Trust, with support from the Economic and Social Research Council and the Department of Health.	Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; [Anonymous], 2005, RESP RESP STRAT ACT; [Anonymous], 2010, SEX HLTH WELLB ACT P; [Anonymous], 2001, STRAT FRAM PROM SEX; Australian Department of Health and Ageing, 2010, 2 NAT SEX TRANSM INF; Bissett SL, 2011, J MED VIROL, V83, P1744, DOI 10.1002/jmv.22167; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; British HIV Association British Association of Sexual Health and HIV British Infection Society, 2008, UK NAT GUID HIV TEST; Centers for Disease Control and Prevention, NAT HLTH NUTR EXAM S; CONNELL JA, 1990, LANCET, V335, P1366, DOI 10.1016/0140-6736(90)91245-6; Craig P, 2012, J EPIDEMIOL COMMUN H, V66, P1182, DOI 10.1136/jech-2011-200375; Department of Health, 2008, SEX HLTH PROM STRAT; Department of Health, 2001, NAT STRAT SEX HLTH H; Department of Health, 2013, FRAM SEX HLTH IMPR E; Department of Health, 2012, PUBL HLTH OUTC FRAM; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Erens B., 2013, 3 NATL SURVEY SEXUAL; Erens B, 2013, SEX TRANSM INFECT; Fenton KA, 2005, J INFECT DIS, V191, pS127, DOI 10.1086/425286; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Field N, 2012, J MED ETHICS, V38, P380, DOI 10.1136/medethics-2011-100068; Flowers P, 2013, HIV MED, V14, P92, DOI 10.1111/j.1468-1293.2012.01041.x; Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752; Gray M., 2009, NATL SURVEY SEXUAL A; Health Protection Agency, 2012, HIV UK 2012 REP; Howell-Jones R, 2012, 28 INT PAP C SAN JUA, pE07; Hughes A, EUROSURVEIL IN PRESS; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Johnson AM, 1994, NATL SURVEY SEXUAL A; Johnson AM, 2012, SEX TRANSM INFECT, V88, P212, DOI 10.1136/sextrans-2011-050306; Laboratory Centre for Disease Control (Canada), 1997, P NAT STD CONS M NAT; Lattimore S, 2011, SEX TRANSM DIS, V38, P221, DOI 10.1097/OLQ.0b013e3181f2ebe1; Lowndes CM, 2004, SEX TRANSM INFECT, V80, P264, DOI 10.1136/sti.2004.010389; Markowitz LE, 2013, J INFECT DIS, V208, P385, DOI 10.1093/infdis/jit192; Mercer CH, 2009, INT J EPIDEMIOL, V38, P206, DOI 10.1093/ije/dyn216; Mercer CH, 2013, LANCET; Ministry of Health, 2001, SEX REPR HLTH STRAT; Nicoll A, 2001, SEX TRANSM INFECT, V77, P242, DOI 10.1136/sti.77.4.242; PARRY JV, 1995, J MED VIROL, V45, P10, DOI 10.1002/jmv.1890450103; Payne R. A., 2012, Health Statistics Quarterly, P22; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Public Health England, GEN MED CLIN ACT DAT; Public Health England, 2013, HLTH PROTECTION REPO; Sheringham J, 2013, SEX TRANSM INFECT, V89, P175, DOI 10.1136/sextrans-2011-050223; Tabrizi SN, 2012, J INFECT DIS, V206, P1645, DOI 10.1093/infdis/jis590; Turner KME, 2006, SEX TRANSM INFECT, V82, P496, DOI 10.1136/sti.2005.019067; University of North Carolina Carolina Population Center, ADD HLTH; Wisniewski CA, 2008, J CLIN MICROBIOL, V46, P1466, DOI 10.1128/JCM.02241-07; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; World Health Organization, 2001, WHO REG STRAT SEX RE	50	243	249	2	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2013	382	9907					1795	1806		10.1016/S0140-6736(13)61947-9	http://dx.doi.org/10.1016/S0140-6736(13)61947-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259QF	24286785	hybrid, Green Published, Green Accepted			2022-12-24	WOS:000327540700024
J	Khan, Z; Ford, MJ; Cusanovich, DA; Mitrano, A; Pritchard, JK; Gilad, Y				Khan, Zia; Ford, Michael J.; Cusanovich, Darren A.; Mitrano, Amy; Pritchard, Jonathan K.; Gilad, Yoav			Primate Transcript and Protein Expression Levels Evolve Under Compensatory Selection Pressures	SCIENCE			English	Article							GENE-EXPRESSION; RAPID EVOLUTION; ABUNDANCE; HUMANS; DROSOPHILA; SILAC	Changes in gene regulation have likely played an important role in the evolution of primates. Differences in messenger RNA (mRNA) expression levels across primates have often been documented; however, it is not yet known to what extent measurements of divergence in mRNA levels reflect divergence in protein expression levels, which are probably more important in determining phenotypic differences. We used high-resolution, quantitative mass spectrometry to collect protein expression measurements from human, chimpanzee, and rhesus macaque lymphoblastoid cell lines and compared them to transcript expression data from the same samples. We found dozens of genes with significant expression differences between species at the mRNA level yet little or no difference in protein expression. Overall, our data suggest that protein expression levels evolve under stronger evolutionary constraint than mRNA levels.	[Khan, Zia; Cusanovich, Darren A.; Mitrano, Amy; Pritchard, Jonathan K.; Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ford, Michael J.] MS Bioworks LLC, Ann Arbor, MI 48108 USA; [Pritchard, Jonathan K.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; Howard Hughes Medical Institute; University of Chicago	Khan, Z (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	zia@uchicago.edu; pritch@stanford.edu; gilad@uchicago.edu		Khan, Zia/0000-0002-7859-3489; Cusanovich, Darren/0000-0001-6889-0095	NIH [GM077959]; Howard Hughes Medical Institute; National Research Service Award [F32HG006972]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG006972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077959] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of our labs for helpful discussions. Funded by NIH grant GM077959 to Y.G. and by Howard Hughes Medical Institute funds to J.K.P. Z.K. is supported by National Research Service Award F32HG006972. Z.K., J.K.P., and Y.G. conceived of the study and designed it; M.J.F. acquired the mass spectrometry data; Z.K. conducted the computational analyses with input from D.A.C., J.K.P., and Y.G. M.J.F. acknowledges assistance from colleagues at MS Bioworks LLC. A.M. cultured cells and prepared protein samples. Z.K., J.K.P., and Y.G. wrote the paper with contributions from all authors. RNA-seq data have been deposited to the Gene Expression Omnibus (GSE49682). The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (PXD000419). J.K.P. is on the scientific advisory boards for 23andMe and DNANexus with stock options.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Cox B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100151; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fu N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000216; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Hanke S, 2008, J PROTEOME RES, V7, P1118, DOI 10.1021/pr7007175; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Mann M, 2008, P NATL ACAD SCI USA, V105, P18132, DOI 10.1073/pnas.0800788105; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Romero IG, 2012, NAT REV GENET, V13, P505, DOI 10.1038/nrg3229; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223	20	149	149	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1100	1104		10.1126/science.1242379	http://dx.doi.org/10.1126/science.1242379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24136357	Green Accepted			2022-12-24	WOS:000327518600059
J	Kong, L; Giang, E; Nieusma, T; Kadam, RU; Cogburn, KE; Hua, YZ; Dai, XP; Stanfield, RL; Burton, DR; Ward, AB; Wilson, IA; Law, M				Kong, Leopold; Giang, Erick; Nieusma, Travis; Kadam, Rameshwar U.; Cogburn, Kristin E.; Hua, Yuanzi; Dai, Xiaoping; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.; Law, Mansun			Hepatitis C Virus E2 Envelope Glycoprotein Core Structure	SCIENCE			English	Article							CRYSTAL-STRUCTURE; VIRAL-HEPATITIS; 3D STRUCTURE; ANTIBODY; NEUTRALIZATION; IDENTIFICATION; INSIGHT; SITE	Hepatitis C virus (HCV), a Hepacivirus, is a major cause of viral hepatitis, liver cirrhosis, and hepatocellular carcinoma. HCV envelope glycoproteins E1 and E2 mediate fusion and entry into host cells and are the primary targets of the humoral immune response. The crystal structure of the E2 core bound to broadly neutralizing antibody AR3C at 2.65 angstroms reveals a compact architecture composed of a central immunoglobulin-fold beta sandwich flanked by two additional protein layers. The CD81 receptor binding site was identified by electron microscopy and site-directed mutagenesis and overlaps with the AR3C epitope. The x-ray and electron microscopy E2 structures differ markedly from predictions of an extended, three-domain, class II fusion protein fold and therefore provide valuable information for HCV drug and vaccine design.	[Kong, Leopold; Nieusma, Travis; Kadam, Rameshwar U.; Cogburn, Kristin E.; Hua, Yuanzi; Dai, Xiaoping; Stanfield, Robyn L.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Kong, Leopold; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Kong, Leopold; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Scripps Ctr HIV AIDS Vaccine Immunol & Immunogen, La Jolla, CA 92037 USA; [Giang, Erick; Cogburn, Kristin E.; Burton, Dennis R.; Law, Mansun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Ward, AB (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.	abward@scripps.edu; wilson@scripps.edu; mlaw@scripps.edu	Stanfield, Robyn/AAH-3190-2019; Ward, Andrew/ABD-7728-2021; Cheng, Yushao/E-6256-2011; Ward, Andrew B/F-9203-2014	Ward, Andrew/0000-0001-7153-3769; Ward, Andrew B/0000-0001-7153-3769; Law, Mansun/0000-0002-8934-9756; Kong, Leopold/0000-0001-7456-1773	NIH [AI079031, AI080916, AI071084, AI084817, U54 GM094586]; Skaggs Institute; American Foundation for AIDS Research; Swiss National Science Foundation; NIH through the National Center for Research Resources' P41 program at the National Center for Research Resources [RR017573]; DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences (NIGMS); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071084, R21AI080916, R01AI084817, R01AI079031, R56AI084817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, U54GM094586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute; American Foundation for AIDS Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH through the National Center for Research Resources' P41 program at the National Center for Research Resources; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH's National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Tien, T. Clayton, and M. C. Deller for help in setting up crystallization screens using the CrystalMation and Douglas robots; J. Robbins for help with protein purification; N. Laursen for useful discussions on refinement; L. Jaroszewski for help in analyzing the HCV E2c protein fold; P. Verdino for discussion of Ig folds; and J. P. Verenini for help in manuscript formatting. This work is supported by NIH grants AI079031 and AI080916 (to M.L.), AI071084 (to D.R.B.), and AI084817 and U54 GM094586 (to I.A.W.) and the Skaggs Institute (I.A.W.). L.K. is grateful to the American Foundation for AIDS Research for a Mathilde Krim Fellowship in Basic Biomedical Research, and R.U.K., to the Swiss National Science Foundation for a postdoctoral fellowship. The EM data were collected at the U.S. National Resource for Automated Molecular Microscopy (NRAMM) at the Scripps Research Institute, which is supported by the NIH through the National Center for Research Resources' P41 program (RR017573) at the National Center for Research Resources. X-ray data sets were collected at the Stanford Synchrotron Radiation Lightsource (SSRL) beamline 12-2, a Directorate of the Stanford Linear Accelerator Center National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program (P41RR001209); and the National Institute of General Medical Sciences (NIGMS). Coordinates and structure factors for the E2c complex with Fab AR3C have been deposited with the Protein Data Bank under accession code 4MWF. The EM reconstruction densities for the E2 Delta TM-Fab AR3C, E2 Delta TM-Fab AR3C-Fab AR2A, and E2 Delta TM-FabAR2A-CD81 LEL complexes have been deposited with the Electron Microscopy Data Bank under accession codes EMD-5759, EMD-5760, and EMD-5761, respectively. Antibodies and expression vectors used in this work are available from the authors (contact M.L.) under a materials transfer agreement with the Scripps Research Institute. The content is the responsibility of the authors and does not necessarily reflect the official views of the NIGMS, National Cancer Institute, or NIH. This is manuscript 24038 from the Scripps Research Institute. The authors declare no competing financial interests.	Almagro JC, 2012, J MOL RECOGNIT, V25, P125, DOI 10.1002/jmr.1168; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Billerbeck E, 2013, CURR TOP MICROBIOL, V369, P49, DOI 10.1007/978-3-642-27340-7_3; Broering TJ, 2009, J VIROL, V83, P12473, DOI 10.1128/JVI.01138-09; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Drummer HE, 2002, J VIROL, V76, P11143, DOI 10.1128/JVI.76.21.11143-11147.2002; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; El Omari K, 2013, CELL REP, V3, P30, DOI 10.1016/j.celrep.2012.12.001; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Houghton M, 2005, NATURE, V436, P961, DOI 10.1038/nature04081; Kapoor A, 2013, MBIO, V4, DOI 10.1128/mBio.00216-13; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Kitadokoro K, 2002, BIOL CHEM, V383, P1447, DOI 10.1515/BC.2002.164; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kong L, 2012, J VIROL, V86, P13085, DOI 10.1128/JVI.01939-12; Kong L, 2012, P NATL ACAD SCI USA, V109, P9499, DOI 10.1073/pnas.1202924109; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Kuiken C, 2008, NUCLEIC ACIDS RES, V36, pD512, DOI 10.1093/nar/gkm962; Kuiken Carla, 2009, V510, P33, DOI 10.1007/978-1-59745-394-3_4; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Li Y, 2013, P NATL ACAD SCI USA, V110, P6805, DOI 10.1073/pnas.1300524110; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Michalak JP, 1997, J GEN VIROL, V78, P2299, DOI 10.1099/0022-1317-78-9-2299; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Vaney MC, 2011, CELL MICROBIOL, V13, P1451, DOI 10.1111/j.1462-5822.2011.01653.x; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Whidby J, 2009, J VIROL, V83, P11078, DOI 10.1128/JVI.00800-09; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	35	296	301	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1090	1094		10.1126/science.1243876	http://dx.doi.org/10.1126/science.1243876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24288331	Green Accepted			2022-12-24	WOS:000327518600056
J	Ostrem, JM; Peters, U; Sos, ML; Wells, JA; Shokat, KM				Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.; Wells, James A.; Shokat, Kevan M.			K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions	NATURE			English	Article							ONCOGENE PRODUCT P21; H-RAS P21; PROTEIN; KRAS; SITE; MUTAGENESIS; DISCOVERY; MUTATION; REVEALS; DOMAIN	Somatic mutations in the small GTPase K-Ras are the most common activating lesions found in human cancer, and are generally associated with poor response to standard therapies(1-3). Efforts to target this oncogene directly have faced difficulties owing to its picomolar affinity for GTP/GDP(4) and the absence of known allosteric regulatory sites. Oncogenic mutations result in functional activation of Ras family proteins by impairing GTP hydrolysis(5,6). With diminished regulation by GTPase activity, the nucleotide state of Ras becomes more dependent on relative nucleotide affinity and concentration. This gives GTP an advantage over GDP(7) and increases the proportion of active GTP-bound Ras. Here we report the development of small molecules that irreversibly bind to a common oncogenic mutant, K-Ras(G12C). These compounds rely on the mutant cysteine for binding and therefore do not affect the wild-type protein. Crystallographic studies reveal the formation of a new pocket that is not apparent in previous structures of Ras, beneath the effector binding switch-II region. Binding of these inhibitors to K-Ras(G12C) disrupts both switch-I and switch-II, subverting the native nucleotide preference to favour GDP over GTP and impairing binding to Raf. Our data provide structure-based validation of a new allosteric regulatory site on Ras that is targetable in a mutant-specific manner.	[Ostrem, Jonathan M.; Peters, Ulf; Sos, Martin L.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	kevan.shokat@ucsf.edu	Sos, Martin L/I-1852-2014; Wells, Jim A/O-9854-2016	Ostrem, Jonathan/0000-0001-9085-1615; Peters, Ulf/0000-0003-4664-8198	postdoctoral fellowship of the Tobacco-related Disease Research Program [19FT-0069]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Prostate Cancer Foundation (PCF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER	postdoctoral fellowship of the Tobacco-related Disease Research Program; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Prostate Cancer Foundation (PCF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to M. Burlingame and J. Sadowsky for assistance with the tethering screen; P. Ren and Y. Liu for assistance in chemical design and discussions; N. Younger for preparing several compounds; J. Kuriyan for sharing SOS and H-Ras constructs; F. McCormick and T. Yuan for discussion and sharing K-Ras reagents; R. Goody, K. Shannon and F. Wittinghofer for discussion. U.P. was supported by a postdoctoral fellowship of the Tobacco-related Disease Research Program (19FT-0069). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231. M.L.S. is a fellow of the International Association for the Study of Lung Cancer (IASLC) and receives a Young Investigator Award of the Prostate Cancer Foundation (PCF).	Ahmadian MR, 1999, P NATL ACAD SCI USA, V96, P7065, DOI 10.1073/pnas.96.12.7065; Bar-Sagi D, 2001, MOL CELL BIOL, V21, P1441, DOI 10.1128/MCB.21.5.1441-1443.2001; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Burlingame MA, 2011, ACS COMB SCI, V13, P205, DOI 10.1021/co200038g; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Forbes SA, 2008, CURR PROTOC HUM GENE, V57, DOI DOI 10.11.1-10.11.26; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; Hall BE, 2001, J BIOL CHEM, V276, P27629, DOI 10.1074/jbc.M101727200; Hwang MCC, 1996, J BIOL CHEM, V271, P8196, DOI 10.1074/jbc.271.14.8196; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHN J, 1993, J BIOL CHEM, V268, P923; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Naven RT, 2013, TOXICOL RES-UK, V2, P235, DOI 10.1039/c3tx50027f; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Sadowsky JD, 2011, P NATL ACAD SCI USA, V108, P6056, DOI 10.1073/pnas.1102376108; SCHERER A, 1989, J MOL BIOL, V206, P257, DOI 10.1016/0022-2836(89)90540-8; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Sun Q., 2012, ANGEW CHEM, V124, P6244, DOI DOI 10.1002/ange.201201358; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; SUNG YJ, 1995, BIOCHEMISTRY-US, V34, P3470, DOI 10.1021/bi00010a040; Taveras AG, 1997, BIOORGAN MED CHEM, V5, P125, DOI 10.1016/S0968-0896(96)00202-7; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624	30	1190	1259	32	323	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	2013	503	7477					548	+		10.1038/nature12796	http://dx.doi.org/10.1038/nature12796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	258MU	24256730	Green Accepted			2022-12-24	WOS:000327464200048
J	Kwon, I; Kato, M; Xiang, SH; Wu, L; Theodoropoulos, P; Mirzaei, H; Han, T; Xie, SH; Corden, JL; McKnight, SL				Kwon, Ilmin; Kato, Masato; Xiang, Siheng; Wu, Leeju; Theodoropoulos, Pano; Mirzaei, Hamid; Han, Tina; Xie, Shanhai; Corden, Jeffry L.; McKnight, Steven L.			Phosphorylation-Regulated Binding of RNA Polymerase II to Fibrous Polymers of Low-Complexity Domains	CELL			English	Article							CARBOXY-TERMINAL DOMAIN; CELL-FREE FORMATION; EWING SARCOMA; IN-VITRO; CTD; TRANSCRIPTION; PROTEIN; KINASE; FUS; EXPRESSION	The low-complexity (LC) domains of the products of the fused in sarcoma (FUS), Ewings sarcoma (EWS), and TAF15 genes are translocated onto a variety of different DNA-binding domains and thereby assist in driving the formation of cancerous cells. In the context of the translocated fusion proteins, these LC sequences function as transcriptional activation domains. Here, we show that polymeric fibers formed from these LC domains directly bind the C-terminal domain (CTD) of RNA polymerase II in a manner reversible by phosphorylation of the iterated, heptad repeats of the CTD. Mutational analysis indicates that the degree of binding between the CTD and the LC domain polymers correlates with the strength of transcriptional activation. These studies offer a simple means of conceptualizing how RNA polymerase II is recruited to active genes in its unphosphorylated state and released for elongation following phosphorylation of the CTD.	[Kwon, Ilmin; Kato, Masato; Xiang, Siheng; Wu, Leeju; Theodoropoulos, Pano; Mirzaei, Hamid; Han, Tina; Xie, Shanhai; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Corden, Jeffry L.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu	Xiang, Siheng/A-5063-2010	Xiang, Siheng/0000-0003-4475-5707	NIH [GM066108]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066108] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the shared resource cores in Microscopic Imaging, Proteomics and DNA Sequencing at UTSWMC for technical support; Dr. Robert Tycko for provision of the electron micrograph of amyloid fibers included in the graphical abstract; Dr. David Trudgian for help with mass spectrometry; and Drs. Bruce Alberts, Deepak Nijhawan, Michael Brown, and Michael Rosen for helpful comments on the composition of the manuscript. This work was funded by an unrestricted endowment provided S.L.M. by an anonymous donor and NIH grant GM066108 for J.L.C.	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Bertolotti A, 1999, ONCOGENE, V18, P8000, DOI 10.1038/sj.onc.1203207; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Guipaud O, 2006, PROTEOMICS, V6, P5962, DOI 10.1002/pmic.200600259; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Huntley MA, 2002, PROTEINS, V48, P134, DOI 10.1002/prot.10150; Ichikawa H, 1999, MOL CELL BIOL, V19, P7639; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Lessnick SL, 2012, ANNU REV PATHOL-MECH, V7, P145, DOI 10.1146/annurev-pathol-011110-130237; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Ramanathan Y, 2001, J BIOL CHEM, V276, P10913, DOI 10.1074/jbc.M010975200; Rasband W., 2006, IMAGEJ; Rickert P, 1999, ONCOGENE, V18, P1093, DOI 10.1038/sj.onc.1202399; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; Schwartz JC, 2013, CELL REP, V5, P918, DOI 10.1016/j.celrep.2013.11.017; Schwartz JC, 2012, GENE DEV, V26, P2690, DOI 10.1101/gad.204602.112; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513	38	347	350	3	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1049	1060		10.1016/j.cell.2013.10.033	http://dx.doi.org/10.1016/j.cell.2013.10.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267890	Bronze, Green Accepted			2022-12-24	WOS:000327500600010
J	Bricard, A; Caussin, JB; Desreumaux, N; Dauchot, O; Bartolo, D				Bricard, Antoine; Caussin, Jean-Baptiste; Desreumaux, Nicolas; Dauchot, Olivier; Bartolo, Denis			Emergence of macroscopic directed motion in populations of motile colloids	NATURE			English	Article							DENSITY-FLUCTUATIONS; COLLECTIVE MOTION; ACTIVE MATTER; HYDRODYNAMICS	From the formation of animal flocks to the emergence of coordinated motion in bacterial swarms, populations of motile organisms at all scales display coherent collective motion. This consistent behaviour strongly contrasts with the difference in communication abilities between the individuals. On the basis of this universal feature, it has been proposed that alignment rules at the individual level could solely account for the emergence of unidirectional motion at the group level(1-4). This hypothesis has been supported by agent-based simulations(1,5,6). However, more complex collective behaviours have been systematically found in experiments, including the formation of vortices(7-9), fluctuating swarms(7,10), clustering(11,12) and swirling(13-16). All these (living and man-made) model systems (bacteria(9,10,16), biofilaments and molecular motors(7,8,13), shaken grains(14,15) and reactive colloids(11,12)) predominantly rely on actual collisions to generate collective motion. As a result, the potential local alignment rules are entangled with more complex, and often unknown, interactions. The large-scale behaviour of the populations therefore strongly depends on these uncontrolled microscopic couplings, which are extremely challenging to measure and describe theoretically. Here we report that dilute populations of millions of colloidal rolling particles self-organize to achieve coherentmotion in a unique direction, with very few density and velocity fluctuations. Quantitatively identifying the microscopic interactions between the rollers allows a theoretical description of this polar-liquid state. Comparison of the theory with experiment suggests that hydrodynamic interactions promote the emergence of collective motion either in the form of a single macroscopic 'flock', at low densities, or in that of a homogenous polar phase, at higher densities. Furthermore, hydrodynamics protects the polar-liquid state from the giant density fluctuations that were hitherto considered the hallmark of populations of self-propelled particles(2,3,17). Our experiments demonstrate that genuine physical interactions at the individual level are sufficient to set homogeneous active populations into stable directed motion.	[Bricard, Antoine; Caussin, Jean-Baptiste; Desreumaux, Nicolas; Bartolo, Denis] Univ Paris Diderot, ESPCI ParisTech, CNRS UMR7636, PMMH, F-75005 Paris, France; [Bricard, Antoine; Caussin, Jean-Baptiste; Desreumaux, Nicolas; Bartolo, Denis] Univ Paris 06, F-75005 Paris, France; [Caussin, Jean-Baptiste; Bartolo, Denis] Ecole Normale Super Lyon, Phys Lab, CNRS UMR5672, F-69007 Lyon, France; [Dauchot, Olivier] ESPCI ParisTech, EC2M, CNRS Gulliver UMR7083, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Bartolo, D (corresponding author), Univ Paris Diderot, ESPCI ParisTech, CNRS UMR7636, PMMH, 10 Rue Vauquelin, F-75005 Paris, France.	denis.bartolo@ens-lyon.fr	Dartolo, Denis/B-5537-2015; Dauchot, Olivier/D-7156-2015	Dartolo, Denis/0000-0001-5035-6898; Dauchot, Olivier/0000-0002-7039-5787	Paris Emergence programme; C'Nano IdF; Institut Universitaire de France	Paris Emergence programme; C'Nano IdF(Region Ile-de-France); Institut Universitaire de France	We acknowledge support from the Paris Emergence programme (D. B.), C'Nano IdF (D. B.) and the Institut Universitaire de France (D. B.). We thank L. S. Tuckerman and H. Chate for their useful comments and suggestions.	Bertin E, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/44/445001; Brotto T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.038101; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Chate H, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046113; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Deseigne J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.098001; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; Farrell FDC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.248101; Gregoire G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025702; HACKBORN WW, 1990, J FLUID MECH, V218, P531, DOI 10.1017/S0022112090001100; Kudrolli A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058001; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; MELCHER JR, 1969, ANNU REV FLUID MECH, V1, P111, DOI 10.1146/annurev.fl.01.010169.000551; O'Loan OJ, 1999, J PHYS A-MATH GEN, V32, pL99, DOI 10.1088/0305-4470/32/8/002; Palacci J, 2013, SCIENCE, V339, P936, DOI 10.1126/science.1230020; Quincke G., 1896, ANN PHYS-BERLIN, V295, P417; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Schaller V, 2013, P NATL ACAD SCI USA, V110, P4488, DOI 10.1073/pnas.1215368110; Schaller V, 2010, NATURE, V467, P73, DOI 10.1038/nature09312; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; Sumino Y, 2012, NATURE, V483, P448, DOI 10.1038/nature10874; Theurkauff I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.268303; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Wioland H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.268102; Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107	27	573	575	17	296	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					95	98		10.1038/nature12673	http://dx.doi.org/10.1038/nature12673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24201282	Green Submitted			2022-12-24	WOS:000326585600038
J	Kim, TM; Laird, PW; Park, PJ				Kim, Tae-Min; Laird, Peter W.; Park, Peter J.			The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes	CELL			English	Article							MITOCHONDRIAL TRANSCRIPTION FACTOR; NONPOLYPOSIS COLON-CANCER; FRAMESHIFT MUTATIONS; BETA RECEPTOR; DNA; GENE; EXPRESSION; CARCINOMA; CELLS; PATTERNS	Microsatellites-simple tandem repeats present at millions of sites in the human genome-can shorten or lengthen due to a defect in DNA mismatch repair. We present here a comprehensive genome-wide analysis of the prevalence, mutational spectrum, and functional consequences of microsatellite instability (MSI) in cancer genomes. We analyzed MSI in 277 colorectal and endometrial cancer genomes (including 57 microsatellite-unstable ones) using exome and whole-genome sequencing data. Recurrent MSI events in coding sequences showed tumor type specificity, elevated frameshift-to-inframe ratios, and lower transcript levels than wild-type alleles. Moreover, genome-wide analysis revealed differences in the distribution of MSI versus point mutations, including overrepresentation of MSI in euchromatic and intronic regions compared to heterochromatic and intergenic regions, respectively, and depletion of MSI at nucleosome-occupied sequences. Our results provide a panoramic view of MSI in cancer genomes, highlighting their tumor type specificity, impact on gene expression, and the role of chromatin organization.	[Kim, Tae-Min; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Kim, Tae-Min] Catholic Univ Korea, Coll Med, Canc Evolut Res Ctr, Seoul 137701, South Korea; [Laird, Peter W.] Univ So Calif, Keck Sch Med, USC Epigenome Ctr, Dept Surg & Biochem & Mol Biol,USC Norris Compreh, Los Angeles, CA 90033 USA; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Catholic University of Korea; University of Southern California; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital	Park, PJ (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA.	peter_park@harvard.edu	Laird, Peter W/G-8683-2012	Laird, Peter W/0000-0001-9117-3641; Park, Peter/0000-0001-9378-960X	National Institutes of Health [R01 GM082798, U24CA144025]; National Research Foundation of Korea [2012R1A5A2047939]; NATIONAL CANCER INSTITUTE [U24CA144025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank The Cancer Genome Atlas Research Network for generating the data used in this work. We also thank the members of the Park laboratory (especially Drs. Eunjung Lee, Nils Gehlenborg, and Semin Lee) and Dr. Peter Kharchenko for providing comments on the manuscript, Dr. David Wheeler for helpful discussions, and the Research Information Technology Group at Harvard Medical School for providing computational resources. This work was supported by grants from the National Institutes of Health (R01 GM082798 and U24CA144025 to P.J.P.) and the National Research Foundation of Korea (2012R1A5A2047939 to T.-M.K.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Brough R, 2012, EMBO J, V31, P1160, DOI 10.1038/emboj.2011.490; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; de la Chapelle A, 2010, J CLIN ONCOL, V28, P3380, DOI 10.1200/JCO.2009.27.0652; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dorard C, 2011, NAT MED, V17, P1283, DOI 10.1038/nm.2457; DUGGAN BD, 1994, J NATL CANCER I, V86, P1216, DOI 10.1093/jnci/86.16.1216; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gurin CC, 1999, CANCER RES, V59, P462; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Krawitz P, 2010, BIOINFORMATICS, V26, P722, DOI 10.1093/bioinformatics/btq027; Kuismanen SA, 2002, AM J PATHOL, V160, P1953, DOI 10.1016/S0002-9440(10)61144-3; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Metzgar D, 2000, GENOME RES, V10, P72; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakayama Y, 2012, ONCOL REP, V27, P1325, DOI 10.3892/or.2012.1640; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; PARSONS R, 1995, CANCER RES, V55, P5548; Paun BC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007715; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Plaschke J, 2012, INT J COLORECTAL DIS, V27, P911, DOI 10.1007/s00384-011-1408-0; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Tolstorukov MY, 2011, NAT STRUCT MOL BIOL, V18, P510, DOI 10.1038/nsmb.2012; Tsao JL, 2000, P NATL ACAD SCI USA, V97, P1236, DOI 10.1073/pnas.97.3.1236; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Xiong H, 2008, NEOPLASIA, V10, P287, DOI 10.1593/neo.07971; Yuan ZQ, 2009, CANCER RES, V69, P7811, DOI 10.1158/0008-5472.CAN-09-0986; Zhou XP, 1997, ONCOGENE, V15, P1713, DOI 10.1038/sj.onc.1201337	56	235	242	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					858	868		10.1016/j.cell.2013.10.015	http://dx.doi.org/10.1016/j.cell.2013.10.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209623	Green Accepted, Bronze			2022-12-24	WOS:000326934300015
J	Folkmann, AW; Collier, SE; Zhan, XY; Aditi; Ohi, MD; Wente, SR				Folkmann, Andrew W.; Collier, Scott E.; Zhan, Xiaoyan; Aditi; Ohi, Melanie D.; Wente, Susan R.			Gle1 Functions during mRNA Export in an Oligomeric Complex that Is Altered in Human Disease	CELL			English	Article							NUCLEAR-PORE COMPLEX; SPINAL MUSCULAR-ATROPHY; BOX PROTEIN DBP5; CONSERVED MECHANISM; NUCLEOPORIN RIP1P; YEAST; ARCHITECTURE; ACTIVATION; INTERACTS; SURVIVAL	The conserved multifunctional protein Gle1 regulates gene expression at multiple steps: nuclear mRNA export, translation initiation, and translation termination. A GLE1 mutation (FinMajor) is causally linked to human lethal congenital contracture syndrome-1 (LCCS1); however, the resulting perturbations on Gle1 molecular function were unknown. FinMajor results in a proline-phenylalanine-glutamine peptide insertion within the uncharacterized Gle1 coiled-coil domain. Here, we find that Gle1 self-associates both in vitro and in living cells via the coiled-coil domain. Electron microscopy reveals that highmolecular- mass Gle1 oligomers form similar to 26 nm diameter disk-shaped particles. With the Gle1-Fin(Major) protein, these particles are malformed. Moreover, functional assays document a specific requirement for proper Gle1 oligomerization during mRNA export, but not for Gle1's roles in translation. These results identify a mechanistic step in Gle1's mRNA export function at nuclear pore complexes and directly implicate altered export in LCCS1 disease pathology.	[Folkmann, Andrew W.; Collier, Scott E.; Zhan, Xiaoyan; Aditi; Ohi, Melanie D.; Wente, Susan R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Wente, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA.	susan.wente@vanderbilt.edu	Gupta, Aditi/HGD-9632-2022		National Cancer Institute Cancer Center [P30 CA068485]; NIH [R37GM051219, F31NS070431, 1DP2OD004483, T32CA119925, T32GM008320]; NATIONAL CANCER INSTITUTE [P30CA068485, T32CA119925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051219, T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS070431] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004483] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank T.R. Dawson for advice and critical reading of the manuscript; the Wente laboratory, M. Rout, and C. Cole for discussions; C. Cole for yeast strains; and Y. Takizawa for technical assistance with cryo-EM. This work was supported in part by the National Cancer Institute Cancer Center Support Grant P30 CA068485 utilizing the Cell Imaging Shared Resource and grants NIH R37GM051219 (to S.R.W.), NIH F31NS070431 (to A.W.F.), NIH 1DP2OD004483 (to M.D.O.) and training positions on T32CA119925 (to A.W.F.) and T32GM008320 (to S.E.C.).	Al-Qattan MM, 2012, GENE, V500, P216, DOI 10.1016/j.gene.2012.03.009; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; Bolger TA, 2011, J BIOL CHEM, V286, P39750, DOI 10.1074/jbc.M111.299321; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010; HALL JG, 1985, CLIN ORTHOP RELAT R, P44; HERVA R, 1985, AM J MED GENET, V20, P431, DOI 10.1002/ajmg.1320200303; Hurt JA, 2008, DIS MODEL MECH, V1, P103, DOI 10.1242/dmm.000745; Jao LE, 2012, DEVELOPMENT, V139, P1316, DOI 10.1242/dev.074344; Kendirgi F, 2003, J CELL BIOL, V160, P1029, DOI 10.1083/jcb.200211081; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Kiseleva E, 2004, J STRUCT BIOL, V145, P272, DOI 10.1016/j.jsb.2003.11.010; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; Muller-McNicoll M, 2013, NAT REV GENET, V14, P275, DOI 10.1038/nrg3434; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Noble KN, 2011, GENE DEV, V25, P1065, DOI 10.1101/gad.2040611; Nousiainen HO, 2008, NAT GENET, V40, P155, DOI 10.1038/ng.2007.65; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; Renoux AJ, 2012, PROG NEUROBIOL, V97, P173, DOI 10.1016/j.pneurobio.2011.10.006; Roberts-Galbraith RH, 2010, MOL CELL, V39, P86, DOI 10.1016/j.molcel.2010.06.012; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Stutz F, 1997, GENE DEV, V11, P2857, DOI 10.1101/gad.11.21.2857; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tzschach A, 2012, AM J MED GENET A, V158A, P1709, DOI 10.1002/ajmg.a.35398; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Watkins JL, 1998, P NATL ACAD SCI USA, V95, P6779, DOI 10.1073/pnas.95.12.6779; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; WENTE SR, 1993, J CELL BIOL, V123, P275, DOI 10.1083/jcb.123.2.275; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96	42	54	57	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					582	593		10.1016/j.cell.2013.09.023	http://dx.doi.org/10.1016/j.cell.2013.09.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243016	Green Accepted, Bronze			2022-12-24	WOS:000326571800013
J	Zhang, FR; Liu, H; Irwanto, A; Fu, XA; Li, Y; Yu, GQ; Yu, YX; Chen, MF; Low, HQ; Li, JH; Bao, FF; Foo, JN; Bei, JX; Jia, XM; Liu, J; Liany, H; Wang, N; Niu, GY; Wang, ZZ; Shi, BQ; Tian, HQ; Liu, HX; Ma, SS; Zhou, Y; You, JB; Yang, Q; Wang, C; Chu, TS; Liu, DC; Yu, XL; Sun, YH; Ning, Y; Wei, ZH; Chen, SL; Chen, XC; Zhang, ZX; Liu, YX; Pulit, SL; Wu, WB; Zheng, ZY; Yang, RD; Long, H; Liu, ZS; Wang, JQ; Li, M; Zhang, LH; Wang, H; Wang, LM; Xiao, P; Li, JL; Huang, ZM; Huang, JX; Li, Z; Liu, J; Xiong, L; Yang, J; Wang, XD; Yu, DB; Lu, XM; Zhou, GZ; Yan, LB; Shen, JP; Zhang, GC; Zeng, YX; de Bakker, PIW; Chen, SM; Liu, JJ				Zhang, Fu-Ren; Liu, Hong; Irwanto, Astrid; Fu, Xi-An; Li, Yi; Yu, Gong-Qi; Yu, Yong-Xiang; Chen, Ming-Fei; Low, Hui-Qi; Li, Jing-Hui; Bao, Fang-Fang; Foo, Jia-Nee; Bei, Jin-Xin; Jia, Xiao-Ming; Liu, Jian; Liany, Herty; Wang, Na; Niu, Gui-Ye; Wang, Zhen-Zhen; Shi, Ben-Qing; Tian, Hong-Qing; Liu, Hua-Xu; Ma, Shan-Shan; Zhou, Yan; You, Jia-Bao; Yang, Qing; Wang, Chuan; Chu, Tong-Sheng; Liu, Dian-Chang; Yu, Xiu-Lu; Sun, Yong-Hu; Ning, Yong; Wei, Zhong-He; Chen, Sheng-Li; Chen, Xue-Chao; Zhang, Zhao-Xia; Liu, Yong-Xia; Pulit, Sara L.; Wu, Wen-Bin; Zheng, Zhong-Yi; Yang, Rong-De; Long, Heng; Liu, Zuo-Sheng; Wang, Jing-Quan; Li, Ming; Zhang, Lian-Hua; Wang, Hong; Wang, La-Mei; Xiao, Peng; Li, Jin-Lan; Huang, Zhi-Ming; Huang, Jun-Xin; Li, Zhen; Liu, Jian; Xiong, Li; Yang, Jun; Wang, Xiao-Dong; Yu, De-Bao; Lu, Xian-Mei; Zhou, Gui-Zhi; Yan, Liang-Bin; Shen, Jian-Ping; Zhang, Guo-Cheng; Zeng, Yi-Xin; de Bakker, Paul I. W.; Chen, Shu-Min; Liu, Jian-Jun			HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WHOLE-GENOME ASSOCIATION; HLA-B; CHINA; LOCI; POPULATION; HAPLOTYPES; ALLELES; LEPROSY	BackgroundDapsone is used in the treatment of infections and inflammatory diseases. The dapsone hypersensitivity syndrome, which is associated with a reported mortality of 9.9%, develops in about 0.5 to 3.6% of persons treated with the drug. Currently, no tests are available to predict the risk of the dapsone hypersensitivity syndrome. MethodsWe performed a genomewide association study involving 872 participants who had received dapsone as part of multidrug therapy for leprosy (39 participants with the dapsone hypersensitivity syndrome and 833 controls), using log-additive tests of single-nucleotide polymorphisms (SNPs) and imputed HLA molecules. For a replication analysis, we genotyped 24 SNPs in an additional 31 participants with the dapsone hypersensitivity syndrome and 1089 controls and performed next-generation sequencing for HLA-B and HLA-C typing at four-digit resolution in an independent series of 37 participants with the dapsone hypersensitivity syndrome and 201 controls. ResultsGenomewide association analysis showed that SNP rs2844573, located between the HLA-B and MICA loci, was significantly associated with the dapsone hypersensitivity syndrome among patients with leprosy (odds ratio, 6.18; P=3.84x10(-13)). HLA-B*13:01 was confirmed to be a risk factor for the dapsone hypersensitivity syndrome (odds ratio, 20.53; P=6.84x10(-25)). The presence of HLA-B*13:01 had a sensitivity of 85.5% and a specificity of 85.7% as a predictor of the dapsone hypersensitivity syndrome, and its absence was associated with a reduction in risk by a factor of 7 (from 1.4% to 0.2%). HLA-B*13:01 is present in about 2 to 20% of Chinese persons, 1.5% of Japanese persons, 1 to 12% of Indians, and 2 to 4% of Southeast Asians but is largely absent in Europeans and Africans. ConclusionsHLA-B*13:01 was associated with the development of the dapsone hypersensitivity syndrome among patients with leprosy. (Funded by the National Natural Science Foundation of China and others.)	[Zhang, Fu-Ren; Liu, Hong; Fu, Xi-An; Yu, Gong-Qi; Yu, Yong-Xiang; Chen, Ming-Fei; Li, Jing-Hui; Bao, Fang-Fang; Liu, Jian; Wang, Na; Niu, Gui-Ye; Wang, Zhen-Zhen; Shi, Ben-Qing; Tian, Hong-Qing; Liu, Hua-Xu; Ma, Shan-Shan; Zhou, Yan; You, Jia-Bao; Yang, Qing; Wang, Chuan; Chu, Tong-Sheng; Liu, Dian-Chang; Yu, Xiu-Lu; Sun, Yong-Hu; Chen, Sheng-Li; Chen, Xue-Chao; Zhang, Zhao-Xia; Liu, Yong-Xia; Lu, Xian-Mei; Zhou, Gui-Zhi; Chen, Shu-Min] Shangdong Prov Inst Dermatol & Venereol, Jinan, Peoples R China; [Ning, Yong] Sichuan Prov Inst Dermatol, Chengdu, Peoples R China; [Wei, Zhong-He] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Wu, Wen-Bin] Fujian Ctr Dis Control & Prevent, Fuzhou, Peoples R China; [Zheng, Zhong-Yi] Honghe Inst Dermatol, Honghe, Yunnan, Peoples R China; [Yang, Rong-De; Long, Heng] Wenshan Inst Dermatol, Wenshan, Yunnan, Peoples R China; [Liu, Zuo-Sheng] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Wang, Jing-Quan] Zhejiang Prov Inst Dermatol, Deqing, Peoples R China; [Li, Ming] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Zeng, Yi-Xin] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zeng, Yi-Xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Lian-Hua] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Peoples R China; [Wang, Hong] Guangxi Prov Inst Dermatol, Nanning, Peoples R China; [Wang, La-Mei] Jiangxi Inst Parasit Dis, Nanchang, Peoples R China; [Xiao, Peng] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Li, Jin-Lan] Guizhou Prov Ctr Dis Control & Prevent, Guizhou, Peoples R China; [Huang, Zhi-Ming] Shenzhen Baoshan Chron Dis Control Ctr, Shenzhen, Peoples R China; [Huang, Jun-Xin] Shenzhen Chron Dis Control Ctr, Shenzhen, Peoples R China; [Li, Zhen] Shenzhen Nanshan Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Liu, Jian] Beijing Friendship Hosp, Res Inst Trop Med, Beijing, Peoples R China; [Yan, Liang-Bin; Shen, Jian-Ping; Zhang, Guo-Cheng] Chinese Acad Med Sci, Inst Dermatol, Beijing 100730, Peoples R China; [Yan, Liang-Bin; Shen, Jian-Ping; Zhang, Guo-Cheng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xiong, Li; Yang, Jun] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China; [Wang, Xiao-Dong; Yu, De-Bao] Jinan Inst Dermatol, Jinan, Peoples R China; [Irwanto, Astrid; Li, Yi; Low, Hui-Qi; Foo, Jia-Nee; Bei, Jin-Xin; Liany, Herty; Liu, Jian-Jun] Natl Univ Singapore, Genome Inst Singapore, Singapore 117548, Singapore; [Irwanto, Astrid; Liu, Jian-Jun] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Jia, Xiao-Ming] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA USA; [Pulit, Sara L.; de Bakker, Paul I. W.] Broad Inst Harvard & Massachusetts Inst Technol, Program Med & Populat Genet, Cambridge, MA USA; [Pulit, Sara L.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; State Key Lab Oncology South China; Sun Yat Sen University; Jiangsu Provincial Center for Disease Control & Prevention; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zhang, FR (corresponding author), Shangdong Prov Inst Dermatol & Venereol, Jinan, Peoples R China.	zhangfuren@hotmail.com; liuj3@gis.a-star.edu.sg	Foo, Jia Nee/D-6069-2014; de Bakker, Paul IW/B-8730-2009; Bei, Jin-Xin/AAO-1259-2020	Foo, Jia Nee/0000-0001-9899-2308; de Bakker, Paul IW/0000-0001-7735-7858; Sun, Yonghu/0000-0003-4553-2871; Jia, Xiaoming/0000-0002-5104-5431; Pulit, Sara/0000-0002-2502-3669; Liu, Jianjun/0000-0002-3255-3019	National Natural Science Foundation of China [81071288, 81072391, 81101187, 81271746, 31200933]; 973 Program [2011CB512105]; National Clinical Key Project of Dermatology and Venereology; Taishan Scholar Project; Medical Leading Scholar of Shandong Province Project; Natural Science Foundation of Shandong Province [ZR2011HQ003, ZR2012HQ031]; Agency for Science, Technology, and Research of Singapore; Netherlands Organization for Scientific Research (NWO project) [016.126.354]; Singapore International Graduate Award	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Clinical Key Project of Dermatology and Venereology; Taishan Scholar Project; Medical Leading Scholar of Shandong Province Project; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Agency for Science, Technology, and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Netherlands Organization for Scientific Research (NWO project)(Netherlands Organization for Scientific Research (NWO)); Singapore International Graduate Award	Supported by grants from the National Natural Science Foundation of China (81071288, 81072391, 81101187, 81271746, and 31200933), the 973 Program (2011CB512105), the National Clinical Key Project of Dermatology and Venereology, the Taishan Scholar Project, the Medical Leading Scholar of Shandong Province Project, the Natural Science Foundation of Shandong Province (ZR2011HQ003 and ZR2012HQ031), and the Agency for Science, Technology, and Research of Singapore. Dr. de Bakker is the recipient of the Vidi award from the Netherlands Organization for Scientific Research (NWO project 016.126.354). Ms. Irwanto was supported by the Singapore International Graduate Award.	ALLDAY EJ, 1951, LANCET, V261, P205; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P365; Bade-Doeding C, 2007, IMMUNOGENETICS, V59, P253, DOI 10.1007/s00251-007-0197-7; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Fromm E, 1908, BER DTSCH CHEM GES, V41, P2264, DOI 10.1002/cber.190804102131; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; Leslie KS, 2003, CLIN EXP DERMATOL, V28, P496, DOI 10.1046/j.1365-2230.2003.01336.x; Lorenz M, 2012, ACTA DERM-VENEREOL, V92, P194, DOI 10.2340/00015555-1268; LOWE J, 1949, Int J Lepr, V17, P181; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rao PN, 2001, LEPROSY REV, V72, P57; RICHARDUS JH, 1989, LEPROSY REV, V60, P267; Shi L, 2006, TISSUE ANTIGENS, V67, P38, DOI 10.1111/j.1399-0039.2005.00526.x; Tian WW, 2012, LEPROSY REV, V83, P370; Wozel VEG, 2010, DERMATOL CLIN, V28, P599, DOI 10.1016/j.det.2010.03.014; Yang G, 2006, TISSUE ANTIGENS, V67, P146, DOI 10.1111/j.1399-0039.2006.00529.x; Zhu YI, 2001, J AM ACAD DERMATOL, V45, P420, DOI 10.1067/mjd.2001.114733	26	201	216	0	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1620	1628		10.1056/NEJMoa1213096	http://dx.doi.org/10.1056/NEJMoa1213096			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	24152261				2022-12-24	WOS:000326031100011
J	Roth, TL; Nayak, D; Atanasijevic, T; Koretsky, AP; Latour, LL; McGavern, DB				Roth, Theodore L.; Nayak, Debasis; Atanasijevic, Tatjana; Koretsky, Alan P.; Latour, Lawrence L.; McGavern, Dorian B.			Transcranial amelioration of inflammation and cell death after brain injury	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; IN-VIVO; STERILE INFLAMMATION; HEAD-INJURY; MICE; BIOMARKERS; INSERTION; RELEASE; CORTEX; FLUID	Traumatic brain injury (TBI) is increasingly appreciated to be highly prevalent and deleterious to neurological function(1,2). At present, no effective treatment options are available, and little is known about the complex cellular response to TBI during its acute phase. To gain insights into TBI pathogenesis, we developed a novel murine closed-skull brain injury model that mirrors some pathological features associated with mild TBI in humans and used long-term intravital microscopy to study the dynamics of the injury response from its inception. Here we demonstrate that acute brain injury induces vascular damage, meningeal cell death, and the generation of reactive oxygen species (ROS) that ultimately breach the glial limitans and promote spread of the injury into the parenchyma. In response, the brain elicits a neuroprotective, purinergic-receptor-dependent inflammatory response characterized by meningeal neutrophil swarming and microglial reconstitution of the damaged glial limitans. We also show that the skull bone is permeable to small-molecular-weight compounds, and use this delivery route to modulate inflammation and therapeutically ameliorate brain injury through transcranial administration of the ROS scavenger, glutathione. Our results shed light on the acute cellular response to TBI and provide a means to locally deliver therapeutic compounds to the site of injury.	[Roth, Theodore L.; Nayak, Debasis; Atanasijevic, Tatjana; Koretsky, Alan P.; Latour, Lawrence L.; McGavern, Dorian B.] NINDS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	McGavern, DB (corresponding author), NINDS, NIH, Bethesda, MD 20892 USA.	mcgavernd@mail.nih.gov	McGavern, Dorian/HCH-3601-2022; Latour, Larry/AAH-5663-2021; Koretsky, Alan P/C-7940-2015	McGavern, Dorian/0000-0001-9568-545X; Latour, Larry/0000-0001-6160-5263; Koretsky, Alan P/0000-0002-8085-4756; Nayak, Debasis/0000-0002-4762-4553; Roth, Theodore/0000-0002-3970-9573	National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS); Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences; NIH; Department of Defense; Walter Reed National Military Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003120, ZIANS002989] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Walter Reed National Military Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by the National Institutes of Health (NIH), the National Institute of Neurological Disorders and Stroke (NINDS), and the Center for Neuroscience and Regenerative Medicine (CNRM) at the Uniformed Services University of the Health Sciences-a collaborative effort between the NIH, the Department of Defense and the Walter Reed National Military Medical Center to develop innovative approaches for brain injury diagnosis and recovery.	Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chuang KH, 2009, MAGN RESON MED, V61, P1528, DOI 10.1002/mrm.21962; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Faust N, 2000, BLOOD, V96, P719; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Mamourian AC, 2000, AM J NEURORADIOL, V21, P105; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	26	353	366	7	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2014	505	7482					223	+		10.1038/nature12808	http://dx.doi.org/10.1038/nature12808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286CG	24317693	Green Accepted			2022-12-24	WOS:000329441500040
J	Wiser, MJ; Ribeck, N; Lenski, RE				Wiser, Michael J.; Ribeck, Noah; Lenski, Richard E.			Long-Term Dynamics of Adaptation in Asexual Populations	SCIENCE			English	Article							ESCHERICHIA-COLI; EXPERIMENTAL EVOLUTION; BENEFICIAL MUTATIONS; BACTERIAL POPULATION; CLONAL INTERFERENCE; FITNESS LANDSCAPES; EPISTASIS; SELECTION	Experimental studies of evolution have increased greatly in number in recent years, stimulated by the growing power of genomic tools. However, organismal fitness remains the ultimate metric for interpreting these experiments, and the dynamics of fitness remain poorly understood over long time scales. Here, we examine fitness trajectories for 12 Escherichia coli populations during 50,000 generations. Mean fitness appears to increase without bound, consistent with a power law. We also derive this power-law relation theoretically by incorporating clonal interference and diminishing-returns epistasis into a dynamical model of changes in mean fitness over time.	[Wiser, Michael J.; Ribeck, Noah; Lenski, Richard E.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Wiser, Michael J.; Lenski, Richard E.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Ribeck, Noah; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Lenski, RE (corresponding author), Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA.	lenski@msu.edu	Wiser, Mike/AFN-9188-2022	Wiser, Mike/0000-0003-1686-9272; Lenski, Richard/0000-0002-1064-8375	National Science Foundation [DEB-1019989]; BEACON Center for the Study of Evolution in Action [DBI-0939454]; Hannah Chair Endowment at Michigan State University; Division Of Environmental Biology [1019989] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); BEACON Center for the Study of Evolution in Action; Hannah Chair Endowment at Michigan State University; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation (DEB-1019989) including the BEACON Center for the Study of Evolution in Action (DBI-0939454), and by funds from the Hannah Chair Endowment at Michigan State University. We thank three reviewers for comments; I. Dworkin, J. Krug, A. McAdam, C. Wilke, and L. Zaman for discussions; and N. Hajela for technical assistance. R. E. L. will make strains available to qualified recipients, subject to completion of a material transfer agreement that can be found at www.technologies.msu.edu/inventors/mta-cda/mta/mta-forms. Datasets and analysis scripts are available at the Dryad Digital Repository (doi: 10.5061/dryad.0hc2m).	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Burch CL, 1999, GENETICS, V151, P921; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; EAGON RG, 1962, J BACTERIOL, V83, P736, DOI 10.1128/JB.83.4.736-737.1962; Elena SF, 1997, EVOLUTION, V51, P1058, DOI 10.1111/j.1558-5646.1997.tb03953.x; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Goyal S, 2012, GENETICS, V191, P1309, DOI 10.1534/genetics.112.141291; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; Park SC, 2007, P NATL ACAD SCI USA, V104, P18135, DOI 10.1073/pnas.0705778104; Sibani P, 1998, INT J MOD PHYS B, V12, P361, DOI 10.1142/S0217979298000259; Szendro IG, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/01/P01005; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wielgoss S, 2013, P NATL ACAD SCI USA, V110, P222, DOI 10.1073/pnas.1219574110; Wielgoss S, 2011, G3-GENES GENOM GENET, V1, P183, DOI 10.1534/g3.111.000406; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	24	288	291	1	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 13	2013	342	6164					1364	1367		10.1126/science.1243357	http://dx.doi.org/10.1126/science.1243357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	268UL	24231808				2022-12-24	WOS:000328196000049
J	Ikeda, Y; Kumagai, H; Skach, A; Sato, M; Yanagisawa, M				Ikeda, Yuichi; Kumagai, Hidetoshi; Skach, Amber; Sato, Makito; Yanagisawa, Masashi			Modulation of Circadian Glucocorticoid Oscillation via Adrenal Opioid-CXCR7 Signaling Alters Emotional Behavior	CELL			English	Article							SUBCAPSULAR CELL HYPERPLASIA; MAJOR DEPRESSION; MICE DEFICIENT; ANIMAL-MODEL; STRESS; CLOCK; MOUSE; RHYTHM; PROENKEPHALIN; RECEPTOR	Circulating glucocorticoid levels oscillate with a robust circadian rhythm, yet the physiological relevance of this rhythmicity remains unclear. Here, we show that modulation of circadian glucocorticoid oscillation by enhancing its amplitude leads to anxiolytic-like behavior. We observed that mice with adrenal subcapsular cell hyperplasia (SCH), a common histological change in the adrenals, are less anxious than mice without SCH. This behavioral change was found to be dependent on the higher amplitude of glucocorticoid oscillation, although the total glucocorticoid secretion is not increased in these mice. Genetic and pharmacologic experiments demonstrated that intermediate opioid peptides secreted from SCH activate CXCR7, a beta-arrestin-biased G-protein-coupled receptor (GPCR), to augment circadian oscillation of glucocorticoid levels in a paracrine manner. Furthermore, recapitulating this paracrine axis by subcutaneous administration of a synthetic CXCR7 ligand is sufficient to induce anxiolytic-like behavior. Adrenocortical beta-arrestin-biased GPCR signaling is a potential target for modulating circadian glucocorticoid oscillation and emotional behavior.	[Ikeda, Yuichi; Kumagai, Hidetoshi; Skach, Amber; Sato, Makito; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Ikeda, Yuichi; Kumagai, Hidetoshi; Skach, Amber; Sato, Makito; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Kumagai, Hidetoshi; Yanagisawa, Masashi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tsukuba	Yanagisawa, M (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	masashi.yanagisawa@utsouthwestern.edu			Perot Family Foundation; Japan Science and Technology Corporation through Exploratory Research for Advanced Technology (ERATO); Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST)	Perot Family Foundation; Japan Science and Technology Corporation through Exploratory Research for Advanced Technology (ERATO); Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST)	We thank members of the M.Y. laboratory, Dr. Christopher Sinton, and Dr. James Richardson for technical assistance and scientific discussion. We also thank Tairo Ogura and Tubasa Ibushi (Shimadzu Corporation) for mass spectrometry analyses of adrenal peptides. This research was supported in part by the Perot Family Foundation, the Japan Science and Technology Corporation through Exploratory Research for Advanced Technology (ERATO), and the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST). M.Y. is an Investigator of the Howard Hughes Medical Institute.	Aiba M, 2011, J HISTOCHEM CYTOCHEM, V59, P557, DOI 10.1369/0022155411404071; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bastida CM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1010, DOI 10.1152/ajpendo.00316.2006; Becker JB, 2007, J NEUROSCI, V27, P11851, DOI 10.1523/JNEUROSCI.3565-07.2007; Bielohuby M, 2007, AM J PHYSIOL-ENDOC M, V293, pE139, DOI 10.1152/ajpendo.00705.2006; Bland ML, 2003, ANN NY ACAD SCI, V995, P59, DOI 10.1111/j.1749-6632.2003.tb03210.x; Boivin DB, 2000, J PSYCHIATR NEUROSCI, V25, P446; BRESLIN MB, 1993, J BIOL CHEM, V268, P27084; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; CRAWLEY JN, 1981, PHARMACOL BIOCHEM BE, V15, P695, DOI 10.1016/0091-3057(81)90007-1; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; DILLEN L, 1993, NEUROCHEM INT, V22, P315, DOI 10.1016/0197-0186(93)90016-X; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Gallo-Payet N, 2003, MICROSC RES TECHNIQ, V61, P275, DOI 10.1002/jemt.10337; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; Jahn H, 2004, ARCH GEN PSYCHIAT, V61, P1235, DOI 10.1001/archpsyc.61.12.1235; Janes ME, 2008, ENDOCRINOLOGY, V149, P1898, DOI 10.1210/en.2007-0949; JINGAMI H, 1984, EUR J BIOCHEM, V142, P441, DOI 10.1111/j.1432-1033.1984.tb08306.x; Johanning K, 1998, J BIOL CHEM, V273, P22672, DOI 10.1074/jbc.273.35.22672; Keers R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038263; Keller J, 2006, BIOL PSYCHIAT, V60, P275, DOI 10.1016/j.biopsych.2005.10.014; Kim JS, 2005, EXP ANIM TOKYO, V54, P107, DOI 10.1538/expanim.54.107; Konig M, 1996, NATURE, V383, P535, DOI 10.1038/383535a0; KOVATCH RM, 1986, ENVIRON HEALTH PERSP, V68, P105, DOI 10.2307/3430254; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Malek ZS, 2007, ENDOCRINOLOGY, V148, P5165, DOI 10.1210/en.2007-0526; Mansour HA, 2005, ANN MED, V37, P196, DOI 10.1080/07853890510007377; Marathe CS, 2013, PEPTIDES, V44, P75, DOI 10.1016/j.peptides.2013.01.014; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; STARKMAN MN, 1981, PSYCHOSOM MED, V43, P3, DOI 10.1097/00006842-198102000-00002; van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007; Willie JT, 2008, NEUROSCIENCE, V156, P819, DOI 10.1016/j.neuroscience.2008.08.048; Wolkowitz OM, 2009, ANN NY ACAD SCI, V1179, P19, DOI 10.1111/j.1749-6632.2009.04980.x; Yehuda R, 1996, BIOL PSYCHIAT, V40, P79, DOI 10.1016/0006-3223(95)00451-3; YOSHIDA A, 1986, JPN J VET SCI, V48, P719; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269	56	66	70	4	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 5	2013	155	6					1323	1336		10.1016/j.cell.2013.10.052	http://dx.doi.org/10.1016/j.cell.2013.10.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	269VS	24315101	Bronze, Green Accepted			2022-12-24	WOS:000328271100016
J	Matsui, A; Tran, M; Yoshida, AC; Kikuchi, SS; Mami, U; Ogawa, M; Shimogori, T				Matsui, Asuka; Tran, May; Yoshida, Aya C.; Kikuchi, Satomi S.; Mami, U.; Ogawa, Masaharu; Shimogori, Tomomi			BTBD3 Controls Dendrite Orientation Toward Active Axons in Mammalian Neocortex	SCIENCE			English	Article							VISUAL-CORTEX; RECEPTOR; GROWTH; MECHANISMS; EXPRESSION; DROSOPHILA	Experience-dependent structural changes in the developing brain are fundamental for proper neural circuit formation. Here, we show that during the development of the sensory cortex, dendritic field orientation is controlled by the BTB/POZ domain-containing 3 (BTBD3). In developing mouse somatosensory cortex, endogenous Btbd3 translocated to the cell nucleus in response to neuronal activity and oriented primary dendrites toward active axons in the barrel hollow. Btbd3 also directed dendrites toward active axon terminals when ectopically expressed in mouse visual cortex or normally expressed in ferret visual cortex. BTBD3 regulation of dendrite orientation is conserved across species and cortical areas and shows how high-acuity sensory function may be achieved by the tuning of subcellular polarity to sources of high sensory activity.	[Matsui, Asuka; Tran, May; Yoshida, Aya C.; Kikuchi, Satomi S.; Mami, U.; Ogawa, Masaharu; Shimogori, Tomomi] RIKEN Brain Sci Inst, Lab Mol Mech Thalamus Dev, Wako, Saitama 3510198, Japan	RIKEN	Shimogori, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Mech Thalamus Dev, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tshimogori@brain.riken.jp	Shimogori, Tomomi/L-2893-2013	Shimogori, Tomomi/0000-0002-6931-5401; Tran, May/0000-0001-9370-2682	RIKEN Brain Science Institute; MEXT Strategic Research Program for Brain Science (SRPBS); Center of Novel Science Initiative Brain Science Project; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST); Human Frontier Science Program (HFSP); Japan-U.S. Educational Commission (Fulbright Japan)	RIKEN Brain Science Institute; MEXT Strategic Research Program for Brain Science (SRPBS); Center of Novel Science Initiative Brain Science Project; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Japan-U.S. Educational Commission (Fulbright Japan)	We thank C. Yokoyama, A. Kania, T. Young, and A. Terashima for critical reading. We also thank Y. Takahashi, S. Tonegawa, S. Blackshaw, and S. Itohara for providing plasmids and mouse line, and F. Matsuzaki, D. Konno, T. Suetsugu, H. Mashiko, and Y. Maeda for technical assistance. This work was supported by the RIKEN Brain Science Institute, MEXT Strategic Research Program for Brain Science (SRPBS), Center of Novel Science Initiative Brain Science Project, Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST), and the Human Frontier Science Program (HFSP). M.T. is funded by the Japan-U.S. Educational Commission (Fulbright Japan).	Bathellier B, 2009, J NEUROSCI, V29, P12641, DOI 10.1523/JNEUROSCI.1124-09.2009; Callaway EM, 2011, J NEUROSCI, V31, P7456, DOI 10.1523/JNEUROSCI.5222-10.2011; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Datwani A, 2002, MOL CELL NEUROSCI, V21, P477, DOI 10.1006/mcne.2002.1195; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kawasaki H, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-24; KOSSEL A, 1995, J NEUROSCI, V15, P3913; Lebrand C, 1998, J COMP NEUROL, V401, P506; Lee LJ, 2005, J COMP NEUROL, V485, P280, DOI 10.1002/cne.20481; Lee SU, 2012, IMMUNOL REV, V247, P107, DOI 10.1111/j.1600-065X.2012.01116.x; Li WJ, 2004, NEURON, V43, P823, DOI 10.1016/j.neuron.2004.08.040; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Mashiko H, 2012, J NEUROSCI, V32, P5039, DOI 10.1523/JNEUROSCI.4788-11.2012; Nakagami Y, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00043; Narboux-Neme N, 2012, J NEUROSCI, V32, P6183, DOI 10.1523/JNEUROSCI.0343-12.2012; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Siggs OM, 2012, CELL CYCLE, V11, P3358, DOI 10.4161/cc.21277; Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Xu NJ, 2011, NAT NEUROSCI, V14, P1421, DOI 10.1038/nn.2931	26	60	64	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	2013	342	6162					1114	1118		10.1126/science.1244505	http://dx.doi.org/10.1126/science.1244505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259HS	24179155				2022-12-24	WOS:000327518600063
J	Storer, M; Mas, A; Robert-Moreno, A; Pecoraro, M; Ortells, MC; Di Giacomo, V; Yosef, R; Pilpel, N; Krizhanovsky, V; Sharpe, J; Keyes, WM				Storer, Mekayla; Mas, Alba; Robert-Moreno, Alexandre; Pecoraro, Matteo; Ortells, M. Carmen; Di Giacomo, Valeria; Yosef, Reut; Pilpel, Noam; Krizhanovsky, Valery; Sharpe, James; Keyes, William M.			Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and Patterning	CELL			English	Article							APICAL ECTODERMAL RIDGE; CELL-CYCLE ARREST; LIMB DEVELOPMENT; HUMAN FIBROBLASTS; VERTEBRATE LIMB; UP-REGULATION; ROOF PLATE; CANCER; P21; DIFFERENTIATION	Senescence is a form of cell-cycle arrest linked to tumor suppression and aging. However, it remains controversial and has not been documented in nonpathologic states. Here we describe senescence as a normal developmental mechanism found throughout the embryo, including the apical ectodermal ridge (AER) and the neural roof plate, two signaling centers in embryonic patterning. Embryonic senescent cells are nonproliferative and share features with oncogene-induced senescence (OIS), including expression of p21, p15, and mediators of the senescence-associated secretory phenotype (SASP). Interestingly, mice deficient in p21 have defects in embryonic senescence, AER maintenance, and patterning. Surprisingly, the underlying mesenchyme was identified as a source for senescence instruction in the AER, whereas the ultimate fate of these senescent cells is apoptosis and macrophage-mediated clearance. We propose that senescence is a normal programmed mechanism that plays instructive roles in development, and that OIS is an evolutionarily adapted reactivation of a developmental process.	[Storer, Mekayla; Mas, Alba; Robert-Moreno, Alexandre; Pecoraro, Matteo; Ortells, M. Carmen; Di Giacomo, Valeria; Sharpe, James; Keyes, William M.] Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Storer, Mekayla; Mas, Alba; Robert-Moreno, Alexandre; Pecoraro, Matteo; Ortells, M. Carmen; Di Giacomo, Valeria; Sharpe, James; Keyes, William M.] UPF, Barcelona 08003, Spain; [Yosef, Reut; Pilpel, Noam; Krizhanovsky, Valery] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Weizmann Institute of Science	Keyes, WM (corresponding author), Ctr Genom Regulat CRG, Barcelona 08003, Spain.	bill.keyes@crg.eu	Sharpe, James/L-1150-2014; Robert-Moreno, Alex/K-8640-2014; Sharpe, James/AAB-7948-2019	Sharpe, James/0000-0002-1434-9743; Robert-Moreno, Alex/0000-0001-9042-1316; Storer, Mekayla/0000-0003-0242-1418; Keyes, William M./0000-0002-8917-2268	"La Caixa" fellowship; Spanish Ministry; Plan Nacional grant; Spanish Ministry for Science and Innovation [SAF2010-18829]; CRG core funding	"La Caixa" fellowship(La Caixa Foundation); Spanish Ministry(Spanish Government); Plan Nacional grant; Spanish Ministry for Science and Innovation(Spanish Government); CRG core funding	We are grateful to the CRG genomics, histology, and mouse facilities for technical help, Manuela Hummel for bioinformatics analysis, Juan Valcarcel for helpful discussions, Juan-Martin Caballero for mouse models, and Juan Jose Sanz and Jelena Raspopovic for technical advice. In addition, we thank Manuel Serrano for sharing unpublished data, technical assistance, and submission coordination. M. S. and V. D. G. are funded by "La Caixa'' fellowships, and M. P. by an FPI fellowship from the Spanish Ministry. This work was funded in part by a Plan Nacional grant to W.M.K. from the Spanish Ministry for Science and Innovation (SAF2010-18829) and CRG core funding.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chizhikov VV, 2004, NAT REV NEUROSCI, V5, P808, DOI 10.1038/nrn1520; Cobrinik D, 1996, GENE DEV, V10, P1633, DOI 10.1101/gad.10.13.1633; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Devgan V, 2006, J BIOL CHEM, V281, P30463, DOI 10.1074/jbc.M604684200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gammill LS, 2003, NAT REV NEUROSCI, V4, P795, DOI 10.1038/nrn1219; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kim SH, 2006, J CELL SCI, V119, P2435, DOI 10.1242/jcs.02989; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rae F, 2007, DEV BIOL, V308, P232, DOI 10.1016/j.ydbio.2007.05.027; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Vasey DB, 2011, TRANSGENIC RES, V20, P23, DOI 10.1007/s11248-010-9385-6; Wood W, 2000, DEVELOPMENT, V127, P5245; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	56	655	671	4	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1119	1130		10.1016/j.cell.2013.10.041	http://dx.doi.org/10.1016/j.cell.2013.10.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24238961	Green Published, Bronze			2022-12-24	WOS:000327500600015
J	Owusu-Ansah, E; Song, W; Perrimon, N				Owusu-Ansah, Edward; Song, Wei; Perrimon, Norbert			Muscle Mitohormesis Promotes Longevity via Systemic Repression of Insulin Signaling	CELL			English	Article							LIFE-SPAN; MITOCHONDRIAL-FUNCTION; OXIDATIVE STRESS; PROTEIN; GROWTH; DETERMINANT; HOMEOSTASIS; MODULATION; AUTOPHAGY; HOMOLOG	Mitochondrial dysfunction is usually associated with aging. To systematically characterize the compensatory stress signaling cascades triggered in response to muscle mitochondrial perturbation, we analyzed a Drosophila model of muscle mitochondrial injury. We find that mild muscle mitochondrial distress preserves mitochondrial function, impedes the agedependent deterioration of muscle function and architecture, and prolongs lifespan. Strikingly, this effect is mediated by at least two prolongevity compensatory signaling modules: one involving a muscle-restricted redox-dependent induction of genes that regulate the mitochondrial unfolded protein response (UPR mt) and another involving the transcriptional induction of the Drosophila ortholog of insulin-like growth factor-binding protein 7, which systemically antagonizes insulin signaling and facilitates mitophagy. Given that several secreted IGFbinding proteins (IGFBPs) exist in mammals, our work raises the possibility that muscle mitochondrial injury in humans may similarly result in the secretion of IGFBPs, with important ramifications for diseases associated with aberrant insulin signaling.	[Owusu-Ansah, Edward; Song, Wei; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Perrimon, Norbert] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Owusu-Ansah, E (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	ekowuans@genetics.med.harvard.edu; perrimon@receptor.med.harvard.edu	Song, Wei/HHZ-8716-2022	Song, Wei/0000-0002-7007-5281; Perrimon, Norbert/0000-0001-7542-472X	F32 NRSA Postdoctoral Fellowship [5F32AR57291]; career Development Grant from the Muscular Dystrophy Association [202260]; Howard Hughes Medical Institute;  [AR057352]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057291, R01AR057352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088718] Funding Source: NIH RePORTER	F32 NRSA Postdoctoral Fellowship; career Development Grant from the Muscular Dystrophy Association; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Rexford Ahima for critical discussions, and Eileen Furlong, Ernst Hafen, Liqun Luo, Fannis Missirlis, Linda Partridge, and David Walker for stocks and reagents. We thank the DSHB for antibodies; the BDSC, the NIG (Japan), and the TRiP for various fly strains; Christians Villalta for embryo injections; and Elizabeth Bennechi for assistance with electron microscopy. This work was supported by an F32 NRSA Postdoctoral Fellowship (5F32AR57291) and a career Development Grant from the Muscular Dystrophy Association (Award #202260) to E. O.-A., and RO1 grant #AR057352 to N. P. N. P. is an investigator of the Howard Hughes Medical Institute.	Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; Andreux PA, 2013, NAT REV DRUG DISCOV, V12, P465, DOI 10.1038/nrd4023; Bai J, 2007, DEV CELL, V13, P828, DOI 10.1016/j.devcel.2007.10.003; Berger I, 1996, CLIN CHIM ACTA, V256, P197, DOI 10.1016/S0009-8981(96)06420-0; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Evdokimova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003184; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Glembotski CC, 2011, J MOL CELL CARDIOL, V51, P512, DOI 10.1016/j.yjmcc.2010.10.008; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Hollinshead M, 1997, J HISTOCHEM CYTOCHEM, V45, P1053, DOI 10.1177/002215549704500803; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Karpac J, 2011, DEV CELL, V20, P841, DOI 10.1016/j.devcel.2011.05.011; Kirchman PA, 1999, GENETICS, V152, P179; Kutsukake M, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-54; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Peternelj TT, 2011, SPORTS MED, V41, P1043, DOI 10.2165/11594400-000000000-00000; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505	39	256	258	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 24	2013	155	3					699	712		10.1016/j.cell.2013.09.021	http://dx.doi.org/10.1016/j.cell.2013.09.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	246WQ	24243023	Green Accepted, Bronze			2022-12-24	WOS:000326571800022
J	Nathanson, DA; Gini, B; Mottahedeh, J; Visnyei, K; Koga, T; Gomez, G; Eskin, A; Hwang, K; Wang, J; Masui, K; Paucar, A; Yang, HJ; Ohashi, M; Zhu, SJ; Wykosky, J; Reed, R; Nelson, SF; Cloughesy, TF; James, CD; Rao, PN; Kornblum, HI; Heath, JR; Cavenee, WK; Furnari, FB; Mischel, PS				Nathanson, David A.; Gini, Beatrice; Mottahedeh, Jack; Visnyei, Koppany; Koga, Tomoyuki; Gomez, German; Eskin, Ascia; Hwang, Kiwook; Wang, Jun; Masui, Kenta; Paucar, Andres; Yang, Huijun; Ohashi, Minori; Zhu, Shaojun; Wykosky, Jill; Reed, Rachel; Nelson, Stanley F.; Cloughesy, Timothy F.; James, C. David; Rao, P. Nagesh; Kornblum, Harley I.; Heath, James R.; Cavenee, Webster K.; Furnari, Frank B.; Mischel, Paul S.			Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA	SCIENCE			English	Article							GROWTH-FACTOR-RECEPTOR; DOUBLE-MINUTE CHROMOSOMES; HOMOGENEOUSLY STAINING REGIONS; DRUG-RESISTANCE; CELL-LINES; GLIOBLASTOMA-MULTIFORME; KINASE INHIBITORS; GENE; AMPLIFICATION; TUMORIGENICITY	Intratumoral heterogeneity contributes to cancer drug resistance, but the underlying mechanisms are not understood. Single-cell analyses of patient-derived models and clinical samples from glioblastoma patients treated with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) demonstrate that tumor cells reversibly up-regulate or suppress mutant EGFR expression, conferring distinct cellular phenotypes to reach an optimal equilibrium for growth. Resistance to EGFR TKIs is shown to occur by elimination of mutant EGFR from extrachromosomal DNA. After drug withdrawal, reemergence of clonal EGFR mutations on extrachromosomal DNA follows. These results indicate a highly specific, dynamic, and adaptive route by which cancers can evade therapies that target oncogenes maintained on extrachromosomal DNA.	[Gini, Beatrice; Koga, Tomoyuki; Gomez, German; Masui, Kenta; Yang, Huijun; Zhu, Shaojun; Wykosky, Jill; Reed, Rachel; Cavenee, Webster K.; Furnari, Frank B.; Mischel, Paul S.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Nathanson, David A.; Paucar, Andres; Ohashi, Minori; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Hwang, Kiwook; Wang, Jun; Heath, James R.] CALTECH, NanoSyst Biol Canc Ctr, Pasadena, CA 91030 USA; [Hwang, Kiwook; Wang, Jun; Heath, James R.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91030 USA; [Mottahedeh, Jack; Visnyei, Koppany; Paucar, Andres; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Neuropsychiat Inst, Los Angeles, CA 90095 USA; [James, C. David] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Cloughesy, Timothy F.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Henry Singleton Brain Tumor Program, Los Angeles, CA 90095 USA; [Cloughesy, Timothy F.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Cloughesy, Timothy F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Rao, P. Nagesh] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Eskin, Ascia; Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Cavenee, Webster K.; Furnari, Frank B.; Mischel, Paul S.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology; California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego	Mischel, PS (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	pmischel@ucsd.edu	Cloughesy, Timothy Francis/AGV-1013-2022; Wang, Jun/A-8216-2015; Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114; Furnari, Frank/0000-0003-1909-4361; Koga, Tomoyuki/0000-0002-8330-117X; Mischel, Paul/0000-0002-4560-2211	Ben and Catherine Ivy Foundation; National Institutes of Health (NIH) [NS73831, U54 CA151819, P01-CA95616, R01-NS080939, NINDS R01 NS052563]; Ziering Family Foundation; Art of the Brain Fund; James S. McDonnell Foundation; European Commission [PIOF-GA-2010-271819]; Ruth L. Kirschstein Institutional National Research Service Award [T32 CA009056]; UCLA Scholars in Oncologic Molecular Imaging (SOMI) Program; NATIONAL CANCER INSTITUTE [P01CA095616, P30CA023100, T32CA009056, U54CA151819, U54CA119347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080939, R01NS073831, R01NS052563] Funding Source: NIH RePORTER	Ben and Catherine Ivy Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ziering Family Foundation; Art of the Brain Fund; James S. McDonnell Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Ruth L. Kirschstein Institutional National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Scholars in Oncologic Molecular Imaging (SOMI) Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Ben and Catherine Ivy Foundation Fund (P. S. M., J.R.H., and T. F. C.); by National Institutes of Health (NIH) grants NS73831 (P. S. M.), U54 CA151819 (P. S. M. and J.R.H., principal investigator), P01-CA95616 (W. K. C. and F. B. F.), R01-NS080939 (F. B. F.), and NINDS R01 NS052563 (H. I. K.); and by the Ziering Family Foundation in memory of Sigi Ziering (T. F. C. and P. S. M.), the Art of the Brain Fund (T. F. C.), the James S. McDonnell Foundation (to F. B. F.), the European Commission PIOF-GA-2010-271819 (B. G.), Ruth L. Kirschstein Institutional National Research Service Award T32 CA009056 (D.A.N.), and the UCLA Scholars in Oncologic Molecular Imaging (SOMI) Program (D.A.N.). W. K. C. is a Fellow of the National Foundation for Cancer Research. We thank R. Kolodner for careful reading of the manuscript and helpful suggestions. We also thank W. Yong and the UCLA Brain Tumor Translational Resource.	Aldape KD, 2004, J NEUROPATH EXP NEUR, V63, P700, DOI 10.1093/jnen/63.7.700; BENNER SE, 1991, ANTI-CANCER DRUG, V2, P11, DOI 10.1097/00001813-199102000-00002; BIGNER SH, 1990, CANCER RES, V50, P8017; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Brandes AA, 2008, CLIN CANCER RES, V14, P957, DOI 10.1158/1078-0432.CCR-07-1810; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Del Vecchio CA, 2013, ONCOGENE, V32, P2670, DOI 10.1038/onc.2012.280; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; Frederick L, 2000, CANCER RES, V60, P1383; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; HABER DA, 1981, CELL, V26, P355, DOI 10.1016/0092-8674(81)90204-X; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; HUMPHREY PA, 1990, P NATL ACAD SCI USA, V87, P4207, DOI 10.1073/pnas.87.11.4207; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jeuken J, 2009, BRAIN PATHOL, V19, P661, DOI 10.1111/j.1750-3639.2009.00320.x; KAUFMAN RJ, 1981, MOL CELL BIOL, V1, P1084, DOI 10.1128/MCB.1.12.1084; KURPAD SN, 1995, GLIA, V15, P244, DOI 10.1002/glia.440150306; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; Sanborn JZ, 2013, CANCER RES, V73, P6036, DOI 10.1158/0008-5472.CAN-13-0186; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; SCHIMKE RT, 1978, SCIENCE, V202, P1051, DOI 10.1126/science.715457; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Sun J, 2010, CANCER RES, V70, P6128, DOI 10.1158/0008-5472.CAN-10-0076; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Vogt N, 2004, P NATL ACAD SCI USA, V101, P11368, DOI 10.1073/pnas.0402979101; VONHOFF DD, 1992, P NATL ACAD SCI USA, V89, P8165, DOI 10.1073/pnas.89.17.8165	34	328	351	7	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2014	343	6166					72	76		10.1126/science.1241328	http://dx.doi.org/10.1126/science.1241328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	282HR	24310612	Green Accepted			2022-12-24	WOS:000329162000050
J	Nangalia, J; Massie, CE; Baxter, EJ; Nice, FL; Gundem, G; Wedge, DC; Avezov, E; Li, J; Kollmann, K; Kent, DG; Aziz, A; Godfrey, AL; Hinton, J; Martincorena, I; Van Loo, P; Jones, AV; Guglielmelli, P; Tarpey, P; Harding, HP; Fitzpatrick, JD; Goudie, CT; Ortmann, CA; Loughran, SJ; Raine, K; Jones, DR; Butler, AP; Teague, JW; O'Meara, S; McLaren, S; Bianchi, M; Silber, Y; Dimitropoulou, D; Bloxham, D; Mudie, L; Maddison, M; Robinson, B; Keohane, C; Maclean, C; Hill, K; Orchard, K; Tauro, S; Du, MQ; Greaves, M; Bowen, D; Huntly, BJP; Harrison, CN; Cross, NCP; Ron, D; Vannucchi, AM; Papaemmanuil, E; Campbell, PJ; Green, AR				Nangalia, J.; Massie, C. E.; Baxter, E. J.; Nice, F. L.; Gundem, G.; Wedge, D. C.; Avezov, E.; Li, J.; Kollmann, K.; Kent, D. G.; Aziz, A.; Godfrey, A. L.; Hinton, J.; Martincorena, I.; Van Loo, P.; Jones, A. V.; Guglielmelli, P.; Tarpey, P.; Harding, H. P.; Fitzpatrick, J. D.; Goudie, C. T.; Ortmann, C. A.; Loughran, S. J.; Raine, K.; Jones, D. R.; Butler, A. P.; Teague, J. W.; O'Meara, S.; McLaren, S.; Bianchi, M.; Silber, Y.; Dimitropoulou, D.; Bloxham, D.; Mudie, L.; Maddison, M.; Robinson, B.; Keohane, C.; Maclean, C.; Hill, K.; Orchard, K.; Tauro, S.; Du, M-Q; Greaves, M.; Bowen, D.; Huntly, B. J. P.; Harrison, C. N.; Cross, N. C. P.; Ron, D.; Vannucchi, A. M.; Papaemmanuil, E.; Campbell, P. J.; Green, A. R.			Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; ACTIVATING MUTATION; EXON-12 MUTATIONS; V617F MUTATION; CALRETICULIN; MECHANISMS; MYELOFIBROSIS; GUIDELINE	BackgroundSomatic mutations in the Janus kinase 2 gene (JAK2) occur in many myeloproliferative neoplasms, but the molecular pathogenesis of myeloproliferative neoplasms with nonmutated JAK2 is obscure, and the diagnosis of these neoplasms remains a challenge. MethodsWe performed exome sequencing of samples obtained from 151 patients with myeloproliferative neoplasms. The mutation status of the gene encoding calreticulin (CALR) was assessed in an additional 1345 hematologic cancers, 1517 other cancers, and 550 controls. We established phylogenetic trees using hematopoietic colonies. We assessed calreticulin subcellular localization using immunofluorescence and flow cytometry. ResultsExome sequencing identified 1498 mutations in 151 patients, with medians of 6.5, 6.5, and 13.0 mutations per patient in samples of polycythemia vera, essential thrombocythemia, and myelofibrosis, respectively. Somatic CALR mutations were found in 70 to 84% of samples of myeloproliferative neoplasms with nonmutated JAK2, in 8% of myelodysplasia samples, in occasional samples of other myeloid cancers, and in none of the other cancers. A total of 148 CALR mutations were identified with 19 distinct variants. Mutations were located in exon 9 and generated a +1 base-pair frameshift, which would result in a mutant protein with a novel C-terminal. Mutant calreticulin was observed in the endoplasmic reticulum without increased cell-surface or Golgi accumulation. Patients with myeloproliferative neoplasms carrying CALR mutations presented with higher platelet counts and lower hemoglobin levels than patients with mutated JAK2. Mutation of CALR was detected in hematopoietic stem and progenitor cells. Clonal analyses showed CALR mutations in the earliest phylogenetic node, a finding consistent with its role as an initiating mutation in some patients. ConclusionsSomatic mutations in the endoplasmic reticulum chaperone CALR were found in a majority of patients with myeloproliferative neoplasms with nonmutated JAK2. (Funded by the Kay Kendall Leukaemia Fund and others.) The authors show that the diverse mutations in CALR that occur in nonmutated JAK2 myeloproliferative diseases all introduce frameshift mutations that alter the C-terminal part of the protein and affect its distribution within cells. The myeloproliferative neoplasms are chronic myeloid cancers that are characterized by the overproduction of mature blood cells, and that may evolve into acute myeloid leukemia.(1),(2) In addition to chronic myeloid leukemia with the BCR-ABL fusion gene, the three most common myeloproliferative neoplasms are essential thrombocythemia, polycythemia vera, and myelofibrosis. Many patients with a BCR-ABL-negative myeloproliferative neoplasm carry a Janus kinase 2 (JAK2) V617F mutation.(3)-(6) The JAK2 V617F mutation or JAK2 exon 12 mutations are found in most patients with polycythemia vera,(7),(8) whereas the JAK2 V617F mutation is found in only 50 to 60% of ...	[Nangalia, J.; Massie, C. E.; Baxter, E. J.; Nice, F. L.; Kollmann, K.; Kent, D. G.; Aziz, A.; Godfrey, A. L.; Jones, A. V.; Fitzpatrick, J. D.; Goudie, C. T.; Ortmann, C. A.; Loughran, S. J.; Silber, Y.; Dimitropoulou, D.; Huntly, B. J. P.; Green, A. R.] Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Nangalia, J.; Massie, C. E.; Baxter, E. J.; Nice, F. L.; Li, J.; Kollmann, K.; Kent, D. G.; Aziz, A.; Godfrey, A. L.; Jones, A. V.; Fitzpatrick, J. D.; Goudie, C. T.; Ortmann, C. A.; Loughran, S. J.; Silber, Y.; Dimitropoulou, D.; Huntly, B. J. P.; Green, A. R.] Wellcome Trust MRC Stem Cell Inst, Cambridge, England; [Nangalia, J.; Massie, C. E.; Baxter, E. J.; Nice, F. L.; Li, J.; Aziz, A.; Godfrey, A. L.; Jones, A. V.; Ortmann, C. A.; Loughran, S. J.; Silber, Y.; Dimitropoulou, D.; Huntly, B. J. P.; Campbell, P. J.; Green, A. R.] Univ Cambridge, Dept Haematol, Cambridge CB2 1TN, England; [Du, M-Q] Univ Cambridge, Div Mol Histopathol, Dept Pathol, Cambridge CB2 1TN, England; [Nangalia, J.; Massie, C. E.; Gundem, G.; Wedge, D. C.; Hinton, J.; Martincorena, I.; Van Loo, P.; Tarpey, P.; Raine, K.; Jones, D. R.; Butler, A. P.; Teague, J. W.; O'Meara, S.; McLaren, S.; Mudie, L.; Maddison, M.; Robinson, B.; Papaemmanuil, E.; Campbell, P. J.] Wellcome Trust Sanger Inst, Cambridge, England; [Nangalia, J.; Godfrey, A. L.; Bianchi, M.; Bloxham, D.; Maclean, C.; Huntly, B. J. P.; Campbell, P. J.; Green, A. R.] Addenbrookes Hosp, Dept Haematol, Cambridge, England; [Avezov, E.; Harding, H. P.; Ron, D.] Univ Cambridge, Metab Res Labs, Cambridge, England; [Avezov, E.; Harding, H. P.; Ron, D.] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England; [Jones, A. V.; Cross, N. C. P.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Hill, K.; Orchard, K.] Southampton Univ Hosp, Dept Haematol, Southampton, Hants, England; [Keohane, C.; Harrison, C. N.] Guys & St Thomas Natl Hlth Serv Fdn Trust, Guys Hosp, London, England; [Greaves, M.] Inst Canc Res, Div Mol Pathol, Haematooncol Res Unit, London SW3 6JB, England; [Tauro, S.] Ninewells Hosp, Dept Hematol, Dundee DD1 9SY, Scotland; [Bloxham, D.] St James Hosp, St James Inst Oncol, Leeds LS9 7TF, W Yorkshire, England; [Van Loo, P.] VIB, Dept Human Genet, Louvain, Belgium; [Van Loo, P.] Katholieke Univ Leuven, Louvain, Belgium; [Guglielmelli, P.; Vannucchi, A. M.] Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy	University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; University of Southampton; University of Southampton; Guy's & St Thomas' NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Dundee; Saint James's University Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Florence	Green, AR (corresponding author), Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	arg1000@cam.ac.uk	huntly, brian JP/E-6725-2014; Guglielmelli, Paola/K-7509-2016; Vannucchi, Alessandro M./K-7499-2016; Orchard, Kim H/A-3073-2016; Kent, David/AAZ-4916-2021; Wedge, David/AAC-4977-2021; Cross, Nicholas/B-4817-2009	huntly, brian JP/0000-0003-0312-161X; Guglielmelli, Paola/0000-0003-1809-284X; Vannucchi, Alessandro M./0000-0001-5755-0730; Orchard, Kim H/0000-0003-2276-3925; Kent, David/0000-0001-7871-8811; Cross, Nicholas/0000-0001-5481-2555; Baxter, Elizabeth Joanna/0000-0002-5946-5238; Fitzpatrick, John D./0000-0003-0342-1364; Martincorena, Inigo/0000-0003-1122-4416; Green, Anthony/0000-0002-9795-0218; Kollmann, Karoline/0000-0002-7937-4245; Massie, Charlie/0000-0003-2314-4843; Avezov, Edward/0000-0002-2894-0585; Du, Ming-Qing/0000-0002-1017-5045; Jones, Amy Victoria/0000-0003-3467-6765; Harding, Heather P/0000-0002-7359-7974; Raine, Keiran/0000-0002-5634-1539; Wedge, David/0000-0002-7572-3196; Ron, David/0000-0002-3014-5636; Van Loo, Peter/0000-0003-0292-1949	Kay Kendall Leukaemia Fund; Wellcome Trust; Leukemia and Lymphoma Research; Cancer Research UK; National Institute for Health Research Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Leukemia and Lymphoma Society of America; Research Foundation-Flanders; Associazione Italiana per la Ricerca sul Cancro (AIRC)-Gruppo Italiano Malattie Mieloproliferative; Canadian Institutes of Health Research; Lady Tata Memorial Trust; MRC [G0300497] Funding Source: UKRI; Cancer Research UK [8961, 12526, 12765, 15488] Funding Source: researchfish; Medical Research Council [G0300497, 1479733] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10079] Funding Source: researchfish	Kay Kendall Leukaemia Fund; Wellcome Trust(Wellcome TrustEuropean Commission); Leukemia and Lymphoma Research; Cancer Research UK(Cancer Research UK); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); Research Foundation-Flanders(FWO); Associazione Italiana per la Ricerca sul Cancro (AIRC)-Gruppo Italiano Malattie Mieloproliferative(Fondazione AIRC per la ricerca sul cancro); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Lady Tata Memorial Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by the Kay Kendall Leukaemia Fund (including a clinical research fellowship to Drs. Nangalia and Godfrey), the Wellcome Trust (including fellowships to Drs. Campbell and Ron), Leukemia and Lymphoma Research, Cancer Research UK, the National Institute for Health Research Cambridge Biomedical Research Centre, the Cambridge Experimental Cancer Medicine Centre, and the Leukemia and Lymphoma Society of America; a postdoctoral research grant from the Research Foundation-Flanders (to Dr. Van Loo); a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC)-Gruppo Italiano Malattie Mieloproliferative (to Drs. Vannucchi and Guglielmelli); and a Canadian Institutes of Health Research Fellowship and the Lady Tata Memorial Trust grant (to Dr. Kent).	Abdel-Wahab O, 2011, LEUKEMIA, V25, P1219, DOI 10.1038/leu.2011.82; Ambaglio I, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.2755.2755; Barbui T, 2011, J CLIN ONCOL, V29, P761, DOI 10.1200/JCO.2010.31.8436; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Butcher CM, 2008, LEUKEMIA, V22, P870, DOI 10.1038/sj.leu.2404971; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Campbell PJ, 2006, BLOOD, V107, P2098, DOI 10.1182/blood-2005-08-3395; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; Carbuccia N, 2009, LEUKEMIA, V23, P2183, DOI 10.1038/leu.2009.141; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Godfrey AL, 2012, BLOOD, V120, P2704, DOI 10.1182/blood-2012-05-431791; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Harrison CN, 2010, BRIT J HAEMATOL, V149, P352, DOI 10.1111/j.1365-2141.2010.08122.x; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Lasho TL, 2010, NEW ENGL J MED, V363, P1189, DOI 10.1056/NEJMc1006966; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Ley TJ, 2013, NEW ENGL J MED, V369, P98; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; McMullin MF, 2007, BRIT J HAEMATOL, V138, P821, DOI 10.1111/j.1365-2141.2007.06741.x; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pardanani A, 2010, LEUKEMIA, V24, P1146, DOI 10.1038/leu.2010.77; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Pocanschi CL, 2011, J BIOL CHEM, V286, P27266, DOI 10.1074/jbc.M111.258467; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Stegelmann F, 2011, LEUKEMIA, V25, P1217, DOI 10.1038/leu.2011.77; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Swerdlow E., 2008, WHO CLASSIFICATION T; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang WA, 2012, INT J BIOCHEM CELL B, V44, P842, DOI 10.1016/j.biocel.2012.02.009	41	1213	1285	6	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 19	2013	369	25					2391	2405		10.1056/NEJMoa1312542	http://dx.doi.org/10.1056/NEJMoa1312542			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	274DQ	24325359	Green Accepted			2022-12-24	WOS:000328586000007
J	Praetorius, C; Grill, C; Stacey, SN; Metcalf, AM; Gorkin, DU; Robinson, KC; Van Otterloo, E; Kim, RSQ; Bergsteinsdottir, K; Ogmundsdottir, MH; Magnusdottir, E; Mishra, PJ; Davis, SR; Guo, T; Zaidi, MR; Helgason, AS; Sigurdsson, MI; Meltzer, PS; Merlino, G; Petit, V; Larue, L; Loftus, SK; Adams, DR; Sobhiafshar, U; Emre, NCT; Pavan, WJ; Cornell, R; Smith, AG; McCallion, AS; Fisher, DE; Stefansson, K; Sturm, RA; Steingrimsson, E				Praetorius, Christian; Grill, Christine; Stacey, Simon N.; Metcalf, Alexander M.; Gorkin, David U.; Robinson, Kathleen C.; Van Otterloo, Eric; Kim, Reuben S. Q.; Bergsteinsdottir, Kristin; Ogmundsdottir, Margret H.; Magnusdottir, Erna; Mishra, Pravin J.; Davis, Sean R.; Guo, Theresa; Zaidi, M. Raza; Helgason, Agnar S.; Sigurdsson, Martin I.; Meltzer, Paul S.; Merlino, Glenn; Petit, Valerie; Larue, Lionel; Loftus, Stacie K.; Adams, David R.; Sobhiafshar, Ulduz; Emre, N. C. Tolga; Pavan, William J.; Cornell, Robert; Smith, Aaron G.; McCallion, Andrew S.; Fisher, David E.; Stefansson, Kari; Sturm, Richard A.; Steingrimsson, Eirikur			A Polymorphism in IRF4 Affects Human Pigmentation through a Tyrosinase-Dependent MITF/TFAP2A Pathway	CELL			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; GENETIC-DETERMINANTS; EXPRESSION; VARIANTS; ENHANCER; RECEPTOR; LOCUS; INVOLVEMENT; MELANOCYTES; RS6983267	Sequence polymorphisms linked to human diseases and phenotypes in genome-wide association studies often affect noncoding regions. A SNP within an intron of the gene encoding Interferon Regulatory Factor 4 (IRF4), a transcription factor with no known role in melanocyte biology, is strongly associated with sensitivity of skin to sun exposure, freckles, blue eyes, and brown hair color. Here, we demonstrate that this SNP lies within an enhancer of IRF4 transcription in melanocytes. The allele associated with this pigmentation phenotype impairs binding of the TFAP2A transcription factor that, together with the melanocyte master regulator MITF, regulates activity of the enhancer. Assays in zebrafish and mice reveal that IRF4 cooperates with MITF to activate expression of Tyrosinase (TYR), an essential enzyme in melanin synthesis. Our findings provide a clear example of a noncoding polymorphism that affects a phenotype by modulating a developmental gene regulatory network.	[Praetorius, Christian; Grill, Christine; Bergsteinsdottir, Kristin; Ogmundsdottir, Margret H.; Magnusdottir, Erna; Sigurdsson, Martin I.; Steingrimsson, Eirikur] Univ Iceland, Fac Med, Dept Biochem & Mol Biol, Biomed Ctr, IS-101 Reykjavik, Iceland; [Stacey, Simon N.; Helgason, Agnar S.; Stefansson, Kari] Decode Genet, IS-101 Reykjavik, Iceland; [Metcalf, Alexander M.; Kim, Reuben S. Q.; Smith, Aaron G.; Sturm, Richard A.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Gorkin, David U.; McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Gorkin, David U.] Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD 21205 USA; [Robinson, Kathleen C.; Fisher, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Dermatol, Boston, MA 02114 USA; [Van Otterloo, Eric; Cornell, Robert] Univ Iowa, Iowa City, IA 52242 USA; [Kim, Reuben S. Q.; Smith, Aaron G.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Mishra, Pravin J.; Guo, Theresa; Zaidi, M. Raza; Merlino, Glenn] NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA; [Davis, Sean R.; Meltzer, Paul S.] NCI, Genet Branch, Bethesda, MD 20892 USA; [Petit, Valerie; Larue, Lionel] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Loftus, Stacie K.; Pavan, William J.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Adams, David R.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Sobhiafshar, Ulduz; Emre, N. C. Tolga] Bogazici Univ, Dept Mol Biol & Genet, Lab Genome Regulat, TR-34342 Istanbul, Turkey	University of Iceland; University of Queensland; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Iowa; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Bogazici University	Steingrimsson, E (corresponding author), Univ Iceland, Fac Med, Dept Biochem & Mol Biol, Biomed Ctr, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland.	eirikurs@hi.is	Smith, Aaron/A-8329-2010; Helgason, Agnar/K-1522-2015; Sturm, Richard A/C-9943-2009; Stefansson, Kari/AAE-7187-2019; Emre, Tolga/A-1787-2016; Sigurdsson, Martin Ingi/I-9655-2016; Davis, Sean/AAD-1801-2021; Magnúsdóttir, Erna/T-8993-2019; Larue, Lionel/I-6532-2016; Magnúsdóttir, Erna/H-5181-2013; Guo, Theresa/AAF-2216-2021; Fisher, David/AAH-2878-2019; Zaidi, M. Raza/H-1386-2016	Sturm, Richard A/0000-0003-1301-0294; Emre, Tolga/0000-0001-8021-5228; Sigurdsson, Martin Ingi/0000-0001-7054-0844; Davis, Sean/0000-0002-8991-6458; Magnúsdóttir, Erna/0000-0002-3369-4390; Pavan, William/0000-0001-8281-5120; Steingrimsson, Eirikur/0000-0001-5826-7486; Loftus, Stacie/0000-0002-1958-4689; Cornell, Robert/0000-0003-4207-9100; Helgason, Agnar/0000-0002-8545-3767; Praetorius, Christian/0000-0001-7514-5333; PETIT, Valerie/0000-0003-1645-9396; Gorkin, David/0000-0003-4944-4107; Zaidi, M. Raza/0000-0003-0480-3188; Smith, Aaron/0000-0003-2937-1713; Sobhiafshar, Ulduz/0000-0002-4698-3909	NIH [5R01 AR043369-16]; Melanoma Research Alliance; Dr. Miriam and Sheldon Adelson Medical Research Foundation; US-Israel Binational Science Foundation; Ligue Nationale Contre le Cancer; INCa; Icelandic Research Fund; Research Fund of the University of Iceland; Haskolasjodur Student Fund; Jules Verne Fund; National Institute of General Medical Sciences [GM071648]; National Institute of Neurological Disease and Stroke [NS062972]; National Human Genome Research Institute's Intramural Research Program; NSF Graduate Research Fellowship; NATIONAL CANCER INSTITUTE [ZIABC011091, P01CA163222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062547, R01AR043369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062972] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Dr. Miriam and Sheldon Adelson Medical Research Foundation; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); Icelandic Research Fund; Research Fund of the University of Iceland(Istanbul University); Haskolasjodur Student Fund; Jules Verne Fund; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute's Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Thorunn Rafnar, Magnus Karl Magnusson, Unnur Thorsteinsdottir, Colin R. Goding, and Thorarinn Gudjonsson for critical comments on the manuscript. This work was supported by grants from NIH (5R01 AR043369-16), Melanoma Research Alliance, Dr. Miriam and Sheldon Adelson Medical Research Foundation, US-Israel Binational Science Foundation (to D.E.F.), Ligue Nationale Contre le Cancer (Equipe labellisee) and INCa (to L.L.), the Icelandic Research Fund and the Research Fund of the University of Iceland (to E.S.), the Haskolasjodur Student Fund (to E.S., C.P., and C.G.), the Jules Verne Fund (to E.S. and L.L.), by the National Institute of General Medical Sciences (GM071648) and National Institute of Neurological Disease and Stroke (NS062972; to A.S.M.), the National Human Genome Research Institute's Intramural Research Program (to W.J.P. and S.L.), and an NSF Graduate Research Fellowship (to D.U.G.).	Adachi S, 2000, J IMMUNOL, V164, P855, DOI 10.4049/jimmunol.164.2.855; Aoki H, 2002, LIFE SCI, V71, P2171, DOI 10.1016/S0024-3205(02)01996-3; Bastiaens M, 2001, HUM MOL GENET, V10, P1701, DOI 10.1093/hmg/10.16.1701; Beleza S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003372; Bertolotto C, 1996, J CELL BIOL, V134, P747, DOI 10.1083/jcb.134.3.747; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; Debbache J, 2012, GENETICS, V191, P133, DOI 10.1534/genetics.111.135996; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Do TN, 2010, BBA-MOL BASIS DIS, V1802, P292, DOI 10.1016/j.bbadis.2009.10.015; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Duffy DL, 2010, AM J HUM GENET, V87, P6, DOI 10.1016/j.ajhg.2010.05.017; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Gorkin DU, 2012, GENOME RES, V22, P2290, DOI 10.1101/gr.139360.112; Grossman A, 1996, GENOMICS, V37, P229, DOI 10.1006/geno.1996.0547; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Iida S, 1997, NAT GENET, V17, P226, DOI 10.1038/ng1097-226; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Smith AG, 2001, GENE, V281, P81, DOI 10.1016/S0378-1119(01)00791-0; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Strub T, 2011, ONCOGENE, V30, P2319, DOI 10.1038/onc.2010.612; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Sundram U, 2003, MODERN PATHOL, V16, P802, DOI 10.1097/01.MP.0000081726.49886.CF; Sviderskaya EV, 2002, JNCI-J NATL CANCER I, V94, P446; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tsuboi K, 2000, LEUKEMIA, V14, P449, DOI 10.1038/sj.leu.2401696; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Van Otterloo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001122; Visser M, 2012, GENOME RES, V22, P446, DOI 10.1101/gr.128652.111; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	51	137	142	1	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 21	2013	155	5					1022	1033		10.1016/j.cell.2013.10.022	http://dx.doi.org/10.1016/j.cell.2013.10.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	259AU	24267888	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000327500600008
J	Cho, Y; Sloutsky, R; Naegle, KM; Cavalli, V				Cho, Yongcheol; Sloutsky, Roman; Naegle, Kristen M.; Cavalli, Valeria			Injury-Induced HDAC5 Nuclear Export Is Essential for Axon Regeneration	CELL			English	Article							PROTEIN-KINASE-C; NEURITE GROWTH; TRANSCRIPTION; EXPRESSION; AXOTOMY; NEURONS; MECHANISMS; INHIBITION; CALCIUM; ACTIVATION	Reactivation of a silent transcriptional program is a critical step in successful axon regeneration following injury. Yet how such a program is unlocked after injury remains largely unexplored. We found that axon injury in peripheral sensory neurons elicits a back-propagating calcium wave that invades the soma and causes nuclear export of HDAC5 in a PKC mu-dependent manner. Injury-induced HDAC5 nuclear export enhances histone acetylation to activate a proregenerative gene-expression program. HDAC5 nuclear export is required for axon regeneration, as expression of a nuclear-trapped HDAC5 mutant prevents axon regeneration, whereas enhancing HDAC5 nuclear export promotes axon regeneration in vitro and in vivo. Components of this HDAC5 pathway failed to be activated in a model of central nervous system injury. These studies reveal a signaling mechanism from the axon injury site to the soma that controls neuronal growth competence and suggest a role for HDAC5 as a transcriptional switch controlling axon regeneration.	[Cho, Yongcheol; Cavalli, Valeria] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Sloutsky, Roman; Naegle, Kristen M.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Cavalli, V (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	cavalli@pcg.wustl.edu		Naegle, Kristen/0000-0001-7146-9592; Sloutsky, Roman/0000-0002-0794-1255	NIH [DE022000, NS082446]; McDonnell Center for Cellular and Molecular Neurobiology; Hope Center for Neurological Disorders; National Research Foundation of Korea [NRF-2012R1A6A3A03039290]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082446] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Center for Cellular and Molecular Neurobiology; Hope Center for Neurological Disorders; National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Vitaly Klyachko for critical reading of the manuscript. We thank Eric Olson for the generous gift of the HDAC5 KO mice. We thank Domini Montgomery for technical support, Dennis Oakley for assistance with imaging, Ernie Gonzales and the Animal Surgery Core of the Hope Center for Neurological Disorders for assistance with optic nerve surgeries, and Seth Crosby and the Genome Technology Access Center at Washington University for microarray analysis. This work was supported in part by grants from NIH (DE022000 and NS082446), the McDonnell Center for Cellular and Molecular Neurobiology, the Hope Center for Neurological Disorders (to V. C.), and the National Research Foundation of Korea (NRF-2012R1A6A3A03039290) (to Y.C.).	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; Ambron RT, 1996, MOL NEUROBIOL, V13, P61, DOI 10.1007/BF02740752; Befort K, 2003, EUR J NEUROSCI, V18, P911, DOI 10.1046/j.1460-9568.2003.02827.x; Ben-Yaakov K, 2012, EMBO J, V31, P1350, DOI 10.1038/emboj.2011.494; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Blesch A, 2012, EXP NEUROL, V235, P162, DOI 10.1016/j.expneurol.2011.12.037; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Broude E, 1997, EXP NEUROL, V148, P367, DOI 10.1006/exnr.1997.6665; Buschmann T, 1998, NEUROSCIENCE, V84, P163, DOI 10.1016/S0306-4522(97)00487-9; CAMPENOT RB, 1994, J NEUROCHEM, V63, P868; Cayrou C, 2002, ENDOCRINOLOGY, V143, P2242, DOI 10.1210/en.143.6.2242; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gaub P, 2010, CELL DEATH DIFFER, V17, P1392, DOI 10.1038/cdd.2009.216; Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Kamber D, 2009, EXP NEUROL, V219, P112, DOI 10.1016/j.expneurol.2009.05.004; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; LEAH JD, 1993, NEUROSCIENCE, V57, P53, DOI 10.1016/0306-4522(93)90111-R; Mandolesi G, 2004, FASEB J, V18, P1934, DOI 10.1096/fj.04-1805fje; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; MCQUARRIE IG, 1973, ARCH NEUROL-CHICAGO, V29, P53, DOI 10.1001/archneur.1973.00490250071008; Michaelevski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000952; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Pelzel HR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-62; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perry RB, 2012, NEURON, V75, P294, DOI 10.1016/j.neuron.2012.05.033; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Rishal I, 2010, EXP NEUROL, V223, P5, DOI 10.1016/j.expneurol.2009.08.010; Shadiack AM, 2001, J NEUROSCI, V21, P363, DOI 10.1523/JNEUROSCI.21-02-00363.2001; Shields SD, 2012, PAIN, V153, P2017, DOI 10.1016/j.pain.2012.04.022; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Smith DS, 1997, J NEUROSCI, V17, P646; Tedeschi A, 2012, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmo1.2011.00060; Tsai SY, 2007, J NEUROSCI RES, V85, P321, DOI 10.1002/jnr.21119; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wu DY, 2003, INVEST OPHTH VIS SCI, V44, P2783, DOI 10.1167/iovs.02-0715; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Zhang XF, 2010, NEUROPHARMACOLOGY, V59, P201, DOI 10.1016/j.neuropharm.2010.05.009; ZIV NE, 1993, EUR J NEUROSCI, V5, P657, DOI 10.1111/j.1460-9568.1993.tb00531.x; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	52	211	215	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 7	2013	155	4					894	908		10.1016/j.cell.2013.10.004	http://dx.doi.org/10.1016/j.cell.2013.10.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	251MW	24209626	Bronze, Green Accepted			2022-12-24	WOS:000326934300018
J	Sabelstrom, H; Stenudd, M; Reu, P; Dias, DO; Elfineh, M; Zdunek, S; Damberg, P; Goritz, C; Frisen, J				Sabelstrom, Hanna; Stenudd, Moa; Reu, Pedro; Dias, David O.; Elfineh, Marta; Zdunek, Sofia; Damberg, Peter; Goritz, Christian; Frisen, Jonas			Resident Neural Stem Cells Restrict Tissue Damage and Neuronal Loss After Spinal Cord Injury in Mice	SCIENCE			English	Article							CILIARY NEUROTROPHIC FACTOR; CENTRAL-NERVOUS-SYSTEM; DIFFERENTIATION; GROWTH; ORIGIN; BRAIN; RATS; SCAR; PROLIFERATION; EXPRESSION	Central nervous system injuries are accompanied by scar formation. It has been difficult to delineate the precise role of the scar, as it is made by several different cell types, which may limit the damage but also inhibit axonal regrowth. We show that scarring by neural stem cell-derived astrocytes is required to restrict secondary enlargement of the lesion and further axonal loss after spinal cord injury. Moreover, neural stem cell progeny exerts a neurotrophic effect required for survival of neurons adjacent to the lesion. One distinct component of the glial scar, deriving from resident neural stem cells, is required for maintaining the integrity of the injured spinal cord.	[Sabelstrom, Hanna; Stenudd, Moa; Reu, Pedro; Dias, David O.; Elfineh, Marta; Zdunek, Sofia; Goritz, Christian; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Reu, Pedro] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Damberg, Peter] Karolinska Inst, Dept Clin Sci Intervent & Technol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Universidade de Coimbra; Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Göritz, Christian/AAK-5348-2021	Göritz, Christian/0000-0003-0799-766X; Oliveira Dias, David/0000-0002-2144-6621; Sabelstrom, Hanna/0000-0002-1736-7234; Reu, Pedro/0000-0001-7454-7189	Swedish Research Council; Swedish Cancer Society; Karolinska Institute; Tobias Stiftelsen; AFA Forsakringar; StratRegen; Knut och Alice Wallenbergs Stiftelse; Foundation for Science and Technology from the Portuguese government [SFRH/BD/63164/2009, SFRH/BD/33465/2008]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; AFA Forsakringar; StratRegen; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Foundation for Science and Technology from the Portuguese government	We thank F. Barnabe-Heider and O. Bergmann for discussions and M. Barbacid for providing Ras mutant mice through a materials transfer agreement with Centro Nacional de Investigaciones Oncologicas (Spanish National Cancer Institute, CNIO), Spain. Requests for mice should be directed to M. Barbacid (CNIO, Spain). This study was supported by the Swedish Research Council, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftelsen, AFA Forsakringar, StratRegen, and Knut och Alice Wallenbergs Stiftelse. D.O.D. and P.R. were supported by the Foundation for Science and Technology from the Portuguese government (SFRH/BD/63164/2009 and SFRH/BD/33465/2008).	Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hung KS, 2007, J NEUROSURG-SPINE, V6, P35, DOI 10.3171/spi.2007.6.1.35; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kitamura K, 2007, J NEUROSCI RES, V85, P2332, DOI 10.1002/jnr.21372; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; NIETOSAMPEDRO M, 1982, SCIENCE, V217, P860, DOI 10.1126/science.7100931; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pfenninger CV, 2011, GLIA, V59, P68, DOI 10.1002/glia.21077; Sabelstrom H, 2014, EXP NEUROL, V260, P44, DOI 10.1016/j.expneurol.2013.01.026; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tripathi RB, 2008, J COMP NEUROL, V510, P129, DOI 10.1002/cne.21787; Yan J, 2004, J COMP NEUROL, V480, P101, DOI 10.1002/cne.20344; Yasuda A, 2011, STEM CELLS, V29, P1983, DOI 10.1002/stem.767; Ye JL, 2004, BRAIN RES, V997, P30, DOI 10.1016/j.brainres.2003.10.036	27	185	193	5	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					637	640		10.1126/science.1242576	http://dx.doi.org/10.1126/science.1242576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24179227				2022-12-24	WOS:000326334300053
J	Hansen, MC; Potapov, PV; Moore, R; Hancher, M; Turubanova, SA; Tyukavina, A; Thau, D; Stehman, SV; Goetz, SJ; Loveland, TR; Kommareddy, A; Egorov, A; Chini, L; Justice, CO; Townshend, JRG				Hansen, M. C.; Potapov, P. V.; Moore, R.; Hancher, M.; Turubanova, S. A.; Tyukavina, A.; Thau, D.; Stehman, S. V.; Goetz, S. J.; Loveland, T. R.; Kommareddy, A.; Egorov, A.; Chini, L.; Justice, C. O.; Townshend, J. R. G.			High-Resolution Global Maps of 21st-Century Forest Cover Change	SCIENCE			English	Article							DEFORESTATION; TRANSITION; EMISSIONS	Quantification of global forest change has been lacking despite the recognized importance of forest ecosystem services. In this study, Earth observation satellite data were used to map global forest loss (2.3 million square kilometers) and gain (0.8 million square kilometers) from 2000 to 2012 at a spatial resolution of 30 meters. The tropics were the only climate domain to exhibit a trend, with forest loss increasing by 2101 square kilometers per year. Brazil's well-documented reduction in deforestation was offset by increasing forest loss in Indonesia, Malaysia, Paraguay, Bolivia, Zambia, Angola, and elsewhere. Intensive forestry practiced within subtropical forests resulted in the highest rates of forest change globally. Boreal forest loss due largely to fire and forestry was second to that in the tropics in absolute and proportional terms. These results depict a globally consistent and locally relevant record of forest change.	[Hansen, M. C.; Potapov, P. V.; Turubanova, S. A.; Tyukavina, A.; Chini, L.; Justice, C. O.; Townshend, J. R. G.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Moore, R.; Hancher, M.; Thau, D.] Google, Mountain View, CA USA; [Stehman, S. V.] SUNY Syracuse, Dept Forest & Nat Resources Management, Syracuse, NY USA; [Goetz, S. J.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Loveland, T. R.] US Geol Survey, Sioux Falls, SD 57198 USA; [Kommareddy, A.; Egorov, A.] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA	University System of Maryland; University of Maryland College Park; Google Incorporated; State University of New York (SUNY) System; Woods Hole Research Center; United States Department of the Interior; United States Geological Survey; South Dakota State University	Hansen, MC (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	mhansen@umd.edu	Loveland, Thomas/AAW-3332-2020; Goetz, Scott J/A-3393-2015; Stevens, Raymond/K-7272-2015; Noojipady, Praveen/B-2511-2010; Hansen, Matthew C/ABE-7226-2020; Tyukavina, Alexandra/AGW-0785-2022; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022; potapov, peter/AAE-7388-2019; Han, Gye Won/GLQ-8673-2022	Goetz, Scott J/0000-0002-6326-4308; Stevens, Raymond/0000-0002-4522-8725; Han, Gye Won/0000-0003-4107-835X; Potapov, Peter/0000-0003-3977-0021; Jo, Euijung/0000-0003-1131-2723; Tyukavina, Alexandra/0000-0003-3872-9844	NASA [NNH05ZDA001N, NNH07ZDA001N, NNX12AB43G, NNX12AC78G, NNX08AP33A, NNG06GD95G]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055509, U01AI074564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, P50GM073197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for Landsat data analysis and characterization was provided by the Gordon and Betty Moore Foundation, the United States Geological Survey, and Google, Inc. GLAS data analysis was supported by the David and Lucile Packard Foundation. Development of all methods was supported by NASA through its Land Cover and Land Use Change, Terrestrial Ecology, Applied Sciences, and MEaSUREs programs (grants NNH05ZDA001N, NNH07ZDA001N, NNX12AB43G, NNX12AC78G, NNX08AP33A, and NNG06GD95G) and by the U.S. Agency for International Development through its CARPE program. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U. S. government. Results are depicted and viewable online at full resolution: http://earthenginepartners.appspot.com/science-2013-global-forest.	Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/nclimate1354, 10.1038/NCLIMATE1354]; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; Edwards DP, 2011, NATURE, V477, P33, DOI 10.1038/477033a; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Food and Agricultural Organization of the United Nations, 2012, 169 FAO; Gardiner B., 2010, Destructive storms in European forests: past and forthcoming impacts; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hansen MC, 2004, ECOSYSTEMS, V7, P695, DOI 10.1007/s10021-004-0243-3; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Houghton R., 2001, CARBON MANAG, V1, P253; Instituto Nacional de Pesquisas Especias, 2013, MON BRAZ AM FOR SAT; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Potapov P, 2008, REMOTE SENS ENVIRON, V112, P3708, DOI 10.1016/j.rse.2008.05.006; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Prishchepov AV, 2013, LAND USE POLICY, V30, P873, DOI 10.1016/j.landusepol.2012.06.011; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rudel TK, 1998, RURAL SOCIOL, V63, P533, DOI 10.1111/j.1549-0831.1998.tb00691.x; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; United Nations Framework Convention on Climate Change, 2005, RED EM DEF DEV COUNT; Waterworth RM, 2007, FOREST ECOL MANAG, V238, P231, DOI 10.1016/j.foreco.2006.10.014	23	6084	6344	174	611	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	2013	342	6160					850	853		10.1126/science.1244693	http://dx.doi.org/10.1126/science.1244693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	251IY	22344443				2022-12-24	WOS:000326923000036
J	Hanson, MA; Roth, CB; Jo, EJ; Griffith, MT; Scott, FL; Reinhart, G; Desale, H; Clemons, B; Cahalan, SM; Schuerer, SC; Sanna, MG; Han, GW; Kuhn, P; Rosen, H; Stevens, RC				Hanson, Michael A.; Roth, Christopher B.; Jo, Euijung; Griffith, Mark T.; Scott, Fiona L.; Reinhart, Greg; Desale, Hans; Clemons, Bryan; Cahalan, Stuart M.; Schuerer, Stephan C.; Sanna, M. Germana; Han, Gye Won; Kuhn, Peter; Rosen, Hugh; Stevens, Raymond C.			Crystal Structure of a Lipid G Protein-Coupled Receptor	SCIENCE			English	Article							LIGAND-BINDING POCKET; S1P(1); IDENTIFICATION; AGONIST; GPCR; RHODOPSIN; DISCOVERY; EDG1	The lyso-phospholipid sphingosine 1-phosphate modulates lymphocyte trafficking, endothelial development and integrity, heart rate, and vascular tone and maturation by activating G protein-coupled sphingosine 1-phosphate receptors. Here, we present the crystal structure of the sphingosine 1-phosphate receptor 1 fused to T4-lysozyme (S1P(1)-T4L) in complex with an antagonist sphingolipid mimic. Extracellular access to the binding pocket is occluded by the amino terminus and extracellular loops of the receptor. Access is gained by ligands entering laterally between helices I and VII within the transmembrane region of the receptor. This structure, along with mutagenesis, agonist structure-activity relationship data, and modeling, provides a detailed view of the molecular recognition and requirement for hydrophobic volume that activates S1P(1), resulting in the modulation of immune and stromal cell responses.	[Hanson, Michael A.; Roth, Christopher B.; Griffith, Mark T.; Scott, Fiona L.; Reinhart, Greg; Desale, Hans; Clemons, Bryan] Receptos, San Diego, CA 92121 USA; [Jo, Euijung; Cahalan, Stuart M.; Sanna, M. Germana; Rosen, Hugh] Scripps Res Inst, Dept Biol Chem, La Jolla, CA 92037 USA; [Schuerer, Stephan C.; Han, Gye Won; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Kuhn, Peter] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Rosen, Hugh] Scripps Res Inst, Mol Screening Ctr, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Hanson, MA (corresponding author), Receptos, 10835 Rd Cure,Suite 205, San Diego, CA 92121 USA.	mhanson@receptos.com; hrosen@scripps.edu; stevens@scripps.edu	Loveland, Thomas/AAW-3332-2020; Goetz, Scott J/A-3393-2015; Stevens, Raymond/K-7272-2015; Noojipady, Praveen/B-2511-2010; Hansen, Matthew C/ABE-7226-2020; Tyukavina, Alexandra/AGW-0785-2022; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022; potapov, peter/AAE-7388-2019; Han, Gye Won/GLQ-8673-2022	Goetz, Scott J/0000-0002-6326-4308; Stevens, Raymond/0000-0002-4522-8725; Han, Gye Won/0000-0003-4107-835X; Potapov, Peter/0000-0003-3977-0021; Jo, Euijung/0000-0003-1131-2723; Tyukavina, Alexandra/0000-0003-3872-9844	Protein Structure Initiative (PSI) [U54 GM094618]; NIH [P50 GM073197]; NIH Roadmap Molecular Libraries Probe Production Centers [U54 MH084512];  [AI074564];  [AI055509]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055509, U01AI074564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, P50GM073197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	Protein Structure Initiative (PSI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap Molecular Libraries Probe Production Centers; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the Protein Structure Initiative (PSI): Biology grant U54 GM094618 for structure production, NIH Roadmap grant P50 GM073197 for technology development, NIH Roadmap Molecular Libraries Probe Production Centers grant U54 MH084512 for antagonist and class II agonist identification, and AI074564 and AI055509 to H. R. and M. B. Oldstone for studying the role of S1P in infection and immunity. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences (NIGMS) or the NIH. We thank E. Chien for preliminary analysis; M. Mileni for critical evaluation of the structure; V. Cherezov, V. Katritch, and I. Wilson for careful review of the manuscript; J. Johnson, A. Leslie, W. Kabsch, and A. Perrakis for discussion and review of the experimental microdiffraction data assembly processing method; and A. Walker for assistance with manuscript preparation. We acknowledge J. Smith, R. Fischetti, and N. Sanishvili at the GM/CA-CAT beamline at the Advanced Photon Source, for assistance in development and use of the minibeam and beamtime. The GM/CA-CAT beamline (23-ID) is supported by the National Cancer Institute (Y1-CO-1020) and the NIGMS (Y1-GM-1104). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification code 3V2W and 3V3Y. R. C. S. is a founder and on the Board of Directors, and H. R. is a founder and on the Scientific Advisory Board, of Receptos, a GPCR structure-based drug discovery company with an S1P<INF>1</INF> clinical compound. H. R. is an inventor on a patent application by The Scripps Research Institute (TSRI) on CYM-5442 and related S1P receptor modulators (US2010/0010001). Materials will be made available under a Material Transfer Agreement with TSRI.	[Anonymous], 2011, GLID VERS 5 7; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Fujiwara Y, 2007, J BIOL CHEM, V282, P2374, DOI 10.1074/jbc.M609648200; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schrodinger LLC, 2011, PRIM VERS 3 0; Schurer SC, 2008, ACS CHEM BIOL, V3, P486, DOI 10.1021/cb800051m; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Suite S., 2011, 2011 IND FIT DOCK PR; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	35	6084	6344	174	611	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 17	2012	335	6070					851	855		10.1126/science.1215904	http://dx.doi.org/10.1126/science.1215904			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	893LC	22344443	Green Accepted			2022-12-24	WOS:000300356400043
